<SEC-DOCUMENT>0000950170-25-042017.txt : 20250319
<SEC-HEADER>0000950170-25-042017.hdr.sgml : 20250319
<ACCEPTANCE-DATETIME>20250319161617
ACCESSION NUMBER:		0000950170-25-042017
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		97
CONFORMED PERIOD OF REPORT:	20241231
FILED AS OF DATE:		20250319
DATE AS OF CHANGE:		20250319

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SERA PROGNOSTICS, INC.
		CENTRAL INDEX KEY:			0001534969
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				261911522
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40606
		FILM NUMBER:		25752956

	BUSINESS ADDRESS:	
		STREET 1:		2749 E. PARLEYS WAY
		STREET 2:		SUITE 200
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84109
		BUSINESS PHONE:		(801) 990-0520

	MAIL ADDRESS:	
		STREET 1:		2749 E. PARLEYS WAY
		STREET 2:		SUITE 200
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84109
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>sera-20241231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2025-03-19T15:38:33.2847+00:00 -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ecd-sub="http://xbrl.sec.gov/ecd-sub/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:sera="http://seraprognostics.com/20241231">
 <head>
  <title>10-K</title>
  <meta http-equiv="Content-Type" content="text/html"/>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_20540d76-2417-448e-8443-a4499e56e8da" name="dei:AmendmentFlag" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5">false </ix:nonNumeric><ix:nonNumeric id="F_26fa8a1d-30a2-4a04-9d85-96a76be3b10e" name="dei:DocumentFiscalPeriodFocus" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5">FY</ix:nonNumeric><ix:nonNumeric id="F_8f911407-2773-435d-a717-d82119880830" name="dei:EntityCentralIndexKey" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5">0001534969</ix:nonNumeric><ix:nonFraction id="F_8e83aa39-64c6-422c-87be-b01e50d376c8" name="us-gaap:CommitmentsAndContingencies" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_acf9886f-1dd5-4da5-9964-486ff2df08a0" name="us-gaap:CommitmentsAndContingencies" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonNumeric id="F_78f058f5-e77e-4f42-8f14-9e5f77a00420" name="us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5">http://fasb.org/srt/2024#ChiefExecutiveOfficerMember</ix:nonNumeric><ix:nonNumeric id="F_0f18ae55-e115-46af-9133-2a37b7dbec78" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16">http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric id="F_499cda77-bfd5-40a5-a5fa-38b8c2a78467" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229">http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric id="F_b631bde4-1e5a-491c-8bd3-1cb6b5c51baa" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16">http://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</ix:nonNumeric><ix:nonNumeric id="F_72a4c378-6838-4602-82e9-f25639674292" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229">http://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</ix:nonNumeric><ix:nonNumeric id="F_556e664f-e809-4c83-9e64-ccae8a1500b7" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16">http://fasb.org/us-gaap/2024#AccruedLiabilitiesAndOtherLiabilities</ix:nonNumeric><ix:nonNumeric id="F_e1166b60-a008-49df-82fa-558051a272f2" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229">http://fasb.org/us-gaap/2024#AccruedLiabilitiesAndOtherLiabilities</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="sera-20241231.xsd"/></ix:references><ix:resources><xbrli:context id="C_809b9d4c-c63e-4d53-8e85-6d4684e3609d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sera:Plan2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_81d045e5-217b-44a8-91f1-c06381b7f02f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_82b9b7fb-68e4-45aa-8dc3-daea6ea244e1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_82cc2c89-a0ca-4534-9da0-23ce655262eb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-02-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_84137556-2fb3-4bc3-987b-4443923c3d54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_841fc982-9aa4-444b-812e-b8d2f53536de"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8442a0e1-b203-45a1-bf13-205667c7fbae"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt1238SharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_849392ea-c9bb-46ce-b852-5562b8505f07"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_84c625f9-260e-4db9-b7ab-0dd11718650f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sera:CommercialCollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sera:ElevanceHealthIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8510e741-314c-421f-9b15-649e0930202c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sera:Plan2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_85982594-37df-45db-b0b5-a89d1853eece"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8620e36e-b199-4b2d-8cc2-4ba15f93a3c0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8c0b2f25-3d73-42db-83a0-927dc46b55f2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8c97b2f6-6bfd-442f-8d5f-fae8ac4320ac"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8cc8bb60-d9e5-4087-a779-404d0c630ac2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8dc4e1a7-bd95-4cb8-aa85-12c3382baabd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_91155194-5f56-4b2a-aafc-4c8a052b5661"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_953152ac-0b0e-4a0d-8ab5-c817f16e31e7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_958742c3-77d5-4074-ba9f-54937420e759"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sera:DefinedContributionPlanEmployerMatchingContributionMatchingTierAxis">sera:DefinedContributionPlanEmployerMatchingContributionSecondTierMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_978306e0-1a64-43db-891b-ab7f3d2e279c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_987117f3-a2cb-4114-ba3b-abb5e5ee31bf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt520SharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_993c8440-8e32-404e-a58d-36ed574ab4c3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9992b3c4-e005-45ff-a893-0307d53ac290"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9ec8a49d-6940-415c-bf39-e752664f6f55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a0cb604e-1c55-4ed9-a4a7-e778eada5e8d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a1e8075a-0b21-49e0-992e-366ff149e4be"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:NonCurrentMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a1fba1e9-19c8-4131-8870-80ec56eace4a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sera:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a3cd6426-e326-48ef-a767-d68bae526b8f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a3f22057-cfb4-4d74-a910-d271c95221d1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a4a98f25-89ec-4c7d-be42-82aacc24e38e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-13</xbrli:startDate><xbrli:endDate>2025-02-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a5ccbc75-c805-4d9b-b60c-5763efe0a38b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sera:MasterServicesAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sera:CarelonResearchMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a77c3867-9623-4313-a505-f21cd62befe2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-01</xbrli:startDate><xbrli:endDate>2025-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a9e61099-b6f3-486b-b333-a0f9e6559dc9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_aa504e3e-c144-468e-9c38-a006e10b950c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ac36fee8-490e-4504-a78e-09b7ddd118aa"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sera:LaboratoryServicesAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sera:ElevanceHealthIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_acdfb23b-77fd-4983-9ece-002da2eb742e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ae2c36a5-c404-4f89-b850-51f7ae29526d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_aef51065-45c9-4f35-8eb3-5f34b000ac42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_afe93441-ddca-40ee-9cbe-6bed962e175a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b020dd07-c5cb-461b-9677-a054282faf68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sera:AtTheMarketOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sera:TwoThousandTwentyFourSalesAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sera:TdCowenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-08-01</xbrli:startDate><xbrli:endDate>2024-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b105c69c-9306-46d2-b61c-acf709b3eb96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:NonCurrentMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b1d570cd-e3f2-4acc-ab96-99d8ef06cb44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt1238SharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b2ca6d62-c8a1-49ad-b68e-21f1e5f6bb63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt520SharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b3f42472-6a24-481b-929b-311bab556a79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b55ca18f-71fd-40e9-91aa-6ca09f99f3fd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt9.03SharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b56db086-392f-4885-98c2-c27491c047ea"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-02-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b7b69a92-c42e-4043-8b6b-6e1b509663d8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-08-01</xbrli:startDate><xbrli:endDate>2024-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b7e93a2d-70e5-4c3d-a5e8-2305fb8f5a8b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b91d11ff-c343-4366-83fa-e644ceaf19e4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ba06682c-931b-4d72-8219-fe9762cb8c51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_bb275bcf-b99b-45c0-b9f6-74f2cafd0a81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_bbe124b6-5e26-4340-9b7f-2ec3e167c7a7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_bc82f716-4cb8-4ed6-9807-7a362747d97c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_bd4804da-dfef-46a4-bf86-8a1aff8a5a72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_bee59d28-e5cc-40c9-a976-6776fef6babc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt9.03SharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c0c33cde-1b31-4d14-83be-384eb68acebe"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c1db559f-42af-47ed-b6d7-b2aa626db456"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c35d80b0-e824-4576-b648-1c68918bb474"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c65254c7-ac81-4069-a809-c971b11aa622"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c6567a19-3bfb-4b14-8ef7-62764c3fa312"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">sera:CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c6d246ba-4eb3-4ae3-9dc3-001abd64e5cc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">sera:WarrantsToPurchaseCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c8b03d4a-856b-4b56-989b-21dbe3a3d5e4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c8c170a9-1f93-4318-a2c3-b52ae62d57d1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sera:PlanEspp2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c9f1b32e-78dd-4176-9085-97902cd1f5c8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ca338088-ae30-4c78-a94a-8fc204241aa6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_caa15026-25b9-4c02-9ea0-d4206fb85094"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_caf15085-5fb3-478e-a2a5-829cc0c348a7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cb3ea4ea-93f7-4d45-b83e-1681dda66e30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cca6413f-9960-434b-8f2f-706f727e0013"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ce3c3c85-8edf-485c-a7db-c348c7b6135c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d345d9ff-4db5-4fb9-821b-1c04eafbe0f2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d619847f-a838-4f86-a29f-cd037355836b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d64a0010-f1a5-45de-9e6c-65d4f9fdd0dd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-02-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d8ac3adc-d2c5-4821-b662-56b9921fc31c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sera:AtTheMarketOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sera:TwoThousandTwentyFourSalesAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sera:TdCowenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_dac51163-3c66-43ba-8012-e6571ccfbd56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_db7a6971-25dd-4ecb-8f48-615fa9b2e446"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_dbdf5e62-5392-4d8b-9ae4-125c21ee2824"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_dcf610fd-ad27-414d-89a5-21a6bd40cf69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_de5e20fe-662d-4df6-87a3-c106313ed801"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_df26b36a-abf1-4ee8-92c3-99bf73fea9e8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_df96dede-3972-4662-bb40-d24aff923983"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt10.84SharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e26ec1fe-0438-4812-b032-9b354ebc1852"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e47cfbc9-cd42-436b-8a5a-31f13439a6df"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e5d8bf32-01c3-478c-ac80-62dc4611786f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e79b8c0c-c0db-4a39-81c4-3583a483beb6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sera:Plan2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e8115fc4-0d0a-4b48-968a-84b5f89677cc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:NonCurrentMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ea61173b-bc9e-42d8-8fbb-5139f085543f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt10.84SharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_eac6e522-39b5-4d4e-9e0f-de03dd6c55f5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_eb565e2c-bfbf-4eb0-a9c0-cbb1dcb06aca"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ecdd66a3-70fa-4c7e-a8c2-b633e3ee94ea"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ecfa7a3b-6a0d-49ef-9b51-2fcd10725943"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ee684bec-2a33-4dd4-bdbb-02595b796850"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:NonCurrentMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f2bfc23e-e300-4c03-89d2-d8604b93c026"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f375d679-1976-474c-901f-6de9f5d1164a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">sera:WarrantsToPurchaseCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f3b8da5f-d721-4ba9-9244-5fd80bad0881"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f4fd4321-eb36-4c63-ab4e-5f27e634d46d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-12</xbrli:startDate><xbrli:endDate>2025-02-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f644480d-0cbe-48d3-a1e8-381afc09c8c6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f652abc9-1d38-472f-bc10-183e164a2e16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f78c9a8e-0786-4b1b-bdc3-6e22b3d933f8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f91bfb70-0a79-432d-a466-f33c51ec490d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f96481c1-18cb-423a-941d-d5f0e9523ae3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fa1f5377-96a0-459c-99fd-200157552294"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">sera:WarrantsToPurchaseCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fad988d1-5034-478c-8516-20f5782f4f85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fbe5cd8d-06e5-47a6-a5f5-846c4699e03a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fff4f4f8-fdc0-4e2f-8c2d-857db712f284"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:NonCurrentMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_02e513ef-eb63-431b-a54e-7db176d6f3b0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_04695d1b-8064-4772-b23e-9ee08052db28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_05252941-47eb-419d-ad91-9a0440a3d146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_05256ced-5cef-411f-a2d3-9a1cd711dc5a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_060bbe9a-71b5-4045-95d0-1ffa4cf95206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_08aeb0e4-961e-4e83-9bf3-97b2ea84cd08"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_09f10352-d759-4530-8098-b6299171a509"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0a1a9334-cc92-43d9-b390-4fce8c10c525"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sera:CommercialCollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sera:ElevanceHealthIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0a27554e-ce58-4e26-90cb-8b0b7c2027a4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0d3d312a-a883-406f-a482-b3aab18bb031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_12580e9a-ae3c-43b5-bd47-c7e4bcb0df5e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_13d531e2-fd1b-4238-a5d7-2fd7b67c5076"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">sera:CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_161991af-bae7-4347-80d9-c0890d8f55a6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sera:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1660a0e7-df13-4027-9e38-15f6ddf11b0a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">sera:CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_170c4dc3-4c1f-4587-ac98-abecb38c3bcc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_179d008a-1bc2-40a6-ac89-86e6010d037c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_187fc49c-d6d6-4802-9f01-b957d0bc88c4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1897da0a-32c6-4bd9-ab52-d7b11d48dbc4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_18bf2f02-7c59-4b81-af8a-e4dee36352a3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1928429d-8377-45e6-a6ab-694d0e5a190a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1a18dcc9-5298-4f3a-9d2a-ee711ea1c709"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1ae1e03b-7d7a-4b1a-b6fb-a10eb7afe2e2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1ae32300-4e33-4c46-af0e-181100bd03ab"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1c9fd511-344f-4ec1-9e7e-971dfed29d81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1d2ae6de-1a53-435d-93ea-e493cb1853b9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1e202fd9-3575-429f-acb1-9d054feb99d5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1e828831-28e3-4d62-916b-97cfb64c3c0f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1ea882d4-0679-4c9f-9dff-1ef9e04dcf6b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1faeebd3-23ce-493d-af5a-c79bb9e92d83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sera:Plan2011Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-01</xbrli:startDate><xbrli:endDate>2021-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_208b76c5-59c1-4209-a49b-266bd3873544"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">sera:OtherOfficersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_20e6caf7-a789-4725-a954-593c6c8d5ceb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202307Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_23ca8b3a-fc86-4de2-84db-b4ac53b0b0a2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_275f65a9-d875-4114-9eef-facc7efca0e4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_28f64bcb-45ac-4b38-ac92-aba2705b7334"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_34623022-fd17-429b-802b-fd3f934c6118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_36d0dab8-25a4-4445-bd06-e502a277df24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sera:OfficeAndLaboratorySpaceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3759c1ab-699f-41b4-a2c6-1a2c4e3d2044"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3823e7c9-9de3-4740-a0b6-1918db41ffaa"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3879982c-10a3-45e6-8f45-744fccd1614e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3b6bd3f1-4ef1-4f65-afbc-9caec8647ffa"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4066f0e7-4d45-4120-9721-5f25ca3c40f2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sera:DefinedContributionPlanEmployerMatchingContributionMatchingTierAxis">sera:DefinedContributionPlanEmployerMatchingContributionFirstTierMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_41343767-6b2c-42a9-a746-3a9c961b2efb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_428b350f-b950-4c70-b038-a16d2e148ef6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_43042710-b071-477a-ab25-8b8bacc949b5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_44bf1f0c-7e45-4ddb-a68d-b3794ce96d49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_44f85d7b-18dc-4a86-bed7-b1560a6fe25f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt20.77SharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4604871b-61c7-42a4-83ac-1df44766218b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_472b27ba-d433-4ec0-97d1-4934923032a3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_49022522-db49-4ec2-87f5-e2146f11c06f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4902770f-8a0e-430e-93da-63b3fc8fb693"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_49e34717-cb5a-4860-9e99-7bca256906a4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-02-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4a4b0457-af40-4380-abc2-adf8d6e99ae1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4b80e6fd-7982-44e8-a550-11ab6d1ec368"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4c8e016f-98b6-437d-bf3b-2afd8d1a2252"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4d86a42a-d0b5-4b77-9427-1f77696fdc95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5a27522b-3fd7-4775-b4b1-c07ac5059bc8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sera:MasterServicesAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sera:CarelonResearchMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5c263358-4220-4048-b609-a9b779332d4c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5daf51f1-d84a-4a9b-8b05-31cbd8535172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5e807c43-ac3c-4c9f-8c9f-aa73f1509b36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:NonCurrentMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5f4da6b1-9c8a-4b7e-8a90-5d3ea9ae78a1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_638a878b-120b-4eee-b75c-90162633cf80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_645b404b-8bbd-4848-a0d4-aeaf0829da3f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_66868af1-9b8d-4e30-a6a8-7b403eee8c4e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_67bb9b90-53de-4dc1-9ea3-fca6651bdf57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">sera:DomainNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6926825c-e381-4fc0-8ca5-c547d26c00af"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:NonCurrentMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6a5f0bd4-0f79-4071-ac0b-e3d379500212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sera:Plan2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6b649540-a349-4de7-a667-163e2396f87b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6df1f8d2-5436-460d-9378-2e480850c840"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">sera:WarrantsToPurchaseCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6e3121ea-3b26-4fbf-a9e4-ba6bb516cb52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt20.77SharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_700f906f-1edc-4815-8c6f-063af0170797"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_710fd514-29df-4675-8ad6-a812b659c2ba"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_72fc74dc-bc8c-4dc3-9e53-0a0e671982ea"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">sera:CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7330604e-585d-4c2f-b88a-fa3bec9d68eb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_743227ba-f29d-4c56-aaf6-1d4fe3a4d79e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_762a6bec-dfb1-4943-9527-797ae4764d93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:NonCurrentMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_79fad083-6839-4292-87a4-80611ccece36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7c6f287f-0cf6-4dfb-9a02-3a6ce54488cd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7e2de8e1-9b90-401b-b5d2-78a35f931945"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="U_pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="U_UnitedStatesOfAmericaDollarsShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="U_sqft"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit><xbrli:unit id="U_shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="U_CommonStockClass"><xbrli:measure>sera:CommonStockClass</xbrli:measure></xbrli:unit><xbrli:unit id="U_Vote"><xbrli:measure>sera:Vote</xbrli:measure></xbrli:unit><xbrli:unit id="U_USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="U_Segment"><xbrli:measure>sera:Segment</xbrli:measure></xbrli:unit><ix:relationship linkRole="http://www.xbrl.org/2003/role/link" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="FNT_2dcb3b77-9a24-48d2-af9f-a1d39507d595" fromRefs="F_f9c4a6fc-3bec-484b-b399-d505aff6f469 F_caaf99d2-d8a8-431a-b018-f19a87936092"/><ix:relationship linkRole="http://www.xbrl.org/2003/role/link" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="FNT_a7b0fa6b-e70a-4d12-b747-675c650fdd97" fromRefs="F_9dfc5991-3acf-4daa-9315-2bf66f7f4e40 F_5ac347dd-685a-4ec6-af84-254528d32312"/></ix:resources></ix:header></div>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="z-index:-3;min-height:0.75in;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:2.25pt double;text-align:left;"><span style="white-space:pre-wrap;font-size:2pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:2pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">UNITED STATES</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SECURITIES AND EXCHANGE COMMISSION</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">WASHINGTON, DC 20549</span></p>
  <p style="margin-left:40%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:40%;text-align:center;"><span style="white-space:pre-wrap;font-size:4pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:40%;text-align:center;"><span style="white-space:pre-wrap;font-size:4pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:14pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FORM </span><span style="font-size:14pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1b124054-d698-433a-bb21-4ba5e87f4630" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="dei:DocumentType"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:14pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10-K</span></ix:nonNumeric></span></p>
  <p style="margin-left:40%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:40%;text-align:center;"><span style="white-space:pre-wrap;font-size:4pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:40%;text-align:center;"><span style="white-space:pre-wrap;font-size:4pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Mark One)</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:4.1%;box-sizing:content-box;"/>
    <td style="width:95.9%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:7pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.04in;vertical-align:top;padding-bottom:0in;padding-right:0.04in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="font-size:7.5pt;font-family:'Wingdings',serif;"><ix:nonNumeric id="F_35f25447-a0c2-4084-96c8-bf1db37ea299" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="dei:DocumentAnnualReport" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">x</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;padding-left:0.04in;vertical-align:top;padding-bottom:0in;padding-right:0.04in;"><p style="font-size:7.5pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the fiscal year ended </span><span style="font-size:7.5pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2dd1f789-9ad1-4c80-bb2e-e5bca6663881" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en"><span style="font-size:7.5pt;font-family:Times New Roman;"><ix:nonNumeric id="F_92b69695-4b87-41cf-a73c-3558a732a74d" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="font-size:7.5pt;font-family:Times New Roman;"><ix:nonNumeric id="F_38d4a575-c0a2-4c7c-b61b-c8fe288a6029" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="dei:DocumentFiscalYearFocus"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2024</span></ix:nonNumeric></span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">OR</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:4.1%;box-sizing:content-box;"/>
    <td style="width:95.9%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:7pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.04in;vertical-align:top;padding-bottom:0in;padding-right:0.04in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="font-size:7.5pt;"><ix:nonNumeric id="F_98673e51-40a3-4d58-8a46-a6f738faa412" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;padding-left:0.04in;vertical-align:top;padding-bottom:0in;padding-right:0.04in;"><p style="font-size:7.5pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Commission File Number: </span><span style="font-size:7.5pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b9f323f6-49ab-4565-a2da-c4ab47660f01" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="dei:EntityFileNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">001-40606</span></ix:nonNumeric></span></p>
  <p style="margin-left:40%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:40%;text-align:center;"><span style="white-space:pre-wrap;font-size:4pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:40%;text-align:center;"><span style="white-space:pre-wrap;font-size:4pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:14pt;font-family:Times New Roman;"><ix:nonNumeric id="F_fcb5d6d4-c1b0-4c58-afed-d6743af28f1f" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="dei:EntityRegistrantName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:14pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SERA PROGNOSTICS, INC.</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Exact Name of Registrant as Specified in its Charter)</span></p>
  <p style="margin-left:40%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:40%;text-align:center;"><span style="white-space:pre-wrap;font-size:4pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:40%;text-align:center;"><span style="white-space:pre-wrap;font-size:4pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:48.93%;box-sizing:content-box;"/>
    <td style="width:2.14%;box-sizing:content-box;"/>
    <td style="width:48.93%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:7pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:7.5pt;"><ix:nonNumeric id="F_10fd54cd-86f5-4988-ab5c-fed0d01dd476" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:7.5pt;"><ix:nonNumeric id="F_815ae5f1-6b0a-4a4e-b4c3-17bb8201c72f" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="dei:EntityTaxIdentificationNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">26-1911522</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:7.5pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(State or other jurisdiction of</span></p><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">incorporation or organization)</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:7.5pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(I.R.S. Employer</span></p><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Identification No.)</span></p></td>
   </tr>
   <tr style="height:7pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="font-size:7.5pt;"><ix:nonNumeric id="F_2dbf3e1c-6ad0-4103-a636-06a7e7023d4c" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="dei:EntityAddressAddressLine1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2749 East Parleys Way</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-kerning:none;min-width:fit-content;">,</span><span style="font-size:7.5pt;"><ix:nonNumeric id="F_0b70c593-2cf5-4f28-b57b-39ad7a42018c" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="dei:EntityAddressAddressLine2"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> Suite 200</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="font-size:7.5pt;"><ix:nonNumeric id="F_5747d6ba-f673-4277-b442-3c285296f60c" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="dei:EntityAddressCityOrTown"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Salt Lake City</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-kerning:none;min-width:fit-content;">, </span><span style="font-size:7.5pt;"><ix:nonNumeric id="F_c2570b19-d17f-4129-870e-5b52cb64bab0" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Utah</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="font-size:7.5pt;"><ix:nonNumeric id="F_2972d1ec-fbea-4ba8-b827-a76e03020207" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="dei:EntityAddressPostalZipCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">84109</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:7.5pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Address of principal executive offices)</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:7.5pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Zip Code)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Registrant&#8217;s telephone number, including area code: (</span><span style="font-size:7.5pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f2f2953c-8675-4042-8a03-f9b3ccc4e757" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="dei:CityAreaCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">801</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) </span><span style="font-size:7.5pt;font-family:Times New Roman;"><ix:nonNumeric id="F_dab6fefd-8b56-44ba-80be-4e56019af833" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="dei:LocalPhoneNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">990-0520</span></ix:nonNumeric></span></p>
  <p style="margin-left:40%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:40%;text-align:center;"><span style="white-space:pre-wrap;font-size:4pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:40%;text-align:center;"><span style="white-space:pre-wrap;font-size:4pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:3pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:40%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:18%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:40%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:7pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.75pt solid #000000;padding-right:0.037in;"><p style="font-size:7.5pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Title of each class</span></p></td>
    <td style="padding-top:0in;padding-left:0.021in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.75pt solid #ffffff03;padding-right:0.021in;"><p style="font-size:7.5pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.75pt solid #000000;padding-right:0.037in;"><p style="font-size:7.5pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Trading Symbol(s)</span></p></td>
    <td style="padding-top:0in;padding-left:0.021in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.75pt solid #ffffff03;padding-right:0.021in;"><p style="font-size:7.5pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.75pt solid #000000;padding-right:0.037in;"><p style="font-size:7.5pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Name of each exchange on which registered</span></p></td>
   </tr>
   <tr style="height:7pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:10pt;margin-top:2.5pt;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="font-size:7.5pt;"><ix:nonNumeric id="F_4213036d-3a5f-4215-a318-c55c7529f48b" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="dei:Security12bTitle"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Class A Common Stock, $0.0001 par value per share</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:10pt;margin-top:2.5pt;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="font-size:7.5pt;"><ix:nonNumeric id="F_7cb445c6-a907-417f-bdd4-52b5caf743ee" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="dei:TradingSymbol"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">SERA</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:10pt;margin-top:2.5pt;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="font-size:7.5pt;"><ix:nonNumeric id="F_69451bb4-a01d-4a6e-8a58-6f756dad90e3" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">The Nasdaq Stock Market LLC</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes &#9744; </span><span style="font-size:7.5pt;font-family:Times New Roman;"><ix:nonNumeric id="F_78934355-e031-464a-8d73-027c51643fd5" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="dei:EntityWellKnownSeasonedIssuer"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> &#9746;</span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes &#9744; </span><span style="font-size:7.5pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d5a66e34-f456-45f2-96d1-d327dd69ca60" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="dei:EntityVoluntaryFilers"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> &#9746;</span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. </span><span style="font-size:7.5pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2b4a694b-f3dc-4cd2-9404-4fbdcbfbc8fd" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="dei:EntityCurrentReportingStatus"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Yes</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> &#9746; No &#9744;</span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). </span><span style="font-size:7.5pt;font-family:Times New Roman;"><ix:nonNumeric id="F_fb97d482-3204-4f81-a5d8-c6b8a7c8c245" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="dei:EntityInteractiveDataCurrent"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Yes</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> &#9746; No &#9744;</span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:3pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:45.9%;box-sizing:content-box;"/>
    <td style="width:4.1%;box-sizing:content-box;"/>
    <td style="width:45.9%;box-sizing:content-box;"/>
    <td style="width:4.1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:7pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Large accelerated filer</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accelerated filer</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</span></p></td>
   </tr>
   <tr style="height:7pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:7.5pt;"><ix:nonNumeric id="F_3e9e63a6-b61a-4f87-a28c-4a0bf4336af2" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Non-accelerated filer</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9746;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Smaller reporting company</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:7.5pt;"><ix:nonNumeric id="F_baeae65a-ad30-436b-afad-f738fd76e4c3" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Emerging growth company</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:7.5pt;"><ix:nonNumeric id="F_a3cb1b09-f088-492a-8778-9e437fda0f8b" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-size:7.5pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3fef36e6-bb93-48b8-92d1-96448c733b1c" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="dei:EntityExTransitionPeriod" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. </span><span style="font-size:7.5pt;font-family:Times New Roman;"><ix:nonNumeric id="F_16e86883-361d-40f6-844c-d0dad58aca26" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="dei:IcfrAuditorAttestationFlag" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. </span><span style="font-size:7.5pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a765e5c2-c136-44a9-9b86-fc8810705cd9" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="dei:DocumentFinStmtErrorCorrectionFlag" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b). &#9744;</span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes &#9744; No </span><span style="font-size:7.5pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7adef727-1057-443b-8d48-46401a28b537" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="dei:EntityShellCompany" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The aggregate market value of the registrant&#8217;s Class A common stock held by non-affiliates of the registrant, computed by reference to the closing price as reported on the Nasdaq Stock Exchange on June 28, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the last business day of the registrant&#8217;s most recently completed second fiscal quarter, was approximately $</span><span style="font-size:7.5pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b1d958e2-b49a-4701-9092-bb64ba88cba0" contextRef="C_953152ac-0b0e-4a0d-8ab5-c817f16e31e7" name="dei:EntityPublicFloat" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">183.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">million. As of March 14, 2025, the registrant had </span><span style="font-size:7.5pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b7d6b8e6-c3b3-4699-b4f1-3be98f60d08c" contextRef="C_afe93441-ddca-40ee-9cbe-6bed962e175a" name="dei:EntityCommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">36,695,803</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="font-size:7.5pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c2b71523-6131-4432-923c-7da94d00b548" contextRef="C_de5e20fe-662d-4df6-87a3-c106313ed801" name="dei:EntityCommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">967,759</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Class A and B common stock, $0.0001 par value per share, outstanding, respectively.</span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">DOCUMENTS INCORPORATED BY REFERENCE</span></p>
  <div style="font-size:7.5pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a604322c-3ddd-431e-80a2-40b51ca729dd" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="dei:DocumentsIncorporatedByReferenceTextBlock" escape="true"><p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:3pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Portions of the registrant&#8217;s definitive proxy statement relating to its </span><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2025 annual meeting of stockholders (the &#8220;Proxy Statement&#8221;) are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated. The Proxy Statement will be filed with the Securities and Exchange Commission within 120 days after the end of the registrant&#8217;s fiscal year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p></ix:nonNumeric></div>
  <p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:2.25pt double;text-align:left;"><span style="white-space:pre-wrap;font-size:2pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.75in;justify-content:flex-end;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="z-index:-3;min-height:0.75in;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="toc_page"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TABL</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">E OF CONTENTS</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:11.22%;box-sizing:content-box;"/>
    <td style="width:82.88%;box-sizing:content-box;"/>
    <td style="width:5.9%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;text-indent:2.75pt;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="margin-left:2.75pt;text-indent:0;font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Page</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#special_note_regarding"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Special Note Regarding Forward-Looking Statements</span></a></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><a href="#part_i"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">PART I</span></a></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_1_business"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Item 1.</span></a></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_1_business"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Business</span></a></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_1a_risk_factors"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Item 1A.</span></a></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_1a_risk_factors"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Risk Factors</span><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></a></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">42</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item1b_unresolved_staff_comments"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Item 1B.</span></a></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item1b_unresolved_staff_comments"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Unresolved Staff Comments</span><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></a></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">85</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_1c_cybersecurity"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Item 1C.</span></a></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_1c_cybersecurity"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Cybersecurity</span></a></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">85</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_2_properties"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Item 2.</span></a></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_2_properties"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Properties</span></a></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">86</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_3_legal_proceedings"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Item 3.</span></a></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_3_legal_proceedings"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Legal Proceedings</span></a></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">86</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_4_mine_safety_disclosures"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Item 4.</span></a></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_4_mine_safety_disclosures"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Mine Safety Disclosures</span><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></a></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">86</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><a href="#part_ii"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">PART II</span></a></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_5_market_for_registrant"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Item 5.</span></a></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_5_market_for_registrant"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></a></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">87</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_6_reserved"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Item 6.</span></a></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_6_reserved"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">[ Reserved ]</span></a></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">87</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_7_management_discussion"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Item 7.</span></a></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_7_management_discussion"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></a></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">88</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_7a_quantitative_and_qualitative"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Item 7A.</span></a></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_7a_quantitative_and_qualitative"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Quantitative and Qualitative Disclosures About Market Risk</span><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></a></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">97</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_8_financial_statements"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Item 8.</span></a></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_8_financial_statements"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Financial Statements and Supplementary Data</span><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></a></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">98</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_9_changes_in_and_disagreements"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Item 9.</span></a></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_9_changes_in_and_disagreements"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Changes in and Disagreements With Accountants on Accounting and Financial Disclosure</span></a></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">124</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_9a_controls_and_procedures"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Item 9A.</span></a></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_9a_controls_and_procedures"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Controls and Procedures</span><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></a></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">124</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_9b_other_information"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Item 9B.</span></a></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_9b_other_information"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Other Information</span></a></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">124</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_9c_disclosure_regarding"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Item 9C.</span></a></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_9c_disclosure_regarding"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Disclosure Regarding Foreign Jurisdiction that Prevent Inspections</span></a></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">125</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><a href="#part_iii"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">PART III</span></a></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_10_directors_executive_officers"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Item 10.</span></a></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_10_directors_executive_officers"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Directors, Executive Officers and Corporate Governance</span><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></a></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">126</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_11_executive_compensation"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Item 11.</span></a></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_11_executive_compensation"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Executive Compensation</span><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></a></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">126</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_12_security_ownership_of_certain"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Item 12.</span></a></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_12_security_ownership_of_certain"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></a></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">126</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_13_certain_relationships_and"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Item 13.</span></a></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_13_certain_relationships_and"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Certain Relationships and Related Transactions, and Director Independence</span></a></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">126</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_14_principal_accounting"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Item 14.</span><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></a></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_14_principal_accounting"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Principal Accounting Fees and Services</span><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></a></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">126</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><a href="#part_iv"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">PART IV</span></a></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_15_exhibit_and_financial"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Item 15.</span></a></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_15_exhibit_and_financial"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Exhibits and Financial Statement Schedules</span><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></a></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">127</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_16_form_10_k_summary"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Item 16.</span></a></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_16_form_10_k_summary"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form 10-K Summary</span><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></a></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">129</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#signatures"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Signatures</span></a></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:center;"><p style="font-size:10pt;margin-top:3.75pt;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">130</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;Sera,&#8221; &#8220;PreTRM,&#8221; &#8220;The Pregnancy Company&#8221; and our logo are our trademarks. All other service marks, trademarks, and trade names appearing in this Annual Report on Form 10-K for the fiscal year ended December 31, 2024, or the Annual Report, are the property of their respective owners. We do not intend our use or display of other companies&#8217; trade names, trademarks, or service marks to imply a relationship with, or endorsement or sponsorship of us by, these other companies. Solely for convenience, trademarks and tradenames referred to in this Annual Report may appear without the &#174; or &#153; symbols, but such references are not intended to indicate in any way that we will not assert, to the fullest extent under applicable law, our rights, or that the applicable owner will not assert its rights, to these trademarks and tradenames. Unless the context otherwise requires, we use the terms &#8220;Sera,&#8221; &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;our&#8221; in this Annual Report to refer to Sera Prognostics, Inc.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="special_note_regarding"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SPECIAL NOTE REGARDING F</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ORWARD-LOOKING STATEMENTS</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This discussion contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. In some cases, you can identify forward-looking statements by words such as &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;contemplate,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;plan,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;seek,&#8221; &#8220;should,&#8221; &#8220;target,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; or the negative of these words or other comparable terminology. These forward-looking statements include, but are not limited to, statements about:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">estimates of our addressable market, market growth, future revenue, key performance indicators, expenses, capital requirements, and our needs for additional financing;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our expectations regarding the rate and degree of market acceptance of our products and services, including our PreTRM test;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the impact of our PreTRM test, including the results of any studies of the test, on the field of bioinformatics and proteomics and the size and growth of the addressable bioinformatics and proteomics market;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our expectations regarding the future use of our PreTRM test based on the PRIME study results and that the PreTRM test has the potential to address a significant unmet need;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to obtain funding for our operations;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to manage and grow our business and commercialize our PreTRM test;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to develop and commercialize new products and services;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to retain the continued service of our key professionals and to identify, hire, and retain additional qualified professionals;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the pricing and reimbursement of our products and services, including new CPT codes and their payment rates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the implementation of our business model, strategic plans for our business, products, services, and technology;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the scope of protection we are able to establish and maintain for intellectual property rights covering our product candidates and technology;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">regulatory developments in the United States and foreign countries, including changes in U.S. Food and Drug Administration regulation of laboratory-developed tests;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">developments relating to our competitors and our industry;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the accuracy of our estimates regarding expenses, capital requirements, and needs for additional financing;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the expected impact of global business, political, and macroeconomic conditions, including inflation, fluctuations in interest rates, and volatile market conditions, uncertainty with respect to the federal budget and debt ceiling and potential government shutdowns related thereto, cybersecurity events, instability in the global banking system, and global events, including regional conflicts around the world, on our business, clinical trials, financial condition, liquidity, and results of operations; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our financial performance.</span></div></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These forward-looking statements are subject to a number of risks, uncertainties, and assumptions, including those described in the &#8220;Risk Factors&#8221; section and elsewhere in this Annual Report. Moreover, we operate in a very competitive and rapidly changing environment, and new risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties, and assumptions, the forward-looking events and circumstances discussed in this Annual Report may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in the forward-looking statements are reasonable as of the date of this Annual Report, we cannot guarantee that the future results, levels of activity, performance or events and circumstances reflected in the forward-looking statements will be achieved or occur. We undertake no obligation to update publicly any forward-looking statements for any reason after the date of this Annual Report to conform these statements to new information, actual results or to changes in our expectations, except as required by law.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="part_i"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">P</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ART I</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_1_business"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Ite</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">m 1. Business</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Overview</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are a women&#8217;s health company utilizing our proprietary proteomics and bioinformatics platform, and significant data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. Our vision is to deliver pivotal and actionable information to pregnant women, their physicians, and health care payers to significantly enhance a mother&#8217;s pregnancy journey, improve maternal and neonatal health, and reduce health care costs. We believe that our method of combining the disciplines of proteomics and bioinformatics with rigorous clinical testing, data, and economic analysis enables us to provide physicians and expectant mothers with personally insightful, clinically meaningful, and economically impactful information designed to improve the pregnancy experience and outcomes for mothers and babies.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There are approximately 140 million births globally each year, and approximately 3.7 million births annually in the United States. Of these, it is estimated that as many as 30% are affected by various complications (</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">i.e.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, a high-risk pregnancy), including: preterm birth, preeclampsia, fetal growth restriction, stillbirth, hypertension of pregnancy, gestational diabetes, and others. In many cases these complications have profound short- and long-term health consequences for the mother and baby. These health consequences of preterm birth alone are estimated to be approximately $25 billion annually in the United States. This underscores that existing methods to predict adverse pregnancy outcomes are insufficient for timely and effective proactive management for the vast majority of high-risk pregnancies. We believe that positive patient outcomes are the result of appropriate care, and the primary differentiator of patient care should be based on a determination of risk informed by a number of factors including our novel diagnostic tests.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have built an advanced, proprietary, and scalable proteomics and bioinformatics platform to characterize the biology of pregnancy and to discover and validate key protein biomarkers found in blood that are highly accurate predictors of dynamic changes that occur during pregnancy. By incorporating our proprietary technology platform into our rigorous data-driven development process, we have created a differentiated approach for effectively addressing major milestones, conditions, and features of pregnancy. We believe our large and growing pregnancy dataset (clinical, demographic, and proteomic) is a substantial asset for understanding pregnancy complications, health inequities, and the personal pregnancy journey. We envision that our comprehensive approach will enable us to fully characterize one of the most important periods in the lives of women and their babies, and will help to improve the well-being of each.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our first commercial product, the PreTRM test, is the only broadly validated, commercially available blood-based biomarker test to accurately predict the risk of a premature delivery, also known as preterm birth. The PreTRM test is a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation that provides an accurate prediction of the expectant mother&#8217;s risk of delivering spontaneously before 37 weeks&#8217; gestation. Our commercialization strategy focuses on demonstrating the health and economic benefits of early and accurate detection of preterm birth risk coupled with well-recognized interventions in higher risk patients, illustrating these benefits to healthcare providers and insurance payers, and providing convenient access to the test through streamlined specimen collection options. Clinical trials conducted to date include the Prediction and Prevention of Preterm Birth, or the PREVENT-PTB Study, Serum Assessment of Preterm Birth Outcomes Compared to Historical Controls study, or the AVERT PRETERM TRIAL, and the </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">P</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">rematurity </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">R</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">isk Assessment Combined With Clinical </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">nterventions for Improving Neonatal outco</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ME</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">s study, or the PRIME study.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In July 2024, we announced the publication of the positive results from the AVERT PRETERM TRIAL in Diagnostics, an international, peer-reviewed, open access journal on medical diagnosis. Diagnostics highlighted this study on the cover of the July issue. Notable results included an 18% reduction in severe neonatal morbidity and mortality. Additionally, there was a 7-day reduction in the mean neonatal hospital length of stay among neonates with the longest stays. The trial also showed an increase in the average gestational age at birth before 32 weeks by 2.48 weeks. Furthermore, we observed a 28-day reduction in the neonatal length of hospital stay for babies born before 32 weeks&#8217; gestation, significantly reducing the time spent in the hospital for those at risk of the earliest delivery. Significant reductions in neonatal morbidity and mortality were also reported, as well as hospital and NICU lengths of stay, in the entire intent-to-treat population. The test-and-treat strategy was linked to decreased odds of preterm birth and spontaneous preterm birth at various gestational ages.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In December 2023, we announced that the Data Safety Monitoring Board, or DSMB, overseeing our PRIME study recommended stopping enrollment due to efficacy, reporting that either co-primary endpoints, neonatal hospital length of stay and composite neonatal morbidity and mortality, met the stopping criteria for statistical significance at the pre-planned</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">interim analysis. We adopted the DSMB&#8217;s recommendation and stopped the PRIME study enrollment to focus on analyzing and reporting the available data. In May 2024, deliveries of all PRIME study participants were complete, inclusive of the approximately 2,000 remaining participants who were enrolled but had not delivered before enrollment was stopped in December 2023 per DSMB recommendation. In September 2024, the final PRIME database was locked. Top-level trial results were communicated to the DSMB and us in October 2024. Topline results were published in an abstract by the Society for Maternal Fetal Medicine (SMFM) and presented at the podium at SMFM&#8217;s Pregnancy Meeting on January 31, 2025. Notable results from the PRIME study showed the primary endpoints being met in the prespecified modified intent-to-treat population (mITT), indicating a 25% reduction in neonatal morbidity and mortality, and an 18% reduction in neonatal hospital length of stay for the approximately 10% of babies who stay beyond the standard number days for routine deliveries. The mITT population excluded any participants at high-risk by the test that didn't receive the treatment bundle. It therefore focuses on treatment efficacy. In contrast, a more conservative intent-to-treat analysis (ITT) is often used to assess more real-world benefit of a technology. The ITT analysis, inclusive of subjects who declined treatment, indicated a 20% reduction in neonatal morbidity and mortality, and a 20% reduction in NICU admissions. We are currently seeking publication of these and other results from the PRIME study in a highly respected, peer-reviewed journal.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our studies support a strategy where identifying and intervening in higher-risk pregnancies, not identifiable by traditional or standard approaches, can allow babies who were destined for premature delivery to remain in utero longer. This prolongation of gestation in the preterm period can lead to more mature babies that require shorter hospital/NICU stays due to improved neonatal health. The PRIME study, for which enrollment was stopped due to efficacy at the interim analysis and is being prepared for publication, includes the same primary and secondary endpoints as the AVERT PRETERM TRIAL and affords the continued assessment of this model.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Beyond demonstration of clinical study efficacy, we look forward to studying the effectiveness and implementation of the PreTRM test in a real-world setting. Our real-world evidence implementation programs, targeting to expand PreTRM clinical utility data and replicate randomized controlled trial evidence in the real world, have been developed for study launches anticipated in early 2025.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We believe market adoption by both health care providers and payers should be aided by the recent publication of our AVERT PRETERM TRIAL, as well as upcoming publications related to our PRIME study and real-world evidence studies. We believe that all data expected to be published in coming months and years, together with our current body of evidence, will continue to demonstrate the clinical and economic utility of using our test.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are actively discovering and developing additional biomarker tests to predict other specific major conditions of pregnancy, such as a pregnancy risk prediction panel test. We believe these tests have the potential to offer significant health benefits to women and their babies. Among other products, we are developing a lifestyle test designed to provide a more accurate estimate of the delivery date for expectant mothers for the purposes of planning maternity leave, family support, travel arrangements, and related considerations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our Proprietary Technology Platform</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The complexities of the biology of pregnancy have been a major obstacle in developing effective tests for pregnancy-related conditions. We are working to overcome this obstacle through our development of a proprietary technology platform consisting of biobanks, advanced mass spectrometry, immunoassays, and other proteomic analytic methods and bioinformatics, which enables superior characterization of the biology of pregnancy and more accurate prediction of pregnancy outcomes.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">An analysis of protein pathways and expression at various points during pregnancy reveals dynamic changes affecting both the mother and the baby. Earlier detection of changes in protein expression indicating the emergence of adverse pregnancy outcomes can enable proactive management of those conditions. A fundamental component of our platform is our proprietary biobank, consisting of comprehensive, clinically and demographically annotated specimens collected from thousands of pregnant U.S. women, representing the broad demographic and geographic diversity inherent in the U.S. population. This differentiated resource enables us to develop and broadly validate our predictors. Further biobank diversity is also provided through our scientific collaborations with leading maternal fetal medicine experts around the globe, enabling us to analyze specimens collected from patients in the United States, Europe, Asia and Africa. In strict adherence to the authoritative National Academy of Medicine, or NAM, guidelines, we apply our innovative mass-spectrometry and other proteomic analytical methods and our knowledge of protein information networks to probe biobank specimens for meaningful protein expression changes. We then subject the data to inventive bioinformatics analysis and use advanced tools, such as machine learning and artificial intelligence, to find relationships between various proteins and to discover important predictors.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our Discovery, Development, and Commercialization Approach</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our product discovery and development approach is based on rigorous science and health-based economic analyses as we discover, develop and commercialize biomarker tests and predictive analytic products and services designed to transform pregnancy-related care for patients, doctors and payers. We have initially applied our platform and capabilities to address the problem of preterm birth, given its profound health and economic impacts worldwide. In the future, we may use this technology to develop products for a number of health conditions other than premature birth. Our development and commercialization strategy also involves transitioning some products from proteomic discovery platforms (such as mass spectrometry) to immunoassays, which we believe also have low costs, high-throughput, and ease of implementation. Technology development also includes removing bottlenecks in specimen collection and shipment by use of whole-blood collection and ambient shipping.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We use the following multifaceted approach in our research, development and commercialization efforts:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant Unmet Need</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">:   We select specific conditions or features of pregnancy that are clinically and personally meaningful and economically important and with significant unmet needs that lack effective solutions. We have initially applied our platform and capabilities to address the problem of preterm birth, given its profound health and economic impact worldwide. We intend to explore other areas of significant unmet need in pregnancy, including preeclampsia, gestational diabetes and others.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Proteomic and Bioinformatics Platform</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">:   We utilize our platform to understand the biology underlying selected pregnancy-related conditions in order to discover, verify and broadly validate high-performing predictive biomarker tests and predictive analytic products and services. Our various studies and other research have endowed us with an extensive biobank of blood samples that provide a deep view into the care and outcomes of diverse singleton pregnancies across the United States, enabling prediction of various other outcomes. We are continuing to conduct analyses of our growing biobank of data from multiple sources to provide new insights that will be the basis of discovering and developing biomarker predictions for a variety of important conditions of pregnancy.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Immunoassays</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: We identify antibodies to discovered pregnancy biomarkers and develop immunoassays for use in our own or other CLIA laboratories, including the potential for eventual use in ex-US territories. </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Blood Collection, Logistics and Processing</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: We evolve our draw windows, sample types, collection techniques, and lab processes to enable greater access to our tests, ease of use for providers and patients, and cost effectiveness for our products to scale. </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Demonstration of Health and Economic Impact of Our Test and Treat Strategy</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">:   We believe a critical element of our success will be to demonstrate the beneficial health and economic impacts of using the information provided by our biomarker tests. In the case of the PreTRM test, our commercialization strategy involves amassing clinical and economic data to definitively demonstrate that detecting a mother&#8217;s risk of preterm birth can enable proactive interventions which improve her health and her baby&#8217;s, while at the same time saving substantial health care system costs. Our rigorous, controlled intervention trials, PREVENT-PTB, AVERT PRETERM TRIAL and PRIME, evaluated our test-and-treat strategy in a total of more than 7,000 patients enrolled in the treatment arms. We have published multiple peer-reviewed papers supporting clinically beneficial results from PREVENT-PTB and the AVERT PRETERM TRIAL, and presented positive results from the PRIME study at the 2025 SMFM Pregnancy Meeting, and we are actively working toward peer-reviewed publications for the PRIME study.</span><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"><br/><br/></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We also work with leading health economists and organizations to build rigorous models that describe how application of the PreTRM test-and-treat strategy impacts both health and economic outcomes. We work to publish models that provide peer reviewed evidence of the value of our strategy.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Societal Guidelines</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: We believe that broad market adoption of a product benefits from the product being included in clinical societal guidelines, and therefore we support organizations such as the Society for Maternal-Fetal Medicine and the American College of Obstetricians and Gynecologists, by providing them insights from our accumulating evidence development. </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Payment and Reimbursement</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">:   We have focused on building third-party reimbursement for early commercialization of our clinical tests, by seeking to leverage the health and economic benefits of our biomarker approach to gain reimbursement from integrated systems, institutional physician networks, and major health insurance payers. For example, we have a multi-year contract with Elevance Health, one of the largest U.S. health benefits companies, under which Elevance Health agreed to purchase a substantial number of PreTRM tests for pregnant women in their network, and to facilitate commercializing PreTRM testing among its members. The AMA Editorial Board has issued a unique CPT</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PLA code for the PreTRM test, which we believe will also help drive payment and coverage decisions for PreTRM testing. In November 2021, this code was priced by the Centers for </span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">6</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Medicare &amp; Medicaid Services, or CMS, at $750. Other products or market segments may be more conducive to direct patient or consumer payment models.</span></div></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We envision that our comprehensive approach will enable us to fully characterize one of the most important periods of time in the lives of both women and their babies. We believe that the data and predictions that we develop will ultimately create important information tools and services for a variety of customers, including women, health care workers, insurers, pharmaceutical companies, researchers and related companies. Several future opportunities may be created by comprehensively profiling pregnancy, including, but not limited to:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">additional diagnostic predictors;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">epidemiologic, efficacy and best practice assessment tools to better understand and address critical patient outcomes and disparities across the United States;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">pregnancy educational content development, based on our actual data, for physicians, PAs, nurse practitioners, midwives, regulators, insurers, researchers and health care students; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">pharmaceutical drug development tools.</span></div></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We also believe that the work we perform in pregnancy could be leveraged more broadly to address other areas in medicine and health care.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our Pipeline</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are developing a robust pipeline of novel blood-based biomarker tests for a number of major pregnancy related conditions beyond preterm birth by leveraging the biological insights provided by our proprietary technology platform. Our product candidates are designed to accurately predict and enable better management of a range of serious pregnancy-related conditions. We believe these product candidates, if successfully developed, have the potential to address significant unmet needs by providing more accurate prediction of these pregnancy-related conditions and providing patients with meaningful information and physicians with earlier opportunities for intervention.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our biomarker pregnancy pipeline consists of the following:</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img152117643_0.jpg" alt="img152117643_0.jpg" style="width:672px;height:377px;"/></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Strengths</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We attribute our success and future growth prospects to the following:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our differentiated approach to understanding and addressing major conditions of pregnancy.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">   We take a focused and data-driven approach based on rigorous science to understand the biology of pregnancy and the health and economic impacts of major pregnancy conditions. Our approach involves conducting controlled trials and health economic analyses to demonstrate the beneficial health and economic impacts of using the information provided by our products. We also work with leading health economists and organizations to build rigorous models that describe how the application of our products impacts both health and economic outcomes. Leveraging the demonstrated short- and long-term health and economic benefits of our approach, we aim to gain reimbursement from integrated systems, institutional physician networks, self-insured employers, and major health insurance payers by working with them to demonstrate the benefits of using our products. We also expect to explore alternative payment models for some products and market segments. We will then seek to capitalize on reimbursement decisions to facilitate obtaining widespread commercial coverage of our biomarker tests from other health care payers, while also expanding any successful alternative payment models for these and other products.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our proprietary and scalable proteomics, bioinformatics platform technology, and clinical outcome data creates clinically meaningful and economically impactful predictions for pregnancy</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.   We believe our proprietary proteomic and bioinformatics technology platform has the potential to enable critical advances in the management of pregnancy and its outcomes. Our platform consists of biobanks, advanced mass spectrometry, immunoassays, and other proteomic analytic methods and bioinformatics, which enables superior characterization of the biology of pregnancy and accurate characterization of pregnancy outcomes and features. Our technology expertise includes the ability to identify antibodies to proteomically-discovered biomarkers to allow transition from mass spectrometry to simple, high-throughput, lower-cost immunoassay approaches over time. We believe this platform has the potential to address significant unmet needs in the large, underserved market for the prediction of outcomes associated with pregnancy. Our research allows for the development of testing technology on other platforms in cases when partnering with leading instrument providers proves to be the most effective route to broad-based adoption for any of our products. </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Sample Collection and Logistics.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> We have years of experience evaluating sample collection approaches and methods of shipment. We recently leveraged our serum biobank to develop options for whole-blood collection and ambient specimen shipment. This has the potential to lower costs, ease patient/consumer experience and accelerate market penetration. </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The PreTRM Test, which is the only broadly validated, commercially available blood test proven to predict the risk of a woman to deliver prematurely.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">   The predictive performance of the PreTRM biomarkers has been extensively validated in diverse populations and geographies and enables earlier proactive care addressing higher preterm birth risk that occurs among the 3.7 million annual singleton pregnancies in the United States. We believe that based on our growing body of evidence regarding the clinical and economic benefits of the PreTRM test, as greater payer and physician adoption and supportive medical society guidelines occur, the PreTRM test has the potential to become an important standard of care for preterm birth.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Collaboration with Elevance Health.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">   We have contracted for early payment for the PreTRM test through our commercial collaboration with Elevance Health. We believe this and other collaborations may help with broader market adoption through coverage decisions by major payers.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Broad pipeline covering additional significant conditions of pregnancy.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">   We are also developing a novel pipeline of blood-based biomarker tests and predictive analytic products and services directed at a number of major pregnancy-related conditions and features beyond preterm birth. We believe these product candidates, if successfully developed, have the potential to address significant unmet needs by providing more accurate detection of these pregnancy-related conditions and features, which in turn can give consumers helpful information about their pregnancy journey and give patients and physicians earlier opportunities for intervention. </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Deeply experienced team in development and commercialization of molecular diagnostics tests and predictive analytic products and services.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">   Our team has decades of experience in building and commercializing molecular diagnostics tests and predictive analytic products and services. We have worked to build a first-class scientific organization capable of harnessing and translating our platform technologies into innovative solutions. We strive to deliver actionable information to pregnant women, their physicians and payers to improve the pregnancy experience and the health of patients as well as the economics of health care delivery. Our experienced discovery and development team performs rigorous bioinformatics analyses and strictly adheres to the authoritative NAM guidelines on how to reliably develop and validate omics predictions made on complex biological data sets. </span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Adhering to these guidelines, in the case of predicting preterm birth, we have been able to document generalizable biomarker predictive performance across independent cohorts of patients from the United States, Europe, Asia and Africa. Reflective of the scientific rigor of our efforts, our scientists have published best practice recommendations for the analysis of preterm delivery data. We believe this will improve the quality of statistical analysis of research data related to proteomic test development, enabling the broad community of statisticians, researchers, clinicians and regulators to better validate predictions prior to their clinical use.</span></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Strategy</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our vision is to deliver pivotal and actionable information to pregnant women, their physicians and health care payers to significantly improve the pregnancy experience and maternal and neonatal health, and to dramatically reduce health care costs. Our goal as The Pregnancy Company is to discover, develop and commercialize clinically meaningful and economically impactful biomarker tests and predictive analytic products and services designed to improve the pregnancy experience and neonatal outcomes. We assess product opportunities across physician-ordered, direct-to-consumer and business-to-business commercialization models and both payer-reimbursed and consumer-pay approaches. We believe it is critical to develop products that will be viewed as cost-effective by payers in order to receive reimbursement for our tests. We are pursuing our vision by implementing the following strategies:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Expand payments for the PreTRM test to a variety of market segments and payment models to maximize the commercial opportunity.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">   We believe that growing payment for the PreTRM test by integrated systems, institutional physician networks, self-insured employers, major health insurance payers and even patient self-payment models should help drive physicians to more broadly offer the testing to their patients, thereby expanding the number of U.S. pregnancies benefiting from our technology. We also believe that based on our growing body of evidence regarding the clinical and economic benefits of the PreTRM test, our commercial collaboration with Elevance Health, and the anticipated greater payer and physician adoption throughout the United States, the PreTRM test has the potential to create a new standard of care in pregnancies.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Apply our platform capabilities to broaden our pipeline and develop novel and high-performing products for pregnancy-related conditions and potentially other health conditions.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">   Our proprietary technology platform is designed to provide deep characterization of the biology of pregnancy, which we are using to develop additional products addressing pregnancy outcomes, such as time-to-birth, preeclampsia, gestational diabetes, and other conditions. We plan to leverage the strength of our technology platform and expertise to discover and develop novel and high-performing products that will provide women and physicians more timely and actionable information on pivotal pregnancy conditions and features, which can lead to an improved pregnancy experience and improved maternal and newborn health. In the future, we aspire to expand our product offerings by deeply characterizing the biology of the pregnancy journey. </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Continually enhance the value and capabilities of our proprietary technology platform through ongoing expansion and integration of our biobank and our proteomics and bioinformatics databases.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">   We believe that the breadth and depth of our databases, our unique proteomic analytical techniques, immunoassay capabilities, and our bioinformatics approaches all position us to be the leader in providing important pregnancy information to women and doctors. The continued expansion of our proprietary biobank, together with our innovative proteomic analytical methods and bioinformatics analyses, is designed to enable us to discover and broadly validate new biomarker and predictive analytic products and services for various conditions and features of pregnancy.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Evolution of our testing, specimen collection and shipping technologies.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">   Market penetration and optimal patient/consumer experience can also be realized by implementation of whole-blood collection technologies and development of ambient specimen shipment approaches. Whole-blood collection can remove laborious specimen processing steps such as centrifugation and enable at-home consumer channels. Ambient specimen shipping removes requirements for temperature-control, which lowers costs, and its simplicity can improve clinical implementation and further streamline at-home collection. For certain products, affinity-capture and/or immunoassay development can minimize overall costs of goods and maximize sample throughput and turnaround time. Our strategy includes evolving from discoveries made using mass-spectrometry analysis of our proprietary biobank to identification of antibodies for use in immunoassays. </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Continue building an evidence portfolio of clinical and economic outcomes driven by our products.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">   In addition to publication of AVERT and the recent presentation of key PRIME study results at the SMFM Pregnancy Meeting and the anticipated publication of full PRIME study results, we seek to complete economic analyses for both studies and to publish additional exploratory analyses related to the PRIME study. Additionally, we plan to further corroborate our test and treat strategy in real-world evidence studies, which we expect to launch in 2025. </span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">9</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Engage with professional societies.   </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have historically engaged and will continue working closely with professional societies and guideline setting bodies to advocate for the continued evolution of treatment guidelines to include the latest research and innovations for maternal and newborn health.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Partner with employers to expand the payer mix for our products.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">   We are partnering with employer cooperative organizations to include our products in benefit packages for maternal care for some of the largest employers in the United States. </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Complement our products with a potential care coordination offering.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">   We may offer our large institutional customers assistance in delivering the care coordination protocol for all their patients that test at higher risk for preterm birth.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Build a women&#8217;s health commercial infrastructure.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">   We are continually shaping our commercial, sales, and marketing capabilities to fit the current stage and future life cycle of our product portfolio, including institutional sales, self-insured employer markets, sales operations, and professional as well as consumer directed marketing. When commercial opportunities and market conditions warrant, we will expand our commercial operations to penetrate each market in a cost-effective manner.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Evaluate strategic partnerships to maximize the value of our product offerings.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">   We may strategically enter into collaborations or other partnerships to maximize the commercial potential of the PreTRM test and the rest of our product portfolio within or outside of the United States. We may explore strategic alliances or collaboration to accelerate the discovery, development, validation and commercialization of our portfolio.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Build long-term relationships with our expectant mother customers to support their pregnancy journeys.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">   With the expansion of our product portfolio, we have many opportunities to support mothers in their pregnancies. Building an ongoing relationship with our customers via digital channels should allow us to offer more products and solutions, enhance the predictive power of our technology, and increase the return on investment on our customer acquisition cost. </span></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Biology of Pregnancy</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pregnancy is a highly complex, dynamic process that leads to the formation of a human being. From its beginning, genes, proteins and metabolites are expressed in a coordinated fashion to enable the placenta, the uterus and the mother to support the development of a child during pregnancy. The duration of a term pregnancy is usually between 37 and 42 weeks.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At the inception of pregnancy, the placenta begins its development as a critical organ necessary for a healthy pregnancy for both the baby and the mother. The placenta initially forms and evolves during pregnancy to become a large, highly active metabolic organ conducting numerous vital biological functions through the time of delivery. The placenta is the primary means of communication between the mother and the baby. Life-enabling exchanges of oxygen, nutrients and protective antibodies as well as elimination of wastes are affected by the placenta.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Proteins and protein expression are critical molecular elements in driving and carrying out key processes that take place during pregnancy in both the mother and the baby. Protein expression can, in some cases, become disordered, leading to adverse pregnancy outcomes, such as preterm birth, preeclampsia, gestational diabetes, stillbirth and other conditions. There are approximately 140 million births globally each year. It is estimated that as many as 30% of pregnancies may have complications affecting the mother and/or the baby.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Maternal blood is a window through which maternal, fetal and placental communication can be deciphered. Subtle abnormalities in protein expression in the mother&#8217;s blood may provide insights into complications earlier in pregnancy that can be utilized to benefit the mother and the baby. These changes, if appropriately detected and understood, have the potential to predict that the mother and/or baby are trending toward adverse conditions in pregnancy, which can be serious and costly. Timely detection of these subtle changes can enable the application of specific interventions to address the emergence of such complications and thereby improve the health of mothers and babies.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To date, a deeper understanding of the abnormalities of protein expression has been limited by the lack of understanding of the molecular events of the biology of pregnancy. The development of meaningful predictions in pregnancy requires improved methods to better understand such biology.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Building clinically meaningful and economically impactful predictions for pregnancy requires a significant commitment of resources, the proper selection and application of state-of-the-art laboratory technologies, access to well-annotated biologic specimens and advanced bioinformatics capabilities.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Proprietary Technology Platform</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We believe our proprietary proteomic and bioinformatics technology platform has the potential to enable critical advances in the management of pregnancy and its outcomes. Our platform consists of biobanks, advanced mass spectrometry and other proteomic analytic methods and bioinformatics, which enables superior characterization of the biology of pregnancy and accurate prediction of pregnancy outcomes. Our platform, built on differentiated tools and capabilities, provides pregnant mothers and their doctors more clinically meaningful and economically impactful predictions of adverse pregnancy outcomes to enable more timely intervention and improve the well-being of both mother and baby.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Proprietary Biobanks</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have built proprietary biobanks of blood specimens and related data over a number of years, which are key resources required to develop a deeper understanding of the biology of normal and adverse pregnancy outcomes. By continuing to aggregate proprietary bioinformatics insights gained from analyses of comprehensively annotated biobank specimens, we are working to develop and commercialize a variety of clinically meaningful and economically impactful biomarker tests for pregnant women and their health care providers.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our large proprietary U.S. biobank resource was built by collecting blood from thousands of comprehensively annotated blood specimens from patients, which cover a broad range of gestational ages and represent the broad demographic diversity and geographic distribution of pregnant women across the United States. We collected the specimens in two large multi-center trials: our PAPR study, beginning in 2011, and our TREETOP study, beginning in 2016. These two studies prospectively collected specimens, together encompassing weeks 17 through 28 of pregnancy, from women carrying a single baby, and, as &#8220;all comers&#8221; studies, collected information on a variety of important pregnancy outcomes, including preterm birth, preeclampsia, gestational diabetes and other conditions. These specimens and their associated data are carefully analyzed to discover and develop informative biomarker signatures for intended use pregnancy populations. We continuously work to add new specimens to our biobanks in additional studies, generating greater opportunities for ongoing development of clinically meaningful and economically impactful biomarker predictions.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We believe our work on proprietary biobanks has established us as a leader in proteomic approaches to characterize pregnancy. We also conduct our bioinformatics analyses on additional specimens from other institutions in the United States and abroad. We analyze each specimen by conducting proteomic and other measurements in our laboratory, which generates large sets of biomarker data for each specimen. Through the analysis and evaluation of biomarkers with advanced bioinformatics approaches, we discover novel predictions for various adverse pregnancy outcomes. We then are able to apply these predictions to non-overlapping independent specimens from different biobanks available to us to confirm and validate the accuracy and performance of the predictions. We add to our biobanks on an ongoing basis by continuously analyzing larger numbers of specimens from our own sponsored studies as well as those from collaborations with maternal fetal medicine leaders around the world. We have validated proprietary biomarker signatures consisting of proteins and clinical variables in specimens collected from the United States, Europe, Asia and Africa. We believe that as our database and sets of predictions grow, verifying and validating the predictions can lead to more rapid and efficient development required to commercialize such predictions in the future.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Advanced Mass Spectrometry Approaches</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Mass spectrometry is a highly developed analytical technology capable of precise identification, quantification and characterization of proteins. We have developed and applied innovative state-of-the-art mass spectrometry techniques to screen and detect in our bio-specimens the dynamic changes in protein expression occurring in normal and abnormal pregnancy development. Our proprietary proteomics workflows enable detailed and efficient measurements of hundreds of proteins simultaneously from complex matrices, such as blood. We also utilize a variety of other screening techniques to explore and understand the pregnancy proteome, including large- and small-scale immunoassay screens, other ligand-binding assays and RNA analyses, among others. To ultimately validate biomarker performance, we translate and confirm, on our mass spectrometry platform, the findings that we have generated with these other analytical measurement technologies. Our rich and extensive database of omics data, combined with highly annotated clinical information, is analyzed by state-of-the-art bioinformatics capabilities.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Through our innovative approaches and advances in proteomics, we have discovered and validated meaningful predictions for adverse pregnancy outcomes. Importantly, our mass spectrometry process is well-suited not only for discovery and development activities, but also for high volume commercial production through the use of robotics and automation. Mass spectrometry measurements can be performed on very small blood volumes, which is appealing for patient specimen collection and can lower cost of goods in laboratory analyses. We endeavor to remain at the forefront of the clinical application of mass spectrometry-based proteomics by making advancements in specimen collection/shipping and laboratory</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">11</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">processes. We believe that our specific applications of mass spectrometry-based proteomics can be scaled to efficiently and cost-effectively accommodate the growth that we anticipate in addressing the large pregnancy testing market.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are continually enhancing our analytical techniques. This includes improving customer experience with the identification and validation of whole-blood collection devices, ambient specimen shipping, and laboratory process changes. We continually refine the laboratory process to make it more efficient, lower costs, and improve turnaround time, or TAT. A significant goal in our strategy is the migration to immunoassays in cases where this is advantageous, such as consumer ordered tests or international clinical testing kits. Antibodies are the currency that applies across the immunodiagnostic space as they apply uniformly despite the variations in immunoassay platform technologies. An automated affinity-capture mass-spectrometry, or AC-MS, PreTRM assay was launched in 2024. This approach uses custom, proprietary antibodies, coupled to magnetic beads to isolate PreTRM analytes for mass spectrometry measurement. AC-MS enables parallel processing of specimens, very short LC-MS analysis times, quicker overall TAT, and lower costs. We continue to evaluate additional antibodies to PreTRM analytes for potential development of sandwich immunoassays (e.g. ELISA) or clinical analyzer-compatible assays. Current efforts also include the identification of antibodies and the development of immunoassays for other pipeline products.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Advanced Bioinformatics</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have assembled a powerful collection of advanced bioinformatics capabilities as a critical component of our platform. Bioinformatics is an essential field of science in which biology, statistics, advanced computational science and information technology are combined to systematically and comprehensively analyze complex biological information. The advanced bioinformatics tools that we apply at great scale to measurements conducted on our biobank specimens to develop high-performing, important predictive algorithms include, but are not limited to: machine learning, artificial intelligence, causal inference, supervised learning methods, dimensionality reduction methods and advanced statistics. As a result of rigorously applying our core expertise and proprietary approaches in bioinformatics, we have discovered high-performing algorithms that reliably distinguish pregnancies with normal protein expression compared to those showing disordered protein expression. Deep bioinformatics insights into the biology of pregnancy have enabled us to discover, verify and validate important predictions of adverse pregnancy outcomes.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have built an experienced discovery and development team with the deep expertise in science and mathematics necessary to perform rigorous bioinformatics analyses. We strictly adhere to the authoritative guidelines published by NAM on how to reliably develop and validate omics predictions made on complex biological data sets. These guidelines require disciplined validation of predictions to ensure validity and reliability of such predictions before they can be used clinically or commercially. The NAM guidance calls for pre-specifying how the predictions are to be made and then applying testing in completely independent specimen cohorts, in order to be certain that the predictions are valid. Adhering to these guidelines, we have been able to validate that a number of our adverse pregnancy predictors are replicable in independent cohorts of patients residing in United States, Europe, Asia and Africa.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Preterm Birth</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Term pregnancy usually lasts between 37 and 42 weeks. Preterm birth is defined as any pregnancy delivering before 37 weeks&#8217; gestation. Preterm delivery includes two major categories: medically indicated preterm birth, where the doctor intervenes because of concerns for the health of the mother and/or the baby, and spontaneous preterm birth where the mother goes into labor spontaneously with no apparent or known pathology.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Of the estimated 140 million annual births globally, approximately 15 million births are preterm. In the United States, there are approximately 3.7 million annual births, and the 2024 March of Dimes Report Card shows that the preterm birth rate is now 10.4% of U.S. births.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Preterm birth remains a leading cause of neonatal morbidity and mortality throughout the world. In the United States, approximately 20,000 annual deaths occur before age one, with prematurity being a major cause. Of the approximately 15 million preterm babies born every year across the globe, about one million die. As a consequence of their preterm birth, many infants require significant medical support in intensive care settings to survive and continue to develop. Preterm birth is also associated with significant long-term disability for many individuals, including learning disabilities, cerebral palsy, chronic respiratory illness, intellectual disability, seizures and impairment of vision and hearing, which can generate significant costs throughout the lives of affected children. The annual U.S. health care costs to manage short- and long-term complications of preterm birth have been estimated to be approximately $25 billion, consisting of direct medical costs incurred during pregnancy, lost productivity due to preterm birth in the perinatal period as well as additional associated longer term medical costs for the mother and child. The estimated average expense per preterm delivery in the United States is approximately</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$65,000. Earlier preterm births are associated with higher costs due to the greater severity of complications occurring in babies born at earlier gestational ages. Given this, the ability to prolong the gestation period by even one week has the potential for significant savings as shown in the figure below. As a result, the economic benefit of a test that can enable effective interventions to prolong the length of time for a baby to continue developing in utero, even for a short period of time, and to improve neonatal health before delivery is substantial.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Distribution of U.S. Preterm Births and Estimated Average 6-Month Cost per PTB by Gestational Age at Birth</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img152117643_1.jpg" alt="img152117643_1.jpg" style="width:672px;height:377px;"/></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unfortunately, traditional methods to predict preterm birth risk fail to identify the great majority of pregnancies that will result in preterm births. Currently, the two most commonly used predictors of preterm birth risk are a woman&#8217;s history of prior preterm delivery or a short cervical length measurement found early in pregnancy. It is estimated that only about 1 out of 6 singleton spontaneous preterm births can be detected proactively with these clinical methods. The great majority of singleton preterm births only become apparent when the woman goes into labor and delivers, at which point proactive management options are no longer possible. Therefore, the ability to identify the great majority of women who will, in fact, deliver prematurely, and thus be able to more proactively manage their risk, represents a significant unmet medical need and offers a pivotal opportunity to make a positive difference for the mother and the baby.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Proactive interventions to address higher preterm birth risk may include more frequent contact with the patient, additional clinical visits, more intensive education and monitoring of the patient during pregnancy, prophylactic administration of progesterone or anti-inflammatory medications, heightened awareness of impending delivery and reacting more promptly to changes indicative of preterm birth as the pregnancy progresses.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The PreTRM Test&#8201;&#8212;&#8201;Our Solution for Preterm Birth</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Utilizing our product discovery, development and commercialization approach, and in view of these stark realities of preterm birth, we focused our first development and commercialization efforts on addressing preterm birth. Our first product, the PreTRM test, is the only broadly validated, commercially available blood-based biomarker test to accurately predict the risk of spontaneous preterm birth. The PreTRM test is a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation. The specimen analyzed in the PreTRM test is drawn once in singleton pregnancies where there is no evidence of significant fetal anomalies by non-invasive pre-natal genetic screening, or NIPS, or ultrasound, and the women tested are not taking progesterone. In addition to traditional phlebotomy for obtaining a patient specimen, we recently validated and added a whole-blood collection kit option that utilizes the less invasive fingerprick method of collection. We have contracted with a Food and Drug Administration-registered supplier to produce our branded</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">13</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">kit under applicable quality systems requirements and have begun making the kit available at a limited scale. Whether the patient's blood specimen is collected via phlebotomy methods or by using the collection kit, the specimen is then sent to and analyzed in our CLIA certified clinical laboratory using our high throughput mass spectrometry technology. Once the laboratory analysis is completed, a risk report is generated from our validated algorithm and the results are transmitted to the ordering clinician. The PreTRM test provides an accurate prediction of the expectant mother&#8217;s individualized risk, expressed as a percentage, of delivering spontaneously before 37 weeks&#8217; gestation, as well as her relative risk compared to the average population risk. The great majority of singleton preterm births are spontaneous, where the mother goes into labor and delivers without any apparent known pathology.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The PreTRM test combines the ratio of insulin-like growth factor-binding protein 4, or IBP4, to sex hormone-binding globulin, or SHBG, with a woman&#8217;s height and weight to predict the risk of spontaneous preterm birth. These protein biomarkers have been extensively validated in multiple maternal fetal medicine centers located in the United States, Europe, Asia and Africa. In addition, we continue to build on our existing data to further demonstrate the clinical and economic benefits of intervening based on PreTRM test results. The PreTRM test accuracy has been rigorously assessed and validated in our PAPR study involving 5,501 women in 11 obstetric centers across the United States. Our completed PAPR study validated the biomarker signature which is highly predictive of spontaneous preterm birth risk. The performance of the PreTRM test biomarkers was replicated in a second independent large prospective U.S. study, TREETOP, supporting that the IBP4 to SHBG predictor can be used to accurately risk-stratify patients for implementation of preterm birth preventive strategies and direct patients to appropriate levels of care. The ability to accurately risk-stratify is critical for enabling precision care management. We and our collaborators have completed three prospective controlled intervention studies&#8201;&#8212;&#8201;PREVENT-PTB, AVERT PRETERM TRIAL and PRIME&#8201;&#8212;&#8201;to demonstrate the value of identifying higher risk pregnancies coupled with proactive interventions to improve the well-being of mothers and newborns.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We believe our comprehensive approach to build evidence for our PreTRM test addresses key elements payers require in order to reimburse testing, including:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">analytical validation of the testing platform, or measurement validity;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">clinical validation, or test validity;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">clinical utility of using validated predictions, or positive health benefit; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">economic utility, or cost effectiveness and health care savings.</span></div></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Underscoring the benefits of the PreTRM test and treat strategy, the clinical and economic utility of the PreTRM test administered mid-pregnancy has been published by respected independent health economists in a leading maternal fetal medicine journal.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The strength of the data from our studies of the PreTRM test has enabled us to pursue an innovative and accelerated approach to commercialization. Elevance Health, whose health plans cover more than 10% of U.S. pregnancies annually, agreed to pay for our PreTRM test for eligible pregnant members as part of a multi-year contract. The collaboration also enables us to generate more data to demonstrate the value of the PreTRM test and treat approach across diverse patient populations within Elevance Health&#8217;s insurance plans.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Biomarker Discovery and Clinical Validation of the PreTRM Test</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Adherence to National Academy of Medicine Guidelines</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We rigorously adhere to authoritative NAM guidelines published in 2012 for developing and validating multi-omics predictions and applying important principles to address adverse conditions that arise in pregnancy. The guidelines specify three phases of work to be performed in non-overlapping sets of specimens:</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Discovery Phase</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.   A set of specimens from patients whose outcomes are known are analyzed in the lab to find biomarker differences between individuals with an adverse outcome versus individuals without that particular outcome (e.g., pregnancies that deliver preterm versus term pregnancies). Algorithms are built on high performing predictions that can be tested in the next phase.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Verification Phase</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.   High-performing predictive algorithms selected from discovery work are pre-specified and applied to a completely independent set of non-overlapping specimens, with the laboratory being blinded to the outcomes. The performance of the algorithms is either independently verified, or confirmed, by an external statistician, who ranks the</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">algorithms according to predictive accuracy. Once verified, highest performing algorithms are locked down in the form of optimized tests that can be validated in final validation phases before commercialization.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Validation Phase</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.   In a third, entirely independent set of non-overlapping specimens, the laboratory measurements are performed, and the laboratory is blinded to patient outcomes. The laboratory data are time-stamped and are transferred to an external statistician, who applies the pre-specified algorithm to the laboratory measurements and independently validates the performance of the test by breaking the blind. At this point, a prediction that has been independently and rigorously validated can be used for clinical decision-making in trials and/or commercialization.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">PAPR Study</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The biomarkers used in the PreTRM test have demonstrated strong clinical performance in accurately predicting women at risk of preterm birth across diverse patient populations in the United States, Europe, Asia and Africa. The initial discovery, verification and validation of our spontaneous preterm birth biomarker risk predictor was performed in the 5,501 patient </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">P</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">roteomic </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ssessment of </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">P</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">reterm </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">R</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">isk, or PAPR, study.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The PAPR study was initiated in April 2011 and the last observed birth occurred in February 2014. The study was designed to discover, verify and validate biomarkers and clinical variables that accurately predict the risk of spontaneous preterm birth. We measured and evaluated protein expression of thousands of distinct proteins, using our proprietary proteomic workflow, by their levels in maternal serum to assess their effectiveness as predictors of spontaneous preterm birth early in pregnancy before symptoms occur. This analysis showed strong predictive power of a specific combination of two proteins, IBP4 and SHBG, coupled with clinical variables consisting of a woman&#8217;s height and weight, which we developed into a proprietary predictive algorithm that forms the basis of the PreTRM test. These results of the PAPR study were reported in detail at Saade et al., Am. J. Obstet. Gynecol. (2016) 214:633. Samples from PAPR subjects consented for biobanking are used to develop predictors and products for other pregnancy complications.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">TREETOP Study</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our second large clinical validation study, A Mul</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">T</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">icente</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">R</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Ass</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">E</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ssm</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">E</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">nt of a Spon</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">T</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ane</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">O</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">us </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">P</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">reterm Birth Predictor, or TREETOP, enrolled patients beginning in October 2016 with the last delivery occurring in May 2019. The TREETOP study enrolled 5,011 pregnant women from 18 sites across the United States, and validated a PreTRM test risk threshold to statistically stratify higher versus lower risk patients based on a pre-specification of the threshold from PAPR data and by applying it to specimens in this cohort. The validated threshold of 15%, twice the average population risk of spontaneous preterm birth, was demonstrated to statistically separate patients at higher versus lower risk of preterm delivery based on the PreTRM test results. This is the risk threshold for interventional actions to be taken in the PRIME prospective intervention trial that was initiated in 2020. These results were reported in detail at Burchard et al., J. Clin. Med. (2021) 10:5088.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Given the large body of evidence generated from PAPR and our other collaborative biomarker studies, the TREETOP specimens were randomized into two cohorts:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a first patient cohort of 847 specimens to validate certain pre-specified predictions originating from our earlier PAPR study work, and to verify new potentially enhanced predictions that could be validated later on the specimens of the remaining unanalyzed cohort of patients; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a second cohort of remaining specimens was held in reserve to validate, in the future, a number of potentially enhanced predictions that may eventually be incorporated into our commercially available testing as we build our pipeline of adverse pregnancy outcome predictions.</span></div></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Thus, PAPR and TREETOP together encompass a powerful resource of specimens and clinical data from thousands of pregnant women collected over an eight-year period to characterize what takes place biologically in pregnancy. Both PAPR and TREETOP enrolled a large number of women who were not known to be at risk of preterm birth based on other identified clinical factors, and as such, were not already covered by professional society guidelines addressing the need for risk stratification and guidance of treatment. We believe further analysis of the specimens and data from these studies may provide a deep view into the outcomes of diverse singleton pregnancies across the United States and prediction of these outcomes. For example, we used some of these specimens to improve the predictive performance of the PreTRM test and expand the blood draw window to a three-week period.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">15</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our Prospective Intervention Studies&#8201;&#8212;&#8201;Demonstrating the Benefits of the PreTRM Test and Treat Strategy</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Following the validation of predictors for spontaneous preterm birth, we set out to demonstrate the value of identifying higher-risk pregnancies coupled with proactive interventions to improve the well-being of mothers and newborns. We have worked with respected collaborators to conduct three prospective intervention studies in order to demonstrate the clinical utility and economic value of the PreTRM test and treat approach.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">PREVENT-PTB Study</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Prediction and Prevention of Preterm Birth, or PREVENT-PTB, study (Clinical trials identifier: NCT03530332) was a prospective randomized controlled intervention study conducted at Intermountain Healthcare in Salt Lake City, Utah. The PREVENT-PTB study enrolled a total of 1,208 patients to evaluate the health and economics impact of applying the PreTRM test.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the PREVENT-PTB trial, women enrolled were randomized 1:1 to either the screened or control group. Women in the screened group received the PreTRM test, and those at higher risk of preterm birth according to the test result were offered a menu of proactive interventions. These included care management (i.e. weekly contact with a care management nurse, preterm prevention clinic visits, evaluation of signs and symptoms of prematurity, education, cervical length monitoring) and medications (17-&#945;-hydroxyprogesterone caproate, low-dose aspirin and the administration of corticosteroid treatment at a lower threshold if patients indicated clinical signs or symptoms of imminent delivery). Patients in the screened group that were found not to be at higher risk by the PreTRM test and those in the control group received standard obstetrical care. The diagram below illustrates the study design for PREVENT-PTB:</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The PREVENT-PTB results were published on August 16, 2021 in the American Journal of Perinatology. The key reported findings were:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Hospital and NICU length-of-stay reduced by more than 70% in preterm infants;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Severe neonatal morbidity or death was reduced by 66% across infants affected by complications of prematurity;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significantly faster discharge rates of preterm deliveries from the NICU; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A 23-80% trend in reduction in preterm delivery rates occurring before 37, 35, and 32 weeks of pregnancy, but the study was not statistically powered to definitively answer whether rate reductions occurred.</span></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">AVERT PRETERM TRIAL</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Serum Assessment of Preterm Birth Outcomes Compared to Historical Controls, or AVERT PRETERM TRIAL (Clinical trials identifier: NCT03151330), was a large prospective, historically-controlled intervention trial conducted at ChristianaCare in Newark, Delaware. The purpose of the study was to evaluate the impact on health and economics by applying the PreTRM test to screen pregnant women for risk of spontaneous preterm delivery and to proactively intervene in individuals who were shown by the PreTRM test to be at higher risk of spontaneous preterm birth. Those deemed by the test to be at lower risk received standard care, as did the historical control population. As in the PREVENT-PTB study, interventions in the higher-risk group included care management (closer monitoring by their clinicians and case management nurses) and medications (e.g. vaginal progesterone, low-dose aspirin). The two co-primary endpoints were reduction in total neonatal hospital length of stay and improvement in composite neonatal morbidity and mortality in the PreTRM-screened group versus the historical control group, which did not have a PreTRM test.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">16</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Design of the AVERT PRETERM TRIAL</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img152117643_2.jpg" alt="img152117643_2.jpg" style="width:525px;height:502px;"/></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Health and economic outcomes of the screened group were compared with those of the historical control arm. Due to the COVID-19 pandemic and the halting of all non-COVID research at ChristianaCare, trial enrollment of the prospective arm was stopped in March 2020. On February 15, 2023, we announced that both co-primary outcomes&#8212;reduction of severe neonatal morbidity or neonatal death; and decreased length of neonatal hospital stay&#8212;met their endpoints, and the improvements in outcome with a PreTRM test-and-treat approach were statistically significant. Detailed results of the AVERT PRETERM TRIAL were published in the journal </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Diagnostics</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in July 2024.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">PRIME Study</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In collaboration with Elevance Health, we are conducting </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">P</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">rematurity </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">R</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">isk Assessment Combined With Clinical </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">nterventions for Improving Neonatal outco</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ME</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">s, or PRIME (Clinical trials identifier: NCT04301518), study, which is a prospective randomized controlled study anticipated to enroll up to 6,500 pregnancies in 19 respected maternal fetal medicine centers. We began enrollment in November 2020. In December 2023, we announced that the Data Safety Monitoring Board, or DSMB, overseeing our PRIME study recommended stopping enrollment due to efficacy, reporting that either co-primary endpoints, neonatal hospital length of stay and composite neonatal morbidity and mortality, met the stopping criteria for statistical significance at the pre-planned interim analysis. We adopted the DSMB&#8217;s recommendation and stopped PRIME study enrollment to focus on analyzing and reporting the available data. Patients who were enrolled at the time the study stopped continued as part of the final study results, with final outcomes available in September 2024. In January 2025, an abstract of the data was published in </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Pregnancy Journal</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and the principal investigator from the PRIME study presented key results of the study at the 2025 SMFM Pregnancy Meeting. A manuscript reporting final PRIME study results, including top-line and exploratory analyses, is being prepared for submission to a peer-reviewed publication.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">17</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">After enrollment, subjects had a blood specimen collected once during either week 19 or 20 of pregnancy (after June 28, 2022, the collection window was expanded to include the 18</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">th</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> week of pregnancy). Prospectively enrolled pregnant women were randomized 1:1 to either a screened arm, called the PTB Prevention arm, or a control arm that received standard obstetrical care. Only subjects randomized to the PTB Prevention arm received the results of the PreTRM test. Those women randomized to the PTB Prevention arm received either routine standard care pregnancy management or a multimodal intervention protocol reserved for higher risk pregnancies based on the results of the PreTRM test. The design of the PRIME study is illustrated below.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Design of the PRIME Study</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img152117643_3.jpg" alt="img152117643_3.jpg" style="width:672px;height:343px;"/></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the PTB Prevention arm, PreTRM test results were reported to the subject, the study investigator and the subject&#8217;s primary pregnancy care provider. A woman with a reported &#8220;Higher Risk&#8221; test result, at or above the 15% threshold (which is equivalent to more than a doubling of average population risk of spontaneous preterm delivery less than 37 weeks&#8217; gestation), received multiple interventions, including weekly nurse case management contact, daily vaginal progesterone, daily low dose aspirin and additional vaginal ultrasound cervical length determinations, with cerclage considered for cervical lengths less than 10 millimeters. Subjects in the &#8220;Not Higher Risk&#8221; group received standard obstetrical care for the duration of pregnancy through hospital discharge.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Major perinatal outcomes to be evaluated in each group include length of NICU and total hospital stay, measures of neonatal health, NICU preterm costs and preterm delivery rates. All subjects will be followed through the duration of the pregnancy and delivery, and neonates will be followed until initial hospital discharge to assess the course of pregnancy, labor and any related maternal or fetal complications. Readmission of infants will also be assessed at 180 days, 1 year and 3 years of life using the Elevance Health/Carelon Research Integrated Research Database to evaluate longer-term outcomes and costs associated with preterm delivery.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Other Relevant Studies and Publications</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Clinical and Economic Evaluation of the PreTRM Test</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This study modeled the clinical and economic impact of the PreTRM test for patients in the TREETOP study using actual prospectively determined test results. The model predicted improvements in neonatal and maternal hospital length of stay by 19% (p = .029) and 8.5% (p = .001), respectively, compared with standard care; neonatal costs&#8217; point estimate reductions of 16% (p = .098); and a reduction in moderate-to-severe neonatal morbidity/mortality by 29% (p = .025). In a manuscript published in December 2022, the authors concluded that the modeled evaluation of a biomarker-based test-and-treat strategy in a diverse population predicts clinically and economically meaningful improvements in neonatal and maternal outcomes (Burchard et al. J. Med. Econ. 2022 Jan-Dec;25(1):1255-1266.)</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">18</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Care Management as a Component of Obstetric Care</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This review investigated the obstetrical benefit of care management, defined as specialty clinics, social services, coordination of specialty services such as nutrition counseling, home visits or frequent phone calls by specially trained personnel, and other elements. Evidence was found for consistent reductions or trends toward reductions in preterm birth with care management, particularly among individuals with high a priori risk of preterm birth across systematic reviews, meta-analyses, and randomized controlled studies. The authors concluded that care management has substantial potential to improve the environmental, behavioral, social, and psychological factors with patients at risk of preterm birth (Garite and Manuck. Am. J. Obstet. Gynecol. 2022 Sep 19:S0002-9378(22)00746-3).</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Carelon Research/Elevance Health and Economic Study</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Carelon Research, a subsidiary of Elevance Health, conducted an insurance claims data analysis on the cost-effectiveness of screening more than 40,000 mothers and babies within Elevance Health&#8217;s commercially insured membership. The model evaluated the cost impact to be expected from screening with the PreTRM test, and from then providing a bundle of interventions to PreTRM-higher risk patients as compared to the effect of standard care without a PreTRM test. The model predicted that these interventions would result in:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a 20% reduction in preterm birth before 37 weeks&#8217; gestation;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$1,608 in gross savings per pregnant woman tested (accounting for all costs except that of a $745 list price cost modeled for the PreTRM test);</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a 10% reduction in neonatal intensive care admissions;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a 7% reduction in overall hospital length-of-stay; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a 33% reduction in births at less than 32 weeks&#8217; gestation.</span></div></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The authors concluded that the PreTRM test and treat strategy demonstrated cost savings across a variety of reasonable assumptions and scenarios examined. An abstract reporting these results was presented at the 2021 International Society for Pharmacoeconomics and Outcomes health economic conference on May 18, 2021, and a manuscript was published on the results on September 14, 2021 in the journal ClinicoEconomics and Outcomes Research. Grabner et al., Cost-Effectiveness of a Proteomic Test for Preterm Birth Prediction; Clinicoecon. Outcomes Res. (2021) 13:809-820.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The Vietnam Preterm Birth Biomarker (PBB) Study</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have continued our commitment to bring our technology to ex-US geographies and low- and middle-income settings through Bill &amp; Melinda Gates Foundation funded research by validating the PreTRM test in a large cohort in Vietnam. On March 13, 2024, the manuscript entitled: Validating the ratio of insulin like growth factor binding protein 4 to sex hormone binding globulin as a prognostic predictor of preterm birth in Viet Nam: a case-cohort study, was accepted for publication in The Journal of Maternal-Fetal &amp; Neonatal Medicine.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Product Pipeline</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">While we have leveraged our technology platform to currently pursue the development and commercialization of the PreTRM test, we believe our technology platform has broad applicability across a wide array of pregnancy-related conditions. We and our clinical trial collaborators are also continuing to conduct analyses by combining biobank data from the PAPR and TREETOP studies, to provide new insights into the predictive capabilities of the PreTRM test and other predictive biomarker algorithms. We are discovering, developing and validating a broad portfolio of product candidates including those focused on the conditions listed below.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">When we refer to &#8220;discovering, developing and validating&#8221; our product candidates, we are referring to the three phases of work for development of predictive tests as published in the NAM guidelines, as summarized below.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the &#8220;discovery&#8221; phase, we analyze a set of biologic specimens from patients whose pregnancy outcomes are already known to find biomarker differences between individuals who had an adverse pregnancy outcome versus individuals who did not have an adverse pregnancy outcome (e.g., pregnancies that delivered preterm versus pregnancies that lasted to term). We then build predictive algorithms, based on high performing predictions, to be tested in the next phase.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the &#8220;verification&#8221; phase, we apply the high performing predictive algorithms selected during the discovery phase to a completely independent set of new biologic specimens that were not tested during the discovery phase. An independent,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">19</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">external statistician then verifies, or confirms, the performance of the algorithms, and ranks them according to predictive accuracy. Once they are verified through this process, the highest performing algorithms are &#8220;locked down&#8221; in the form of optimized tests that can be validated in a final phase, prior to commercialization.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the &#8220;validation&#8221; phase, a third, entirely independent set of biologic specimens that were not tested during either the discovery phase or the verification phase are tested in a laboratory, with the laboratory blinded to patient outcomes. The laboratory data are time-stamped and are transferred to an external statistician, who applies the pre-specified algorithms to the laboratory measurements and independently validates the performance of the test by breaking the blind. At this point, a prediction that has been independently and rigorously validated can be used for clinical decision-making in trials and/or commercialization.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Molecular Time-to-Birth</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Problem and Need</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. We have already developed a high performing biomarker signature in our PreTRM test for spontaneous preterm birth risk. For a pregnant woman who is not at higher risk of preterm birth by our PreTRM test, she would typically like to know how much time is remaining in her pregnancy until delivery. Unfortunately, current methods for predicting the length of gestation, including due date prediction from last menstrual period and ultrasound dating based on fetal measurements early in pregnancy, lack precision and provide inaccurate dating as to when delivery will occur. We have identified biomarker signatures that predict the time remaining in a pregnancy with greater accuracy than is available from current methods.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Objective for a Biomarker Test</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Our objective is to develop a more accurate time-to-birth prediction for women not at higher risk of PTB. We believe this will be of great interest to pregnant women as a consumer test that may serve as an aid to decision-making for travel, work, vacation planning and other life-scheduling decisions.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Development Status</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Using our proprietary biobanks and proteomics platform, we have discovered and verified biomarkers with superior time-to-birth predictive performance, as compared to current dating methods. We have developed the ability to determine more precisely how much time is remaining in a woman&#8217;s pregnancy based on her individual biology at the time of her blood draw. We are exploring the optimal commercialization strategy of a molecular time-to-birth predictor. A manuscript entitled: </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Clock Proteins Have the Potential to Improve Term Delivery Date Prediction: A Proof-of-Concept Study</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> was published in the journal Life on February 3, 2025.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Predictive Analytics</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Problem and Need</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. As we have accumulated tens of thousands of highly curated pregnancies in our databases, the application of machine learning has opened the potential for predictive pregnancy analytics that give insight on many critical aspects of pregnancy that are relevant to both the mother (e.g. planning, expectations, education) and her physician (e.g. risk assessment, management planning).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Objective for a Predictive Analytics Tool</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. We are working to develop a predictive analytics products that can be used in combination with our clinical tests, or on its own, as a tool to understand various features and conditions of pregnancy, for both the benefit of the mother and physician.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Development Status</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. We recently developed the LikeMine</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TM</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> webapp. This product allows a user to input her health and demographic information, compares that information to large public and private databases, groups the user with a cohort of women with the same or similar health and demographic characteristics, and reports incidence levels of various pregnancy events and outcomes for that cohort at a greater level of specificity than nation-wide statistics. LikeMine is available on the internet as we conduct beta testing. This webapp was developed to provide useful information to women who are pregnant or considering becoming pregnant, and we believe it may help drive engagement with us, generate interest in our lab testing (including PreTRM testing), and potentially be a source of revenue.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Pregnancy Risk Prediction Panel</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Condition</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Up to 31% of pregnancies will develop a significant complication. Furthermore, traditional clinical risk factors miss two-thirds of these complications. The intended use of the pregnancy risk prediction panel is to identify those pregnancies at high risk of developing a significant complication, beyond spontaneous preterm birth, so they can be triaged to enhanced management and further assessment.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">20</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Development Status</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Discovery and verification work are complete, as well as a robust initial market assessment of physicians, patients, and payers.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Preeclampsia</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Condition.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Preeclampsia, estimated to affect 5% - 8% of pregnancies in the United States, is a complication characterized by high blood pressure and signs of damage to one or more organs, including liver, brain and kidneys, and may also have adverse effects on blood coagulation. Preeclampsia usually begins after 20 weeks of pregnancy in women whose blood pressure had been normal, but it can also arise earlier in pregnancies. Left untreated, preeclampsia can lead to serious, even fatal, complications for both the mother and baby. Once a pregnant woman is diagnosed with preeclampsia, a common treatment is to deliver the baby; however, if the delivery occurs before the infant reaches term (preterm preeclampsia), complications of preterm birth can ensue and clinical decisions are challenged by weighing the risk to the mother of continuing the pregnancy versus the risks to the baby associated with early delivery. We believe that a biomarker test to better identify women who are at higher risk of preterm preeclampsia earlier in pregnancy could lead to better management of this serious condition. It is estimated that the U.S. annual cost of preeclampsia is approximately $5 billion.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Objective for a Biomarker Test</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. We are working to develop a protein biomarker test that can identify women at higher risk of developing preterm preeclampsia as a means to enable earlier proactive interventions to mitigate the complications that occur as a result of this condition. We believe that such interventions could also prevent preeclampsia in certain patients, which has the potential of lowering the long-term risk of cardiovascular disease and stroke that occur later in life in women who suffer preeclampsia. There is also potential for a predictive biomarker test to inform therapeutic development to address this condition.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Development Status.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> We have completed discovery, verification and validation using our proprietary biobanks of several preterm preeclampsia biomarker predictors, some of which have been published. Some of these predictions include the use of our PreTRM test biomarkers as well as others. We are in the process of selecting the final predictor and the optimal commercialization strategy.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other Potential Products</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Growth Restriction</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Condition</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Fetal growth restriction, or FGR, is estimated to affect as many as approximately 3%-7% of pregnancies worldwide. There are immediate consequences of FGR, including fetal challenges in withstanding the stresses of vaginal delivery, decreased oxygen levels and brain injury, hypoglycemia (low blood sugar), lower resistance to infection, difficulty in maintaining body temperature and abnormally high red blood cell counts. In the longer term, infants can have neurodevelopment issues, metabolic and cardiovascular complications.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Objective for a Biomarker Test for FGR</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. By identifying molecular events that precede measurable changes in fetal size, we aim to address the placental dysfunction and other growth restriction etiologies that lead to fetal growth restriction and thereby enable earlier proactive interventions.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Development Status</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. We have discovered placental dysfunction biomarkers as a first step to predicting fetal growth restriction. We are working to discover additional biomarkers that illustrate expression differences in normal and growth-restricted pregnancies. We believe that this work could lead to improved detection of FGR pregnancies earlier and may lead to proactive interventions to better address this problem. Verification and validation phases and publication of our findings, based on the NAM guidelines described above, will be required before such testing can be commercialized.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Gestational Diabetes Mellitus</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Condition</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Gestational diabetes mellitus, or GDM, is characterized by high blood sugar levels, or hyperglycemia, during pregnancy in a woman who was not diabetic before her pregnancy. GDM is estimated to affect approximately 10% of pregnancies and cost $1.6 billion annually in the United States as a result of short- and long-term maternal and child complications. GDM increases the risk of preeclampsia, depression, and the need for Caesarean sections. Babies born to mothers with poorly treated GDM are at increased risk of being too large, having low blood sugar after birth, and jaundice. If untreated, GDM can also result in stillbirth. Children born from mothers with GDM are also at risk of being overweight and developing type 2 diabetes. We believe that knowing who is at high risk of GDM earlier in pregnancy would be of great benefit given that interventions could significantly reduce the adverse effects of this condition. Current methods for</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">21</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">identifying GDM in most patients typically take place between 24-26 weeks&#8217; gestation, missing opportunities to allow such women to receive proactive interventions earlier in pregnancy that may be effective in preventing or mitigating GDM.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Objective for a Biomarker Test</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Our goal is to develop a blood-based biomarker test that can identify earlier in pregnancy which women are likely to develop GDM. We believe that such information will enable earlier interventions to mitigate risks and help focus resources on higher risk pregnancies as a means to improve the health of mothers and babies.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Development Status</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. We have discovered and verified high performing biomarker prediction of GDM by applying our proteomics platform technologies to specimens from our PAPR and TREETOP biobanks. We plan on further verifying and ultimately validating a GDM predictor and publishing its performance data prior to making it available commercially, based on the NAM guidelines described above.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stillbirth</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Condition</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Stillbirth is a heartbreaking and tragic outcome, with a reported incidence of 5.7 per 1,000 pregnancies in the United States. Stillbirth is typically defined as fetal loss occurring after 20 weeks&#8217; gestation. Causes of stillbirth include placental or umbilical cord problems, preeclampsia, lupus, clotting disorders, lifestyle choices, and infection, among others. Approximately one-third of U.S. stillbirth cases occur without any known cause.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Objective for a Biomarker Test for Stillbirth</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Our goal is to discover biomarker expression changes that occur early during pregnancy that are highly predictive of changes taking place in the mother and/or the fetus that increase the risks of stillbirth, so that appropriate interventional strategies can be developed to address this condition. Given that our vision is to comprehensively profile the biology of pregnancy by leveraging our platform technologies to characterize disruption of normal developmental biology in both the mother and the fetus, we believe that there is a significant opportunity to improve earlier detection and the potential to develop targeted interventions to better address this serious problem.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Development Status</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. We have developed the ability to measure the expression of hundreds of proteins by our advanced mass spectrometry proteomic technology. These proteins are members of key biochemical proteomic pregnancy signaling pathways, including pathways that are operative in stillbirth. As we increase the density of proteins characterized in future discovery work, we believe that further characterization of pregnancy and key proteomic expression factors in stillbirths vs. normal pregnancies is a promising area for further discovery, verification and validation of high performing biomarkers predictors with potential to improve detection and enable new interventions for stillbirth. Finally, we note that development for prediction of other adverse outcomes (e.g., growth restriction) has the potential to reduce stillbirth.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Postpartum Depression</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Condition</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. There are hormonal, physiological and psychological changes that occur in women both during and after pregnancy. Postpartum depression is a severe form of clinical depression related to pregnancy and childbirth, affecting approximately 15% of women during the year following delivery of a child. By contrast, the &#8220;baby blues&#8221; is a transient, well-known phenomenon that typically resolves on its own. The annual U.S. economic burden of postpartum depression is estimated to be approximately $2.4 billion. We believe that a biomarker test for postpartum depression is another area where our platform can be beneficially applied. We believe that early identification of such pregnancies will enable a number of approaches that may prevent or mitigate the severity of this common condition, and that this information may also facilitate drug discovery.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Objective for a Biomarker Test for Postpartum Depression</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Our objective is to leverage our understanding of key pregnancy, pathways gained through the application of our advanced proteomic technologies and bioinformatics, to develop further insights for early identification of pregnancies that are destined to develop postpartum depression.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Development Status</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. In our discovery efforts, we have discovered protein expression patterns in hormone signaling pathways and other pathways of pregnancy that we believe may be operative in the development of postpartum depression. We are working to increase the coverage of biochemical signaling pathways and expression patterns related to postpartum depression in our protein expression database, which we believe will enable the development of a high performing predictor to address this area.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">22</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Timing of Pipeline Development</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">s</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the development of high-performing biomarker signatures, the timing of when to move from the discovery phase to the verification phase to the validation phase, based on the NAM guidelines described above, is entirely dependent on the performance data. There are also the additional requirements to analytically validate the particular components measured in biomarker tests by our laboratory and to build the informatics and automation for integrating all components into new testing processes. Given the uncertainties in reliably predicting timing for these phases and additional requirements, we estimate that the timing for our next new commercially available product is a matter of months or years. We will only advance our programs from one stage to the next if we believe that they qualify for advancement pursuant to the NAM guidelines described above. We believe that additional capital required to do this work could help to accelerate the progress on our comprehensive pregnancy pipeline.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Commercialization</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Health care insurers characterize preterm birth as an exceptionally costly condition and develop data and models that underscore the economic impact of preterm births. Given the substantial economic benefits demonstrated by the use of the PreTRM test, we are pursuing reimbursement for the PreTRM test by integrated systems, institutional physician networks, self-insured employers, and major health insurance payers. Furthermore, we have an existing commercial collaboration agreement with Elevance Health that we believe could introduce PreTRM testing into its various health plans.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">With the publication of results from the AVERT trial and anticipated publication of results from the PRIME study, we have entered a new phase of commercialization focused on driving clinician awareness, seeking early reimbursement, creating supporting evidence for guideline inclusion, accelerating PreTRM test adoption in the United States, and exploring international expansion.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Drive Clinician Awareness and Education with New Evidence</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We plan to continue driving awareness by deploying online and in-person training and educational tools that demonstrate the unmet need surrounding preterm birth and how the clinically-proven PreTRM test-and-treat strategy can be a solution to this need. To date, our use of leading digital education platforms have shown strong effectiveness in reaching physicians as evidenced by an extremely high engagement rate.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additionally, we expect to spread general awareness of our test and amplify awareness and education through public relations efforts and collaborating with advocacy groups to include our latest research and insights on benefits to the health of mothers and newborns.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Critically, we believe clinician awareness needs to include PreTRM test-and-treat implementation guidance and we intend to distribute the data for care protocols and outcomes from the implementation of the test-and-treat strategy in our clinical trials and real-world evidence trials, once available.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Finally, we will partner with professional societies to support physicians in seeking reimbursement for the intervention bundle used in our trials.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Partner with Early Adopter Payers for Reimbursement</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are pursuing reimbursement from commercial and public payers in those markets where the PreTRM test is already being used with support of clinical opinion leaders. We are also engaging with benefits design managers and employers directly to ensure we find innovators and early adopters in the market.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We will seek to publish our health economics data in a peer-reviewed journal and make our health economics model available for payers and health systems to model the potential impact of implementing the PreTRM test in their member population using varying assumptions such as the prevalence of preterm birth, the costs of the PreTRM test and accompanying interventions for those deemed at higher risk, and total costs of care for neonates who have complications due to preterm births, among other relevant factors in their markets.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">23</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Guidelines Development Support</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Generating publications and scientific presentations based on new evidence from AVERT, PRIME, and additional studies is a core pillar in our efforts to establish the validity and utility of the PreTRM test in the community for guideline inclusion. We plan to work closely with maternal fetal medicine experts, payers and key opinion leaders to generate clear use cases, as well as peer-reviewed publications that illustrate our product performance claims and value proposition. We have worked and continue to work with more than 60 investigators worldwide.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have launched efforts to broaden our PreTRM investigator and key opinion leader network with the Investigator-Initiated Research Program at the SMFM meeting in January 2025. This program will support investigators interested in researching the use of the PreTRM test and current and novel interventions to reduce health complications of preterm birth.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We believe that interventions which are effective in reducing health disparities are a priority for professional societies to evaluate. We will seek to publish the efficacy of the PreTRM test-and-treat strategy from our recently completed PRIME study and to continue real-world evidence studies to understand the impact of the PreTRM test in reducing health disparities.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Accelerate Test Adoption</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Achieving broad-based adoption within each geographic area requires building a strong ecosystem of payer support for reimbursement, leading local key opinion leader championship to help educate physicians in the community, early adopter institutions choosing to implement the PreTRM test-and-treat strategy, building consumer awareness to reduce the time needed for physicians to educate mothers, and enabling access to care management delivery resources for physicians to be able to care for patients identified at higher risk of preterm birth.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The prevalence and economic burden of preterm birth varies dramatically across the United States For example, according to the March of Dimes report in 2024, Nevada and Louisiana, have nearly 50% higher preterm birth rates than the national average (15% versus 10.3% national average). We have begun expanding our commercial efforts and team to be available to partner with stakeholders in states with higher rates of preterm birth, where the need is greatest, to ensure effective communication and support to each stakeholder in those areas and to expand to additional states as adoption grows. This staged expansion allows us to build strong, locally-supported ecosystems and to drive adoption cost effectively, while maintaining national campaigns to educate clinicians that can scale with additional reimbursement agreements and institutional champions supporting our growth.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Medicaid pays for the costs of 43% of births in the United States Given the focus of public health agencies on improving maternal care and saving costs, we will pursue partnerships to measure and demonstrate the impact on the Medicaid population in each area we enter.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Accelerating adoption will include increasing the size of our commercial team, adding capabilities and staffing through additional investment in field and inside sales, marketing, clinical/medical, customer service, managed care and revenue cycle personnel. We anticipate that our sales team will promote our products with a targeted focus on OB/GYNs and maternal-fetal medicine providers in certain key markets and segments (e.g., integrated systems, large physician practices).</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Full commercialization of clinical tests may also require the expansion of our market access team to secure contracts with commercial and governmental payers as adoption grows. Achievement of professional society recommendations will be a catalyst for further expansion of our commercial team and efforts to support broad-based adoption nationwide. Our multi-faceted digital marketing platform will support scaling consumer awareness and engagement.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Exploring International Expansion</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are also evaluating the expansion of our business internationally, with an initial focus on Europe. The prevalence of preterm birth, single-payer environments, and guidelines which already include components of our intervention bundle for preterm birth, make larger European markets an accessible opportunity for the PreTRM test.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are actively preparing test manufacturing capabilities through partnerships with companies present in Europe and are working with opinion leaders and regulators to potentially bring the PreTRM test-and-treat solution to these markets.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additionally, we may pursue other market expansions through partners who have expressed interest in commercializing PreTRM in their markets.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">24</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Clinical Laboratory Characteristics</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our PreTRM testing laboratory is based in Salt Lake City, Utah. We operate under federal regulations as a CLIA-certified laboratory, and we hold all required state licenses. We undergo regular inspections from federal and state regulatory authorities, and our laboratory is accredited by the College of American Pathologists, or CAP.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have optimized our mass spectrometry-based proteomics workflow to be analytically validated to produce accurate and precise patient results. To meet the demands of the large intended use population of the PreTRM test, we have validated an ambient specimen collection and shipping process that removes the need to ship specimens under frozen conditions using dry ice. Additionally, we are further developing state-of-the-art affinity-capture mass spectrometry, or AC-MS, process. This higher through-put and lower-cost improvement to our current workflow utilizes custom monoclonal antibodies and magnetic beads. Affinity capture of our PreTRM test analytes using magnetic beads coated with antibodies is amenable to automated liquid handling robots using 96 or 384 well plates. Moreover, the AC-MS process results in a large decrease in the complexity of patient serum specimens in a single highly parallel and multiplexed step, which translates to shorter mass spectrometry processing times. We believe the AC-MS process can be leveraged to enable a many-fold increase in capacity and significantly decrease turn-around time and cost of goods sold. We are also developing immunoassays, some of which may be able to incorporate the custom antibodies developed for the AC-MS process. AC-MS and immunoassay versions of our testing products may be suitable for our current ambient process and other lower-cost specimen collection and shipping devices in the future.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Material Agreements</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Elevance Health Commercial Collaboration Agreement</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In February 2021, we entered into a commercial collaboration agreement with Elevance Health, or the Commercial Collaboration Agreement, relating to the commercialization of the PreTRM test.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under this agreement, we agreed to provide PreTRM tests to eligible individuals enrolled in, or serviced or covered by, the health insurance products of Elevance Health. We also agreed to develop a sales, marketing, and customer service program, and to provide training and marketing to duly licensed physicians specializing in obstetrics and gynecology or family medicine, or licensed nurse midwives, at the reasonable request of Elevance Health. Pursuant to the agreement, Elevance Health agreed to purchase a specified minimum number of tests from us for each of the first three years of the term of the agreement. Additionally, Elevance Health agreed to pay us a specified minimum amount per year for the first three years of the term of the agreement.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Elevance Health has been participating in our PRIME study, and at the conclusion of the PRIME study, under the Commercial Collaboration Agreement, the parties agreed to use commercially reasonable efforts to enter into Elevance Health&#8217;s standard lab provider agreement. Unless earlier terminated due to breach, the Commercial Collaboration Agreement will remain in effect until the later of (a) the third anniversary of the effective date or (b) the date on which Elevance Health has purchased a fixed number of PreTRM tests as agreed by the parties.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Elevance Health Laboratory Services Agreement</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Effective in November 2020, we entered into a laboratory services agreement with Elevance Health, or the Laboratory Services Agreement, relating to our provision of PreTRM tests and related services during the course of the PRIME study.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under this agreement, we provided clinical laboratory services as requested by participating physicians and other health care professionals, and written reports to those physicians and professionals of the results of the services performed in accordance with the PRIME study. Elevance Health agreed to collaborate with us on the conduct of the PRIME study, and paid us a specified amount per test up to a specified maximum number of tests.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Competition</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The life science industry, including companies engaged in molecular diagnostics and proteomics, is characterized by rapidly advancing technologies, intense competition, substantial resources devoted to securing strong intellectual property protection and a focus on developing innovative, proprietary products. To our knowledge, however, there have been few successful efforts by others to date to discover, verify and validate prognostic biomarker tests to predict conditions of pregnancy, and we are aware of no competitors that have discovered, verified and broadly validated a blood-based biomarker</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">25</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">test to predict a pregnant woman&#8217;s risk of a spontaneous preterm birth. We therefore believe that our PreTRM test has the benefit of strong first-to-market positioning and validated performance as we pursue our commercialization efforts. In addition, we believe that our proprietary technology platform, including our extensive biobanks, advanced mass spectrometry approaches and bioinformatics capabilities, provides us with valuable competitive assets to utilize in discovering and developing other products and services for pregnancy conditions, several of which are already in our pipeline. Coupled with the experience and expertise of our management and scientific teams, we believe we possess meaningful potential to compete in developing and commercializing important products to improve the pregnancy experience and the health of mothers and babies.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notwithstanding the foregoing advantages, given the potential market opportunity represented by the PreTRM test and other pregnancy-related products and services that we may develop, we expect competition to emerge and intensify in the coming years, with one or more competitive offerings resulting from competitors&#8217; efforts. Competing products may arise from various sources, including molecular diagnostic companies, clinical laboratory companies, life sciences tool companies, third-party service providers, academic research institutions, governmental agencies and public and private research institutions. From time to time, results of early biomarker discovery work are published in scientific literature. These publications are demonstrative of interest in the field, but they have so far typically lacked evidence of strict adherence to the NAM guidelines for multi-omics prediction development and have not achieved rigorous validation of predictions of interest.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Many of the potential competitors that may emerge, either alone or with their collaborators, may have significantly greater resources, established presence in the market, expertise in research and development and greater experience in laboratory operations, obtaining regulatory approvals, gaining reimbursement and commercializing approved products than we do. These competitors are also expected to compete with us in recruiting and retaining qualified scientific, sales, marketing and management personnel, conducting clinical studies, publishing scientific research and acquiring technologies that may be complementary to, or necessary for, the ongoing robustness of our discovery, development and commercialization efforts. Other smaller or early-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies. Additional mergers and acquisitions may result in even more resources being concentrated in our competitors.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Intellectual Property</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We rely on a combination of patents, trade secrets, copyrights and trademarks, as well as contractual protections, to establish and protect our intellectual property rights. Our success depends in part on our ability to obtain and maintain intellectual property protection for our tests and technology. In particular, we seek to protect the PreTRM test and any potential future products or services through a variety of methods, including seeking and maintaining patents intended to cover current and future products and services, their methods of use and processes for their manufacture, and any other inventions that are commercially important to the development of our business. We seek to obtain domestic and international patent protection which includes, in addition to filing and prosecuting patent applications in the United States, typically filing counterpart patent applications in additional countries where we believe such foreign filing is likely to be beneficial, including Europe, Japan, Canada, Australia and China.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December&#8239;31, 2024, our intellectual property portfolio encompasses four issued U.S. patents, eight pending U.S. non-provisional patent applications, one international patent application under the Patent Cooperation Treaty (PCT), twenty-three granted foreign patents in Canada, Poland, Switzerland, China, France, Germany, Italy, Ireland, Japan, Spain, Russia, Australia, Israel, the United Kingdom, and seventeen member states of the European Union through a European patent with unitary effect, thirty-five pending foreign patent applications, and two U.S. provisional applications. Our owned patents and patent applications, if issued, are expected to expire between 2034 and 2045, in each case without taking into account any possible patent term adjustments or extensions and assuming payment of all appropriate maintenance, renewal, annuity, or other governmental fees.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Within our intellectual property portfolio, we own three patent families that relate to our PreTRM test. The patent applications of the first patent family include composition claims directed to panels of biomarkers and corresponding method claims for determining probability for preterm birth, gestational age at birth or time to birth in a pregnant female. The first patent family includes a pending U.S. patent application, nine foreign patents granted in Australia, France, Germany, Italy, Ireland, Spain, Canada, Japan, and the United Kingdom, and five pending foreign patent applications in the EPO, China, Australia, Japan, and Canada. The granted patents and pending patent applications, if issued, are expected to expire in 2034, without taking into account maintenance, renewal, annuity, or other governmental fees. The patent applications of the second patent family include composition claims directed to compositions of biomarkers, panels of biomarkers, and corresponding method claims for determining probability for preterm birth in a pregnant female, and discloses methods for determining probability of gestational diabetes. The second patent family includes three issued U.S. patents, twelve foreign patents</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">26</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">granted in Japan, Russia, Australia, China, Israel, Ireland, Poland, Spain, Switzerland, the United Kingdom, and seventeen member states of the European Union through a European patent with unitary effect, one pending U.S. patent application and ten pending foreign patent applications in the EPO, Canada, Australia, Japan, Hong Kong, Brazil, and China. The granted patents and pending patent applications, if issued, are expected to expire in 2036, without taking into account any possible patent term adjustment or extensions and assuming payment of all appropriate maintenance, renewal, annuity, or other governmental fees. The patent applications of the third patent family include claims directed to antibodies and methods of using such antibodies for binding to specific biomarkers. The third patent family includes one pending U.S. application and six pending foreign patent applications in the EPO, Canada, Japan, Australia, Korea, and Brazil. The pending patent applications, if issued, are expected to expire in 2043, without taking into account any possible patent term adjustment or extensions and assuming payment of all appropriate maintenance, renewal, annuity, or other governmental fees.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">   </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We also own granted patents and pending patent applications directed to other indications. One patent family relates to determining probability for preeclampsia in a pregnant female, and includes two granted patents in Australia and Canada, and five patent applications pending in the U.S., the EPO, Australia, Hong Kong, and Canada. The granted patent and pending patent applications, if issued, are expected to expire in 2034, without taking into account any possible patent term adjustment or extensions and assuming payment of all appropriate maintenance, renewal, annuity, or other governmental fees. Similarly, another related patent family is directed to biomarker panels and methods for predicting preeclampsia in a pregnant female. This includes four patent applications pending in the U.S., the EPO, Canada, and Japan. The pending patent applications, if issued, are expected to expire in 2042, without taking into account any possible patent term adjustment or extensions and assuming payment of all appropriate maintenance, renewal, annuity, or other governmental fees. A third patent family relates to determining probability for preterm birth associated with preterm premature rupture of membranes in a pregnant female. It includes one pending U.S. patent application and three patent applications pending in Japan, Australia, and Israel. The pending patent applications, if issued, are expected to expire in 2037, without taking into account any possible patent term adjustment or extensions and assuming payment of all appropriate maintenance, renewal, annuity, or other governmental fees. A fourth patent family relates to determining the estimated due date for a pregnant female, and includes one granted patent in the U.S. and four patent applications pending in the U.S., the EPO, Canada and Australia. The pending patent applications, if issued, are expected to expire in 2038, without taking into account any possible patent term adjustment or extensions and assuming payment of all appropriate maintenance, renewal, annuity, or other governmental fees. A fifth patent family relates to pairs of biomarkers, compositions, and methods for predicting the probability for preterm birth in a pregnant female. It includes two pending applications in the U.S. and Canada. Any patent applications from this patent family, if issued, are expected to expire in 2042, without taking into account any possible patent term adjustment or extensions and assuming payment of all appropriate maintenance, renewal, annuity, or other governmental fees.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">   </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We also continue to file patent applications on new developments and improvements that may be important to our future business.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We cannot be sure that patents will be granted with respect to any of our pending patent applications or with respect to any patent applications we may own or license in the future, nor can we be sure that any of our existing patents or any patents we may own or license in the future will be useful in protecting our technology. Please see &#8220;Risk Factors &#8212; Risks Related to Our Intellectual Property&#8221; for additional information on the risks associated with our intellectual property strategy and portfolio.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We continually assess and refine our intellectual property strategy in order to fortify our position, and file additional patent applications when our intellectual property strategy warrants such filings. We intend to pursue additional intellectual property protection to the extent we believe it would be beneficial and cost-effective. Our ability to stop third parties from making, using, selling, offering to sell, importing or otherwise commercializing any of our patented inventions, either directly or indirectly, will depend in part on our success in obtaining, defending and enforcing patent claims that cover our technology, inventions, and improvements. With respect to our intellectual property, we cannot provide any assurance that any of our current or future patent applications will result in the issuance of patents in any particular jurisdiction, or that any of our current or future issued patents will effectively protect any of our tests or technology from infringement or prevent others from commercializing infringing tests or technology. Even if our pending patent applications are granted as issued patents, those patents may be challenged, circumvented or invalidated by third parties. Consequently, we may not obtain or maintain adequate patent protection for any of our tests or technology.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition to our reliance on patent protection for our inventions, tests and technology, we also rely on trade secrets, know-how, confidentiality agreements and continuing technological innovation to develop and maintain our competitive position. For example, some elements of manufacturing processes, analytics techniques and processes, as well as computational-biological algorithms, and related processes and software, are based on unpatented trade secrets and know-how that are not publicly disclosed. Although we take steps to protect our proprietary information and trade secrets, including</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">27</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">through contractual means with our employees, advisors and consultants, these agreements may be breached and we may not have adequate remedies for any breach. In addition, third parties may independently develop substantially equivalent proprietary information and techniques or otherwise gain access to our trade secrets or disclose our technology. As a result, we may not be able to meaningfully protect our trade secrets. For further discussion of the risks relating to intellectual property, see the section titled &#8220;Risk factors &#8212; Risks Related to our Intellectual Property.&#8221;</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Government Regulation</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Federal and State Regulations Related to Clinical Laboratories</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Clinical Laboratory Improvement Amendments of 1988</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a clinical laboratory, we are required to be certified under CLIA to conduct our business. Our clinical laboratory facility located in Salt Lake City, Utah holds a CLIA Certificate of Accreditation.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are also accredited by CAP. CMS has deemed CAP standards to be equal to or more stringent than CLIA regulations, and CAP is authorized to inspect the laboratories that it accredits on CMS&#8217; behalf.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under CLIA, a laboratory is any facility that performs laboratory testing on specimens derived from human beings for the purpose of providing information for the diagnosis, prevention, or treatment of disease or the impairment or assessment of health. CLIA requires that such laboratories obtain certification from the federal government and maintain compliance with various operational, personnel qualification, facilities administration, quality control and assurance, and proficiency testing requirements intended to ensure the accuracy, reliability, and timeliness of patient test results. CMS, part of the U.S. Department of Health and Human Services, or HHS, administers the CLIA certification program. CLIA certification is also necessary to bill state and federal health care programs, as well as many private insurers, for laboratory testing services.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CLIA requires that we hold a certificate that specifies the categories of testing we perform and that we comply with certain standards applicable to such tests. In addition, CLIA specifies certain testing categories requiring periodic proficiency testing, and certified laboratories performing these tests must enroll in an approved proficiency testing program.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, as a condition of CLIA certification, our laboratory is subject to survey and inspection every other year, as well as random inspections. These biannual surveys are typically conducted by CAP because we hold a CLIA Certificate of Accreditation.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Laboratories like ours that perform high-complexity testing are required to meet more stringent requirements than laboratories performing less complex tests. A high-complexity CLIA-certified laboratory may develop, validate, and use proprietary tests referred to as laboratory developed tests, or LDTs. All of our current products are LDTs (as discussed further below under &#8220;Federal Oversight of Laboratory Developed Tests&#8221;). CLIA requires laboratories to demonstrate the analytical validity of any LDT used in clinical testing.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If our laboratory is determined to be out of compliance with CLIA requirements at any inspection or otherwise, we may be subject to sanctions such as suspension, limitation or revocation of our CLIA certificate, a directed plan of correction, on-site monitoring, civil monetary penalties, civil injunctive suits, criminal penalties, among other potential penalties, as well as significant adverse publicity, all of which may have a materially adverse impact on our business.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">State Regulation of Clinical Laboratories</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our laboratory is located in Salt Lake City, Utah. Utah requires that laboratories located in this state hold a CLIA certificate (which we do), as well as approval by the Utah Department of Health, or UT DOH, to operate a laboratory. In addition to meeting CLIA requirements and holding a valid CLIA certificate, Utah requires that our laboratory timely notify the UT DOH of certain changes and demonstrate successful performance of proficiency testing in an approved proficiency testing program or approved alternative testing program. If our clinical laboratory is out of compliance with these standards, the UT DOH may revoke our approval to perform testing or potentially impose other remedial measures, any of which could materially affect our business. We maintain an approval in good standing with the UT DOH.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CLIA provides that a state may adopt laboratory regulations that are more stringent than those under federal law, and one such state, New York, has implemented its own more stringent laboratory regulatory requirements. Additionally, several states require the licensure of out-of-state laboratories that accept specimens from those states and/or receive specimens from</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">28</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">laboratories in those states. One such state is New York. We have obtained licenses from states where we believe we are required to be licensed. Other states beyond those from which our laboratory currently holds licenses may adopt licensure requirements in the future, which could require us to modify, delay, or discontinue our operations in such jurisdictions. If we identify any other state with such requirements or if we are contacted by any other state advising us of such requirements, we intend to follow instructions from the state regulators as to how to comply with such requirements.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, as part of the laboratory licensure process, the New York State Department of Health, or NY DOH, requires that laboratories seeking licensure establish the analytic and clinical performance characteristics of all tests performed, and also imposes specific review and approval requirements on certain categories of testing, including LDTs. As an LDT, our PreTRM test is subject to this NY DOH review and approval process.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If a laboratory is out of compliance with state laws or regulations governing licensed laboratories, penalties may include suspension, limitation or revocation of the license, assessment of financial penalties or fines, or imprisonment. Loss of a laboratory&#8217;s state license may also result in the inability to receive payments from state and federal health care programs as well as private insurers, all of which may have a materially adverse impact on our business.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We also may become subject to regulation in foreign jurisdictions as we begin seeking to expand international utilization of our PreTRM test and any future tests we develop, and the jurisdictions in which we pursue operations adopt licensure requirements for U.S.-based clinical laboratories offering and providing diagnostic testing services to professionals located in those jurisdictions. Foreign licensure requirements could require review and modification of our tests in order to offer them in certain jurisdictions or could impose other limitations, such as restrictions on international data transfer or on the U.S. importation of human tissue specimens necessary for our Utah laboratory to perform our tests, that may limit our ability to make our tests available outside of the United States on a broader scale.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Regulation of Clinical Trials</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have conducted and are currently conducting a variety of studies for the PreTRM test and our other tests in development that involve clinical investigators at multiple sites in the U.S. We may need to conduct additional studies for the PreTRM test, as well as other tests we may offer in the future, to drive test adoption in the marketplace and reimbursement. Should we not be able to perform these studies, or should their results not provide clinically meaningful data and value for clinicians, adoption of our tests could be impaired and we may not be able to obtain reimbursement for them.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The conduct of clinical trials is also subject to extensive federal and institutional regulations, which regulations are intended to assure that the data and reported results are credible and accurate, and that the rights, safety, and welfare of study participants are protected. Most studies involving human participants must be reviewed and approved by, and conducted under the auspices of, a duly-constituted institutional review board, or IRB, which is a multi-disciplinary committee responsible for reviewing and evaluating the risks and benefits of a clinical trial for participating subjects and monitoring the trial on an ongoing basis. Companies sponsoring the clinical trials and investigators also must comply with, as applicable, regulations, guidelines and IRB requirements for obtaining informed consent from the study subjects, following the protocol and investigational plan, adequately monitoring the clinical trial, and timely reporting of adverse events. We believe our clinical trials conducted to date have met applicable regulatory requirements. The sponsoring company or the IRB may suspend or terminate a clinical trial at any time on various grounds, including a finding that the subjects are being exposed to an unacceptable health risk. In addition, studies involving human participants often require significant time and cash resources to complete and are subject to a high degree of risk, including risks of experiencing delays, failing to complete the trial or obtaining unexpected or negative results.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The International Committee of Medical Journal Editors, or ICMJE, requires trial registration as a condition of the publication of research results generated by a clinical trial. To fulfill this obligation organizations and individuals can provide the information required by ICMJE either to ClinicalTrials.gov, which is maintained by the U.S. National Institutes of Health, or to a World Health Organization registry. In accordance with this publication policy to ensure that our investigators can publish their findings, and to further our participant enrollment activities for various studies, we register all of the clinical trials that we sponsor with ClinicalTrials.gov.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Federal Oversight of Laboratory Developed Tests</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our first commercial clinical diagnostics product, the PreTRM test, is an LDT that we process in our single CLIA-certified central laboratory. The Food and Drug Administration, or FDA, had historically exercised enforcement discretion to not enforce medical device regulatory requirements with respect to most tests developed, manufactured and performed within a single high-complexity CLIA-certified laboratory. In May 2024, FDA issued a final rule aimed at regulating LDTs under</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">29</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the current medical device framework and phasing out its existing enforcement discretion policy over several years, as discussed further below. Any changes in FDA&#8217;s approach to regulation of LDTs generally, or its approach to regulating the PreTRM test specifically, could adversely impact our business.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FDA Oversight of LDTs and In Vitro Diagnostics Devices</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">While clinical laboratory tests are regulated under CLIA, which is administered by CMS, as well as by applicable state laws, the FDA separately has jurisdiction over medical devices pursuant to its authority under the Food, Drug, and Cosmetic Act, or FD&amp;C Act. In vitro diagnostic devices, or IVDs, intended for clinical purposes are a type of medical device under the FD&amp;C Act and thus fall within the FDA&#8217;s jurisdiction, and the agency applies its authority under the FD&amp;C Act to those IVDs, which include both test kits and specimen collection kits, that are manufactured, packaged, and distributed in interstate commerce. LDTs are considered to be a subset of IVDs that are designed, manufactured, and used within a single laboratory. The FDA regulates, among other matters, the research, testing, manufacturing, safety, labeling, storage, recordkeeping, premarket clearance or approval, marketing and promotion and sales and distribution of medical devices, including IVDs, in the U.S. to ensure that such products on the domestic market are safe and effective for their intended uses. In addition, the FDA regulates the import and export of medical devices. Many of the instruments, reagents, kits or other consumable products used within our laboratory, as well as our recently developed whole-blood collection kit, are regulated as medical devices and therefore must comply with FDA quality system regulations and certain other device requirements. We have policies and procedures in place to ensure that we source such materials from suppliers that are in compliance with any applicable medical device regulatory requirements.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Although the FDA has statutory authority to ensure that medical devices, including IVDs, are safe and effective for their intended uses, the FDA historically exercised enforcement discretion and generally did not enforce applicable provisions of the FD&amp;C Act and regulations with respect to LDTs. Despite its exercise of enforcement discretion, there have been numerous proposals over the years to modify how LDTs may be brought into a harmonized paradigm for oversight by the FDA and CMS. As noted above, the FDA issued a final rule in May 2024 that is intended to regulate LDTs under the current medical device framework and to phase out the agency&#8217;s existing enforcement discretion policy for this category of diagnostic tests; the final rule became effective on July 5, 2024. The LDT enforcement policy phase-out process will occur in gradual stages over a total period of four years, with premarket approval applications for high-risk tests to be submitted by the 3.5-year mark. Moderate-risk and low-risks tests are expected to be in compliance at the 4-year mark, although FDA has stated that if premarket submissions are pending review it will continue to exercise enforcement discretion with respect to those tests. The FDA&#8217;s final rule is complex and, concurrently, the agency announced several exceptions from the requirement to comply with full medical device regulatory controls, depending upon the specific nature of the LDT and the clinical laboratory that is offering such LDT for use by health care providers. Importantly, under the agency&#8217;s transition plan, LDTs that were marketed prior to the official publication date of the final rule (May 6, 2024) are considered to be &#8220;currently marketed&#8221; tests. &#8220;Currently marketed&#8221; tests will become subject to many of the device regulatory controls but are exempted from the premarket review and FDA authorization requirements, unless or until significant modifications are made to such &#8220;currently marketed&#8221; tests. Similarly, FDA has created a partial enforcement discretion policy for tests approved by the NY DOH&#8217;s Clinical Laboratory Evaluation Program, whereby such tests also do not need to undergo FDA premarket review but must come into compliance with all other device general controls in a staggered fashion between 2025 and 2027.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Publication of the LDT final rule prompted the American Clinical Laboratory Association (ACLA) and one of its members, on May 29, 2024, as well as the Association for Molecular Pathology (AMP) and one of its members, on August 19, 2024, to file complaints against the FDA in the Eastern District of Texas and the Southern District of Texas, respectively. Both complaints allege that the agency does not have authority to promulgate the LDT final rule and seek to vacate the FDA&#8217;s action; the two cases were subsequently consolidated into a single action pending in the Eastern District of Texas. Arguments in the consolidated case took place on February 19, 2025 and the outcome of this ongoing litigation is uncertain at this time. Further, it remains possible that the Trump Administration may take steps to rescind or modify the LDT final rule in the future. Affected stakeholders also continue to press for a comprehensive legislative solution to create a harmonized paradigm for oversight of LDTs by both the FDA and CMS, instead of implementation of the FDA final rule, which may be disruptive to the industry and to patient access to certain diagnostic tests. However, this FDA rulemaking was initiated after years of failed congressional attempts to harmonize the regulatory paradigms applicable to LDTs and other IVDs, making unclear whether any legislative efforts would be successful going forward.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the FDA's LDT final rule and staggered implementation timeline, we would become subject to increased regulatory burdens such as registration and listing requirements, adverse event reporting requirements, and quality control requirements with respect to our currently marketed PreTRM test. Further, significant updates or modifications to the PreTRM test, as well as any other future LDTs we may develop, will become subject to more onerous regulation by the FDA, if and when the FDA begins to actively enforce its device premarket submission regulations with respect to LDTs, whether as</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">30</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a result of new legislative authority in the future or under the May 2024 LDT final rule. Depending upon the risk classification of each individual test, we may be required to obtain premarket clearance for future tests under Section 510(k) of the FDC Act or approval of a premarket approval application, or PMA. The process for submitting a 510(k) premarket notification and receiving FDA clearance usually takes from 3 to 12 months, but it can take significantly longer, and clearance is never guaranteed. The process for submitting and obtaining FDA approval of a PMA generally takes from 1 to 3 years or even longer, and approval is not guaranteed. A PMA typically requires extensive clinical data and can be significantly longer, more expensive and more uncertain than the 510(k) clearance process. Any such process would likely be costly and time-consuming, and we cannot assure that significant modifications to PreTRM, or any new tests that we may develop in the future, will be authorized for marketing by the FDA in a timely or cost-effective manner, if at all.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Moreover, if the FDA were to disagree with our conclusion that the currently marketed PreTRM test falls within the scope of the agency&#8217;s existing LDT definition and enforcement discretion policies, and the agency thus asserts that the existing PreTRM test is subject to FDA&#8217;s medical device authorities and implementing regulations, the agency could require that we obtain premarket approval or another type of device premarket authorization in order for us to continue commercializing the PreTRM test. As part of this process, we may also be required to conduct additional clinical testing before applying for commercial marketing authorization. Clinical trials must be conducted in compliance with FDA regulations in order to support a marketing submission to the agency for a regulated product, or the FDA may take certain enforcement actions or reject the data. Performing additional, new clinical studies and trials in order to obtain product approval from the FDA, if necessary, would take a significant amount of time and would substantially delay our ability to commercialize the PreTRM test, all of which would adversely impact our business. In addition, the FD&amp;C Act was recently amended to require sponsors of most clinical studies of investigational medical devices intended to support marketing authorization to develop and submit a diversity action plan for such clinical trial. The action plan must include the sponsor&#8217;s diversity goals for enrollment, as well as a rationale for the goals and a description of how the sponsor will meet them. If the FDA objects to a sponsor&#8217;s diversity action plan, it may delay trial initiation or review of the device&#8217;s premarket submission.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FDA enforces its medical device requirements by various means, including inspection and market surveillance. If the FDA finds a violation, it can institute a wide variety of enforcement actions, ranging from an Untitled Letter or Warning Letter to more severe sanctions, such as: fines, injunctions, and civil penalties; recall or seizure of products; operating restrictions, partial suspension or total shutdown of production; and criminal prosecution. Failure to comply with any applicable FDA requirements could trigger a range of enforcement actions by the FDA, including warning letters, civil monetary penalties, fines, injunctions, criminal prosecution, consent decrees, repairs, replacements, refunds, recalls or seizures of products, operating restrictions, partial suspension or total shutdown of operations and denial of or challenges to applications for clearance or approval, as well as significant adverse publicity.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">FDA Oversight of Software Products</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In general, software that is intended for a medical purpose, whether it is included with a hardware device or is standalone software, is considered a medical device and subject to the same regulatory pathways as other medical devices when it meets the definition of a &#8220;device&#8221; codified in the FD&amp;C Act. However, Congress amended the Act in 2016 to explicitly exclude from the device definition certain software functions, such as software to support healthcare facility administration, general wellness software, and electronic health records. The FDA has also published guidance for industry describing its approach to general wellness products, including software, which states that the agency does not intend to examine the regulatory compliance status of low-risk general wellness products, as long as they are intended to (i) maintain or encourage general health or healthy activity and do not make any claims relating to specific diseases or conditions, or (ii) encourage a healthy lifestyle to help reduce the risk or impact of or help the user live well with certain chronic diseases or conditions where there is an established connection between a healthy lifestyle and the disease or condition.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on its functionalities and offerings for consumers, our recently launched LikeMineTM webapp is not intended for a medical purpose and it also meets the applicable criteria to be considered a low-risk general wellness product. It is therefore not subject to medical device regulatory controls or FDA premarket authorization.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">U.S. Advertising of Laboratory Services, LDTs and IVDs and Consumer Products</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our advertising for laboratory services and tests - as well as for nonmedical products such as our LikeMine</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TM</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> webapp - is subject to federal truth-in-advertising laws enforced by the Federal Trade Commission, or FTC, as well as similarly broad state laws.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the Federal Trade Commission Act, or FTC Act, the FTC is empowered, among other things, to (i) prevent unfair methods of competition and unfair or deceptive acts or practices in or affecting commerce; (ii) seek monetary penalties and other relief for conduct injurious to consumers; and (iii) gather and compile information and conduct investigations relating</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">31</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">to the organization, business, practices, and management of entities engaged in commerce. The FTC has very broad enforcement authority, and failure to abide by the substantive requirements of the FTC Act and other consumer protection laws can result in administrative or judicial penalties, including civil penalties, injunctions affecting the manner in which we would be able to market services or products in the future, or criminal prosecution. In recent years, the FTC has become more active in its scrutiny of health claims used in advertising goods and services, including with its publications of a sweeping &#8220;health products compliance guidance&#8221; document in December 2022.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Further, as a medical device under the FDA&#8217;s LDT Final Rule, our tests will become subject to the device labeling requirements that presently apply to other FDA-regulated IVD products, which prohibit the distribution of false or misleading labels or promotional labeling for such products. Enforcement actions by the FDA may include, among other things, the issuance of untitled or warning letters, injunctions, and civil or criminal penalties.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">EU Regulation of Diagnostic Medical Devices</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Medical devices, including IVD products, are subject to extensive regulation, such as premarket review, marketing authorization or certification, by regulatory agencies or notified bodies in other countries. Regulatory requirements and approval or certification processes are not harmonized and vary from one country to another, and international regulators and notified bodies are not bound by the findings of the FDA.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the European Union in particular, where we are exploring introduction of PreTRM testing in the near future subject to regulatory authorizations and fully vetted partnerships, IVD products had historically been regulated under EU-Directive 98/79/EC (IVD Directive) and corresponding national provisions. The IVD Directive required that medical devices meet the essential requirements, including those relating to device safety and efficacy, set out in an annex of the Directive. According to the IVD Directive, EU Member States have presumed compliance with these essential requirements for devices that are in conformity with the relevant national standards transposing the harmonized standards, such as ISO 13485:2016, the quality system standard for medical device manufacturers.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">IVD medical devices, other than devices for performance evaluation, must bear the CE marking of conformity when they are placed on the European market. The CE mark is a declaration by the manufacturer that the product meets all the appropriate provisions of the applicable legislation implementing the relevant European Directive. As a general rule, the manufacturer must follow the EU declaration of conformity procedure to obtain or apply a CE mark. The advertising and promotion of medical devices is also subject to general principles set forth by EU directives, which establish that devices that are CE marked may only be marketed and advertised in the EU in accordance with their intended purpose. Specific requirements defined at the EU Member State level may vary between jurisdictions and may limit or restrict a manufacturer&#8217;s promotional communications with healthcare professionals.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In May 2022, the Directive was replaced by the In Vitro Diagnostic Device Regulation, or IVDR, (EU) 2017/746. Unlike the IVD Directive, the IVDR has binding legal force throughout every Member State. The major goal of the IVDR was to standardize diagnostic procedures within the EU, increase reliability of diagnostic analysis and enhance patient safety. Under the IVDR as enacted by the European Commission, or EC, IVDs are subject to additional legal requirements. Among other things, the IVDR introduced a new risk-based classification system and requirements for conformity assessments. It also imposes additional requirements relating to post-market surveillance and submission of post-market performance follow-up reports. Under the IVDR and subsequent amendments, IVDs already certified under the IVD Directive by a Notified Body may remain on the market until December 31, 2027, and IVDs certified under the IVD Directive without the involvement of a Notified Body may be placed on, or remain in, the market for up to two additional years (until December 31, 2029) depending on the classification of the IVD. Nonetheless, the manufacturers of such devices must comply with specific requirements in the IVDR according to the timelines established, but ultimately, such products, as with all new IVDs, will have to undergo the IVDR&#8217;s conformity assessment procedures. Notified Bodies are entities accredited by an EU Member State to independently assess whether a product to be placed on the market meets certain preordained standards and that manufacturing facilities and records comply with applicable requirements such as International Organization for Standardization, or ISO, standards such as ISO 13485 and ISO 27001. Such international standards establish extensive requirements for quality assurance and control as well as manufacturing and change control procedures. The EC has designated thirteen (13) Notified Bodies to perform conformity assessments under the IVDR. MedTech Europe has issued guidance relating to the IVDR in several areas, e.g., clinical benefit, technical documentation, state of art, accessories, and EUDAMED.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The IVDR has introduced an enhanced level of EU regulatory oversight for diagnostic tests developed as LDTs, and our commercial clinical laboratory in Salt Lake City, Utah may be considered a health institution in the context of the IVDR if it begins to provide testing for EU citizens. We believe that LDTs produced outside of the EU and involving samples obtained from EU citizens must fully comply with the IVDR and accordingly, we are working towards ISO 13485 compliance and to</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">32</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">prepare the PreTRM test for future conformity assessments by a designated Notified Body. We expect to engage in initial regulatory discussions with European authorities as well as potential collaboration partners in 2025.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our tests also may become subject to other foreign premarket review, compliance, and regulatory approval regimes applicable to IVDs if we decide to expand and offer our services internationally beyond certain EU markets.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Data Privacy and Security Laws</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We believe that we have taken the steps required of us to comply with both federal and state health information privacy and security statutes and regulations, including genetic testing and genetic information privacy laws. However, existing laws regulating such matters continue to evolve, including through amendments, new interpretations and guidance, and, around the world, lawmakers continue to propose new laws regulating privacy and data security. We may not be able to maintain compliance in all jurisdictions where we do business. Failure to maintain compliance, or changes in laws regarding privacy or security could result in civil and/or criminal penalties, significant reputational damage and could have a material adverse effect on our business.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">U.S. Federal Privacy and Security Laws</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a clinical laboratory, we are acting as a Covered Entity and are subject to the Health Insurance Portability and Accountability Act of 1996, or HIPAA, as amended by the federal Health Information Technology for Economic and Clinical Health Act, or HITECH, and the regulations promulgated thereunder. HIPAA established comprehensive federal standards for the privacy and security of health information. The HIPAA standards apply to health plans, health care clearing houses, and health care providers that conduct certain health care transactions electronically (Covered Entities), as well as their respective business associates that perform services for them that involve the use, or disclosure of, individually identifiable health information. Title II of HIPAA, the Administrative Simplification Act, contains provisions that address the privacy and security of health data, the standardization of identifying numbers used in the health care system and the standardization of certain health care transactions. The privacy regulations protect medical records and other protected health information by limiting their use and release, giving patients the right to access their medical records and limiting most disclosures of health information to the minimum amount necessary to accomplish an intended purpose. The HIPAA security standards require the adoption of administrative, physical, and technical safeguards and the adoption of written security policies and procedures.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under HITECH&#8217;s breach notification requirements, Covered Entities must report breaches of protected health information that has not been encrypted or otherwise secured in accordance with guidance from the Secretary of HHS, or the Secretary. Required breach notices must be made as soon as is reasonably practicable, but no later than 60 days following discovery of the breach. Reports must be made to affected individuals and to the Secretary and, in some cases depending on the size of the breach and location of affected individuals, they must be reported through local and national media. Breach reports can lead to investigation, enforcement and civil litigation, including class action lawsuits. We are currently subject to the HIPAA regulations as a Covered Entity and maintain an active compliance program. We are subject to audit by HHS as well as compliance reviews. We may also be investigated in connection with a privacy or data security complaint.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There are significant civil and criminal fines and other penalties that may be imposed for violating HIPAA. These fines are adjusted for inflation each year. A Covered Entity or business associate is liable for civil monetary penalties for a violation that is based on an act or omission of any of its agents, including a downstream business associate, as determined according to the federal common law of agency. Penalties for failure to comply with a requirement of HIPAA and HITECH vary significantly depending on the nature of the failure and include civil monetary penalties. A single breach incident can violate multiple requirements.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additionally, a person who knowingly obtains or discloses protected health information in violation of HIPAA may face a criminal penalties, which increase if the wrongful conduct involves false pretenses or the intent to sell, transfer or use information for commercial advantage, personal gain or malicious harm. In January 2025, HHS issued a notice of proposed rule-making to significantly amend the HIPAA security regulations, which if finalized, could lead to additional expenses in implementing new security measures, policies and procedures in order to comply with the new regulations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Further, submission of electronic health care claims and payment transactions that do not comply with the electronic data transmission standards established under HIPAA and HITECH could result in delayed or denied payments. Any non-compliance with HIPAA and HITECH, and related penalties, could adversely impact our business.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">33</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">State Privacy and Security Laws</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The HIPAA privacy, security, and breach notification regulations establish a uniform federal "floor" but do not supersede state laws that are more stringent or that provide individuals with greater rights with respect to the privacy or security of, and access to, their records containing PHI, or insofar as such state laws apply to personal information that is broader in scope than PHI, as defined under HIPAA. In addition to federal enforcement, Covered Entities are also subject to enforcement by state attorneys general who were given authority to enforce HIPAA under HITECH. HIPAA privacy, security, and breach notification regulations do not supersede state laws that are more stringent or provide individuals with greater privacy and security rights or greater access to their records and we are subject to enforcement by state regulatory authorities for failure to comply with more stringent state laws.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The compliance requirements of these laws, including additional breach reporting requirements, and the penalties for violation vary widely and new privacy and security laws in this area are evolving. For example, several states, such as California, have implemented comprehensive privacy laws and regulations. The California Confidentiality of Medical Information Act, or CMIA, imposes restrictive requirements regulating the use and disclosure of health information and other personally identifiable information. In addition to fines and penalties imposed upon violators, some of these state laws also afford private rights of action to individuals who believe their personal information has been misused. California's patient privacy laws, for example, provide for penalties of up to $250,000 and permit injured parties to sue for damages.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The California Consumer Privacy Act, or CCPA, and the California Privacy Rights Act, or CPRA, set forth a privacy framework for covered businesses by creating an expanded definition of personal information, establishing data privacy rights for California consumers and employees, imposing special rules on the collection of consumer data from minors, and creating a new and potentially severe statutory damages framework for businesses that violate the CCPA and/or fail to implement reasonable security procedures and practices to prevent data breaches. Although the CCPA does not directly apply to medical information covered by HIPAA or CMIA, certain other personal information that our business may collect and use, including through our direct-to-consumer PreTRM test or our LikeMine webapp, is within the scope of the CCPA and does not fall under the CCPA exception. Additionally, the CPRA provides the newly-established California Privacy Protection Agency, or CPPA, with the power to administer and enforce the CRPA and privacy rights in California. The CPPA has the power to levy fines and bring other enforcement actions and is in the process of implementing further regulations that could have operational impacts. In addition to California, 18 other states have passed similar privacy laws, including Colorado, Connecticut, Delaware, Florida, Indiana, Iowa, Kentucky, Maryland, Montana, Nebraska, New Hampshire, New Jersey, Oregon, Rhode Island, Tennessee, Texas, Utah, and Virginia. Additionally, we must identify and comply with all applicable state laws for the protection of personal information with respect to employee information or other personal information that we collect. There are also several federal privacy proposals under consideration in Congress, and other states may introduce privacy legislation for consideration in 2025. These various privacy laws could impact our operations or that of our collaborators and business partners and impose new regulatory requirements and increase costs of compliance.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Regulation of Artificial Intelligence</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As noted above, several states have laws governing uses and disclosures of health information, many of which differ from each other in significant ways and often are not preempted by HIPAA, thus complicating compliance efforts.  More than thirty have also begun regulating the use of Artificial Intelligence, or AI, or are considering proposed legislation that would regulate AI. Generally, such regulations aim to protect individuals such as consumers, employees, and/or job applicants from bias, discrimination, and invasion of privacy and to promote transparency with respect to use of AI by companies. Additionally, in December 2023, the European Commission, the Council, and the Parliament agreed on the provisional rules that will comprise the European Union&#8217;s Artificial Intelligence Act, the AI Act. This comprehensive EU AI Regulation is broad in scope, defines high-risk AI activities, and seeks to prohibit certain AI uses. The AI Act will potentially regulate entities that intend to utilize AI applications in the European Commission. Anticipated range of fines for entities that are found to violate the AI Act may reach up to EUR 35 million or up to 7% of the Company&#8217;s total worldwide annual turnover for the preceding financial year, whichever is higher.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Foreign Privacy Laws</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We will also be subject to foreign privacy laws in the jurisdictions in which we may introduce our PreTRM testing and collect patient samples. The interpretation, application, and interplay of consumer and health-related data protection laws in the United States, Europe, and elsewhere are often uncertain, contradictory, and in flux. For example, the General Data Protection Regulation, or GDPR, and Cybersecurity Directive applies to personal data in the European Union. These regulations introduced many changes to privacy and security in the European Union, including stricter rules on consent and security duties for critical industries, including for the health sector generally and for genetic data specifically. The</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">34</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">interpretation of some rules continues to evolve in guidance from the main regulatory authority, the European Data Protection Board, and some requirements may be completed by national legislation. This makes it difficult to assess the impact of these foreign data protection laws on our business at this time.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">More generally, foreign laws and interpretations governing data privacy and security are constantly evolving, and it is possible that laws may be interpreted and applied in a manner that is inconsistent with our current practices, in which case we could be subject to government-imposed fines or orders requiring that we change our practices. These fines can be very high. For instance, the GDPR provides for fines of up to approximately $22 million or 4% of a group&#8217;s worldwide annual turnover for certain infringements. In addition, privacy regulations differ widely from country to country and are enforced by individual country data protection authorities, which have power to enforce privacy regulations. Various data protection authorities have issued fines in the millions of euros for violations of privacy laws.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Other U.S. Federal and State Health Care Laws</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A variety of state and federal laws prohibit fraud and abuse involving private insurers (as well as state and federal health care programs). These laws are interpreted broadly and enforced aggressively by various state and federal agencies, including CMS, the Department of Justice, or DOJ, the Office of Inspector General for HHS, or OIG, and various state agencies. Sanctions for violations of these laws may result in a range of penalties, including but not limited to significant criminal and civil fines and penalties, and loss of licensure. Any such penalties would adversely affect our business.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Anti-Kickback Statute</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Anti-Kickback Statute, or AKS, prohibits, among other things, knowingly and willfully offering, paying, soliciting, or receiving remuneration, directly or indirectly, in exchange for or to induce either the referral of an individual, or the furnishing, arranging for or recommending of an item or service that is reimbursable, in whole or in part, by a federal health care program. &#8220;Remuneration&#8221; is broadly defined to include anything of value, which can include (but is not limited to) cash payments, gifts or gift certificates, discounts, or the furnishing of services, supplies or equipment. A person or entity does not need to have actual knowledge of the federal AKS or specific intent to have committed a violation. In addition, a claim including items or services resulting from a violation of the AKS constitutes a false or fraudulent claim for purposes of the federal False Claims Act, or FCA.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The AKS has safe harbors and exceptions that protect certain conduct and arrangements that meet every element of the applicable safe harbor or exception. However, an arrangement that does not meet all elements of a safe harbor or exception does not necessarily violate the AKS. A facts-and-circumstances analysis of the arrangement or conduct at issue is necessary to determine whether a potential violation has occurred. Some states have their own kickback laws, and some apply to claims submitted to private insurers. Some of these statutes have their own safe harbor provisions or exceptions, or they may cross-reference the AKS safe harbors.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The penalties for violating federal or state AKS provisions can be severe. Possible sanctions include criminal and civil penalties (including penalties under the FCA or a state law equivalent), imprisonment, and possible exclusion from state or federal health care programs.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, the OIG has issued Special Fraud Alerts describing the agency&#8217;s view of how certain arrangements between laboratories and referring physicians implicate and potentially violate the AKS. For example, the OIG issued such Alerts in December 1994 and June 2014, and an Alert related to speaker programs issued in November 2020 also applies to the business of laboratories. These Special Fraud Alerts do not have the force of law but do provide insight into the agency&#8217;s potential enforcement priorities and its interpretation of the AKS as it relates to laboratories&#8217; business practices. Similarly, state enforcement agencies may issue opinion letters or other guidance documents that describe their interpretation of how the state AKS applies to certain arrangements, and also provide insight into that agency&#8217;s enforcement priorities.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Physician Self-Referral Prohibitions</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Subject to certain exceptions, the federal ban on physician self-referrals (referred to as the Stark Law) is a civil statute that prohibits physicians from referring Medicare and Medicaid patients to an entity providing certain designated health services, which include laboratory services, if the physician or his/her immediate family member has any financial relationship with the entity. Many states also have their own self-referral bans, which may extend to all self-referrals regardless of the payer, unless an exception applies.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">35</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Potential penalties for Stark Law violations include the return of funds received for all prohibited referrals, fines, civil monetary penalties (including penalties under the FCA or state law equivalents), and possible exclusion from state or federal health care programs.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Eliminating Kickbacks in Recovery Act</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In October 2018, Congress enacted the Eliminating Kickbacks in Recovery Act of 2018, or EKRA, as part of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act, or SUPPORT Act. EKRA is an all-payer anti-kickback law that criminalizes paying any remuneration to induce referrals to, or in exchange for, patients using the services of a recovery home, a substance use clinical treatment facility, or laboratory.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Although it appears that EKRA was intended to reach patient brokering and similar arrangements in the context of substance use recovery and treatment, EKRA&#8217;s language is broad. For example, as written, EKRA seems to prohibit the payment of incentive compensation to sales employees, whereas such payments are expressly protected under the AKS and its safe harbors (and this practice is common in the industry). And most of the safe harbors available under the AKS are not reiterated under EKRA&#8217;s exceptions. Therefore, compliance with an AKS safe harbor may not guarantee protection under EKRA. EKRA thus potentially expands the universe of arrangements that could be subject to enforcement under federal fraud and abuse laws, as well as substantial penalties.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">EKRA permits DOJ to issue regulations clarifying or expanding the statute&#8217;s exceptions, but such regulations have not yet been issued. Moreover, there is little guidance to indicate how and to what extent it will be applied and enforced by government agencies. The relationships between laboratories and physicians, sales representatives, hospitals, and customers may be subject to scrutiny under this statute. If imposed for any reason, sanctions under EKRA could have a negative effect on our business.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">False Claims Act</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FCA imposes civil liability on any person or entity that, among other things, knowingly presents, or causes to be presented, to the federal government, claims for payment that are false or fraudulent; knowingly making, using or causing to be made or used, a false statement or record material to a false or fraudulent claim or obligation to pay or transmit money or property to the federal government or knowingly concealing or knowingly and improperly avoiding or decreasing an obligation to pay money to the federal government. The FCA also prohibits the knowing retention of overpayments (sometimes referred to as &#8220;reverse false claims&#8221;). Under the reverse false claims provision, improperly retained overpayments must be repaid within 60 days of identification unless a favorable decision is obtained on appeal. The FCA also permits a private individual acting as a &#8220;whistleblower&#8221; (also referred to as a </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">qui tam</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> relator) to bring actions on behalf of the federal government alleging violations of the FCA and to share in any monetary recovery. The federal government may elect or decline to intervene in such matters, but if the government declines intervention, the whistleblower may still proceed with the litigation on the government&#8217;s behalf.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Penalties for violating the FCA include payment of up to three times the actual damages sustained by the government, plus substantial per-claim civil penalties, as well as possible exclusion from federal health care programs.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Various states have enacted similar laws modeled after the FCA that apply to items and services reimbursed under Medicaid and other state health care programs, and, in several states, such laws apply to claims submitted to any payer, including private insurers.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There is also a federal criminal false claims statute that prohibits, in pertinent part, the making or presentation of a false claim, knowing such claim to be false, to any person or officer in the civil, military, or naval service or any department or agency thereof.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Health Care Fraud and False Statements</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The federal health care fraud statute criminalizes knowingly and willfully defrauding a health care benefit program, including private insurers. A violation of this statute may result in fines, imprisonment, or exclusion from government health care programs. The false statements statute prohibits knowingly and willfully falsifying, concealing, or covering up a material fact or making a materially false, fictitious, or fraudulent statement in connection with the delivery of or payment for health care benefits, items, or services. A violation of this statute may result in fines or imprisonment.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">36</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Civil Monetary Penalties Law</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The federal Civil Monetary Penalties Law, or CMP Law, prohibits, among other things, (1) the offering or transfer of remuneration to a Medicare or Medicaid beneficiary if the person knows or should know that remuneration is likely to influence the beneficiary&#8217;s selection of a particular provider, practitioner, or supplier of services reimbursable by Medicare or a state health care program, unless an exception applies; (2) employing or contracting with an individual or entity that the provider knows or should know is excluded from participation in a federal health care program; (3) billing for services requested by an unlicensed physician or an excluded provider; and (4) billing for medically unnecessary services. The penalties for violating the CMP Law include exclusion from participation in federal health care programs, substantial fines, and payment of up to three times the amount billed, depending on the nature of the offense.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Physician Payments Sunshine Act</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In pertinent part, the federal Physician Payments Sunshine Act, or Sunshine Act, imposes reporting requirements on manufacturers of certain devices, drugs and biologics reimbursed under Medicare, Medicaid, or the Children&#8217;s Health Insurance Program, or CHIP, for certain payments and transfers of value by them (and in some cases their distributors) to physicians, teaching hospitals and certain advanced non-physician health care practitioners, as well as ownership and investment interests held by physicians and their immediate family members. The reporting program (known as the Open Payments program) is administered by CMS. A number of states also have laws similar to the Sunshine Act.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Because we develop our LDTs solely for use by or within our own laboratory, we believe we are exempt from these reporting requirements. We could, however, become subject to such reporting requirements under the terms of current CMS regulations if the FDA requires us to obtain premarket clearance or approval for our tests as medical devices (whether because the agency determines that one or more of the tests do not fall within the scope of the agency's existing LDT definition or because of its recently issued final rule to exercise authority over LDTs as medical devices) or Congress enacts legislative reforms to the federal oversight of LDTs to subject them to FDA regulation and/or the reporting requirements of the Sunshine Act. It is presently unknown how CMS will respond to the recently finalized FDA policy change to effectively render all LDTs medical device products under federal law, and whether or when it will assert that the Sunshine Act&#8217;s reporting requirements will begin to apply to the manufacturers of such LDTs. Given that litigation is ongoing between members of the clinical laboratory industry and FDA/HHS in relation to the May 2024 LDT final rule, it may be many months or even years before we have clarity on the applicability of state and federal Sunshine Act laws to our business. Certain states also require medical device manufacturers to maintain compliance programs and/or be licensed as manufacturers or distributors by a state professional board or health department. Because the FDA&#8217;s now-in-effect final rule renders a clinical laboratory like ours a &#8220;medical device manufacturer,&#8221; we have begun the process of evaluating whether and to what extent those kinds of medical device-specific state requirements may be applicable to our operations.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Other Potentially Applicable State Laws</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are subject to state equivalents of each of the health care laws and regulations described above, among others, some of which may be broader in scope and may apply regardless of the payer. Many U.S. states have adopted laws similar to the AKS and FCA, and may apply to our business practices, including, but not limited to, research, distribution, sales or marketing arrangements and claims involving health care items or services reimbursed by non-governmental payers, including private insurers. Such laws include fee-splitting restrictions, insurance fraud laws, anti-markup laws, prohibitions on waiving coinsurance, copayments, deductibles and other amounts owed by patients, and prohibitions on the provision of tests at no or discounted cost to induce physician adoption. Other potentially applicable state laws include direct billing requirements and prohibitions on the corporate practice of medicine. Many of our agreements may be subject to such laws. There are ambiguities as to what is required to comply with these state requirements, and if we fail to comply with an applicable state law requirement we could be subject to penalties.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Reimbursement and Billing</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Coverage and Reimbursement</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the United States and markets in some other countries, patients generally rely on third-party payers to reimburse all or part of the costs associated with their treatment. Adequate coverage and reimbursement from government health care programs, such as Medicare and Medicaid, and commercial insurers is critical to new product acceptance. Our ability to successfully commercialize our products will depend in part on the extent to which coverage and adequate reimbursement for these products and related treatments will be available from government health care programs, commercial insurers and other third-party payers. Third-party payers, including managed care organizations, or MCOs, and other commercial insurers,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">37</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">decide which medical products and services they will pay for and establish reimbursement levels. The availability of coverage and extent of reimbursement by third-party payers is essential for most patients to be able to afford treatments. Sales of the PreTRM test or other clinical testing that we may develop will in large part depend, both domestically and abroad, on the extent to which the costs of our tests will be paid by MCOs or other commercial insurers, or reimbursed by government health care programs, and other third-party payers. If coverage and adequate reimbursement is not available, or is only partially available, we may not be able to successfully continue to commercialize our tests. Even if coverage is provided, the approved reimbursement amount may not be high enough to allow us to establish or maintain pricing sufficient to realize a sufficient return on our investment.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Factors payers consider in determining reimbursement are based on whether the product is:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a covered benefit under its health plan;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">safe, effective and medically necessary;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8203;appropriate for the specific patient;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8203;cost-effective; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8203;neither experimental nor investigational.</span></div></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8203;In addition, market-based changes have affected and will continue to affect the clinical laboratory business. Reimbursement from private insurers for diagnostic testing may shift away from traditional, fee-for-service models to alternatives, including value-based, bundled, and other risk-sharing payment models.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The growth of the managed care sector and consolidation of MCOs may also present various challenges and opportunities to us and other clinical laboratories. For example, MCOs have different contracting philosophies. Some MCOs contract with a limited number of clinical laboratories and engage in direct negotiation of rates, while others adopt broader networks with more uniform fee structures for participating clinical laboratories, and still others use capitation rates to fix the cost of laboratory testing services for enrollees. Our revenues may vary depending on the MCOs with which we enter contracts, if we decide to enter such contracts.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition to the potential reductions in test reimbursement, we may also see a decline or change in test volumes as a result of increased controls over the utilization of laboratory services by third-party payers, particularly MCOs. For example, MCOs have implemented, either directly or through third parties, various types of laboratory benefit management programs, which may include lab networks, utilization management tools (such as prior authorization and/or prior notification), and claims edits, which impact coverage and reimbursement of clinical laboratory tests. Some of these programs address clinical laboratory testing broadly, while others are focused on certain types of testing.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Despite the potentially negative market changes related to reimbursement, several factors may positively impact test volume, including the expansion of managed care and private insurance exchanges. In addition, continued innovation in laboratory medicine may continue to foster greater appreciation of the value of women&#8217;s health diagnostics. Additional factors that may lead to future volume growth include an increase in the number and types of tests that are readily available (due to advances in technology and increased cost efficiencies).</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The Protecting Access to Medicare Act of 2014</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Reimbursement and billing for diagnostic services is highly complex. Laboratories must bill various payers, including private insurers and MCOs. Submitting claims to various payers is complicated because each payer may have different billing requirements. Additionally, the audit requirements laboratories must meet to ensure compliance with applicable laws and regulations, as well as internal compliance policies and procedures, add further complexity to the billing process.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In April 2014, Congress passed the Protecting Access to Medicare Act of 2014, or PAMA, which substantially changed the way in which clinical laboratory services are paid under Medicare&#8217;s Clinical Laboratory Fee Schedule, or CLFS.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PAMA took effect on January 1, 2018 and requires certain clinical laboratories to report to CMS private insurer payment rates and volumes for their tests, though the reporting requirement has been delayed. CMS then takes the weighted-median of payments made by private insurers for these tests to set reimbursement under the CLFS for qualifying tests, subject to certain phase-in limits. Laboratories that fail to report the required payment information may be subject to substantial civil monetary penalties.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">38</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Since December 2019, Congress has passed a series of laws to modify PAMA&#8217;s statutory requirements related to the data reporting period and phase-in of payment reductions under the CLFS for clinical diagnostic laboratory tests, or CDLTs, that are not advanced diagnostic laboratory tests, or ADLTs. Most recently, on September 26, 2024, Section 221 of the Continuing Appropriations and Extensions Act, 2025, was passed, and it delayed data reporting requirement for CDLTs that are not ADLTs as well as the phase-in of payment reductions. The next data reporting period for CDLTs that are not ADLTs will be January 1, 2026 through March 31, 2026, and will be based on the original data collection period of January 1, 2019 through June 30, 2019. After this data reporting period, the three-year data reporting cycle for these tests will resume (e.g., 2028, 2031, etc.).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The same series of laws modified the phase-in of payment reductions resulting from private payer rate implementation so that a 0.0% reduction limit was applied for calendar years, or CYs, 2021 through 2024, as compared to the payment amounts for a test the preceding year. The Further Continuing Appropriations and Other Extensions Act, 2025, further applied a 0.0% reduction limit for CY 2025. Consequently, payment may not be reduced by more than 15% per year for CYs 2026 through 2028 as compared to the payment amounts established for a test the prior year.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CMS&#8217;s methodology under PAMA (as well as the willingness of private insurers to recognize the value of diagnostic testing and pay for that testing accordingly) renders private insurer payment levels even more significant. This calculation methodology has resulted in significant reductions in reimbursement, even though CMS imposed caps on those reductions. The reduction of reimbursement under the CLFS also affects rates paid by private insurers because those insurers often set their pricing for laboratory testing as a percentage of the amount set on the CLFS.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Following the implementation of a unique PLA code for the PreTRM test in April 2021, CMS priced this code at $750 under the PAMA framework in November 2021. While this price and how it may change over time under PAMA directly affect Medicare reimbursement for our testing, we do not currently bill Medicare in any material amount for our tests. However, PAMA and the price set by CMS have an indirect effect on rates paid by commercial insurers.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Given the many uncertainties built into PAMA&#8217;s price-setting process, we cannot predict how payments we receive from private insurers (or possibly from Medicare in the future), and thus our revenue, may change from year to year.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Health Care Reform and Legislation</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We likewise cannot predict whether or when Congress or state legislatures may take steps to regulate or change pricing of laboratory testing, and thus affect the reimbursement we receive as well as our revenue. Examples of such initiatives might include changes to the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010, or collectively the ACA, steps to address surprise billing, and increased price transparency, as well as administrative requirements that may continue to affect coverage, reimbursement, and utilization of laboratory services in ways that are currently unpredictable.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the Trump Administration and the 119</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">th</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Congress, there remains uncertainty around the future of the ACA and other health care legislation, and in particular the impact to reimbursement levels and the number of insured individuals. Further changes may lead to delay in the purchasing decisions of our customers.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other legislative changes have been proposed and adopted in the United States since the ACA was enacted. For example, the Budget Control Act of 2011, among other things, created measures for spending reductions by Congress. A Joint Select Committee on Deficit Reduction, tasked with recommending a targeted deficit reduction of at least $1.2 trillion for the years 2013 through 2021, was unable to reach required goals, thereby triggering the legislation&#8217;s automatic reduction to several state and federal health care programs. This includes aggregate reductions of Medicare payments to providers up to 2% per fiscal year, and, due to subsequent legislative amendments, will remain in effect through 2032 unless additional Congressional action is taken (with the exception of a temporary suspension from May 1, 2020 through March 31, 2022 due to the COVID-19 pandemic). As another example, in January 2013, the American Taxpayer Relief Act of 2012 was signed into law, which, among other things, increased the statute of limitations period for the government to recover overpayments to providers from three to five years.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Other Applicable Environmental, Health, And Safety Regulations</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our clinical laboratory and its operations are subject to numerous federal, state and local environmental, health and safety, or EHS, laws and regulations relating to, among other matters, safe working conditions, environmental protection and handling or disposition of products, including those governing the generation, storage, handling, use, transportation, release and disposal of hazardous or potentially hazardous materials, medical waste and infectious materials.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">39</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Some of these laws and regulations also require us to obtain licenses or permits to conduct our operations. If we fail to comply with such laws or obtain and comply with the applicable permits, we could face substantial fines or possible revocation of our permits or limitations on our ability to conduct our operations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain of our development activities involve use of hazardous materials, and we believe we are in compliance with the applicable environmental laws, regulations, permits, and licenses. However, we cannot ensure that EHS liabilities will not develop in the future. EHS laws and regulations are complex, change frequently and have tended to become more stringent over time.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Although the costs to comply with applicable laws and regulations, we cannot predict the impact on our business of new or amended laws or regulations or any changes in the way existing and future laws and regulations are interpreted or enforced, nor can we ensure we will be able to obtain or maintain any required licenses or permits.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Human Capital</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, we had 64 employees, including 63 full-time employees. Our headquarters are located in Salt Lake City, Utah. None of our employees are subject to a collective bargaining agreement. We consider our relationship with our employees to be good.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Talent Acquisition and Retention</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We recognize that our employees largely contribute to our success. To this end, we support business growth by seeking to attract and retain best-in-class talent. We use internal and external resources to recruit highly skilled candidates for open positions. We believe that we are able to attract and retain superior talent as measured by our low turnover rate and high employee service tenure.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Total Rewards</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our total rewards philosophy has been to create investment in our workforce by offering a competitive compensation and benefits package. We provide employees with compensation packages that include base salary, annual incentive bonuses and long-term equity incentive awards. We also offer comprehensive employee benefits, such as life, disability and health insurance, health savings and flexible spending accounts, paid time off, and a 401(k) plan. It is our express intent to be an employer of choice in our industry by providing a market-competitive compensation and benefits package.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Health, Safety and Wellness</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have always invested, and will continue to invest, in the health, safety, and wellness of our employees. We provide our employees with access to a variety of innovative, flexible, and convenient health and wellness programs. Program benefits are intended to provide protection and security, so employees can have peace of mind concerning events that may require time away from work or that may impact their financial well-being.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Inclusiveness</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We believe a diverse workforce is critical to our success. Our mission is to value differences in races, ethnicities, religions, nationalities, genders, ages and sexual orientations, as well as education, skill sets and experience. We are focused on inclusive hiring practices, fair and equitable treatment, organizational flexibility and training and resources.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Training and Development</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We believe in encouraging employees in becoming lifelong learners by providing ongoing learning and leadership training opportunities. While we strive to provide real-time recognition of employee performance, we have a formal annual review process not only to determine pay and equity adjustments tied to individual contributions, but to identify areas where training and development may be needed.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">40</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Information About Our Executive Officers and Directors</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following persons were our executive officers and directors as of March 14, 2025:</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:auto;width:98.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:37.9%;box-sizing:content-box;"/>
    <td style="width:2.16%;box-sizing:content-box;"/>
    <td style="width:59.94%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Name</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #ffffff03;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Position</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-style:italic;font-kerning:none;min-width:fit-content;">Executive Officers</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="margin-left:12pt;text-indent:0;font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Zhenya Lindgardt</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">President and Chief Executive Officer</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="margin-left:12pt;text-indent:0;font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Austin Aerts</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Financial Officer</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="margin-left:12pt;text-indent:0;font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">John J. Boniface, Ph.D.</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Scientific Officer</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="margin-left:12pt;text-indent:0;font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Paul Kearney, Ph.D.</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Data Officer</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="margin-left:12pt;text-indent:0;font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Robert G. Harrison</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Information Officer</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="margin-left:12pt;text-indent:0;font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Benjamin G. Jackson</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General Counsel</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-style:italic;font-kerning:none;min-width:fit-content;">Directors</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="margin-left:12pt;text-indent:0;font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Jane F. Barlow, M.D.</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Executive Officer, Jane Barlow &amp; Associates, LLC</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="margin-left:12pt;text-indent:0;font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gregory C. Critchfield, M.D., M.S.</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Co-Chief Executive Officer, EarlyDiagnostics, Inc., and Executive Chair, RefloDx, Inc.</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="margin-left:12pt;text-indent:0;font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Kim Kamdar, Ph.D.</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Partner, Domain Associates, LLC</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="margin-left:12pt;text-indent:0;font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Sandra A.J. Lawrence</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Independent Corporate Director</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="margin-left:12pt;text-indent:0;font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Mansoor Raza Mirza, M.D.</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Oncologist, the Copenhagen University Hospital, Denmark and Medical Director of the Nordic Society of Gynaecological Oncology</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="margin-left:12pt;text-indent:0;font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Joshua Phillips</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Managing Partner, Catalyst Health Ventures</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="margin-left:12pt;text-indent:0;font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Ryan Trimble</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Independent Corporate Director</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:12pt;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="margin-left:12pt;text-indent:0;font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Marcus Wilson, Pharm.D.</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Independent Corporate Director</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Available Information</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our website address is www.seraprognostics.com. Our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and amendments to reports filed pursuant to Sections 13(a) and 15(d) of the Exchange Act are filed with the SEC. Such reports and other information filed by us with the SEC are available free of charge on our website at investors.seraprognostics.com when such reports are available on the SEC&#8217;s website. The SEC maintains an internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC at www.sec.gov. The information contained on the websites referenced in this Form 10-K is not incorporated by reference into this filing. Further, our references to website URLs are intended to be inactive textual references only.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">41</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_1a_risk_factors"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 1A. Risk Fac</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">tors</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Investing in our Class A common stock involves a high degree of risk. You should carefully consider the risks and uncertainties described below, the section of this Annual Report entitled &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and our financial statements and related notes, before investing in our Class A common stock. The risks and uncertainties described below are not the only ones we face. Additional risks and uncertainties that we are unaware of, or that we currently believe are not material, may also become important factors that affect us. If any of the following risks occur, our business, operating results and prospects could be materially harmed. In that event, the price of our Class A common stock could decline, and you could lose part or all of your investment.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Summary of Risk Factors</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our business is subject to numerous risks and uncertainties, including those highlighted in this section below, that represent challenges that we face in connection with the successful implementation of our strategy. The occurrence of one or more of the events or circumstances described in more detail in the risk factors below, alone or in combination with other events or circumstances, may have an adverse effect on our business, cash flows, financial condition, and results of operations. Such risks include, but are not limited to:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have incurred net losses since our inception and we anticipate that we will continue to incur losses for the foreseeable future, which could harm our future business prospects.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Operating our business requires a significant amount of cash, and our ability to generate sufficient cash depends on many factors, some of which are beyond our control and if we cannot raise additional capital when needed, we may have to curtail or cease operations.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our quarterly and annual results may fluctuate from period to period, which could adversely impact the value of our Class A common stock.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have derived substantially all of our revenues to date from the PreTRM test, and if our efforts to further increase the use and adoption of the PreTRM test or to develop new products and services in the future do not succeed, our business will be harmed.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the near future, we expect to rely on sales to a limited number of direct customers for a significant portion of our revenue and cash flows related to the sale of the PreTRM test, making us subject to customer concentration risk.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we are unable to establish and maintain sales and marketing capabilities, we may not be successful in commercializing the PreTRM test.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Competition in the life science industry, including companies engaged in molecular diagnostics and proteomics, is intense. If we are unable to compete successfully with respect to our current or future products or services, we may not be able to increase or sustain our revenues or achieve profitability.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If our CLIA-certified laboratory facility becomes inoperable, we will be unable to perform our tests and our business will be harmed.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Interim, top-line and preliminary data from our clinical trials that we announce or publish from time to time may change as additional data become available and are subject to confirmation, audit, and verification procedures that could result in material changes in the final data.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our business would be materially harmed if our proprietary biobank were to become contaminated, lost or destroyed.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Some of our products and services rely heavily on access to internal and external databases, and loss of access to such databases could materially harm our business.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We rely on third parties for specimen collection, including phlebotomy services, and commercial courier delivery services, and if these services are disrupted, our business will be harmed.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We rely on a limited number of suppliers or, in some cases, single suppliers, for some of our laboratory instruments and materials, as well as for our recently developed whole-blood collection kit, and may not be able to find replacements or immediately transition to alternative suppliers on a cost-effective basis, or at all.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our ability to utilize our net operating loss carryforwards and certain other tax attributes may be limited.</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">42</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our estimates of total addressable market opportunity and forecasts of market growth may prove to be inaccurate, and even if the market in which we compete achieves the forecasted growth, our business could fail to grow at a similar rate.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">An inflationary environment could materially adversely impact our business and results of operations. </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If third-party payers do not adequately reimburse for the PreTRM test or any new products we may develop, such may not be purchased or used, which may adversely affect our revenue and profits.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">New reimbursement methodologies applicable to the PreTRM test, and other future products, including new CPT codes, may decrease reimbursement rates from third-party payers.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Billing disputes with third-party payers, including disagreement regarding the selection and use of CPT codes when submitting claims, may decrease realized revenue and may lead to requests for recoupment of past amounts paid.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">When third-party payers deny coverage, we are often unable to collect from the patient or any other source and risk disputes if we attempt to do so.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our revenues may be adversely impacted if third-party payers withdraw coverage or provide lower levels of reimbursement due to changing policies, billing complexities or other factors.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Status as an out-of-network provider with a large commercial insurer may cause health care providers to avoid recommending our tests.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If the validity of an informed consent from a patient is challenged, we could be precluded from billing for such patient&#8217;s testing, be forced to stop performing certain tests, forced to exclude the patient&#8217;s data or specimens from clinical trial results or be subject to lawsuits or regulatory enforcement.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Changes in the way the FDA regulates the reagents, other consumables, and testing equipment we use when developing, validating, and performing our tests could result in delay or additional expense in bringing our tests to market or performing such tests for our customers.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we fail to comply with federal and/or state laboratory licensing requirements, we could lose the ability to perform our tests or experience disruptions to our business.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any failure to obtain, maintain, and enforce our intellectual property rights could impair our ability to protect our proprietary technology and our brand.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Issued patents covering our tests and technology could be found invalid or unenforceable, if challenged.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our intellectual property may be infringed by a third party.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we are not able to prevent disclosure of our trade secrets and other proprietary information, the value of our tests and technology could be significantly diminished.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The price of our Class A common stock may be volatile, and you could lose all or part of your investment.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Sales of a substantial number of shares of our Class A common stock by our existing stockholders in the public market could cause our stock price to fall.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our inability to maintain effective disclosure controls and procedures could adversely affect our results of operations, liquidity and financial positions, as well as our stock price and investor confidence in us.</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">43</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Our Financial Position and Need for Additional Capital</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We have incurred net losses since our inception and we anticipate that we will continue to incur losses for the foreseeable future, which could harm our future business prospects.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have incurred net losses each year since our inception in 2008. To date, we have financed our operations primarily through private placements of our equity and debt securities, bank loans and the sale and issuance of Class A common stock in our initial public offering, or the IPO, which was completed in July 2021. Our net loss for the years ended December 31, 2024 and 2023 was $32.9 million and $36.2 million, respectively. As of December 31, 2024, we had an accumulated deficit of $279.8 million. Our losses may continue to increase in the future as we continue to devote a substantial portion of our resources to efforts to increase the adoption of, and reimbursement for, the PreTRM test, make improvements to this product, and research, develop and commercialize new products and services.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We currently receive substantially all of our revenues from the sales of the PreTRM test and expect to continue to receive revenue from sales of the PreTRM test and our other pipeline products and services in the future. It is possible that we will not generate sufficient revenue from the sales of any of our products and services to cover our costs, including research and development expenses related to furthering our product pipeline, and achieve or sustain profitability. A significant element of our business strategy is to increase and maintain our in-network coverage with third-party payers. However, third-party payers, such as commercial insurers and government health care programs, may decide not to reimburse for the PreTRM test or other tests we may develop, may not reimburse for uses of the PreTRM test or our other tests for the pregnant patient population, or may set the amounts of such reimbursements at prices that do not allow us to cover our expenses. Many third-party payers currently either have negative coverage determinations or otherwise do not reimburse for low-risk patient preterm birth screening tests. State Medicaid programs currently do not reimburse for our tests; third-party payers are increasingly requiring that prior authorization be obtained prior to conducting testing as a condition to reimbursing for it, which may reduce and/or delay the reimbursement amounts.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As there is a possibility that our Company, any collaborators and/or licensees may not successfully develop additional products, obtain required regulatory authorizations for such products, manufacture such products at an acceptable cost or with sufficient quality or successfully market and sell such products with desired margins, our expenses may continue to exceed any revenues we may receive. Our operating expenses also will increase as, or if, among other factors:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our earlier-stage products move into later-stage development, which is generally more expensive than early-stage development;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we select additional technologies or products for development;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we increase the number of patents we are prosecuting or otherwise expend additional resources on patent prosecution or defense; or</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we acquire or in-license additional technologies, product candidates, products or businesses.</span></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Operating our business requires a significant amount of cash, and our ability to generate sufficient cash depends on many factors, some of which are beyond our control and if we cannot raise additional capital when needed, we may have to curtail or cease operations.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the future, we expect to incur significant costs in connection with our operations, including, but not limited to, the development, marketing authorization, and commercialization of new tests, new services, and other products. These development activities generally require a substantial investment before we can determine commercial viability. We expect to need to raise additional funds through public or private equity or debt financings, collaborations or licensing arrangements to continue to fund or expand our operations.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our actual liquidity and capital funding requirements will depend on numerous factors, including:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to achieve broad commercial success with the PreTRM test and other pipeline products and services;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the scope and duration of, and expenditures associated with, our discovery efforts and research and development programs, including for our proprietary proteomics and bioinformatics platform;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the costs to fund our commercialization strategies for any product candidates which we launch and to prepare for potential product marketing authorizations, as required;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the costs of any acquisitions of complementary businesses or technologies that we may pursue;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">potential licensing or partnering transactions, if any;</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">44</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our facility expenses, which will vary depending on the time and terms of any facility lease or sublease we may enter into, and other operating expenses;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the scope and extent of the expansion of our sales and marketing efforts;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the commercial success of our other products and services;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to obtain more extensive coverage and reimbursement for the PreTRM test and other products and services, if any; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to collect our accounts receivable.</span></div></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The availability of additional capital, whether from private capital sources, such as banks, or the public capital markets, may fluctuate as our financial condition and market conditions in general change. There may be times when the private capital sources and the public capital markets lack sufficient liquidity or when our securities cannot be sold at attractive prices, or at all, in which case we would not be able to access capital from these sources. In addition, any weakening of our financial condition or deterioration in our credit ratings could adversely affect our ability to obtain necessary funds. Even if available, additional financing could be costly or have adverse consequences.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additional capital, if needed, may not be available on satisfactory terms or at all. Furthermore, any additional capital raised through the sale of equity or equity-linked securities will dilute our stockholders&#8217; ownership interests and may have an adverse effect on the price of our Class A common stock. In addition, the terms of any financing may adversely affect stockholders&#8217; holdings or rights. Debt financing, if available, may include restrictive covenants. To the extent that we raise additional funds through collaborations and licensing arrangements, it may be necessary to relinquish some rights to our technologies or grant licenses on terms that may not be favorable to us.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we are not able to obtain adequate funding when needed, we may be required to delay development programs or sales and marketing initiatives. If we are unable to raise additional capital in sufficient amounts or on satisfactory terms, we may have to reduce our workforce and may be prevented from continuing our discovery, development and commercialization efforts and leveraging other corporate opportunities. In addition, it may be necessary to work with a partner on one or more of our tests or products under development, which could lower our economic value of those products. Each of the foregoing factors may harm our business, operating results, and financial condition and may impact our ability to continue as a going concern.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our quarterly and annual results may fluctuate from period to period, which could adversely impact the value of our Class A common stock.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our quarterly and annual results of operations, including our revenues, gross margin, net loss, and cash flows, may vary from period to period as a result of a variety of factors, many of which are outside of our control, including those listed elsewhere in this &#8220;Risk Factors&#8221; section, and as a result, period-to-period comparisons of our operating results may not be meaningful. Our quarterly and annual results should not be relied upon as an indication of future performance. In addition, to the extent that we continue to spend considerably on our internal sales and marketing and research and development efforts, we expect to incur costs in advance of achieving the anticipated benefits of such efforts. We also face competitive pricing and reimbursement pressures, and we may not be able to maintain our premium pricing in the future, which would adversely affect our operating results. Fluctuations in quarterly and annual results and key metrics may cause our results to fall below our financial guidance, if any, or other projections or goals, or the expectations of analysts or investors, which could adversely affect the price of our Class A common stock.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Adverse developments affecting the financial services industry, such as actual events or concerns involving liquidity, defaults or non-performance by financial institutions or transactional counterparties, could adversely affect our current and projected business operations and our financial condition and results of operations.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Actual events involving limited liquidity, defaults, non-performance or other adverse developments that affect financial institutions, transactional counterparties or other companies in the financial services industry or the financial services industry generally, or concerns or rumors about any events of these kinds or other similar risks, have in the past and may in the future lead to market-wide liquidity problems. For example, on March 10, 2023, Silicon Valley Bank, or SVB, was closed by the California Department of Financial Protection and Innovation, which appointed the Federal Deposit Insurance Corporation, or the FDIC, as receiver. Similarly, on March 12, 2023, Signature Bank and Silvergate Capital Corp. were each swept into receivership. In addition, on May 1, 2023, the FDIC announced that First Republic had been closed by the California Department of Financial Protection and Innovation and its assets seized by the FDIC. If any of our partners, suppliers, or other parties with whom we conduct business are unable to access funds pursuant to such instruments or lending</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">45</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">arrangements with such a financial institution, such parties&#8217; ability to pay their obligations to us or to enter into new commercial arrangements requiring additional payments to us could be adversely affected. Similar impacts have occurred in the past, such as during the 2008-2010 financial crisis.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Inflation and rapid increases in interest rates have led to a decline in the trading value of previously issued government securities with interest rates below current market interest rates. Although the U.S. Department of Treasury, FDIC and Federal Reserve Board have announced a program to provide up to $25 billion of loans to financial institutions secured by certain of such government securities held by financial institutions to mitigate the risk of potential losses on the sale of such instruments, widespread demands for customer withdrawals or other liquidity needs of financial institutions for immediate liquidity may exceed the capacity of such program. There is no guarantee that the U.S. Department of Treasury, FDIC and Federal Reserve Board will provide access to uninsured funds in the future in the event of the closure of other banks or financial institutions, or that they would do so in a timely fashion.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Although we assess our banking relationships as we believe necessary or appropriate, our access to funding sources and other credit arrangements in amounts adequate to finance or capitalize our current and projected future business operations could be significantly impaired by factors that affect us, the financial institutions with which we have arrangements directly, or the financial services industry or economy in general. These factors could include, among others, events such as liquidity constraints or failures, the ability to perform obligations under various types of financial, credit or liquidity agreements or arrangements, disruptions or instability in the financial services industry or financial markets, or concerns or negative expectations about the prospects for companies in the financial services industry. These factors could involve financial institutions or financial services industry companies with which we have financial or business relationships, but could also include factors involving financial markets or the financial services industry generally.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The results of events or concerns that involve one or more of these factors could include a variety of material and adverse impacts on our current and projected business operations and our financial condition and results of operations. These could include, but may not be limited to, the following:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Delayed access to deposits or other financial assets or the uninsured loss of deposits or other financial assets; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Loss of access to revolving existing credit facilities or other working capital sources and/or the inability to refund, roll over or extend the maturity of, or enter into new credit facilities or other working capital resources; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Potential or actual breach of contractual obligations that require us to maintain letters or credit or other credit support arrangements; or </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Termination of cash management arrangements and/or delays in accessing or actual loss of funds subject to cash management arrangements. </span></div></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, investor concerns regarding the U.S. or international financial systems could result in less favorable commercial financing terms, including fluctuations in interest rates or higher costs and tighter financial and operating covenants, or systemic limitations on access to credit and liquidity sources, thereby making it more difficult for us to acquire financing on acceptable terms or at all. Any decline in available funding or access to our cash and liquidity resources could, among other risks, adversely impact our ability to meet our operating expenses, financial obligations or fulfill our other obligations, result in breaches of our financial and/or contractual obligations or result in violations of federal or state wage and hour laws. Any of these impacts, or any other impacts resulting from the factors described above or other related or similar factors not described above, could have material adverse impacts on our liquidity and our current and/or projected business operations and financial condition and results of operations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, any further deterioration in the macroeconomic landscape or financial services industry could lead to losses or defaults by parties with whom we conduct business, which in turn, could have a material adverse effect on our current and/or projected business operations and results of operations and financial condition.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">46</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Our Business and Industry</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We have derived substantially all of our revenues to date from the PreTRM test, and if our efforts to further increase the use and adoption of the PreTRM test or to develop new products and services in the future do not succeed, our business will be harmed.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We currently receive and expect to continue to receive substantially all of our revenues from the sales of the PreTRM test in the near term. We intend to establish reimbursement for the PreTRM test by collaborating with payers to perform rigorous analysis to demonstrate the health and economic benefits of our biomarker tests within their own network using customized inputs based on the plan&#8217;s patient population. We plan to leverage early payer reimbursement decisions to obtain widespread commercial coverage of the PreTRM test from many regional and national plans and medical groups with doctors ordering the PreTRM test. We are also evaluating the expansion of our business internationally, with an initial focus on Europe. If we are unable to execute on this commercial strategy and increase our revenues from the sale of the PreTRM test, our business may be materially adversely impacted. Our ability to increase sales of the PreTRM test and establish greater levels of adoption and reimbursement for the PreTRM test is uncertain for many reasons, including, among others:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may be unable to demonstrate to clinics, clinicians, physicians, payers, and patients that the PreTRM test is superior to alternatives with respect to value, convenience, accuracy, scope of coverage, and other factors;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">third-party payers may set the amounts of reimbursement at prices that reduce our profit margins or do not allow us to cover our expenses;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may not be able to maintain and grow effective sales and marketing capabilities;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our sales and marketing efforts may fail to effectively reach customers or communicate the benefits of the PreTRM test;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">superior alternatives to the PreTRM test may be developed and commercialized and we may not be able to compete against these alternatives;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may face competitive pressures;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may experience supply constraints, including due to the failure of our key suppliers to provide laboratory supplies, instruments, and reagents;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may encounter difficulties with transportation logistics, regulations and quality associated with shipping blood specimens, including infrastructure conditions, transportation delays and temperature stress;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may encounter laboratory process difficulties that impact the quality and timeliness of reporting of test results;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">U.S. or foreign regulatory or legislative bodies may adopt new regulations or policies or take other actions that impose significant restrictions on, or other challenges to, our ability to sell or market our products and services;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">news media organizations, medical societies, or industry groups may issue publications, guidance, or analyses that negatively impact patients&#8217; and/or health care providers&#8217; perception or utilization of the PreTRM test (or certain types of prenatal testing and related health care services, generally) and thereby negatively impact our ability to sell or market the PreTRM test;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may be unable to compete successfully with respect to our current or future products or services, as a result of which we may not be able to increase or sustain our revenues or achieve profitability; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may not be able to protect our intellectual property position.</span></div></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If our market share for the PreTRM test fails to grow or grows more slowly than expected, or if our efforts to develop new products and services in the future do not succeed, our business, operating results, and financial condition would be adversely affected.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our success depends on broad scientific and market acceptance of the PreTRM test and our other pipeline products and services, which we may fail to achieve.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our ability to achieve and maintain scientific and commercial market acceptance of the PreTRM test will depend on a number of factors. We expect that the PreTRM test will be subject to the market forces and adoption curves common to other new technologies. The market for proteomics and bioinformatics technologies and products is in its early stages of development. If widespread adoption of the PreTRM test or any other products and services that we commercialize in the</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">47</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">future takes longer than anticipated, we will continue to experience operating losses. The success of life sciences technologies and products is due, in large part, to acceptance by the scientific and medical communities and their adoption of certain products in the applicable field of research. The life sciences scientific community is often led by a small number of early adopters and key opinion leaders who significantly influence the rest of the community through publications in peer-reviewed journals. In such journal publications, the researchers will describe their discoveries, and also the methods, and typically the products used, to fuel such discoveries. Mentions in peer-reviewed journal publications may be a driver for the general acceptance of products for the life sciences industry, such as the PreTRM test. In addition, continuing collaborative relationships with opinion leaders will be vital to maintaining any market acceptance we achieve. If too few researchers describe the use of our products or services, too many researchers shift to a competing product or service and publish research outlining their use of that product or service, or too many researchers negatively describe the use of our products or services in publications, it may drive customers away from our products or services. Other factors in achieving commercial market acceptance include:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to market and increase awareness of the capabilities of the PreTRM test;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the ability of the PreTRM test to demonstrate comparable performance in intended use applications broadly in the hands of customers;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our customers&#8217; willingness to adopt new products, services, and workflows;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the PreTRM test&#8217;s ease of use and whether it reliably provides advantages over other alternative technologies;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the rate of adoption of the PreTRM test by patients, physicians, payers and the medical community at large;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">medical society guidelines supporting the use of the PreTRM test and clinical interventions based on it;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the prices we charge for the PreTRM test;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to develop new products, services, and solutions for customers;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">whether competitors develop and commercialize products that perform similar functions as the PreTRM test; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the impact of our investments in product and service innovation and commercial growth.</span></div></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We cannot assure that we will be successful in addressing each of these criteria or other criteria that might affect the market acceptance of any products or services we commercialize, particularly the PreTRM test. If we are unsuccessful in achieving and maintaining market acceptance of the PreTRM test, our business, financial condition, and results of operations would be adversely affected.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">In the near future, we expect to rely on sales to a limited number of direct customers for a significant portion of our revenue and cash flows related to the sale of the PreTRM test, making us subject to customer concentration risk.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We expect that a significant portion of our revenue and cash flows in the near future will be related to sales to a limited number of customers, including Elevance Health, the loss of any of which could adversely affect our business, financial condition, cash flows, and results of operations. Accordingly, we are subject to customer concentration risk. Furthermore, any termination of our relationship with Elevance Health would also adversely impact our strategy to rapidly accelerate commercialization of the PreTRM test and help incentivize broader market adoption.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we are unable to establish and maintain sales and marketing capabilities, we may not be successful in commercializing the PreTRM test.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have limited experience as a company in sales and marketing and our ability to achieve profitability depends on our being able to attract customers for the PreTRM test and our future products or services, once approved. Although members of our management team have considerable industry experience, successfully commercializing the PreTRM test will require adapting our sales, marketing, distribution, and customer service and support capabilities to current and ever-changing market conditions. To perform sales, marketing, distribution, and customer service and support successfully, we will face a number of risks, including:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to attract, retain, and manage the sales, marketing, and customer service and operations workforce necessary to commercialize and gain market acceptance for our technology;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the time and cost of establishing a specialized sales, marketing, and customer service and operations workforce; and</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">48</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our sales, marketing, and customer service and support team may be unable to initiate and execute successful commercialization activities.</span></div></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may seek to enlist one or more third parties to assist with sales, distribution, and customer service and support. There is no guarantee, if we do seek to enter into such arrangements, that we will be successful in attracting desirable sales and distribution partners or that we will be able to enter into such arrangements on favorable terms. If our sales and marketing efforts, or those of any third-party sales and distribution partners, are not successful, the PreTRM test may not gain market acceptance, which could materially impact our business operations.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Even if the PreTRM test achieves broad scientific and market acceptance, if we fail to improve it or introduce compelling new products and services, our future revenues and prospects could be harmed.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Even if we are able to achieve broad scientific and market acceptance for the PreTRM test, our ability to grow our business will depend in large part on our ability both to enhance and improve the PreTRM test and to introduce compelling new products and services, including for major pregnancy related conditions beyond preterm birth. The success of any enhancement to the PreTRM test or introduction of new products or services depends on several factors, including completion of certain clinical development requirements, timely completion and delivery of the product or service, competitive pricing, adequate quality testing, integration with existing technologies, appropriately timed and staged product or service introductions, and overall market acceptance. Any new product, new service, or enhancement to the PreTRM test that we develop may not be introduced in a timely or cost-effective manner, may contain defects, errors or vulnerabilities or may not achieve the market acceptance necessary to generate significant revenue.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The typical development cycle of new life sciences products or services can be lengthy and complicated and may require new scientific discoveries or advancements, considerable resources, and complex technology and engineering. Such developments may involve external suppliers and service providers, making the management of development projects complex and subject to risks and uncertainties regarding timing, timely delivery of required components or services and satisfactory technical performance of such components or assembled products. If we do not achieve the required technical specifications or successfully manage development processes of the new product or service, or if development work is not performed according to schedule, then such new technologies, products, or services may be adversely impacted. To date, we have only completed the development process for one product. We cannot assure you that we will ever succeed in completing that process for another product, including for major pregnancy related conditions beyond preterm birth, or that even if we do, it will be launched successfully in the market and find commercial acceptance. If we are unable to successfully develop new products or services, enhance the PreTRM test to meet customer requirements, compete with alternative products and services or otherwise gain and maintain market acceptance, our business, results of operations, and financial condition could be harmed.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Competition in the life science industry, including companies engaged in molecular diagnostics and proteomics, is intense. If we are unable to compete successfully with respect to our current or future products or services, we may not be able to increase or sustain our revenues or achieve profitability.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are a women&#8217;s health diagnostic company utilizing our proprietary proteomics and bioinformatics platform to discover, develop, and commercialize biomarker tests, and our first commercial product, the PreTRM test, is designed to accurately predict the risk of premature delivery. The proteomics and bioinformatics industry is characterized by rapid technological changes, frequent new product introductions, reimbursement challenges, emerging competition, intellectual property disputes and litigation, price competition, aggressive marketing practices, evolving industry standards and changing customer preferences. We cannot guarantee that research, discoveries or other advancements by other companies will not render our existing or potential products and services uneconomical or result in products and services that are superior or otherwise preferable to our current or future products and services.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We face competition with respect to the PreTRM test and expect to face competition with respect to any product candidates that we may seek to develop or commercialize in the future. Many of the companies against which we are competing or may compete against in the future have significantly greater financial resources and expertise in research and development, manufacturing, and commercialization. Mergers and acquisitions in our industry may result in even more resources being concentrated among a smaller number of our competitors. Smaller and early-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies. These third parties compete with us in recruiting and retaining qualified scientific and management personnel and conducting clinical trials, as well as in acquiring technologies complementary to, or necessary for, our products and services.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">49</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To remain competitive over time, we will need to continually research and develop improvements to our products and services. However, we cannot assure you that we will be able to develop and commercialize any improvements to our products and services on a timely basis. Our competitors may develop and commercialize competing or alternative products and services and improvements faster than we are able to do so, which would negatively affect our ability to increase or sustain our revenue or achieve profitability.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If our products do not perform as expected, our operating results, reputation, and business will suffer.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our success depends on the market&#8217;s confidence that we can provide reliable, high-quality testing results. There is no guarantee that the accuracy and reproducibility we have demonstrated to date will continue as our test volumes continue to increase and our product portfolio continues to expand. We believe that patients that rely on our tests are particularly sensitive to test limitations and errors, including inaccurate test results. As a result, if our tests do not perform as expected or favorably in comparison to competing tests, our operating results, reputation, and business will suffer. We may also become subject to legal claims arising from such limitations, errors or inaccuracies.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The PreTRM test uses, and our future tests will use, a number of complex and sophisticated proteomic and bioinformatics processes and advanced mass spectrometry techniques, which are highly sensitive to external factors. An operational, technological or other failure in one of these complex processes may result in sensitivity or specificity rates that are lower than we anticipate. In addition, we regularly evaluate and refine our testing processes, and any refinements we make may not improve our tests as we expect and may result in unanticipated issues that may adversely affect our test performance as described above. Such operational, technical, and other difficulties adversely affect test performance, may impact the commercial attractiveness of our products and may increase our costs or divert our resources, including management&#8217;s time and attention, from other projects and priorities. Furthermore, any changes to our testing process may require us to use new or different suppliers or materials with whom or which we are unfamiliar, and which may not perform as we anticipate, and could cause delays, downtime or other operational issues.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If our CLIA-certified laboratory facility becomes inoperable, we will be unable to perform our tests and our business will be harmed.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We currently operate a CLIA-certified laboratory facility in Salt Lake City, Utah, which processes the PreTRM test and likely any other future test, if approved, that is or will be the source of substantially all of our revenues. Our facility could be harmed or rendered inoperable, or our supplies or other assets could be damaged or destroyed, by natural or man-made disasters, including earthquakes, severe weather, flooding, power outages, and contamination, including as a result of a public health threat, which may render it difficult or impossible for us to operate our business and/or perform our tests for some period of time. The inability to perform our tests or the backlog of tests that could develop if our facility is inoperable&#8201;&#8212;&#8201;for even a short period of time&#8201;&#8212;&#8201;may harm our reputation and result in a material adverse effect on our revenues.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The marketing, sale, and use of the PreTRM test and any other products that we develop in the future could result in substantial damages arising from product liability or professional liability claims, associated with product recalls or otherwise, that exceed our resources.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The marketing, sale, and use of the PreTRM test and any other products that we develop and commercialize in the future could lead to product liability claims against us if someone were to allege that the PreTRM test or any future product failed to perform as it was designed or as claimed in our promotional materials, was performed pursuant to incorrect or inadequate laboratory procedures, if we delivered incorrect or incomplete test results or if someone were to misinterpret test results. In addition, we may be subject to liability for errors in, a misunderstanding of, or inappropriate reliance upon, the information we provide, or for failure to provide such information, in connection with our marketing and promotional activities or as part of the results generated by the PreTRM test and other future products or services. Even though the PreTRM test is highly accurate, no test is 100% accurate, and we may report false results. In such a scenario, the patient or her family may file a lawsuit against us claiming product or professional liability. In addition, any manufacturing or design defects in our products could lead to product recalls, either voluntary or as required by government authorities, which could result in the removal of a product from the market.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A product liability or professional liability claim could result in substantial damages and be costly and time-consuming for us to defend. Although we maintain product and professional liability insurance, our insurance may not fully protect us from the financial impact of defending against product liability or professional liability claims or any judgments, fines or settlement costs arising out of any such claims, or the financial and reputational consequences of a product recall. Any product liability or professional liability claim brought against us, with or without merit, could increase our insurance rates, cause our insurance coverage to be terminated or prevent us from securing insurance coverage in the future. As we attempt to</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">50</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">bring new products to market, we may need to increase our product liability coverage, which would be a significant additional expense that we may not be able to afford. Additionally, any product liability or professional liability lawsuit could harm our reputation, result in a cessation of PreTRM testing or cause our partners to terminate our agreements with them, any of which could adversely impact our results of operations.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The results of our clinical trials and studies may not support the use of our tests and other product candidates, or may not be replicated in later studies.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have conducted and are currently conducting a variety of observational and interventional studies for the PreTRM test and our other tests in development that involve clinical investigators at multiple sites in the United States. We may need to conduct additional studies for the PreTRM test, as well as other tests we may offer in the future, to drive test adoption in the marketplace and reimbursement. Should we not be able to perform these studies, or should their results not provide clinically meaningful data and value for clinicians, or if our results are unfavorable, adoption of our tests could be impaired.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The administration of clinical and economic utility studies is expensive and demands significant attention from certain members of our management team. Data collected from these studies may not be positive or consistent with our existing data, or may not be statistically significant or compelling to the medical community or payers. If the results obtained from our ongoing or future studies are inconsistent with certain results obtained from our previous studies, adoption of our products would suffer and our business would be harmed.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Peer-reviewed publications regarding our products and product candidates may be limited by many factors, including delays in the completion of, poor design of, or lack of compelling data from clinical studies, as well as delays in the review, acceptance, and publication process. If our products or product candidates or the technology underlying our current or future products or product candidates do not receive sufficient favorable exposure in peer-reviewed publications, or are not published, the rate of health care provider adoption of our tests and positive reimbursement coverage decisions for our tests and other products could be negatively affected. The publication of clinical data in peer-reviewed journals can be a crucial step in commercializing and obtaining reimbursement for tests, and our inability to control when, if ever, results are published may delay or limit our ability to derive sufficient revenues from any test that is the subject of a study. The performance achieved in published studies may not be repeated in later studies that may be required to obtain FDA marketing authorizations should we decide to do so for business reasons, or should we be required to submit applications to the FDA or other health authorities seeking such authorizations.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, clinical trials must be conducted in accordance with applicable laws and subject to the oversight of Institutional Review Boards, or IRBs. We rely on clinical trial sites to ensure the proper and timely conduct of our clinical trials and while we have agreements governing their committed activities, we have limited influence over their actual performance. We depend on our collaborators and on medical institutions to conduct our clinical trials in compliance with applicable human subject protection regulations and Good Clinical Practice, or GCP, requirements. To the extent our collaborators fail to enroll participants for our clinical trials, fail to conduct our trials in compliance with applicable law and GCP requirements, or are delayed for a significant time in the execution of trials, including achieving full enrollment, we may be affected by increased costs, program delays, or both.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Interim, top-line and preliminary data from our clinical trials that we announce or publish from time to time may change as additional data become available and are subject to confirmation, audit, and verification procedures that could result in material changes in the final data.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, we may publicly disclose interim, top-line or preliminary data from our clinical trials, which is based on a preliminary analysis of then-available data, and these results and related findings and conclusions may be subject to change following a more comprehensive review of the data. We also make assumptions, estimations, calculations, and conclusions as part of our analyses of data, and we may not have received or have had the opportunity to fully and carefully evaluate all data. As a result, the interim, top-line or preliminary data that we report may differ from future results of the same trials, or different conclusions or considerations may qualify such results once additional data have been received and fully evaluated. Interim data from clinical trials are subject to the risk that one or more of the clinical outcomes may materially change as patient enrollment continues and more patient data become available. Preliminary, interim or top-line data also remain subject to audit and verification procedures that may result in the final data being materially different from the preliminary top-line data we previously published. As a result, preliminary, interim, and top-line data should be viewed with caution until the final data are available. Adverse differences between preliminary, interim, and top-line data and final data could significantly harm our business prospects and may cause the price of our Class A common stock to fluctuate or decline.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">51</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Further, payers, physicians, and others may not accept or agree with our assumptions, estimates, calculations, conclusions or analyses or may interpret or weigh the importance of data differently, which could adversely impact the potential of the particular product or program, the prospects for commercialization of any product, and the business prospects of our Company in general. In addition, the information we choose to publicly disclose regarding a particular study or clinical trial is derived from information that is typically extensive, and you or others may not agree with what we determine is material or otherwise appropriate information to include in our disclosure.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If the preliminary, interim or top-line data that we report differ from later or final results, or if payers, physicians or others disagree with the conclusions reached, our ability to commercialize our product candidates may be significantly impaired, which could materially harm our business, operating results, prospects or financial condition.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our business would be materially harmed if our proprietary biobank were to become contaminated, lost or destroyed.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A fundamental component of our platform is our proprietary biobank, consisting of comprehensive, clinically and demographically annotated blood specimens collected from thousands of pregnant U.S. women, representing the broad demographic and geographic diversity inherent in the U.S. population. This biobank is maintained at our facility in Salt Lake City, Utah, in a secure environment. If the specimens and information contained in the biobank were to become compromised or destroyed, through contamination, theft, a cybersecurity breach, a natural disaster or otherwise, our ability to rely on the data represented in the biobank could be significantly impaired, which could materially harm our business, operating results, prospects or financial condition.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Some of our products and services rely heavily on access to internal and external databases, and loss of access to data or such databases could materially harm our business.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Data is a critical driver of our business, and access to large amounts of data housed in both internal and external databases is essential for our existing and future products and services. We maintain much of this data in our own proprietary databases. While we take reasonable measures to protect such internal databases, those measures may be unsuccessful, which could lead to a temporary loss of access to or permanent loss of data, or to other unavailability or modification of such data. Other data used in or essential to our products and services is stored in databases controlled by third parties, including governmental databases. Continued access to such data depends on the third party maintaining such databases and continuing to allow our access on reasonable terms. Loss of access to either internal or external data or databases, or other unavailability or modification of such data could materially harm our business, including the possibility of us needing to discontinue certain products or services.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">International expansion of our business will expose us to business, regulatory, political, operational, financial, and economic risks associated with doing business outside the United States.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To the extent that we decide to market our products and services outside the United States, including but not limited to jurisdictions in the European Union, our business will be subject to the risks associated with doing business outside the United States, including an increase in our expenses and diversion of our management&#8217;s attention from the development of future products and services. Accordingly, our business and financial results in the future could be adversely affected due to a variety of factors, including:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">multiple, conflicting and changing laws and regulations such as data privacy, information security, and data use regulations, tax laws, export and import restrictions, economic sanctions and embargoes, employment laws, anti-corruption laws, regulatory requirements applicable to clinical laboratories and to IVD products, reimbursement or payer regimes and other governmental approvals, permits and licenses;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">failure by us or our distributors to obtain any necessary regulatory clearance, authorization or approval for the use of our products and services in various countries;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">additional potentially relevant third-party patent rights;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">complexities and difficulties in obtaining intellectual property protection and maintaining, defending, and enforcing our intellectual property outside the United States;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">difficulties in staffing and managing foreign operations;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">employment risks related to hiring employees outside the United States;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">complexities associated with managing multiple payer reimbursement regimes, government payers or patient self-pay systems;</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">52</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">difficulties in negotiating favorable reimbursement negotiations with governmental authorities;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">logistics and regulations associated with the international shipment of patient specimens, including infrastructure conditions, licensure requirements and transportation delays;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">limits in our ability to penetrate international markets if we are not able to sell our products or conduct services locally;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">financial risks, such as longer payment cycles, difficulty collecting accounts receivable, the impact of local and regional financial crises on demand and payment for our products and services and exposure to foreign currency exchange rate fluctuations;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">natural disasters, political and economic instability, including wars, terrorism, and political unrest, outbreak of disease, boycotts, curtailment of trade, and other business restrictions;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">regulatory and compliance risks that relate to maintaining accurate information and control over sales and distributors&#8217; activities that may fall within the purview of the U.S. Foreign Corrupt Practices Act, or FCPA, its books and records provisions, or its anti-bribery provisions, or laws similar to the FCPA in other jurisdictions in which we may operate, such as the United Kingdom Bribery Act of 2010, or the U.K. Bribery Act; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">onerous anti-bribery requirements of several member states in the European Union, the United Kingdom, Japan, and other countries that are constantly changing and require disclosure of information to which U.S. legal privilege may not extend.</span></div></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any of these factors could significantly harm our future international expansion and operations and, consequently, our revenue and results of operations.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may not be able to obtain and maintain the third-party relationships that are necessary to develop and commercialize some or all of our tests.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We expect to depend on collaborators, partners, licensees, and other third parties to support our test development and validation efforts, to deliver needed supplies, and to transport patient specimens both domestically and internationally, among other things. Any problems we experience with any of these third parties could delay the development, validation, commercialization, and performance of our testing, which could harm our results of operations.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We cannot guarantee that we will be able to successfully negotiate agreements for, or maintain relationships with, collaborators, partners, licensees, and other third parties on favorable terms, if at all. If we are unable to obtain or maintain these agreements, we may not be able to develop, validate, obtain regulatory authorizations for, or commercialize any future tests, which will in turn adversely affect our business.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We expect to expend substantial management time and effort to enter into relationships with third parties and, if we successfully enter into such relationships, to manage these relationships. In addition, substantial amounts will be paid to third parties in these relationships. However, we cannot control the amount or timing of resources our future contract partners will devote to our business endeavors, and we cannot guarantee that these parties will fulfill their obligations to us under these arrangements in a timely fashion, if at all. In addition, while we manage the relationships with third parties, we cannot control all of the operations of and protection of intellectual property by such third parties.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We rely on third parties for specimen collection, including phlebotomy services, and commercial courier delivery services, and if these services are disrupted, our business will be harmed.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We rely on third parties to perform specimen collection, including phlebotomy services, and to transport specimens to our laboratory facility in a timely and cost-efficient manner. Disruptions in these services, whether due to any natural or other disasters, pandemics, acts of war or terrorism, shipping embargoes, labor unrest, political instability or similar events could adversely affect specimen integrity and our ability to process specimens in a timely manner and to service our customers, and ultimately our reputation and our business. In addition, if we are unable to continue to obtain expedited delivery services on commercially reasonable terms, our operating results may be adversely affected.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, our relationships with these service providers could be scrutinized under federal and state health care laws such as the federal Anti-Kickback Statute and the Stark Law, and their implementing regulations, to the extent, for example, that these services provide a financial benefit to or relieve a financial burden for a potential referral source. If our operations are found to be in violation of any of these (or other) laws and regulations, we may be subject to administrative, civil and/or</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">53</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">criminal penalties, damages, fines, individual imprisonment, refunding of payments received by us, exclusion from government health care programs, and/or curtailment or cessation of our operations, among other potential penalties, any of which could harm our reputation and adversely affect our business, operating results, and financial condition.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We rely on a limited number of suppliers or, in some cases, single suppliers, for some of our laboratory instruments and materials, as well as for our recently developed whole-blood collection kit, and may not be able to find replacements or immediately transition to alternative suppliers on a cost-effective basis, or at all.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We source components of our technology from third parties and certain components are sole sourced. Obtaining substitute components may be difficult or require us to re-design our products. We expect to continue to depend on third-party contract suppliers for the foreseeable future. Any natural or other disasters, pandemics, acts of war or terrorism, shipping embargoes, labor unrest or political instability or similar events at our third-party suppliers&#8217; facilities that cause a loss of manufacturing capacity or a reduction in the quality of the items manufactured would heighten the risks that we face. In addition, inflation and/or global supply chain disruptions may have a negative impact on our third-party contract suppliers&#8217; ability to acquire the materials necessary for our business and we could incur higher costs for certain goods or services due to inflation or increased freight costs. Changes to, failure to renew or termination of our existing agreements or our inability to enter into new agreements with other suppliers could result in the loss of access to important components of our tests and could impair, delay or suspend our commercialization efforts. Our failure to maintain a continued and cost-effective supply of high-quality components could materially and adversely harm our business, operating results, and financial condition.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, our Sera-branded specimen collection kits are produced by a third-party supplier. If demand for the kit increases significantly, we will need to either expand production capabilities through our existing third-party manufacturer or outsource to other manufacturers. If our third-party supplier fails to manufacture and deliver the collection kit in a timely manner for any reason, including as a result of supply chain failures, or they are unable to fulfil our orders due to regulatory non-compliance or other quality-related issues, our future relationships with our customers could be seriously harmed. We cannot assure you that manufacturing or quality control problems will not arise as we attempt to increase the production of the recently developed collection kit or that we may be able to increase our manufacturing capabilities and maintain quality control in a timely manner or at commercially reasonable costs. If we cannot have the collection kit manufactured consistently on a timely basis because of these or other factors, it could have a significant negative impact on our ability to continue performing tests and generating revenues.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we are unable to successfully scale our operations, or attract and retain highly skilled employees, our business could suffer.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As our test volumes grow and we develop future product offerings, we will need to continue to ramp up our testing capacity and implement increases in scale, such as increased headcount, additional or upgraded equipment, additional qualified laboratory personnel, increased office and laboratory space, expanded customer service capabilities, improved billing and systems processes, enhanced controls and procedures and expanded or internal quality assurance program and technology platform. The value of the PreTRM test and our other testing products that we may develop in the future depends on our ability to perform, and our reputation for performing, these tests on a timely basis and with an exceptionally high standard of quality. Failure to implement necessary procedures, transition to new facilities, purchase and maintain equipment, establish processes, or hire the necessary personnel in a timely and effective manner could result in higher processing costs or an inability to meet market demand or could otherwise affect our operating results.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To execute our growth plan, we must attract and retain highly qualified personnel. Competition for these personnel is intense, especially for sales, scientific, medical, laboratory, research and development, and other technical personnel. The turnover rate of such personnel can be high. We may, from time to time, experience difficulty in hiring and retaining employees with appropriate qualifications. Furthermore, replacing executive officers and key employees may be difficult and may take an extended period of time due to the limited number of individuals in our industry with the breadth of skills and experience required to successfully develop, gain regulatory approval of, and commercialize products. Competition to hire from the limited pool referred to above is intense, and we may be unable to hire, train, retain, or motivate these key personnel on acceptable terms given the competition among numerous pharmaceutical and biotechnology companies for similar personnel. Many of the companies with which we compete for highly qualified personnel have greater resources than we have. If we hire employees from competitors or other companies, their former employers may attempt to assert that these employees or our Company have breached their legal obligations to their former employers, which occurs from time to time. Furthermore, to the extent that we are unable to retain our employees and they leave our Company to join one of our competitors, we cannot assure you that any invention, non-disclosure or non-compete agreements we have in place will provide meaningful protection against a departing employee&#8217;s unauthorized use or disclosure of our confidential information.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">54</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, our growth may place a significant strain on our operating and financial systems and our management, sales, marketing, and administrative resources. As a result of our growth, our operating costs may escalate faster than we anticipate, we may face difficulties in obtaining additional office or laboratory space and some of our internal systems may need to be enhanced or replaced. If we cannot effectively manage our expanding operations and our costs, we may not be able to grow successfully or we may grow at a slower pace, and our business could be adversely affected.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risks associated with any operations outside of the United States and developments in international trade by the U.S. and foreign governments could adversely affect our business.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may establish operations or develop material partnerships outside the United States, and such operations or partnerships may become material to our business. Therefore, we may become subject to risks related to operating in foreign countries, which include unfamiliar foreign laws or regulatory requirements or unexpected changes to those laws or requirements; other laws and regulatory requirements to which our business activities abroad may be subject, such as the Foreign Corrupt Practices Act and the U.K. Bribery Act; changes in the political or economic condition of a specific country or region, including Russia&#8217;s invasion of Ukraine, the conflict in the Middle East, and the potential for a wider European or global conflict; fluctuations in the value of foreign currency versus the U.S. dollar; volatility in inflation and interest rates; our ability to deploy overseas funds in an efficient manner; tariffs, trade protection measures, import or export licensing requirements, trade embargoes, and sanctions (including those administered by the Office of Foreign Assets Control of the U.S. Department of the Treasury), and other trade barriers; global instability from an outbreak of pandemic or contagious disease; difficulties in attracting and retaining qualified personnel; and cultural differences in the conduct of business. For example, given developments related to international trade over the past few years, unexpected changes in tariffs could adversely affect our cost of goods sold and/or the foreign sales of our product candidates. Changes impacting our ability to conduct business outside of the United States, or changes to the regulatory regime applicable to our operations in countries outside of the United States (such as with respect to the approval of our product candidates), may materially and adversely impact our business, prospects, operating results, and financial condition.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Any headcount reductions undertaken to extend our cash runway and focus more of our capital resources on our prioritized research and development programs as well as commercialization activities may not achieve our intended outcome.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, we have made select headcount reductions to more effectively allocate costs toward a refined focus on those opportunities deemed most promising in the near-term from a product adoption and revenue generation perspective. Such headcount reductions may result in unintended consequences and costs, such as the loss of institutional knowledge and expertise, attrition beyond the intended number of employees, decreased morale among our remaining employees, and the risk that we may not achieve the anticipated benefits of the headcount reductions. In addition, while positions have been eliminated, certain functions necessary to our operations remain, and we may be unsuccessful in distributing the duties and obligations of departed employees among our remaining employees. The headcount reductions could also make it difficult for us to pursue, or prevent us from pursuing, new opportunities and initiatives due to insufficient personnel, or require us to incur additional and unanticipated costs to hire new personnel to pursue such opportunities or initiatives. If we are unable to realize the anticipated benefits from the headcount reductions, or if we experience significant adverse consequences from the headcount reductions, our business, financial condition, and results of operations may be materially adversely affected.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may engage in acquisitions, dispositions or other strategic transactions that could disrupt our business, cause dilution to our stockholders or reduce our financial resources.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, we may enter into transactions to acquire or dispose of businesses, products or technologies or to engage in other strategic transactions. Because we have not made any such acquisitions to date, our ability to do so successfully is unproven. Even if we identify suitable transactions, we may not be able to complete such transactions on favorable terms or at all. Any acquisitions or other strategic transactions we consummate may not strengthen our competitive position, and these transactions may be viewed negatively by customers or investors. We may decide to incur debt in connection with an acquisition or issue shares of our common stock or other equity securities to the stockholders of the acquired company, which would cause dilution to our existing stockholders. We could incur losses resulting from such strategic transactions, including undiscovered liabilities of an acquired business that are not covered by any indemnification we may obtain from the seller. In addition, we may not be able to successfully integrate any acquired personnel, technologies, and operations into our existing business in an effective, timely and non-disruptive manner. Any dispositions may also cause us to lose revenue and may not strengthen our financial position. Strategic transactions may also divert management attention from day-to-day responsibilities, increase our expenses, result in accounting charges, and reduce our cash available for operations and other uses. We cannot predict the number, timing or size of future strategic transactions or the effect that any such transactions might have on our operating results.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">55</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may need to raise additional funds through equity or debt financings, corporate collaborations or licensing arrangements to continue to fund or expand our operations. Additional capital, if needed, may not be available on satisfactory terms or at all. Furthermore, any additional capital raised through the sale of equity or equity-linked securities, or grant of equity or equity-linked securities in connection with any debt financing, will dilute stockholders&#8217; ownership interests in us and may have an adverse effect on the price of our Class A common stock. In addition, the terms of any financing may adversely affect stockholders&#8217; holdings or rights. To the extent that we raise capital through collaborations and licensing arrangements, it may be necessary to relinquish some rights to our technologies or grant licenses on terms that may not be favorable to us.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we are not able to obtain adequate funding when needed, we may have to delay development programs or sales and marketing initiatives. In addition, we may have to work with a partner on one or more of our tests or programs, which could lower the economic value of those programs to our Company.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Public health threats, such as pandemics or epidemics, could materially affect our operations, as well as the business or operations of third parties with whom we conduct business. Our business could be adversely affected by the effects of other future public health threats in regions where we, or third parties on which we rely, have significant business operations.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our business and operations, including, but not limited to, our laboratory operations, sales and marketing efforts, supply chain operations, research and development activities, and fundraising activities, could be adversely affected by public health disruptions in regions where we have business operations, and such health disruptions could cause significant disturbance in the operations of third parties upon whom we rely. For example, in March 2020, the World Health Organization declared the COVID-19 outbreak a pandemic, and the U.S. government imposed restrictions on travel between the United States, Europe, and certain other countries. In the years following the initial outbreak, numerous state and local jurisdictions, including the jurisdictions where our headquarters and laboratory are located, imposed quarantines, shelter-in-place orders, executive orders, and similar government orders for their residents to control the spread of COVID-19. A new serious public health threat could result in similar restrictions being imposed. The future impact of a public health threat is highly uncertain and subject to change. We cannot predict the full extent of potential delays or impacts on our business, our clinical trials, health care systems or the global economy as a whole.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We cannot ensure that our employees will fully adhere to compliance policies and procedures.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have implemented and strive to continuously develop and improve compliance policies and procedures intended to train our sales, billing, marketing, and other personnel regarding compliance with state and federal laws applicable to our business. Our efforts to implement appropriate monitoring of compliance with such policies and procedures are likewise ongoing. Despite our compliance policies and procedures, and related training and monitoring, we may experience situations in which employees may have failed to fully adhere to our policies and/or applicable laws in the past or in which they fail to adhere to applicable policies and/or laws in the future. Such failures may subject us to administrative, civil, and criminal actions, penalties, damages, fines, individual imprisonment, exclusion from participation in state and/or federal health care programs, refunding of payments received by us, and curtailment or cessation of our operations. In addition, commercial third-party payers may refuse to provide all or any reimbursement for tests administered, seek repayment from us of amounts previously reimbursed and harm our ability to secure network contracts with third-party payers. Any of the foregoing could adversely affect our revenue, cash flow, and financial condition, and reduce our growth prospects. As of the date hereof, we are not aware of any noncompliance with any state and federal laws applicable to our business.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our ability to utilize our net operating loss carryforwards and certain other tax attributes may be limited.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have a significant amount of net operating loss, or NOL, carryforwards that can be used to offset potential future taxable income and related income taxes. As of December 31, 2024, we had federal NOL carryforwards of approximately $239.6 million, of which, $70.3 million, if not utilized, begin to expire in 2028. Approximately $169.3 million of these federal NOLs can be carried forward indefinitely. Under Section 382 of the Internal Revenue Code of 1986, as amended, if a corporation undergoes an &#8220;ownership change&#8221; (generally defined as a greater than 50% change, by value, in equity ownership over any three-year period), the corporation&#8217;s ability to use its pre-change NOL carryforwards and other pre-change tax attributes to offset its post-change income or taxes may be limited. We may experience ownership changes in the future as a result of shifts in our stock ownership, some of which may not be within our control. Our ability to use these carryforwards could be limited if we experience an &#8220;ownership change.&#8221;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">56</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our estimates of total addressable market opportunity and forecasts of market growth may prove to be inaccurate, and even if the market in which we compete achieves the forecasted growth, our business could fail to grow at a similar rate.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Total addressable market opportunity estimates and growth forecasts are subject to significant uncertainty and are based on assumptions and estimates that may not prove to be accurate. Our publicly announced estimates and forecasts relating to the size and expected growth of our market may prove to be inaccurate. Even if the market in which we compete meets our size estimates and forecasted growth, our business could fail to grow at similar rates.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">An inflationary environment and unstable global economic and geopolitical conditions could materially adversely impact our business and results of operations.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our operating results could be materially impacted by changes in the overall macroeconomic environment and other economic factors that impact customer confidence and spending, including capital spending. Changes in economic conditions, supply chain constraints, logistics challenges, labor shortages, global conflicts, and steps taken by governments and central banks, particularly in response to public health threats as well as other stimulus and spending programs, could lead to higher inflation, which is likely, in turn, to lead to an increase in costs and may cause changes in fiscal and monetary policy, including increased interest rates. In a higher inflationary environment, we may be unable to raise the prices of our products sufficiently to keep up with the rate of inflation. Impacts from inflationary pressures could be more pronounced and materially adversely impact aspects of our business where revenue streams and cost commitments are linked to contractual agreements that extend further into the future, as we may not be able to quickly or easily adjust pricing, reduce costs, or implement counter measures.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Changes in U.S. federal policy that affect the geopolitical landscape could give rise to circumstances outside our control that could have negative impacts on our business operations. For example, during the prior Trump administration, increased tariffs were implemented on goods imported into the U.S., particularly from China, Canada, and Mexico. On February 1, 2025, the United States imposed a 25% tariff on imports from Canada and Mexico, which were subsequently suspended for a period of one month, and a 10% additional tariff on imports from China. Historically, tariffs have led to increased trade and political tensions, between not only the United States and China, but also between the United States and other countries in the international community. In response to tariffs, other countries have implemented retaliatory tariffs on U.S. goods. Political tensions as a result of trade policies could reduce trade volume, investment, technological exchange and other economic activities between major international economies, resulting in a material adverse effect on global economic conditions and the stability of global financial markets. Any changes in political, trade, regulatory, and economic conditions, including U.S. trade policies, could have a material adverse effect on our financial condition or results of operations.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Inadequate funding for the FDA, the SEC and other government agencies, or a work slowdown or stoppage at those agencies as part of a broader federal government shutdown, could hinder their ability to hire and retain key leadership and other personnel, prevent new products and services from being developed or commercialized in a timely manner, or otherwise prevent those agencies from performing normal business functions on which the operation of our business may rely, which could negatively impact our business.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The ability of the FDA or other governmental agencies to review and approve new products can be affected by a variety of factors, including government budget and funding levels, the ability to hire and retain key personnel and accept the payment of user fees, and statutory, regulatory, and policy changes. Average review times at the agency have fluctuated in recent years as a result. In addition, government funding of the SEC and other government agencies on which our operations may rely, including those that fund research and development activities, is subject to the political process, which is inherently fluid and unpredictable. For example, over the last several years, the U.S. government has shut down several times and certain regulatory agencies, such as the FDA and the SEC, have had to furlough critical FDA, SEC and other government employees and stop critical activities. If a prolonged government shutdown or slowdown occurs, it could have a material adverse effect on our business. Further, future government shutdowns could impact our ability to access the public markets and obtain necessary capital in order to properly capitalize and continue our operations.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">57</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Reimbursement</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If third-party payers do not adequately reimburse for the PreTRM test or any new tests we may develop, such tests may not be purchased or used, which may adversely affect our revenue and profits.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the United States and markets in some other countries, patients generally rely on third-party payers to reimburse all or part of the costs associated with their treatment or tests. Adequate coverage and reimbursement from third-party payers such as federal and state health care programs (e.g., Medicare and Medicaid) and commercial insurers is critical to new product acceptance. Our business depends on our ability to obtain or maintain adequate reimbursement from third-party payers. We expect third-party payers such as commercial insurers to be our most significant source of payment in the near future. In particular, we believe that for our Company to achieve commercial success, it will be necessary to gain acceptance from third-party payers for the PreTRM test, and to obtain positive coverage determinations and favorable reimbursement rates from third-party payers for our tests over time. We do not yet know, however, whether and to what extent certain of our products, including those under development, will be covered or reimbursed. If we are unable to obtain or maintain coverage or adequate reimbursement from, or achieve in-network status with, third-party payers for our existing or future tests or other products, our ability to generate revenues will be limited. For example, health care providers may be reluctant to order our tests or other products due to the possibility that a patient may incur substantial costs if third-party payer coverage or reimbursement is unavailable or insufficient. Such coverage and reimbursement may depend upon a number of factors, including the determination that the test and its use or administration for a particular patient are:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a covered benefit;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">safe, effective, and medically necessary;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">appropriate for the specific patient;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">supported by guidelines established by the relevant professional societies;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">approved in any states where specific assay approval is necessary;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">cost-effective; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">neither experimental nor investigational.</span></div></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the United States, CMS, an agency within HHS, and its Medicare Administrative Contractors make decisions regarding Medicare coverage for new tests. Other third-party payers, including commercial insurers, often follow Medicare coverage policy and payment limitations in setting their own reimbursement rates, and both CMS and certain commercial insurers may have sufficient market power to demand significant price reductions.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Obtaining coverage and reimbursement approval for a test from each third-party payer is a time-consuming and costly process that could require us to provide to each payer supporting scientific and clinical information, as well as information about patient insurance eligibility and benefits, and billing. We may not be able to provide data sufficient to satisfy third-party payers that they should cover and pay for the test. There is substantial uncertainty whether any particular payer will cover and reimburse the use of any test incorporating new technology. Even when a payer determines that a test is eligible for reimbursement, the payer may impose coverage limitations that preclude payment under certain circumstances or for certain patient populations. Moreover, eligibility for coverage does not mean that any test will be reimbursed in all cases or at a rate that allows us to make a profit or even cover our costs. Interim payments for new tests, if applicable, may also not be sufficient to cover our costs and may not be made permanent. In addition, some payers may require prior authorization before they will pay for a test. We may also have to engage in lengthy and costly appeals in order to overturn payers&#8217; coverage and reimbursement determinations and ultimately obtain payment. Furthermore, reimbursement rates may vary, for example, according to the use of the test and the clinical setting in which it is used, and may reflect budgetary constraints and/or imperfections in Medicare, Medicaid or other data used to calculate these rates.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There have been, and we expect that there will continue to be, federal and state proposals to constrain expenditures for health care products and services, which may affect payments for our tests. Third-party payers, including the Medicare program, frequently change coverage policies, product and service codes and payment methodologies and reimbursement amounts. Due in part to actions by third-party payers, the health care industry is experiencing a trend toward containing or reducing costs through various means, including lowering reimbursement rates and negotiating reduced payment schedules with service providers for certain products and/or services.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our inability to promptly obtain coverage and profitable reimbursement rates from third-party payers for our tests could have a material and adverse effect on our business, operating results, and financial condition.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">58</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, leading professional societies may not recommend our products or services or may recommend alternatives to our tests, which may provide a basis for third-party payers not to cover or reimburse our tests. In making coverage determinations, third-party payers often rely on practice guidelines issued by professional societies. Test-ordering providers may also rely on such guidelines when deciding whether to order testing for their patients. If any relevant professional societies issue guidelines suggesting, or otherwise make recommendations, that providers not use our tests or instead use alternatives to our tests, payers may make unfavorable coverage and reimbursement decisions and test-ordering providers may not order our tests. Any such outcomes could have a material and adverse effect on our business, operating results, and financial condition.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">New reimbursement methodologies applicable to the PreTRM test, and other future tests, including new CPT codes, may decrease reimbursement rates from third-party payers.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Generally, two types of coding systems may be used to describe laboratory testing services: (i) CMS&#8217;s Healthcare Common Procedure Coding System, or HCPCS, and (ii) the American Medical Association&#8217;s, or AMA, Current Procedural Terminology, or CPT, coding systems. Both coding systems use alphanumeric codes to describe the services at issue. Third-party payers, including Medicare, determine which CPT or HCPCS codes they will cover, as well as the circumstances under which they will (or will not) cover those codes and the amount they will reimburse for each code. In some circumstances (such as when a laboratory becomes an in-network provider with a commercial insurer), the third-party payer will negotiate reimbursement amounts with the provider. We use CPT codes to submit claims to payers for our testing and those payers use those same codes to make payments to us.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">One type of CPT code is a Proprietary Laboratory Analysis, or PLA, code. PLA codes describe proprietary clinical laboratory analyses. The AMA has issued a unique CPT</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#174;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> PLA code for the PreTRM test. CMS priced this code at $750 in November 2021. Before the AMA issued a PLA code for the PreTRM test, we submitted claims for reimbursement using CPT codes existing at the time based on the guidance of external coding experts.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We cannot guarantee that we will be able to negotiate favorable rates for our unique code, nor can we guarantee that we will receive reimbursement at all, especially if we are unable to collect and publish additional data and obtain positive coverage determinations for the PreTRM test or our other future tests.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We do not currently have specific CPT codes assigned for any of our other tests under development, and there is a risk that we may not be able to obtain such codes or, if obtained, we may not be able to negotiate favorable rates for such codes.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Finally, third-party payers may not establish positive coverage policies for our tests or adequately reimburse for any CPT code we may use, or seek recoupment for testing previously performed, which is a common occurrence in our industry.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Billing disputes with third-party payers, including disagreement regarding the selection and use of CPT codes when submitting claims, may decrease realized revenue and may lead to requests for recoupment of past amounts paid.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">It is possible that payers could dispute our billing or coding from time to time. Payers may likewise seek to recoup reimbursements already paid, and we expect that such disputes and requests for recoupment may arise. Third-party payers may also decide to deny payment or recoup payment for testing that they contend to have been not medically necessary, against their coverage determinations, or for which they have otherwise overpaid. There is also a risk that the CPT codes we previously submitted, are currently submitting, or will submit in the future on claims will be rejected or withdrawn or that third-party payers will seek refunds of amounts that they claim were inappropriately billed based on, for example, the CPT code used, the modifier attached, or the number of units billed. Claims for recoupment require the time and attention of our management and other key personnel, which can be a distraction from operating our business.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If third-party payers deny payment for testing, reimbursement revenue for our testing could decline. If a third-party payer successfully challenges that payment for prior testing was in breach of contract or otherwise contrary to policy or law, they may recoup payment, which amounts could be significant and would impact our operating results and financial condition, and it may decrease reimbursement going forward. We may also decide to negotiate and settle with a third-party payer in order to resolve an allegation of overpayment. Any of these outcomes, including recoupment or reimbursements, might also require us to restate our financials from a prior period, any of which could have a material and adverse effect on our business, operating results, and financial condition.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">59</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Failure to comply with laws and regulations related to submission of claims for our services could result in substantial financial penalties and/or potential civil or criminal liability.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are subject to a variety of complex federal and state laws and regulations applicable to the submission of claims for payment for our services. If a third-party payer or a regulatory or enforcement agency, or, in some cases, a </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">qui tam</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> relator, believes or alleges that we engaged in improper billing practices&#8212;including, but not limited to, not adequately pursuing patient cost share responsibilities or submitting improper CPT codes, multipliers or modifiers on our claims&#8212;we may be subject to investigation and/or enforcement actions under federal and/or state law.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Responding to and defending such investigations and/or enforcement actions may require significant time and attention from management and key personnel, include significant expenditures, and result in significant penalties, damages, fees, and reputational harm, all of which could have a material adverse effect on our business, operating results, and financial condition. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">See &#8220;&#8212; Risks Related to Government Regulation&#8201;&#8212;&#8201;If we, or our employees or contractors on our behalf, engage in conduct that violates health care laws, are suspected or accused of engaging in such conduct, or are subject to investigation for actual or alleged such conduct, we could face substantial penalties and damage to our reputation, and our business operations and financial condition could be adversely affected</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.&#8221;</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">&#8220;Most favored nation&#8221; provisions in contracts with third-party payers may limit potential for revenue growth and may lead to claims for recoupment.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Some of our contracts with third-party payers may in the future contain &#8220;most favored nation&#8221; provisions, pursuant to which we typically agree that we will not bill the third-party payer more than we bill any other third-party payer. These contract provisions limit the amount we are able to charge for our products and can negatively impact revenue. We monitor our billing and claims submissions for compliance with these contractual requirements with third-party payers. If we do not successfully manage compliance with these most favored nation provisions, we may be required to forego revenues from some third-party payers or reduce the amount we bill to each third-party payer with a most favored nation clause in its contract that is violated, which would adversely affect our business, operating results, and financial condition. This situation could also subject us to claims for recoupment, which could ultimately result in an obligation to repay amounts previously earned.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">When third-party payers deny coverage, we are often unable to collect from the patient or any other source and risk disputes if we attempt to do so.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If a third-party payer denies coverage, or if the patient has a large deductible or co-insurance amount, it may be difficult for us to collect from the patient, and we may not be successful in doing so. If we are in-network, we may be contractually prohibited from seeking payment beyond applicable deductibles, co-insurance, or co-payments from the patient. If we are out-of-network, we may be unable to collect the full amount of a patient&#8217;s responsibility, despite our good faith efforts to collect. As a result, we may not always be able to collect the full amount due for our tests if third-party payers deny coverage or cover only a portion of the billed amount or if the patient has a large deductible, which could cause payers to raise questions regarding our billing policies and patient collection practices.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We believe that our practices with respect to billing and collecting patient responsibility amounts are compliant with applicable laws; however, we may in the future receive inquiries from third-party payers regarding our practices in these areas. There is no guarantee that we will be successful in addressing such concerns, and if we are unsuccessful, this may result in a third-party payer deciding to reimburse for our tests at a lower rate or not at all, seeking recoupment of amounts previously paid to us, or bringing legal action to seek reimbursement of previous amounts paid. Any such occurrences could cause reimbursement revenue for our testing, which constitutes the large majority of our revenue, to decline. Additionally, if we were required to make a repayment, such repayment could be significant, which could have a material and adverse effect on our business, operating results, and financial condition.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our revenues may be adversely impacted if third-party payers withdraw coverage or provide lower levels of reimbursement due to changing policies, billing complexities or other factors.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we become an in-network provider by entering into an agreement with any of the third-party payers from which we receive reimbursement, this means that we will have an agreement that governs approval or payment terms. However, such a contract would not guarantee reimbursement for all testing we perform.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, the terms of any such agreement may require a physician or qualified practitioner&#8217;s signature on test requisitions or require other controls and procedures prior to conducting a test. In particular, third-party payers have been</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">60</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">increasingly requiring prior authorization to be obtained prior to conducting a test as a condition to reimbursing for the test. If the payers were to do so for the PreTRM test, it could place a burden on our billing operations and require us to dedicate resources to monitoring that these prior authorization requirements are met. To the extent we or the health care providers ordering our tests do not follow the prior authorization requirements, we may be subject to claims for recoupment of reimbursement amounts previously paid to us, or may not receive some or all of the reimbursement amounts to which we would otherwise be entitled. This may occur in the future, which could have a material and adverse effect on our business, operating results, and financial condition.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we are considered to be an out-of-network provider, which we expect to be the case with at least some of the largest third-party payers from which we may receive reimbursement in the future, such third-party payers could withdraw coverage and decline to reimburse for our tests, for any reason. They can also impose prior authorization requirements through the terms of the patients&#8217; health plans. Managing reimbursement on a case-by-case basis is time-consuming and contributes to an increase in the number of days it takes us to collect on accounts, which also increases our risk of non-payment. Negotiating reimbursement on a case-by-case basis also typically results in the receipt of reimbursement at a significant discount to the list price of our tests.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Even if we are being reimbursed for our tests, third-party payers may unilaterally review and adjust the rate of reimbursement, require co-payments from patients or stop paying for our tests. Federal and state health care programs as well as commercial insurers continue to increase their efforts to control the cost, utilization, and delivery of health care services by demanding price discounts or rebates and limiting coverage of, and amounts they will pay for, molecular tests. These measures have resulted in reduced payment rates and decreased utilization in the clinical laboratory industry. Because of these cost-containment measures, third-party payers&#8201;&#8212;&#8201;including those that may reimburse our tests in the future&#8201;&#8212;&#8201;may reduce, suspend, revoke or discontinue payments or coverage at any time. Reduced reimbursement of our tests may harm our business, operating results, and financial condition.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Billing for clinical laboratory testing services is complex. We perform tests in advance of payment and without certainty as to the outcome of the billing process. In cases where we expect to receive a fixed fee per test due to our reimbursement arrangements, we may nevertheless encounter variable reimbursement, leading to disputes over pricing and billing. Each third-party payer typically has different billing requirements, and the billing requirements of many payers have become increasingly difficult to meet. Among the factors complicating our billing of third-party payers are:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">disparity in coverage among various payers;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">disparity in information and billing requirements among payers, including with respect to prior authorization requirements and procedures and establishing medical necessity; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">incorrect or missing billing information, which is required to be provided by the ordering health care provider.</span></div></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These risks related to billing complexities, and the associated uncertainty in obtaining payment for our tests, could harm our business, operating results, and financial condition.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Status as an out-of-network provider with a large commercial insurer may cause health care providers to avoid recommending our tests.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may be considered to be an out-of-network provider with respect to the large commercial insurers from which we may receive reimbursement in the future. Physician groups and other health care providers may view this negatively and may insist upon only using laboratories that are in-network with their patients&#8217; insurance companies. These types of decisions could reduce our revenue and harm our financial condition.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Changes in government health care policy could increase our costs and negatively impact coverage and reimbursement for our tests by governmental and other third-party payers.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The U.S. government is pursuing health care reform and aiming to reduce health care costs. Government health care policy has been, and will likely continue to be, a topic of extensive legislative and executive activity in the U.S. federal government and many U.S. state governments. As a result, our business could be affected by significant and potentially unanticipated changes in government health care policy, which could in turn substantially impact our revenues, increase costs, and divert management attention from our business strategy. We cannot predict the impact of governmental health care policy changes on our future business, operating results, and financial condition.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">61</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the United States, the Affordable Care Act, or ACA, was signed into law in March 2010 and significantly impacted the U.S. pharmaceutical and medical device industries, including the diagnostics sector, in a number of ways. The ACA restricts insurers from charging higher premiums or denying coverage to individuals with pre-existing conditions, and requires insurers to cover certain preventative services without charging any copayment or coinsurance, including screening for lung, breast, colorectal and cervical cancers. The ACA also created a new system of health insurance &#8220;exchanges&#8221; designed to make health insurance available to individuals and certain groups through state- or federally-administered marketplaces in addition to existing channels for obtaining health insurance coverage. In connection with such exchanges, certain &#8220;essential health benefits&#8221; are intended to be made more consistent across plans, setting a baseline coverage level. The states (and the federal government) have some discretion in determining the definition of &#8220;essential health benefits&#8221; and we do not know whether our tests or other products will fall into a benefit category deemed &#8220;essential&#8221; for coverage purposes across the plans offered in any or all of the exchanges. If any of our tests are not covered by plans offered in the health insurance exchanges, our business, operating results and financial condition could be adversely affected.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the Trump Administration and the 119</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">th</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Congress, there remains uncertainty around the future of the ACA and other health care legislation, and in particular the impact to reimbursement levels and the number of insured individuals. Future changes may lead to delay in the purchasing decisions of our customers.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition to the ACA, various health care reform proposals have also emerged from federal and state governments. The Protecting Access to Medicare Act of 2014, or PAMA, for example, introduced a multi-year pricing program for services payable under the Clinical Laboratory Fee Schedule, or CLFS, that is designed to bring Medicare allowable amounts in line with the amounts paid by commercial insurers. The rule issued by CMS to implement PAMA required certain laboratories to report third-party payer rates and test volumes, though these reporting requirements have been delayed.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The implementation of Medicare rates pursuant to PAMA has negatively impacted overall pricing and reimbursement for many clinical laboratory testing services and may do so in the future. Since January 1, 2018, the Medicare payment rate for such tests is equal to the weighted median private payer rate reported to CMS, which for many tests is lower than the previous CLFS payment rates due to the often lower negotiated commercial insurer rates applicable to large commercial laboratories that were required to report data to CMS. Likewise, because commercial insurers often base their pricing for laboratory testing on a percentage of the price set on the CLFS, PAMA has in turn affected rates paid by commercial insurers.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The rates paid by Medicare and other state and federal health care programs have been the subject of controversy in the industry, including a lawsuit by the American Clinical Laboratory Association, and it is unclear whether and to what extent the new rates may change.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other legislative changes have been proposed and adopted in the United States since the ACA was enacted. For example, the Budget Control Act of 2011, among other things, created measures for spending reductions by Congress. A Joint Select Committee on Deficit Reduction, tasked with recommending a targeted deficit reduction of at least $1.2 trillion for the years 2013 through 2021, was unable to reach required goals, thereby triggering the legislation&#8217;s automatic reduction to several state and federal health care programs. This includes aggregate reductions of Medicare payments to providers up to 2% per fiscal year, and, due to subsequent legislative amendments, will remain in effect through 2032 unless additional Congressional action is taken (with the exception of a temporary suspension from May 1, 2020 through March 31, 2022 due to the COVID-19 pandemic). As another example, in January 2013, the American Taxpayer Relief Act of 2012 was signed into law, which among other things, increased the statute of limitations period for the government to recover overpayments to providers from three to five years.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We cannot predict whether future health care initiatives will be implemented at the federal or state level or how any such future legislation, regulation, or initiative may affect us. Current or potential future federal legislation and the expansion of government&#8217;s role in the U.S. health care industry, as well as changes to the reimbursement amounts paid by third-party payers for our current and future tests, may adversely affect our test volumes and adversely affect our business, operating results, and financial condition.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If the validity of an informed consent from a patient is challenged, we could be precluded from billing for such patient&#8217;s testing, be forced to stop performing certain tests, forced to exclude the patient&#8217;s data or specimens from clinical trial results or be subject to lawsuits or regulatory enforcement.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are required to ensure that all clinical data and blood specimens that we receive have been collected from subjects who have provided appropriate informed consent for us to perform our testing, both commercially and in clinical trials. Among other things, in our consent forms, we seek to ensure that the subjects from whom the data and specimens are</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">62</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">collected do not retain or have conferred on them any proprietary or commercial rights to the data or any discoveries derived from them. A subject&#8217;s informed consent could be challenged in the future, and the informed consent could prove invalid, unlawful or otherwise inadequate for our purposes. Any such findings against us, or our partners, could deny us access to, or force us to stop, testing specimens in a particular territory or could call into question the results of our clinical trials. We could also be precluded from billing third-party payers for tests for which the underlying informed consents are challenged, or we could be requested to refund amounts previously paid by third-party payers for such tests. We could become involved in legal challenges or regulatory enforcement, which could require significant management and financial resources and adversely affect our operating results.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Government Regulation</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may be adversely impacted by changes in laws and regulations, or in their application.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The health care industry in which we operate is highly regulated, and failure to comply with applicable regulatory, supervisory, accreditation, registration, or licensing requirements may adversely affect our business, operating results, and financial condition. The laws and regulations governing our research and marketing efforts are extremely complex and in many instances there are no clear regulatory or judicial interpretations of these laws and regulations, which increases the risk that we may be found to be in violation of these laws.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Furthermore, the industry is growing, and regulatory agencies such as HHS or the FDA may apply heightened scrutiny to new developments. While we have taken steps to ensure compliance with current regulatory frameworks in all material respects as historically enforced by the applicable regulatory agencies, given the highly complex and often unclear guidelines, there could be areas where we are unintentionally and unknowingly noncompliant. Any change in the federal or state laws or regulations relating to our business may require us to implement changes to our business or practices, and we may not be able to do so in a timely or cost-effective manner. Should we be found to be noncompliant with current or future regulatory requirements, we may be subject to sanctions that could include changes to our operations, adverse publicity, substantial financial penalties, exclusion from state and federal health care programs, and criminal proceedings, which may adversely affect our business, operating results, and financial condition by increasing our cost of compliance or limiting our ability to develop, market, and commercialize our products.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, there has been a longstanding trend of heightened U.S. federal and state scrutiny of payments made to physicians and other referral sources, which are governed by various state and federal laws and regulations including the Stark Law, the federal Anti-Kickback Statute, the Physician Payments Sunshine Act, the Eliminating Kickbacks in Recovery Act of 2018, and the federal False Claims Act, as well as state equivalents of such laws.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">While we have implemented and strive to continuously develop and improve compliance policies and procedures intended to address compliance with applicable federal and state laws and regulations, including applicable fraud and abuse laws and regulations such as those described in this risk factor, the evolving compliance environment and the need to build and maintain robust and scalable systems to comply with regulations in multiple jurisdictions with different compliance and reporting requirements increases the possibility that we could inadvertently violate one or more of these requirements.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Changes in the way the FDA regulates the reagents, other consumables, and testing equipment we use when developing, validating, and performing our tests could result in delay or additional expense in bringing our tests to market or performing such tests for our customers.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Many of the sequencing instruments, reagents, kits, and other consumable products used to collect samples or perform our testing, as well as the instruments and other capital equipment that enable the testing, are offered for sale as analyte specific reagents, or ASRs, or for research use only, or RUO. ASRs are medical devices and must comply with FDA quality system requirements provisions and other device requirements, but most are exempt from premarket review by the FDA as an </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">in vitro</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> diagnostic product. Products that are intended for RUO and are labeled as RUO are exempt from compliance with most FDA requirements, including the approval or clearance and other product quality requirements for medical devices. A product labeled RUO but which is actually intended for clinical diagnostic use, such as a test reagent or part of a blood collection kit, may be viewed by the FDA as adulterated and misbranded under the Federal Food, Drug and Cosmetic Act, or the FD&amp;C Act, and subject to FDA enforcement action. The FDA has said that when determining the intended use of a product labeled RUO, it will consider the totality of the circumstances surrounding distribution and use of the product, including how the product is marketed and to whom. The FDA could disagree with a supplier&#8217;s or lab's assessment that the supplier&#8217;s products are RUOs, or could conclude that products labeled as RUO are actually intended for clinical diagnostic use, and could take enforcement action against the supplier or the lab, including requiring the supplier to cease offering the product to the lab, or requiring the lab to cease distributing the supplier's product, while it seeks appropriate marketing</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">63</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">authorization from FDA. Suppliers of ASRs and RUO products that we employ in our tests may cease selling their respective products, or we may need to cease distributing them for use in our testing, and we may be unable to obtain an acceptable substitute on commercially reasonable terms or at all, which could significantly and adversely affect our ability to provide timely testing results to our customers or could significantly increase our costs of conducting business.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we fail to comply with federal and/or state laboratory licensing requirements, we could lose the ability to perform our tests or experience disruptions to our business.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a clinical laboratory, our business is subject to regulation by CMS through its Clinical Laboratory Improvement Amendments of 1988, or CLIA, program. The CLIA program regulates the quality of most laboratory testing performed on human specimens in the United States. CLIA regulations establish quality standards for laboratory testing in an effort to ensure the accuracy, reliability, and timeliness of patient results. To that same end, CLIA regulations require clinical laboratories to obtain a CLIA certificate and to meet specific standards with respect to operations, personnel, facilities, quality control and assurance, administration, participation in proficiency testing, and patient test management. CLIA certification is also required in order for us to be eligible to bill federal and state health care programs, as well as commercial insurers for our tests. To renew and maintain our CLIA certification, we are subject to survey and inspection every two years. Our laboratory holds a CLIA Certificate of Accreditation.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our laboratory is also accredited by the College of American Pathologists, or CAP. CMS has deemed CAP standards to be equal to or more stringent than CLIA regulations and has approved CAP as a recognized accrediting organization. Inspection by CAP is performed in lieu of inspection by CMS for CAP-accredited laboratories. Because we are accredited by CAP, we are deemed to also comply with CLIA. Many commercial insurers require CAP accreditation as a condition to contracting with clinical laboratories to cover their tests.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the event of any CLIA-related violations, CMS has the authority to impose a wide range of sanctions, including revocation of the CLIA certification, directed plans of correction, onsite monitoring, civil monetary penalties, civil injunctive suits, a bar on the ownership or operation of a CLIA-certified laboratory by any owners or operators of the deficient laboratory, and many others, depending on the nature of the CLIA violation. Any sanction imposed under CLIA and its implementing regulations, including but not limited to those applicable to proficiency testing, or our failure to renew a CLIA certificate, could have a material and adverse effect on our business, operating results and financial condition. If we were to lose our CLIA certification, we would not be able to operate our clinical laboratory or conduct our testing, which would adversely impact our business, operating results, and financial condition. In such case, even if we were able to bring our laboratory back into compliance, we could incur significant expenses and lose revenue while doing so. Failure to maintain CAP accreditation could likewise have a material adverse effect on the sales of our tests and the results of our operations.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our laboratory is located in Salt Lake City, Utah. Utah requires that laboratories located in this state hold a CLIA certificate (which we do), as well as approval from the Utah Department of Health, or UT DOH, to operate a laboratory. In addition to meeting CLIA requirements and holding a valid CLIA certificate, Utah requires that our laboratory timely notify the UT DOH of certain changes and demonstrate successful performance of proficiency testing in an approved proficiency testing program or approved alternative testing program. If our clinical laboratory is out of compliance with these standards, the UT DOH may revoke our approval to perform testing or potentially impose other remedial measures, any of which could materially affect our business. We maintain an approval in good standing with the UT DOH.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Moreover, several states require that out-of-state laboratories hold laboratory licenses from those states in order to test specimens from patients, or accept specimens from laboratories, in those states. One such state is New York. As part of the laboratory licensure process, the New York Department of Health, or NY DOH, requires that laboratories seeking licensure establish the analytic and clinical performance characteristics of all tests performed, and also imposes specific review and approval requirements on certain categories of testing, including laboratory developed tests, or LDTs. As an LDT, our PreTRM test is thus subject to this NY DOH review and approval process.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have obtained licenses from states where we believe we are required to be licensed. From time to time, we may become aware of other states that require out-of-state laboratories to obtain licensure in order to accept specimens from those states, and it is possible that other states do have such requirements or will have such requirements in the future. If we identify any other state with such requirements or if we are contacted by any other state advising us of such requirements, we expect to seek to comply with such requirements. However, there is no assurance that we will be able to obtain any such required license for the particular state. We also may become subject to regulation in foreign jurisdictions as we seek to expand international utilization of our PreTRM test if jurisdictions in which we pursue operations have licensure requirements for U.S.-based clinical laboratories offering and providing diagnostic testing services to professionals located in those jurisdictions. Foreign licensure requirements could require review and modification of our tests in order to offer them</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">64</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">in certain jurisdictions or could impose other limitations that may limit our ability to make our tests more widely available outside the United States. Complying with licensure requirements, if applicable, in new jurisdictions may be expensive and time-consuming.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If a clinical laboratory is out of compliance with state laboratory licensure laws and regulations, the state authority may suspend, restrict or revoke the license to operate the clinical laboratory, assess substantial civil money penalties, or impose specific corrective action plans. If we were to lose a required state license, we would not be able to operate our clinical laboratory and conduct our tests, in full or in particular states, which would adversely impact our business, operating results, and financial condition. Any such actions could materially affect our business.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The FDA recently finalized its rulemaking to regulate Laboratory Developed Tests, and Congress continues to debate whether to take action to reform the current legal requirements applicable to LDTs. In either case we may become subject to extensive regulatory requirements and may be required to conduct additional clinical trials prior to continuing to sell our existing tests or launching any other tests we may develop, which may increase the cost of conducting, or otherwise harm, our business.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We launched the PreTRM test as an LDT and may in the future develop other tests that would be considered to be LDTs. Although historically the FDA applied a policy of enforcement discretion with respect to LDTs whereby the agency did not generally actively enforce the IVD medical device regulatory requirements for such tests, in May 2024, the FDA issued a final rule aimed at regulating LDTs under the current medical device framework and phasing out its current enforcement discretion policy for this category of diagnostic tests over several years. This FDA rulemaking was initiated after years of failed congressional attempts to harmonize the regulatory paradigms applicable to LDTs and other </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">in vitro</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> diagnostic tests, as discussed further below. The effective date of the agency's rule was July 5, 2024.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FDA&#8217;s final rule provides that the LDT enforcement policy phase-out process will occur in gradual stages over a total period of four years, with premarket approval applications for high-risk tests to be submitted by the 3.5-year mark. Moderate-risk and low-risks tests are expected to be in compliance at the 4-year mark, although the FDA has stated that if premarket submissions are pending review it will continue to exercise enforcement discretion with respect to those tests. The FDA&#8217;s final rule is complex and, concurrently, the agency announced several exceptions from the requirement to comply with full medical device regulatory controls, depending upon the specific nature of the LDT and the clinical laboratory that is offering such LDT for use by health care providers. Importantly, under the agency&#8217;s transition plan, LDTs that were marketed prior to the official publication date of the final rule (May 6, 2024) are considered to be "currently marketed" tests. &#8220;Currently marketed&#8221; tests are subject to many of the device regulatory controls but are exempted from the premarket review and FDA authorization requirements, unless or until significant modifications are made to such &#8220;currently marketed&#8221; tests. Similarly, FDA has created a partial enforcement discretion policy for tests approved by the NY DOH&#8217;s Clinical Laboratory Evaluation Program whereby such tests also do not need to undergo FDA premarket review but must come into compliance with all other device general controls in a staggered fashion between 2025 and 2027.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have begun the process of evaluating the final rule&#8217;s potential impact on our PreTRM tests, our operations, and our business more generally and are preparing to be in compliance with the Stage 1 obligations of the final rule that come into effect in May 2025.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On May 29, 2024, the American Clinical Laboratory Association (ACLA) and one of its members filed a complaint against the FDA in the Eastern District of Texas, alleging that the agency does not have authority to promulgate the LDT final rule and seeking to vacate the FDA&#8217;s action. A second lawsuit was also filed against FDA by the Association for Molecular Pathology (AMP) on August&#8239;19, 2024 in the Southern District of Texas, and subsequently the two cases were consolidated into a single action pending in the Eastern District of Texas. Arguments in the consolidated case took place on February 19, 2025 and the outcome of this ongoing litigation is uncertain at this time. Further, it remains possible that the Trump Administration may take steps to rescind or modify the LDT final rule in the future.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Affected stakeholders also continue to press for a comprehensive legislative solution to create a harmonized paradigm for oversight of LDTs by both the FDA and CMS, instead of implementation of the FDA final rule, which may be disruptive to the industry and to patient access to certain diagnostic tests. However, it is unclear whether any future legislative efforts would be successful going forward.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the FDA&#8217;s LDT final rule and stagged implementation timeline, we will become subject to increased regulatory burdens such as registration and listing requirements, adverse event reporting requirements, and quality control requirements with respect to our currently marketed PreTRM test. Further, our next version of the PreTRM term, as well as any other future LDTs we may develop, will become subject to more onerous regulation by the FDA, if and when the FDA begins to</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">65</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">actively enforce its device premarket submission regulations with respect to LDTs, whether as a result of new legislative authority in the future or under the May 2024 LDT final rule. Depending upon the risk classification of each individual test, we may be required to obtain premarket clearance for future tests under Section 510(k) of the FDC Act or approval of a premarket approval application, or PMA. The process for submitting a 510(k) premarket notification and receiving FDA clearance usually takes from 3 to 12 months, but it can take significantly longer, and clearance is never guaranteed. The process for submitting and obtaining FDA approval of a PMA generally takes from 1 to 3 years or even longer, and approval is not guaranteed. PMA approval typically requires extensive clinical data and can be significantly longer, more expensive and more uncertain than the 510(k) clearance process. Any such process would likely be costly and time-consuming, and we cannot assure that the next version of PreTRM, or any new tests that we may develop future, will be authorized for marketing by the FDA in a timely or cost-effective manner, if at all.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Moreover, if the FDA were to disagree with our conclusion that the currently marketed PreTRM test falls within the scope of the agency&#8217;s existing LDT definition and enforcement discretion policies, and the agency thus asserts that the existing PreTRM test is subject to FDA&#8217;s medical device authorities and implementing regulations, the agency could require that we obtain premarket approval or another type of device premarket authorization in order for us to continue commercializing the PreTRM test. As part of this process, we may be required to conduct additional clinical testing before applying for commercial marketing authorization. Clinical trials must be conducted in compliance with FDA regulations in order to support a marketing submission to the agency for a regulated product, or the FDA may take certain enforcement actions or reject the data. Performing additional, new clinical studies and trials in order to obtain product approval from the FDA, if any were to become necessary, would take a significant amount of time and would substantially delay our ability to commercialize the PreTRM test, any or all of which would adversely impact our business. Any such clinical trial may need to comply with recent amendments to the FD&amp;C Act requiring sponsors of most clinical studies of investigational devices to develop and submit a diversity action plan to the FDA. If we were to be required to develop a diversity action plan for any future clinical trial, such an obligation could result in further costs and potentially delay our ability to begin such a clinical trial.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The outcome and ultimate impact on our business of any changes to the federal government&#8217;s regulation of LDTs is difficult to predict. Increased regulation of our LDTs under the FDA's final rule is expected to result in increased costs and administrative and legal actions for noncompliance, including warning letters, fines, penalties, product suspensions, product recalls, injunctions and other civil and criminal sanctions, which could have a material and adverse effect upon our business, operating results, and financial condition. In addition, at this time it is unclear what testing and data may be required to support any required FDA clearance or approval of our tests, should the final rule be fully implemented as envisioned by FDA and HHS following resolution of any pending or future litigation.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Furthermore, should it be required in the future, we cannot be sure that the PreTRM test, any new tests that we may develop, or new uses for our products that we may develop, will be reviewed and authorized for marketing by the FDA in a timely or cost-effective manner, if authorized at all. Even if such tests are authorized for marketing by the FDA, the agency could limit the test&#8217;s indications for use, which may significantly limit the market for that product and may adversely affect our business and financial condition. In addition, failure to comply with any applicable FDA requirements could trigger a range of governmental enforcement actions, including but not limited to warning letters, civil monetary penalties, injunctions, criminal prosecution, recall or seizure, operating restrictions, partial suspension or total shutdown of operations and denial of or challenges to applications for marketing authorization, as well as significant adverse publicity.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we were to be required by the FDA to conduct additional clinical studies before continuing to offer the PreTRM test or future tests that we may develop as LDTs, those studies could lead to delays or failure to obtain necessary regulatory authorization, which could cause significant delays in commercializing any future products and harm our ability to achieve profitability.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If the FDA decides to require that we obtain any form or type of premarket authorization in order for us to commercialize our current PreTRM test or any future tests developed as LDTs, whether as a result of new legislative authority or following finalization and implementation of the May 2024 final rule or based on its determination that the PreTRM test does not meet the definition of an LDT, we may be required to conduct additional clinical testing before submitting a regulatory submission for commercial marketing authorization. Clinical trials to support marketing authorization from the FDA must be conducted in compliance with various regulatory requirements, including investigational device exemption regulations and good clinical practices, or else the FDA may take certain enforcement actions or reject the data. Such clinical trials may take several years to design and conduct, and they are often expensive and resource-driven.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Further, even if clinical trials are completed as planned, we cannot be certain that their results would be able to support the PreTRM test&#8217;s claims or that the FDA will agree with our conclusions regarding the results of our clinical trials. If we are</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">66</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">required to conduct clinical trials to support a premarket submission to the FDA, whether using prospectively acquired samples or archival samples, delays in the commencement or completion of clinical testing could significantly increase the development costs for the PreTRM test or any future tests and delay commercialization. Many of the factors that may cause or lead to a delay in the commencement or completion of clinical trials may also ultimately lead to delay or denial of regulatory authorization. See related risks described above at &#8220;</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The results of our clinical trials and studies may not support the use of our tests and other product candidates, or may not be replicated in later studies.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221;</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The Federal Trade Commission and/or state enforcement or regulatory agencies may object to the methods and materials we use to promote our tests, our services and our nonmedical products and initiate enforcement against us, which could adversely affect our business and financial condition.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Federal Trade Commission, or FTC, and/or state enforcement or regulatory agencies (including but not limited to the offices of state attorneys general) may object to the materials and methods we use to promote our current tests or other LDTs we may develop in the future, including with respect to the product claims in our promotional materials, as well as our testing services and nonmedical products such as our recently developed LikeMine</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TM</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> webapp, and may initiate enforcement actions against us. Enforcement actions by the FTC may include, among others, injunctions, civil penalties, and equitable monetary relief. Recently the FTC has become more active in its scrutiny of health claims used in advertising goods and services, including through its publication of a sweeping &#8220;health products compliance guidance&#8221; document in December 2022.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Medical product manufacturers&#8217; use of social media platforms presents new risks.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We believe that our customer base and potential patient populations are active on social media and we have begun engaging through those platforms to elevate our national marketing presence. Social media practices in the diagnostic, pharmaceutical, biotechnology, and medical device industries are evolving, which creates uncertainty and risk of noncompliance with regulations applicable to our business. For example, patients may use social media platforms to comment on the effectiveness of, or adverse experiences with, the PreTRM test or any future products we may develop, which could result in reporting obligations or the need for us to conduct an investigation. In addition, there is a risk of inappropriate disclosure of sensitive information or negative or inaccurate posts or comments about us or our testing products on any social networking website. If any of these events were to occur or we otherwise fail to comply with any applicable regulations, we could incur liability, face restrictive regulatory actions, or incur other harm to our business.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Actual or perceived failures to comply with applicable data protection, data privacy and information security laws, regulations, standards, and other requirements could adversely affect our business, results of operations, and financial condition.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The global data protection landscape is rapidly evolving, and we are or may become subject to numerous state, federal, and international laws, requirements, and regulations governing the collection, use, disclosure, retention, and security of personal information. Implementation standards and enforcement practices are likely to remain uncertain for the foreseeable future, and we cannot yet determine the impact future laws, regulations, or standards or perception of their requirements may have on our business. This evolution may create uncertainty in our business, affect our ability to operate in certain jurisdictions or to collect, store, transfer, use and share personal information, necessitate the acceptance of more onerous obligations in our contracts, result in liability, or impose additional costs on us. The cost of compliance with these laws, regulations, and standards is high and is likely to increase in the future. Any failure or perceived failure by us to comply with federal or state laws or regulations, our internal policies and procedures, or our contracts governing our use and disclosures of personal information could result in negative publicity, government investigations and enforcement actions, claims by third parties, and damage to our reputation, any of which could have a material adverse effect on our operations, financial performance, and business.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As our operations and business grow, including for example in connection with the launch of the LikeMine</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TM</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> webapp, we may become subject to or affected by new or additional privacy and security laws and regulations and face increased scrutiny or attention from regulatory authorities. In the United States, HIPAA requires organizations like ours to develop and implement policies and procedures with respect to information that is protected under HIPAA, called protected health information, or PHI, that is created, used or disclosed in connection with our services, including the adoption of administrative, physical, and technical safeguards to protect such information.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">HIPAA further requires organizations subject to HIPAA, called &#8220;covered entities&#8221; to notify affected individuals without unreasonable delay and in no case later than 60 calendar days following discovery, of certain unauthorized access, uses, or disclosures of PHI. If a breach affects 500 individuals or more in a particular state or jurisdiction, covered entities must report</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">67</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">it to the HHS and local media contemporaneously with notice to affected individuals, and HHS will post information regarding the breach, including the name of the entity reporting the breach, on its public website. If a breach affects fewer than 500 individuals, the covered entity must notify HHS within the first 60 days of the following calendar year in which the breach occurred.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Penalties for failure to comply with HIPAA are substantial and could include corrective action plans, and/or the imposition of civil monetary or criminal penalties. HIPAA also authorizes state attorneys general to enforce HIPAA on behalf of state residents. Courts can award damages, costs, and attorneys&#8217; fees related to violations of HIPAA in such cases. While HIPAA does not create a private right of action allowing individuals to sue us in civil court for HIPAA violations, its standards have been used as the basis for a duty of care claim in state civil suits such as those for negligence or recklessness in the misuse or breach of PHI.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain states have also adopted privacy and security laws and regulations, some of which may be more stringent than HIPAA and/or regulate information other than PHI. Such laws and regulations will be subject to interpretation by various courts and other governmental authorities, thus creating potentially complex compliance issues for us and our future customers and strategic partners. At the state level, for example, California has enacted the California Consumer Privacy Act, or CCPA, an extremely comprehensive and stringent privacy law. The CCPA took effect on January 1, 2020, and became enforceable by the California Attorney General on July 1, 2020. It creates individual privacy rights for California consumers (as that term is broadly defined) and increases the privacy and security obligations of entities handling certain personal data. The CCPA provides for civil penalties for violations, as well as a private right of action for data breaches. CCPA does not apply to health information that is protected by HIPAA or the California Confidentiality of Medical Information Act, but CCPA still applies to other types of personal information held by HIPAA covered entities, such as personnel or marketing information. The regulations issued under the CCPA have been modified several times, and there is still some uncertainty about how the law will be interpreted and enforced.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, California voters also approved a new privacy law, the California Privacy Rights Act, or CPRA, on November 3, 2020 which went into effect in January 2023 with enforcement commencing in July 2023. CPRA modifies the CCPA significantly, resulting in further uncertainty, additional costs and expenses stemming from efforts to comply, and additional potential for harm and liability for failure to comply. The CPRA imposes additional obligations on companies covered by the legislation and expands consumers&#8217; rights with respect to certain sensitive personal information. The CPRA also creates a new regulatory entity, the California Privacy Protection Agency, which is vested with authority to implement and enforce the CCPA and the CPRA. In addition to California, more U.S. states are enacting similar legislation, increasing compliance complexity and increasing risks of failures to comply. A number of other U.S. states, including Colorado, Connecticut, Delaware, Florida, Indiana, Iowa, Kentucky, Maryland, Montana, New Hampshire, New Jersey, Oregon, Rhode Island, Tennessee, Texas, Utah and Virginia have proposed or enacted comprehensive privacy laws, and additional states are likely to follow.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The CCPA, the CPRA, and similar laws may increase our compliance costs and potential liability. Any liability from failure to comply with the requirements of these laws could adversely affect our financial condition. All U.S. states have implemented data breach notification laws that overlap and often conflict with HIPAA and apply simultaneously. Additionally, various U.S. state and federal consumer protection laws and regulations govern the collection, use, disclosure and protection of health-related and other personal information. We must comply with all of these laws simultaneously in the event of a data breach which is a complicated and expensive proposition.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The collection, use, disclosure, transfer, or other processing of personal data regarding individuals in the European Union (EU), including personal health data, is subject to the EU&#8217;s General Data Protection Regulation, or GDPR, which became effective on May 25, 2018. The GDPR is wide-ranging in scope and imposes numerous requirements on companies that process personal data, including requirements relating to processing health and other sensitive data, obtaining consent of the individuals to whom the personal data relates, providing information to individuals regarding data processing activities, implementing safeguards to protect the security and confidentiality of personal data, providing notification of data breaches, and taking certain measures when engaging third-party processors. The GDPR also imposes strict rules on the transfer of personal data to countries outside the EU, including the U.S., and permits data protection authorities to impose large penalties for violations of the GDPR, including potential fines of up to &#8364;20 million or 4% of annual global revenues, whichever is greater. The GDPR also confers a private right of action on data subjects and consumer associations to lodge complaints with supervisory authorities, seek judicial remedies, and obtain compensation for damages resulting from violations of the GDPR. Our operations currently do not subject us to the GDPR. However, contemplated new initiatives, e.g., marketing the PreTRM test or conducting research in a member country of the EU, may subject us to and require us to comply with the GDPR.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">68</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In July 2023, the European Commission adopted an adequacy decision for a new mechanism for transferring personal data from the EU to the United States &#8211; the EU-U.S. Data Privacy Framework, which provides EU individuals with several new rights, including the right to obtain access to their data, or obtain correction or deletion of incorrect or unlawfully handled data. In addition, the EU-U.S. Data Privacy Framework offers additional redress avenues for violations, including free of charge independent dispute resolution mechanisms and an arbitration panel. The European Commission will continually review developments in the United States along with its adequacy decision. Adequacy decisions can be adapted or even withdrawn in the event of developments affecting the level of protection in the applicable jurisdiction. Future actions of EU data protection authorities are difficult to predict. If we become subject to the GDPR and its transfer restrictions, some customers or other service providers may respond to these evolving laws and regulations by asking us to make certain privacy or data-related contractual commitments that we are unable or unwilling to make. This could lead to the loss of current or prospective customers or other business relationships.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The regulatory framework governing the collection, storage, use, and sharing of certain information, particularly financial and other personal information, is rapidly evolving and is likely to continue to be subject to uncertainty and varying interpretations. It is possible that these laws may be interpreted and applied in a manner that is inconsistent with our existing practices. Any failure or perceived failure by us, or any third parties with which we do business, to comply with our privacy policies, changing expectations, evolving laws, rules and regulations, industry standards, or contractual obligations to which we or such third parties are or may become subject, may result in actions or other claims against us by governmental entities or private actors, the expenditure of substantial costs, time and other resources or the incurrence of significant fines, penalties or other liabilities. In addition, any such action, particularly to the extent we were found to be guilty of violations or otherwise liable for damages, would damage our reputation and adversely affect our business, financial condition, and results of operations.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Although we strive to comply with applicable laws, regulations and standards, our contractual obligations, and other legal obligations, these requirements are evolving and may be modified, interpreted, and applied in an inconsistent manner from one jurisdiction to another, and may conflict with one another or other legal obligations with which we must comply. Any failure or perceived failure by us or our employees, representatives, contractors, consultants, Contract Research Organizations, or CROs, collaborators, or other third parties to comply with such requirements or adequately address privacy and security concerns, even if unfounded, could result in additional cost and liability to us, damage our reputation, and adversely affect our business and results of operations.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Security breaches, losses of data, and other disruptions could compromise sensitive information related to our business or prevent us from accessing critical information and expose us to liability, which could adversely affect our business and reputation.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the ordinary course of our business, we collect and store sensitive data, including PHI (such as patient medical records, including test results), and other personally identifiable information. We also store business and financial information, intellectual property, research and development information, trade secrets, and other proprietary and business critical information, including that of our employees, customers, payers and collaboration partners. We manage and maintain our data utilizing a combination of on-site systems, managed data center systems and cloud-based data center systems. We are highly dependent on information technology networks and systems, including the internet, to securely process, transmit and store critical information. Although we take measures to protect sensitive information from unauthorized access or disclosure, our information technology and infrastructure, and that of our third-party billing and collections provider and other service providers, may be vulnerable to attacks by hackers, viruses, disruptions and breaches due to employee error or malfeasance.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A security breach or privacy violation that leads to unauthorized access, disclosure or modification of, or prevents access to, patient information, including PHI, or other personally identifiable information, could implicate state and federal breach notification laws, subject us to fines and mandatory corrective action and require us to verify the correctness of, or to reconstruct, database contents. Such a breach or violation also could result in legal claims or proceedings brought by a private party or a governmental authority, liability under laws and regulations that protect the privacy of personal information, such as HIPAA and laws and regulations of various U.S. states, as well as penalties imposed by the Payment Card Industry Security Standards Council for violations of the Payment Card Industry Data Security Standards. If we are unable to prevent such security breaches or privacy violations or implement satisfactory remedial measures, we may suffer loss of reputation, financial loss, and civil or criminal fines or other penalties. In addition, these breaches and other forms of inappropriate access can be difficult to detect, and any delay in identifying them may lead to increased harm of the type described above.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unauthorized access, loss, or dissemination of information could disrupt our operations, including our ability to perform tests, provide test results, bill payers or patients, process claims and appeals, provide customer assistance services, conduct</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">69</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">research and development activities, develop and commercialize tests, collect, process and prepare company financial information, provide information about our tests, educate patients and health care providers about our service, and manage the administrative aspects of our business, any of which could damage our reputation and adversely affect our business. Any cybersecurity incident could also result in the compromise of our trade secrets and other proprietary information, which could adversely affect our competitive position.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, health-related, privacy, and data protection laws and regulations in the United States and elsewhere are subject to interpretation and enforcement by various governmental authorities and courts, resulting in complex compliance issues and the potential for varying or even conflicting interpretations, particularly as laws and regulations in this area are in flux. It is possible that these laws may be interpreted and applied in a manner that is inconsistent with our practices. If so, this could result in government-imposed fines or orders requiring that we change our practices, which could adversely affect our business and our reputation. Complying with these laws could cause us to incur substantial costs or require us to change our business practices and compliance procedures in a manner adverse to our business, operating results, and financial condition.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any failure or perceived failure by us or any third-party collaborators, service providers, contractors or consultants to comply with privacy, confidentiality, cybersecurity or similar obligations, or any cybersecurity incidents or other security breaches that result in the accidental, unlawful, or unauthorized access to, use of, release of, or transfer of sensitive information, including personally identifiable information, or PHI, may result in negative publicity, harm to our reputation, governmental investigations, enforcement actions, regulatory fines, litigation or public statements against us, could cause third parties to lose trust in us or could result in claims by third parties, including class action lawsuits, any of which could have a material adverse effect on our reputation, business, financial condition or results of operations. While we have implemented cybersecurity measures intended to protect our information, data, information technology systems, applications and infrastructure, there can be no assurance that such measures will successfully prevent service interruptions or cybersecurity incidents or that these measures will be satisfactory to regulatory authorities in the event of an audit, investigation or complaint.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our internal information technology systems, or those of any of our third party service providers, or potential future collaborators, may fail or suffer security or data privacy breaches or other unauthorized or improper access to, use of, or destruction of our proprietary or confidential data, employee data or other personal data, which could result in regulatory enforcement, additional costs, loss of revenue, significant liabilities, harm to our brand and material disruption of our operations.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the ordinary course of our business, we and the third parties upon which we rely collect, receive, store, process, generate, use, transfer, disclose, make accessible, protect, secure, dispose of, transmit, and share (collectively, process) proprietary, confidential, and sensitive data, including personal data, intellectual property, trade secrets, and other sensitive data (collectively, sensitive information). We have implemented a variety of security measures designed to protect systems that store our information, given their size and complexity and the increasing amounts of information maintained on our internal information technology systems and those of our third-party service providers and suppliers, and consultants. These systems are potentially vulnerable to breakdown or other damage or interruption from system malfunction, natural disasters, terrorism, war, and telecommunication and electrical failures, as well as cybersecurity incidents from inadvertent or intentional actions by our employees, contractors, consultants, business partners, and/or other third parties, or from cyber-attacks by malicious third parties, which may compromise our system infrastructure or lead to the loss, destruction, alteration or unauthorized dissemination of, or damage to, our data.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Threat actors now engage and are expected to continue to engage in cyber-attacks, including without limitation nation-state actors for geopolitical reasons and in conjunction with military conflicts and defense activities. During times of war and other major conflicts, we, and the third parties upon which we rely, may be vulnerable to a heightened risk of these attacks, including retaliatory cyber-attacks, that could materially disrupt our systems and operations, supply chain, and ability to produce, sell and distribute our goods and services. In particular, severe ransomware attacks are becoming increasingly prevalent, especially in the health care industry, and can lead to significant interruptions in our operations, ability to provide our products or services, loss of sensitive data and income, reputational harm, and diversion of funds. Extortion payments may alleviate the negative impact of a ransomware attack, but we may be unwilling or unable to make such payments due to, for example, applicable laws or regulations prohibiting such payments. Additionally, payment of ransom does not guarantee that data access will be restored by the threat actor.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To the extent that any disruption or cybersecurity incident were to result in, or be perceived to result in, loss, destruction, unavailability, alteration or dissemination of, or damage to, our data or applications, we could incur liability and reputational damage and the development and commercialization of our programs could be delayed. Further, our insurance policies may not be adequate to compensate us for the potential losses arising from any such disruption in, or failure or cybersecurity</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">70</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">incident impacting, our systems or third-party systems where information important to our business operations or commercial development is stored.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">While we have implemented security measures designed to protect against cybersecurity incidents, there can be no assurance that these measures will be effective. We may be unable in the future to detect vulnerabilities in our information technology systems because such threats and techniques change frequently, are often sophisticated in nature, and may not be detected until after a cybersecurity incident has occurred. Further, we may experience delays in developing and deploying remedial measures designed to address any such identified vulnerabilities. Applicable data privacy and security obligations may require us to notify relevant stakeholders of cybersecurity incidents. Such disclosures may be costly and may result in reputational harm, and the disclosure or the failure to comply with such requirements could lead to adverse consequences.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We rely on third-party service providers and technologies to operate critical business systems to process sensitive information in a variety of contexts. Our ability to monitor these third parties&#8217; information security practices is limited, and these third parties may not have adequate information security measures in place. If our third-party service providers experience a cybersecurity incident or other interruption, we could experience adverse consequences. While we may be entitled to damages if our third-party service providers fail to satisfy their privacy or security-related obligations to us, any award may be insufficient to cover our damages, or we may be unable to recover such award. In addition, supply-chain attacks have increased in frequency and severity, and we cannot guarantee that third parties&#8217; infrastructure in our supply chain or our third-party partners&#8217; supply chains have not been compromised.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we, or a third party upon whom we rely, experience a cybersecurity incident or are perceived to have experienced a cybersecurity incident, we may experience adverse consequences, such as government enforcement actions. For example, we may face investigations, fines, penalties, audits, and inspections; additional reporting requirements and/or oversight; restrictions on processing sensitive information, including personal identifiable information or PHI; litigation, including class claims; indemnification obligations; negative publicity; reputational harm; monetary fund diversions; interruptions in our operations, including availability of data; financial loss; and other similar harms. Cybersecurity incidents and attendant consequences may cause stakeholders, including investors and potential customers to stop supporting our platform, products and services, deter new customers from products and services, and negatively impact our ability to grow and operate our business.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our contracts may not contain limitations of liability, and even where they do, there can be no assurance that limitations of liability in our contracts are sufficient to protect us from liabilities, damages, or claims related to our data privacy and security obligations. We cannot be sure that our insurance coverage will be adequate or sufficient to protect us from or to mitigate liabilities arising out of our privacy and security practices, that such coverage will continue to be available on commercially reasonable terms or at all, or that such coverage will pay future claims.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Artificial intelligence presents risks and challenges that can impact our business including by posing security risks to our confidential information, proprietary information, and personal data.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Issues in the development and use of artificial intelligence, combined with an uncertain and evolving regulatory environment, may result in reputational harm, liability, or other adverse consequences to our business operations. As with many technological innovations, artificial intelligence presents risks and challenges that could impact our business. Additionally, our vendors and suppliers may incorporate generative artificial intelligence tools into their offerings without disclosing this use to us, and the providers of these generative artificial intelligence tools may not meet existing or rapidly evolving regulatory or industry standards with respect to privacy and data protection, which may inhibit our or our vendors&#8217; and suppliers&#8217; ability to maintain an adequate level of service and experience. Additionally, we expect to see increasing government and supranational regulation related to artificial intelligence use and ethics, which may also significantly increase the burden and cost of research, development and compliance in this area. For example, the European Union&#8217;s Artificial Intelligence Act, or the AI Act, is the world&#8217;s first comprehensive law regulating the development and use of artificial intelligence&#8212;entered into force on August 1, 2024 and, with some exceptions, will become fully effective from August 2, 2026. The AI Act regulates artificial intelligence systems based on risk level, has extraterritorial reach in certain circumstances, and imposes obligations on providers, manufacturers, importers, distributors, and deployers of artificial intelligence systems. The AI Act also prohibits certain uses of artificial intelligence. If we develop or use artificial intelligence systems that are governed by the AI Act, we may be required to ensure higher standards of data quality, transparency, and human oversight, and adhere to specific and potentially burdensome and costly ethical, accountability, and administrative requirements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we, our vendors, our suppliers, or our third-party partners experience an actual or perceived breach of privacy or other cybersecurity incident because of the use of generative artificial intelligence, we may lose valuable intellectual property,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">71</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">personal information, and confidential information, and our reputation and the public perception of the effectiveness of our privacy and security measures could be harmed. These events could also result in obligations pursuant to, and subject us to liability under, applicable laws and contracts that we have entered into. Further, bad actors around the world are using increasingly sophisticated methods, including the use of artificial intelligence, to engage in illegal activities involving the theft and misuse of personal information, confidential information, and intellectual property. Any of these outcomes could damage our reputation, result in the loss of valuable property and information, and adversely impact our business.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we, or our employees or contractors on our behalf, engage in conduct that violates health care laws, are suspected or accused of engaging in such conduct, or are subject to investigation for actual or alleged such conduct, we could face substantial penalties and damage to our reputation, and our business operations and financial condition could be adversely affected.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We operate in one of the most highly regulated industries in the United States. Our business activities are, or may in the future be, subject to comprehensive compliance obligations under state and federal laws and regulations, including:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Federal and state laws governing laboratory testing, including but not limited to the Clinical Laboratory Improvement Amendments of 1988 and state laboratory licensure and related laws.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FDA laws and regulations, including but not limited to requirements for offering LDTs following the July 2024 effective date of the agency's LDT final rule.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The federal Anti-Kickback Statute, or AKS, which generally prohibits, among other things knowingly and willfully offering, paying, soliciting, or receiving any remuneration, directly or indirectly, covertly or overtly, in cash or in kind in return for (i) referring an individual to a person for the furnishing or arranging of any item or service, or (ii) purchasing, leasing, ordering, or arranging for or recommending the purchasing, leasing, or ordering of any good, facility, service, or item, for which payment may be made by federal health care programs. A person or entity does not need to have actual knowledge of the AKS or specific intent to violate it to have committed a violation. Safe harbors and exceptions to the AKS protect specified arrangements and conduct if every element of the applicable safe harbor or exception is met. However, failure to satisfy each such requirement does not necessarily mean that the arrangement or conduct at issue violates the AKS. In such circumstances, a facts-and-circumstances analysis is necessary to determine AKS compliance or lack thereof. Violations of the AKS are subject to civil and criminal fines and penalties for each violation, plus up to three times the remuneration involved, imprisonment, and exclusion from federal health care programs. In addition, claims submitted to federal health care programs for items or services resulting from a violation of the AKS are deemed to be false or fraudulent claims for purposes of the False Claims Act, or FCA.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Stark Law, also known as the physician self-referral prohibition, which, unless an exception applies, generally prohibits physicians or an immediate family member from making referrals for certain designated health services covered by Medicare or Medicaid, including clinical laboratory services, if the physician or an immediate family member has a prohibited financial relationship with the entity providing the services at issue. Many states have statutes that are similar to the Stark Law. Federal and state enforcement agencies may assert that a claim including items or services resulting from a violation of the Stark Law or state law equivalent constitutes a false or fraudulent claim for purposes of the federal FCA or any state false claims statute. </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The federal False Claims Act imposes civil liability on any person or entity that, among other things, knowingly presents, or causes to be presented, to the federal government, claims for payment that are false or fraudulent; and/or knowingly makes, uses, or causes to be made or used, a false statement or record material to a false or fraudulent claim or obligation to pay or transmit money or property to the federal government. The FCA also prohibits the knowing retention of overpayments (sometimes referred to as &#8220;reverse false claims&#8221;) and permits private individuals acting as &#8220;whistleblowers&#8221; (also referred to as </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">qui tam</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> relators) to bring actions on behalf of the federal government alleging violations of the FCA and to share in any monetary recovery. The federal government may elect or decline to intervene in such matters, but if the government declines intervention, the whistleblower may still proceed with the litigation on the government&#8217;s behalf.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The federal Civil Monetary Penalties Law, or CMP Law, which, unless an exception applies, prohibits, among other things, (1) the offering or transfer of remuneration to a beneficiary of Medicare or a state health care program, if the person knows or should know it is likely to influence the beneficiary&#8217;s selection of a particular provider, practitioner, or supplier of services reimbursable by Medicare or a state health care program; (2) employing or contracting with an individual or entity that the provider knows or should know is excluded from participation in a federal health care program; (3) billing for services requested by an unlicensed physician or an excluded provider; and (4) billing for medically unnecessary services. Violations of the CMP Law may result in the imposition of civil </span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">72</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">monetary penalties, as well as damages and possible exclusion from participation in state and federal health care programs.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The federal health care fraud statute, which imposes criminal liability for knowingly and willfully executing or attempting to execute a scheme to defraud any health care benefit program (which includes commercial insurers). Violations of this statute are punishable by imprisonment, fines, or both.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The federal statute prohibiting false statements relating to health care matters, which criminalizes knowingly and willfully falsifying, concealing or covering up by any trick or device a material fact or making any materially false, fictitious, or fraudulent statements or representations in connection with the delivery of, or payment for, health care benefits, items or services relating to health care matters. Violations of this statute are punishable by imprisonment, fines, or both.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">HIPAA, as amended by HITECH and its respective implementing regulations, including the Final Omnibus Rule published in January 2013, which impose requirements on certain covered health care providers, health plans, and health care clearinghouses as well as their respective business associates. HITECH also created new tiers of civil monetary penalties, amended HIPAA to make civil and criminal penalties directly applicable to business associates, and gave state attorneys general new authority to file civil actions for damages or injunctions in federal courts to enforce HIPAA and seek attorneys&#8217; fees and costs associated with pursuing federal civil actions. There are additional federal, state, and non-U.S. laws which govern the privacy and security of health and other personal information, many of which differ from each other in significant ways and may not have the same effect, thus complicating compliance efforts.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Eliminating Kickbacks in Recovery Act of 2018, or EKRA, which is an all-payer anti-kickback law that criminalizes the offer, payment, solicitation, or receipt of any remuneration, directly or indirectly, overtly or covertly, in cash or in kind, in return for referring, to induce referrals of, or in exchange for referring patients to recovery homes, clinical treatment facilities, or laboratories, unless an exception applies. Most of the safe harbors applicable under the AKS are not reiterated under EKRA&#8217;s exceptions. Therefore, compliance with an AKS safe harbor may not guarantee protection under the EKRA. EKRA thus could be interpreted to potentially expand the universe of arrangements that could be subject to enforcement under federal fraud and abuse laws, as well as substantial penalties.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">State data privacy and security laws, which may be more stringent than HIPAA. For example, the CCPA creates individual privacy rights for California consumers and increases the privacy and security obligations of certain entities handling certain personal data. The CCPA provides for civil penalties for violations, as well as a private right of action for data breaches. The CCPA is expected to increase data breach litigation and may increase our compliance costs and potential liability. Many similar laws have been proposed at the federal level and in at least 18 other states; in the event that we are subject to or affected by any such privacy and data protection laws, any liability from failure to comply with the requirements of these laws could adversely affect our financial condition.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Federal, state, and local regulations relating to the handling and disposal of regulated medical waste, hazardous waste, and biohazardous waste and workplace safety for health care employees.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Laws and regulations relating to health and safety, labor and employment, public reporting, taxation, and other areas applicable to businesses generally. All such laws are subject to change. For example, significant changes to the taxation of business entities were enacted in December 2017.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additionally, we are subject to state equivalents of each of the health care laws and regulations described above, among others, some of which may be broader in scope and may apply regardless of the payer. Many U.S. states have adopted laws similar to the AKS, Stark Law, and FCA, which may apply to our business practices, including, but not limited to, research, distribution, sales or marketing arrangements, and claims involving health care items or services reimbursed by commercial insurers. In addition, many states have fraud and abuse laws, such as fee-splitting restrictions, insurance fraud laws, anti-markup laws, prohibitions on waiving coinsurance, copayments, deductibles and other amounts owed by patients, and prohibitions on the provision of tests at no or discounted cost to induce physician or patient adoption. Some states also prohibit certain health care practices, such as billing physicians for tests that they order and business corporations practicing medicine or employing or engaging physicians to practice medicine. There are ambiguities as to what is required to comply with these state requirements and if we fail to comply with an applicable state law requirement, we could be subject to penalties. Finally, there are state and foreign laws governing the privacy and security of health information, many of which differ from each other in significant ways and often are not preempted by HIPAA, thus complicating compliance efforts.</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">73</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Because we develop our LDTs solely for use by or within our own laboratory, we believe we are exempt from the reporting requirements imposed under the federal Physician Payments Sunshine Act, or the Sunshine Act. The Sunshine Act requires, among other things, certain manufacturers of drugs, devices, biologics, and medical supplies reimbursed under Medicare, Medicaid or the Children&#8217;s Health Insurance Program to collect and report annually to CMS certain data and information related to payments and other transfers of value provided to physicians, teaching hospitals, and advanced non-physician health care practitioners, as well as ownership and investment interests, including such ownership and investment interests held by a physician&#8217;s immediate family members. A number of states also have laws similar to the Sunshine Act.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">While we believe that the Sunshine Act does not apply to our business, we cannot guarantee that the federal government or other regulators will agree with our determination. Moreover, we could become subject to Sunshine Act reporting requirements if the FDA requires us to obtain premarket authorization for our tests as medical devices (whether because the agency determines that the PreTRM test does not fall within the scope of the agency&#8217;s existing LDT definition or because of its recently issued final rule to exercise authority over LDTs as medical devices) or Congress enacts legislative reforms to the federal oversight of LDTs to subject them to FDA regulation and/or the reporting requirements of the Sunshine Act. A determination that we have violated these laws and related CMS regulations, or a public announcement that we are being investigated for possible violations, could adversely affect our business. It is presently unknown how CMS will respond to the recently finalized FDA policy change to effectively render all LDTs medical device products under federal law, and whether or when it will assert that the Sunshine Act&#8217;s reporting requirements will begin to apply to the manufacturers of such LDTs. Given that litigation is ongoing between members of the clinical laboratory industry and FDA/HHS in relation to the May 2024 LDT final rule, it may be many months or even years before we have clarity on the applicability of state and federal Sunshine Act laws to our business. Certain states also require medical device manufacturers to maintain compliance programs and/or be licensed as manufacturers or distributors by a state professional board or health department. Because the FDA&#8217;s now-in-effect final rule renders a clinical laboratory like ours a &#8220;medical device manufacturer,&#8221; we have begun the process of evaluating whether and to what extent those kinds of medical device-specific state requirements may be applicable to our operations.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Many physicians are exploring alternative ways to deliver care to their patients, including purchasing testing services from a laboratory and, in turn, selling these services directly to the patient. Such arrangements can be compliant, depending on the state in which the lab and physician are located and the specifics of the arrangement. At the same time, a shifting landscape in the health care laws discussed below may present unexpected challenges to some such arrangements.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, rapid growth and expansion of our business may increase the risk of violating applicable health care laws or related internal compliance policies and procedures, as well as the possibility that we may be accused of and/or investigated for violating these laws, regulations, and related internal policies and procedures. We likewise may be accused of, and subject to investigation and/or enforcement for, violating these laws on the basis of conduct engaged in by our employees, contractors and/or other related third parties. Such accusations and investigations may stem from allegations made by whistleblowers under the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">qui tam</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> provisions of the FCA or state law equivalents, as well as investigative efforts undertaken by state and federal regulatory and enforcement agencies. The evolving interpretations of these laws and regulations by courts and regulators increase the risk that we may be alleged to be, or in fact found to be, in violation of these or other laws and regulations.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Because of the breadth of these laws and the narrowness of the statutory exceptions and safe harbors available, it is possible that some of our business activities could be subject to challenge and may not comply under one or more of such laws, regulations, and guidance. Law enforcement authorities are increasingly focused on enforcing fraud and abuse laws, and it is possible that some of our practices may be challenged under these laws. Efforts to ensure that our current and future business arrangements with third parties, and our business generally, will comply with applicable health care laws and regulations will involve substantial costs. If our operations, including our arrangements with physicians and other health care providers, are found to be in violation of any of such laws or any other governmental regulations that apply to us, we may be subject to penalties, including, without limitation, administrative, civil and criminal penalties, damages, fines, disgorgement, contractual damages, reputational harm, diminished profits and future earnings, the curtailment or restructuring of our operations, exclusion from participation in federal and state health care programs (such as Medicare and Medicaid), and imprisonment, as well as additional reporting obligations and oversight if we become subject to a corporate integrity agreement or other agreement to resolve allegations of non-compliance with these laws, any of which could adversely affect our ability to operate our business and our financial results.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Companies in our industry occasionally receive investigative demands, subpoenas, or other requests for information from state and federal governmental agencies. We cannot predict the occurrence, timing, outcome, or impact of any such investigations. Any adverse outcome in one or more of these investigations could include the commencement of civil and/or criminal proceedings, substantial fines, penalties, administrative remedies and/or entry into corporate integrity agreements</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">74</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">with governmental agencies, among other penalties. In addition, resolution of any of these matters could involve the imposition of additional costly compliance obligations. These potential consequences, as well as any adverse outcome from government investigations, could have a material and adverse effect on our business, operating results, and financial condition.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Intellectual Property</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Any failure to obtain, maintain, and enforce our intellectual property rights could impair our ability to protect our proprietary technology and our brand.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our success and ability to compete depend, in part, on our ability to obtain, maintain, and enforce patents, trade secrets, trademarks, and other intellectual property rights and to operate without having third parties infringe, misappropriate, or circumvent the rights that we own or license. If we are unable to obtain, maintain, and enforce intellectual property protection covering our current and future tests or technology, others may be able to make, use or sell tests or technology that are substantially the same as ours without incurring the sizeable development costs that we have incurred, which would adversely affect our ability to compete in the market. Our ability to stop third parties from making, using, selling, offering to sell or importing our tests or technology is dependent upon the extent to which we have rights under valid and enforceable patents that cover these activities. However, the patent positions of diagnostic companies, including ours, can be highly uncertain and involve complex legal and factual questions for which important legal principles remain unresolved. The U.S. Supreme Court and U.S. Court of Appeals for the Federal Circuit have in recent years issued a number of decisions relating to the patent-eligibility of diagnostic method claims. We cannot predict what impact these decisions may have on our ability to obtain or enforce patents relating to diagnostic methods in the future. We believe that no consistent policy regarding the scope of valid patent claims in these fields has emerged to date in the United States. The patent situation in the diagnostics industry outside the United States also is uncertain at least in a number of countries. Moreover, U.S. patent laws frequently change, including changes regarding how patent laws are interpreted, and the U.S. Patent and Trademark Office, or USPTO, frequently issues new procedures to the patent system. We cannot accurately predict future changes in the interpretation of patent laws or changes to patent laws that might be enacted into law. Those changes may materially affect our patents or our ability to obtain patents. Therefore, there can be no assurance that any current or future patent applications will result in the issuance of patents or that we will develop additional proprietary tests or technology which are patentable. Moreover, patents or pending applications that may issue in the future may not provide us with any competitive advantage. Our patent position is subject to numerous additional risks, including the following:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may fail to seek patent protection for inventions that are important to our success;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any current or future patent applications may not result in issued patents;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we cannot be certain that we were the first to file patent applications for the inventions covered by pending patent applications and, if we are not, we may be subject to priority or derivation disputes;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may be required to disclaim part or all of the term of certain patents or part or all of the term of certain patent applications;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may file patent applications but have claims restricted or we may not be able to supply sufficient data to support our claims and, as a result, may not obtain the original claims desired or we may receive restricted claims. Alternatively, it is possible that we may not receive any patent protection from an application;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we could inadvertently abandon a patent or patent application, resulting in the loss of protection of certain intellectual property rights in a particular country. We or our patent counsel may take action resulting in a patent or patent application becoming abandoned which may not be able to be reinstated or if reinstated, may suffer patent term adjustments;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the claims of our issued patents or patent applications when issued may not cover our tests or technology;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">no assurance can be given that our patents would be declared by a court to be valid and enforceable or that a competitor&#8217;s test or technology would be found by a court to infringe our patents. Our patents or patent applications may be challenged by third parties in patent litigation or in proceedings before the USPTO or its foreign counterparts, and may ultimately be declared invalid or unenforceable, or narrowed in scope;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">there may be prior art of which we are not aware that may affect the validity of a patent claim. There also may be prior art of which we are aware, but which we do not believe affects the validity or enforceability of a claim, which may, nonetheless, ultimately be found to do so;</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">75</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">third parties may develop tests or technology that have the same or similar effect as our tests and technology without infringing our patents. Such third parties may also intentionally circumvent our patents by means of alternate designs or processes or file applications or be granted patents that would block or hurt our efforts;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">there may be patents relevant to our tests or technology of which we are not aware;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">certain of our intellectual property was partly supported by a U.S. government grant awarded by the National Institutes of Health, and the government accordingly has certain rights in this intellectual property, including a non-exclusive, non-transferable, irrevocable worldwide license to use applicable inventions for any governmental purpose. Such rights also include &#8220;march-in&#8221; rights, which refer to the right of the U.S. government to require us to grant a license to the technology to a responsible applicant if we fail to achieve practical application of the technology or if action is necessary to alleviate health or safety needs, to meet requirements of federal regulations or to give preference to U.S. industry;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our patent counsel, lawyers or advisors may have given us, or may in the future give us incorrect advice or counsel;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the patent and patent enforcement laws of some foreign jurisdictions may not protect intellectual property rights to the same extent as laws in the United States, and many companies have encountered significant difficulties in protecting and defending such rights in foreign jurisdictions. If we encounter such difficulties or we are otherwise precluded from effectively protecting our intellectual property rights in foreign jurisdictions, our business prospects could be substantially harmed, and we may not pursue or obtain patent protection in all major markets; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may not develop additional tests or technology that are patentable.</span></div></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any of these factors could hurt our ability to gain patent protection for our tests and technology.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Issued patents covering our tests and technology could be found invalid or unenforceable, if challenged.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our patents and patent applications may be subject to validity, enforceability and priority disputes. The issuance of a patent is not conclusive as to its inventorship, scope, validity or enforceability. Some of our patents or patent applications may be challenged at a future point in time in opposition, derivation, reexamination, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">inter partes</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> review, post-grant review or interference or other similar proceedings. Any successful third-party challenge to our patents in this or any other proceeding could result in the unenforceability or invalidity of such patents, which may lead to increased competition to our business, which could have a material adverse effect on our business, financial condition, results of operations, and prospects. In addition, if we initiate legal proceedings against a third party to enforce a patent covering our tests or technology, the defendant could counterclaim that such patent covering our tests or technology, as applicable, is invalid and/or unenforceable. In patent litigation in the United States, defendant counterclaims alleging invalidity or unenforceability are commonplace. There are numerous grounds upon which a third party can assert invalidity or unenforceability of a patent. Grounds for a validity challenge could be an alleged failure to meet any of several statutory requirements, including lack of novelty, obviousness or non-enablement. Grounds for an unenforceability assertion could be an allegation that someone connected with prosecution of the patent withheld relevant information from the relevant patent office, or made a misleading statement, during prosecution. Third parties may also raise similar claims before administrative bodies in the United States or abroad, even outside the context of litigation. Such mechanisms include </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">ex parte</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> re-examination</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">, inter partes</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> review, post-grant review, derivation and equivalent proceedings in non-U.S. jurisdictions, such as opposition proceedings. Such proceedings could result in revocation of or amendment to our patents in such a way that they no longer cover and protect our tests or technology. With respect to the validity of our patents, for example, we cannot be certain that there is no invalidating prior art of which we, our licensor, our or its patent counsel and the patent examiner were unaware during prosecution. The outcome following legal assertions of invalidity and unenforceability during patent litigation is unpredictable. If a defendant or other third party were to prevail on a legal assertion of invalidity or unenforceability, we would lose at least part, and perhaps all, of the patent protection on certain aspects of our tests and technology, which could have a material adverse effect on our business, financial condition, results of operations, and prospects. In addition, if the breadth or strength of protection provided by our patents and patent applications is threatened, regardless of the outcome, it could dissuade companies from collaborating with us to license intellectual property or develop or commercialize current or future tests and technology.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may not be aware of all third-party intellectual property rights potentially relating to our tests or technology. Publications of discoveries in the scientific literature often lag behind the actual discoveries, and patent applications in the United States and other jurisdictions are typically not published until approximately 18 months after filing or, in some cases, not until such patent applications issue as patents. We might not have been the first to make the inventions covered by each of our pending patent applications and we might not have been the first to file patent applications for these inventions. To determine the priority of these inventions, we may have to participate in interference proceedings, derivation proceedings or other post-grant proceedings declared by the USPTO, or other similar proceedings in non-U.S. jurisdictions, that could result</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">76</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">in substantial cost to us and the loss of valuable patent protection. The outcome of such proceedings is uncertain. No assurance can be given that other patent applications will not have priority over our patent applications. In addition, changes to the patent laws of the United States allow for various post-grant opposition proceedings that have not been extensively tested, and their outcome is therefore uncertain. Furthermore, if third parties bring these proceedings against our patents, regardless of the merit of such proceedings and regardless of whether we are successful, we could experience significant costs and our management may be distracted. Any of the foregoing events could have a material adverse effect on our business, financial condition, results of operations, and prospects.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our intellectual property may be infringed by a third party.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Third parties may infringe one or more of our patents, trademarks or other intellectual property rights. We cannot predict if, when or where a third party may infringe our intellectual property rights. To counter infringement, we may be required to file infringement lawsuits, which can be expensive and time consuming. There is no assurance that we would be successful in a court of law in proving that a third party is infringing one or more of our issued patents or trademarks. Any claims we assert against perceived infringers could also provoke these parties to assert counterclaims against us, alleging that we infringe their intellectual property. In addition, in a patent infringement proceeding, a court may decide that a patent of ours is invalid or unenforceable, in whole or in part, construe the patent&#8217;s claims narrowly and/or refuse to stop the other party from using the technology at issue on the grounds that our patents do not cover the technology in question, any of which may adversely affect our business. Even if we are successful in proving in a court of law that a third party is infringing our intellectual property rights, there can be no assurance that we would be successful in halting their infringing activities, for example, through a permanent injunction, or that we would be fully or even partially financially compensated for any harm to our business. We may be forced to enter into a license or other agreement with the infringing third party at terms less profitable or otherwise commercially acceptable to us than if the license or agreement were negotiated under conditions between those of a willing licensee and a willing licensor. We may not become aware of a third-party infringer within legal timeframes for compensation or at all, thereby possibly losing the ability to be compensated for any harm to our business. Such a third party may be operating in a foreign country where the infringer is difficult to locate and/or the intellectual property laws may be more difficult to enforce. Some third-party infringers may be able to sustain the costs of complex infringement litigation more effectively than we can because they have substantially greater resources. Any inability to stop third-party infringement could result in loss in market share of some of our tests and technology or even lead to a delay, reduction and/or inhibition of the development, manufacture or sale of certain tests and technology by us. There is no assurance that a test or technology produced and sold by a third-party infringer would meet our or other regulatory standards or would be safe for use. Such third-party infringer tests or technology could irreparably harm the reputation of our tests or technology thereby resulting in substantial loss in our market share and profits.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Developments or uncertainty in the patent statute, patent case law or USPTO rules and regulations may impact the validity of our patent rights.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our patent rights may be affected by developments or uncertainty in the patent statute, patent case law or USPTO rules and regulations. For example, the patent position of companies engaged in the development and commercialization of diagnostic tests are particularly uncertain. Changes in either the patent laws or interpretation of the patent laws in the United States or in other jurisdictions could increase the uncertainties and costs surrounding the prosecution of patent applications and the enforcement or defense of issued patents. For instance, under the Leahy-Smith America Invents Act, or the America Invents Act, enacted in September 2011, the United States transitioned to a first inventor to file system in which, assuming that other requirements for patentability are met, the first inventor to file a patent application is entitled to the patent on an invention regardless of whether a third party was the first to invent the claimed invention. These changes include allowing third-party submission of prior art to the USPTO during patent prosecution and additional procedures to challenge the validity of a patent by USPTO administered post-grant proceedings, including post-grant review, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">inter partes</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> review and derivation proceedings. The America Invents Act and its implementation could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents, all of which could have a material adverse effect on our business, financial condition, results of operations, and prospects.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Various courts, including the U.S. Supreme Court, have rendered decisions that impact the scope of patentability of certain inventions or discoveries relating to the life sciences technology. Specifically, these decisions stand for the proposition that patent claims that recite laws of nature are not themselves patentable unless those patent claims have sufficient additional features that provide practical assurance that the processes are genuine inventive applications of those laws rather than patent drafting efforts designed to monopolize the law of nature itself. What constitutes a &#8220;sufficient&#8221; additional feature is uncertain. Furthermore, in view of these decisions, since December 2014, the USPTO has published and continues to publish revised guidelines for patent examiners to apply when examining process claims for patent eligibility.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">77</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, U.S. Supreme Court rulings have narrowed the scope of patent protection available in certain circumstances and weakened the rights of patent owners in certain situations. In addition to increasing uncertainty with regard to our ability to obtain patents in the future, this combination of events has created uncertainty with respect to the value of patents, once obtained. Depending on decisions by the U.S. Congress, the federal courts and the USPTO, the laws and regulations governing patents could change in unpredictable ways that may have a material adverse effect on our ability to obtain new patents and to defend and enforce our existing patents and patents that we might obtain in the future.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We cannot assure you that our patent portfolio will not be negatively impacted by the current uncertain state of the law, new court rulings or changes in guidance or procedures issued by the USPTO or other similar patent offices around the world. From time to time, the U.S. Supreme Court, other federal courts, the U.S. Congress or the USPTO may change the standards of patentability, scope and validity of patents within the life sciences technology and any such changes, or any similar adverse changes in the patent laws of other jurisdictions, could have a negative impact on our business, financial condition, prospects, and results of operations.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may be subject to claims challenging the inventorship of our patents and other intellectual property.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may be subject to claims that former employees, collaborators or other third parties have an interest in our patents, trade secrets or other intellectual property as an inventor or co-inventor. For example, we may have inventorship disputes arise from conflicting obligations of employees, consultants or others who are involved in developing our tests and technology. In addition, counterparties to our consulting, sponsored research, software development and other agreements may assert that they have an ownership interest in intellectual property developed under such arrangements. In particular, certain software development agreements pursuant to which certain third parties have developed parts of our proprietary software may not include provisions that expressly assign to us ownership of all intellectual property developed for us by such third parties. As such, we may not have the right to use all such developed intellectual property under such agreements, we may be required to obtain licenses from third parties and such licenses may not be available on commercially reasonable terms or at all, or may be non-exclusive. If we are unable to obtain such licenses and such licenses are necessary for the development, manufacture, and commercialization of our tests and technology, we may need to cease the development, manufacture, and commercialization of our tests and technology. Litigation may be necessary to defend against these and other claims challenging inventorship of our patents, trade secrets or other intellectual property. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights, such as exclusive ownership of, or right to use, intellectual property that is important to our business, including our software, workflows, consumables, and reagent kits. In such an event, we may be required to obtain licenses from third parties and such licenses may not be available on commercially reasonable terms or at all, or may be non-exclusive. If we are unable to obtain and maintain such licenses, we may need to cease the development, manufacture, and commercialization of our tests and technology. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management and other employees, and certain customers or partners may defer engaging with us until the particular dispute is resolved. Any of the foregoing could have a material adverse effect on our business, financial condition, results of operations, and prospects.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may be subject to claims that our employees, consultants or independent contractors have wrongfully used or disclosed confidential information of third parties.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We employ individuals who were previously employed at other biotechnology or diagnostic companies. We may be subject to claims that we or our employees, consultants or independent contractors have inadvertently or otherwise used or disclosed confidential information of our employees&#8217; former employers or other third parties. We may also be subject to claims that former employers or other third parties have an ownership interest in our patents. Litigation may be necessary to defend against these claims. There is no guarantee of success in defending these claims, and if we do not prevail, we could be required to pay substantial damages and could lose rights to important intellectual property. Even if we are successful, litigation could result in substantial cost and be a distraction to our management and other employees.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we are not able to prevent disclosure of our trade secrets and other proprietary information, the value of our tests and technology could be significantly diminished.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We rely on trade secret protection to protect our interests in proprietary know-how and in processes for which patents are difficult to obtain or enforce, including the proprietary algorithm that we use for our tests and technology, including the PreTRM test. We may not be able to protect our trade secrets adequately. We have a policy of requiring our consultants, advisors, and collaborators to enter into confidentiality agreements and our employees to enter into invention, non-disclosure, and non-compete agreements. However, no assurance can be given that we have entered into appropriate agreements with all parties that have had access to our trade secrets, know-how or other proprietary information. There is also no assurance that</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">78</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">such agreements will provide for a meaningful protection of our trade secrets, know-how or other proprietary information in the event of any unauthorized use or disclosure of information. Furthermore, we cannot provide assurance that any of our employees, consultants, contract personnel or collaborators, either accidentally or through willful misconduct, will not cause serious damage to our programs and our strategy, for example by disclosing important trade secrets, know-how or proprietary information to our competitors.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">It is also possible that our trade secrets, know-how or other proprietary information could be obtained by third parties as a result of breaches of our physical or electronic security systems. Any disclosure of confidential data into the public domain or to third parties could allow our competitors to learn our trade secrets and use the information in competition against us. In addition, others may independently discover our trade secrets and proprietary information. Any action to enforce our rights is likely to be time consuming and expensive, and may ultimately be unsuccessful, or may result in a remedy that is not commercially valuable. These risks are accentuated in foreign countries where laws or law enforcement practices may not protect proprietary rights as fully as in the United States or Europe. Any unauthorized disclosure of our trade secrets or proprietary information could harm our competitive position.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Our Class A Common Stock</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The price of our Class A common stock may be volatile, and you could lose all or part of your investment.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The trading price of our Class A common stock is likely to be highly volatile and could be subject to wide fluctuations in response to various factors, some of which are beyond our control, including limited trading volume. In addition to the factors discussed in this &#8220;Risk Factors&#8221; section and elsewhere in this Annual Report, these factors include:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to successfully execute under our commercial agreement with Elevance Health and obtain broader market adoption of our PreTRM test;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">actual or anticipated variations in our and our competitors&#8217; results of operations, as well as how those results compare to analyst and investor expectations;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our failure to successfully commercialize our product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">announcements by us or our competitors of new products  and services, significant acquisitions, other strategic transactions, including strategic and commercial partnerships and relationships, joint ventures, divestitures, collaborations or capital commitments;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">changes in reimbursement practices by current or potential payers;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">failure of analysts to initiate or maintain coverage of our Company, issuance of new securities analysts&#8217; reports or changed recommendations for our Class A common stock;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">forward-looking statements related to our financial guidance or projections, our failure to meet or exceed our financial guidance or projections or changes in our financial guidance or projections;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">actual or anticipated changes in regulatory oversight of our products and services;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">development of disputes concerning our intellectual property or other proprietary rights;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">commencement of, or our involvement in, litigation;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">announcement or expectation of additional debt or equity financing efforts;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any major change in our management;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our inability to establish collaborations, if needed;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">additions or departures of key scientific or management personnel;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to effectively manage our growth;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">overall performance of the equity markets;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">sales of our common stock by us, our directors and officers, or our other stockholders in the future;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">trading volume of our Class A common stock;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">changes in accounting practices;</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">79</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ineffectiveness of our internal controls;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">general political and economic conditions; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">other events or factors, many of which are beyond our control.</span></div></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, the stock market in general, and the market for diagnostics companies in particular, has experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of the companies, including as a result of inflationary pressures, supply chain disruptions and geopolitical instability. Broad market and industry factors may negatively affect the market price of our Class A common stock, regardless of our actual operating performance. In the past, securities class action litigation has often been instituted against companies following periods of volatility in the market price of a company&#8217;s securities. This type of litigation, if instituted, could result in substantial costs and a diversion of management&#8217;s attention and resources.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We do not intend to pay dividends on our Class A common stock, so any returns will be limited to the value of our Class A common stock.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We currently anticipate that we will retain future earnings for the development, operation and expansion of our business and do not anticipate declaring or paying any cash dividends for the foreseeable future. Furthermore, future debt or other financing arrangements may contain terms prohibiting or limiting the amount of dividends that may be declared or paid on our Class A common stock. Any return to stockholders will therefore be limited to the appreciation of their stock.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our executive officers, directors and their affiliates and our stockholders holding 5% or more of our common stock own a significant percentage of our Class A common stock and will be able to exert significant control over matters subject to stockholder approval.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our executive officers, directors and our stockholders holding 5% or more of our common stock and their affiliates beneficially hold a significant percentage of our outstanding Class A common stock. These stockholders, acting together, would be able to significantly influence our management and affairs and the outcome of matters submitted to our stockholders for approval, including the election of directors and any sale, merger, consolidation, or sale of all or substantially all of our assets. This concentration of ownership control may adversely affect the market price of our Class A common stock by:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delaying, deferring or preventing a change in control;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">entrenching our management and the board of directors;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">impeding a merger, consolidation, takeover or other business combination involving us that other stockholders may desire; and/or</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">discouraging a potential acquirer from making a tender offer or otherwise attempting to obtain control of us.</span></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The dual class structure of our common stock may limit your ability to influence corporate matters and may limit your visibility with respect to certain transactions.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The dual class structure of our common stock may limit your ability to influence corporate matters. Holders of our Class A common stock are entitled to one vote per share, while holders of our Class B common stock are not entitled to any votes per share. Nonetheless, each share of our Class B common stock may be converted at any time into one share of our Class A common stock at the option of its holder by providing written notice to us, subject to the limitations provided for in our amended and restated certificate of incorporation. Consequently, if holders of our Class B common stock exercise their option to make this conversion, this will have the effect of increasing the relative voting power of those prior holders of our Class B common stock, and correspondingly decreasing the voting power of the holders of our Class A common stock, which may limit your ability to influence corporate matters. Additionally, stockholders who hold, in the aggregate, more than 10% of our Class A common stock and Class B common stock, but 10% or less of our Class A common stock, and are not otherwise an insider, may not be required to report changes in their ownership due to transactions in our Class B common stock pursuant to Section 16(a) of the Exchange Act, and may not be subject to the short-swing profit provisions of Section 16(b) of the Exchange Act.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">80</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We are an emerging growth company and a smaller reporting company, and we cannot be certain if the reduced reporting requirements applicable to emerging growth companies will make our Class A common stock less attractive to investors.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are an emerging growth company, or EGC, as defined in the JOBS Act. For as long as we continue to be an EGC, we may take advantage of exemptions from various reporting requirements that are applicable to other public companies that are not EGCs, including not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, or SOX, reduced disclosure obligations regarding executive compensation in this Annual Report and our periodic reports and proxy statements and exemptions from the requirements of holding nonbinding advisory votes on executive compensation and stockholder approval of any golden parachute payments not previously approved. We may remain an EGC until the earliest to occur of: (1) the last day of the fiscal year in which we have at least $1.235 billion in annual revenue; (2) the last day of the fiscal year in which we are deemed to be a &#8220;large accelerated filer,&#8221; as defined in Rule 12b-2 under the Exchange Act, which would occur if the market value of our common stock held by non-affiliates exceeded $700.0 million as of the last business day of the second fiscal quarter of such year; (3) the date on which we have issued more than $1.0 billion in non-convertible debt securities during the prior three-year period; and (4) December 31, 2026.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are also a smaller reporting company, meaning that the market value of our Class A common stock held by non-affiliates is less than $700.0 million and our annual revenue is less than $100.0 million during the most recently completed fiscal year. We may continue to be a smaller reporting company if either (1) the market value of our Class A common stock held by non-affiliates is less than $250.0 million or (2) our annual revenue is less than $100.0 million during the most recently completed fiscal year and the market value of our Class A common stock held by non-affiliates is less than $700.0 million. If we are a smaller reporting company at the time we cease to be an EGC we may continue to rely on exemptions from certain disclosure requirements that are available to smaller reporting companies. Specifically, as a smaller reporting company, we may choose to present only the two most recent fiscal years of audited financial statements in our Annual Report on Form 10-K and, similar to emerging growth companies, smaller reporting companies have reduced disclosure obligations regarding executive compensation.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may choose to take advantage of some, but not all, of the available exemptions. We have taken advantage of reduced reporting burdens in this Annual Report. In particular, we have not included all of the executive compensation information that would be required if we were not an EGC. We cannot predict whether investors will find our Class A common stock less attractive if we rely on certain or all of these exemptions. If some investors find our Class A common stock less attractive as a result, there may be a less active trading market for our Class A common stock and our stock price may be more volatile.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the JOBS Act, EGCs can also delay adopting new or revised accounting standards until such time as those standards apply to private companies, which may make our financial statements less comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Sales of a substantial number of shares of our Class A common stock by our existing stockholders in the public market could cause our stock price to decline.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Substantially all of our shares of Class A common stock and Class B common stock are eligible for public sale, if they are registered under the Securities Act or if they qualify for an exemption from registration under the Securities Act, including under Rules 144 or 701. If our existing stockholders sell, or indicate an intention to sell, substantial amounts of our Class A common stock in the public market, the trading price of our Class A common stock could decline.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain holders of shares of our common stock will be entitled to rights with respect to the registration of their shares under the Securities Act as provided under the terms of an investors&#8217; rights agreement between us and the holders of our stock. Registration of these shares under the Securities Act would result in the shares becoming freely tradable without restriction under the Securities Act, except for shares held by affiliates, as defined in Rule 144 under the Securities Act. Any sales of securities by these stockholders could have a material adverse effect on the trading price of our common stock.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have registered on Form S-8 all shares of common stock that are issuable under our existing equity compensation plan, including the 2011 Employee, Director and Consultant Equity Incentive Plan, as amended, or the 2011 Plan, which expired in 2021, the 2021 Equity Incentive Plan, or the 2021 Plan, and the 2021 Employee Stock Purchase Plan, or the 2021 ESPP, as well as the shares of common stock underlying option awards outstanding under the 2011 Plan. Additionally, the number of shares of our Class A common stock reserved for issuance under our 2021 Equity Plan automatically increases on January 1 of each year, beginning on January 1, 2022, by 4% of the total number of shares of our capital stock outstanding on December 31 of the preceding calendar year, or a lesser number of shares determined by our board of directors or compensation committee. Furthermore, the number of shares of our Class A common stock reserved for issuance under our 2021 ESPP automatically increases on January 1 of each year, beginning on January 1, 2022, by 1% of the total number of</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">81</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">shares of our capital stock outstanding on December 31 of the preceding calendar year, or a lesser number of shares determined by our board of directors or compensation committee. Unless our board of directors elects not to increase the number of shares available for future grant each year, our stockholders may experience additional dilution. As a consequence, these shares can be freely sold in the public market upon issuance, subject to volume limitations applicable to affiliates.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Anti-takeover provisions under our charter documents and Delaware law could delay or prevent a change in control which could limit the market price of our Class A common stock and may prevent or frustrate attempts by our stockholders to replace or remove our current management.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our amended and restated certificate of incorporation and amended and restated bylaws contain provisions that could delay or prevent a change in control of our Company or changes in our board of directors that our stockholders might consider favorable. Some of these provisions include:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a board of directors divided into three classes serving staggered three-year terms, such that not all members of the board will be elected at one time;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a prohibition on stockholder action through written consent, which requires that all stockholder actions be taken at a meeting of our stockholders;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a requirement that special meetings of stockholders be called only by the board of directors acting pursuant to a resolution approved by the affirmative vote of a majority of the directors then in office;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">advance notice requirements for stockholder proposals and nominations for election to our board of directors;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a requirement that no member of our board of directors may be removed from office by our stockholders except for cause and, in addition to any other vote required by law, upon the approval of not less than two-thirds of all outstanding shares of our voting stock then entitled to vote in the election of directors;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a requirement of approval of not less than two-thirds of all outstanding shares of our voting stock to amend any bylaws by stockholder action or to amend specific provisions of our certificate of incorporation; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the authority of the board of directors to issue convertible preferred stock on terms determined by the board of directors without stockholder approval and which convertible preferred stock may include rights superior to the rights of the holders of common stock.</span></div></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, because we are incorporated in Delaware, we are governed by the provisions of Section 203 of the General Corporation Law of the State of Delaware, which may prohibit certain business combinations with stockholders owning 15% or more of our outstanding voting stock. These anti-takeover provisions and other provisions in our amended and restated certificate of incorporation and amended and restated bylaws could make it more difficult for stockholders or potential acquirers to obtain control of our board of directors or initiate actions that are opposed by the then-current board of directors and could also delay or impede a merger, tender offer or proxy contest involving our Company. These provisions could also discourage proxy contests and make it more difficult for you and other stockholders to elect directors of your choosing or cause us to take other corporate actions you desire. Any delay or prevention of a change in control transaction or changes in our board of directors could cause the market price of our Class A common stock to decline.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If securities or industry analysts do not publish research or publish inaccurate or unfavorable research about our business, our stock price and trading volume could decline.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The trading market for our Class A common stock will depend in part on the research and reports that securities or industry analysts publish about us or our business. We do not have any control over these analysts. If few analysts commence coverage of us, the trading of our stock would likely decrease. Even if we do obtain sufficient analyst coverage, there can be no assurance that analysts will provide favorable coverage. If one or more of the analysts who covers us downgrades our stock or publishes inaccurate or unfavorable research about our business, our stock price may decline. If one or more of these analysts ceases coverage of our Company or fails to publish reports on us regularly, demand for our stock could decrease, which might cause our stock price and trading volume to decline.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">82</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our amended and restated certificate of incorporation designates certain courts as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by our stockholders, which could limit our stockholders&#8217; ability to obtain a favorable judicial forum for disputes with us or our directors, officers, or employees.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our amended and restated certificate of incorporation provides that, unless we consent in writing to an alternative forum, the Court of Chancery of the State of Delaware will be the sole and exclusive forum for any state law claims for (i) any derivative action or proceeding brought on our behalf, (ii) any action or proceeding asserting a claim of breach of fiduciary duty owed by any of our current or former directors, officers and employees, to us or our stockholders, (iii) any action or proceeding asserting a claim arising pursuant to any provision of the General Corporation Law of the State of Delaware, our amended and restated certificate of incorporation or our bylaws (in each case, as they may be amended from time to time), (iv) any action or proceeding to interpret, apply, enforce or determine the validity of our amended and restated certificate of incorporation or bylaws, (v) any action or proceeding as to which the Delaware General Corporation Law confers jurisdiction to the Court of Chancery of the State of Delaware, or (vi) any action asserting a claim against us or any of our directors, officers or employees that is governed by the internal affairs doctrine; provided, however, that this exclusive forum provision will not apply to any causes of action arising under the Exchange Act. Our amended and restated certificate of incorporation will further provide that, unless we consent in writing to an alternative forum, the United States District Court for the District of Utah will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act. We have chosen the United States District Court for the District of Utah as the exclusive forum for such Securities Act causes of action because our principal executive offices are located in Salt Lake City, Utah. In addition, our amended and restated certificate of incorporation will provide that any person or entity purchasing or otherwise acquiring any interest in shares of our Class A common stock is deemed to have notice of and consented to the foregoing provisions. We recognize that the forum selection clause in our amended and restated certificate of incorporation may impose additional litigation costs on stockholders in pursuing any such claims, particularly if the stockholders do not reside in or near the State of Delaware or the State of Utah, as applicable. Additionally, the forum selection clause in our amended and restated certificate of incorporation may limit our stockholders&#8217; ability to bring a claim in a forum that they find favorable for disputes with us or our directors, officers, or employees, which may discourage such lawsuits against us and our directors, officers, and employees even though an action, if successful, might benefit our stockholders. The Court of Chancery of the State of Delaware or the United States District Court for the District of Utah may also reach different judgments or results than would other courts, including courts where a stockholder considering an action may be located or would otherwise choose to bring the action, and such judgments may be more or less favorable to us than our stockholders. Alternatively, if a court were to find the choice of forum provisions contained in our amended and restated certificate of incorporation to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could harm our business, results of operations, and financial condition.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Because the applicability of the exclusive forum provision is limited to the extent permitted by applicable law, we do not intend that the exclusive forum provision would apply to suits brought to enforce any duty or liability created by the Exchange Act or any other claim for which the federal courts have exclusive jurisdiction. We also acknowledge that Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder and that there is uncertainty as to whether a court would enforce an exclusive forum provision for actions arising under the Securities Act.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our inability to maintain effective disclosure controls and procedures could adversely affect our results of operations, liquidity and financial positions, as well as our stock price and investor confidence in us.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a public company, we are subject to certain reporting requirements of the Exchange Act. Our disclosure controls and procedures are designed to reasonably assure that information required to be disclosed by us in reports we file or submit under the Exchange Act is accumulated and communicated to management, recorded, processed, summarized, and reported within the time periods specified in the rules and forms of the SEC. We believe that any disclosure controls and procedures or internal controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by an unauthorized override of the controls. Accordingly, because of the inherent limitations in our control system, misstatements or insufficient disclosures due to error or fraud may occur and not be detected.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">83</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As management continues to work with outside counsel to adopt formal training procedures to periodically educate the Company&#8217;s officers as to the Company&#8217;s SEC reporting responsibilities, our principal executive and principal financial officers have concluded that we had effective disclosure controls and procedures as of December 31, 2024. However, we cannot provide assurance that we will not have further lapses in our disclosure controls and procedures, which could result in our failure to provide accurate and timely disclosure to our investors.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We expect to continue incurring significant costs as a result of operating as a public company, and our management is required to devote substantial time to new compliance initiatives.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a public company, we expect to continue incurring significant legal, accounting, and other expenses that we did not incur as a private company. We are subject to the reporting requirements of the Exchange Act, which require, among other things that we file with the SEC annual, quarterly, and current reports with respect to our business and financial condition. In addition, SOX, as well as rules subsequently adopted by the SEC and The Nasdaq Global Market to implement provisions of SOX, impose significant requirements on public companies, including requiring establishment and maintenance of effective disclosure and financial reporting controls and changes in corporate governance practices. Further, in July 2010, the Dodd-Frank Wall Street Reform and Consumer Protection Act, or the Dodd-Frank Act, was enacted. There are significant corporate governance and executive compensation related provisions in the Dodd-Frank Act concerning areas such as &#8220;say on pay&#8221; and proxy access. EGCs are permitted to implement many of these requirements over a longer period, which may be up to five years from the pricing of our IPO. Stockholder activism, the current political environment and the current high level of government intervention and regulatory reform may lead to substantial new regulations and disclosure obligations, which may lead to additional compliance costs and impact the manner in which we operate our business in ways we cannot currently anticipate.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Rules and regulations applicable to public companies have substantially increased and are expected to increase our legal and financial compliance costs and to make some activities more time-consuming and costly. If these requirements divert the attention of our management and personnel from other business concerns, they could have an adverse effect on our business. The increased costs will decrease our net income or increase our net loss, and may require us to reduce costs in other areas of our business or increase the prices of our products or services. For example, these rules and regulations make it more difficult and more expensive for us to obtain director and officer liability insurance and we incur substantial costs to maintain the same or similar coverage as when we were a private company. We cannot predict or estimate the amount or timing of additional costs we may incur to respond to these requirements. The impact of these requirements could also make it more difficult for us to attract and retain qualified persons to serve on our board of directors, our board committees or as executive officers.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we fail to maintain an effective system of internal control over financial reporting, we may not be able to accurately report our financial results or prevent fraud. As a result, stockholders could lose confidence in our financial and other public reporting, which would harm our business and the trading price of our Class A common stock.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Effective internal controls over financial reporting are necessary for us to provide reliable financial reports and, together with adequate disclosure controls and procedures, are designed to prevent fraud. Any failure to implement required new or improved controls, or difficulties encountered in their implementation could cause us to fail to meet our reporting obligations. In addition, any testing by us conducted in connection with Section 404, or any subsequent testing by our independent registered public accounting firm, may reveal deficiencies in our internal controls over financial reporting that are deemed to be material weaknesses or that may require prospective or retroactive changes to our financial statements or identify other areas for further attention or improvement. Inferior internal controls could also cause investors to lose confidence in our reported financial information, which could have a negative effect on the trading price of our stock.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are required to disclose changes made in our internal controls and procedures on a quarterly basis and our management are required to assess the effectiveness of these controls annually. However, for as long as we are an EGC, our independent registered public accounting firm will not be required to attest to the effectiveness of our internal controls over financial reporting pursuant to Section 404. We could be an EGC for up to five years. An independent assessment of the effectiveness of our internal controls over financial reporting could detect problems that our management&#8217;s assessment might not. Undetected material weaknesses in our internal controls over financial reporting could lead to restatements of our financial statements and require us to incur the expense of remediation.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">84</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item1b_unresolved_staff_comments"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 1B. Unresolved</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Staff Comments</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">None.</span></p>
  <div><ix:nonNumeric id="F_35886bec-98ff-4347-a279-8a96d85eccbb" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" escape="true" continuedAt="F_35886bec-98ff-4347-a279-8a96d85eccbb_1"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_1c_cybersecurity"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 1</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">C. Cybersecurity</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cybersecurity</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We recognize the critical importance of maintaining the trust and confidence of stakeholders toward our business and are committed to protecting the confidentiality, integrity, and availability of our business operations and systems. Our board of directors is actively involved in oversight of our risk management activities, and cybersecurity represents an important element of our overall approach to risk management. Our cybersecurity policies, standards, processes, and practices are based on recognized frameworks established by the National Institute of Standards and Technology, or NIST, and other applicable industry standards. In general, we seek to address cybersecurity risks through a comprehensive approach that is focused on preserving the confidentiality, security, and availability of the information that we collect and store by monitoring, identifying, preventing, and mitigating cybersecurity threats and effectively responding to cybersecurity incidents when they occur.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cybersecurity Risk Management and Strategy; Effect of Risk</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Like all companies w</span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b33f3706-9285-4db1-98dd-39c33c5d7386" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock" escape="true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">e face risks related to cybersecurity such as unauthorized access, cybersecurity attacks and other security incidents, loss of data, and misappropriation of confidential information. To identify and assess material risks from cybersecurity threats, we maintain a comprehensive cybersecurity program to ensure our systems are effective and prepared for information security risks, including regular oversight of our programs for security monitoring for internal and external threats to ensure the confidentiality and</span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e5291f75-56df-4510-b3d3-099cc872a6d6" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="cyd:CybersecurityRiskManagementProcessesIntegratedFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> integrity of our information assets.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8d92a08b-b4e2-4c44-a664-3f765ed77d4a" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="cyd:CybersecurityRiskManagementThirdPartyEngagedFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We consider risks from cybersecurity threats alongside other company risks as part of our overall risk assessment process. We employ a range of tools and services, including third-party real-time risk assessments of cyber assets and mitigation of security risks, data loss prevention, regular air-gapped backups, continuous monitoring and threat response, next generation firewall systems, and security information and event management.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> As discussed in more detail under &#8220;Cybersecurity Governance&#8221; below, our audit committee provides oversight of our cybersecurity risk management and strategy processes, which are led by our Chief Information Officer.</span></ix:nonNumeric></span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We also identify our cybersecurity threat risks by comparing our processes to standards set by NIST. To provide for the availability of critical data and systems, maintain regulatory compliance, manage our material risks from cybersecurity threats, and protect against and respond to cybersecurity incidents, we undertake the following activities:</span></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">monitor emerging data protection best practices and laws and implement changes to our processes that are designed to comply with such;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">annual HIPAA security and privacy risk assessments performed with third party provider, as well as annual HIPAA compliance audits;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_97d81745-74f8-413f-85ef-9cac1b229089" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" continuedAt="F_97d81745-74f8-413f-85ef-9cac1b229089_1" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">through our policies, practices and contracts (as applicable), require employees, as well as third parties that provide services on our behalf, to treat confidential information and data with care, and to maintain applicable compliance standards;</span></ix:nonNumeric></span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span><ix:continuation id="F_97d81745-74f8-413f-85ef-9cac1b229089_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">employ technical safeguards that are designed to protect our information systems from cybersecurity threats, including next generation firewall systems, endpoint detection and response, data loss prevention, regular air-gapped backups, and security information and event management, which are evaluated and improved through third-party real-time risk assessments and mitigation of security risks</span></ix:continuation></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">provide regular, mandatory training for our employees and contractors regarding cybersecurity threats as a means to equip them with effective tools, information and education to recognize and address cybersecurity threats;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">conduct regular phishing email simulations for all employees and contractors with access to our email systems to enhance awareness and responsiveness to possible threats;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">leverage the NIST incident handling framework to help us identify, protect, detect, respond and recover when there is an actual or potential cybersecurity incident;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">carry and maintain information security risk insurance that provides protection against the potential losses arising from a cybersecurity incident; and</span></div></div></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">85</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_35886bec-98ff-4347-a279-8a96d85eccbb_1"><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">document internal policies and procedures for cybersecurity incident response and recovery.</span></div></div><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our incident response plan coordinates the activities we take to prepare for, detect, respond to, and recover from cybersecurity incidents, which include processes to prepare for the incident, while complying with potentially applicable legal obligations and mitigate damage to our business and reputation.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our policies and processes also address cybersecurity threat risks associated with our use of third-party service providers. In addition, cybersecurity considerations affect the selection and oversight of our third-party service providers. We perform due diligence on third parties that have access to our data to ensure they have adequate cybersecurity safeguards in place and continually monitor cybersecurity threat risks identified through such due diligence.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_38bb06cf-8503-4c99-afb6-a71e37cdb845" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e2537937-015c-4b91-acf1-97c8ea7efe06" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We describe whether and how risks from identified cybersecurity threats, including as a result of any previous cybersecurity incidents, have materially affected or are reasonably likely to materially affect us, including our business strategy, results of operations, or financial condition</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, under the heading &#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Security breaches, losses of data, and other disruptions could compromise </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">sensitive</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> information related to our business or prevent us from accessing critical information and expose us to liability, which could adversely affect our business and reputation</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">,&#8221; which disclosures are incorporated by reference herein.</span></p></ix:nonNumeric></div><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cybersecurity Governance; Management</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a734fffd-f3d1-4615-bf85-78c923615af3" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock" escape="true"><div><ix:nonNumeric id="F_362e804d-1215-40fd-8f76-65c2483c52fb" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cybersecurity is an important part of our risk management processes and an area of focus for our board of directors and management. The audit committee of our board of directors is responsible for the oversight of risks from cybersecurity threats.</span></p></ix:nonNumeric></div><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1d6a09c5-1c83-40f1-b232-148a17708128" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" escape="true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At least annually, our audit committee receives an update from management of our cybersecurity threat risk management and strategy processes covering topics such as data security, results from third-party assessments, our incident response plan, and material cybersecurity threat risks or incidents and developments, as well as the steps management has taken to respond to such risks.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> In such sessions, our audit committee generally receives materials that include a cybersecurity scorecard and other materials discussing current and emerging material cybersecurity threat risks, and describing our ability to mitigate those risks, as well as recent developments, evolving standards, and information security considerations arising with respect to our peers and third parties. The audit committee discusses such matters with our Chief Information Officer.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div><ix:nonNumeric id="F_bf2820d4-8788-4b78-80c4-ee945bed1f32" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="cyd:CybersecurityRiskRoleOfManagementTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b0a4a6ec-a375-4516-b025-0cfe36f3f2b3" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" escape="true"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_072de6cd-0dac-494e-8d50-193ddd10328a" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our cybersecurity risk management and strategy processes, which are discussed in greater detail above, are led by our Chief Information Officer and the information technology team.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_40250cc6-1105-4de7-aae6-eb0479500469" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" escape="true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Such individuals have extensive experience in various roles, including in other publicly traded companies, involving managing information security, developing cybersecurity strategy, and implementing effective information and cybersecurity programs.</span></ix:nonNumeric></span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_93770e55-89a5-47d4-84d7-0a8d20320fe8" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" escape="true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These management team members monitor the prevention, mitigation, detection, and remediation of cybersecurity incidents through their management of the cybersecurity risk management and strategy processes described above, including the operation of our incident response plan.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5a11cf93-6fe4-42f8-9247-ce81d5141001" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As discussed above, these management team members report to the audit committee of our board of directors about cybersecurity threat risks, among other cybersecurity related matters, at least annually.</span></ix:nonNumeric></span></p></ix:nonNumeric></div></ix:continuation></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_2_properties"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 2. Prop</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">erties</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our corporate headquarters and facilities are located in Salt Lake City, Utah. We currently lease a total of approximately 24,300 square feet of building space in Salt Lake City dedicated to research and development, administration and our CLIA-certified laboratory. The lease on our existing Salt Lake City facility expires on December 31, 2025 and we have had an option to terminate the lease under certain circumstances after July 1, 2024.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_3_legal_proceedings"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 3. Legal Pr</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">oceedings</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are not currently a party to any material litigation or other material legal proceedings. We may, from time to time, be involved in various legal proceedings arising from the normal course of business activities, and an unfavorable resolution of any of these matters could materially affect our future results of operations, cash flows, or financial position.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_4_mine_safety_disclosures"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 4. Mine Safety D</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">isclosures</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:13pt;font-family:'Cambria',serif;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">None.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">86</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="part_ii"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PA</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RT II</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_5_market_for_registrant"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 5. Market for Regis</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">trant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Market Information</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Class A common stock began trading on the Nasdaq Global Market under the symbol &#8220;SERA&#8221; on July 15, 2021. Prior to that time, there was no public market for our stock. Our Class B common stock is not listed on any stock exchange nor traded on any public market.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Holders of Record</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of March 14, 2025, we had 90 stockholders of record of our Class A common stock. Stockholders of record are defined as those stockholders whose shares are registered in their names in our stock records and do not include beneficial owners of common stock whose shares are held in the names of brokers, dealers or clearing agencies. As of March 14, 2025, we had two stockholders of record of our Class B common stock.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Dividend Policy</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have never declared or paid any cash dividend on our common stock. We intend to retain any future earnings to finance the operation and growth of our business, and we do not anticipate declaring or paying any cash dividends in the foreseeable future.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unregistered Sales of Securities and Use of Proceeds</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On September 10 2024, we issued 53,827 shares of our Class A common stock to Blue Ox Healthcare Partners, LLC to fulfill our contractual obligations related to the development of strategies for insurance coverage of the PreTRM test. The shares were valued at $7.55 per share.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All shares were issued in reliance on an exemption from registration under Section 4(a)(2) of the Securities Act as we did not engage in any general solicitation or advertising. The recipient of the shares was an accredited investor (as defined in Rule 501(a) of Regulation D) and represented its intention to acquire the shares for investment purposes only, and not with a view to, or for sale in connection with, any distribution thereof. The recipient received, or had, through its relationship with us, adequate access to information about us. Appropriate legends were affixed to the certificates evidencing the shares issued in this transaction. No underwriter participated in the offer and sale of these shares, and no commission or other remuneration was paid or given directly or indirectly in connection therewith.</span></p>
  <p style="text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Issuer Purchases of Equity Securities</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">None.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_6_reserved"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> 6. [ Reserved ]</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">87</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_7_management_discussion"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 7. Managem</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ent&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">You should read the following discussion and analysis of our financial condition and results of operations together with our financial statements and related notes appearing elsewhere in this Annual Report. Some of the information contained in this discussion and analysis or set forth elsewhere in this Annual Report, including information with respect to our plans and strategy for our business and related financing, includes forward-looking statements that involve risks and uncertainties. As a result of many factors, including those factors set forth in the &#8220;Risk Factors&#8221; section of this Annual Report, our actual results could differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Investors and others should note that we routinely use the Investors section of our website to announce material information to investors and the marketplace. While not all of the information that we post on the Investors section of our website is of a material nature, some information could be deemed to be material. Accordingly, we encourage investors, the media, and others interested in us to review the information that we share on the Investors section of our website, investors.seraprognostics.com.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Overview</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are a women&#8217;s health company utilizing our proprietary proteomics and bioinformatics platform, and significant data resources, to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests and predictive analytic products and services. Our vision is to deliver pivotal and actionable information to pregnant women, their physicians, and health care payers to significantly enhance a mother&#8217;s pregnancy journey, improve maternal and neonatal health, and reduce health care costs. We believe that our method of combining the disciplines of proteomics and bioinformatics with rigorous clinical testing, data, and economic analysis enables us to provide physicians and expectant mothers with personally insightful, clinically meaningful, and economically impactful information designed to improve the pregnancy experience and outcomes for mothers and babies.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There are approximately 140 million births globally each year, and approximately 3.7 million births annually in the United States. Of these, it is estimated that as many as 30% are affected by various complications (i.e., a high-risk pregnancy), including: preterm birth, preeclampsia, fetal growth restriction, stillbirth, hypertension of pregnancy, gestational diabetes and others. In many cases these complications have profound short- and long-term health consequences for the mother and baby. These health consequences of preterm birth alone are estimated to be approximately $25 billion annually in the United States. This underscores that existing methods to predict adverse pregnancy outcomes are insufficient for timely and effective proactive management for the vast majority of high-risk pregnancies. We believe that positive patient outcomes are the result of appropriate care, and the primary differentiator of patient care should be based on a determination of risk informed by a number of factors including our novel diagnostic tests.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our first commercial product, the PreTRM test, is the only broadly validated, commercially available blood-based biomarker test to accurately predict the risk of a premature delivery, also known as preterm birth. The PreTRM test is a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation that provides an accurate prediction of the expectant mother&#8217;s risk of delivering spontaneously before 37 weeks&#8217; gestation. Our commercialization strategy includes utilizing results derived from past and future clinical trials to demonstrate the health and economic benefits of early and accurate detection of preterm birth risk coupled with well-recognized interventions in higher risk patients, illustrating these benefits to health care providers and insurance payers, and providing convenient access to the test through streamlined specimen collection options. Clinical trials conducted to date include the Prediction and Prevention of Preterm Birth, or the PREVENT-PTB Study, Serum Assessment of Preterm Birth Outcomes Compared to Historical Controls study, or the AVERT PRETERM TRIAL, and the </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">P</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">rematurity </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">R</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">isk Assessment Combined With Clinical </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">I</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">nterventions for Improving Neonatal outco</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ME</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">s study, or the PRIME study.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Recent Developments</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In July 2024, we announced the publication of the positive results from the AVERT PRETERM TRIAL in Diagnostics, an international, peer-reviewed, open access journal on medical diagnosis. Diagnostics highlighted this study on the cover of the July issue. Notable results indicated an 18% reduction in severe neonatal morbidity and mortality. Additionally, there was a 7-day reduction in the mean neonatal hospital length of stay among neonates with the longest stays. The trial also showed an increase in the average gestational age at birth before 32 weeks by 2.48 weeks. Furthermore, there was a 28-day reduction in the neonatal length of hospital stay for babies born before 32 weeks&#8217; gestation, significantly reducing the time spent in the hospital for those at risk of the earliest delivery. Significant reductions in neonatal morbidity and mortality were also</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">88</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">reported, as well as hospital and NICU lengths of stay, in the entire intent-to-treat population. The test-and-treat strategy was linked to decreased odds of preterm birth and spontaneous preterm birth at various gestational ages.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In January 2025, key results of the PRIME study were presented at the Society for Maternal Fetal Medicine&#8217;s 2025 SMFM Pregnancy Meeting, and an abstract of primary endpoint data was made public in the Pregnancy Journal. Notable results from the PRIME study showed the primary endpoints being met in the prespecified modified intent-to-treat population (mITT), indicating a 25% reduction in neonatal morbidity and mortality, and an 18% reduction in neonatal hospital length of stay for the approximately 10% of babies who stay beyond the standard number days for routine deliveries. The mITT population excluded any participants at high-risk by the test that didn't receive the treatment bundle. It therefore focuses on treatment efficacy. In contrast, a more conservative intent-to-treat analysis (ITT) is often used to assess more real-world benefit of a technology. The ITT analysis, inclusive of subjects who declined treatment, indicated a 20% reduction in neonatal morbidity and mortality, and a 20% reduction in NICU admissions. We are currently seeking publication of full PRIME data, which includes these and other study results, in a highly respected, peer-reviewed journal, and we expect to generate additional publications on exploratory analyses and economic benefits in the coming months.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The PRIME study includes the same Primary and Secondary outcomes as the AVERT PRETERM TRIAL. When performing a meta-analysis of data from the two studies, we can demonstrate pooled effect sizes showing a 22% decreased risk of prolonged hospital stay and 22% reduction in neonatal morbidity and mortality. This powerful evidence from our studies makes a compelling case for a strategy where using the PreTRM test to identify higher-risk pregnancies, not currently identifiable by standard care, and applying widely accepted interventions, can result in prolonged gestation. When babies who were destined for premature delivery remain in utero longer, the result is that the more mature babies with improved health require shorter hospital/NICU stays. We believe the substantial health benefits of this model translate very favorably to health economic savings, creating a powerful value proposition to insurance payers. Data from these studies suggests that the number of patients needed to screen (NNS) to save a NICU admission is 41, and to save a NICU day is only about 3-4. To put this in context, standard of care for short cervix, which utilizes transvaginal ultrasound plus progesterone treatments, has an NNS to save a NICU admission of 150.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Beyond demonstration of clinical efficacy, we look forward to studying the effectiveness and implementation of the PreTRM test in a real-world setting. Our real-world evidence implementation programs, targeting to expand PreTRM clinical utility data and replicate randomized controlled trial evidence in the real world, have been developed for study launches anticipated in early 2025.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We believe market adoption by both health care providers and payers should be aided by the publications of our AVERT PRETERM TRIAL, PRIME study, and forthcoming real-world evidence studies. We believe that all data expected to be published in coming months and years, together with our current body of evidence, will continue to demonstrate the clinical and economic utility of using our test.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are actively discovering and developing additional biomarker and predictive analytics tests to predict other specific major conditions of pregnancy. We believe these tests have the potential to offer significant health benefits to women and their babies. Among other products, we are developing a test designed to provide a more accurate estimate of the delivery date for expectant mothers for the purposes of planning maternity leave, required support, travel arrangements, and related considerations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our operations are headquartered in Salt Lake City, Utah, including a CLIA-certified laboratory. Since our inception, we have devoted the majority of our efforts and resources to performing research and development, acquiring product rights, raising capital, establishing facilities, conducting clinical trials, and establishing commercial operations to develop and commercialize our testing and analytics products, primarily the PreTRM test. We have largely funded our operations with proceeds from the sale and issuance of convertible preferred stock, debt financings, bank loans, and the sale and issuance of Class A common stock in our initial public offering, or IPO, which was completed in July 2021. In February 2025, we completed an underwritten public offering, or the February 2025 Offering, in which we issued and sold shares of Class A common stock and pre-funded warrants to purchase shares of Class A common stock, including shares of Class A common stock issued upon exercise of the underwriters' option to purchase additional shares in full, receiving aggregate gross proceeds of approximately $57.5 million before deducting underwriting discounts and commissions and other offering expenses.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have incurred significant operating losses since inception. Our net losses were $32.9 million and $36.2 million for the years ended December 31, 2024 and 2023, respectively. We expect to incur significant additional operating losses and negative cash flows for the foreseeable future, principally as a result of our commercialization activities for the PreTRM test,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">89</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and to support additional clinical studies, publications, and anticipated research and development of our other pipeline products and services.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We significantly reduced our annual operating expenses across all aspects of our business over the past 18 months and will continue to prudently monitor our operating expense levels. We believe our cash runway is sufficient to enable us to operate through 2028 based on our existing operating plans. We will continue to evaluate the allocation of our resources as we focus our efforts to accelerate the market adoption of our PreTRM test and the development and launch of additional pipeline products and services.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We will continue to pursue contracts with private and governmental payers and health systems with positive data from the PREVENT-PTB study, the AVERT PRETERM TRIAL, and now the PRIME study, along with real-world evidence studies and other data we plan to generate, and we believe these efforts may eventually result in material revenues. However, if we are unable to secure payer contracts and generate significant market adoption by providers resulting in significant revenues, or if we fail to develop and successfully market our additional tests that generate additional revenues, we may be required to delay, scale back or abandon some, or all, of our development programs and other operations. Until such time as we can generate significant revenue from the sales of our products, if ever, we may need to continue to finance our cash needs through equity offerings, debt financings or other capital sources, potentially including collaborations or other similar arrangements. Debt financing and preferred equity financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making acquisitions or capital expenditures or declaring dividends and may require the issuance of warrants. If we raise additional funds through collaborations, strategic alliances or licensing arrangements with third parties, we may have to relinquish valuable rights to our technologies, future revenue streams, or product candidates or grant licenses on terms that may not be favorable to us. If we are unable to raise additional funds through equity or debt financings when needed, we may have to significantly delay, reduce, or eliminate some or all of our product development or future commercialization efforts, or grant rights to develop and market product candidates that we would otherwise prefer to develop and market ourselves. Our ability to access capital when needed is not assured and, if not achieved on a timely basis, will materially harm our business, financial condition, and results of operations.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Factors Affecting Our Performance</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We believe there are several important factors that have impacted, and that we expect will continue to impact, our operating performance and results of operations, including:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to furt</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">her increase the use and adoption of the PreTRM test;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to develop and successfully commercialize new products and services in the future;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the continued development of the market for proteomics and bioinformatics;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to secure payer and health system contracts that result in significant revenues or to access additional funds;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">raising substantial additional capital to continue operations and execute on our business plan, until such time as we can generate significant revenue from the sales of our products, if ever;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">obtaining and maintaining intellectual property protection for our technology and products; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">other factors described </span><span style="color:#231f20;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">in the &#8220;Risk Factors&#8221; section and elsewhere in this Annual Report.</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">90</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Key Components of Our Results of Operations</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenues</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Substantially all of our revenue in the near term is expected to come from sales of the PreTRM test. We expect to derive future revenues from PreTRM and other pipeline tests. As we continue to engage with payers and health systems using our latest evidence, we aim to close additional contracts which are expected to eventually result in additional revenues when health care providers order the PreTRM test. We believe market adoption by both health care providers and payers could be aided by the recent publication of the AVERT PRETERM TRIAL results, the future publication of positive PRIME study data, and other evidence generated within the next few years. We believe accessibility of the test for patients could be improved by our recent developments in simplified specimen collection methods, and enhanced awareness and engagement with patients, including our PreTRM website which allows patients to access the test directly. Revenue from our other pipeline products and services is expected to be dependent on our ability to successfully market them to patients, providers, payers, and, in most cases, a combination of the three.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Operating Expenses</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cost of Revenue</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cost of revenue reflects the aggregate costs incurred in delivering products to customers (e.g., proteomic testing results to clinicians) and includes expenses related to third-party specimen collection and shipping costs, as well as our lab personnel, materials and supplies, equipment, and infrastructure expenses associated with clinical testing, and allocated overhead including rent and equipment depreciation. Some of these components can vary significantly in cost and reliability of supply, and we periodically seek ways to make our supplier network more robust. For example, to address the risk posed by potential disruptions in specimen collection services described in the &#8220;Risk Factors&#8221; section of this Annual Report, we have contracted with alternative specimen collection providers beyond those that have traditionally supplied the majority of our needs, and have developed additional collection methods. We expect costs of revenue will generally move in line with the sales of our products.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Research and Development Expenses</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Research and development expenses consist of costs incurred for our research activities and development of our product candidates. These expenses include:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">clinical and real-world studies;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">laboratory processes;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">research and bioinformatic activities;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">biobanking and publication efforts;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">personnel-related expenses, including salaries, payroll taxes, employee benefits, and stock-based compensation charges for employees engaged in these research and development activities;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">direct study expenses incurred under agreements with study sites or contract research organizations;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">consultants engaged in our research and development efforts;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">laboratory materials and supplies;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">facilities costs; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">depreciation, amortization, and other direct and allocated expenses, including insurance and other operating costs, incurred as a result of our research and development activities.</span></div></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We expense all research and development costs, both internal and external, in the period in which they are incurred. We expect that our research and development expenses will increase in 2025 compared to 2024 due to increased product development activities and additional planned studies. Research and development costs may increase in the medium to long-term as we support current and additional clinical studies, publications, and other product development activities.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">91</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Selling and Marketing Expenses</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Selling and marketing expenses consist primarily of salaries, payroll taxes, employee benefits, and stock-based compensation charges for sales, marketing, and related commercial support personnel. Other significant costs include travel, consulting, public relations, facilities, and legal costs related to commercial efforts. We expect selling and marketing expenses will increase in 2025 compared to 2024 as we continue to add strategic headcount and consultants, prepare for publication of PRIME study data, expand our investment in pursuit of PreTRM commercial opportunities, and invest in our product portfolio.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">General and Administrative Expenses</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">General and administrative expenses consist primarily of salaries, payroll taxes, employee benefits, and stock-based compensation charges for personnel in executive, finance, information technology, human resources, and other administrative functions. Other significant costs include facilities, corporate and intellectual property legal fees, accounting, insurance, consulting, and other professional fees. We expect general and administrative expenses to increase slightly in 2025 compared to 2024 to support the organization as it begins to scale in the pursuit of PreTRM commercial opportunities and other strategic initiatives.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Interest Expense</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Interest expense represents interest incurred on our finance leases.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Other Income, Net</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other income, net consists of interest income and other investment income earned on our cash, cash equivalents, and marketable securities, and other gains and losses.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Results of Operations</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The results of operations presented below should be reviewed in conjunction with the financial statements and related notes included elsewhere in this Annual Report.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Comparison of the Years Ended December 31, 2024 and 2023</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes our results of operations for the years ended December 31, 2024 and 2023:</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:57.477%;box-sizing:content-box;"/>
    <td style="width:1.399%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:10.776%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.399%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:10.776%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.399%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:10.776%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">$ Change</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(in thousands)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revenue</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">77</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">306</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(229</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating expenses:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cost of revenue</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">82</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">210</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(128</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,730</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,225</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(495</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Selling and marketing</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,771</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,349</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(2,578</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,129</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,343</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(214</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total operating expenses</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">36,712</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40,127</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(3,415</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss from operations</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(36,635</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(39,821</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,186</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest expense</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(28</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(55</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other income, net</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,765</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,634</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">131</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(32,898</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(36,242</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,344</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">92</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Research and Development Expenses</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes our research and development expenses for the years ended December 31, 2024 and 2023:</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:57.477%;box-sizing:content-box;"/>
    <td style="width:1.399%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:10.776%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.399%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:10.776%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.399%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:10.776%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">$ Change</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(in thousands)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development expenses:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Clinical studies</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,430</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,784</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(2,354</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and bioinformatics</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,209</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,412</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,797</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Laboratory operations</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,091</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,029</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(938</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total research and development expenses</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,730</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,225</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(495</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The $0.5 million decrease was due to a $2.4 million decrease in clinical study costs, and a $0.9 million decrease in laboratory operations costs, partially offset by a $2.8 million increase in research and bioinformatics expense. The $2.4 million decrease in clinical study costs was primarily due to a $1.9 million decrease in PRIME study costs resulting from stopping enrollment in December 2023 due to efficacy and a $0.5 million decrease in personnel costs due to decreased average headcount in this department. The $0.9 million decrease in laboratory operations costs was primarily due to a $0.8 million in personnel costs due to decreased average headcount in this department and a $0.2 million decrease in lab supplies and equipment, partially offset by a $0.1 million increase in consulting costs. The $2.8 million increase in research and bioinformatics expense was primarily due to a $1.6 million increase in consulting and outside processing expenses related to product development activities, a $0.9 million increase in stock-based compensation expense, and a $0.4 million increase in personnel costs due to increased average headcount in this department.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Selling and Marketing Expenses</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The $2.6 million decrease was due primarily to decreases of $2.4 million in personnel-related costs driven by decreased average headcount, $0.4 million in travel expenses, $0.3 million in stock-based compensation expense, and $0.2 million in marketing programs and materials, partially offset by a $0.8 million increase in consulting and other professional service costs.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">General and Administrative Expenses</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The $0.2 million decrease was due primarily to decreases of $0.8 million related to one-time personnel costs, $0.5 million in personnel-related costs driven by decreased average headcount, and $0.2 million of director and officer insurance costs, partially offset by increases of $1.1 million in stock-based compensation expense and $0.3 million in professional service fees.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Other Income, net</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The $0.1 million increase in other income was due to a $1.1 million increase related primarily to interest income on our marketable securities, partially offset by a $1.0 million decrease in investment income related primarily to our marketable securities.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Liquidity and Capital Resources</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Sources of Liquidity</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Since inception, we have not generated a significant amount of commercial revenue from product sales or any other sources and have incurred significant operating losses and negative cash flows from operations. We anticipate that we will continue to incur net losses for the foreseeable future. We have financed our operations primarily through proceeds from the sale and issuance of convertible preferred stock and convertible notes, bank loans, and the sale and issuance of Class A common stock in our IPO, which was completed in July 2021. As of December 31, 2024, we had aggregate cash, cash equivalents, and available-for-sale securities of $68.2 million, and an accumulated deficit of $279.8 million.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">93</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On August 7, 2024, we filed a universal shelf registration on Form S-3 with the SEC, which was declared effective on August 13, 2024, or the 2024 Form S-3, pursuant to which we registered for sale up to $100.0 million of any combination of our Class A common stock, preferred stock, debt securities, warrants, rights and/or units from time to time and at prices and on terms that we may determine. This registration statement will remain in effect for up to three years from the date it became effective.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The 2024 Form S-3 included a prospectus, or the ATM Prospectus Supplement, covering up to $50.0 million in shares of Class A common stock that could be issued and sold under the sales agreement, dated August 7, 2024, between us and TD Securities (USA) LLC, or TD Cowen, or the 2024 Sales Agreement, with respect to an at-the-market offering program under which we may offer and sell, from time to time at our sole discretion, shares of our Class A common stock having an aggregate offering price of up to $50.0 million. In connection with the February 2025 Offering, we terminated the ATM Prospectus Supplement, but the 2024 Sales Agreement remains in full force and effect. We make no assurances as to the continued effectiveness of the 2024 Form S-3. As of December 31, 2024, we have not sold any shares of Class A common stock to date under the 2024 Sales Agreement.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 12, 2025, we closed the February 2025 Offering in which we issued and sold 1,250,000 shares of our Class A Common Stock and pre-funded warrants to purchase up to 11,250,000 shares of our Class A Common Stock. The gross proceeds to us from the February 2025 Offering were approximately $50.0 million before deducting underwriting discounts and commissions and other offering expenses. On February 13, 2025, the representatives of the underwriters exercised their option in full to purchase an additional 1,875,000 shares of Class A Common Stock, for additional gross proceeds to us of $7.5 million.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cash Flows</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes our cash flows for the periods indicated:</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:66.993%;box-sizing:content-box;"/>
    <td style="width:1.62%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.883000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.62%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.883000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(in thousands)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash (used in) provided by:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating activities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(14,189</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(27,188</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Investing activities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,743</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">438</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Financing activities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,609</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">752</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net increase (decrease) in cash and cash equivalents</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">163</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(25,998</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Operating Activities</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The net cash used in operating activities during the year ended December 31, 2024 was primarily due to a net loss of $32.9 million, partially offset by non-cash charges of $7.4 million and an increase in operating assets and liabilities of $11.3 million. The net cash used in operating activities during the year ended December 31, 2023 was primarily due to a net loss of $36.2 million, partially offset by non-cash charges of $5.5 million and an increase in operating assets and liabilities of $3.5 million.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Investing Activities</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Net cash provided by investing activities for the year ended December 31, 2024 was primarily due to $48.7 million in proceeds from maturities and sales of marketable securities, partially offset by $35.8 million in purchases of marketable securities and $1.0 million in purchases of intangible assets. Net cash used in investing activities for the year ended December 31, 2023 was primarily due to $54.4 million in proceeds from maturities and sales of marketable securities, partially offset by $54.1 million in purchases of marketable securities.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Financing Activities</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Net cash provided by financing activities for the year ended December 31, 2024 was due to $3.0 million in proceeds from employee equity transactions, partially offset by $0.4 million of finance lease principal payments. Net cash provided by financing activities for the year ended December 31, 2023 was due to $1.2 million in proceeds from options exercised, partially offset by $0.5 million of finance lease principal payments.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">94</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Future Funding Requirements</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">It is likely we will continue to incur significant additional operating losses and negative cash flows for the foreseeable future. We expect our losses in the future to arise principally as a result of our commercialization activities for the PreTRM test and the development, commercialization, marketing, and distribution of our other pipeline products and services, especially the costs of evidence-generating initiatives. There can be no assurance that we will eventually achieve significant revenues or profitability, or if achieved, can sustain either on a continuing basis. If we are unable to achieve significant revenues or raise additional funding, when needed, we may not be able to continue the development or commercialization of our products and services and could be required to delay, scale back, or abandon some or all of our development programs and other operations. No assurance can be given that we will be successful in raising the required capital at reasonable cost and at the required times, or at all.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any additional equity financing may not be available on favorable terms, most likely will be dilutive to our current stockholders, and debt financing, if available, may involve restrictive covenants and dilutive financing instruments. Further, our operating plan may change, and we may need additional funds to meet operational needs and capital requirements for product development and commercialization sooner than planned. We currently have no credit facility or committed sources of capital. Our future funding requirements will depend on many factors, including the following:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the timing, receipt, and amount of sales from the PreTRM test and other pipeline products and services, if approved;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the cost and timing of establishing sales, marketing, and other commercialization capabilities in the United States and abroad;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to develop and commercialize other products and services;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the terms and timing of any collaborative, licensing, and other arrangements that we may establish;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the cost, timing, and outcomes of regulatory approvals;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the scope, rate of progress, results, and cost of our clinical, scientific, and real-world studies, and other related activities;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the cost of preparing, filing, prosecuting, defending, and enforcing any patent claims and other intellectual property rights;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the extent to which we acquire or invest in businesses, products or technologies, although we currently have no commitments or agreements relating to any of these types of transactions;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">partnerships and other strategic options for our PreTRM test and other product candidates; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">other factors described in the &#8220;Risk Factors&#8221; section and elsewhere in this Annual Report.</span></div></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We evaluated that our existing cash and cash equivalents will enable us to fund our operating expenses and capital expenditure requirements for at least the next 12 months.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Contractual Obligations and Commitments</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our material cash requirements include the following contractual and other obligations.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Leases</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have lease arrangements for certain equipment and facilities. As of December 31, 2024, we had future minimum lease payments of $0.9 million, which is payable within 12 months.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Critical Accounting Policies and Estimates</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our management&#8217;s discussion and analysis of financial condition and results of operations is based on our financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles. The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported revenue and expenses incurred during the reporting periods. Our estimates are based on our historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">95</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">may differ from these estimates under different assumptions or conditions. We believe that the accounting policies discussed below are critical to understanding our historical and future performance, as these policies relate to the more significant areas involving management&#8217;s judgments and estimates.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock-based Compensation</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We maintain a stock-based compensation plan as a long-term incentive for employees and non-employee consultants. The plan allows for the issuance of incentive stock options and non-qualified stock options, as well as other stock rights.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We recognize stock-based compensation expense for stock options on a straight-line basis over the requisite service period and estimate forfeitures based on historical evidence. Our stock-based compensation expenses are based upon the grant date fair value of options estimated using the Black-Scholes option pricing model. Input assumptions used in calculating the fair value of stock-based awards represent management&#8217;s estimates and involve inherent uncertainties and the application of management&#8217;s judgment. These input assumptions include the expected term of the awards, the expected common stock price volatility over the term of the awards, risk-free interest rates, and the expected dividend yield. Changes in the assumptions can materially affect the fair value and ultimately how much stock-based compensation expense is recognized. We will continue to use judgment in evaluating the expected volatility and interest rates utilized for our stock-based compensation expense calculations on a prospective basis.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Emerging Growth Company and Smaller Reporting Company Status</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are an emerging growth company, or EGC, as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. We elected to use the extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date that we (1) are no longer an EGC or (2) affirmatively and irrevocably opt out of the extended transition period provided in the JOBS Act. Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private companies, reduce disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and are exempt from the requirements of holding a nonbinding advisory vote on executive compensation and any golden parachute payments not previously approved. As an EGC, we are also not required to have our internal control over financial reporting audited by our independent registered public accounting firm pursuant to Section 404 of SOX. As a result, our financial statements may not be comparable to companies that comply with the new or revised accounting pronouncements as of public company effective dates and we are not required to provide auditor attestation regarding requirements of Section 404(b) of SOX.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We will remain an EGC until the earliest to occur of: (1) the last day of the fiscal year in which we have at least $1.235 billion in annual revenue; (2) the last day of the fiscal year in which we are deemed to be a &#8220;large accelerated filer,&#8221; as defined in Rule 12b-2 under the Exchange Act, which would occur if the market value of our common stock held by non-affiliates exceeded $700.0 million as of the last business day of the second fiscal quarter of such year; (3) the date on which we have issued more than $1.0 billion in non-convertible debt securities during the prior three-year period; and (4) December 31, 2026.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are also a &#8220;smaller reporting company&#8221; as defined in the Exchange Act. We may continue to be a smaller reporting company even after we are no longer an emerging growth company. We may take advantage of certain of the scaled disclosures available to smaller reporting companies until the fiscal year following the determination that the market value of our voting and non-voting common stock held by non-affiliates is more than $250 million measured on the last business day of our second fiscal quarter, or our annual revenues are less than $100 million during the most recently completed fiscal year and the market value of our voting and non-voting common stock held by non-affiliates is more than $700 million measured on the last business day of our second fiscal quarter.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Recent Accounting Pronouncements</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A description of recent accounting pronouncements that may potentially impact our financial position, results of operations or cash flows is disclosed in Note 2&#8212;Significant Accounting Policies, appearing in Part II, Item 8 of this Annual Report on Form 10-K.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">96</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_7a_quantitative_and_qualitative"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 7A. Quantitative and Q</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ualitative Disclosures about Market Risk</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Interest Rate Risk</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our exposure to changes in interest rates relates primarily to interest earned and market value on our cash and cash equivalents and marketable securities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our cash and cash equivalents and marketable securities consist of cash held in banks, money market funds, commercial paper, U.S. government securities, U.S. federal agency securities and investment grade corporate securities. Our investment policy and strategy are focused on preservation of capital and supporting our liquidity requirements. Changes in U.S. interest rates affect the interest earned on our cash and cash equivalents and marketable securities, and the market value of those securities. A hypothetical 100 basis point increase in interest rates would have resulted in a decrease of $0.4 million in the market value of our available-for-sale debt securities as of December 31, 2024. Any realized gains or losses resulting from such interest rate changes would only occur if we sold the investments prior to maturity. We do not intend to sell investments while they are in an unrealized loss position and do not believe we will be required to sell the investments before recovery, which may be maturity.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Foreign Currency</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We do not regularly incur expenses with vendors outside the United States or that are denominated in currencies other than the U.S. dollar. We may incur such expenses in the future at which point exchange rate fluctuations might adversely affect our expenses, results of operations, financial position and cash flows. To date, exchange rate fluctuations have not had a material effect on our results of operations.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Effects of Inflation</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We do not believe inflation has had a material effect on our results of operations during the periods presented. However, an inflationary environment could affect us by increasing our costs of labor, laboratory supplies, and clinical trials and could adversely affect our business, results of operations, financial position and cash flows. In addition, increased inflation has had, and if it continues to increase, may have, an effect on interest rates and may adversely affect our borrowing rate and our ability to obtain any potential additional funding.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">97</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_8_financial_statements"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 8. Financial State</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ments and Supplementary Data</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INDEX TO FINANCIAL STATEMENTS</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:94%;box-sizing:content-box;"/>
    <td style="width:6%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Page</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#report"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Report of Independent Registered Public Accounting Firm (PCAOB ID: </span><span><ix:nonNumeric id="F_03726a05-9974-4b6b-9f4d-8009271dbffc" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="dei:AuditorFirmId"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">42</span></ix:nonNumeric></span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">)</span></a></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">99</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#balance_sheets"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Balance Sheets</span></a></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#statements_of_operations_and_comp_loss"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Statements of Operations and Comprehensive Loss</span></a></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">101</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#statements_of_stockholders_equity"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Statements of Stockholders&#8217; Equity</span></a></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">102</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#statements_of_cash_flows"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Statements of Cash Flows</span></a></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">103</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#notes_to_financial_statements"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Notes to Financial Statements</span></a></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">104</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">98</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="report"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Report of Independent Registe</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">red Public Accounting Firm</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To the Stockholders and the Board of Directors of Sera Prognostics, Inc.</span></p>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3819071b-cee0-401f-8d65-d438bcea9ec1" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="dei:AuditorOpinionTextBlock" escape="true"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Opinion on the Financial Statements</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have audited the accompanying balance sheets of Sera Prognostics, Inc. (the Company) as of December 31, 2024 and 2023, the related statements of operations and comprehensive loss, stockholders&#8217; equity and cash flows for each of the two years in the period ended December 31, 2024, and the related notes (collectively referred to as the &#8220;financial statements&#8221;). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2024 and 2023, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, in conformity with U.S. generally accepted accounting principles.</span></p></ix:nonNumeric></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basis for Opinion</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/s/ </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_54784db8-af05-453c-8b1d-3fd9899f07e6" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="dei:AuditorName"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Ernst &amp; Young LLP</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have served as the Company&#8217;s auditor since 2012.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_683e2755-b0fe-47ff-8928-423824084a0f" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="dei:AuditorLocation"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Salt Lake City, Utah</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 19, 2025</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">99</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SERA PROGNOSTICS, INC.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="balance_sheets"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Bala</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">nce Sheets</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(in thousands, except share and per share data)</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:66.993%;box-sizing:content-box;"/>
    <td style="width:1.62%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.883000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.62%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.883000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Assets</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current assets:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_900f1095-4dcd-46bb-b144-7a3879cd33d3" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,043</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4fe8c58f-ff6a-478e-bb54-107739436e21" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,880</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Marketable securities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_286ba177-2e30-46be-b9d2-a6c62c74808f" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:MarketableSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">42,193</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_45d51203-8dfd-4de8-9975-81474e1a5e58" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:MarketableSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">45,199</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts receivable</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_325a3d2b-ff18-4898-9edd-887750eef58f" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:AccountsReceivableNetCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">34</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_265bda49-994f-4732-a20e-caac835fa23a" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:AccountsReceivableNetCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">160</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other receivables</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_78a91325-6972-4f38-95cb-f0395ca81b07" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:OtherReceivablesNetCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4dac3b7d-81ea-4678-8876-2021d98b9cce" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:OtherReceivablesNetCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,310</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid expenses and other current assets</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_47e6bb85-b58b-49e6-b109-ae0492abe462" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,311</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d9a10fe9-67eb-4755-97dd-0b6c1d0f5129" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">795</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current assets</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_46ed9c47-f439-4eea-832d-6b858e6cf26e" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">47,600</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_67a7af21-2df5-4574-a155-b8ed4a642375" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">61,344</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Property and equipment, net</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_857ea9fc-9ca0-4af9-a811-1cbc98816251" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,239</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_82aac161-bbc1-43c1-91ad-2e1a2f7daa19" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,999</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Long-term marketable securities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7bdf0288-966a-48f3-b529-58a113d59df7" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:MarketableSecuritiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,973</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_388235aa-3793-43b1-b1e2-709985f23671" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:MarketableSecuritiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">30,841</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Intangible assets, net</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ddc637b6-7432-428a-8631-ad87beb0369e" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,026</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_74380e85-f22f-43f4-ac51-c5a81724d93d" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other assets</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ef0f27e2-69aa-4406-897f-8bdac0cfdef2" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:OtherAssetsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">737</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_37ba9fbf-48ab-4134-856d-1e4f43d3de34" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:OtherAssetsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,257</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c0e72cc3-78f6-40a8-b846-faa288374387" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">72,575</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d3f170e6-e19c-4f8b-aaf7-d07394c292da" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">95,441</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Liabilities and Stockholders' Equity</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current liabilities:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts payable</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8e0cb871-dcaf-4b7b-8ba4-efe878b2538e" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:AccountsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,969</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_95b5e006-4b88-47a7-af9d-2bb5fe31438b" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:AccountsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,046</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued and other current liabilities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c41e582f-67b2-456c-b433-41f2f4ff6701" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,384</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_32d75fc8-e406-4512-b7a9-ae30be90b0fa" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,722</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Finance lease obligation, current portion</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f5d68177-204c-40d8-89e1-380a1a97d62a" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:FinanceLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">194</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6642750a-24ba-48a7-8be0-f34a8bdf3c9e" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:FinanceLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">440</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred revenue</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9b2f7cbb-3c9c-437b-b20d-a1c014a76f5e" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:ContractWithCustomerLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,223</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b00cad88-aac8-4194-a74f-c8e214b3dc12" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:ContractWithCustomerLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,235</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current liabilities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2a0a4992-b994-4d66-bbfa-7df7a18dbc8d" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,770</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_63bfc8b3-950c-4f13-b57a-e46579043ab3" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,443</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Finance lease obligation, net of current portion</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2a42fa76-6275-42ae-aa6d-18b2dd5fef78" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:FinanceLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9b1f0aae-5150-4c25-aa16-f61a9e5ddd9b" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:FinanceLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">196</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease obligation, net of current portion</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c88f1fd2-bdf3-450f-96bf-7b0ab5bba2c5" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ddd60159-ba45-4156-8631-63307b972cf9" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">644</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total liabilities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d859a383-c448-4406-9028-b2e3bec40fa7" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:Liabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,772</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fe26ed70-11e1-41d1-b3bf-3dc13ed6d121" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:Liabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25,283</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_8e83aa39-64c6-422c-87be-b01e50d376c8;"><span style="-sec-ix-hidden:F_acf9886f-1dd5-4da5-9964-486ff2df08a0;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commitments and contingencies (Note 13)</span></span></span></span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stockholders&#8217; equity:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c6d8b86c-46ed-408b-993e-41f084912cec" contextRef="C_e26ec1fe-0438-4812-b032-9b354ebc1852" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_dcfc2b9f-0647-4feb-9c44-e34b3e2c00ae" contextRef="C_7e2de8e1-9b90-401b-b5d2-78a35f931945" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_4e49d761-37e0-48e8-a36f-40014798c0b6" contextRef="C_1a18dcc9-5298-4f3a-9d2a-ee711ea1c709" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_2b85c712-57a8-4d6d-8aae-e7c7cf0a6180" contextRef="C_bb275bcf-b99b-45c0-b9f6-74f2cafd0a81" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.0001</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d80ee4db-4943-49ea-9f4d-1601d7b23c6f" contextRef="C_e26ec1fe-0438-4812-b032-9b354ebc1852" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_ca88c19b-630b-4dc8-a5f8-b14e19f6e0ef" contextRef="C_7e2de8e1-9b90-401b-b5d2-78a35f931945" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">150,000,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Class A shares authorized; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eb926258-cc9d-459c-9be3-96f99cc9e9c4" contextRef="C_e26ec1fe-0438-4812-b032-9b354ebc1852" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_72568580-e9e2-4daa-92e3-a08852212b45" contextRef="C_e26ec1fe-0438-4812-b032-9b354ebc1852" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">33,206,909</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;and </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3ce3dd21-1005-4ca1-8211-a4c930616c8e" contextRef="C_7e2de8e1-9b90-401b-b5d2-78a35f931945" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_fabbf274-df39-4e17-9ca2-8a4e7cb069e7" contextRef="C_7e2de8e1-9b90-401b-b5d2-78a35f931945" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">30,736,513</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Class A shares issued and outstanding as of December 31, 2024 and 2023, respectively; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_935fa58f-ad1d-423f-b7c4-04c1ed383b60" contextRef="C_1a18dcc9-5298-4f3a-9d2a-ee711ea1c709" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_4a3d291e-c28b-4823-9bae-7287f7fff6b8" contextRef="C_bb275bcf-b99b-45c0-b9f6-74f2cafd0a81" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,500,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Class B shares authorized; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1546ee53-aeb6-4347-be02-1a523d8b0b53" contextRef="C_1a18dcc9-5298-4f3a-9d2a-ee711ea1c709" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">967,759</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;and </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2dfe623f-29ac-40be-bd73-68ac0bbe53cd" contextRef="C_bb275bcf-b99b-45c0-b9f6-74f2cafd0a81" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,405,259</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Class B shares issued as of December 31, 2024 and 2023, respectively; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_18a95d24-50d0-46f0-af58-3e0aea53e2b6" contextRef="C_1a18dcc9-5298-4f3a-9d2a-ee711ea1c709" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_a1380144-9612-4f20-a53a-5ada1768044e" contextRef="C_bb275bcf-b99b-45c0-b9f6-74f2cafd0a81" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">967,759</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;Class B shares outstanding as of December 31, 2024 and 2023.</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5724bfaa-dbea-4d2b-bd9a-d1a3fea10d8c" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:CommonStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_11d29cfc-a631-45db-ad23-6111a887f977" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:CommonStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additional paid-in capital</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cd1bd377-7993-499b-bca5-66fa2e7748a2" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:AdditionalPaidInCapitalCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">327,534</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c3830e82-a7cf-4f1e-8390-730fea02adf5" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:AdditionalPaidInCapitalCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">317,066</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accumulated other comprehensive income (loss)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_af82fbc9-544f-40dc-8e9c-20e063ffb336" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">60</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9887f2a4-30cc-4814-a675-8a1c0cb425e3" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">15</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accumulated deficit</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9bb4bc39-cdc0-4edf-81a8-476b3d510cbc" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">279,794</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_92f445e0-8941-45aa-b3fd-04e6e091645b" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">246,896</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stockholders' equity</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f786e8d3-53db-4e89-a96e-14e368711b82" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">47,803</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e164a3b4-222a-4536-94c4-b6f55e3dadf4" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">70,158</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total liabilities and stockholders' equity</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3fb283e1-13bc-4a2e-a5b0-7a4f90bc347c" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">72,575</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dccf1e86-0e78-48d2-a18d-f72068c43575" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">95,441</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The accompanying notes are an integral part of the financial statements</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">100</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SERA PROGNOSTICS, INC.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="statements_of_operations_and_comp_loss"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Statements of Operation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">s and Comprehensive Loss</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(in thousands, except share and per share data)</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:66.9%;box-sizing:content-box;"/>
    <td style="width:1.76%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.860000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.62%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.860000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:right;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:right;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:right;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:right;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revenue</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_83fc8867-1257-4668-8009-28cdbadb2cdf" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">77</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a9f0027d-59c2-43bf-b544-ac75ce0b25b2" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">306</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating expenses:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cost of revenue</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d5e1a4a0-a1d9-4097-8a8e-3f4c812f9d1a" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="sera:CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">82</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_43ae48e9-dc7f-4b98-97b1-2932fa793f21" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="sera:CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">210</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d7eef4c6-0cfe-4139-8157-aa81c657b706" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,730</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7dfe3e71-1206-4b04-a87d-1435b39894a5" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,225</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Selling and marketing</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c265d3e8-0258-4998-9bae-9692eb9dea9e" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:SellingAndMarketingExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,771</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bc5ddac1-6910-4bba-bd86-e1faa6d36050" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:SellingAndMarketingExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,349</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_40a31dd7-885c-4c95-bd80-8e29d3b4ea62" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,129</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_01060304-41db-420e-9be5-a12d4fa2d42a" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,343</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total operating expenses</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8fa6e42c-48cf-4204-bd20-14a13a46f372" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">36,712</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b99e23be-8521-4102-9275-d9c3e9d45e44" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">40,127</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss from operations</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_001f57d9-3c28-4639-a7eb-03ffd8099600" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">36,635</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9ef07e05-9559-4d82-8901-d61d6fffa7df" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">39,821</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest expense</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a7b89a57-cb81-4237-9509-8e36cb15c031" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:InterestExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">28</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fdf8d905-10e3-4408-b199-e63902395a3f" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:InterestExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">55</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other income, net</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d971e5f9-c489-431e-90d9-f92b8fd515a4" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:NonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,765</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d4015c51-f9ed-4132-b3a3-dd788bd6af46" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:NonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,634</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c505d64d-b4b4-4b5a-91df-6adff9ebef74" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">32,898</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_482850b6-36f7-4a1e-aa87-8b21e330efd7" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">36,242</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss per share, basic and diluted</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8ed1c964-e3d2-4dd3-92d1-2901bb9c0c50" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_199629e8-639e-4a9f-bb28-5149fbe55f6b" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">0.99</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bcefaca5-41e6-4946-b8ff-93db6d0e4228" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal"><ix:nonFraction id="F_cfce51d5-f07f-4a89-a8c9-2f538e793b9c" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">1.16</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average shares outstanding, basic and diluted</span></p></td>
    <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c08ba177-e92e-4058-879f-e5a7b953dec0" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_c0bb5f42-169d-496d-8473-b72ddc320f28" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">33,156,936</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7ebc8b45-24cf-432a-acc8-5b0458d50e6f" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_4b0cff8c-43b0-4063-bb48-c29f838c4f46" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">31,200,652</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other comprehensive income:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Unrealized gain on available-for-sale debt securities, net of tax</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6f27cf38-2b35-4988-83c3-f85053b44004" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">75</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_62c7411f-4885-40fb-bb5c-c9c92a21cb3b" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">966</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total other comprehensive income</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_28ef8728-8d2d-42bc-a3ea-12526a58339f" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">75</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_70a2aa8e-1543-4155-b827-d4c6dec642ab" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">966</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Comprehensive loss</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8037ec3b-4ccf-4dcb-b484-4a4ac54638ec" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:ComprehensiveIncomeNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">32,823</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dfa240bd-7754-4d32-81f4-8716ae16e5de" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:ComprehensiveIncomeNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">35,276</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The accompanying notes are an integral part of the financial statements</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">101</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SERA PROGNOSTICS, INC.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="statements_of_stockholders_equity"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Statements of Stock</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">holders&#8217; Equity</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(in thousands, except share data)</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:31.099%;box-sizing:content-box;"/>
    <td style="width:1.001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:9.207999999999998%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.161%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:5.305%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.161%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:8.047%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.161%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:10.088%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.161%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:8.726999999999999%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.161%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:8.726999999999999%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Accumulated</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Common Stock</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Additional</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Other</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Class A and B)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Paid-In</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Comprehensive</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Accumulated</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Stockholders'</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Shares</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Capital</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Loss) Income</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Deficit</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Equity</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2022</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_86db99e7-2e1f-4012-b1a0-07665b200fe5" contextRef="C_1897da0a-32c6-4bd9-ab52-d7b11d48dbc4" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">31,017,946</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b7ca321f-af4e-48f9-bdbf-6963ccef6017" contextRef="C_1897da0a-32c6-4bd9-ab52-d7b11d48dbc4" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b85f0a90-8b77-407a-954d-8df5af1c1027" contextRef="C_4902770f-8a0e-430e-93da-63b3fc8fb693" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">310,575</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a48d7175-87f6-4ba0-9ff0-f2f02d869500" contextRef="C_4604871b-61c7-42a4-83ac-1df44766218b" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">981</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d9b6727f-9d5a-4d74-90aa-e47d58b66a4a" contextRef="C_4a4b0457-af40-4380-abc2-adf8d6e99ae1" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">210,654</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d93704b1-383d-41f4-b23c-3ea98e6463fc" contextRef="C_bbe124b6-5e26-4340-9b7f-2ec3e167c7a7" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">98,943</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of common stock upon<br/>&#160;&#160;&#160;exercise of stock options</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_adbff6d3-7779-4837-b110-84fe5173589c" contextRef="C_34623022-fd17-429b-802b-fd3f934c6118" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">593,091</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3fc868d6-683d-4b3a-8b05-4ecbdf22d2b2" contextRef="C_08aeb0e4-961e-4e83-9bf3-97b2ea84cd08" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,095</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5ffa846b-af2e-498d-9f67-7d8eee6ea3ed" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,095</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of common stock under<br/>&#160;&#160;&#160;employee stock purchase plan</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_44173446-442b-4ce8-8f69-e0fce814c112" contextRef="C_34623022-fd17-429b-802b-fd3f934c6118" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">93,235</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_79f4fa24-e936-43ed-b170-4ea5c903c2c7" contextRef="C_08aeb0e4-961e-4e83-9bf3-97b2ea84cd08" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">123</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1bcef833-c34f-4e22-9207-d378e8e4716f" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">123</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation expense</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e17aa25d-1ead-48e4-8eaf-e21277b0b5ba" contextRef="C_08aeb0e4-961e-4e83-9bf3-97b2ea84cd08" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,273</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_16009326-99ef-4de5-9aad-747fa9e8bf68" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,273</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other comprehensive income</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f8ef88c4-c355-46fa-92b4-e773de8bf596" contextRef="C_aef51065-45c9-4f35-8eb3-5f34b000ac42" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">966</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_94bd10a7-c657-4f3d-9e79-6e5e437bae56" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">966</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7ea0cacc-e402-4f4b-8387-242d7752c3da" contextRef="C_1ae32300-4e33-4c46-af0e-181100bd03ab" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">36,242</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8ac03d62-18a5-470c-9eca-4a37b77150cd" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">36,242</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2023</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7a6e01fd-30b3-4241-9e25-895aa1fa4c5a" contextRef="C_23ca8b3a-fc86-4de2-84db-b4ac53b0b0a2" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">31,704,272</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_33dc8ead-b5f8-4402-889a-fd31f43f2f4c" contextRef="C_23ca8b3a-fc86-4de2-84db-b4ac53b0b0a2" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a539fb15-5ad2-4552-bc17-c6b1945d0248" contextRef="C_710fd514-29df-4675-8ad6-a812b659c2ba" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">317,066</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6183d400-bdaf-4dbb-8f37-9d1aaf1bc162" contextRef="C_dcf610fd-ad27-414d-89a5-21a6bd40cf69" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">15</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9a224115-c3ac-4f4d-9a79-bd4c29644f01" contextRef="C_66868af1-9b8d-4e30-a6a8-7b403eee8c4e" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">246,896</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2a4f464c-1e94-4dbc-8607-e76d09ac2dec" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">70,158</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of common stock upon<br/>&#160;&#160;&#160;exercise of stock options</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ade17afb-c6b7-4029-bedd-1711a4372f7b" contextRef="C_1ae1e03b-7d7a-4b1a-b6fb-a10eb7afe2e2" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,102,513</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_03a1fac3-82ff-4f6d-9390-5740b727c6e8" contextRef="C_f78c9a8e-0786-4b1b-bdc3-6e22b3d933f8" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,902</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e7c35921-1d3b-4949-8660-7a7d0e3e24ec" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,902</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of restricted stock units</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e5bbff5d-b0a9-41bf-8bb7-5cf8013617b5" contextRef="C_1ae1e03b-7d7a-4b1a-b6fb-a10eb7afe2e2" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,257,345</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of common stock under<br/>&#160;&#160;&#160;employee stock purchase plan</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_966b8dea-c50d-4a22-88b9-06404da38d7b" contextRef="C_1ae1e03b-7d7a-4b1a-b6fb-a10eb7afe2e2" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">48,740</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c6d42a2d-35bb-40d9-a229-c8a8f896827d" contextRef="C_f78c9a8e-0786-4b1b-bdc3-6e22b3d933f8" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">147</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5f8a03f1-f083-4a7a-9682-4424f9a519a0" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">147</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common stock warrant exercises</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cdfc457b-ff57-45c8-8215-5154bee2c86e" contextRef="C_1ae1e03b-7d7a-4b1a-b6fb-a10eb7afe2e2" name="sera:StockIssuedDuringPeriodSharesStockWarrantExercised" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">7,971</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other issuance of common stock</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f441f52d-062f-4cb6-9b27-b160786f79d6" contextRef="C_1ae1e03b-7d7a-4b1a-b6fb-a10eb7afe2e2" name="us-gaap:StockIssuedDuringPeriodSharesOther" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">53,827</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b387187f-f0e6-4f68-be85-baccc9e7eb43" contextRef="C_f78c9a8e-0786-4b1b-bdc3-6e22b3d933f8" name="us-gaap:StockIssuedDuringPeriodValueOther" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">406</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_da0a76b9-cfcd-4708-aed9-91143f868c8f" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:StockIssuedDuringPeriodValueOther" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">406</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation expense</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c9ccdffa-341c-4dd3-8153-56139543c033" contextRef="C_f78c9a8e-0786-4b1b-bdc3-6e22b3d933f8" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,013</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_74225255-3878-4778-b093-577e5886b374" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,013</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other comprehensive income</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f7fc08e5-42d9-498e-9cf1-b7b6c8927157" contextRef="C_4d86a42a-d0b5-4b77-9427-1f77696fdc95" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">75</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f5b038dd-bd0b-47f7-b6d3-edc862af9630" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">75</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ed708596-6f30-40a8-bc03-81abd1f600d3" contextRef="C_b3f42472-6a24-481b-929b-311bab556a79" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">32,898</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5106d171-fd5c-473a-8e79-f30f9a546493" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">32,898</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balance as of December 31, 2024</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_238f4b6b-376d-4930-9443-e6a679c9e309" contextRef="C_cca6413f-9960-434b-8f2f-706f727e0013" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">34,174,668</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_06cb4e6d-5673-4569-b1f7-50fbc3231bcf" contextRef="C_cca6413f-9960-434b-8f2f-706f727e0013" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1888d418-65ef-4847-86df-5cb2af537890" contextRef="C_fbe5cd8d-06e5-47a6-a5f5-846c4699e03a" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">327,534</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6854dd43-4068-47c9-8178-94b0e9656da3" contextRef="C_a3cd6426-e326-48ef-a767-d68bae526b8f" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">60</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_819891ea-c149-4837-8ced-722fcaf98380" contextRef="C_5f4da6b1-9c8a-4b7e-8a90-5d3ea9ae78a1" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">279,794</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_107504b2-b376-4f2a-92b3-5405a757f13e" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">47,803</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The accompanying notes are an integral part of the financial statements</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">102</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SERA PROGNOSTICS, INC.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="statements_of_cash_flows"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Statements o</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">f Cash Flows</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(in thousands)</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:66.993%;box-sizing:content-box;"/>
    <td style="width:1.62%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.883000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.62%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.883000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Cash flows from operating activities</span></p></td>
    <td style="padding-top:0in;text-indent:5pt;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss</span></p></td>
    <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eb98380e-965f-46bd-bc96-6873bd069bc3" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">32,898</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_47249746-17ce-4575-8ce1-508f6ab3c0a2" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">36,242</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Adjustments to reconcile net loss to net cash used in operating activities:</span></p></td>
    <td style="padding-top:0in;text-indent:5pt;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Depreciation and amortization</span></p></td>
    <td style="padding-top:0in;text-indent:15pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d99c4824-0a57-4196-85ba-1f3d0e5b5393" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:DepreciationDepletionAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">833</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_19253910-c3f8-4b46-9442-4a9c1259baf0" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:DepreciationDepletionAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">900</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation</span></p></td>
    <td style="padding-top:0in;text-indent:15pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a3e2037e-84a5-4c03-878d-a06d531f93ff" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,013</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_04d6e5ff-0655-404c-9b68-9070bce4cb37" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,273</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Non-cash lease expense</span></p></td>
    <td style="padding-top:0in;text-indent:15pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7dc237e2-f2fe-4e82-a631-43d2db04fc69" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">567</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c8e7dedc-1a38-4749-a3f9-1024dbce9a09" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">526</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Non-cash investment income, net</span></p></td>
    <td style="padding-top:0in;text-indent:15pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_347dfd5c-0f38-406f-b1bd-e94abe3e42cd" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="sera:NoncashInvestmentIncomeExpenseNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">910</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_732294eb-93d6-429e-8521-df7f70594155" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="sera:NoncashInvestmentIncomeExpenseNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,182</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
    <td style="padding-top:0in;text-indent:15pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f6060645-d39c-479b-a67d-3ead9ef25e88" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:OtherNoncashIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">69</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a8f74708-019e-42b1-897c-ce67ee0b3574" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:OtherNoncashIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">18</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:10pt;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Changes in operating assets and liabilities:</span></p></td>
    <td style="padding-top:0in;text-indent:15pt;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts receivable</span></p></td>
    <td style="padding-top:0in;text-indent:20pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_01f519a0-80d0-425b-be60-9427a5ddc654" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">126</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_311e35f4-d73c-4a1d-87e1-8c5df03dfb03" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">47</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other receivables</span></p></td>
    <td style="padding-top:0in;text-indent:20pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e76a8a3c-d0da-4b45-9182-d9e3ea1f2f8f" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:IncreaseDecreaseInOtherReceivables" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">11,291</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_08d6397e-16e7-443e-a0ef-8a0b79434db4" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:IncreaseDecreaseInOtherReceivables" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,310</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid expenses and other assets</span></p></td>
    <td style="padding-top:0in;text-indent:20pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eb4ef8aa-9118-4e14-a7f4-f9ef8e360ce6" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_613f6095-88fa-4859-85a3-7dd6bbdd5bc8" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">465</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts payable</span></p></td>
    <td style="padding-top:0in;text-indent:20pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_31f9c80f-f4f4-4ed1-a089-7128120c8d49" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:IncreaseDecreaseInAccountsPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">455</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_55f9e9ab-097b-4d58-86f5-0102408c81d0" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:IncreaseDecreaseInAccountsPayable" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">442</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued and other current liabilities</span></p></td>
    <td style="padding-top:0in;text-indent:20pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_034fa077-f54e-4cea-a8fd-2d5f8c617bfd" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">575</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2774ff9d-85a7-4e14-b5f3-d1a2e5360099" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">2,301</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred revenue</span></p></td>
    <td style="padding-top:0in;text-indent:20pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f1b9c57a-06be-401b-9a88-dc756716b275" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">12</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a2e532ae-b40e-4787-a0b3-d8c64cf5dacb" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,154</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0in;text-indent:30pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:30pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash used in operating activities</span></p></td>
    <td style="padding-top:0in;text-indent:25pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:25pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cc2d52b1-eca2-461a-8403-4cb4521c7a29" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">14,189</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_865cce26-6418-4e47-9c29-70c7d0af84e2" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">27,188</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Cash flows from investing activities</span></p></td>
    <td style="padding-top:0in;text-indent:5pt;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchases of marketable securities</span></p></td>
    <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ae7e9ff7-0fdb-4c18-a9e8-46c77fb0e755" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">35,831</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_57b8131e-1d2e-46bb-89ac-6815accca035" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">54,143</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Proceeds from maturities and sales of marketable securities</span></p></td>
    <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e658973e-faed-4f9d-87a5-f0de152050f4" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">48,675</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_766057ec-76a6-4bb5-927e-abf548777bd6" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">54,398</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchases of property and equipment</span></p></td>
    <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_37fb7875-92b2-40a2-99a7-9d6d4520715e" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">56</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bb4c45dc-0fe2-4a36-abe0-cd0bc861e420" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">128</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Proceeds from disposal of property and equipment</span></p></td>
    <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d72478fc-a5a4-4511-beae-86762d7b00e7" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_32575993-6c3e-489e-8081-98121a6ed34a" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">311</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchases of intangible assets</span></p></td>
    <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b0645ec4-c5d3-49e3-b719-44a6b3089901" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:PaymentsToAcquireIntangibleAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,045</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_78a8ddca-e54e-40e2-a1d1-b0390a8c6d59" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:PaymentsToAcquireIntangibleAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0in;text-indent:30pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:30pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash provided by investing activities</span></p></td>
    <td style="padding-top:0in;text-indent:25pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:25pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_85f157c5-1a89-44ad-88ec-01391ad69d5a" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,743</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5c088d23-0c24-4ef6-86ca-18e541817605" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">438</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Cash flows from financing activities</span></p></td>
    <td style="padding-top:0in;text-indent:5pt;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Proceeds from exercise of stock options</span></p></td>
    <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7a7a995d-eb23-4c86-8cf9-bdf72b1ffcd9" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:ProceedsFromStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,902</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f12d7921-319d-4a02-979a-85fd669fcd4d" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:ProceedsFromStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,095</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Proceeds from employee stock purchase plan</span></p></td>
    <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_259babac-7700-40f7-90f9-77a95121f9fd" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">147</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5cbf852f-460c-432b-906b-54881c862567" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">123</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Finance lease principal payments</span></p></td>
    <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e6d7ee2d-3a14-438a-9077-584601eae0ec" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:FinanceLeasePrincipalPayments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">440</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_89f3566a-90cb-45dc-abfd-8b52a6514a23" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:FinanceLeasePrincipalPayments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">466</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0in;text-indent:30pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:30pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash provided by financing activities</span></p></td>
    <td style="padding-top:0in;text-indent:25pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:25pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4c068946-1542-4abc-820f-6931f3bbb639" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,609</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d1152f34-8d74-431c-8643-a6d8465337a7" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">752</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net increase (decrease) in cash and cash equivalents</span></p></td>
    <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_62402ec0-c8eb-49b5-8353-7a68d8a4c5ef" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">163</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7820cb3d-2b1d-4339-a95c-3d8d511045da" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">25,998</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents at beginning of period</span></p></td>
    <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_27ffc23a-4547-4a74-8c91-152177ed4ca9" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,880</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2b03abd7-f5c7-43c7-a8ef-8bb43f770bda" contextRef="C_bbe124b6-5e26-4340-9b7f-2ec3e167c7a7" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">29,878</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents at end of period</span></p></td>
    <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_efecd9c4-6d3c-4f95-af4d-4540a5d7ad35" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,043</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_63f96fd7-134a-4a1e-818f-acb8417bfb07" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,880</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Supplemental disclosure of cash flow information</span></p></td>
    <td style="padding-top:0in;text-indent:5pt;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash paid for interest</span></p></td>
    <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cab533bd-a1a6-4815-aeca-3b813d99f9ec" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:InterestPaidNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">28</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ddfb13e5-4bfd-45e7-9f19-a5b3cb92e38f" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:InterestPaidNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">55</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Supplemental disclosure of non-cash investing and financing information</span></p></td>
    <td style="padding-top:0in;text-indent:5pt;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of stock to settle accrued and other current liabilities</span></p></td>
    <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b05d05b0-2c0d-4a1c-8297-874da6b01d27" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="sera:IssuanceOfStockToSettleAccruedAndOtherCurrentLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">406</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c3b349db-7135-4e0e-ba3f-da18caa5b204" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="sera:IssuanceOfStockToSettleAccruedAndOtherCurrentLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchases of property and equipment in accounts payable and accrued and other<br/>&#160;&#160;&#160;current liabilities</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eae7a8c9-cd72-42fe-92c6-3ff10e1bdddf" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="sera:PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bfade963-d2c6-4b83-8408-ba96ae34023e" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="sera:PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20</ix:nonFraction></span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The accompanying notes are an integral part of the financial statements</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">103</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SERA PROGNOSTICS, INC.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="notes_to_financial_statements"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notes to Finan</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">cial Statements</span></p>
  <div><ix:nonNumeric id="F_e54bf638-8466-4714-9b2a-0227f410ee4b" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" escape="true" continuedAt="F_e54bf638-8466-4714-9b2a-0227f410ee4b_1"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Description of Business and Financial Condition</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Sera Prognostics, Inc. (the &#8220;Company&#8221;) is a women&#8217;s health company utilizing its proprietary proteomics and bioinformatics platform, and significant data resources, to improve maternal and neonatal health by discovering, developing and commercializing blood-based biomarker tests and predictive analytic products and services. Our vision is to deliver pivotal and actionable information to pregnant women, their physicians, and health care payers to significantly enhance a mother's pregnancy journey, improve maternal and neonatal health, and reduce health care costs. We believe that our method of combining the disciplines of proteomics and bioinformatics with rigorous clinical testing, data, and economic analysis enables us to provide physicians and expectant mothers with personally insightful, clinically meaningful, and economically impactful information designed to improve the pregnancy experience and outcomes for mothers and babies.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company was incorporated in the State of Delaware on January 17, 2008 and its operations are located in Salt Lake City, Utah, including a Clinical Laboratory Improvement Amendments, or CLIA, certified laboratory. Since its inception, the Company&#8217;s activities have consisted of performing research and development, conducting clinical studies for its pipeline products and services, acquiring product rights, raising capital, establishing facilities, and organizing commercial operations to market the PreTRM test.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Liquidity and Capital Resources</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has incurred net losses and negative cash flows from operations since inception and had an accumulated deficit of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_238c4f53-cb95-458f-945e-52e8c56979c4" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="6" decimals="-5" sign="-" format="ixt:num-dot-decimal">279.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> as of December 31, 2024. The Company&#8217;s management expects the Company to incur significant additional operating losses and negative cash flows for the foreseeable future, principally as a result of the Company&#8217;s activities relating to the PreTRM test and the Company&#8217;s other pipeline products and services, including clinical and preclinical trials and anticipated research and development activities as well as commercialization activities. There can be no assurance that the Company will eventually achieve significant revenues or profitability to sustain operations, or if achieved, can sustain either on a continuing basis. If the Company is unable to achieve significant revenues or raise additional funds, when needed, it may not be able to continue the development or commercialization of its products and services and could be required to delay, scale back, or abandon some or all of its operations. No assurance can be given that the Company will be successful in raising the required capital on reasonable terms and at the required times, or at all.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In August 2024, the Company filed a universal shelf registration on Form S-3 with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;), which was declared effective on August 13, 2024 (the &#8220;2024 Form S-3&#8221;), pursuant to which the Company registered for sale up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_33baed85-f99e-440f-8620-f148fed17765" contextRef="C_b7b69a92-c42e-4043-8b6b-6e1b509663d8" name="sera:AmountFromSaleOfCombinationOfSecuritiesUnderShelfRegistration" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">100.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of any combination of Class A common stock, par value $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c26c443a-186c-4992-a40a-2e40796a2650" contextRef="C_84137556-2fb3-4bc3-987b-4443923c3d54" name="us-gaap:CommonStockNoParValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.0001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share ("Class A common stock"), preferred stock, debt securities, warrants, rights and/or units from time to time and at prices and on terms that the Company may determine.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In August 2024, the Company entered into a sales agreement with TD Securities (USA) LLC (&#8220;TD Cowen&#8221;) with respect to an at-the-market offering program under which the Company may offer and sell, from time to time at the Company&#8217;s sole discretion, shares of Class A common stock having an aggregate offering price of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1f282820-7a4d-4b90-a819-c67688a17872" contextRef="C_b020dd07-c5cb-461b-9677-a054282faf68" name="sera:AggregateOfferingPriceFromSaleOfCommonStock" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">50.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million (the &#8220;2024 Sales Agreement&#8221;). As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company has </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d9e13839-2ce7-482b-a931-597509e5c105" contextRef="C_d8ac3adc-d2c5-4821-b662-56b9921fc31c" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t sold any shares of Class A common stock under the 2024 Sales Agreement.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any additional equity financing, if available to the Company, may not be available on favorable terms and may be dilutive to current stockholders, and any debt financing, if available, may involve restrictive covenants and dilutive financing instruments. The Company&#8217;s future operations are highly dependent on a combination of factors, including (i) the commercialization and market acceptance of the PreTRM test and the successful development, commercial launch, marketing, and distribution of other pipeline products and services; (ii) the success of scientific and clinical studies and other research and development programs that support current and future products and services; (iii) the development of competitive products by other biotechnology and laboratory companies; (iv) the Company&#8217;s ability to manage growth of the organization; (v) the Company&#8217;s ability to protect its intellectual property, technology, and products; and, ultimately (vi) the timely and successful completion of any additional financing.</span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">104</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_e54bf638-8466-4714-9b2a-0227f410ee4b_1"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The principal sources of the Company&#8217;s working capital to date have been the proceeds from the sale and issuance of convertible preferred stock and convertible notes, bank loans, and the sale and issuance of Class A common stock in an initial public offering (&#8220;IPO&#8221;), which was completed in July 2021. As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company had aggregate cash, cash equivalents, and available-for-sale securities of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_102d4b24-21fe-467b-b48c-300749838e69" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">68.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. See Note 3&#8212;Cash, Cash Equivalents and Marketable Securities.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company evaluated that its existing financial resources are sufficient to continue operating activities at least 12 months from the issuance date of these financial statements.</span></p></ix:continuation></div>
  <div><ix:nonNumeric id="F_0607dae5-555c-4cad-9229-0c8f57e84399" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:SignificantAccountingPoliciesTextBlock" escape="true" continuedAt="F_0607dae5-555c-4cad-9229-0c8f57e84399_1"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Significant Accounting Policies</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ce810c1f-34b9-44ac-8c3a-752fca0e983f" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Basis of Presentation</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;). Any reference in these notes to applicable accounting guidance is meant to refer to the authoritative U.S. GAAP included in the Accounting Standards Codification (&#8220;ASC&#8221;), and Accounting Standards Updates (&#8220;ASU&#8221;) issued by the Financial Accounting Standards Board (&#8220;FASB&#8221;).</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a9a7491e-8746-46da-b958-20050144dc15" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:UseOfEstimates" escape="true"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The preparation of the financial statements in conformity with U.S. GAAP requires the Company&#8217;s management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The Company evaluates these estimates on an ongoing basis. The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that the Company believes are reasonable under the circumstances, including assumptions as to future events. Actual results could differ materially from those estimates.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s financial statements as of and for the year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> reflect the Company&#8217;s estimates of the impact of the current macroeconomic environment, including the impact of inflation and higher interest rates. The extent to which these conditions will directly or indirectly impact the Company&#8217;s business, results of operations, and financial condition is uncertain. The Company is not aware of any specific event or circumstance that would require an update to its estimates, judgments, and assumptions or a revision of the carrying value of the Company&#8217;s assets or liabilities as of the date of this filing.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e8f711d9-be45-453b-8334-72327f1c1360" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cash and cash equivalents</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company considers all highly liquid financial instruments with maturities of 90 days or less at the date of purchase to be cash equivalents. The carrying amounts reported in the balance sheets for cash and cash equivalents are valued at cost, which approximates their fair value. As of December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, cash and cash equivalents consisted of cash and money market funds. Cash and cash equivalents are stated at fair value.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e3a62bdc-8122-4be1-a8c2-58cb4228111d" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:MarketableSecuritiesPolicy" escape="true"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Marketable Securities</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has classified its marketable securities, all of which are debt securities, as available-for-sale securities. These securities are carried at estimated fair value. Available-for-sale debt securities with an estimated fair value below the amortized cost basis are assessed to determine what amount of that difference, if any, is attributable to expected credit losses. An allowance for credit losses on available-for-sale debt securities is recognized as a charge in other income, net on the Company&#8217;s statements of operations and comprehensive loss, and any remaining unrealized losses, net of the related tax effect, are included in accumulated other comprehensive loss in stockholders&#8217; equity until realized. Gains and losses on marketable security transactions are reported on the specific-identification method.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p></ix:nonNumeric></div><div><ix:nonNumeric id="F_96ee8c78-670f-41dc-aac5-4535e45a4267" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:ConcentrationRiskCreditRisk" escape="true" continuedAt="F_96ee8c78-670f-41dc-aac5-4535e45a4267_1"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Concentration of credit risk</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and marketable securities. The Company maintains bank deposits in accounts at federally insured financial institutions and these deposits may exceed federally insured limits. The Company is exposed to credit risk in the event of default by the financial institution holding its cash to the extent recorded in the balance sheet. The Company has not experienced any losses on its deposits of cash. The Company&#8217;s cash equivalents consist of money market funds and investment grade commercial paper. Marketable securities consist of investments in U.S. government securities, U.S. federal</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">105</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_0607dae5-555c-4cad-9229-0c8f57e84399_1" continuedAt="F_0607dae5-555c-4cad-9229-0c8f57e84399_2"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_96ee8c78-670f-41dc-aac5-4535e45a4267_1"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">agency securities, investment grade commercial paper, and investment grade corporate securities. The Company&#8217;s investment portfolio in corporate debt securities is highly liquid and diversified among individual issuers. The Company did not experience any credit losses related to its investment portfolio for the years ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p></ix:continuation></div><div><ix:nonNumeric id="F_20b98139-53a4-4a3a-959c-15d6049539cd" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Property and Equipment</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Property and equipment are recorded at cost less accumulated depreciation and amortization. Depreciation and amortization are computed using the straight-line method over the shorter of estimated useful lives of the assets or the respective lease term.</span><span style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_254e9cb3-a7ff-45f7-86e0-cabd2cd16956" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="sera:ScheduleOfEstimatedUsefulLifeOfEachAssetCategoryTableTextBlock" escape="true" continuedAt="F_254e9cb3-a7ff-45f7-86e0-cabd2cd16956_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The estimated useful life of each asset category is as follows:</span></ix:nonNumeric></span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:continuation id="F_254e9cb3-a7ff-45f7-86e0-cabd2cd16956_1"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
        <table style="border-spacing:0;table-layout:auto;width:98.0%;border-collapse:separate;">
         <tr style="visibility:collapse;">
          <td style="width:50.46%;box-sizing:content-box;"/>
          <td style="width:49.54%;box-sizing:content-box;"/>
         </tr>
         <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Computer equipment</span></p></td>
          <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span><ix:nonNumeric id="F_91972586-101b-427b-8ec9-cc58fd01a955" contextRef="C_a3f22057-cfb4-4d74-a910-d271c95221d1" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Software</span></p></td>
          <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span><ix:nonNumeric id="F_9cd086db-1a1b-4a24-b3a7-27ab41cb2a81" contextRef="C_1d2ae6de-1a53-435d-93ea-e493cb1853b9" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Machinery and equipment</span></p></td>
          <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span><ix:nonNumeric id="F_3ecdae4f-beae-4b85-a40a-a039654dc0d0" contextRef="C_1928429d-8377-45e6-a6ab-694d0e5a190a" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Furniture and fixtures</span></p></td>
          <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span><ix:nonNumeric id="F_f8d60565-c7da-4fdc-876f-284207ab8d23" contextRef="C_caa15026-25b9-4c02-9ea0-d4206fb85094" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Leasehold improvements</span></p></td>
          <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shorter of useful life or remaining lease term</span></p></td>
         </tr>
        </table></ix:continuation></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Amortization expense of assets acquired through finance leases is included in depreciation and amortization expense in the accompanying statements of operations and comprehensive loss. Costs of repairs and maintenance that do not extend the useful life or improve the related assets are expensed as incurred. Costs of major replacements or improvements are capitalized. When assets are sold, or otherwise disposed of, the cost and related accumulated depreciation are removed from the accounts and any gain or loss is included in operating expense.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c69935b8-25c5-4c36-ad5b-ca1bc86c5e0e" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:LesseeLeasesPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Leases</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s operating lease relates to office and laboratory space at its headquarters. The Company&#8217;s finance leases are for certain equipment related to the Company&#8217;s information technology infrastructure and laboratory operations. The Company determines if an arrangement is a lease at inception. The Company has elected not to separate lease components from non-lease components for all classes of leased assets except for building leases.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company elected to treat leases with lease terms of 12 months or less as short-term leases. No right-of-use assets or lease liabilities are recognized for short-term leases. For leases with a lease term greater than 12 months, right-of-use assets and lease liabilities are recognized on the balance sheets at the commencement date based on the present value of the remaining lease payments and includes only payments that are fixed and determinable at commencement. The Company&#8217;s lease terms may include options to extend or terminate when it is reasonably certain that the Company will exercise such options.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To date, the rates implicit in the Company&#8217;s finance leases have been determinable, and the Company uses those rates to calculate the present value of its finance lease liabilities. The implicit rate in the Company&#8217;s operating lease is not readily determinable. As such, the Company uses its incremental borrowing rate to calculate the present value of its operating lease liabilities.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Operating lease costs are recognized on a straight-line basis over the lease terms. Finance lease assets are amortized on a straight-line basis over the shorter of the estimated useful lives of the assets or the lease terms.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f890e758-3a52-41c3-977e-3aeb1197206c" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:RevenueRecognitionDeferredRevenue" escape="true"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Deferred Revenue</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recognizes deferred revenue in accordance with ASC 606, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue from Contracts with Customers</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (&#8220;ASC 606&#8221;). Deferred revenue is recognized when a customer pays consideration, or the Company has a right to an amount of consideration that is unconditional before the Company transfers the good or service to the customer. The Company&#8217;s deferred revenue balance as of December 31, 2024 and 2023 relates to certain contractual minimum payments received by the Company as part of its commercial collaboration agreements. Deferred revenue is recognized as revenue when the Company delivers PreTRM test results to customers pursuant to its commercial collaboration agreements. The Company assesses its deferred revenue balance for current versus long-term classification based on expectations and the ability to meet performance obligations. As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company believes it has the ability and capacity to meet all performance obligations under its commercial collaboration agreements and has concluded to classify its deferred revenue as a current asset.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p></ix:nonNumeric></div></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">106</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_0607dae5-555c-4cad-9229-0c8f57e84399_2" continuedAt="F_0607dae5-555c-4cad-9229-0c8f57e84399_3"><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7ff3e80f-7f9e-4ae3-9774-e918f18a2060" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue Recognition</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Revenue is generated from the sale of PreTRM tests. The Company recognizes revenue based on accounting standards applied to determine the measurement of revenue and timing of when it is recognized. The Company applies the following five-step approach as set forth under ASC 606: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the Company satisfies a performance obligation. The Company applies the five-step model when it is probable that the Company will collect the consideration it is entitled to in exchange for fulfilling its performance obligation. The Company recognizes revenue upon delivery of test results, which it considers to be the only performance obligation, and allocates all of the transaction price to this performance obligation.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In determining the transaction price, which is an estimate of the amount of variable consideration expected to be received, the Company uses the expected value method under ASC 606. The Company considers all reasonably available information to identify various possible consideration amounts and considers the probability of the variable consideration for each scenario. The Company&#8217;s estimate of transaction price does not include any estimated amount of variable consideration that is constrained.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant judgments are required in determining the estimates for each transaction. These estimates include many assumptions, any of which, if incorrect, could result in significant differences between the estimated price and the amount ultimately collected for any given transaction. The Company applies this method consistently to portfolios of similar contracts when estimating the effect of any uncertainty on the amount of variable consideration to which it will be entitled. In the aggregate, across the numerous transactions within each portfolio, these differences can lead to material variances between estimated and actual revenue in any given period.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The estimate of revenue is necessarily founded on assumptions of payer behavior such as changes in payer mix, payer collections, current customer contractual requirements, and experience with ultimate collection from third-party payers and patients. Each of these aspects of payer behavior (and various others) can change significantly from period to period, and the Company currently has limited experience with historical payment patterns. Each of these contributes to the potential variability between estimated transaction price and actual consideration received as discussed above, which is expected to be more pronounced early in the process of commercializing a diagnostic test.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company makes its best efforts to continually refine its estimates of expected consideration as the Company gains additional experience with collections and historical payment patterns. Accordingly, the Company may update its estimate of the amount of revenue to be recognized for previously delivered tests.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3be424e5-9461-4aed-b449-321da219f0e0" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:CostOfSalesPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cost of Revenue</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cost of revenue reflects the aggregate costs incurred in delivering the proteomic testing results to clinicians and includes expenses for third-party specimen collection and shipping costs, as well as the Company&#8217;s lab personnel, materials and supplies, equipment and infrastructure expenses associated with clinical testing, and allocated overhead including rent and equipment depreciation. Costs associated with performing the Company&#8217;s tests are recorded as the tests are processed regardless of whether and when revenue is recognized with respect to such tests.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2465e8d8-ce74-4892-bfb5-3f402e64a90b" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:ResearchAndDevelopmentExpensePolicy" escape="true"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Research and Development Expenses</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company expenses all research and development costs as they are incurred. Research and development expenses consist primarily of personnel costs, stock-based compensation charges, clinical trial costs, and third-party contracted services associated with research and development. The Company recognizes expense associated with third-party contracted services based on the completion of activities as specified in the applicable contracts. Costs incurred under contracts with clinical sites are generally accrued as patient encounters occur, consistent with the terms outlined in the associated contract. Upon termination of contracts with third parties, the Company&#8217;s obligations are limited to costs incurred or committed to date. As a result, accrued research and development expenses represent the estimated contractual liability to third parties at the reported period.</span></p></ix:nonNumeric></div><div><ix:nonNumeric id="F_1a3b37dd-ffad-454f-acbe-710791a911de" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" escape="true" continuedAt="F_1a3b37dd-ffad-454f-acbe-710791a911de_1"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock-based Compensation</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recognizes stock-based compensation for all stock-based awards in accordance with ASC 718, C</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">ompensation-Stock Compensation</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, which requires an entity to measure the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award.</span></p></ix:nonNumeric></div></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">107</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_0607dae5-555c-4cad-9229-0c8f57e84399_3" continuedAt="F_0607dae5-555c-4cad-9229-0c8f57e84399_4"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_1a3b37dd-ffad-454f-acbe-710791a911de_1"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair value of restricted stock units granted under the Company&#8217;s equity incentive plans is measured based on the grant-date fair value of the Company&#8217;s Class A common stock.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair value of stock options granted under the Company&#8217;s equity incentive plans is estimated using the Black-Scholes option pricing model. Input assumptions used in calculating the fair value of stock options represent management&#8217;s estimates and involve inherent uncertainties and the application of management&#8217;s judgment. These input assumptions include the expected term of the awards, the expected common stock price volatility over the term of the awards, risk-free interest rates, and the expected dividend yield.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair value of the Company&#8217;s Class A common stock is determined by using the closing price per share of the Company&#8217;s Class A common stock as reported on Nasdaq. The Company uses the simplified calculation of expected life since the Company does not have sufficient historical exercise data to estimate the expected term. Volatility is based on an average of the historical volatility of the Company&#8217;s common stock and the volatilities of the common stock of select comparable publicly-traded entities with characteristics similar to those of the Company. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods corresponding with the expected life of the option. Forfeitures are estimated at the time of grant based on the Company&#8217;s historical experience and are adjusted as necessary.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair value of equity awards is recognized as compensation cost on a straight-line basis by the Company over the participant&#8217;s requisite service period, which is the award&#8217;s vesting period. All stock-based compensation costs are classified in the statements of operations and comprehensive loss based upon the underlying participant&#8217;s role within the Company.</span></p></ix:continuation></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_73e16ad1-f981-4dfa-9c44-cdc7f59b4ddd" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:IncomeTaxPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recognizes deferred tax assets to the extent that it believes these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If the Company determines that it would be able to realize its deferred tax assets in the future in excess of their net recorded amount, the Company would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company records uncertain tax positions in accordance with ASC 740 on the basis of a two-step process whereby (1) it determines whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, it recognizes the largest amount of tax benefit that is more than 50 percent likely to be realized upon ultimate settlement with the related tax authority.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recognizes interest and penalties related to unrecognized tax benefits within the income tax expense line in the accompanying statements of operations and comprehensive loss. Any accrued interest and penalties related to uncertain tax positions will be reflected as a liability in the balance sheets.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e4727564-7c9b-4577-a5bf-093899fbce7e" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:PostemploymentBenefitPlansPolicy" escape="true"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Retirement Savings Plan</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company sponsors a safe harbor 401(k) plan that covers all of the Company&#8217;s eligible employees. The plan allows employees to make contributions up to a specified percentage of their compensation, subject to statutory limitations. The Company makes safe harbor matching contributions equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_badefe53-69a1-4d6e-80e6-2e338a25d342" contextRef="C_4066f0e7-4d45-4120-9721-5f25ca3c40f2" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">100</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the first </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c7752def-10ff-43e0-ab4b-21551246b678" contextRef="C_4066f0e7-4d45-4120-9721-5f25ca3c40f2" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of a plan participant&#8217;s eligible compensation, plus </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_28fcc7c3-9355-4f9d-b396-6cdbf55ab342" contextRef="C_958742c3-77d5-4074-ba9f-54937420e759" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">50</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the next </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8e730684-7c1a-4585-b361-61e8c6a15bb8" contextRef="C_958742c3-77d5-4074-ba9f-54937420e759" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of a plan participant&#8217;s eligible compensation. The Company may also make an additional discretionary match or profit sharing contribution to the plan. The Company recorded expense related to its 401(k) plan of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dbcc892b-c993-4c0b-bba7-d84ff9d15fb6" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:DefinedContributionPlanCostRecognized" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_17beaaa8-e201-43ab-b2df-c0a179ca5b8f" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:DefinedContributionPlanCostRecognized" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for the years ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">108</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_0607dae5-555c-4cad-9229-0c8f57e84399_4" continuedAt="F_0607dae5-555c-4cad-9229-0c8f57e84399_5"><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_36bca3f1-fe25-4c4e-af02-b92f545f912e" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Segments</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company operates as </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0c67911e-f28e-48fc-a367-682e4073a2ec" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:NumberOfOperatingSegments" unitRef="U_Segment" decimals="INF" format="ixt-sec:numwordsen">one</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> operating segment, which is developing and commercializing its medical diagnostic products and services. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e33153f7-b723-4e6a-826b-d750e993fbec" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s Chief Operating Decision Maker ("CODM"), its </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_78f058f5-e77e-4f42-8f14-9e5f77a00420;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">chief executive officer</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, assesses performance for the Company&#8217;s one operating segment and allocates resources based on net loss, consistent with what is reported on the statements of operations and comprehensive loss. The CODM also assesses the performance of the Company&#8217;s one operating segment by using operating expenses to monitor budget versus actual results.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Improvements to Reportable Segments Disclosures</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, which updates reportable segment disclosure requirements primarily through enhanced disclosures about significant segment expenses. While ASU 2023-07 requires incremental disclosures, it does not change how an entity identifies its operating segments, aggregates those operating segments, or applies the quantitative thresholds to determine reportable segments. This ASU is effective for all public business entities for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Entities must adopt the changes to the segment reporting guidance on a retrospective basis. The Company </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e2c5baab-3b70-4e09-8168-ac1e34971330" contextRef="C_20e6caf7-a789-4725-a954-593c6c8d5ceb" name="us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">adopted</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> this standard effective </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1ff67354-b7bb-4252-a647-cecd6451cc60" contextRef="C_20e6caf7-a789-4725-a954-593c6c8d5ceb" name="us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">January 1, 2024</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and retrospectively to all prior periods. The adoption impacted the Company's disclosures and did </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ea0a1cd2-1cb8-4ca4-a62a-873c66ceb10b" contextRef="C_20e6caf7-a789-4725-a954-593c6c8d5ceb" name="us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">not</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> impact the financial statements. See Note </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">16 &#8212; Segment Information</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, for disclosures related to the Company&#8217;s single operating segment.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1f55bf83-e39a-424c-af1b-6f4ba72644e4" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Comprehensive Loss</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Comprehensive loss consists of net loss and other gains and losses affecting stockholders&#8217; equity that, under U.S. GAAP, are excluded from net loss. For the years ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, comprehensive loss includes unrealized gains (losses) on the Company&#8217;s available-for-sale debt securities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2ec1ec6b-4335-4a28-b0c4-f69fa878d5a2" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:EarningsPerSharePolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Net Loss per Share</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basic net loss per share is calculated by dividing net loss by the weighted-average number of shares of common stock outstanding for the period, without consideration of potentially dilutive securities. Diluted net loss per share is computed by dividing net loss by the weighted-average number of shares of common stock and potentially dilutive securities outstanding for the period. For purposes of the diluted net loss per share calculation, stock options and warrants to purchase common stock are considered to be potentially dilutive securities. For periods in which the Company reports a net loss, all potentially dilutive shares are anti-dilutive and are therefore excluded from the calculation of diluted net loss per share.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has two classes of common stock and calculates net loss per share using the two-class method. The rights, including the liquidation and dividend rights, of the holders of the Company&#8217;s Class A and Class B common stock are identical, except with respect to voting and conversion. The undistributed earnings for each period are allocated based on the contractual participation rights of the Class A and Class B common shares as if the earnings for the period had been distributed. As the liquidation and dividend rights are identical, the undistributed earnings are allocated on a proportionate basis and the resulting amount per share for Class A and Class B common stock was the same for the years ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_fb42a72c-bd34-47a7-8f2e-0e0d0a4c343f" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recently Issued Accounting Pronouncements Not Yet Adopted</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In December 2023, the FASB issued ASU 2023-09, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes (Topic 740): Improvements to Income Tax Disclosures</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, which is intended to improve the transparency of income tax disclosures by requiring consistent categories and greater disaggregation of information in the effective tax rate reconciliation and income taxes paid by jurisdiction. The ASU is effective for public business entities&#8217; annual periods beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of adopting this guidance on its financial statements.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2024, the FASB issued Accounting Standards Update No. 2024-03, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (ASC Subtopic 220-40) - Disaggregation of Income Statement Expenses</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, which enhances the transparency and comparability of financial statements by requiring companies to disclose more granular information about expense components. The guidance is effective for annual periods beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the potential impact of adopting this new guidance on its financials statements and related disclosures.</span></p></ix:nonNumeric></div></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">109</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_0607dae5-555c-4cad-9229-0c8f57e84399_5"><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_844f33c9-20da-4a27-8815-97830643e9e0" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="sera:EmergingGrowthCompanyStatusPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Emerging Growth Company Status</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;). Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards until such time as those standards apply to private companies. The Company has elected to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date that it is (a) no longer an emerging growth company or (b) affirmatively and irrevocably opt out of the extended transition period provided in the JOBS Act. As a result, these financial statements may not be comparable to companies that comply with the new or revised accounting pronouncements as of public company effective dates.</span></p></ix:nonNumeric></div></ix:continuation></div>
  <div><ix:nonNumeric id="F_d160e401-0b6c-4619-9740-13ef1e424934" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock" escape="true" continuedAt="F_d160e401-0b6c-4619-9740-13ef1e424934_1"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="section34"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash, Cash Equivalents and Marketable Securities</span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_241f92cb-721f-4214-a9b8-7c504967d84e" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has classified its marketable securities as available-for-sale. The Company&#8217;s cash, cash equivalents and marketable securities by major security type as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 were as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:42.137%;box-sizing:content-box;"/>
        <td style="width:1.421%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:11.044%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.421%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:11.044%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.421%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:11.044%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.421%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:11.044%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amortized Cost</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gross Unrealized Gains</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gross Unrealized Losses</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2c871f5d-1b39-4c1c-bc08-866da0188941" contextRef="C_49022522-db49-4ec2-87f5-e2146f11c06f" name="sera:CashAndCashEquivalentsAmortizedCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,983</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d88a84a6-0b80-411c-abde-362e50d32a5e" contextRef="C_49022522-db49-4ec2-87f5-e2146f11c06f" name="sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cc2d59dc-35d5-4d8e-bf24-24836c8d5362" contextRef="C_49022522-db49-4ec2-87f5-e2146f11c06f" name="sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b84c9bf7-f7a1-4ad7-9b9c-ea8c44b5276c" contextRef="C_49022522-db49-4ec2-87f5-e2146f11c06f" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,983</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dbe93419-2450-499e-9c9f-9640f83bea49" contextRef="C_c35d80b0-e824-4576-b648-1c68918bb474" name="sera:CashAndCashEquivalentsAmortizedCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,060</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f1825818-c20c-4394-afdf-bee6ff72d604" contextRef="C_c35d80b0-e824-4576-b648-1c68918bb474" name="sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ad0fbb6e-144d-49fc-9b18-65b06192a84b" contextRef="C_c35d80b0-e824-4576-b648-1c68918bb474" name="sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_121ce6d6-5567-4495-996d-0d4203229be8" contextRef="C_c35d80b0-e824-4576-b648-1c68918bb474" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,060</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total cash and cash equivalents</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b3afbc89-f145-4601-bd1f-eb7883c06a5e" contextRef="C_5c263358-4220-4048-b609-a9b779332d4c" name="sera:CashAndCashEquivalentsAmortizedCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,043</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7ac21e18-6003-4bda-9d49-0e546def8223" contextRef="C_5c263358-4220-4048-b609-a9b779332d4c" name="sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f946eaf5-bc96-4fd4-a35a-b5ec392c3ff0" contextRef="C_5c263358-4220-4048-b609-a9b779332d4c" name="sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1e5564ab-8ffb-46d7-95d4-c75ee774d4c5" contextRef="C_5c263358-4220-4048-b609-a9b779332d4c" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,043</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current marketable securities:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_85f6a0c9-add3-4763-adb0-4c3419247a25" contextRef="C_41343767-6b2c-42a9-a746-3a9c961b2efb" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,449</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b3468057-9ce7-433c-9b0a-50ac46fd9057" contextRef="C_41343767-6b2c-42a9-a746-3a9c961b2efb" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c7d8c7f4-b50d-44ea-85ec-8e66a96ad046" contextRef="C_41343767-6b2c-42a9-a746-3a9c961b2efb" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_30c04b6f-ac77-424c-8912-b857e406f0cc" contextRef="C_41343767-6b2c-42a9-a746-3a9c961b2efb" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,446</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_069fd1b7-05bc-4cd6-bbf2-3424fcc80371" contextRef="C_02e513ef-eb63-431b-a54e-7db176d6f3b0" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26,701</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7e8ef983-95bc-492f-93a0-209448ff0624" contextRef="C_02e513ef-eb63-431b-a54e-7db176d6f3b0" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">84</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5b3b7028-816f-4e06-ab04-a74f03834a62" contextRef="C_02e513ef-eb63-431b-a54e-7db176d6f3b0" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8211;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d9814207-1af4-4b61-838f-2353c7796ebe" contextRef="C_02e513ef-eb63-431b-a54e-7db176d6f3b0" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26,785</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. federal agency securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9f92ba4c-41d7-4c75-8e9e-1bf0df6ddc5d" contextRef="C_05252941-47eb-419d-ad91-9a0440a3d146" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,453</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_146e8f4c-a1b7-4933-b0a3-108de4abe69d" contextRef="C_05252941-47eb-419d-ad91-9a0440a3d146" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_aea680b9-fb5d-4735-91fa-94d9a50cdbd6" contextRef="C_05252941-47eb-419d-ad91-9a0440a3d146" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_12f30ed0-956c-4b3a-9fe2-328a2668d8a8" contextRef="C_05252941-47eb-419d-ad91-9a0440a3d146" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,459</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_539f14c9-517d-4c38-baca-d8319807f9bc" contextRef="C_ca338088-ae30-4c78-a94a-8fc204241aa6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,502</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6dc08813-b3a1-456a-a67a-8c48e2f8dd28" contextRef="C_ca338088-ae30-4c78-a94a-8fc204241aa6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_951e5c88-0b3d-4c40-be15-1dc76e792901" contextRef="C_ca338088-ae30-4c78-a94a-8fc204241aa6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8211;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ece2c848-dee5-4317-9102-cc7ac10990ca" contextRef="C_ca338088-ae30-4c78-a94a-8fc204241aa6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,503</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current marketable securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_677a27dc-d822-4ef9-9792-993a00594a16" contextRef="C_8dc4e1a7-bd95-4cb8-aa85-12c3382baabd" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">42,105</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_28526a02-9d91-4d0a-85c4-b8eabd99cd5f" contextRef="C_8dc4e1a7-bd95-4cb8-aa85-12c3382baabd" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">93</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b28bdf65-970a-4780-a201-bf40618b8c38" contextRef="C_8dc4e1a7-bd95-4cb8-aa85-12c3382baabd" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6998ec1d-09a7-4614-84d1-f75c75618fda" contextRef="C_8dc4e1a7-bd95-4cb8-aa85-12c3382baabd" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">42,193</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Long-term marketable securities:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1fc0b05d-1366-444b-baad-7b97957da409" contextRef="C_e8115fc4-0d0a-4b48-968a-84b5f89677cc" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,066</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c75893b3-b1ec-47ad-885e-060abc031a82" contextRef="C_e8115fc4-0d0a-4b48-968a-84b5f89677cc" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">36</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8a4f74e6-a447-47bb-969e-1e18ca7c4d07" contextRef="C_e8115fc4-0d0a-4b48-968a-84b5f89677cc" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8e4cd624-548a-4619-b883-860124993489" contextRef="C_e8115fc4-0d0a-4b48-968a-84b5f89677cc" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,097</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Municipal debt securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8a4b2158-8667-4163-b5c2-8fb148785a9f" contextRef="C_a1e8075a-0b21-49e0-992e-366ff149e4be" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,072</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_37aa2a2c-f945-4767-8e6c-71d726f6ecdf" contextRef="C_a1e8075a-0b21-49e0-992e-366ff149e4be" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bfb3abf5-e965-4f7b-bea8-a4defb26298e" contextRef="C_a1e8075a-0b21-49e0-992e-366ff149e4be" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7057f39a-30cd-4a98-8c2c-68aaef94f08b" contextRef="C_a1e8075a-0b21-49e0-992e-366ff149e4be" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,072</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. federal agency securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f463734f-2bf0-4b9c-b1e7-28df48473949" contextRef="C_6926825c-e381-4fc0-8ca5-c547d26c00af" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,863</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_54f30270-290e-466f-8fef-1e0e5e66c55f" contextRef="C_6926825c-e381-4fc0-8ca5-c547d26c00af" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ef70ee04-5646-459b-984a-b85ebdfc7f5d" contextRef="C_6926825c-e381-4fc0-8ca5-c547d26c00af" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">59</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_95a76028-f8bc-4ff0-9e57-1b25bc7e3496" contextRef="C_6926825c-e381-4fc0-8ca5-c547d26c00af" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,804</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total long-term marketable securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cdccc645-1aba-4f2a-8ff7-c3a9f3f22588" contextRef="C_fff4f4f8-fdc0-4e2f-8c2d-857db712f284" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22,001</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b6fa5e25-0f4d-4225-8358-e4bcd4ee1fc8" contextRef="C_fff4f4f8-fdc0-4e2f-8c2d-857db712f284" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">36</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_008d310b-fb73-4b3e-93aa-706e38a99e7b" contextRef="C_fff4f4f8-fdc0-4e2f-8c2d-857db712f284" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">64</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c74fe402-7a76-41b3-92e5-e9a6d0395a8d" contextRef="C_fff4f4f8-fdc0-4e2f-8c2d-857db712f284" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,973</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total cash, cash equivalents and marketable<br/>&#160;&#160;&#160;securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6a6b3b35-4bc5-4240-8409-1eb40ee8f82f" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">68,149</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b4d75e41-d704-4f4b-957e-42d5bad77da8" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">129</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_24f52198-c615-4d2b-841d-e283583a2d66" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">69</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bd46c95c-3f48-4dff-9d04-3dca7e46c789" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">68,209</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:42.137%;box-sizing:content-box;"/>
        <td style="width:1.421%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:11.044%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.421%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:11.044%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.421%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:11.044%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.421%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:11.044%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amortized Cost</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gross Unrealized Gains</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gross Unrealized Losses</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e5261b47-4b56-43e9-8339-5de01ac2ce95" contextRef="C_81d045e5-217b-44a8-91f1-c06381b7f02f" name="sera:CashAndCashEquivalentsAmortizedCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,608</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7f42fc4c-a9dc-4a58-8c51-d7c7d9d76a4c" contextRef="C_81d045e5-217b-44a8-91f1-c06381b7f02f" name="sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e4027ac1-693b-4054-9f0d-dee427b8302e" contextRef="C_81d045e5-217b-44a8-91f1-c06381b7f02f" name="sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ece325bf-5766-410a-b652-2c17b3dd6a46" contextRef="C_81d045e5-217b-44a8-91f1-c06381b7f02f" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,608</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c748b3a9-ba23-4dcf-89a1-40afa5ece5f3" contextRef="C_eac6e522-39b5-4d4e-9e0f-de03dd6c55f5" name="sera:CashAndCashEquivalentsAmortizedCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,272</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d5e1285c-5e83-4afe-a742-2c83e974e712" contextRef="C_eac6e522-39b5-4d4e-9e0f-de03dd6c55f5" name="sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cdd7e54b-3fef-4e35-b268-58f8aeef9b00" contextRef="C_eac6e522-39b5-4d4e-9e0f-de03dd6c55f5" name="sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_831e7286-b777-4355-be29-589b5c400c33" contextRef="C_eac6e522-39b5-4d4e-9e0f-de03dd6c55f5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,272</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total cash and cash equivalents</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1658bdb0-9c5b-483c-823c-9ca06fe235a0" contextRef="C_04695d1b-8064-4772-b23e-9ee08052db28" name="sera:CashAndCashEquivalentsAmortizedCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,880</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5af1f620-287d-41ce-a396-671e3fc2dd5d" contextRef="C_04695d1b-8064-4772-b23e-9ee08052db28" name="sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ea0e1c89-275c-4e68-ae5c-506d8620eb96" contextRef="C_04695d1b-8064-4772-b23e-9ee08052db28" name="sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d6567c61-fe53-4002-9f10-7d7e9a5b50b3" contextRef="C_04695d1b-8064-4772-b23e-9ee08052db28" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,880</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current marketable securities:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bdbc613f-efa3-4b85-b024-80da6d89fa01" contextRef="C_4c8e016f-98b6-437d-bf3b-2afd8d1a2252" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,769</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a0112ae7-1e27-4a00-a0e0-65b8a0e52ec9" contextRef="C_4c8e016f-98b6-437d-bf3b-2afd8d1a2252" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e6101819-8e37-41b2-8edf-72257d22c23d" contextRef="C_4c8e016f-98b6-437d-bf3b-2afd8d1a2252" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5bbfdbae-700e-4e85-8076-b44fa5de3b3d" contextRef="C_4c8e016f-98b6-437d-bf3b-2afd8d1a2252" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,773</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0e892835-6362-40dc-a54a-05cdf93cb585" contextRef="C_e5d8bf32-01c3-478c-ac80-62dc4611786f" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,155</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a1e5fb90-41e3-4f3e-b96c-a08acf13f396" contextRef="C_e5d8bf32-01c3-478c-ac80-62dc4611786f" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8c69c182-84c4-4461-87d8-d5e3f1763445" contextRef="C_e5d8bf32-01c3-478c-ac80-62dc4611786f" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3b309d10-b010-409d-afbf-6585edd592f8" contextRef="C_e5d8bf32-01c3-478c-ac80-62dc4611786f" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,153</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. federal agency securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ee0e1dd2-07dc-44eb-ab32-4823813e6174" contextRef="C_638a878b-120b-4eee-b75c-90162633cf80" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,644</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ee8680b3-7497-4a5e-bc72-ac81fe83a316" contextRef="C_638a878b-120b-4eee-b75c-90162633cf80" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ca0325c4-2b78-4dab-8dc5-db23e27f3893" contextRef="C_638a878b-120b-4eee-b75c-90162633cf80" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">102</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_40985960-dc67-4aa2-80ca-adcab8c3464b" contextRef="C_638a878b-120b-4eee-b75c-90162633cf80" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,542</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1240cce2-bd56-4677-9701-c5db5b2dc1a5" contextRef="C_3b6bd3f1-4ef1-4f65-afbc-9caec8647ffa" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,812</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_24b83c2c-dbc0-4096-b960-bb4f449dd495" contextRef="C_3b6bd3f1-4ef1-4f65-afbc-9caec8647ffa" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_98f532aa-efc4-47f5-beac-e532d25ee3c9" contextRef="C_3b6bd3f1-4ef1-4f65-afbc-9caec8647ffa" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">81</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f7defe03-437f-402c-a21e-c4fb3f10b33e" contextRef="C_3b6bd3f1-4ef1-4f65-afbc-9caec8647ffa" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,731</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current marketable securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1af20f05-1068-438f-8fa3-3aab96f294f7" contextRef="C_5daf51f1-d84a-4a9b-8b05-31cbd8535172" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">45,380</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_774328b2-baf4-4d44-a34c-a6f2077cf86b" contextRef="C_5daf51f1-d84a-4a9b-8b05-31cbd8535172" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_24ac2beb-9a45-44ed-98e0-d202bebc898d" contextRef="C_5daf51f1-d84a-4a9b-8b05-31cbd8535172" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">187</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_18bec175-4249-4e4b-ba41-4d029b8a37e4" contextRef="C_5daf51f1-d84a-4a9b-8b05-31cbd8535172" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">45,199</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Long-term marketable securities:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. federal agency securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_208d75fc-75f2-42fb-87a4-a7dfba1fc9ec" contextRef="C_ee684bec-2a33-4dd4-bdbb-02595b796850" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,406</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_daefa73b-6633-4860-ae40-ed105b2fbbcf" contextRef="C_ee684bec-2a33-4dd4-bdbb-02595b796850" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">27</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d23f2d5b-77a7-4c80-ae17-626c2c44c02e" contextRef="C_ee684bec-2a33-4dd4-bdbb-02595b796850" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_11ab0326-2841-4d3e-86ae-da185a4c9d9b" contextRef="C_ee684bec-2a33-4dd4-bdbb-02595b796850" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,416</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_44ff14a0-f06d-4fed-aa83-36116c53308d" contextRef="C_762a6bec-dfb1-4943-9527-797ae4764d93" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,388</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_330747e3-3a10-4162-85dc-d425724df438" contextRef="C_762a6bec-dfb1-4943-9527-797ae4764d93" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d2d0e44b-22d3-4bd4-ab4d-b531bfac9e7d" contextRef="C_762a6bec-dfb1-4943-9527-797ae4764d93" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f774c012-dd50-4125-87b0-8e047d502780" contextRef="C_762a6bec-dfb1-4943-9527-797ae4764d93" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,386</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0e4ae9cd-5245-4b0f-8a17-d1490c582d38" contextRef="C_b105c69c-9306-46d2-b61c-acf709b3eb96" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,880</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4abdcd6e-5a6a-4e11-a1e6-8216b1ca1bad" contextRef="C_b105c69c-9306-46d2-b61c-acf709b3eb96" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">159</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eb3d1ce7-06ca-4d46-a144-bfee67a8fd94" contextRef="C_b105c69c-9306-46d2-b61c-acf709b3eb96" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_54ecdae0-a17c-46b5-89c8-3124da89d568" contextRef="C_b105c69c-9306-46d2-b61c-acf709b3eb96" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,039</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total long-term marketable securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4161107a-2bea-46a7-ad4e-290483809ebc" contextRef="C_5e807c43-ac3c-4c9f-8c9f-aa73f1509b36" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">30,674</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7343d866-0cac-4830-874f-d12c7cb96a04" contextRef="C_5e807c43-ac3c-4c9f-8c9f-aa73f1509b36" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">189</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_087a37d6-75c5-4f8f-bd60-52f07fd471f7" contextRef="C_5e807c43-ac3c-4c9f-8c9f-aa73f1509b36" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5d66a186-07d4-4639-986e-15bb52caf848" contextRef="C_5e807c43-ac3c-4c9f-8c9f-aa73f1509b36" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">30,841</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total cash, cash equivalents and marketable<br/>&#160;&#160;&#160;securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2b004d85-66b3-4d3a-b73c-991c5023e72f" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">79,934</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3c798ead-af9b-41a6-a9f2-575b4146735d" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">195</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bbe76a74-8778-461a-8db3-57debeb58237" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">209</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4ad91b02-3175-4c34-a2af-d3c1c7d63306" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">79,920</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">110</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_d160e401-0b6c-4619-9740-13ef1e424934_1"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_dcc1bb86-7c01-44ca-bc69-e3461c3e0487" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following tables summarize the Company&#8217;s available-for-sale debt securities and cash equivalents with unrealized losses as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023, aggregated by major security type and the length of time that individual securities have been in a continuous loss position (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:32.066%;box-sizing:content-box;"/>
        <td style="width:1.08%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:7.942%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.08%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:7.942%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.08%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:7.942%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.08%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:7.942%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.08%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:8.842%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.08%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:8.842%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="22" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Less than 12 months</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">12 months or greater</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized Losses</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized Losses</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized Losses</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_03bfcef2-153a-4585-b371-bc67c3205937" contextRef="C_dac51163-3c66-43ba-8012-e6571ccfbd56" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,446</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2cb8743f-37af-4944-bec7-09610391e7e0" contextRef="C_dac51163-3c66-43ba-8012-e6571ccfbd56" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_61c6f6d7-d57b-460c-8fb6-b9c3d23a7b65" contextRef="C_dac51163-3c66-43ba-8012-e6571ccfbd56" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_713c142d-5ccd-49f9-bcaf-42c94e8eff42" contextRef="C_dac51163-3c66-43ba-8012-e6571ccfbd56" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_01f1a87e-3d32-49b1-bed3-2b9b7865b75b" contextRef="C_dac51163-3c66-43ba-8012-e6571ccfbd56" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,446</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4d878524-9e5e-4a92-a305-80ecdad017d4" contextRef="C_dac51163-3c66-43ba-8012-e6571ccfbd56" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d2e98c8d-470e-4ca0-ae66-c2c46e32ab93" contextRef="C_ce3c3c85-8edf-485c-a7db-c348c7b6135c" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,059</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b2e1cb4f-3459-4f6a-93a3-87d28c7b38c5" contextRef="C_ce3c3c85-8edf-485c-a7db-c348c7b6135c" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d1995b08-8fac-454a-a1ce-db01db2d7ae4" contextRef="C_ce3c3c85-8edf-485c-a7db-c348c7b6135c" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a07ab0ef-3397-4a73-bdeb-275632da8ba2" contextRef="C_ce3c3c85-8edf-485c-a7db-c348c7b6135c" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7f55accc-7ccc-432e-8eb4-58dcc0314917" contextRef="C_ce3c3c85-8edf-485c-a7db-c348c7b6135c" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,059</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f340e4bf-39f3-4397-a307-72c1e7805f05" contextRef="C_ce3c3c85-8edf-485c-a7db-c348c7b6135c" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. federal agency securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2f6f55e3-da08-4464-b89b-9a2778689ef6" contextRef="C_8cc8bb60-d9e5-4087-a779-404d0c630ac2" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,804</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_43eda637-50a3-478a-9ae4-eaf21f51bebc" contextRef="C_8cc8bb60-d9e5-4087-a779-404d0c630ac2" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">59</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_01625950-58a7-4c2c-a87f-68226c43709b" contextRef="C_8cc8bb60-d9e5-4087-a779-404d0c630ac2" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,021</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_27b70d0a-f3a2-408c-b13c-97382575c9a4" contextRef="C_8cc8bb60-d9e5-4087-a779-404d0c630ac2" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_99044edd-3f0e-44e3-94e8-b17233c356a9" contextRef="C_8cc8bb60-d9e5-4087-a779-404d0c630ac2" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,825</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0c854f46-40f5-4ff8-9069-f31214ceed18" contextRef="C_8cc8bb60-d9e5-4087-a779-404d0c630ac2" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">61</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_833256b5-8de8-4e9c-9f90-cc5f78d406a7" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,309</ix:nonFraction></span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cdce33c3-cf9c-4f5e-ae29-fdd3c7d5f4dd" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">67</ix:nonFraction></span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0bbbb1f9-adb3-4e1a-bc8c-5468c65bd92c" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,021</ix:nonFraction></span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4f4c5e55-d322-4004-8bed-15610d455d44" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_67457e53-65b9-4cbc-9648-21e59d1e6bf5" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,330</ix:nonFraction></span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1a85ddc9-b166-4c89-b398-23795368853a" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">69</ix:nonFraction></span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:32.066%;box-sizing:content-box;"/>
        <td style="width:1.08%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:7.942%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.08%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:7.942%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.08%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:7.942%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.08%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:7.942%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.08%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:8.842%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.08%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:8.842%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="22" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Less than 12 months</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">12 months or greater</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized Losses</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized Losses</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized Losses</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c0634d7c-3207-4853-8940-1e7082e5b20f" contextRef="C_aa504e3e-c144-468e-9c38-a006e10b950c" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,453</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_89691ebe-533a-4b2e-9821-342a0c3ba78b" contextRef="C_aa504e3e-c144-468e-9c38-a006e10b950c" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0346c4f5-bac8-4ff3-9183-357108754bc2" contextRef="C_aa504e3e-c144-468e-9c38-a006e10b950c" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_82e0de90-b90d-4b99-bfe1-cd3f07a8c8bc" contextRef="C_aa504e3e-c144-468e-9c38-a006e10b950c" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ce38ef35-ae0a-46af-bc87-082fe148debd" contextRef="C_aa504e3e-c144-468e-9c38-a006e10b950c" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,453</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_309a3d00-02bd-4ffb-963c-92a899ce51a9" contextRef="C_aa504e3e-c144-468e-9c38-a006e10b950c" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5d000c02-dcbe-4d25-a424-67e1a68d15e9" contextRef="C_f2bfc23e-e300-4c03-89d2-d8604b93c026" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,153</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_26cad724-c05b-4519-80df-e0ddb6fb53da" contextRef="C_f2bfc23e-e300-4c03-89d2-d8604b93c026" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7202e4d0-6594-4204-91c8-72e98136c1e1" contextRef="C_f2bfc23e-e300-4c03-89d2-d8604b93c026" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7f1b2310-5a53-408c-baf4-ece592b60621" contextRef="C_f2bfc23e-e300-4c03-89d2-d8604b93c026" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cc27b044-58ba-4506-9e18-08894f0769ed" contextRef="C_f2bfc23e-e300-4c03-89d2-d8604b93c026" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,153</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_32576350-b5ff-4493-8e69-8b41619670f9" contextRef="C_f2bfc23e-e300-4c03-89d2-d8604b93c026" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. federal agency securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_14e23381-d4ee-4b99-92df-939b84481cb8" contextRef="C_bd4804da-dfef-46a4-bf86-8a1aff8a5a72" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,308</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fd362439-370a-4527-8e6e-a38e18236b64" contextRef="C_bd4804da-dfef-46a4-bf86-8a1aff8a5a72" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">52</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_df1d3cc6-e32c-40da-b80f-92704b1c94a6" contextRef="C_bd4804da-dfef-46a4-bf86-8a1aff8a5a72" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,751</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_58f74bab-c7c7-4b30-a795-f33706706669" contextRef="C_bd4804da-dfef-46a4-bf86-8a1aff8a5a72" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">67</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9026de99-7cb5-42dc-8668-1da793ff2e01" contextRef="C_bd4804da-dfef-46a4-bf86-8a1aff8a5a72" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,059</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_33eaec2c-700d-4e26-805d-7ab5b29b6bc0" contextRef="C_bd4804da-dfef-46a4-bf86-8a1aff8a5a72" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">119</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f0a191a3-ee99-4a7e-8413-408abbd92122" contextRef="C_a9e61099-b6f3-486b-b333-a0f9e6559dc9" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,769</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_00dd7bcc-48ea-4f83-9b39-3ce7738d9c22" contextRef="C_a9e61099-b6f3-486b-b333-a0f9e6559dc9" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e51da0f3-2ec9-45ba-a852-1dff9cd5aa49" contextRef="C_a9e61099-b6f3-486b-b333-a0f9e6559dc9" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,895</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_27a43c71-7c53-4d7e-869a-c92fbf3a333b" contextRef="C_a9e61099-b6f3-486b-b333-a0f9e6559dc9" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">73</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e665f067-a247-4a7a-ad1e-e0d8ff8a0510" contextRef="C_a9e61099-b6f3-486b-b333-a0f9e6559dc9" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,664</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7d0ed5b6-3f08-4b10-8a84-f2e3d1d74a8b" contextRef="C_a9e61099-b6f3-486b-b333-a0f9e6559dc9" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">86</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_940d7c9d-e311-45b6-96e2-37db046abd48" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26,683</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d1224de5-1615-4dcf-9bb4-4352268ce908" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">69</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5b73c4cc-23bd-443d-af47-45d658b88662" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,646</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b32cb1fd-6bc1-4527-bac1-bbdfa64e01cc" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">140</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_afceaed0-6bc8-4050-87d8-fc33b3e88adc" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">46,329</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6d813749-c915-43f2-b5b7-19a084978f67" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">209</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company had </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8e4cbc6e-443c-432a-a4ab-73ae17bf046c" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_f95be004-a9dc-4fb0-bd71-59e8e5d4e0f9" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t recorded any allowance for credit losses related to its available-for-sale securities. The Company attributes the declines in the fair value of its available-for-sale securities to normal market and interest rate fluctuations. The declines in fair value are not attributed to declines in credit quality. The Company does not intend to sell investments while they are in an unrealized loss position and does not believe that it is more likely than not that the Company will be required to sell the investments before recovery of their amortized cost basis, which may be maturity. All of the Company&#8217;s investments mature in less than three years.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2024, the Company received approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ae54dd3f-e161-42fd-a146-d30697903e0a" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in proceeds from the sale of available-for-sale securities prior to maturity. There was an immaterial amount of gross realized losses on the sales. The Company sold the securities in order to reinvest the funds at improved rates. The Company did not sell any available-for-sale securities prior to maturity during the year ended December 31, 2023.</span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_85c3f410-ccdf-4ab0-a1eb-3685e840b5b6" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" escape="true" continuedAt="F_85c3f410-ccdf-4ab0-a1eb-3685e840b5b6_1"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s marketable securities classified by contractual maturities as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 were as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:59.272%;box-sizing:content-box;"/>
        <td style="width:2%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:16.363%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:2%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:16.363%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amortized Cost</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Due within one year</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0c06e295-11e1-4826-8d0a-2140ac30eb9d" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">42,105</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2d905c93-a580-432f-b00e-3b5b6717fd6c" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">42,193</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Due after one year through five years</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4c6ffbbb-f04c-422f-882b-eeb857dd0e98" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22,001</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_388de662-5845-4420-80ee-1e71d70bf206" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,973</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_44cde81a-c5e6-4c58-add7-e72b9da8754c" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">64,106</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9ee47b8e-a573-43e1-b8e9-861e8de86fda" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">64,166</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:continuation></div>
  <div><ix:continuation id="F_85c3f410-ccdf-4ab0-a1eb-3685e840b5b6_1"></ix:continuation></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">111</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1b4dd2e9-bdec-4314-97c3-b7c2254ebd1e" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Property and Equipment</span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_decd56f5-12a7-4e86-996b-3f2f1ea44a93" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:PropertyPlantAndEquipmentTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table presents the components of property and equipment, net, as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:59.272%;box-sizing:content-box;"/>
        <td style="width:2%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:16.363%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:2%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:16.363%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Laboratory equipment</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b18871dd-be3a-4b8b-9a70-0144aa11446a" contextRef="C_161991af-bae7-4347-80d9-c0890d8f55a6" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,663</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_98b893b3-c934-44fa-9741-e6c8accb2f8c" contextRef="C_a1fba1e9-19c8-4131-8870-80ec56eace4a" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,734</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Computer equipment</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_74cf9fe9-bbfc-4028-a3b5-e0b96385c5d4" contextRef="C_a3f22057-cfb4-4d74-a910-d271c95221d1" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,099</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3a3f42d1-6103-44cc-b1ad-df198d1317d4" contextRef="C_275f65a9-d875-4114-9eef-facc7efca0e4" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,054</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Leasehold improvements</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_723d7be0-90ff-4bf9-95c2-f38571fff9b1" contextRef="C_ba06682c-931b-4d72-8219-fe9762cb8c51" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">772</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ce7f60b8-ee04-454f-9731-c42ed7052698" contextRef="C_1c9fd511-344f-4ec1-9e7e-971dfed29d81" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">772</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Software</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d6e1b7ad-45d9-4f54-96bf-98f219ae775a" contextRef="C_1d2ae6de-1a53-435d-93ea-e493cb1853b9" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,141</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7710a37d-2579-49d8-bc8e-9f55a90ba2ff" contextRef="C_428b350f-b950-4c70-b038-a16d2e148ef6" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,141</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Furniture and fixtures</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1d6bd3b9-d9a9-48a3-afaa-c7d476f9333c" contextRef="C_caa15026-25b9-4c02-9ea0-d4206fb85094" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">320</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a18b3018-d0f6-414d-a079-648f222c92a9" contextRef="C_9ec8a49d-6940-415c-bf39-e752664f6f55" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">320</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total property and equipment</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_054f640a-616b-48c6-a5df-d881c0d02a52" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,995</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_085118e7-709e-4d6e-9ff1-e241fde70fc1" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,021</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less accumulated depreciation and amortization</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_236f9a05-c0ea-402f-bdc9-5d9c52f89d8d" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,756</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_84522eba-72d2-4ce8-8cfe-5252df339494" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,022</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Property and equipment, net</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e6801eca-c150-411c-a312-e113af75b755" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,239</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7a6e81d0-caa4-4c37-b074-615390532083" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,999</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Depreciation and amortization expense was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e73a754d-f596-4c4e-b86e-5463c57210b7" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:DepreciationDepletionAndAmortization" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_624fe7bc-cd71-4a58-993a-e9bf2e5aac57" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:DepreciationDepletionAndAmortization" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for the years ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively.</span></p></ix:nonNumeric></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_554a43e1-cf82-4ca5-80fd-ec11a9b94521" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:IntangibleAssetsDisclosureTextBlock" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5. Intangible Assets, net</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_777cf1c3-96b8-461d-89a2-d862733cba5e" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes intangible assets (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:57.477%;box-sizing:content-box;"/>
        <td style="width:1.399%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:10.776%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.399%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:10.776%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.399%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:10.776%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gross Carrying Amount</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Accumulated Amortization</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Net Carrying Amount</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Indefinite-lived intangible assets:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Domain names</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e38b3c6e-7c4f-4038-91fc-5e2c18c7fae1" contextRef="C_67bb9b90-53de-4dc1-9ea3-fca6651bdf57" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">697</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ff921688-5d8f-417d-8cee-0d250c6465d2" contextRef="C_67bb9b90-53de-4dc1-9ea3-fca6651bdf57" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">697</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Definite-lived intangible assets:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Software developed for sale</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7539b478-ee09-416f-837d-cb9cfe66b7c0" contextRef="C_1d2ae6de-1a53-435d-93ea-e493cb1853b9" name="us-gaap:FiniteLivedIntangibleAssetsGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">348</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_db08757b-e41f-4bfb-b901-5adf887850c7" contextRef="C_1d2ae6de-1a53-435d-93ea-e493cb1853b9" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_767c57d3-f3d5-4f83-94cd-3857070b4d2c" contextRef="C_1d2ae6de-1a53-435d-93ea-e493cb1853b9" name="us-gaap:FiniteLivedIntangibleAssetsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">329</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total intangible assets</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2969e6eb-3fcb-48ce-979f-3a9980ac7eb9" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,045</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f77e96c7-e59a-4cbc-b410-cf2dd5794e13" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a34b2e8d-4d54-4bad-b159-0fb80468a7d0" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,026</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company acquired domain names resulting in capitalized intangible assets of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_48c3b726-9719-4bec-9ecf-7a838ec259a0" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="sera:CapitalizedIntangibleAssets" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The Company determined that the domain names have an indefinite useful life and are therefore not subject to amortization. The Company assesses its intangible assets for impairment annually, or more frequently if circumstances dictate. No indefinite-lived intangible asset impairment charges were recorded during the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company capitalized approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a5135ea3-dae4-485a-968d-6772cbe40b2e" contextRef="C_849392ea-c9bb-46ce-b852-5562b8505f07" name="sera:CapitalizedIntangibleAssets" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of costs associated with software developed for sale. The software was placed in service in November 2024 and is being amortized on a straight-line basis over a three-year useful life. Amortization expense was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8650bd0f-fe5e-469f-9c6d-3c278a0cff82" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:AmortizationOfIntangibleAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> thousand for the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, and is recorded in cost of revenue</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p></ix:nonNumeric></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_643cdbf2-b70f-4d6d-b088-508caffb731f" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" escape="true"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">6. Accrued and Other Current Liabilities</span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_cad49438-d783-416f-bc3a-3b2c84866f9d" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table presents the components of accrued and other current liabilities as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued compensation</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_aaf9f8c3-b0af-4ce3-a282-954b3a43037b" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:AccruedSalariesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,041</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dfa9d446-3df6-4486-89a2-a8c5e249a06f" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:AccruedSalariesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">779</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued vacation</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1f775213-5a3a-4220-9b06-35b0c2533ba0" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:AccruedVacationCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">403</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1324b308-f025-4b4c-be2d-3c977ee6230c" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:AccruedVacationCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">365</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued 401(k) matching contributions</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ab61965b-15b9-4a15-a9e0-7718416bd874" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:AccruedEmployeeBenefitsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1c441a64-05aa-4418-843c-cece0741d4d6" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:AccruedEmployeeBenefitsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">74</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease liability, current portion</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a5abbc00-c915-4115-acc0-7e9cd055b280" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">644</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6984c642-6e15-4494-ae19-eaa63a472a51" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">578</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other current liabilities</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2518d465-e41e-4250-8ddb-72b193ee2ed4" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:OtherAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">296</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4e915a12-c1f8-4f97-878c-8a5748171e5a" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:OtherAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">926</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total accrued and other current liabilities</span></p></td>
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ff55f0d2-42b7-4cf0-963d-3bf46b688004" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,384</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bf23ac63-0766-4267-a9b6-24cc2a444bcc" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,722</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">112</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4310fb03-31ca-477b-b1fa-ccf58dbb3ecf" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Other Income, Net</span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_895fa288-1eb4-4e23-9a14-b9be6a9f1a06" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table presents the components of other income, net, for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:68.094%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.123000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.66%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.123000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest income</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4f891b0e-f124-40fd-8a31-f1deaed8767d" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:InterestIncomeOther" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,747</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5f689409-daca-419c-8bfd-42146369ee9b" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:InterestIncomeOther" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,640</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Investment income, net</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_697ce95e-442e-45d2-965f-1722fc9d7ca4" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,018</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_411d7075-a1e1-4cdf-b9fa-66ad49a51e52" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,994</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other income, net</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d78d63a1-fef7-4ea8-9938-8b5b507e9476" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:NonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,765</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_86f6e268-c280-48d3-9b52-8f8f48be3a43" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:NonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,634</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div><ix:nonNumeric id="F_22bbe70b-f99a-4fcc-a343-d8efb931979b" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:FairValueDisclosuresTextBlock" escape="true" continuedAt="F_22bbe70b-f99a-4fcc-a343-d8efb931979b_1"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Fair Value Measurements</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024 and 2023, the carrying amounts of the Company&#8217;s receivables, prepaid and other current assets, accounts payable, and accrued and other current liabilities approximate their fair values, principally due to the short-term nature of the assets and liabilities. The recorded values of the finance leases approximate fair value as the interest rates approximate market interest rates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Money market funds are highly liquid investments and are actively traded. The pricing information on money market funds is readily available and can be independently validated as of the measurement date. This approach results in the classification of these securities as Level 1 of the fair value hierarchy.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">U.S. government agency bonds, U.S. government bonds, commercial paper, and corporate debt securities are measured at fair value using Level 2 inputs. The Company reviews trading activity and pricing for these investments as of each measurement date.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company follows a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. The three levels of the fair value hierarchy are as follows:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 1 inputs are observable, quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company can access at the measurement date.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 2 inputs are observable inputs other than quoted prices included in Level 1 that are observable either directly or indirectly or quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 3 inputs are unobservable inputs in which there is little or no market data, which require the Company to develop its own assumptions.</span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">113</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_22bbe70b-f99a-4fcc-a343-d8efb931979b_1"><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1b4b7268-ae71-47bb-b5e8-d4c3a94256bc" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" escape="true" continuedAt="F_1b4b7268-ae71-47bb-b5e8-d4c3a94256bc_1"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table shows the Company&#8217;s assets measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands) as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:57.477%;box-sizing:content-box;"/>
        <td style="width:1.399%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:10.776%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.399%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:10.776%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.399%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:10.776%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Assets:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash equivalents:</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e1925ac0-0140-4cf7-92e3-61e8ed4d204d" contextRef="C_7330604e-585d-4c2f-b88a-fa3bec9d68eb" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,060</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4ba174c6-bb30-4a8a-b4bb-f09adeb291e9" contextRef="C_18bf2f02-7c59-4b81-af8a-e4dee36352a3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3a9bcd4d-3cf6-4126-ac19-50b69715f6bc" contextRef="C_c1db559f-42af-47ed-b6d7-b2aa626db456" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Marketable securities:</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_67c9df9a-bc21-4bb4-b6f5-2301812c8a9e" contextRef="C_a0cb604e-1c55-4ed9-a4a7-e778eada5e8d" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2c2fa8f6-c0c6-42e7-89b6-4b1f223c6d2c" contextRef="C_700f906f-1edc-4815-8c6f-063af0170797" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,446</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_95da331e-47d7-4d7c-8cf5-d30cd04582c1" contextRef="C_9992b3c4-e005-45ff-a893-0307d53ac290" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_19213756-5f04-4a09-80b2-8d4be0b57b67" contextRef="C_4b80e6fd-7982-44e8-a550-11ab6d1ec368" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e56ab853-30a1-4698-809d-5f15a5b46f48" contextRef="C_472b27ba-d433-4ec0-97d1-4934923032a3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">42,882</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_237724e8-458b-4b4a-b87b-a648f30efa4c" contextRef="C_8c97b2f6-6bfd-442f-8d5f-fae8ac4320ac" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Municipal debt securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_30a9544d-43f6-4d5d-a4df-17e8c765da15" contextRef="C_187fc49c-d6d6-4802-9f01-b957d0bc88c4" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a5df092e-9b32-47d1-8674-0add0349c698" contextRef="C_79fad083-6839-4292-87a4-80611ccece36" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,072</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c3ad8eee-1e31-4664-b803-c92105bcef3d" contextRef="C_f96481c1-18cb-423a-941d-d5f0e9523ae3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. federal agency securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_afccf2bc-91d3-41d9-a686-7eab4500469a" contextRef="C_cb3ea4ea-93f7-4d45-b83e-1681dda66e30" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_03343683-ab68-46f4-ba7c-f3b4110f046f" contextRef="C_91155194-5f56-4b2a-aafc-4c8a052b5661" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,263</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_67b56a67-0948-40c6-bc36-da9f19ff4d0a" contextRef="C_d345d9ff-4db5-4fb9-821b-1c04eafbe0f2" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4aaba101-dab0-4d5f-a1b2-e8ac514774f8" contextRef="C_db7a6971-25dd-4ecb-8f48-615fa9b2e446" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f4431a93-b649-4e8c-9575-75ec97b64080" contextRef="C_85982594-37df-45db-b0b5-a89d1853eece" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,503</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_497479da-a705-4dff-badc-7540a9a06acc" contextRef="C_743227ba-f29d-4c56-aaf6-1d4fe3a4d79e" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets</span></p></td>
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3eaa49c3-3aa3-4e9d-871d-f208fb1b0e8d" contextRef="C_c9f1b32e-78dd-4176-9085-97902cd1f5c8" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,060</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_516e7e4d-9997-4c19-904a-99309c46eaa7" contextRef="C_fad988d1-5034-478c-8516-20f5782f4f85" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">64,166</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_14cd40b5-6b90-4c34-8524-03117ae7cc46" contextRef="C_ecdd66a3-70fa-4c7e-a8c2-b633e3ee94ea" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table shows the Company&#8217;s assets and liabilities measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands) as of December 31, 2023:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:57.477%;box-sizing:content-box;"/>
        <td style="width:1.399%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:10.776%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.399%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:10.776%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.399%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:10.776%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Assets:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash equivalents:</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e03fb90a-979e-42b6-a9b3-afc17c836edf" contextRef="C_8c0b2f25-3d73-42db-83a0-927dc46b55f2" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,272</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_15b0ba67-ce7a-4cab-92bf-81ee3a1e5ff8" contextRef="C_3759c1ab-699f-41b4-a2c6-1a2c4e3d2044" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e047e2ce-ea38-49c4-89f6-98dbaa0cb809" contextRef="C_c0c33cde-1b31-4d14-83be-384eb68acebe" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Marketable securities:</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dd8607c9-e499-4f6c-8974-d01008f2b207" contextRef="C_d619847f-a838-4f86-a29f-cd037355836b" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2ed66490-e382-4631-8689-5f0ab825d916" contextRef="C_170c4dc3-4c1f-4587-ac98-abecb38c3bcc" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,773</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f5e986e6-cf76-4745-afce-12fd7d99aa06" contextRef="C_841fc982-9aa4-444b-812e-b8d2f53536de" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_89207f22-53cb-4807-8d89-7f513a46dee4" contextRef="C_6b649540-a349-4de7-a667-163e2396f87b" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_28c7e05c-f2a1-4bd2-ac5f-b708b3cfb792" contextRef="C_3879982c-10a3-45e6-8f45-744fccd1614e" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,192</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3483f1bd-2034-4336-801a-5644915f1e79" contextRef="C_f91bfb70-0a79-432d-a466-f33c51ec490d" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. federal agency securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_48c223f3-fbcd-4153-96dd-189f428f7c12" contextRef="C_05256ced-5cef-411f-a2d3-9a1cd711dc5a" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_05662441-1710-435a-8cef-18e5bac1c599" contextRef="C_993c8440-8e32-404e-a58d-36ed574ab4c3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">28,958</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9ab651b9-5902-406b-b3ce-8959d9e9230e" contextRef="C_ecfa7a3b-6a0d-49ef-9b51-2fcd10725943" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ce3415f2-f796-43c3-85d5-c004fb7db90b" contextRef="C_eb565e2c-bfbf-4eb0-a9c0-cbb1dcb06aca" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ad647ab5-abba-4e79-af6b-041dbe6a97df" contextRef="C_caf15085-5fb3-478e-a2a5-829cc0c348a7" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,117</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d4000ae0-3092-4f99-9e24-82cb6e5261f8" contextRef="C_28f64bcb-45ac-4b38-ac92-aba2705b7334" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets</span></p></td>
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_98a8e4dd-44bf-4aa0-89d5-60ac7a087026" contextRef="C_dbdf5e62-5392-4d8b-9ae4-125c21ee2824" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,272</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6e02e365-7096-4c89-b70c-16b2e908aade" contextRef="C_f644480d-0cbe-48d3-a1e8-381afc09c8c6" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">76,040</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ec03751c-aaad-4174-88f9-c68312541a94" contextRef="C_df26b36a-abf1-4ee8-92c3-99bf73fea9e8" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:continuation></div>
  <div><ix:continuation id="F_1b4b7268-ae71-47bb-b5e8-d4c3a94256bc_1"></ix:continuation></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div><ix:nonNumeric id="F_6647a8f8-6b37-4945-8fd8-18fbea4736a4" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" escape="true" continuedAt="F_6647a8f8-6b37-4945-8fd8-18fbea4736a4_1"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">9</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Related Party Transactions</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In June 2019, the Company entered into a master services agreement with Carelon Research, a subsidiary of Elevance Health, Inc. (&#8220;Elevance Health&#8221;). This agreement covers a range of research projects, including Carelon Research&#8217;s role as a contract research organization for the </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">P</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">rematurity </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">R</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">isk Assessment Combined With Clinical </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">nterventions for Improving Neonatal outco</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ME</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">s (&#8220;PRIME&#8221;) study. The Company paid fees related to this agreement of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bd09b866-74f8-4bd6-87b9-9235a187a3d8" contextRef="C_5a27522b-3fd7-4775-b4b1-c07ac5059bc8" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0884b22b-6ff4-4269-84b4-aaa44b4bd8c4" contextRef="C_a5ccbc75-c805-4d9b-b60c-5763efe0a38b" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for the years ended December 31, 2024 and 2023, respectively, which were recorded in research and development expenses in the Company&#8217;s statements of operations and comprehensive loss. In November 2020, the Company entered into a Laboratory Services Agreement with Elevance Health related to the PRIME study. This agreement provides a contracted rate for certain tests performed pursuant to the study. In December 2023, enrollment in the PRIME study was stopped due to efficacy, and as such, there was an immaterial amount of revenue recognized related to this agreement for the year ended December 31, 2024. The Company recognized revenue related to this agreement of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1081f29c-bf49-466e-beaa-7fff4e50aa37" contextRef="C_ac36fee8-490e-4504-a78e-09b7ddd118aa" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">61</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> thousand</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for the year ended December 31, 2023.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In February 2021, the Company entered into a commercial collaboration agreement with Elevance Health and its affiliates (the &#8220;Commercial Collaboration Agreement&#8221;). The Commercial Collaboration Agreement provides defined payment within a defined period for use of the PreTRM test within Elevance Health&#8217;s network of covered members. Pursuant to the Commercial Collaboration Agreement, Elevance Health agreed to purchase a certain minimum number of tests for each of the first three years of the term of the agreement. Additionally, Elevance Health agreed to pay a certain minimum amount per year for the first</span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b9647126-d194-48bd-9f61-b68b75759dcd" contextRef="C_84c625f9-260e-4db9-b7ab-0dd11718650f" name="sera:RelatedPartyTransactionCommercialCollaborationAgreementTerm" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> three years</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of the term of the Commercial Collaboration Agreement. The Company received $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9655e0ae-7170-41d3-918d-1f5dfc59e818" contextRef="C_0a1a9334-cc92-43d9-b390-4fce8c10c525" name="sera:RelatedPartyTransactionOtherReceivablesRelatedToMinimumPayments" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">11.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million during the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, which amount related to the minimum payments for the year ended December 31, 2023. Such minimum payments were initially recorded as deferred revenue. Deferred revenue is recognized as revenue when the Company delivers PreTRM test results to Elevance Health patients pursuant to the Commercial Collaboration Agreement. The Company also agreed to develop a sales, marketing, and customer service program, and to provide training and marketing to duly licensed physicians specializing in obstetrics and gynecology or family medicine, or licensed nurse midwives, at the reasonable request of Elevance Health.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Elevance Health has been participating in the Company&#8217;s PRIME study and at the conclusion of the PRIME study, under the Commercial Collaboration Agreement, the parties agreed to use commercially reasonable efforts to enter into Elevance Health&#8217;s standard lab provider agreement. Unless earlier terminated due to breach, the Commercial Collaboration Agreement</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">114</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_6647a8f8-6b37-4945-8fd8-18fbea4736a4_1"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">will remain in effect until the later of (a) the third anniversary of the effective date or (b) the date on which Elevance Health has purchased a fixed number of PreTRM tests as agreed by the parties.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Commercial Collaboration Agreement with Elevance Health is considered to be within the scope of ASC Topic 808, Collaborative Arrangements (&#8220;ASC 808&#8221;), as the parties are active participants and exposed to the risks and rewards of the collaborative activity. The Company determined the PreTRM tests to be a performance obligation for which Elevance Health is a customer and a unit of account within the scope of ASC 606. The associated transaction price is based on the contractual minimum number of tests and the agreed upon defined payment amount per test. The transaction price was allocated to this single performance obligation, which will be recognized upon delivery of test results expected to occur over the term of the agreement. All other items promised to Elevance Health are immaterial in the context of the Commercial Collaboration Agreement. There were no material revenues related to the Commercial Collaboration Agreement for the years ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p></ix:continuation></div>
  <div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_10a3d855-90c0-4da0-b1e9-a81c808f12f2" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" escape="true"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Capital Structure</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Common Stock</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1f508903-e1a5-4f76-89a6-7aa42b9a78fd" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="sera:NumberOfCommonStockClassesAuthorized" unitRef="U_CommonStockClass" decimals="INF" format="ixt-sec:numwordsen">two</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> authorized classes of common stock, Class A and Class B. The rights of the holders of Class A and Class B common stock are identical, except with respect to voting and conversion. Each share of Class A common stock is entitled to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a18416c2-408b-499a-9ac8-0f00344aa36c" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="sera:NumberOfVotesPerShare" unitRef="U_Vote" decimals="INF" format="ixt-sec:numwordsen">one</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> vote and shares of Class B common stock are non-voting. Each share of Class B common stock may be converted at any time to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_52794771-027b-47f6-a68b-8648f34ccc53" contextRef="C_e26ec1fe-0438-4812-b032-9b354ebc1852" name="sera:CommonStockConversionRatio" unitRef="U_pure" decimals="INF" format="ixt-sec:numwordsen">one</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> share of Class A common stock at the option of its holder, subject to the ownership limitations provided for in the Company&#8217;s amended and restated certificate of incorporation.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In August 2024, the Company entered into the 2024 Sales Agreement with respect to an at-the-market offering program with TD Cowen, which allows the Company to issue and sell shares of Class A common stock pursuant to the 2024 Form S-3 for total gross sales proceeds of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ef6fdfad-2e75-4fb7-af6c-345904b52354" contextRef="C_b020dd07-c5cb-461b-9677-a054282faf68" name="sera:GrossSalesProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">50.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million from time to time through TD Cowen, acting as its agent. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company has </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dc8e5150-8232-419a-a409-24d525587094" contextRef="C_d8ac3adc-d2c5-4821-b662-56b9921fc31c" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t sold any shares of Class A common stock under the 2024 Sales Agreement.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_dfd408c2-0777-4cf1-98c3-1d12ab647eb5" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="sera:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following shares of Class A common stock were reserved for future issuance:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.967%;box-sizing:content-box;"/>
        <td style="width:1.16%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.357%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.16%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.357%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Warrants to purchase Class A common stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_30c7fe63-ec50-45e5-a38e-258542aa7c98" contextRef="C_f375d679-1976-474c-901f-6de9f5d1164a" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2,646,247</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1ac6ca9e-4067-4865-b96d-a09e769408bc" contextRef="C_fa1f5377-96a0-459c-99fd-200157552294" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2,775,978</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Options to purchase Class A common stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1909e7fe-4bfe-4d74-991a-e9297053684e" contextRef="C_44bf1f0c-7e45-4ddb-a68d-b3794ce96d49" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">6,113,155</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9bc409a7-0192-4f0b-827b-a16f65ac9932" contextRef="C_0d3d312a-a883-406f-a482-b3aab18bb031" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">7,251,663</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Restricted stock units outstanding</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_23370249-c262-44a3-953a-e2a796db52fc" contextRef="C_0a27554e-ce58-4e26-90cb-8b0b7c2027a4" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,631,162</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_83458099-e271-4649-bb8a-a92d78bc8794" contextRef="C_060bbe9a-71b5-4045-95d0-1ffa4cf95206" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2,692,459</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Class A common stock available for future grants under the 2021 Equity Incentive<br/>&#160;&#160;&#160;Plan</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ddc1cf61-5a50-4f05-8ff2-c387e2771681" contextRef="C_72fc74dc-bc8c-4dc3-9e53-0a0e671982ea" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2,071,498</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_132cdb3b-65ab-46fa-8284-77f695a71dfa" contextRef="C_1660a0e7-df13-4027-9e38-15f6ddf11b0a" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,002,091</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Class A common stock available for future grants under the 2021 Employee Stock<br/>&#160;&#160;&#160;Purchase Plan</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_61a2864a-8f0e-424c-b691-eceb5dc9be30" contextRef="C_c6567a19-3bfb-4b14-8ef7-62764c3fa312" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,060,293</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_036c0dd4-4f1f-4436-a0e7-981e64fbd583" contextRef="C_13d531e2-fd1b-4238-a5d7-2fd7b67c5076" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">801,668</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_aa9da507-ece5-418c-adfd-9ad0d778c630" contextRef="C_e26ec1fe-0438-4812-b032-9b354ebc1852" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">13,522,355</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8e8b89e3-a5c5-430a-a93e-5a3d47bd77a3" contextRef="C_7e2de8e1-9b90-401b-b5d2-78a35f931945" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">14,523,859</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Preferred Stock</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is authorized to issue up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b6b89078-a0e8-4a25-90f1-64a3c9b29638" contextRef="C_1ea882d4-0679-4c9f-9dff-1ef9e04dcf6b" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">5,000,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of preferred stock, par value $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c6d60388-54e9-4298-be14-68d4bb43094c" contextRef="C_1ea882d4-0679-4c9f-9dff-1ef9e04dcf6b" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.0001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share. There were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1e64f15f-bad4-45b6-af33-20bc0837c6d8" contextRef="C_1ea882d4-0679-4c9f-9dff-1ef9e04dcf6b" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_57d6de8f-aad9-4d9f-b798-81ab8f37a3a9" contextRef="C_978306e0-1a64-43db-891b-ab7f3d2e279c" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> preferred shares outstanding at </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p></ix:nonNumeric></div>
  <div><ix:nonNumeric id="F_cf4d93b8-a8dd-4b8d-b30c-d7b4d8984dac" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" escape="true" continuedAt="F_cf4d93b8-a8dd-4b8d-b30c-d7b4d8984dac_1"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">11</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Stock-Based Compensation</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Equity Incentive Plans</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2011, the Company established the 2011 Employee, Director and Consultant Equity Incentive Plan (the &#8220;2011 Plan&#8221;) and reserved shares of the Company&#8217;s common stock for sale and issuance under the 2011 Plan. Options granted under the 2011 Plan generally vest over a </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_15b67bf7-a316-44e4-b2a0-3aac6ca84a54" contextRef="C_1faeebd3-23ce-493d-af5a-c79bb9e92d83" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">four-year</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> period and generally expire </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7ce46bc5-f359-49ea-889f-14ce39e769a1" contextRef="C_1faeebd3-23ce-493d-af5a-c79bb9e92d83" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ten years</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> from the date of grant. Options are exercisable only to the extent vested. The 2011 Plan terminated in November 2021, and accordingly, no additional shares are available for grant under the 2011 Plan. The 2011 Plan continues to govern outstanding awards granted under the 2011 Plan.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">115</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_cf4d93b8-a8dd-4b8d-b30c-d7b4d8984dac_1" continuedAt="F_cf4d93b8-a8dd-4b8d-b30c-d7b4d8984dac_2"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The 2021 Equity Incentive Plan (the &#8220;2021 Plan&#8221;) was established in July 2021. The 2021 Plan provides for the grant of incentive and non-statutory stock options as well as other stock rights to employees, directors and consultants of the Company. Options generally vest over a </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_763c7cb6-4e14-4d7d-8dc3-0189fd7987a4" contextRef="C_6a5f0bd4-0f79-4071-ac0b-e3d379500212" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">four-year</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> period, are exercisable only to the extent vested, and generally expire </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2233805b-1dcb-4df6-a242-617876b88372" contextRef="C_6a5f0bd4-0f79-4071-ac0b-e3d379500212" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ten years</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> from the date of grant. Restricted stock units (&#8220;RSUs&#8221;) generally vest over either a </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d652a980-f293-45b7-9cbb-90071bbc125e" contextRef="C_809b9d4c-c63e-4d53-8e85-6d4684e3609d" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">two-year</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> or a </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3a7401ca-1b67-4505-bbc3-afe46e270a4a" contextRef="C_8510e741-314c-421f-9b15-649e0930202c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">four-year</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> period. The 2021 Plan includes provisions for annual automatic increases to the number of shares of Class A common stock reserved for issuance under the 2021 Plan. In addition, any shares that otherwise would be returned to the 2011 Plan as a result of the expiration or cancellation of stock options may be added to the 2021 Plan. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, there were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5e396114-b18b-4811-b932-1c9ff5474e81" contextRef="C_e79b8c0c-c0db-4a39-81c4-3583a483beb6" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2,071,498</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of the Company&#8217;s Class A common stock that were available for future grants under the 2021 Plan.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The 2021 Employee Stock Purchase Plan (the &#8220;2021 ESPP&#8221;) was established in July 2021. The 2021 ESPP includes provisions for annual automatic increases to the number of shares of Class A common stock reserved for issuance under the 2021 ESPP. As of December 31, 2024, there were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_055e5c27-cf7e-4520-9afa-87ec9cb6de24" contextRef="C_c8c170a9-1f93-4318-a2c3-b52ae62d57d1" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,060,293</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of the Company&#8217;s Class A common stock that were available for future grants under the 2021 ESPP.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock Options</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unless otherwise noted, references to &#8220;options&#8221; in the subsequent disclosures, refers to the combined incentive and non-statutory stock options issued as employee and non-employee stock-based compensation, and authorized under the 2011 Plan and the 2021 Plan. </span><span><ix:nonNumeric id="F_1dbb36a6-6b2b-41e3-a364-750bce65cf82" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" escape="true" continuedAt="F_1dbb36a6-6b2b-41e3-a364-750bce65cf82_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes information about these options granted and outstanding:</span></ix:nonNumeric></span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:continuation id="F_1dbb36a6-6b2b-41e3-a364-750bce65cf82_1"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:52.241%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:9.164%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.16%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:8.403%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:9.164%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.16%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:8.703000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of<br/>Shares<br/>Subject to<br/>Options<br/>Outstanding</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted-<br/>Average<br/>Exercise<br/>Price Per<br/>Share</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Life (In<br/>Years)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Aggregate<br/>Intrinsic<br/>Value (In<br/>Thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding &#8211; December 31, 2023</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_058030a3-3ee4-42dc-810c-5143028ac6d7" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">7,251,663</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0a7c3d20-3fc8-4547-b33c-7b06435fce61" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">3.66</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_f0cc5662-f045-4dbf-aa8c-ce8e86317a09" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.9</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f0f0d88c-0bc5-4816-b698-d07ea2c25070" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,014</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Granted</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dff64cb1-4cf6-4be3-b202-38f615450671" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">84,392</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_898745b3-3bef-40d5-af3a-eaf5b8c6e5e7" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">8.43</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expired</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cc4e3f9f-2c86-4f64-b639-2ce6a0009e2f" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" unitRef="U_shares" decimals="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a4147e75-0d6f-41d9-a387-1507295e269f" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cancelled</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bcc5ebe7-2627-4499-b5bb-1e0655c2ba5b" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">120,387</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6b8a8717-5f68-4149-aa9b-830718046220" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">3.68</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercised</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_877a619c-34a6-4770-8f4f-a27361c216d4" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,102,513</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_785c738f-a8c9-4865-83b3-86bbcc952860" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">2.63</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding &#8211; December 31, 2024</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2dcbbdea-c14b-4fc0-9532-33b8f01fab82" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">6,113,155</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_87b2f6d9-28bf-43fa-9546-69d10b28b99b" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">3.91</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_6e12f4ad-6cb1-47c2-ae07-9fa301861300" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.3</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_83aecce7-3cb7-4bf3-9eb0-06b332db84fd" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">27,008</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Vested and expected to vest at December 31, 2024</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bc91743e-27ed-499f-a637-3ecef47b7540" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">6,073,028</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0373d022-f2c8-4122-921a-1a46667b139c" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">3.90</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_e0a00184-ba6d-4867-84ca-ddf5447908ef" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.3</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_022a1bac-c33d-4787-8b18-239201a130fe" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26,849</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Vested and exercisable at December 31, 2024</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c98d06d5-4214-4b94-8dd4-cfd467abda5f" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">5,380,324</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_68bab7bc-e2b9-419f-9447-394bc4fb9371" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">3.77</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_131d637d-be4b-471a-a897-d9e342b023b3" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.1</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_db0078fe-372e-46a2-976b-029a41728853" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,500</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:continuation></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The weighted-average grant date fair value of options granted during the years ended December 31, 2024 and 2023 was </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cd659edb-8878-4608-b980-fa9f42643a31" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">5.54</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_facda6b5-22b6-443d-bb30-e1e9fc912c02" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">2.28</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, respectively. The total aggregate intrinsic value of options exercised during the years ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_55f53b47-03b0-460b-959a-7dd1d6d8683e" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_df0757e2-91b0-44cb-a01c-28d73bad68af" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively. The total fair value of options vested for the years ended December 31, 2024 and 2023 was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5f31d270-fa0c-4fa2-936d-f38390f46fdd" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">3.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_640f0959-dcde-4cf8-8d86-355706adfdd7" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_305d43b7-32fc-4f86-a928-c2a6464de20a" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair values calculated using the Black-Scholes option pricing model were estimated on each grant date using the following assumptions:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"/>
        <td style="width:1.16%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.343%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.16%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.343%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected volatility</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_41aaec42-f2dc-4321-bd67-a7f9d54bdaa4" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">78.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">% - </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_76f856fa-cd97-4d85-8fc2-b9bf0bb81fe2" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">78.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2eefab42-fc10-460c-a6f8-22ef0d572b03" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">70.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">% - </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1dced4d4-b6b1-4c16-b7f6-23c1d43d02a6" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">72.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Risk-free interest rate</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a3ceb8f2-9385-435e-bccc-19c9be4203c0" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">4.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">% - </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6f74a057-b75d-4207-93a2-01f6d1832365" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">4.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4c62f924-84ea-43c6-bd73-8e077e608aea" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">3.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">% - </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_90bc513e-6924-4817-8c36-edf65bd85edb" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">4.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected term (in years)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_1104f191-a7d1-4da4-bf6e-2081cdf1e670" contextRef="C_12580e9a-ae3c-43b5-bd47-c7e4bcb0df5e" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.2 </span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">- </span><span><ix:nonNumeric id="F_4cdc751a-d569-42d9-9dea-43460b5c1618" contextRef="C_645b404b-8bbd-4848-a0d4-aeaf0829da3f" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.3</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_606e1304-1d2f-4eb1-b6c3-8ba3c8956cb4" contextRef="C_b91d11ff-c343-4366-83fa-e644ceaf19e4" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.3</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;- </span><span><ix:nonNumeric id="F_88406945-24f8-418e-9d80-f8cb98d977fc" contextRef="C_acdfb23b-77fd-4983-9ece-002da2eb742e" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.0</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected dividend yield</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a9b52a30-ca06-4221-9c7b-6b410964f204" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">0</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8a3c6b76-557b-44dd-a4a9-ac18f551f644" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">0</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">116</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_cf4d93b8-a8dd-4b8d-b30c-d7b4d8984dac_2"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">RSUs</span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_59dc700a-52dc-4916-ab47-802a3a319b3d" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes information about RSUs granted and outstanding under the 2021 Plan:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:68.88%;box-sizing:content-box;"/>
        <td style="width:1.06%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.5%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.54%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.020000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of Awards</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted-Average<br/>Grant Date Fair<br/>Value</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding &#8211; December 31, 2023</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_358ab3fd-5039-4cc2-8bed-cabf74b62934" contextRef="C_c65254c7-ac81-4069-a809-c971b11aa622" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2,692,459</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_46737bad-cf43-4c3d-9680-d2bd0e5b3e13" contextRef="C_c65254c7-ac81-4069-a809-c971b11aa622" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">2.01</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Granted</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_37762d20-732a-42d3-a02c-133a3c4db668" contextRef="C_b7e93a2d-70e5-4c3d-a5e8-2305fb8f5a8b" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">249,040</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f1172988-54ba-471e-98bd-76366ebeb920" contextRef="C_b7e93a2d-70e5-4c3d-a5e8-2305fb8f5a8b" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">8.52</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Forfeited</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_21870b27-0cc9-4b9d-b929-3175bb648315" contextRef="C_b7e93a2d-70e5-4c3d-a5e8-2305fb8f5a8b" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">52,992</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8e0c77a9-bf92-40fd-8934-1597a019590e" contextRef="C_b7e93a2d-70e5-4c3d-a5e8-2305fb8f5a8b" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">2.02</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Vested</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_26b55749-4a5a-4de8-aa16-5c9dd488a767" contextRef="C_b7e93a2d-70e5-4c3d-a5e8-2305fb8f5a8b" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,257,345</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5bf55164-ff35-4c02-b3e1-5900d628ae74" contextRef="C_b7e93a2d-70e5-4c3d-a5e8-2305fb8f5a8b" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">2.54</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding &#8211; December 31, 2024</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2c442635-d4a8-470b-a19b-e40f28ac5875" contextRef="C_1e828831-28e3-4d62-916b-97cfb64c3c0f" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,631,162</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eae6e444-df64-4ba0-bdd7-955c938d76e9" contextRef="C_1e828831-28e3-4d62-916b-97cfb64c3c0f" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">2.60</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock-Based Compensation Expense</span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f7267973-a04e-4372-8f29-e8ab14c16fa2" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table presents the impact of stock-based compensation expense in the statements of operations for the periods indicated (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development expense</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1fe87e85-79b8-453c-9c72-20c95e9fde12" contextRef="C_82b9b7fb-68e4-45aa-8dc3-daea6ea244e1" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,502</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_47178c76-610d-4eac-9809-b6b0ac2433a8" contextRef="C_e47cfbc9-cd42-436b-8a5a-31f13439a6df" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,574</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Sales and marketing expense</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8bd8d315-ba66-451e-a8c7-184f5efac2ba" contextRef="C_f3b8da5f-d721-4ba9-9244-5fd80bad0881" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">390</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5397cf3c-79de-44b2-bc46-60a5864e9786" contextRef="C_179d008a-1bc2-40a6-ac89-86e6010d037c" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">657</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative expense</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5cebda52-6be2-43c9-a313-36322f6bd6fd" contextRef="C_c8b03d4a-856b-4b56-989b-21dbe3a3d5e4" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,121</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4b4e59ab-c907-4730-bdec-3e3399346b48" contextRef="C_3823e7c9-9de3-4740-a0b6-1918db41ffaa" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,042</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total employee stock-based compensation</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6f2ac375-3a5d-4352-b26c-2e31e93b4e38" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,013</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_16303fa4-ed6d-416c-9682-616bedeed16b" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,273</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_906c630b-4119-416c-b6bc-913444d34f34" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" escape="true" continuedAt="F_906c630b-4119-416c-b6bc-913444d34f34_1"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information about unrecognized stock-based compensation expense for outstanding unvested stock options and RSUs as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 was as follows (in thousands, except years):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:68.88%;box-sizing:content-box;"/>
        <td style="width:1.54%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.020000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.06%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.5%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrecognized<br/>Stock-Based<br/>Compensation<br/>Expense</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted-Average<br/>Period of<br/>Recognition<br/>(in years)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock Options</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_265f5620-217f-46c0-817b-7b56ed425a39" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,975</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_b883805c-a8b1-485f-91fe-fe46951719fe" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.0</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">RSUs</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_09ca5baa-e964-41ba-9c33-de3e810f8ad0" contextRef="C_1e828831-28e3-4d62-916b-97cfb64c3c0f" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,099</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_f5dd5e42-bedf-451a-a318-55d8382df102" contextRef="C_b7e93a2d-70e5-4c3d-a5e8-2305fb8f5a8b" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.9</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total unrecognized stock-based compensation expense</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_369db8a0-771d-4728-9297-abe26a51d3a5" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,074</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:continuation></div>
  <div><ix:continuation id="F_906c630b-4119-416c-b6bc-913444d34f34_1"></ix:continuation></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div><ix:nonNumeric id="F_c031851b-2401-4ed1-b874-6980763bdd6e" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="sera:WarrantsTextBlock" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12. Warrants</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All outstanding common stock warrants were exercisable immediately when granted. All outstanding common stock warrants are exercisable for shares of Class A common stock. </span><span style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d6f9f668-07a8-4eba-9dc7-19f88431a02d" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" escape="true" continuedAt="F_d6f9f668-07a8-4eba-9dc7-19f88431a02d_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s common stock warrants outstanding were as follows:</span></ix:nonNumeric></span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:continuation id="F_d6f9f668-07a8-4eba-9dc7-19f88431a02d_1"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:29.08%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:2.92%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:29.54%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:2.92%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:29.54%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of Warrants Outstanding as of:</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exercise Price</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2211fbf6-bc02-4511-91c3-bb10b65fb3ec" contextRef="C_987117f3-a2cb-4114-ba3b-abb5e5ee31bf" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">5.20</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6a936abd-94c9-4c2b-887d-febbed063bcc" contextRef="C_987117f3-a2cb-4114-ba3b-abb5e5ee31bf" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4e7dda8c-c612-4e29-9d23-937205822a91" contextRef="C_b2ca6d62-c8a1-49ad-b68e-21f1e5f6bb63" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">3,473</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d7fcbc5a-a8ec-4873-8cce-d13f6b1881aa" contextRef="C_bee59d28-e5cc-40c9-a976-6776fef6babc" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">9.03</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0505f1b3-7c8b-4af1-9f7e-462aca180cab" contextRef="C_bee59d28-e5cc-40c9-a976-6776fef6babc" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">969,275</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d33faf2e-a530-4859-a173-2eb6d65cbe47" contextRef="C_b55ca18f-71fd-40e9-91aa-6ca09f99f3fd" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,032,404</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6dbdc5e6-1d58-42e2-8a26-22b310ed53ad" contextRef="C_ea61173b-bc9e-42d8-8fbb-5139f085543f" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">10.84</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1617107b-3cdb-499d-960f-e4052d399022" contextRef="C_ea61173b-bc9e-42d8-8fbb-5139f085543f" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">946,666</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_497a8ac4-1f6f-4831-90ba-e50c5cd20c52" contextRef="C_df96dede-3972-4662-bb40-d24aff923983" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,009,795</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_38363434-b5ed-4092-b7e5-4197ac5b2fd0" contextRef="C_b1d570cd-e3f2-4acc-ab96-99d8ef06cb44" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">12.38</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_70c4b5f7-73bc-4aff-b87d-25df3bebfdac" contextRef="C_b1d570cd-e3f2-4acc-ab96-99d8ef06cb44" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">8,083</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_29ebff23-3411-4217-a3f1-c14cc1a4af70" contextRef="C_8442a0e1-b203-45a1-bf13-205667c7fbae" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">8,083</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_50bb9390-ec64-4c16-8bda-ec70fb674a9b" contextRef="C_44f85d7b-18dc-4a86-bed7-b1560a6fe25f" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">20.77</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e409d6b3-e769-4b0d-bf33-78df114d697a" contextRef="C_44f85d7b-18dc-4a86-bed7-b1560a6fe25f" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">722,223</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3770fdf3-1182-4340-bf48-63088bb7e9cb" contextRef="C_6e3121ea-3b26-4fbf-a9e4-ba6bb516cb52" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">722,223</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b47ebfc0-283d-4443-a232-ef83e61ca023" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2,646,247</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e28254d5-788d-483a-9796-44bab940759f" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2,775,978</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:continuation></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b58f192d-b792-4c2b-81ea-f6029550205f" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="sera:ClassOfWarrantOrRightExercised" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">126,258</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> common stock warrants were net exercised, resulting in the issuance of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e758925d-7373-40c4-be8f-c20cae6cbce4" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="sera:StockIssuedDuringPeriodSharesStockWarrantExercised" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">7,971</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Class A common stock. Additionally, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fe913a09-5e41-4aea-8341-4804ec9d3b5d" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="sera:StockIssuedDuringPeriodSharesStockWarrantExpired" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">3,473</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> common stock warrants expired unexercised during the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">117</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:nonNumeric id="F_bf0e7080-1ea5-480a-a1cb-f02d8d208474" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" escape="true" continuedAt="F_bf0e7080-1ea5-480a-a1cb-f02d8d208474_1"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">13</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Commitments and Contingencies</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Leases</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is the lessee in all of its lease arrangements. The Company did not enter into any leases with related parties during the presented periods. The Company makes assumptions and judgments when assessing contracts for lease components, determining lease classifications, and calculating right-of-use asset and lease liability values. These assumptions and judgments may include the useful lives and fair values of the leased assets, the implicit rate underlying the Company&#8217;s leases, the Company&#8217;s incremental borrowing rate or the Company&#8217;s intent to exercise or not exercise options available in lease contracts.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_375a6b36-43ad-4a50-a938-015031cdbf17" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="sera:ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table shows right-of-use assets and lease liabilities, and the associated financial statement line items as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:27.18%;box-sizing:content-box;"/>
        <td style="width:1.52%;box-sizing:content-box;"/>
        <td style="width:40.46%;box-sizing:content-box;"/>
        <td style="width:1.52%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:11.9%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.52%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:11.9%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Lease-Related Assets and Liabilities</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Financial Statement Line Items</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Right-of-use assets:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating leases</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_0f18ae55-e115-46af-9133-2a37b7dbec78;"><span style="-sec-ix-hidden:F_499cda77-bfd5-40a5-a5fa-38b8c2a78467;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other assets</span></span></span></span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3a79fc84-90fd-4b0a-b2a3-f7641c1b34a1" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">613</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_720239b0-7d1b-4ec6-be23-fb0dbd22d1f7" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,180</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Finance leases</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_b631bde4-1e5a-491c-8bd3-1cb6b5c51baa;"><span style="-sec-ix-hidden:F_72a4c378-6838-4602-82e9-f25639674292;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Property and equipment, net</span></span></span></span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9881803b-4543-4a56-a676-9711838f5c9a" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:FinanceLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">699</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_411cad9e-3622-4af8-8a90-c05552c6602d" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:FinanceLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,008</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total right-of-use assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d610d91d-ac51-424f-84aa-83ad258f60dc" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="sera:RightOfUseAssetTotal" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,312</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_13174817-0ad4-42b0-a828-ea77218a2175" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="sera:RightOfUseAssetTotal" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,188</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lease liabilities:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating leases</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_556e664f-e809-4c83-9e64-ccae8a1500b7;"><span style="-sec-ix-hidden:F_e1166b60-a008-49df-82fa-558051a272f2;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued and other current liabilities</span></span></span></span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_783943b5-5796-41f3-98a5-34dd08c8e84d" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">644</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8f9f5bfb-fa71-4242-a6e3-c21f4a433a71" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">578</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease obligation, net of current portion</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_797eddb1-89f7-4e43-bedd-5ade242bec84" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5d04ca00-0a93-4100-9d78-7bba5be8366a" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">644</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Finance leases</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Finance lease obligation, current portion</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_846f76c7-0cd3-4acd-a160-72bd8b529eea" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:FinanceLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">194</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_81deb444-fb38-4e5c-b81f-91318cd60efa" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:FinanceLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">440</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Finance lease obligation, net of current portion</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fd1e7f75-9661-4325-8f96-dc76d2dc426f" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:FinanceLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4b333e9d-87c1-4f48-a9b8-173c2ca50262" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:FinanceLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">196</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total lease liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2909f2f6-06ed-4904-b857-f1d3cad74c4e" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="sera:LeaseLiabilitiesTotal" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">840</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6b50b7f5-8cb4-4fae-b6a5-9fb140b64870" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="sera:LeaseLiabilitiesTotal" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,858</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2860dd50-a731-427c-b632-6e6c957fd5fb" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:LeaseCostTableTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Lease costs and other information consisted of the following (in thousands, except terms and rates):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.882%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.882%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Lease cost</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Finance lease cost:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amortization of right-of-use assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fe40b275-ab66-42b9-9161-75e848c95a54" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">314</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3822d63f-d358-4c22-a434-0d9d17d3eb26" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">312</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest on lease liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_75897362-4265-46d7-8382-4842f286e453" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:FinanceLeaseInterestExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2e87a8c8-b890-4c38-8f01-72bb53cb3818" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:FinanceLeaseInterestExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">55</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease cost</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1d2f5696-57a9-4b22-9cea-b213258e0944" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:OperatingLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">636</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e93d6403-e24d-468b-981a-9a1070f9e3b5" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:OperatingLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">636</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total lease cost</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c6b81855-6fe0-412e-88e6-780782c22e1a" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:LeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">976</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1a1dc5fc-f108-4a42-a149-88a6b2213f70" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:LeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,003</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Other information</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Finance leases:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating cash outflows</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4ff3546f-9a37-40df-ae4c-1969cf7ffa5b" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_14fe2600-7de4-4db7-9b06-3f5b33074ad4" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">55</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Financing cash outflows</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_81220d79-68d9-46f5-b9f0-23adc10d16b0" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:FinanceLeasePrincipalPayments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">440</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_da9a69ec-e2f1-4968-a679-308ca25a3171" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:FinanceLeasePrincipalPayments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">466</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Right-of-use assets obtained in exchange for lease liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_39e91f4a-7e5e-4769-bfc3-ada2ab5c7db0" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_894033ba-b59b-4bf2-b9d3-12b9b4b9d01f" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average remaining lease term (in years)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_0ef53702-ab2b-4976-b260-4865cf8aafba" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.4</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_6059f189-bc64-43ec-9237-8074313e42d0" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.4</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average discount rate</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8544f795-4edf-43a4-a27f-f611f59f9504" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">6.7</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6e4b374c-1c57-4a82-8599-bd7fecf470c1" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">6.5</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating leases:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating cash outflows</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bd41cc94-813e-42ef-ba86-9605921b7b00" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:OperatingLeasePayments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">646</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_265b0944-be9b-4ae4-8c7f-84dec7811614" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:OperatingLeasePayments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">628</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Right-of-use assets obtained in exchange for lease liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3c756995-5029-422c-89ec-937a4e065dd3" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0163fc01-045d-462b-a7ed-7a35a67271e0" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average remaining lease term (in years)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_4ea3ecd3-9160-4cc5-95ca-4084230629b6" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.0</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_472980ff-2c67-4d0a-b292-699121efb22e" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.0</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average discount rate</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_de714f13-4a2b-48bd-9d9f-1b6fade25753" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">7.5</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e33ddfb9-1e3e-4f21-a3f9-9fcf7a28253b" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">7.5</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">118</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="font-size:12pt;font-family:Times New Roman;"><ix:continuation id="F_bf0e7080-1ea5-480a-a1cb-f02d8d208474_1"><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_66d46088-206e-4424-9411-3a81e2359d1d" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Future minimum lease payments for the Company&#8217;s leases as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 were as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:46.649%;box-sizing:content-box;"/>
        <td style="width:1.74%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:14.043000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.74%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:14.043000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.74%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:14.043000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Operating Leases</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Finance Leases</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2025</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ad6a893e-2eb3-4847-8372-2a9e1ebee815" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">666</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7e5ac8e0-58cc-45a8-ae65-d1cc483b73c2" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">197</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7dc48371-0023-4574-aab5-90cde76bfb43" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="sera:LeaseLiabilityToBePaidYearOne" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">863</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2026</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b6dc8ab6-8a89-436b-b354-6b62a62cfbe6" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4e37c4e6-cc75-42fa-8708-32cbfd9c7879" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e50b4e53-28d7-48bf-969a-07b6386f756b" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="sera:LeaseLiabilityToBePaidYearTwo" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2027 and thereafter</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_848f41e1-8d4f-42b5-8a7d-6682260555f9" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="sera:LesseeOperatingLeaseLiabilityToBePaidYearThreeAndThereafter" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0a55a20c-a9e5-4504-8823-bffbc852a296" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="sera:FinanceLeaseLiabilityToBePaidYearThreeAndThereafter" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d29ae8c5-79ff-4b63-b02d-b9cb140182a0" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="sera:LeaseLiabilityToBePaidYearThreeAndThereafter" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total minimum lease payments</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e3dce93b-07f2-4248-9968-59d4fa8e5c7a" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">666</ix:nonFraction></span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_08f3c15c-795f-4b97-ba9c-8fcae7d9c22d" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">199</ix:nonFraction></span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9e429eb3-f817-41e3-9bf5-97986a37b64b" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="sera:LeaseLiabilityPaymentDue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">865</ix:nonFraction></span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: imputed interest</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1fb37d29-557a-4f96-9f59-06e360d7abd0" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a64848c2-28cd-4e7f-9d9b-ed36c2d9fea2" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9c715b37-2f09-4870-921f-fe2a3e2510e7" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="sera:LeaseLiabilityUndiscountedExcessAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Present value of future lease payments</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2e93db67-5d77-4358-9ec8-4c6a564bfdc3" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:OperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">644</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_de769ec4-47aa-4369-9247-f04a5a7dae2e" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:FinanceLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">196</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8f03ee5e-6dc9-4250-a3b8-7bf420fb3ae0" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="sera:LeaseLiabilitiesTotal" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">840</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: current portion</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f296cf1a-b628-40a0-9bf2-528cb8364f9f" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">644</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ea6f54dd-9d4c-488a-8106-735eb7f5625f" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:FinanceLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">194</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0dd5248d-c8a0-4829-a2f9-2daac121325f" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="sera:LeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">838</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Long-term portion</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0350fee2-c39e-469d-bc52-1cc127b57f67" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b719851b-54db-490f-a4d3-8d3201a0120f" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:FinanceLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_29e31ddd-4d88-43db-930d-c6f444c42909" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="sera:LeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Operating Leases</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company leases a total of approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ce77bf01-70a4-4923-a940-d1177275e833" contextRef="C_36d0dab8-25a4-4445-bd06-e502a277df24" name="sera:LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory" unitRef="U_sqft" decimals="0" format="ixt:num-dot-decimal">24,300</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> square feet of office and laboratory space under a single non-cancelable operating lease with a termination date of December 31, 2025 (as amended, the &#8220;Office Lease&#8221;). The Office Lease includes an early termination right which termination would occur under certain circumstances, as provided in the amended Office Lease, after July 1, 2024 if exercised. The Company is reasonably certain it will not exercise the termination right. The implicit rate provided in the Company&#8217;s operating lease is not readily determinable. As such, the Company uses its incremental borrowing rate to calculate the present value of its operating lease liabilities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Finance Leases</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company leases certain equipment related to its information technology infrastructure and laboratory operations. All of the Company&#8217;s current finance leases include bargain purchase options that the Company is reasonably certain to exercise. The Company has elected not to separate lease and non-lease components for its equipment leases. The rates implicit in the Company&#8217;s finance leases are determinable, and the Company uses those rates to calculate the present value of its finance lease liabilities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Indemnification</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has agreed to indemnify its officers and directors for certain events or occurrences, while the officer or director is or was serving at the Company&#8217;s request in such capacity. The maximum amount of potential future indemnification is unlimited; however, the Company purchases director and officer insurance coverage that provides for corporate reimbursements of covered obligations that limits the Company&#8217;s exposure and enables it to recover a portion of potential future amounts paid. The Company is unable to reasonably estimate the maximum amount that could be payable under these arrangements since these obligations are not capped but are conditional to the unique facts and circumstances involved. Accordingly, the Company has </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7f5ea489-f5da-4712-860e-c74125a30455" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="sera:IndemnificationLiability" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_110fa6fc-8bdb-49b8-81e3-ef85d8af0aa3" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="sera:IndemnificationLiability" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> liabilities recorded for these agreements as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023. The Company has never incurred costs to defend lawsuits or settle claims related to these indemnification agreements.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Employee Agreements</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has signed various employment agreements with key executives pursuant to which if their employment is terminated by the Company without cause or by the employees for good reason, or following a change of control of the Company, the employees are entitled to receive certain benefits, including severance payments, accelerated vesting of stock and stock options, and certain insurance benefits.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Legal Matters</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is not currently a party to any material litigation or other material legal proceedings. The Company may, from time to time, be involved in various legal proceedings arising from the normal course of business activities, and an unfavorable resolution of any of these matters could materially affect the Company&#8217;s future results of operations, cash flows, or financial position.</span></p></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">119</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:nonNumeric id="F_f6a61e1d-5b3c-4e24-b739-f91f5c159573" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:IncomeTaxDisclosureTextBlock" escape="true" continuedAt="F_f6a61e1d-5b3c-4e24-b739-f91f5c159573_1"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Income Taxes</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2571faa0-87de-40db-b227-6ee390d7fa4a" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_df40cfd0-e9b0-48fa-b0e6-41574e1e54e6" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t recorded any income tax expense for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 due to its history of operating losses.</span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_47ae5b6f-31f1-42bf-9856-925d74d09afe" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The provision for income taxes includes the following components for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Federal</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a428abda-8063-47e6-b696-c144099be8d6" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:CurrentFederalTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a2e225d0-df61-4cb3-a692-b46e3069bf5c" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:CurrentFederalTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_babe92b8-a1d3-469d-8454-9a0003b572a8" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_547155eb-0dbb-4e03-8307-c09cab2e9187" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current benefit (provision)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_037e646b-16dc-48ba-8cbe-d6d6cabda947" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:CurrentIncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e1e91f75-904a-4560-9df4-844e790ded2e" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Federal</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ce050f94-16a2-447d-ab75-78cbd4a9c618" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,981</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ed160817-fc88-438a-b3ac-56a87a9d9ef9" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,178</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e626b711-ee82-4c2f-8d23-c46a9bc4c231" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,198</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f2a1a4c2-1712-4eac-915d-db99c7e3e4cd" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,198</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in valuation allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b3c24c6e-aec2-4154-8900-ccc2db73f7d2" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,179</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2b496e9a-dc0d-4fb9-91dd-fa27eb2d1159" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,376</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred benefit (provision)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f1bd2165-d3b5-4ee0-82a9-72152a429609" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:DeferredIncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b3d6fdda-1162-498c-bb6f-b997f2fa948d" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total income tax benefit (provision)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8d87d28f-66a2-455c-a478-5083738d3be3" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="INF" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0ac98ce0-dd29-4a90-970a-635e72d146fe" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="INF" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_623cc598-b197-48c1-9a5b-2530d3ab6d74" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The benefit (provision) for income taxes differs from the amount computed at federal statutory rates as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.36%;box-sizing:content-box;"/>
        <td style="width:1.22%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:8.940000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:9.66%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.22%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:8.940000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:9.66%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Computed Federal income tax benefit (expense) at the<br/>&#160;&#160;&#160;statutory rate</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3803a476-72c0-46ff-9fd7-0f62806d8bfa" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,908</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c215f7a2-4192-4bf9-92f5-fbcb406de710" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:num-dot-decimal">21.00</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a03e685b-8901-4493-bc92-f49f6c96e9b2" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,602</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_93537ac5-2177-48e3-9891-bb9b83b6682e" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:num-dot-decimal">21.00</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">R&amp;D credits</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_77b7ecf5-e789-4fcc-9131-e735cc03b493" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">837</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0a760076-1faf-442f-9adb-6d2728ba6d00" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" unitRef="U_pure" scale="-2" decimals="4" sign="-" format="ixt:num-dot-decimal">2.54</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_59171449-5195-4a8c-9e05-08e019ca7a47" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">698</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c456652c-a4fa-4b14-8f3c-616673ae8f6c" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" unitRef="U_pure" scale="-2" decimals="4" sign="-" format="ixt:num-dot-decimal">1.93</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equity-based expenses</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8c6e29ba-ecb5-4179-88c1-4623785e988b" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="sera:EffectiveIncomeTaxRateReconciliationEquityBasedExpensesAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,366</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_132311c2-d238-476e-a05d-95c1b02140f9" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="sera:EffectiveIncomeTaxRateReconciliationEquityBasedExpensesPercent" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">7.19</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3ba23ea5-3597-4d77-9305-0b13e8ed4286" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="sera:EffectiveIncomeTaxRateReconciliationEquityBasedExpensesAmount" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">63</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_618bd9c4-9409-4d40-9cf2-50f560c142bd" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="sera:EffectiveIncomeTaxRateReconciliationEquityBasedExpensesPercent" unitRef="U_pure" scale="-2" decimals="4" sign="-" format="ixt:num-dot-decimal">0.17</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State income taxes, net of federal benefit</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4b22e65c-2ee9-4c18-9f0a-41b65d071f1c" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,272</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3cbf4a8e-cfda-441a-b1ab-846b79bcb580" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">9.95</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ed7fcd36-b776-4250-af22-91dbf31f3012" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,783</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c8ebb853-2c51-4be7-bd0d-a51e5a3b820d" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">4.92</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State net operating loss carryforward true up</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_993e5cc5-9a34-4bb7-a2e8-a026f892c353" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="sera:EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_472d6472-48d0-4e1f-b958-a4ee08552405" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="sera:EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpPercent" unitRef="U_pure" scale="-2" decimals="2" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4c622d30-de54-4e16-bca4-829032bc0ebe" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="sera:EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">154</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_92bf802c-1960-4580-9257-9a34e50a97d8" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="sera:EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpPercent" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">0.42</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in statutory rates</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c77a235f-0b05-496c-bb28-fdbb372478e8" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">813</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7a107438-017f-4ab2-97f2-44f786132752" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">2.47</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4c2d429e-0857-462a-b3ae-d585a90056f8" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">163</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c0e10b14-df70-4bea-8636-57260fbecdf7" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">0.45</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d9379bfe-56ba-454a-8aa0-d22c440daba3" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1,017</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d2d1c7b3-1f9f-4128-8c47-9156abdd2208" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" unitRef="U_pure" scale="-2" decimals="4" sign="-" format="ixt:num-dot-decimal">3.09</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_70522c5f-d3c1-405c-a82d-68ae4f685692" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">39</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ec5ffc8e-ef6a-4ca4-97a9-cdd3c3904bc9" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">0.11</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Valuation allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_12b70770-2372-4eaf-9504-db9ad9d88097" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">13,179</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_28b64c20-6603-4bc3-945f-d15a5e614800" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" unitRef="U_pure" scale="-2" decimals="4" sign="-" format="ixt:num-dot-decimal">40.06</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fc5750b2-ec77-41ba-85e8-c20c7139c52c" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">10,376</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5e8e4504-e43f-497e-880f-0ebc28b593e5" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" unitRef="U_pure" scale="-2" decimals="4" sign="-" format="ixt:num-dot-decimal">28.66</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Income tax benefit (provision)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_66c4a045-1866-4173-ac54-0d63f13e10ff" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_381ad98e-585a-4e1c-a7d1-6c40d63e8791" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" unitRef="U_pure" scale="-2" decimals="2" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_53be27ac-c932-482a-b52f-bc7c5bcd0f5d" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7e401488-e7b1-43a4-a7c2-3a1aacd2e3af" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" unitRef="U_pure" scale="-2" decimals="2" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">120</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_f6a61e1d-5b3c-4e24-b739-f91f5c159573_1" continuedAt="F_f6a61e1d-5b3c-4e24-b739-f91f5c159573_2"><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_25686407-724a-4f7c-a1b3-9116f118189d" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant components of the Company&#8217;s net deferred income tax assets (liabilities) are as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred tax assets:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net operating loss carryforwards</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8de97f4a-97d9-4b1c-a21a-5e73c755fb26" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">61,615</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1de62604-1639-4ddf-8a4e-41d666c99ad6" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">53,072</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">R&amp;D credits</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_472de35a-62f3-4971-8de2-bfb5295d7d09" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,693</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ba4e65ab-3ade-496f-88ed-343b9b0e32c3" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,856</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">R&amp;E expenses</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9b562895-7ed9-43b6-9985-7933be7c9046" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,127</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6878e48b-b6b9-4e95-a21e-988ccc1ef9d7" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,219</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accruals and reserves</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_86bf524e-aa49-4441-8170-5ffb39defa78" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">409</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6f7db906-a148-4afb-8239-78d9c07bc949" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">278</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equity-based compensation</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_39a50b7f-5687-43c5-90ee-19735607c84e" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,193</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9c58656d-4293-42a3-9e02-55127418278c" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,440</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Depreciation and amortization</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_037ebebe-ca9d-4ba8-baa7-855694ad74b6" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ba109a19-4d9c-4f9a-8186-be95f38eb663" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lease liability</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_012bab27-6b3d-482b-b248-557ad3ce8dc6" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="sera:DeferredTaxAssetsLeaseLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">184</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6bee4584-d20b-46f7-b434-5ad26d4a6ef4" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="sera:DeferredTaxAssetsLeaseLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">317</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_25315cf1-f948-4538-b70b-58226b813086" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:DeferredTaxAssetsOther" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7e57a639-9ac4-4f74-9081-bc718101ac94" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:DeferredTaxAssetsOther" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred tax asset before allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b65d2d88-9946-4e60-927d-ae20657a10e6" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:DeferredTaxAssetsGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">78,233</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_59f69086-da82-4805-8dc9-f95f1e7cb2a2" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:DeferredTaxAssetsGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">65,189</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: valuation allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_db13fc30-576f-400d-b050-4165de70968b" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">78,058</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_06a042aa-4900-4d75-bdbf-4b57bc0b6ff6" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">64,879</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred tax asset</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d9be1189-f6f7-4938-9705-103beeff118d" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:DeferredTaxAssetsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">175</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_21be7105-dd1b-47e0-be5f-2bf3711e707b" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:DeferredTaxAssetsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">310</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred tax liabilities:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Right-of-use asset</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9953280e-b254-4be1-896e-9c20d23730ff" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="sera:DeferredTaxLiabilitiesRightOfUseAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">175</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9bfddd28-84c0-4338-a75a-06dfb19fa9c4" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="sera:DeferredTaxLiabilitiesRightOfUseAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">306</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Depreciation and amortization</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_aee079ba-12a9-4c25-93f4-fef3ce12992b" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net deferred tax assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8b909d95-7e62-40bf-8d4f-12a4b17f1e11" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_052fab6e-aebe-49ae-bca4-5bbf3259a584" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Management assesses the available positive and negative evidence to estimate if sufficient future taxable income will be generated to use the existing deferred tax assets. A significant piece of objective negative evidence evaluated is the cumulative loss incurred since inception. Such objective evidence limits the ability to consider other subjective evidence such as the Company&#8217;s projections for future growth.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On the basis of this evaluation, a full valuation allowance of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ffeeafd2-aa9d-4e1f-befb-462a7d0bd65f" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">78.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_97e2fcc9-0499-4d70-9175-f5edfe42981c" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">64.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million has been recorded as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, as it is more likely than not that the deferred tax assets will not be realized. The valuation allowance increased by $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2caffd96-91c5-4360-8c93-2a275deab40b" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">13.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_20dd3c13-29e7-4f80-9c30-4d603e41115d" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">10.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023, respectively, and there is no tax benefit presented in the accompanying financial statements.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is subject to minimum taxes in several of the state jurisdictions where it files income tax returns. The amounts paid are immaterial and not presented above as a component of the current state tax provision.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company had U.S. federal and state net operating loss carryforwards of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_66039dc1-f865-468f-be0f-67def062d2c2" contextRef="C_43042710-b071-477a-ab25-8b8bacc949b5" name="us-gaap:OperatingLossCarryforwards" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">239.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3ceba08c-ae75-4392-9d05-b3c3e21cc46f" contextRef="C_ae2c36a5-c404-4f89-b850-51f7ae29526d" name="us-gaap:OperatingLossCarryforwards" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">182.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively. Of the federal amount, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f2fa59e3-f060-4171-8c72-bba1f05b1799" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:OperatingLossCarryforwards" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">169.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million can be carried forward indefinitely, while the remainder begins to expire after 2028, if not utilized. The state amounts begin to expire at various dates after 2030.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Because of the change of ownership provisions of the Tax Reform Act of 1986, use of a portion of the Company&#8217;s NOL and tax credit carryforwards may be limited in future periods. Further, a portion of the carryforwards may expire before being applied to reduce future income tax liabilities. There are currently no federal or state tax audits in progress. All prior tax years remain subject to examination by Federal and State of Utah authorities due to the existence of net operating loss carryforwards.</span></p></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">121</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div><ix:continuation id="F_f6a61e1d-5b3c-4e24-b739-f91f5c159573_2"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recognizes the tax benefit of an uncertain tax position only if it is more likely than not that a tax position will be sustained upon examination by the appropriate taxing authorities, based on technical merits. The reversal of the uncertain tax positions would not affect the Company&#8217;s effective tax rate to the extent that it continues to maintain a full valuation allowance against its deferred tax assets. As of December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company did not record any material interest expense or penalties related to uncertain tax positions or the settlement of audits for prior periods. The Company does not expect a significant increase or decrease in its uncertain tax positions within the next 12 months. </span><span><ix:nonNumeric id="F_479298b4-8749-4612-9090-609fa6e0f163" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" escape="true" continuedAt="F_479298b4-8749-4612-9090-609fa6e0f163_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A reconciliation of the beginning and ending amount of uncertain tax positions (in thousands):</span></ix:nonNumeric></span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:continuation id="F_479298b4-8749-4612-9090-609fa6e0f163_1" continuedAt="F_479298b4-8749-4612-9090-609fa6e0f163_2"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at the beginning of the year</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e5690328-d722-4391-af93-e2d2f29f0035" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,570</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2d714ef5-6d6f-4572-bce4-b31407346ed8" contextRef="C_bbe124b6-5e26-4340-9b7f-2ec3e167c7a7" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,025</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gross increases&#8212;prior period</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a59837de-4d08-42e8-9a30-fd469359cb1a" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_88c0f062-63b9-42ea-8324-a0f53eee0b17" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">80</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gross increases&#8212;current period</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cfa4daee-9f6d-40ab-8fcc-82c89b0fcf27" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">559</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_40a9cfc6-b7eb-46f8-8542-da51d9a09471" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">465</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at the end of the year</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9bcc5a56-587c-4abe-a371-0064044d8689" contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,129</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_92dbe89b-46ba-4a1b-83e3-f245aafead2c" contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,570</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:continuation></div></ix:continuation></div>
  <div><ix:continuation id="F_479298b4-8749-4612-9090-609fa6e0f163_2"></ix:continuation></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d3f05e52-ca59-42ee-8879-330e0cb13f5c" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:EarningsPerShareTextBlock" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">15</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Net Loss Per Share</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company calculates net loss per share of Class A and Class B common stock using the two-class method. For periods in which the Company reports a net loss, all potentially dilutive shares are anti-dilutive and are therefore excluded from the calculation of diluted net loss per share. For the years ended December 31, 2024 and 2023, the Company reported net losses and as such, basic and diluted net loss per share are the same.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As the liquidation and dividend rights are identical for Class A and Class B common shares, the undistributed earnings are allocated on a proportionate basis and the resulting amount per share for Class A and Class B common stock was the same for the years ended December 31, 2024 and 2023.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_36e14c48-e350-44d2-bf9a-40a65ec62e8b" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company excluded the following potentially dilutive securities, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share for the periods indicated because their impact would have been anti-dilutive:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.967%;box-sizing:content-box;"/>
        <td style="width:1.16%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.357%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.16%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.357%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Warrants to purchase Class A common stock</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dc18f44b-5b08-409f-bdf7-aba78b6ebcdf" contextRef="C_6df1f8d2-5436-460d-9378-2e480850c840" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">2,646,247</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_22e8660d-cd31-4f93-8ca2-cc951c17d797" contextRef="C_c6d246ba-4eb3-4ae3-9dc3-001abd64e5cc" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">2,775,978</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Options to purchase Class A common stock</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9e744b8b-3fc6-4db1-8997-09a93a2b275a" contextRef="C_bc82f716-4cb8-4ed6-9807-7a362747d97c" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">6,113,155</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b7376e45-3566-4435-9c7d-7e2416171652" contextRef="C_8620e36e-b199-4b2d-8cc2-4ba15f93a3c0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">7,251,663</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Restricted stock units outstanding</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_60c86d44-87b2-4775-915a-11ddb35f3d85" contextRef="C_7c6f287f-0cf6-4dfb-9a02-3a6ce54488cd" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">1,631,162</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b35e2415-cdda-4c90-b325-3727d69d644a" contextRef="C_09f10352-d759-4530-8098-b6299171a509" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">2,692,459</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_67b05d94-5d76-412c-8a15-d5218908b422" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">10,390,564</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2fcdc85c-1842-40a5-a3d7-7acec601d348" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">12,720,100</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">122</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_451dab98-6c3c-49f0-90eb-63d20fd6f61d" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:SegmentReportingDisclosureTextBlock" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">16. Segment Information</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s revenue was generated in the U.S. for all periods presented and its assets are all located in the U.S.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c56bcfce-6cde-4ed3-aff9-48cf2d4b142a" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" escape="true"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table presents segment information for revenue, significant segment expenses, and segment loss expenses that are regularly provided to the CODM for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 (in thousands):</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:68.094%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.123000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.66%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.123000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revenue</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9c383f3c-adfb-42ee-a69c-38d74d298da2" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:Revenues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">77</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_93aa8d90-2705-4b46-af7f-5228f0c49546" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:Revenues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">306</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less:</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cost of revenue</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9a91ca32-ccef-4453-a613-1868f1625ac8" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:CostOfRevenue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">82</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1a7621b7-1c21-4a0f-b2fa-bbeef8ba473f" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:CostOfRevenue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">210</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payroll related expenses</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5ae1871b-ccfe-43cf-b590-278095485feb" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:OtherLaborRelatedExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,269</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_12c8872a-c056-4057-865c-4c7b05280290" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:OtherLaborRelatedExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,878</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation expense</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_03b98036-7a96-4ff9-9fe6-b735a56d4599" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,013</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fbd35f3c-2185-487f-89db-e7fe310fd4a5" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,273</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Consulting and professional fees</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bec39c92-cb88-44ce-8e6d-b11e3068d866" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:ProfessionalFees" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,581</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_030b4a0e-888f-4898-86d3-10cc21fe1139" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:ProfessionalFees" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,012</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Clinical studies and outside processing</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cf56b1f4-370b-4015-8ae7-120aa65ebfa7" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="sera:ClinicalStudiesAndOutsideProcessing" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,383</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d42107a0-9d3d-4133-8dc0-55d2eed357b1" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="sera:ClinicalStudiesAndOutsideProcessing" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,728</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equipment, lab supplies, and facility expenses</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7507b8da-73a6-4c89-aeed-0eefaaf3071a" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="sera:EquipmentLabSuppliesAndFacilityExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,635</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_47a1f0d7-6762-4c23-a45d-d466ec6b35c0" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="sera:EquipmentLabSuppliesAndFacilityExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,037</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Depreciation and amortization</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(1)</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_caaf99d2-d8a8-431a-b018-f19a87936092" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:DepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">814</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f9c4a6fc-3bec-484b-b399-d505aff6f469" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:DepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">900</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other segment items</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(2)</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5ac347dd-685a-4ec6-af84-254528d32312" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:SegmentReportingOtherItemAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,935</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9dfc5991-3acf-4daa-9315-2bf66f7f4e40" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:SegmentReportingOtherItemAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,089</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss from operations</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8e56f7b6-2f77-496c-9866-c2d59143ed97" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">36,635</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1bfc62a5-f82b-4603-bc95-8d3d5936c072" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">39,821</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest expense</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1a5d7ae0-ffe5-49c0-b3f9-fbf2515513f5" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:InterestExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">28</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_756c83ef-b7a5-47d0-b6b0-437b4df8cb9f" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:InterestExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">55</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other income, net</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5da40c2b-8231-4748-b5e4-ad285bff41d2" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:NonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,765</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_55debb58-92b3-4a32-98d7-b1bdae851549" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:NonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,634</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_759593d6-07e8-4a16-bec8-01ff5906d475" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">32,898</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_327b4fb9-fb29-49a1-a5ef-3bf257ad4818" contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">36,242</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(1) </span><ix:footnote id="FNT_2dcb3b77-9a24-48d2-af9f-a1d39507d595" xml:lang="en-US"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain amortization amounts are included within cost of revenue.</span></ix:footnote></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(2) </span><ix:footnote id="FNT_a7b0fa6b-e70a-4d12-b747-675c650fdd97" xml:lang="en-US"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other segment items consist primarily of insurance costs, IT services, travel expenses, marketing expenses, taxes, and other miscellaneous expense.</span></ix:footnote></p></ix:nonNumeric></div></ix:nonNumeric></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8a1c9c74-82a0-4f21-a259-e890779f9e5f" contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5" name="us-gaap:SubsequentEventsTextBlock" escape="true"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">17</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Subsequent Events</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 12, 2025, the Company closed an underwritten public offering (the "February 2025 Offering") in which the Company issued and sold </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_12883359-fea4-4a6e-9271-9bdd76c928c6" contextRef="C_d64a0010-f1a5-45de-9e6c-65d4f9fdd0dd" name="us-gaap:CommonUnitIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,250,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of the Company&#8217;s Class A common stock at a price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6fcc08f4-7936-42e5-b266-0325c6b76690" contextRef="C_d64a0010-f1a5-45de-9e6c-65d4f9fdd0dd" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">4.00</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share and pre-funded warrants (the &#8220;Pre-Funded Warrants&#8221;) to purchase up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d19d57c3-7880-481a-a098-0f6c466028a7" contextRef="C_49e34717-cb5a-4860-9e99-7bca256906a4" name="sera:WarrantsIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">11,250,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of the Company&#8217;s Class A common stock (the &#8220;Firm Shares&#8221;) at an offering price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bc4fc840-f0c2-4fb3-8ac7-0b6ebc09661a" contextRef="C_49e34717-cb5a-4860-9e99-7bca256906a4" name="sera:WarrantIssuedPricePerPre-FundedWarrantAndAccompanyingWarrant" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">3.9999</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per Pre-Funded Warrant, which represents the per share offering price for the Firm Shares less the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a1405f98-3511-456e-a505-b8baf0f35be6" contextRef="C_49e34717-cb5a-4860-9e99-7bca256906a4" name="sera:IssuePricePerShareAndWarrant" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.0001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share exercise price for each Pre-Funded Warrant. These Pre-Funded Warrants were recorded as a component of shareholders&#8217; equity within additional paid-in capital. The gross proceeds to the Company from the February 2025 Offering were $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0a398f8e-25ee-4e92-b872-50dc8829a9a8" contextRef="C_a77c3867-9623-4313-a505-f21cd62befe2" name="sera:ProceedsFromIssuanceOfSharesAndPreFundedWarrants" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">50.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million before deducting underwriting discounts and commissions and other offering expenses. The net proceeds to the Company from the February 2025 Offering were approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7fbebdec-ad4a-4f2a-9813-143b6f942599" contextRef="C_a77c3867-9623-4313-a505-f21cd62befe2" name="sera:ProceedsFromIssuanceOfSharesAndPreFundedWarrantsNet" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">46.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, after deducting underwriting commissions and offering expenses. The Pre-Funded Warrants are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the warrant if the holder, together with its affiliates, would beneficially own more than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_66486d99-f012-4de0-982c-b91d38d4d582" contextRef="C_49e34717-cb5a-4860-9e99-7bca256906a4" name="sera:PercentageOfMinimumOwnershipBeneficiallyOwnByHolderWithAffiliatesToWarrantExercise" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">4.99</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the number of shares of Class A common stock outstanding immediately after giving effect to such exercise. A holder of Pre-Funded Warrants may increase or decrease this percentage, but not in excess of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_68efdfd7-dbd3-43aa-b720-987cde38f2e9" contextRef="C_f4fd4321-eb36-4c63-ab4e-5f27e634d46d" name="sera:FairValueAdjustmentOfPreFundedWarrants" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">19.99</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, by providing at least 61 days&#8217; prior notice to the Company.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 13, 2025, the representatives of the underwriters in connection with the February 2025 Offering exercised their option in full to purchase an additional </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_977ac64b-73d8-4bd7-b827-7e87ef56210d" contextRef="C_82cc2c89-a0ca-4534-9da0-23ce655262eb" name="sera:CommonStockAdditionalShares" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,875,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Class A common stock, which increased the aggregate number of shares of Class A common stock sold in the February 2025 Offering to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_26a605cc-1f55-49e2-a94a-cf65509e6f1c" contextRef="C_82cc2c89-a0ca-4534-9da0-23ce655262eb" name="us-gaap:CommonUnitIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">3,125,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Company&#8217;s aggregate gross proceeds from the February 2025 Offering were $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_59f1e0c5-4595-419d-9a03-71c603e2c50c" contextRef="C_a77c3867-9623-4313-a505-f21cd62befe2" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">57.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, before deducting underwriting discounts and commissions and offering expenses; $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_72c040b1-8c08-476d-8c3e-9ef2f0513fb4" contextRef="C_b56db086-392f-4885-98c2-c27491c047ea" name="sera:OfferingExpenses" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">7.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of which relates to the exercise of the underwriters&#8217; option on February 13, 2025. The Company&#8217;s aggregate net proceeds from the February 2025 Offering were $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_144c557c-3166-4185-a272-dc6b54105818" contextRef="C_a77c3867-9623-4313-a505-f21cd62befe2" name="sera:ProceedsFromIssuanceInitialPublicOfferingNet" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">53.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, after deducting underwriting discounts and commissions and offering expenses; $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e8c5f925-c747-4bd4-bbdc-5856ed52f7fd" contextRef="C_a4a98f25-89ec-4c7d-be42-82aacc24e38e" name="us-gaap:ProceedsFromStockOptionsExercised" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">7.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of which relates to the exercise of the underwriters&#8217; option on February 13, 2025.</span></p></ix:nonNumeric></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">123</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_9_changes_in_and_disagreements"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 9. Changes in and Di</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">sagreements With Accountants on Accounting and Financial Disclosure</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">None.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_9a_controls_and_procedures"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 9A. Controls and</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Procedures</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Evaluation of Disclosure Controls and Procedures</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We maintain &#8220;disclosure controls and procedures,&#8221; as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, that are designed to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Our management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and our management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our management, with the participation of our Chief Executive Officer (our principal executive officer) and Chief Financial Officer (our principal financial officer and principal accounting officer), evaluated the effectiveness of our disclosure controls and procedures as of December 31, 2024. Based on the evaluation of our disclosure controls and procedures as of December 31, 2024, our Chief Executive Officer and Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Changes in Internal Control Over Financial Reporting</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There were no changes in our internal control over financial reporting that occurred during the period covered by this Annual Report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Management&#8217;s Annual Report on Internal Control Over Financial Reporting</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our management assessed the effectiveness of our internal control over financial reporting as of December 31, 2024. In making this assessment, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control-Integrated Framework. Based on our assessment, management believes that, as of December 31, 2024, our internal control over financial reporting is effective based on those criteria.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_9b_other_information"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 9B. Other Infor</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">mation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Rule 10b5-1 Trading Arrangements</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the quarter ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, none of the other officers (as defined in Section 16 of the Exchange Act) and directors </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0149da50-ea7e-4309-bea0-499cbfb32218" contextRef="C_208b76c5-59c1-4209-a49b-266bd3873544" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-false"><ix:nonNumeric id="F_4e817ffd-2b11-4c41-ac44-b0007145f6a6" contextRef="C_208b76c5-59c1-4209-a49b-266bd3873544" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">adopted </span></ix:nonNumeric></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">or </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0512cf42-08c6-42c8-8ce9-931905fbc93b" contextRef="C_208b76c5-59c1-4209-a49b-266bd3873544" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-false"><ix:nonNumeric id="F_4475edec-bb1b-4253-882f-e983aa3847a8" contextRef="C_208b76c5-59c1-4209-a49b-266bd3873544" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">terminated</span></ix:nonNumeric></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> any contract, instruction, or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense of Rule 10b5-1(c) or any &#8220;non-Rule 10b5-1 trading arrangement,&#8221; as defined in Item 408(a) of Regulation S-K.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Appointment of Jeffrey T. Elliot as Director</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 17, 2025, our board of directors appointed Jeffrey T. Elliot, effective March 20, 2025 (the &#8220;Effective Date&#8221;), as a director to our board of directors to serve as a Class II Director with a term expiring at our 2026 Annual Meeting of Stockholders and as a member of the audit committee of the board of directors.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">124</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Mr. Elliot, age 47, has served as a Senior Advisor of Boston Consulting Group, a global consulting firm, since August 2024. Mr. Elliot has served on the board of directors of Quanterix Corporation (Nasdaq: QTRX), a publicly traded life sciences research and diagnostics company, since August 2024 and previously served on the board of directors of Exagen Inc. (Nasdaq: XGN), a publicly traded diagnostics company from March 2019 to July 2021. Prior to his current roles, Mr. Elliot was Chief Financial Officer of Exact Sciences Corporation, a molecular diagnostics company, from November 2016 to August 2024. Formerly, Mr. Elliott served as the Vice President, Business Development and Strategy of Exact Sciences from June 2016 to November 2016. From 2007 to 2016, Mr. Elliott was with Robert W. Baird &amp; Co., where from June 2012 to June 2016 he was a senior research analyst who covered diagnostics and life science tools companies. Earlier in his career, Mr. Elliott worked in a supply chain role for Walgreens and as a consultant at Cap Gemini Ernst &amp; Young. Mr. Elliott earned a B.S. in business administration from the University of Illinois at Urbana-Champaign and an M.B.A. from the University of Chicago Booth School of Business. Mr. Elliott is a CFA charterholder.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with Mr. Elliot&#8217;s appointment to our board of directors, and pursuant to our Non-Employee Director Compensation Policy, on the Effective Date (the &#8220;Grant Date&#8221;), we will grant Mr. Elliot the lesser of (a) an equity award with a grant date fair value of $240,000, with approximately equal value coming from options and from restricted stock units (&#8220;RSUs&#8221;), or (b) an equity award of 100,000 option equivalents (the &#8220;Award&#8221;); where &#8220;option equivalents&#8221; means a specific number of shares, in the case of options, and a different number of RSUs that have value approximately equal to the fair market value of that specific number of options based on a Black-Scholes valuation method and rounded down to the nearest whole share. The Award shall have a per share exercise price for options equal to the fair market value (as defined in our 2021 Equity Incentive Plan) of our Class A common stock on the Grant Date. The Award will vest in thirty-six (36) substantially equal monthly installments following the Grant Date, subject to Mr. Elliot continuing to provide services to us through each such vesting.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, Mr. Elliot is entitled to receive an annual cash retainer of $35,000 for his service as our non-employee director and $15,000 for his service as a member of the audit committee of the board of directors, pursuant to our Non-Employee Director Compensation Policy, prorated for the portion of the year that Mr. Elliot serves as a director.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Also in connection with Mr. Elliot&#8217;s appointment to the board of directors, we will enter into an indemnification agreement with Mr. Elliot in the form we have entered into with our other non-employee directors, which form is filed as Exhibit 10.1 to our Amendment No. 1 to our Registration Statement on Form S-1 (File No. 333-257038) filed by on July 8, 2021. Under this agreement, we will agree, among other things, to indemnify Mr. Elliot for certain expenses (including attorneys&#8217; fees), judgments, fines and settlement amounts reasonably incurred by Mr. Elliot in any action or proceeding arising out of his service as one of our directors to the maximum extent allowed under Delaware law.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There are no arrangements or understandings between Mr. Elliot and any other person pursuant to which Mr. Elliot was appointed as a director. There are no transactions to which we are a party and in which Mr. Elliot has a material interest that are required to be disclosed under Item 404(a) of Regulation S-K. Mr. Elliot has not previously held any positions with us and has no family relations with any of our directors or executive officers.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Departure of Directors</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 14, 2025, Ryan Trimble notified our board of directors of his decision to resign from our board of directors and any committees thereof, effective June 30, 2025. Mr. Trimble&#8217;s decision to resign was not due to any disagreement with the Company on any matter relating to the Company&#8217;s operations, policies or practices.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 17, 2025, Marcus Wilson, Pharm.D., notified our board of directors of his decision not to stand for re-election to the board of directors at the end of his current term at our 2025 annual meeting of stockholders currently expected to be held on June 5, 2025. Dr. Wilson&#8217;s decision not to stand for re-election was not due to any disagreement with the Company on any matter relating to the Company&#8217;s operations, policies or practices.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_9c_disclosure_regarding"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 9C. Disclosure Re</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">garding Foreign Jurisdiction that Prevent Inspections</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Not applicable.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">125</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="part_iii"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PART</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> III</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_10_directors_executive_officers"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 10. Directors, Exe</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">cutive Officers and Corporate Governance</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The response to this item is incorporated by reference from the discussion responsive thereto under the captions &#8220;Board of Directors and Corporate Governance&#8221;, &#8220;Executive Officers,&#8221; and "Prohibition on Hedging and Pledging" in our Proxy Statement to be filed with the SEC within 120 days of the fiscal year ended December 31, 2024 in connection with the solicitation of proxies for our 2025 annual meeting of stockholders.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_11_executive_compensation"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 11</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Executive Compensation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The response to this item is incorporated by reference from the discussion responsive thereto under the captions &#8220;Non-Employee Director Compensation&#8221; and &#8220;Executive Compensation&#8221; in our Proxy Statement to be filed with the SEC within 120 days of the fiscal year ended December 31, 2024.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_12_security_ownership_of_certain"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 12. Security</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The response to this item is incorporated by reference from the discussion responsive thereto under the caption &#8220;Security Ownership of Certain Beneficial Owners and Management&#8221; in our Proxy Statement to be filed with the SEC within 120 days of the fiscal year ended December 31, 2024.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_13_certain_relationships_and"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 13. Certain Relation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ships and Related Transactions, and Director Independence</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The response to this item is incorporated by reference from the discussion responsive thereto under the captions &#8220;Certain Relationships, Related Party and Other Transactions&#8221; and &#8220;Board of Directors and Corporate Governance&#8221; in our Proxy Statement to be filed with the SEC within 120 days of the fiscal year ended December 31, 2024.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_14_principal_accounting"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 14. Principa</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">l Accounting Fees and Services</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The response to this item is incorporated by reference from the discussion responsive thereto under the caption &#8220;Ratification of Appointment of Independent Registered Public Accounting Firm&#8221; in our Proxy Statement to be filed with the SEC within 120 days of the fiscal year ended December 31, 2024.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">126</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="part_iv"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PA</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RT IV</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_15_exhibit_and_financial"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 15. Exhibits an</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">d Financial Statement Schedules</span></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:9pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(a)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Documents Filed as Part of This Annual Report</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:9pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial Statements</span></div></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">See &#8220;Index to Financial Statements&#8221; at Item 8 to this Annual Report.</span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:9pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial Statement Schedules</span></div></div>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial statement schedules have been omitted because they are not applicable or because the required information is included in the financial statements and accompanying notes included in this Annual Report.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:9pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(3)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibits</span></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:9%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:90%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.75pt solid #000000;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit</span></p><p style="font-size:8pt;margin-top:0.75pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.75pt solid #ffffff03;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.75pt solid #000000;padding-right:0.037in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:1.5pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Description</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.1</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534969/000110465921094030/tm2122556d1_ex3-1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Amended and Restated Certificate of Incorporation of Sera Prognostics, Inc., as amended (incorporated by reference to Exhibit 3.1 of the Registrant&#8217;s Current Report on Form 8-K (File No. 001-40606) filed with the SEC on July 20, 2021).</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.2</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534969/000153496923000069/a20230608-8xkxexhibit31.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Certificate of Amendment to Amended and R</span></a><a href="https://www.sec.gov/Archives/edgar/data/1534969/000153496923000069/a20230608-8xkxexhibit31.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">estated</span></a><a href="https://www.sec.gov/Archives/edgar/data/1534969/000153496923000069/a20230608-8xkxexhibit31.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;"> Certificate of Incorporation of Sera Prognostics, Inc., dated June 9, 2023 (inc</span></a><a href="https://www.sec.gov/Archives/edgar/data/1534969/000153496923000069/a20230608-8xkxexhibit31.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">orporated by reference to Exhibit 3.1 of the Registrant</span></a><a href="https://www.sec.gov/Archives/edgar/data/1534969/000153496923000069/a20230608-8xkxexhibit31.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">&#8217;</span></a><a href="https://www.sec.gov/Archives/edgar/data/1534969/000153496923000069/a20230608-8xkxexhibit31.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">s Current Report on Form 8-K (File No. 001-40606) filed with the SEC on June 14, 2023).</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.3</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534969/000110465921094030/tm2122556d1_ex3-2.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Amended and Restated Bylaws of Sera Prognostics, Inc. (incorporated by reference to Exhibit 3.2 of the Registrant&#8217;s Current Report on Form 8-K (File No. 001-40606) filed with the SEC on July 20, 2021).</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.1</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534969/000110465921089973/tm2110724d14_ex4-1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Specimen Class A Common Stock Certificate (incorporated by reference to Exhibit 4.1 of the Registrant&#8217;s Registration Statement on Form S-1/A (File No. 333-257038) filed with the SEC on July 8, 2021).</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.2</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534969/000110465921080206/tm2110724d11_ex4-2.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form of Common Stock Purchase Warrant&#8201;&#8211;&#8201;I (incorporated by reference to Exhibit 4.2 of the Registrant&#8217;s Registration Statement on Form S-1 (File No. 333-257038) filed with the SEC on June 11, 2021).</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.3</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534969/000110465921080206/tm2110724d11_ex4-3.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form of Common Stock Purchase Warrant&#8201;&#8211;&#8201;II (incorporated by reference to Exhibit 4.3 of the Registrant&#8217;s Registration Statement on Form S-1 (File No. 333-257038) filed with the SEC on June 11, 2021).</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.4</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534969/000110465921080206/tm2110724d11_ex4-4.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form of Series E Warrant (incorporated by reference to Exhibit 4.4 of the Registrant&#8217;s Registration Statement on Form S-1 (File No. 333-257038) filed with the SEC on June 11, 2021).</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.5</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534969/000110465921080206/tm2110724d11_ex4-5.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Fourth Amended and Restated Investors&#8217; Rights Agreement, dated as of February 23, 2021 (incorporated by reference to Exhibit 4.5 of the Registrant&#8217;s Registration Statement on Form S-1 (File No. 333-257038) filed with the SEC on June 11, 2021).</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.6</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534969/000153496922000034/sera-20211231x10kxex46.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Description of Securities (incorporated by reference to Exhibit 4.6 of the Registrant&#8217;s Annual Report on Form 10-K (File No. 001-40606) filed with the SEC on March 29, 2022).</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.7</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534969/000119312525024518/d862672dex41.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form of Pre-Funded Warrant (incorporated by reference to Exhibit 4.1 of the Registrant's Current Report on Form 8-K (File No. 001-40606) filed with the SEC on February 12, 2025).</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001534969/000110465921089973/tm2110724d14_ex10-1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form of Indemnification Agreement (incorporated by reference to Exhibit 10.1 of the Registrant&#8217;s Registration Statement on Form S-1/A (File No. 333-257038) filed with the SEC July 8, 2021).</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.2+</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001534969/000110465921089973/tm2110724d14_ex10-3.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">2021 Equity Incentive Plan (incorporated by reference to Exhibit 10.3 of the Registrant&#8217;s Registration Statement on Form S-1/A (File No. 333-257038) filed with the SEC on July 8, 2021).</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.3+</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001534969/000110465921089973/tm2110724d14_ex10-4.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form of 2021 Employee Stock Purchase Plan (incorporated by reference to Exhibit 10.4 of the Registrant&#8217;s Registration Statement on Form S-1/A (File No. 333-257038) filed with the SEC on July 8, 2021).</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.4+</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534969/000153496924000055/sera-20231231x10kxex104.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Non-Employee Director Compensation Policy (incorporated by reference to Exhibit 10.4 of the Registrant&#8217;s Annual Report on Form 10-K (File No. 001-40606) filed with the SEC on March 20, 2024.</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.5&#134;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001534969/000110465921080206/tm2110724d11_ex10-5.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Commercial Collaboration Agreement, dated as of February 17, 2021, by and between Anthem, Inc. and the Registrant (incorporated by reference to Exhibit 10.5 of the Registrant&#8217;s Registration Statement on Form S-1 (File No. 333-257038) filed with the SEC on June 11, 2021).</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.6&#134;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001534969/000110465921080206/tm2110724d11_ex10-6.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Laboratory Services Agreement, effective as of November 10, 2020, by and among Anthem Health Insurance and Amerigroup Corporation and the Registrant (incorporated by reference to Exhibit 10.6 of the Registrant&#8217;s Registration Statement on Form S-1 (File No. 333-257038) filed with the SEC on June 11, 2021).</span></a></p></td>
   </tr>
  </table>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">127</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:9%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:90%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.7&#134;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001534969/000110465921080206/tm2110724d11_ex10-8.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Side Letter with Baker Bros. Advisors LP, dated as of April 29, 2021, by and between Baker Bros. Advisors LP and the Registrant (incorporated by reference to Exhibit 10.8 of the Registrant&#8217;s Registration Statement on Form S-1 (File No. 333-257038) filed with the SEC on June 11, 2021).</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.7.1&#134;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534969/000153496923000030/sera-20221231x10kxex108.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Amendment No. 1, dated February 16, 2023, to Side Letter with Baker Bros. Advisors LP, dated as of April 29, 2021, by and between Baker Bros. Advisors LP and the Registrant (incorporated by reference to Exhibit 10.8 of the Registrant&#8217;s Annual Report on Form 10-K (File No. 001-40606) filed with the SEC on March 22, 2023).</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.7.2&#134;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534969/000153496924000055/sera-20231231x10kxex1072.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Amendment No. 2, dated December 6, 2023, to Side Letter with Baker Bros. Advisors LP, dated as of April 29, 2021, by and between Baker Bros. Advisors LP and the Registrant (incorporated by reference to Exhibit 10.7.2 of the Registrant&#8217;s Annual Report on Form 10-K (File No. 001-40606) filed with the SEC on March 20, 2024).</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.8+</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534969/000153496922000034/sera-20211231x10kxex1011.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consulting Agreement by and between the Registrant and Douglas Fisher, dated January 10, 2022 (incorporated by reference to Exhibit 10.11 of the Registrant&#8217;s Annual Report on Form 10-K (File No. 001-40606) filed with the SEC on March 29, 2022).</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.9+</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001534969/000110465921080206/tm2110724d11_ex10-13.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Employment Agreement by and between the Registrant and John J. Boniface, dated March 14, 2012 (incorporated by reference to Exhibit 10.13 of the Registrant&#8217;s Registration Statement on Form S-1 (File No. 333-257038) filed with the SEC on June 11, 2021).</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.10+</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534969/000153496924000055/sera-20231231x10kxex1013.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Amendment to Employment Agreement by and between the Registrant and John J. Boniface, dated March 18, 2024 (incorporated by reference to Exhibit 10.13 of the Registrant&#8217;s Annual Report on Form 10-K (File No. 001-40606) filed with the SEC on March 20, 2024).</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.11+</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001534969/000110465921080206/tm2110724d11_ex10-16.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Employment Agreement by and between the Registrant and Benjamin Jackson, dated April 13, 2021 (incorporated by reference to Exhibit 10.16 of the Registrant&#8217;s Registration Statement on Form S-1 (File No. 333-257038) filed with the SEC on June 11, 2021).</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.12+</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534969/000153496922000034/sera-20211231x10kxex1015.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Amendment to Employment Agreement by and between the Registrant and Benjamin Jackson, dated May 20, 2021 (incorporated by reference to Exhibit 10.15 of the Registrant&#8217;s Annual Report on Form 10-K (File No. 001-40606) filed with the SEC on March 29, 2022).</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.13+</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534969/000153496924000055/sera-20231231x10kxex1016.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Amendment to Employment Agreement by and between the Registrant and Benjamin Jackson, dated March 18, 2024 incorporated by reference to Exhibit 10.16 of the Registrant&#8217;s Annual Report on Form 10-K (File No. 001-40606) filed with the SEC on March 20, 2024).</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.14+</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001534969/000153496921000018/sera-20210930x10qxex101.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Employment Agreement by and between the Registrant and Paul Kearney, dated October 1, 2021 (incorporated by reference to Exhibit 10.1 of the Registrant&#8217;s Quarterly Report on Form 10-Q (File No. 001-40606) filed with the SEC on November 9, 2021).</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.15+</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534969/000153496924000055/sera-20231231x10kxex1018.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Amendment to Employment Agreement by and between the Registrant and Paul Kearney, dated March 18, 2024 (incorporated by reference to Exhibit 10.18 of the Registrant&#8217;s Annual Report on Form 10-K (File No. 001-40606) filed with the SEC on March 20, 2024.</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.16+</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534969/000153496922000034/sera-20211231x10kxex1019.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Employment Agreement by and between the Registrant and Robert Gardner Harrison, dated March 30, 2021 (incorporated by reference to Exhibit 10.19 of the Registrant&#8217;s Annual Report on Form 10-K (File No. 001-40606) filed with the SEC on March 29, 2022).</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.17+</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534969/000153496922000034/sera-20211231x10kxex1020.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Amendment to Employment Agreement by and between the Registrant and Robert Gardner Harrison, dated May 20, 2021 (incorporated by reference to Exhibit 10.20 of the Registrant&#8217;s Annual Report on Form 10-K (File No. 001-40606) filed with the SEC on March 29, 2022).</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.18+</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534969/000153496924000055/sera-20231231x10kxex1023.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Amendment to Employment Agreement by and between the Registrant and Robert Gardner Harrison, dated March 18, 2024 (incorporated by reference to Exhibit 10.23 of the Registrant&#8217;s Annual Report on Form 10-K (File No. 001-40606) filed with the SEC on March 20, 2024).</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.19+</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534969/000153496923000112/sera-20230930x10qxex101.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Employment Agreement by and between the Registrant and Evguenia (Zhenya) Lindgardt, dated November 6, 2023 (incorporated by reference to Exhibit 10.1 of the Registrant&#8217;s Quarterly Report on Form 10-Q (File No. 001-40606) filed with the SEC on November 8, 2023).</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.20+</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534969/000153496923000112/sera-20230930x10qxex102.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Employment Agreement by and between the Registrant and Austin Aerts, dated November 6, 2023 (incorporated by reference to Exhibit 10.2 of the Registrant&#8217;s Quarterly Report on Form 10-Q (File No. 001-40606) filed with the SEC on November 8, 2023).</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.21+</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534969/000153496924000055/sera-20231231x10kxex1028.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Amendment to Employment Agreement by and between the Registrant and Austin Aerts, dated March 18, 2024 (incorporated by reference to Exhibit 10.28 of the Registrant&#8217;s Annual Report on Form 10-K (File No. 40606) filed with the SEC on March 20, 2024).</span></a></p></td>
   </tr>
  </table>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">128</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:9%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:90%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.22+</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534969/000153496924000055/sera-20231231x10kxex1029.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form of Restricted Stock Unit Agreement under the Registrant&#8217;s 2021 Equity Incentive Plan (incorporated by reference to Exhibit 10.29 of the Registrant&#8217;s Annual Report on Form 10-K (File No. 001-40606) filed with the SEC on March 20, 2024).</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.23</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001534969/000110465921080206/tm2110724d11_ex10-20.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Lease Agreement, effective as of August 1, 2017, by and between Eastland Regency, L.C. and the Registrant (incorporated by reference to Exhibit 10.20 of the Registrant&#8217;s Registration Statement on Form S-1 (File No. 333-257038) filed with the SEC on June 11, 2021).</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.24</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534969/000153496922000034/sera-20211231x10kxex1022.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">First Amendment to Lease, effective as of June 7, 2021, by and between Eastland Regency, L.C. and the Registrant (incorporated by reference to Exhibit 10.22 of the Registrant&#8217;s Annual Report on Form 10-K (File No. 001-40606) filed with the SEC on March 29, 2022).</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.25</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534969/000153496922000130/sera-20220930x10qxex101.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Second Amendment to Lease, effective October 10, 2022, by and between Eastland Regency, L.C. and the Registrant (incorporated by reference to Exhibit 10.1 of the Registrant&#8217;s Quarterly Report on Form 10-Q (File No. 001-40606) filed with the SEC on November 9, 2022).</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.26</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534969/000153496923000092/sera-20230630x10qxex103.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Third Amendment to Lease, effective as of July 25, 2023, by and between Eastland Regency, L.C. and the Registrant (incorporated by reference to Exhibit 10.3 of the Registrant&#8217;s Quarterly Report on Form 10-Q (File No. 001-40606) filed with the SEC on August 9, 2023).</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.27</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534969/000119312524196036/d813517dex12.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Sales Agreement, dated as of August 7, 2024, by and between Sera Prognostics, Inc. and TD Securities (USA) LLC (incorporated by reference to Exhibit 1.2 of the Registrant&#8217;s Registration Statement on Form S-3 (File No. 333-281347) filed on August 7, 2024).</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19.1*</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><a href="sera-ex19_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Insider Trading Policy</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21.1</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001534969/000110465921080206/tm2110724d11_ex21-1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Subsidiaries of the Registrant (incorporated by reference to Exhibit 21.1 of the Registrant&#8217;s Registration Statement on Form S-1 (File No. 333-257038) filed with the SEC on June 11, 2021).</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23.1*</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><a href="sera-ex23_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consent of Independent Registered Public Accounting Firm</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24.1*</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><a href="#signatures"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Power of Attorney (included on signature page)</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31.1*</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><a href="sera-ex31_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31.2*</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><a href="sera-ex31_2.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32.1**</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><a href="sera-ex32_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Certification of Principal Executive Officer and Principal Financial Officer and Principal Accounting Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">97.1+</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1534969/000153496924000055/sera-20231231x10kxex971.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Clawback Policy of the Registrant (incorporated by reference to Exhibit 97.1 of the Registrant&#8217;s Annual Report on Form 10-K (File No. 333-40606) filed with the SEC on March 20, 2024).</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">101.INS</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Inline XBRL Instance Document &#8211; the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">101.SCH</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">104</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.75pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></p></td>
   </tr>
  </table>
  <p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid;margin-right:80%;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">* Filed herewith.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">** The Certification attached as Exhibit 32.1 that accompanies this Annual Report on Form 10-K is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Sera Prognostics, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Annual Report on Form 10-K, irrespective of any general incorporation language contained in such filing.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">+ Indicates a management contract or any compensatory plan, contract or arrangement.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#134; Portions of this exhibit (indicated by asterisks) have been omitted in accordance with the rules of the Securities and Exchange Commission.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_16_form_10_k_summary"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">16. Form 10-K Summary</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">None.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">129</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#toc_page"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;display:inline-block;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></a></p></div>
  <div style="padding-top:0.31in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="signatures"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SIGN</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ATURES</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:0.093%;border-spacing:0;table-layout:auto;width:98.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:47.42%;box-sizing:content-box;"/>
    <td style="width:52.58%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">SERA PROGNOSTICS, INC.</span></p></td>
   </tr>
   <tr style="height:10.1pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date: March 19, 2025</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.75pt solid #000000;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Zhenya Lindgardt</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.5pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Zhenya Lindgardt</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">President and Chief Executive Officer</span></p></td>
   </tr>
  </table>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Each person whose individual signature appears below hereby authorizes and appoints Zhenya Lindgardt and Austin Aerts, and each of them, with full power of substitution and resubstitution and full power to act without the other, as his or her true and lawful attorney-in-fact and agent to act in his or her name, place and stead and to execute in the name and on behalf of each person, individually and in each capacity stated below, and to file any and all amendments to this Annual Report on Form 10-K and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing, ratifying and confirming all that said attorneys-in-fact and agents or any of them or their or his substitute or substitutes may lawfully do or cause to be done by virtue thereof.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed below by the following persons on behalf of the registrant in the capacities and on the dates indicated.</span></p>
  <p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:auto;width:98.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:34.233%;box-sizing:content-box;"/>
    <td style="width:2.18%;box-sizing:content-box;"/>
    <td style="width:41.492%;box-sizing:content-box;"/>
    <td style="width:2.18%;box-sizing:content-box;"/>
    <td style="width:19.916%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0.037in;text-align:left;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Name</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #ffffff03;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0.037in;text-align:left;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Title</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #ffffff03;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0.037in;text-align:left;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Date</span></p></td>
   </tr>
   <tr style="height:6.5pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Zhenya Lindgardt</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #ffffff03;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td rowspan="2" style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">President and Chief Executive Officer (Principal Executive Officer)</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 19, 2025</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Zhenya Lindgardt</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.5pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Austin Aerts</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #ffffff03;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td rowspan="2" style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Financial Officer (Principal Accounting Officer and Principal Financial Officer)</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 19, 2025</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Austin Aerts</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.5pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Kim Kamdar, Ph.D.</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #ffffff03;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chair of the Board of Directors</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 19, 2025</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Kim Kamdar, Ph.D.</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.5pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Jane F. Barlow, M.D.</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #ffffff03;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 19, 2025</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Jane F. Barlow, M.D.</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.5pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Gregory C. Critchfield, M.D., M.S.</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #ffffff03;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 19, 2025</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gregory C. Critchfield, M.D., M.S.</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.5pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Sandra A.J. Lawrence</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #ffffff03;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 19, 2025</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Sandra A.J. Lawrence</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:12pt;margin-top:2.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.5pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Mansoor Raza Mirza, M.D.</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #ffffff03;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 19, 2025</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Mansoor Raza Mirza, M.D.</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.5pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Joshua Phillips</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #ffffff03;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 19, 2025</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Joshua Phillips</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.5pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Ryan Trimble</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #ffffff03;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 19, 2025</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Ryan Trimble</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.5pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Marcus Wilson, Pharm.D.</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #ffffff03;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 19, 2025</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Marcus Wilson, Pharm.D.</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.18in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">130</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-19.1
<SEQUENCE>2
<FILENAME>sera-ex19_1.htm
<DESCRIPTION>EX-19.1
<TEXT>
<html>
 <head>
  <title>EX-19.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="padding-top:0.8in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 19.1</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">sera prognostics, Inc.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">INSIDER TRADING POLICY</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Last updated: November 15, 2024</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">TABLE OF CONTENTS</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <table style="border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:8.2%;box-sizing:content-box;"></td>
    <td style="width:88.12%;box-sizing:content-box;"></td>
    <td style="width:3.68%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:center;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">I.</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">The Need for an Insider Trading Policy</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">2</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:center;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">II.</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">What is Material Non-Public Information?</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">3</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:center;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">III.</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">The Consequences of Insider Trading</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">4</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:center;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">IV.</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Our Policy</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">4</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:center;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">V.</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Individual Responsibility</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">9</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:center;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">VI.</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Additional Prohibited Transactions</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">10</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:center;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">VII.</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Post-Termination Transactions</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">11</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:center;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">VIII.</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Company Assistance</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">11</font></p></td>
   </tr>
   <tr style="height:12pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:center;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">IX.</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Certifications</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">11</font></p></td>
   </tr>
  </table>
  <p style="text-indent:6.957%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:4.167%;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.8in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Sera Prognostics, Inc.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">(the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d;) has adopted the following policy regarding trading by Company personnel in the Company&#x2019;s securities (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Insider Trading Policy</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">,&#x201d; or this &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Policy</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d;). This Policy applies to </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">all</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> Company personnel, including directors, officers, employees and consultants of the Company and its subsidiaries. This Policy also applies to certain family members, other members of a person&#x2019;s household and entities controlled by Company personnel, as described in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Section IV</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> below.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">All such persons are collectively referred to as &#x201c;Covered Persons&#x201d; herein.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Covered Persons are responsible for compliance with this Policy, including the particular obligations outlined in Section IV below. As detailed below, certain Covered Persons, including directors, senior management and other designated employees (as described below) have additional duties hereunder. The specific duties of the &#x201c;Policy Administrator&#x201d; (defined below) under this Policy are also explained below.</font></p>
  <p style="font-size:10pt;margin-top:24pt;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">I.	</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">The Need for an Insider Trading Policy</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">This Policy has been developed:</font></p>
  <p style="margin-left:6.667%;text-indent:-3.704%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">	to educate all Covered Persons as to the federal securities laws and the rules of the Securities and Exchange Commission (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">SEC</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d;) on insider trading in public company securities;</font></p>
  <p style="margin-left:6.667%;text-indent:-3.704%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">	to set forth requirements that apply to Covered Persons who seek to trade in the Company&#x2019;s securities;</font></p>
  <p style="margin-left:6.667%;text-indent:-3.704%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">	to protect the Company and its personnel from legal liability; and</font></p>
  <p style="margin-left:6.667%;text-indent:-3.704%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">	to preserve the reputation of the Company and its personnel for integrity and ethical conduct.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Because the Company is a public company, transactions in the Company&#x2019;s securities are subject to the federal securities laws and regulations adopted by the SEC. These laws and regulations make it illegal for an individual to buy or sell securities of the Company while aware of </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">material non-public information</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">. The SEC takes insider trading very seriously and devotes significant resources to uncovering the activity and to prosecuting offenders. Liability may extend not only to the individuals who trade while in possession of material non-public information but also to their &#x201c;tippers,&#x201d; people who leak material non-public information to individuals who then trade based on that information.</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:8.040000000000001pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">1</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> The Company and &#x201c;controlling persons&#x201d; of the Company may also be liable for violations by Company personnel.</font></p>
  <div class="page-border-spacing">
   <hr style="border-top: 2px solid black; width: 192px; margin-left:0px"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">In order to incur liability for &#x201c;tipping,&#x201d; the tipper must (1) know or have reason to know that the information may be used in order to trade, and (2) derive some benefit from providing the information to the tippee. In order to incur liability for trading on a tip, the tippee must know or have reason to know that the information was provided in violation of a duty of trust or confidence. </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;font-style:italic;font-kerning:none;min-width:fit-content;">See, e.g., SEC v. Musella</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">, 678 F. Supp. 1060, 1063 (S.D.N.Y. 1988).</font></p><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">2</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.8in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <p style="font-size:10pt;margin-top:24pt;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">II.	</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">What is Material Non-Public Information?</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Definition</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Material non-public information is any information (positive or negative) that:</font></p>
  <p style="margin-left:6.667%;text-indent:-3.704%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">is not generally known to the public, and</font></p>
  <p style="margin-left:6.667%;text-indent:-3.704%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">which, if publicly known, would likely affect either the market price of the Company&#x2019;s securities or a person&#x2019;s decision to buy, sell or hold the Company&#x2019;s securities.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Examples</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">. Common examples of information that will frequently be regarded as material include, but are not limited to:</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:10%;text-indent:-3.846%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf02d;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">quarterly or annual financial results;</font></p>
  <p style="margin-left:10%;text-indent:-3.846%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf02d;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">clinical trial results or other meaningful clinical/scientific data or the status of developments in any of the Company&#x2019;s clinical trials or development programs;</font></p>
  <p style="margin-left:10%;text-indent:-3.846%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf02d;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">projections of future financial results;</font></p>
  <p style="margin-left:10%;text-indent:-3.846%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf02d;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">news of a pending or proposed merger, acquisition or tender offer;</font></p>
  <p style="margin-left:10%;text-indent:-3.846%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf02d;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">news of a pending or proposed acquisition or disposition of a significant asset;</font></p>
  <p style="margin-left:10%;text-indent:-3.846%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf02d;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">news of a pending or proposed collaboration, partnership or joint venture;</font></p>
  <p style="margin-left:10%;text-indent:-3.846%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf02d;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">the status of any capital raising efforts, including the contemplated public or private sale of additional securities of the Company;</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:10%;text-indent:-3.846%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf02d;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">a company restructuring;</font></p>
  <p style="margin-left:10%;text-indent:-3.846%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf02d;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">significant transactions with officers, directors or greater than 5% shareholders;</font></p>
  <p style="margin-left:10%;text-indent:-3.846%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf02d;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">the declaration of a stock split or the offering of additional securities;</font></p>
  <p style="margin-left:10%;text-indent:-3.846%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf02d;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">establishment of a  program to repurchase securities of the Company;</font></p>
  <p style="margin-left:10%;text-indent:-3.846%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf02d;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">a change in control or significant changes in management of the Company;</font></p>
  <p style="margin-left:10%;text-indent:-3.846%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf02d;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">changes in or dispute with the Company&#x2019;s auditors, or a notification that the auditor&#x2019;s reports may no longer be relied upon;</font></p>
  <p style="margin-left:10%;text-indent:-3.846%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf02d;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">pending or threatened significant litigation, or the resolution of such litigation;</font></p>
  <p style="margin-left:10%;text-indent:-3.846%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf02d;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">a default on outstanding debt or impending bankruptcy or financial liquidity problems;</font></p>
  <p style="margin-left:10%;text-indent:-3.846%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf02d;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">the gain or loss of a significant contract, license, registration or collaboration;</font></p>
  <p style="margin-left:10%;text-indent:-3.846%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf02d;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">the entry into, amendment or termination of a material contract (disclosable in SEC filings); or</font></p>
  <p style="margin-left:10%;text-indent:-3.846%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf02d;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">other items that require the filing of a Current Report on Form 8-K with the SEC.</font></p>
  <p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Twenty-Twenty Hindsight</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">. In determining whether information is material, the SEC and other regulators will view the information after-the-fact with the benefit of hindsight. As a result, in determining whether any information is material, we will and any Covered Person considering a trade in Company securities should carefully consider whether regulators and others might view the information as being material in hindsight, with the benefit of all relevant information that later becomes available. For example, if there is a significant change in the Company&#x2019;s stock</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">3</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.8in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">price following release of certain information, that information will likely be determined to have been material when viewed with the benefit of hindsight.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">In addition to addressing the relevant statutes and regulations in this area, we are adopting this Policy to avoid even the appearance of improper conduct on the part of anyone employed by or associated with the Company and certain related persons, not just members of senior management.</font></p>
  <p style="font-size:10pt;margin-top:24pt;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">III.	</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">The Consequences of Insider Trading</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">The consequences of insider trading violations can be severe, and can include the following (subject to changes in the law):</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">For individuals</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> who trade while in possession of material non-public information (or tip information to others):</font></p>
  <p style="margin-left:6.667%;text-indent:-3.704%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">	a civil penalty of up to three times the profit gained or loss avoided;</font></p>
  <p style="margin-left:6.667%;text-indent:-3.704%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">	a criminal fine (no matter how small the profit) of up to $5 million; and</font></p>
  <p style="margin-left:6.667%;text-indent:-3.704%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">	a jail term of up to 20 years.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">These penalties can apply even if the individual is not a member of the Board of Directors or an officer of the Company. Moreover, if an employee violates this Policy, he or she may also be subject to Company-imposed sanctions, including termination for cause.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">For a company</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> (as well as possibly any supervisory person) that fails to take appropriate steps to prevent illegal trading:</font></p>
  <p style="margin-left:6.667%;text-indent:-3.704%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">	a civil penalty of the greater of $1 million or three times the profit gained or loss avoided as a result of the employee&#x2019;s violation; and</font></p>
  <p style="margin-left:6.667%;text-indent:-3.704%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">	a criminal penalty of up to $25 million.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Any of the above consequences, including an SEC investigation that does not result in prosecution, can tarnish the Company&#x2019;s or an individual&#x2019;s reputation and irreparably damage a career.</font></p>
  <p style="font-size:10pt;margin-top:24pt;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">IV.	</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Our Policy</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">General Prohibition on Trading</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">. Company personnel and Related Persons (as defined below in this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Section IV</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">) may not buy or sell securities of the Company while in possession of material non-public information or engage in any other action to take advantage of, or pass on to others, that information, subject to the specific exceptions noted below in this </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Section IV</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> under the caption &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Exceptions for Certain Transactions</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">.&#x201d;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">4</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.8in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Transactions by Family Members, Others in Your Household and Entities You Control</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">. The restrictions in this Policy also apply to (1) immediate family members who reside with you, (2) others living in your household (whether or not related to you), (3) family members who do not live in your household but whose transactions in the Company&#x2019;s securities are directed by you or are subject to your influence or control (e.g., parents or children who consult with you before they trade in the Company&#x2019;s securities) and (4) any entities that you influence or control, including any corporations, limited liability companies, partnerships or trusts (each person or entity identified in clauses (1) &#x2013; (4), a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Related Person</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d;). SEC regulations specifically provide that any material non-public information about the Company communicated to any spouse, parent, child or sibling is considered to have been communicated under a duty of trust or confidence; and that any trading in the Company&#x2019;s securities by such family members while they are aware of such information may, therefore, violate insider trading laws and regulations. Company personnel are expected to be responsible for informing all Related Persons of these obligations and for the compliance of all Related Persons with this Policy, including, without limitation, compliance with the black-out period, the pre-clearance procedures for transactions in the Company&#x2019;s securities, as applicable,  and all other restrictions in this Policy. Company personnel may be subject to the same penalties for failing to do so, including termination for cause. Furthermore, you should not participate in any investment club (i.e., groups of people who pool their money to make investments) that may invest in the Company&#x2019;s securities.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Other Companies&#x2019; Non-public Information</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">. This Policy also applies with equal force to information relating to any other company, including our collaborators, obtained by Company personnel during the course of their service to or employment by the Company. For example, no Company personnel who, in the course of work on behalf of the Company, learns of material non-public information about a company with which the Company does business or that is involved in a potential transaction or business relationship with the Company may trade in the other company&#x2019;s securities until the information becomes public or is no longer material.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Personal or Independent Reasons Are Not Exceptions</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">. Transactions in the Company&#x2019;s securities that may be necessary or justifiable for independent reasons (such as the need to raise money for an emergency expenditure) are no exception. Even the appearance of an improper transaction must be avoided to preserve our reputation for adhering to the highest standards of conduct.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Policy Administrator</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-style:italic;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">This Policy shall be administered by the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Policy Administrator</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">,&#x201d; who shall initially be Benjamin G. Jackson, General Counsel, and if such person is not available, then Austin Aerts, Chief Financial Officer, shall serve as the alternate Policy Administrator. The Policy Administrator may, however, change from time to time; to confirm the name of the then-current Policy Administrator, please contact the General Counsel.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">When Information Becomes Public</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">. This Policy applies to material </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">non-public</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> information about the Company, which means that trading is permitted once the information becomes known to the public (unless some other Company policy or legal obligation restricts trading at that time); provided that the trading window is otherwise open, and the Policy Administrator has notified previously-blocked Company personnel that trading is permitted. Because the</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">5</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.8in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Company&#x2019;s shareholders and the investing public should be afforded time to receive and absorb information, as a general rule you should not engage in any transactions until the beginning of the second</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">business day after the day on which the material information has been released. Thus, if an announcement is made at any time on a Monday (e.g., before or after the market opens),</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Wednesday</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">generally would be the first day on which you may trade. If an announcement is made at any time on a Friday, Tuesday generally would be the first day on which you may trade. However, if the information released is complex, such as a major financing or other significant transaction, it may be necessary to allow additional time for the information to be absorbed by the investing public. In such circumstances, you will be notified by the Policy Administrator regarding a suitable waiting period before trading. In addition, we have established specified black-out periods, as described below.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Prohibited Trading Periods</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">. While it is never permissible to trade based on material non-public information, we are implementing the following procedures to help prevent inadvertent violations of this Policy and avoid even the appearance of an improper transaction (which could result, for example, where Company personnel engage in a trade while unaware of a pending major development</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-style:italic;font-kerning:none;min-width:fit-content;">).</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">All Company personnel and Related Persons are prohibited from trading in any of the Company&#x2019;s securities during the following periods:</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:6.667%;text-indent:-3.704%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">the periods from</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">15 days prior to the close of each fiscal quarter until the beginning of the second</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">business day after the release of the Company&#x2019;s financial results for each quarter and, in the case of the fourth quarter, financial results for the year end;</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:6.667%;text-indent:-3.704%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">from the time each such individual becomes aware of the material information (the black-out start times often vary), until the beginning of the second</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">business day after the day the Company has made a public announcement of material information, including earnings releases, unless the information released is complex, in which case it may be necessary to extend this period and the Company will notify you by e-mail of any such extension of the black-out period;</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:6.667%;text-indent:-3.704%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">during other specified periods when significant developments or announcements are anticipated, as notified by the Policy Administrator; and</font></p>
  <p style="margin-left:6.667%;text-indent:-3.704%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">any other periods as determined by the Company.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">The Company will notify you by e-mail when you and your Related Persons may not trade (or request pre-clearance to trade) in the Company&#x2019;s securities during periods when significant developments or announcements are anticipated. The Company will also notify you when such trading restrictions are lifted.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-style:italic;font-kerning:none;min-width:fit-content;">Of course, even during periods when trading is permitted, no one, including persons or entities who do not fall within the definition of Related Persons, should trade in the Company&#x2019;s securities if he or she possesses material non-public information.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">6</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.8in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">The following members of management constitute the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Senior Management</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d; of the Company: all Executive (Section 16) Officers, as listed on </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit A</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> hereto, which list shall be amended from time to time to reflect the then-current group of such individuals.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">The following individuals constitute the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Financial Team Members</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d; of the Company: all members of the Company&#x2019;s financial team, as listed on </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit B</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> hereto, which list shall be amended from time to time to reflect the then-current group of such individuals.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">The following individuals constitute other &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Designated Employees</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d; of the Company: additional members of Company personnel, as listed on </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit C</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> hereto, which list shall be amended from time to time to reflect the then-current group of such individuals.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Exceptions for Certain Transactions</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-style:italic;font-kerning:none;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;vertical-align:super;font-size:8.040000000000001pt;font-family:'Calibri',sans-serif;font-style:italic;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">(1)	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Gifts</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">. </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Bona fide</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> gifts are not transactions that are subject to this Policy, unless the person making the gift (the donor) has reason to believe that the recipient of the gift intends to sell the Company&#x2019;s securities while the donor is in possession of material non-public information. Note that even </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">bona fide</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> gifts that are not subject to restrictions under this Policy may still be subject to Section 16 and require the filing of a Form 4 (e.g., gifts by Section 16 officers and Board members).</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">(2)	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Mutual Funds and Exchange Traded Funds</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">. Transactions in mutual funds and exchange traded funds that are invested in the Company&#x2019;s securities are not transactions subject to this Policy.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">(3)	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Transactions Involving Company Equity Plans</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-style:italic;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Except as otherwise noted below, this Policy does not apply to the following transactions:</font></p>
  <p style="margin-left:6.667%;text-indent:-3.704%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Stock Option Exercises</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">. This Policy does not apply to the exercise of an employee stock option acquired pursuant to the Company&#x2019;s equity plans, or to the exercise of a tax withholding right pursuant to which a person has elected to have the Company withhold shares subject to an option to satisfy tax withholding requirements. This Policy does apply, however, to any sale of stock as part of a broker-assisted cashless exercise of an option, or any other market sale of stock for the purpose of generating the cash needed to pay the exercise price and or taxes upon the exercise of an option.</font></p>
  <p style="margin-left:6.667%;text-indent:-3.704%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Restricted Stock Awards and Restricted Stock Unit Awards</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">. This Policy does not apply to the vesting of restricted stock or restricted stock units, or the exercise of a tax withholding right pursuant to which a person elects to have the Company withhold shares of stock to satisfy tax withholding requirements upon the vesting of any restricted stock or restricted stock unit. This Policy does apply, however, to any market sale of restricted stock or shares received upon vesting of restricted stock units.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">7</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.8in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <p style="margin-left:6.667%;text-indent:-3.704%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Employee Stock Purchase Plan</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">. This Policy will not apply to purchases of the Company&#x2019;s securities under an employee stock purchase plan. This Policy does apply, however, to subsequent sales or other transfers of such securities.</font></p>
  <p style="margin-left:6.667%;text-indent:-3.704%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Other Transactions with the Company</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">. Any other purchase of the Company&#x2019;s securities from the Company or sales of the Company&#x2019;s securities to the Company are not subject to this Policy.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">(4)	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Rule 10b5-1 Trading Plans</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">. Notwithstanding the restrictions and prohibitions on trading in the Company&#x2019;s securities set forth in this Policy, members of the Company&#x2019;s Board of Directors, Senior Management, Financial Team Members, and Designated Employees are permitted to effect transactions in the Company&#x2019;s securities pursuant to approved trading plans established under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Trading Plans</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d;), provided that the Trading Plan is established while the person is not in possession of material non-public information, and that the Trading Plan is not entered into during any applicable Company-imposed black-out period. The use of any such Trading Plan by the Company&#x2019;s Board of Directors, Senior Management, Financial Team Members and Designated Employees, Restricted Employees and each of their Related Persons must comply with the Company&#x2019;s Rule 10b5-1 Trading Plan Policy, set forth on </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Addendum A</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> hereto.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Pre-Clearance of All Acquisitions, Sales and Other Transfers by Certain Company Personnel and their Related Persons</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-style:italic;font-kerning:none;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> In order to ensure compliance with this Policy and with any Section 16 reporting requirements, all transactions in the Company&#x2019;s securities (including acquisitions, sales, gifts and other transfers, whether or not for value), including the execution of Trading Plans (as defined above), (a) by members of the Company&#x2019;s Board of Directors, Senior Management, Financial Team Members, Designated Employees and each of their Related Persons, and (b) by any Company personnel outside the Company&#x2019;s designated broker relationship ((a) and (b) collectively referred to herein as &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Pre-Clearance Trades</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d;), must be pre-cleared by the Policy Administrator. If you are contemplating a Pre-Clearance Trade, you must contact the Policy Administrator or other designated individual prior to executing the transaction. The Policy Administrator will use his or her reasonable best efforts to provide approval or disapproval within two business days. You must wait until receiving pre-clearance before you or your Related Persons execute the Pre-Clearance Trade. Neither the Company nor the Policy Administrator shall be liable for any delays that may occur due to the pre-clearance process. If the Pre-Clearance Trade is pre-cleared by the Policy Administrator, it must be executed by the end of the tenth business day after receipt of pre-clearance. Notwithstanding receipt of pre-clearance of a Pre-Clearance Trade, if you or any Related Person become aware of material non-public information about the Company after receiving the pre-clearance but prior to the execution of the transaction, you may not execute the Pre-Clearance Trade. The responsibility for determining whether you are in possession of material non-public information rests with you, as discussed below in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Section V</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">. If you are a Section 16 reporting person, promptly following execution of any transaction in the Company&#x2019;s stock, but in no event later than the end of the first business day after the execution of the transaction, you must notify the Policy Administrator and provide details regarding the transaction sufficient to complete the required Section 16 filing.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">8</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.8in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Employees of the Company who are not Directors, members of Senior Management, Financial Team Members or Designated Employees, and who transact in the Company&#x2019;s stock within the Company&#x2019;s designated broker relationship, may, but are not required to, pre-clear transactions in the Company&#x2019;s securities in the same manner as set forth above. Such employees are not required to notify the Policy Administrator following execution of the transaction.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">The Policy Administrator may, from time to time, amend the list of and/or designate other employees as Senior Management, Financial Team Members or Designated Employees, in which case the Policy Administrator shall notify the affected individuals. While advance approval from the Board or Audit Committee is not required, the Policy Administrator shall give notice to the Audit Committee promptly after any such amendment to such list and at the next regular meeting of the Audit Committee.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Please note that pre-clearance does not provide Company personnel or Related Person with immunity from investigation or suit as it is the responsibility of the individual to comply with the federal securities regulations.</font></p>
  <p style="font-size:10pt;margin-top:24pt;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">V.	</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Individual Responsibility</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Persons subject to this Policy have ethical and legal obligations to maintain the confidentiality of information about the Company and to not engage in transactions in the Company&#x2019;s securities while in possession of material non-public information. Each individual is responsible for making sure that he or she complies with this Policy, and that any Related Person, whose transactions are subject to this Policy, also comply with this Policy. In all cases, the responsibility for determining whether an individual is in possession of material non-public information rests with that individual, and any action on the part of the Company, the Policy Administrator or any other employee or director pursuant to this Policy (or otherwise) does not in any way constitute legal advice or insulate an individual from liability under applicable securities laws. You may be subject to legal penalties and disciplinary action by law enforcement officials and/or the Company for any conduct prohibited by this Policy or applicable securities laws, as described in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Section III</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> above.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Tipping Information to Others</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">. Company personnel must not disclose non-public information about the Company to others outside the Company who do not have an obligation to maintain the confidentiality of such information. If the outsider trades on such information, penalties for insider trading may apply in these situations whether or not you derive any monetary benefit from the other person&#x2019;s trading activities. Material non-public information is sometimes inadvertently disclosed or overheard in casual, social conversations. Please take care to avoid such disclosures.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Prevention of Insider Trading by Others</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">. If you become aware of a potential insider trading violation, you must immediately advise our Policy Administrator and/or report the matter using the Company&#x2019;s anonymous whistleblower reporting procedures. You should also take steps, where appropriate, to prevent persons under your supervision and/or control from using</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">9</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.8in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">material non-public information for trading purposes. Moreover, Company-imposed sanctions, including termination for cause, could result if an employee fails to comply with this Policy.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Confidentiality</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">. Serious problems could be caused for the Company by the unauthorized disclosure of internal information about the Company, whether or not for the purpose of facilitating improper trading in the Company&#x2019;s securities. Company personnel must closely safeguard material non-public information even within the Company, and only share it with colleagues on a need-to-know basis. Company personnel should not discuss internal Company matters or developments (whether or not you think such information is material) with anyone outside of the Company (including, but not limited to, family, friends, business associates, investors and expert consulting firms), except as required in the performance of regular corporate duties. This prohibition applies specifically (but not exclusively) to inquiries about the Company that may be made by the financial press, investment analysts or others in the financial community and also includes posting material non-public information on any social media outlets such as Facebook, Twitter, etc. It is important that all such communications on behalf of the Company be made only through an authorized officer under carefully controlled circumstances. Unless you are expressly authorized to the contrary, if you receive any inquiries of this nature, you should decline comment and refer the inquirer to the General Counsel. Please review the Company&#x2019;s separate Regulation FD Policy,</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:8.040000000000001pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">which governs all public communications with people outside the Company.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:24pt;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">VI.	</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Additional Prohibited Transactions</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Because we believe it is generally improper and inappropriate for Company personnel to engage in short-term or speculative transactions involving the Company&#x2019;s securities, it is our policy that Company personnel and Related Persons not engage in any of the following activities, except in each case in limited circumstances with prior approval of the Policy Administrator:</font></p>
  <p style="margin-left:6.667%;text-indent:-3.704%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">trading in the Company&#x2019;s securities on a short-term basis. Any shares of Company common stock purchased in the open market must be held for a minimum of six months and ideally longer (exercise-and-sale of Company-issued stock options are exempted from this prohibition);</font></p>
  <p style="margin-left:6.667%;text-indent:-3.704%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">purchasing of financial instruments (including prepaid variable forward contracts, equity swaps, puts, calls, straddles, collars and exchange funds) that are designed to hedge or offset any decrease in the market value of the Company&#x2019;s equity securities and entering into other transactions with the same economic effect, including short sales;</font></p>
  <p style="margin-left:6.667%;text-indent:-3.704%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">borrowing or other arrangements involving the pledge of Company securities as collateral for a loan or holding such securities in a margin account;</font></p>
  <p style="margin-left:6.667%;text-indent:-3.704%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">selling a security future that establishes a position that increases in value as the value of the underlying equity security decreases; and</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">10</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.8in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <p style="margin-left:6.667%;text-indent:-3.704%;padding-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Symbol',serif;font-kerning:none;min-width:fit-content;">&#xf0b7;	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">transactions in publicly-traded options relating to the Company&#x2019;s securities (i.e., options that are not granted by the Company).</font></p>
  <p style="font-size:10pt;margin-top:24pt;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">VII.	</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Post-Termination Transactions</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">This Policy will no longer apply to any individual after that individual&#x2019;s termination of service to the Company. However, if an individual is in possession of material non-public information when his or her service terminates, that individual may not trade in the Company&#x2019;s securities until that information has become public or is no longer material. It is prudent for the individual, if he or she is subject to a black-out period upon termination of service, to refrain from trading until those restrictions no longer apply to Company personnel.</font></p>
  <p style="font-size:10pt;margin-top:24pt;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">VIII.	</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Company Assistance</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Any person who has any questions about specific transactions or this Policy in general may obtain additional guidance from the Policy Administrator. Remember, however, the ultimate responsibility for adhering to this Policy and avoiding improper transactions rests with you. In this regard, please use your best judgment when considering a transaction in the Company&#x2019;s securities.</font></p>
  <p style="font-size:10pt;margin-top:24pt;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">IX.	</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Certifications</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">As a condition to employment, all employees will be required to certify their understanding of and intent to comply with this Policy. Members of the Board of Directors, Senior Management and other personnel may be required to certify compliance on an annual basis.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">11</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.8in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Certification Under Insider Trading Policy</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">The undersigned hereby certifies that he/she has read and understands, and agrees to comply with, the Company&#x2019;s Insider Trading Policy, a copy of which was distributed with this Certification.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Date: __________________________	Signature __________________________</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:33.333%;text-indent:10%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Name: __________________________</font></p>
  <p style="margin-left:53.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">(Please Print)</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Title: __________________________</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">12</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.8in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">ADDENDUM A</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">RULE 10b5-1 TRADING PLAN POLICY</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">This Rule 10b5-1 Trading Plan Policy applies to members of the Company&#x2019;s Board of Directors, Senior Management, Financial Team Members, and Designated Employees who use or seek to use a Trading Plan (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Participants</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d;). Capitalized terms used herein and not otherwise defined are defined as set forth in the Insider Trading Policy.</font></p>
  <p style="text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">1.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Plan Establishment</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">A.	No 10b5-1 Plan may become effective (that is, no transaction may occur) until the Participant has (i) delivered a complete copy of the 10b5-1 Plan to the Policy Administrator, (ii) certified that such Participant is not aware of any material nonpublic information about the Company and that such Participant is adopting the 10b5-1 Plan in good faith and not as part of a plan or scheme to evade the prohibitions of Rule 10b5-1 and (iii) received the written acknowledgment by the Company to enter into the 10b5-1 Plan. Additionally, Participants entering into a 10b5-1 Plan must act in good faith with respect to that 10b5-1 Plan during its term. Disclosure regarding a 10b5-1 Plan&#x2019;s adoption may, at the Company&#x2019;s discretion, be made through a press release or Current Report on Form 8-K.</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">B.	Each 10b5-1 Plan must be a written plan or binding agreement entered into with a national brokerage firm or other financial professional reasonably acceptable to the Company.  10b5-1 Plans must use a Company-approved template.</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">C.	The 10b5-1 Plan may only be adopted during the generally applicable quarterly open trading window described in the Company&#x2019;s insider trading policy and at a time when the 10b5-1 Plan Participant does not otherwise possess material, non-public information concerning the Company.</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">D.	Purchases or sales pursuant to a 10b5-1 Plan may not occur until expiration of a cooling-off period that ends no earlier than thirty (30) days after adoption of the 10b5-1 Plan, and if the Participant is a director or officer (as defined in Rule 16a-1(f) of the Act), no earlier than the later of (i) ninety (90) days after adoption of the 10b5-1 Plan or (ii) two business days following the disclosure of the Company&#x2019;s financial results in Form 10-Q or Form 10-K for the completed fiscal quarter in which the 10b5-1 Plan was established; provided that the required cooling-off period for directors and officers is subject to a maximum of one hundred twenty (120) days after adoption of the 10b5-1 Plan (in each case, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Cooling Off Period</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d;).</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">E.	A Participant may have only one 10b5-1 Plan with respect to the Company&#x2019;s securities in operation at any time, except as follows:</font></p>
  <p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">(i) Participants may have one additional 10b5-1 Plan under which trading is not authorized to begin until after all trades under the first 10b5-1 Plan are completed or expired without execution, provided, however, that if the first trade under the later-commencing 10b5-1 Plan is scheduled during the Effective Cooling-Off</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">13</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.8in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Period (as defined below), the later-commencing 10b5-1 Plan may not rely upon this exception.  The &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Effective Cooling-Off Period</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201d; means the cooling-off period that would be applicable to the later-commencing 10b5-1 Plan if the date of adoption of the later-commencing 10b5-1 Plan were deemed to be the date of termination of the earlier-commencing 10b5-1 Plan; and</font></p>
  <p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">(ii) Participants may enter into a 10b5-1 Plan providing for sell-to-cover transactions that sell only such securities as are necessary to satisfy tax withholding obligations arising exclusively from the vesting of a compensatory award. This exception does not apply to sales made to cover taxes in connection with the exercise of stock option awards.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">F.	A Participant may purchase or sell securities pursuant to a 10b5-1 Plan designed to cover a single trade only one time during any consecutive twelve (12) month period.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">2.</font><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Plan</font><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> A</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">mendments</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">A.	Any 10b5-1 Plan amendment, modification or change to the amount, price, or timing of the purchase or sale of securities (or a modification or change to a written formula or algorithm, or computer program that affects the amount, price, or timing of the purchase or sale of Company securities) under the 10b5-1 Plan is deemed to be a termination of such 10b5-1 Plan and the adoption of a new 10b5-1 Plan, and must comply with all requirements of this Policy applicable to the adoption of a new 10b5-1 Plan.</font></p>
  <p style="text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">3.</font><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Plan</font><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Termination</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">A.	Early termination of 10b5-1 Plans should occur only in unusual circumstances, and the effectiveness of a 10b5-1 Plan termination will be subject to the prior review and approval of the Company. If a 10b5-1 Plan is terminated, disclosure regarding such termination may, at the Company&#x2019;s discretion, be made through a press release or Current Report on Form 8-K. Furthermore, in the event a Participant terminates a Trading Plan, the Company may require that the Participant be subject to the required Cooling-Off Period before engaging in any new transactions in Company securities or adopting a new 10b5-1 Plan.</font></p>
  <p style="text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">4.</font><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Miscellaneous</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">A.	Consistent with Section VI of the Company&#x2019;s Insider Trading Policy, which prohibits transactions that are designed to hedge or offset any decrease in the market value of the Company&#x2019;s equity securities, at the time of entering into the 10b5-1 Plan, the Participant may not be, and during the term of the 10b5-1 Plan may not become, a party to a corresponding or hedging transaction involving Company securities.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">B.	The Company has the right at any time to require additional and/or different requirements in connection with the modification or termination of a 10b5-1 Plan in order to protect the Participant and the Company from potential liability. The Company may suspend 10b5-1 Plans immediately upon notice to the 10b5-1 Plan Participant for any reason, including</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">14</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.8in;z-index:-3;min-height:0.75in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">but not limited to as underwritten public offerings, private placement transactions or other material events of the Company.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">C.	In accordance with SEC rules and regulations, the Company will disclose in Form 10-Qs and Form 10-Ks whether, during the Company&#x2019;s last fiscal quarter, any director or officer adopted or terminated (a) a 10b5-1 Plan for the purchase or sale of Company securities that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or (b) a non-Rule 10b5-1 trading arrangement. In such disclosure, the Company will provide a description of the material terms of such trading arrangement, including the name and title of the director or officer, the date of adoption or termination of the trading arrangement, the duration of the trading arrangement, and the aggregate number of Company securities to be sold or purchased under the trading arrangement.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">D.	The 10b5-1 Plan Participant will be solely responsible for determining the 10b5-1 Plan&#x2019;s compliance with Rule 10b5-1 and other applicable laws and regulations.  Acknowledgement of a 10b5-1 Plan by the Company should not be characterized or understood to signify consent, approval or a legal opinion as to the 10b5-1 Plan&#x2019;s compliance with Rule 10b5-1 or other applicable laws and regulations.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">*****</font></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.75in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">15</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>sera-ex23_1.htm
<DESCRIPTION>EX-23.1
<TEXT>
<html>
 <head>
  <title>EX-23.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="z-index:-3;min-height:1in;position:relative;"></div>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:13pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 23.1</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:13pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consent of Independent Registered Public Accounting Firm</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:13pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We consent to the incorporation by reference in the following Registration Statements:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:13pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(1) Registration Statement (From S-3 No. 333-281347),</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:13pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(2) Registration Statement (From S-8 No. 333-278104) pertaining to the 2021 Equity Incentive Plan, and 2021 Employee Stock Purchase Plan of Sera Prognostics, Inc.,</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:13pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(3) Registration Statement (From S-8 No. 333-270746) pertaining to the 2021 Equity Incentive Plan, and 2021 Employee Stock Purchase Plan of Sera Prognostics, Inc.,</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:13pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(4) Registration Statement (Form S-8 No. 333-263943) pertaining to the 2021 Equity Incentive Plan, and 2021 Employee Stock Purchase Plan of Sera Prognostics, Inc., and</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:13pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(5) Registration Statement (Form S-8 No. 333-258696) pertaining to the 2011 Employee, Director and Consultant Equity Incentive Plan, as amended, 2021 Equity Incentive Plan, and 2021 Employee Stock Purchase Plan of Sera Prognostics, Inc.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:13pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of our report dated March 19, 2025, with respect to the financial statements of Sera Prognostics, Inc. included in this Annual Report (Form 10-K) of Sera Prognostics, Inc. for the year ended December 31, 2024.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:13pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/s/ Ernst &amp; Young LLP</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Salt Lake City, Utah</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 19, 2025</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>sera-ex31_1.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html>
 <head>
  <title>EX-31.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="z-index:-3;min-height:0.5in;position:relative;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 31.1</font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SARBANES-OXLEY SECTION 302(a) CERTIFICATION</font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I, Zhenya Lindgardt, certify that:</font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1. I have reviewed this annual report on Form 10-K of Sera Prognostics, Inc.;</font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4. The registrant&#x2019;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">c) evaluated the effectiveness of the registrant&#x2019;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">d) disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5. The registrant&#x2019;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#x2019;s auditors and the audit committee of the registrant&#x2019;s board of directors (or persons performing the equivalent functions):</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#x2019;s ability to record, process, summarize and report financial information; and</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#x2019;s internal control over financial reporting.&#x200b;</font></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:4.099%;box-sizing:content-box;"></td>
    <td style="width:47.95%;box-sizing:content-box;"></td>
    <td style="width:47.95%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="2" style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date: March 19, 2025</font></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x200b;</font></p></td>
   </tr>
   <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x200b;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x200b;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.15pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</font></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.15pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Zhenya Lindgardt</font></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;border-bottom:1pt solid #ffffff03;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.15pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x200b;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:1.15pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x200b;</font></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:1.15pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Zhenya Lindgardt</font></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:1.15pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x200b;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.15pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x200b;</font></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.15pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">President and Chief Executive Officer</font></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.15pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x200b;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.15pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x200b;</font></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.15pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Principal Executive Officer)</font></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.15pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x200b;</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>sera-ex31_2.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html>
 <head>
  <title>EX-31.2</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="z-index:-3;min-height:0.5in;position:relative;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 31.2</font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SARBANES-OXLEY SECTION 302(a) CERTIFICATION</font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I, Austin Aerts, certify that:</font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1. I have reviewed this annual report on Form 10-K of Sera Prognostics, Inc.;</font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4. The registrant&#x2019;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">c) evaluated the effectiveness of the registrant&#x2019;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">d) disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5. The registrant&#x2019;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#x2019;s auditors and the audit committee of the registrant&#x2019;s board of directors (or persons performing the equivalent functions):</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#x2019;s ability to record, process, summarize and report financial information; and</font></p>
  <p style="margin-left:6.667%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#x2019;s internal control over financial reporting.&#x200b;</font></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:4.099%;box-sizing:content-box;"></td>
    <td style="width:47.95%;box-sizing:content-box;"></td>
    <td style="width:47.95%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="2" style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date: March 19, 2025</font></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x200b;</font></p></td>
   </tr>
   <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x200b;</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x200b;</font></p></td>
   </tr>
   <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</font></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Austin Aerts</font></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;border-bottom:1pt solid #ffffff03;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x200b;</font></p></td>
   </tr>
   <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:1.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x200b;</font></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:1.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Austin Aerts</font></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:1.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x200b;</font></p></td>
   </tr>
   <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x200b;</font></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Financial Officer</font></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x200b;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.15pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x200b;</font></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.15pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Principal Accounting Officer and Principal Financial Officer)</font></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.15pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x200b;</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>sera-ex32_1.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html>
 <head>
  <title>EX-32.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="z-index:-3;min-height:0.5in;position:relative;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 32.1</font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certification</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)</font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Sera Prognostics, Inc., a Delaware corporation (the &#x201c;Company&#x201d;), does hereby certify, to such officer&#x2019;s knowledge, that:</font></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Annual Report on Form 10-K for the year ended December 31, 2024 (the &#x201c;Form 10-K&#x201d;) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.&#x200b;</font></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:4.099%;box-sizing:content-box;"></td>
    <td style="width:44.691%;box-sizing:content-box;"></td>
    <td style="width:2.42%;box-sizing:content-box;"></td>
    <td style="width:4.099%;box-sizing:content-box;"></td>
    <td style="width:44.691%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="2" style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date: March 19, 2025</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date: March 19, 2025</font></p></td>
   </tr>
   <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</font></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Zhenya Lindgardt</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #ffffff03;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</font></p></td>
    <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Austin Aerts</font></p></td>
   </tr>
   <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="2" style="padding-top:0in;padding-left:0.037in;vertical-align:middle;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Zhenya Lindgardt</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0in;padding-left:0.037in;vertical-align:middle;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Austin Aerts</font></p></td>
   </tr>
   <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="2" style="padding-top:0in;padding-left:0.037in;vertical-align:middle;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">President and Chief Executive Officer</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0in;padding-left:0.037in;vertical-align:middle;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Financial Officer</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="2" style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.15pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Principal Executive Officer</font></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td colspan="2" style="padding-top:0in;padding-left:0.037in;vertical-align:middle;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Principal Accounting Officer and Principal Financial Officer</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>img152117643_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img152117643_0.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" 0P!W8# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **C:YC2Y6$R1B:16=4+?,RK@$@=<#<N3VR/6I* "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^(K8GYRD1LYL>S+E?_'*WK</8J"W3]'_ )I'56X4QM-7O%^C?ZI'Z045XO\
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MHY;7J477BM%?UT-J>!JSI.M%:(_:.BFQMN'_ -:G5P'&%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 <7KW_)PWA7_L7M8_]*=+KM*XO7O^3AO"O_8O:Q_Z
M4Z77:5K4^&/I^K.S%?PZ7^%_^ER"BBBLCC"BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQGX+\>+)'_:MY:"SUF)?^6&H08CG7'8%AO _NR+7NU?A5_P;(?MD?\*T^/\
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M>F:C"ES:7=I,LT%U$X#))&ZDJRL""&!((.:-=P+E%%% !1110 4444 %%%%
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MG)VBFSZWHK#^&/C^S^*_PV\/^*-.CNH=/\2:;;ZI;1W*!)DBGB61 X!(#!6
M(!(!SR:^?OBU_P %EOV9_@S%>?VG\6O#=_<V3-&]MHYDU29G!*E1]G5QG(ZD
M@=\XYJ84:DWRPBV_)"C3G)VBKGT[17F/[(/[5_AO]M?X%Z;\1/"-KKEKX>U:
MXN8+3^U+5;>:;R)GA9PJNPV%XVP<YXY (($G[4O[7OP[_8P^'#>*OB-XDM?#
M^ELYAMU96EN+Z7&?*AB0%Y&^@P!RQ R:/93Y_9VUVL+V<N;DMJ>E45\0^(O^
M"ZG@KPOX;'B"\^"O[2T/A%AO7Q')X%$6E.G)WB9YU^7@\X[&O=/V,/\ @H-\
M+?V^O#FJ:A\-=>N-4;0C$NJ6ES8S6MQIYE\SR@X=0K;A$Y!1F'R]0>*TJ82M
M"//*+MW-)4*D5S-:'6?M&?M1> /V2O #>)_B)XHTWPOH^_R8I;IB9+F3:6\N
M*-07D?:I.U%)P#47[*O[3?AG]L7X$Z+\1?!_]H?\([K[W*VAOH!!.WD7,MLY
M* G +PL1SG!&0#P/A?\ X.F+:-_V /"$S1QF:/Q]9HKE?F53I^HD@'K@[5R.
M^!Z5[G_P0HM([+_@E-\)$A18U:UOI"!W9M0NF8_B23^-;RPL%@U7ZN5O*UF:
M2HQ6'57JW8^N****X#E/&?VO?V/)/VL[70UA^*GQ@^&,V@K<['\#>(CI*W[3
M"+!N@$;S1&8OD&5QYDG/S<?AOX$\:_'?6?\ @IVOP!U3]HSXXPZ?%XTN/#$V
MIP>,-0$[PQ3R1B95:8J&=4!&<@;NAZ5_1=7\]_AO_E9-F_[*I=_^CI:][)ZC
M<:D7LHMK1:,]/+Y-J47T5S],O%7_  1LUZ[\.-%HG[6_[6&GZOMPMS?>.)+R
MV!P>3"BQ,1G!QY@XXSW'YZS?\%&OVEO^"0G[;LO@#XI>.-4^)WA?2YX#>Q:I
M,UX=2T^0 K<VT\N9DE"$G!<KO4JP;&:_>2[NXK"UDGGDCAAA0R222,%6-0,D
MDG@ #G)K\%?^"@/PXU#_ (+)_P#!7BZT/X00R:UX=T.VL]#U/Q+"F_3;..$L
MT]R91\I12[J@SF4Q_)D,#1E=9UI2CB+.%KMM+3YCP=3VC<:NL;?<?O%H&NVO
MBC0K+4K&9;BQU"!+FWE7.)(W4,K#//((-?EK_P %QO\ AL'_ (:H\'_\*3_X
M6?\ \(3_ &=!]G_X0_SO)^W^=)YGVWR?X=OE?Z_]UM_X%7Z:"X\/_ GX5QMJ
M&HV6B>&O"NG)'+>7]PL,%I;PH%WR2-A5 5>2<"OEWXT?\%YOV8?@UILD@^(2
M>++Q?N6/ARREOI)>O23"P#I_%(.M>?@?:1J\]*'/\KG+AN=3YH1YOD?4GPG_
M .$@_P"%6^&_^$L^S_\ "4_V7;?VQY&/*^V>4OG[,<;?,W8QQBN@K,\%^*K?
MQUX/TK6[..>.UUBSBO84G3;(J2('4,,G# $9&3S5/XG?%3PW\%O!-]XD\6ZY
MI?AS0=-3?<WVH7*P0Q#L-S$98] HR2<  GBN.S<K6U.?5NQOT5\67?\ P7,^
M'&KV-YJ7@OX:_'[XF>'+!V2;7O"W@B2XTU=IQDRS218!QW _"NK_ &2/^"RW
MP'_;'\81^&= \1WGA_Q9,_EPZ)XCM/[/N[A^<I&=S122#!^17+\'C%=$L'7C
M'F<79?AZFCP]1*[BSZHHJGXA\0Z?X1T"^U;5KZSTO2]+MY+N\O+N98;>TAC4
MO)+)(Q"HBJ"Q9B  "2<5\F_&+_@NW^S!\'M+FF;XD6_B>[C&4LO#UI+?RS>R
MN%$(_P"!2**RIT*E1VIQ;]$3"G.?PIL^OJ*^9/VF_P#@KC\&?V1_ACX7\1>,
MM4U.WO?&&F0:MIOAZUMEN-8>"5 ZL\0?9&!G:2\@4L" 6P:\P_9U_P"#B/\
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M^SZ=XIOI)KLSB4Y\R2<A-OE=-C9W=1BOT]_X+#?\HROC)_V 6_\ 1L=?"_\
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MV?/^"X?P-^/'Q57P+>S^*OAOXPEF%M%I7C72QI<LLQZ1;E>2-)#D85V4L6
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M+?CI!^TQ^R[I_CSP#(';Q3H1O]'%R #%.\1*1R#D I)\K#) *FOSB_X(T_\
M#9W_  V_XD_X7'_PLW_A!_L=S_:?_"5^=]A^T[QY/V#S/DZ[O^/?]WLSG^"O
MH/\ X)]?';P'_P $]O\ @FS\'=#^+_C3P]X'U>^T5M2BL=2NECNGBGF>88A&
M7.T2J#@<$$<$$5Z'^S?_ ,%>O@M^UU^T2WPU^'>J:WXDU2.PFU!]0CTN2WT]
M8XF16&^79(22XP1&5/KTSSJ,Z4:L(0YHN^K6R3[F5I04XQC==[?J?3U%>8_M
M ?MH?"G]E:2WB^(GC_PSX3NKR$W$%K?7BK=3Q@E=Z0C,C+D$9"D9!'8UYO\
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MK;BXU6>%T#AFB5L(HSC<[!2<@$D5S_5*^BY'KMIN9_5ZFGNO4^D:*^ ?@_\
M\')W[-WQ4\76^DWTGCCP2MT_EI?>(-*A2S!/3<]O/,4!/&Y@%'4D#FOO;1]8
MM/$&E6U]875O>V-Y$L]O<02"2*>-AE65APRD$$$<&IK8:K1=JL6B:E&=/XU8
ML45@_$KXH>'/@WX+OO$7BS7-+\.Z%IR;[F^U"X6"&(>[,0,GH .2> ":^3/%
M7_!<;X<Z1HT^N:'\-?C[XU\&V['=XJT/P1(VB[1U<3SR1?+CG.WI13P]2I\"
MN$*4Y_"C[1HKPK]B_P#X*0_"/]O?2;F7X>^)!=:GIZ>9>Z-?0FUU*S7.-S1-
M]Y.0-\99,D#.>*]UJ*E.4)<LU9DRC*+Y9*S"BBBH)"BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H(R*** /R_P#^#AG]E/6/
M%-KX5^*NBV%Q?6VAVKZ/KGD1EVMX2YD@F8#G8&:12>VY>W(^+_\ @F__ ,$_
M=<_;J^,-K;M!=6?@7295EUW55&U?+!S]GB;H9I.G&=HRQZ '^@RZM8[N!XY8
MUDCD4JR,,JP/4$=Z^<_VLOVU_#__  3^\3> ;'5/",EOX)\77DME<ZUIX2&W
MT28;2N^%5&X,&9B000J,0&(Q7U&7Y]BHX;ZE1C>6MGU2WVZ^1]IE/$V,A@UE
MN&AS3UY7U2W>G5[V/>O!'@G2_AWX3T_0]%L;?3=)TFW2TL[6% L<$2 *J@?0
M?C6I*_EQLW]T$U!9:G%J%G'/#+'-#,JR1O&=RR*0""#W!!SFI@^\?YXKY>3N
M[O<^+D[O4\K^'G[<?PA^*NK2:?H/Q(\'ZAJ$4S0-:C48XIBX;:0$<JS<\< Y
MKU<'-?.M]_P2B^ >J?&&3QQ<> +&;7);O[>R&XF%F;C=N\W[.&$>[=SC;C/.
M,U]$@;!71B%037L&]M;VW^1UXI896^K.6VO-;?R:W^Y"GI7Y(_\ !Q%\:K?4
M?B]X$\&6LRO-H.FSZE=JK9V/<.JH#[[82?HXK](_VJ?VJ/"W[(7P=U'QEXJO
M$BM;5"MK:JP^T:C<$?)!$O=F/?H!DG %?SY?$_Q_XP_;5_:4O]:FM9M5\6>.
MM35+6RM\MAG(2*"/_910JC/0#)[U])PK@7*O];GI"/7S_P" ?6\$Y9*IB'CI
MZ0@GKW?_  %=L^]/^#=3X4W&L^/_ (@^/IHF%IIUE%H5K(1PTLKB:7!_V5CC
MS_OBOUD%>+_L$?LJ6O[&O[,GA_P3%Y<VH01F[U:Y0<75[)AI6'^R#A%_V46O
M:!TKQ<WQBQ6+G5CMLO1'S^?9@L9CJE>/PWLO1:(*_)WX+?L3^"OVV/\ @IO^
MTGI?C=M<>U\/ZJ;FS%AJ#6I5GE96S@'(P!Q7ZQ5^?7_!-WG_ (*K_M7?]?T?
M_I0];975G3I5YP=FHK7_ +>1T9+6G2H8FI3=FH+5?XHG6W?_  01^!A@;[+=
M?$"PN/X)X-?;S(SZC<A'Z5YC;>+OB1_P2'_:4\&>&_$7C35/B%\$/']Z-,M+
MG5V,EYH,Q95 WDGA=ZL0#M9 V%5EY_20/D?XBOSA_P""R_CW3_VB/B[\(?@;
MX2N(=:\8S>)X]1OXK9A(=+B V#S"N=IVL[D'D+'DXR,[Y=C*^*J^QQ$G*#3O
M?IIO?I8Z,IQV(QM?ZOBI.=-IWOKRJWQ)]+,]4_X+P3/;?\$Y_$3HS*RZKIO*
MG'_+RM<C\$_^"'WP/\>_!GPCKE^/&GV[6M%L[ZY,>NNJ&26!'? V\#<QXKJO
M^"\:>5_P3=\0*O(75-, _P# A:^E?V7\_P##-/P[Z?\ (LZ;_P"DL=9T\56H
M9?!T9.-Y2O;3I$SACJ^&RNF\/-Q;G*]M.D3Y$\>_\$3;+X:Z?)K/P/\ B3\0
M/ OB^Q4R6:SZLT]E<..1')@!E#=,G<.>5(XKT[_@E?\ MM:Y^UE\*]=TGQK:
MQ6/Q"^'NH'2-=5(Q&MPPW!9MHX5B4=6 XW(2." /HCXC_$;0_A+X-U#Q!XDU
M2RT?1M,B:>YNKJ41QQJ.O)ZGL .2< 9-?"?_  19AO/'OCK]H#XRK8W%GX?\
M>>(G?2DD7;YZQR3S.0/;S47TW!AV-'MJF)PE2>(U<;<KMK>^JOU[B^L5<9@:
MM3%>\X<O+)K6[=N6_736WD=-^VS^VQ\0OB9^T;'^SW\ /L\?C$Q>;XC\1RX:
M'P_$0"0IP0K*K*6;!(+*JC=TA\'_ /!!_P"'NO6PU#XH>+O'GQ(\3W/SW5]=
M:H\$1<]=B_,^/]YS^%8?_!!71(_&?A;XN?$O4,7'B3Q;XNG@N;AQF01HHFVY
M[ O.QQ[#T%?H.GW:>,Q4\'/ZKA7R\N[6[=M=>W9#S#&5,!4^I81\O+;FDMY.
MUWKO;HEL?G]\0O\ @CAJGP BD\2?LW_$?Q?X-\26 \V/2;_4/M&GZECGRCP,
M9Z?O ZD]<=1Z[_P37_;YNOVL_#NM^&?%^FKX=^*7@6;[+X@TPH8Q)ABGGQJ2
M2HW@JR\[6Q@D,*^HWB#Y]Z_//XIZ;'\%O^"^W@.\T8?9U^)'AN1-7CCX$[".
M=-S >IMX#GU3-31K2QM.=*OK))N,NNFK3[I^9.'Q$LPI5*.)UG&+E&77W=6G
MW35[7V9[-_P4H_;ZOOV5-*T/PAX(TM/$GQ8\>R"UT'3MGF+;@ML^T2*#\WS'
M:BY 8AB3M5J\E\!?\$9]3^.ZQ^)/VCOB1XN\:^);X>;+I=AJ'D:?89Y\I3@Y
MQT_=A%&.,CDU?@5IL7QJ_P""\7Q2U76%\]OAOH$=KI$<G(@)2",NH['][,?^
MVIK]"8X@@XHK8B6!C"E0TDXJ4I===4D^B2_$K$8F674Z=##>[.45*4NOO*Z2
M[)+MNSX8\6?\$'_AOHL!O?AGXH\>?#GQ);_/:ZA::L\\:N.F]3AR/]UUKZ"_
M8@\*_%[P)\()-)^,>M:+XB\06-[)#9:A8@^9=6:X$<D[8 :1L$\*#@C=ELFO
M9G.W\JX7X+_M'^"_VAH]:?P;KUKKR^';YM-U$PQR+]EN%ZQG<!R,=1D5QU<=
MB:]-QJ>\EU:U7SWU/-K9CBL31<:SYTNK5VOGNKGYP_\ !9N^\<Z?_P %'?A7
M=?#F2\'C#3_#+7VG1VS?/,T,US*Z!>C[D1@4/W@2O>ON7]@+]MS0_P!N'X&6
M_B*P$=CKUB5M->THM^\T^Z YP#R8WY9&/49!Y4U\W?M>_P#*<K]GG_L!2_SO
M:Q?VW/@SX@_X)M?M&Q_M(?"RP>;PGJTRP^._#T VPLKL-UP%'"JS<YQB.7!^
MZ[ >U4ITJ^'HX9V4^6\7W=W[K]>C[GT5:C1Q.$P^#:Y:CA>+[OFE[K]=+/OZ
MGZ.2+NC.?2O@/_@WYD>3X,_%3<[.1XVG'S'/_+*.OM#X)?&GP_\ M"_"O1_&
M'A>_CU#1=<MQ-;R#AD/1HW'\+HV593T(-?%G_!OR<?!CXK>_C><?^08Z\S#P
M<<'74EJG#\V>/AH.. Q,9K5."]-6>D_\%(/V^-=^!&N>'?A?\+]-C\1?&#QT
M0FG6Y4/'ID+$J)Y%/!8X;:&PH",S<#!X'P+_ ,$3X?BU$NO?M ?$;QG\0O%5
MX!+/;VVHM;Z?:,>3''P6('3*[%]%%97[#^EQ_%S_ (+'?M$>+M8_TB^\&HFC
MZ6).3:QEA"2OI\D)&1_ST;U-?H7&,5K7KRP2C0P^DK)REU;:O:_1)=C?%8J>
M7*&&PONRY4Y2^TW)7LGT25EH?"'CC_@A=X3\&V_]K?!OQSXY^&OBJU^>UG34
MWN+5W'02+Q)@]"0QX_A/2MS_ ()^?MS>-+SXRZQ\!_CA;6]C\4O#T9DL=1C
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M>3_\&LWAR[NOVY_'6K1Q,UA8^"9[2:3LDDU_9-&/Q6"0_P# :]8_X.T/]1\
M_P#>\0_^XNOH73C'-UR]=?\ R5GJ<J6/5OZT/M#_ ()6?L5Z#\/?V=? 7Q"\
M41P^,/B=XD\.:==2Z]J42S3:5:FVC-M86F1B""&/8N$P78,[$D@"O_P5^_X)
MM>"_VQ_V7O%FK1:#IUG\1/#>G7&K:-K%M;K'=3RPH9#;2NH!DCE"E,/G:S!A
M@@Y]U_8E_P"3-/A+_P!B;I'_ *10UTOQVUVU\+? _P 9:G?2K!9:=H=[=7$K
M' CC2W=F8_0 FO"^L5%B/:)ZW_7;T/-]K-5N9/6Y^4O_  ;!_':X^)WPY^*7
MP2\400Z]X7L[=-2M+*^B6XM_(N=\%Y;.C@JT3_(=A!4[Y<CYC7B/_!RS^S[X
M%^ ?[0'PYA\"^#?#'@VWU30)I;N#0],AT^&X=;@A7:.)54M@XSC.,>@KUS_@
MU.^#VI?V[\6/'TD;QZ0T5IH-LY'RW$VYIY0#_L+Y.?\ KJ*Y/_@ZS_Y.(^%?
M_8N7'_I2:^@IM+-G&.W7UL>I%VQS4?ZT/V4_9_TPZ)\"/!=FS^8UIH5E"7 Q
MNVP(,X_"OS/_ .#D#]CSX9?"O]B31/%/@WX>^!_".N1>,;:*YOM'T2WT^XNH
M);:[WQNT**7!D6)OFSRG'4Y_3SX0?\DF\,?]@FU_]$K7P7_P<]7L5K_P3FTN
M.1MK7/C6PCC&/OM]FO&Q_P!\JQ_"O%RV<EBXV>[//P<FJZMW/5/^"!VG2:7_
M ,$F?A/'-M#,FJ3#!S\KZK>.OZ,*^%_V]_V@/#L'_!Q;X1M_C%+&OPQ^'_V*
MVM4ODW6-N9M-%Q'<,I&W:+Z>,NYR (>>$P/OC_@AG_RBJ^$7_7C=_P#I?<U0
M_P""F'_!&GX>_P#!2"[L]=O-0O/!OCK3X!:1ZY8VZW"W4(R5CN(&*B4*2=K!
MD89QN(  WIXBG3QM1U=GS*ZZ7>YI3JPAB)N>SNO2[/JWPEXQT3XC>'(=3T+5
M-+U[2+Q?W5W87,=U;3*?[KH2K#Z&O ?V,/V%?^&1/VD?CMXBTN'P_8>#OB9J
M>G:EHNG:=N22P,=NXN5DC\M8XP9Y'*"-F&TC[OW:_+?QC_P;U?M1?LLWD^M_
M"7Q]I^LR6_[V/^P=:N-#U20KR,*VV//I^^)S7MO_  0Q_P""G7QB\>_M1:Y\
M!?C1<ZEK>IV=M=-:W.J0B/4]*NK5@)K:=L R C=R^75DQDAN">!Y:4YX>HI1
MMJMG:]]@EAK4Y2I34EU[G+?\''O[#]G\+O@KIGQ6N?B-\5/&&M:OXOBTJ/3?
M$&KP7&DZ5;S6UY.5M8(X(_*VM BCYC\N=VXG=4?_  3?_P"#?OX-_M@_L5>!
M?B1XF\3?$VQUSQ-;SS74&F:C8Q6D92YEB&Q9+1W VQ@G+GDGZ5[E_P '2W_*
M/CPG_P!E LO_ $W:E7NO_!#+_E%5\(_^O*[_ /2ZYK?ZY6AE\9PE9\UOE8T^
ML5(X6,HO6Y]#_ CX-Z3^SQ\%_"O@306NI-'\(Z7;Z3:273*UQ-'#&J!Y"JJI
MD;;N8JJ@L20!TKK***\"4FW=GEMMN["OYR_'/PZ_X6Y_P< ^(/#7]O>)/#']
ML_$N]MO[5T"]^Q:G8YFD_>03;6\MQCAL&OZ-*_GO\-_\K)LW_95+O_T=+7MY
M*VO:M?RL]++M.=^3/T3^-G_!!#3?C-X?^Q:A^T7^T;K&/^6?BCQ+'KMH<'(!
MA>) 1G/!.#FOD/QS^V9^T1_P05^,FE?#GQ+;>!_'?PSNHS=:2]EH%KHHU&UW
M!79&M40QW"M]X2B7E@<LK*U?MS7Y,_\ !UTMH?@U\("XA^W?VSJ A)QYGE^3
M#YFWOMSY>??;[5.78J5:JL/6M*+[K;3="PE9U)JE4U3/TA^#WQ/\%?MN_LUZ
M/XFLK.S\0>"_'6FB1[+4K5)XI8VRLMO/$X*,5<,CJ<C*D<BOQ._X.5/V</ ?
M[/O[1?P__P"$%\(^'O!UOK/A^1[RTT73XK&UE>.X95D\J)50/M."0,D 9Z5^
MCW_!O9X:U#PW_P $L? G]H0R0?VA=:C>6ROU,+WDNUL=@V"P]00>]?"W_!UG
M_P G"_"O_L7;C_TI-:Y9'V>8.E%Z)M?<7@UR8KDB]-3]GO@]_P DE\+_ /8)
MM?\ T2M?CC^UA\8;S_@K-_P6N\,_ RXOKB3X2^"==FM)].@G*PZ@]E%)+>SR
M%>K.T3P*P/RH05VEF)_8[X/?\DE\+_\ 8)M?_1*U^ O_  3(\1?\*?\ ^"^$
M%KK^Z&YD\5Z_HMPTC8:.YD2[B4'/))EVK@X.6_ Y97!?O:J^*,7;\=3/!1^.
M:W2=C^@_PSX9T_P9X=L=(TBQM=-TO38$MK2TMHA%#;1( JHBKPJ@   =,5^0
M7_!S3^Q!I?A.P\-?'KPI8)I6K2ZBND^(I+-?*,\C*TEM=MMQB0%&1GZG,7.1
M7[%U\4_\'"<%C-_P2F^(37;%9XKK2VL@/XIO[0MP1T_YYF0]NGX5RY96E#%0
M:ZNS^9C@ZCC6BUU=OO-G_@CS^U-)_P %!O\ @G;IEWXVAL_$&J6?VGPGXF2\
MA6>'53&B@F:-@5?S;>6(R*PPQ=^,'%?F[_P<Q?LX?#_X ?$_X6MX%\%^%_!B
MZQIE]]MBT/3(=/AN3'+%L9HXE5"PWL-V,D'DG Q]?_\ !KQX<N]$_P"">GB"
MZN(FCAUCQO>W=JQ'^LC6TLH21_VTB<?\!KYU_P"#K_\ Y*5\&_\ L&:E_P"C
M8*]+!KV>9NG#:[T^1V4/=QCC':[/T8_X)J?LB^&?@-^SEX/UUK2'6?'OB/1+
M.^UOQ+>KY^HWLLD"'RQ*V62"-2(XXE(544<9))_/_P#X.>OV,O"'@7P9X+^+
M7AS0;'1-6U'5VT+67L8$@CU O"\T,DBJ!F0""4;NI!P<X%?JQ^S!_P FV?#_
M /[%O3__ $FCKX2_X.E?^4>_A/\ [*!9?^F_4JX\!6G]>3ON['/A:DOK*=]V
M=O\ \$,_@-IOBC]C[P;\7_&$C>-/B-XDM6@BUO6!]JNM)L+69[>WL[9GSY4:
MK"'.S!9W8L6XQYW_ ,'*_P"R5X/\1_L?'XI0:-IUCXR\+ZK:Q2:E! L<]_;3
ML8FBE8#,F'9&7<?EPV#\Q!^@/^"&'_**KX1_]>5W_P"EUS6?_P %]O\ E$G\
M6O\ =TG_ -/%C50K368Z/[5OE>UAQJ26+_[>M\KG%_\ !MW\2=4\?_\ !->P
MM=3N9;I?"^O7ND632/N9+<".94SZ*9F '8 #H ![-_P4$_8:OOVW_$/PDL[C
M4;&/P9X/\4+K?B72KN239K=O&H*0>6JE),N,$.0 KM@YX/SS_P &PW_*.O5/
M^QROO_2>UJM_P7!_X*L^,OV6_%_ACX._" PQ_$3QA%'+<:B8EFETZ.:0PP10
MHP*>=*X;YF!V*%(&6#*5*52682C1T=W\N['*G.6*:I[W9]^ZSX \'Z?\/IM'
MU#1?#</A6&+;+8W-G"NGI'C&&C8>6%P<<C'-?@7^T!X=\%_L5_\ !<?P3>?!
M/6M'N/#-QXATF\BM]'U%+JWL/M4RPW=EO0L%4AI1LS\J2J.PK]#/@O\ \$'-
M-\?6ECX@_:4^)'CWXT>*I0MQ<:?=ZW<1Z1:.0#Y: -YKA?N[@Z*0/N <5^?O
M_!7SX$^#_P!F'_@JY\._#OP_\/:;X2T6UMM#N8[;3H_* E-X^9"?O,YP/F))
MX'/ KJRN-.-65.,W*Z=]-/SO^!M@E!3<%*]T[]C]^/&O@70_B?X3N]#\2:+I
M/B#0]20)=:=J5I'=VMRH8, \4@*, P!P0>0#VK\#/^#B;]G_ ,'?LM?MN^"[
MCP%X8T#PKIVI>&K?49M-TJQ2SM6N8[RX4R".,*J[D6,$*!]W/4U_0/ ?W*?[
MHK\/_P#@YS@CN_V[OA)%+&LD<GAR!'1QN5P=0G!!'<&N;(YR6)4;Z6?Y&.6R
M?MK=-3[*\/\ _!"WX<?M#>!+OQ9\=&U_Q=\8/'%LE]K.MQZG/9KHURZ ^19P
M(PB$4(VQJ)5DR(QPH.T?3W[#'[*T'[$W[+/A7X8VVK_V]#X72X1;_P"QBS-S
MYMS+.28P[@',I!.XY()XS@>KVW_'O'_NBGUYU7%U:D>2;TWMT7IV.6I7G-<L
MGH?A+^V+_P K/^C_ /8W^%?_ $WZ?7WO^V/^W_XQ^-'Q&O?@1^RU%:^)/B(0
MT/B7Q9NSI'@:(Y5BTV"C7/7 &[85("NX*I^=7_!1;X>6?Q;_ .#C>;POJ%QJ
M-G8^(/$/AO3YY["Y-M=0I)IE@A:*1>4< Y![&LGQ+X/^,'_!NI^VU!K%F9_$
MGP^\0.8XYB6BL?$]D#DPR@9$5W$#D9R58Y&Y&(;Z26'A5C2VYU!63V?]=OT/
M6E1C-0_FY59/9GZK?\$^O^"/GPX_8@ME\07\8\??%&^8W&H^*]7B\Z83L=SF
MV1RWDC=D[\F1B3N<C 'MW[8?[1%K^R;^R_XX^(MW"MTOA32I;N&!CA;B<X2"
M,G(P'E:-21R QQD\4W]DG]K;P5^VK\%=-\=>!=26^TN^&R>!\+<Z=. "]O.F
M3LD7/3H00P)4@GY^_P"#@+3M0U'_ ()2_$K["V(X)-,FNT ):6$:C;9 P#T8
MHQZ8"$Y['P8^TK8J,:][MI._J>9'FJ5E&KO=)GRY_P &ZO@BX_:N^*_Q5_:,
M^(UPWBKQT=2CTG3[^]7>;!FB\R<Q#&U/D>&-0H&Q%91@,17Z=?M&? /P]^U!
M\$_$?@7Q196]]I'B*RDM7$L0D^SN5.R9!QB2-L.I!!!4<BOQW_X-_P#]CNT_
M:P_9Z\;;?C1\>_AU?:%XB'FZ9X'\7?V1I\T<MM#LGDB\I]TS-'(I?(RL:#'R
MU][2_P#!'-)XVCD_:B_;$EC<%71_B3E7!Z@C[-T-=N91A]:;<[-6LK/2VUCI
MQBC[9OFM;RV/S^_X-E?V@-8^&W[6WC7X/WEW))H>O:?/J$-N'W1PZA:R(A9
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M_P"#<[_E+#\1O^Q6U;_TY6-5EM::PU:SV2MY;E8.I)4JGHC]L/"7P,\%^ _
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M:J_;8_3CP9_P7(_9Y\4>&8;Z\\57V@W4B!I+"]TJX-Q"W=<QJR-]58@UY/\
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M7ZJ?"72/#&F?##0[?P;!I=OX4^Q1MI<>GJJVIMV7<A0#C:5.<]\DGFIOBO\
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M;SM?R/I[6M!LO$.GS6NHVMK?6DRE9(;B)98G'H5;(/XU^:_[:7P5\-_L:_\
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M\I& 7=N>. , 8  K\T?^#I?]F'Q-XMTKX?\ Q1TC3[K4="\.VUSI&M/"A?\
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M[C'FV>H6J7-O+CD;D<%3CW%=$<RC'$O$1AO>ZO??MHK?B;1QD56]JH[[Z_\
M /C7X;_\%[/@O\:M#TFQ\"V7C?QC\0]:AQ;>#=/T.;[<L^W.R2=P+98P?O2^
M:5506/ K\IO^"Q>I^/O _P#P4GT'Q-\5KC2Y-?FM-,UM]+THE[;0K59W,=BD
MI ,S(L>6E*C<[N0,8K^@#X5?LU_#GX$W5U/X'\ >"?!LU\H2XDT/0[73FN%'
M(#F%%+#@<&NVI8?'TL/5YZ4-+=7K^7]=PHXJ%*?-".GF]?R/GOX=?\%2?@;\
M3?V<O$_Q4T7QG)=>"?!+QP:W?'1[Z-K&5_+VIY30B1SF5!F-6'S=< X_#_\
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M?FR1QG]^**]2GCZ4<.\/R.SU?O:]/[OD=T<53C2=+E=GY_\  .=^$GQ8\/\
MQT^&NB^,/"NH?VIX=\16J7NGW?D20?:(7&5;9(JNN1V90?:NBHHKS':^APOR
M/G7]MK_@J5\'_P!@/5+/2OB!K6H0:]JEBVH6.FV>FSW$ES$&= ?,5/*7+HRX
M9@1UQCFOQ(_X(>?MW^#?V*/VS]>\4?$?4[[3_#GB;0KC39;V*SDNVAN'N;>9
M))%C#2%=L<@.U6.6'!K^D&BO1PV-I4J4J3@WS;N_Y:?YG91Q$(0<'&]]]?\
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M_:4\72?$C1=%M?A'\)Y(+K3/#<%LOVG4Y;B2<6[7=T<RLJI!(6CB:-&9ER"
M03+XQ4Y8B<?=COY7VM^@85)2=62T7]([CX,?\%&?^"</PCL=+NO#=OX%\+ZA
M81(D,_\ PKJ];4H=HP-]RMF[N_<L9&)/))->T:7_ ,%[/V2]7U"&UA^+ENDD
MS!%,WA[5H(P?]IWM0JCW8@5ZU;_\$Y/V>[:!(U^!?P?*QJ%!?P;ISL0/4F$D
MGW)S7QW_ ,%QO^"9/P6TK]@WQ9X\\+> O"O@7Q/X)6WN[6Z\/Z;#IL=TCW$<
M3PS1PJJ.&$N0Q7<&1<'&0;I_5*U10ESZNUVT]_D5'V%2:B^;7S7^1]X_$?\
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M &C?A3HOC;PC?/J7ASQ!;BYLKE[>2!I$R1RDBJRD$$<CM7\V_P"P]^W;J/\
MP3O_ &\->\?6FAKXBTZ5KW2M8L]Q21K.6YC=FC?HCB2.(@L"#]WC=D?TZ5^#
MO_!O+H]IX@_X*G?$ZRO[6WOK.Z\)ZO'-!<1"2*53J5CE65@00?0UU97*$:5>
M4E>-EI?IKU-L%**A4;6EMC[^\/\ _!Q'^S#XB\+PW</B3Q.NL7&U8M!'AN\D
MU"5VQB-2B- 6R<?ZWDUSD?["7B[_ (*??M/>&?C-\;])N/!?P[\(A6\)?#R[
M ?4+A=P?[1J/\,32,$9H5W':J(Q&T[OL7P)^R1\*?A=XI.N>&?AC\/?#NML2
M3J&E^'+.SNB3G/[V.,-SD]^]>A5PO$TZ;OADT^[=VO333UW.;VT8.]%->;_0
M\Y_:P_9PTG]K/]FWQ=\-]8=K?3O%&GFT$R+N-K(I62&4#OLE2-\=]N.*_"_]
MDO\ :(^*7_!O_P#M8:]X:^(GA+4;[P?K[B+4;>'B/4$C)\J]L9FPCL QRI(R
M&VMM8 K_ $+5C>.?AUX?^)^B-IGB70=&\1::QW&TU.RCNX"?79(I7]*K!X[V
M4)4JD>:$MU^J'A\3R1<)*\7T/C6S_P"#BG]E>Z\)_P!HMXQUV&^VY&DMX<O3
M>$_W=RQF'/;_ %N/>O7_ -D;]M+7/VEO"WC#QSK7P]U_X<_#?28UET.ZU^(Q
MZIJ\*(\D]T]NN3'$%\O8%W%L/@G@#O/ G[''PA^%NM1ZEX9^%?PW\.ZC$P=+
MK2_#-E9S(PY!#QQA@1ZYKTBL:M3#VM2B_5O\K+\[D3E2M:"?S9^ ?_!P3_P4
M?^%_[=^I?#;3?AGJEYK=MX-;4GO;V6QFLXW:X-LJJBS(KG @)R0/O#TK]%_^
M"4/_  53^#_QU^!_@;X<Z=KE];>./"G@ZV.IZ=/IEP$06ENB7#)*$,;*I&1\
MP+!A@$Y ^Y:*Z*V-I3H1H*#7+>SYN_?W36IB(2I*ERO3;7_@'X.?\%__ /@I
MW\+/VXO"7@3PW\,]8U#6U\.ZC>76HW$VFRV</*QI%L\Y5<YQ(?NCC&>>!]=_
M\$;O^"MGP;N_V6/ OPNU+6-2T?QEX/\ #DYO+>;3)Y(7ALH7EEE22-64CR49
M\'#'! !. ?THHJJF.HRPZP_([+5/F_\ M0EB:;I*ERO3S_X!_/I_P<$_M_\
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M:C;#:VD"PPQ#.<*B@ <^@J[7#6E!O]W&R];O^OD<M246_<5D%%%%8F84444
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M7_Z7(****R.,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^&;-;.T1VW2,!RSNW\3NQ9F/=F)KL:**XI2;=V8-MN["BBBD(**** "BBB@
MHHHH **** "BBB@ HHHH _.CXV?\%^;/]FW]M/XA?"_Q)\,?%FMZ?HLT=MX<
MGT*UW7VHS"%?-66*5U#1F;=LEBS\F/D8\GV?_@G%\(/'GB;Q;XU^/'Q=T5/#
MWCWXEF&VTW0WRTOAC18!_H]HV?NR,Q,D@P"6P6 ;*CZPHKLJ8B')RTX<K:2;
MO>]OROU.B5:/+RPC;OJ%%%%<9SA1110 4444 %%%% !1110!X'^V!^W1=?LI
M:Q:Z;8_!CXV?%"\O[!KR"?P;X:.HZ?"^YE$,\ZOF)R5R0$8A6!P<XK\=?^"3
ML/QH_8*_;+U3XC^+/V<_CWKFEZ]I%WI=W'IG@F]-U$9IX)_,17C1&PT(&"R\
M-7] U%>AA\=&E3E34+\V^K.JCB%"#AR[[G(_ GXM_P#"]/A7I7BK_A&?%W@[
M^U5=O[(\3Z=_9^JV>UV3$T&YMA.W<.3E6![UUU%%<$K-W1S/?0****0@HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MD# HJ5N:"C\V34J<T5%!CFBBBN<Q"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH XO7O^3AO"O_8O:Q_Z4Z77:5Q>O?\ )PWA
M7_L7M8_]*=+KM*UJ?#'T_5G9BOX=+_"__2Y!11161QA1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$G[V*)HDRZD?.RXQD\<U482D[15RHQ;=D>L454U[7K'PKH=[JFJ7EIINFZ;
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M,7B3X0W\&N>+]7@TB\\)7NM-97&C/)!=S9>9K9BQ M0-IB7/F9R,8/D^C?\
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MK7P9<:6=-#0PR)%';R2C:_G'*KN5/*!#, >!N/TC\!?B;>?\$.?^"/7@&_\
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MO6? ER+?5]#>+3T@=%D966,%1&XW@+(#(F5/S#T'_@FSX ^#GQC_ &I/$7Q
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MHHH **** "BBOS/_ &G_ /@J9^TMI_\ P4]\7_L^?!?P3\+?$DFAVUK=V/\
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M'5YS<173;#(L99HH71G0;D)CVMC ;)4-V_[6?_!3_P#X9=_;K^$_P5_X0?\
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M4+SXTW'PYA_9#\52>/;.(33^'U\3R'4(D,:RAC#_ &=N \MT;..C U]*2?\
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MHG_!./PA\(?C9^VWIGCCX3V?[4GQ#U_P7HE]=6>N^/=3L9-&6[-O+#'97#K
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MA=\?_ ?QQ6\/@KQMX1\8#3V"W1T36+?4/LQ/0/Y+MM/UQ7&_M]_M :S^RO\
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MGQ[A\-W'@:;4H;9(M;T)M:MWO"LC1XMUAE)?:LA#;. #R*P?^"AG_!.#P/\
M\%&/AG8Z+XHEOM'UK096N-$UW3\?:M,D;;N&#P\;[5W(<9VJ05(!'S-H'_!O
MW>>/O'.@WGQP_:$^(7QF\-^&65K#0KZ&2VA&WHKO)<SDJ0 &*!&8#&X5FJE"
MK"G[2;BXJS26K]'M]Y"G2G&//*W+_6AXY_P<4:CX?O\ P!^R;X@T&UAC^%JW
M-Q-%#;69M+9+-X]-DMD6!E0Q#[.DH6,JI4 C Q@??W_!3?Q-H,7_  32^,FH
M:A/:W&DWG@J_6VF#AXI9IK=DM65@<',SQ;2#R2.M=9^US^QEX&_;4^ -W\.?
M&6GR?V%(8Y;22R80SZ7/&"(IH#@JK*"RX(*E692""17P_%_P;KZQXETS2?"G
MC']IOXE>)_A9HDRO:>%#;-#'#&I&U%=[F2)< $ B ;<G:!SETZU"=.FJDN5P
M;Z-W3=^G4<*E.48J3MRM^=];G5?\$!_A9'\2/^"/P\-^)K.:;P_XOO-:LS'+
M]VXLYG:"39G(QN$HZ8W FOS_ /AQ^UAJO["/_!/K]JK]G76[I[7Q58^(UT32
ME)"F9+MVMK_;@Y*&WM2PQD'S\YP>?WL^%?PNT'X)_#C1?"/A?3;?2/#_ (>M
M([&PM(1\L,2# Y/+,>I8DEB222237P_^V#_P00\-_M;_ +=EM\9+GQM_8VGW
M%SI]SK7AQ="%PNK&VV*X%QYZ>7YL4:*?W38.YOFS@:8;'476J.MI&3YEZIW7
MW]2Z.)INI)U-F[_-,[3]A;]F'_ADW_@C?'X<N+7[+K6I>#M0US6 01)]KN[6
M29E<'HT:-'$<<?NN_4_GI_P1-^&G[7GC+]EOQ%=? 'XA?#/PGX/C\5W$5[:>
M(K9I+J2_%I9EY%(LY_W9B,  WCE6^4=3^WGQ(\'?\+!^'.O>'_M'V/\ MS3;
MC3_/\OS/(\V)H]^W(W8W9QD9QU%?FS\&O^#?SXL?L[>&;C1? ?[8GC#PCI%W
M=-?36>E>&I;6&6=D1&D*KJ(!8K&BYZX0>E+"XR#A4]JTG)IZIM?DQ4<1%QGS
MM7;OJKGMG[=^B?$3PY_P1.^(ME\5]8T37_B!!X<F&L7^D)LLKAS= H8QY46
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M_P CX%.HZAI?_!JDTFFM(MRVBK$Q3KY+Z^$F_#RF?/MFOK'_ ((9:/I.D?\
M!+/X4G2(X5CNK.YN+ET7!EN3=S>:6.!DAP5R>R@= *Z7]C7]AI_A3_P3?T/X
M$_$E=%UY5TB\TG6!ITLDEK/'<33/^[>2-'R%E&&* JPR.@-?(O@K_@DA^UU^
MR/HVM>!?@5^T%X7TWX8ZQ<231IK-N\>I:<),;C$5M9@CXX+1R1@GY@$8Y&LZ
ME*M"=+F4??<DW>S6Q4I0J1E#FM[S?DT<[_P0@\GPY_P4X_:PT/P[+(O@V#5;
MK[+%%_Q[E8M3N$MCTQD1,X'3@FOB[]G_ /9%\1?'5_VE_B1X!NKZS^)'P/\
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MX0N?VHOVM?CY^TYK=NQ?7-7GTC12Z96 32"XF12>1Y<0M(P1SM9@3R<^_?\
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MT;$^4_MC](?'OQ2\,_"GPA)X@\5>(=#\,Z%#L$FHZM?165K&7("AI9&5022
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MJ==I6M;XODOR1V8[^(O\,/\ TB(4445D<84444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<7\4O^1S^'7_ &,4
MG_IJU"NTKB_BE_R.?PZ_[&*3_P!-6H5M1^+Y/\F=F!_BO_#/_P!(D=I1116)
MQA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MF:KJ&D6]U?:=M8NODS.A>/#$L-I&"<]:ZRBG&36P)M;!1112 **** "BBB@
MHHHH **** "BBB@ HHHH *XKXH?LV?#KXW7MO=>-/ /@KQ?<68Q!+K>AVVH/
M .ORM*C%?PKM:*J,G%W0U)K5%'PYX:TWP=HEOIND:?8Z7IMFNR"ULX%@@A7T
M5% 51[ 5>HHJ1!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110!Q>B?\G$>)O^Q<TC_TIU.NTKB]$_Y.(\3?]BYI'_I3J==I6M;XODOR
M1V8[^(O\,/\ TB(4445D<84444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %<7\4O^1S^'7_ &,4G_IJU"NTKB_B
ME_R.?PZ_[&*3_P!-6H5M1^+Y/\F=F!_BO_#/_P!(D=I1116)QA1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Q
M?P(_Y$[4O^QBUO\ ].EU7:5Q?P(_Y$[4O^QBUO\ ].EU7:5K7_B2]6=F8?[U
M4_Q/\PHHHK(XPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH XO1/\ DXCQ-_V+FD?^E.IUVE<7HG_)Q'B;_L7-(_\ 2G4Z[2M:WQ?)?DCL
MQW\1?X8?^D1"BBBLCC"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ KB_BE_R.?PZ_[&*3_P!-6H5VE<7\4O\
MD<_AU_V,4G_IJU"MJ/Q?)_DSLP/\5_X9_P#I$CM****Q.,**** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .+^!'
M_(G:E_V,6M_^G2ZKM*XOX$?\B=J7_8Q:W_Z=+JNTK6O_ !)>K.S,/]ZJ?XG^
M84445D<84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <7H
MG_)Q'B;_ +%S2/\ TIU.NTKB]$_Y.(\3?]BYI'_I3J==I6M;XODOR1V8[^(O
M\,/_ $B(4445D<84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %<7\4O\ D<_AU_V,4G_IJU"NTKB_BE_R.?PZ
M_P"QBD_]-6H5M1^+Y/\ )G9@?XK_ ,,__2)':4445B<84444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <7\"/\
MD3M2_P"QBUO_ -.EU7:5Q?P(_P"1.U+_ +&+6_\ TZ75=I6M?^)+U9V9A_O5
M3_$_S"BBBLCC"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MOB%=?M1_%;2?BK>37,D^C>'O$*66E>%IUE98K>72POS(H"Y\SEP<@\@UA_\
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MP_:^(]86+Q5XHM+FWCO/#^F(NYS;K*P)ED/RJR*Y7!.!G->%:7X7\7?L._\
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M3OBAJUSH^N>'_&FM_P!M"2*.'S&N[?<H:#R\Y.P;< #@$YX+]OK]HCPE;?\
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MON?^1?\ J]FO_0-4_P# )?Y'M%%>+_\ #PKX/_\ 0W?^4J]_^,T?\/"O@_\
M]#=_Y2KW_P",T?4<3_S[E]S_ ,@_U>S7_H&J?^ 2_P CM/@1_P B=J7_ &,6
MM_\ ITNJ[2OG'X3?MT_"OPSX:O;>^\4^3--K6J7:+_9MXV8IK^>6-LB(CYD=
M3CJ,X(!R*Z;_ (>%?!__ *&[_P I5[_\9K6M@<2ZC:IRW[/_ ".K'9!FDL34
ME'#5&N9_8EW]#VBBO%_^'A7P?_Z&[_RE7O\ \9H_X>%?!_\ Z&[_ ,I5[_\
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M17B__#PKX/\ _0W?^4J]_P#C-'_#PKX/_P#0W?\ E*O?_C-'U'$_\^Y?<_\
M(/\ 5[-?^@:I_P" 2_R/:**\7_X>%?!__H;O_*5>_P#QFC_AX5\'_P#H;O\
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M"3Q!K>BW@\ Z)H>E6=KI865&=?W2M=0I!G;^]< G@X.%K]H)H5N(6CD59(Y
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M![PK-KOB[Q%H7A;1+=TCEU#5[^*QM8V<[5#2RLJ L2  3R3BO./^'BG[/O\
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M]F^V_;?)V_+Y/E[/DVU\K_\ !8+_ ()J_ _2OV1OC1\5K?P#81_$%K.75SK
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 ?BI\"OV0/AU^VM_P7X_:-\*_$WP[_PDV@Z?
M8ZAJL%K]ON;/R[E+S3HEDWV\D;G"32#:6*_-G&0"/U'_ &7O^"?7P:_8PGNY
M_AIX!TCPS>WT?DSWH>:[O)(\Y\OSYWDE"$X)4-@D#(X&/9**[<3CJE5**;2L
ME:^FAT5L3.=EJE9*U^Q^2O\ P;]_\I!/VM?^PPW_ *<KVOG[]LG]GH?L2_\
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M*Y<1C)55'HXWUOO=W,:N(<U'NK_B1VEI%86L<$$4<,$*"...-0JQJ!@  <
M<8%?-/\ P63_ .48/QF_[ )_]&QU]-45ST:G)44^S3^XQIRY9*78^./^" /_
M "B/^$O_ '&/_3S?5^56K_ ;3?\ @G3^UC\2O#GQXU?]HCP;X5U>]:\\-Z]\
M.-1CM;?6D,LC(\QE4I*3&Z_=;=$X=64[LK_0Y17=1S)PJU)VTF[VOYWWM^AU
M4\8XSE*VDO\ .Y^/_P"S3\+?#OPR_P""97Q@\7?#KX"_%CXEZ#XTURV&J>'?
MB/=Q&ZUW3K?S&74;3[);I*S*\H9L!BK(Q20[":^:O#WBGP_HOQF^&LG[$-Y\
M:]%^)&I7T9\1>$+]Y)M&TSE=T4[$?/"'W!S+O38NXE",'^A6BM89K9R;C>_G
MIM;5=?P+CCK-MJ]_/\^_X'Y$?\%-/BLO[#O_  7;^%?QO\8:#X@N/ -KX;:U
M^V:?;"8SR/:ZA:M&FYE4R(UQ&Q0L#M(/<5^LO@[Q1;^-_".EZU:)/':ZO9PW
ML*3+MD5)$#J&&3A@&&1DX-:5%<6(Q"JP@K:Q5KWW7H<U6LIQBK:I6/R-_P""
M*OP]_P"%N?$W]OOPH+C[+_PD^I_V3YV,^3Y\NNQ;OPWY_"O-_P!@_P#X*(-_
MP2&_9R^('P)^*7PX\;6WQ&35[Z[T*&+3TFL]5DF@BB129&&Z/S(U8.BR*Z2#
M /0_MU175+,HSE+VD+QE;2_5*V]OT-WC%)OFC=.VE^R/YO?VB_V2?%G[+7_!
M'3P'<^,]-O-$U?QU\2)=:ATVZC\N>UM?[,,41D0_,COL=]K8(5DR <BOZ(OA
M-_R2OPS_ -@JU_\ 1*5T%%98S'RQ$4I+5-O[_P#(C$8IU4DUU;^\****X#E"
MBBB@ HHHH **** /YXO^#D3]H1OC!_P4/NO#=O<-)IGPYTFWTA(QG8+F0?:)
MWP?XCYL:$C_GB/2O@"O?/^"IFMS:_P#\%'OC=/<*R21^,M2M@&Z[(KAXE/T*
MH"/8UX'7Z-@J:AAX179'UV'CRTHI=@HHHKJ-CZB_X)+_ !1^%7P:_;"TGQ%\
M9+?3+KP7I^GW3-'?:2VJ1?:=G[@B%4?+!^0Q7"GG(ZU^X_[ G_!6+P5^W[\7
M/$?A/P+X8US2]'\*Z8MX+_4O*@,^91$J1P1E]J8Y!+@]!M';^:K3>WTK]6O^
M#7'_ ).'^)G_ &+D'_I2M>'G&#IRI2KRO=+3MN<>886$J4JTMTM.VYC?\'''
M_)_>B_\ 8F67_I5>UZ+_ ,&W'P&L/%/Q0\=?$#4+-)[CPK:V^FZ5)(H98IKG
MS3,Z>CK'$JY_NS,.YKSK_@XX_P"3^]%_[$RR_P#2J]KZ3_X-H?\ DC?Q._[#
M%I_Z(>L:TG'*5;LOS.JK-QR>\>R7XHYK_@JA_P %4/BI\(?VPM2\$> =<7PS
MI/A".W2<I903OJ,\L,<[,YE1OE42! HQT8G.1C[,\/W]G_P4:_X)LPW>K068
MN/&?AV0R%8PT=IJ,.Y#(@)X"7,1(&<X&,]:_)S_@KW_RDE^)G_7Q9?\ I!;5
M^J7_  1MQ_P[:^'.[[O_ !,\Y_["EW7+CJ,*6#HUJ:M+37U5_P R<RP]*AEV
M'Q%&*4TXZK?6-]?FCXB_91_:-^&.N?LM^!?!/C7QIJ'P_P!2^&_C%?$L,L.D
MW&H1ZW$':3R_W(S&^9&7<V0H4'#9('M/[646I6>E>.M3\$^"_$>L_$#XV1PS
M7Z6NDR75QX<\/B-(HTF5%;RI+KR2S*<$ D'YHU-?"/['OBOP+X#^-NFZ]\0K
M/4M2T/14DOH+&TB5Q>W<:[H(I<L,1EP,GD$@ C:6(^Y/@7^UK+^T9\$%=?BE
MX=^&/Q C\<KK^OR:E?\ ]FQZM8]%BB?_ ):(D8BB$3$Y$ 5^"">_%T'3J^T@
MFU?6^VKOT5[75W\EM<^DQV#E0Q"KTDW&]W?X;MWZ*]KI-WOKRK:Y\+PV<VG7
M<EO<1207$#&.2.12KQL#@J0>00>"#6UIO:O0/VX_B+H/Q8_:Y\::_P"&)H[C
M1;ZYB$$\:;4G9((HY)!ZAI$=@>^<]Z\_TWM7NT9.4%)JS:6G;0_0\OJRJT85
M)QY7))M=FUM\CH--[5]2?\$P_B0_@O\ :+@TMYMEGXFM9+-T/W3(H\R,_7Y6
M4?[YKY;TWM7KW[(US):_M(^!6C5F8ZW:H0/1I%4_D"36..IJIAYQ?9G1F^&C
MB,MKT9[.#^]*Z^YZGZV4445^:G\P!1110 4444 %%%% !1110 5\,?\ !PW^
MT5)\"?\ @G+K>FV5T;75?B!?0>'X2I(?R6S-<8([&*)D/_72ON>OR+_X.PM<
MFM_AW\%=-6-C;W>HZM<R/_"KQ1VJJ#[D2O\ D:[\KIJ>*A%][_=J=6"BI5XI
MGXKT445^@GU04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M-HDT/2K"=JKP]*L)VHZFT22BBBJ*"BBB@ HHHH **** "BBB@ HHHH ****
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MJT>Z!K@*K3#>DCAG&X>9MR=H)VIX1*+<WK9M+7T-(T$D^;>S=C[\^(7BO_A
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M2&?&GXWZ]^T;_P $Z?V./&/B>Y2]U[6/B_X4:\N5C$?VAUEN4,A48 +;<D
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M;X=_"/X+^(O#^BZA+IMUM%Q:W#SQ113/&B2ZD&8^7-'@@$$MCD@BO;OV9_\
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M8F.WGQS;7*,LL$@_W940GU&1WKJP594:\:CV3_ VP]3V=6,WW/Y-Z*VOB/\
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M_'7'2O/_  )_P3W^(7ACX4_M Z/8?$)?!'B+XF_$K4?''AO6_#]Q,\FG0S&
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M=:3^ZQ\*> ?^"37B2V_85M_A[JWB;1='\?\ AOQG/XV\,ZYI@DN[:PO!=/-
M)!(D;LI5RCJ!@$Y&[;@^@_#GX$?M+?$GXS>$];^+OC_P3H'ACP6[W"Z+\.Y]
M1@_X2><KM5K]Y]O[I?O>2H92W4FOH#XI?';P/\#=/@N_&WC+PKX/M;IBD,VM
MZM;Z?',PZA6F=03["M;PUXXT7QGX6AUS1]8TO5M%N8S-#J%G=QSVLJ#JZRJ2
MI48/(..*TEBJK3E);WUMWWL7*M-J[Z^7?L?#_A/]@?\ :,^!%G\1O OP[\9?
M"1?AO\1-7OM3.J:W8WLGB'2A>9$J+'&/L\S!> TC=><8PHN:5_P31^(D?[#G
M[/?PUO-6\%MXA^$OQ!TKQ1JMQ%=7/V.ZLK.XN'*P,8-[3,DJ85D1=VX;@ "?
MK#X??M-_#;XM>);C1?"OQ"\#^)M8LP3<6.DZ[:WMS !P2T<;LRX]Q3_B?^TG
M\.O@EJ%K9^-/'W@KPC=7PS;0ZUKEMI\EP,X^1974MSZ53Q5=NUM=]M7I8KVU
M2]K:[[&C\9/AS%\8OA#XJ\(SW4UC#XJT>[T>2YB7=);K<0O$74=RH?('J*_/
MWX@_\$V_VJOB!^PU-^SS+XR^!MGX'TO3[?3M/O[>TU!=2U>&WEC>".ZS&8X/
M]6K-)$LC,5 [L3^A?B+XF>&_"'@:7Q1JWB#1-+\,P0K<2:M=WT4%C'$Q 60S
M,P0*2R@$G!R/6N*\&_MO_!;XC>)[/1/#WQ>^%^O:UJ#^7:V&G>*K&ZNKEL$[
M4C24LQP"< '@&HP]:K35X*]G?:]FB*52<5[J\]CSOX<_LC>,-"_X* _\+>U:
M\\-?V3/\/K;PO-:VD\[7 O4F61W56B"^3P0"7W=,J*YGQC_P35NOC!\<?VH+
M[Q5J.EKX-^/&BZ%I>G"RD>2_T^2PMF1I94:-8QB;8Z!7;<%YVU];75U'96TD
MTTD<,,*EY)'8*J*!DDD\  =ZXOX>_M._#7XN>)+G1O"GQ"\#^)]8LP3<6.DZ
M]:WMS!@X.^.-V9<'@Y%*.(J_%'LEZ)--?BA*K/==K?J?%/QJ_8-_:T_:$_9@
MC^$_B;QQ\%9-#T62S:TU.W@U!=2UY;:>,H+LM&T=O^[!8F)7+.JCY5+&OT'T
MRV:RTVWA;:6AB5"1T)  KF/BG^T#X#^!D=LWC;QMX1\'K>DBW.N:Q;Z>)\==
MGG.N[\*WM(\6:7K_ (<BUBPU+3[[29H?M$=];W"26TD>,[Q(I*E<<Y!QBIK5
MISBN966NRMJ]_P @J5)22NM/0T**X?X>_M._#7XN>)+G1O"GQ"\#^)]8LP3<
M6.DZ]:WMS!@X.^.-V9<'@Y%=%XU\>:'\-O#\VK>(M:TG0-*M_P#6WNI7<=K;
MQ_[TDA"C\36+C).S6IGRM.S-:BLWPAXRT?X@^&K/6M!U73=<T?48Q-:7^GW*
M7-M=(>C)(A*LI]02*TJG;1DA1110 4444 %%%% !1110 4444 %%%% !1110
M!\G_ +./_!,#_AG_ /X*._$S]H'_ (3C^UO^%C6%S8_V#_8WV?\ L_SKBTFW
M?:?/;S-OV7;CRESOSD8P<W3_ /@E"_@+_@IK<_M%^"/B!_PBT.NJ5\0^%_[#
M^TPZP)$"W'[_ .T)Y?F,L<O^K;;*F[Y@=M?85%=/URM=N^ZMLMNW]:FWUBI>
M]^EOD?$_P9_X(OZ#X$^-_P"T-XE\4>+3XN\/_M!'4%OM$7238MI<=W>276%N
M!.YD9"X"N$0Y4-@=*\PF_P"#?OQ%=_#F+X8S_M->/IO@G#=BX3P@VD1;P@F,
MP3[3YVWB0[\>3MW_ #; <5^D]%:1S#$)WYNW1=-%TW\]REBJJ=[_ )=#XQ^+
M?_!'31?&W[5'P(^('AWQ8OA30?@58:?IMAX=&C_:OMT-G<-*@-SYZ%&8-M+&
M-SD%CDG%6M _X)/O\*_^"D5Y^T!\._B!_P (?9>(L_\ "2^$_P"Q#=6NM>9S
M<GSA<)Y9D<+*/W;;)06^8'97V)14?7:UK<W2W39_UZD_6*EK7Z6^1P7[3G[-
MOA7]KKX':]\/?&EI+=>'_$,(CF\EQ'/;NK!XYHF((61'564D$9&"""0?@S2_
M^#=>ZUBWT/PKXT_:+^(GB[X1^';I;BP\&O;-!'"JDX02FX=%&&=<I"I <[=I
MYK],**5'&5J2Y:;LOE_2^04\14@K19\F_M_?\$L;']M:'X/6NE^*H? >F?"&
M^^TV=G%HWVZ.YA'V8) O[^+R@JVX4'Y^&Z<<_65%%92K3E%0D]%>WSW(E4DT
MHO9'R5\)/^"6_P#PJW_@IUXS_:._X3K[=_PEUG+:?\(]_8OE?9-\=NF[[5YY
MWX\C./*7[WMS]:T445*TZC3F]E;Y()U)3UEZ'R?^Q?\ \$P/^&0_VR?C)\6_
M^$X_X2'_ (6W?W=]_97]C?9/[*\^^>[V^=Y[^;MW[,[$SC.!TKG_ -M3_@CC
MIO[1_P"T'#\7?A[\1_$WP5^*#0BWO=9T2,S)J"A!&&>-98G$AC 0E9 K*H!4
MGD_:%%;?7*RJ>TOK:W3;M;8OZQ44N>^NQ\Q_L6?\$WI/V8O#OCA?&/Q2\=?%
MS7OB-"MMKE[K=W)';O&(VCQ% 9)"C%7*ES(QVA0-H'/E_P"Q)_P10_X8[\0^
M*M)N/BUX@\;?"'Q58WME<> M0T\PV4AN4CC>65UG*22>6@3<L2$C'3 K[LHH
M^N5O>U^+?1=-O3Y!]8J:Z[GYLV?_  ;\:]X#BU/PSX#_ &GOBAX-^%>KW$DM
MSX5@A9]R2<.GG)<1I\R@*6,!W ?-NKT[]J;_ ((VVO[0WC+X"ZA8_$C6-)L_
M@6D$4*:K8'6+W6TBF@E!EN3/%M<^1@ML8?-P  %K[8HJWF&(<E)RU7DNNG;7
MYE?6JM[W_!'R?_P5<_X)@?\ #SOP)X1T3_A./^$'_P"$6OYK[SO[&_M+[5YD
M83;M\^';C&<Y.?05;_X*%?\ !-3_ (;Q^*_P8\4?\)I_PBO_  J'5YM4^S?V
M1]N_M;S)K*79O\^/R<?8\9P^?,S@;<'ZEHK*&*JQ45%_#>VW7<F-><;6>U[?
M/<^3_P!J[_@F!_PT]^WE\)_C=_PG']A_\*O^R_\ $E_L;[3_ &GY%W)<?Z_S
MT\K=OV_ZM\8SSTKZ5^)?@[_A8GPX\0>'_M'V/^W=-N-/\_R_,\CS8FCW[<C=
MC=G&1G'45MT5,JTY**;^'8F523LGTV/R[^$'_!OG\5?@#X0N_#_@G]L+QEX3
MT._N'N[FRTCPY+9Q33.B1M(0FHCYRD:+NZX4>E>Q?"/_ ((>^$?@C^Q-\3_A
M5H?BS4I?$7Q8MTAUKQ9?V0GE)C8M&%MQ(HV*6D.WS-Q,C$L< #[BHKHGF6(G
MO+JGLEJMKV6OS-98RK+=_@C\Z_B'_P $#/\ A/?V1_@?\*_^%L?9?^%,ZAJE
M]_:G_",>9_;'VV\-UM\G[6/)V9VYWONZX7I7UA^WG^Q?H?[?'[-6L?#C7M0O
M-'AU"6&ZMM0M5#R65Q$X9'V$@..JE21D,<$'!'LE%9RQE:34F]4VUMNW=_B1
M+$5&TV]G?[]3\V_B'_P0+\4?%C]D'0?A1XE_:*UK7D\-:ZFIZ9J.H>'&N%L+
M1+/[+'8PPM>_)&H^8$/@=-HZU[I_P5"_X)@?\/(Q\._^*X_X0S_A ;^XOO\
MD#?VC]N\WR/E_P!?%Y>/)Z_-G=T&.?K"BJ^O5^93OJKM:+KOT*^M5;J5]5?H
MNNX#@4445QG.%%%% %'Q+X;T_P 9>'K[2=5L[?4--U*![:ZMIT#QSQ."K(P/
M4$$BOYW_ /@KS_P1B\2_L)^,]0\6>#;&^U[X0WC^=#>+F6;P^68#[/==]H8@
M)+T8$ X;K_1=4&IZ9;:WIMQ9WEO!>6=W&T,\$T8DCF1AAE93PRD$@@\$&N[
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M+_Y H_M3"?SH/KE#^9'YJT5^E7_$++^T%_T.'P;_ /!MJ7_R!1_Q"R_M!?\
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M\WTZU/%_2OT=7_@V9^+ /_(_?#S_ +ZO/_C-2)_P;0?%=?\ F??A[_WU>?\
MQFC^U<)_.BUFV$_G1^<J=JGA^]7Z+K_P;2_%8?\ ,^?#W_OJ\_\ C-2)_P &
MUGQ60_\ (^?#W_OJ\_\ C-']JX3^=&L<WP?_ #\7XGYUQU-#UK]$E_X-LOBH
MO_,]_#__ +ZO/_C-2)_P;;?%1/\ F>_A_P#G=_\ QFC^U<)_.C59Q@O^?B_$
M_/%.U3)UK]#%_P"#;[XIC_F>OA__ -]7?_QFI%_X-POBD#_R/7@'_OJ[_P#C
M-']JX3^=&D<ZP7_/Q?B?GO'4T?05^A"_\&Y/Q17_ )GGP#^=W_\ &:<O_!N=
M\4%_YGCP#_WU=_\ QFC^U<)_.C19Y@?^?B_'_(_/V/H*L0]:^_U_X-U?B@O_
M #/'@+_OJ[_^,U*G_!NY\3D_YG?P'^=W_P#&:/[5PG\Z-%GF _Y^+\?\CX!3
MI4T/2OOQ?^#>+XG+_P SMX#_ .^KO_XS4B?\&\_Q-3_F=O G_?5W_P#&:/[6
MPG\Z_$N.?8#_ )^K\?\ (^!X^HJ:.OO9?^#>[XF+_P SKX%_.Z_^-5(O_!OE
M\2U_YG3P+_WU=?\ QJC^U<)_.C2.?9?_ ,_5^/\ D?!J=*FCZ"OO!?\ @WZ^
M)0_YG3P-_P!]77_QJI%_X-_OB4O_ #.G@?\ .Z_^-4?VMA/YU^)K'B#+O^?J
M_'_(^$XNU31U]U)_P0%^)"_\SEX'_P"^KK_XU6=K_P#P0V^(7AK5=#M)O%W@
MV1]>OFL(2AN<1N+>>XRW[KIM@8<=R/>J6:85O2:-Z>?Y?)VC57?KTU?3L?%L
M7]*G'6ON1/\ @@A\1U_YG+P3^=U_\:J4?\$%_B,#_P CCX)_.Z_^-5/]K83^
M=?B4N),M_P"?R_'_ "/AV'[U3QU]O)_P0<^(J'_D</!7YW/_ ,:J5?\ @A%\
M1!_S.'@O\[G_ .-4?VMA/YU^):XDRS_G\OQ_R/B*+M5B/J*^V$_X(3_$1?\
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MY_P?^0?Z[9)_T$+[I?Y'R317UM_PZ4\1?]#=HO\ X#2T?\.E/$7_ $-VB_\
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MW2=)M)K[4+[[''##$NYG/V2'] ,DGL!7UI^Q[^QYIW[.OAU+Z^6*]\5WD?\
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M_.YY?\!/^"DNH>#_ /@F/\,_%6A?#OP7%X]^(_B2\\+^&/"7ARV_L?1OM?\
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M]I*"5EA+# 8I(K+D<';FORV^'7[ G@G]E$^)/!/Q;_9G^-7Q2UBVU2YE\/\
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M^$'PC\2P^";Q_&/AF^U37KW3+.ZB"W4!P!:^9,VR(]Q(';_:%+#^W#K6G?\
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MG@WX Z#\-5T?X7W2Z7K>O>-I+UH;_4=NZ2TMH[4AE\O(#2.2,GA2"*Y[7/\
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M624VHA1116!F%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%?&3_P %OA3_ .4M>R44>VEY?<O\@]H_+[D>-_\ #,?C;_HXKXR?^"WPI_\
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M_P""WPI_\I:/^&8_&W_1Q7QD_P#!;X4_^4M>R44>VEY?<O\ (/:/R^Y'C?\
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MM\*?_*6C_AF/QM_T<5\9/_!;X4_^4M>R44>VEY?<O\@]H_+[D>-_\,Q^-O\
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M?&3_ ,%OA3_Y2T?\,Q^-O^CBOC)_X+?"G_REKV2BCVTO+[E_D'M'Y?<CQO\
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M_AF/QM_T<5\9/_!;X4_^4M>R44>VEY?<O\@]H_+[D>-_\,Q^-O\ HXKXR?\
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MQ7QD_P#!;X4_^4M>R44>VEY?<O\ (/:/R^Y'C?\ PS'XV_Z.*^,G_@M\*?\
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MM\*?_*6C_AF/QM_T<5\9/_!;X4_^4M>R44>VEY?<O\@]H_+[D>-_\,Q^-O\
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M "#VC\ON1XW_ ,,Q^-O^CBOC)_X+?"G_ ,I:/^&8_&W_ $<5\9/_  6^%/\
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M(?V0_P";\/\ @G]>U%?R$_\ "Z/&/_0V>)O_  :3_P#Q5'_"Z/&/_0V>)O\
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M+)K_ &_P_P""?V'45_(7X:\9:QX5+?V7JNI:;YGWOLMR\.[Z[2*VH_C)XO\
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M#_@EKPYO_P Q'_DG_P!L?T!45^ <?459B_I1_JW_ -//P_X)?_$-_P#J(_\
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MB4*CS0&;RKA\ 9>979CRQ)YKI>,HNRUTY>B^RK=]/Q-O;TW9:Z6_!6[GS?\
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M2.3Q#K3*RG*L#J=U@@UVU</^SW9PZ=X"O+>WC2&"#Q!K,<<:+M5%&IW0  [
M"NXKX'$?Q)6[L_G#,K?6ZEOYG^84445B<04444 %%%% !1110 4444 %%%%
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MQ&(A1INI/9'/F.94,!AI8K$.T8K[WT2\V>,1_#OQ!+&K+H6L,K#((LI""/\
MOFG?\*W\1?\ 0!UK_P  9?\ XFOV%1%B1550JJ,  < 4M?.?ZRR_Y]_C_P
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M7\"/^1.U+_L8M;_].EU7:5S5_P")+U9Y>8?[U4_Q/\PHHHK(XPHHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5^2/\ P6+_ ." ]Q\4?$.L?%7X'V=NNL72M=ZS
MX2C C6_ESEI[,Y"K(PR6B. Q&5^8[3^MU%=.%Q=3#SYZ;_X)M1KSI2YH'\>G
MBOPCJW@37[G2=<TS4-'U2S;9/9WUN]O/"WHR. RGZBLZOZR/VC?V'_A+^UO#
M&OQ&\ ^'O%$\,9ABN[BW\N\A0_PI<1E95'? 8#-?(?C+_@V/_9O\3W&^QN_B
M1X=7<6\O3M;AD4CT_P!(MY3C\<^]?3T>(*,E^\33^]'M4\VIM>^FC\!]-[?2
MM_3?Z5^XT'_!KK\ ;?[OC#XP^G.JZ=_\@U;@_P"#8_X"P?=\7?%W\=4T[_Y!
MK?\ M["=W]QV4LXPT=[_ ''XG:?]ZM_3>U?L]#_P;5? N _+XL^+/XZGI_\
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MU!W#Q1,688\MN&8'.3G[>HJXXNHG=6^Y6T\K6OY[E*O-.ZM]R_R/DO\ ;/\
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MJD=7#7FFW$VYN^9"/0"N?_X9C\;?]'%?&3_P6^%/_E+6BIQ:^)?C_D7RKO\
MG_D>R45XW_PS'XV_Z.*^,G_@M\*?_*6C_AF/QM_T<5\9/_!;X4_^4M/V<?YE
M^/\ D/E7=?C_ )'LE%>-_P##,?C;_HXKXR?^"WPI_P#*6C_AF/QM_P!'%?&3
M_P %OA3_ .4M'LX_S+\?\@Y5W7X_Y'LE%>-_\,Q^-O\ HXKXR?\ @M\*?_*6
MC_AF/QM_T<5\9/\ P6^%/_E+1[./\R_'_(.5=U^/^1[)17C?_#,?C;_HXKXR
M?^"WPI_\I:/^&8_&W_1Q7QD_\%OA3_Y2T>SC_,OQ_P @Y5W7X_Y'LE%>-_\
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M.*^,G_@M\*?_ "EH_P"&8_&W_1Q7QD_\%OA3_P"4M'LX_P R_'_(.5=U^/\
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M7QD_\%OA3_Y2T>SC_,OQ_P @Y5W7X_Y'LE%>-_\ #,?C;_HXKXR?^"WPI_\
M*6C_ (9C\;?]'%?&3_P6^%/_ )2T>SC_ #+\?\@Y5W7X_P"1[)17C?\ PS'X
MV_Z.*^,G_@M\*?\ REH_X9C\;?\ 1Q7QD_\ !;X4_P#E+1[./\R_'_(.5=U^
M/^1[)17C?_#,?C;_ *.*^,G_ (+?"G_REH_X9C\;?]'%?&3_ ,%OA3_Y2T>S
MC_,OQ_R#E7=?C_D>R45XW_PS'XV_Z.*^,G_@M\*?_*6C_AF/QM_T<5\9/_!;
MX4_^4M'LX_S+\?\ (.5=U^/^1[)17C?_  S'XV_Z.*^,G_@M\*?_ "EH_P"&
M8_&W_1Q7QD_\%OA3_P"4M'LX_P R_'_(.5=U^/\ D>R45XW_ ,,Q^-O^CBOC
M)_X+?"G_ ,I:/^&8_&W_ $<5\9/_  6^%/\ Y2T>SC_,OQ_R#E7=?C_D>R45
MXW_PS'XV_P"CBOC)_P""WPI_\I:/^&8_&W_1Q7QD_P#!;X4_^4M'LX_S+\?\
M@Y5W7X_Y'LE%>-_\,Q^-O^CBOC)_X+?"G_REH_X9C\;?]'%?&3_P6^%/_E+1
M[./\R_'_ "#E7=?C_D>R45XW_P ,Q^-O^CBOC)_X+?"G_P I:/\ AF/QM_T<
M5\9/_!;X4_\ E+1[./\ ,OQ_R#E7=?C_ )'LE%>-_P##,?C;_HXKXR?^"WPI
M_P#*6C_AF/QM_P!'%?&3_P %OA3_ .4M'LX_S+\?\@Y5W7X_Y'LE%>-_\,Q^
M-O\ HXKXR?\ @M\*?_*6C_AF/QM_T<5\9/\ P6^%/_E+1[./\R_'_(.5=U^/
M^1[)17C?_#,?C;_HXKXR?^"WPI_\I:/^&8_&W_1Q7QD_\%OA3_Y2T>SC_,OQ
M_P @Y5W7X_Y'LE%>-_\ #,?C;_HXKXR?^"WPI_\ *6C_ (9C\;?]'%?&3_P6
M^%/_ )2T>SC_ #+\?\@Y5W7X_P"1[)17C?\ PS'XV_Z.*^,G_@M\*?\ REH_
MX9C\;?\ 1Q7QD_\ !;X4_P#E+1[./\R_'_(.5=U^/^1[)17C?_#,?C;_ *.*
M^,G_ (+?"G_REH_X9C\;?]'%?&3_ ,%OA3_Y2T>SC_,OQ_R#E7=?C_D>R45X
MW_PS'XV_Z.*^,G_@M\*?_*6C_AF/QM_T<5\9/_!;X4_^4M'LX_S+\?\ (.5=
MU^/^1[)17C?_  S'XV_Z.*^,G_@M\*?_ "EH_P"&8_&W_1Q7QD_\%OA3_P"4
MM'LX_P R_'_(.5=U^/\ D>R45XW_ ,,Q^-O^CBOC)_X+?"G_ ,I:/^&8_&W_
M $<5\9/_  6^%/\ Y2T>SC_,OQ_R#E7=?C_D>R45XW_PS'XV_P"CBOC)_P""
MWPI_\I:/^&8_&W_1Q7QD_P#!;X4_^4M'LX_S+\?\@Y5W7X_Y'LE%>-_\,Q^-
MO^CBOC)_X+?"G_REH_X9C\;?]'%?&3_P6^%/_E+1[./\R_'_ "#E7=?C_D>R
M45XW_P ,Q^-O^CBOC)_X+?"G_P I:/\ AF/QM_T<5\9/_!;X4_\ E+1[./\
M,OQ_R#E7=?C_ )'LE%>-_P##,?C;_HXKXR?^"WPI_P#*6C_AF/QM_P!'%?&3
M_P %OA3_ .4M'LX_S+\?\@Y5W7X_Y'LE%>-_\,Q^-O\ HXKXR?\ @M\*?_*6
MC_AF/QM_T<5\9/\ P6^%/_E+1[./\R_'_(.5=U^/^1[)17C?_#,?C;_HXKXR
M?^"WPI_\I:/^&8_&W_1Q7QD_\%OA3_Y2T>SC_,OQ_P @Y5W7X_Y'LE%>-_\
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M/9Q_F7X_Y!RKNOQ_R/9**\;_ .&8_&W_ $<5\9/_  6^%/\ Y2T?\,Q^-O\
MHXKXR?\ @M\*?_*6CV<?YE^/^0<J[K\?\CV2BO&_^&8_&W_1Q7QD_P#!;X4_
M^4M'_#,?C;_HXKXR?^"WPI_\I:/9Q_F7X_Y!RKNOQ_R/9*XOXI?\CG\.O^QB
MD_\ 35J%<?\ \,Q^-O\ HXKXR?\ @M\*?_*6N3^)'[-OC*W\6^ U?]H'XNSM
M/KTB([Z=X7#6Y_LV^;>NW1P"V%*_,&&';C.UAK1IQYOB6S[]GY'5@8KVCU^S
M+O\ ROR/I"BO&_\ AF/QM_T<5\9/_!;X4_\ E+1_PS'XV_Z.*^,G_@M\*?\
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M0<J[K\?\CV2BO&_^&8_&W_1Q7QD_\%OA3_Y2T?\ #,?C;_HXKXR?^"WPI_\
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M,G_@M\*?_*6CV<?YE^/^0<J[K\?\CV2BO&_^&8_&W_1Q7QD_\%OA3_Y2T?\
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M P68(JKD]3M4#T Z5$HI;._W_JB912V9/1114DA1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <7HG_)Q'B;_
M +%S2/\ TIU.NTKB]$_Y.(\3?]BYI'_I3J==I6M;XODOR1V8[^(O\,/_ $B(
M4445D<84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %<7\4O\ D<_AU_V,4G_IJU"NTKB_BE_R.?PZ_P"QBD_]
M-6H5M1^+Y/\ )G9@?XK_ ,,__2)':4445B<84444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <7\"/\ D3M2_P"Q
MBUO_ -.EU7:5Q?P(_P"1.U+_ +&+6_\ TZ75=I6M?^)+U9V9A_O53_$_S"BB
MBLCC"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M'FK%22%%<_\ %;XH:)\$_AIKWB_Q)>#3] \-V,NHZA<E&?R88E+,0J@LQP.
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MPO9A^)2$@?C7\]</2K$?04?ZNT/YG^'^1I'A?#=92_#_ "/Z!!_P61_9K/\
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M0$C\5TZ5:AZU4>'\/%W4I?AU^1TT>#\)3ES*4MFMUU37;S/W''_!6+]GT_\
M-1+;_P %5_\ _&*</^"KO[/Y_P":B6W_ (*K[_XQ7X>)TJS%_6I_U=P_\TOP
M_P A1X(P3^W/[U_\B?MV/^"K'P /_-0K;_P5WW_QBF3?\%8/V?X&PWQ C;(S
M\FC:@P_2 U^)T=6(ON4?ZNX?^:7WK_(T7 N!ZSG]\?\ Y$_:@?\ !6/]G\_\
MS]_Y0]2_^1Z</^"KWP!8?\C]_P"434?_ )'K\74ZU8B^Y1_J[AOYI?>O\BUP
M)@/YY_?'_P"1/V<'_!5GX!G_ )GS_P HFH__ "/3A_P54^ K#_D?/_*)J/\
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MIDLX)I&>V62X8K$K1B,@K+EE?YE/RKP]I_P6H_:@^,'PS\5?&3X;_ OP?<?
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M_#;5-92'7TGF>74].UV'[0BP1-N57MVBW/N,>?F3E3E:],_;%_;1^+G[+O\
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MH,\GVK3F<Q@&=#<3@L@EC+1D1MC<5R5*UTWQ:_X*F_'#XN_MO^-_@O\ LY^
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M@ZB^*.ORZGSO&V20QF6RQ$5^\I*Z?EU7W:^J\S]%****^%/P,**** "BBB@
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MH^'?VU/AGKVA6=X_B[2+%[J)9&M[B;9+"2,E6'8CI5S_ (:^^&/_ $/'A_\
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MX^,7Q:U:]9?&%UX8@L+7PYIEO&)9G%G&_ERNH.V/>?F(.X9P:XFR_P""9OQ
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M?A2YO;O2[4V=S!)?ZA D$D:Q82+]S I>-5EVH2&W$D^I_M,?M%?&#]B#X:>
M? ?B#XM>$_$WQ.^+GB*>VL_%^LZ%:Z+I/A6PBBCDN&,*R;)C%N 0R,-Y?!Y
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MLN?:.RO\/=]/A[7LT^W4F/)S=.G;_AONU.\_;Q_;/^)/PI\3_!?PI?>*-%^
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MWW*B[239^+?_  1K^-/[7W@7]CV^TSX$_!_P5XU\(S:_=N=8U?58+>6"\:&
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M;'.N<%3@-PRY!X^NR/,(RA]7F]5MYK_@'O9;BDX^RENMCY<HHHKZ(]8_;O\
MX(W?\%:?V??V7/\ @GUX+\#^._B!_8?BC29]0>ZLO[#U*Z\H2WT\L9\R&W>,
MY1U/#'&<'!R*_);XBZW:^)?BCXDU*QD\ZSU#5+FYMY-I7S(WF9E." 1D$'!
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M[X>X_P"X[IG_ ,D5L6/_  2<_: A^]X!Q_W'--_^2*_:"BC_ %BQ/\L?N?\
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M7PI_\&=__P#(5?M=11_;V+[K[BO]8<9W7W'XKQ_\&XWQO3_F:OA5_P"#*_\
M_D*I%_X-S/C<O_,T_"O_ ,&5_P#_ "'7[244?V]B^Z^XK_63&]U]Q^.>A_\
M!N3\5)8,ZAXX^']K)GA;=[N=3^+0I_*M!?\ @W'^(2C_ )*!X,_[\7/_ ,17
MZ^44O[<Q?=?<@_UDQW\R^Y'Y$+_P;G_$)?\ FH'@W_OS<_\ Q%2Q_P#!NO\
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M-Q_\34B?\$#?':_\SQX2_P"_-Q_\37ZG45']N8ONON1A_K=F2^TON1^6J_\
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MS#_>JG^)_F%%%%9'&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MNJ/8R\OO7^8>S?E]Z/9**\;_ .&G/&W_ $;K\9/_  9>%/\ Y=4?\-.>-O\
MHW7XR?\ @R\*?_+JCV,O+[U_F'LWY?>CV2BO&_\ AISQM_T;K\9/_!EX4_\
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MA3_Y=4?\-.>-O^C=?C)_X,O"G_RZH]C+R^]?YA[-^7WH]DHKQO\ X:<\;?\
M1NOQD_\ !EX4_P#EU1_PTYXV_P"C=?C)_P"#+PI_\NJ/8R\OO7^8>S?E]Z/9
M**\;_P"&G/&W_1NOQD_\&7A3_P"75'_#3GC;_HW7XR?^#+PI_P#+JCV,O+[U
M_F'LWY?>CV2BO&_^&G/&W_1NOQD_\&7A3_Y=4?\ #3GC;_HW7XR?^#+PI_\
M+JCV,O+[U_F'LWY?>CV2BO&_^&G/&W_1NOQD_P#!EX4_^75'_#3GC;_HW7XR
M?^#+PI_\NJ/8R\OO7^8>S?E]Z/9**\;_ .&G/&W_ $;K\9/_  9>%/\ Y=4?
M\-.>-O\ HW7XR?\ @R\*?_+JCV,O+[U_F'LWY?>CV2BO&_\ AISQM_T;K\9/
M_!EX4_\ EU1_PTYXV_Z-U^,G_@R\*?\ RZH]C+R^]?YA[-^7WH]DHKQO_AIS
MQM_T;K\9/_!EX4_^75'_  TYXV_Z-U^,G_@R\*?_ "ZH]C+R^]?YA[-^7WH]
MDHKQO_AISQM_T;K\9/\ P9>%/_EU1_PTYXV_Z-U^,G_@R\*?_+JCV,O+[U_F
M'LWY?>CV2BO&_P#AISQM_P!&Z_&3_P &7A3_ .75'_#3GC;_ *-U^,G_ (,O
M"G_RZH]C+R^]?YA[-^7WH]DHKQO_ (:<\;?]&Z_&3_P9>%/_ )=4?\-.>-O^
MC=?C)_X,O"G_ ,NJ/8R\OO7^8>S?E]Z/9**\;_X:<\;?]&Z_&3_P9>%/_EU1
M_P -.>-O^C=?C)_X,O"G_P NJ/8R\OO7^8>S?E]Z/9**\;_X:<\;?]&Z_&3_
M ,&7A3_Y=4?\-.>-O^C=?C)_X,O"G_RZH]C+R^]?YA[-^7WH]DHKQO\ X:<\
M;?\ 1NOQD_\ !EX4_P#EU1_PTYXV_P"C=?C)_P"#+PI_\NJ/8R\OO7^8>S?E
M]Z/9**\;_P"&G/&W_1NOQD_\&7A3_P"75'_#3GC;_HW7XR?^#+PI_P#+JCV,
MO+[U_F'LWY?>CV2BO&_^&G/&W_1NOQD_\&7A3_Y=4?\ #3GC;_HW7XR?^#+P
MI_\ +JCV,O+[U_F'LWY?>CV2BO&_^&G/&W_1NOQD_P#!EX4_^75'_#3GC;_H
MW7XR?^#+PI_\NJ/8R\OO7^8>S?E]Z/9**\;_ .&G/&W_ $;K\9/_  9>%/\
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MU1_PTYXV_P"C=?C)_P"#+PI_\NJR]C+R^]?YG+[-^7WH]DHKQO\ X:<\;?\
M1NOQD_\ !EX4_P#EU1_PTYXV_P"C=?C)_P"#+PI_\NJ/8R\OO7^8>S?E]Z/9
M**\;_P"&G/&W_1NOQD_\&7A3_P"75'_#3GC;_HW7XR?^#+PI_P#+JCV,O+[U
M_F'LWY?>CV2BO&_^&G/&W_1NOQD_\&7A3_Y=4?\ #3GC;_HW7XR?^#+PI_\
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ME]Z_S#V;\OO1[)17C?\ PTYXV_Z-U^,G_@R\*?\ RZH_X:<\;?\ 1NOQD_\
M!EX4_P#EU1[&7E]Z_P P]F_+[T>R45XW_P -.>-O^C=?C)_X,O"G_P NJ/\
MAISQM_T;K\9/_!EX4_\ EU1[&7E]Z_S#V;\OO1[)17C?_#3GC;_HW7XR?^#+
MPI_\NJ/^&G/&W_1NOQD_\&7A3_Y=4>QEY?>O\P]F_+[T=A\"/^1.U+_L8M;_
M /3I=5VE?-_P7_:2\96?A34%C_9^^+MTK:]J[EXM1\+A5+:C<L4.[6%.Y22I
MP,94X+#!/6?\-.>-O^C=?C)_X,O"G_RZK6M1E[26V_=?YG5F$&\34?\ >?5=
MSV2BO&_^&G/&W_1NOQD_\&7A3_Y=4?\ #3GC;_HW7XR?^#+PI_\ +JLO8R\O
MO7^9R^S?E]Z/9**\;_X:<\;?]&Z_&3_P9>%/_EU1_P -.>-O^C=?C)_X,O"G
M_P NJ/8R\OO7^8>S?E]Z/9**\;_X:<\;?]&Z_&3_ ,&7A3_Y=4?\-.>-O^C=
M?C)_X,O"G_RZH]C+R^]?YA[-^7WH]DHKQO\ X:<\;?\ 1NOQD_\ !EX4_P#E
MU1_PTYXV_P"C=?C)_P"#+PI_\NJ/8R\OO7^8>S?E]Z/9**\;_P"&G/&W_1NO
MQD_\&7A3_P"75'_#3GC;_HW7XR?^#+PI_P#+JCV,O+[U_F'LWY?>CV2BO&_^
M&G/&W_1NOQD_\&7A3_Y=4?\ #3GC;_HW7XR?^#+PI_\ +JCV,O+[U_F'LWY?
M>CV2BO&_^&G/&W_1NOQD_P#!EX4_^75'_#3GC;_HW7XR?^#+PI_\NJ/8R\OO
M7^8>S?E]Z/9**\;_ .&G/&W_ $;K\9/_  9>%/\ Y=4?\-.>-O\ HW7XR?\
M@R\*?_+JCV,O+[U_F'LWY?>CV2BO&_\ AISQM_T;K\9/_!EX4_\ EU1_PTYX
MV_Z-U^,G_@R\*?\ RZH]C+R^]?YA[-^7WH]DHKQO_AISQM_T;K\9/_!EX4_^
M75'_  TYXV_Z-U^,G_@R\*?_ "ZH]C+R^]?YA[-^7WH]DHKQO_AISQM_T;K\
M9/\ P9>%/_EU1_PTYXV_Z-U^,G_@R\*?_+JCV,O+[U_F'LWY?>CV2BO&_P#A
MISQM_P!&Z_&3_P &7A3_ .75'_#3GC;_ *-U^,G_ (,O"G_RZH]C+R^]?YA[
M-^7WH]DHKQO_ (:<\;?]&Z_&3_P9>%/_ )=4?\-.>-O^C=?C)_X,O"G_ ,NJ
M/8R\OO7^8>S?E]Z/9**\;_X:<\;?]&Z_&3_P9>%/_EU1_P -.>-O^C=?C)_X
M,O"G_P NJ/8R\OO7^8>S?E]Z/9**\;_X:<\;?]&Z_&3_ ,&7A3_Y=4?\-.>-
MO^C=?C)_X,O"G_RZH]C+R^]?YA[-^7WH]DHKQO\ X:<\;?\ 1NOQD_\ !EX4
M_P#EU1_PTYXV_P"C=?C)_P"#+PI_\NJ/8R\OO7^8>S?E]Z/9**\;_P"&G/&W
M_1NOQD_\&7A3_P"75'_#3GC;_HW7XR?^#+PI_P#+JCV,O+[U_F'LWY?>CV2B
MO&_^&G/&W_1NOQD_\&7A3_Y=4?\ #3GC;_HW7XR?^#+PI_\ +JCV,O+[U_F'
MLWY?>CV2BO&_^&G/&W_1NOQD_P#!EX4_^75'_#3GC;_HW7XR?^#+PI_\NJ/8
MR\OO7^8>S?E]Z/9**\;_ .&G/&W_ $;K\9/_  9>%/\ Y=4?\-.>-O\ HW7X
MR?\ @R\*?_+JCV,O+[U_F'LWY?>CV2BO&_\ AISQM_T;K\9/_!EX4_\ EU1_
MPTYXV_Z-U^,G_@R\*?\ RZH]C+R^]?YA[-^7WH]DHKQO_AISQM_T;K\9/_!E
MX4_^75'_  TYXV_Z-U^,G_@R\*?_ "ZH]C+R^]?YA[-^7WH]DHKQO_AISQM_
MT;K\9/\ P9>%/_EU1_PTYXV_Z-U^,G_@R\*?_+JCV,O+[U_F'LWY?>CV2BO&
M_P#AISQM_P!&Z_&3_P &7A3_ .75'_#3GC;_ *-U^,G_ (,O"G_RZH]C+R^]
M?YA[-^7WH]DHKQO_ (:<\;?]&Z_&3_P9>%/_ )=4?\-.>-O^C=?C)_X,O"G_
M ,NJ/8R\OO7^8>S?E]Z/9**\;_X:<\;?]&Z_&3_P9>%/_EU1_P -.>-O^C=?
MC)_X,O"G_P NJ/8R\OO7^8>S?E]Z/9**\;_X:<\;?]&Z_&3_ ,&7A3_Y=4?\
M-.>-O^C=?C)_X,O"G_RZH]C+R^]?YA[-^7WH]DHKQO\ X:<\;?\ 1NOQD_\
M!EX4_P#EU1_PTYXV_P"C=?C)_P"#+PI_\NJ/8R\OO7^8>S?E]Z/9**\;_P"&
MG/&W_1NOQD_\&7A3_P"75'_#3GC;_HW7XR?^#+PI_P#+JCV,O+[U_F'LWY?>
MCV2BO&_^&G/&W_1NOQD_\&7A3_Y=4?\ #3GC;_HW7XR?^#+PI_\ +JCV,O+[
MU_F'LWY?>CV2BO&_^&G/&W_1NOQD_P#!EX4_^75'_#3GC;_HW7XR?^#+PI_\
MNJ/8R\OO7^8>S?E]Z/9**\;_ .&G/&W_ $;K\9/_  9>%/\ Y=4?\-.>-O\
MHW7XR?\ @R\*?_+JCV,O+[U_F'LWY?>CV2BO&_\ AISQM_T;K\9/_!EX4_\
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M7B"[\'^+? TTES/;G2O$=E]DOD$4K()"F3\CA=RGNK UW%?E+\&_VP?BC?\
M["'P\\,:5XTUK_A.OB]\3]0\*IXGU.[>_N]&L4NI#*\33%CO6,*J \*"<8(!
M'LGQ=\'^-/\ @F3\7/A#X@T?XM?$[XA^#_B%XQLO!'B'1?'&L_VP1+>[A!=V
MLC*K0%&C;<J_*1VHJ8&TW&Z3N[+76W]:!+#VE:_>R]#[VHK\X_V>?@KXW_;4
M_:7_ &DK+7/CM\9O#/AGPAX\N].T?3/#7B&2Q:T8JIR)CO80JNT+ FU =Q(.
M[CW;_@D!\;_%GQK_ &2&'C;6)O$7B#PGKVH^'9M5F'[[44MIV6.20]WV%06Z
MDC)R236=;"\D7)2O:U_FKHBI1Y5>^UOQ/J:BODGX:?$CQ%?_ /!9+XF>%Y]>
MUJ;PS8>!=,O+;2)+Z5K&WG>3#2I"6V*[=V !/K7@>I_'KQU'/_P4&V^-/%B_
M\(7$A\/8U>X_XD1\B<_Z)\_[CD _N]O(%$<')NU^B?WM+]1QP[;WZ)_?;_,_
M3*BORO\ C#X(^)_[./\ P36\*_M+0_'[XO:YXVT/3=$UJ^TR]UK.@7]M<2V\
M;6S66TJY"S*#*[%W*LQ.2,>T_%Z]\9?MO_\ !1'4OA':_$3QO\-_ ?PY\+6>
MLZL?"&I'2]3UB^O/FC4W*@LL*1_PCJ1[\4\%U4E97N]>EO\ -#^K];Z:W^5O
M\T?0?PB_:T_X6K^V#\8/A1_PC_V#_A5-OHL_]J?;O-_M3^T;9Y\>3Y:^5Y>W
M;G>^[.?EZ5[)7Y@_!CQ;JG[ O[2?[=NO7GB+6OB%J'@;PWX9O+/4-=96O+S-
MA<&VCN'0*)"@>-&D !<(6(!->&^(?^"@GA[P%^SOI_Q2TG]KKQ]XF^/5L+75
M;_P?-<7/_",7[/*AN-.2S-L(8U6-F D#9S&2,;ACH>6N<OW6WN]&]7%/Y+7J
M:_4W)^YMIWW:7W'[845^<7B?0?&W[;/_  4X\1>$;;XR?%;X;^!1X"TG7I=/
M\+:R;.=I90,>4[;T@.6R[(F7P 3BFZU^T_XN_8ZT_P#:Z\"ZIXI\3>(-=T-[
M35/ =SK&J27=ZRZQ&MO;Q0.YSMAN"#L7 4[L "N?ZBW9)ZV3MZM+]3+ZL]D]
M=';UM_F?H_17Y;VG[1/Q0'[ -E\%]3\;:XOQK_X6A;_#.[\06VJSKJAB-P+H
MWRS[O."_9-H+YR5)'4D5ZU^W)XMT/0_VBK?1?B-^T=XR\!>$[;1(?[*\*_#Z
M?4%\13S])+R]DLX9KAHR>$!VJ< G)W9/J,E+E;[[)NZ5M5ZW']6=[7[GW=17
MY3^!?CC\4/C=_P $SOB_XA\(_$CQQKFM? 'XBW,OAS69Y;FPU+Q'I%CY$YBU
M! (GD#032,Z3)D^6 RYSCWJT_:2U3]M#]N_X(Z5X)\3:QIW@C0O!A^('B2/3
M;^2W34FO%6.SL[H(P#@?ZW8P(ZY["B6!E&]WM>_R5_QN$L*UN]K_ )7_ !/L
MKQKXYT7X:^%KS7/$6L:7X?T73U#W6H:E=QVMK;*2%!>60A5!8@9)') J]87\
M&JV,-U:S0W-M<()(I8G#QRJ1D,K#@@CD$5\;_P#!>'X30>.O^">?C;7I-<\5
MZ;)X5L?.CLM,U>:TL=2,MS;*5O(4(6X5=N4#Y"DDCK7$_%";Q9\&/AC^SG\"
M_A[X\\::;J?QQO9GO/$VJ:L^J:II-A:V<=S<Q6LL^[RR58+'U"8( YXFGA5.
MFI)ZMOY)*[?W$QHJ44T];O\ !7/T$HKX3\0Z3XN_X)N_M8_!W3K'XH?$;XC^
M OBUJ4_A[5=,\;:N=7NM.NA'YD-U:W#*'52?E:,Y7&3R2-OUA^U!K&L:!^SY
MXNO-!\4>'_!6K6^G2-;Z]K8!L-(/>>7/'R+DC.1N"Y!&0<ZE"SC9W4MG\[$2
MIV:L]&=Y17Y(W'[4NB_!GXH?!/4OAK^T=\:/B=XF\3^-M*\.^)[+Q$FI3>&]
M6M+QVCGGMOM%K';1E6*^6('S@@\A2:]0_;I^)NJZ-^W#XDT_XQ?$CXX?"#X-
M0:78_P#"%ZUX&-Q9Z;=7319O&OKFVBD?<DI"JC@)MY.!@GH_L^7,E?HWL[Z:
M:+=_Y&OU5WM^CO\ <?H]17YY_$WQ]\;M#_X)C:+J'A7XD3?%:2;Q1!#J'C/P
M+$M_K)\+;Y#-/&NP WT:A4;:I(())SN(/V)_BUH^F?&#4M6^&_[1WBKXF>!M
M)\/W5[XH\&_$+4KFX\3V$\2EUFMEN(4E5!C:X^X"V<G*U'U)\KE?:_1]._:_
M2Y/U=\K=_P _Z1^AE%?BO8?\%!/#?QE^"/B3XE>*OVM_'W@7XT2_;;_0?!^B
M7%S%X?THQLYM;*6U%N8KC>%4,[L?]9SG:<_07[1W[6/Q&^-'[-G[.?C2ZOOB
M1X/^%?C/36OOB%K7P]@9]7T^?R%,(#QJ\L-NTF_+1IG'!YVBM99;4BTF^MMG
MO:^G?RL:2P<DTG_7^9^DU%?!7[*'CGQA/\'OC+>_!7XX)\>M!M=&:;P=:^(+
MQ[WQ1HFJ>2^8;HS1QLR.P!C$V.5QC&ZO&/V9/B=>:_XK\ ?V7^TS\4O#OQZD
MU"V_X2KP1\5[FYMM(U4-_P ?5I:6LD B1RV1$86+#COS6:P+?-KMY/M?5="?
MJSUUV]?Q['ZN45Y1^W%X0\1>.OV/?B)IOA76-8T'Q0VA7%QIE[I%Y+:7D5S"
MOG1K'+&5==[($.",AR.A(KX _:@_X*"?$3XI?!;X#^(/ASK>IVNH>%?"\7Q.
M\=V]K>O#_:%I;7%O:S6<NPC>K-]K)1N&$9.,@$9X?"RJ_"^MO32Z^\BE0=38
M_37XN>//^%6?"GQ/XG^R_;O^$<TFZU3[-YOE?:/(A>79OPVW=MQG!QG.#TKF
MOV1OV@/^&J/V;?!_Q"_LG^P?^$LTZ/4/L'VK[5]EWC.SS-B;\>NT?2ODOXP_
M%O6/VD/VE/C--HOB/5?^%>_#OX,2B>PM+^1-/U#4M2M)KF.:2($)(R6X &X$
MKN'3->#?#_X"^//A?_P1VT'XW:'\<OBII?BCPKX=MM7TC1K+4Q:^'(+=)$ M
M9;%5*S9CSN=V)9CDX'RUT0P47!*3M)M=^JV-8X=<NKU;7XH_3OQ!\9;C0OCS
MH7@E?!_BZ^M=:TV>_?Q%;66_1]/:-@H@GFS\DCY)5<<C\<=Q7PSXI_:5\1:K
M^WS^SO>/K6M6/AWQ)\.M0U[5=&M;V1;*ZE$8D#/"&".R\A2P)'J*Y']F+X)_
M$[_@H_\  &_^-6H_'?XI>"?$OBJ[OI?"NC>'-8-AH.@Q0S216\<]LJ$7(S&"
MY<DD'')RQSEA+14I.R^;U;?^1'L-+MV7_#_Y'U9\1?VO/^$ _;3\ _!__A'O
MM?\ PG&CWFK?VM]O\O[%]G./+\GRSOW?WMZX]#7M%?F=^T/\(_B7\2_V_P#]
MFOPKXP\=?\(OXYE\$ZC#X@U_P><23A'_ 'IM7EC4PM* /G\O*;FVCH:]6_9!
MN/%7[./_  4E\;?!&[^(/CKXA>#Y_"-KXITR7Q=JAU34=.E,WE2QBX8!F1BV
M0IX 48[DU4PL>1.+UM=[ZZM7'.BN5-/6U_Q/MNN'^)GQEN?AW\1?!.@P^#_%
MOB"'QA=7%M-JFE67G66@"*,.)+Q\CRT<G:IYR017S!_P5]USQL?&'P!\->"?
M'WB3X>W'C'QB^EWFH:1<,CF%H>0T88))@9*A\@-@XXK$^._A3Q)^R'\<OV4/
M ^D_%+XJ>)M/UKQ=JPU:[\0^(I+J[U>,VPD6&X9!&LL2,3L1U(4=*BGA4U&3
M>Z>FO1/_ ")A132;>]]/2Y]Y5XW\=_VM/^%*?M._!?X<?\(__:?_  MZZU6V
M_M'[=Y/]D_8;1;C/E>6WG;]VW&]-N,_-TKX5^//Q4U1?VF_BI9_'+XV?''X$
M75OK4\/PVN='>XT_PC/IP %K--)#$\<SLP)D$S 8&,@D@2?MS?M)WW[+OC#]
MBGXD?$C7-*^(%]X=A\37%UJ?A<^=;^()'TV&*!X"% _?-)%D@;07)' K:G@/
M>2>MT^^_*VK/KJ:0PNJ3UNG^5T?J517RG_P2_'B[XW>!;GXZ>-O'%YKNH?$Z
M-;G3O#VGZG*V@>%K-3A+:*W#F,W V@2R,N_<",YW%OJRN"M3]G-PO>QS5(\L
MN4****S("BBB@ HHHH **** "BBB@ HHHH ***I^(=;B\-:!?:E.LC0:?;R7
M,BQ@%F5%+$#) S@=R* +E%?G#I__  <\? W5K:2:U\ ?'"YABX>2+0]/=4XS
MR1?8''-?6G[%/_!0'X9?M_>![S6_AWK$UV=+D6+4=/O(#;WVG,X)3S(\D88
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MJLNR5$D0..0KKGOD@@F98><4W)6L[>?W;BE2E%-OH>P445\G_P#!+W_@I_\
M\/)/^%B?\4/_ ,(9_P (#?V]C_R&?[1^W>;Y_P W^HB\O'D]/FSNZC',QHSE
M"4TM(VO\]A1IR<7);+<^L****S("BBB@ HHHH **** "BBB@ HHHH *CO+V'
M3K.:XN)8[>WMT,DLLC!4C4#)9B>  .23TJOK^OV/A70[S4]3N[?3]/T^%KBY
MN;B01Q01J,LS,>  !DDU_/'_ ,%>O^"T?B3]N?Q5J'@WP;=76@_"6QF:*."-
MC'/XCVL")[GOLRN4BZ <MENG=@<!4Q4^6.B6[['5A<+*M*RVZL_2?]KG_@XS
M^!W[.>LSZ/X774OBEK5OD2-HTB1:;&PS\INGR&/O&CCW[5\9>,/^#JWXJ7KM
M_P (_P##/X?Z8O\ "-0FO+XCZ[)(<_I7Y8T5]91R7"P6JYGYGN4\NH16JOZG
MZ;VG_!T5\?[C[W@_X/=,\:5J/_R=6G:?\'.'QZG^]X1^$7X:7J/_ ,G5^9.F
M]OI6_IO]*W_LO"?R([Z.7X9[P1^E=K_P<J_'2<_-X3^$WX:9J'_R;6I:?\''
M?QPN/O>%?A5^&F7_ /\ )M?G!I_WJW]-[4?V7A/Y$>E1RG!O>FC]%+3_ (.(
M/C5<?>\+_"[\--O_ /Y,K4M/^#@7XRW'WO#/PR_#3K[_ .2Z_/?3>U=!IO:G
M_9>$_D1Z='(\ ]Z2/ORT_P""]?Q@N/O>&_AM^&GWO_R76I:?\%T/BU<?>\._
M#K\+"\_^2J^#]-[5T&F]J7]EX3^1'J4>'<M>]%'WQX2_X+?^/%D_XG'A#PC>
MKUQ9FXM3CZM))7T?\"/^"L7P[^+-]'8ZU'>>"[Z0#:U\ZR6;GT$RXQ]751[U
M^3.F_P!*W]-[5E6R3"5%I'E?=?U8UK\%Y7B(V4.1]XM_D[K\#]YK2[BO[6.>
M"2.:&90\<D;!E=2,@@C@@CN*DK\O/V&_VZ]7_9\UJUT77+BXU'P3,=CP-\[Z
M;DD^9#WQDG*=#G(YZ_IWI6JV^NZ9;WEG-'<VMU&LL,L9W+(C#((/N*^3S#+Z
MF%GRRU3V?]=3\LX@X=Q&55E"KK&7PRZ/_)KJBQ1117GGSX4444 %%%% !111
M0 4444 %%%% !16+\0_B)H?PF\$ZEXD\3:M8Z'H.CP-<WM]>2B.&WC49))/Z
M <DX R3BOQA_;\_X.9O$OBV_N_#OP%L5\,Z7%(\3^)M2MTGOKQ02 T$#@QPJ
M1SF0._(X0@UV83 UL3*U-?/H=&'PU2L[01^W%%?R4_%C]K[XJ?'35YK[Q?\
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M%>E?#7]IWXA_"B^6X\/^,_$6FLHV[$O7>%AZ&-B4;\0:F7#<K>[4_"WZL)<
M3M^[K)OSC;]7^1^\U%?GS^R+_P %E'U&[L]"^*MO"C32")/$%G&(T7/>XB'
M&<?/'@ ?PC!-??\ IFIV^M:?#=V<\-U:W""2*6)PR2*>001P0:\/%8.KAY<M
M5?/HSY#,\HQ6 J<F)C:^SW3]'_3)Z***Y3S HKPW]C']M32?VHO#'V>X\G3?
M%E@N+RQ#86< #,T6?X"<\9)7'.1@GW*M:U&=*;IU%9HZL;@JV$K.AB(\LE_7
MW!7%_%+_ )'/X=?]C%)_Z:M0KM*XOXI?\CG\.O\ L8I/_35J%.C\7R?Y,K _
MQ7_AG_Z1([2BBBL3C"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M[0H!^\-I( W8&I\/_P!A_P"*WQB_:ZT#XL?'2Y^$]M-X3T6\T:STSP3!>/\
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MVJ7J^)%R&\Q[2WGB=SY>$<,KH 24?((9OSU_93_X*'>)OV1_AC\8?A_X!?\
MLWQU\6O$5K86NN27*VT>B6ZM<1R2K*Q CE8S*JR$@1C<^054U]__  +_ .";
MWQH^.7_!1WP'\9O&/PC\ _LY:+X%*7-W9^&K^VN)_$,Z;CRMJ[1_O"^QF;:?
M+# ESMKSO]E;_@@3XL\<_L]?'S1OBIX+L_"OC;7+RVO? FL2:A:7LD,D1N79
M<V\S^7%(6C1P^"0^0"4&*A6PT7+VC334=--[OMH[;NW0J-2C&_.T]NW?RT=C
M]-_V$_V:O$'[+G[/^FZ#XN\>>+?B/XNN,7>LZQKNL7.H%KA@,Q0>>[&.%/NJ
M!C=@L>6('LM?+_\ P28M_CAX4_97T_P?\=_"4WA_Q)X.V:=I^H/JEG?_ -LV
M(7]TS&WFDVR1 >6V_&X!&!8E\?4%?-XFZJRNT]=UM\CQZU^=W=_0****Q,PH
MHHH **** "BBB@ HHHH _*;_ (.=/VWYOAU\+/#_ ,$M#NIK?4O&B+K&NM&=
MO_$N21DBA)!Z2S(Q(QT@QT-?AY7UQ_P70^+-W\6O^"GOQ,>X=6@\.W46@VBK
MTCCMHE4CZF0R,?=C7R/7Z!E>'5+#12W:N_F?58*DJ=%+YA1117H'4?K/_P $
MAO\ @@9H_P"T+\(M'^*GQBO-2CT/7H_M.C>';&7[.UW;<A;BYF'SJK\LJ1[3
MMVL7PVVOJWPI_P $OOV"?C#XCN?"'A%_"]]XHMTD62VT?Q[=7>H1^7P[>4;J
M0$J>OR$ ]1BORE^&/_!53]IWQ7\.=#^#/A_Q[<3:'J&FP>#=,TBVT;3(YGMW
MC6TBMTN/($JL5*H)/,#@_-NSS7T?_P $Q/\ @C_^T'X$_;3\!^*?$OA:^\"Z
M#X3U.+5;W4;B]MRTL<9RULB1R,S&89C/& KL21P#\[BJ-=.=2M6Y?Y4G_P -
M^IY]2G57-4JUN7LD_P#AC@O^"IO_  2ZO/\ @G=X[TFYTK4[SQ!X$\3&1=.O
M;J,+<VDR8+6\Y4!"VTAE<!=X#?*-IS?_ &'/^"0OQ2_;0\(V/BK37T3P[X-O
MI7CBU74+H.T_ENT<GEP1[G)5E(^?8#V-?6?_  <F?M#>&+[P+X+^&-K?17GB
MJUU<:[>P0L&_L^ 6\L2"7^ZTAFW*O7:A)P"N?C+X-_\ !5;XQ? []G+1_AEX
M,U;3/#6BZ.\[I>VMBLFH3^=-),X:24NH^:0X,:(0 .>I/3AJV+K82,H6YGU?
M;N>U@:N,K8.,J5N=O=]N_P"1^B.@_P#!"3X4_ _X+>)M4\27^N>.M>L=%N;B
M.669M/LX)HX797CBA;?]['#R./E''7/Y:_#+PA<?$'QSHN@6;11W>N7\&GP-
M*2$5Y9%C4L1VRPS7[J_!SQ)J'C'_ ()AZ'JVK7UUJ6J:E\.5N;N[NI6EFN97
MT_<SN[$EF))))Y)-?@YX:U.XT35+>\LYI;6[LY5F@FB8J\3J0592.000"#[5
M&3UJU1U%4E=IV_,ZN&<1B*KK*K.[327;KT/O;XI_\$Y_A=H?AGXJ:1X0\3^-
M[CQY\'=-AU+6&U6*V&EWZM%YKK (U$BD*#]XG#8'S [A\^_%']G?7_@1H'A*
M\\12:?;77B_3SJEOIJS%KZRMRV(WN(RH\OS.2HR3A6!VD$#Z]_8]_:T\9?M2
MZ?XKU[QMX=\%Z?X/T^&UA\2:II>C"UU3QM= B.STR29I-DAD9E5EP %8)\JR
M5C?M>?L::G\4/%WQ(\67GQ0T?Q#\1?"=@FM:_P"&(=.EBATBS\O>L4%PS;9%
MCB' "*3P6VEQEX?%5*=7V5>7KUULE;1:*[OKM=+J>EEN95J&(^KXR>FE]Y:M
M)6NE9*[O=[7BNI\@:;_2M_3>U8&F_P!*W]-[5[R/T2B=!IO:OT._X)3_ !YE
M\3>$-1\#:C<-+<Z(OVO3MYY^S,0KH.>B.01[2>U?GCIO:O?/V _&$O@W]J/P
MK)'_ *O4)VT^4?WEE4J/R;:?PK@S3#JMAI1>Z5U\CAXHRV.-RFK!K6*YEZQ5
M_P 5=?,_4ZBBBOSL_F\**** "BBB@ HHHH **** "D=Q&A9B%51DD] *6ODG
M_@MW^U)=?LJ?\$\/&6I:7=?8]>\3!/#FFRJX62-[G(E=>^Y8%F((Y!P<C%:4
M:3JU%3CNW8NG!SDH+J?DI_P7/_X*FWW[:/QKNO OA:^N(/AGX+NY;:-(V*IK
METC;7NG'\2 KB,'H,MC+5\"49HK]&P^'A1IJG#9'UM*E&G!0B%%%%;&@4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M";>5T/WU5%YX!ZL/I_\ ;(T?QOXA_96\?6/PWN9;/QU=:+<1Z-+%*(95G*'
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M^REXD_:"_P""C7Q8T_\ LK6-/\.^,O@L_AVU\026,HTU+U[@[8S-M*%E.&9
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MPQIS7FI7UGI]HA"M/<S+#&I)P 68@<D@"OSM_P""H?\ P6:L_!W[!WA?QO\
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MH?%.N>+/&.DVVLVOAKP[8+?ZC#!.F]#)N>.-<_-@;]Q"DA<<U<_9_P#^"O\
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M2L/VF!67)[9^S'KZ5Z646^MPOY_DSLP'\>-_ZT/P]HHHK[X^H"BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M9()M*VQ31X=TD1C%(/E<D%<$#BOHOXT?\%2O!/PF^)>O^%=+\'_%+XCWW@\
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M7LOA1;P7'B2X\1Z=_9XLC)$TCQF,L9?,B*,CJR#YUPF\$$N-"JDJB3M_P?\
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MGA/4M#^&'AK_ (1G2]8NQ?7<']HW5[YTVQ4W;KB61A\J@8! XZ9KN?B+\/\
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M^&7_  4J_8@\5_$2ZL[/X=K\.O#HL[V^PMC9RQP2[BY("JR3R02,YR%5XR2
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MHA^@64VI7D-O;Q23W$[B...-2S2,3@  <DD]J_5_]AW]F]_V<?@Y'::@L?\
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ME;TM_D?G_P#MC?&67QG\$/@K=:E^U%X9^(DFM>,- U#_ (0O1=%TFTM=+59
M6?-NIN84AW!,3.,EL'D8'U]^SF%;_@M3\>FX/_%'^'<'V\@U]%V?[%_P=TZW
MOH;?X3_#2WBU29+B\2/PQ9*MW*C;T>0"+YV5OF!;)!YZUV&F?#3PWHOC2_\
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M ,H*/^$W_:"_Z)C\&_\ PYVI?_*"CV,O+[U_F'LWY?>CV2BO&_\ A-_V@O\
MHF/P;_\ #G:E_P#*"C_A-_V@O^B8_!O_ ,.=J7_R@H]C+R^]?YA[-^7WH]DH
MKQO_ (3?]H+_ *)C\&__  YVI?\ R@H_X3?]H+_HF/P;_P##G:E_\H*/8R\O
MO7^8>S?E]Z/9**\;_P"$W_:"_P"B8_!O_P .=J7_ ,H*/^$W_:"_Z)C\&_\
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M ,H*/^$W_:"_Z)C\&_\ PYVI?_*"CV,O+[U_F'LWY?>CV2BO&_\ A-_V@O\
MHF/P;_\ #G:E_P#*"C_A-_V@O^B8_!O_ ,.=J7_R@H]C+R^]?YA[-^7WH]DH
MKQO_ (3?]H+_ *)C\&__  YVI?\ R@H_X3?]H+_HF/P;_P##G:E_\H*/8R\O
MO7^8>S?E]Z/9**\;_P"$W_:"_P"B8_!O_P .=J7_ ,H*/^$W_:"_Z)C\&_\
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M ,H*/^$W_:"_Z)C\&_\ PYVI?_*"CV,O+[U_F'LWY?>CV2BO&_\ A-_V@O\
MHF/P;_\ #G:E_P#*"C_A-_V@O^B8_!O_ ,.=J7_R@H]C+R^]?YA[-^7WH]DH
MKQO_ (3?]H+_ *)C\&__  YVI?\ R@H_X3?]H+_HF/P;_P##G:E_\H*/8R\O
MO7^8>S?E]Z/9**\;_P"$W_:"_P"B8_!O_P .=J7_ ,H*/^$W_:"_Z)C\&_\
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M ,H*/^$W_:"_Z)C\&_\ PYVI?_*"CV,O+[U_F'LWY?>CV2BO&_\ A-_V@O\
MHF/P;_\ #G:E_P#*"C_A-_V@O^B8_!O_ ,.=J7_R@H]C+R^]?YA[-^7WH]DH
MKQO_ (3?]H+_ *)C\&__  YVI?\ R@H_X3?]H+_HF/P;_P##G:E_\H*/8R\O
MO7^8>S?E]Z/9**\;_P"$W_:"_P"B8_!O_P .=J7_ ,H*/^$W_:"_Z)C\&_\
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M ,H*/^$W_:"_Z)C\&_\ PYVI?_*"CV,O+[U_F'LWY?>CV2BO&_\ A-_V@O\
MHF/P;_\ #G:E_P#*"C_A-_V@O^B8_!O_ ,.=J7_R@H]C+R^]?YA[-^7WH]DH
MKQO_ (3?]H+_ *)C\&__  YVI?\ R@H_X3?]H+_HF/P;_P##G:E_\H*/8R\O
MO7^8>S?E]Z/9**\;_P"$W_:"_P"B8_!O_P .=J7_ ,H*/^$W_:"_Z)C\&_\
MPYVI?_*"CV,O+[U_F'LWY?>CV2BO&_\ A-_V@O\ HF/P;_\ #G:E_P#*"C_A
M-_V@O^B8_!O_ ,.=J7_R@H]C+R^]?YA[-^7WH[#1/^3B/$W_ &+FD?\ I3J=
M=I7S=H_C/X]#X[^(F7X;?")KMM!TL21GXDZB(T07&H[&#_V%DL27!4J  JD%
MMQ"];_PF_P"T%_T3'X-_^'.U+_Y05K6HRYNFRZKLO,ZL;!NHO\,.J_EB>R45
MXW_PF_[07_1,?@W_ .'.U+_Y04?\)O\ M!?]$Q^#?_ASM2_^4%9>QEY?>O\
M,Y?9OR^]'LE%>-_\)O\ M!?]$Q^#?_ASM2_^4%'_  F_[07_ $3'X-_^'.U+
M_P"4%'L9>7WK_,/9OR^]'LE%>-_\)O\ M!?]$Q^#?_ASM2_^4%'_  F_[07_
M $3'X-_^'.U+_P"4%'L9>7WK_,/9OR^]'LE%>-_\)O\ M!?]$Q^#?_ASM2_^
M4%'_  F_[07_ $3'X-_^'.U+_P"4%'L9>7WK_,/9OR^]'LE%>-_\)O\ M!?]
M$Q^#?_ASM2_^4%'_  F_[07_ $3'X-_^'.U+_P"4%'L9>7WK_,/9OR^]'LE%
M>-_\)O\ M!?]$Q^#?_ASM2_^4%'_  F_[07_ $3'X-_^'.U+_P"4%'L9>7WK
M_,/9OR^]'LE%>-_\)O\ M!?]$Q^#?_ASM2_^4%'_  F_[07_ $3'X-_^'.U+
M_P"4%'L9>7WK_,/9OR^]'LE%>-_\)O\ M!?]$Q^#?_ASM2_^4%'_  F_[07_
M $3'X-_^'.U+_P"4%'L9>7WK_,/9OR^]'LE%>-_\)O\ M!?]$Q^#?_ASM2_^
M4%'_  F_[07_ $3'X-_^'.U+_P"4%'L9>7WK_,/9OR^]'LE%>-_\)O\ M!?]
M$Q^#?_ASM2_^4%'_  F_[07_ $3'X-_^'.U+_P"4%'L9>7WK_,/9OR^]'LE%
M>-_\)O\ M!?]$Q^#?_ASM2_^4%'_  F_[07_ $3'X-_^'.U+_P"4%'L9>7WK
M_,/9OR^]'LE%>-_\)O\ M!?]$Q^#?_ASM2_^4%'_  F_[07_ $3'X-_^'.U+
M_P"4%'L9>7WK_,/9OR^]'LE%>-_\)O\ M!?]$Q^#?_ASM2_^4%'_  F_[07_
M $3'X-_^'.U+_P"4%'L9>7WK_,/9OR^]'LE%>-_\)O\ M!?]$Q^#?_ASM2_^
M4%'_  F_[07_ $3'X-_^'.U+_P"4%'L9>7WK_,/9OR^]'LE<7\4O^1S^'7_8
MQ2?^FK4*X_\ X3?]H+_HF/P;_P##G:E_\H*Y/XD>,_CT_BWP&9OAM\(HY%UZ
M0VZI\2=1=97_ +-O@58G0AM7:7.X!CE5&,,676C1ES=-GU79^9U8&#51_P"&
M75?RL^D**\;_ .$W_:"_Z)C\&_\ PYVI?_*"C_A-_P!H+_HF/P;_ /#G:E_\
MH*R]C+R^]?YG+[-^7WH]DHKQO_A-_P!H+_HF/P;_ /#G:E_\H*/^$W_:"_Z)
MC\&__#G:E_\ *"CV,O+[U_F'LWY?>CV2BO&_^$W_ &@O^B8_!O\ \.=J7_R@
MH_X3?]H+_HF/P;_\.=J7_P H*/8R\OO7^8>S?E]Z/9**\;_X3?\ :"_Z)C\&
M_P#PYVI?_*"C_A-_V@O^B8_!O_PYVI?_ "@H]C+R^]?YA[-^7WH]DHKQO_A-
M_P!H+_HF/P;_ /#G:E_\H*/^$W_:"_Z)C\&__#G:E_\ *"CV,O+[U_F'LWY?
M>CV2BO&_^$W_ &@O^B8_!O\ \.=J7_R@H_X3?]H+_HF/P;_\.=J7_P H*/8R
M\OO7^8>S?E]Z/9**\;_X3?\ :"_Z)C\&_P#PYVI?_*"C_A-_V@O^B8_!O_PY
MVI?_ "@H]C+R^]?YA[-^7WH]DHKQO_A-_P!H+_HF/P;_ /#G:E_\H*/^$W_:
M"_Z)C\&__#G:E_\ *"CV,O+[U_F'LWY?>CV2BO&_^$W_ &@O^B8_!O\ \.=J
M7_R@H_X3?]H+_HF/P;_\.=J7_P H*/8R\OO7^8>S?E]Z/9**\;_X3?\ :"_Z
M)C\&_P#PYVI?_*"C_A-_V@O^B8_!O_PYVI?_ "@H]C+R^]?YA[-^7WH]DHKQ
MO_A-_P!H+_HF/P;_ /#G:E_\H*/^$W_:"_Z)C\&__#G:E_\ *"CV,O+[U_F'
MLWY?>CV2BO&_^$W_ &@O^B8_!O\ \.=J7_R@H_X3?]H+_HF/P;_\.=J7_P H
M*/8R\OO7^8>S?E]Z/9**\;_X3?\ :"_Z)C\&_P#PYVI?_*"C_A-_V@O^B8_!
MO_PYVI?_ "@H]C+R^]?YA[-^7WH]DHKQO_A-_P!H+_HF/P;_ /#G:E_\H*/^
M$W_:"_Z)C\&__#G:E_\ *"CV,O+[U_F'LWY?>CL/@1_R)VI?]C%K?_ITNJ[2
MOF_X+^,_CU'X4U 6OPV^$4T?]O:N6:7XDZC&P<ZC<EU &A-E0VX!L@L "0I.
MT=9_PF_[07_1,?@W_P"'.U+_ .4%:UJ,O:2VW[K_ #.K,(-XFH_[SZKN>R45
MXW_PF_[07_1,?@W_ .'.U+_Y04?\)O\ M!?]$Q^#?_ASM2_^4%9>QEY?>O\
M,Y?9OR^]'LE%>-_\)O\ M!?]$Q^#?_ASM2_^4%'_  F_[07_ $3'X-_^'.U+
M_P"4%'L9>7WK_,/9OR^]'LE%>-_\)O\ M!?]$Q^#?_ASM2_^4%'_  F_[07_
M $3'X-_^'.U+_P"4%'L9>7WK_,/9OR^]'LE%>-_\)O\ M!?]$Q^#?_ASM2_^
M4%'_  F_[07_ $3'X-_^'.U+_P"4%'L9>7WK_,/9OR^]'LE%>-_\)O\ M!?]
M$Q^#?_ASM2_^4%'_  F_[07_ $3'X-_^'.U+_P"4%'L9>7WK_,/9OR^]'LE%
M>-_\)O\ M!?]$Q^#?_ASM2_^4%'_  F_[07_ $3'X-_^'.U+_P"4%'L9>7WK
M_,/9OR^]'LE%>-_\)O\ M!?]$Q^#?_ASM2_^4%'_  F_[07_ $3'X-_^'.U+
M_P"4%'L9>7WK_,/9OR^]'LE%>-_\)O\ M!?]$Q^#?_ASM2_^4%'_  F_[07_
M $3'X-_^'.U+_P"4%'L9>7WK_,/9OR^]'LE%>-_\)O\ M!?]$Q^#?_ASM2_^
M4%'_  F_[07_ $3'X-_^'.U+_P"4%'L9>7WK_,/9OR^]'LE%>-_\)O\ M!?]
M$Q^#?_ASM2_^4%'_  F_[07_ $3'X-_^'.U+_P"4%'L9>7WK_,/9OR^]'LE%
M>-_\)O\ M!?]$Q^#?_ASM2_^4%'_  F_[07_ $3'X-_^'.U+_P"4%'L9>7WK
M_,/9OR^]'LE%>-_\)O\ M!?]$Q^#?_ASM2_^4%'_  F_[07_ $3'X-_^'.U+
M_P"4%'L9>7WK_,/9OR^]'LE%>-_\)O\ M!?]$Q^#?_ASM2_^4%'_  F_[07_
M $3'X-_^'.U+_P"4%'L9>7WK_,/9OR^]'LE%>-_\)O\ M!?]$Q^#?_ASM2_^
M4%'_  F_[07_ $3'X-_^'.U+_P"4%'L9>7WK_,/9OR^]'LE%>-_\)O\ M!?]
M$Q^#?_ASM2_^4%'_  F_[07_ $3'X-_^'.U+_P"4%'L9>7WK_,/9OR^]'LE>
M:_M+_LL^'_VJ;'P7;^(;S6;-/ OBW3_&5@=.ECC,UY9%S%'+OC?,)\P[E7:Q
MP,,M8O\ PF_[07_1,?@W_P"'.U+_ .4%'_";_M!?]$Q^#?\ X<[4O_E!51IS
MB^:+5_5?YA&,D[JWWHUOC;^RCX=^//Q8^&OC+6+S6K;5/A;J%SJ6E16<T207
M$D\0B<3AHV9E"@$!&0YZD]*9XH_9)\,^+OVJM%^+UY<ZNWB+0_#T_AJ*R$D1
MTZ:UFE,CF2,QEV?)(R'"XZJ>M9G_  F_[07_ $3'X-_^'.U+_P"4%'_";_M!
M?]$Q^#?_ (<[4O\ Y052]JE9-;6W6S^97O[7_%'C%[_P0]^%]SX;UKPS#XT^
M,ECX UAKB7_A#;;Q64T&SEE#?O8H?++91V\Q5=W3>H+*W(/K&C_L ^$=(USX
M$Z@=:\675U^SY8W6G^'FGN8&^WQW%FEFYO,0@R,(XU(,?E_-DG(XJ_\ \)O^
MT%_T3'X-_P#ASM2_^4%'_";_ +07_1,?@W_X<[4O_E!6DJE>6\OQ756?7L4Y
MU7N_Q1K>(/V4?#OB/]K'0OC%/>:TOB;P_H$WAVWM8YHA8/;RR^:S.AC,AD#<
M B0#'\)ZUS/A'_@GE\._!OBKXH7%O#J5QX;^+W[SQ#X2N)(I-"><KMDN(8O+
M$D4LG5BLF,X( *KMT/\ A-_V@O\ HF/P;_\ #G:E_P#*"C_A-_V@O^B8_!O_
M ,.=J7_R@J/WJ5E)=MUZ]R??[_BCS;P+_P $B?!'@S6]"^T?$'XT^(_"WA>\
MAOM(\(ZQXL:?0;"6%@\&V%8U=EB8 JKR,!@=:[OQ]^P1X8\;?M7:3\8[/Q)X
M\\*^++&U@L;V'0]66VL=>MX7WI#>1-&QD3H"%9,@5>_X3?\ :"_Z)C\&_P#P
MYVI?_*"C_A-_V@O^B8_!O_PYVI?_ "@JG4KMW<E]Z_S*YJC=[_BCIOVH?V==
M$_:T^ GB3X=^([K5++1?%$"6]U/ILD<=U&JR)("C2(Z@[D'53QGZTGQ+_9D\
M'?&7X!3?#7Q5I:Z[X5GL8[%X;EOWN(P D@=<%9%*A@ZX((R*YK_A-_V@O^B8
M_!O_ ,.=J7_R@H_X3?\ :"_Z)C\&_P#PYVI?_*"LXQJ)))K1WW6_WD)36S_%
M'%?"3_@ESX5^&?Q%\/\ B+4_B)\9OB!_PB$IGT#3/%?BHWVG:/)L,:O%$D<>
MYE1BH,A<@'UYJCX]_P""2G@?Q/XY\3:QX>\=?%_X;VGC2YDO/$&B^$?$_P#9
M^E:O/(,2R20M&^UG&0WELF1^%>A_\)O^T%_T3'X-_P#ASM2_^4%'_";_ +07
M_1,?@W_X<[4O_E!6OM*]^;F_%?YE\]6][_BC'^(7_!-?X5^/O@)X2^'L>F:E
MX>TWP"RR^&M1T:^>UU;0Y@.9H;GEM[=6+;@YY8$@$-^!/_!.SPG\&?$6N:UJ
MWBCXC?$_7-?TJ30KC4/&^O'4Y8]/DYDM8U5(XTC<@$X3<<=:VO\ A-_V@O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O%_P!M3]OOX9_L
M$?#S^WOB!K:VLUP"NGZ5:KYVH:HX!.V*(=N""[E47NP) -7_ (*$_MS>&_\
M@G]^S?JGCC76CN+XAK31--W8?5+YD8QQ<<A/ER[#[J@GK@'^9+]I3]I?QE^U
MM\7-2\;>.M9N-:US4G/S2']W:Q9)2").B1ID@*.._)))]C*\K>)?//2*_$]#
M!8)UGS2^'\S[O_:K_P"#FKXP?$_5+VS^&>FZ/\.=!<-'!<20+J&JLI&-S22
MPJ>X"QY7^\>M?*/BG_@JA^TAXRFWWGQN^)4))SBQUV>Q'Y0,@KP&@=:^MI8'
M#TU:$%]WZGNT\-2@K1BCWBP_X*&?'Y_O?'+XP'Z^,M1_^/5N:?\ \% ?CRY^
M;XV_%QN>_C#4?_CU>!Z=_A70:;U_&MO84_Y5]QZ-&C3_ )5]Q[O8?M[?'1S\
MWQH^+!^OB[4/_CM;FG_MU_&]\;OC)\56^OBR_P#_ ([7A6G=:Z#3>U'L*?\
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MQ<'_ "?B_P#,C^S\/_+^+_S/V._XBT?^J _^7Q_][Z/^(M'_ *H#_P"7Q_\
M>^OQQHH_L7!_R?B_\P_L_#_R_B_\S]CO^(M'_J@/_E\?_>^GQ_\ !V9YA_Y(
M#_Y?'_WOK\;JFM^M']BX/^3\7_F/^S\/_+^+_P S]DHO^#K[S#_R0/\ \O?_
M .]]6(O^#K#S?^:#8_[G;_[@K\=+;[U7[3K1_8N#_D_%_P"9O'*\*_L_B_\
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M*5&"<9)! 7U6JH\S7Y7[;;B]C.W-;^O3<^CJ*^6_^"E'_!4#0_\ @GCI?AN
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M4Q"BBB@ HHHH **^3_\ @E[_ ,%/_P#AY)_PL3_BA_\ A#/^$!O[>Q_Y#/\
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ME7(SD?J]-_P2V_94_9E\)Z='\0KFU>>Z)CCU#Q%XEET]KR0#+;%BEB3CT .
M1DD\U\)_\$-_C/H/P;_;<M_^$@NH+&W\4://H5K<3$+'%<R2P2QAF) 7>82@
M/=G4=\U]B?\ !9+]A7XE_M+?$SPCXF\#:;-XBL['36TRYT]+N*$V<GG/()@)
M&4'>'"L0<CRESQ7S^85JDL7&A*;A&U[K2_S/(S+$598^&&E5=*G:]T[7>O4B
M_:U_X(U>"=0^%=UXK^#\UU9WME9_;H=-^V&^L]6A"E_W4CEG5V7!4[V5L 8&
M[</FC]EC]FCP%XA_9W\2?%'XE:MXJM?#NCZO#HD%IX>2'[7+,ZQLSL9@5V@2
MJ<<'Y6Y)P#^D'[/.GG]@K]@#18/B-JELLWA'39I;YVFWJ'DFDECM4.3O8>8D
M*A>"5  Q@5^7_P"RC^U?XN^#>F7O@_1]!\,^,M)\57L#'0M=TPZA;S7>Y5C9
M(PRGS"0@')Y5>,@&IP%;$5:<X*7,HM6>UU?77T_,[,CQ..Q%"M2A4<E"2M*]
MFXW]Y*3OT2=WM?<].^*O_!._5O"'QZ\2^&O#VJ6DWA[0=%7Q')J^JN8([6S9
M6(69D0CS"RNH 'S;<X49QX;IO:OT.^/WA*Z^(?P9U[3_ !=\0-+\(PVES:2^
M/]:@TZ2^CEU!EC-OI=O"CAA! K1$]<LRL?F,M?&G[1?[/&H?LQ_%.3PW?7UO
MJD4EO'>V5] NU+RWDSM?;DE3E6!&3R.I&#7H9;C'47+4>OH];)7=]M;WMVL?
M5\-9M+$1]E7G>=M-'K9*[O9)MW3LM4FFTKG.:;VK]$/^"47QCD\1_#W5O!MY
M(S2>'W%U9$DG]Q*3N7_@,G/_ &TK\[]-[5]/?\$PM>ETG]J&QMDD98]4L+FW
MD7/#A4\T?K&#6F<454PD[]-?N_X!ZG%V!CBLFK*6\%S+R<=?RNOF?I11117Y
MZ?SD%%%% !1110 4444 %%%% !7Q]_P6X_;G?]B']BG5+C1[[[)XU\:,=#T$
MHP\V!G7,]RH(/^JCS@]G>/UK[!K\%/\ @Z$^-]QXT_;0\->"5W+I_@G0$FQO
MR'N+MC([8[?NTA'X&O2RK#JMB8QELM7\CKP-%5*R3VW/S2N[N6_NI)YY))II
MG+R2.Q9G8G)))Y))YR:CHHK[X^I"BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ J:WZU#4UOUH OVWWJOVG6J%
MM]ZK]IUH.J!H6GWOPK0M>M9]I][\*T+7K0=D"_:=:OVO2J%IUJ_:]*#KIFA:
M]ZT+7K6?:]ZT+7K0=E,OVG2M&WZ#\*SK3I6C;]!^%!UP-"WZ5>M_N51MZO6_
MW*#LIFC!U%7[?I5"#J*OV_2@[*9H6W5:O6_6J-MU6KUOUH.J!H6_4?A7V3_P
M3 _;CT[]GK4=1\+^,=0:S\)Z@#=6UPT<DJV-P!R-J!CM<#L.H![FOC:WZC\*
MT+?K6.*P\*]-TI[,G'Y=1QV'>&K[/MNO->9^Q2_\%*_@B_3QU;_^"V\_^,UY
M5^W%^VW\+_BY^RUXI\/^'?%4.I:QJ M?L]NME<QF39=PR-\SQA1A58\D=*_-
MJWZ5H6_6O+I9#0IS512=TT^G3Y'A8+@+ 4*\,1"<[Q::NXVNG?7W30L9FMYU
MDC9HY(V#*RG!4CH0:_0S_@G_ /M[+XZ2S\$>,KI5UI0(=-OY6P+X <1N?^>G
M8'^+@=:_/&WZUI64SV\\<D;-')&P964X92.A!KT,9@J>)I\D_D^Q]1G61X?-
M,/["OO\ 9?5/^MUU/V^KB_BE_P CG\.O^QBD_P#35J%?/7[!7[=R^/(;7P;X
MRNECUJ-?+L+^4X6^ P!&Y_YZ8Z'^+'KU^A?BE_R.?PY_[&*3_P!-6H5\/4PM
M3#UG3J=G\]&?A&(RC$9;C98;$K7EG9]&N66J.THHHKA/GPHHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH XOX$?
M\B=J7_8Q:W_Z=+JNTKB_@1_R)VI?]C%K?_ITNJ[2M:_\27JSLS#_ 'JI_B?Y
MA11161QA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 5S/QJTSQ%K?P;\6V?A&[CL/%EYHMY#HMS(<);7K0.()
M"<'A9"AZ'I7344XNSN"=G<^/_P#@C;\)/VB/A!\"?$5C^T/K&IZGKEQK3S:4
MFIZVNL7D%ML0'=.LD@V,X)5-Y*C/"YQ7FW_!8OQ/KW@S]M[]CW5/"_AB3QGK
MUGK/B![/18[^&P;4'^S68V">8B./@DY;CC'>OT)KPS]IC]B[_AHK]I+X)_$+
M_A)/['_X4[?ZA??8/[/^T?VO]KBBCV^9YJ^3L\K.=KYW8P,9/;1Q2>(=:HDK
MIZ+;5-=#JIUE[7VDO/TV/!/C-\/?V@_^"B?BOX>^'?&'PCL?@MX!\)^*+/Q3
MJ][>>+;+6K_4VM2S1V]NEJ&";BW+.1^F&WOV %V?\%(_VOE_NZOH8_\ )-Z^
MT*^6/BA_P3S\7K^TMXH^)7PE^,VH_"F]\?06T7B>Q/ARVUNWU"2W0QQSPB9U
M$$FPX)P^3DD=J<,1&<94Y6BK:;VW3\WT"-523@[)6TW[I^;/@+7/^4./[<W_
M &6"X_\ 2_2*]T_;R_8F\&_L!? 3PW\</AK+XCTGXG>%=;TMKW7;C6[N[N/$
MD4\R13PWGFR,KK('R<*,=  #7J6A?\$:5T7]AKXQ?!63XG:EJ2_%KQ3_ ,)(
M^OWFCK)=V(\ZSD,<B"8+/(?LF#*#&"9<[!C!U[W_ ()<^,OB+KGA+2OB3\?/
M$?Q ^&/@O48-3L?#%SX>M+2XO9;?F 7M]&VZX5#U!C7=SDYYKM^MT[W4].9M
MJSU5HJVWD]SH>(A>ZEI?SU5E_D<II,YN?^"NOQTD;[TGPFL6/XJU?.WP<UW5
M/&7_  3N_8_^#]OK&K:#X?\ BYXFU*S\0W6F7+6UU/96UQ/*UJ)%Y592P#$$
M'"XZ$BOT$@_8F$'[7_CSXK+XE^7QMX4@\+C2O[._X\?+!'G>=YOSYS]S8N/[
MQKS[1O\ @D[I=G^Q#X%^$\WC;5(?$/PVU(ZUX>\8Z;9+:76GWOGR2K((&>16
M3$A1HV<AP.W&,8XJDDKO^7Y6BU?Y-HB-:"2N^WX)K\&;/P=_X)<>$?V6OVA_
M#WC+X0ZIJ'@#08+6YM/$WA=);B_L?$P=?W,I,TY\B:*3YO,"ON7Y<+DL?/\
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M#O)/5^NW9:6U/RF_:$_;3^$_QX_9/^(OCKQ!X\TW4?C9\3M:TZ6/0TM[EO\
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M'6-8\1:G#]KT2X*R;=B7%Q)<DJZ1_P"JW(R3$$!ER.3_ &O?^"4/Q1UKX:_
M#Q[\-;/X;Z?\:?@FD3W.C:-81Z3H&J.+C[4?(CPD:8N#*S*1&LAN)6'EG"UV
M'[*OP@_; ^/?[;.C_%#XY7X^%/@KPK8-;P^!_#OB%I;+6YBLJJ]Q##<2Q-AI
M2Y>1BQ\N)0H +#EJ5*7LG[)Q4?>NGO>^ENNUK/;N8RE#V?N6MK=/>]]+=?0^
M5/\ @AWK_BOPM^S)^UWJ/@C7O"7A;Q19WUC)9:SXGG,.E:5@WGF7$S".3B./
M>R@HREE4,-I)KQ;XN?MT>+/V<O"7A_QEX._;6\4_%#XL0ZJ!K_AE(-4F\-B$
M^8V^W-U"EO)&NV-678I/F,5V[>?HS]EO_@CA\;+G]B#]IOX=>)]+C\#:Y\1-
M3TO4/#SSZM:W%OJ7V2XFG:.4VTDI1&^1?F (9E."%(KDOC'^P;^VM\8O^"?_
M (7^!K_!_P "Z'X>^'M[#-$+#7;!=0\1R*)46?)N#$F!([2%RCNS @=17=&I
MAW6E)RBTVKZK;E75IW5^BMZG2ITG4;;6Z[;67??Y'7_M;_M!?&+XN_\ !7WX
M0^#/!/Q5\5?#>Q^(W@K3YY;>TNYKK3;%[NSNVFE%DTBQ22JI.QV *ND;Y!0$
M8/P^\/\ [2WA;_@ICXM_91L_VG/&5UI.J:='J$_BC4EDO]2M8!:QW1^RB65F
MMY27\H^7*!MRW7 'L4G_  3]^,VK_P#!5K]GKXJ2>!WM?!W@_P ':1I^O7;Z
MO8,VF745C<1S0F-9S)(4DD5=T:LISD$CFO2=$_8L^)EI_P %\-8^-4GAK;\,
M[KPZMA%K/]H6IW3#3X8=OD>;YX_>*PR8\<9SCFN7ZQ2C'E3CI#R?O)Z?/R,/
M:P2LK?#Y;W/F_P#8P_:/^,'PB^.W[7/P(\4?%/Q7\0+7X>^ ==U?1]>U2[E;
M4;2YM!&B2Q2L[RQEA=!L>80K1*5QSGSK]D7X>_M)_M<_\$V_%WQ@M?VH_B5H
M]U\.)=2EL-(.I7;MJ7V2&.ZE^T7?GB1]RL41'5T7:.,,:]W_ .&'?BE\)/VX
M_P!LSXM^(/"_]G_#WQC\-?$UKH^J_P!I6DOVN21;61%\E)6F3*02G+HH&W!P
M2 ?FO_@FK#^UIXO_ .":OBOP/\$_!G@OQ)X&\<ZKJ&E7NIW-_%:ZIHTDUO!%
M<X$T\:,C0LNUE5V4ESC(6NA2@X.I3<;^Y=NUMM?(U3BXN4;?9[6VU/1_B[_P
M5@^./Q$_X(]_#CQAHNI:II.JW'B6X\+^.?&&EV>ZZM(X CQ2KM 6%IHY%+.N
MW+QD*R[\#U7_ ()P^(_%FM_M8>'YOA/^V!8_'#X<S6:OXE\->/M4O5\2+D-Y
MCVEO/$[GR\(X970 DH^00S=3H?\ P3/_ &@OV1/V /ASX6^"7C715\;^'M0N
MM8\8:'=)#_9?BUKIHBUMOEC.5B2)8OF*"1'D)9?E4<7\"_\ @F]\:/CE_P %
M'? ?QF\8_"/P#^SEHO@4I<W=GX:O[:XG\0SIN/*VKM'^\+[&9MI\L,"7.VL)
M5,.Z<U!Q2][M\M&K^C3T,G*DX246DM>WRT>OI8R_^"7'[1WQ>^(?QX_;(LX_
MB'=:EJ'A<W/_  C9\:Z]=3:'H#K>7JB5@QD$,,:(I.Q,;8P#@=/EWXS_ +9W
MB[X-?#K_ (3#2OVYO$GCGXUVFK!KOPUHL>IS>&);<R,,P-/;QVCE5V.5,2I@
MLB@X!;ZB_9P_X)'_ !EO#^V1HOB328_!=K\8UD7PSJDFIVMQ'=D:A<7*AUMY
M))(XW4HK;U!VR-P2"*\]\1?L$?MI:U_P3E?]G6#X0_#_ $WP[X=OUOSJ%KKE
MDNH^*&^U^8 I\_RU92^]GF$;-'"JCYOE;>G/#^U;YHVO'^7:RONG?7=*WJ;1
ME2YV[KIVVMY_DC]<?V5OBE>_'']F#X;^-M2AAM]1\8>%M,UNZBASY<<MS:13
M.JY_A#.0/:N]KRO]AKP7KWPT_8R^%7AGQ1I+Z'XB\,>$]-T;4;%KF*X,$UM;
M1P-^\B9HV!,>X;6(PW6O5*^9JV4VH[79XL[<SL%%%%9DA1110 4444 %%%%
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M=#\0.B:QM_=7"_V5?@1N>\HY.1P1UP>OS9^R7^RAK'[3/B[RX_,L= LF!O\
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M;KQ<FC1^(5LDMYMLVGR,$6XCFV>5(I8@?(Y()Y J+3?VH_ 6J^/?''AN+Q%
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M>/V 1XH%N_@%O&_BW^T!=!3:'4/M-S_9N_/&[SMVW/?-?IG\0O\ A2Q_;;\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7?\ 13O'W_@/:?\ Q%?JA11_:V+_ )W^ ?7J_P#,?E?_ ,0J'PN_Z*=X^_\
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M7?\ 13O'W_@/:?\ Q%?JA11_:V+_ )W^ ?7J_P#,?E?_ ,0J'PN_Z*=X^_\
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M8XE?:/S%B_X-??AG$?\ DI/CK_OQ:_\ Q%31_P#!L5\-8_\ FI'CC_OQ:_\
MQ%?II11_:V+_ )W^!?\ :F*_G?X'YI1_\&S'PWB_YJ-XX_[\6O\ \14\?_!M
M+\.8_P#FHGC;_OQ:_P#Q%?I-11_:V+_G?X%+.,8OMO\ #_(_-^/_ (-LOAS'
M_P U#\:_]^+;_P"(J:/_ (-P/AW'_P U"\:?]^+;_P"(K]&J*/[6Q?\ ._P*
M6=8Y;5'^'^1^=L?_  ;F_#V+I\0/&?\ WYMO_B*F3_@W;^'Z?\S]XR_[\VW_
M ,17Z&44?VMB_P"=_@7_ &]CU_R\?X?Y'Y])_P &]/@!/^9\\8?]^;;_ .)J
M=/\ @WV\ H/^1[\7_P#?FW_^)K[^HH_M;%_SO\/\BUQ#F*VJO\/\CX'3_@@)
MX#3_ )GKQ=_WYM__ (FID_X((^!8_P#F>/%O_?FW_P#B:^\J*/[6Q?\ ._P_
MR*_UDS)?\O7^'^1\,Z?_ ,$(? $%PIN/&7C":(=5C6VC8_B8V_E7K?P>_P""
M5_P;^#\JSCP_-XFO$8,MQKLPNMN.G[M56+\TS7T7145,RQ4U:4W^7Y&=;/\
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MHHHK(XPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M $4[X-_^&QU+_P"7]'LX_P R_'_(.5=U^/\ D>R45XW_ ,(1^T%_T4[X-_\
MAL=2_P#E_1_PA'[07_13O@W_ .&QU+_Y?T>SC_,OQ_R#E7=?C_D>R45XW_PA
M'[07_13O@W_X;'4O_E_1_P (1^T%_P!%.^#?_AL=2_\ E_1[./\ ,OQ_R#E7
M=?C_ )'LE%>-_P#"$?M!?]%.^#?_ (;'4O\ Y?T?\(1^T%_T4[X-_P#AL=2_
M^7]'LX_S+\?\@Y5W7X_Y'LE%>-_\(1^T%_T4[X-_^&QU+_Y?T?\ "$?M!?\
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M%.^#?_AL=2_^7]'_  A'[07_ $4[X-_^&QU+_P"7]'LX_P R_'_(.5=U^/\
MD>R45XW_ ,(1^T%_T4[X-_\ AL=2_P#E_1_PA'[07_13O@W_ .&QU+_Y?T>S
MC_,OQ_R#E7=?C_D>R45XW_PA'[07_13O@W_X;'4O_E_1_P (1^T%_P!%.^#?
M_AL=2_\ E_1[./\ ,OQ_R#E7=?C_ )'LE%>-_P#"$?M!?]%.^#?_ (;'4O\
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M_P @Y5W7X_Y'LE%>-_\ "$?M!?\ 13O@W_X;'4O_ )?T?\(1^T%_T4[X-_\
MAL=2_P#E_1[./\R_'_(.5=U^/^1[)17C?_"$?M!?]%.^#?\ X;'4O_E_1_PA
M'[07_13O@W_X;'4O_E_1[./\R_'_ "#E7=?C_D>R45XW_P (1^T%_P!%.^#?
M_AL=2_\ E_1_PA'[07_13O@W_P"&QU+_ .7]'LX_S+\?\@Y5W7X_Y'LE%>-_
M\(1^T%_T4[X-_P#AL=2_^7]'_"$?M!?]%.^#?_AL=2_^7]'LX_S+\?\ (.5=
MU^/^1[)17C?_  A'[07_ $4[X-_^&QU+_P"7]'_"$?M!?]%.^#?_ (;'4O\
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M%>-_\(1^T%_T4[X-_P#AL=2_^7]'_"$?M!?]%.^#?_AL=2_^7]'LX_S+\?\
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M%>-_\(1^T%_T4[X-_P#AL=2_^7]'_"$?M!?]%.^#?_AL=2_^7]'LX_S+\?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110!Q>B?\G$>)O\ L7-(_P#2G4Z[2N+T3_DXCQ-_V+FD?^E.IUVE:UOB
M^2_)'9COXB_PP_\ 2(A11161QA1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 5Q?Q2_P"1S^'7_8Q2?^FK4*[2
MN+^*7_(Y_#K_ +&*3_TU:A6U'XOD_P F=F!_BO\ PS_](D=I1116)QA1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110!Q?P(_P"1.U+_ +&+6_\ TZ75=I7%_ C_ )$[4O\ L8M;_P#3I=5VE:U_
MXDO5G9F'^]5/\3_,****R.,**** "BBB@ HHHH **** "BBB@ HHHH ****
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M2/\ TIU.NTJZWQ?)?DCJQW\1?X8?^D1"BBBLCC"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KB_BE_R.?PZ_
M[&*3_P!-6H5VE<7\4O\ D<_AU_V,4G_IJU"MJ/Q?)_DSLP/\5_X9_P#I$CM*
M***Q.,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** .+^!'_(G:E_V,6M_^G2ZKM*XOX$?\B=J7_8Q:W_Z=+JNT
MK6O_ !)>K.S,/]ZJ?XG^84445D<84444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7/?$WXN>$_@KX;_MG
MQEXG\/>$M',RVXOM:U&&PMC(P)5/,E95W$*Q SDX/I7R[_P3U_X*[Z1^W[\?
M_B%X#L_!.I>&9/!.Z6WO)[X7(U&%9C$6=!&ODOG!V;GX)YXKE?\ @X6O;'3O
MV)_#-QJ?E?V;;^/]'DN_-3>GD@3E]RX.1MSD8.179#!S5>-"KHW;\3HC0E[1
M4YZ'U7\-?VM_A3\9]?\ [)\'_$[X>^+-4VE_L>C>(K.^N-HR2?+BD9L<'G':
MNB'Q7\,M\3SX*&O:4?%RZ=_:QT?[2OVP6GF>7Y_EYW>7O^7=C&2*_+7]J_XV
M?LT_M-^(_A#X5_9MM?!S_&!O&FG7=CJ6@:&-%;2[>)MUP\T[11!D*_\ +,;R
MQ'"DX!^S=:^.\?AK_@J[;^";OP[X,AM%^$4OB:Z\3/IW_$\C\O5/)-M]JW?\
M>@7,ACV??^;/:M*F#Y5=)K1NST>GZ,J>'MKKL]'OH?3M%?#/@O\ ;5_:8_:7
M^'&J?%;X3^!?A6WPQMYKHZ/I/B&XOT\1>);:W=D,L3QD00&0HVQ75N1R<$,3
MXR?\%5_%.N_!C]GWQ=\'/"^@:Q/\:M:DT=]-\0RR0FSE12KQ^=$X"&.97#-M
MDR$.%R16?U&I?ET[;[.U[/[B?J\[V_I>I]S45\%^*/VV_P!J;X/_ +3.@_"#
MQ+X(^#.O>)_B/9377A35M&O=0M-+L##\T_VY9M\L@CC#-B+:6)0#J=OI'[*_
M[8'Q2N_VJ/&'P9^,NA^"1XJT#0(?$^G:EX,-T;'4;1W*,ABN6,BR*VT<MACN
MX P3,L'.,>:ZVOOT[BEAY)7T[[GU917PK\5_VT/VIOAM\%-?^,NH?#GX8^&_
MA_X=D>YG\)ZU/??\)5)8I/Y9D,T9^S1RLI#A"C  ]2< [/[5O[?_ ,5?#_QA
M^!_A/X-^%?!VO77QDT6[U*-/$DD\ L2D22I(TL4@Q&BLS.H1F;;M4@G--8.H
MW96Z]>RNP^KR>UNO7L?3NK?M"^#]#^.VE_#2ZUCRO&VLZ7)K5GIOV6=O.M(W
M\MY/-"&)<-QM9PQ[#%=I7YM?&+XXWW[.'_!2_P"&OC;XZ:EX2TC4O#_P?U&Y
MU^?P^9VTWS/MY"I;"?\ >L6)555OF+-BO=_AQ^W/XV\.?LD^.OCQ\7/#6F>$
M?!-G"VI^&- MX)/[::P.%MS>2-*T8FG=T 18T";@6)R0KJ8.247'K;YMO9#E
MAVDG'K^?D?5U%?">L?MX?M%? 7P=X1^*'Q8\$_"ZQ^%/BC4;*TO=/T:ZO3XA
M\,0WC!8I[AY?W$P0E=ZQJI!; SUK0^*7[9W[1/C+]O#QU\&_@[X9^$UU:>%]
M)TS5DUGQ7+>PQ6JW$(=UE%NY>5G8X3RT4($.XMD4?4JE]U;O?32R?YA]7EY?
M>?;E<W\7OBWX>^ _PTUCQAXLU#^RO#OA^W-U?W?D23^1&" 6V1JSMR1PJDT_
MXF?$>Q^#_P +->\6:](L6G>&M,GU2^:/M'#$TC[<]20I '<XK\V/VNOVB_VF
M/VC/^"9?CKX@ZIX+^%>D_"OQ=HC7%KI27EZOB:ST^1U,-T\C9MI"1L<H%4E6
MXP>*G"X9U9*^BNE]_;S)HT7-Z[7L?HQ:?M ^"KS4/"%FOB72HK[Q];/>>'K2
M>7R;G5XDC$KM%$^'.V,AB,9 Z@8-=A7Q5;?&9O 'Q5_8A\+IX7\'ZM_PG6BZ
MG#)J^I:;Y^J:*MMH\,P^PS;AY)D)VR<-N4 <=:H3?MT_'SX^_&#XM:9\&- ^
M#_\ 97P?UNYT*[TKQ/>7CZ_K\UL 9)+=(&5(8W.5C:0,&/<8(JOJC>L=K7NW
MYM?H5]7;V_K6Q]R45\C_ !>_X*%^-M$^&/PBTKPU\-6L_C5\9)9(+'PSXCF>
MVM]!\A-]W<794"0Q1C[H4*7!R#D;6UO@_P#M(?''X<?&2[\*_'?P;X6.A/H<
MVN6WC;P/:Z@VAV8@R9;:\$^]HI=@+*=V& P 2>,_JL^6[MZ7U=NQ/L96N?45
M%?"?A;]MK]I[XY_!^_\ C)\/_ /PJ7X7PBXO=-T'6KN^7Q-K=C S RI+&?LT
M+R*C,B,K=N3D9Z_3?^"EUUXJ^(/[.^M:7I^EQ?"?XY6US92W5W#)_:6D:NB%
MXK=G63R]K,&BQL8EU)W 5<L'47;KUV:5[>HWAYH^O:*^6[K]O^\TG]I/XX6M
M]#I,7PG^!GAVWNM5U!+:5M0NM3DC,[P1OYOEE4C 0IY>[>Z_,!P?*=8_X*"_
MM'?#_P" NG_'SQ1X!^&%K\&;LVM[=:);7=\WBK3=,N)4C2Z=V_T=V D1S&J
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MX/\ A'I-TT+>.)9-4UH(2&:SMG3R8SS]UYLMCG_45^'5?>O_  <B^-9O$_\
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M_&3P7I5QJL$5A(\FFZFD<*R[ ID<J=CI(I65U="Q!4K\WS[\"?\ @M=^UO\
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M]B/5/B5-IL-OXL\$RV,EG?I&$N)H)[J*W>WE.,LG[_> ?NLG&,L#\@?L&_\
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M !;T;XK_ +2'CSX'^'OAYK<OAKPWH7A"]N=/GO)+<E)[ZYFA@D,H:3(6-B%
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MH?Q*_9K_ &=?A?\ M!0?'+XJ:]XNUS6M%?7-&O\ 4E_X1J_AOG4RP1Z>B+'
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MJ.!7N?\ P6&^(_B+X9? 7P#>>&]>UKP_>7GQ'T*QN)],O9;22>WDE<20NT;
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MS-M &6.2?K6%?#RI64M]?P=C*I2<-_,=1117.9!1110 4444 %%%% !1110
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M21L+)(5!&2!BOVBHKJJ9IS1FE'62UU=O6W<VEC;QEIK+?73UL?@?_P $3_\
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M^!G[2OC;XA? '6OANUG\36@NO$/AWQLMZMK!?1+L^UVTMJ&<-(OWT88)Y!Z
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M*^LS_/\ $^.9?V._CA^R[\:_'6O?L_Z]\,;KPK\2M4?7]3\/^.%O8X])U&3
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
F4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>img152117643_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img152117643_1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" 0U!WL# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-/\ %_@'Q1H?C#POJ@)M=3TF[2ZMI2IPR[E) 93D,IPRD$$ \4 =7117S?\
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M&0<8YKH/A#X^\,_%+X6^'_$7@N^T_4O".LV$-UH]U8C;:SVK(#$T0P,(5QC
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MKQ3?V2?^"S7[+_[<WBV/P_\ #'XQ>&=>\03EA;Z5=1W&DW]V5&2(8+R.&27
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MX0\(^*O&6@Z+XJ\?7PT[P_I$]R/MNJS[2V(XERVT8P7(" E02"R@^8?MC?\
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M=7(%WJUU*VQ$BB&78%L MC:"0"1D9 /0**^=_P!LO_@K%^SM_P $^]3M=/\
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M?$*+XV^ 4\%Z-JTNA3ZM/J @@FOHHHI7MX-X!N7$<T3?N0X(<$9YKSWX4?\
M!P_^Q?\ &GQVGAO0_CUX9CU263RH_P"UK&_T>UD<G "W%Y!%"V3TP_.1CJ*
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M\U?^,?QJ\(_L]_#K4O%WCCQ'H_A3PSI$1EN]1U.Z6WMX0 3C<QY8XP%&68\
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M3-'N;=X8[K2M MK'4[1F4+YT5Y&@G68;5^<N2=HW;AQ7Y2_\&FGC?7?V5O\
M@I'^TS^ROJ6K27VD^'Y-0NXE<JL1U#2=2339I(UW'#S1RH6"YRMNO/RBOZ *
M_GC_ ."'7_*UW^U5_P!A3QY_ZD,= 'WU_P '-7_!5?7/^":/[%&GZ?X%OO[-
M^)?Q6NYM(T:_4CS-(M(45KR\C!ZRH)88T/\ "UP'SE #YS_P0KUC]C']A/\
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MOI[N;2=* MM/M=0T^2WD#1Q+Q''<0W!C>) (\1-\H\P@_O7^P!_R8?\ !/\
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M_H>^+GAE_!?[$_BC1Y)FN)-)\$7=FTK.7:0QV#H6+'DDXSD\FOR8_P"#(O\
MY-4^-W_8VVG_ *1B@#ZL\:?\&VOP,U7_ (*'?#;X]>&1)X!M?AR]C=Q>#O#^
MG6]GI-W>64GF6T_[L*8_F"F0 'S2@)();=\._P#!Q=_P41N/VG?^"CW@?]B^
MV\?6?PU^%-OJ6G+\2]?GU2+3H)_M(CG>.:>0B-8;>U96"LP5YI<."8TK]\*_
MEK\4>"=!N?\ @[PU30/BGH6B^)O#WB#XG3VEQI>N64=]97L5[;,MDDD,RLCK
MF:W*AE(!"XZ T ?N=\ _VIOV#?V8/@S:_#_P+\8/V7?#WA&WMQ;MIUOXUT3R
M[L<Y:?,Y,SL22SR%F8L222:_(_X$?M3>!/\ @F]_P<S6_AO]GWQIX9U_X _'
MC5--TR^TKPOJD6I:-!=:BHBC6(V[M$KP7[[EQ_JX96CX!K]MO^'3O[+/_1M/
M[/\ _P"&\TC_ .1ZT/"G_!,G]FWP'XITW7-#_9[^!^BZUHMU%?:?J%CX$TNW
MNK&XB</%-%*D :.1'565U(*D @@B@#XW_P"#I#]EOX8W?_!)OXV_$Z;X<^ Y
M?B5;1:%'#XL?0+1M<B7^V=.@VK>^7YX'DLT> _W&*]"17GO_  ;,?\$__@3\
M>/\ @D#X!\3>.O@G\)?&?B.^U+6$GU;7O!^GZC?7"IJ,Z(&FFA9V"JH4 G@
M =*]Q_X.F]:CTO\ X(<?&*%D9FU*?0[9".B$:U8RY/MB,CZD5/\ \&MCJ_\
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MO"/Q*O+SQ)JW@'4)O"-U>7<KM/J>ERVR/!YLP(9I DDL);.[;$C$EB37V/\
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M?NR,##)@@@$$$"OPX_X,;U":K^U&J\!1X7 _/6:_?^OP!_X,<O\ D,?M2?\
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MZA\2O >EQZSI6L-ID,FJ16=I-Y]U;17&TRK&T'VAO+5L,^."37DO_!G?\0/
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MQ/\ ''A'^V_'/PN\#ZK<^&-2_M6]MO[,D6)I0?*AF2*7YU!Q*CCC'3BO'O\
M@S<_Y1+ZE_V/FI?^B+2OLC_@LU_RB=_:*_[$#5__ $E>OC?_ (,W/^42^I?]
MCYJ7_HBTH ^(_P#@[^_X)Z_![]E23P)\1O /@\:#XT^+7BC6]2\5:E_:M]='
M5+A_)G9_*FF>*+,L\C8B1!\V    /W$_8(_8[\!_LP_ ?0?^$?T&'^WM;TVV
MNM=UV^F.H:QKER\*>9+=7L@\V<G&!NPJJ JJB@*/RB_X/A/^2+?L_?\ 89UG
M_P!$VE?MC\'/^21^%_\ L$VO_HI: /Y_?^#CGX8Z;_P28_X*V? ']I3X76%O
MX2D\33R7^JV>EPBV@O+FRFB6].U1M'VFUNTCD 'S9=C\SDG^@KQ[\1-)^%WP
MUUKQ9K]W'I^A>'=,GU?4KIQ\MM;01-++(?945C^%?A'_ ,'S/_(/_9A_ZZ>*
M?Y:/7ZG?\%I+74+S_@D#\?TTOS/M0\!W[MLZ^2L.Z;\/*#Y]LT ?E7_P2S\.
M7?\ P<G_ /!33XA?'3XXVUUJ_P '_@_-%!X.\$73;])ADG=S!%+'DI+MBA\R
M?(_?221[OW:B*OVV^/?[.WA+XK?L\:]X)OO ?A3Q-H\FE7%M9Z!?V48L)',3
M".,#@1 M@;D*E>H((!'X_P#_  9"^+]-NOV<OCCH,;6_]L6/B2QU"=0_[WR)
MK4QQ$K_=W02X/KGT%?N10!^2/_!J%\ OCO\  _\ 9.^*7@3XU^#_ !AX2\)P
MZZ%\,Z9XBMYK.9%ECD6]6".3#K;EA&RE0$9Y)&4DEC7YQ_\ !;#]A#PG_P $
MY_\ @MW^SGX3_9?\'V'A;6-3M_#NNZ/87VIWFH6MSKSZ]=16[RO=32NL;-!;
MJRA@H"DX!))_J*K\ ?\ @X*_Y6>/V+?^Y+_]2R\H ^YI/^#;;X.^//V._&'@
M[QY<W7BSXP?$A5OO$WQ6OH$NO$$NI>='.TENTN[R+??&J>1&5#1C#$L2]1_%
M&'PS_P &RO\ P1&UBW\)ZA>>+-4\.M)!HUQJJHC:IK-_,Q1VC4@"*/+2&-3D
MQP$;BQ+5^CE?C_\ \'I6A:EJ7_!,OP->6JRR:;I_Q#M'O57.$+6%^L;L.F 2
MRY/0N!WH \G_ .#=GQK^S;%\-]:_:2_:0^-GP9UC]HCXE:S=SR3^./%NF1ZM
MH%K%*T**D%Q*&MVD*,X*HO[EHE7"  ]1_P '-_Q/_97_ &HOV';GXC> ?C)\
M&-6^.7PSU+3]0\.W?A;QCIL_B"[C:[BADA3[/*9Y%C63SQCF,P%@5&[/J7_!
MNC^Q#^SE^TS_ ,$@OA3XF\3? SX-^*O$^-1L=5U+6?!FFW]_/-#J%S&#+-+"
MSN3&(R,DX4J.U?;W_#IW]EG_ *-I_9__ /#>:1_\CT >9_\ !"#]M_Q#^W__
M ,$L_ /CKQ#.MYXVMX;G1-7N9E*K>7=I*\*SL0.LJ+%(^T<,[ #BODW_ (-R
M_P#@GW\8?!/[07[0'Q:_:D^&L(^)&OZW:'1/$WB".*[U25U-P;O[,Q9A%;C_
M $4(T84,%V@E8U"_J-X,^'7PX_9!^$NH0^&_#W@WX9^!]!AN-5O(-)TZWTC3
M+&-5,D]PZ1*D:@*I9G(Z DFOS;\'?\%N_CM_P5+^-GB/P;^Q+\-?"O\ PAOA
M686^J_$[XB/<1:8C-NQY%I#B0LP7<@)=L$%XXP0: /)_^#SS]G;PWH/[,GPQ
M^-FDZ=;:1\0M'\9P:"-:LE^SWTL$MK=7*;I$PS&*2T#(2<H7;;C<:_4[_@G3
M\<;[]I;]@GX-^/\ 59/.U?Q=X-TK5-0<+@&ZEM8VFQP./,+5^)__  <]_LY?
MM/?#7_@G_P"%_$7QM_:0T/XF:#>>.[*UC\(:1\/K/1;33KQK#4'2Z2^61KB0
M(B2Q^6X"MYNX\J*_7K_@BYI,VC?\$EOV<XIPJO)\/=&G&#GY9+..1?\ QUA0
M!^1'_!M%^TK\/?C[_P %1?CUXL^.TVEG]H+Q=J<<OA4^(G622V EN/M-I8M+
M]R:,+;HJ+AA%&%0!585]U_\ !RS_ ,$K=)_;B_86\0>+O"?@N35/C-X$\K4-
M%FT72S/JVLP>8J7%B1$IEF4Q.\BH Q#QC& S9\?_ ."F'_!L7\)_^"F>M7GQ
MO_9[^(&B>$?$_C!CJCS64J:CX6\13L23<I);DM \C\O)$9%)!/E[BS'XRT;_
M (*$?\% /^#=3X@:/X;^.NGWOQ,^%-W.+>SDU>];4[.[C4'*V&JC,L,@49$-
MP#A5SY*@[J /Z _VM/VF-)_8N_9&\:?%+Q!"\VG>!="EU.2V#B-[N1$Q' ">
M TDA2,$]"XK\.?\ @A;\=/@S^VS^TA\3/VJOVR/BS\(Y/B$NK+I'A#0/&WB.
MPL8-"@5%F,UI974H B7S4BB<*0K1S'<9"S5]L?\ !=KX\:;^W!_P;=^,?B9\
M/VO+CP[XLTW1-<$4B;+A+?\ M.T:2.15R-T3CYP"0#$QR0,U\X_\&D?[)WP'
M_:H_X)X^+)_'WP?^%?CKQ5X?\;W5G)?>(O"EAJEX+=[2TEB EGB9Q'EY %S@
M$,<<T ?0?_!<[XM?L9?MV?\ !.?XB:7)\:/V?-:\:^$] NM9\(2V'C/2)]4A
MO;6)IH[:UV2F1O/V>3Y2@[_, QN"D7?^#4C]OKQ1^VG_ ,$[;O1?&VIWFM^)
MOA9K!T!=1NF,D][8F&.6V:20\O(H9XLGDK$A)))-?7W_  Z=_99_Z-I_9_\
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M0XM>\97&IZI::=?:K,;Y=$MDO'4Q644@V6@>12[^4-TC'<S'Y53ZI_X.(/\
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M_P )?X7L-3CUF"R_M.\T_9=QQRQ))YEK+%(<)/*-I8J=V2"0"/QF_P""C_\
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M/A32?#R_'7Q7;#]['!/'&+;38'/W5ECNWF8JV20AP!UKY)_X*81-_P $C/\
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MM<1S26MV4YSM;;;GY1@$$]6Y_>>OYZ?^#8[_ )3K?M/?]>>K_P#IWCK^A:@
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M\1O#OPMT]M.OY+KQ/I+GQ/XQF6_MMEMI>FVS2,4C#^?)<;I$*0.BX;)'TO\
M\&XG[0'B30/V1/ /[/?B_P" _P"T)\./$GP]\.7=W>^(/%_@J71_#MZW]H$B
MWMKF5P[SE;I6"-$N5AF.<+S^E5% 'X1?\%F?^"/GQF_9 _X**:;^VO\ LKZ#
M=^++R/6E\0^(O#&G6QGO+2\(VW4L<"?O+BVO%:03+&#*K32,/E;,?U_\ O\
M@Z*_9C^)?AFPL_&5YXX^&_Q):,1WW@N^\'ZKJ&H0W07YXXC:6TJR*6R%+;&(
MP61#D#]'J* /E']G#]H#XX_MA_M#6'BJU\&:I\'?V?\ 0;>X1;7Q=IZP^*?'
MES(JB*46C OIUG$=S#S")I25RBJ3M^<?^#K3]@+QI^V__P $]--U+X?Z3>^(
M?$GPOUP:])I%G&9;F_L6@DBN!#&.7D3='(%7+,J.%!8@']/** /Q%_X)J_\
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M.O&&F2Z'<:9X?EU%-.&L2+I2$P"XD^2)F7<%9_E#8SQFOZ2*_GH_:]E74_\
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M_P#8^_X*,Z1^VQ^SIX=O/&$4&KPZ]XAT'3;9YKNPO$ 6XD,,8\R2UN4W^8R
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M'_A_7/&*^+-"O;34/'>N^']0T;P]I%I);NLB6_VJ".:]O)5)CBC@B=59P[L
M &_1.B@#\*?^#6SQG\0OV!?"NM?"'XD?LW_M.Z7J_P 1/&/VVWU]_AY<V_AW
M2X/LD,8DN[J=HVB&Z)\D1L "G))('9?\'9GB+XC_ +5GPE\/? KX8_ WXZ>.
M+W0/$MOXBU76M'\":A>Z*0MC(L207443+,W^F.&V'"-&RM\PP/VDHH ^(_\
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M7^Q%XC^ '[)?C+XA>-]+U?3/$7C+5?[(TVVU.WDBFM=+L6<*%60!D5KF:Z.
M " IYXQWG_!V%^PO>_M;_P#!-Z/Q/X=T>\UCQ=\*=7CU.T@L[=KBZGL[@K;W
M44:*"S$DP2'': U^H%% 'QK_ ,$%_P!E/5_V5/\ @FWX-B\5_;Y/'WCPR^,_
M%<]_G[9-J%^?-839Y\Q(S'&Q/.8Z^I/C)\48/@M\,=8\47.C>)O$$&CPB9].
M\/:5+JNJ7665=L%M$#)*WS9PHS@$] :Z:B@#^;7]A;XD_&;]G;_@N'\5OVG/
M&/[)O[6=YX/\=2:W]AL-'^&5[/J5NEW=Q2VZNLHAC^6./#$/G..#DFOWB_;9
M^!5Q^VM^PC\1/ 5F+C1[_P ?>%KFSLUOD\J2TN)(2T(F7G;B38&'89KVBB@#
M^;?_ ((A_P#!7.Z_X(8:3X[_ &=_C]\)OBHNK3^(9=1T6VT72([B]>Y,:0RP
M".26(21N85:.2)G#%S_#@U^P'[-_[<'QFU/X$^-_C9\6OA'XL\-^#[ZY@/@O
MX>Z!X>N=:\<0V>!&9KR&(\R3.0XA" PI]]CSM^R** /YLO\ @CSXD^+W['O_
M  5F^*GQZ^(W[)W[5QT_XF0ZE:6=KH7PWO9_L+W^I071:8W A C01 ;@Q(Y^
M4]1_0E^T-\=XOV>/@QJ?C.;PKXY\8+IL:.-%\*:)+J^L7;,0%2*VBRS')&3T
M49)( )KNZ* /YN_^"&^M?&#]B?\ X*:?$KXI?$/]E7]J:'2?BH)[&TCTKX<7
MLRZ;)=:@DWF7,DX@5(8U'S.-QQDXXK^D**3S8E;:R[@#AA@CZTZB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **^/_ -E+
M_@N'\"?VROVW_&OP!\%W_B&3QIX*^U!KJ[L%BTS6#:R"*Y%G*)&9_+8G[Z(&
M"EDWJ,U]@4 %%%% !1110 4444 %%>6_MH_MA^"?V"/V:?%'Q6^(5U=VOA?P
MK"DEPMI")KJZDDD6**"%"5#222.B@%E49RS*H+##_P""?'_!0+X??\%,/V;-
M/^*/PVEU7^P;RZFL)[75+=;>^TZYBV[X)D1W0. Z-\KLI5U()S0![=17"_M+
M_M)^#/V0?@7XD^)'Q!UJ'0/"/A6U^UZA>2*7*@L$1$106>1W941%!+,R@<FO
MSW\=?\'%7C7P7^S?%\?'_9!^)T7[.LKPL/&.H>)=+L[]K>>:.&"X72]S3&.2
M210K[Q&VY"'(;( /U"HKX'_: _X.2/V9_P!G7X#?!WXB:MJ7BS5-#^-D$MWH
ML.E:4D]W86\,ODW$MVC2J(UAFW1,$9W9T<(KA21]V>'O$%EXL\/V.JZ;<1WF
MG:E;QW=K<1G*3Q2*&1U/H5((^M %RBBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ KXH_X*:_\ !#/P!_P5>\6Z;??$KXG?&S3]&T<*
MUCX;T'6;"WT:UG"E&N%AFLI6\YE."Q<X&0 N3G[7HH ^9/\ @G/_ ,$O]%_X
M)KZ+J.D^'?BS\=/'^@W5E:Z?8:1XZ\4)JNG^'H;??L2P@C@B2W!#A6"C!"(
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M"<G[<VB?\%(?V0/"_P 8O#NBZIX?T?Q5+>QV]CJ+HUS$+:\GM27*$K\QA+
MG 8"O<* "BBB@ HKG?BW\5-"^!OPM\1>,_%%\FF>'?"NFW&K:G=,I806\$;2
M2-@<L0JG"@$DX !)KP+_ ()C?\%<?A+_ ,%9? WB36_A>?$=JWA.]6RU+3]=
MLX[6\@W@F*7;'+(ACD"L5(;/RD$ @B@#Z?HHHH **** "BBB@ HHHH ****
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M>L:O_H7Q#\7_ -N6>C[$MW_T*/R8_)W>9M/)RJ(.U?K=^RG_ ,$:?^%4>(O
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MLD6V98(G(VRL#O+=%QC'(!_5@IRHHK\_U_X(%Y4?\9J?M_\ _AWO_N2OT '
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M.7B+XB?&KXF_$C1;;Q//K]_XXU6W;1I;J'>(+86]Q&%,(<QG?O\ F5QPI"
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M=O NG^.?B)I/C7_A-/%FHZF[K/XBN+MIOLM\LL7EO$8D66U\I&V+&BCA92@
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MT30K.YM;^Z:"QA\A9((UDMHPJ>:5"EN"<$?2?_!+G_@BW_PNO_@G5\%_%O\
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M%O#&9'..I.U3@#DG ')H Z2BOQ#_ &&/%_Q0_P"#G/X[_$#QKXZ\8>-/AO\
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M'.@:S<:'X>B@N6N2%N)+9DFN;A!;#<Q96!DSG:RH@!^Z5%?@'_P7-_8I/_!
MNV^&?[0/[*'BCQE\.;&;Q$NAZOX9DUZ]U/1[V5XI[F-I([F5VD1Q%<"2.1F!
M)5EV,"Q_;_\ 98^.5M^TW^S-\/?B-9P_9;7QYX<T_P 010DY,*W5O',$/N-^
M/PH _#[7?^5YZS_X!_Z@IK]_J_ '7?\ E>>L_P#@'_J"FOW^H ***_&O_@I;
M^VI\1OVJO^"[7@/]BBQ\7>.OA?\ "J\MTF\0:AX0?['K/B%WTZ2_PMWC=%;
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M\3%W,VV[T<98Y)_XF%OUH M?\&K_ /R@T^#G_7QKO_I[OZ_0JOPC_P""%O\
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M (-H_P!F>+P]O_XNL?'/D",^.?\ A8&J_P!O-(,GSBPF^S[MY+X\G;N)X[4
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M0ZIJ6N:]K'P^T.\U'4-1N7N;N^N)+&%I)997)>21F)+,Q)))))->^4 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?@'_ ,%-?^"
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MK^(.I>"O^"-^N6.GR/'!XI\4Z3I-_M)&Z 2/=8/L9+:*OT\KYI_X*]_L(?\
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M?7_)A_QJ_P"Q"US_ --T]?E[_P &37_)@OQ6_P"R@-_Z;K.OT/\ ^"MOQ_\
M"?[//_!.7XTZIXHUS2-'^U^!]9M-.@O;Q+>34[J2RDBAMX0W+R/+)&@"@\N*
M_,#_ (,O?VA? /@W]EOQYX#UCQQX/TGQQXD\=R7&D>';S6;:#5M4C&G6V7@M
M6<2RJ/+DR44@>6WH< '[G4444 ?S2_\ !)[Q>WQE_P"#N7QYKWB:;SM5C\4>
M,_L =-^QH8[NVBB!/*B.V#*#UP@'?-?TM5_-M_P6*_9M\;?\$2_^"WOAS]K_
M ,+Z#>:K\,?%7BK_ (2*>XM@=L-W=+(FK:=*^?W<EQ')=21LV%(G(&[RW _?
MS]E+]L7X;?ML_!O3O'GPS\6:3XH\/:A DS/;3J9K!F7<8;F+.^"5>0R2 ,"#
MQ0!TD/P.\$VWQ9F\?1^#_"T?CJYLQITWB-=*@&K2VHY$#76SS3$.R%MH]*\T
M_;M_:U^!7[$W@'2_B#\<-9\+Z):Z-<NVA3:A9B\U%KHJ PL8E1YFE*D;C$/E
M4Y8A<D8C?\%)_"OCC]L31/@S\,]/F^*&L0O)+XVU;1;E7TGP#:K%(8VN[D!H
MVN99D2-+56$N&=SM"8;\-_\ @MM\6K'PM_P=!>#;O]H.&XNO@GX3N_#\VG6U
M] UQ8+I)MH9)IA",^9$+\W!E4*2PB9"'  (!^H_A'_@MK\6/VGM$36?V??V*
M?C-\0O#=THDL-9\5ZQIW@FQU2/C]];R7+2"2)ER5=>O P#D#\ZO^#2B]U/6_
M^"NO[2VH:MI+:+J5QHM_)?6/GK<KI\[ZS$SP>:HVOM;<NX<-M)'%?KG\5_\
M@N%^RG\)/ <>K6_QI\">-+JYV0Z;H'@S58-?UO4YWPL5M!9VKO)YCLRJH<(
MQP2O./Q__P"#8W]IKP/\!/\ @IA^U)>?%+Q5X7^%5UXAG>W@LO%>MVFF2_:S
MJDQ>T4RR*LDR$[65"W(]* /TT_X.BO\ E!3\<_IH/_J0:;4?_!K:BI_P0K^"
M!"@%FUXD@=3_ &_J0_H*Y/\ X.O?CSX5\!_\$=_B-X-U#7-)M_$_C:YT6VTO
M2WNT6\NA'JMM=-(D7WV01VDV6P%&T\YX,?\ P:J_M"> O$/_  2/^$OPYL/'
M/@Z_^(.@VVNW^H^%[;6+>36M-MFUZ\(FGM%<S1QD3PD.R!2)H_[RD@'Z1^*M
M2GT;POJ5Y:P_:+FUM99H8MI;S'5"57 Y.2 ..:_E._X-H_V76_X*#_M]_$NU
MUCXP?&;X9^)&\*76NRZU\//$HT+5]3+ZC:"=)IO*DWPM)+&[( ,NL9_AK^L"
MOYG)?AQJ7_!L]_P7_L?&GB#2]0A^ 'CN\OK2SUBWM6EA&C7Q#-$"H_UME-Y)
M>,#>R0;E7]XM 'ZR?\."_P#J]3]O_P#\.]_]R59_80_X-X_A%^P!^U_=?'#P
M_P"/OC1XR\>:C#>QWUQXNUNRU!=0DO&W3SS,EG%-),S98NTA)9B3DFOM+P9\
M8?"?Q%^'-KXPT'Q+H6L>%;ZW%U!J]I?1RV4D1 (<2J=F,'KGBO%?@U_P4K\(
M_M/_ +5UY\./A387?Q"T#PS9SR^*_'.F3*WAW0[L;/(L([C!2[N9-S%EA8B)
M4RQ)R% /HZBBJ/B3Q-IO@[1+C4]8U"QTK3;-=\]W>3K!!",@99V(51D@<GO0
M!^"?_!)=0W_!W)^TYD [4\3D<=/^)A9U^_5?S:_\$F_VS_A?HO\ P<X?M#_$
MSQ!\0/!7A3P'KS^*(]-U[6M;M[#3M05M2M_(:.>9T0F5(S(HSDKGK@FOZ1K2
M[BO[6.>"2.:"9!)')&P99%(R""."".<B@#^:;_@]G\;ZM?\ [?'PH\-S-)_8
M6E> %U*T4@[!<W.HWD<Y!Z9*6MOGOP/:OU3T#_@@C:7&A64EA^VG^WRMC) C
M6XB^+FV,1E1MVC[)P,8P/2O!?^#N#_@ECXE_;!_9\\+_ !B^'^DW>N>*OA3'
M<0:QIMI'YEQ>Z/+B1I8T +.UO(N[8O\ !-*W.P _1G_!OK_P51\&_P#!07]A
M?P5HS>(+%?BIX#T>WT/Q-HL\JQWLCV\8B6]2,G+Q3(BN70;5=G0X*XH \]^.
M/_!K/\,OVG;/3[?XE?M'?MB?$*WTAWDL8O$WC^TU9+)G #M$+BP<(6"J"5QG
M:,]!7G7_  =>V1_9>_X(9>"/AWX=GOI]#_X2?0/"#R74BM/-9VEC=31F4JJJ
MS%[&$G"J-W( Z5]__MJ?\%)_AG^Q)H\=KK&I-XE^(&K$V_A[P)H&+[Q'XCNB
M,I#!:IEU4G&Z5P(T');H#Y5_P67_ &)?$O\ P4^_X),^)/!]OH:Z+\2)K&S\
M2Z5H\EW'/]EU2WVRM9&881F9&FMPX(7=(&SM'(!PW_!JUHUII?\ P0X^$,]M
M&J3:E=:[<71'5Y!K5]$"??RXXQ] *^D?^"K?_*+C]I/_ +)9XG_]--U7Y7?\
M&D'_  4;T'X;?#CQ-^RC\3+[_A#?B!X8\075UX>T_65-D]TDK 7-@HD(Q<Q7
M"R.8B S"8[0VQ\?H7_P6\_:L\$_!#_@GE\8O">L:M]H\8?$#P'KVC>'_  ]I
MZ&[U;4I9M-N$:5+=,OY$*L9992-D<<;,3T! /D'_ (,J/^47'Q _[*G?_P#I
MITBO!_\ @^:A=K/]F&0*QC5_%*LV/E!(T? )]\'\C7HO_!F7^T?\//!W[#'B
MCX>ZOX\\%Z7X^\0?$R_N]+\-7FMVT&L:E#_9.F#S(+1G$TJ?N9OF12/W3_W3
MC;_X/3/V>];^(G[#OPY\?:7:7%YI_P ._$LL6K>4 5M+>^B6-9W[[1-#%'D=
MYE_  _7GX2_\DK\,_P#8*M?_ $4M?A1_P>5_\G1?LF_]==2_]*]/K]8_^"4_
M[:7@_P#;,_X)]?#GQQH?B#3[Y[7PY9VWB%/M0:31[^&W1;F*XW'<A5U<Y?&Y
M<.,A@:_#W_@Z5_;*\-_M8_ME_ 5_!T5Q?> _!M]>:9%XUDQ%H6NWPN[,WD5G
M<MB.:*U @$DZL8]TI&<)N(!^W7_!9?X@:G\,/^"3WQ^UK1Y9+?48? ^H0131
MDJ\/G0F%G4CD,JR$@CH0#7YO?\&1&FZ?'^RM\;KR/;_:L_BNSAN/W8#>2EF#
M%ENI&Z2;CMSZFOU9UG5OA3_P4K_96\=>%_#7CCPGX_\ !/BS3;WPIJNH^%]:
MMM4AM7FM@LD?FP.RK,B31N%)##<AZ$&OP,_X(L?'W6/^#=O_ (*B^/\ X#_M
M%!O"OA'XA);VR:]/D:8LT,L@L=260_+]CF229'D_Y9L5\S9Y4@4 _I7KEOA/
M\#?!/P%T.YTSP+X/\+>"]-O+E[VXM-"TF#3H)YW^_*Z0HJM(W=B,GN:GU3XO
M>$]#^'C>+KWQ1X=L_":V_P!L.M3ZE#'IP@QN\W[06$>S )W;L8'6O)OV,/V\
M=/\ VZ/$'C+4/!?AC6O^%7^'YX;+0_&]V&M[/QE<?/\ :6L870.]M"RH@N,[
M)69PF0A) /QU_P""P]O9>(?^#M#]F*VE\NX6UE\)O(@;_5RIJ=Q,F<=P=C8^
MG8U_0+7\[?\ P<L3WG[%?_!>S]G7X_W]E=+X26/1-2FN8%+FY;3-28WL"@\;
MQ;/#P,<2KWR:_6;XU?\ !</]GGX>>!-!O/!OCK0_C%XN\92P6WACP=X&U&#5
MM<UR>5PBH(4?]P =VYI_+5?+<'YAMH \&_X.Y/\ E#1XD_[&72/_ $>:]Y_X
M(&_\H<OV?/\ L4X/_0WKY/\ ^#P#]H3PKX?_ ."7$?@FYUC38O%_BGQ/IC6^
MBM=QM?QQ1"2>25HE+'8H55+?=S(OS$D _0'_  ;N?M"^ ?B)_P $N/@WX/\
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M_9]D*J9%UC655L?, 8;/(!]\#\A7ZR?\$\OVA? /QZ_99\&_\(+XX\'^-/\
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M?UC4/AGX8\JUL_'DP\G3/$M]ND$\-BC*'FAA"IFX!V,SE5SM)(!^6G_!9O\
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M.:_2Z@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M<9[;,8XQBOM:B@"OI&CVGA_2K>QL+6WL;&SC6&"WMXA'% BC"JJJ %4#@ #
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M7O\ P1V_9G_;P\4'7?BI\(?#?B/7G54EU6"2XTO4+@+@*);BTDBEDP  -['
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M>G^(_#'P%^"_AOQ#I4OVBRU32_!.F6=[9R<C?'-'"KHV">5(/->T44 ?A_\
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M"?'7QS>>*/&_P1^$/C+Q-J(C%WJVN>#M.U"^NA&BQH'FFA9VVHJJ,DX50!P
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M9B268DDDDU[E10!R7P:^ 7@7]G/PH^@_#WP5X2\!Z').UT^G>'='M]+M&F8
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M3TJ^T>;544;F:U%Y#%]I 7YLP[^.>G->^U^?O[9/[-O[8/[8/PB3P[JOA_\
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MT;%4)0ON()521CY1TK9KG.4**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \S_:Q
M_96\/?MC?"9/!OB:\UFQTN/5K#6!+I<L<5QYUG<QW,2YDCD787C4,-N2I."#
MR#XU?LK>'OCO\6?ACXRU>\UFWU3X3ZM<:QI$5G+&EO<S36SVSK.&C9F0(Y("
M,AW8Y(XKTRL/XG?$C1?@W\-O$/B_Q)>?V;X=\*Z9<ZQJEWY,DWV6UMXFFFDV
M1JSMMC1CM12QQ@ G JE)[(J,I;+^KG-_M3_LXZ'^UW^SUXL^&OB2ZU6QT+QC
M8FPO9],ECCNXHRP;,;2(Z!OE'+(P]J[3P]HD7AK0+'38&D:#3[>.VC:0@LRH
MH4$X &<#L!5;P+XVTOXE^"-'\1Z)=?;=%\06,&I6%QY;Q^?;S1K)&^UP&7<C
M*<, 1G! /%:M*[M8+NUCP_\ :L_8,\-?M5^-/"WBR3Q-XZ\ >-_!L=Q;:7XE
M\'ZHEAJ,=M<;?.MG,D4L4L+[%.V2-L$97!))=K_["'AOQ=IOP?AUCQ-XZUBZ
M^"^NCQ#I6H7^I1W-[JMT(IHB;Z5XB95(G<G9Y9R%P0!BO;J*?/*UA^TE:USB
M?VD?@-H_[47P$\7?#KQ!<:E9Z)XTTN?2;V?3Y$CNHHI5*LT;.CJ& /!96'L:
MY[XN_L6?#_X]?L\Z7\,_%VES:UX?T."T33KAKAH-0T^>U15@NX+B+8\-PFT$
M/'MZD8VDJ?5Z*%)K82DUL?+WA'_@EAH5AXST'5?%WQ;^/7Q0L_"U_#JFE:/X
ML\6B?3;6Z@;?!,\=O#"UP\;!64W#R8*@G))S]0T442DWN$I.6YXO^U1^PEX+
M_:RUK0=>U.[\4>$_&OA42)H_BSPIJKZ5K6GQ28\R$3*")(6QS'*KIG) !))Y
M7X4?\$Q/"7@?XOZ/X\\6>-OBE\8?%'ADL^A7'CO74OX-"E8%6FMK:&&&W28J
M<>88RXZ@@\U])44>TDE:Y2J22LF>6?%G]D?P_P#&+]HKX9_$S4M6\56NM?"P
MWS:796.I>3IUY]KB$4GVF':?,P%!7:R\CG<.*\R\4_\ !*GPG_PG.M:_X!^(
MGQD^#<_B2^EU/5;+P3XF%MIE[=2G,DYL[F*XMXY'.2QB1,DD]:^H**%4DMA*
MI);,\'_9Z_X)X>!OV=I/%VI6NI^-O%7C#QY:"PUOQ=XEUV74->N[=5*I"LYV
MB&-,DJL2H <''RKCR7Q[^QCXB_9S\#?LK_"WX1^,/BQ'H/@[XAQW6M7IOWG^
MW:1&E[?W4>JSQHBM#(X6W1&"H3/&H4E5Q]I5QW@[X_>$?'WQ@\9^ =)U;[7X
ML^'L6GS>(+'[+-']@2^CDDM3YC((Y/,2*0_NV;;MPVTD TJDM_Z[%1J3WW_J
MWZG8U\UZK_P3$\+I^T%K7Q \-_$#XN> F\5:O!KWB#P_X;\0I::)KM]%L_?S
M0M"[JS^6@D\J2,2!<,""<^M? +]I?P1^U!H&MZIX%UQ=>L?#NM77AW491:SV
M_P!FO[8J)X<3(A;;O7YE!4YX)KNJF\HZ$J4H.VQYGX-_96\/>!_VI?&WQ<M+
MS69/$GCS2=.T>_MII8S8PPV7F^4T2",.KGS6W%G8' P%YR?&K]E;P]\=_BS\
M,?&6KWFLV^J?"?5KC6-(BLY8TM[F::V>V=9PT;,R!') 1D.[')'%>F44<SO<
M7,[W/"_VFO\ @GUX+_:7^(.E>-O[5\9?#_XB:+;-86OBWP;JO]EZL;5F#&VE
M8J\5Q#N (2:-U!SC&3F7]F?]A'P_^S;X^U7QA)XN^)'Q$\::Q8C3)M>\9:Z=
M0N8K02"3[/%'&D5O#'O"L1'$I) ))YKV^N%^,G[2_@C]G_7_  7I?B[7%T>^
M^(6M1>'?#\1M9YO[0OY!E(<QHPCSC[TA5?>FI2:Y44IS:Y4=I?V$&JV,UK=0
MPW-K<QM%-#*@>.5&&&5E/!!!((/!!KY+'_!'/P;X?M+_ $?P=\4OCQ\.O NI
M322R^#?#7B_[+HD0D):2.!9(9)[:)R6)C@FC7YB  #BOKJBE&;CL3&I*.QXW
MX[_8!^$_Q$_9CTCX0W_A.WC\$>'8X!HUO:SR6]UHTL',-S;7"L)8[A&RWFAM
MS%FW%@S ^=^&O^"37A-O&>AZMX[^)'QH^,5GX7NX[_2=%\<^)DU#2;.YCR8I
MF@BAB%Q(F<JUP92" >3S7U113522ZE*K-;,\$_:$_P""?NC?'7XJ_P#"<:=\
M1/B]\-?%DME%IUS?>#O$[6<=[!$S-&DMK.DULVTO)@^4&^=CG."-/]E[]ACP
MK^RYXI\0>)K?6O&?C;QOXIAAMM5\4>+=6.I:I=00EC' K!4CBA5F8B.*-%R<
MXX&/:**7M)6L+VDK<MSYK^"O_!,3PO\ L\?%E?$'@[X@?%S0_#4>KW.N1>!8
M/$*?\(O#=7&\RE;<P^:(V:5W\KSO+#-N"Y Q]*4442DWJQ2DY:L^:_@M_P $
MQ/"_[/'Q97Q!X.^('Q<T/PU'J]SKD7@6#Q"G_"+PW5QO,I6W,/FB-FE=_*\[
MRPS;@N0,2_&3_@F3X0^)'QAU3X@>%_&'Q,^#_C'Q#&D6N:CX#UM-.77M@PCW
M4$L4UO)(HR!+Y8DP?O'C'HO[3'[7_P ./V/?#.G:M\1?$T'A^WUB[%CIT*VL
M][>:C/C/EP6UNDDTI Y.Q#C(SC(K>^"/QO\ #'[1GPST[QAX-U)]6\.ZJ95M
MKE[2:U9FBE>&16BF1)$9)(W0JR@AE((XJN:?Q&G/4^,Y#]E3]BOP7^R#8:V_
MAW^W-8\0>*KA+K7_ !)X@U%]2UK7I4!5&N+A^6"@D*BA44$X49-=+^TC\!]'
M_:B^ GB[X=^(+C4K/1?&FESZ3>SZ?(D=U%%*I5FC9T=0P!X+*P]C7;45/,[\
MW4SYG?FZF3X#\'VOP\\#:+X?LI+B6ST.Q@T^!YV#2O'%&L:EB  6(49( &>P
MKB?V3OV5_#_['7PGD\'>&;S6;[3)-6O]9,NJ2QRS^=>7,ES*N8XXUV!Y&"C;
MD*!DD\GTRBES.U@YG:QY;X!_9&\+?#_XV?%SQU#+JFH:A\:&TXZ_97SQ26*+
M96(L8TA01JP5XAEP[/EB<;1\M>,^'/\ @CKX+\*::/#MC\3/CK#\,59E'P_'
MC CP\+=OO68Q%]K^RD9!A^T["K$8P2*^N**KVDEU*56:V?\ 2/G/0/\ @F'\
M/_#7_!/*^_9GM-2\51^ +^VOK1KH7%L-3BCN[V6]D".(!"-LDS*O[H@(%!R0
M6/T!X=T2+PSX?L=-MVD>#3[>.VC:0@NRHH4$X &<#L!5RBE*3>Y,I-[G@?@[
M_@FY\-?#/[(GB+X(W\.K^)O OBB^O]0OHM4N5^TF6[O&O&*20I'L,<Y#1L!N
M4HAR2,UYKXX_X(N>$?B]\.-4\(^/?B]^T#\0?#=]:26MKI_B'Q7%=0:6S*52
M>-%ME$TT6<QO="?8RJP^89K[&HJE4FM4RE6FM4SY<_X* >!OA'X+_9"\.^%_
MBCX3\=>+/ NCSV=E#J/A_3;F^U'PP]O"1!JC/9@30F,H!YL2DAI -A4MCX+_
M &C[[X _'WX'>(/!7@;XU_'3]K+XDZ]I-UH_@_PAJNISZI:Z/?W4+6\5_<I'
M:P1QFU\PR>=>LS1F,L/G&1^R]%53K<O_  YI3K<O?[_^ >./^QAX3^(?[%_A
MWX,_$32[+Q5H>E^']/T>Z4EH]TMK!'&L\,B[9(I%9-R.A5E.""*\STO_ ())
M>';B\TF#Q5\8/V@OB%X9T2YAN[7PUXB\8^;IADA</#YODPQ3W 1E5@)IG&5!
M.<5]7T5"J26S,U4DMF%%<+^T'^TKX)_97\$VOB+Q]K:Z#HU]J=MH\%P;2>YW
MW5P^R&/;"CL-S<;B-HZD@<UW519[D6=KA1110(**** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBOD#]M#]J/QW\)O^"JW[&/P
MV\/ZY_9_@OXL2>-%\5:=]BMY?[5&GZ/%<V?[UXVEB\N9F;]TZ;LX;<.* /K^
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HJ.ZNH[*W>::2.&&,;G
M=V"JH]23TKP_XJ?MZ>%?!$LUKHT<OB.^C)4F)O+ME/\ UT(.[_@((/K6U'#U
M*KM35SNP.6XK&3Y,-!R?X+U>R^9[I17PQXL_;T\?>(7D%G<:?HL+'A;6V5F
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^V+_ ,$Y_P!N#X<^')(X_$'B#XX^,GTP27#6Z37-OJEO=11-(I!59'A5"20
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M(9941O+=9&5RN .NRO\ L>_\I@?VS?\ L&> ?_3?J%<!\8?VBM!_X*N?M%_
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M+#%=X-=A\8OVBM!_X*N?M$_ _P (_!=K[Q9X)^&_CJR^(7BWQO#8S0Z/I_\
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M[^&+^SN(P/-\;W(,.J3+QC$%O BK_=^W-@GYJF,4US-;;_I_D1&*:YI+;?\
M3_(_1*S69+2);AXY)P@$CQH41FQR0I)(!/8DX]3UJ2BBN<Y@HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KX _X*+?\IR/^"=G_77X
MC?\ I@@K[_KX _X*+?\ *<C_ ()V?]=?B-_Z8(* /O\ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MN)KNUDFD6=C*49 R@*$1"!G)/6NF_P""8/[4OB#]M7]A+X??$_Q59Z/I^O\
MBRUN)[NWTJ*2*SC:.ZFA'EK))(X&V-2<N>2>W ^=_A7_ ,IA?VTO^Q!\-_\
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MV6?^CEOV?_\ PX>D?_)% 'T!17S_ /\ #V+]EG_HY;]G_P#\.'I'_P D4?\
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M^!L7_P 578>R;5%8O_"Q_#W_ $'M%_\  V+_ .*H_P"%C^'O^@]HO_@;%_\
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MZ1_\D4?\/8OV6?\ HY;]G_\ \.'I'_R10!] 45\__P##V+]EG_HY;]G_ /\
M#AZ1_P#)%'_#V+]EG_HY;]G_ /\ #AZ1_P#)% 'T!17S_P#\/8OV6?\ HY;]
MG_\ \.'I'_R11_P]B_99_P"CEOV?_P#PX>D?_)% 'T!17S__ ,/8OV6?^CEO
MV?\ _P .'I'_ ,D4?\/8OV6?^CEOV?\ _P .'I'_ ,D4 ?0%%?/_ /P]B_99
M_P"CEOV?_P#PX>D?_)%'_#V+]EG_ *.6_9__ /#AZ1_\D4 ?0%%?/_\ P]B_
M99_Z.6_9_P#_  X>D?\ R11_P]B_99_Z.6_9_P#_  X>D?\ R10!] 45\_\
M_#V+]EG_ *.6_9__ /#AZ1_\D4?\/8OV6?\ HY;]G_\ \.'I'_R10!] 45\_
M_P##V+]EG_HY;]G_ /\ #AZ1_P#)%'_#V+]EG_HY;]G_ /\ #AZ1_P#)% 'T
M!17S_P#\/8OV6?\ HY;]G_\ \.'I'_R11_P]B_99_P"CEOV?_P#PX>D?_)%
M'T!17S__ ,/8OV6?^CEOV?\ _P .'I'_ ,D4?\/8OV6?^CEOV?\ _P .'I'_
M ,D4 ?0%%?/_ /P]B_99_P"CEOV?_P#PX>D?_)%'_#V+]EG_ *.6_9__ /#A
MZ1_\D4 ?0%%?/_\ P]B_99_Z.6_9_P#_  X>D?\ R11_P]B_99_Z.6_9_P#_
M  X>D?\ R10!] 45\_\ _#V+]EG_ *.6_9__ /#AZ1_\D4?\/8OV6?\ HY;]
MG_\ \.'I'_R10!] 45\__P##V+]EG_HY;]G_ /\ #AZ1_P#)%'_#V+]EG_HY
M;]G_ /\ #AZ1_P#)% 'T!17S_P#\/8OV6?\ HY;]G_\ \.'I'_R11_P]B_99
M_P"CEOV?_P#PX>D?_)% 'T!17S__ ,/8OV6?^CEOV?\ _P .'I'_ ,D4?\/8
MOV6?^CEOV?\ _P .'I'_ ,D4 ?0%%?/_ /P]B_99_P"CEOV?_P#PX>D?_)%'
M_#V+]EG_ *.6_9__ /#AZ1_\D4 ?0%%?/_\ P]B_99_Z.6_9_P#_  X>D?\
MR11_P]B_99_Z.6_9_P#_  X>D?\ R10!] 45\_\ _#V+]EG_ *.6_9__ /#A
MZ1_\D4?\/8OV6?\ HY;]G_\ \.'I'_R10!] 45\__P##V+]EG_HY;]G_ /\
M#AZ1_P#)%'_#V+]EG_HY;]G_ /\ #AZ1_P#)% 'T!17S_P#\/8OV6?\ HY;]
MG_\ \.'I'_R11_P]B_99_P"CEOV?_P#PX>D?_)% 'T!17S__ ,/8OV6?^CEO
MV?\ _P .'I'_ ,D4?\/8OV6?^CEOV?\ _P .'I'_ ,D4 ?0%%?/_ /P]B_99
M_P"CEOV?_P#PX>D?_)%'_#V+]EG_ *.6_9__ /#AZ1_\D4 ?0%%?/_\ P]B_
M99_Z.6_9_P#_  X>D?\ R11_P]B_99_Z.6_9_P#_  X>D?\ R10!] 45\_\
M_#V+]EG_ *.6_9__ /#AZ1_\D4?\/8OV6?\ HY;]G_\ \.'I'_R10!] 45\_
M_P##V+]EG_HY;]G_ /\ #AZ1_P#)%'_#V+]EG_HY;]G_ /\ #AZ1_P#)% 'T
M!17S_P#\/8OV6?\ HY;]G_\ \.'I'_R11_P]B_99_P"CEOV?_P#PX>D?_)%
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M_#V+]EG_ *.6_9__ /#AZ1_\D4 ?0%%?/_\ P]B_99_Z.6_9_P#_  X>D?\
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MJ#Q]\1+?Q1<ZY8Z\MQ;>%-!DL!;V_@>SN[V6_OK:!_,;S!-=.K[MJ%5C5?F
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MD>5W>4G 'E_C?PQX%\,?ME_$B;X)_M5>'?@?\0-2ODG\=^#]<T^UU+2]2O3
MC"^BL[J6W=9FC9/,GMY61RH#_,K"J<E+2/9:Z_\ #ERFI747T6NO_#E?6OV8
M/!?[-W_!<7X*2>![>U\.Z;XK\)>*M1O/#6G_ +G3[*["V227L5NH$<+W*B-7
M\L .;0$C.2?-?A5XG\6?&+]N+]H;QYJ'[,&H?'[5O"WCB[\$:-J%WX@T&WM?
M"^G6440CMK:UOK@-&\WF&X>94'F"<#.585J?LJ_"^Q\>_P#!9[0_%6C?%>\^
M/&O>"O!.ICQWXQC, TNQFNI8H]/TJUCMR;>#8JW,GE(6;YI&D8L>/J3XR?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MAD4CD U^CU? '_!1;_E.1_P3L_ZZ_$;_ -,$% CW_P#X=._LL_\ 1M/[/_\
MX;S2/_D>C_AT[^RS_P!&T_L__P#AO-(_^1Z^@** /G__ (=._LL_]&T_L_\
M_AO-(_\ D>C_ (=._LL_]&T_L_\ _AO-(_\ D>OH"B@#Y_\ ^'3O[+/_ $;3
M^S__ .&\TC_Y'H_X=._LL_\ 1M/[/_\ X;S2/_D>OH"B@#Y__P"'3O[+/_1M
M/[/_ /X;S2/_ )'H_P"'3O[+/_1M/[/_ /X;S2/_ )'KZ HH ^?_ /AT[^RS
M_P!&T_L__P#AO-(_^1Z/^'3O[+/_ $;3^S__ .&\TC_Y'KZ HH ^?_\ AT[^
MRS_T;3^S_P#^&\TC_P"1Z/\ AT[^RS_T;3^S_P#^&\TC_P"1Z^@** /G_P#X
M=._LL_\ 1M/[/_\ X;S2/_D>C_AT[^RS_P!&T_L__P#AO-(_^1Z^@** /G__
M (=._LL_]&T_L_\ _AO-(_\ D>C_ (=._LL_]&T_L_\ _AO-(_\ D>OH"B@#
MY_\ ^'3O[+/_ $;3^S__ .&\TC_Y'H_X=._LL_\ 1M/[/_\ X;S2/_D>OH"B
M@#Y__P"'3O[+/_1M/[/_ /X;S2/_ )'H_P"'3O[+/_1M/[/_ /X;S2/_ )'K
MZ HH ^?_ /AT[^RS_P!&T_L__P#AO-(_^1Z/^'3O[+/_ $;3^S__ .&\TC_Y
M'KZ HH ^?_\ AT[^RS_T;3^S_P#^&\TC_P"1Z/\ AT[^RS_T;3^S_P#^&\TC
M_P"1Z^@** /G_P#X=._LL_\ 1M/[/_\ X;S2/_D>C_AT[^RS_P!&T_L__P#A
MO-(_^1Z^@** /G__ (=._LL_]&T_L_\ _AO-(_\ D>C_ (=._LL_]&T_L_\
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MHO\ X!1?_$UM44 8O_"N/#W_ $ =%_\  *+_ .)H_P"%<>'O^@#HO_@%%_\
M$UM44 8O_"N/#W_0!T7_ , HO_B:/^%<>'O^@#HO_@%%_P#$UM44 8O_  KC
MP]_T =%_\ HO_B:/^%<>'O\ H Z+_P" 47_Q-;5% &+_ ,*X\/?] '1?_ *+
M_P")J?3?AAX3O-1MX=0\*^&]0L99%2YM;G3898;F,D!HW1E*LK+D$$$$$@UI
MU/IELU[J5O"N=TTJH,=>2!2EJM2:B3BU+8^R(_\ @D_^RRT:G_AFG]G_ )&?
M^2>:1_\ (]+_ ,.G?V6?^C:?V?\ _P -YI'_ ,CU[]",0K]!3J_/#^:3Y_\
M^'3O[+/_ $;3^S__ .&\TC_Y'H_X=._LL_\ 1M/[/_\ X;S2/_D>OH"B@#Y_
M_P"'3O[+/_1M/[/_ /X;S2/_ )'H_P"'3O[+/_1M/[/_ /X;S2/_ )'KZ HH
M ^?_ /AT[^RS_P!&T_L__P#AO-(_^1Z/^'3O[+/_ $;3^S__ .&\TC_Y'KZ
MHH ^?_\ AT[^RS_T;3^S_P#^&\TC_P"1Z/\ AT[^RS_T;3^S_P#^&\TC_P"1
MZ^@** /G_P#X=._LL_\ 1M/[/_\ X;S2/_D>C_AT[^RS_P!&T_L__P#AO-(_
M^1Z^@** /G__ (=._LL_]&T_L_\ _AO-(_\ D>C_ (=._LL_]&T_L_\ _AO-
M(_\ D>OH"B@#Y_\ ^'3O[+/_ $;3^S__ .&\TC_Y'H_X=._LL_\ 1M/[/_\
MX;S2/_D>OH"B@#Y__P"'3O[+/_1M/[/_ /X;S2/_ )'H_P"'3O[+/_1M/[/_
M /X;S2/_ )'KZ HH ^?_ /AT[^RS_P!&T_L__P#AO-(_^1Z/^'3O[+/_ $;3
M^S__ .&\TC_Y'KZ HH ^?_\ AT[^RS_T;3^S_P#^&\TC_P"1Z/\ AT[^RS_T
M;3^S_P#^&\TC_P"1Z^@** /G_P#X=._LL_\ 1M/[/_\ X;S2/_D>C_AT[^RS
M_P!&T_L__P#AO-(_^1Z^@** /G__ (=._LL_]&T_L_\ _AO-(_\ D>C_ (=.
M_LL_]&T_L_\ _AO-(_\ D>OH"B@#Y_\ ^'3O[+/_ $;3^S__ .&\TC_Y'H_X
M=._LL_\ 1M/[/_\ X;S2/_D>OH"B@#Y__P"'3O[+/_1M/[/_ /X;S2/_ )'H
M_P"'3O[+/_1M/[/_ /X;S2/_ )'KZ HH ^?_ /AT[^RS_P!&T_L__P#AO-(_
M^1Z/^'3O[+/_ $;3^S__ .&\TC_Y'KZ HH ^?_\ AT[^RS_T;3^S_P#^&\TC
M_P"1Z/\ AT[^RS_T;3^S_P#^&\TC_P"1Z^@** /G_P#X=._LL_\ 1M/[/_\
MX;S2/_D>C_AT[^RS_P!&T_L__P#AO-(_^1Z^@** /G__ (=._LL_]&T_L_\
M_AO-(_\ D>C_ (=._LL_]&T_L_\ _AO-(_\ D>OH"B@#Y_\ ^'3O[+/_ $;3
M^S__ .&\TC_Y'H_X=._LL_\ 1M/[/_\ X;S2/_D>OH"B@#Y__P"'3O[+/_1M
M/[/_ /X;S2/_ )'H_P"'3O[+/_1M/[/_ /X;S2/_ )'KZ HH ^?_ /AT[^RS
M_P!&T_L__P#AO-(_^1Z/^'3O[+/_ $;3^S__ .&\TC_Y'KZ HH ^?_\ AT[^
MRS_T;3^S_P#^&\TC_P"1Z/\ AT[^RS_T;3^S_P#^&\TC_P"1Z^@** /G_P#X
M=._LL_\ 1M/[/_\ X;S2/_D>C_AT[^RS_P!&T_L__P#AO-(_^1Z^@** /G__
M (=._LL_]&T_L_\ _AO-(_\ D>C_ (=._LL_]&T_L_\ _AO-(_\ D>OH"B@#
MY_\ ^'3O[+/_ $;3^S__ .&\TC_Y'H_X=._LL_\ 1M/[/_\ X;S2/_D>OH"B
M@#Y__P"'3O[+/_1M/[/_ /X;S2/_ )'H_P"'3O[+/_1M/[/_ /X;S2/_ )'K
MZ HH ^?_ /AT[^RS_P!&T_L__P#AO-(_^1Z/^'3O[+/_ $;3^S__ .&\TC_Y
M'KZ HH ^?_\ AT[^RS_T;3^S_P#^&\TC_P"1Z/\ AT[^RS_T;3^S_P#^&\TC
M_P"1Z^@** /G_P#X=._LL_\ 1M/[/_\ X;S2/_D>C_AT[^RS_P!&T_L__P#A
MO-(_^1Z^@** /G__ (=._LL_]&T_L_\ _AO-(_\ D>C_ (=._LL_]&T_L_\
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M3BNXHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M /\ AWO_ +DH_P"'!?\ U>I^W_\ ^'>_^Y* /O\ HKX _P"'!?\ U>I^W_\
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MZG[?_P#X=[_[DH_X<%_]7J?M_P#_ (=[_P"Y* /O^BO@#_AP7_U>I^W_ /\
MAWO_ +DH_P"'!?\ U>I^W_\ ^'>_^Y* /O\ HKX _P"'!?\ U>I^W_\ ^'>_
M^Y*/^'!?_5ZG[?\ _P"'>_\ N2@#[_HKX _X<%_]7J?M_P#_ (=[_P"Y*/\
MAP7_ -7J?M__ /AWO_N2@#[!^-O[./AWXYV2_P!I0M;:C"I6&^@XE3V;LP]C
MT[8KY+^*G[%?C/X<RS36MF?$&FJ3MGL5+R!?]J+[P_#(]ZI?\."_^KU/V_\
M_P .]_\ <E'_  X+_P"KU/V__P#P[W_W)7H87,JU#1:KLSZ+*.*,;@%R0?-#
M^5[?+JOR\CS">"2UF:.1&CDC.UE8;64^A%0W5U'9P-)(P55[FNN^)?\ P0&\
M)Z)H-QK?B?\ ;!_;DN[73U\QFOOBC%<YQT4*]D0Q/0"O%?#'[.5KX'TUM-M?
M'7Q,\06D,C&&[\1:I;WM\ZDG;YCK B9 X^5!^/6OI,#COK-_=:L?J?#O$']I
MW;I.*CN[IJ_9;:_+0UM6\5S7A9(<PQ],C[S5EJK3/@!F9O3DFKDOP9AF'S:]
MXB_X#/$O\HZCB^"4=O\ ZOQ-XPC_ -W40/\ V6O6]HELC[..*IP5H1+>G>$K
MB[(:7]S'[_>_+_&NCTW2H=+BVQ+UZL>IKE/^%-_]35XS_P#!G_\ 8T?\*;_Z
MFKQG_P"#/_[&LY3;.6KB)SWV.SH!P:XS_A3?_4U>,_\ P9__ &-'_"F_^IJ\
M9_\ @S_^QJ3$^CO@K^V+XH^$TD=K<32:YHZGFUNI"7C'^Q(<E?H<CVK[0^%O
MQ9T7XP>&UU+1;I9H_NRQ-Q+;M_==>W\C7Y0_\*;_ .IJ\9_^#/\ ^QIFH_!S
M4+G1+RRL/B5\7/#37T?E/>^'_%4VEWL8[%)H@"".HSE<]01Q7DX[*X5ES4])
M?GZGQ^?\)8?&Q=7#I0J?@_7_ #^^Y^PU%?FK\&_^",^F_&?P5;ZQIW[:_P"W
M\K,-MQ ?B_\ /;2=U/\ HGY'N*ZO_AP7_P!7J?M__P#AWO\ [DKY.<90DXRW
M1^.5J,Z-1TJJM).S1]_T5\ ?\."_^KU/V_\ _P .]_\ <E'_  X+_P"KU/V_
M_P#P[W_W)4F1]_T5\ ?\."_^KU/V_P#_ ,.]_P#<E'_#@O\ ZO4_;_\ _#O?
M_<E 'W_17P!_PX+_ .KU/V__ /P[W_W)1_PX+_ZO4_;_ /\ P[W_ -R4 ??]
M%? '_#@O_J]3]O\ _P##O?\ W)1_PX+_ .KU/V__ /P[W_W)0!]_T5\ ?\."
M_P#J]3]O_P#\.]_]R4?\."_^KU/V_P#_ ,.]_P#<E 'W_17P!_PX+_ZO4_;_
M /\ P[W_ -R4?\."_P#J]3]O_P#\.]_]R4 ??]%? '_#@O\ ZO4_;_\ _#O?
M_<E'_#@O_J]3]O\ _P##O?\ W)0!]_T5\ ?\."_^KU/V_P#_ ,.]_P#<E'_#
M@O\ ZO4_;_\ _#O?_<E 'W_17P!_PX+_ .KU/V__ /P[W_W)1_PX+_ZO4_;_
M /\ P[W_ -R4 ??]%? '_#@O_J]3]O\ _P##O?\ W)1_PX+_ .KU/V__ /P[
MW_W)0!]_T5\ ?\."_P#J]3]O_P#\.]_]R4?\."_^KU/V_P#_ ,.]_P#<E 'W
M_17P!_PX+_ZO4_;_ /\ P[W_ -R4?\."_P#J]3]O_P#\.]_]R4 ??]%? '_#
M@O\ ZO4_;_\ _#O?_<E'_#@O_J]3]O\ _P##O?\ W)0!]_T5\ ?\."_^KU/V
M_P#_ ,.]_P#<E'_#@O\ ZO4_;_\ _#O?_<E 'W_17P!_PX+_ .KU/V__ /P[
MW_W)1_PX+_ZO4_;_ /\ P[W_ -R4 ??]%? '_#@O_J]3]O\ _P##O?\ W)1_
MPX+_ .KU/V__ /P[W_W)0!]_T5\ ?\."_P#J]3]O_P#\.]_]R4?\."_^KU/V
M_P#_ ,.]_P#<E 'W_17P!_PX+_ZO4_;_ /\ P[W_ -R4?\."_P#J]3]O_P#\
M.]_]R4 ??]%? '_#@O\ ZO4_;_\ _#O?_<E'_#@O_J]3]O\ _P##O?\ W)0!
M]_T5\ ?\."_^KU/V_P#_ ,.]_P#<E'_#@O\ ZO4_;_\ _#O?_<E 'W_17P!_
MPX+_ .KU/V__ /P[W_W)1_PX+_ZO4_;_ /\ P[W_ -R4 ??]%? '_#@O_J]3
M]O\ _P##O?\ W)1_PX+_ .KU/V__ /P[W_W)0!]_T5\ ?\."_P#J]3]O_P#\
M.]_]R4?\."_^KU/V_P#_ ,.]_P#<E 'W_17P!_PX+_ZO4_;_ /\ P[W_ -R4
M?\."_P#J]3]O_P#\.]_]R4 ??]%? '_#@O\ ZO4_;_\ _#O?_<E'_#@O_J]3
M]O\ _P##O?\ W)0!]_T5\ ?\."_^KU/V_P#_ ,.]_P#<E'_#@O\ ZO4_;_\
M_#O?_<E 'W_17P!_PX+_ .KU/V__ /P[W_W)1_PX+_ZO4_;_ /\ P[W_ -R4
M ??]%? '_#@O_J]3]O\ _P##O?\ W)1_PX+_ .KU/V__ /P[W_W)0!]_T5\
M?\."_P#J]3]O_P#\.]_]R4?\."_^KU/V_P#_ ,.]_P#<E 'W_17P!_PX+_ZO
M4_;_ /\ P[W_ -R4?\."_P#J]3]O_P#\.]_]R4 ??]%? '_#@O\ ZO4_;_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%Z)X"N!\";/PO=2K'=?V"FES2#YU1_LXB9O< Y/O76T5PXS-*V)Y>=)6[?\
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M)R"A+_IL.!5UK[/<TQ#=U%[_ .84445@<X4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M-0^UWJV+'-O-<#RHQ#-(F',(W[ P!<MD#U*I:L[,B46G9A7P!_P46_Y3D?\
M!.S_ *Z_$;_TP05]_P!? '_!1;_E.1_P3L_ZZ_$;_P!,$%(1]_T444 %%%%
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M^(?BWQ7XLTAM'MK6TAU6>^ALK5)<22W4A>-&VKB(]0R[F7]FP,"JQ%[V;O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M6W>0A&BGM9+M?)5<G>9BJ  \G(S,(*VJ]=/^#H*%.-KM>NG_  58^I/V]?\
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M/H.EZ;HFD6*E+:QL+9+:VMU))(2- %49). !R345+*\5Y?E_P3.K:+<5Y/\
M#_@FE11161B%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %5=;UNS\-:+>:EJ%U;V.GZ? ]
MS<W$[B.*WB12SNS'A55022> !5JJ?B+P[I_B_0+W2M6L;/5-+U*![:[L[N!9
M[>ZB<%7CD1@5964D%2""#@T ?!__  4Y_9DU?Q#J1_:X\!_&ZQT74/A)X0N;
M_P -66H:=9ZMX;F4(\LK(\A.R2Z7;%YT7SXV!2>E>N>%/'J?\%-?V -/\/3>
M*F^&GCGXH> ]/UC5+71[E3JFB6UZHW2QQ.1((9=LT:NP&5)P<BLJU_X(5_LG
MV?BF'5D^#ND>9#<"[2R?5-0?2Q(#G/V%K@VI^ABQVQBN]_:5_P""8WP'_:\U
M^RUCQ_\ #C1]6UK3[=;2WU.TGN-+OXX5X6/[1:212E%!("EB "0!@D'H]I&R
M6NG6R_S.KVD+)7>G6R_SU/F7]@#Q/\3?V7/CM\4/V2]$\1>#_B):?"_P)!K7
M@?6+K2ETJ+2KF7<D.FZHMF""#(5D:15\YDWN=S-A?I3X"_$'XX^ ++7M6_:2
MNO@'X9\.VXM8M.O?"FJZ@%6>6;RMMR]]'&BAG>%$VDDL^.XSU_[+?[&'PO\
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MG9_UU^(W_I@@K,S#_AX?^W9_TCJ_\SWX?_\ C-'_  \/_;L_Z1U?^9[\/_\
MQFOO^B@#X _X>'_MV?\ 2.K_ ,SWX?\ _C-'_#P_]NS_ *1U?^9[\/\ _P 9
MK[_HH ^?_P!AC]HCX[_'I_%'_"ZOV<_^%!#2A:_V.?\ A/M/\5?V[YGG>?\
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MX>'_ +=G_2.K_P SWX?_ /C-??\ 10!\ ?\ #P_]NS_I'5_YGOP__P#&:/\
MAX?^W9_TCJ_\SWX?_P#C-??]% 'P!_P\/_;L_P"D=7_F>_#_ /\ &:/^'A_[
M=G_2.K_S/?A__P",U]_T4 ? '_#P_P#;L_Z1U?\ F>_#_P#\9H_X>'_MV?\
M2.K_ ,SWX?\ _C-??]% 'P!_P\/_ &[/^D=7_F>_#_\ \9H_X>'_ +=G_2.K
M_P SWX?_ /C-??\ 10!\ ?\ #P_]NS_I'5_YGOP__P#&:/\ AX?^W9_TCJ_\
MSWX?_P#C-??]% 'P!_P\/_;L_P"D=7_F>_#_ /\ &:/^'A_[=G_2.K_S/?A_
M_P",U]_T4 ? '_#P_P#;L_Z1U?\ F>_#_P#\9H_X>'_MV?\ 2.K_ ,SWX?\
M_C-??]% 'P!_P\/_ &[/^D=7_F>_#_\ \9H_X>'_ +=G_2.K_P SWX?_ /C-
M??\ 10!\ ?\ #P_]NS_I'5_YGOP__P#&:/\ AX?^W9_TCJ_\SWX?_P#C-??]
M% 'P!_P\/_;L_P"D=7_F>_#_ /\ &:/^'A_[=G_2.K_S/?A__P",U]_T4 ?
M'_#P_P#;L_Z1U?\ F>_#_P#\9H_X>'_MV?\ 2.K_ ,SWX?\ _C-??]% 'P!_
MP\/_ &[/^D=7_F>_#_\ \9H_X>'_ +=G_2.K_P SWX?_ /C-??\ 10!\ ?\
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MP.,_X3;Q?_T(_P#Y68?\*/\ A-O%_P#T(_\ Y68?\*[.B@#C/^$V\7_]"/\
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MX<-%Y]W\^GD? '_#P_\ ;L_Z1U?^9[\/_P#QFC_AX?\ MV?](ZO_ #/?A_\
M^,U]_P!%>:?+GP!_P\/_ &[/^D=7_F>_#_\ \9H_X>'_ +=G_2.K_P SWX?_
M /C-??\ 10!\ ?\ #P_]NS_I'5_YGOP__P#&:/\ AX?^W9_TCJ_\SWX?_P#C
M-??]% 'P!_P\/_;L_P"D=7_F>_#_ /\ &:/^'A_[=G_2.K_S/?A__P",U]_T
M4 ? '_#P_P#;L_Z1U?\ F>_#_P#\9H_X>'_MV?\ 2.K_ ,SWX?\ _C-??]%
M'P!_P\/_ &[/^D=7_F>_#_\ \9H_X>'_ +=G_2.K_P SWX?_ /C-??\ 7,_&
M7QXOPR^&&M:VQ&^QMB8@>\C?*@_[Z(JH1<I**W9I1HRJU(TH;R:2]7H?G-\7
M?VY/C;\>M"MM.\;? ^+X9:CIL\B7F@P^.K/6\2*V%9[B&)(V.!D*NX#/7.0/
M._\ A-O%_P#T(_\ Y68?\*[>\NY+^[DGF=I)9F+NS')8DY))J.ON\/0C1IJG
M'H?T+EF7T\%AH8:GM%?>^K^;.,_X3;Q?_P!"/_Y68?\ "C_A-O%__0C_ /E9
MA_PKLZ*W.\XS_A-O%_\ T(__ )68?\*/^$V\7_\ 0C_^5F'_  KLZ* .,_X3
M;Q?_ -"/_P"5F'_"C_A-O%__ $(__E9A_P *[.B@#C/^$V\7_P#0C_\ E9A_
MPH_X3;Q?_P!"/_Y68?\ "NSHH ;\(_VO_BG^SM<ZAJ7AWX7Q^*+F:W94T2;Q
M7;Z?%J$O\"^>T;K$V> S+CGD@<CU*/\ X*)_MU31JR_\$ZPRL,@CX^>'L$?]
M^:\OK[\_8Y^([?$7X'Z<TTADO-))L)RQRQ* ;2?JA7GUS7SN>85:5X^C_0_-
M./LJ5HX^FM?AE^C_ $^X^5/^'A_[=G_2.K_S/?A__P",T?\ #P_]NS_I'5_Y
MGOP__P#&:^_Z*^=/S(^ /^'A_P"W9_TCJ_\ ,]^'_P#XS1_P\/\ V[/^D=7_
M )GOP_\ _&:^_P"B@#X _P"'A_[=G_2.K_S/?A__ .,T?\/#_P!NS_I'5_YG
MOP__ /&:^_Z* /@#_AX?^W9_TCJ_\SWX?_\ C-'_  \/_;L_Z1U?^9[\/_\
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M ,SWX?\ _C-'_#P_]NS_ *1U?^9[\/\ _P 9K[_HH ^ /^'A_P"W9_TCJ_\
M,]^'_P#XS1_P\/\ V[/^D=7_ )GOP_\ _&:^_P"B@#X _P"'A_[=G_2.K_S/
M?A__ .,T?\/#_P!NS_I'5_YGOP__ /&:^_Z* /@#_AX?^W9_TCJ_\SWX?_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M ^_Z*^ /^(HW]A/_ *+E_P"69X@_^0:/^(HW]A/_ *+E_P"69X@_^0: /O\
MHKX _P"(HW]A/_HN7_EF>(/_ )!H_P"(HW]A/_HN7_EF>(/_ )!H ^_Z*^ /
M^(HW]A/_ *+E_P"69X@_^0:/^(HW]A/_ *+E_P"69X@_^0: /O\ HKX _P"(
MHW]A/_HN7_EF>(/_ )!H_P"(HW]A/_HN7_EF>(/_ )!H ^_Z*^ /^(HW]A/_
M *+E_P"69X@_^0:/^(HW]A/_ *+E_P"69X@_^0: /O\ HKX _P"(HW]A/_HN
M7_EF>(/_ )!H_P"(HW]A/_HN7_EF>(/_ )!H ^_Z*^ /^(HW]A/_ *+E_P"6
M9X@_^0:/^(HW]A/_ *+E_P"69X@_^0: /O\ HKX _P"(HW]A/_HN7_EF>(/_
M )!H_P"(HW]A/_HN7_EF>(/_ )!H ^_Z*^ /^(HW]A/_ *+E_P"69X@_^0:/
M^(HW]A/_ *+E_P"69X@_^0: /O\ HKX _P"(HW]A/_HN7_EF>(/_ )!H_P"(
MHW]A/_HN7_EF>(/_ )!H ^_Z*^ /^(HW]A/_ *+E_P"69X@_^0:/^(HW]A/_
M *+E_P"69X@_^0: /O\ HKX _P"(HW]A/_HN7_EF>(/_ )!H_P"(HW]A/_HN
M7_EF>(/_ )!H ^_Z*^ /^(HW]A/_ *+E_P"69X@_^0:/^(HW]A/_ *+E_P"6
M9X@_^0: /O\ HKX _P"(HW]A/_HN7_EF>(/_ )!H_P"(HW]A/_HN7_EF>(/_
M )!H ^_Z*^ /^(HW]A/_ *+E_P"69X@_^0:/^(HW]A/_ *+E_P"69X@_^0:
M/O\ HKX _P"(HW]A/_HN7_EF>(/_ )!H_P"(HW]A/_HN7_EF>(/_ )!H ^_Z
M*^ /^(HW]A/_ *+E_P"69X@_^0:/^(HW]A/_ *+E_P"69X@_^0: /O\ HKX
M_P"(HW]A/_HN7_EF>(/_ )!H_P"(HW]A/_HN7_EF>(/_ )!H ^_Z&4.I!&0>
M"#WKX _XBC?V$_\ HN7_ )9GB#_Y!H_XBC?V$_\ HN7_ )9GB#_Y!H 3]K3X
M-R?"+XJW0ACVZ3JC&ZLV'0 _>3_@+9'TQ7E]=!\<?^#BC]@/XW>")M+O/CDL
M=PN9+2X_X0OQ!NMY,<'_ (\.AZ$=Q7BG@3]L;X8_%/PS!K?AGQ9;ZWHUV6^S
MWD%G<HLH!(/RO&KJ<C[K*&'<"OL,KQRK4^27Q+\?,_;.%,^CCL,J51_O(*S\
MUT?^?GZGI=%<9_PT'X0_Z"__ )*S?_$4?\-!^$/^@O\ ^2LW_P 17J'UAV=%
M<9_PT'X0_P"@O_Y*S?\ Q%'_  T'X0_Z"_\ Y*S?_$4 =G17&?\ #0?A#_H+
M_P#DK-_\11_PT'X0_P"@O_Y*S?\ Q% '9UROBC6S>W!@C/[F,\_[1JN?C9X?
MUF"6'3M0,]QMX MY5VCIG+*!6)+XBLX(FD>8*JC+$J>!^5;4X]3NP=)/WV:N
MF6#:E>I$O\1Y/H.]=M'&L,:JHPJC %>?Z#\9_!^D6_S:L#,WWB+6;CV'R5?_
M .&@_"'_ $%__)6;_P"(J:DKLSQ5;GE9;([.BN,_X:#\(?\ 07_\E9O_ (BC
M_AH/PA_T%_\ R5F_^(K,Y3LZ*XS_ (:#\(?]!?\ \E9O_B*/^&@_"'_07_\
M)6;_ .(H [.BN,_X:#\(?]!?_P E9O\ XBC_ (:#\(?]!?\ \E9O_B* .U@G
M>VG22-FCDC8,K*<,I'((-?=7['?[0C_&3P?)8ZE(IUS2 JRG/-S'C"R?7/!]
M^>]?G!_PT'X0_P"@O_Y*S?\ Q%=?\"OVUO"?P<^)NFZY_;,GV6%_+O%2SG8O
M V-X "$D@<@#DE17#F&%5>DUU6W]>9\_Q)D\<PP<HI>_'6+\^WSV/U4HKX#N
MO^#H/]ABQN9(9OC>T4T+%'1O!?B$,C#@@_Z#VIG_ !%&_L)_]%R_\LSQ!_\
M(-?$GX.??]%? '_$4;^PG_T7+_RS/$'_ ,@T?\11O["?_1<O_+,\0?\ R#0!
M]_T5\ ?\11O["?\ T7+_ ,LSQ!_\@T?\11O["?\ T7+_ ,LSQ!_\@T ??]%?
M '_$4;^PG_T7+_RS/$'_ ,@T?\11O["?_1<O_+,\0?\ R#0!]_T5\ ?\11O[
M"?\ T7+_ ,LSQ!_\@T?\11O["?\ T7+_ ,LSQ!_\@T ??]%? '_$4;^PG_T7
M+_RS/$'_ ,@T?\11O["?_1<O_+,\0?\ R#0!]_T5\ ?\11O["?\ T7+_ ,LS
MQ!_\@T?\11O["?\ T7+_ ,LSQ!_\@T ??]%? '_$4;^PG_T7+_RS/$'_ ,@T
M?\11O["?_1<O_+,\0?\ R#0!]_T5\ ?\11O["?\ T7+_ ,LSQ!_\@T?\11O[
M"?\ T7+_ ,LSQ!_\@T ??]%? '_$4;^PG_T7+_RS/$'_ ,@T?\11O["?_1<O
M_+,\0?\ R#0!]_T5\ ?\11O["?\ T7+_ ,LSQ!_\@T?\11O["?\ T7+_ ,LS
MQ!_\@T ??]%? '_$4;^PG_T7+_RS/$'_ ,@T?\11O["?_1<O_+,\0?\ R#0!
M]_T5\ ?\11O["?\ T7+_ ,LSQ!_\@T?\11O["?\ T7+_ ,LSQ!_\@T ??]%?
M '_$4;^PG_T7+_RS/$'_ ,@T?\11O["?_1<O_+,\0?\ R#0!]_T5\ ?\11O[
M"?\ T7+_ ,LSQ!_\@T?\11O["?\ T7+_ ,LSQ!_\@T ??]%? '_$4;^PG_T7
M+_RS/$'_ ,@T?\11O["?_1<O_+,\0?\ R#0!]_T5\ ?\11O["?\ T7+_ ,LS
MQ!_\@T?\11O["?\ T7+_ ,LSQ!_\@T ??]%? '_$4;^PG_T7+_RS/$'_ ,@T
M?\11O["?_1<O_+,\0?\ R#0!]_T5\ ?\11O["?\ T7+_ ,LSQ!_\@T?\11O[
M"?\ T7+_ ,LSQ!_\@T ??]%? '_$4;^PG_T7+_RS/$'_ ,@U]'?L1?\ !2'X
M+_\ !1OPSK6L?!GQG_PF6F^';I;/4)O[(OM/^SRL@=5VW<,3-E2#E01[T >X
MT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%>*_M'
M?MA:G^S[XWM=%L_@G\:OB1%=6*7IU/PAI=A=6,!:21/(=KB\@<2CRPQ 0KMD
M3YB20/&_AK_P67M_C##KDGAC]FW]IW6D\-ZQ=>']3-OH.D'[%?VS!)[=\ZF/
MGC8@$5HJ<FKHTC2DU='V=17AO@O]M!_&'[:]O\'I/!^H:/)/\,[/XBM>W]VJ
M75J;B_DM#I\MJJLJR1^7N9UF89)4 @;C[E42BUN3*+6X4444B0HHKYO_ &>/
MVYO$W[4?_!-_2/CEX-^&#ZMXHU_2Y[_3O!*>((HVNI([F2#R1?2Q(@R(R^YH
MQZ8)QFE%O4I1;5T?2%%>,?M2?M=R?LJ_LXZ7XRU;P?JFK>)M<O-,T73_  KI
M]U$]Q=:O?RQPPV0G.(\"5]IE^[A20#P#M?LR_$SXF?$K0=2E^)OPOL_AAJ5K
M,B6MO:^*8?$$-]&RY+B6.*(H5/RE60<\@D<T<KMS!R.W,>FT45QWCCX_>$?A
MQ\5? _@G6M6^Q^*/B/+>P^';+[+-)_:+V=N;FY'F(ACCV0@M^\9=V,+D\5.^
MQ-F]CL:*X/\ :)^(GC3X9>![/4/ OP_D^)&L3:I:6<VEIK4&DFWM99 LUUYL
MP*L(E.[8!ENQ')'>46TN.VEPHHHH$%%%% !1110 4444 %%%% !17'1_'[PC
M+^T!-\+5U;/CR#P\GBI],^RS?+IKW+VJS^=L\KF:-UV;]_&=N"#78T!9K<**
M** "BBB@ HHHH **** "BBB@ HK@_P!G?XB>-/B;X(O-0\=?#^3X;ZQ!JEU9
MP:8^M0:L;BUCD*PW7FP@*HE4;MA&5[D\$]Y0]-!M6=@HKC?CM^T#X1_9G\"+
MXF\;:M_8NAM?6NFBY^RS7.;BYF6"!-D*._S2.JYQ@9R2!DUV5&NXK.UPHHHH
M **P_B=XS_X5Q\-?$/B+[-]L_L'3+G4?L_F>7Y_DQ-)LW8.W.W&<'&<X/2N3
M_8]_:$_X:P_9;\!?$K^R/[ _X3C1;;6/[.^U?:OL7G(&\OS=B;\9QNV+GT%/
ME=KE<KM<](HHHI$A117 ? ?XC^-OB(?%?_"9_#V3X?\ ]CZ[<:=H^_6H-3_M
MZQ3'E7X\H#R1)D_NGRR[>30.W4[^BN.^ 'Q^\(_M1_"#1?'O@35O[<\)^(HW
MFT^^^RS6OVA4D:-CY<R)(N'1A\RCIGI@UQW[(O[67_#5&H_%JW_L#^P?^%7?
M$'4? F[[=]J_M/[)#;2_:L>6GE;_ +1CR_GV[,[SG KE>OD/E>OD>Q4445)(
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% 'F/[5_B#XL^%?AK;ZA\'?#OA+Q9XEM
M+^*2[TG7]2DT^._LL-YL<$RHRI.24VM)A  V<\ _(?QM^%W[1'_!3'Q_\*=#
M\=? W2?@;X-^'OC2P\::CKMYXRL?$&I7;V99DM;&.U7]WYA;#22$8'.WC:WZ
M%45I&IR[(TA4Y=DK]SY5^+W[-OC3Q/\ \%=/A#\3['1?M'@7POX*UC2-3U/[
M7 OV:ZGD4Q1^4SB5MP!^94*CN17KEE^QG\(O#WQ,F\>:7\)?AC:^/'NIM1&O
MQ^&K*#4Y+N7<9)FNUA,WF2%VW29+'>Q.<G/IU%)U&P=23LOD?$NK_M&?MH6O
MA.^\*ZI^ROX%\6:W<0O9?\)%I_Q"LX?#=SO!7S9+.Y3[6(\$DQ;6+#C(SQY%
MXW_9>_:I_8A_X)K?"/\ 9_\ @1X=F\9Z@L%VOC7Q7IFO:?IMYI,4]T]Q-;Z?
M]MDCQ(QN94CN-K>6L2G8&8;?TWHJU6MLE_7S+C6MM%=^O^9\8?\ !-K_ (6-
M\"-/\/?"U/V1]1^#OP]M8YI;GQ!/\0-'UJ5[G86,UPENYGGFFD #/SC(Z*H
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M'OQ2>ZTJYTKQ)JSZOK'A748X'GM[F&]E199+:;RVA:*5G*NR,I^8BOH+XZ?
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MFW&YAW72):7-L%*(I616)5R>"%"YFVGY=T3SMM/?3NB?]@?X?>%_#]OKFM>
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ML\8!V;6CZZ]5Y=39R6CZZ]5Y6UV]#S+]GWPO;^!/@S\2?&/P*^/7B[]H%?\
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MQ_$CQC_P1Q^)'P1U2.U\'^-O%&O:UJ%BEU>1SVTL<FM-?0)-);LX$-Q$JQN
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MI8/*W^;S#&[;PFSC&[) KZ3K&HTVGY&%5IM-=@HHHK,R"BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1117">"%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M4TMFN[K[%!J4NG7T&BSS[@HC34I(5LV8L< "8Y/ I*,GLB8TY/9'TW17R?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M R1K<F;Y<A=EP5W #:?TO\4_";P+J/P,OO!NK:'X>7X=MI+6%SI<L,<6F1V
MCP4*\(D:H.HP% R,8S6!X'_8Y^'?@3]FAOA#%H*ZIX#N+6>UO+#5KB74&U 3
MNTD[S22LSO))([R%B<[FR,8&/$=)_P""-7@FRT&'PO??%#X]:Y\,X0(E\!ZC
MXS:706MP1BU?$2W4EN ,>2]PR;>"","B512W=M?Z^8I5(SW=M;_UYG)_\&YZ
M:?%_P3"T-=)NIK[2U\3:^+.XE.9+B'^TY]CL3_$RX)]S70?\%NO^3;OAQ_V5
MOPC_ .G*.O>?V/\ ]DCPO^Q+\&5\"^#YM4FT./4[[5(Q?O$TD3W=P]P\:^5'
M&@C5I"J*%R% !)/-7/VI_P!E[PG^V'\&-0\"^,H;YM)OI8;J.XL+IK2]T^Y@
MD66&XMYE^:.6-U!##W!!!(,NHO:\_2XO:+VW/TN>!_\ !=+6+S2?^"<7B:-;
MNZT[P_J>L:+IWB>\MG9);71I]2MXKU@1SM,3%6Y4;';GL?I.V^%7@JU^"J^#
MXM#\/Q^ 5TO[ NEK;QC318^7CR]GW/+V?ACFN)^#'[&6F?#/X<^)O"_B;QG\
M0/C!IOBV,6^H_P#"?ZC#JF^W\LQF!4CABB6,JQW )EB<DD\UY"O_  1C\%P>
M&O\ A$X/BM^T%;_#(#RAX$C\;/\ V(+;I]D#&(W@M\?+Y0N=N.,47C;EOU%>
M/+RWV8G_  0LU:\U'_@GEHMO]INK[PSH^O:UI?A*[N&+O<Z'!J,\=D0QY9!&
MNQ3D_(B\XKSO_@JGX)\%_$7_ (*I_L+Z/X^CL[C0+N^\7,MI> &UOKM+73I+
M2&0-PP:X2+"'(=@JD'=BOO#P'X$T;X7>"M)\-^'=,L]%T'0[6.QT^PM(A'!:
M01J%2-%' 4* *\=_; _X)R_#7]NCQUX(USXB6^K:DO@.VU2VL;""Z%O;3&_2
MW5Y795\Y98FMHI(9(9(V1QNRW&"-1>T<GY_BAQJKVKF]%K^*9A_\%?\ P7X,
M\9?\$U_C ?'"VB:;HWAN\U6QNY0!)I^HPPLUE- W59A<>6J[2"Q?;T8@_(OC
MCQ!\:OB)^W7^RHG]D_#C6O&=K\$5\165IX^U*\LK >(7:W74IH!;VTK->QQ>
M7MR!MC>9OE(&?J&T_P""1O@_7_$FDW/Q ^)/QL^+VAZ#>QZCI_AOQKXI%]HT
M%Q$28I)(8X8FN60GC[0\O3G.3GUO]JK]CGP/^V+X2TW3?%UKJ$-[H-V-0T/6
M](O9-/UC0+H#'GVEU&0\;8X(Y5L#<IP,5&I&.F^Y4*D8KEWW_'^M3Y;^/O[-
M?[67[2GC7X9ZMKVA?LS^']4^'?BRR\0:?K6E>)=9?4H(HY!]KMH_,TX*R7%O
MYD;H3M(()^Z"/O:OF[X4_P#!-'0_ OQ8T'QGXF^)WQH^*NL>$Y'GT)/&/B9;
MBSTB9HWB::.WMH8(WE,<CIOE5VPQ&:^D:SJ23LD9U))V2Z!11169B%%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %8?Q.\=Q_"_X=:YXCFTS6M:CT.REOFL-'LVO-0O!&I;RX(5
MYDD;&%48R2.E;E(\BQ(S,P55&22< "@#X4^('_!6?XO_  +\##XB?$;]DSQ=
MX1^$-N\3ZAK8\7V%YK6DV\CJBSSZ4B!T +#<OFEESR!V[[XY?\%+M6LOCE;_
M  S^"'PMO_CAXTCT2W\1ZJ(]>M]!TG1K&Y&;9I;R9'S)*OS+&J$E2#GKCRO]
MHSQ]JW_!9;Q3J'P7^%]Q):_L_P"FWBP_$3XA0@^7KS0R*[:-I+=)"6"B6X&4
M4<#/ D],^.__  3:U?4_VBX?B9\$?B[>?!'QO/H%OX?UB!- MM>TO6;&WRML
M9+.9XRLD8RBR*_W54 #YMW5:"^)6?S^5^IV<M-6YE9_.WE?KW.R_8X_;Q?\
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M* /O^BO@#_AP7_U>I^W_ /\ AWO_ +DH_P"'!?\ U>I^W_\ ^'>_^Y* /O\
MHKX _P"'!?\ U>I^W_\ ^'>_^Y*/^'!?_5ZG[?\ _P"'>_\ N2@#[_HKX _X
M<%_]7J?M_P#_ (=[_P"Y*/\ AP7_ -7J?M__ /AWO_N2@#[_ **^ /\ AP7_
M -7J?M__ /AWO_N2C_AP7_U>I^W_ /\ AWO_ +DH ^_Z*^ /^'!?_5ZG[?\
M_P"'>_\ N2C_ (<%_P#5ZG[?_P#X=[_[DH ^_P"BO@#_ (<%_P#5ZG[?_P#X
M=[_[DH_X<%_]7J?M_P#_ (=[_P"Y* /O^BO@#_AP7_U>I^W_ /\ AWO_ +DH
M_P"'!?\ U>I^W_\ ^'>_^Y* /O\ HKX _P"'!?\ U>I^W_\ ^'>_^Y*/^'!?
M_5ZG[?\ _P"'>_\ N2@#[_HKX _X<%_]7J?M_P#_ (=[_P"Y*/\ AP7_ -7J
M?M__ /AWO_N2@#[_ **^ /\ AP7_ -7J?M__ /AWO_N2C_AP7_U>I^W_ /\
MAWO_ +DH ^_Z*^ /^'!?_5ZG[?\ _P"'>_\ N2C_ (<%_P#5ZG[?_P#X=[_[
MDH ^_P"BO@#_ (<%_P#5ZG[?_P#X=[_[DH_X<%_]7J?M_P#_ (=[_P"Y* /O
M^BO@#_AP7_U>I^W_ /\ AWO_ +DH_P"'!?\ U>I^W_\ ^'>_^Y* /O\ HKX
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M .KU/V__ /P[W_W)1_PX+_ZO4_;_ /\ P[W_ -R4 ??]%? '_#@O_J]3]O\
M_P##O?\ W)1_PX+_ .KU/V__ /P[W_W)0!]_T5\ ?\."_P#J]3]O_P#\.]_]
MR4?\."_^KU/V_P#_ ,.]_P#<E 'W_17P!_PX+_ZO4_;_ /\ P[W_ -R4?\."
M_P#J]3]O_P#\.]_]R4 ??]%? '_#@O\ ZO4_;_\ _#O?_<E'_#@O_J]3]O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L;XB^ -)^*_P^UWPM
MKUJU[H?B73KC2M1MUGD@:>VGC:*5!)&RNA9&8;D96&<@@@&MFB@#XSTW_@WY
M_9+T:R2VL_AGJUK;QYV10^./$$:+DY. +[ R23^->@_&?_@DY\ ?V@]"\(:=
MXN\"SZI;^ ]%A\.Z&Z>(=4M;BTT^)0J0--#<I+*N ,F5G9B 22>:^BZ*T]M/
M>[^\T]M4O?F?WG"_L\_LS> ?V3OAU#X3^''A/1O!_A^%S+]DT^#9YTA !DD<
MY>60@ %W9F(4#. *VOBE\*?#/QN\!:EX6\8:#I7B;P[K$7DWFG:C;+<6]PN0
M1N1@1D$ @]5(!!! -=!14<SO<CF;=^I\M?##_@BI^S!\'OB)I?BK0OA1IL>L
M:'.+K3C>ZIJ&H6MA*#E7AMKB>2"-@0""J @@$8(%>I_M2?L4?"S]M/PW8:7\
M3O!NF^*;?29C/832/+;7E@Y&&,-S"Z319P,A' .U<YP,>I44_:2;NV6ZDV^9
MMW/,/V6_V,?A?^Q7X1O-#^&/@_3_  K8ZE<?:KYXI);BZOY><//<3.\TI&3@
MN[8R<8R:]/HHI.3;NR)2;=V%? '_  46_P"4Y'_!.S_KK\1O_3!!7W_7P!_P
M46_Y3D?\$[/^NOQ&_P#3!!2$??\ 1110 4444 %?,'_!1?\ 9^\?>,/$WPF^
M+7PMTW3?$GCSX(ZU=ZE;>';Z[%G'X@L[VT>TN[9)V^2*;RV#(S_*"ISVS]/U
M\,_\%CM#\2_%WXD?L\_"KP7\1OB%\+_$WQ)\37UL-:\->(+C2XX+&UL_M=V9
M8X60W$NR)5A5F"JTCGG.*TI?$:T?C_KMJ?-_[&W[)_[0_P =/!G@/X3^-OA+
M<?"SX:>#_B=<_$;Q'K>L:K!+>ZTR:C->VNFVMO"2P4R.@DF) (&488P_Z[#@
M5^2_[=W_  3Q\9_L;W7PO\3Z9^UQ^UMJ7A/6_&.F^%O$%I>_$*62^C^W2&**
MZMGV"(B.787ADB?>FX!UKZ^_X)8_&GQMXT\/?%3X??$+7W\8>)/@QXWNO"B>
M(I($AFURR$4,]M/.JX43[)MK[1CY <L236U;WESK8WQ"YUSIJWS/JJBBBN4X
MPHHHH **** "BBB@ HHK'^(?C:U^&O@#7/$=]'<36/A_3[C4KA(%#2O'#&TC
M! Q +$*< D#/<=:<8MNR'&+;LC8HKX%/_!Q=\$@?^17^*G_@ML/_ ),H_P"(
MB_X)?]"O\5/_  6V'_R97I_V+CO^?3/5_L',/^?3/OJBN?\ A+\2;'XR?"SP
MWXNTN&[M]-\4:7;:M:1W2JL\<4\2RHKA690P5@" Q&<X)ZUT%>;*+B^5[GER
MBXOE>X4445)(4444 %%%% !1110 4444 %%%% !17S3_ ,$X/^"A_P#P\$\/
M>*K_ /X0_P#X1'_A&;R*U\O^U?M_VG>K-NSY,6W&WI@YS6;X9_;N\>:Y_P %
M%KSX/3?"W4+3PC;B4#Q&ZS#"I TBW!.SRS%(X$:@'.6').17;++Z\9SIR5G!
M7>JV^_7Y'=++<1&I.E)6<%=ZK;[]?D?5%%<U\2?C-X/^#5G:W'C#Q9X:\*6]
MZYCMY=8U."Q2=@,E4,K*&(!!(%=*K;AD<@\@CO7)RM*[6AQN+2NUHPHHHJ20
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_,WXH:XWB7XCZ[J#L6
M:\OYI<GW<FOTRK\N=;1HM9NE;[RS.#]<FOH,A7O3?I^I^D>'<5[2O+K:/XW_
M ,BK1117TA^H!1110 4444 %%%% !1110 J.T;JRDJRG((/(-?ISX"U@^(?!
M&CW[<F\LXIB?]Y ?ZU^8M?I/\#D:+X->%5?[RZ3; _7REKP,^7N0?FS\Z\0X
MKV-&76[_ "7^1U-%%%?-'Y8%%%% !1110 4444 %%%% !1110 4444 %%%%
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M"M+,W/$XQVI4]^EWN]>B2U?JCZS?_@KM"+K:O@&4PY^^=: ;'^[Y&/UKV?\
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M'^@^/[>:;0=:TG6H;=@DKV%Y'<K&Q&0&*$@''8U^5/[2'_)Q'CW_ +&/4/\
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M^"L^L? =]-\,CPAI]@EU'>+;S_VDS'3X;D@OYWEXWR,.(Q\H'?D^&_\ !M\
MOPY^*07[O]K6F/\ OU)3O#7_ "L?>)O^P1'_ .F:UKKQE&%3'XKG5[0;7DTH
MZG9C:-.IF.+YU>T&UY-*.IX]_P %UO&OQJUW7+/3_'?A'P[HOP]T_7KQ?"FJ
M6<RM=:G'@ &91<R$'RPIYBCY)X[#[8_9&^+G[7'BWXO6%C\6OA=X%\+^!VMI
M6GU#3+N.2Y20)^Z "W\QP6X/[L_45X9_P<C?\D<^&O\ V%[O_P!$I7Z1V?\
MQYP_[@_E7/C,4O[/HKV<=>=;/2S6JUW>[WU.;&8Q?V;07LXZ\ZV>EFM5KN]W
MOJ?'_P ;/^"@WC/X;_\ !3[P5\%;'3/#$OA7Q);P2W-U/;3MJ"%TF8['681@
M9C7&8SU/X?8E?F/^UXC:7_P7S^$<UPI@ANK&S,3N-JR96ZC&#WRX*_48K].*
M\_,J,(4Z+@K<T$WYN[/.S.C3ITZ#@K<T$WYN[/D3]E#]OOQC\=?^"@WQ7^$^
MKZ;X9M_#O@47?V"XL[>=+V;RKJ.%?-9IF0Y5B3M1><=!Q6!_P47_ ."HVO?L
M+?M0>"O#G]EZ'?>#=6TK^T]6DEMII-1XEF39 RRK&I;RU WHP!8DG'3RG_@F
M]=Q7O_!9W]HJ2&1)8S_:8#(<@D:C$#S]15/_ (*R>%;#QQ_P5?\ V>=)U2WC
MO--U!=.AN8'&4GC.IR[D8=U(X(]":]6.#P_UY4Y1]WDNUY\M_O/8IX+#_P!H
M*G.'N^SNUY\M[^I]!?L;_M<_M!_M-_%;3]3UOX0:;X*^$.I6\MQ#J%W.6U)@
M4W0$!I49E;CYA;X(.00.:S_VS?\ @JI=?";XSQ_"CX2>#;CXF?$S_EZMX]S6
MFGG;NV,(_FD=5Y<914'5LY ^RE78H Z#@5^*7[ WQ _:&T?]HSXPZW\)_ /@
M_P <^++S46&OSZ]=(ES9;[B9ML>^\@)5Y Q8C?S&F2.,\^!HT<3*I7<(Q4$K
M1NTFV]&VW_E?0Y<OHT,5*I7<(QC!*T;M)MNR<FW]^U]#Z9\1?\%*_P!J;]F2
M.W\0?&;X"Z/%X)8J;JZT"5O-M$8X#.ZW-PB')'RR!,G RI(-?=7P3^,OA_\
M:#^%>B^,O"]Y]NT/7K<7%M*5VL.2K(P_A=6#*P[%2*^'?&7Q6_;X\?\ A'5-
M#U;X!_"FZTS6+66RNX7OH"LL4BE&4YU7N":](_X(P_L[?%#]EW]G_P 1>%OB
M5H0T%SKCWVEP_;[>[/E211AP##+(JKO0D X.68\YI8_#T7A_:^Y&::TA*Z:?
ME=V:%F&&H/#>U]R,TUI"5TT_*[::/L2BBBOGSYP**** "BBB@ HHHH ****
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MS6?[6_9+\.QX;=8RW5NQ./F_TB1AC_@+ ?A7M]>%_P#!./29-,_9.T&20_\
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M<>)-8M]/M;ZZCCB=+*-TBPBA00&9CG ]:^^/V#O#<^N_L8:9I.L0R+9:@E[
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M>!79EU3&>UJ/$W45WV^7E8]KA?%9T\9B7FMXTU=IM))._P!E]5;KJOF?<W[
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M45\R?E(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M"I.2>>@'K_\ PT'_ ,%"/^B%_"O_ ,#X?_EM7WU17K5<X]I-U*E&#;W=G_\
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M(?M8?\$X/B5X)_:1OOC5^SCXDM=#\5:T6;6M%NG6.WU!F(+LI<&-A(PW,DF
M&^96!P!]WT5RX7&5,/+FA;71IJZ:[-''@\94PTW*G;56::NFNS1^>NJ^(/\
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M@B39_P LCDD;> >P&#G.^('_  3'^(WAG4Y$T6/3?$MGUCEANDMI,9_B24J
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MS@$+"PR V.&[5QY7*&"Q-2G7DET/#X1J8?(LTQ.&S"HHV22?1ZW_ ":9]:_
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MOX4TWP7\+_AA&_P^\/20W<[6^I7L6)-5U!GF=LJAQ"K!C&4R>H)K[OUSXB^
M/VP/ /B;P3X.^+.FMJ&J:;)#-?>"_$=I+J^E1OA//B9#)Y; L '*D D=\50_
M8?\ V/M%_9 _8V\(?"F.WM=0M])TK[/J[RQ*\>JW4P+WDLBG(82RO(<-GY6
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M\1O_ $P05B<X?\;3O^K /_+NH_XVG?\ 5@'_ )=U??\ 10!\ ?\ &T[_ *L
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ML_E>1C=\^_S,\;:^GJ*Q.<^ /^-IW_5@'_EW4?\ &T[_ *L _P#+NK[_ **
M/@#_ (VG?]6 ?^7=1_QM._ZL _\ +NK[_HH ^ /^-IW_ %8!_P"7=1_QM._Z
ML _\NZOO^B@#X _XVG?]6 ?^7=1_QM._ZL _\NZOO^B@#X _XVG?]6 ?^7=1
M_P ;3O\ JP#_ ,NZOO\ HH ^ /\ C:=_U8!_Y=U'_&T[_JP#_P NZOO^B@#X
M _XVG?\ 5@'_ )=U'_&T[_JP#_R[J^_Z* /@#_C:=_U8!_Y=U'_&T[_JP#_R
M[J^_Z* /@#_C:=_U8!_Y=U'_ !M._P"K /\ R[J^_P"B@#X _P"-IW_5@'_E
MW4?\;3O^K /_ "[J^_Z* /@#_C:=_P!6 ?\ EW4?\;3O^K /_+NK[_HH ^ /
M^-IW_5@'_EW4?\;3O^K /_+NK[_HH ^ /^-IW_5@'_EW4?\ &T[_ *L _P#+
MNK[_ ** /@#_ (VG?]6 ?^7=1_QM._ZL _\ +NK[_HH ^ /^-IW_ %8!_P"7
M=1_QM._ZL _\NZOO^B@#X _XVG?]6 ?^7=1_QM._ZL _\NZOO^B@#X _XVG?
M]6 ?^7=1_P ;3O\ JP#_ ,NZOO\ HH ^ /\ C:=_U8!_Y=U'_&T[_JP#_P N
MZOO^B@#X _XVG?\ 5@'_ )=U'_&T[_JP#_R[J^_Z* /@#_C:=_U8!_Y=U'_&
MT[_JP#_R[J^_Z* /@#_C:=_U8!_Y=U'_ !M._P"K /\ R[J^_P"B@#X _P"-
MIW_5@'_EW4?\;3O^K /_ "[J^_Z* /@#_C:=_P!6 ?\ EW4?\;3O^K /_+NK
M[_HH ^ /^-IW_5@'_EW4?\;3O^K /_+NK[_HH ^ /^-IW_5@'_EW4?\ &T[_
M *L _P#+NK[_ ** /@#_ (VG?]6 ?^7=1_QM._ZL _\ +NK[_HH ^ /^-IW_
M %8!_P"7=1_QM._ZL _\NZOO^B@#X _XVG?]6 ?^7=1_QM._ZL _\NZOO^B@
M#X _XVG?]6 ?^7=1_P ;3O\ JP#_ ,NZOO\ HH ^ /\ C:=_U8!_Y=U'_&T[
M_JP#_P NZOO^B@#X _XVG?\ 5@'_ )=U'_&T[_JP#_R[J^_Z* /@#_C:=_U8
M!_Y=U'_&T[_JP#_R[J^_Z* /@#_C:=_U8!_Y=U'_ !M._P"K /\ R[J^_P"B
M@#X _P"-IW_5@'_EW4?\;3O^K /_ "[J^_Z* /@#_C:=_P!6 ?\ EW4?\;3O
M^K /_+NK[_HH ^ /^-IW_5@'_EW5Q>N?LG?M^?%SQ_#J7CJR_8KBM64BYD\,
MWOB6SO)3V8^?#+&Y'H0I/]X=_P!,Z*UHUITI<]-V9V8''5\)55;#RY9+^K/N
MC\H_B1\&_C-\)M0-OKFE^$[5<X2<"Y:"7_=<<'^=<Q_Q<+_J3/\ R9K]?=1T
MRWUBRDMKRWANK>4;7BFC$B./0@\&O)_&7[#_ ,/_ !=-)-'I]SH\TG):PG,:
MY]D8,@^@ KZ"AGD6K5H_<?H^7^(%*2Y<;!I]XZK[GJOQ/S5NKWQQ81;KP^%%
MMV.UC +CS.?3/&?K69F^_P"G3_QZOI?]L7]F+3O@S?Z/:Z?K%Y=B^629EGB7
M=&%("\KC.<GL.E>*IX&4?>N6/T3']:^@PN(IU*:G%Z,_2LIS+#5\,L12>DO)
M^AR7^G?].G_CU2VMGJE[)MBCMG;V#5V5OX0LX3\PDE_WF_PK2A@2W3;&BHOH
MHQ6SJKH=L\=%?"CA)/"_BVUNEDLT\-,J]KIYF.?HH _4U:_XN%_U)G_DS79T
M5E*3>YP5*DIN\CC/^+A?]29_Y,T?\7"_ZDS_ ,F:[.BI(.,_XN%_U)G_ ),T
M?\7"_P"I,_\ )FNSHH XS_BX7_4F?^3-3:??_$C2K^&ZMY/!L5Q;NLD;K]IR
MC Y!_.NMHH!ZZ,] \*^.?^"F'Q)T6/6O#+_L)OH-ZS-9'44\5)>",,0!,L99
M!(,?,%)&<XXK1_XVG?\ 5@'_ )=U>^_\$[?$S:G\)]0TV0Y_LR_;9[(ZAO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M$R/VVM>_;"_9>U;QYXWM_#^CW&E:M=6DG]F0RPVT=O##%(78222-D;VR=V,
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M/,_L7_M]^,?VB_VX/C)\--;TWPS:Z#\/+V\MM.GL;>>.[F6&]:W4S,\SHQ*
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MDF_*^YAALKKUJ?M5:,=KR:2;[*^Y^BM%?*/[ G_!473/VN?%&H>!_%'AVZ\
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M_F>I1R=PH5JM6TE&.C4KI.Z[/>W<_4ZBBBO!/G0HHHH **** "BBB@ HHHH
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M??=R0$4#G  &!7OEI=Q7]K'/!)'-!,@DCDC8,LBD9!!'!!'.17R!_P $Y_\
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M#Y98X)(%CX<_M@_"3XP^,I/#OA'XI?#GQ5X@A#%]+TCQ)9WUXFT$MF&*1G&
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M+2I]J#!WC&S#$&MJ,;NVGS_X=&U"/,[67?5VV^:&_LD:9\6?V<?B;:R^$O\
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M_!4O0]#\2_\ !93X#Z?XC6WDT6ZTS2H[E+AML4H.IWNU&[;6;:"#P<XKV?\
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M+TW='JVH17<+7NHH(F56'E7$WS[]K86.,'H<#I@_M!?L;_$CQO\ \%??A_\
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M%'&4(8JE",TU3@X\VR;L]F^BV1]O00+;0)'&JK'&H55 P !TK\T+"QA\*_\
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M90KW$A8O(^T<+N=F('. <9/6J7[7/P_\??%#X$:OHGPT\46G@_Q9>&,VVIW
M?$2JX9E#("R%L8W!6P"1CG(\&+C'$WHRLE+1OIKHV?/1<8XI.C*R4M&^BOHV
M?%'P@\*?ML?L#> +?PEHOA'P+\4/!N@[H[+R;A1<Q1%RV$_>0RMRQX9'(SQP
M*]P_8>_X*AQ_M.?%K5?AKXR\$ZI\.?B-H\+32Z;=2&2.X"$;PI9$9& 96VL#
ME3D,<5Y/HWCK_@H=X M&TJ3P1\//&GRB-=6N;FS1UZC> MW!D]_FB/3IU%=1
M^P/_ ,$^_B5X>_:?UWX\?&[6-/N/'>L0-;V^G:>RO';!D2/=(RC8-L:+&J(2
M O)8GI[F*C1G3G/$.GS6T<'JWYK;UND>_BXT)TJE3$NGS6T<'JY>:VL^K:1Y
MKJG_ "L<6O\ V"A_Z9J_2RO@O]O;]AGXNP?MD:'\?O@<-)U7Q-96Z6][I-_.
MD/FLL1AR#(R(T;Q':REU8$ @\_+[A^Q#XJ_:-\7ZGXAN_CIX9\'^%K-HX%TF
MST>X621'!?S2VV:<$,-AR9>".!R<<N81A6HTZT)Q]V"BU?WKKR.+,HPKT*5>
MG./NPC%J_O73[?,^._\ @C/X6L=2_P""B?Q\U:>VCEOM+GN8K65E!:$2WTF_
M:>Q.Q1D=LCO7Z+?M"_''1_V;/@MXB\<Z\)FTKP[:FYE2$9DF)8(D:YXW,[*H
MSQEN:^1_^"87[&_Q(_9X_:T^-'B;QCX<_L?0_%ERTFE7/]H6MQ]J4W4T@.R*
M1G3Y64_.%Z^M?4O[6G[/MK^U3^SEXL\ 7ETUC'XCM!%'<A=WD3(ZRQ.1W421
MH2.,@$9'6C-*E*ICDY2O"T4VM=+*_P"H9M6HU<?%RE>%H)M.^EE?;YGQ5\._
M^"A_[87[3VBMXF^%OP+\'2>$;AV%G/J]P5>=0Q7*R2WEL),%2"43&1BO!OBK
MXS^-7B/_ (*H_ K4_C1X-\->"/%#WNGV]K%HLB2I=6AO)%WN5N;@;LM(O+ X
M XZ&O9_@EX!_;L_8V\&P_#WPMX4^'_C3PQI1DM]-U&ZN[?;:QL[-N3-S;RD9
M8D"1&(Z8P,5A:I_P3S_:6\5_MR?"KXG>.Y+'QE-:ZC97^M7-C?6T%GX>ABN-
MWV6..1T=]B#>3&A!9S@L<L?:HRP]*I/E]FHVDDTVY/32]W]]_D>[1GAJ52?*
MZ48\LE%IMR>FE[O3SNO)'N__  7L_P"4?][_ -ARR_\ :E>\?L$?\F/?!_\
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M>%PM>,ZL7*4=$G?9_=?LM]S]#****^</F HHHH **** "BBB@ HHHH ****
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M[',/[6F@>%[C3_%&J> _''P_UA=?\*^)=/MXKJ72KL1O$P>"4%)X9(W97B;
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MR?M:W'PQ\0?M*?L]^%?&UCKLWC#4O$E]K'@FZT^1H8[2\L-/EFG%Q(KJWE/
MS IAE<@!ABM*?Q7-*7Q7]?R/SA^"'Q3_ &DM/^%_PU^+GBK]I_Q9JW@^_P#B
MU_P@.OZ+'H.GQ2+"-2DLHKA9!&Q96>-/,C"JP25BKY4!OV>'2OSU_:G_ &$_
M@5^QC\9_"WQ@UVX^*FHZ/XB^)^G7-KX)M_$*MX3T_P 0W]P575QI[@?O$D)<
M['8C^%,# _0H'(K2M)2LU^1KB)*5I1_*P445\P_MK?\ !9;]FW_@G;\4-/\
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M $5\ ?\ $4;^PG_T7+_RS/$'_P @T?\ $4;^PG_T7+_RS/$'_P @T ??]%?
M'_$4;^PG_P!%R_\ +,\0?_(-'_$4;^PG_P!%R_\ +,\0?_(- 'W_ $5\ ?\
M$4;^PG_T7+_RS/$'_P @T?\ $4;^PG_T7+_RS/$'_P @T ??]%? '_$4;^PG
M_P!%R_\ +,\0?_(-?1W[$7_!2'X+_P#!1OPSK6L?!GQG_P )EIOAVZ6SU";^
MR+[3_L\K('5=MW#$S94@Y4$>] 'N-%%% !1110 4444 %%%% !1110 4444
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MO_M"?'GPW^S=X*_X2/78[BZO+B5--TG3K"#[1JFN7DI_=65I$/FDED8<+D*
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-)K>^UK0/LEN9TOX[F**-S$S;D*NH7".!D@%/HOX!W7[5,OQ?9?BC8_L_0>
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M9Y4A3=YGEQYSC.-O'O7LE56I3I3=.:LUHRJU&=*HZ516:=GZA11169F%%%%
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M"QO8#NANHMZGRYHV.4D7#*>017)I^R'\)H_B<WC9?A?\.U\9M)YQUX>&[/\
MM0O_ 'OM/E^;N]]V:]$HI\S*YFMC&\;_  Y\/?$W3;:S\2:#HWB"SL[N'4+>
M#4K*.[C@N86WQ3HLBD+(C ,KCYE(R"#2ZQ\._#_B+QAHOB+4-"T>^\0>&UN$
MTG4[BRCEO-+6X55G$$K*7B$JH@<(1O"J#D 5L44KDW9!JFEVVMZ9<65[;P7E
MG>1-!/!/&)(IXV!5D93PRD$@@\$&N*\ ?LL?#'X4>'=:T?PM\./ ?AK2?$D;
M1:O9:5X?M+.WU1&5E99XXXU64%68$.""&([FN\HHNQ\SV*/ACPQIO@GPUI^B
MZ+I]CI&CZ1;1V5C8V4"V]M901J$CBBC0!4C15"JJ@     "JOA#X=^'_ (?2
M:LV@Z%H^AMK^H2:OJC:?91VQU*]D"K)=3;%'F3.J(&D;+$(H).!6Q10*YC>.
M_ASX>^*6@C2_$V@Z-XCTM9XKH6>J64=Y;B:)Q)%)LD4KO1U5E;&58 C!%+KG
MP[\/^)_%>AZ]J6A:/J&N>&6F?1]1N;*.:[TEIHS%,;>5E+PF2,E&*$;E.#D<
M5L447879C_$#X=^'_BQX/OO#OBK0M'\3>']34)>:9JME'>6=VH8,!)%(K(X#
M*I 8'! /45L444 <G\7?@)X%_:!T2#3/'G@OPGXVTVUD\Z&TU_2+?4H(GZ;U
M29&4-[@9J8_!;P:Q\-Y\)>&?^*,<R>'_ /B5P?\ $B8H8RUK\O[@E"4)CV_*
M2.G%=-13YF/F>QE>./ FA_$WPG?:!XDT;2O$.A:I%Y-[IVIVD=W:7<?79)%(
M"CKP.&!'%6;SP[I^H:#)I5Q8V<^ER0?9GLY(%:W>+&WRRA&TKCC;C&.*N44A
M7//?A9^R3\*?@9X@N-6\$_#+X>^#M5NP1/>Z'X=L]/N)@<YW20QJS9R>I[UZ
M%110VWN-R;W,+XC?"[PS\8?"\NA^+O#NA>*=%G8/)I^KV$5]:R$9P3'*K*2,
MGJ.]97PA_9S^'O[/MI<6_@+P'X-\$07F//CT#1+;34GP21N$**&P2>OJ:[*B
MGS.U@YG:QBZK\-_#NN^-=)\2WV@Z+>>(M!CFATS59[&*2]TY)@%E2&8J7C5P
M &"D!@!G-<S\6_V3_A9\?K^.Z\>?#3X?^-KJ$ 1S:]X>M-2DC R!AIHV(P">
MGK7H%%',T/F:V,'PI\+?#'@/P<?#NA^'-!T7P^R/&=,L=/BM[,JXPR^2BA,,
M.",<BK7@GP-HOPT\)V&@^&]'TOP_H>EQ""RT[3;2.UM+.,=$CBC 1%'HH K4
MHI7)NPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "O@#_@HM_P IR/\ @G9_UU^(W_I@@K[_ *^ /^"BW_*<C_@G
M9_UU^(W_ *8(* /O^BBB@ HHHH *^'_^"PW]DZS\2?V;/#_Q$N([7X%Z_P".
M)HO&QNI3#I]S/'92R:7;WCY"?9WNE&Y)#L8JN>E?<%>"Z+\;? _[;/Q8^,7P
M7U/P3_PD_ACX?_8M-UZ\U6V@N-'U&]N(S.]FD;$LSP+Y+,VW 9^JE5+:4W9\
MQI2=I<W;_AC\QO@7XT\-Z5^R9^SKX/\ !>H6$7Q4M_VB;VX\,:1I<ZK-;::N
MK7B7TCPQGY;(69D5R1MVD8Z''[9CI7Y?_LJ^-O!O["?[3'AFVO/V'I/@+I_Q
M$\1+X1LO')UJTU,_;+GS#;P #,L4<[QA0JLJ@E1@X K]0*TQ#N_Z_0VQ4KO_
M (;] HHHKG.4**** "BBB@ HHHH *\1_X*3?\F%_%?\ [%VY_P#0:]NKQ'_@
MI-_R87\5_P#L7;G_ -!KIP?^\0_Q+\SJP/\ O-/_ !+\T?G;_P $YOV_OB!X
M _9AT+X5_!?X9S_$#QQ;W-WJ&HW%R'73]+CEG?RP^&0$L,'<TB*,XRQSM]HU
M3_@K)\=_V3_&&F0_M$?!:QT/P[J4RP_VIH#,R0YY.UO/GAD8+D^7YBL<'TQ7
M:?\ !OWH.BV'[#,E]I\=O_:FH:]=C595 ,AD38(T8]<"(H0O0;R?XC7N7_!2
MWP_H'B/]@WXIQ^)%@-C;^'[FZMVEQ\EY&A>U(..&,XC QUW8[U[^,Q&&>/E0
ME133E9N[YKM[K6WHK'T>-Q.%>82P\Z*:<K-W?-=O=:V]%8X#_@H5^W/XP^ 7
M[,'ACXM?"6V\)^+?"FH3Q'4)M0M[B8"VG"^1-&8Y8]@W?(V\,0TB# ((/T1\
M$OBUI?QW^$7ASQEHT@?3?$EA%?PC=DQ[U!*-_M*<J1V*D5\:_P#!([X<+^T9
M_P $F;KP5XH\Z;1=9FU/2K=I%W&&%G)5X\]TF9F7T9?:N>_X(M_'>Z^"=G\3
MO@3X^NUL=1^%=W=ZC TK%HXK-7(N@I_YYI)^]! Y%P2,BN7$8&FJ-2G37OTI
M:]W%NWWIG'BLOIJC4I4U[]&3N^KBW:_JG^9Z]^W?^WIXP^"O[1WPS^$OPQTS
MP[K'C+QQ,'O?[7MYKB'3[5WV))MAEC;@).[9/"19P<\?6D(<1+YA5I,#<5&
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M_"W_  47_:X_:)TQO%'PN^ /A_\ X0N0--:RZS,WGW<(/#1N]S;B0G!_U<;
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MG@%0!\QX7KWIW[5O_*?SX5?]>5I_Z*NJ[\-3IX7'5Z$(II1;5[O[*=M]M?\
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MX7JG[=?[;7A'P\/%6K?L]>&V\+JAGDM[996U&.(<DM&MV\J8 /+0#'7%<O\
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MBOD3\9"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MA9):N/OKR6CVZ:E'_@W#T2XMOA/\3+[R9!87&M06\,Q'RR-'"2P![D"1"?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M%%%<!\Z%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M ).H ^_Z*^ /^(7']A/_ *(;_P"7GX@_^3J/^(7']A/_ *(;_P"7GX@_^3J
M/O\ HKX _P"(7']A/_HAO_EY^(/_ ).H_P"(7']A/_HAO_EY^(/_ ).H ^_Z
M*^ /^(7']A/_ *(;_P"7GX@_^3J/^(7']A/_ *(;_P"7GX@_^3J /O\ HKX
M_P"(7']A/_HAO_EY^(/_ ).H_P"(7']A/_HAO_EY^(/_ ).H ^_Z*^ /^(7'
M]A/_ *(;_P"7GX@_^3J/^(7']A/_ *(;_P"7GX@_^3J /O\ HKX _P"(7']A
M/_HAO_EY^(/_ ).H_P"(7']A/_HAO_EY^(/_ ).H ^_Z*^ /^(7']A/_ *(;
M_P"7GX@_^3J/^(7']A/_ *(;_P"7GX@_^3J /O\ HKX _P"(7']A/_HAO_EY
M^(/_ ).H_P"(7']A/_HAO_EY^(/_ ).H ^_Z*^ /^(7']A/_ *(;_P"7GX@_
M^3J/^(7']A/_ *(;_P"7GX@_^3J /O\ HKX _P"(7']A/_HAO_EY^(/_ ).H
M_P"(7']A/_HAO_EY^(/_ ).H ^_Z*^ /^(7']A/_ *(;_P"7GX@_^3J/^(7'
M]A/_ *(;_P"7GX@_^3J /O\ HKX _P"(7']A/_HAO_EY^(/_ ).H_P"(7']A
M/_HAO_EY^(/_ ).H ^_Z*^ /^(7']A/_ *(;_P"7GX@_^3J/^(7']A/_ *(;
M_P"7GX@_^3J /O\ HKX _P"(7']A/_HAO_EY^(/_ ).H_P"(7']A/_HAO_EY
M^(/_ ).H ^_Z*^ /^(7']A/_ *(;_P"7GX@_^3J/^(7']A/_ *(;_P"7GX@_
M^3J /O\ HKX _P"(7']A/_HAO_EY^(/_ ).H_P"(7']A/_HAO_EY^(/_ ).H
M ^_Z*^ /^(7']A/_ *(;_P"7GX@_^3J/^(7']A/_ *(;_P"7GX@_^3J /O\
MHKX _P"(7']A/_HAO_EY^(/_ ).H_P"(7']A/_HAO_EY^(/_ ).H ^_Z*^ /
M^(7']A/_ *(;_P"7GX@_^3J/^(7']A/_ *(;_P"7GX@_^3J /O\ HKX _P"(
M7']A/_HAO_EY^(/_ ).H_P"(7']A/_HAO_EY^(/_ ).H ^_Z*^ /^(7']A/_
M *(;_P"7GX@_^3J/^(7']A/_ *(;_P"7GX@_^3J /O\ HKX _P"(7']A/_HA
MO_EY^(/_ ).H_P"(7']A/_HAO_EY^(/_ ).H ^_Z*^ /^(7']A/_ *(;_P"7
MGX@_^3J/^(7']A/_ *(;_P"7GX@_^3J /O\ HKX _P"(7']A/_HAO_EY^(/_
M ).H_P"(7']A/_HAO_EY^(/_ ).H ^_Z*^ /^(7']A/_ *(;_P"7GX@_^3J/
M^(7']A/_ *(;_P"7GX@_^3J /O\ HKX _P"(7']A/_HAO_EY^(/_ ).H_P"(
M7']A/_HAO_EY^(/_ ).H ^_Z*^ /^(7']A/_ *(;_P"7GX@_^3J/^(7']A/_
M *(;_P"7GX@_^3J /O\ HKX _P"(7']A/_HAO_EY^(/_ ).H_P"(7']A/_HA
MO_EY^(/_ ).H ^_Z*^ /^(7']A/_ *(;_P"7GX@_^3J/^(7']A/_ *(;_P"7
MGX@_^3J /O\ HKX _P"(7']A/_HAO_EY^(/_ ).H_P"(7']A/_HAO_EY^(/_
M ).H ^_Z*^ /^(7']A/_ *(;_P"7GX@_^3J/^(7']A/_ *(;_P"7GX@_^3J
M/O\ HKX _P"(7']A/_HAO_EY^(/_ ).H_P"(7']A/_HAO_EY^(/_ ).H ^_Z
M*^ /^(7']A/_ *(;_P"7GX@_^3J/^(7']A/_ *(;_P"7GX@_^3J /O\ HKX
M_P"(7']A/_HAO_EY^(/_ ).H_P"(7']A/_HAO_EY^(/_ ).H ^_Z*^ /^(7'
M]A/_ *(;_P"7GX@_^3J/^(7']A/_ *(;_P"7GX@_^3J /O\ HKX _P"(7']A
M/_HAO_EY^(/_ ).H_P"(7']A/_HAO_EY^(/_ ).H ^_Z*^ /^(7']A/_ *(;
M_P"7GX@_^3J/^(7']A/_ *(;_P"7GX@_^3J /O\ HKX _P"(7']A/_HAO_EY
M^(/_ ).H_P"(7']A/_HAO_EY^(/_ ).H ^_Z*^ /^(7']A/_ *(;_P"7GX@_
M^3J/^(7']A/_ *(;_P"7GX@_^3J /O\ HKX _P"(7']A/_HAO_EY^(/_ ).H
M_P"(7']A/_HAO_EY^(/_ ).H ^_Z*^ /^(7']A/_ *(;_P"7GX@_^3J/^(7'
M]A/_ *(;_P"7GX@_^3J /O\ HKX _P"(7']A/_HAO_EY^(/_ ).H_P"(7']A
M/_HAO_EY^(/_ ).H ^_Z*^ /^(7']A/_ *(;_P"7GX@_^3J/^(7']A/_ *(;
M_P"7GX@_^3J /O\ HKX _P"(7']A/_HAO_EY^(/_ ).H_P"(7']A/_HAO_EY
M^(/_ ).H ^B?VQOV9!\4M';Q!HL(_P"$@L4_>1J.;Z,=O]X#IZCBOB9T:-V5
M@593@@]J]0_XA<?V$_\ HAO_ )>?B#_Y.KI_%O\ P1#^#_@/X;P:;\,?#=UH
M?]EHWDV-UKVH7T<XZ[!)<SR.I[ ;MO/0=:]W+,S5->RJ[='V_P" ?H/"G%4<
M.E@\8_<^S+MY/R[/IZ;>#T$X%<[XI_9.T/P3J\EAJWANXT^\B.&CFN)U/U'S
M\CW%<]KOP>\*^'Q$]MI82YW;E8W$K;<=\%B*^GC[VQ^L4;5;<CNGU-?Q'KIU
M.;RXS^X0\?[1]:RZJ?V':_\ /+_QX_XT?V':_P#/+_QX_P"-=:5E9'NP@H+E
M1;HJI_8=K_SR_P#'C_C1_8=K_P \O_'C_C3*+=3:?82:E=+%&.3U/H/6H=+\
M$1ZK(-D&V/NY8X'ZUK7WP5\.:LJ?;+%[AD&,FYE7]%8"LY3L<U?$*"LMSH].
ML(]-M5BCZ#J?4^M3UQG_  SYX0_Z!'_DU-_\71_PSYX0_P"@1_Y-3?\ Q=<Y
MY+;;NSLZ[_\ 9X^.]]\"_&L=Y&6FTRZ(2^ML\2)_>'^T.H/X5X;_ ,,^>$/^
M@1_Y-3?_ !='_#/GA#_H$?\ DU-_\745*<:D7">S.?$X:GB*4J-97C+1H_73
MPOXEL_&/AZSU33YEGL[Z)9HG'=2,_G[=JOU^2_P$_P""-O[)G[7GQ,U3_A9O
MPHAU[Q)- LMM>KXCU:Q,B)A2A2WNHT8C(.2-Q&>2 ,>T_P#$+C^PG_T0W_R\
M_$'_ ,G5\/C,.Z%5TW\O0_ \ZRR6 Q<L/+9:I]T]OZ[GW_17P!_Q"X_L)_\
M1#?_ "\_$'_R=1_Q"X_L)_\ 1#?_ "\_$'_R=7,>4??]%? '_$+C^PG_ -$-
M_P#+S\0?_)U'_$+C^PG_ -$-_P#+S\0?_)U 'W_17P!_Q"X_L)_]$-_\O/Q!
M_P#)U'_$+C^PG_T0W_R\_$'_ ,G4 ??]%? '_$+C^PG_ -$-_P#+S\0?_)U'
M_$+C^PG_ -$-_P#+S\0?_)U 'W_17P!_Q"X_L)_]$-_\O/Q!_P#)U'_$+C^P
MG_T0W_R\_$'_ ,G4 ??]%? '_$+C^PG_ -$-_P#+S\0?_)U'_$+C^PG_ -$-
M_P#+S\0?_)U 'W_17P!_Q"X_L)_]$-_\O/Q!_P#)U'_$+C^PG_T0W_R\_$'_
M ,G4 ??]%? '_$+C^PG_ -$-_P#+S\0?_)U'_$+C^PG_ -$-_P#+S\0?_)U
M'W_17P!_Q"X_L)_]$-_\O/Q!_P#)U?1W[$7_  3>^"__  3D\,ZUH_P9\&?\
M(;IOB*Z6\U"'^U[[4?M$JH$5MUW-*RX4 84@>U 'N-%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#"\=_#/0?B;IOV37=+M=1A7.PR+\\>>ZL/F7\#7
MYS?M,?#'2_#WQCUK3="FN%L=.F^SHL[^80RCYQN '1LCG)XZU^FU?F+X\U1M
M;\;ZO>/]ZZO)93]6<FOH<AE/GEKHEMZGZ5X=UJZK5;3?+%+2^EV][?(\]F\'
MWD9^41R?[K?XTP>%;XG_ %(_[[7_ !KKZ*^G]JS]:^NU/(Y>#P7<R??>*/\
M')K2L?"%M:G=)NF;_:X7\JUJ*3J29G+%5)=1$4(H50%4<  =*6BBH.<****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7P!_P46_Y3D?\$[/^
MNOQ&_P#3!!7W_7P!_P %%O\ E.1_P3L_ZZ_$;_TP04 ??]%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@H ^_P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P#\-YI'_P CT?\ #IW]EG_HVG]G_P#\-YI'_P CT '_  ]B_99_Z.6_9_\
M_#AZ1_\ )%'_  ]B_99_Z.6_9_\ _#AZ1_\ )%'_  Z=_99_Z-I_9_\ _#>:
M1_\ (]'_  Z=_99_Z-I_9_\ _#>:1_\ (] !_P /8OV6?^CEOV?_ /PX>D?_
M "11_P /8OV6?^CEOV?_ /PX>D?_ "11_P .G?V6?^C:?V?_ /PWFD?_ "/1
M_P .G?V6?^C:?V?_ /PWFD?_ "/0 ?\ #V+]EG_HY;]G_P#\.'I'_P D4?\
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M_P#\-YI'_P CT?\ #IW]EG_HVG]G_P#\-YI'_P CT '_  ]B_99_Z.6_9_\
M_#AZ1_\ )%'_  ]B_99_Z.6_9_\ _#AZ1_\ )%'_  Z=_99_Z-I_9_\ _#>:
M1_\ (]'_  Z=_99_Z-I_9_\ _#>:1_\ (] !_P /8OV6?^CEOV?_ /PX>D?_
M "11_P /8OV6?^CEOV?_ /PX>D?_ "11_P .G?V6?^C:?V?_ /PWFD?_ "/1
M_P .G?V6?^C:?V?_ /PWFD?_ "/0 ?\ #V+]EG_HY;]G_P#\.'I'_P D4?\
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M_P#\-YI'_P CT?\ #IW]EG_HVG]G_P#\-YI'_P CT '_  ]B_99_Z.6_9_\
M_#AZ1_\ )%'_  ]B_99_Z.6_9_\ _#AZ1_\ )%'_  Z=_99_Z-I_9_\ _#>:
M1_\ (]'_  Z=_99_Z-I_9_\ _#>:1_\ (] !_P /8OV6?^CEOV?_ /PX>D?_
M "11_P /8OV6?^CEOV?_ /PX>D?_ "11_P .G?V6?^C:?V?_ /PWFD?_ "/1
M_P .G?V6?^C:?V?_ /PWFD?_ "/0 ?\ #V+]EG_HY;]G_P#\.'I'_P D4?\
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M_P#\-YI'_P CT?\ #IW]EG_HVG]G_P#\-YI'_P CT '_  ]B_99_Z.6_9_\
M_#AZ1_\ )%'_  ]B_99_Z.6_9_\ _#AZ1_\ )%'_  Z=_99_Z-I_9_\ _#>:
M1_\ (]'_  Z=_99_Z-I_9_\ _#>:1_\ (] !_P /8OV6?^CEOV?_ /PX>D?_
M "11_P /8OV6?^CEOV?_ /PX>D?_ "11_P .G?V6?^C:?V?_ /PWFD?_ "/1
M_P .G?V6?^C:?V?_ /PWFD?_ "/0 ?\ #V+]EG_HY;]G_P#\.'I'_P D4?\
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M_P#\-YI'_P CT?\ #IW]EG_HVG]G_P#\-YI'_P CT '_  ]B_99_Z.6_9_\
M_#AZ1_\ )%'_  ]B_99_Z.6_9_\ _#AZ1_\ )%'_  Z=_99_Z-I_9_\ _#>:
M1_\ (]'_  Z=_99_Z-I_9_\ _#>:1_\ (] !_P /8OV6?^CEOV?_ /PX>D?_
M "11_P /8OV6?^CEOV?_ /PX>D?_ "11_P .G?V6?^C:?V?_ /PWFD?_ "/1
M_P .G?V6?^C:?V?_ /PWFD?_ "/0 ?\ #V+]EG_HY;]G_P#\.'I'_P D4?\
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MB_99_P"CEOV?_P#PX>D?_)%'_#V+]EG_ *.6_9__ /#AZ1_\D4?\.G?V6?\
MHVG]G_\ \-YI'_R/1_PZ=_99_P"C:?V?_P#PWFD?_(] !_P]B_99_P"CEOV?
M_P#PX>D?_)%'_#V+]EG_ *.6_9__ /#AZ1_\D4?\.G?V6?\ HVG]G_\ \-YI
M'_R/1_PZ=_99_P"C:?V?_P#PWFD?_(] !_P]B_99_P"CEOV?_P#PX>D?_)%'
M_#V+]EG_ *.6_9__ /#AZ1_\D4?\.G?V6?\ HVG]G_\ \-YI'_R/1_PZ=_99
M_P"C:?V?_P#PWFD?_(] !_P]B_99_P"CEOV?_P#PX>D?_)%'_#V+]EG_ *.6
M_9__ /#AZ1_\D4?\.G?V6?\ HVG]G_\ \-YI'_R/1_PZ=_99_P"C:?V?_P#P
MWFD?_(] !_P]B_99_P"CEOV?_P#PX>D?_)%'_#V+]EG_ *.6_9__ /#AZ1_\
MD4?\.G?V6?\ HVG]G_\ \-YI'_R/1_PZ=_99_P"C:?V?_P#PWFD?_(] !_P]
MB_99_P"CEOV?_P#PX>D?_)%'_#V+]EG_ *.6_9__ /#AZ1_\D4?\.G?V6?\
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MQK%C%=,@!Q&[*"Z<_P!ULC\*Z&O.?V1?#UQX6_9G\%V=TNV;^S(YF7NHDS(
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MVY/@O\*+RW\,3:?XZ\,:OJNNWD=O,LD5U9+;X^S$RX2(M*^1(KM@+\PYS5^
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MB5,HN-K]290<;7ZZA1114DA1110 4444 %%%% !1110 4444 %%%% !1110
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M9CC8@9VQQJ$7( R0!TK]7J*])9^K\[I+F[_TK_B?40\1H*7MY8.'MOY[V?\
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M'P"_X)=_!CX=VNGZGXT\9:;\3M!\1^)9-'LI;O-Q-K!O;Z?;&I(@B:5AYA
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M<_\ !=3_ ),/7_L=?#/_ *=[:OL:BJC+EDF53ERR4NQ^:O\ P4N_96D_;/\
M^"K_ ,'_ (?S>+-;\)^']8^'&KGQ"^D,([S5-.6]MS)9+)_RS65O+#L <H'7
M'S5Z7_P3T^)NM_L3_$BU_9+^*5TDDVCVKR_"SQ/)&D$7C'18NEJVWY1?VJX5
MTX9T ?!P7?[?HK1UKQY7L:NM>/(UI^O<****Q, HHHH **** "BBB@ HHHH
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M_&M/B]JOB?2]/^'-Q\/-!TEH'EU#6_$=G=ZM+%*&4)!%8036NX%=S&5KI<$
M;#UIK4:5STJBO'/V,_C[XB^-_A[QMI_B^ST2W\5?#GQ7<^$]4N=%,HTW4Y(H
M+:Y6XMUE)DC4Q74:M&S.4D21=[  GV.B46G9CE%IV84444B0HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M&_?QO\0>)-;M?%6N:+X+\;>';K7[:$00^(%L[6\BAO5C4 +YL/E,0 !N+$
M@#4_8N\)_M'?L"? >P^"^C?L\^'?%DV@RW,5KX\M?&=CI^D:WYDTDBWM[ X-
M\LQ#@R*L<I8@[7P?ED_9P_8M^+G@G_@D9^T-\,_%6BVLWQ+\>-XX;3K>VNK:
M.'5Y=2CN!;2(?.:.%9GD!"RR QA@'(P35/EM\UV_I%2Y;;]5;5?DMCZH_86_
MY,C^#G_8CZ+_ .D$%>#_ +3?BKQ[^UQ^WJG[/_@[QYKWPS\%^#O"T/BKQQKG
MAUTBUS4)+J=X;/3K:X8-]E&V*25Y0I<C:HQUKZ-_90\$ZI\-/V6OAKX<UNU^
MQ:UX?\*Z7IM_;^8DGD7$-I%'(FY"5;:ZL,J2#C()'->&?M5_L]_%/X:?M>:7
M^T%\%-)T7QEK$_AT>$_%_@S4]1&F?V_8QSM<6T]I=,#'#=0R/(O[P;'1\9!&
M3C!KF?X&$&N=_.Q\N?\ !7/]DKQM^R_^SWX<G\.?%3XA>./AWJ_CCP];:_H?
MCG5WUVYL)1J=O);WEG>2C[0G[Q!$\+NT;"<, I09]1_X*>?MVZ/X6_;"\+_
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M)J&J7<S&6:[E.HVT$ES++(S/)*H(W,1QPH]BHHKFD[NYRR=W<****1(4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% 'FO[(G[+?A_]B_]G_1?AOX7O-8O]#T.>^N(
M)]5ECENW:[O9[R3<T<<:$"2X<+A!A0H.3DGTJBBFVV[L<I-N["BBBD(****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MOAW((]\=IKUU:0"6!E'_ "S620;T!W%882,&4FICAN:']Z_^1,,)S4]/BO\
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MNY<JP*LK \C(!'M]%+VDKWN'MIW3OL?'_P"T'_P11^%?[27[%OPZ^!6N:_\
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M50[GN0HR>U=C116.^IBW=W84444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MS7^W;[_G\NO^_K?XT?V[??\ /Y=?]_6_QH]DP]F>E45YK_;M]_S^77_?UO\
M&C^W;[_G\NO^_K?XT>R8>S/2J*\U_MV^_P"?RZ_[^M_C1_;M]_S^77_?UO\
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MW^-'LF'LSTJBO-?[=OO^?RZ_[^M_C1_;M]_S^77_ '];_&CV3#V9Z517FO\
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MRZ_[^M_C1_;M]_S^77_?UO\ &CV3#V9Z517FO]NWW_/Y=?\ ?UO\:/[=OO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7XI?\%2K[P%^QMJGB;POX9U[XB^.-'^&$_CZ\NK?2K2RTS1$-O=&TN-1MWU
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MA_9A\3:#>^$=8OM5N++P+X1\#>%=-U(7%@;)$,2>)YG#H&+F2224L2541K@
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M^''B;PQ\$?'VF7/@77=3U"";5+3PI<QVUG<V#6T5NUO'XH0W3J[$LXGM^""
M=I#%V!ZI\6/^"H^EV'P1U#7/ '@OQEXP\10^$]2\2SZ?':VD?_",+:-/ QU-
M9KN$@+=6\\31VS2RL;>;8&"[JL_LN_MC?$#]HW]IFY\-3>';'0?"?AOP=I&L
MZK=R6,<TFIWVH1O(@MY5O]UO"%7Y4DMI6;:^YXB$$GS1<?LT_%;PQX(N]/\
M!OPE^,>C:MXK\+ZCX7\8ZEJ6E>#-0&LQWMY>7TMQ;11^*H!:2K<ZC>LFYID"
MS!61BH:O??V)O"OC#X:_';4KG5/A'\6=$L?$^@Z-H<NI:PWAA++3/[+M9T$L
MGV/6[JX?SRX 6.!MC$9)7+J*X'U[1115%!1110 4444 %%%% !1110 4444
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MN"XTSQ1X@TBY_L]-5N%6R1KATB$:[0SR,!A0 QZ5K^"?^">/QWU?Q'I*6_\
MP4[O-4GN+B+981W?F2W1+ ^4%&H$DMTP >O2CFUL+F/V HK\2O\ @J+\3_CY
M\4/^"ZGA/]G_ .'/QW\:_"W2?%6B6H673[N9K6VE6TFG>4P)(FYG\K!^8=<\
MXK'_ &I/C'^UY_P0-^,OPSU_QO\ 'N;X^?#;QMJ#V6H6&K6S+.!&8_-"^8TD
MD;!) R.DN"PPRXX*YPYC]S:*^*?^"Y7_  4*F_89_P""=VK>(?#M[+8^./'
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M1D9BI(HLPU/E_1/^"JGCW5OA%X>U3^P_"\>N?$33-5T#P>DNG7MO'=^+-/\
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M2M:T_P 5:Q#H=M<V,=Q>^,]:N+Z^M+B7S9K.]NFNS/?6KMC-O=22PX"KL"@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \
MU_;&_:'M/V3/V6/'WQ(O8UFB\':+<:C'$QP)YE0B*,_[\A1?^!5_+%^QI\%-
M-_X*,?M/>-OBM^T%X^/A;X;:'<G7O''B.ZE_TB\EG=C%8VPP6:>8JX545BJ1
MMA> *_HJ_P""]OA34/&G_!(7XX6.EI(]TNC079"#)\J"]MYY3]!'&Y/MFOYE
MO^";O[!/CK_@I/\ M%Z7\,?"4EQ:Z;(XO]:U!PS6FCVJX5[AUS@O@[47@LQ
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M7_!3OPSXE\&:]?V?PW^.DFO>&9;:/4?"K^ [R/784N"XCF6%@$EB/EOEXI'
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M6/LL@^QFQ%S%/!&=Z6RCRIH@T9.6?Z\\-?LQ_#7P8OB4:/\ #WP/I(\9[_\
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ME\'^%E\0:M/:W5]J8TF#[9>S6JNMK)++LWN\*R2"-F)*!V"XR:.5@? GC_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MA3XP\)ZQ,)[?0?&NGW6GW&A_* 8X+RR#^;&2"V)82P)(WD4>8S3_ &5?V_\
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MK<O RRK TPE9'5@I# EW0'J=%%% !1110 4444 %%%% !1110 4444 %%%%
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MZO;PP03B"^ECM]16!2D/VB(';(44X!(Y  .0 !Y;\+O^"8VD^&/&EUJ7B3Q
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M)[:G>ZQ>1ZS%MFCFNK$6BVKPM^\$C1S?:%&TI&8Q@R5Y39?\$;/$^D?!+6/
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MX9&ASWGPY\9KK]U:ZI>2VD5W:R:3J6F3!)(X92)4743*BE-KF'86C#;U^?\
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4H **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>img152117643_2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img152117643_2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" 94!I\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *L:;JEQI,[26\GENR[2=H/'7O]*KT4 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 445@?$7XK^%_A!HBZGXM\2:!X7TUI!$
MMWJ^H0V,#.>BAY65<GTSFFDV[(-]C?HJKHVM6?B/2;>_T^[M;^QO(Q+!<V\J
MRPSH1D,K*2&4CH0<5:I %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 445S?Q%^,?A'X/V,=UXM\5>&_
M"]K+G9-J^IPV,;XZX:5E!II-NR#?8Z2BL'X??%3PO\6]';4?"GB30?$VGJVP
MW6DZA%>PAO3?&S#/MFMZAIIV8;;A1112 **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P!T!L="!TH_91_X*'?&[]C3]K^Q^"?[1E[_ &W8:K*D%KK$Y$LT!DXBF6<
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MS/UDHKX[_P""-/[?.L?MP? "_'BQH)O%WA&X2SOKF-!']N1E)CE*C@-P0VT
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?LN>"[SX=_&7X9Z%X+N+ /I-A>6,+3VL.YOE<G3)"3G/\;=>M?5/CSP=<_\
M!6K_ ()OS1ZIX?F\#ZMXHA-WIUK>,TAM)HG)A9F9$)5L#.%'7O7Q5^RI_P %
M&?B9_P $F/#,GPM^,WPP\17V@Z/,W]EWUN?+:%"QRL;L/*FC)Y4AE(R<^E=&
M'YGAW1@DYQ>SL_NN:4[^R]G%+F3V9V_[2/\ P3 _;8_:]\*6>A_$7XN?"?Q!
MI-C<?:H80C6OER8QNW0:9&QX/0G%?9WQ:^'5Y\(O^":VM^%[^ZAO+W0?!SV4
M\\6?+D=(=I*[L'''&0./2OE[3_\ @MQ\1/VGM:L-%^!?P+\1:E/>7")-JNK
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M^'[G  Z_+1C/][C_ -N_H/$?QE\CYU_X-W;>./\ X)_M(L:+))XCO0S!?F;
MCQD]\5P7_!S)_P FV_#O_L8Y/_29Z]!_X-XT9/\ @GRNY2N[Q'?$9'48CK@?
M^#EZUEG_ &:?A^T<<CK'XC?>54D+FW<#/ID\5K3_ .1G_P!O,N/^]_,^S/A_
M_P F*:/_ -B+%_Z0"OBW_@VG_P"2%?$3_L-0_P#HMJ^U/ ",/V%]'7:=W_"#
M1#&.<_8!7Q;_ ,&U431? KXB;E9?^)W$.1CI&V:PC_NU;U7YF:_A3]4>;_\
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M ()5_&[X>_&?]D+PZWP]TVST&TT:%;._TB$_-8W('S[N[;CE@QY.>O%?-/\
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MUG0G5>,@JMKI=+::/L13E-UTIV^1^D_PYMX[/X?Z'##&D44=A J(B[50!!@
M#H*VJR? 8V^"-'!X/V*'_P! %:U>'+<\]A1112 **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH *_*G_ (*E02/_ ,%AO@;A&.YK
M3&!UQ,<U^JU%=&%Q'L9\UKZ-?>:T:OLW<!THHHKG,@HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MV/U[HKF_!/Q6T7XD_"^S\8:#>)J6AZC9?;[:>/@2Q[2?J#P00>A%?D'\3O\
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M ,$/_P!IOP%^Q]XX^*'P]^)FN:/X1\27&K )J.ISK!;W!A+H\;3L=B<G<-S
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M5AU0L23.-FG.#N)Z[VZ=:G#X9.C[=04FWHF[)+[U<5.E>'M$DVW\D>K? ?\
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M.['JS,222>37YE?\% M+M_A[_P %U?A?JFD1K9WFHRZ=<7)0<32;F4L1W)&
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M_>0YQT/-?@%\4M6UW0OVS_%%YX96YD\0VOBZ\DTY;>W%Q*9Q=/LVQE6#G/\
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M  ;??M'GQ7\'O$_PWO+AI+KPW<#4+)&.<6\O# >@#XX]Z\P_X.<?^2F?"O\
M[!E[_P"C8Z\K!T?8YC[/U_(XZ-/DQ/+ZGUW_ ,$)?^4>/AO_ *^KC_T*OL:O
MCG_@A+_RCQ\-_P#7U<?^A5]C5YF._P!XGZLY<1_$EZA1117*8A1110 4444
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M^0O_  5,2\_X)^_\%1?!_P ;])MI&TWQ"@N+Q%Z7$J#9-&2,??7;QZ UW/\
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M%] \23>-M;UZ^BL8HM$MVEA@+MC>\S[8]H]%9C[4?\%J3G_@G-X\_P"N</\
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M4M?EG_P4V_Y39_"/Z:;_ .C&K]9=+TV#1=-M[.UC\JVM8UAB0$G8B@ #)YX
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M_;2M_P#@G#^U/JT_C'2]072=1@?1M9CAC#75B4DR&"'&=KKR <D=*_5#7/\
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MASUXKXA\'ZIXJ_;N^/?PU\(WS?:[J**S\.VV,[1;HY.YO0[203["OZ)OC_\
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M-SEF/))R23S2K8R$\+"@D[K[A5*\948TUNCH:***\TY3^;GPO_RDX_[G^?\
M]+'K^D2/_5K]*^>K?_@E'^S]:?%W_A.X_AW:KXH^W'4OM0U.^\O[06W&3R?.
M\G.XYQLQGM7T.!@5Z68XR&(Y>1/1=3JQ5>-2W+T"OP%_X+U?\I#]>_[!UK_)
MJ_?JO"?V@?\ @F=\#_VI/B!_PE/CKP);ZUKWE+ UVNI7MF9$7[H98)D5L>K
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MMM&L-O;1K%%&O1%48 'T KBQ4L,[?5TUWN<]9TG;V:?S/Q1_X.1O^3M/#/\
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M'643K \\L#1N.C+)$Z.I^C#-5',5'&/$*_*^G6PXXI*NZBV9\Y_\$D_VL_\
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MZ+O>3^70RIUTJ,J;W9Z]1117FG*?C!_P<K_\G$^!O^P-+_Z,%?H5_P $?O\
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MI8Z$\)["HGS+9C^L1E1]G+=;'X1?M6?\I+/$?_8Y)_Z/2OTG_P"#B/\ :/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MX)N?MGZI^W3^SU%XTU3PI_PBTWVE[3:ESYT-VR8W21Y 95R<8.?J:POVA_\
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MA337>R-I8JA%\L8Z'YA_LE_\''OBC1-9M=-^,&@V.N:5(X636-(A%M>6X/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M /S3_P""Q?\ P1SUS]I'Q?-\3OAA'#=^)IHE35M%EF$3:AM&!+"S?+YF."K$
M X&#G@_DSXH\ _$3]E_QG'_:VE>+O >O6KD1230SZ=<*P[H_RD_537](WC/]
ML7X9_#GXUV?P\U_QAI&C>+-0M1=V]G>R^2LB,<*!(V$W-SA<Y.#@5WVN^']-
M\9:-)9ZG8V.JZ?<J-\%U"L\,H[95@5(KVL+FU6A!0J1NNG33]3OI8R=.*C-7
M1_/?\&_^"TO[1GP;GB5/'USXFLX\;K7Q# FH+(!ZRL!-^4@K]$O^"?7_  7L
M\/\ [3/C.R\'?$31K/P3XDU!A%97]O<%M,O93TC(?YH6/;<S _WA7>_MT?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M22><FO$_^"H7P)^(7[27[)&N>$?AQ=:?;ZMJ147,5U,83>6X.6A1\$ MT^;
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P!%"_\ *%IG_P CT?\ #W;]H?\ Z*%_Y0M,_P#D>OFVBC^S\+_SZC_X"O\
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M\^H_^ K_ "#^R\'_ ,^H_P#@*_R/I+_A[M^T/_T4+_RA:9_\CT?\/=OVA_\
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M_(^DO^'NW[0__10O_*%IG_R/1_P]V_:'_P"BA?\ E"TS_P"1Z^;:*/[/PO\
MSZC_ . K_(/[+P?_ #ZC_P" K_(^DO\ A[M^T/\ ]%"_\H6F?_(]'_#W;]H?
M_HH7_E"TS_Y'KYMHH_L_"_\ /J/_ ("O\@_LO!_\^H_^ K_(^DO^'NW[0_\
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M_P"BA?\ E"TS_P"1Z^;:*/[/PO\ SZC_ . K_(/[+P?_ #ZC_P" K_(^DO\
MA[M^T/\ ]%"_\H6F?_(]'_#W;]H?_HH7_E"TS_Y'KYMHH_L_"_\ /J/_ ("O
M\@_LO!_\^H_^ K_(^DO^'NW[0_\ T4+_ ,H6F?\ R/1_P]V_:'_Z*%_Y0M,_
M^1Z^;:*/[/PO_/J/_@*_R#^R\'_SZC_X"O\ (^DO^'NW[0__ $4+_P H6F?_
M "/1_P /=OVA_P#HH7_E"TS_ .1Z^;:*/[/PO_/J/_@*_P @_LO!_P#/J/\
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M_P  C_D>I_\ #:OQ,_Z&;_RG6G_QJC_AM7XF?]#-_P"4ZT_^-5Y911]2P_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MG8<ZD(?&TO4\YHJ2YMI+*YDAFCDAFA8HZ.I5D8<$$'D$>E-CC::15569F.
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%J?C3X.\:6[>,M>B\>>%;IQ%JFD:G8VX6X@;APKI&&5L9QU7U!K[,_X*5_\
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MJ^["4TK)WM%]+Z:7T]-!5*=:EAXT:WNTY5$K*5[1?2^FE]/30\+U_P#X+/\
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M UJ7NA77_!0'_@E;X>ELT:^\=?!_5$TR0*PDFELI2%5G.-VT YP/[@ZUS?\
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M1#I\K*TECJ2P,1T)60 _RKVC_@I5_P G!6O_ &!K7_V:O*O%/_)=[[_L./\
M^CZ]5_X*5?\ )P5K_P!@:U_]FKT)2;Q-)O\ EE^A]+4FY9KA)/=TY_\ MA\]
MT445Z1].%%%% !1110 4444 ?>G[$?\ R;7H'^_<_P#I3+7K%>3_ +$?_)M>
M@?[]S_Z4RUZQ7Y[CO]YJ>K_,_E_B+_D:XG_KY/\ ]*84445RGCA1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;MB]<],?C7GM%=/L8<RG;5*R/4^HT?:PK6]Z":3N]$[7_);A1116AU!1110
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MKL?@7\ O%O[2GQ!A\*^"=)_MK7KB&2XCM?M4-MN2-=SG?,Z)P.<$Y/;-=O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "OS;_P"#A'_FD7_<9_\ ;"OTDK\V_P#@X1_YI%_W&?\
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M3XLF^,G@7Q-HWQ)^%<7VK1M=U?1Y=.NM6MP,M&QE5=YP,,1P>#P>3\Q>+?\
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MR>3D\UY-_P %I/@IX2^"O[7K0^$[&TT:/6M-AU&^TRV 6*SG?.[:HX4-C.T
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M4'_ D:O&***<*4(-N*W=WZE4Z,(-R@K.3N_-GKW[)/[:/BG]C34O$]UX7L-
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^CO\
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M^9_+_$7_ "-<3_U\G_Z4PHHHKE/'"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O@G_@O?X"N-
M<^"_@OQ!"NZ'0=2GAG]A.L8!_P"^HP/QK[VKB_V@_@KIG[0OP?USPCJT:O;:
MM;E%8C_4R#E''N&P:[,OQ*H8F%5[)_ALSNRW%+#8J%9[)Z^FS/YZZ*[+X]?
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M(_ MBNNK\[Q<U.O.2V;?YG\LYU7C6S"O6AM*<FO1ML****YSS0HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH \9_;#_8>\'_MD>$?LNN0_8]:M8V6PU:!!]HM"><'^\F>J
MG]*_+;]H7_@DY\7O@7J<[6>A3>,M%C!=+_1D,S;?]J'_ %BGZ CWK]KZ*];
M9SB,*N6.L>S_ $/:RW/<3@UR1UCV?Z=C^<;6_"VJ>&IO+U+3;_3Y <%;FW>)
MOR8"J%?TD45[2XL?6E_Y-_P#WEQD^M'_ ,F_^U/YMZ*_I(HH_P!;/^G7_DW_
M   _UR_Z<_\ DW_VI_-O17])%%'^MG_3K_R;_@!_KE_TY_\ )O\ [4_FWHK^
MDBBC_6S_ *=?^3?\ /\ 7+_IS_Y-_P#:G\V]%?TD44?ZV?\ 3K_R;_@!_KE_
MTY_\F_\ M3^;>BOZ2**/];/^G7_DW_ #_7+_ *<_^3?_ &I_-O17])%%'^MG
M_3K_ ,F_X ?ZY?\ 3G_R;_[4_FWHK^DBBC_6S_IU_P"3?\ /]<O^G/\ Y-_]
MJ?S;T5_2111_K9_TZ_\ )O\ @!_KE_TY_P#)O_M3^;>BOZ2**/\ 6S_IU_Y-
M_P  /]<O^G/_ )-_]J?S;T5_2111_K9_TZ_\F_X ?ZY?].?_ ";_ .U/YMZ*
M_I(HH_UL_P"G7_DW_ #_ %R_Z<_^3?\ VI_-O17])%%'^MG_ $Z_\F_X ?ZY
M?].?_)O_ +4_FWHK^DBBC_6S_IU_Y-_P _UR_P"G/_DW_P!J?S;T5_2111_K
M9_TZ_P#)O^ '^N7_ $Y_\F_^U/YMZ*_I(HH_UL_Z=?\ DW_ #_7+_IS_ .3?
M_:G\V]%?TD44?ZV?].O_ ";_ ( ?ZY?].?\ R;_[4_FWHK^DBBC_ %L_Z=?^
M3?\  #_7+_IS_P"3?_:G\V]%?TD44?ZV?].O_)O^ '^N7_3G_P F_P#M3^;>
MBOZ2**/];/\ IU_Y-_P _P!<O^G/_DW_ -J?S;T5_2111_K9_P!.O_)O^ '^
MN7_3G_R;_P"U/YMZ*_I(HH_UL_Z=?^3?\ /]<O\ IS_Y-_\ :G\V]%?TD44?
MZV?].O\ R;_@!_KE_P!.?_)O_M3^;>BOZ2**/];/^G7_ )-_P _UR_Z<_P#D
MW_VI_-O17])%%'^MG_3K_P F_P" '^N7_3G_ ,F_^U/YMZ*_I(HH_P!;/^G7
M_DW_   _UR_Z<_\ DW_VI_-O17])%%'^MG_3K_R;_@!_KE_TY_\ )O\ [4_F
MWHK^DBBC_6S_ *=?^3?\ /\ 7+_IS_Y-_P#:G\V]%?TD44?ZV?\ 3K_R;_@!
M_KE_TY_\F_\ M3^;>BOZ2**/];/^G7_DW_ #_7+_ *<_^3?_ &I_-O17])%%
M'^MG_3K_ ,F_X ?ZY?\ 3G_R;_[4_FWHK^DBBC_6S_IU_P"3?\ /]<O^G/\
MY-_]J?S;T5_2111_K9_TZ_\ )O\ @!_KE_TY_P#)O_M3^;>BOZ2**/\ 6S_I
MU_Y-_P  /]<O^G/_ )-_]J?S;T5_2111_K9_TZ_\F_X ?ZY?].?_ ";_ .U/
MYMZ*_I(HH_UL_P"G7_DW_ #_ %R_Z<_^3?\ VI_-O17])%%'^MG_ $Z_\F_X
M ?ZY?].?_)O_ +4_FWHK^DBBC_6S_IU_Y-_P _UR_P"G/_DW_P!J?S;T5_21
M11_K9_TZ_P#)O^ '^N7_ $Y_\F_^U/YMZ*_I(HH_UL_Z=?\ DW_ #_7+_IS_
M .3?_:G\V]%?TD44?ZV?].O_ ";_ ( ?ZY?].?\ R;_[4_FWHK^DBBC_ %L_
MZ=?^3?\  #_7+_IS_P"3?_:G\V]%?TD44?ZV?].O_)O^ '^N7_3G_P F_P#M
M3^;>BOZ2**/];/\ IU_Y-_P _P!<O^G/_DW_ -J?S;T5_2111_K9_P!.O_)O
M^ '^N7_3G_R;_P"U/YMZ*_I(HH_UL_Z=?^3?\ /]<O\ IS_Y-_\ :G\V]%?T
MD44?ZV?].O\ R;_@!_KE_P!.?_)O_M3^;>BOZ2**/];/^G7_ )-_P _UR_Z<
M_P#DW_VI_-O17])%%'^MG_3K_P F_P" '^N7_3G_ ,F_^U/YMZ*_I(HH_P!;
M/^G7_DW_   _UR_Z<_\ DW_VI_-O17])%%'^MG_3K_R;_@!_KE_TY_\ )O\
M[4_FWHK^DBBC_6S_ *=?^3?\ /\ 7+_IS_Y-_P#:G\V]%?TD44?ZV?\ 3K_R
M;_@!_KE_TY_\F_\ M3^;>BOZ2**/];/^G7_DW_ #_7+_ *<_^3?_ &I_-O17
M])%%'^MG_3K_ ,F_X ?ZY?\ 3G_R;_[4_FWHK^DBBC_6S_IU_P"3?\ /]<O^
MG/\ Y-_]J?S;T5_2111_K9_TZ_\ )O\ @!_KE_TY_P#)O_M3^;>BOZ2**/\
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M +0_+.BOU,HH_P!8O^G?X_\  #_B*G_4+_Y/_P#:'Y9T5^IE%'^L7_3O\?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBORD^)W_!2CXU^'OB
M3XAT^S\:>39V.IW-O!'_ &18-L1)651DP$G  &22:ZL+A)UVU"VG<[,'@IXA
MM0:T[GZMT5X+_P $X_C1XF^//[.":]XLU+^UM6;4[BW,_P!GB@^1=FT;8U5>
M,GG&:]ZK&I3<)N#Z'/6ING-TY;H****S,PHHHH **** "BBB@ HHHH ****
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MDOP*Q6%GAY\D[7\@HHHKG.8**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBO%_VU?BQX@^$G@K2;SP_J']GW%U>&*5_(CEW+L)QAU8=?2ML/1E6J
M*G'=G=EN7U,=BH82DTI2=E?;OK9/\CVBBOB_X)_M9?$#Q=\6?#^F:AX@^T6-
M]>)%-']AMDWJ>HRL8(_ U]H5MC,#4PTE&HUKV_I'?GW#^(RFK&EB7%N2NN5M
M];=4@HHHKC/""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 5^=_\ P6W_ .1[\!_]>%S_ .C$KTC]N[]NOXH?LE_%*'3]/T?P?>^'
M]3@$]A<7=G<-*<<.C%;A02#CG:,YZ5\4_M2_M?\ B7]KC5M)O/$ECH=C+HT+
MPPC3898U8.03N\R1\GCMBO8R["5%.-;H>]E6!J1J1KZ<NIWW_!)S_D\O1_\
MKPO/_11K]8*_$/\ 9Z^/FL?LU_$RV\5:%;:;=ZA:PR0I'?QO)"0Z[3D(Z-G'
M3YJ^POV9/^"EWQ<_:,^,NC^%[;0? L<-Y)NNIH[&[S;PKR[\W.,@=,UKF6$J
M5)^T6R1MFV!J5)^UC:R1]]44#I17A'S84444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %?.O_!1O_DG.@_]A!O_ $6:^BJ^=?\ @HW_ ,DYT'_L(-_Z
M+->AE7^]P]?T/IN#?^1SA_7]&?.?[.'_ "7;PK_V$(Z_1:OSI_9P_P"2[>%?
M^PA'7Z+5Z'$/\6/I^I]/XG_[[1_P?JPHHHKY\_,@HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /S-_X*Z_LY?\*_
M^*MKXWT^';IOBCY+K:.([I1UZ_Q*,] /E]Z^/:_;']J?X'6O[0_P/USPS.J^
M?<PF2SD(R8ITY1NH[_SK\6=>T2Z\,ZW>:=>Q-#>6,SV\T9ZHZD@C\Q7TV68C
MVE+E>Z_+H?791BO:T>1[Q_+H:?PP^'U_\5OB!I/AW38VEO-6N4MXP!TR>3^
MYK]LOA!\,K#X.?#31O#.FHJVNDVRP@@8\QOXF/U;)_&OB/\ X(Z?LX_:+O4O
MB/J5O\L.ZQTK>O5C_K)!]!Q^-?H!7GYKB.>?LULOS/+SK%<]3V4=H_F%%%%>
M2>*%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M45\^?F04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !7YU_\ !2;]C&_U;]I7P_JWART9H?'UREI.$'$5T.K'G^)!
MGH -OO7Z*5'-:QW#(TD<<C1MN0LH.T^H]#71AL1*C/GB=6$Q4J$^>)S_ ,(/
MAE8?!SX::-X9TU%6UTFV6$$#'F-_$Q^K9/XUTE%%82DV[LYY2<G=A1112)"B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M** "BBB@ HHHH **\=_:T_;A\#_L>>&Q=>([N2ZU2X7-II-IAKJY]\$X5?\
M:;]:_/+XN?\ !<_XI>+-2D7PIIV@>$]/#'RLV_VZZ([;GD^3\D'XUZF#R?$X
ME<U-67=Z(]; Y)B\6N>G&T>[T1^M]%?B7)_P5X_:&=RP^("J#V&A:;@?G;TW
M_A[M^T/_ -%"_P#*%IG_ ,CUZ'^J^+_FC][_ ,CU/]4,9_-'[W_\B?MM17XD
M_P##W;]H?_HH7_E"TS_Y'H_X>[?M#_\ 10O_ "A:9_\ (]'^J^+_ )H_>_\
M(/\ 5#&?S1^]_P#R)^VU%?B3_P /=OVA_P#HH7_E"TS_ .1Z/^'NW[0__10O
M_*%IG_R/1_JOB_YH_>_\@_U0QG\T?O?_ ,B?MM17XD_\/=OVA_\ HH7_ )0M
M,_\ D>C_ (>[?M#_ /10O_*%IG_R/1_JOB_YH_>_\@_U0QG\T?O?_P B?MM1
M7XD_\/=OVA_^BA?^4+3/_D>C_A[M^T/_ -%"_P#*%IG_ ,CT?ZKXO^:/WO\
MR#_5#&?S1^]__(G[;45^)/\ P]V_:'_Z*%_Y0M,_^1Z/^'NW[0__ $4+_P H
M6F?_ "/1_JOB_P":/WO_ "#_ %0QG\T?O?\ \B?MM17XD_\ #W;]H?\ Z*%_
MY0M,_P#D>C_A[M^T/_T4+_RA:9_\CT?ZKXO^:/WO_(/]4,9_-'[W_P#(G[;4
M5^)/_#W;]H?_ **%_P"4+3/_ )'H_P"'NW[0_P#T4+_RA:9_\CT?ZKXO^:/W
MO_(/]4,9_-'[W_\ (G[;45^)/_#W;]H?_HH7_E"TS_Y'H_X>[?M#_P#10O\
MRA:9_P#(]'^J^+_FC][_ ,@_U0QG\T?O?_R)^VU%?B3_ ,/=OVA_^BA?^4+3
M/_D>C_A[M^T/_P!%"_\ *%IG_P CT?ZKXO\ FC][_P @_P!4,9_-'[W_ /(G
M[;45^)/_  ]V_:'_ .BA?^4+3/\ Y'H_X>[?M#_]%"_\H6F?_(]'^J^+_FC]
M[_R#_5#&?S1^]_\ R)^VU%?B3_P]V_:'_P"BA?\ E"TS_P"1Z/\ A[M^T/\
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M_P H6F?_ "/1_JOB_P":/WO_ "#_ %0QG\T?O?\ \B?MM17XD_\ #W;]H?\
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MW[0__10O_*%IG_R/1_JOB_YH_>_\@_U0QG\T?O?_ ,B?MM17XD_\/=OVA_\
MHH7_ )0M,_\ D>C_ (>[?M#_ /10O_*%IG_R/1_JOB_YH_>_\@_U0QG\T?O?
M_P B?MM17XD_\/=OVA_^BA?^4+3/_D>C_A[M^T/_ -%"_P#*%IG_ ,CT?ZKX
MO^:/WO\ R#_5#&?S1^]__(G[;45^)/\ P]V_:'_Z*%_Y0M,_^1Z/^'NW[0__
M $4+_P H6F?_ "/1_JOB_P":/WO_ "#_ %0QG\T?O?\ \B?MM17XD_\ #W;]
MH?\ Z*%_Y0M,_P#D>C_A[M^T/_T4+_RA:9_\CT?ZKXO^:/WO_(/]4,9_-'[W
M_P#(G[;45^)/_#W;]H?_ **%_P"4+3/_ )'H_P"'NW[0_P#T4+_RA:9_\CT?
MZKXO^:/WO_(/]4,9_-'[W_\ (G[;45^)/_#W;]H?_HH7_E"TS_Y'H_X>[?M#
M_P#10O\ RA:9_P#(]'^J^+_FC][_ ,@_U0QG\T?O?_R)^VU%?B3_ ,/=OVA_
M^BA?^4+3/_D>C_A[M^T/_P!%"_\ *%IG_P CT?ZKXO\ FC][_P @_P!4,9_-
M'[W_ /(G[;45^)/_  ]V_:'_ .BA?^4+3/\ Y'H_X>[?M#_]%"_\H6F?_(]'
M^J^+_FC][_R#_5#&?S1^]_\ R)^VU%?B3_P]V_:'_P"BA?\ E"TS_P"1Z/\
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M9_-'[W_\B?MM17XD_P##W;]H?_HH7_E"TS_Y'H_X>[?M#_\ 10O_ "A:9_\
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M["#?^BS7H95_O</7]#Z;@W_D<X?U_1GSG^SA_P EV\*_]A".OT6K\Z?V</\
MDNWA7_L(1U^BU>AQ#_%CZ?J?3^)_^^T?\'ZL****^?/S(**** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O
M.?VK_P!H;3_V7_@9K?BZ_P!K-8Q;+6$L ;B=N$0?4UZ-7Y[_ /!?[Q9<:=\.
MOAWHT<I6WU2^O;B9!_RT\E(0OY&6N[+<.J^)A2ELWK\M3T,JPJQ.+A1ELWKZ
M+5_D?G)\7?BUKGQP^(6I>)O$5Y)?:IJ<ADD=B<(.R*.R@< 5S5%%?J$8J*Y8
M['Z]&*BE&.R"BBBJ*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M[_/O_P 2^ZKS\TIQJ82HI=F_NU/-SBC&I@JJE_*W\TKG[=4445^7GY"%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7SK_P %&_\
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MHIU-@_U"?[HIU?CY^'A1110 5^<'_!P=_P >7PF_W]6_E95^C]?G!_P<'?\
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MR'+"<$Y*3232OOU?9=SYHHHHKH.H**M:%;)>ZW9PR+NCFG1'&<9!8 U]8?\
M!63]F'P-^S/XC^'=OX(T/^Q8==\/I?7R_;+BY\^8A<M^^D?;U/"X'M7/4Q$8
M58TGO*]OD<U3%0A6A1=[RO;MIW/D6BBBN@Z0HHHH **** "BBB@ KZ._X))_
M\I"?AY_OW_\ Z;KJOG&OH[_@DG_RD)^'G^_?_P#INNJX\P_W6I_AE^3.',O]
MSJ_X9?DS]NJ***_*S\="BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ KYU_P""C?\ R3G0?^P@W_HLU]%5\Z_\%&_^2<Z#_P!A!O\
MT6:]#*O][AZ_H?3<&_\ (YP_K^C/G/\ 9P_Y+MX5_P"PA'7Z+5^=/[.'_)=O
M"O\ V$(Z_1:O0XA_BQ]/U/I_$_\ WVC_ (/U84445\^?F04444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M?FW_ ,'"/_-(O^XS_P"V%?I)7YM_\'"/_-(O^XS_ .V%>QD'^_T_G_Z2SW.&
M_P#D8T_G_P"DL_-NBBBOT@_5 HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#]*/V-O#^H>*O^")
M'Q4T_2[&\U*^N;^98;:UA:::4_)PJ*"2?H*^$?\ AE[XF?\ 1._'7_@ANO\
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MK/'/AKP]9_V?HNCZF]O9VWFO-Y,8 P-SLS'KU8DU^E7[<'[.OPQ\3_##X/\
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MU0**** "BBB@ HHHH ^^OVVO^4,W[-__ %^S?^@SU\"U]]?MM?\ *&;]F_\
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MYE_N=7_#+\F?MU1117Y6?CH4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %?.O_!1O_DG.@_\ 80;_ -%FOHJOG7_@HW_R3G0?^P@W
M_HLUZ&5?[W#U_0^FX-_Y'.']?T9\Y_LX?\EV\*_]A".OT6K\Z?V</^2[>%?^
MPA'7Z+5Z'$/\6/I^I]/XG_[[1_P?JPHHHKY\_,@HHHH **** "BBB@ HHHH
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M#*O][AZ_H?3<&_\ (YP_K^C/G/\ 9P_Y+MX5_P"PA'7Z+5^=/[.'_)=O"O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 5M_#CPE)X\\=:7H\,;R2ZE<+ J(/F8GTK$
MK[>_X(L?LK77Q&^-3>/]0MY$T/PKG[,[*0MQ=,, +QSM')Q7+C<3'#T)59=%
M^/0X\PQ4<-AY5I=%^/0_6B(;8E'L*=117Y2?C84444 %?G!_P<'?\>7PF_W]
M6_E95^C]?GS_ ,%_/"%SJ?PW^'NM1PO);Z3?7EO,X'$?G)"5S]3$17K9%)+'
M4[^?Y,]KAV268TV_/\F?E[1117Z4?JP4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !7T=_P23_Y2$_#S_?O_ /TW75?.-?8'_!%;X37GC/\ :\L_$<<+&S\(V\T\
MLIX4&6"6 #W/[SIZ5PYE)1PE1O\ E?XJQY^;34<%5<OY6OO5C]B****_+3\?
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KYU_X*
M-_\ ).=!_P"P@W_HLU]%5\Z_\%&_^2<Z#_V$&_\ 19KT,J_WN'K^A]-P;_R.
M</Z_HSYS_9P_Y+MX5_["$=?HM7YT_LX?\EV\*_\ 80CK]%J]#B'^+'T_4^G\
M3_\ ?:/^#]6%%%%?/GYD%%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110!\3?\ !0/_ ()(Z?\ M#:E
M=^+O <EGHGBZ?Y[JTE/EVFIM_>R,^7(?7&#WQUK\TOBW^R?\2/@9J4EOXH\&
MZ]IJQL5%P;1I+67'=)5!1A]#7] U%>]@>(*^'BJ<ES)=]_O/I,OXFQ&&@J<U
MSQ6U]U\S^;=E*M@C!'!![45_2117I?ZV?].O_)O^ >I_KE_TY_\ )O\ [4_F
MWHK^DBBC_6S_ *=?^3?\ /\ 7+_IS_Y-_P#:G\V]%?TD44?ZV?\ 3K_R;_@!
M_KE_TY_\F_\ M3^;>BOZ2**/];/^G7_DW_ #_7+_ *<_^3?_ &I_-O17])%%
M'^MG_3K_ ,F_X ?ZY?\ 3G_R;_[4_FWHK^DBBC_6S_IU_P"3?\ /]<O^G/\
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M/^G7_DW_   _UR_Z<_\ DW_VI_-O17])%%'^MG_3K_R;_@!_KE_TY_\ )O\
M[4_FWHK^DBBC_6S_ *=?^3?\ /\ 7+_IS_Y-_P#:G\V]%?TD44?ZV?\ 3K_R
M;_@!_KE_TY_\F_\ M3^;>BOZ2**/];/^G7_DW_ #_7+_ *<_^3?_ &I_-O17
M])%%'^MG_3K_ ,F_X ?ZY?\ 3G_R;_[4_FWHK^DBBC_6S_IU_P"3?\ /]<O^
MG/\ Y-_]J?S;T5_2111_K9_TZ_\ )O\ @!_KE_TY_P#)O_M3^;>BOZ2**/\
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M'^MG_3K_ ,F_X ?ZY?\ 3G_R;_[4_FWHK^DBBC_6S_IU_P"3?\ /]<O^G/\
MY-_]J?S;T5_2111_K9_TZ_\ )O\ @!_KE_TY_P#)O_M3^;>@#)K^DBBC_6S_
M *=?^3?\ /\ 7+_IS_Y-_P#:GX&_L^_L4?$K]I;7+>U\-^%]2:SD8"34KF%H
M+&!>Y,K *<?W5RQ]*_8S]B/]CG1_V-?A-'H=G(M]JUV1-J=_MQ]IE_V1V4=
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 5^4GQ._P""E'QK\/?$GQ#I
M]GXT\FSL=3N;>"/^R+!MB)*RJ,F DX  R237ZMU^&/QH_P"2Q>+/^PS>?^CW
MKU\IIPG*7.D]MSW,EHPG*7.D]MU<_53_ ()Q_&CQ-\>?V<$U[Q9J7]K:LVIW
M%N9_L\4'R+LVC;&JKQD\XS7O5?+O_!(3_DT&/_L,W?\ [)7U%7!BHI5I)=SS
M<=%1KS4597"BBBN<Y0HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M".OT6KT.(?XL?3]3Z?Q/_P!]H_X/U84445\^?F04444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7X8_&C_DL7BS_L
M,WG_ */>OW.K\,?C1_R6+Q9_V&;S_P!'O7M9-\4OD?09#\4_D?I9_P $A/\
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M#VG_ *)2O9SGX8_,]_/O@AZLZBBBBO!/F@HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3XY^#^C:SXPM=+L=;U2$7+V]A#)'%"C<H,.[G.,$\]^E=Q38HUAC5%4*JC
M' %.KY&4KNZ/AY2O)M!1114DA1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M'D/[2W[1^K? "\L7CT"#4]/O@0L[7+1[''52-I'3GK7S7^T)^U9<?'[P]8Z?
M-HL.F+97!G#I<F7?E2,8*BOKS]H+X6Q?%SX7ZAI95?M2H9K5R.4E7D>_/3BO
MSNOK*73;V:WF1HYH',;HPY5@<$5]5DM+#U(<_+[\?7[S]C\/L'EF)HJO[->W
MI/5W?79VO;NMNAJ_#SQ@WP_\;Z7K26ZW3:;<+.(F;:),=LX.*^C-!_X*&:MX
MDUJUT^U\'VLEQ>2K%&HOF.23C^Y7RS7T9^P%\(?[>\47'BB\BS:Z9^ZM=PX:
M4]3^ _4UWYE2P_LW6K1NTM-SZ?BW!Y9]5ECL?3YG!6CJUJ]EHUU/KRR>62SB
M:95CF9 753E5;'(!J2BBOAC^=7JPHHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5'-:QW#(TD<<C1MN0LH.T^H]#4E% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %#+N7!
M&0>"#WHHH 9!;QVL*QQ1I'&O157:H_"GT44 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 1BUC6X,WEQ^<PVE]HW$>F:DHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH KZ=I-KI$<BVMO
M#;K*YD<1J%#,>I/N:L4447ON.4FW=A1110(**** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MW_XY7FU%'U>E_*ON0?5:/\B^Y'I/_#9?Q@_Z*M\2?_"FO?\ XY1_PV7\8/\
MHJWQ)_\ "FO?_CE>;44?5Z7\J^Y!]5H_R+[D>D_\-E_&#_HJWQ)_\*:]_P#C
ME'_#9?Q@_P"BK?$G_P *:]_^.5YM11]7I?RK[D'U6C_(ON1Z3_PV7\8/^BK?
M$G_PIKW_ ..4?\-E_&#_ **M\2?_  IKW_XY7FU%'U>E_*ON0?5:/\B^Y'I/
M_#9?Q@_Z*M\2?_"FO?\ XY1_PV7\8/\ HJWQ)_\ "FO?_CE>;44?5Z7\J^Y!
M]5H_R+[D>D_\-E_&#_HJWQ)_\*:]_P#CE'_#9?Q@_P"BK?$G_P *:]_^.5YM
M11]7I?RK[D'U6C_(ON1Z3_PV7\8/^BK?$G_PIKW_ ..4?\-E_&#_ **M\2?_
M  IKW_XY7FU%'U>E_*ON0?5:/\B^Y'I/_#9?Q@_Z*M\2?_"FO?\ XY1_PV7\
M8/\ HJWQ)_\ "FO?_CE>;44?5Z7\J^Y!]5H_R+[D>D_\-E_&#_HJWQ)_\*:]
M_P#CE'_#9?Q@_P"BK?$G_P *:]_^.5YM11]7I?RK[D'U6C_(ON1Z3_PV7\8/
M^BK?$G_PIKW_ ..4?\-E_&#_ **M\2?_  IKW_XY7FU%'U>E_*ON0?5:/\B^
MY'I/_#9?Q@_Z*M\2?_"FO?\ XY1_PV7\8/\ HJWQ)_\ "FO?_CE>;44?5Z7\
MJ^Y!]5H_R+[D>M:#^WG\:/#<PDM_BCXXD93G%UJ\UTOY2LP_"OI/]G3_ (+E
M^-O".IPVOQ&T^U\5:4<*]W9PI:WT8_O87$;_ $POUKX2HK"OEN&K*TX+[K/[
MSFQ&5X2M'EJ4U]UG]Z/Z&?@E\=O"_P"T/X$MO$7A/5(=2T^X W8XDMVQDI(O
M56'I^6:Z^OPB_88_;#UK]D#XOVVJ6LDDVAZ@ZP:K9%\1SQ$_>QTW+U!K]S?"
MGB>Q\:^&K'5]-G2YL-2@2X@E4@AT89'2O@LVRN6#J::Q>S_0_.<ZRB6!JZ:Q
M>S_1FA1117DGBA1110 4444 %0ZCJ-OI-C-=74T=O;VZ&2261@JQJ.223T%3
M5^6?_!8#]ON\\8^++KX7^%;R2WT?2WVZO<0R;?MDH_Y99'\*]QW-=V7X&>+J
M^SA\WV1Z&6Y=4QE94H?-]D>H_M=_\%NM'\ :A?:#\,=-@\0:E;MY;:O>Y^P(
MPZ^6@(:3'J2H^M?%WQ!_X*=_'+XB:C)<3>/]6TM'X$&D[;&.,>WE@-^))/O7
M@=%?H&%RC"T(VC!-]WJS]*P>28/#QM&";[O5_P!>AZ4W[9GQ@9L_\+6^)'/I
MXFO?_CE)_P -E_&#_HJWQ)_\*:]_^.5YM179]7I?RK[D=_U6C_(ON1Z3_P -
ME_&#_HJWQ)_\*:]_^.4?\-E_&#_HJWQ)_P#"FO?_ (Y7FU%'U>E_*ON0?5:/
M\B^Y'I/_  V7\8/^BK?$G_PIKW_XY1_PV7\8/^BK?$G_ ,*:]_\ CE>;44?5
MZ7\J^Y!]5H_R+[D>D_\ #9?Q@_Z*M\2?_"FO?_CE'_#9?Q@_Z*M\2?\ PIKW
M_P".5YM11]7I?RK[D'U6C_(ON1Z3_P -E_&#_HJWQ)_\*:]_^.4?\-E_&#_H
MJWQ)_P#"FO?_ (Y7FU%'U>E_*ON0?5:/\B^Y'I/_  V7\8/^BK?$G_PIKW_X
MY1_PV7\8/^BK?$G_ ,*:]_\ CE>;44?5Z7\J^Y!]5H_R+[D>D_\ #9?Q@_Z*
MM\2?_"FO?_CE'_#9?Q@_Z*M\2?\ PIKW_P".5YM11]7I?RK[D'U6C_(ON1Z3
M_P -E_&#_HJWQ)_\*:]_^.4?\-E_&#_HJWQ)_P#"FO?_ (Y7FU%'U>E_*ON0
M?5:/\B^Y'I/_  V7\8/^BK?$G_PIKW_XY1_PV7\8/^BK?$G_ ,*:]_\ CE>;
M44?5Z7\J^Y!]5H_R+[D>D_\ #9?Q@_Z*M\2?_"FO?_CE'_#9?Q@_Z*M\2?\
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M*ON0?5:/\B^Y'I/_  V7\8/^BK?$G_PIKW_XY1_PV7\8/^BK?$G_ ,*:]_\
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M44?5Z7\J^Y!]5H_R+[D>D_\ #9?Q@_Z*M\2?_"FO?_CE'_#9?Q@_Z*M\2?\
MPIKW_P".5YM11]7I?RK[D'U6C_(ON1Z3_P -E_&#_HJWQ)_\*:]_^.4?\-E_
M&#_HJWQ)_P#"FO?_ (Y7FU%'U>E_*ON0?5:/\B^Y'I/_  V7\8/^BK?$G_PI
MKW_XY1_PV7\8/^BK?$G_ ,*:]_\ CE>;44?5Z7\J^Y!]5H_R+[D>E#]LSXP
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M"<,L/'&8^/-*6JB]DNEUU;\]#LM1_:(\=ZK,9)/%WB!6)SB&^DA7\D(%5_\
MA>?C;_H</%7_ (-I_P#XNN5HKW/84EM%?<C]%CEN$2LJ4?\ P%?Y'5?\+S\;
M?]#AXJ_\&T__ ,71_P +S\;?]#AXJ_\ !M/_ /%URM%/V-/^5?<']GX7_GW'
M_P !7^1U7_"\_&W_ $.'BK_P;3__ !='_"\_&W_0X>*O_!M/_P#%URM%'L:?
M\J^X/[/PO_/N/_@*_P CJO\ A>?C;_H</%7_ (-I_P#XNC_A>?C;_H</%7_@
MVG_^+KE:*/8T_P"5?<']GX7_ )]Q_P# 5_D=5_PO/QM_T.'BK_P;3_\ Q='_
M  O/QM_T.'BK_P &T_\ \77*T4>QI_RK[@_L_"_\^X_^ K_(ZK_A>?C;_H</
M%7_@VG_^+H_X7GXV_P"AP\5?^#:?_P"+KE:*/8T_Y5]P?V?A?^?<?_ 5_D=5
M_P +S\;?]#AXJ_\ !M/_ /%T?\+S\;?]#AXJ_P#!M/\ _%URM%'L:?\ *ON#
M^S\+_P ^X_\ @*_R.J_X7GXV_P"AP\5?^#:?_P"+H_X7GXV_Z'#Q5_X-I_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !7O'_!-SXTM\#_VMO#.HR321V-Y*;*["GAHW&.?
MIUKP>K>A:Q-X?U>WO8.)K5Q(GU%95Z2JTY4Y;-6,<115:E*E+9IH_H]!R**;
M"<PK]!3J_)#\5"BBB@ K\\O^#@+7I;3P-\-=-61EBO;V_G= >',:0 9^GF'\
MZ_0VOS@_X.#O^/+X3?[^K?RLJ]?(=<=3^?Y,]KAU7S&G?S_])9^:U%%%?I)^
MK!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %?6G_!&'Q]/X9_;0TG2(YFCA\107
M$$D8/$GEV\LHS]"F:^2Z^CO^"2?_ "D)^'G^_?\ _INNJXLRBGA*B?\ *_R/
M/S6*E@ZJ?\K_  1^W5%%%?EA^/A1110 4444 ?E_XAOFU/7KVX9BS3SO(2>^
M6)JG4EW_ ,?4G^^?YU'7Z7'1'];4TE%)!1113*"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HS110!^@W[)VO2>)/@%H-U(S.VR6++=<)*Z#_P!!KT:O)_V(_P#DVO0/
M]^Y_]*9:]8K\]QL;8B:7=_F?R[GT%#,\1".RG+_TIA1117*>2%%%% !1110
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M/S6HHHK](/U0**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M35G5M$O= NA#?6=U93%0XCGB:-BIZ'# ''O4WA/_ )&K3/\ K[B_]#%>Z?\
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M#R,GOQ7SIH'QD_8Q\,ZY9ZE9?#OXEPWEC,EQ#(-=?Y'4@@]?45G?!/\ ;_\
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M9A*KB<)-1IM:JR>[U5W;H9'_  2%_P"4@_@'_KZ?_P!!-9?[</\ RDB\8?\
M8T1_^A1UA?L ?'30OV;_ -K'PKXR\2->+HVCSM)<&VA\V7!!'"Y&?SJC^TQ\
M9=%^*O[8GB#QOI)NCH>I:VE_"9HMDWE!E)RN>#P>,UM[.?UUSMIR6OYW-O8S
M^ORJ6TY+7\[['TS_ ,%];R67X_\ @B%I&:*'PS"40GA<XSCZXKYJ_8%N9+3]
ML_X:R1LR.NO6^"#T^:O0_P#@J?\ M:^$?VO/BYX=UKP>VI-9:7HL5A-]LMO(
M;S%ZX&3D>]>-_LN?$73OA)^T1X-\3:N9QIFAZI#=W)A3?)L4Y.U>,GVK/!T9
MQR]4Y+7E>GWD8&A.&6JE)6ERM6^\^D_VFI-,LO\ @MGJ;:MY":8OC"T,_FC]
MV%V1=?QQ7N?_  4C\3?LU^&_VL=>C^)W@?X@:IXFF2*4W=KK+QVTT10;#$O1
M5X/ [YKX:_;E^-^D_'K]K_QIXY\,R7BZ5K6H+=V3SQ^3,H6- "5R<'*GO7OV
MB?MZ_"7]JCX:Z/X?_:(\+ZM/K?AVW%M9>*=$/^ERQC@+*N1NX]\<5RU,+44:
M-5J7NQ2:B[-;??MJCBJ8.JHT*S4O=@HM1=I+1??MJC2^$O[3O[(/P1^(^D>*
M_#O@#XD6>M:'<+<VLK:T[JKCU4G##V-=I_P3<^+>B?'3_@I/\5O%F@VBZ?<>
M(M&O;G0K>< 2QRF,9Q[\$G'K7F,/QJ_9+_9\TF\U#P1X0\5?$#Q--"\-J?$B
M"&TM2P(WE,D,1[<U\N_![XZ:[\!_C!I_C7PO-'INJZ;=&XA5!^["D\QD=T(X
MQZ57U%5J=3E4DVK)R?SVWL4LO]O3J\JFFXV3F]^NVK2N8OQ!34HO'FM+K.[^
MUUOIA>[NOG;SO_\ 'LU]A_\ !!R'7'_;"OVT_P [^QUT"\_M3;]S;L/E;O\
M@>,5?\<?M%?LG?M8WW_"4_$#PSXP\#^,KS#:E_8"":VO9,#=)C( +?G78?L[
M_P#!3+X'_LF^.K?P_P##[PKK&D>![J&5M:UJZB^T:KJ4GED1)MS\J!CDC-/&
M5ZU;#2HQI/F:MMI\GU\K%8[$5ZV$E0C1ES-6=TK+T?7RL?!/QE_Y*]XJ_P"P
MO=_^CGKFZV/B)KD'B;Q_KFI6N[[-J&H3W,6X8;8\C,,CL<&L>O;IZ129[]/2
M"3[!1115%A1110 4444 %%%% '](T'^H3_=%.IL'^H3_ '13J_'S\/"BBB@
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MI$6'KM=@WZ5[M_P1Z^"#_%WXA>.OB9J>DR^--8\%V+76FZ=)B62_U!\["0Q
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MS_\ W"I\O_2D>'Q)_P BZI\O_2D?I)1117YN?E84444 %%%% 'SC_P %;?\
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ML2Q;R+2[*Q@GT'0?A3KO]L;XI7_CV+Q1/X\\23>(((9+>.^>[9I4CD4JZCL
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MJ<8-]DD>K_#_ /;3\?\ PV\+PZ/8:E;36-L,0I>6J7!A'HI8<5P'C7QWJGQ
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M*8PHHHH **** "BBB@ HHHH **** "OS;_X.$?\ FD7_ '&?_;"OTDK\V_\
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M]J\._8=^)WB+P1^T3X1T_2-:U'3;+5-:MENX+><QI<C>!A@.O%>[_P#!7_\
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M//C1XL^*-K!#XB\1:MK4-JY>)+RY:58V(P2 >AQ3P<\4\144Y)I-=^RVUT#
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MP_8<^+>J?$F^\(VW@+7KCQ%IH4W5G'$K&WW#(W.#L&1_M4?%_P#8;^+GP$T
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ME,M>L5Y/^Q'_ ,FUZ!_OW/\ Z4RUZQ7Y[CO]YJ>K_,_E_B+_ )&N)_Z^3_\
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MQ1W0WR,![$DY'\-?E&#BNU^(W[1OCKXN^%=)T/Q-XJUC6](T%0NGVEU.7BM
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MNO&M4Y5RW^%.[OW\CFI9?6>(C7J\L>6_PIW=^_D9]%%%>L>T%%%% !7Z2?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MUX#\&^)I;C0[+1_'5^^G:?<7-[Y:QR)]XR\?(OOS7J&A?\$H?'GB>UOYM/\
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MI.]U9\VEKJRM^&WG<SQD:U'FJ)._,K/FTM=65K_+;7>Y^=-?37C;2[7X&_\
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M\]8S\YP01@XKVCX/R_#_ /;N^'WQ TB7X8^%? &N>%]$EUO3]8T)7AC4Q_\
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M[W-)8*#@X7>LN;YWN?1R_%WPV/\ @F-_PAG]K6W_  E'_"6F_P#[/PWF^1L
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M:D\D>;GMKL>@^-/VH/&?Q"^!_A_X>:QJGV[PSX7NGO--BDC!EMV92I7S.I4
MG"]!FO/J**(4XP5HJPJ=.,%:"MU^\WOA?\1M2^$7Q"T?Q-H_V7^U-#N5N[;[
M3 L\6]>FY&X8>QKWS7_^"LGQ2\5:I)?:E9> ;^\F^_-<>&+621OJ2N:^9:*R
MJX6E4?-4BFS*MA*-67-4BF_,[+XJ_''6/C#\1X_%&J6NBV^H1B(".QL([6V/
MEG*YB4;?KZTSXX_'+Q%^T/\ $";Q-XGNH;G4IHH[<>3"(888HUVI&B+PJ@=
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M_7YMU^CG_!O/>K+J?QDAW?-"FB,1Z9_M#_"O'S__ '"?R_-'A<2RMEU3Y?\
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M):_Y^3_]*84445RGCA1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/\S(HHHKTSZX**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/_(SVO\ P/\ ] :E+84MC*HHHIC"BBB@ HHHH **** "BBB@ HHHH *^3?\
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M)[_Y7=3_ /DBOI*BC^T,7_S]E_X$_P#,/[4QG_/V7_@3_P SYM_X=$_L\?\
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M_*[J?_R11_PZ)_9X_P"B>_\ E=U/_P"2*^DJ*/[0Q?\ S]E_X$_\P_M3&?\
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M ,D4?\.B?V>/^B>_^5W4_P#Y(KZ2HH_M#%_\_9?^!/\ S#^U,9_S]E_X$_\
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M /)%'_#HG]GC_HGO_E=U/_Y(KZ2HH_M#%_\ /V7_ ($_\P_M3&?\_9?^!/\
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M7_@3_P P_M3&?\_9?^!/_,^;?^'1/[/'_1/?_*[J?_R11_PZ)_9X_P"B>_\
ME=U/_P"2*^DJ*/[0Q?\ S]E_X$_\P_M3&?\ /V7_ ($_\SYM_P"'1/[/'_1/
M?_*[J?\ \D4?\.B?V>/^B>_^5W4__DBOI*BC^T,7_P _9?\ @3_S#^U,9_S]
ME_X$_P#,^;?^'1/[/'_1/?\ RNZG_P#)%'_#HG]GC_HGO_E=U/\ ^2*^DJ*/
M[0Q?_/V7_@3_ ,P_M3&?\_9?^!/_ #/FW_AT3^SQ_P!$]_\ *[J?_P D4?\
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M4_\ Y(KZ2HKH_M#%_P#/V7_@3_S.K^U,9_S]E_X$_P#,^;?^'1/[/'_1/?\
MRNZG_P#)%'_#HG]GC_HGO_E=U/\ ^2*^DJ*/[0Q?_/V7_@3_ ,P_M3&?\_9?
M^!/_ #/FW_AT3^SQ_P!$]_\ *[J?_P D4?\ #HG]GC_HGO\ Y7=3_P#DBOI*
MBC^T,7_S]E_X$_\ ,/[4QG_/V7_@3_S/FW_AT3^SQ_T3W_RNZG_\D4?\.B?V
M>/\ HGO_ )7=3_\ DBOI*BC^T,7_ ,_9?^!/_,/[4QG_ #]E_P"!/_,^;?\
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M=%X(_P"";?P/^'>IQWFE?#W28[J$@I)<33W94^H\Z1J]PHJ98_$M6=27WO\
MS)EF6+DK2JR?_;S_ ,R&QL(-,M4@MH8K>&,86.-0JJ/8"IJ**Y3C"BBB@ HH
MHH **** "LGQ5X&T?QQ9?9]7TVTU"'^[-&&_7K6M151DT[HNG4G3ESP;375:
M,\QN?V-/AK=R;F\,QJ?]B]N4'Y+(!47_  Q5\,_^A9_\J-W_ /':]3HKH^NX
MC_GY+[V>FL_S1:+$U/\ P.7^9Y9_PQ5\,_\ H6?_ "HW?_QVC_ABKX9_]"S_
M .5&[_\ CM>IT4?7L1_S\E]['_K!FG_034_\#E_F>6?\,5?#/_H6?_*C=_\
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M^5&[_P#CM'_#%7PS_P"A9_\ *C=__':]3HH^O8C_ )^2^]A_K!FG_034_P#
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *U?!/_(SVO\ P/\ ] :LJM7P3_R,]K_P/_T!J4MA
M2V,JBBBF,**** "BBB@ HHHH **** "BBB@ KY-_X+D?\HMOBA_W"O\ T[V5
M?65?)O\ P7(_Y1;?%#_N%?\ IWLJZ<'_ +Q#_$OS-:'\2/JCWS]FO_DW/P!_
MV+>G?^DL==M7$_LU_P#)N?@#_L6]._\ 26.NVK"I\3(ENPHHHJ23Y5_X+/\
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M(1D@%B 33 @_X(C%)-)^/DFFX_X1U_BAJG]G[/\ 5[@5\[;_ ,#ZUV__  4
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MT\:N8_N>9]I/EANV['XXK[HKYW_8+_8NU/\ 9K3Q9XL\;:]%XM^*7Q%O1?\
MB'5HXO+A0*,16T"]5BC' '<\U]$4QA1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3G_!63_@N7H/_!.SQGI/P^\,^%[OXC?%37HUEM]&M2?+ME8X0R;,N68]$7G
MS1S+<7,MS[VHK\>_A;_P<P_$+X5_%S0]!_:4^ ][\,]'\1S+%:ZK:K.J0AC@
M,PFR& SDA2"!S7MG_!:W_@MQKW_!,"]^%\_A/POX;\9:/X]@DO);B\GF4K"I
M0JT7ED [E;(S[4N9!S(_1BBOQ+^(/_!TA\9/ "Z3XSO_ -FN?2_A+J\JK;:I
M?-<QSW*GNLG$8)[9&#[UT7Q*_P"#GSXA?$C3KS7/@'^SWJ_C#P?H-NLNL:OJ
ML<YCMVVAG5?)P/EY'4],X%',@YD?LE17QU_P2"_X*\^&_P#@JE\&M8UF'2F\
M+^)/"LBQ:SISR[XHPP)66-SU0X/7D5\N_M0?\')7B2]_:&UKX<_LU?!^Z^+E
M]X;F:"_U&03-;,R$J^Q8L$*&& S'!/2G<?,C]9Z*_.7_ ()?_P#!?.V_;)^.
MUQ\'_BAX$O/A7\4XT9H+&;>+>]91EHU$@WHV.0#G=VKR7]M[_@Y,\8?L<_\
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M+]C3X6^%=0\"Z#X?\0^(O%GB.UT"WM]9FEBM4,QP&+1D-Q0!],45\;Q?$O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M#_DX_P#:P_[&.R_]*M6KOP_^[UO2/YG12_A3^7YGZ7T445P'.%%%% !1110
M4444 ?"'PIM(?'O_  7T^)DVO;;FZ\%_#W3QX=BF'%HD\[":2,'NV "17W?7
MRC^W/^Q5XS\7_&?PO\;O@SJVGZ/\5_!]N]C+::AD:?XFT]CEK2<CE3GE7_A-
M8</_  4%_: B@_LR?]D?QLVOJFPW,6NV?]DM+_>$I._R\\_=SBD(^@/VR?\
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MBBB@ HHHH **** "BBB@ HHHH *U?!/_ ",]K_P/_P! :LJM7P3_ ,C/:_\
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M/B%JFGZI?ZC+\1->;7[I+A45;61D5-B;1RN%SSS7JE% !1110 4444 %%%%
M!7&?M#? O1/VEO@MXB\"^(HV?2/$EF]G.4^_%N'#KZ,IP1[BNSHH Y?X)_#F
M;X0?"3P[X7N-:OO$4GA^QBL?[2O%5;B[$:[59PN!NP ./2NHHHH **** "BB
MB@ HHHH **** "BBB@ KG_BI\--+^,GPZUCPMK2W#Z3KMLUI=K!*8I&C;J P
MY&?:N@HH H>%O#5GX,\-:?H^G0K;Z?I=M':6T0Z1QQJ%5?P  J_110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M5_Z=[*NG!_[Q#_$OS-:'\2/JCWS]FO\ Y-S\ ?\ 8MZ=_P"DL==M7$_LU_\
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M.^6;POK6FKJMO=2#;B KN)89X*X((SP0:\=_87_X*H_"W_@HEXM\8:3\-?\
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MX[+A2/2F-GV_^S1^WOX=_:/_ &3;_P"+,6GW.B:;I:7+7EE<3+)-;F%=Q!8
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M7GPD\2'X;V>C3WB:SJ4D2V>NHH.Z)(S\^&P<,1@CFG>#_P!L[X>? _\ 8/\
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MX*@PV'C+X@3RZ#\'WG^TZ)X3MFQ)K<:M\D]XXZJ<9$8X]:ZK_@KM\*Y/$O\
MP3G\7:/H=F8[?2(;>Y%O;)@I;P.I8(!Z*. *7FA>:/!_@MX)_91AT.ST_P"+
M_B[PMXT^*WBJ))]7N]8N'FEAN9@',,<F-D07.  1C%?HAX2T:Q\.>%=-T_2]
MO]FV-K%;VFU]X\I$"IAN_P H'/>OD\_"GX'WG_!+XS"P\,GPFWA;SS?%(VD^
MT>1DL9/O>;YG7G.:Z?\ X)=>-;[1_P#@GW\,)O'&I06&H7=D(+9M0N%BDG4N
MPB7+D;F*XP.I&*$"/%O^"MVN?#F#]K;X#V?Q5DTA/!"F^NM0&IJTELRJH4!E
M4$G)/7%>[?L6_#O]F>[U*X\4? _2_ OVZ.+R)[O18]DZ(W9@<, ?<5[AXA\/
M>&_%FJQ6NK6.AZG?11EHXKN&*:5$/4A6!('TXKXFO/"OA_X=_P#!:#PA:_#&
MWLK(ZEX<O)/&EIIV%MDQCR6D5?E5SSCOD"@/,R/AGX3^&_Q5A_:(U3XP+H\W
MC+3]:O8,:O,$FTZS2+_13;[B"H/7*]ZB^%GQ+\9?'/\ 90^$OP.L[R\C\3^+
M-,^T>)-2+M]HTK1%E8!G)Y$DL85%SS@YKZ3_ &TO 7P?\#^#]2^)7CGP7X?U
MK5]+B5;1Y[8-<7L^<0PK_?9F( !S7RSJ'P:\0:#XH^&.C^+M0O-#UCX[ZV][
MXKN+28V\D5M%$6M])C=<%%"X!"XR0: /T,^'_@32_AAX)TOP_HMK'9Z7H]LE
MK;0H,!$48'X]R?6M:658(FD=E5$!9F)X '4U\A_LW^&Q^SE_P4'\1?#/PSJ6
MJ77@N\\+Q:R^GWEX]V-,NO-V;D9B2H<=B<5]*?'&RU#4O@UXJM]*9EU*;2KE
M+8CKO,38Q[U11\_:Q_P4XN/%?B[6=/\ A9\*/&7Q4L?#TSVVH:II\T5I:+*A
MPR1M)_K"/:NU^"O[=>E_M#?"'Q/K7A/PWK-WXN\);H;_ ,(W16UU&.Y'2++?
M+\W9NE<!_P $6?%&@W?[!GAC2K&>W37-":XM]?MR0L\%X)GWF0=<XQR>N*Y[
M]C^:#Q=_P55^/&O^'Y([CPU'I5EIUS/;C,$M^K!F^8<%@O!Q4W)/*/\ @DE\
M1->\5_&[XF3:I\([V\DUOQ?/)J'B"YNK>5M#9<[8'W#>Q7IE"!Q7Z47U['IU
ME-<3,(X;=&DD8]%4#)/Y5\:?\$??^/OXZ?\ 8_7G\VK[(U>SM]0TFZM[K;]E
MGA>.;<=HV$$-D]N,TX[#6Q\JV'_!3K5?'UQ=ZAX!^"OCKQMX-LKMK-]?MIX;
M>*0HVUVCB;YG4'N.M>6_\%<_VFO'W@_6?A98Z!X-\20Z7=:[8W?V^#4$@75)
M'4DV!3[P8<9+?+3?B+X)^(W_  2?^'>H^,OAYXMTKQ=\'[6Z:^G\-:JH,]JD
MKY;[+.OWASPO>N@_X*F>+(_'?PK_ &??$ZPM:V6H>+M,U!A*<?9UFC#*&^FX
M"D(]<\5?MVZK\,/A?X6UWQE\--:\,ZCXG\11Z!'I4^HPRRP!R MP74;2IR?E
M'/%=_P#M;_M)6G[)GP'UCQU>Z7<:Q;Z1Y>ZT@E$3R;F"\,00,9]*\$_X+&ZM
M#X;^%GPUUBZRFG:7XVT^:YF_AA0N!N)[#FI?^"U/Q%T/2?\ @GSKL<VIV:R:
M\]M'IZB4,UX3(I&P#[PQSD<8HN.Y[-\:OVRO"OP!_9\TWX@^(UNH;76+>W>R
MT^!?.NKN:=%9((U'WF^;'ZU\:?\ !1_]N_Q!X[_8@\::5XM^#?C?X?V/B+3S
M'IFI7\D5Q!,Y(*I((^8BW;=]*Z#]LN\A\/>(?V.]8\0%4\&V=_9+>RS?\>\,
MYM4\MG[ >YKU#_@M5XWT'0_^"=OC:'4+VS635K9(M/C9@S7$A8%2@[^N1TH$
M;7P@_:^L?ACK'P-^%^K:+>0+XV\(6DVG:SYZ_9VFCM8\P%,9W'MSS7H'[3?[
M6EE^SEXC\#:&NC7?B+7/'VKKI5A96TRQ,F1EIF+ _*HKYW_;'^%]UJW_  3Q
M^%7Q"T6-O^$D^%%AI'B*U=%RYA2"(3KZG,9/'K5K]GKQ3:_MU?\ !0.3XBVK
M?:O"/PP\/P6>F'.Z/^T;R,22D=B50@9[&@#[:!R*^7?%W_!3BPT7XZ>,_AOI
M'@3Q)XG\8>%YXH;6PTZ1&;4PZ;S)E@!$B]"6)YKZBKXA_9!\1Z!8?\%8?VAK
M"ZFM8?$%X+-K19"%DEA$:[PF>O.#@50V>K?LW_\ !06S^,WQAO/AUXI\&>(/
MAKX\MK<WD.E:LZ2B]A'5XI4^5L=<#M5KXU_ME>+/A_\ $._\/^$_@MXW\>_V
M6BM<W]K-#9VH)&=J-)]\_2O)?VEKVW\?_P#!7'X(Z;H$D=UJGA?3+Z\UEH""
M;6W;&U9".F[G -4?A]\1OBA^WE\4/B,=.^*'_"K?!W@35Y-'6TTJVB?4)!'G
M=/)))G:#@XXQBI$?0G[,_P"V=H/[3GP@UKQ/INGZAI=[X;DGMM6T>]PMU8SQ
M*2T;8XYQP>]>2_!S_@JG=?M$6VDR>!?A#XP\3)<,R:K-;W<*V^C$,P57D8 .
MQVY(49&1FO-/^"4)MQX:_:82U\07OBJWCUR9%U:[(,U^1;2 R,5XY(/(XQ7K
M/_!%S0;71/V#/#\EO$L;7U[>7$Q Y=S,PR?P H \%_9C_;&^+-[^WW\61+\)
M_%VK><UG#+HK:U!_Q3B':"QR-K _>^6OJ[P?X\\$WG_!0CQ5X5M?!5M:>.-/
M\+6NJWGB0;?,N[>64HL&,;OE(SG->4_L?#['_P %4OVBX9=L<L\-C-&A/S.F
MT#<!Z9JQI$=Q-_P5Y^+:6F?M3?"RQ$..N_SWV_KB@#J/'/\ P4J6?XK:QX/^
M&?PW\5?%;4O#;F'59]+ECMK.SD'6/S9/E9AZ#O57]HS]IOPQK'['NG^-OB1\
M)]0N+?\ M^RT^3PWJYC$]G<R7"QI)NP5(5B&R.N*YW_@B?KVD)^S;KFBM-;Q
M>,-,\27_ /;]L^%NA.93\[@\D$=#TK0_X++:G;:K^Q9'):W$%PB^+]$1FBD#
MA6%['D$CN/2GT#I<[[]J']O/PY^R#\1O!?A?6-%U"YB\66T[VLMF0S1-$!MA
M6+&79R0  17'1?\ !4";P9\0=#TOXD?"?QE\-]&\37"VFFZWJ,T,]M)(W"+(
M$YC)XZGO7'?MZ^(-!\-?\%&_V:KKQ%-;6]CF]2.2<@1I,=HC))X'S=S6Y_P6
MK\0:;=_LD6OAU)(;CQ!XDU[3H='M4(:::03JVY!UX'.12 ]P_:2_:/U3X'QZ
M3!H/P_\ %'Q"U;6"WE6NDA$2-5ZM)*_RK_6N1_9M_;SC^-'Q@U+X>^*/!.O?
M#CQQ86@OTTS5)8YA=P9QOCD3Y6QZ5YG\:/C1\2O$W[3'@WX"^$/%&G^!;C_A
M&8]5U769H%N+JX*J%\J -QNR"2>:\T^$?A"X^'O_  64\-Z+J'Q*USXDZQ:^
M%+QKVXU(QYL2PR(E$8  ZG!Y'% 7/>OB#_P4RL?"'[0?B?X8Z7X$\2>*/%VA
MI"UI9Z=(C-J6\;B<L (E4=68FM?]F;_@H';?'SQ_XD\$ZQX*U_P+\0/#=K]L
M?0=3E222ZBYVM'(ORD$\?C7 _LOZ1;2?\%6_CQ?-#&UU'IEA"DA'S*IY('Y5
M3\8_Z)_P6^\)F/\ =FZ\$W(FVC'F!<XSZXH \I^"'[8WQ8?_ (*/_$Y3\*?%
MVK!M/M86T#^VH0-%CWC]_P C:0W7"C-?3'Q9_P""@\WA?XLW7@3P3\-_%'Q(
M\6:/;1W.KVNG316\.EAQD*\LG!;V%>>_LUK]A_X+"?'".8K')<>'[&6)&(W2
M)O'('IQ6Y\??V/O%WASXV>)/BY\%/'EEX?\ %%]"JZ_I&HHMSIVI&(9 ?O&^
MT 9[4 ?07P#^*U]\9?AS;ZWJ7A?5_!U])(\4VE:D5-Q;LIP<E>"/<5VE>!_L
M-?MGI^TS^S4/&GB>'3?"]UINHSZ1J1>Y"6?GPL%9D=R!L8GC)KWJWN([N!)8
MG62.10R.AW*P/0@]Q5%'A7[7?[>>A?L>>,?"6EZYH^H:A'XL,RQS6K@M"T:Y
M"B/&79C@ #UJ#2_V[(_#/P&UOX@?$CP1X@^&>G:7,(K6TU*6*>ZU,-_JS&D?
M\3$@!3SDUYI^WOH-KXA_;V_9JBNX5FCAU6YG56&1N1,J?SK&_P""XEAK$OPW
M^%=Y87\&DZ?8^,[=[^^N;;[1:V:E2(Y)4/#*),<'BIU)UW.LTG_@J?-H^JZ%
M<>.OA#XX\ ^$?$US':Z?XAOY(I;<O(<1^:B_-$&R/O5Y+_P6X^*WB-=0^&_A
MN#P'J6L^&I/$=E=B^2]B6UUF3DBS\L\YX!W-\O-=?\;_ -CKXW?M'_!\Z%XJ
M^/'@6Z\*ZFT,P>'PU# 'VL&0I*&XY P0:9_P52T"7PI\._V?=+FN/M<VF^,-
M/MGGQCSF2,*6_'&:'L&IF_MG:S=>(?!?[/M[?>!6^'=Y-\0K82:.[1.T6$(#
M%H@%.17T1^U+^V[HW[-.M:+X=MM#UCQGXV\19.G:!I(!N)E'5V8\(H]37E__
M  53_P"0I\!?^Q^M/_0#7D?QI\/^/I?^"QNI+H'C;0_ ^H:KX0MUT6\U?2TO
MHKI5<^9#"'("N.IQR1Q0!],_LY?MZP_&+XLW7P_\5>"?$'PU\<0VIOK?2]6=
M)A?0#J\4J?*V.X["JWQW_P""AEA\-OC$WP\\'>#?$7Q,\;6\0GO=.TADCCT]
M#T\V9_E4GT/-<1X?_8K^)^M_M:>!?'WQ"^+?AK7]0\'QSI;6-CHJ:?/<0R#Y
MU.ULL..XK#_X)?:S8:)^TI^T%HFN2P6_CN;Q0UT\<_RW%S9D'RF3/+(!CIQ1
MJ&I<_:G_ &TOB!K'[%'CC4;7X0>-/#.NV\,]C>1S7\,<FCQ^66%X)!Q(G;"\
M\TG[#?[17B3QQ^Q*L?C[X8:POAO2?"C73ZIJ&HQ7$7B-0#N0+C<NX9.6S7M?
M[>MS%KO[&'Q4M;.:&ZN(] N4>.*0,R'9G! /!^M><_L_74=Y_P $B-+>&1)%
M_P"$*E&5.1D1L#3ZCZEO2OVSO!OP!_X)V>'?BGHG@MM'\(M#!]GT*UF2/[$D
MLQ3[V-N <L>.:Y_QK_P5H;P3HEOXJG^#_CQOAG*Z*_BHM$D**V!YGDGYS'G^
M+C(YKQ;XE0)=_P#!!+P7%(H:.1=.1E/<&\P17U/^V3HMK;_\$UO&EDMO$+6'
MP>R)%M^50(5Q@>U(6IVGQK_:[\%_ GX"Q_$35[YYM!O(8I;$6Z^9-?M* 8TC
M7NS9'%> ^-O^"MVJ?"7X;7GB[QI\"_B!X8\/_96GT^[N)X9%O7ZI&X49A+]B
MPQ7AOQ=U'^SOV7/V,M8UY]W@W3]=LFUAY/FC0;"$+]MN<#GO7U)_P5M\>>'-
M!_X)U_$0ZE?6*QZMH[6^F@NK?:)GQY?EC//U'2@+GNGP4^)\/QI^$WA[Q9;V
MLEC#X@L8KY+>1P[0AUSM)'!(]:X?]LG]L+2?V,_!>C:]K6FW&H66K:I%IK&&
M98_L^_\ Y:'(.0/0<FIOV$?^3./AM_V +7_T6*\4_P""Q^C6_B'X;_#.RNHQ
M);W'C>P21#T8;Q3Z#Z'IOPE_;.U;XE>%O$WB*\^%?C30?#FCVOVS3+NX$<DV
MOQ]O)A7YU)X(#>M>?ZS_ ,%0]8^'%SIFH>/?@EXZ\$^#=4NX[-=>N[F":.!I
M&"H9(D^9021U/%>B?\% _P!I34/V0_V5-2\6:':VDVI1S6NG6?V@?N+>2>01
MK(X_NIG)'H*^,_\ @HS\+/&OA3]CI?$GQ#^/.K:_=:U<6;6V@V-O!;Z;>R.Z
MMA5 W,J]<@\#FDQ,^[_VFOVNO"/[*_PRM_$VO37%TNI2)!IEE9)YMUJDSC*Q
MQ*.I/Z"N(^"O[;'C'XE?$'2-)U[X'^./!>E:XK-;:M>W,,T*X&0)$3YH\^]>
M$_M5:G:^%?VJOV3=9\3/%#X-ALG@>:Y'^CPW[1)Y)8G@'&<$U]Z/K5G$UNK7
M5LK7?^H!E4>=QGY>?FX]*8SPG]CWXH^"?%&I_%5_"?@B+PK-X?UZ:#5WMPK/
MK%PBEC-A0/F/H>>:X?QK_P %.O$G@#2+KQ'JGP#^(EGX%L7S<Z[-/ AAAS@S
M&W^_M'7UKSS]ESXR2?L]?"[]JSQM#:?;I?#/B.\OTMR<"5E3@?G7*?&K0?B)
M\3/V!M:^*GQ!^/=YI^EZ]H;7L6AZ#;006,OF+E+4D@LYY"D#DD&ET$>N?\%9
M?'.F_$O_ ()]:1X@T>X%UI>L>(=!N[:4#[Z/=QD?CS7V-9_\></^X/Y5^<?[
M0AS_ ,$2OACW_P!/\/\ _I8E?HY9_P#'G#_N#^5"!'C/[6?[;N@_LL76BZ.=
M)U;Q9XQ\3.8](\/Z4H:ZO,=6)/"*/[QXKXO_ ."@?[6^J?%_7_A#X:\5?#?Q
M1\-]?A\96E[#;ZF\=Q#=Q="4EC^7<">5/->O>*=4M?#7_!;S2Y?$4D-O:ZIX
M*%OH#W! 1K@.WG*A/ 8C'3DUG_\ !9;QGH?_  E'P.T-KJUDUYO&EM<QP AI
MHXAP6(ZA23CWH8,]N^*GC[P7HG[<'PU\-ZAX(M=5\::[HU_>:7K[% ^G1P*"
M\0R,_/GJ#Q6]^R7^UW8_M4P>+88]%O/#NK>#=9ET?4+"YF65U93\LF5 ^5P"
M0,=*\E^/G_*7#X _]BMKG_H*5YY\>/B-#_P3P_;_ /%7BZXW6_A7XH^%Y[QL
M#$8U.U7(_P"!., ?C0%SZ/\  G[<.A^./B]\2_#XT^:ST/X7QJ=3\02SK]E>
M4KN:-5QG*KR3FO*9_P#@K1+<:#=>+--^#?Q U3X9V<A$GBF,Q+&8@<&98#^\
M:,>H[5Y1K7P$\1>#?^",?CO5!#,WB_Q]#-XGUDHI,K+.^\IZD+&1Q]:Z?X"_
M!WXW_%C]D_08]#^.GP^/@S4-"CMO(3PI"R6\)B"M&S9X9>02><C-&H79[]^T
M/^WSX7^ _P"SSX?^)D5M-X@\.>(KFUA@DMYEB*),0/,.X'[O<=>,5C^%/^"A
MT-[X-\5>,/$?P_\ %7A#P#X?M/MEEKVH&,KK:YP!#"/G!;J-W45\W?MA_LV_
M\,^_\$T_AG\/;[78?%-OIOBK3H1>Q+MCGC:YW8 R>.<=:^VOV@_@9X9^.WP
MU'P/X@E&GZ)JUJEJ)(Y!"UNW&PH3QD'&!1J&IYA\(/V\O%OQ3\7Z##/\#/'6
MA^%_$<BK::_=7$#1*C<K))$OSHI'/-7=?^*OA'1OVZM3T*S^'L>H?$*U\*?V
MFFMQNB374.XA;4$C(R>Y..:\<TOXJ?%O_@G5\6OASX#\9:_I?Q(^'OC&_30M
M)O3#Y.L::0OR!P.)%"@#-=; <_\ !9^Y_P"Q!C_]'&@#Q;]D/]L#XKZE^W5\
M9HYOA7XLUA+C4K2&72WUJ''A=/+7@Y&U@?O?)ZU]B?LL_M@6/[3'B'QQHO\
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M^,'C2+4%_M*2Q@OM.L7'VAY"7+"(L6"JO).:JW<JW?L?E%^SA_P6(U+]FO\
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MSJ?Q,_:>\3>)-"\)7D=WI]GIPGAFC\M@5&^1V Z 9 S7T/\ \%H/^".>N_\
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MBKW9LX ]:_6K]K_X&7'[3/[,'CKX?V>H0Z5=>+M(GTR*\FC,D=NTBX#,H()
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M:7>*;'5/#?B&2WN+P@96':_#X(R,#(Q7Z*?\%7_^"&?@;_@IIK.F^+(]9OO
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MX#\2?M,Z9\7+S2Y9?&VDV9LK>Y\]O*$>" 3']TL,G#'D9KU&B@#RWXE?L;^
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MIJFE7LFGWC(.BM)&06 ]#7M5% 'FOP7_ &2O!/P'^'FI>%]#T^YFTO6BQO\
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M/@";P_>6/V#3=(B@NEC94^RS(,2"0?PMN!)S]:\#_8>5-?\ &'[8'B30RO\
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M?%7_  5'USX;:5;^(?%WP)^('AGP+).D4NNW-Q WV9'("R20+\ZKSZ\5X?\
MLN_M!W?[-O[*O[2/Q:T&RBOM)O/&%Q)X?$GR6TK9,9E_ZY[B"2.M4/VZ?A[X
M\/\ P3O\1>.OB-\?-4OO[?T99[70=*MX+?3+Z28!D@Z%V49P2#VHOH%S[/\
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MI9"<+&#( ,GZTG_!:0FW^#/P[U6[5I/"^E^,;"YULA=\8M]PVLX_NAL')XH
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M!,\19MC8ZE1SST% 'MG[(_[<^C_M3:SK_A^?0=9\%^-O"S#^U- U7;]H@5N
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M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5J^"?\
MD9[7_@?_ * U95:O@G_D9[7_ ('_ .@-2EL*6QE4444QA1110 4444 %%%%
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M-M%@4_7 R?QKL*JZ3K5GKVDP7]C=6]Y8W48EAN(9!)%*AY#*PX(]Q7@?Q/\
M^"LG[-_P9^(/_"*^)?C#X-TS7_-\DVAN6E*/G&UF1653GU(Q0!]#45XGX>_X
M*.? [Q;\<M/^&NE_$KPYJ7C?58EGL]+M9'F>Y1EW!E=5,9! S]ZNJ_:$_:Q^
M&_[*/AM-6^(WC30?"-A(2(WO[@(TN.NU!EF_ &@#T*BO&OV;O^"A?P3_ &O;
MV6U^&_Q*\,^++R$$M;6MP4GP.I$<@5B/H#6S^T7^V1\+?V2-'BOOB3XY\/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/^S3^Q7\2M%\">&M,\,Z;/H-[--#9Q[1-)Y##>QZLQ]37%_L/_L^>!?VBO\
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M7YQ_LG?L0>%_VH_^"F'[66M?$&W;Q%X;T'QC:Q6&@7$K?8'N'LHRT\L8(#L
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MX$)<<9QWKW[_ (*D>!M-^&7_  2ZU[P_HT:Q:7H]E:6EJH.?D1E .??&<^]
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M#P'X=736U#QMX1L5UI=VGFXUBWB^WC(7,6YQY@R0/ESR1774 %%%% !1110
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M.V1U.#A0Q(7 ''%?U8542HA1115%!1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3C_VL/\ L8[+_P!*M6KOP_\ N];TC^9T4OX4_E^9^E]%%%<!SA1110 4444
M%%%% 'S1^TE\<O'VE^,=8\+S?L\ZE\3/"LR 6=]:W=L89LKR)8Y>5Y[CM7.?
ML"_L:>)_A3^R-XZ\+^*;>WT>;QQ>7]W9:)#<&2'1(IU8)"&]LC(' Q7UU10!
M\<?\$Y+?XG?"?X!6_P &?&'PQU?2%\(:;=V5MXB%W$]CJ8W2&/8H._+;N^*[
M_P#X)>_";Q%\%OV4;/0_%.DW&BZM'JM].UM.5WA'F+(WRDCD'-?1%% 'Y_\
M[/'AKXR_L3>.OB+X>M?@S)XZD\5^(KK6-*\56MY#'$JSN2J7)?YPL>>B]@:]
M'_X)A? #Q]\+/"/Q8M?B)8/9ZMXH\27%XLXQY5TDB'+QX).P$X&<' KZYHI6
M%8^)/^"?O@CXC?L^6?B/X*^*?AGJQ\,WVKZE<0>+;:\B:Q:VN"2H*$[]V#CI
MUKF?@/X0^*'[ ^EZA\/9O@1_PM;PO97D\V@:UI+VJS+;NQ98IQ*,Y7.,BOT!
MHHL%CYS\:? G6?VP?V)?%'A7Q-X3TWX<:WXGAD6WLK5UD^QLN#"\C( "X/4#
M@5Y?\-OCM^T9X-^#$/P\U+X+W#>(M%L/[+7Q4^IQ+HSQ1IL%P5_UF0H!QCDU
M]B>/M"OO$_@O5-/TS4IM&U"\MVBM[Z(9>U<CAP/:OE?Q!^R'^TQX_P##<OAG
M7OC[HJ^&[I3;W,^G>'1!JDT)X(\W=@,1GD#O0!E_\$+='N8_V)]:@U1DO)+C
MQCK'G2[<1W>9%#.!_=8YKQ_]E/X!:IJ?_!1S5OAS+-%>?#GX,:W=^*[%%;<J
M75X 88B.@\LECM]*^R!^S!KGP4_92T_X>_!77].\'ZEI(C2WU/4['[>K+NS,
MSID9=^>>QJ7]B_\ 9!M_V4?"6L&[U>;Q-XN\67S:GK^M3)L>^G/  '\**. .
MPI6%8U/BY\3/B+X5^.G@/1?#/@F#7O!^N22+XAUE[CRVT51]TA<_-GZ'I7J=
M%%44%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %:O@
MG_D9[7_@?_H#5E5J^"?^1GM?^!_^@-2EL*6QE4444QA1110 4444 %%%% !1
M110 4444 %?)O_!<C_E%M\4/^X5_Z=[*OK*ODW_@N1_RBV^*'_<*_P#3O95T
MX/\ WB'^)?F:T/XD?5'OG[-?_)N?@#_L6]._])8Z[:N)_9K_ .3<_ '_ &+>
MG?\ I+'7;5A4^)D2W84445)(4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5^:'_!!#_DX_]K#_ +&.R_\ 2K5J_2^OS0_X((?\G'_M8?\ 8QV7_I5JU=^'
M_P!WK>D?S.BE_"G\OS/TOHHHK@.<**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
MU?!/_(SVO_ __0&K*K5\$_\ (SVO_ __ $!J4MA2V,JBBBF,**** "BBB@ H
MHHH **** "BBB@ KY-_X+D?\HMOBA_W"O_3O95]95\F_\%R/^46WQ0_[A7_I
MWLJZ<'_O$/\ $OS-:'\2/JCWS]FO_DW/P!_V+>G?^DL==M7$_LU_\FY^ /\
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M@ZG(#63??!']HK_@@5_P4:\>?$3P-\-=1^)WPZ\<2SC?96TEQYUM+-YXC81
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MI'\SHI?PI_+\S]+Z***X#G"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4I!R"R[<$@\C(JY<_#[0;WPS'HLVAZ/-HT.-E@]G&UJF#D8C(VC!YZ=:V**
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MMO)COHHW,TC_ +N1DR1AQS@5],446UN%M;D=O9PV=JL$,4<4,:[5C10JJ/0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "M7P3_R,]K_P/_T!JRJU?!/_ ",]K_P/_P! :E+84MC*HHHI
MC"BBB@ HHHH **** "BBB@ HHHH *\H_;F^$+_'G]D/XA>$HSMFUC1YDB/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "M7P3_ ,C/:_\  _\
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M_P *RR_^3*/J<OYH_P#@2_S#V#[K[T?=%%?"_P#PT_\ MU?]&S^"?_"LLO\
MY,H_X:?_ &ZO^C9_!/\ X5EE_P#)E'U.7\T?_ E_F'L'W7WH^Z**^%_^&G_V
MZO\ HV?P3_X5EE_\F4?\-/\ [=7_ $;/X)_\*RR_^3*/J<OYH_\ @2_S#V#[
MK[T?=%%?"_\ PT_^W5_T;/X)_P#"LLO_ ),H_P"&G_VZO^C9_!/_ (5EE_\
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M?_)E'U.7\T?_  )?YA[!]U]Z/NBBOA?_ (:?_;J_Z-G\$_\ A667_P F4?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !6KX)_Y&>U_P"!_P#H#5E5J^"?^1GM
M?^!_^@-2EL*6QE4444QA1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %:O@G_ )&>U_X'_P"@-656KX)_
MY&>U_P"!_P#H#4I;"EL95%%%,84444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !6KX)_Y&>U_X'_Z U95:
MO@G_ )&>U_X'_P"@-2EL*6QE4444QA1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %:O@G_D9[7_@?_H#
M5E5J^"?^1GM?^!_^@-2EL*6QE4444QA1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M3[$2GV/WE\:_\'F7AC2=9>'0_@9J&M6(?"W%QXL^QNR^NS["^/IFO2OV=O\
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M(IR"KJ&Q]1G!]Q1%]PB^YTE%%%44%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !6KX)_Y&>U_X'_Z U95:O@G
M_D9[7_@?_H#4I;"EL95%%%,84444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MU:^1?^"$_P 3KKXK_P#!*[X1ZE>R-)=0Z5]C=V.2WE.R#_QT 5]=5J:GSO\
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MK1[E88_A/ 5>WUK^=CX4?M(?%3XI_M_ZE^T%H/P]U'XEZW9:V^K&U^P3WEO
M[$^2'\L$C:N,#VK]H-1_X(;_ !\UG_@G(O[.=Y\</#UQX?BU)+F*];3)_.6U
M7)^RGY^4WX(]LBOJ#_@CO_P2XLO^"6O[.-UX2DU2T\1>(-7OVO=2U.&W,*S\
M81 I).%&>_>G9L=FS\,?^"HW[=?[2/\ P4H^%&F:;\0?V?[[0(/"]PU_#JMI
MH5[');IM(<,SK@)CDY]*_13_ (-/OV[_ /A<?[,VK?!_6KSS-<^'\GGZ<LC?
M/)8R'H/]Q^/^!5^L7B;PQ9>+O#E_I5]!'-9:E;O;3QLHPZ.I5A^1K\L/V%?^
M#>#QI^P1^WROQ7\)?%#1_P#A&6O;@2Z(VGR+)+8RL3Y);=C<H(P<=11RM.X^
M5IW/U?HHHJR@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *U?!/\ R,]K_P #_P#0&K*K5\$_\C/:_P# _P#T
M!J4MA2V,JBBBF,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "OY[?^#R/X9WMM^U#\*?&/V>0Z=>>%6T<S;?E$L-W/-MS
MZE9\X]C7]"5>1?MF_L.?#C]O?X3MX-^)6AKK&EB030.CF*XM)!QOCD'*GMQ2
MDKJQ,E='\KG_  24_P""9GB+_@IG^TW8>&;*.>S\*Z:ZW7B#5 IV6MN#R@/3
MS'Z ?C7]97[/'[/7A/\ 9;^$>C^"?!>DVNCZ#HL"PPPPH%WD#EV/\3$\DGJ:
M^>_V)=*_9S_8+^+MU^S5\.K1O#/BZ*R369(;R-O-UE&S\ZSMS,R@<CM7UU2C
M&P1C8**^5/V^_P#@G]XZ_:I\?>&O$W@#XW>,OA+J>AH;>XCTQ]]M>1D@Y*'C
M>,=:^B?A-X/U+P!\.-'T;6-?OO%&IZ?;+#<ZK>*JSWSCK(P7C)]JHHZ*OY5?
M^#F+Q?9^+?\ @K+XU2S9'.EVMK8S%3G]XJ9/_H0K^D3]O/\ ;5\)_L%?LW:_
MX_\ %5]# FGV["QM2X\V_N2#Y<2+W).,^@K^7W]C7X">,/\ @L;_ ,%-EDNH
M9IQXDUIM;\0704M'96@DW,"?]T! .]1/L1+L?T9_\$,OA;<_"+_@EG\(]+O(
MVCNI=)^V2*PP1YKLX_\ '2*^M:S?!WA6S\#>$]-T73H5M[#2;6.TMXU'"1HH
M51^  K2JRS\]_P!H;_@J-\=K'_@H+XH^!?P>^%/@_P 9W7AG2(-7FN-4U26T
M<QR'!Z<<'%2:G^W#^V]X!LWU/7OV7_">K:7:C?/!H7B)I+PJ.NQ7X)Q7,_L]
M_P#*R/\ &/\ [$*S_P#1HK]*6<(I9B%51DD]JDD\"_8#_P""B'@W_@H#X!U#
M4/#\&H:'X@\/W'V+7?#^IIY=]I$XZHZ]QUPPZU\P^)O^"J?[1?Q"_;0^*GPK
M^#_P=\$^++?X8W<<%Q=ZEJ\UI)(KHK X''?M6#^P5J%CXQ_X+X?M%:QX'>&;
MP?!H=K::O/:<VLNI!UW<CY2X Y^AK2_X)=?\IC_VQO\ L(67_HI*-0.@UW]O
M_P#;.^$.G2:UXQ_9=T+5=!LP9+M?#.OM/>QQCEF5'X.!V&37U)^P_P#MR>"?
MV^/@Y'XP\%SW")#*;74=.NT\N\TNY7[T,J=F!_.O8+NXBM+626=XXX8U+2.Y
MPJJ.I)/:ORE_X)A?$2U\*?M2_MP?$#P:H?X=Z??-<V3P#_19[R*%BYCQ\I^8
M-G'K3&?47[<7_!7'P[^RY\2;7X:^#?#.M?%?XN:D@>'PUH@#&U4]'N).D:_7
M]*\N;]L+]OJVMO[:D_9L^'LFD@>8=-C\0R?VEMZ[<9V[OQQFH/\ @WA^"]IX
M@_9RUCX]:\BZI\0/B_J]UJ-WJ4XWS0VXD98X$8\JHP>![5^BE+?46^I\G?L'
M_P#!63PK^V%XSU#P'KV@ZQ\,_BQHJ[K_ ,*ZVNR=E'5X7X$B^X_6O?\ X]_'
MWPG^S)\*]6\:>-M8M=#\/:-$9;BYF;'T51_$QZ #DFO@K_@X,^%D/PD\*?#_
M /:/\+HFE>//AKXDLHGO8!LDO;.:4(\,A'WEYZ&N=_X*&:E_PW]_P45_9I^"
MNIM(/ E]IA\<:W8[R$U HBO'&X[KUXHN%^AUN@?\%7?VC_VNC+J?[/G[.BW7
M@PL19Z_XROVT^/45[/'&OS;3[@_6M"V_X*O?'?\ 9F\3:7;_ +1?[/ESH?AS
M4[E+3_A(_"%TVJ6EH[D*OF)R^,GJ,5^@6AZ'9^&='M=/T^UAL[&SC6&""% D
M<2*,!0!P !6?\0/%/A_P=X9FU#Q1?:3INCPLHEGU&1([=&)^7)?Y<YZ>],9P
M'[8'[24O[.7['_C+XGZ78PZI)X;T235[:UN=T:W&%#!6Z,,Y^M>7?\$GO^"I
M7A?_ (*@? -?$6GQV^C^*M+;R=;T02;FLI.S+GDQL.AK2_X*Z7L.H_\ !+OX
MR7%M)'-;S>%+EXI(V#*ZE0001P017YP^ /V7/%W[(?[)'P3_ &N/@?9R2:QH
M_AVWC\=^';8$1^(=/!.^78.LBKSGKQFAB=[G[4>)]6;0/#6H7RJLC65M).%/
M1BJEL?I7SU_P2W_;EU/_ (* ?L\ZCXTU;1+'0;FRU^]T<6]I([QLL#A0^6.<
MG-=?\#?VJ_"?[9_[(K>/_!M]'>:5K.D3NR9_>6DOE-OBD'9E/!%?'?\ P0%\
M8?\ "OO^"8/Q UW&XZ/XFUZ\ ]3&=P_E1U'U/<OVZ?\ @K3X9_9,\?6/P\\+
M^'-:^*7Q:U9-UKX7T,;I(%/1YWZ1K]?TKRG_ (;#_;Z^S?VU_P ,V?#W^R<>
M9_9O_"0R?VEMZ[<9V[L>^,UG_P#!O/\ ".U\>?!KQ3^T)XB5=4\??%C7+NYE
MU"<;Y;:T60K'"A/*J,=!Z"OT<I;ZBW/DG]A7_@K7X9_:S\?WWP[\4>'=8^%O
MQ:TE"UWX7UL;9)E'5X'Z2+]/UKK_ /@H5_P42\._L!^!]'FO-)U+Q5XN\5W8
MT_P[X=TT9NM5N#V']U1W-?-'_!PM\(+?P%\)O!_[0WAM4TOQ]\*_$%E)'J$
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M@&)&6]*^D?C+\9?#7[/_ ,-=6\7>+]6M=$\/Z+"9[N[N&VJBCL/4GH .2:^
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MKE-^/*;<"-N3G\*^A=0_X(P_%;QY;G3_ !A^V!\9M8T.;Y;FS@>*#[0AZJ6
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MV]OX^\/B;4M/YL-8LI3:ZC8'UCF3##Z9KYI/_! 6WFM_[,F_:*^.TWAG[O\
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MQ_$'P;^R;\+[J+Q'X@U_6K;4/%=S9-YUOH=C!('/FNN0&)'3-??^C?$GP/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >,_&G
M_@H'\(_V>/%[:#XR\6+HNJ*4412:?=2*S/\ =572,JS'L <UO?#+]K3P+\8O
M%EEHOAW5I+Z^U#3'U>!6M98=]LL@B+8D56'S$#!%>3_\%.?"[:WX;^%S6^G-
M>21_$+1I)3';^8RQB;DM@?='<GBN)^/G[+&F?M#?\%-]+L]:&OVOAZS\ 3%A
MIMS)9PSRFZC 5WCQG'W@N>HS2 ^UJ*_)_P >>+OB9!\"OAOI.OWVL2?#W2_$
M>M:5J]YJ3WJETAE=;(74EO\ OC'M PW0D#-?9G_!+N+74^ E\VI>)(_$FCOJ
MLQT214N@;2UXQ"'N0)'56SM8]C[4P.@B_P""E/P1D\73:&WCW3XKZWO6TZ4R
MVUQ';QW"ML,9F,?E AN/O=:]RBF6XB62-E=' 964Y# ]Q7YG_L_? #XR?'G]
MGCXA> +/0? FC^#?$GB_5XI=8U6.9]4@A:[)9XXN%W8'RMT[UU'ASX#>+],^
M*_[0&JZ'JGBS4O$'P]T>ST_P7:SW<JV33"Q96E6/[KR';UYP:0C]"J*_*?\
M8^O/'VK>)+6Y\$^*HX?&7_".7KZ]I=Q_:DUQ?7GD':9_M \F.99N05//0<5E
MV'B;0_#?B;X!_P!DWWQ>L_B=J?C'3[?QHNJM>1VT\A)\Y)C)B)E+YV"/(QCM
M1<+GZV45^8NM? O6M1^ GQO^*DFL^/U\>>%?&EY)X<V7]PL=I%%)#M2*$<-&
MP+9X(-<S_P %!/BWK&I>/_%6HZ;:ZQH/C3PS::=+I=Q)=ZDUSJ$C!&9[."$>
M2$R2&#YSSFBX7/U@HK\_+[X!WG[3_P"TC\5[[Q=JGC6.TT;P;I5WI5O9W\]G
M;1WK6TKM*@7 :0, /:N(LO'5UXYTGX2M\?M:\::?\/)O!KLES:"ZB6ZU9)=G
M^E&%2^_RAE=PP3[T7"Y^G50:GJ=OHNG37=Y/#:VMLADEFE<(D:@9))/  ]:_
M/7XM_%?6/V37\,^(OA_=>,/$OACXO:'_ ,(OH\6K-+)=6NJAF%K,ZR?,H9&8
M$D _*N:]N_:D_9S\50?\$T-1\"Z#<7^N^(;32H?M>9B;C5MKK)<QACSF3YP!
M[XIC._\ A]_P4$^#_P 4_'T'AG0?&UA?:M>2-%:J()HX;QQU6*5D$<A_W6->
MR5\E>"/VTOA-XQ\ :+X8\"Z3<1^-H[!X=)T5O#DT4VB720D*)2T82+:P W;N
M?>OG#X):^JZ[\*;OPKKGQ$O/CU?:_%'XYL;\W?D+;ES]L%PKKY*Q*/\ 5E3Z
M8I7%<_42BORH\0?L_>(+W]D_Q%\1H?$7Q(M/B#_PL*>RM;B#4;E6M;![\QM%
M'%T\LQD\X[YKO?C7X$U3]DW5_C5X=\(ZKXNA\+W7PP?6D-S?37/D:BLH0R12
M/G;(RDD@'DT7&?HU17Y<?L]>,-'L=;^#VH?"36OB1XD\77NFM/X^M;Y[QEEM
M1:%G,QF4(LOF8$90D\C'%8W[,7Q0UJ3]KSP+?>'%U/3;7Q5;:LGB#3/M6I7D
M]OB!WC6\:<>4LJN!C9CVXHN*Y^L%%?F#\/?@GKG@3]E[X;_%:WUCQ]<?$*\\
M:QVM\;B^N)%>QFU"2)X&@/ B$>.W'6NXT+5?'$_[1Q_9GDO-::SL=?'BZ36O
M-;<=!+&5;?S,YW&?,>/[I% S[;TSXX>$]8^)%UX1M=<L9O$EFGF36"M^]1:Z
MNO/= _9=\&^&OC->>/K333'XEOH_*EN/,)!&,'Y>G2O0J8!1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %:O@G_D9[7_ ('_ .@-656KX)_Y&>U_
MX'_Z U*6PI;&51113&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ,FMX[@+YD:2;3N
M&Y<X/K1]GC\_S/+3S,;=^WYL>F:?10!#)IMO-;-"]O"T,G+1E 5;ZCI3[>WC
MM(5CBC2.-!A51=JJ/84^B@!L,$=NNV-%C4G)"C&30D$<4C,J*K2<L0,%OK3J
M* *<OAZQFBND^RP*+U#'.438TJD8.6&#T]Z\M\._L)_"_P ,>+-&UNWT+4KC
M4/#LQN=,-_X@U&_AL)3D%XX9YWC5N3@A>.V*]>HH B^Q0^4T?DQ;)#EEV##'
MW%1W&C6=U.LDMK;22*NU7>)68#T!QTJS10!&MK$CLRQQJSC:Q"C+#T-1W&DV
MMU:K!+:V\D*\B-XPRC\.E6** //]9_9;\#^(OBG8>--0TFYOO$&E2^?923ZG
M=R6UI)MV^9';&7R%?;QN$8/O7H%%% %>#1[2UO'N([6WCN)/ORK$ [?4XR:6
M+3+:"[>X2W@2XDX>18P';ZGJ:GHH B^PP^5Y?DQ>7G=MV#&>N<5D_$'X<:+\
M4_"&J:#KUA'J&DZS;-:7D)=HS-$W5=Z$,!]"*VZ* ,OPIX,TOP/HUKI^DV,%
ME:V<"6T2H,L(T4*JECEFP !DDFK4.BV=M,TD=G:QR,=S,L2AB?4G%6J* *]Q
MI5O=6+6SPQ^0P(V ;0,^F.A]QS7%?"S]F7P5\&?%.JZYX?TJXAUG6D6*\OKS
M4KK4+B5%)*H'N))"J DX52%]J[VB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ K5\$_\C/:_\#_] :LJM7P3_P C/:_\#_\ 0&I2V%+8
MRJ***8PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "M7P3_R,]K_ ,#_ /0&K*K5\$_\C/:_\#_] :E+
M84MC*HHHIC"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH *U?!/\ R,]K_P #_P#0&K*K5\$_\C/:_P#
M_P#T!J4MA2V,JBBBF,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ K5\$_\ (SVO_ __ $!J**4MA2V/
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>img152117643_3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img152117643_3.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" /2!W@# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MG_X0E=8TPZ.86W!H#;71!8]?,))+[OFW[MW.:\V_;_\ ^4%/[/O_ &%=+_\
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M+S6;'2;S4]2N7FTN6.*X#11AE :2.1<$]?E_*OT"_P""*?\ RC*^&G_<4_\
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M4:_X*%Z#\"_ -UI?E^![6:2>>^=ELHKTQB6X>5EC<[4588@-K8<L.-QQE?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC0!5RQ)X Y)/>M*BBLFVW=F3;;NPHHHI""BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M5QO[0?Q^\)_LM?!;Q)\0?'6L6V@^%?"EE)?ZA>3-]Q%'"J.KR.V$1%RSNRJ
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MM[\"_AWX5:ZA>.#5/">AVV@ZA9.1\LJ2VR)N93@A9 Z'&"I&17Y3_P#!!/\
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MPJ70@O+D [&*_HC82M-8PNW+,BDGU)% $M%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ML'_*+/\ :6_[)5XH_P#31=5^?_\ P94_\HL_'W_95=0_]-&CT <1_P %PO\
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MIO8;U92161_P9O6NFV__  2/U!K'_CZG\?:H^H?*HS/]GLE'0Y/[E8>6P?P
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M-?+I-P;9)3B-Y/M\6P,?0MC/M7]#]?SU?\'C?_)^?[,7_7A+_P"G&&@#[?\
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M/O'VB_"OP3JWB3Q)JECH>@:%:R7VH:A>2B*WLX(U+/(['@* "<U_,A_P;D_
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M=%)^45^P=?@+_P &G&GPZ3_P5%_:\M;:-8;>U:2**->B(NJW  'T H ^M/\
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MQ<O9/ Y\YEE*M(DB,55!D8Y^#O\ @BGXG\4>/_\ @ZC^*NM>,?"#>!?%5_\
M\)+=:QX>&IQ:I_8D[.F^ W4($<VQCM\Q0%;MUK]@?^"^5]#I_P#P1Q_:#DGD
M2&-O"LL89S@%GEC51]2Q 'N10!^6_P#P;3_\$MO^&Q/^"=MYXM_X:,_:H^%G
ME^+;^P_L;X>>/O[#TAMD5LWG&#R)/WS;\,^[D*O'%?K!8?L _$CX._L?7GPW
M^%/[3WQ8TWQ?<:R-4B\??$.*U\?:O;Q'8)+0)<K%&82$^4$90LQ&<U\P?\&@
M^F06'_!'32YH8PDE[XLU>:9@3^\</&@/_?**./2OU$H _"__ (-T?VJ/B_\
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MZ_?.^O8=-LIKBXD6&"W1I))&.%10,DGV % '\N'_  :N_L)_\-M_$7XT6?\
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M1BM' :"9V)>4/ 5N(V?+A1(&8_*!]%_\."_^KU/V_P#_ ,.]_P#<E5OV4/\
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M3I@O-;NH[&P_M'2KFYB,#2RD*C2+=2-&6(5@I )+*#^WWP&_X*B_#/\ :O\
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MNZ;I5UXF\)7VC:3:S7"+<:E=7"K D<,9.Z0AYD+;0=JY8X )KX]_X,[/VA?
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M>@KQ7X"?\&_W['?[-/C*W\0>$_@5X875K219K>?6+N]UP6\BD%71+Z>948$
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M(_ 7P1;>&? OA7PWX+\-V;O);Z5H6F0Z=8P,[%W*0PJJ*68EB0.223R:X/\
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ME/"MOH7Q&\#^#_'VAVMVM_!I_B/1K?5;6&X5'19EBG1T60))(H<#(#L,X)R
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M'Q5X1A\KR]#UC1[>^TU/*XBQ;RHT8V8&W"_+VQ7FVD?\$M?V8_#^K6NH:?\
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M/%7AS5D$=]I6KV,5]97BA@P62&561P&53A@>0#U%>-?\.G?V6?\ HVG]G_\
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MGX2\):3X \*Z;H.@Z7I^BZ'HMK%8Z?IUA;);6MA;Q($CABB0!(XT10JJH 4
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M>+_ VB?$'P=J'AW7M'TO7/#^JVS6=[IFH6D=S9WD##:T4D3@HZ%>"K @CC%
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M@+X+_"?P1X@CB>!-3T#PCI^FWB1OC>@FAB5PK8&1G!Q0!^-/_![/\(M<L%^
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\/\ BK5/!,\-KKL.EWB77]F2RJ7CCD9"5#%5;C.05(.",5W% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^'W[-_P"Q%_P5 \!:
MA\9?@_XB\2:7JWA'XPWRI<?%'6O%@U'_ (1NU<RI>2Z99B87*330R*%C:.-(
MVB7:4^^/V&_9B_9T\,_LC_L^^$/AIX/M7M?#?@O3(=,LED.Z214'S22'C=([
M;G9L<L['O7=T4 %%%% !1110 445RLGQV\#P_%N/P WC+PJOCR2T^WIX;.K6
MXU=[;G]\+7?YICX/S[=O'6@#JJ*** "BBB@ HHHH **** "BBB@ HHHH **@
MU35+;1-,N+V]N(+.SLXFGGGGD$<4$:@LSLQX50 22> !7R!>?\' W[&=C\0T
M\+R?M!>!CJ3R&,3(UQ)IX(VYS>K&;4#YAR9<'#8/RM@ ^QJ*K:-K-GXBTBUU
M#3[JWOK"^A2XMKFWD$L-Q&X#*Z,I(96!!!!P0:LT %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?\&K[_M:/X&^,S?LWM^SRUJVI:8=?;XF'63,9?+N?)-M]@XVX\S?YG.=N.]
M'],=?E5JW_!OIXWU/_@OW'^UC_PLO2D\#+J*:\=.Q.=<^TK9BV^Q?=\K[,0/
MO^9N\O\ =^7_ !U]?_LY^(?VN?"/P9^(VK?&SP[\!_%WC/2[![OP9H7PTO\
M4M/BUJ>."5_LEU<:F"L#2RB&-90"B!V9A@5\)> ?^"]/[17C7_@LU\+?V9_'
M?P7\-_!%=4NY&\1::^OP^)K^:%].FNK<)=P;8$!VHQVJS<X)7D4 ?L'169XU
M\::3\./!VJ^(-?U*ST?0]#M);_4+Z[E$5O9V\2%Y)9'/"JJJ22>@%?EK\"_^
M"I7[2'_!:GXR^++/]E$>$_A#\$/ UY_9U[\1O%FD/JVI:U<X#*MG9%EC7*%7
M,<ARJ.C,Z,ZQT ?J[17Y0?MK?M.?MS?\$7_!-G\3O&7B[P%^U9\';&ZAM_$\
M@\*)X3UW1TE=465!:R/"(R[*GF,),,Z@H =P^^_V"_VZO /_  49_9IT/XH_
M#G4)+K1=6!AN;6<!+O2;M /-M+A 3ME0D="0RLK*65E8@'LE%?BO_P %=O\
M@X0_:H_8*\>^'/"]]^SIH'PMA\5:M*FCZQ>^*+;Q9<:]8VUPBRO#:VNSR'D2
M2+"S98;R!DC*_;'B?PU^V=^USX7;6/#OCKP1^ROIMY"TFF:5<^%(_&7B/:R_
M(U]))<1V=O(<@F*))Q&1@R2<@ 'VA17X[?LE_P#!9W]H+]D__@K!:_LD_M>?
M\(CXBF\430VOAKQKHEC]@^U2W(+6;NBA8WBG;$&%C1HYN"7&2/UA^-_QBT+]
MGGX->*O'GB>X:T\.^#=)NM:U*5%W.EO;Q-+)M7(W,54@+U)('>@#J**_)W]B
M']IW]M3_ (+6^&-:^*W@'XE^!_V8_@V^K3V'A> >#H?%>M:K'!(%>2X^T2+$
M!N5HRR%.?, 3Y5<[FK?\%"OVNOV*?^"@_P #_P!G_P"+VG_"WQYX>^+FN-!8
M?$32]*NM/DO[..$^?;M:";RX+V.0QL6!>,QRKA222H!^HU%%% 'X\_\ !Y5^
MV'K/P-_88\%_#+0[R73Y/B_K$ZZG)$Y5Y]/L%BDD@R#G:\T]L6]0A4\,:^M_
MVK/^",W@C]HO_@E);_LO^&KRS^'NDV%GIR:=JMKI,=W]FN+5XG:>2+=&9'FV
M,'?S%=C(6+'D'\5?^#K;_AJ;R?@3_P -*?\ #/\ Y>_7_P#A&_\ A6?]K[O^
M8;]I^V?;_P#MW\OR_P#IKN_AK]I_V>/^'AO_  MOPW_PM#_AC'_A7GVA?[;_
M .$6_P"$E_MK[/M/_'M]H_<^9G;]_C&: /=OV#OV4H/V'/V/OA]\);?7KSQ/
M'X%TB/3/[4NHO)DO67)9Q'N?RTW$[8]S;%"KN.,UZY7Q3_P6+_X+0>%?^"5'
M@W0=+M]#N/B!\7/'CFW\*^$+*0K+<DL(UGG*AF6+S"J*JJ7E?*H/E=DX;P'^
MSS_P48^+W@FU\6>)?VD/A5\)_$5Y$+M?!&D_#B#6=/M2PR+>>^FF\X,N0&,6
M\!@<,XP2 ?H?17Y8?L.?\%ZO&?A']N6\_95_;!\+>'? /Q9CNTLM%\2Z&\BZ
M#XD>0 VZA9"3&9U*F.0-M=FV%(7 0_=/[;'QM^+WP-^'VEZE\&_@A_PO;7KK
M4!;WFC_\)C9>&/L-MY;L;GS[I623YU1-BC=\^>@- 'LU%?AC_P $^?\ @Z=^
M(O[3%Y\7EU;X>V7B?Q_JFJ:-I'PE^&WASY9[R>X2^-R;BZ?YO(A6WBDFN&PB
M;QA8U;*GQ3_;Q_X*;?LE?\%+?@[X5^(%KX4\6^'/BE<V<DWAOPEX9%SH=C!-
M=F*XM_MQA%REQ!$OF,S3O&@=6.]>2 ?N=10IRM% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MK]]*_ /]NO4X+_\ X/+/@U%#('DLAHL,X /[MS93R ?]\NIX]:_?R@#^?/\
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MT !E+>);NV;/UA15Y["OZ!:_G]_X+YW4=Q_P=,?L8I')'(T#>!TD56!,;?\
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M /P5%\6>&]0TJ\7]@%K34[:2TF 'BW)212K=01T)Z@BN%_X-R?\ @B[\9_\
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MM>:'-+:ZGXHCM?"Z3QL5,,-Y<)%<].?FMO/3KU<'G&#B?\$/7;]K[XH_'O\
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MM\_]<Q[U_0W7\_\ _P &.;YUS]J/Y201X8.[L/FUC_/X5_0!0 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_:$N/BSJ'Q[_ &JY/B;<W8OF\40^+M-M]5294$:ND\>G*\96,!%V$!5 48
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M^VCX^^%_PYCN))K/PWX@\%Z7XQ324=V<P6L]R4>&(%CA1GDY.YB6/>_L7_\
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M,?Q]8:K\/OC)^T7?Z#8M<RGP?K7BVWE\,74T\7E-/+8P6D*/* %97SD,BGG
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M?=?$KXH?&[3]#TG9)9>&M!UJPM]%MIPA0W*PS64K&9E8@LSG )"A0S9^U:*
M/F/_ ()Q_P#!+K0_^":.AZEI'AGXK_'+QYH%U9VUA8:/XX\3QZIIWAZ* R%5
ML((X(DMPV_#!1@A$&!BOIRBB@ KY#_X*3_\ !$+X"?\ !44Q:IX\T&\T;QQ9
MQ+#9^+_#TZV6L0HO*H[%6CG0=A,CE03L*9)KZ\HH _.OX;?\$F/VM_@E96^B
M^$O^"A7C>/PK:E5AM?$/PUTOQ%J*1#.$^VWDSN<#@';@8Z8P!ZM\+_\ @C]X
M9D^(ND^-OC9\0/B!^T=XPT"X2]TA_&MS$-#T.Y7)$]II-ND=I'*"21(Z2.O&
MUA@5]?44 >9?M<?LTG]K3X,7G@IO'WQ"^'-OJ#_Z3JG@S4(+'4I82CH\'FS0
M3*L;A^=JALJN&&.?B+]DO_@U_P#A/^Q!\2;3Q-\-?CA^U)X9GCOK2\O[*P\9
M6=E9:ZMM+YB6][';V,9G@)+*R,>5D< C<37Z544 ?'/_  4U_P""+G@O_@JU
M=:?;_$3XH_&K1_#.F^5-#X8\.ZQ8VVC?:HQ*HNVBFLIG:?;*R[B^ .B@EB=3
M_@F[_P $BO#?_!,:>:W\(?%WX^>,/#?]FG3++PSXQ\4Q:AH6CJ9A,9;2TBMX
M4AE+!@67M(_&6S7UE10!^9_Q^_X-=?A/^T[\??\ A:'C3XY?M/:MXZAEAEM-
M6/B?3$N--\EM\ MV73<PB)N4VD%3\V=Q)/W1^R?^SE_PRE\$M-\$_P#">?$C
MXD_V;+/+_;WCK6O[8UNZ\V5I-LMSL3<J;MJ#:-JJHYQFO2** /S-^-7_  :W
M_";]H+]HMOBUXH^.?[4%]\0EO(+ZUUQ/%.F17FG2P%6MS;R+IP:'R2JE"A!4
MJ"#GFOK"/]@26W_8IL_@M%\</C\OV5IO,\=2^)H+GQE>)+/-,T<M_-;.K*!,
M8E(B#+''& P*[J^@J* /S*_9A_X-9_A%^QO\0(?$GPW^.7[4_A&]\^"2]BTK
MQG96$.K1PR"18+H6]A&9H21@HQP0QZ9S7Z)_%OX1^&?CS\,];\&^,M$T_P 2
M>%_$=H]EJ6FWL7F07<3=58=B."&&"I (((!'144 ?ES\/?\ @W!\1?L7?$C6
M=<_9._:H^(OP'TWQ!-YU[H.H:%:^+-+/7:!#<21(Q3.U'E$DBKD;SDFOH#P%
M_P $D6\;>,=#\3?M'?&#QI^TIK/AJ=;O2]-URPLM'\+65ROW;D:19QK!+.O.
M'G,NWJ #DG[&HH ^>/\ @I=_P3,^&_\ P50_9W?X>_$6'4+>.UN1?Z1JVFR+
M'?:-=A2HEB+!E8%6*LCJ593V8*R_ ?P%_P"#5_QQ\$[5?"\'[<?QXT_X5AY"
M?"?AAKC0HRKG+C<+Z6#+<[C]FY)S7[!T4 ?G#\8O^#7;]G+XC>.? /B+PQK?
MQ8^$6J?#;28M+T>X\#:];V%QOCNKBZ%[)<36TUP]X9;F0F;S V @XVBO>/B%
M_P $M;7XE_L/:9\"=2^.W[14FBVOVR+4_$K^*;:Y\3^);6Z>=I+2_O)[202P
M!9S&%6-"(XHTW$ AOJ:B@#\[?V(O^#;7X8_\$^/BCIOB;X:_&S]IO28+34K?
M4[_05\86D&B^(&@)*17]M;V40N(L,RE6/1F (R:_1*BB@"IKVEMKFA7MDMW=
MZ>UY \"W5JP6>V+*5\R,L" ZYR"01D#@]*_,OQQ_P:J_"/XC_'QOBGK7QZ_:
MJO?B0UW'?+XE/B[38]4AGC $3QSKIP>,H%4)L(VA0!@ 5^G]% 'C?P=_8^F^
M#/[*%Q\*[?XL_&3Q%--#=Q)XU\0^((]3\66YG=W$BW<D!0M%NQ'OB9555!#8
MY^']&_X-2_A%X9^-U_\ $O2?C[^UEH_Q$U2YN+RZ\2Z=XTL+/5IYKC<9W-S%
MIZR9DWMN^;Y@Q!XK]1** .+O/@Y-/\ %\!V_C'QI931Z(FC)XHCOHY/$"%81
M$+SSY(W1KHXWEWC92Y)*G.*_.WP=_P &HOPA^'7Q<U#X@>'?C]^UIX=\=:M+
M<3WOB'2O&UC9:I=/<,7G9[B+3UD8R,26RWS$\YK]1J* ,?3/!5K:^ ;?P[?2
M7.NV4=@NG7$FJ.+F;4(Q'Y;&=B,2,XSN)'S%CQS7Y+VO_!I])\#_ (]ZUXI_
M9^_:H^*WP)\/^(F=+W1M&@E>Y^SL6(MUO([N!C&FX^698Y64[6W%AN/[ 44
M>'_L%_\ !/WP!_P3O^$,WA7P3'JFH7FK73:CKWB+6KG[9K7B6];[US>7& 9'
M[  !5'0#))\'_P""C?\ P0(^$?[?_P 6K#XHV.J^)OA)\9-*EAN+?QEX3F6"
MYGEAQY,EQ&1B1TP-LB-'+A5!<JH6ONBB@#X-\*?\$P_VI=5LI-%\??M^?$;7
M/"LB"$P>&? &B^&]7\OD$?VDHGF#E2/G4!@1GKC'TY^R)^Q7\.?V'/AM-X9^
M'>A?V9;WURU_JE_<SO=ZEKEV_P!^ZO+J0F6>9O[SDX'    'JU% 'YK_ +4?
M_!L+\)_VQ_C_ "?$WQ]\;/VEM6\7*Z&QNQXDTQ3I$<<C2PPVI_LXM%'$S,4
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MVYW2(T;'E)I "-Q-?I!110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[P'\$[@/XD;7K._U'2#?QV/_  D>GQI,KV?FRLD:_O7@FQ(ZJ?L^,\@'U?\
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M^.<GCC2_'MA>)I/A"/PGI.FQ:6([TPI>275K#'))(RV\F(^$"S_,"ZC;^B5
M!1110 4444 %%%% !1110 4444 %%%% !117C/P)_;J\$_M%?M2?&;X2^&TU
MB7Q%\#)-)A\17<L,2V$LNHPS31QV[K(SNT8@=9-Z(%; !;G ![-1110 4451
M\4Z%_P )1X9U'3?ME]IW]HVLMK]KL9?)NK7>A7S(GP=LBYRK8." : ':OXAT
M_P /FU^WWUG8_;KA;2V^T3+']HF;.V)-Q&YS@X49)P>*N5_-[^UA^SWJG['O
M_!RU^R_\.&^+?QH^*VB_VMX?UZ.Z^(GBA]=O8+B:\FB<(^Q%5=D" 83/7DC
M'](5 !117*_'#XW>%?V;OA)X@\=>.-:L_#OA/PO:-?:EJ-TV([>)>.@R69B0
MJJH+,S*J@D@$ ZJBORJ^#O\ P4]_:H_X+&^,-6F_93\+^%?A#\#]'O'L6^)7
MCVQ>^U#6)$'/V&Q5O+R#U5]Z@8W2(V8Z])\3_L3?\%"O >DW6J>&?VW/!_Q
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M1Z1_\LZ /U^HK\@?^(U;]EG_ *$']H#_ ,$>D?\ RSH_XC5OV6?^A!_: _\
M!'I'_P LZ /U^HK\@?\ B-6_99_Z$']H#_P1Z1_\LZ/^(U;]EG_H0?V@/_!'
MI'_RSH _7ZBOR!_XC5OV6?\ H0?V@/\ P1Z1_P#+.C_B-6_99_Z$']H#_P $
M>D?_ "SH _7ZBOR!_P"(U;]EG_H0?V@/_!'I'_RSH_XC5OV6?^A!_: _\$>D
M?_+.@#]?J*_('_B-6_99_P"A!_: _P#!'I'_ ,LZ/^(U;]EG_H0?V@/_  1Z
M1_\ +.@#]?J*_('_ (C5OV6?^A!_: _\$>D?_+.C_B-6_99_Z$']H#_P1Z1_
M\LZ /U^HK\@?^(U;]EG_ *$']H#_ ,$>D?\ RSH_XC5OV6?^A!_: _\ !'I'
M_P LZ /U^HK\B]&_X/1OV4]4U".&?P?\=M-C<X-Q<:#IC1I]1'J#M^2FOOS]
MAW_@IC\$/^"C7A*;5OA#X]TOQ,UDH-]IK![74].SQF:UE"RJI.0'VE&(.UFH
M ]XHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#X
M _X.CO\ E!1\<_\ N ?^I!IE8/\ P:A?\H2/AM_V%-;_ /3G<5O?\'1W_*"C
MXY_]P#_U(-,K!_X-0O\ E"1\-O\ L*:W_P"G.XH @_X*T?\ !PTG_!,N7Q-I
M/_#/?QJU:^TVZ32M+\4ZOHO]F>"=5O9;?SXU@U'>QGPHD+1HBL3!( 0 6'&^
M%_\ @M'^U=^W)\!?#7B+]E/]EJ'Q.T^BVMQK7B?QEJ*:3H1U0VR/=6>GP37%
MO+=QQS%H1<"4(60CH-]<O_P>K?\ *++P#_V573O_ $T:Q7W]_P $FT6/_@EC
M^S2%4*/^%5^&#@#N=)M2: /S:_98_P"#JGQ#\)/VC/$'PG_;:^&5G\&O$6AP
MRR2:KHMK=-;VTB1F58I;1GGD994 \N6&6179DPNU]X]1^*G_  5-_;\^.GAF
M7QA^SC^QQ9V/@!4$UC=?$>^CAUK6H#DB:/35O;62($8*KNDW@J5+9P/CW_@\
M#\ V?A'_ (*'_LQ>-[".*WUK6;0V,\Z+AW%EJ,,D);L2INW .,X&.0 !_0M0
M!^8/_!$[_@XD_P"'CGQKUWX+_%7P/#\,/C-HBW#PV4+RK:ZH;8E;J 13?O;>
MYAPQ:)B^520Y!0K7V1^WE^T1\7_V;_A_INL?"/X%_P#"]+QYI?[6LO\ A-++
MPQ_9-LD9?S_,ND<39(V[$&X=:_&']I;P)#\$_P#@]%\ 7VA,MB?%]_IVJ7"0
MJ% :XTB2UN.,=91'(S'J3*QSDU^[/[4G_)LOQ&_[%C4__226@#\NO^"9_P#P
M<8_&_P#X*>GQ9HOP]_9NT_5O%FGW\9MYWUYK'PWX<L'C.)=2OW1Y))VD5@D-
MO;AG56/ 4FNP_;%_X*$?\%"O^";G@FX^)GQ*^#_[./Q,^%^DOOUB/X=ZCK,6
MI:/ 6P)9I+P?ZL?Q.ENZKG+;5R1\Z_\ !CM_R2+]H;_L,:)_Z)O*_<KQ;X4T
MWQWX5U/0]8LX-1TC6;26QOK29=T=U!*A22-AW5E8@CT- '@__!,__@IK\-?^
M"J'[/$?Q ^'5S=0_99_L.LZ-?JJ7^B784,8I54D,K*0R2*2KC/1E95^5?^"L
MW_!QBG_!-J#Q1HUO^SY\:KS7M/OCI&C>(_$6A?V7X*U>Z,>\/!?B1GN%5=S;
M$C5G\MAN098?F?\ \&M7B+5/V4O^"YGQ.^#5KJ%S)H.I6>N:!=P-EDN)M+NR
MT$[;1C>JQSJ&.!B=QU8"OL;_ (/9O^3 /A3_ -E!7_TVWE 'MWQ9_P""Y?Q#
M^*NB:7X3_99^#$GQF^*EOX7T_P 1>,;R>Y^R>%_ S75HES]FGG9T,]R%9O\
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M5+O$D[ AKV[/F'YBTTLT#OD\F)#UK]UIH5N(6CD59(Y 596&58'J"* /G?\
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M84$LEN@;+)(8<S(RO(DL:LP8?*'_ $PNKN*QM9)YY(X885+R2.P544#)))X
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MUMJ=KJ>GHLDEI<0,2I:-OED0JSJ5)'WL@@@&@#YO^$/[<G[<W[=_PNL_B/\
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M6X@U'P9K-P)OM+P$B;[+/M0R,@4LT;(KJH+#>BLX^\*_FU_X.Q?"NH?L/_\
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M@\.K>W,866.:[1@X2&(VR(@&V-B.!@5^R_\ P\/_ &[/^D=7_F>_#_\ \9H
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MOL#RQ1)(\UR-0B-PY,9VLR*$5RH'+,P!]H?\$_'\S]@OX(L,X;P#H1&1@_\
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M<_MD^"?"_P *='@6PM)-)TH:UK-K:+A5CB>[L(I8]J ! +K"  +@"MKXD_\
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M$WBZQ@DMK*\/ER"^TB6Y2XM0I_Y:B.YE<@?PVS_W:_HZK\U?^"HO_!NIX?\
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M.;P02ZUHZ>#%UB;6;B&8RQLUP;R!DB5A$WEA3EHE8MVK)_X(^?\ !)_XI?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&R&@:QXYTK3-13QQK&DX$<L1M7_T&&>:'=&\H=@ Q(4DT 9'Q$^-^G_M,?\
M!6#_ ()[_$;2;>XM-+\>?#_Q+X@M()_];#%=:9:SHK?[05P#[UYW\%_VV[;_
M ()V?"G_ (*/?%V;3XM6N?"_QHO5T^QEDV1W=Y/'96]NKD<B,22JSXYV*^.<
M5]:>)/\ @FO?:#^VM^ROXO\ !,V@Z9\-OV>?"VK^&'TVZN9O[0:&>SAM;18
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MUW_T]W]?H70 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M]"#^T!_X(](_^6=?K]10!^0/_$:M^RS_ -"#^T!_X(](_P#EG1_Q&K?LL_\
M0@_M ?\ @CTC_P"6=?K]10!^0/\ Q&K?LL_]"#^T!_X(](_^6='_ !&K?LL_
M]"#^T!_X(](_^6=?K]10!^0/_$:M^RS_ -"#^T!_X(](_P#EG1_Q&K?LL_\
M0@_M ?\ @CTC_P"6=?K]10!^0/\ Q&K?LL_]"#^T!_X(](_^6='_ !&K?LL_
M]"#^T!_X(](_^6=?K]10!^0/_$:M^RS_ -"#^T!_X(](_P#EG1_Q&K?LL_\
M0@_M ?\ @CTC_P"6=?K]10!^0/\ Q&K?LL_]"#^T!_X(](_^6='_ !&K?LL_
M]"#^T!_X(](_^6=?K]10!^0/_$:M^RS_ -"#^T!_X(](_P#EG1_Q&K?LL_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** /#_^'G'[-G_1PGP/_P#"[TO_ ./U-%_P4?\ @!?Z%KVH
M:;\:/ACK\7AG2+O7M2AT/Q':ZM=V]C:0M-<3BWMGDF=8XU9B$1CQP"2!7Y._
M\')O_!,#X#_L4_L,^%/%7PO^'>F^$?$&H>.[32KB\M[RZF:2U?3]1E:/$LKK
M@O#$V0,_(.<9S]4>+/\ @F!\!_V</^"67Q*^)'@GX=Z;H/C:\^!VM>=JD5Y=
M22/]HT*4S?*\K)\Q)_AX[8KJ]E3Y5)-Z^AV^QI<JDF]7;H?;W[+'[6OP^_;5
M^$T/CCX9>(/^$F\+3W4MFE[]AN;/=+$0'7R[B..3@D<[<'L37HU?SW_\$B]/
M_;E\0_\ !-W5-4^ /B_P%X%^'_@C4-0NHH=1L(KC5/%%RJK-<)&9[>>,(JD(
MIS$"XVY^\R_87[,/_!P/J&M_\$9/&'QX\:Z)8ZA\0? 6K?\ "*O9VRFWM=;O
MY%A:UG*C/EH5GS(JGK!+M"AD *F%:;Y-=;>8JN#:D^1WUMY_,_4ZBOP2F_X*
MX?M=>&/@?9_'*X_:4_99UFSDBBU.;X40ZKI7]L):OM/EF%4%R)E#$M"+DRJ!
MC!<%!^RO[#'[5>G?MO?LD^!?BII=JVGVWC#3OM,EH7W_ &2='>&>+=_$$FCD
M4'C(7/%9U*$H*[,ZV'E35V7OBQ^V=\'O@+XI70_'7Q8^&O@O6V@6Y&GZ[XGL
MM.NC$Q(63RII5;:2K -C!VGTJU\(OVL?A7^T!J$UGX#^)?P_\;75LN^:'0/$
M-IJ4D2^K+#(Q Y')]:_%O_@L[X:^'_C'_@XQ^%&E_%2318?AY>Z%I4>NOJ]\
M+&Q6V\R]SYLY=!&N<?-N'UKS/_@L!X)_9K_9B^-7P9U_]B?Q)I"_%9=9;?;^
M"/$4FM6^[]TML=PDE597D8Q^6K@2*[AD/6NB.%BTE=W:OY'1'!QDHJ[NU?;0
M_HPHK\^O^"I?Q7_:<\%?%#PW9^!?CI^SS\ / ]YHL4UWJ_C._M+>\EU'>XFA
MB%VDR21A1'M(C3[[98D"O,O^")__  5L^*WQ]_;&\<?L^_&'Q)X%^)&K>'=-
MEU/2_&GA*2WEL=2$+PJZB2V5(98V6=65TC0J4=6&3A>?V$G#G1SK#R<.=-'Z
MI45^%_\ P3^_;A_X*#_\%+M9^)/AGX>?$[P/I$'@O4]]SXF\0Z#9QM:K(95M
M[*%(;-XWW&%V9GB9@,'<.%;Z%_X)8?\ !:#Q[KWP\_:/T']HR&SO?&G[-=M=
MW^I7^F6T=N^IQVK7$5Q R1A8O-6: *K(JJPE&0-I+5+"RC?5:%3P<XWU3MT7
MF?J77CO[)?[?GPE_;G_X2;_A5?BS_A*/^$-NH[/6/^)7>6/V.63S-B_Z3#'O
MSY3\IN V\GD9_,O]E7]JC_@HU_P4>\!:U\=/AGXA^%_A3P+9WUPFB>"M0L('
M77Q QW0+,T#S?],_,>X@#2*<>6N2/(_^#?W]L"V_8I_8B_;&^+WB#36N'\+W
MVE7;:<I,?G7DS74,,!/)4-<31H3@E02<'%7]5M%W>JMMYFGU.T97=VK:+S?4
M_?*BOQA\$_M$?\%*OVAOV5KS]IKPSXP^&6B^"_LUQK=AX"31[=[B_P!/@+^8
MR&2W>7E48JK7:NX3(P2H;<_:F_X+I_$#XH_\$0?#WQZ^%^H6_P /?B''XVM_
M"?B%+>RMM0M[>=;>665(DNDE CD0V\J[AO0/MW-@LT?597LFM[>AG]3G>R:W
MMZ/S/V"HK\._VB?VZ_\ @HA^S+^RGX%_::\1>,/AF/ /B4V+MX/AT>!IH8;A
M-]O)<EH%ES,H^<0W.4,BX5?F"7OCW^W9_P %"_AS^R)H_P"UM-XD^&NB_"W6
M)+34(_ UOI$=Q-::=>2*EI-/))!YI20R1<I<AL2QG W,J5]5D^J[?/L5]3D_
MM+MOU['Z/?\ !1;_ (*O?"W_ ()?IX(/Q*C\3S'Q[=7%O8#1K!+HP);^3Y\\
MNZ1,1I]HBR%W.=WRHV#CZ4LKR/4+.&XA;?#.@D1L$;E(R#@\]*_''_@M7_P4
M.\2^)?V6OV./B-X7T_PWIJ_$Z<:U=66L^&M,U_[#*8;)P(6OK>7RFC:60"6(
M(Y&"<< >\?\ !6^[_:S^ NK>-/BMX-_:6^'OPI^"^B6,$D&E:KH-K>7JS+"J
MO'&TEC*TDLTV=B>8<EP/E'1>PNH]&[_GZ"^KWC'HW?\ !^A^C5%?D'_P3>_X
M*1_M->!O^"?7Q8_:D_:/\0/XH^'^E:7$O@S2I='L-,N-5NVN%@68-;6\;+ \
MTD409]V<NP7"@MX=8_\ !6[]KSQG\#[CXX6W[2O[*^AVL,4VI1_"F?5=*CU>
M:VCWDQ^3(AN?.8*"L/VD2N,8PQ",_JLKM76FGS']2G=JZTT^?W'[VUYS^U/^
MUK\/OV*OA--XX^)OB#_A&?"T%U%9O>_8;F\VRRDA%\NWCDDY(/.W [D5^<G[
M4?\ P<2:O8?\$T/@_P#$#X:^&;%?BQ\;+VZT2TTZZ!N+71KJSD2&\=5R/-)D
ME@\E6(&+A6?.THWR[_P6:\)?MV?#3]@6'_AH;Q?\/_'_ (%\4:I8O>+I5E!!
M?^%+U=TD43-!;P(Z-\R%AYR[EP& *LY3PK<DIZ:V\PI8-N24W;6WGIO8_>?X
M8_$G1?C)\-?#WB_PW>?VEX=\5:9;:QI=WY,D/VJUN(EFADV2*KKNC=3M=0PS
M@@'(JYXJ\7:3X%T&XU37-4T_1]+M%WSWE]<I;V\*^K.Y"J/<FO'O^"8W_*-C
M]GO_ +)IX<_]-=M7Y=?M::#JG_!8W_@OQ??L\^,_$6M:1\'OA/9O=OHUG*;<
MZB\5O \LG(_UDDUPJB0AML*'9@L6.<**E)J^B,Z=%2FU>R5S]</A5^V#\)/C
MMK[Z3X'^*7PY\9:I&I9[/0_$EGJ-PH )),<,C,  ">G:O1J^!/''_!MA^S#J
MNM^$=4\(Z#XF^&^J>%=1M[W[;X?\0WJW%^D3;O+=Y97:-B>?.B*2@]&X&/-/
MVY?^"E/Q^^,?_!1]OV3OV5Y?#/AO7_#]@EUX@\6:["+K[&?)29]HE25/+C26
M)2QBE=Y'P H4EG[.,W^[?K?H"HQF[4WZWTL?J-17Y6_LN_\ !1_]I#]CW_@I
M-X=_9J_:NO/"_C5?B) DOAGQAHMK%:!WD,BP[ECCA1D:2)X60Q+(DA4Y9""W
MD/PL_;P_;F_;$_X*._M$_!'X4?$#PCI^F>#?%.K0V>L>(-#LQ%X5TZTU*>VB
MBB,5LQFED!B4>>DI(A)R/G:G]5EW5K7N5]3EW5K7OTL?MA6+X:^)'AWQGJ=[
M9:/KVBZM>::VV[@L[Z*>6U.2N)%5B5.01SCD&ORY_P""<_\ P4-_::^)_P"T
M)\?/V4?BMXB\+M\;/"WAG4+GPIXRMK"!+6VOUCCCB:6..$12Q;KF"X0FW!VI
M(KJQ(4?'W_!#OX2_M*>)?^"A7QLC\ _%/PQX=U#P]XG@;XD37>EPS+XIB74K
MD3K;AK5_)+LMP04$6/-7D8&*^JNSYFM+?B5]3:4N9K2WXG]$-%?C-\8O^"A?
M[97Q$_X+1?%3]GGX*^*_#+:=#&(M+CU[2;,67A:%;>TGDO6F2 SR,"SQA9/.
M!-Q]PD*5]!_;2_X*0?M+?"WXQ?!S]D?X9WWA3Q#^T9XDT."X\4^,KJS3["D_
MERR.\$/E+$@$4$DSLT+!4("QEND_5I:*ZU5_D3]4EIJM5?T7F?JQ7C?@W_@H
M#\(_B!^UCKWP-TCQ;]L^*7AFW:ZU+1/[+O8_LT:K$Q;[0T(MVPLT1PLA/S>Q
MQ^>.C_\ !0[]K#_@EY^V[\-?AS^U9KW@[XF> _BY<K8Z=XGT:QBLWTZ8RQ0L
MP\J"W!6%YX3*CQ$E)%9'R"IY_P#8W_Y6QOCO_P!B_<_^D^EU2P]DV^UU8I86
MR;D^EU8_3#]DO]OSX2_MS'Q-_P *L\6?\)1_PAMU'9ZQ_P 2N\L?L<LF_8O^
MDPQ[\^6_*;@-O7D9]BK\&O\ @A#^UGIO[#'[(W[:GQ6U2S;4+?P?J^G3Q6BM
ML^UW$LMW!;Q%L':'FEC4M@X#$X.,57L/^"MW[7GC3X(7'QPMOVE?V5]#M88I
MM2C^%-QJNE1ZO-;1[R8_)D0W/FL%!6'[2)7&,88A&J6$?,U';S]"IX)\[4-E
M;?TN?O;7G/[4W[6GP^_8J^$TWCCXF^(/^$9\+6]S%9R7OV&YO-LLI(1?+MXY
M).2#SMP.Y%?G)^U%_P '$NK6'_!-#X/_ ! ^&WAFQ7XL?&J]NM#M-.N@;BUT
M:ZLY$ANW5<CS29)8/)5B!BX5GSM*-\O?\%F/"7[=GPT_8$B_X:%\7_#_ ,?^
M!?%&J6+WBZ59007_ (5O5W211,T%O CHWS(6'G#<N P!5GFGA6Y)3TUMYDTL
M&W)*;MK;STWL?O-\,/B3HOQE^&OA[QAX;O/[2\.^*M,MM8TN[\F2'[5:W$2R
MPR;)%5UW(ZG:ZAAG! .17FNN?\%'/V>?#&M7FFZE\>/@SI^HZ?.]M=6MSXVT
MV&:VE1BKQNC3!E96!!4@$$$&J?\ P3%_Y1L?L]_]DU\.?^FNVK\]?^#AK_@F
M!\!_@;^P'\0?BIX4^'>FZ/X_NM<LKF76([RZ>5Y+J^3SVV/*8_GWMGY>,\8J
M*=.+GR2OO8SITX2J<DK[V1^DG@#]O;X%_%?QA8^'O"WQH^$_B77]3<QV>F:5
MXNT^\O+M@I8K'%'*SN0JDX4'@$]J]8K\V_\ @E+_ ,$U?@=X$_82^$?QRTGX
M?Z;9_%:W\%1ZY'X@%U<M,MZ]F^Z;RVD,1)W-P4V\]*^;_P#@C]^VQ^WQ_P %
M,X3<V/Q$\%VO@WP9XEMY/$.OZMHEE!>ZK;MY+/I=O'!:F/B-'8R&-''VG_6\
M*JTZ"=W%Z+N6\.G=P>D=[GZ,?LY_\%:OA1^U!^VM\0O@+X:7Q.GC;X;M=I?S
M7NGK%I]XUI<+;7(@D$C.?+E8*?,1 V<H6'-?3E?E;_P3%_:0\8?$O_@N/^UM
MX0NV\)I8:%'?BPE@\*Z;9WCM#J$,,/VF[MX([JZ548C$TSYZYS@CP_\ :;_;
MH_;8^ GAWQ%XSUK]JS]E#3M6\,N]Q<_#/3-3TF?4I(D)W1)%+"T[2>D0GWD#
MAMW!;P]Y6CIHOQ^0Y87FGRQTT6_G\C]=?VL?VQOAQ^PY\+H_&GQ2\1?\(OX9
MDOH]-6\^P75[FXD5V1-EO'(_(C<YVX&.2,BNX\">-M+^)?@C1_$>B77VW1?$
M%C!J5A<>6\?GV\T:R1OM<!EW(RG# $9P0#Q7XL?\%</VV;G_ (*$?\&Z?P\^
M*&H:7;Z/K&L>-;2UU.UM\_9TNK<7\$C1;B2(W*;P"25#[221D_K1^PK_ ,F1
M_!W_ +$?1?\ T@@K.I2Y87>]VON,ZE'D@F][M?<=!-^TG\.K?XR1?#F3Q]X+
MC^(,Z[X_##:Y;#69%\HSY%IO\XCRE:3(3[@+=!FNTK\6?&'_ "N/^%_^P8__
M *B=U1I/[>_[;?[3G_!5#X[? 7X0^.?"=GIWAO5[[['?Z_HEI]G\*Z=;70BR
MCQVS/-*QDB11,)<X/ Y=='AGI9]$]31X1Z6?1-W/VFHK\I/^"=G_  4#_:3U
MS]M[XM?LB_';Q3HMQ\2=)T*YN= \9Z/IEJILKKR(I8I/*\A(9HC#<).F^ $;
M-KJ=V%Z?_@CO_P %:?&'C'X-?'_1?VEM>CE^(G[/=[=WVMW+V5O8R/IT2NKH
M(8(XT9XIK>9<JN6\Z$8)()B6'DDWZ?B1+"SBF]':WX]3]-**_&OX%?\ !:OX
MV?"7_@F'\1/VHOBE?6WBA?&WC'_A&_A?X8FTZVM+&QP9W=GEMXHYI8E$<R?O
M)&=OL)&X%R]5?B#^T1_P4J_9Q_9;L?VF/$GC#X9:]X*-O;ZUJ'@0:/;K-IUA
M<;"C2&.WCEP Z[@ET[H'!.[#;*^JRO9M;V^97U.=[-K>WJS]//VM/V^_A+^P
MP/#/_"U/%G_"+_\ "8W4EGI'_$KO+[[7+'LWK_HT,FS'F)R^T'=UX./8@<BO
MPA_X+W?M7Z3^W%^R3^Q?\5=%M9+"R\8:MJ%P]H\@D:SN$>TAN(=P^]Y<T<B;
ML#(7.!G ^M-0_;X^+W[+/_!>JT^#/Q*\6'6?@U\6=.\[P2D^E65J-,N)AF*,
M3Q1))(5N(9K8+([DB:)CR0:;P[Y4UOK?Y#>%?(FM];KT['Z545^:&E_\%*OB
M+\<?^"S'Q$\+>&/%QT?]G7]G?PY<WWC=+;2[.X.K75O%(94\^2)YD83L4VQN
M@*V,F,%MQ^5O"7_!8?\ :<_;ON?%'CGP1^T)^S3^SOX7T?4)+?1O"'C#6=+M
MM4UA$"NH?[7%+)AE(4RYB0N6"X ++,<+-_UW)C@YOMT_$_=BN;^,'Q<\/? 3
MX7:]XT\6:A_9/AGPQ92:CJ=YY$D_V:"-=SOLB5G; '15)/8&OS ^#_\ P<=7
MM]_P2;\;?%KQ)X<T>X^*W@/6(/"C6%I(?[+U2^N%+6]UE7)$)1)W94?YC P5
M@'4KXI^T+XA_X*)>/_\ @F+XP^+7CSQ7\.]<^&?CKPO-<:AX-&FV]OJ6EZ1=
MQ?+=QM% A#)&XEV-<2,%QN5FW(*CA97M+36W_#%1P<KVFTM;?\,?L=^S%^U-
MX#_;)^$%CX\^&^N_\))X3U*6:"WOOL5Q9^8\4ACD'EW$<<@PRD9*@''&1S7H
M%?BA_P $]?\ AJC_ (<-?"?_ (92_LO_ (2S_A+M5_MC[3_9_G?8OM<_^K^W
M?N-N_&_^/&-O>OV5^&W]O?\ "N]!_P"$H^Q?\)-_9UO_ &O]CS]G^U^6OG>7
MGG9YF[;GMBLZU-0;L^K]3*O14).SZM>>G<VJ***Q, HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **CN[N*PM9)YY(X884,DDDC!5C4#)))X  YR:^0_C
M7_P7&^ OP:\0S:7'JFO>+[JV8I,?#]BL\,;#MYDLD2-]4+#WKHP^%K5W:C%R
M]#IPV#KXA\M&+EZ(^P**^!?^(B_X)?\ 0K_%3_P6V'_R91_Q$7_!+_H5_BI_
MX+;#_P"3*[/[%QW_ #[9V_V#F'_/IGWU17P+_P 1%_P2_P"A7^*G_@ML/_DR
MC_B(O^"7_0K_ !4_\%MA_P#)E']BX[_GVP_L',/^?3/OJBO@7_B(O^"7_0K_
M !4_\%MA_P#)E'_$1?\ !+_H5_BI_P""VP_^3*/[%QW_ #[8?V#F'_/IGWU1
M7P+_ ,1%_P $O^A7^*G_ (+;#_Y,H_XB+_@E_P!"O\5/_!;8?_)E']BX[_GV
MP_L',/\ GTS[ZHKX%_XB+_@E_P!"O\5/_!;8?_)E'_$1?\$O^A7^*G_@ML/_
M ),H_L7'?\^V']@YA_SZ9]]45\"_\1%_P2_Z%?XJ?^"VP_\ DRC_ (B+_@E_
MT*_Q4_\ !;8?_)E']BX[_GVP_L',/^?3/OJBO@7_ (B+_@E_T*_Q4_\ !;8?
M_)E'_$1?\$O^A7^*G_@ML/\ Y,H_L7'?\^V']@YA_P ^F??5%? O_$1?\$O^
MA7^*G_@ML/\ Y,H_XB+_ ()?]"O\5/\ P6V'_P F4?V+CO\ GVP_L',/^?3/
MOJBO@7_B(O\ @E_T*_Q4_P#!;8?_ "91_P 1%_P2_P"A7^*G_@ML/_DRC^Q<
M=_S[8?V#F'_/IGWU17P+_P 1%_P2_P"A7^*G_@ML/_DRC_B(O^"7_0K_ !4_
M\%MA_P#)E']BX[_GVP_L',/^?3/OJBO@7_B(O^"7_0K_ !4_\%MA_P#)E'_$
M1?\ !+_H5_BI_P""VP_^3*/[%QW_ #[8?V#F'_/IGWU17P+_ ,1%_P $O^A7
M^*G_ (+;#_Y,H_XB+_@E_P!"O\5/_!;8?_)E']BX[_GVP_L',/\ GTS[ZHKX
M%_XB+_@E_P!"O\5/_!;8?_)E'_$1?\$O^A7^*G_@ML/_ ),H_L7'?\^V']@Y
MA_SZ9]]45\"_\1%_P2_Z%?XJ?^"VP_\ DRC_ (B+_@E_T*_Q4_\ !;8?_)E'
M]BX[_GVP_L',/^?3/OJBO@7_ (B+_@E_T*_Q4_\ !;8?_)E'_$1?\$O^A7^*
MG_@ML/\ Y,H_L7'?\^V']@YA_P ^F??5%? O_$1?\$O^A7^*G_@ML/\ Y,H_
MXB+_ ()?]"O\5/\ P6V'_P F4?V+CO\ GVP_L',/^?3/OJBO@7_B(O\ @E_T
M*_Q4_P#!;8?_ "91_P 1%_P2_P"A7^*G_@ML/_DRC^Q<=_S[8?V#F'_/IGWU
M17P+_P 1%_P2_P"A7^*G_@ML/_DRC_B(O^"7_0K_ !4_\%MA_P#)E']BX[_G
MVP_L',/^?3/OJBO@7_B(O^"7_0K_ !4_\%MA_P#)E'_$1?\ !+_H5_BI_P""
MVP_^3*/[%QW_ #[8?V#F'_/IGWU17P+_ ,1%_P $O^A7^*G_ (+;#_Y,KMO@
MQ_P7-^ OQ@\0PZ;-J6O^#[BX8)$_B"Q2&%V/0&2&25%^KE1[U,LHQL5S.F_N
M)GDN.A'FE2=O0^Q**CLKV'4K.&XMYH[BWN$$D4L;!DD4C(8$<$$<Y%25YIY8
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !7Y0_\$#O^4J'_  44_P"RA1_^G/7*_5ZORA_X('?\I4/^
M"BG_ &4*/_TYZY51V94=F?J]1114DA1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 44V:9+:%I)&6..,%F9CA5
M ZDFO"_B)_P49^&?P^U62S6\U+79H25D_LNV$B*?3>[(I_X"2*VHX>K5=J<6
M_0[L#EN+QDN3"TW-K>RO;U['NU%?,?\ P]<^'?\ T!?&G_@);?\ R11_P]<^
M'?\ T!?&G_@);?\ R175_96+_P"?;/6_U/SG_H'E_7S/IRBOF/\ X>N?#O\
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M_P !+;_Y(H_LK%_\^V'^I^<_] \OZ^9].45\Q_\ #USX=_\ 0%\:?^ EM_\
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MA_J?G/\ T#R_KYGTY17S'_P]<^'?_0%\:?\ @);?_)%'_#USX=_] 7QI_P"
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MOE_5M3XIHKTO]L_0;'PM^V!\5=,TRSM=-TW3O%^K6UK:6L*PP6L27DJI&B*
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M\#?'']DVVIZEX2UFW:SAFLO.D1;RUBAN)K%U\YGC>2!MV0H;H*^N*^4_'_[
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MUV/C#]H'2_@5\=OVE_B&MY^SO\7/VC-<T"_BTK6M1M8X+S1_#EVMK QLK/\
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M_P KJ\X_X-U?^3WO$G_8E7?_ *6V%?M+7YSQ-)K&NW9'Y=Q9)K'NW9'Y0_\
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M^KU%'/(.>1^//CC_ ()H^!/^"6VJ1^!?A_JWBW6-)UR(:[/-XANK>XN$G<F
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MMU6ZMY1$LAC::6X!8*&4YJ8T[DQIW5[GV=17Q/\ M"_M-?%;XH_MB_ /P?\
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MBCXDL_$'[=/PM^#NK6]S*VD^%Q:^'XULK8L?LXOEU%Y+J:0J!O,3VZDDA0,
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M3MV_4_7^'ZBEE]+E[6^YA1117K'LA1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110!][_P#!NK_R>]XD_P"Q*N__ $ML*_:6OR3_ .#<3X,ZE<_$[QW\
M0I+=H])L],70(9F'$\TLL<\BJ?\ 86*,G_KHM?K97YKQ))2QTK=$OR/RKBJ:
MEF$K=$E^ 4445X)\X%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'P!_P5?_Y+WH/_
M & (_P#THN*^7J^Q/^"LO@"['B'PSXH2,M9-;-IDL@'^K=7:1 ?]X.V/]TU\
M=U^A91)2PD+=C^E^"JT:F2T'%[*S]4V%%%%>D?4A1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110!]*?\$K_ /DY"_\ ^P#<?^CH*_0ROA?_ ()0?#^Z
MN?'7B#Q.T;+8VMG_ &<DA'$DCLKL!] BD_[PK[HKX3/I)XMVZ)'\\^(E6,\Z
MDHO:,4_6U_U"BBBO&/A0HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^6_
M&O[-OQD^#G[6?CCXF?!NZ^'.M:;\4X-/;Q)X?\875YI_V:^LK<6L5W:W5M#.
M<-;I$CQ/%@F,,'&2*E_8E_9/^*7P@_:D^-?Q,^)WB;PKX@O?BM9^'X[:#0XY
MX8=).GK?H]NL<JY\E5N80KEV>1A*[+'D+7T_16GM':QI[5VM\CQ;_@GE^SEK
MG[)?['O@_P"'WB.ZTJ]UKP_]M^T3:;+)):OYU[<7"[&D1&.$E4'*CD'J,$^*
M>.?^"<?CCQ/_ ,$^_P!H[X46^J>%4\1?%_QAXE\0:-<27-P+*V@U+4C=0+<,
M(2ZR+&<.$1P&X!8<U]J44*I)._S#VLD^;SN>,_MX_LTZE^U%^S[<:3X:OK'1
MO'GA[4;3Q+X.U6[+"'3-8LI1+;NY5681/AX9"%8^5/( I)Q6#\ _V%+'PY^Q
M#K/PM^(<UKXDU;XC6^I77C[4+0LJZMJ6I[VO98F<;@JF3RX6(#*D,7 *X'T)
M14^T:7*+VDE'E1\:>$?V:/VD/AAX-M/!=A'^SCXKL=,@%C9^-=<TZ\@U<PJ-
ML<MSIL,)AGG5=NXK=1*Y!.%R:]0^*?[*WB#QG\?_ -G'Q5:7WA];#X07^JW>
MN 0O9M>_:]%N;%6M8$5T7,\P<HSJ%3.&8@ ^]T53J,;JMN_]:GE?[1,'QL@U
MC1;[X33_  SO+.W25-5T?Q8M[:F\+%#')#>VWF&$J X*M;R [\Y&!7S_ .#?
M^">OCS6-0^/'B[Q%'\+_  EXJ^+G@)O!=IH/@\7 T:%UCN]E]>7$D,<D]PS7
M(0N+=2L40 #GI]J441J-*R"-1Q5D?+?QB_8E\8>,/V)_@YX/T#6/#=G\1/@S
M=>&];TZ:^$TNCWU_I421O#*RJ)1!*OFKO5-X#*=N1BM3XLZ[I?CW]E;Q[X(_
M:8USX6>$[C7-$NWU2QT7Q!)-'8Z4Z&-;H/<QPS,ZR+(5<1*N]%"Y8&OI"N*^
M)G[-GPZ^-6OZ7JWC+P#X*\6ZIHA!TZ\UG0[:_N+ AMP\EY49H_FY^4CGFA3[
M@JG<^=O^",WPK\96'[,B?%#XG74^H_$OXN0V6H:A<3PO!*FG6MLMMIL31L28
MV,"FX=>TMY-7U1IG@'0M$U!;NST72;.Z7.)H;...09X/S 9YK6HJ92<G<4YN
M4G(^(_@-^R/^TE^Q]XG^*NH>!]:^$WB[2?B7\0->\8+H'B2^U"S32!>WDDL+
MPW<%M(0S0F,2V[0LHD0LDV&(.KJ?_!,_Q/\ &;X#_'B/XD>-M.D^*?Q^TB/1
MK_4]#LGCTGP[9VR2+9V5K'(WFR0JTLK2L[!I3*W"X7'V/15>VE>Y?MI7OU/S
M[_:'_8._:*_:7_9KNOAQ<:5^S)\/[5!9?Z7X;AOG;4UM[B*01*KVBC3XR(P?
MD^T-\NP%0Q=?I3X\Z?\ M!1>/KF3P#;_  7\5>"[ZTCB;1O%<NH:5=VLHW"1
MOM,$5TDR/E3M:!-N,9/4^X44>T;$ZS>Z1\.>$O\ @DGJEY\ O%UCJ_B#PKX7
M\?:]\08OB7H1\-:1YGAWPAJ<,$<$4<-K-C[1%)&LJS[A'YHN9<*AP:]!\ _"
M/X^ZSXRT6'Q5X>_9I\-Z!8W<4VJ7^A65]JE]JT*-EX8;>>*!+,R ;=[37!0$
MD*Q KZBHH]K)[@ZTGN?,/CO]F/XK?!C]I3Q9\2/@=J'@*^MOB5]EF\5^%/%\
MES96DE];0K;QW]I=VL4KPR/"B))&\+JYC5LJ236+\!/V.OC!9_\ !1/_ (7U
M\3?$_@O4/MGP]N_!QT30!<QVVBLVHV=U D'G)NF4K#.TL\C(S.\86%57CZXH
MH]H["]K*WX'EW[8G[,%G^UU\#;SPE/JUUX=U**\M-8T36[6)99]#U.TG2XM+
MM$8A7V2QJ2A(#*67(SD>(?$_X"?M1_M0?#&^^&/CS7?@SX9\&^(K9M+\2>(O
M"SZE/K6L6#C;-%!:3QI#9O/'N1G,]P$$C;03@C[ HI1J-!&HXJQX'J?[(U]9
M_MN?"OQ]H;:+8>"_AYX'U7PG_9YEE^UHUQ+8FW$2["IC2.U8,6D# E<!LDCW
MRBBE*3>Y,I-[F3'X!T*'5_[071=)6_\ ,,WVD6<8FWDY+;\9W$G.<YKX_P##
M7[%7QD^ ?Q)^)8\":7\ O$^@_$;Q;?\ BQ==\6PWJ:WI,E[)YKPR0PP.EY'"
MQ98@9X"(PJDCK7VM11&;0XU'$^0_V6_V1_CG^R%^QW!X2\,>*/AGJ7CJW\8Z
MOKUW/JUA=-I>LV5Y>7,XB/D>4]I,?.C<E$E1&1D"NIW57\/?L=?&#XD_M4:'
M\7/&$/P9^'?B3P?H>KZ=IA\()>:O+K%U?0I&DFHSSPVC2V\#)YBP!<LYSYBU
M]B457M'=LKVTKM]6?#W[2_[(/[0W[;OPOG^'?Q&L?V>-.TJ^D@67QGH[ZE<Z
MW8)'+'(9[&SG@"6UQ\K;7^UN$)!^;I7HOCK]F+XI_!G]H[Q;\2/@?J'@.\A^
M) M9?%7A3Q<]S9V<U[;PK;I?VMY:QRO#(T"1I)&T$BN8U;*L2:^G**/:/;H'
MMI6MT/F'X7_L-Z]\1_&WQ \<?'J_\,^(/$_Q"\*/X$;1O#L<Z:/H6A2&1IK2
M*2;$L\D[R;Y)G5,E$"HH7%8/@'X.?M:? SX;6/PW\->)O@KXC\/Z';)I6B^,
MO$"ZC%KEG91KLA-SI\,9M[NXC0*N\7$*R%=S+DG/UY11[1]1>U?4\$UC]E[Q
M3JO[<'PM^)MSK.DZAIO@KP1JWAO59)%:WO;^\NY;%UGCA5#$L9^S2%AO!4LH
M 89(\<^'?[#OQH_9TUOQUHG@C3_@#K_AWQCXHU/Q)!XG\3V]X?$%@U].\[+<
M6T<+1WS1,^Q&-Q!E$4$#H/MZBA5'L"JR2L?&/@#_ ()F>)[?_@D-JG[.WB#Q
M1HZ>++Q]6GBUVRA:6S6XFUNYU2UE:,I'P"\(D15 !WA=P )[3Q[^S-\3OVS/
MV<M<\'_&9OA_X1UR.[L-3\-:MX*N;K5/[+U&SE$\5ZR7D,(.)DC/D88%#(AD
M.=P^FJ*/:2O?SN/VTKW\[GR?X9^#'[16HZII>EZYHO[,6E:7:W,)U#Q!IVFW
MU[?:C CJ76/3Y(HHK=Y%!7)NI0F\D X K8^+_P"RY\2_A_\ M/:A\7/@?JG@
MM=2\7:9::3XN\+^*S<6^F:RMGO%I=PW-LDDMO<QI(\1S%(CIMRH* GZ8HH]H
MQ>T=SX]\'?L=_&SQE^WW\.?CA\2/$G@'R?"VAZSHLWAO0&NC:Z5'<K;&!H)9
MH@]U*[K.9I)!  J6X2(D.3[Y^V#\(M2_:"_9)^*7@+19K&UUCQOX1U;0+&:]
M=DMHI[JSE@C:5D5F$8:0%BJL0 < GBO1J*3FVT^P2J-M/L>;K\']37]D3_A
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MN_\ $.A\;?\ H:/A7_X,K_\ ^0Z/^(=#XV_]#1\*_P#P97__ ,AU^T5%<_\
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MY.4G=L****DD**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_H->"_\ P+N?_D>OT$HH_M_%]U]P?\1'SG^:/_@)^??_  ZC^(G_ $&O!?\
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M!KP7_P"!=S_\CU^@E%']OXONON#_ (B/G/\ -'_P$_/O_AU'\1/^@UX+_P#
MNY_^1Z/^'4?Q$_Z#7@O_ ,"[G_Y'K]!**/[?Q?=?<'_$1\Y_FC_X"?GW_P .
MH_B)_P!!KP7_ .!=S_\ (]'_  ZC^(G_ $&O!?\ X%W/_P CU^@E%']OXONO
MN#_B(^<_S1_\!/S[_P"'4?Q$_P"@UX+_ / NY_\ D>C_ (=1_$3_ *#7@O\
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M/!OB;P_XNT25S&FH:+J,-_:NP )42Q,RD@$'&>XK'TW]ISX:ZSJN@V%G\0O
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ KYI_X*I_\FXZ=_P!A^#_T1<5]+5\T
M_P#!5/\ Y-QT[_L/P?\ HBXKORO_ 'NGZGT7"/\ R.</_B1](:;_ ,@ZW_ZY
MK_(5-4.F_P#(.M_^N:_R%35P'S\MV%%%%!(4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^]#;2G!!S7-?#F\^(7BW_@HW^T?J47P;^'/Q2\7^'M<M-(TZ7Q7XV.DW6@Z
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M&\F-S=_9(CYU],?^6L\S$R32=M\C,WO6DIQYG)>?XFTJD>9S5];_ (GYY?\
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M^%?_  38^$.M:3HFGQZ_XE\.6VJ:GJS0*U]>RRQ@X>8@NRHFR)%)PD<:*
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M1FQM$EQ<S,\TS@<!I'8@<"O0:SJ23=T95))RN@HHHJ2 HHHH **** "BBB@
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MX*5?]'!_"'_P70?_ "FH_P"&:O\ @I5_T<'\(?\ P70?_*:OT<HH^N/^6/\
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M **** "BBB@ HHHH **** "BBB@ KYI_X*I_\FXZ=_V'X/\ T1<5]+5\T_\
M!5/_ )-QT[_L/P?^B+BN_*_][I^I]%PC_P CG#_XD?2&F_\ (.M_^N:_R%35
M#IO_ "#K?_KFO\A4U<!\_+=A11102%%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% 'YQ_M._P#*R3^SS_V(EU_Z)UZOT<K\X_VG
M?^5DG]GG_L1+K_T3KU?HY79BOAI_X5^;.[&?#3_PK\V%%%%<9PA1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P#(.M_^N:_R%35#IO\ R#K?_KFO\A4U<!\_+=A11102%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M]@,D^E?'/C'_ (."_@/X7UB6UL[3Q]X@BC;:+K3]*A6&3W'GSQ/CZJ*^%?\
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MV'_R97XNT4?ZLX'L_O#_ %3R_L_O/VB_XB+_ ()?]"O\5/\ P6V'_P F4?\
M$1?\$O\ H5_BI_X+;#_Y,K\7:*/]6<#V?WA_JGE_9_>?M%_Q$7_!+_H5_BI_
MX+;#_P"3*/\ B(O^"7_0K_%3_P %MA_\F5^+M%'^K.![/[P_U3R_L_O/VB_X
MB+_@E_T*_P 5/_!;8?\ R91_Q$7_  2_Z%?XJ?\ @ML/_DROQ=HH_P!6<#V?
MWA_JGE_9_>?M%_Q$7_!+_H5_BI_X+;#_ .3*/^(B_P""7_0K_%3_ ,%MA_\
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M_P""V_\ _DRO@6BC^Q<#_P ^T']@Y?\ \^D??7_$1?\ &W_H5_A7_P""V_\
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M#_S[0?V#E_\ SZ1]]?\ $1?\;?\ H5_A7_X+;_\ ^3*/^(B_XV_]"O\ "O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MGO)X=.LY+J2"!,;Y66,$JBY&6/ R,FAR25V$I)*[,>B@C!HIC"BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M]O9?_P _4? M%??7_$.A\;?^AH^%?_@RO_\ Y#H_XAT/C;_T-'PK_P#!E?\
M_P AT?VU@?\ GX@_M[+_ /GZCX%HK[Z_XAT/C;_T-'PK_P#!E?\ _P AT?\
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M/_/Q!_;V7_\ /U'P+17WU_Q#H?&W_H:/A7_X,K__ .0Z/^(=#XV_]#1\*_\
MP97_ /\ (=']M8'_ )^(/[>R_P#Y^H^!:*^^O^(=#XV_]#1\*_\ P97_ /\
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MK9E_=_<?B[17[1?\0Z'P2_Z&CXJ?^#*P_P#D.C_B'0^"7_0T?%3_ ,&5A_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P#Q5'_"Z]5_Y]]/_P"_;_\ Q5'U"J'U.H>H45Y?_P +KU7_ )]]/_[]O_\
M%4?\+KU7_GWT_P#[]O\ _%4?4*H?4ZAZA17E_P#PNO5?^??3_P#OV_\ \51_
MPNO5?^??3_\ OV__ ,51]0JA]3J'J%%>7_\ "Z]5_P"??3_^_;__ !5'_"Z]
M5_Y]]/\ ^_;_ /Q5'U"J'U.H>H45Y?\ \+KU7_GWT_\ []O_ /%4?\+KU7_G
MWT__ +]O_P#%4?4*H?4ZAZA17E__  NO5?\ GWT__OV__P 51_PNO5?^??3_
M /OV_P#\51]0JA]3J'J%%>7_ /"Z]5_Y]]/_ ._;_P#Q5'_"Z]5_Y]]/_P"_
M;_\ Q5'U"J'U.H>H45Y?_P +KU7_ )]]/_[]O_\ %4?\+KU7_GWT_P#[]O\
M_%4?4*H?4ZAZA17E_P#PNO5?^??3_P#OV_\ \51_PNO5?^??3_\ OV__ ,51
M]0JA]3J'J%%>7_\ "Z]5_P"??3_^_;__ !5'_"Z]5_Y]]/\ ^_;_ /Q5'U"J
M'U.H>H45Y?\ \+KU7_GWT_\ []O_ /%4?\+KU7_GWT__ +]O_P#%4?4*H?4Z
MAZA17E__  NO5?\ GWT__OV__P 51_PNO5?^??3_ /OV_P#\51]0JA]3J'J%
M%>7_ /"Z]5_Y]]/_ ._;_P#Q5'_"Z]5_Y]]/_P"_;_\ Q5'U"J'U.H>H45Y?
M_P +KU7_ )]]/_[]O_\ %4?\+KU7_GWT_P#[]O\ _%4?4*H?4ZAZA17E_P#P
MNO5?^??3_P#OV_\ \51_PNO5?^??3_\ OV__ ,51]0JA]3J'J%%>7_\ "Z]5
M_P"??3_^_;__ !5'_"Z]5_Y]]/\ ^_;_ /Q5'U"J'U.H>H45Y?\ \+KU7_GW
MT_\ []O_ /%4?\+KU7_GWT__ +]O_P#%4?4*H?4ZAZA17E__  NO5?\ GWT_
M_OV__P 51_PNO5?^??3_ /OV_P#\51]0JA]3J'J%%>7_ /"Z]5_Y]]/_ ._;
M_P#Q5'_"Z]5_Y]]/_P"_;_\ Q5'U"J'U.H>H45Y?_P +KU7_ )]]/_[]O_\
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M;_\ Q5'U"J'U.H>H45Y?_P +KU7_ )]]/_[]O_\ %4?\+KU7_GWT_P#[]O\
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M_P#Q5'_"Z]5_Y]]/_P"_;_\ Q5'U"J'U.H>H45Y?_P +KU7_ )]]/_[]O_\
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M;_\ Q5'U"J'U.H>H45Y?_P +KU7_ )]]/_[]O_\ %4?\+KU7_GWT_P#[]O\
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M_P#Q5'_"Z]5_Y]]/_P"_;_\ Q5'U"J'U.H>H45Y?_P +KU7_ )]]/_[]O_\
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M;_\ Q5'U"J'U.H>H45Y?_P +KU7_ )]]/_[]O_\ %4?\+KU7_GWT_P#[]O\
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M_P#Q5'_"Z]5_Y]]/_P"_;_\ Q5'U"J'U.H>H45Y?_P +KU7_ )]]/_[]O_\
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M;_\ Q5'U"J'U.H>H45Y?_P +KU7_ )]]/_[]O_\ %4?\+KU7_GWT_P#[]O\
M_%4?4*H?4ZAZA17E_P#PNO5?^??3_P#OV_\ \51_PNO5?^??3_\ OV__ ,51
M]0JA]3J'J%%>7_\ "Z]5_P"??3_^_;__ !5'_"Z]5_Y]]/\ ^_;_ /Q5'U"J
M'U.H>H45Y?\ \+KU7_GWT_\ []O_ /%4?\+KU7_GWT__ +]O_P#%4?4*H?4Z
MAZA17E__  NO5?\ GWT__OV__P 51_PNO5?^??3_ /OV_P#\51]0JA]3J'J%
M%>7_ /"Z]5_Y]]/_ ._;_P#Q5'_"Z]5_Y]]/_P"_;_\ Q5'U"J'U.H>H45Y?
M_P +KU7_ )]]/_[]O_\ %4?\+KU7_GWT_P#[]O\ _%4?4*H?4ZAZA17E_P#P
MNO5?^??3_P#OV_\ \51_PNO5?^??3_\ OV__ ,51]0JA]3J'J%%>7_\ "Z]5
M_P"??3_^_;__ !5'_"Z]5_Y]]/\ ^_;_ /Q5'U"J'U.H>H45Y?\ \+KU7_GW
MT_\ []O_ /%4?\+KU7_GWT__ +]O_P#%4?4*H?4ZAZA17E__  NO5?\ GWT_
M_OV__P 51_PNO5?^??3_ /OV_P#\51]0JA]3J'J%%>7_ /"Z]5_Y]]/_ ._;
M_P#Q5'_"Z]5_Y]]/_P"_;_\ Q5'U"J'U.H>H45Y?_P +KU7_ )]]/_[]O_\
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M;_\ Q5'U"J'U.H>H45Y?_P +KU7_ )]]/_[]O_\ %4?\+KU7_GWT_P#[]O\
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M_P#Q5'_"Z]5_Y]]/_P"_;_\ Q5'U"J'U.H>H45Y?_P +KU7_ )]]/_[]O_\
M%44?4*H?4ZAQ]%%%>X>L%%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !17+ZC\;_!>C_$BT\&WGB_PO:^+[^/S;70YM5@CU*Y3!.Y+<MYC
M# )R%(P#744 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'Y"_P#!
M2K_@H5^TQX,_X*GS?!?X0^.[?1;75GTJSTFPGTC398UN+FWB8[II[=WP7<G)
M8@9XP.*ZC_A6G_!4K_HH7@__ ,!M#_\ D*OFO_@J]>>--/\ ^"\\$_PYM;>^
M\>17>@MH-O.8UCFO!:P>4K&1E3!;'WF ]2*^E/\ A9?_  5*_P"B>^#_ /P)
MT/\ ^3:#HMHK6/KO7?V[/#?[!_P#^&4'[3'C:WT7QYXBTMEN[B#2KB\CO[RW
M6'[4RBR@9$ ::/\ A0'=\HX./<?B!\8/#OPM^$^I>.->U'[#X7T?3VU6[O?L
M\LODVRIO,GEHID/R\X"EO:ORC_X.O/\ F@G_ ',/_N+K[E_;_P!3MV_X))_$
M:X%Q";>?X?R>7+O&R3?:J$P>AW$@#'7(QUH,^71/N7[G]N3P#^UC^Q;\6_%W
MPC\77.K0^&]!U2 ZA;VEYITUE=I8O*A0S1QN&4%&#KT.,'(KXY_X-Z/VA_B!
M\:O@3\=KSQEXY\8>+;O1Q:?8)]9UFYOY++=;W9/E-*[%,E5)VXR5'H*X_P#X
M(9?\HC?VF?\ =U;_ -,RT?\ !LY_R;Q^T1_NV7_I->4&G*DFC:_X-J/VC_B)
M\=_'WQ9A\<>//&GC*'3=/TU[1-=UNYU%;5FDN QC$SL%+!1DC&<#TK]:J_&+
M_@U2_P"2C_&;_L&Z7_Z-N:_9V@SJ_$?'_P#P6J_;ZU']@S]DO[=X6U"*Q\?>
M++U--T&1K>.X^S;<27%QY<@*,$C&T;@1OE3@C-> ?\$1?^"IWQ,_:!^/?B[X
M3_'+5I;[Q9]D74M#>YTRVTV9/*'[^V:.&*,,Q1TE4D9VQR<XQCY&_P""E/[:
M7@?]JO\ X*XZ./'&H71^#7POU%=(E%G$;G[<EN[2715!U\^=?)W*?]6J-GBL
M/_@H;^WU\.=;_P""AO@G]H#X$7>H_P!L:?\ 9Y]9M+W3VLUFN+8B,'G.4FMB
M(6QR!&3_ !"@TC3]VQ^[O[0W[1O@S]E/X6WGC3Q]K']@^&=/EBAN+S[)/=>6
MTKB-!Y<*.YRS <*<9YP*\3UG_@M/^R_H'@S1]>N?BUI(T_74DDM$CTZ^FNRJ
M2O"QDMD@,\0WQN!YB+N W#*D$^0_\%M?BQHWQV_X(PZAXR\/7'VK1?$[:+J-
MG)_%Y<EU"P##LPS@CL01VKQS_@B'_P $K_@E^T)^PA!XU\>>#X?%>O>*KZ]M
MWFN[F9/L,,4K0JD(C=0A^4MO'SY;K@ 4&<8KENS]*/V?/VG? '[5?@H^(?AY
MXJTKQ5I*OY4LMHYWV[XSLEC8"2-L<[74'%>9_''_ (*Q_LZ_LY^)YM%\6?%3
M0+75K60Q7%I8Q7&J2VSC@I(MK'+Y;#NK8(]*_,__ ((!23_!3_@JU\6/AWI=
MU<2>'5T_5;%HIFR939:A&D$K8 RZJ9!V'[UN.E7OB7^T5^RW\2OVNO'S?#O]
ME7QE^T!X@U:_FO=4OK*6X:!Y 0LLMK:PK(1"TFYS(R*Q9R>A7 5[-7L?JU^S
M7^VE\+/VP-)N+SX;^-M'\4K9J'N((&>&[ME/1I+>55E0'H"R $\5^:?[6W[2
MWQ'\-_\ !PKX0\%:=\0/&VG^#;K7/#T4V@VVN746F2I+# 9%:V5Q$5<DE@5P
MV3G-?.__  3CU23X7?\ !<_PU9^'?!/BCX1Z;JU[<6DWA'6GF-YI]K-ISS&W
ME\Y5D9"VR5-XSM\HY. Q]2_;0_Y68?!/_8P>&O\ T1;T%1BE+Y'ZC?"W_@HM
M\&_C-^T'JGPJ\.^,&NOB!HLEU%>://I%]9R1/;-MF4/-"D;%3GA6)(!(R 37
M3?M._M;?#O\ 8U\ V_B?XE>)(?#.B7=XFGP3M:SW333LKN$6.!'D/RHY)"X
M')%?EG_P6W^'6J?L#?\ !1/X:_M.>$;0?9=8O8FU.),)'+?6RA)8F(Z"YM,J
M2!DE)6SDUG_\%!?BM:_\%C_^"EOPB^#O@;49-0^'NDVUOJ.H7MN24*W$27=W
M-E3C,=J(HES]V4NN>:"/9K1]#].O'7_!1#X+_#'X.>'/'WB+Q]I6A^&?%UJM
M]HLM[#/!=:G P#"2*U9!<,N"#D1]&4_Q#/+_  7_ ."N_P"SA^T#XOL]!\+_
M !4T6YUC4)TM;2UO;6ZTQ[J5R D<?VJ*,.S$@ *222 ,GBOAW_@L=_P36^)'
MBW]L3P?\3O"OPY_X6M\-M$TRPTV;PI8WC6\EM!:%B;0(C"18I%)VM"&P2P*C
MC=C_ +/?[0?[+?@#]L#X?1^/OV7_ !=^SQ\0[&]C;1Y[S[0;%)Y-T<;31N(B
MR;V!27R#M8*Q*J"0!R*UT=Y^TE^R_P#L^ZS_ ,%M]!\0:]\;M;T?XC3ZYHVH
M#P5'X=O9FNKY$@-HJ:BJ^5%$XCB)4Y(RPWIQM^\_VE_V[_A#^Q[]G7XD>/-%
M\,W5W&9H;.3S+B\ECY&\6\*O*5R"-VW!((SFORH_;0_Y68?!/_8P>&O_ $1;
MUT7_  4N_P"">/Q2TS_@II??&>;X1W7[0'PVU:2"X;0[2_DBE CM$@%M(L>Z
M5-CH'4JCQL, C)90%<J=K]C]$OV?/^"I/P!_:E\76_A_P/\ $O1M5UR\++;:
M?<07&GW-TR@L1''<QQLY"@G"@G )K:^%_P#P4&^#7QH^/&K?#/POX^TG6/'&
MBF5;G38HYER8CB412L@BF*8.X1.Q !)X!KX!_8%_:"_9=T7]NSPU87'[/_BK
M]GWXR21R:;I4&I+/]C>6X7RPACD*M',Z[T1_)4-YC@MD@5]?? #_ () _!_]
MFW]K/5OC)X<A\1'Q-J4EU-!:W=\LNGZ7)<[A,T"",."RNZ_/(X <@ <8")12
M/J2BBB@S"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH ^&?\ @J+_ ,%%]6^"WB#_ (5[X%NEL]<6
M%)M6U-<-)9!QE(8_[LA4JY8YP&7')./S;\4>,M7\;ZI)?:SJFH:M>3-N>>\N
M'FD8^[,2:[W]M;5YM:_:\^)DTS,SQ^);^W!)S\L<[QJ/P50*\PK[3 X>%*DN
M5:VU9^D9;@Z="A'E6K2;84445V'H!1110 4444 %%%% !1110 4444 %%%%
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M_P"A]_\ *)IW_P CU\\44?5*'\B^Y!]0PO\ S[C]R_R/H?\ X>M?'S_H??\
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M_C_\;+?_ (*D_LV_%*:WM;>'Q%\&M7EU_P -Q)&L4DOAQ\1RQ$9Y:(1K(Y
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MDMFY.^E]4DO(X8T<9-2C-.S2T=W9J2V;D[Z7U22\CD/VDOV<O#OB#]F[X/\
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MU7U-^V7^VWX3^+?[//A7X7^"U^(6L:3X?U.75I-=\<7L5QJTKLK*($$195B
M;IN[#CC)^6:]; \_L4JB:>N[;Z^;;^3>A[67^T]BE433N]VV]]]6W\F] HHH
MKL.X**** "BBB@ HHHH **** "BBB@#^A;3?^0=;_P#7-?Y"IJATW_D'6_\
MUS7^0J:OS\_)PHHHH **** /%_V[/^2.V?\ V%HO_14U?(]?7'[=G_)';/\
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M-;^.?$OB.PT7PM>1P26][=;D^T>< T21QX\QY'!XC52YYXX- CMJ*\-\/_\
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M*)^3^(W^\4?1_F%%%%>6?FX4444 %%%% !1110 4444 %%%% !1110 4444
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M#\!/&U]:6L,-YKGQ(\3W5]*J@-<2)JD\*ECU.(XD49Z8KZ6_X0W1_P#A+_\
MA(/[*TW^WOL?]G?VE]F3[9]FW^9Y'FXW^7O^;9G;NYQFD\*>"]'\!Z;)9Z'I
M.F:+9S7$MW)!8VJ6\;S2N9)92J  N[LS,W5F8DDDT!S:'RM_P3#^)7A'X7_
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MOPKX@M?%,NC_  \M)9)M>O[0E[3SIFMK58HXY3YA C=F**-P!-?5G_"&Z/\
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M.BOZ'**/[=_N?C_P _UH_P"G7_DW_ /YXZ*_H<HH_MW^Y^/_   _UH_Z=?\
MDW_ /YXZ*_H<HH_MW^Y^/_ #_6C_ *=?^3?\ _GCHK^ARBC^W?[GX_\  #_6
MC_IU_P"3?\ _GCHK^ARBC^W?[GX_\ /]:/\ IU_Y-_P#^>.BOZ'**/[=_N?C
M_P  /]:/^G7_ )-_P#^>.BOZ'**/[=_N?C_P _UH_P"G7_DW_ /YXZ*_H<HH
M_MW^Y^/_   _UH_Z=?\ DW_ /YXZ*_H<HH_MW^Y^/_ #_6C_ *=?^3?\ _GC
MHK^ARBC^W?[GX_\  #_6C_IU_P"3?\ _GCHK^ARBC^W?[GX_\ /]:/\ IU_Y
M-_P#^>.BOZ'**/[=_N?C_P  /]:/^G7_ )-_P#^>.BOZ'**/[=_N?C_P _UH
M_P"G7_DW_ /YXZ*_H<HH_MW^Y^/_   _UH_Z=?\ DW_ /YXZ*_H<HH_MW^Y^
M/_ #_6C_ *=?^3?\ _GCHK^ARBC^W?[GX_\  #_6C_IU_P"3?\ _GC R:]@_
M9N_8=^(7[3'B.T@TG0[VQT>20+<:Q>0M%9VZ=20Q'SMCHJY))'0<U^WE%14S
MR35H1L_6_P"B,ZG$TW&U.%GWO?\ 1')? KX.:7\ /A-H?A'1E/V'1;<0B1@
MT[G+/*V/XG<LQ]VKK:**\24G)W>Y\S*3E)RENPHHHJ20HHHH **** "BBB@
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M /)ZY_\ CE']I4NS_#_,/^(AY=_)/[H__)'Q/17VQ_PR-\/?^A?_ /)ZY_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%:W_"+_ /3?_P <_P#KT?\ "+_]-_\ QS_Z]<_UJEW_ #,?K%/N9-%:W_"+
M_P#3?_QS_P"O1_PB_P#TW_\ '/\ Z]'UJEW_ ##ZQ3[F316M_P (O_TW_P#'
M/_KT?\(O_P!-_P#QS_Z]'UJEW_,/K%/N9-%:W_"+_P#3?_QS_P"O1_PB_P#T
MW_\ '/\ Z]'UJEW_ ##ZQ3[F316M_P (O_TW_P#'/_KT?\(O_P!-_P#QS_Z]
M'UJEW_,/K%/N9-%:W_"+_P#3?_QS_P"O1_PB_P#TW_\ '/\ Z]'UJEW_ ##Z
MQ3[F316M_P (O_TW_P#'/_KT?\(O_P!-_P#QS_Z]'UJEW_,/K%/N9-%:W_"+
M_P#3?_QS_P"O1_PB_P#TW_\ '/\ Z]'UJEW_ ##ZQ3[F316M_P (O_TW_P#'
M/_KT?\(O_P!-_P#QS_Z]'UJEW_,/K%/N9-%:W_"+_P#3?_QS_P"O1_PB_P#T
MW_\ '/\ Z]'UJEW_ ##ZQ3[F316M_P (O_TW_P#'/_KT?\(O_P!-_P#QS_Z]
M'UJEW_,/K%/N9-%:W_"+_P#3?_QS_P"O1_PB_P#TW_\ '/\ Z]'UJEW_ ##Z
MQ3[F316M_P (O_TW_P#'/_KT?\(O_P!-_P#QS_Z]'UJEW_,/K%/N9-%:W_"+
M_P#3?_QS_P"O1_PB_P#TW_\ '/\ Z]'UJEW_ ##ZQ3[F316M_P (O_TW_P#'
M/_KT?\(O_P!-_P#QS_Z]'UJEW_,/K%/N9-%:W_"+_P#3?_QS_P"O1_PB_P#T
MW_\ '/\ Z]'UJEW_ ##ZQ3[F316M_P (O_TW_P#'/_KT?\(O_P!-_P#QS_Z]
M'UJEW_,/K%/N9-%:W_"+_P#3?_QS_P"O1_PB_P#TW_\ '/\ Z]'UJEW_ ##Z
MQ3[F316M_P (O_TW_P#'/_KT?\(O_P!-_P#QS_Z]'UJEW_,/K%/N9-%:W_"+
M_P#3?_QS_P"O1_PB_P#TW_\ '/\ Z]'UJEW_ ##ZQ3[F316M_P (O_TW_P#'
M/_KT?\(O_P!-_P#QS_Z]'UJEW_,/K%/N9-%:W_"+_P#3?_QS_P"O1_PB_P#T
MW_\ '/\ Z]'UJEW_ ##ZQ3[F316M_P (O_TW_P#'/_KT?\(O_P!-_P#QS_Z]
M'UJEW_,/K%/N9-%:W_"+_P#3?_QS_P"O1_PB_P#TW_\ '/\ Z]'UJEW_ ##Z
MQ3[F316M_P (O_TW_P#'/_KT?\(O_P!-_P#QS_Z]'UJEW_,/K%/N9-%:W_"+
M_P#3?_QS_P"O1_PB_P#TW_\ '/\ Z]'UJEW_ ##ZQ3[F316M_P (O_TW_P#'
M/_KT?\(O_P!-_P#QS_Z]'UJEW_,/K%/N9-%:W_"+_P#3?_QS_P"O1_PB_P#T
MW_\ '/\ Z]'UJEW_ ##ZQ3[F316M_P (O_TW_P#'/_KT?\(O_P!-_P#QS_Z]
M'UJEW_,/K%/N9-%:W_"+_P#3?_QS_P"O1_PB_P#TW_\ '/\ Z]'UJEW_ ##Z
MQ3[F316M_P (O_TW_P#'/_KT?\(O_P!-_P#QS_Z]'UJEW_,/K%/N9-%:W_"+
M_P#3?_QS_P"O1_PB_P#TW_\ '/\ Z]'UJEW_ ##ZQ3[F316M_P (O_TW_P#'
M/_KT?\(O_P!-_P#QS_Z]'UJEW_,/K%/N9-%:W_"+_P#3?_QS_P"O1_PB_P#T
MW_\ '/\ Z]'UJEW_ ##ZQ3[F316M_P (O_TW_P#'/_KT?\(O_P!-_P#QS_Z]
M'UJEW_,/K%/N9-%:W_"+_P#3?_QS_P"O1_PB_P#TW_\ '/\ Z]'UJEW_ ##Z
MQ3[F316M_P (O_TW_P#'/_KT?\(O_P!-_P#QS_Z]'UJEW_,/K%/N9-%:W_"+
M_P#3?_QS_P"O1_PB_P#TW_\ '/\ Z]'UJEW_ ##ZQ3[F316M_P (O_TW_P#'
M/_KT?\(O_P!-_P#QS_Z]'UJEW_,/K%/N9-%:W_"+_P#3?_QS_P"O1_PB_P#T
MW_\ '/\ Z]'UJEW_ ##ZQ3[F316M_P (O_TW_P#'/_KT?\(O_P!-_P#QS_Z]
M'UJEW_,/K%/N9-%:W_"+_P#3?_QS_P"O1_PB_P#TW_\ '/\ Z]'UJEW_ ##Z
MQ3[F316M_P (O_TW_P#'/_KT?\(O_P!-_P#QS_Z]'UJEW_,/K%/N9-%:W_"+
M_P#3?_QS_P"O1_PB_P#TW_\ '/\ Z]'UJEW_ ##ZQ3[F316M_P (O_TW_P#'
M/_KT?\(O_P!-_P#QS_Z]'UJEW_,/K%/N9-%:W_"+_P#3?_QS_P"O1_PB_P#T
MW_\ '/\ Z]'UJEW_ ##ZQ3[F316M_P (O_TW_P#'/_KT?\(O_P!-_P#QS_Z]
M'UJEW_,/K%/N9-%:W_"+_P#3?_QS_P"O1_PB_P#TW_\ '/\ Z]'UJEW_ ##Z
MQ3[F316M_P (O_TW_P#'/_KT?\(O_P!-_P#QS_Z]'UJEW_,/K%/N9-%:W_"+
M_P#3?_QS_P"O1_PB_P#TW_\ '/\ Z]'UJEW_ ##ZQ3[F316M_P (O_TW_P#'
M/_KT?\(O_P!-_P#QS_Z]'UJEW_,/K%/N9-%:W_"+_P#3?_QS_P"O1_PB_P#T
MW_\ '/\ Z]'UJEW_ ##ZQ3[F316M_P (O_TW_P#'/_KT?\(O_P!-_P#QS_Z]
M'UJEW_,/K%/N9-%:W_"+_P#3?_QS_P"O1_PB_P#TW_\ '/\ Z]'UJEW_ ##Z
MQ3[F316M_P (O_TW_P#'/_KT?\(O_P!-_P#QS_Z]'UJEW_,/K%/N9-%:W_"+
M_P#3?_QS_P"O1_PB_P#TW_\ '/\ Z]'UJEW_ ##ZQ3[F316M_P (O_TW_P#'
M/_KT?\(O_P!-_P#QS_Z]'UJEW_,/K%/N9-%:W_"+_P#3?_QS_P"O1_PB_P#T
MW_\ '/\ Z]'UJEW_ ##ZQ3[F316M_P (O_TW_P#'/_KT?\(O_P!-_P#QS_Z]
M'UJEW_,/K%/N9-%:W_"+_P#3?_QS_P"O1_PB_P#TW_\ '/\ Z]'UJEW_ ##Z
MQ3[F316M_P (O_TW_P#'/_KT?\(O_P!-_P#QS_Z]'UJEW_,/K%/N9-%:W_"+
M_P#3?_QS_P"O1_PB_P#TW_\ '/\ Z]'UJEW_ ##ZQ3[F316M_P (O_TW_P#'
M/_KT?\(O_P!-_P#QS_Z]'UJEW_,/K%/N9-%:W_"+_P#3?_QS_P"O1_PB_P#T
MW_\ '/\ Z]'UJEW_ ##ZQ3[F316M_P (O_TW_P#'/_KT?\(O_P!-_P#QS_Z]
M'UJEW_,/K%/N9-%:W_"+_P#3?_QS_P"O1_PB_P#TW_\ '/\ Z]'UJEW_ ##Z
MQ3[F316M_P (O_TW_P#'/_KT?\(O_P!-_P#QS_Z]'UJEW_,/K%/N9-%:W_"+
M_P#3?_QS_P"O1_PB_P#TW_\ '/\ Z]'UJEW_ ##ZQ3[F316M_P (O_TW_P#'
M/_KT?\(O_P!-_P#QS_Z]'UJEW_,/K%/N9-%:W_"+_P#3?_QS_P"O1_PB_P#T
MW_\ '/\ Z]'UJEW_ ##ZQ3[F316M_P (O_TW_P#'/_KT?\(O_P!-_P#QS_Z]
M'UJEW_,/K%/N9-%:W_"+_P#3?_QS_P"O1_PB_P#TW_\ '/\ Z]'UJEW_ ##Z
MQ3[F316M_P (O_TW_P#'/_KT?\(O_P!-_P#QS_Z]'UJEW_,/K%/N9-%:W_"+
M_P#3?_QS_P"O1_PB_P#TW_\ '/\ Z]'UJEW_ ##ZQ3[F316M_P (O_TW_P#'
M/_KT?\(O_P!-_P#QS_Z]'UJEW_,/K%/N9-%:W_"+_P#3?_QS_P"O1_PB_P#T
MW_\ '/\ Z]'UJEW_ ##ZQ3[F316M_P (O_TW_P#'/_KT?\(O_P!-_P#QS_Z]
M'UJEW_,/K%/N9-%:W_"+_P#3?_QS_P"O1_PB_P#TW_\ '/\ Z]'UJEW_ ##Z
MQ3[F316M_P (O_TW_P#'/_KT?\(O_P!-_P#QS_Z]'UJEW_,/K%/N9-%:W_"+
M_P#3?_QS_P"O1_PB_P#TW_\ '/\ Z]'UJEW_ ##ZQ3[F316M_P (O_TW_P#'
M/_KT?\(O_P!-_P#QS_Z]'UJEW_,/K%/N9-%:W_"+_P#3?_QS_P"O1_PB_P#T
MW_\ '/\ Z]'UJEW_ ##ZQ3[F316M_P (O_TW_P#'/_KT?\(O_P!-_P#QS_Z]
M'UJEW_,/K%/N9-%:W_"+_P#3?_QS_P"O1_PB_P#TW_\ '/\ Z]'UJEW_ ##Z
MQ3[F316M_P (O_TW_P#'/_KT?\(O_P!-_P#QS_Z]'UJEW_,/K%/N9-%:W_"+
M_P#3?_QS_P"O1_PB_P#TW_\ '/\ Z]'UJEW_ ##ZQ3[F316M_P (O_TW_P#'
M/_KT?\(O_P!-_P#QS_Z]'UJEW_,/K%/N9-%:W_"+_P#3?_QS_P"O1_PB_P#T
MW_\ '/\ Z]'UJEW_ ##ZQ3[F316M_P (O_TW_P#'/_KT?\(O_P!-_P#QS_Z]
M'UJEW_,/K%/N9-%:W_"+_P#3?_QS_P"O1_PB_P#TW_\ '/\ Z]'UJEW_ ##Z
MQ3[F316M_P (O_TW_P#'/_KT?\(O_P!-_P#QS_Z]'UJEW_,/K%/N9-%:W_"+
M_P#3?_QS_P"O1_PB_P#TW_\ '/\ Z]'UJEW_ ##ZQ3[F316M_P (O_TW_P#'
M/_KT?\(O_P!-_P#QS_Z]'UJEW_,/K%/N9-%:W_"+_P#3?_QS_P"O1_PB_P#T
MW_\ '/\ Z]'UJEW_ ##ZQ3[F316M_P (O_TW_P#'/_KT?\(O_P!-_P#QS_Z]
M'UJEW_,/K%/N9-%:W_"+_P#3?_QS_P"O1_PB_P#TW_\ '/\ Z]'UJEW_ ##Z
MQ3[F316M_P (O_TW_P#'/_KT?\(O_P!-_P#QS_Z]'UJEW_,/K%/N9-%:W_"+
M_P#3?_QS_P"O1_PB_P#TW_\ '/\ Z]'UJEW_ ##ZQ3[F316M_P (O_TW_P#'
M/_KT?\(O_P!-_P#QS_Z]'UJEW_,/K%/N9-%:W_"+_P#3?_QS_P"O1_PB_P#T
MW_\ '/\ Z]'UJEW_ ##ZQ3[F316M_P (O_TW_P#'/_KT?\(O_P!-_P#QS_Z]
M'UJEW_,/K%/N9-%:W_"+_P#3?_QS_P"O1_PB_P#TW_\ '/\ Z]'UJEW_ ##Z
MQ3[F316M_P (O_TW_P#'/_KT?\(O_P!-_P#QS_Z]'UJEW_,/K%/N9-%:W_"+
M_P#3?_QS_P"O1_PB_P#TW_\ '/\ Z]'UJEW_ ##ZQ3[F316M_P (O_TW_P#'
M/_KT?\(O_P!-_P#QS_Z]'UJEW_,/K%/N9-%:W_"+_P#3?_QS_P"O1_PB_P#T
MW_\ '/\ Z]'UJEW_ ##ZQ3[F316M_P (O_TW_P#'/_KT?\(O_P!-_P#QS_Z]
M'UJEW_,/K%/N9-%:W_"+_P#3?_QS_P"O1_PB_P#TW_\ '/\ Z]'UJEW_ ##Z
MQ3[F316M_P (O_TW_P#'/_KT?\(O_P!-_P#QS_Z]'UJEW_,/K%/N9-%:W_"+
M_P#3?_QS_P"O1_PB_P#TW_\ '/\ Z]'UJEW_ ##ZQ3[F316M_P (O_TW_P#'
M/_KT?\(O_P!-_P#QS_Z]'UJEW_,/K%/N9-%:W_"+_P#3?_QS_P"O1_PB_P#T
MW_\ '/\ Z]'UJEW_ ##ZQ3[F316M_P (O_TW_P#'/_KT?\(O_P!-_P#QS_Z]
M'UJEW_,/K%/N9-%:W_"+_P#3?_QS_P"O1_PB_P#TW_\ '/\ Z]'UJEW_ ##Z
MQ3[F316M_P (O_TW_P#'/_KT?\(O_P!-_P#QS_Z]'UJEW_,/K%/N9-%:W_"+
M_P#3?_QS_P"O1_PB_P#TW_\ '/\ Z]'UJEW_ ##ZQ3[F316M_P (O_TW_P#'
M/_KT?\(O_P!-_P#QS_Z]'UJEW_,/K%/N9-%:W_"+_P#3?_QS_P"O1_PB_P#T
MW_\ '/\ Z]'UJEW_ ##ZQ3[F316M_P (O_TW_P#'/_KT?\(O_P!-_P#QS_Z]
M'UJEW_,/K%/N9-%:W_"+_P#3?_QS_P"O11]:I=_S#ZQ3[FM1117CGFA1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MW;]H?_HH7_E"TS_Y'H_X>[?M#_\ 10O_ "A:9_\ (]'^J^+_ )H_>_\ (/\
M5#&?S1^]_P#R)^VU%?B3_P /=OVA_P#HH7_E"TS_ .1Z/^'NW[0__10O_*%I
MG_R/1_JOB_YH_>_\@_U0QG\T?O?_ ,B?MM17XD_\/=OVA_\ HH7_ )0M,_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@#\ ?VSO^3P/BM_V.&K?^EDM>:UZ5^V=_P G@?%;_L<-6_\ 2R6O-:_6L/\
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M>'OA[X@\6Z'JVJ:3H>L:GIN@1I-J=W:64DT&G(Y(5IG4%8U8@@%B 2#7M?\
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M/W@(,9W(0037U1+_ ,$M?"^E>/U\$K^S)XTU/PNLHT^3XB-X]ACU(Y&TWRV
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MYUCL6\.\1:-M=->CL?)OQ+^!/CCX+K9MXQ\&^*O":ZD7%H=9TFXL/M6S;O\
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M=*RLJW,YGN3' %WE2[891(>-N\B8TJ:BKK=>9$:--15U>Z\_T/TX_P""F_\
MP5T\'_\ !/3X'>'/$5K9KXTUWQW$9O#6GP7(AANH=BO]JDDP2L($D?127+@#
M'++\)_$;_@LS^U9KW[,WB;7OB-^SM:V/PE\::%=:=#K6FZ7?V<EE'=P/#%<-
M)-+(K1YD4@E(U?(PPW"O._\ @X&_9,UC]ES1/V:YC<7/B[P;X+\*P^$!?S1[
M$N)K23S%5URZIYL+ *.1B%AR%Q7V;^UU_P %ROV;/'W_  3X\8+I'B6'6-:\
M7^%[K2;/PH;&1;R*XN+=HA%,K)Y:)&SY9\E2$.PN2H,QIQ48N*O<F%.*C%QC
MS7>YYM_P:;_\F]_%K_L8K3_TF-?JEXVU5]"\&:O?1QQ226=E-.J2C<CE49@&
M'&0<<U^5O_!IO_R;W\6O^QBM/_28U^I/Q0_Y)GXB_P"P9<_^BFK'$?Q6<^*_
MCL_./_@WQ_;_ -4_;&\7?%33;KX:_"'X>V^DPV6HM_PA'AY]);49YI)U9[C,
MT@D8;>#@'YFY.:\0^$/_  <>_M"?%'XG:_X)T3X-^$_'?BF6=[?0K/0+.^C>
M/RY&\R6X4SRF1 @'"^4!DL7 &#2_X-+?^2G?&O\ [!FE?^C;FL;_ (-D[6.7
M_@HI\89FCC:6+P]=A'*@L@.I09P>V<#\JZ)0@I3;6UCJG3@I5&U>UCVG]F__
M (. OBKX/_:ZT?X4_M+?"O2? MUKUY!8QW6GVUUI\FFM.RI#++%<2S"6%F.#
M(CJ "2-VT@_,W_!S-\4?BIXR_:6T+0?&7A.QT3P#X7N=03P1JT-M)'-KL<L-
M@UVTCM*ROY<BQ*-B1X#'.[J.T_X.;?W'_!1'X,S1_)-_PCUK\Z\-QJ<Y'/MD
M_G7??\';?A^\N?#GP'U2.!VL+.XURTFF ^6.65=/:-3[LL,I'^X:=-14X22W
MN51454A-*W,F?47_  25_:H^/GC/X9ZY)\?/A_H/PZ\#>#?#5C<Z%JT%G/;"
M]MDB?S)97DN)58+#'&Y*JGWB?8?/OB/_ (+Y_'3]J'XHZ[IG[*_P,A\:>&_#
MLFV;5=7L+N\>X0Y"R,D,L*V^_!*H[LY"DX!R%^A-(_:1\ _\%#O^":OC#X6_
M"3Q?IOB3QXWPN^SR:7$LL4T$C6?DB)RZ@!C*/+(R<%@3P03^0_\ P32OM%TR
MV\3>$?%G[5'Q2_9BU*TU!I?[.T\7MOI]_($"2&4PSQB.Y0Q[6$J@D! "2"HB
M%.+<I26O;4SITXR<I26O;7\MS]9_^"9'_!:B?]K?XU:A\'OBMX'F^&/Q>T]9
M&AT]DFCAU$Q(9)8Q%,/-@F2,%]CE@R*S!N,5X)^TI_P<&_%K]G__ (*%>-OA
M1I_PW\*^-=&T74Y='T:QT^VO(]:U"X:,"W!D$LB,?,895(,L!M&TG<.=_P""
M<O[(OP?^.'_!1FS\:^&_VM/%GQ>^(/P[EBU.X_MK29UFUN!8S"RQ7-Q.9)8X
MU8(Q4,%#*!E3FN'^"5K'>?\ !UM>+-''*J^)-:<*ZA@&70[ME//<, 0>Q -/
MV=/F>G2]@]G24Y:;*]M=ST/6_P#@X,_:,_92^+VBV7[0GP'TGPQX9US]["EG
M9WEA?& , \D4DTTL4S1AAF/"')4$KN!I/^#F?X\?$3QC\(_!^DZ'X;TV_P#@
M/KUGI?B)?%:V\AG.J2&]$=LLGF[/+:V\N3;Y1;+9WXX'3?\ !V/&I_9]^$K[
M5W+XANP&QR ;9<C]!^55?^"J^BWVO?\ !N)\#;N&*2X33='\'7EY)U\J-M+$
M6]C[R2QK]6%$.6\)I;L*?)>%1*UW8U?^#?7]H7]HK5_!/P]\"ZS\-='LO@/9
MZ/?/IOBM+&=;JZD$TCJ#*;@QG,K2+Q".% Z\G3_88_X*'ZM\5?\ @MA\4/AA
M)\,_@[H,-CJGB#3YO$NC^'7M?$6IQV%T\<7VF[\YA*6"*7RF">0%Z5WO_!!G
M]N7X4Z[^Q=\(_A';^,M/;XD6]I?P/H!CE%T&CN+FX8_=VX\GYP=V"..H('Q]
M_P $P_\ E9-^,/\ V,?C/_TNFI.-W.ZZ"E%.51M6T_7<^G/V]?\ @O?K'PS_
M &F)_@O^S_\ #^/XH>/;.X?3[NXF2>XMTO5^_;PV\!62;R\-YC[T"E&'(4L.
M)^&__!P;\4_V?OCII/@W]JSX.P_#^TUAD U73+6ZM?L4;-M$YAFDE\^%<_.8
MI-R@$A6(V'YO_86^-.A_\$I/^"TGQ0B^-UI<:';ZU_:6FP:Q);/,MF+F\BN8
M+OY06,$T:8WJI(\P9P ^-[_@X0_;H^&_[?&O_"SX?_!^Y_X3_P 0:;J$Q:]T
MVUD8/)<B***SA)4-*[L 2%R 0@Y.0*5&-U#ETMN7&C#F4.72VY]A?\%M?^"O
MGQ _X)R^(?AO#\.]+\!Z]8>-;"[O9I]9MKFZ&(FA$9A:"XB&UED)R=V>,$=_
M#?BI_P %Z/VK="\$Q_%'2_V<=-T7X-W$B/;ZCK-A?SRR6[L!'(UPDL:(KY 6
M0PE"64 MD9\9_P"#C+X?ZE\)OAE^RCX5UJ7S]8\,^!GTJ^DW!O,G@BL8I&R.
M#EE)R.M?J5_P4'LX8/\ @D!\284BC2&+X=2A$50%0+:#;@=!C QZ8J+0C&.E
M[_YF?+3C&'NWO_F=9_P3B_;NT/\ X**?LPZ?\0]'T^31[C[5+IFJZ9),)FTZ
M\B"L\>\ ;E*/&ZD@$K(N0#D5[Q7XW?\ !OK\$K[]I;_@EC\=O -AXDNO"-UX
ME\1FT@U>WB::33G-I:GS519(R3\H'#K]:]M_91_X(+>-OV;OVC/"/CK4/VFO
M%/BZR\,7ZWLVC7&BSPQ:@ "/+9VU"0*.<Y*-TZ5E4IP4FKV,:M&$927-:W0_
M+WX_?'O]H#Q-_P %:O#_ (W\4?#O2=*^.=KJ>DS6/A:*RF2UGGBCB%JAB:X:
M0B10A($P)W<%:_:OX8?\%!?&/P4_X)[:M\8/VG_"MKX!\1:/=SPOHNF6DD+7
M8W!;:.*.6:4F24G&2^T8).T FOS>_P""H/B[3_@#_P '&7@WQGXMF;2/#-KJ
M'AS5YKUXV=4M(TCBDFPH+%5:*0' )^0\&OI[_@NIXST7_@H3_P $JKGQ7\&]
M9M_'&A> ?&=O?ZS/IJ2,(XH;2>.; *@L(_MD,C$ @("V?E..BI:7(FM';_AC
MJJI3]FFM';7]#S/0?^"[W[6_[0FEZIXR^$O[-^EZG\.]*ED$L\FG:AJDV$Y9
M1/%+"CNJX+!(F*Y&17V)_P $GO\ @L!X9_X*9:#JVF2:0WA'XA>&X5N-1T8S
M^?%/ 6"?:;=R 2@<JK*P!0NHRP8,? _^"4?_  6;_9W^$G_!._P?X;\6>++?
MP;X@\ Z:UC?Z5-93-+>,K,WG6_EJPE\W=N(!W!RV0!@GYO\ ^"$/@/5OVH?^
M"G?QJ^+'AW3;SPWX#O[?7")1%B*U?4KK?;6@Q@%D0ERJG@0CD97,RIIQE>-K
M;$5*47&5X\MMF?NE7\Z/_!Q/\3_BE\0/VRQ8_$+PG8^'-!\./?6'@^Z@MY(G
MUK31<';<2%Y7#L2!RH0<_=K[4T'_ (-NOB!H^NV=Y)^UOXPN$M9TF:)M N0)
M0K E2?[3/7&.AKQO_@[+\/WD'QC^#VJ-;R?V?<:+?6D<^/E:6.>-G7/J%D0_
MC1AU&-1<KN&%C"-5*+N?<W[(?[8G[2WB7]F?XS^+OCC\,?#W@'7/ ^C2ZEX;
MMX=/N;>#4C':W$K^:'NI690\<0.UD.&/.2"/BW]GG_@XO_:4_:1L[[PSX-^"
M'A7QO\06<W$!T:ROA8V%HJJ"\\7VAV8EVQN,T2CY1\Q;C]!/&'[<_P */VS/
MV-?C5_PK7QEI_BF71? M]<:A%;QR))9+<6-SY0<.J_,?*<%1DJ5YQD9^(?\
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M?\D=\6?]@:\_]$/7YLU^DWQH_P"2.^+/^P->?^B'K\V:^JX>_AS]4?LWA?\
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M'X)?\$U/@G^SI\>M8^)W@WP7_8_CC7OM7V_4O[7O[CS_ +3*)9_W4L[Q+N<
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M+;]3G'EX]J^HZ*%.2=TP52:=TV XHHHJ2 HHHH **** "BBB@ HHHH ****
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MKH4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?H]\ D:+X'^$58;6
M72+8$>G[I:^#O@Q\(=3^,WC6WTNPAD\G>K7=P!\EM%GEB>F<9P.YK]%=%TF'
M0=(M;&W79;VD2PQJ.RJ,"OF>(*T;1IK?<_)?$_'4G&CA(OWDW)KLK65_4M44
M45\R?D(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M#^U,9_S]E_X$_P#,^;?^'1/[/'_1/?\ RNZG_P#)%'_#HG]GC_HGO_E=U/\
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MG_/V7_@3_P SYM_X=$_L\?\ 1/?_ "NZG_\ )%'_  Z)_9X_Z)[_ .5W4_\
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M ,P_M3&?\_9?^!/_ #/FW_AT3^SQ_P!$]_\ *[J?_P D4?\ #HG]GC_HGO\
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M_F']J8S_ )^R_P# G_F?-O\ PZ)_9X_Z)[_Y7=3_ /DBC_AT3^SQ_P!$]_\
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MHG]GC_HGO_E=U/\ ^2*/^'1/[/'_ $3W_P KNI__ "17TE11_:&+_P"?LO\
MP)_YA_:F,_Y^R_\  G_F?-O_  Z)_9X_Z)[_ .5W4_\ Y(H_X=$_L\?]$]_\
MKNI__)%?25%']H8O_G[+_P "?^8?VIC/^?LO_ G_ )GS;_PZ)_9X_P"B>_\
ME=U/_P"2*/\ AT3^SQ_T3W_RNZG_ /)%?25%']H8O_G[+_P)_P"8?VIC/^?L
MO_ G_F?-O_#HG]GC_HGO_E=U/_Y(H_X=$_L\?]$]_P#*[J?_ ,D5])44?VAB
M_P#G[+_P)_YA_:F,_P"?LO\ P)_YGS;_ ,.B?V>/^B>_^5W4_P#Y(H_X=$_L
M\?\ 1/?_ "NZG_\ )%?25%']H8O_ )^R_P# G_F']J8S_G[+_P "?^9\V_\
M#HG]GC_HGO\ Y7=3_P#DBC_AT3^SQ_T3W_RNZG_\D5])44?VAB_^?LO_  )_
MYA_:F,_Y^R_\"?\ F?-O_#HG]GC_ *)[_P"5W4__ )(H_P"'1/[/'_1/?_*[
MJ?\ \D5])44?VAB_^?LO_ G_ )A_:F,_Y^R_\"?^9\V_\.B?V>/^B>_^5W4_
M_DBC_AT3^SQ_T3W_ ,KNI_\ R17TE11_:&+_ .?LO_ G_F']J8S_ )^R_P#
MG_F?-O\ PZ)_9X_Z)[_Y7=3_ /DBC_AT3^SQ_P!$]_\ *[J?_P D5])44?VA
MB_\ G[+_ ,"?^8?VIC/^?LO_  )_YGS;_P .B?V>/^B>_P#E=U/_ .2*/^'1
M/[/'_1/?_*[J?_R17TE11_:&+_Y^R_\  G_F']J8S_G[+_P)_P"9\V_\.B?V
M>/\ HGO_ )7=3_\ DBC_ (=$_L\?]$]_\KNI_P#R17TE11_:&+_Y^R_\"?\
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M /CM>IT4?7L1_P _)?>P_P!8,T_Z":G_ ('+_,\L_P"&*OAG_P!"S_Y4;O\
M^.T?\,5?#/\ Z%G_ ,J-W_\ ':]3HH^O8C_GY+[V'^L&:?\ 034_\#E_F>6?
M\,5?#/\ Z%G_ ,J-W_\ ':/^&*OAG_T+/_E1N_\ X[7J=%'U[$?\_)?>P_U@
MS3_H)J?^!R_S/+/^&*OAG_T+/_E1N_\ X[1_PQ5\,_\ H6?_ "HW?_QVO4Z*
M/KV(_P"?DOO8?ZP9I_T$U/\ P.7^9Y9_PQ5\,_\ H6?_ "HW?_QVC_ABKX9_
M]"S_ .5&[_\ CM>IT4?7L1_S\E][#_6#-/\ H)J?^!R_S/+/^&*OAG_T+/\
MY4;O_P".T?\ #%7PS_Z%G_RHW?\ \=KU.BCZ]B/^?DOO8?ZP9I_T$U/_  .7
M^9Y9_P ,5?#/_H6?_*C=_P#QVC_ABKX9_P#0L_\ E1N__CM>IT4?7L1_S\E]
M[#_6#-/^@FI_X'+_ #/+/^&*OAG_ -"S_P"5&[_^.T?\,5?#/_H6?_*C=_\
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MT2W,CQA=R)+"Q $BD]+8?'/P3JMSJT-KXP\+7$V@VWVS4XXM6@=M.@RZ^;,
M^8TS&XW-@91N>#7E>DW%Y\)?VY-2;5K'QAK5GXR\#^&]"T_6X=#FO()[RPO=
M;>Y-Y-:PBWM&*7T$FZ011MN<)RNVO)-2_9[\2G_@GY;Z;I.C^)-'U*#X@W?B
M/7+'2]/MO[8U&T77[F5I(X+R*2&XE\D0S(DT;+(L,84$^6*.5?D/DC^1]4>#
MOVAO /Q$\"WGBCP_XX\'Z[X9T\L+K5]/UFVNK&VV\MOF1RBX[Y(Q7,>*/VY/
MA'X9^ WB+XF1_$3P=K'@SPO%(][J.DZS;7L/F*NX6Z-'(5:X?A4B!W.S*H!)
M%?/EOX7UBZ\+_$CQMX4U#XW^,/$=W::+I=Q=^-O EAIIGM%U -<2VFGKIMG-
M=W5I;F>1//A=&=HDC+_,%YBY^'/C+XNV'[35OI,GQ@\76_C;X/MHFDZGXV\+
MV_AZ?5]0V:K&EO%#%8V1^3ST ,\0D_>$@^64)KV:*5*/7^MC[C^&_P 4?#/Q
MC\)PZ]X1\1:%XJT.Y9TAU'1[^*^M)61BK!98F9"58$$ \$8K'L/VE_AQJOCN
MT\+VOQ \$W/B;4(A/:Z1%KEJ]_<QD9#I '\QE(YR 1BM'X4?%"R^+WA"/6=/
MT_Q)IEO(YB\C7-$N]'NU90-V8+J..4 $D!MNUL$J6&"?ASX8WUK\1/V"+?X9
M>'?AWXMB\<:UJT]SIUZGAVX_LRWNQJ;O'K+:H$^RH8@HDP9OM \ORQ&< 5,8
M7(C33W/M:_\ VB_A[I?Q.A\$W7COP;;^,[C BT"76K9-4ER,C;;%_-.1R,+T
MJ'XC?M,?#WX2+?#Q)XX\)Z+/IL<LEQ;WNKV]O.GE0I.XV.X.X0R1R$=ED1NC
M GX[_:LM?'WBT^.-'Q\78]:C\76][I/AKPUX%M)/#MY90WEM)#J,NIR:?(S3
M[$\QQ'>I.KH%6,!=S?07P^^%5V_QP_:*U)M%DMKOQ/-86FGW\]L8Q?Q+HMM'
MB.5AAXUF,BG:2 P8'D&CD25V/V<4KO\ K8ZKX;?M:^#?CM\.?#OBKP'XG\&>
M(=%UO4;?3YI7UZ*-K266)93;8C67-\JO'_HK%&^8Y9<#/13_ +0'@.U^)\?@
MF3QMX1C\:2+O30&UBW&J.N-V1;;_ #2,<YV]*^<? 4^I^.?V7O@'HMOX5\;6
M&K> =?\ #=AKEKJ7AV\L7LY+:UV7#@RQJ)8488,\1:$]G(YK6_9SO-/^&WA^
MU^&WB[X;^+M4\8+XKN-2NKY/"\]YI>H3OJ4ES%K)U-D^RY56CF^>47"%=BQE
ME"D<4#IK4]TM?C9H>D^';[4_$FO>#=%L[75+W3EN$UZ.6W_T8RLRR22+$([A
M8H9'EA^;RC'(-S!"]2>'/C_X#\8_#BX\8Z1XV\(ZIX1L]_GZY9ZQ;SZ;!LQO
MW7"N8UVY&<MQFOD/XAZ6_@.W^'$GB7P9KFN6K?M#^(=4&EIISS7%S;_8/$4\
M5W% 1NG5 JW"A S.(QL#,5!VOB#/XH\9^(OB9\1O /A'Q1HGAW6K3PYI<[WW
MA2:/5K^2WU*62^U2WTB[A$DDUO:31B)I8=\CQ#$<@B16KV:'[)'U%X)^/_@/
MXE^"+CQ-X<\;>$?$'ANS=HY]5TW6+>ZL8&7&5::-RBD9&03QD55T#]IKX;^*
M[3Q%<:7\0? ^I6_@^)Y]>DM==M9DT2-%9G>Z*N1 JJK$F3: %)/0U\7ZIX%\
M6?$7PC^U)Y,/QC\8:=XH\ Z'::1?>+?"D6CW^N7*2ZRDZ06UM8V;$HAMU(E@
M$^-A),30U]/^//AH-#_:E^#>HZ#X?^R:?I.G:SI%U<6%CL@LK-X('BMW9%VQ
MQF6&,JIP-R<=ZF4$A2IQ7]>5S1^%7[<WPC^,?P:G\?:-\0O"'_"+6*(^I7MQ
MK%M$FCE_NI=GS-L#GCY9"#S78>"/CCX*^)EGIEQX;\8>%_$%OK2S-I\NFZK!
M=I?B';YIB,;$2!-Z;MN=NY<XR*^3O ]K;M^QAX \,Z]HOQ>\.>)OA)J5F9+S
M3/ ]Y?-IVH0I<QB:.%[=QJ%L5W@O:I,!YT3!E;#+ZK^S%X\U+Q=K6ER>,/ M
MY<:U-?:N- \5#P5+HI-@$LVDFNH;@F>PFN9'V"-L&?['O*( $5R@EL$J:5VC
MO_BU\9-:\+?$/0?!_A7P_IGB+Q+KVG:AJPCU'5GTRSM+>T\A"TDJ6\[@O-=0
M(H$9.#(PSY9!Y+X5_M?ZAXMT3P/<^(O"MCH4OBKQ7KW@N\^QZRU_;Z=J6F75
M_;H$D>WA:6&?^SK@J[)&59HE*DOD7KY&LO\ @H+IC3?*NI?#V[%H#_RT-OJ5
MMY^/]W[3;Y_WUKR2V\.:CH'P?\"Z/?6%]INL:I\?];O+*.YMFCE: ^)M9U#S
M51@,I+8I(ZOT,<@=21C*45;^O,%%6_KS/6/VS?VS_#O['OAWPZVI:EX.M]<\
M7:E_9VD6WB/Q+%H-D^U2\T\UPR2M'!$NT,ZQ28:6)< R"NHA_::\#Z5J/AK1
M?$'C;P'HWBSQ/:PSV>C?\)';O->M(H.+4.4DN$)/RNL8W#!P,XK"_:E\-ZCX
MA\5?!V33]/O;Z/2_'L%Y>-;P-*MI -.U!#+(5!V(&=%W-@9=1G)%>)^,;"3P
M;X#^.O@#7/AWXN\3>*OB5JNK7.E3V7AZYOK#Q#%<QXL?-U!(VM[3[.ICA_TJ
M2+R_L^Y,C:2XQ301C%I'U1JWQ9\*Z!XNL_#]]XF\/V6O:E((;339]1ACO+IR
MC.%CB9@[,41VP 3A6/0&M2U\1Z??:W>:9!?6<VI:?''+=6B3*T]LDF[RV= =
MRA]C[20 =C8S@UX3^S1\(-6\%?M.>,M3\06<E]JD7@KPOHPU^2U8)J$L*WWV
MH0RL!G,GENZJ<\Q[A]VLW]MGP3XNM/&VEZGX(TW5+RZ^)&F/\.M;N+"$R-I$
M,\OF6^JR$?<CLU?4#DY!:Y0=2 5RJ]B>17Y;GO&F_%#PSK/AG2=:L_$6AW6C
M:\\4>F7\-_%):ZBTIQ&L,@;;(7/"A2=W;->=_LV_MK>!_P!HCPYX;CB\1>%-
M-\:>(-,35'\*+KUO<ZI:(RECF+*RLH49W>6!CFO-?@1\$=:\"_M'VWP]C\/W
MFG_"WX5WE]XI\.7AA=;2X?48]EM:1.>&^RM/K"LF6*(;(_+N4#!\ _ 6\\)?
M\$Z?@WI]CX-O-/\ $^A^*O"FJS6D6EM'?6,CZ_9#4;AXPN]3]EENS,[#B-I"
MQ !(?+$KDCL?36N_'_P'X7^(UCX/U/QMX1T[Q=JFW['H=UK%O#J5WNZ>7;LX
MD?/;:IS4/Q _:1^'?PFU*&S\5>/O!?AF\N+A;2*#5=;MK.229E5EC59'4ERK
M*0HY(8'N*^7?'/AZZT?X(_&CX5ZA\/?%NM?$#XA:WX@NM)U&VT.ZN--U;[=<
MSR:9<R:HD9M[7[)#);1'SI(WB^Q_(K?)GU;X+? ]G^/_ ,7)O%FBKJJZYH^A
MZ1/J5Y8_N=:B2R=;A%9AAT,C-N4$@%N><4N5)7#V<4KL]2T?X_\ @/Q#\2+G
MP;I_C;PC?>+[-/,N-#M]8MY=2@3&=SVZN9%&"#DKT-==7QW\(?@5?>$?V)/V
M4+.W\):AI_B'P[>^'-0U>$:=)'>Z9<2V+#499QMWQ,SRRB8OCF1@W4BOL2IE
M%+8B<4M@HHHJ2 HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\&>+M<T&S\-^,/%.KZ#;V,LUOHE@EP9)+QIQ# K-(BJX6W>1VD*1QH\99QO
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M&TO=0GU:\M;>.*>^FCCCDO'50&E98U5%9B"Q"*%!/  P*NUF8A1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MDM'J!NKNWEND=;&=K54C9%8/<!#"CDR+MC=P[@.55@CE?G?X$?"'0M*_;_\
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M-((MS"/<<G:&(&<9K2HHJ20HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH Y'4O@!X#UKXFVWC6\\$^$;OQE9@+;Z]-H]O)J<
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MPGR[,8QQC%<QX%_9F^&_POLIK7PS\/O!'AVVNH)K6:+3-"M;1)89BAFC98T
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M_#V^CMKV&TTSPW#X4C>)8&N+:X>[E3596PY#2VIVJSA55RC*?2=03XC?&?\
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MX!TN_O+J:QU:_P##VG6D$T]Q%(5FAGD@4%I$D4AE<Y5E((!%:7B3PGX%\&>
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M^!_Q4^#.H3>*]-TGX?\ B:;4Y-8NV\J6WO8$T]I;8K)M9N93'M\H@N651NW
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#; ]N9H)DDD@?RX]\4C-&_EKN5MHQ'XI_8L^&_C+Q[=>)+[0[Y;_ %&[BO\
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M!?AUX>T/2M-T_5Y+#PSJJ:UI45_K^H:A_9URENUJGE-<3N5B2%V180?*4'A
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MO"?AWX5^$9_".I7OAV_T[7S>Z@VNZG8R-#=_9Y89(EM;<SH\<;R+,_REF0#
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MXC>-O%%KXHL-3\=3V$8A\1ZE9WVK31VD,BBXN?L.;.%W:9U$-L3$B0QD89F
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M2V,\:'Q7I.1<.]S.)Y">=Z+$,<;.]))]R4I=^W]?@?;E>=W/[-&@W7@CXF:
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MYZ5P>N_L=6EUXSUK4]#\>?$7P;IWB:]&HZUHNA7]M#8ZE<X4/*'DMWN;9GV
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M\,Z7)^_N9Q<W$:233M+'%)N:)$06\8VMR3XM^U[\5_BOXA_X)_>-M#U3XC?
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M']E7_A3^MZ4\'Q%^)6M:#X?A:WTC0-3U&WDL+",H8PK/';I<W053A?M<\^W
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZ/=S//,H?.(Y((B,C8I(9='QQ^SUXM7XOZQXL\!^.K#PF_BNRM;+7;>_\/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>11
<FILENAME>sera-20241231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2025-03-19T15:38:36.5702+00:00 -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://seraprognostics.com/20241231" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:ecd-sub="http://xbrl.sec.gov/ecd-sub/2024" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:srt="http://fasb.org/srt/2024" xmlns:sera="http://seraprognostics.com/20241231" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd" namespace="http://xbrl.sec.gov/ecd-sub/2024"/>
  <xsd:import schemaLocation="https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd" namespace="http://xbrl.org/2020/extensible-enumerations-2.0"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" namespace="http://fasb.org/srt/2024"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" namespace="http://xbrl.sec.gov/dei/2024"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" namespace="http://fasb.org/us-gaap/2024"/>
  <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" namespace="http://www.xbrl.org/dtr/type/2022-03-31"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd" namespace="http://xbrl.sec.gov/cyd/2024"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd" namespace="http://xbrl.sec.gov/ecd/2024"/>
  <xsd:import schemaLocation="https://www.xbrl.org/2023/calculation-1.1.xsd" namespace="https://xbrl.org/2023/calculation-1.1"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/Cover" id="Cover">
        <link:definition>100000 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited" id="BalanceSheetsunaudited">
        <link:definition>100010 - Statement - Balance Sheets (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails2" id="DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails2">
        <link:definition>100020 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Lease Payments (Details) 2</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsDetails2" id="DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsDetails2">
        <link:definition>100030 - Disclosure - Intangible Assets, net - Schedule of Intangible Assets (Details) 2</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
        <link:definition>100040 - Statement - Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/StatementsofOperationsandComprehensiveLoss" id="StatementsofOperationsandComprehensiveLoss">
        <link:definition>100050 - Statement - Statements of Operations and Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/StatementStatementsOfStockholdersEquity" id="StatementStatementsOfStockholdersEquity">
        <link:definition>100060 - Statement - Statements of Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows" id="StatementsofCashFlows">
        <link:definition>100070 - Statement - Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernanceDisclosure" id="DisclosureCybersecurityRiskManagementStrategyAndGovernanceDisclosure">
        <link:definition>995455 - Disclosure - Cybersecurity Risk Management, Strategy, and Governance Disclosure</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/DescriptionofBusinessandFinancialCondition" id="DescriptionofBusinessandFinancialCondition">
        <link:definition>995465 - Disclosure - Description of Business and Financial Condition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/SignificantAccountingPolicies" id="SignificantAccountingPolicies">
        <link:definition>995475 - Disclosure - Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecurities" id="CashCashEquivalentsandMarketableSecurities">
        <link:definition>995485 - Disclosure - Cash, Cash Equivalents and Marketable Securities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/PropertyandEquipment" id="PropertyandEquipment">
        <link:definition>995495 - Disclosure - Property and Equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNet" id="DisclosureIntangibleAssetsNet">
        <link:definition>995505 - Disclosure - Intangible Assets, net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureOtherAssets" id="DisclosureOtherAssets">
        <link:definition>995515 - Disclosure - Other Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/AccruedandOtherCurrentLiabilities" id="AccruedandOtherCurrentLiabilities">
        <link:definition>995525 - Disclosure - Accrued and Other Current Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureOtherIncomeNet1" id="DisclosureOtherIncomeNet1">
        <link:definition>995535 - Disclosure - Other Income, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/FairValueMeasurements" id="FairValueMeasurements">
        <link:definition>995545 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
        <link:definition>995555 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/CapitalStructure" id="CapitalStructure">
        <link:definition>995565 - Disclosure - Capital Structure</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/StockBasedCompensation" id="StockBasedCompensation">
        <link:definition>995575 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/Warrants" id="Warrants">
        <link:definition>995585 - Disclosure - Warrants</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/CommitmentsandContingencies" id="CommitmentsandContingencies">
        <link:definition>995595 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxes" id="IncomeTaxes">
        <link:definition>995605 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureNetLossPerShare1" id="DisclosureNetLossPerShare1">
        <link:definition>995615 - Disclosure - Net Loss Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureSegmentInformation" id="DisclosureSegmentInformation">
        <link:definition>995625 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureSubsequentEvents" id="DisclosureSubsequentEvents">
        <link:definition>995635 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/SignificantAccountingPoliciesPolicies" id="SignificantAccountingPoliciesPolicies">
        <link:definition>995645 - Disclosure - Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/AccountingPoliciesTables" id="AccountingPoliciesTables">
        <link:definition>995655 - Disclosure - Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesTables" id="CashCashEquivalentsandMarketableSecuritiesTables">
        <link:definition>995665 - Disclosure - Cash, Cash Equivalents and Marketable Securities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/PropertyandEquipmentTables" id="PropertyandEquipmentTables">
        <link:definition>995675 - Disclosure - Property and Equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetTables" id="DisclosureIntangibleAssetsNetTables">
        <link:definition>995685 - Disclosure - Intangible Assets, net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureOtherAssetsTables" id="DisclosureOtherAssetsTables">
        <link:definition>995695 - Disclosure - Other Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/AccruedandOtherCurrentLiabilitiesTables" id="AccruedandOtherCurrentLiabilitiesTables">
        <link:definition>995705 - Disclosure - Accrued and Other Current Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureOtherIncomeNetTables" id="DisclosureOtherIncomeNetTables">
        <link:definition>995715 - Disclosure - Other Income, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/FairValueMeasurementsTables" id="FairValueMeasurementsTables">
        <link:definition>995725 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/CapitalStructureTables" id="CapitalStructureTables">
        <link:definition>995735 - Disclosure - Capital Structure (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/StockBasedCompensationTables" id="StockBasedCompensationTables">
        <link:definition>995745 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/WarrantsTables" id="WarrantsTables">
        <link:definition>995755 - Disclosure - Warrants (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/CommitmentandContingenciesTables" id="CommitmentandContingenciesTables">
        <link:definition>995765 - Disclosure - Commitment and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesTables" id="IncomeTaxesTables">
        <link:definition>995775 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureNetLossPerShareTables" id="DisclosureNetLossPerShareTables">
        <link:definition>995785 - Disclosure - Net Loss Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureSegmentInformationTables" id="DisclosureSegmentInformationTables">
        <link:definition>995795 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAndFinancialConditionAdditionalInformationDetails" id="DisclosureDescriptionOfBusinessAndFinancialConditionAdditionalInformationDetails">
        <link:definition>995805 - Disclosure - Description of Business and Financial Condition - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails" id="DisclosureSignificantAccountingPoliciesAdditionalInformationDetails">
        <link:definition>995815 - Disclosure - Significant Accounting Policies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureSignificantAccountingPoliciesScheduleOfEstimatedUsefulLifeOfEachAssetCategoryDetails" id="DisclosureSignificantAccountingPoliciesScheduleOfEstimatedUsefulLifeOfEachAssetCategoryDetails">
        <link:definition>995825 - Disclosure - Significant Accounting Policies - Schedule of Estimated Useful Life of Each Asset Category (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails" id="CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails">
        <link:definition>995835 - Disclosure - Cash, Cash Equivalents and Marketable Securities - Cash, Cash Equivalents and Marketable Securities by Major Security Type (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecuritiesAvailableforsaleDebtSecuritiesAndCashEquivalentsInUnrealizedLossPositionsDetails" id="DisclosureCashCashEquivalentsAndMarketableSecuritiesAvailableforsaleDebtSecuritiesAndCashEquivalentsInUnrealizedLossPositionsDetails">
        <link:definition>995845 - Disclosure - Cash, Cash Equivalents and Marketable Securities - Available-for-sale Debt Securities and Cash Equivalents in Unrealized Loss Positions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecuritiesAdditionalInformationDetails" id="DisclosureCashCashEquivalentsAndMarketableSecuritiesAdditionalInformationDetails">
        <link:definition>995855 - Disclosure - Cash, Cash Equivalents and Marketable Securities - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails" id="CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails">
        <link:definition>995865 - Disclosure - Cash, Cash Equivalents and Marketable Securities - Marketable Securities Classified by Contractual Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentScheduleOfComponentsOfPropertyAndEquipmentNetDetails" id="DisclosurePropertyAndEquipmentScheduleOfComponentsOfPropertyAndEquipmentNetDetails">
        <link:definition>995875 - Disclosure - Property and Equipment - Schedule of Components of Property and Equipment, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/PropertyandEquipmentAdditionalInformationDetails" id="PropertyandEquipmentAdditionalInformationDetails">
        <link:definition>995885 - Disclosure - Property and Equipment - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsDetails" id="DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsDetails">
        <link:definition>995895 - Disclosure - Intangible Assets, net - Schedule of Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetAdditionalInformationDetails" id="DisclosureIntangibleAssetsNetAdditionalInformationDetails">
        <link:definition>995905 - Disclosure - Intangible Assets, net - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfComponentsOfAccruedAndOtherCurrentLiabilitiesDetails" id="DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfComponentsOfAccruedAndOtherCurrentLiabilitiesDetails">
        <link:definition>995915 - Disclosure - Accrued and Other Current Liabilities - Schedule of Components of Accrued and Other Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureOtherIncomeNetScheduleOfComponentsOfOtherIncomeNetDetails" id="DisclosureOtherIncomeNetScheduleOfComponentsOfOtherIncomeNetDetails">
        <link:definition>995925 - Disclosure - Other Income, Net - Schedule of Components of Other Income, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails" id="DisclosureFairValueMeasurementsAdditionalInformationDetails">
        <link:definition>995935 - Disclosure - Fair Value Measurements - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails" id="FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails">
        <link:definition>995945 - Disclosure - Fair Value Measurements - Financial Assets that are Measured at Fair Value on a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" id="DisclosureRelatedPartyTransactionsAdditionalInformationDetails">
        <link:definition>995955 - Disclosure - Related Party Transactions - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureAdditionalInformationDetails" id="DisclosureCapitalStructureAdditionalInformationDetails">
        <link:definition>995965 - Disclosure - Capital Structure - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureScheduleOfCommonStockReservedForFutureIssuanceDetails" id="DisclosureCapitalStructureScheduleOfCommonStockReservedForFutureIssuanceDetails">
        <link:definition>995975 - Disclosure - Capital Structure - Schedule of Common Stock Reserved for Future Issuance (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsDetails_1" id="CommitmentsandContingenciesFutureMinimumLeasePaymentsDetails_1">
        <link:definition>995985 - Disclosure - Commitments and Contingencies - Future Minimum Lease Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails" id="DisclosureStockbasedCompensationAdditionalInformationDetails">
        <link:definition>995995 - Disclosure - Stock-Based Compensation - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionsGrantedAndOutstandingDetails" id="DisclosureStockbasedCompensationSummaryOfOptionsGrantedAndOutstandingDetails">
        <link:definition>996005 - Disclosure - Stock-Based Compensation - Summary of Options Granted and Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfFairValuesCalculatedUsingBlackscholesOptionPricingModelDetails" id="DisclosureStockbasedCompensationScheduleOfFairValuesCalculatedUsingBlackscholesOptionPricingModelDetails">
        <link:definition>996015 - Disclosure - Stock-Based Compensation - Schedule of Fair Values Calculated using Black-Scholes Option Pricing Model (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfInformationAboutRsusGrantedAndOutstandingDetails" id="DisclosureStockbasedCompensationSummaryOfInformationAboutRsusGrantedAndOutstandingDetails">
        <link:definition>996025 - Disclosure - Stock-Based Compensation - Summary of Information about RSUs Granted and Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfImpactOfStockbasedCompensationExpenseInStatementsOfOperationsDetails" id="DisclosureStockbasedCompensationScheduleOfImpactOfStockbasedCompensationExpenseInStatementsOfOperationsDetails">
        <link:definition>996035 - Disclosure - Stock-Based Compensation - Schedule of Impact of Stock-based Compensation Expense in Statements of Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfUnrecognizedStockbasedCompensationExpenseForOutstandingUnvestedStockOptionsAndRsusDetails" id="DisclosureStockbasedCompensationSummaryOfUnrecognizedStockbasedCompensationExpenseForOutstandingUnvestedStockOptionsAndRsusDetails">
        <link:definition>996045 - Disclosure - Stock-Based Compensation - Summary of Unrecognized Stock-based Compensation Expense for Outstanding Unvested Stock Options and RSUs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureWarrantsScheduleOfCommonStockWarrantsOutstandingDetails" id="DisclosureWarrantsScheduleOfCommonStockWarrantsOutstandingDetails">
        <link:definition>996055 - Disclosure - Warrants - Schedule of Common Stock Warrants Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails" id="DisclosureWarrantsAdditionalInformationDetails">
        <link:definition>996065 - Disclosure - Warrants - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeasesInFinancialStatementDetails" id="DisclosureCommitmentsAndContingenciesScheduleOfLeasesInFinancialStatementDetails">
        <link:definition>996075 - Disclosure - Commitments and Contingencies - Schedule of Leases in Financial Statement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeaseCostAndOtherInformationDetails" id="DisclosureCommitmentsAndContingenciesScheduleOfLeaseCostAndOtherInformationDetails">
        <link:definition>996085 - Disclosure - Commitments and Contingencies - Schedule of Lease Cost and Other Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails" id="DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails">
        <link:definition>996095 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Lease Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" id="DisclosureCommitmentsAndContingenciesAdditionalInformationDetails">
        <link:definition>996105 - Disclosure - Commitments and Contingencies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" id="DisclosureIncomeTaxesAdditionalInformationDetails">
        <link:definition>996115 - Disclosure - Income Taxes - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails" id="IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails">
        <link:definition>996125 - Disclosure - Income Taxes - Schedule of Components of Income Tax Provision (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" id="IncomeTaxesEffectiveTaxRateReconciliationDetails">
        <link:definition>996135 - Disclosure - Income Taxes - Effective Tax Rate Reconciliation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" id="IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails">
        <link:definition>996145 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesUnrecognizedTaxPositionsDetails" id="IncomeTaxesUnrecognizedTaxPositionsDetails">
        <link:definition>996155 - Disclosure - Income Taxes - Unrecognized Tax Positions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureNetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromTheComputationOfEarningsPerShareDetails" id="DisclosureNetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromTheComputationOfEarningsPerShareDetails">
        <link:definition>996165 - Disclosure - Net Loss Per Share - Schedule of Anti-dilutive Securities Excluded from the Computation of Earnings per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureSegmentInformationSummaryOfSegmentInformationForRevenueSignificantSegmentExpensesAndSegmentLossExpensesThatAreRegularlyProvidedT" id="DisclosureSegmentInformationSummaryOfSegmentInformationForRevenueSignificantSegmentExpensesAndSegmentLossExpensesThatAreRegularlyProvidedT">
        <link:definition>996175 - Disclosure - Segment Information - Summary of Segment Information for Revenue, Significant Segment Expenses and Segment Loss Expenses that are Regularly Provided to the CODM (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" id="DisclosureSubsequentEventsAdditionalInformationDetails">
        <link:definition>996185 - Disclosure - Subsequent Events (Additional Information) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://seraprognostics.com/20241231/role/Anchoring" id="Anchoring">
        <link:definition>999009 - Disclosure - Anchoring</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbase id="lnk">
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://www.esma.europa.eu/xbrl/esef/arcrole/wider-narrower" xlink:href="http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd#wider-narrower" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="https://xbrl.org/2023/arcrole/summation-item" xlink:href="https://www.xbrl.org/2023/calculation-1.1.xsd#summation-item" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited" xlink:href="sera-20241231.xsd#BalanceSheetsunaudited" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails2" xlink:href="sera-20241231.xsd#DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails2" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsDetails2" xlink:href="sera-20241231.xsd#DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsDetails2" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/StatementsofOperationsandComprehensiveLoss" xlink:href="sera-20241231.xsd#StatementsofOperationsandComprehensiveLoss" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows" xlink:href="sera-20241231.xsd#StatementsofCashFlows" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails" xlink:href="sera-20241231.xsd#CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecuritiesAvailableforsaleDebtSecuritiesAndCashEquivalentsInUnrealizedLossPositionsDetails" xlink:href="sera-20241231.xsd#DisclosureCashCashEquivalentsAndMarketableSecuritiesAvailableforsaleDebtSecuritiesAndCashEquivalentsInUnrealizedLossPositionsDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails" xlink:href="sera-20241231.xsd#CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentScheduleOfComponentsOfPropertyAndEquipmentNetDetails" xlink:href="sera-20241231.xsd#DisclosurePropertyAndEquipmentScheduleOfComponentsOfPropertyAndEquipmentNetDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsDetails" xlink:href="sera-20241231.xsd#DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfComponentsOfAccruedAndOtherCurrentLiabilitiesDetails" xlink:href="sera-20241231.xsd#DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfComponentsOfAccruedAndOtherCurrentLiabilitiesDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureOtherIncomeNetScheduleOfComponentsOfOtherIncomeNetDetails" xlink:href="sera-20241231.xsd#DisclosureOtherIncomeNetScheduleOfComponentsOfOtherIncomeNetDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails" xlink:href="sera-20241231.xsd#FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsDetails_1" xlink:href="sera-20241231.xsd#CommitmentsandContingenciesFutureMinimumLeasePaymentsDetails_1" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfUnrecognizedStockbasedCompensationExpenseForOutstandingUnvestedStockOptionsAndRsusDetails" xlink:href="sera-20241231.xsd#DisclosureStockbasedCompensationSummaryOfUnrecognizedStockbasedCompensationExpenseForOutstandingUnvestedStockOptionsAndRsusDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeasesInFinancialStatementDetails" xlink:href="sera-20241231.xsd#DisclosureCommitmentsAndContingenciesScheduleOfLeasesInFinancialStatementDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeaseCostAndOtherInformationDetails" xlink:href="sera-20241231.xsd#DisclosureCommitmentsAndContingenciesScheduleOfLeaseCostAndOtherInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails" xlink:href="sera-20241231.xsd#DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails" xlink:href="sera-20241231.xsd#IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" xlink:href="sera-20241231.xsd#IncomeTaxesEffectiveTaxRateReconciliationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:href="sera-20241231.xsd#IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureSegmentInformationSummaryOfSegmentInformationForRevenueSignificantSegmentExpensesAndSegmentLossExpensesThatAreRegularlyProvidedT" xlink:href="sera-20241231.xsd#DisclosureSegmentInformationSummaryOfSegmentInformationForRevenueSignificantSegmentExpensesAndSegmentLossExpensesThatAreRegularlyProvidedT" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/Cover" xlink:href="sera-20241231.xsd#Cover" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsParenthetical" xlink:href="sera-20241231.xsd#BalanceSheetsParenthetical" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/StatementStatementsOfStockholdersEquity" xlink:href="sera-20241231.xsd#StatementStatementsOfStockholdersEquity" xlink:type="simple"/>
        <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#IndividualsOnly" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernanceDisclosure" xlink:href="sera-20241231.xsd#DisclosureCybersecurityRiskManagementStrategyAndGovernanceDisclosure" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAndFinancialConditionAdditionalInformationDetails" xlink:href="sera-20241231.xsd#DisclosureDescriptionOfBusinessAndFinancialConditionAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails" xlink:href="sera-20241231.xsd#DisclosureSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureSignificantAccountingPoliciesScheduleOfEstimatedUsefulLifeOfEachAssetCategoryDetails" xlink:href="sera-20241231.xsd#DisclosureSignificantAccountingPoliciesScheduleOfEstimatedUsefulLifeOfEachAssetCategoryDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/PropertyandEquipmentAdditionalInformationDetails" xlink:href="sera-20241231.xsd#PropertyandEquipmentAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetAdditionalInformationDetails" xlink:href="sera-20241231.xsd#DisclosureIntangibleAssetsNetAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails" xlink:href="sera-20241231.xsd#DisclosureFairValueMeasurementsAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" xlink:href="sera-20241231.xsd#DisclosureRelatedPartyTransactionsAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureAdditionalInformationDetails" xlink:href="sera-20241231.xsd#DisclosureCapitalStructureAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureScheduleOfCommonStockReservedForFutureIssuanceDetails" xlink:href="sera-20241231.xsd#DisclosureCapitalStructureScheduleOfCommonStockReservedForFutureIssuanceDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails" xlink:href="sera-20241231.xsd#DisclosureStockbasedCompensationAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfFairValuesCalculatedUsingBlackscholesOptionPricingModelDetails" xlink:href="sera-20241231.xsd#DisclosureStockbasedCompensationScheduleOfFairValuesCalculatedUsingBlackscholesOptionPricingModelDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfInformationAboutRsusGrantedAndOutstandingDetails" xlink:href="sera-20241231.xsd#DisclosureStockbasedCompensationSummaryOfInformationAboutRsusGrantedAndOutstandingDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfImpactOfStockbasedCompensationExpenseInStatementsOfOperationsDetails" xlink:href="sera-20241231.xsd#DisclosureStockbasedCompensationScheduleOfImpactOfStockbasedCompensationExpenseInStatementsOfOperationsDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureWarrantsScheduleOfCommonStockWarrantsOutstandingDetails" xlink:href="sera-20241231.xsd#DisclosureWarrantsScheduleOfCommonStockWarrantsOutstandingDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:href="sera-20241231.xsd#DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" xlink:href="sera-20241231.xsd#DisclosureIncomeTaxesAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureNetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromTheComputationOfEarningsPerShareDetails" xlink:href="sera-20241231.xsd#DisclosureNetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromTheComputationOfEarningsPerShareDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" xlink:href="sera-20241231.xsd#DisclosureSubsequentEventsAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd#eedm" xlink:type="simple"/>
        <link:roleRef roleURI="http://fasb.org/srt/role/srt-eedm/ExtensibleEnumerationLists" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd#eedm1" xlink:type="simple"/>
        <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangements" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/DescriptionofBusinessandFinancialCondition" xlink:href="sera-20241231.xsd#DescriptionofBusinessandFinancialCondition" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/SignificantAccountingPolicies" xlink:href="sera-20241231.xsd#SignificantAccountingPolicies" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecurities" xlink:href="sera-20241231.xsd#CashCashEquivalentsandMarketableSecurities" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/PropertyandEquipment" xlink:href="sera-20241231.xsd#PropertyandEquipment" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNet" xlink:href="sera-20241231.xsd#DisclosureIntangibleAssetsNet" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureOtherAssets" xlink:href="sera-20241231.xsd#DisclosureOtherAssets" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/AccruedandOtherCurrentLiabilities" xlink:href="sera-20241231.xsd#AccruedandOtherCurrentLiabilities" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureOtherIncomeNet1" xlink:href="sera-20241231.xsd#DisclosureOtherIncomeNet1" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/FairValueMeasurements" xlink:href="sera-20241231.xsd#FairValueMeasurements" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/RelatedPartyTransactions" xlink:href="sera-20241231.xsd#RelatedPartyTransactions" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/CapitalStructure" xlink:href="sera-20241231.xsd#CapitalStructure" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/StockBasedCompensation" xlink:href="sera-20241231.xsd#StockBasedCompensation" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/Warrants" xlink:href="sera-20241231.xsd#Warrants" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/CommitmentsandContingencies" xlink:href="sera-20241231.xsd#CommitmentsandContingencies" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxes" xlink:href="sera-20241231.xsd#IncomeTaxes" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureNetLossPerShare1" xlink:href="sera-20241231.xsd#DisclosureNetLossPerShare1" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureSegmentInformation" xlink:href="sera-20241231.xsd#DisclosureSegmentInformation" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureSubsequentEvents" xlink:href="sera-20241231.xsd#DisclosureSubsequentEvents" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/SignificantAccountingPoliciesPolicies" xlink:href="sera-20241231.xsd#SignificantAccountingPoliciesPolicies" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/AccountingPoliciesTables" xlink:href="sera-20241231.xsd#AccountingPoliciesTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesTables" xlink:href="sera-20241231.xsd#CashCashEquivalentsandMarketableSecuritiesTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/PropertyandEquipmentTables" xlink:href="sera-20241231.xsd#PropertyandEquipmentTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetTables" xlink:href="sera-20241231.xsd#DisclosureIntangibleAssetsNetTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureOtherAssetsTables" xlink:href="sera-20241231.xsd#DisclosureOtherAssetsTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/AccruedandOtherCurrentLiabilitiesTables" xlink:href="sera-20241231.xsd#AccruedandOtherCurrentLiabilitiesTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureOtherIncomeNetTables" xlink:href="sera-20241231.xsd#DisclosureOtherIncomeNetTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/FairValueMeasurementsTables" xlink:href="sera-20241231.xsd#FairValueMeasurementsTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/CapitalStructureTables" xlink:href="sera-20241231.xsd#CapitalStructureTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/StockBasedCompensationTables" xlink:href="sera-20241231.xsd#StockBasedCompensationTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/WarrantsTables" xlink:href="sera-20241231.xsd#WarrantsTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/CommitmentandContingenciesTables" xlink:href="sera-20241231.xsd#CommitmentandContingenciesTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesTables" xlink:href="sera-20241231.xsd#IncomeTaxesTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureNetLossPerShareTables" xlink:href="sera-20241231.xsd#DisclosureNetLossPerShareTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureSegmentInformationTables" xlink:href="sera-20241231.xsd#DisclosureSegmentInformationTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecuritiesAdditionalInformationDetails" xlink:href="sera-20241231.xsd#DisclosureCashCashEquivalentsAndMarketableSecuritiesAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionsGrantedAndOutstandingDetails" xlink:href="sera-20241231.xsd#DisclosureStockbasedCompensationSummaryOfOptionsGrantedAndOutstandingDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails" xlink:href="sera-20241231.xsd#DisclosureWarrantsAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesUnrecognizedTaxPositionsDetails" xlink:href="sera-20241231.xsd#IncomeTaxesUnrecognizedTaxPositionsDetails" xlink:type="simple"/>
        <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CommonStockWarrantAt20.77SharePriceMember" xlink:label="sera_CommonStockWarrantAt20.77SharePriceMember"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_OtherOfficersMember" xlink:label="sera_OtherOfficersMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_ScheduleOfEstimatedUsefulLifeOfEachAssetCategoryTableTextBlock" xlink:label="sera_ScheduleOfEstimatedUsefulLifeOfEachAssetCategoryTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:label="us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_NumberOfVotesPerShare" xlink:label="sera_NumberOfVotesPerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:label="us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="us-gaap_OtherNoncashIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName" xlink:label="dei_AuditorName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingOtherItemAmount" xlink:label="us-gaap_SegmentReportingOtherItemAmount"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_WarrantIssuedPricePerPre-FundedWarrantAndAccompanyingWarrant" xlink:label="sera_WarrantIssuedPricePerPre-FundedWarrantAndAccompanyingWarrant"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedVacationCurrent" xlink:label="us-gaap_AccruedVacationCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="us-gaap_AccruedSalariesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CommonStockWarrantAt9.03SharePriceMember" xlink:label="sera_CommonStockWarrantAt9.03SharePriceMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory" xlink:label="sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_Plan2011Member" xlink:label="sera_Plan2011Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorOpinionTextBlock" xlink:label="dei_AuditorOpinionTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_JohnJBonifaceMember" xlink:label="sera_JohnJBonifaceMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRecognitionDeferredRevenue" xlink:label="us-gaap_RevenueRecognitionDeferredRevenue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_WarrantsToPurchaseCommonStockMember" xlink:label="sera_WarrantsToPurchaseCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_NonCurrentMarketableSecuritiesMember" xlink:label="sera_NonCurrentMarketableSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CommitmentsAndContingenciesLineItems" xlink:label="sera_CommitmentsAndContingenciesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CarelonResearchMember" xlink:label="sera_CarelonResearchMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CapitalSharesReservedForFutureIssuanceDomain" xlink:label="sera_CapitalSharesReservedForFutureIssuanceDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_LeaseLiabilityToBePaidYearOne" xlink:label="sera_LeaseLiabilityToBePaidYearOne"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostAbstract" xlink:label="us-gaap_LeaseCostAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:label="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_IssuePricePerShareAndWarrant" xlink:label="sera_IssuePricePerShareAndWarrant"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_AggregateOfferingPriceFromSaleOfCommonStock" xlink:label="sera_AggregateOfferingPriceFromSaleOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_LeaseLiabilityPaymentDue" xlink:label="sera_LeaseLiabilityPaymentDue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxContingencyLineItems" xlink:label="us-gaap_IncomeTaxContingencyLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxContingencyTable" xlink:label="us-gaap_IncomeTaxContingencyTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeasePrincipalPayments" xlink:label="us-gaap_FinanceLeasePrincipalPayments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpenseMember" xlink:label="us-gaap_SellingAndMarketingExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_NumberOfCommonStockClassesAuthorized" xlink:label="sera_NumberOfCommonStockClassesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_EmergingGrowthCompanyStatusPolicyTextBlock" xlink:label="sera_EmergingGrowthCompanyStatusPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_TwoThousandTwentyFourSalesAgreementMember" xlink:label="sera_TwoThousandTwentyFourSalesAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="us-gaap_OtherIncomeAndExpensesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_NoncashInvestmentIncomeExpenseNet" xlink:label="sera_NoncashInvestmentIncomeExpenseNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_DomainNamesMember" xlink:label="sera_DomainNamesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract" xlink:label="us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherReceivables" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="us-gaap_CorporateDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue" xlink:label="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:label="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanCostRecognized" xlink:label="us-gaap_DefinedContributionPlanCostRecognized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_LeaseOtherInformationAbstract" xlink:label="sera_LeaseOtherInformationAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_StockIssuedDuringPeriodSharesStockWarrantExpired" xlink:label="sera_StockIssuedDuringPeriodSharesStockWarrantExpired"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_PlanEspp2021Member" xlink:label="sera_PlanEspp2021Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities" xlink:label="sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:label="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:label="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_TdCowenMember" xlink:label="sera_TdCowenMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MunicipalBondsMember" xlink:label="us-gaap_MunicipalBondsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_AmountFromSaleOfCombinationOfSecuritiesUnderShelfRegistration" xlink:label="sera_AmountFromSaleOfCombinationOfSecuritiesUnderShelfRegistration"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCost" xlink:label="us-gaap_LeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="us-gaap_SellingAndMarketingExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:label="us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember" xlink:label="sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommercialPaperMember" xlink:label="us-gaap_CommercialPaperMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="us-gaap_MachineryAndEquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedEmployeeBenefitsCurrent" xlink:label="us-gaap_AccruedEmployeeBenefitsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="us-gaap_CashAndCashEquivalentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" xlink:label="sera_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_LaboratoryServicesAgreementMember" xlink:label="sera_LaboratoryServicesAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_FairValueAdjustmentOfPreFundedWarrants" xlink:label="sera_FairValueAdjustmentOfPreFundedWarrants"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_ClinicalStudiesAndOutsideProcessing" xlink:label="sera_ClinicalStudiesAndOutsideProcessing"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestorMember" xlink:label="us-gaap_InvestorMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLaborRelatedExpenses" xlink:label="us-gaap_OtherLaborRelatedExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:label="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_LeaseLiabilityCurrent" xlink:label="sera_LeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_LeaseLiabilitiesTotal" xlink:label="sera_LeaseLiabilitiesTotal"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_LeaseLiabilityToBePaidYearTwo" xlink:label="sera_LeaseLiabilityToBePaidYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" xlink:label="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:label="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsDisclosureTextBlock" xlink:label="us-gaap_OtherAssetsDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsMember" xlink:label="us-gaap_CashAndCashEquivalentsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_FinanceLeaseLiabilityToBePaidYearThreeAndThereafter" xlink:label="sera_FinanceLeaseLiabilityToBePaidYearThreeAndThereafter"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_RightOfUseAssetTotal" xlink:label="sera_RightOfUseAssetTotal"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_FinanceLeasesOtherInformationAbstract" xlink:label="sera_FinanceLeasesOtherInformationAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:label="us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember" xlink:label="sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_Plan2021Member" xlink:label="sera_Plan2021Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="us-gaap_FinanceLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_DefinedContributionPlanEmployerMatchingContributionMatchingTierDomain" xlink:label="sera_DefinedContributionPlanEmployerMatchingContributionMatchingTierDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_WarrantsTextBlock" xlink:label="sera_WarrantsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CapitalizedIntangibleAssets" xlink:label="sera_CapitalizedIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_RelatedPartyTransactionCashReceivedFromRelatedParty" xlink:label="sera_RelatedPartyTransactionCashReceivedFromRelatedParty"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="us-gaap_MarketableSecuritiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_DeferredTaxAssetsLeaseLiabilities" xlink:label="sera_DeferredTaxAssetsLeaseLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_IssuanceOfStockToSettleAccruedAndOtherCurrentLiabilities" xlink:label="sera_IssuanceOfStockToSettleAccruedAndOtherCurrentLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:label="us-gaap_DefinedContributionPlanDisclosureLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_ProceedsFromIssuanceOfSharesAndPreFundedWarrants" xlink:label="sera_ProceedsFromIssuanceOfSharesAndPreFundedWarrants"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingStandardsUpdate202307Member" xlink:label="us-gaap_AccountingStandardsUpdate202307Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost" xlink:label="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:label="us-gaap_DeferredTaxLiabilitiesNetAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CommonStockAdditionalShares" xlink:label="sera_CommonStockAdditionalShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" xlink:label="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_WarrantsIssued" xlink:label="sera_WarrantsIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_LeaseLiabilityPaymentDueAbstract" xlink:label="sera_LeaseLiabilityPaymentDueAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_LesseeOperatingLeaseLiabilityToBePaidYearThreeAndThereafter" xlink:label="sera_LesseeOperatingLeaseLiabilityToBePaidYearThreeAndThereafter"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_DefinedContributionPlanEmployerMatchingContributionMatchingTierAxis" xlink:label="sera_DefinedContributionPlanEmployerMatchingContributionMatchingTierAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonUnitIssued" xlink:label="us-gaap_CommonUnitIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="us-gaap_MarketableSecuritiesPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpAmount" xlink:label="sera_EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_PercentageOfMinimumOwnershipBeneficiallyOwnByHolderWithAffiliatesToWarrantExercise" xlink:label="sera_PercentageOfMinimumOwnershipBeneficiallyOwnByHolderWithAffiliatesToWarrantExercise"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_DefinedContributionPlanEmployerMatchingContributionSecondTierMember" xlink:label="sera_DefinedContributionPlanEmployerMatchingContributionSecondTierMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_StockIssuedDuringPeriodSharesStockWarrantExercised" xlink:label="sera_StockIssuedDuringPeriodSharesStockWarrantExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock" xlink:label="sera_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CashAndCashEquivalentsAmortizedCost" xlink:label="sera_CashAndCashEquivalentsAmortizedCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CurrentMarketableSecuritiesMember" xlink:label="sera_CurrentMarketableSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:label="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfOtherAssetsTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm" xlink:label="sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense" xlink:label="sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashMember" xlink:label="us-gaap_CashMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_LeaseLiabilityUndiscountedExcessAmount" xlink:label="sera_LeaseLiabilityUndiscountedExcessAmount"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_IndemnificationLiability" xlink:label="sera_IndemnificationLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:label="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpPercent" xlink:label="sera_EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpPercent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium" xlink:label="us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CommercialCollaborationAgreementMember" xlink:label="sera_CommercialCollaborationAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:label="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PostemploymentBenefitPlansPolicy" xlink:label="us-gaap_PostemploymentBenefitPlansPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_EffectiveIncomeTaxRateReconciliationEquityBasedExpensesPercent" xlink:label="sera_EffectiveIncomeTaxRateReconciliationEquityBasedExpensesPercent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAbstract" xlink:label="us-gaap_CashAndCashEquivalentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseInterestExpense" xlink:label="us-gaap_FinanceLeaseInterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="us-gaap_OtherReceivablesNetCurrent"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_ElevanceHealthIncMember" xlink:label="sera_ElevanceHealthIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesNoncurrent" xlink:label="us-gaap_MarketableSecuritiesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_LaboratoryEquipmentMember" xlink:label="sera_LaboratoryEquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeOther" xlink:label="us-gaap_InterestIncomeOther"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CommonStockConversionRatio" xlink:label="sera_CommonStockConversionRatio"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:label="us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockNoParValue" xlink:label="us-gaap_CommonStockNoParValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SoftwareDevelopmentMember" xlink:label="us-gaap_SoftwareDevelopmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_DefinedContributionPlanEmployerMatchingContributionFirstTierMember" xlink:label="sera_DefinedContributionPlanEmployerMatchingContributionFirstTierMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesPolicyTextBlock" xlink:label="us-gaap_CostOfSalesPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_OperatingLeasesOtherInformationAbstract" xlink:label="sera_OperatingLeasesOtherInformationAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CapitalSharesReservedForFutureIssuanceAxis" xlink:label="sera_CapitalSharesReservedForFutureIssuanceAxis"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CommonStockSharesConverted" xlink:label="sera_CommonStockSharesConverted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_EffectiveIncomeTaxRateReconciliationEquityBasedExpensesAmount" xlink:label="sera_EffectiveIncomeTaxRateReconciliationEquityBasedExpensesAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfessionalFees" xlink:label="us-gaap_ProfessionalFees"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_ClassOfWarrantOrRightExercised" xlink:label="sera_ClassOfWarrantOrRightExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_MasterServicesAgreementMember" xlink:label="sera_MasterServicesAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanTable" xlink:label="us-gaap_DefinedContributionPlanTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:label="us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_RightOfUseAssetAbstract" xlink:label="sera_RightOfUseAssetAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CommonStockWarrantAt520SharePriceMember" xlink:label="sera_CommonStockWarrantAt520SharePriceMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_DeferredTaxLiabilitiesRightOfUseAssets" xlink:label="sera_DeferredTaxLiabilitiesRightOfUseAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_OfferingExpenses" xlink:label="sera_OfferingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_EquipmentLabSuppliesAndFacilityExpenses" xlink:label="sera_EquipmentLabSuppliesAndFacilityExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_RevenueCost" xlink:label="sera_RevenueCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_ProceedsFromIssuanceInitialPublicOfferingNet" xlink:label="sera_ProceedsFromIssuanceInitialPublicOfferingNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaidInKindInterest" xlink:label="us-gaap_PaidInKindInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:label="us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:label="us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:label="us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:label="us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_OfficeAndLaboratorySpaceMember" xlink:label="sera_OfficeAndLaboratorySpaceMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CommitmentsAndContingenciesTable" xlink:label="sera_CommitmentsAndContingenciesTable"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CommonStockWarrantAt1238SharePriceMember" xlink:label="sera_CommonStockWarrantAt1238SharePriceMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_GrossSalesProceedsFromIssuanceOfCommonStock" xlink:label="sera_GrossSalesProceedsFromIssuanceOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_LeaseLiabilityNoncurrent" xlink:label="sera_LeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_AtTheMarketOfferingMember" xlink:label="sera_AtTheMarketOfferingMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiability" xlink:label="us-gaap_FinanceLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_LeaseLiabilitiesAbstract" xlink:label="sera_LeaseLiabilitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CommonStockWarrantAt10.84SharePriceMember" xlink:label="sera_CommonStockWarrantAt10.84SharePriceMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_ProceedsFromIssuanceOfSharesAndPreFundedWarrantsNet" xlink:label="sera_ProceedsFromIssuanceOfSharesAndPreFundedWarrantsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_LeaseLiabilityToBePaidYearThreeAndThereafter" xlink:label="sera_LeaseLiabilityToBePaidYearThreeAndThereafter"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_RelatedPartyTransactionOtherReceivablesRelatedToMinimumPayments" xlink:label="sera_RelatedPartyTransactionOtherReceivablesRelatedToMinimumPayments"/>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CommonStockWarrantAt20.77SharePriceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Warrant issued by the company that allows the purchase of shares of common stock at a price of $20.77 per share.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CommonStockWarrantAt20.77SharePriceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Warrant At20.77 Share Price [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CommonStockWarrantAt20.77SharePriceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">20.77</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_OtherOfficersMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Officers [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_OtherOfficersMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Other officers.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_OtherOfficersMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other Officers</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Board of Directors Oversight [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Accounts Receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Accounts receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_ScheduleOfEstimatedUsefulLifeOfEachAssetCategoryTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Estimated Useful Life Of Each Asset Category [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_ScheduleOfEstimatedUsefulLifeOfEachAssetCategoryTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule Of Estimated Useful Life Of Each Asset Category [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_ScheduleOfEstimatedUsefulLifeOfEachAssetCategoryTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Estimated Useful Life of Each Asset Category</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Computed Federal income tax benefit (expense) at the statutory rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Common Stock Warrants Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents and Investments [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Cash, Cash Equivalents and Marketable Securities by Major Security Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Recurring and Nonrecurring [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value, Recurring and Nonrecurring [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, to be Paid</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total minimum lease payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestPaidNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestPaidNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash paid for interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of Operating Segments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of operating segment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in statutory rates</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_NumberOfVotesPerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number Of Votes Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_NumberOfVotesPerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Votes Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_NumberOfVotesPerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of votes per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, and Marketable Securities [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash, Cash Equivalents and Marketable Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNoncashIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Noncash Income (Expense)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNoncashIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Other</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Hierarchy and NAV [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Hierarchy and NAV [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Auditor Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Federal Income Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 2 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level 2</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingOtherItemAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting, Other Segment Item, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingOtherItemAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other segment items</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_WarrantIssuedPricePerPre-FundedWarrantAndAccompanyingWarrant_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Offering price per pre-funded warrant</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_WarrantIssuedPricePerPre-FundedWarrantAndAccompanyingWarrant_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrant Issued Price Per Pre-Funded Warrant and Accompanying Warrant</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_WarrantIssuedPricePerPre-FundedWarrantAndAccompanyingWarrant_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The offering price per pre-funded warrant and accompanying warrant.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedVacationCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Vacation, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedVacationCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued vacation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and Contingences</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedSalariesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Salaries, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedSalariesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Stock by Class [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Stock by Class [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Indefinite-Lived Intangible Assets (Excluding Goodwill), Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Indefinite-Lived Intangible Assets (Excluding Goodwill), Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Indefinite-Lived Intangible Assets (Excluding Goodwill), Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Intangible assets, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Indefinite-lived intangible assets, net carrying amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Indefinite-lived intangible asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Depreciation, Depletion and Amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation and amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Noncash Investing and Financing Items [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplemental disclosure of non-cash investing and financing information</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party Transaction [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentInformationTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Information [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentInformationTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Information [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Processes Integrated [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Capital Structure</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Warrant or Right [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CommonStockWarrantAt9.03SharePriceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Warrant issued by the company that allows the purchase of shares of common stock at a price of $9.03 per share.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CommonStockWarrantAt9.03SharePriceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Warrant At9.03 Share Price [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CommonStockWarrantAt9.03SharePriceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">9.03</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and Cash Equivalents [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Available-for-sale Debt Securities and Cash Equivalents in Unrealized Loss Positions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The area of leased office and laboratory space.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Area Of Leased Space Office And Laboratory</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of square feet under lease</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_Plan2011Member_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents information pertaining to 2011 Employee, Director and Consultant Equity Incentive Plan.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_Plan2011Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Plan2011 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_Plan2011Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2011 Plan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Securities, Available-for-sale [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Cancelled (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorOpinionTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Opinion [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorOpinionTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Auditor Opinion</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_JohnJBonifaceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">John J Boniface</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_JohnJBonifaceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">John J Boniface [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_JohnJBonifaceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">John J. Boniface</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Operating Capital [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Changes in operating assets and liabilities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueRecognitionDeferredRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue Recognition, Deferred Revenue [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueRecognitionDeferredRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred Revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares, Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Balance at the ending (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Balance at the beginning (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk-free interest rate, minimum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Prepaid expenses and other assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_WarrantsToPurchaseCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Security that gives the holder the right to purchase shares of common stock in accordance with the terms of the instrument, usually upon payment of a specified amount.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_WarrantsToPurchaseCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrants To Purchase Common Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_WarrantsToPurchaseCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants to purchase Class A common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_NonCurrentMarketableSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Non-Current Marketable Securities [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_NonCurrentMarketableSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Non-Current Marketable Securities [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_NonCurrentMarketableSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term marketable securities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock under employee stock purchase plan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, to be Paid, Year One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2025</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Warrant or Right [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CommitmentsAndContingenciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Commitments And Contingencies [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CommitmentsAndContingenciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CommitmentsAndContingenciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments And Contingencies [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CarelonResearchMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">This member stands for Carelon Research, a wholly-owned subsidiary of Elevance Health, Inc.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CarelonResearchMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Carelon Research [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CarelonResearchMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Healthcore Inc</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CapitalSharesReservedForFutureIssuanceDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Information on capital stock reserved for future issuance.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CapitalSharesReservedForFutureIssuanceDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Capital Shares Reserved For Future Issuance [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CapitalSharesReservedForFutureIssuanceDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Capital Shares Reserved for Future Issuance [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Unrealized Loss Position</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total, Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_LeaseLiabilityToBePaidYearOne_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lease, Liability, to be Paid, Year One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_LeaseLiabilityToBePaidYearOne_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease, Liability, to be Paid, Year One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_LeaseLiabilityToBePaidYearOne_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2025</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCostAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease, Cost [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCostAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate intrinsic value, vested and exercisable at the end</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Marketable Securities Classified by Contractual Maturities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_IssuePricePerShareAndWarrant_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issue Price Per Share And Warrant</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_IssuePricePerShareAndWarrant_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The offering price per common share and accompanying warrant.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_IssuePricePerShareAndWarrant_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Offering price per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net increase (decrease) in cash and cash equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Comprehensive Income, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Comprehensive Loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss per share, basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Increase in valuation allowance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Change in valuation allowance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_AggregateOfferingPriceFromSaleOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate offering price from sale of common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_AggregateOfferingPriceFromSaleOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Aggregate Offering Price from Sale of Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_AggregateOfferingPriceFromSaleOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Aggregate offering price from sale of common stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_LeaseLiabilityPaymentDue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lease, Liability, Payment, Due</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_LeaseLiabilityPaymentDue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease, Liability, Payment, Due</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_LeaseLiabilityPaymentDue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total minimum lease payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxContingencyLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Contingency [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxContingencyLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Contingency [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Marketable securities, Gross Unrealized Gains</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxContingencyTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Contingency [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxContingencyTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Contingency [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating expenses:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeasePrincipalPayments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Principal Payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeasePrincipalPayments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financing cash outflows</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeasePrincipalPayments_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Finance lease principal payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contract with Customer, Liability, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentAnnualReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Annual Report</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentAnnualReport_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Annual Report</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SellingAndMarketingExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Selling and Marketing Expense [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SellingAndMarketingExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sales and marketing expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_NumberOfCommonStockClassesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number Of Common Stock Classes Authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_NumberOfCommonStockClassesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Common Stock Classes Authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_NumberOfCommonStockClassesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of common stock classes authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total employee stock-based compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Stock-based compensation expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average discount rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_EmergingGrowthCompanyStatusPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Emerging Growth Company Status [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_EmergingGrowthCompanyStatusPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Emerging Growth Company Status [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_EmergingGrowthCompanyStatusPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Emerging Growth Company Status</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings (Accumulated Deficit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated deficit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_TwoThousandTwentyFourSalesAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Twenty Four Sales Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_TwoThousandTwentyFourSalesAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand twenty four sales agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_TwoThousandTwentyFourSalesAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2024 Sales Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Outstanding at the end (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Outstanding at the beginning (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Current [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current assets:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares reserved for future issuance (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Shares available for future issuance (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Cash And Cash Equivalents, Debt Securities Available-For-Sale, Accumulated Gross Unrealized Loss, Before Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash And Cash Equivalents, Debt Securities Available-For-Sale, Accumulated Gross Unrealized Loss, Before Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Total cash, cash equivalents and marketable securities, Gross Unrealized Losses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Operating Activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash used in operating activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Forfeited (in usd per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares subject to options outstanding, vested and exercisable at the end</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated other comprehensive loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Loss Carryforwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating loss carryforwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from operating activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Recurring [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recurring</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherIncomeAndExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Income and Expenses [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherIncomeAndExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other Income and Expenses [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Par or Stated Value Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, price per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Options to purchase Class A common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Positions or Committees Responsible [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_NoncashInvestmentIncomeExpenseNet_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Noncash Investment Income Expense Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_NoncashInvestmentIncomeExpenseNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Noncash Investment Income Expense Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_NoncashInvestmentIncomeExpenseNet_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Non-cash investment income, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Intangible Assets Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Intangible Assets, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Cash Flows [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement of Cash Flows [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_CounterpartyNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Counterparty Name [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_CounterpartyNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Counterparty Name [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities, Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities, Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Other</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Components [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Components [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Granted (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Intangible Asset, Finite-Lived [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Computer Equipment [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Computer equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_DomainNamesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Domain Names [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_DomainNamesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Domain names.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_DomainNamesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Domain Names</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property, Plant and Equipment [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Net of Valuation Allowance [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred tax assets:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Other Receivables</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Other receivables</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event Type [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in statutory rates</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Nonoperating Income (Expense)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other income, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other income, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Anti-dilutive Securities Excluded from the Computation of Earnings per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Outstanding, ending balance (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Outstanding, beginning balance (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">R&amp;D credits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">R&amp;D credits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Voluntary Filers</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Voluntary Filers</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Income Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current benefit (provision)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Federal Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease obligation, net of current portion</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Long-term portion</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DomesticCountryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Domestic Tax Authority [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DomesticCountryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S Federal</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CorporateDebtSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Corporate Debt Securities [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CorporateDebtSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Corporate debt securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid in Capital, Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional paid-in capital</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Cash And Cash Equivalents, Debt Securities Available-For-Sale, Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash And Cash Equivalents, Debt Securities Available-For-Sale, Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total cash, cash equivalents and marketable securities, Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Depreciation and amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock upon exercise of stock options (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Exercised (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanCostRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Defined Contribution Plan, Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanCostRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Defined contribution plan, cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Amortized Cost, Fiscal Year Maturity [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortized Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Component [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Component [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statistical Measurement [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Financial Statement Error Correction [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Financial Statement Error Correction [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">General and Administrative Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and administrative</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Sale of Property, Plant, and Equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from disposal of property and equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred State and Local Income Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expiration term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Furniture and Fixtures [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Furniture and fixtures</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Processes Integrated [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating cash outflows</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Stock Options Exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from exercise of stock options</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Exercise of stock option</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Indefinite-Lived Intangible Assets [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Intangible Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_LeaseOtherInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lease Other Information</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_LeaseOtherInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease Other Information [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_LeaseOtherInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other information</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock under employee stock purchase plan (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Cash And Cash Equivalents, Debt Securities Available-For-Sale, Accumulated Gross Unrealized Gain, Before Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash And Cash Equivalents, Debt Securities Available-For-Sale, Accumulated Gross Unrealized Gain, Before Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total cash, cash equivalents and marketable securities, Gross Unrealized Gains</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_StockIssuedDuringPeriodSharesStockWarrantExpired_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, Stock Warrant Expired</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_StockIssuedDuringPeriodSharesStockWarrantExpired_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock issued during period, shares, stock warrant expired.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_StockIssuedDuringPeriodSharesStockWarrantExpired_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock warrants expired (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expense and Other Assets, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid expenses and other current assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Weighted average exercise price per share, vested and exercisable at the end (in usd per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Fair Value, Fiscal Year Maturity [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk-free interest rate, maximum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cancelled (in usd per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_PlanEspp2021Member_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents information pertaining to 2021 Employee Stock Purchase Plan.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_PlanEspp2021Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Plan Espp2021 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_PlanEspp2021Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2021 ESPP</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income (Loss), Net of Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other comprehensive income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total other comprehensive income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The amount of Purchases of property and equipment included in accounts payable or accrued expenses that were incurred during a noncash or partial noncash transaction.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Purchases Of Property And Equipment Included In Accounts Payable And Accrued Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Purchases of property and equipment in accounts payable and accrued and other current liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Comprehensive loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares, Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of Shares Subject to Options Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Components of Income Tax Benefit (Provision)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments to Acquire Debt Securities, Available-for-Sale</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Purchases of marketable securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Par or Stated Value Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, par value (in usd per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, in Process Research and Development</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">R&amp;E expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable and Accrued Liabilities, Current [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts Payable and Accrued Liabilities, Current [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Property and equipment, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Effective Income Tax Rate Reconciliation, Amount [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_TdCowenMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">TD Cowen [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_TdCowenMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">TD Cowen.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_TdCowenMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">TD Cowen</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MunicipalBondsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Municipal Bonds [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MunicipalBondsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Municipal Bonds</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite-Lived Intangible Assets [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_AmountFromSaleOfCombinationOfSecuritiesUnderShelfRegistration_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amount from Sale of Combination of Securities under Shelf Registration</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_AmountFromSaleOfCombinationOfSecuritiesUnderShelfRegistration_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amount from sale of combination of securities under shelf registration.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_AmountFromSaleOfCombinationOfSecuritiesUnderShelfRegistration_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amount from sale of combination of securities under shelf registration</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Interactive Data Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Interactive Data Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Due within one year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfAdoptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accruals and reserves</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vested (in usd per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Cash and cash equivalents at end of period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Cash and cash equivalents at beginning of period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transactions Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party Transactions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BalanceSheetLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Balance Sheet Location [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BalanceSheetLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Balance Sheet Location [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Less: imputed interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statistical Measurement [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Fair Value Disclosure</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party, Type [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease, Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total lease cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SellingAndMarketingExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Selling and Marketing Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SellingAndMarketingExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Selling and marketing</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lessee, Operating Lease, Liability, Maturity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseInterestPaymentOnLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Interest Payment on Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseInterestPaymentOnLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating cash outflows</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Common Stock Available For Future Issuance Under2021 Employee Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Available For Future Issuance Under2021 Employee Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class A common stock available for future grants under the 2021 Employee Stock Purchase Plan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommercialPaperMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commercial Paper [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommercialPaperMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commercial paper</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite-Lived Intangible Assets, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Finite-Lived Intangible Assets, Gross, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Gross carrying amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Information about RSUs Granted and Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares available for grant</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Granted (in usd per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Unamortized stock-based compensation cost expected to be recognized over a weighted average period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MachineryAndEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Machinery and Equipment [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MachineryAndEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Machinery and equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net deferred tax assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedEmployeeBenefitsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Employee Benefits, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedEmployeeBenefitsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued 401(k) matching contributions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement Location [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and Cash Equivalents [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected term (in years)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The tabular disclosure of common stock reserved for future issuance.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Common Stock Reserved For Future Issuance [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Common Stock Reserved for Future Issuance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Vested (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recently Issued Accounting Pronouncements Not Yet Adopted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">AOCI Attributable to Parent [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Other Comprehensive (Loss) Income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorLocation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Location</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorLocation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Auditor Location</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Fair Value Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Assets:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Percent [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Effective Income Tax Rate Reconciliation, Percent [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Forfeited (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, to be Paid, Year Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2026</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_LaboratoryServicesAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">This member stands for the laboratory services agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_LaboratoryServicesAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Laboratory Services Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_LaboratoryServicesAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Laboratory Services Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_FairValueAdjustmentOfPreFundedWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value adjustment of pre funded warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_FairValueAdjustmentOfPreFundedWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Adjustment Of Pre Funded Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_FairValueAdjustmentOfPreFundedWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Fair value adjustment of pre funded warrants.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_ClinicalStudiesAndOutsideProcessing_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Clinical Studies And Outside Processing</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_ClinicalStudiesAndOutsideProcessing_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Clinical studies and outside processing</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_ClinicalStudiesAndOutsideProcessing_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Clinical studies and outside processing</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investor [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investor</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLaborRelatedExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payroll related expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLaborRelatedExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Labor-related Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average remaining contractual life, vested and exercisable at the end</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_LeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lease Liability, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_LeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease Liability, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_LeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Less: current portion</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_LeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: current portion</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_LeaseLiabilitiesTotal_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lease Liabilities, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_LeaseLiabilitiesTotal_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease Liabilities, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_LeaseLiabilitiesTotal_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total lease liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Due within one year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-Based Compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_LeaseLiabilityToBePaidYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lease, Liability, to be Paid, Year Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_LeaseLiabilityToBePaidYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease, Liability, to be Paid, Year Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_LeaseLiabilityToBePaidYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2026</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current State and Local Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Expired (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Defined contribution plan, employer matching contribution, percent of employees' gross pay</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average discount rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Disclosures [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finance Leases</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityPublicFloat_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Public Float</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityPublicFloat_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Public Float</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Net of Valuation Allowance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total deferred tax asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, Stock Options Exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock upon exercise of stock options</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Current [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current liabilities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Assets Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and cash equivalents:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_FinanceLeaseLiabilityToBePaidYearThreeAndThereafter_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Finance Lease, Liability, to be Paid, Year Three and Thereafter</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_FinanceLeaseLiabilityToBePaidYearThreeAndThereafter_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, to be Paid, Year Three and Thereafter</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_FinanceLeaseLiabilityToBePaidYearThreeAndThereafter_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2027 and thereafter</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">US Government Agencies Debt Securities [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S. federal agency securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of 12(b) Security</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USGovernmentDebtSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">US Government Debt Securities [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USGovernmentDebtSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S. government securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, at Carrying Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and cash equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_RightOfUseAssetTotal_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Right-of-Use Asset, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_RightOfUseAssetTotal_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Right-of-Use Asset, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_RightOfUseAssetTotal_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total right-of-use assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BalanceSheetLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Balance Sheet Location [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BalanceSheetLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Balance Sheet Location [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease, Cost [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Lease Cost and Other Information</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_FinanceLeasesOtherInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Finance Leases, Other Information</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_FinanceLeasesOtherInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Leases, Other Information [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_FinanceLeasesOtherInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finance leases:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management, Strategy, and Governance [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Stockholders' Equity [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement of Stockholders' Equity [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Period Focus</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Period Focus</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate intrinsic value of options exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Tax Credit Carryforwards, Research</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">R&amp;D credits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationTaxCreditsResearch_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationTaxCreditsResearch_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">R&amp;D credits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationTaxCreditsResearch_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">R&amp;D credits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Granted (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Common Stock Available For Future Issuance Under2021 Equity Incentive Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Available For Future Issuance Under2021 Equity Incentive Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class A common stock available for future grants under the 2021 Equity Incentive Plan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event Type [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_Plan2021Member_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents information pertaining to 2021 Equity Incentive Plan.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_Plan2021Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Plan2021 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_Plan2021Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2021 Plan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finance leases</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Leases [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leases</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions Using the Black-Scholes Method</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Schedule of Fair Values Calculated using Black-Scholes Option Pricing Model</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_DefinedContributionPlanEmployerMatchingContributionMatchingTierDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Defined Contribution Plan, Employer Matching Contribution, Matching Tier [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_DefinedContributionPlanEmployerMatchingContributionMatchingTierDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Defined Contribution Plan, Employer Matching Contribution, Matching Tier [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_DefinedContributionPlanEmployerMatchingContributionMatchingTierDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Defined Contribution Plan, Employer Matching Contribution, Matching Tier [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State income taxes, net of federal benefit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_WarrantsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The entire disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_WarrantsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrants [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_WarrantsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">12 months or greater, Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercise price (in usd per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financial Instruments [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financial Instruments [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CapitalizedIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Capitalized Intangible Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CapitalizedIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Capitalized intangible assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_RelatedPartyTransactionCashReceivedFromRelatedParty_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Related Party Transaction, Cash Received From Related Party</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_RelatedPartyTransactionCashReceivedFromRelatedParty_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction, Cash Received From Related Party</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_RelatedPartyTransactionCashReceivedFromRelatedParty_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party Transaction, Cash Received From Related Party</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Warrant or Right [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from investing activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Marketable Securities, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Marketable securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_DeferredTaxAssetsLeaseLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred Tax Assets, Lease Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_DeferredTaxAssetsLeaseLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Lease Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_DeferredTaxAssetsLeaseLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Effective Income Tax Rate Reconciliation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_IssuanceOfStockToSettleAccruedAndOtherCurrentLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance of Stock to Settle Accrued and Other Current Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_IssuanceOfStockToSettleAccruedAndOtherCurrentLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of stock to settle accrued and other current liabilities.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_IssuanceOfStockToSettleAccruedAndOtherCurrentLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of stock to settle accrued and other current liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management, Strategy, and Governance [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanDisclosureLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Defined Contribution Plan Disclosure [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanDisclosureLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Defined Contribution Plan Disclosure [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrants and Rights Note Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants and Rights Note Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_ProceedsFromIssuanceOfSharesAndPreFundedWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Issuance Of Shares And Pre Funded Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_ProceedsFromIssuanceOfSharesAndPreFundedWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Proceeds From Issuance Of Shares And Pre Funded Warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_ProceedsFromIssuanceOfSharesAndPreFundedWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of shares and warrants</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other issuance of common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, Other</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdate202307Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ASU 2023-07</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdate202307Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update 2023-07 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite-Lived Intangible Assets, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Finite-Lived Intangible Assets, Net, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Finite-Lived Intangible Assets, Net, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Definite-lived intangible assets, net carrying amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Available-for-sale Securities [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Depreciation, Depletion and Amortization, Nonproduction</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Depreciation, Depletion and Amortization, Nonproduction, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation and amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Cash And Cash Equivalents, Debt Securities Available-For-Sale, Amortized Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash And Cash Equivalents, Debt Securities Available-For-Sale, Amortized Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total cash, cash equivalents and marketable securities, Amortized Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total cash, cash equivalents and marketable securities, Amortized Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Accrued Liabilities, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other current liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Accounts Payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesNetAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities, Net [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesNetAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred tax liabilities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities and Equity [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liabilities and Stockholders' Equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Financing Activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash provided by financing activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonClassAMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Class A [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonClassAMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class A common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">ICFR Auditor Attestation Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ICFR Auditor Attestation Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Income tax benefit (provision)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders' Equity Note [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stockholders' Equity Note [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Anti-dilutive securities excluded from the computation of earnings per share (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Due after one year through five years</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonClassBMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Class B [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonClassBMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class B common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CommonStockAdditionalShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchased additional shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CommonStockAdditionalShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Additional Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CommonStockAdditionalShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Common stock additional shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income tax expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total income tax benefit (provision)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_WarrantsIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrants Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_WarrantsIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Warrants Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_WarrantsIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of warrants (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity, Attributable to Parent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Balance at the ending</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Balance at the beginning</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total stockholders' equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total deferred tax asset before allowance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Lived Tangible Asset [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-Lived Tangible Asset [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right, Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of warrants outstanding (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based Compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Stock Units (RSUs) [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted Stock Units (RSUs)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Restricted stock units outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transactions [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party Transactions [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_LeaseLiabilityPaymentDueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lease, Liability, Payment, Due</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_LeaseLiabilityPaymentDueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease, Liability, Payment, Due [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_LeaseLiabilityPaymentDueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property, Plant and Equipment [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management, Strategy, and Governance [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Cash And Cash Equivalents, Accumulated Gross Unrealized Loss, Before Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash And Cash Equivalents, Accumulated Gross Unrealized Loss, Before Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Cash and cash equivalents, Gross Unrealized Losses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change in Accounting Principle, Accounting Standards Update, Adopted [true false]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_LesseeOperatingLeaseLiabilityToBePaidYearThreeAndThereafter_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lessee, Operating Lease, Liability, to be Paid, Year Three and Thereafter</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_LesseeOperatingLeaseLiabilityToBePaidYearThreeAndThereafter_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Three and Thereafter</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_LesseeOperatingLeaseLiabilityToBePaidYearThreeAndThereafter_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2027 and thereafter</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Expertise of Management Responsible [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Impact of Stock-based Compensation Expense in Statements of Operations</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Income Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total deferred benefit (provision)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Marketable securities, Gross Unrealized Losses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unamortized stock-based compensation cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Use of Estimates, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Use of Estimates</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_DefinedContributionPlanEmployerMatchingContributionMatchingTierAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Defined Contribution Plan, Employer Matching Contribution, Matching Tier</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_DefinedContributionPlanEmployerMatchingContributionMatchingTierAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Defined Contribution Plan, Employer Matching Contribution, Matching Tier [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_DefinedContributionPlanEmployerMatchingContributionMatchingTierAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Defined Contribution Plan, Employer Matching Contribution, Matching Tier [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and Cash Equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonUnitIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Unit, Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected volatility, minimum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Marketable Securities, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Marketable Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Future Minimum Lease Payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Effective Income Tax Rate Reconciliation, State Net Operating Loss Carryforward True Up, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, State Net Operating Loss Carryforward True Up, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State net operating loss carryforward true up</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Counterparty Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Counterparty Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total operating expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_PercentageOfMinimumOwnershipBeneficiallyOwnByHolderWithAffiliatesToWarrantExercise_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage of Minimum Ownership Beneficially Own by Holder with Affiliates to Warrant Exercise</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_PercentageOfMinimumOwnershipBeneficiallyOwnByHolderWithAffiliatesToWarrantExercise_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of minimum ownership beneficially own by holder with affiliates to warrant exercise.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_PercentageOfMinimumOwnershipBeneficiallyOwnByHolderWithAffiliatesToWarrantExercise_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of minimum ownership beneficially own by holder with affiliates to warrant exercise</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_DefinedContributionPlanEmployerMatchingContributionSecondTierMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Defined Contribution Plan, Employer Matching Contribution, Second Tier</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_DefinedContributionPlanEmployerMatchingContributionSecondTierMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Defined Contribution Plan, Employer Matching Contribution, Second Tier [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_DefinedContributionPlanEmployerMatchingContributionSecondTierMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Defined Contribution Plan, Employer Matching Contribution, Second Tier</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Lived Tangible Asset [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-Lived Tangible Asset [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Measurements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average grant date fair value of options granted (in usd per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Events</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_StockIssuedDuringPeriodSharesStockWarrantExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock Issued During Period, Shares, Stock Warrant Exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_StockIssuedDuringPeriodSharesStockWarrantExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, Stock Warrant Exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_StockIssuedDuringPeriodSharesStockWarrantExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock Issued During Period, Shares, Stock Warrant Exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_StockIssuedDuringPeriodSharesStockWarrantExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Common stock warrant exercises (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Maximum [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule Of Leases In Statement Of Financial Position</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Leases In Statement of Financial Position [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Leases in Financial Statement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities and Equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities and stockholders' equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsGrossExcludingGoodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Intangible Assets, Gross (Excluding Goodwill)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsGrossExcludingGoodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Intangible assets, gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsGrossExcludingGoodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Intangible assets, gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Right-of-Use Asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating leases</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Operating right-of-use asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Supplemental Cash Flow Information [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplemental disclosure of cash flow information</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss per share, diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Leasehold Improvements [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leasehold improvements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CashAndCashEquivalentsAmortizedCost_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Cash And Cash Equivalents, Amortized Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CashAndCashEquivalentsAmortizedCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash And Cash Equivalents, Amortized Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CashAndCashEquivalentsAmortizedCost_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cash and cash equivalents, Amortized Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CurrentMarketableSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Current Marketable Securities [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CurrentMarketableSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Marketable Securities [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CurrentMarketableSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current marketable securities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Hierarchy and NAV [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Hierarchy and NAV [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfOtherAssetsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Other Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfOtherAssetsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Other Assets [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Investing Activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash provided by investing activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Period for Commercial collaboration agreement , in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction, Commercial Collaboration Agreement Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Term of agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Cost Of Revenue, Excluding Selling, Marketing, General And Administrative Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cost Of Revenue, Excluding Selling, Marketing, General And Administrative Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cost of revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Balance at the beginning of the year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Balance at the end of the year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Valuation allowance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vesting period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Filer Category</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Filer Category</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Property, Plant and Equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation and amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property, Plant and Equipment [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_LeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lease, Liability, Undiscounted Excess Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_LeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease, Liability, Undiscounted Excess Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_LeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Less: imputed interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Cash And Cash Equivalents, Accumulated Gross Unrealized Gain, Before Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash And Cash Equivalents, Accumulated Gross Unrealized Gain, Before Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and cash equivalents, Gross Unrealized Gains</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_IndemnificationLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The amount of indemnification liability.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_IndemnificationLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Indemnification Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_IndemnificationLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Indemnification liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Description of Business and Financial Condition</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Less accumulated depreciation and amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Fiscal Year End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current Fiscal Year End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and Equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value of options vested</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Less: imputed interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Noncash Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate intrinsic value, outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party, Type [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Effective Income Tax Rate Reconciliation, State Net Operating Loss Carryforward True Up, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, State Net Operating Loss Carryforward True Up, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State net operating loss carryforward true up</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investment income, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment Income, Net, Amortization of Discount and Premium</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel">Total, Unrealized Losses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CommercialCollaborationAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">This member stands for the Commercial Collaboration Agreement with Anthem and its affiliates (the "Commercial Collaboration Agreement").</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CommercialCollaborationAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commercial Collaboration Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CommercialCollaborationAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commercial Collaboration Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Weighted Average Remaining Lease Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average remaining lease term (in years)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total property and equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PostemploymentBenefitPlansPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Postemployment Benefit Plans, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PostemploymentBenefitPlansPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Retirement Savings Plan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostOfRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cost of Revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostOfRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cost of Revenue, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostOfRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cost of revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net Loss Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Money Market Funds [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Money market funds</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments to Acquire Intangible Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchases of intangible assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number of Shares Outstanding, Basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average shares outstanding, basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finance lease obligation, net of current portion</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Long-term portion</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Gross increases-prior period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_EffectiveIncomeTaxRateReconciliationEquityBasedExpensesPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Effective Income Tax Rate Reconciliation, Equity-Based Expenses, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_EffectiveIncomeTaxRateReconciliationEquityBasedExpensesPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Equity-Based Expenses, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_EffectiveIncomeTaxRateReconciliationEquityBasedExpensesPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity-based expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating Leases</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected volatility, maximum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares Authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Useful Life</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment, useful life</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Sale and Maturity of Marketable Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from maturities and sales of marketable securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseInterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Interest Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseInterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest on lease liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 1 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level 1</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected dividend yield</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Excluding Option Exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from employee stock purchase plan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average exercise price per share, vested and expected to vest at the end (in usd per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Documents Incorporated by Reference [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Documents Incorporated by Reference</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Granted (in usd per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amortization of Intangible Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortization expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financial Instrument [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financial Instrument [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average remaining contractual life, outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net Loss per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">General and Administrative Expense [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and administrative expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based Payment Arrangement [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherReceivablesNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Receivables, Net, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherReceivablesNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other receivables</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_ElevanceHealthIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Elevance Health, Inc</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_ElevanceHealthIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Elevance Health, Inc [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_ElevanceHealthIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Elevance Health, Inc</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Role of Management [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Marketable securities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Marketable securities, Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Policies [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounting Policies [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Options Granted and Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Marketable Securities, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term marketable securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Gross increases-current period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity, Attributable to Parent [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stockholders' equity:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_LaboratoryEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents information pertaining to laboratory equipment.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_LaboratoryEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Laboratory Equipment [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_LaboratoryEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Laboratory equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestIncomeOther_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Income, Other</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestIncomeOther_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Segments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Property and Equipment, Useful Life</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Schedule of Components of Property and Equipment, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CommonStockConversionRatio_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Common Stock, Conversion Ratio</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CommonStockConversionRatio_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Conversion Ratio</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CommonStockConversionRatio_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, conversion ratio</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Weighted average remaining contractual life, vested and expected to vest at the end</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted- Average Exercise Price Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, authorized (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Segment Information</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Earnings Per Share [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity-based compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State income taxes, net of federal benefit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Financial Position [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement of Financial Position [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Expense, Operating and Nonoperating</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpense_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Interest expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Interest Expense, Operating and Nonoperating, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Income (Loss)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Loss from operations</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss from operations</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockNoParValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, No Par Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockNoParValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, no par value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Shell Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Shell Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Warrant or Right [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Current Reporting Status</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Current Reporting Status</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SoftwareDevelopmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Software Development [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SoftwareDevelopmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Software</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SoftwareDevelopmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Software developed for sale</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Property and Equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Events [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue from Contract with Customer [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue Recognition</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Contract with Customer, Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Year Focus</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Year Focus</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change in Accounting Principle, Accounting Standards Update, Adoption Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_DefinedContributionPlanEmployerMatchingContributionFirstTierMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Defined Contribution Plan, Employer Matching Contribution, First Tier</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_DefinedContributionPlanEmployerMatchingContributionFirstTierMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Defined Contribution Plan, Employer Matching Contribution, First Tier [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_DefinedContributionPlanEmployerMatchingContributionFirstTierMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Defined Contribution Plan, Employer Matching Contribution, First Tier</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Definite-lived intangible assets, accumulated amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Accumulated Amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Uncertain Tax Positions Roll Forward</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance Initial Public Offering</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from offering</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Due after one year through five years</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostOfSalesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cost of Goods and Service [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostOfSalesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cost of Revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_OperatingLeasesOtherInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Operating Leases, Other Information</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_OperatingLeasesOtherInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases, Other Information [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_OperatingLeasesOtherInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating leases:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Liabilities and Other Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total accrued and other current liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Accrued and other current liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CapitalSharesReservedForFutureIssuanceAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The table relating to information on capital stock reserved for future issuance.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CapitalSharesReservedForFutureIssuanceAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Capital Shares Reserved for Future Issuance [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CapitalSharesReservedForFutureIssuanceAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Capital Shares Reserved for Future Issuance [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CommonStockSharesConverted_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Common Stock, Shares Converted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CommonStockSharesConverted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares Converted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CommonStockSharesConverted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock, Shares Converted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Computed Federal income tax benefit (expense) at the statutory rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock outstanding (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other issuance of common stock (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, Other</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less than 12 months, Unrealized Losses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Defined Contribution Plan, Employer Matching Contribution, Percent of Match</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Defined contribution plan, employer matching contribution, percent of match</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Authority [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Authority [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and Contingencies Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_EffectiveIncomeTaxRateReconciliationEquityBasedExpensesAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Effective Income Tax Rate Reconciliation, Equity-Based Expenses, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_EffectiveIncomeTaxRateReconciliationEquityBasedExpensesAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Equity-Based Expenses, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_EffectiveIncomeTaxRateReconciliationEquityBasedExpensesAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity-based expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortized Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Marketable securities, Amortized Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Deferred Tax Assets and Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfessionalFees_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Professional Fees</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfessionalFees_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Consulting and professional fees</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating leases</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Less: current portion</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2009/role/netLabel">Operating lease liability, current portion</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: current portion</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentInformationLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Information [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentInformationLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Information [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Right-of-use assets obtained in exchange for lease liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_ClassOfWarrantOrRightExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Class of Warrant Or Right, Exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_ClassOfWarrantOrRightExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant Or Right, Exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_ClassOfWarrantOrRightExercised_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Class of Warrant Or Right, Exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Authority [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Authority [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_MasterServicesAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">This member stands for the master services agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_MasterServicesAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Master Services Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_MasterServicesAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Master services agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Deficit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Defined Contribution Plan [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Defined Contribution Plan [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments to Acquire Property, Plant, and Equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchases of property and equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Other Nonoperating Income (Expense) [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Components of Other Income, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Financial Assets that are Measured at Fair Value on a Recurring basis</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Transition Report</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Transition Report</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2026</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_RightOfUseAssetAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Right-of-use assets:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_RightOfUseAssetAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Right-of-Use Asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_RightOfUseAssetAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Right-of-Use Asset [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Exercised (in usd per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CommonStockWarrantAt520SharePriceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Common Stock Warrant At 5.20 Share Price [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CommonStockWarrantAt520SharePriceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Warrant At 5.20 Share Price [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CommonStockWarrantAt520SharePriceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">5.20</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Concentration of Credit Risk</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_DeferredTaxLiabilitiesRightOfUseAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred Tax Liabilities, Right Of Use Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_DeferredTaxLiabilitiesRightOfUseAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities, Right Of Use Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_DeferredTaxLiabilitiesRightOfUseAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred Tax Liabilities, Right Of Use Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_DeferredTaxLiabilitiesRightOfUseAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Right-of-use asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorFirmId_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Firm ID</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorFirmId_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Auditor Firm ID</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Minimum [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock (Class A and B)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate intrinsic value, vested and expected to vest at the end</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Outstanding, beginning balance (in usd per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Outstanding, ending balance (in usd per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Right-of-Use Asset, Periodic Reduction</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-cash lease expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_OfferingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Offering Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_OfferingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Offering expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_OfferingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Offering expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid-in Capital [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional Paid-In Capital</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_EquipmentLabSuppliesAndFacilityExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equipment Lab Supplies And Facility Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_EquipmentLabSuppliesAndFacilityExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Equipment lab supplies and facility expenses.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_EquipmentLabSuppliesAndFacilityExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equipment lab supplies and facility expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Well-known Seasoned Issuer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Well-known Seasoned Issuer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_RevenueCost_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The aggregate cost of goods produced and sold and services rendered during the reporting period.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_RevenueCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_RevenueCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cost of revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other comprehensive income:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_ProceedsFromIssuanceInitialPublicOfferingNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from offering net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_ProceedsFromIssuanceInitialPublicOfferingNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance Initial Public Offering Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_ProceedsFromIssuanceInitialPublicOfferingNet_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Proceeds from Issuance Initial Public Offering Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement Location [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2025</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Assets, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total other assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaidInKindInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Paid-in-Kind Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaidInKindInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-cash interest expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Sale of Debt Securities, Available-for-Sale</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from the sale of available-for-sale securities prior to maturity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Common Stock, Shares Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Common Stock, Shares Outstanding (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Income and Other Expense Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other Income, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued and other current liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Less than 12 months, Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Basis of Accounting, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basis of Presentation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Nonvested Award, Cost [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Unrecognized Stock-based Compensation Expense for Outstanding Unvested Stock Options and RSUs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Allowance for Credit Loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Securities, Available-for-Sale, Allowance for Credit Loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finance lease obligation, current portion</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Less: current portion</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: current portion</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Value, Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, $0.0001 par value; 150,000,000 Class A shares authorized; 33,206,909 and 30,736,513 Class A shares issued and outstanding as of December 31, 2024 and 2023, respectively; 1,500,000 Class B shares authorized; 967,759 and 1,405,259 Class B shares issued as of December 31, 2024 and 2023, respectively; 967,759 Class B shares outstanding as of December 31, 2024 and 2023.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseRightOfUseAssetAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Right-of-Use Asset, Amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseRightOfUseAssetAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortization of right-of-use assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash equivalents:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Cash and cash equivalents, Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_OfficeAndLaboratorySpaceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents the information pertaining to office and laboratory space.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_OfficeAndLaboratorySpaceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Office And Laboratory Space [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_OfficeAndLaboratorySpaceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Office and laboratory space</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Present value of future lease payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Frequency [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Frequency [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Accrued Liabilities [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Components of Accrued and Other Current Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss carryforwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and Contingencies</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CommitmentsAndContingenciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents the table relating to information of commitments and contingencies.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CommitmentsAndContingenciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CommitmentsAndContingenciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments And Contingencies [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CommonStockWarrantAt1238SharePriceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Common Stock Warrant At 12.38 Share Price [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CommonStockWarrantAt1238SharePriceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Warrant At 12.38 Share Price [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CommonStockWarrantAt1238SharePriceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">12.38</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">12 months or greater, Unrealized Losses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number of Shares Outstanding, Diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average shares outstanding, diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Significant Accounting Policies [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Significant Accounting Policies</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Segment Information for Revenue, Significant Segment Expenses and Segement Loss Expenses that are Regularly Provided to the CODM</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_GrossSalesProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Gross Sales Proceeds from Issuance of Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_GrossSalesProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Gross sales proceeds from issuance of common stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_GrossSalesProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Gross sales proceeds from issuance of common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares subject to options outstanding, vested and expected to vest at the end (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total minimum lease payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_LeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lease Liability, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_LeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease Liability, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_LeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term portion</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_AtTheMarketOfferingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">At-the-Market Offering [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_AtTheMarketOfferingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">At-the-market offering.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_AtTheMarketOfferingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">At-the-Market Offering</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Third Party Engaged [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Present value of future lease payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_LeaseLiabilitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lease Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_LeaseLiabilitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease Liabilities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_LeaseLiabilitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease liabilities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Small Business</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Small Business</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Intangible Asset, Indefinite-Lived [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Revenues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenues</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Revenues_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Revenues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of restricted stock units (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Expired (in usd per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CommonStockWarrantAt10.84SharePriceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Warrant issued by the company that allows the purchase of shares of common stock at a price of $10.84 per share.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CommonStockWarrantAt10.84SharePriceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Warrant At10.84 Share Price [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_CommonStockWarrantAt10.84SharePriceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">10.84</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from financing activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Outstanding at the end (in usd per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Outstanding at the beginning (in usd per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued and Other Current Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Intangible Assets, Net (Excluding Goodwill)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Intangible assets, net carrying amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Intangible assets, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">State and Local Jurisdiction [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Right-of-use assets obtained in exchange for lease liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Frequency [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Frequency [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_ProceedsFromIssuanceOfSharesAndPreFundedWarrantsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Issuance Of Shares And Pre Funded Warrants Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_ProceedsFromIssuanceOfSharesAndPreFundedWarrantsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The cash inflow from issuance of shares and pre-funded warrants net of underwriting discounts and commissions and offering expenses.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_ProceedsFromIssuanceOfSharesAndPreFundedWarrantsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of shares and warrants, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Valuation Allowance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Valuation allowance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Less: valuation allowance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 3 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level 3</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Weighted Average Remaining Lease Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average remaining lease term (in years)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Events [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Events</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrealized gain on available-for-sale debt securities, net of tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Valuation allowance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_LeaseLiabilityToBePaidYearThreeAndThereafter_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lease, Liability, to be Paid, Year Three and Thereafter</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_LeaseLiabilityToBePaidYearThreeAndThereafter_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease, Liability, to be Paid, Year Three and Thereafter</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_LeaseLiabilityToBePaidYearThreeAndThereafter_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2027 and thereafter</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-Average Grant Date Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change in Accounting Principle, Accounting Standards Update, Immaterial Effect [true false]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_RelatedPartyTransactionOtherReceivablesRelatedToMinimumPayments_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Related Party Transaction, Other Receivables Related To Minimum Payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_RelatedPartyTransactionOtherReceivablesRelatedToMinimumPayments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction, Other Receivables Related To Minimum Payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="sera_RelatedPartyTransactionOtherReceivablesRelatedToMinimumPayments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other receivables related to minimum payments</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_CommonStockWarrantAt20.77SharePriceMember" xlink:to="sera_CommonStockWarrantAt20.77SharePriceMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_OtherOfficersMember" xlink:to="sera_OtherOfficersMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_PlanNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_ScheduleOfEstimatedUsefulLifeOfEachAssetCategoryTableTextBlock" xlink:to="sera_ScheduleOfEstimatedUsefulLifeOfEachAssetCategoryTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:to="us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfOperatingSegments" xlink:to="us-gaap_NumberOfOperatingSegments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_NumberOfVotesPerShare" xlink:to="sera_NumberOfVotesPerShare_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:to="us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNoncashIncomeExpense" xlink:to="us-gaap_OtherNoncashIncomeExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingOtherItemAmount" xlink:to="us-gaap_SegmentReportingOtherItemAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_WarrantIssuedPricePerPre-FundedWarrantAndAccompanyingWarrant" xlink:to="sera_WarrantIssuedPricePerPre-FundedWarrantAndAccompanyingWarrant_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedVacationCurrent" xlink:to="us-gaap_AccruedVacationCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedSalariesCurrent" xlink:to="us-gaap_AccruedSalariesCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ScheduleOfStockByClassTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_CommonStockWarrantAt9.03SharePriceMember" xlink:to="sera_CommonStockWarrantAt9.03SharePriceMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory" xlink:to="sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_Plan2011Member" xlink:to="sera_Plan2011Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorOpinionTextBlock" xlink:to="dei_AuditorOpinionTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_JohnJBonifaceMember" xlink:to="sera_JohnJBonifaceMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionDeferredRevenue" xlink:to="us-gaap_RevenueRecognitionDeferredRevenue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_WarrantsToPurchaseCommonStockMember" xlink:to="sera_WarrantsToPurchaseCommonStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_NonCurrentMarketableSecuritiesMember" xlink:to="sera_NonCurrentMarketableSecuritiesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_CommitmentsAndContingenciesLineItems" xlink:to="sera_CommitmentsAndContingenciesLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_CarelonResearchMember" xlink:to="sera_CarelonResearchMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_CapitalSharesReservedForFutureIssuanceDomain" xlink:to="sera_CapitalSharesReservedForFutureIssuanceDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_LeaseLiabilityToBePaidYearOne" xlink:to="sera_LeaseLiabilityToBePaidYearOne_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_LeaseCostAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_IssuePricePerShareAndWarrant" xlink:to="sera_IssuePricePerShareAndWarrant_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_AggregateOfferingPriceFromSaleOfCommonStock" xlink:to="sera_AggregateOfferingPriceFromSaleOfCommonStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_LeaseLiabilityPaymentDue" xlink:to="sera_LeaseLiabilityPaymentDue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_IncomeTaxContingencyLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxContingencyTable" xlink:to="us-gaap_IncomeTaxContingencyTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeasePrincipalPayments" xlink:to="us-gaap_FinanceLeasePrincipalPayments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpenseMember" xlink:to="us-gaap_SellingAndMarketingExpenseMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_NumberOfCommonStockClassesAuthorized" xlink:to="sera_NumberOfCommonStockClassesAuthorized_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_EmergingGrowthCompanyStatusPolicyTextBlock" xlink:to="sera_EmergingGrowthCompanyStatusPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_TwoThousandTwentyFourSalesAgreementMember" xlink:to="sera_TwoThousandTwentyFourSalesAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsRecurringMember" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_OtherIncomeAndExpensesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_NoncashInvestmentIncomeExpenseNet" xlink:to="sera_NoncashInvestmentIncomeExpenseNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_CounterpartyNameAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerEquipmentMember" xlink:to="us-gaap_ComputerEquipmentMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_DomainNamesMember" xlink:to="sera_DomainNamesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract" xlink:to="us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherReceivables" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DomesticCountryMember" xlink:to="us-gaap_DomesticCountryMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CorporateDebtSecuritiesMember" xlink:to="us-gaap_CorporateDebtSecuritiesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue" xlink:to="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanCostRecognized" xlink:to="us-gaap_DefinedContributionPlanCostRecognized_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_LeaseOtherInformationAbstract" xlink:to="sera_LeaseOtherInformationAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_StockIssuedDuringPeriodSharesStockWarrantExpired" xlink:to="sera_StockIssuedDuringPeriodSharesStockWarrantExpired_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_PlanEspp2021Member" xlink:to="sera_PlanEspp2021Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities" xlink:to="sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:to="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:to="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_TdCowenMember" xlink:to="sera_TdCowenMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MunicipalBondsMember" xlink:to="us-gaap_MunicipalBondsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_AmountFromSaleOfCombinationOfSecuritiesUnderShelfRegistration" xlink:to="sera_AmountFromSaleOfCombinationOfSecuritiesUnderShelfRegistration_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_TypeOfAdoptionMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AssetsFairValueDisclosure_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_LeaseCost_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpense" xlink:to="us-gaap_SellingAndMarketingExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="us-gaap_FinanceLeaseInterestPaymentOnLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember" xlink:to="sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommercialPaperMember" xlink:to="us-gaap_CommercialPaperMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MachineryAndEquipmentMember" xlink:to="us-gaap_MachineryAndEquipmentMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedEmployeeBenefitsCurrent" xlink:to="us-gaap_AccruedEmployeeBenefitsCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_CashAndCashEquivalentsAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" xlink:to="sera_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="us-gaap_AssetsFairValueDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_LaboratoryServicesAgreementMember" xlink:to="sera_LaboratoryServicesAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_FairValueAdjustmentOfPreFundedWarrants" xlink:to="sera_FairValueAdjustmentOfPreFundedWarrants_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_ClinicalStudiesAndOutsideProcessing" xlink:to="sera_ClinicalStudiesAndOutsideProcessing_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestorMember" xlink:to="us-gaap_InvestorMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLaborRelatedExpenses" xlink:to="us-gaap_OtherLaborRelatedExpenses_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_LeaseLiabilityCurrent" xlink:to="sera_LeaseLiabilityCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_LeaseLiabilitiesTotal" xlink:to="sera_LeaseLiabilitiesTotal_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:to="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_LeaseLiabilityToBePaidYearTwo" xlink:to="sera_LeaseLiabilityToBePaidYearTwo_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:to="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" xlink:to="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsDisclosureTextBlock" xlink:to="us-gaap_OtherAssetsDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsMember" xlink:to="us-gaap_CashAndCashEquivalentsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_FinanceLeaseLiabilityToBePaidYearThreeAndThereafter" xlink:to="sera_FinanceLeaseLiabilityToBePaidYearThreeAndThereafter_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="us-gaap_USGovernmentAgenciesDebtSecuritiesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USGovernmentDebtSecuritiesMember" xlink:to="us-gaap_USGovernmentDebtSecuritiesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_RightOfUseAssetTotal" xlink:to="sera_RightOfUseAssetTotal_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_BalanceSheetLocationDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_FinanceLeasesOtherInformationAbstract" xlink:to="sera_FinanceLeasesOtherInformationAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:to="us-gaap_IncomeTaxReconciliationTaxCreditsResearch_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember" xlink:to="sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_Plan2021Member" xlink:to="sera_Plan2021Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="us-gaap_FinanceLeaseRightOfUseAsset_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_DefinedContributionPlanEmployerMatchingContributionMatchingTierDomain" xlink:to="sera_DefinedContributionPlanEmployerMatchingContributionMatchingTierDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_WarrantsTextBlock" xlink:to="sera_WarrantsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_CapitalizedIntangibleAssets" xlink:to="sera_CapitalizedIntangibleAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_RelatedPartyTransactionCashReceivedFromRelatedParty" xlink:to="sera_RelatedPartyTransactionCashReceivedFromRelatedParty_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesCurrent" xlink:to="us-gaap_MarketableSecuritiesCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_DeferredTaxAssetsLeaseLiabilities" xlink:to="sera_DeferredTaxAssetsLeaseLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_IssuanceOfStockToSettleAccruedAndOtherCurrentLiabilities" xlink:to="sera_IssuanceOfStockToSettleAccruedAndOtherCurrentLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:to="us-gaap_DefinedContributionPlanDisclosureLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="us-gaap_WarrantsAndRightsNoteDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_ProceedsFromIssuanceOfSharesAndPreFundedWarrants" xlink:to="sera_ProceedsFromIssuanceOfSharesAndPreFundedWarrants_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingStandardsUpdate202307Member" xlink:to="us-gaap_AccountingStandardsUpdate202307Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost" xlink:to="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesNetAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassAMember" xlink:to="us-gaap_CommonClassAMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassBMember" xlink:to="us-gaap_CommonClassBMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_CommonStockAdditionalShares" xlink:to="sera_CommonStockAdditionalShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" xlink:to="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_WarrantsIssued" xlink:to="sera_WarrantsIssued_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_LeaseLiabilityPaymentDueAbstract" xlink:to="sera_LeaseLiabilityPaymentDueAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_LesseeOperatingLeaseLiabilityToBePaidYearThreeAndThereafter" xlink:to="sera_LesseeOperatingLeaseLiabilityToBePaidYearThreeAndThereafter_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_DefinedContributionPlanEmployerMatchingContributionMatchingTierAxis" xlink:to="sera_DefinedContributionPlanEmployerMatchingContributionMatchingTierAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonUnitIssued" xlink:to="us-gaap_CommonUnitIssued_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesPolicy" xlink:to="us-gaap_MarketableSecuritiesPolicy_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpAmount" xlink:to="sera_EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_PercentageOfMinimumOwnershipBeneficiallyOwnByHolderWithAffiliatesToWarrantExercise" xlink:to="sera_PercentageOfMinimumOwnershipBeneficiallyOwnByHolderWithAffiliatesToWarrantExercise_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_DefinedContributionPlanEmployerMatchingContributionSecondTierMember" xlink:to="sera_DefinedContributionPlanEmployerMatchingContributionSecondTierMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_StockIssuedDuringPeriodSharesStockWarrantExercised" xlink:to="sera_StockIssuedDuringPeriodSharesStockWarrantExercised_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock" xlink:to="sera_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsGrossExcludingGoodwill_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_CashAndCashEquivalentsAmortizedCost" xlink:to="sera_CashAndCashEquivalentsAmortizedCost_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_CurrentMarketableSecuritiesMember" xlink:to="sera_CurrentMarketableSecuritiesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfOtherAssetsTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm" xlink:to="sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense" xlink:to="sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashMember" xlink:to="us-gaap_CashMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:to="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_LeaseLiabilityUndiscountedExcessAmount" xlink:to="sera_LeaseLiabilityUndiscountedExcessAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_IndemnificationLiability" xlink:to="sera_IndemnificationLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:to="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpPercent" xlink:to="sera_EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpPercent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium" xlink:to="us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_CommercialCollaborationAgreementMember" xlink:to="sera_CommercialCollaborationAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:to="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PostemploymentBenefitPlansPolicy" xlink:to="us-gaap_PostemploymentBenefitPlansPolicy_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MoneyMarketFundsMember" xlink:to="us-gaap_MoneyMarketFundsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="us-gaap_FinanceLeaseLiabilityNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_EffectiveIncomeTaxRateReconciliationEquityBasedExpensesPercent" xlink:to="sera_EffectiveIncomeTaxRateReconciliationEquityBasedExpensesPercent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseInterestExpense" xlink:to="us-gaap_FinanceLeaseInterestExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:to="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_FinancialInstrumentAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherReceivablesNetCurrent" xlink:to="us-gaap_OtherReceivablesNetCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_ElevanceHealthIncMember" xlink:to="sera_ElevanceHealthIncMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:to="cyd_CybersecurityRiskRoleOfManagementTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesNoncurrent" xlink:to="us-gaap_MarketableSecuritiesNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_LaboratoryEquipmentMember" xlink:to="sera_LaboratoryEquipmentMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestIncomeOther" xlink:to="us-gaap_InterestIncomeOther_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_CommonStockConversionRatio" xlink:to="sera_CommonStockConversionRatio_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockNoParValue" xlink:to="us-gaap_CommonStockNoParValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SoftwareDevelopmentMember" xlink:to="us-gaap_SoftwareDevelopmentMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_DefinedContributionPlanEmployerMatchingContributionFirstTierMember" xlink:to="sera_DefinedContributionPlanEmployerMatchingContributionFirstTierMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfSalesPolicyTextBlock" xlink:to="us-gaap_CostOfSalesPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_OperatingLeasesOtherInformationAbstract" xlink:to="sera_OperatingLeasesOtherInformationAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_CapitalSharesReservedForFutureIssuanceAxis" xlink:to="sera_CapitalSharesReservedForFutureIssuanceAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_CommonStockSharesConverted" xlink:to="sera_CommonStockSharesConverted_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:to="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_EffectiveIncomeTaxRateReconciliationEquityBasedExpensesAmount" xlink:to="sera_EffectiveIncomeTaxRateReconciliationEquityBasedExpensesAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfessionalFees" xlink:to="us-gaap_ProfessionalFees_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_ClassOfWarrantOrRightExercised" xlink:to="sera_ClassOfWarrantOrRightExercised_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_IncomeTaxAuthorityDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_MasterServicesAgreementMember" xlink:to="sera_MasterServicesAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanTable" xlink:to="us-gaap_DefinedContributionPlanTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:to="us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_RightOfUseAssetAbstract" xlink:to="sera_RightOfUseAssetAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_CommonStockWarrantAt520SharePriceMember" xlink:to="sera_CommonStockWarrantAt520SharePriceMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_DeferredTaxLiabilitiesRightOfUseAssets" xlink:to="sera_DeferredTaxLiabilitiesRightOfUseAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_OfferingExpenses" xlink:to="sera_OfferingExpenses_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_EquipmentLabSuppliesAndFacilityExpenses" xlink:to="sera_EquipmentLabSuppliesAndFacilityExpenses_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_RevenueCost" xlink:to="sera_RevenueCost_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_ProceedsFromIssuanceInitialPublicOfferingNet" xlink:to="sera_ProceedsFromIssuanceInitialPublicOfferingNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaidInKindInterest" xlink:to="us-gaap_PaidInKindInterest_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:to="us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:to="us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:to="us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="us-gaap_FinanceLeaseLiabilityCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="us-gaap_FinanceLeaseRightOfUseAssetAmortization_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_OfficeAndLaboratorySpaceMember" xlink:to="sera_OfficeAndLaboratorySpaceMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_CommitmentsAndContingenciesTable" xlink:to="sera_CommitmentsAndContingenciesTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_CommonStockWarrantAt1238SharePriceMember" xlink:to="sera_CommonStockWarrantAt1238SharePriceMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_GrossSalesProceedsFromIssuanceOfCommonStock" xlink:to="sera_GrossSalesProceedsFromIssuanceOfCommonStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_LeaseLiabilityNoncurrent" xlink:to="sera_LeaseLiabilityNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_AtTheMarketOfferingMember" xlink:to="sera_AtTheMarketOfferingMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:to="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiability" xlink:to="us-gaap_FinanceLeaseLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_LeaseLiabilitiesAbstract" xlink:to="sera_LeaseLiabilitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_CommonStockWarrantAt10.84SharePriceMember" xlink:to="sera_CommonStockWarrantAt10.84SharePriceMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:to="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StateAndLocalJurisdictionMember" xlink:to="us-gaap_StateAndLocalJurisdictionMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_ProceedsFromIssuanceOfSharesAndPreFundedWarrantsNet" xlink:to="sera_ProceedsFromIssuanceOfSharesAndPreFundedWarrantsNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_LeaseLiabilityToBePaidYearThreeAndThereafter" xlink:to="sera_LeaseLiabilityToBePaidYearThreeAndThereafter_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sera_RelatedPartyTransactionOtherReceivablesRelatedToMinimumPayments" xlink:to="sera_RelatedPartyTransactionOtherReceivablesRelatedToMinimumPayments_lbl"/>
        </link:labelLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/Cover" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName" xlink:label="dei_AuditorName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorOpinionTextBlock" xlink:label="dei_AuditorOpinionTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAnnualReport" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentTransitionReport" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntitySmallBusiness" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="26" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_IcfrAuditorAttestationFlag" order="27" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" order="28" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityPublicFloat" order="29" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="30" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock" order="31" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="32" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="33" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="34" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="35" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag" order="36" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorFirmId" order="37" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorName" order="38" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorLocation" order="39" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorOpinionTextBlock" order="40" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentInformationTable" order="49.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="us-gaap_MarketableSecuritiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:label="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesNoncurrent" xlink:label="us-gaap_MarketableSecuritiesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="us-gaap_OtherReceivablesNetCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_MarketableSecuritiesCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityNoncurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_MarketableSecuritiesNoncurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_OtherReceivablesNetCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsParenthetical" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/StatementsofOperationsandComprehensiveLoss" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_RevenueCost" xlink:label="sera_RevenueCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense" xlink:label="sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="us-gaap_SellingAndMarketingExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="sera_RevenueCost" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingExpensesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_InterestExpense" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_SellingAndMarketingExpense" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NonoperatingIncomeExpense" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpenses" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/StatementStatementsOfStockholdersEquity" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_StockIssuedDuringPeriodSharesStockWarrantExercised" xlink:label="sera_StockIssuedDuringPeriodSharesStockWarrantExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued_13"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_14"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="sera_StockIssuedDuringPeriodSharesStockWarrantExercised" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued_13" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity_14" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_IssuanceOfStockToSettleAccruedAndOtherCurrentLiabilities" xlink:label="sera_IssuanceOfStockToSettleAccruedAndOtherCurrentLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:label="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities" xlink:label="sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherReceivables" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeasePrincipalPayments" xlink:label="us-gaap_FinanceLeasePrincipalPayments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaidInKindInterest" xlink:label="us-gaap_PaidInKindInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_NoncashInvestmentIncomeExpenseNet" xlink:label="sera_NoncashInvestmentIncomeExpenseNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="us-gaap_OtherNoncashIncomeExpense"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="sera_IssuanceOfStockToSettleAccruedAndOtherCurrentLiabilities" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_InterestPaidNet" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_FinanceLeasePrincipalPayments" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_PaidInKindInterest" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="sera_NoncashInvestmentIncomeExpenseNet" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_OtherNoncashIncomeExpense" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="ecd_AllIndividualsMember"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_JohnJBonifaceMember" xlink:label="sera_JohnJBonifaceMember"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_OtherOfficersMember" xlink:label="sera_OtherOfficersMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllIndividualsMember" xlink:to="sera_JohnJBonifaceMember" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllIndividualsMember" xlink:to="sera_OtherOfficersMember" order="3.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernanceDisclosure" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskRoleOfManagementTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DescriptionofBusinessandFinancialCondition" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/SignificantAccountingPolicies" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecurities" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAbstract" xlink:label="us-gaap_CashAndCashEquivalentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:label="us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAbstract" xlink:to="us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/PropertyandEquipment" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNet" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureOtherAssets" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsDisclosureTextBlock" xlink:label="us-gaap_OtherAssetsDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="us-gaap_OtherAssetsDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/AccruedandOtherCurrentLiabilities" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureOtherIncomeNet1" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="us-gaap_OtherIncomeAndExpensesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:label="us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/FairValueMeasurements" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/RelatedPartyTransactions" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/CapitalStructure" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/StockBasedCompensation" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/Warrants" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_WarrantsTextBlock" xlink:label="sera_WarrantsTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="sera_WarrantsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/CommitmentsandContingencies" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxes" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureNetLossPerShare1" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureSegmentInformation" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureSubsequentEvents" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/SignificantAccountingPoliciesPolicies" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="us-gaap_MarketableSecuritiesPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRecognitionDeferredRevenue" xlink:label="us-gaap_RevenueRecognitionDeferredRevenue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesPolicyTextBlock" xlink:label="us-gaap_CostOfSalesPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PostemploymentBenefitPlansPolicy" xlink:label="us-gaap_PostemploymentBenefitPlansPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_EmergingGrowthCompanyStatusPolicyTextBlock" xlink:label="sera_EmergingGrowthCompanyStatusPolicyTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_MarketableSecuritiesPolicy" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionDeferredRevenue" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CostOfSalesPolicyTextBlock" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PostemploymentBenefitPlansPolicy" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="sera_EmergingGrowthCompanyStatusPolicyTextBlock" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/AccountingPoliciesTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_ScheduleOfEstimatedUsefulLifeOfEachAssetCategoryTableTextBlock" xlink:label="sera_ScheduleOfEstimatedUsefulLifeOfEachAssetCategoryTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="sera_ScheduleOfEstimatedUsefulLifeOfEachAssetCategoryTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAbstract" xlink:label="us-gaap_CashAndCashEquivalentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:label="us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:label="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAbstract" xlink:to="us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAbstract" xlink:to="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/PropertyandEquipmentTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureOtherAssetsTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfOtherAssetsTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="us-gaap_ScheduleOfOtherAssetsTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/AccruedandOtherCurrentLiabilitiesTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureOtherIncomeNetTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="us-gaap_OtherIncomeAndExpensesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:label="us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/FairValueMeasurementsTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/CapitalStructureTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" xlink:label="sera_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="sera_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/StockBasedCompensationTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:label="us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/WarrantsTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/CommitmentandContingenciesTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock" xlink:label="sera_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="sera_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LeaseCostTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureNetLossPerShareTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureSegmentInformationTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAndFinancialConditionAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_TwoThousandTwentyFourSalesAgreementMember" xlink:label="sera_TwoThousandTwentyFourSalesAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_AtTheMarketOfferingMember" xlink:label="sera_AtTheMarketOfferingMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_TdCowenMember" xlink:label="sera_TdCowenMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_AmountFromSaleOfCombinationOfSecuritiesUnderShelfRegistration" xlink:label="sera_AmountFromSaleOfCombinationOfSecuritiesUnderShelfRegistration"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_AggregateOfferingPriceFromSaleOfCommonStock" xlink:label="sera_AggregateOfferingPriceFromSaleOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue" xlink:label="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockNoParValue" xlink:label="us-gaap_CommonStockNoParValue"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="sera_TwoThousandTwentyFourSalesAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="sera_AtTheMarketOfferingMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="sera_TdCowenMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_RangeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="sera_AmountFromSaleOfCombinationOfSecuritiesUnderShelfRegistration" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="sera_AggregateOfferingPriceFromSaleOfCommonStock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_CounterpartyNameAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CommonStockNoParValue" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingStandardsUpdate202307Member" xlink:label="us-gaap_AccountingStandardsUpdate202307Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_DefinedContributionPlanEmployerMatchingContributionMatchingTierDomain" xlink:label="sera_DefinedContributionPlanEmployerMatchingContributionMatchingTierDomain"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_DefinedContributionPlanEmployerMatchingContributionFirstTierMember" xlink:label="sera_DefinedContributionPlanEmployerMatchingContributionFirstTierMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:label="us-gaap_DefinedContributionPlanDisclosureLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_DefinedContributionPlanEmployerMatchingContributionMatchingTierAxis" xlink:label="sera_DefinedContributionPlanEmployerMatchingContributionMatchingTierAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanTable" xlink:label="us-gaap_DefinedContributionPlanTable"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_DefinedContributionPlanEmployerMatchingContributionSecondTierMember" xlink:label="sera_DefinedContributionPlanEmployerMatchingContributionSecondTierMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanCostRecognized" xlink:label="us-gaap_DefinedContributionPlanCostRecognized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" xlink:label="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" xlink:label="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate202307Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sera_DefinedContributionPlanEmployerMatchingContributionMatchingTierDomain" xlink:to="sera_DefinedContributionPlanEmployerMatchingContributionFirstTierMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:to="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sera_DefinedContributionPlanEmployerMatchingContributionMatchingTierAxis" xlink:to="sera_DefinedContributionPlanEmployerMatchingContributionMatchingTierDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DefinedContributionPlanTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DefinedContributionPlanTable" xlink:to="sera_DefinedContributionPlanEmployerMatchingContributionMatchingTierAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sera_DefinedContributionPlanEmployerMatchingContributionMatchingTierDomain" xlink:to="sera_DefinedContributionPlanEmployerMatchingContributionSecondTierMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:to="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DefinedContributionPlanTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:to="us-gaap_DefinedContributionPlanCostRecognized" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DefinedContributionPlanTable" xlink:to="us-gaap_DefinedContributionPlanDisclosureLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:to="us-gaap_NumberOfOperatingSegments" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:to="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:to="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureSignificantAccountingPoliciesScheduleOfEstimatedUsefulLifeOfEachAssetCategoryDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SoftwareDevelopmentMember" xlink:label="us-gaap_SoftwareDevelopmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="us-gaap_MachineryAndEquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_SoftwareDevelopmentMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_MachineryAndEquipmentMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashMember" xlink:label="us-gaap_CashMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CashAndCashEquivalentsAmortizedCost" xlink:label="sera_CashAndCashEquivalentsAmortizedCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="us-gaap_CashAndCashEquivalentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsMember" xlink:label="us-gaap_CashAndCashEquivalentsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommercialPaperMember" xlink:label="us-gaap_CommercialPaperMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAbstract" xlink:label="us-gaap_CashAndCashEquivalentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CurrentMarketableSecuritiesMember" xlink:label="sera_CurrentMarketableSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommercialPaperMember" xlink:label="us-gaap_CommercialPaperMember_2"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_NonCurrentMarketableSecuritiesMember" xlink:label="sera_NonCurrentMarketableSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="us-gaap_CorporateDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MunicipalBondsMember" xlink:label="us-gaap_MunicipalBondsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost" xlink:label="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue" xlink:label="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_CashMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="sera_CashAndCashEquivalentsAmortizedCost" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_CashAndCashEquivalentsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CommercialPaperMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_BalanceSheetLocationAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_MoneyMarketFundsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="sera_CurrentMarketableSecuritiesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_CommercialPaperMember_2" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="sera_NonCurrentMarketableSecuritiesMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USGovernmentDebtSecuritiesMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CorporateDebtSecuritiesMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_MunicipalBondsMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecuritiesAvailableforsaleDebtSecuritiesAndCashEquivalentsInUnrealizedLossPositionsDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:label="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommercialPaperMember" xlink:label="us-gaap_CommercialPaperMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAbstract" xlink:label="us-gaap_CashAndCashEquivalentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="us-gaap_CorporateDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CommercialPaperMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable" xlink:to="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CorporateDebtSecuritiesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USGovernmentDebtSecuritiesMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecuritiesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAbstract" xlink:label="us-gaap_CashAndCashEquivalentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:label="us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAbstract" xlink:to="us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAbstract" xlink:label="us-gaap_CashAndCashEquivalentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentScheduleOfComponentsOfPropertyAndEquipmentNetDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:label="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_LaboratoryEquipmentMember" xlink:label="sera_LaboratoryEquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:label="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:label="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SoftwareDevelopmentMember" xlink:label="us-gaap_SoftwareDevelopmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="sera_LaboratoryEquipmentMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_SoftwareDevelopmentMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/PropertyandEquipmentAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_LaboratoryEquipmentMember" xlink:label="sera_LaboratoryEquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="sera_LaboratoryEquipmentMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_DomainNamesMember" xlink:label="sera_DomainNamesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SoftwareDevelopmentMember" xlink:label="us-gaap_SoftwareDevelopmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="sera_DomainNamesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_SoftwareDevelopmentMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_IntangibleAssetsGrossExcludingGoodwill" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CapitalizedIntangibleAssets" xlink:label="sera_CapitalizedIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SoftwareDevelopmentMember" xlink:label="us-gaap_SoftwareDevelopmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="sera_CapitalizedIntangibleAssets" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_SoftwareDevelopmentMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfComponentsOfAccruedAndOtherCurrentLiabilitiesDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="us-gaap_AccruedSalariesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedVacationCurrent" xlink:label="us-gaap_AccruedVacationCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedEmployeeBenefitsCurrent" xlink:label="us-gaap_AccruedEmployeeBenefitsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedSalariesCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedVacationCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedEmployeeBenefitsCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureOtherIncomeNetScheduleOfComponentsOfOtherIncomeNetDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="us-gaap_OtherIncomeAndExpensesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeOther" xlink:label="us-gaap_InterestIncomeOther"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium" xlink:label="us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_InterestIncomeOther" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_NonoperatingIncomeExpense" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="us-gaap_PreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="us-gaap_CashAndCashEquivalentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommercialPaperMember" xlink:label="us-gaap_CommercialPaperMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommercialPaperMember" xlink:label="us-gaap_CommercialPaperMember_1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="us-gaap_CorporateDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MunicipalBondsMember" xlink:label="us-gaap_MunicipalBondsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentDebtSecuritiesMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_MoneyMarketFundsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CommercialPaperMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AssetsFairValueDisclosureAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_CommercialPaperMember_1" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CorporateDebtSecuritiesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="us-gaap_AssetsFairValueDisclosure" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_MunicipalBondsMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USGovernmentDebtSecuritiesMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_MasterServicesAgreementMember" xlink:label="sera_MasterServicesAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm" xlink:label="sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestorMember" xlink:label="us-gaap_InvestorMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CarelonResearchMember" xlink:label="sera_CarelonResearchMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_LaboratoryServicesAgreementMember" xlink:label="sera_LaboratoryServicesAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_RelatedPartyTransactionOtherReceivablesRelatedToMinimumPayments" xlink:label="sera_RelatedPartyTransactionOtherReceivablesRelatedToMinimumPayments"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_ElevanceHealthIncMember" xlink:label="sera_ElevanceHealthIncMember"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CommercialCollaborationAgreementMember" xlink:label="sera_CommercialCollaborationAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_RelatedPartyTransactionCashReceivedFromRelatedParty" xlink:label="sera_RelatedPartyTransactionCashReceivedFromRelatedParty"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="sera_MasterServicesAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_InvestorMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="sera_CarelonResearchMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="sera_LaboratoryServicesAgreementMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="sera_RelatedPartyTransactionOtherReceivablesRelatedToMinimumPayments" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="srt_CounterpartyNameAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="sera_ElevanceHealthIncMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="sera_CommercialCollaborationAgreementMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="sera_RelatedPartyTransactionCashReceivedFromRelatedParty" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_OperatingExpenses" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_TwoThousandTwentyFourSalesAgreementMember" xlink:label="sera_TwoThousandTwentyFourSalesAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_AtTheMarketOfferingMember" xlink:label="sera_AtTheMarketOfferingMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_NumberOfCommonStockClassesAuthorized" xlink:label="sera_NumberOfCommonStockClassesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_TdCowenMember" xlink:label="sera_TdCowenMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_NumberOfVotesPerShare" xlink:label="sera_NumberOfVotesPerShare"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CommonStockConversionRatio" xlink:label="sera_CommonStockConversionRatio"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_GrossSalesProceedsFromIssuanceOfCommonStock" xlink:label="sera_GrossSalesProceedsFromIssuanceOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CommonStockSharesConverted" xlink:label="sera_CommonStockSharesConverted"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="sera_TwoThousandTwentyFourSalesAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="sera_AtTheMarketOfferingMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfStockByClassTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="sera_NumberOfCommonStockClassesAuthorized" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="sera_TdCowenMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_PreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="sera_NumberOfVotesPerShare" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="sera_CommonStockConversionRatio" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="srt_CounterpartyNameAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="srt_RangeAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ClassOfStockLineItems" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="sera_GrossSalesProceedsFromIssuanceOfCommonStock" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="sera_CommonStockSharesConverted" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureScheduleOfCommonStockReservedForFutureIssuanceDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CapitalSharesReservedForFutureIssuanceDomain" xlink:label="sera_CapitalSharesReservedForFutureIssuanceDomain"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_WarrantsToPurchaseCommonStockMember" xlink:label="sera_WarrantsToPurchaseCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CapitalSharesReservedForFutureIssuanceAxis" xlink:label="sera_CapitalSharesReservedForFutureIssuanceAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember" xlink:label="sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember" xlink:label="sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sera_CapitalSharesReservedForFutureIssuanceDomain" xlink:to="sera_WarrantsToPurchaseCommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfStockByClassTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sera_CapitalSharesReservedForFutureIssuanceAxis" xlink:to="sera_CapitalSharesReservedForFutureIssuanceDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="sera_CapitalSharesReservedForFutureIssuanceAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sera_CapitalSharesReservedForFutureIssuanceDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ClassOfStockLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sera_CapitalSharesReservedForFutureIssuanceDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sera_CapitalSharesReservedForFutureIssuanceDomain" xlink:to="sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sera_CapitalSharesReservedForFutureIssuanceDomain" xlink:to="sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_Plan2011Member" xlink:label="sera_Plan2011Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_Plan2021Member" xlink:label="sera_Plan2021Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_PlanEspp2021Member" xlink:label="sera_PlanEspp2021Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="sera_Plan2011Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="sera_Plan2021Member" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="sera_PlanEspp2021Member" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionsGrantedAndOutstandingDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_5"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_5" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfFairValuesCalculatedUsingBlackscholesOptionPricingModelDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfInformationAboutRsusGrantedAndOutstandingDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="3.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfImpactOfStockbasedCompensationExpenseInStatementsOfOperationsDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpenseMember" xlink:label="us-gaap_SellingAndMarketingExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_SellingAndMarketingExpenseMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfUnrecognizedStockbasedCompensationExpenseForOutstandingUnvestedStockOptionsAndRsusDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="3.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureWarrantsScheduleOfCommonStockWarrantsOutstandingDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CommonStockWarrantAt520SharePriceMember" xlink:label="sera_CommonStockWarrantAt520SharePriceMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CommonStockWarrantAt9.03SharePriceMember" xlink:label="sera_CommonStockWarrantAt9.03SharePriceMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CommonStockWarrantAt10.84SharePriceMember" xlink:label="sera_CommonStockWarrantAt10.84SharePriceMember"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CommonStockWarrantAt1238SharePriceMember" xlink:label="sera_CommonStockWarrantAt1238SharePriceMember"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CommonStockWarrantAt20.77SharePriceMember" xlink:label="sera_CommonStockWarrantAt20.77SharePriceMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="sera_CommonStockWarrantAt520SharePriceMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="us-gaap_ClassOfWarrantOrRightTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="sera_CommonStockWarrantAt9.03SharePriceMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="sera_CommonStockWarrantAt10.84SharePriceMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="sera_CommonStockWarrantAt1238SharePriceMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="sera_CommonStockWarrantAt20.77SharePriceMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_ClassOfWarrantOrRightExercised" xlink:label="sera_ClassOfWarrantOrRightExercised"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_StockIssuedDuringPeriodSharesStockWarrantExercised" xlink:label="sera_StockIssuedDuringPeriodSharesStockWarrantExercised"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_StockIssuedDuringPeriodSharesStockWarrantExpired" xlink:label="sera_StockIssuedDuringPeriodSharesStockWarrantExpired"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="sera_ClassOfWarrantOrRightExercised" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="sera_StockIssuedDuringPeriodSharesStockWarrantExercised" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="sera_StockIssuedDuringPeriodSharesStockWarrantExpired" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeasesInFinancialStatementDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_RightOfUseAssetAbstract" xlink:label="sera_RightOfUseAssetAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_LeaseLiabilitiesAbstract" xlink:label="sera_LeaseLiabilitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="us-gaap_FinanceLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_RightOfUseAssetTotal" xlink:label="sera_RightOfUseAssetTotal"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:label="us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:label="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_LeaseLiabilitiesTotal" xlink:label="sera_LeaseLiabilitiesTotal"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="sera_RightOfUseAssetAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sera_RightOfUseAssetAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sera_LeaseLiabilitiesAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="sera_LeaseLiabilitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sera_RightOfUseAssetAbstract" xlink:to="us-gaap_FinanceLeaseRightOfUseAsset" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sera_LeaseLiabilitiesAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sera_RightOfUseAssetAbstract" xlink:to="sera_RightOfUseAssetTotal" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sera_LeaseLiabilitiesAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sera_LeaseLiabilitiesAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityNoncurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sera_LeaseLiabilitiesAbstract" xlink:to="sera_LeaseLiabilitiesTotal" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeaseCostAndOtherInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostAbstract" xlink:label="us-gaap_LeaseCostAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:label="us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_LeaseOtherInformationAbstract" xlink:label="sera_LeaseOtherInformationAbstract"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_FinanceLeasesOtherInformationAbstract" xlink:label="sera_FinanceLeasesOtherInformationAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:label="us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_OperatingLeasesOtherInformationAbstract" xlink:label="sera_OperatingLeasesOtherInformationAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseInterestExpense" xlink:label="us-gaap_FinanceLeaseInterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeasePrincipalPayments" xlink:label="us-gaap_FinanceLeasePrincipalPayments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCost" xlink:label="us-gaap_LeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_FinanceLeaseRightOfUseAssetAmortization" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sera_LeaseOtherInformationAbstract" xlink:to="sera_FinanceLeasesOtherInformationAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sera_FinanceLeasesOtherInformationAbstract" xlink:to="us-gaap_FinanceLeaseInterestPaymentOnLiability" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sera_OperatingLeasesOtherInformationAbstract" xlink:to="us-gaap_OperatingLeasePayments" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LeaseCostAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_FinanceLeaseInterestExpense" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sera_LeaseOtherInformationAbstract" xlink:to="sera_OperatingLeasesOtherInformationAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sera_FinanceLeasesOtherInformationAbstract" xlink:to="us-gaap_FinanceLeasePrincipalPayments" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sera_OperatingLeasesOtherInformationAbstract" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="sera_LeaseOtherInformationAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_OperatingLeaseCost" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sera_FinanceLeasesOtherInformationAbstract" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sera_OperatingLeasesOtherInformationAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_LeaseCost" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sera_FinanceLeasesOtherInformationAbstract" xlink:to="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sera_OperatingLeasesOtherInformationAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sera_FinanceLeasesOtherInformationAbstract" xlink:to="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:label="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_LeaseLiabilityPaymentDueAbstract" xlink:label="sera_LeaseLiabilityPaymentDueAbstract"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_LeaseLiabilityToBePaidYearOne" xlink:label="sera_LeaseLiabilityToBePaidYearOne"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_LeaseLiabilityToBePaidYearTwo" xlink:label="sera_LeaseLiabilityToBePaidYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_FinanceLeaseLiabilityToBePaidYearThreeAndThereafter" xlink:label="sera_FinanceLeaseLiabilityToBePaidYearThreeAndThereafter"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_LeaseLiabilityToBePaidYearThreeAndThereafter" xlink:label="sera_LeaseLiabilityToBePaidYearThreeAndThereafter"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_LesseeOperatingLeaseLiabilityToBePaidYearThreeAndThereafter" xlink:label="sera_LesseeOperatingLeaseLiabilityToBePaidYearThreeAndThereafter"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_LeaseLiabilityPaymentDue" xlink:label="sera_LeaseLiabilityPaymentDue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_LeaseLiabilityUndiscountedExcessAmount" xlink:label="sera_LeaseLiabilityUndiscountedExcessAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiability" xlink:label="us-gaap_FinanceLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_LeaseLiabilitiesTotal" xlink:label="sera_LeaseLiabilitiesTotal"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_LeaseLiabilityCurrent" xlink:label="sera_LeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_LeaseLiabilityNoncurrent" xlink:label="sera_LeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sera_LeaseLiabilityPaymentDueAbstract" xlink:to="sera_LeaseLiabilityToBePaidYearOne" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sera_LeaseLiabilityPaymentDueAbstract" xlink:to="sera_LeaseLiabilityToBePaidYearTwo" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="sera_FinanceLeaseLiabilityToBePaidYearThreeAndThereafter" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sera_LeaseLiabilityPaymentDueAbstract" xlink:to="sera_LeaseLiabilityToBePaidYearThreeAndThereafter" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="sera_LesseeOperatingLeaseLiabilityToBePaidYearThreeAndThereafter" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="sera_LeaseLiabilityPaymentDueAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDue" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sera_LeaseLiabilityPaymentDueAbstract" xlink:to="sera_LeaseLiabilityPaymentDue" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sera_LeaseLiabilityPaymentDueAbstract" xlink:to="sera_LeaseLiabilityUndiscountedExcessAmount" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiability" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sera_LeaseLiabilityPaymentDueAbstract" xlink:to="sera_LeaseLiabilitiesTotal" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeaseLiability" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityCurrent" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sera_LeaseLiabilityPaymentDueAbstract" xlink:to="sera_LeaseLiabilityCurrent" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityNoncurrent" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sera_LeaseLiabilityPaymentDueAbstract" xlink:to="sera_LeaseLiabilityNoncurrent" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CommitmentsAndContingenciesLineItems" xlink:label="sera_CommitmentsAndContingenciesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory" xlink:label="sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_OfficeAndLaboratorySpaceMember" xlink:label="sera_OfficeAndLaboratorySpaceMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CommitmentsAndContingenciesTable" xlink:label="sera_CommitmentsAndContingenciesTable"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_IndemnificationLiability" xlink:label="sera_IndemnificationLiability"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sera_CommitmentsAndContingenciesLineItems" xlink:to="sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="sera_OfficeAndLaboratorySpaceMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="sera_CommitmentsAndContingenciesTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sera_CommitmentsAndContingenciesTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sera_CommitmentsAndContingenciesLineItems" xlink:to="sera_IndemnificationLiability" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sera_CommitmentsAndContingenciesTable" xlink:to="sera_CommitmentsAndContingenciesLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxContingencyLineItems" xlink:label="us-gaap_IncomeTaxContingencyLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxContingencyTable" xlink:label="us-gaap_IncomeTaxContingencyTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxContingencyTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxContingencyTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxContingencyTable" xlink:to="us-gaap_IncomeTaxContingencyLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:label="us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_EffectiveIncomeTaxRateReconciliationEquityBasedExpensesAmount" xlink:label="sera_EffectiveIncomeTaxRateReconciliationEquityBasedExpensesAmount"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_EffectiveIncomeTaxRateReconciliationEquityBasedExpensesPercent" xlink:label="sera_EffectiveIncomeTaxRateReconciliationEquityBasedExpensesPercent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpAmount" xlink:label="sera_EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpAmount"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpPercent" xlink:label="sera_EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpPercent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="us-gaap_IncomeTaxReconciliationTaxCreditsResearch" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="sera_EffectiveIncomeTaxRateReconciliationEquityBasedExpensesAmount" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="sera_EffectiveIncomeTaxRateReconciliationEquityBasedExpensesPercent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="sera_EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpAmount" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="sera_EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpPercent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract" xlink:label="us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:label="us-gaap_DeferredTaxLiabilitiesNetAbstract"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_DeferredTaxLiabilitiesRightOfUseAssets" xlink:label="sera_DeferredTaxLiabilitiesRightOfUseAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_DeferredTaxAssetsLeaseLiabilities" xlink:label="sera_DeferredTaxAssetsLeaseLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:to="sera_DeferredTaxLiabilitiesRightOfUseAssets" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesNetAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract" xlink:to="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract" xlink:to="sera_DeferredTaxAssetsLeaseLiabilities" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract" xlink:to="us-gaap_DeferredTaxAssetsOther" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract" xlink:to="us-gaap_DeferredTaxAssetsGross" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract" xlink:to="us-gaap_DeferredTaxAssetsNet" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesUnrecognizedTaxPositionsDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:label="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits_3"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="us-gaap_UnrecognizedTaxBenefits" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="us-gaap_UnrecognizedTaxBenefits_3" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureNetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromTheComputationOfEarningsPerShareDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_WarrantsToPurchaseCommonStockMember" xlink:label="sera_WarrantsToPurchaseCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="sera_WarrantsToPurchaseCommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureSegmentInformationSummaryOfSegmentInformationForRevenueSignificantSegmentExpensesAndSegmentLossExpensesThatAreRegularlyProvidedT" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLaborRelatedExpenses" xlink:label="us-gaap_OtherLaborRelatedExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfessionalFees" xlink:label="us-gaap_ProfessionalFees"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_ClinicalStudiesAndOutsideProcessing" xlink:label="sera_ClinicalStudiesAndOutsideProcessing"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_EquipmentLabSuppliesAndFacilityExpenses" xlink:label="sera_EquipmentLabSuppliesAndFacilityExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingOtherItemAmount" xlink:label="us-gaap_SegmentReportingOtherItemAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_Revenues" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_CostOfRevenue" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_OtherLaborRelatedExpenses" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_ProfessionalFees" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="sera_ClinicalStudiesAndOutsideProcessing" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="sera_EquipmentLabSuppliesAndFacilityExpenses" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_DepreciationAndAmortization" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingOtherItemAmount" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_InterestExpense" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_NonoperatingIncomeExpense" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_NetIncomeLoss" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonUnitIssued" xlink:label="us-gaap_CommonUnitIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_WarrantsIssued" xlink:label="sera_WarrantsIssued"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_WarrantIssuedPricePerPre-FundedWarrantAndAccompanyingWarrant" xlink:label="sera_WarrantIssuedPricePerPre-FundedWarrantAndAccompanyingWarrant"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_IssuePricePerShareAndWarrant" xlink:label="sera_IssuePricePerShareAndWarrant"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_ProceedsFromIssuanceOfSharesAndPreFundedWarrants" xlink:label="sera_ProceedsFromIssuanceOfSharesAndPreFundedWarrants"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_ProceedsFromIssuanceOfSharesAndPreFundedWarrantsNet" xlink:label="sera_ProceedsFromIssuanceOfSharesAndPreFundedWarrantsNet"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_PercentageOfMinimumOwnershipBeneficiallyOwnByHolderWithAffiliatesToWarrantExercise" xlink:label="sera_PercentageOfMinimumOwnershipBeneficiallyOwnByHolderWithAffiliatesToWarrantExercise"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_FairValueAdjustmentOfPreFundedWarrants" xlink:label="sera_FairValueAdjustmentOfPreFundedWarrants"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CommonStockAdditionalShares" xlink:label="sera_CommonStockAdditionalShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_OfferingExpenses" xlink:label="sera_OfferingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_ProceedsFromIssuanceInitialPublicOfferingNet" xlink:label="sera_ProceedsFromIssuanceInitialPublicOfferingNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_CommonUnitIssued" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="sera_WarrantsIssued" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="sera_WarrantIssuedPricePerPre-FundedWarrantAndAccompanyingWarrant" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="sera_IssuePricePerShareAndWarrant" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="sera_ProceedsFromIssuanceOfSharesAndPreFundedWarrants" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="sera_ProceedsFromIssuanceOfSharesAndPreFundedWarrantsNet" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="sera_PercentageOfMinimumOwnershipBeneficiallyOwnByHolderWithAffiliatesToWarrantExercise" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="sera_FairValueAdjustmentOfPreFundedWarrants" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="sera_CommonStockAdditionalShares" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="sera_OfferingExpenses" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="sera_ProceedsFromIssuanceInitialPublicOfferingNet" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://seraprognostics.com/20241231/taxonomy/role/Cover">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName" xlink:label="dei_AuditorName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorOpinionTextBlock" xlink:label="dei_AuditorOpinionTextBlock"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAnnualReport" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentTransitionReport" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="21" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="22" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="23" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="24" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntitySmallBusiness" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="25" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="26" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="27" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_IcfrAuditorAttestationFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="28" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="29" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityPublicFloat" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="30" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="31" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="32" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="33" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="34" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="35" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="36" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="37" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorFirmId" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="38" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorName" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="39" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorLocation" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="40" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorOpinionTextBlock" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsParenthetical">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassBMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://seraprognostics.com/20241231/taxonomy/role/StatementStatementsOfStockholdersEquity">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_StockIssuedDuringPeriodSharesStockWarrantExercised" xlink:label="sera_StockIssuedDuringPeriodSharesStockWarrantExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="sera_StockIssuedDuringPeriodSharesStockWarrantExercised" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/IndividualsOnly">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="ecd_AllIndividualsMember"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_JohnJBonifaceMember" xlink:label="sera_JohnJBonifaceMember"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_OtherOfficersMember" xlink:label="sera_OtherOfficersMember"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllIndividualsMember" xlink:to="sera_JohnJBonifaceMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllIndividualsMember" xlink:to="sera_OtherOfficersMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernanceDisclosure">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskRoleOfManagementTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAndFinancialConditionAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_TwoThousandTwentyFourSalesAgreementMember" xlink:label="sera_TwoThousandTwentyFourSalesAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_AtTheMarketOfferingMember" xlink:label="sera_AtTheMarketOfferingMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_TdCowenMember" xlink:label="sera_TdCowenMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_AmountFromSaleOfCombinationOfSecuritiesUnderShelfRegistration" xlink:label="sera_AmountFromSaleOfCombinationOfSecuritiesUnderShelfRegistration"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_AggregateOfferingPriceFromSaleOfCommonStock" xlink:label="sera_AggregateOfferingPriceFromSaleOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue" xlink:label="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockNoParValue" xlink:label="us-gaap_CommonStockNoParValue"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="sera_TwoThousandTwentyFourSalesAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="sera_AtTheMarketOfferingMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="sera_TdCowenMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="sera_AmountFromSaleOfCombinationOfSecuritiesUnderShelfRegistration" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="sera_AggregateOfferingPriceFromSaleOfCommonStock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CommonStockSharesIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_CounterpartyNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CommonStockNoParValue" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:label="us-gaap_DefinedContributionPlanDisclosureLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanTable" xlink:label="us-gaap_DefinedContributionPlanTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingStandardsUpdate202307Member" xlink:label="us-gaap_AccountingStandardsUpdate202307Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember_default"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_DefinedContributionPlanEmployerMatchingContributionMatchingTierDomain" xlink:label="sera_DefinedContributionPlanEmployerMatchingContributionMatchingTierDomain"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_DefinedContributionPlanEmployerMatchingContributionFirstTierMember" xlink:label="sera_DefinedContributionPlanEmployerMatchingContributionFirstTierMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_DefinedContributionPlanEmployerMatchingContributionMatchingTierAxis" xlink:label="sera_DefinedContributionPlanEmployerMatchingContributionMatchingTierAxis"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_DefinedContributionPlanEmployerMatchingContributionMatchingTierDomain" xlink:label="sera_DefinedContributionPlanEmployerMatchingContributionMatchingTierDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_DefinedContributionPlanEmployerMatchingContributionSecondTierMember" xlink:label="sera_DefinedContributionPlanEmployerMatchingContributionSecondTierMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanCostRecognized" xlink:label="us-gaap_DefinedContributionPlanCostRecognized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" xlink:label="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" xlink:label="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:to="us-gaap_DefinedContributionPlanTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate202307Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="sera_DefinedContributionPlanEmployerMatchingContributionMatchingTierDomain" xlink:to="sera_DefinedContributionPlanEmployerMatchingContributionFirstTierMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:to="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="sera_DefinedContributionPlanEmployerMatchingContributionMatchingTierAxis" xlink:to="sera_DefinedContributionPlanEmployerMatchingContributionMatchingTierDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="sera_DefinedContributionPlanEmployerMatchingContributionMatchingTierAxis" xlink:to="sera_DefinedContributionPlanEmployerMatchingContributionMatchingTierDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DefinedContributionPlanTable" xlink:to="sera_DefinedContributionPlanEmployerMatchingContributionMatchingTierAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="sera_DefinedContributionPlanEmployerMatchingContributionMatchingTierDomain" xlink:to="sera_DefinedContributionPlanEmployerMatchingContributionSecondTierMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:to="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DefinedContributionPlanTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:to="us-gaap_DefinedContributionPlanCostRecognized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:to="us-gaap_NumberOfOperatingSegments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:to="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:to="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureSignificantAccountingPoliciesScheduleOfEstimatedUsefulLifeOfEachAssetCategoryDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SoftwareDevelopmentMember" xlink:label="us-gaap_SoftwareDevelopmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="us-gaap_MachineryAndEquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_SoftwareDevelopmentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_MachineryAndEquipmentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashMember" xlink:label="us-gaap_CashMember"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CashAndCashEquivalentsAmortizedCost" xlink:label="sera_CashAndCashEquivalentsAmortizedCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="us-gaap_CashAndCashEquivalentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsMember" xlink:label="us-gaap_CashAndCashEquivalentsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommercialPaperMember" xlink:label="us-gaap_CommercialPaperMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CurrentMarketableSecuritiesMember" xlink:label="sera_CurrentMarketableSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_NonCurrentMarketableSecuritiesMember" xlink:label="sera_NonCurrentMarketableSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="us-gaap_CorporateDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MunicipalBondsMember" xlink:label="us-gaap_MunicipalBondsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost" xlink:label="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue" xlink:label="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_CashMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="sera_CashAndCashEquivalentsAmortizedCost" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_CashAndCashEquivalentsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CommercialPaperMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_BalanceSheetLocationAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_MoneyMarketFundsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="sera_CurrentMarketableSecuritiesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="sera_NonCurrentMarketableSecuritiesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USGovernmentDebtSecuritiesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_FinancialInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CorporateDebtSecuritiesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_MunicipalBondsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecuritiesAvailableforsaleDebtSecuritiesAndCashEquivalentsInUnrealizedLossPositionsDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:label="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommercialPaperMember" xlink:label="us-gaap_CommercialPaperMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="us-gaap_CorporateDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable" xlink:to="us-gaap_FinancialInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CommercialPaperMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CorporateDebtSecuritiesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USGovernmentDebtSecuritiesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentScheduleOfComponentsOfPropertyAndEquipmentNetDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:label="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_LaboratoryEquipmentMember" xlink:label="sera_LaboratoryEquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:label="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:label="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SoftwareDevelopmentMember" xlink:label="us-gaap_SoftwareDevelopmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="sera_LaboratoryEquipmentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_SoftwareDevelopmentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://seraprognostics.com/20241231/taxonomy/role/PropertyandEquipmentAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_LaboratoryEquipmentMember" xlink:label="sera_LaboratoryEquipmentMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_DepreciationDepletionAndAmortization" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="sera_LaboratoryEquipmentMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_DomainNamesMember" xlink:label="sera_DomainNamesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SoftwareDevelopmentMember" xlink:label="us-gaap_SoftwareDevelopmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="sera_DomainNamesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_SoftwareDevelopmentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_IntangibleAssetsGrossExcludingGoodwill" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CapitalizedIntangibleAssets" xlink:label="sera_CapitalizedIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SoftwareDevelopmentMember" xlink:label="us-gaap_SoftwareDevelopmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="sera_CapitalizedIntangibleAssets" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_SoftwareDevelopmentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_AmortizationOfIntangibleAssets" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="us-gaap_PreferredStockMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://seraprognostics.com/20241231/taxonomy/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="us-gaap_CashAndCashEquivalentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommercialPaperMember" xlink:label="us-gaap_CommercialPaperMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="us-gaap_CorporateDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MunicipalBondsMember" xlink:label="us-gaap_MunicipalBondsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentDebtSecuritiesMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="us-gaap_MoneyMarketFundsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CashAndCashEquivalentsAxis" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CommercialPaperMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AssetsFairValueDisclosureAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CorporateDebtSecuritiesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_CashAndCashEquivalentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="us-gaap_AssetsFairValueDisclosure" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_MunicipalBondsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FinancialInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USGovernmentAgenciesDebtSecuritiesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USGovernmentDebtSecuritiesMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_MasterServicesAgreementMember" xlink:label="sera_MasterServicesAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm" xlink:label="sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestorMember" xlink:label="us-gaap_InvestorMember"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CarelonResearchMember" xlink:label="sera_CarelonResearchMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_LaboratoryServicesAgreementMember" xlink:label="sera_LaboratoryServicesAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_RelatedPartyTransactionOtherReceivablesRelatedToMinimumPayments" xlink:label="sera_RelatedPartyTransactionOtherReceivablesRelatedToMinimumPayments"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_ElevanceHealthIncMember" xlink:label="sera_ElevanceHealthIncMember"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CommercialCollaborationAgreementMember" xlink:label="sera_CommercialCollaborationAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_RelatedPartyTransactionCashReceivedFromRelatedParty" xlink:label="sera_RelatedPartyTransactionCashReceivedFromRelatedParty"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="sera_MasterServicesAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_InvestorMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="sera_CarelonResearchMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="sera_LaboratoryServicesAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="sera_RelatedPartyTransactionOtherReceivablesRelatedToMinimumPayments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="srt_CounterpartyNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="sera_ElevanceHealthIncMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="sera_CommercialCollaborationAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="sera_RelatedPartyTransactionCashReceivedFromRelatedParty" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_OperatingExpenses" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_TwoThousandTwentyFourSalesAgreementMember" xlink:label="sera_TwoThousandTwentyFourSalesAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_AtTheMarketOfferingMember" xlink:label="sera_AtTheMarketOfferingMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_NumberOfCommonStockClassesAuthorized" xlink:label="sera_NumberOfCommonStockClassesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_TdCowenMember" xlink:label="sera_TdCowenMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_NumberOfVotesPerShare" xlink:label="sera_NumberOfVotesPerShare"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CommonStockConversionRatio" xlink:label="sera_CommonStockConversionRatio"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_GrossSalesProceedsFromIssuanceOfCommonStock" xlink:label="sera_GrossSalesProceedsFromIssuanceOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CommonStockSharesConverted" xlink:label="sera_CommonStockSharesConverted"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ScheduleOfStockByClassTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="sera_TwoThousandTwentyFourSalesAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="sera_AtTheMarketOfferingMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="sera_NumberOfCommonStockClassesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="sera_TdCowenMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_PreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="sera_NumberOfVotesPerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="sera_CommonStockConversionRatio" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="srt_CounterpartyNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="sera_GrossSalesProceedsFromIssuanceOfCommonStock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="sera_CommonStockSharesConverted" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureScheduleOfCommonStockReservedForFutureIssuanceDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CapitalSharesReservedForFutureIssuanceDomain" xlink:label="sera_CapitalSharesReservedForFutureIssuanceDomain"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_WarrantsToPurchaseCommonStockMember" xlink:label="sera_WarrantsToPurchaseCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CapitalSharesReservedForFutureIssuanceAxis" xlink:label="sera_CapitalSharesReservedForFutureIssuanceAxis"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CapitalSharesReservedForFutureIssuanceDomain" xlink:label="sera_CapitalSharesReservedForFutureIssuanceDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember" xlink:label="sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember" xlink:label="sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ScheduleOfStockByClassTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="sera_CapitalSharesReservedForFutureIssuanceDomain" xlink:to="sera_WarrantsToPurchaseCommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="sera_CapitalSharesReservedForFutureIssuanceAxis" xlink:to="sera_CapitalSharesReservedForFutureIssuanceDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="sera_CapitalSharesReservedForFutureIssuanceAxis" xlink:to="sera_CapitalSharesReservedForFutureIssuanceDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="sera_CapitalSharesReservedForFutureIssuanceAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="sera_CapitalSharesReservedForFutureIssuanceDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="sera_CapitalSharesReservedForFutureIssuanceDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="sera_CapitalSharesReservedForFutureIssuanceDomain" xlink:to="sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="sera_CapitalSharesReservedForFutureIssuanceDomain" xlink:to="sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_Plan2011Member" xlink:label="sera_Plan2011Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_Plan2021Member" xlink:label="sera_Plan2021Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_PlanEspp2021Member" xlink:label="sera_PlanEspp2021Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="sera_Plan2011Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="sera_Plan2021Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="sera_PlanEspp2021Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfFairValuesCalculatedUsingBlackscholesOptionPricingModelDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfInformationAboutRsusGrantedAndOutstandingDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfImpactOfStockbasedCompensationExpenseInStatementsOfOperationsDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpenseMember" xlink:label="us-gaap_SellingAndMarketingExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_SellingAndMarketingExpenseMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfUnrecognizedStockbasedCompensationExpenseForOutstandingUnvestedStockOptionsAndRsusDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureWarrantsScheduleOfCommonStockWarrantsOutstandingDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CommonStockWarrantAt520SharePriceMember" xlink:label="sera_CommonStockWarrantAt520SharePriceMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CommonStockWarrantAt9.03SharePriceMember" xlink:label="sera_CommonStockWarrantAt9.03SharePriceMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CommonStockWarrantAt10.84SharePriceMember" xlink:label="sera_CommonStockWarrantAt10.84SharePriceMember"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CommonStockWarrantAt1238SharePriceMember" xlink:label="sera_CommonStockWarrantAt1238SharePriceMember"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CommonStockWarrantAt20.77SharePriceMember" xlink:label="sera_CommonStockWarrantAt20.77SharePriceMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_FinancialInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="sera_CommonStockWarrantAt520SharePriceMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="sera_CommonStockWarrantAt9.03SharePriceMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="sera_CommonStockWarrantAt10.84SharePriceMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="sera_CommonStockWarrantAt1238SharePriceMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="sera_CommonStockWarrantAt20.77SharePriceMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CommitmentsAndContingenciesLineItems" xlink:label="sera_CommitmentsAndContingenciesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CommitmentsAndContingenciesTable" xlink:label="sera_CommitmentsAndContingenciesTable"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory" xlink:label="sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_OfficeAndLaboratorySpaceMember" xlink:label="sera_OfficeAndLaboratorySpaceMember"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_IndemnificationLiability" xlink:label="sera_IndemnificationLiability"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="sera_CommitmentsAndContingenciesLineItems" xlink:to="sera_CommitmentsAndContingenciesTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="sera_CommitmentsAndContingenciesLineItems" xlink:to="sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="sera_OfficeAndLaboratorySpaceMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="sera_CommitmentsAndContingenciesTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="sera_CommitmentsAndContingenciesLineItems" xlink:to="sera_IndemnificationLiability" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxContingencyLineItems" xlink:label="us-gaap_IncomeTaxContingencyLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxContingencyTable" xlink:label="us-gaap_IncomeTaxContingencyTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_IncomeTaxContingencyTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_IncomeTaxContingencyTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureNetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromTheComputationOfEarningsPerShareDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_WarrantsToPurchaseCommonStockMember" xlink:label="sera_WarrantsToPurchaseCommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="sera_WarrantsToPurchaseCommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonUnitIssued" xlink:label="us-gaap_CommonUnitIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_WarrantsIssued" xlink:label="sera_WarrantsIssued"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_WarrantIssuedPricePerPre-FundedWarrantAndAccompanyingWarrant" xlink:label="sera_WarrantIssuedPricePerPre-FundedWarrantAndAccompanyingWarrant"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_IssuePricePerShareAndWarrant" xlink:label="sera_IssuePricePerShareAndWarrant"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_ProceedsFromIssuanceOfSharesAndPreFundedWarrants" xlink:label="sera_ProceedsFromIssuanceOfSharesAndPreFundedWarrants"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_ProceedsFromIssuanceOfSharesAndPreFundedWarrantsNet" xlink:label="sera_ProceedsFromIssuanceOfSharesAndPreFundedWarrantsNet"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_PercentageOfMinimumOwnershipBeneficiallyOwnByHolderWithAffiliatesToWarrantExercise" xlink:label="sera_PercentageOfMinimumOwnershipBeneficiallyOwnByHolderWithAffiliatesToWarrantExercise"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_FairValueAdjustmentOfPreFundedWarrants" xlink:label="sera_FairValueAdjustmentOfPreFundedWarrants"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CommonStockAdditionalShares" xlink:label="sera_CommonStockAdditionalShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_OfferingExpenses" xlink:label="sera_OfferingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_ProceedsFromIssuanceInitialPublicOfferingNet" xlink:label="sera_ProceedsFromIssuanceInitialPublicOfferingNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_CommonUnitIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonClassAMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="sera_WarrantsIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="sera_WarrantIssuedPricePerPre-FundedWarrantAndAccompanyingWarrant" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="sera_IssuePricePerShareAndWarrant" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="sera_ProceedsFromIssuanceOfSharesAndPreFundedWarrants" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="sera_ProceedsFromIssuanceOfSharesAndPreFundedWarrantsNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="sera_PercentageOfMinimumOwnershipBeneficiallyOwnByHolderWithAffiliatesToWarrantExercise" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="sera_FairValueAdjustmentOfPreFundedWarrants" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="sera_CommonStockAdditionalShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="sera_OfferingExpenses" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="sera_ProceedsFromIssuanceInitialPublicOfferingNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:label="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://fasb.org/srt/role/srt-eedm/ExtensibleEnumerationLists">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="srt_ChiefExecutiveOfficerMember"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_ChiefExecutiveOfficerMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_FinanceLeaseLiabilityNoncurrent" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesAndOtherLiabilities" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_MarketableSecuritiesNoncurrent" order="2" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="2" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_CommitmentsAndContingencies" order="2" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="2" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_OtherReceivablesNetCurrent" order="2" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_FinanceLeaseLiabilityCurrent" order="2" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="3" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_MarketableSecuritiesCurrent" order="3" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent" order="3" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OtherAssetsNoncurrent" order="4" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="4" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="4" weight="1.0" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:label="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesNoncurrent" xlink:label="us-gaap_MarketableSecuritiesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="us-gaap_OtherReceivablesNetCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="us-gaap_MarketableSecuritiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails2">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="sera_LeaseLiabilityPaymentDue" xlink:to="sera_LeaseLiabilityUndiscountedExcessAmount" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="sera_LeaseLiabilitiesTotal" xlink:to="sera_LeaseLiabilityCurrent" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FinanceLeaseLiability" xlink:to="us-gaap_FinanceLeaseLiabilityCurrent" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="us-gaap_FinanceLeaseLiability" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="sera_LeaseLiabilityPaymentDue" xlink:to="sera_LeaseLiabilitiesTotal" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="sera_LeaseLiabilitiesTotal" xlink:to="sera_LeaseLiabilityNoncurrent" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_OperatingLeaseLiability" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FinanceLeaseLiability" xlink:to="us-gaap_FinanceLeaseLiabilityNoncurrent" order="1" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_LeaseLiabilityPaymentDue" xlink:label="sera_LeaseLiabilityPaymentDue"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_LeaseLiabilityUndiscountedExcessAmount" xlink:label="sera_LeaseLiabilityUndiscountedExcessAmount"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_LeaseLiabilitiesTotal" xlink:label="sera_LeaseLiabilitiesTotal"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_LeaseLiabilityCurrent" xlink:label="sera_LeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiability" xlink:label="us-gaap_FinanceLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_LeaseLiabilityNoncurrent" xlink:label="sera_LeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsDetails2">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsGrossExcludingGoodwill" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="1" weight="-1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://seraprognostics.com/20241231/taxonomy/role/StatementsofOperationsandComprehensiveLoss">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NonoperatingIncomeExpense" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingExpenses" order="0" weight="-1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_InterestExpense" order="1" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_NetIncomeLoss" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_SellingAndMarketingExpense" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="2" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss" order="3" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="sera_RevenueCost" order="3" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense" order="4" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="us-gaap_SellingAndMarketingExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_RevenueCost" xlink:label="sera_RevenueCost"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense" xlink:label="sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="0" weight="-1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_FinanceLeasePrincipalPayments" order="0" weight="-1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables" order="1" weight="-1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" order="1" weight="-1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="2" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_PaidInKindInterest" order="2" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" order="2" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="2" weight="-1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="3" weight="-1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" order="3" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" order="4" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets" order="4" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="5" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetIncomeLoss" order="6" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" order="7" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_OtherNoncashIncomeExpense" order="8" weight="-1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" order="9" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="sera_NoncashInvestmentIncomeExpenseNet" order="10" weight="-1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="11" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" order="12" weight="1.0" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeasePrincipalPayments" xlink:label="us-gaap_FinanceLeasePrincipalPayments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherReceivables" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:label="us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaidInKindInterest" xlink:label="us-gaap_PaidInKindInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="us-gaap_OtherNoncashIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_NoncashInvestmentIncomeExpenseNet" xlink:label="sera_NoncashInvestmentIncomeExpenseNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost" xlink:to="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax" order="0" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="sera_CashAndCashEquivalentsAmortizedCost" xlink:to="sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost" xlink:to="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="sera_CashAndCashEquivalentsAmortizedCost" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" order="1" weight="-1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost" xlink:to="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="sera_CashAndCashEquivalentsAmortizedCost" xlink:to="sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" order="2" weight="-1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" order="2" weight="1.0" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost" xlink:label="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CashAndCashEquivalentsAmortizedCost" xlink:label="sera_CashAndCashEquivalentsAmortizedCost"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue" xlink:label="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecuritiesAvailableforsaleDebtSecuritiesAndCashEquivalentsInUnrealizedLossPositionsDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" order="1" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" order="1" weight="1.0" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentScheduleOfComponentsOfPropertyAndEquipmentNetDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:to="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" order="0" weight="-1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:to="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" order="1" weight="1.0" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:label="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:label="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:label="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="1" weight="-1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfComponentsOfAccruedAndOtherCurrentLiabilitiesDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_AccruedSalariesCurrent" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_AccruedVacationCurrent" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_AccruedEmployeeBenefitsCurrent" order="2" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="3" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="4" weight="1.0" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:label="us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="us-gaap_AccruedSalariesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedVacationCurrent" xlink:label="us-gaap_AccruedVacationCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedEmployeeBenefitsCurrent" xlink:label="us-gaap_AccruedEmployeeBenefitsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureOtherIncomeNetScheduleOfComponentsOfOtherIncomeNetDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_InterestIncomeOther" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium" order="1" weight="1.0" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeOther" xlink:label="us-gaap_InterestIncomeOther"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium" xlink:label="us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://seraprognostics.com/20241231/taxonomy/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" order="1" weight="1.0" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://seraprognostics.com/20241231/taxonomy/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsDetails_1">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="sera_LeaseLiabilityPaymentDue" xlink:to="sera_LeaseLiabilitiesTotal" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="sera_LeaseLiabilityPaymentDue" xlink:to="sera_LeaseLiabilityUndiscountedExcessAmount" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="1" weight="1.0" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_LeaseLiabilityPaymentDue" xlink:label="sera_LeaseLiabilityPaymentDue"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_LeaseLiabilitiesTotal" xlink:label="sera_LeaseLiabilitiesTotal"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_LeaseLiabilityUndiscountedExcessAmount" xlink:label="sera_LeaseLiabilityUndiscountedExcessAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfUnrecognizedStockbasedCompensationExpenseForOutstandingUnvestedStockOptionsAndRsusDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" order="1" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeasesInFinancialStatementDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="sera_LeaseLiabilitiesTotal" xlink:to="us-gaap_FinanceLeaseLiabilityNoncurrent" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="sera_RightOfUseAssetTotal" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="sera_LeaseLiabilitiesTotal" xlink:to="us-gaap_FinanceLeaseLiabilityCurrent" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="sera_RightOfUseAssetTotal" xlink:to="us-gaap_FinanceLeaseRightOfUseAsset" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="sera_LeaseLiabilitiesTotal" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="2" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="sera_LeaseLiabilitiesTotal" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="3" weight="1.0" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_LeaseLiabilitiesTotal" xlink:label="sera_LeaseLiabilitiesTotal"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_RightOfUseAssetTotal" xlink:label="sera_RightOfUseAssetTotal"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="us-gaap_FinanceLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeaseCostAndOtherInformationDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_FinanceLeaseInterestExpense" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_OperatingLeaseCost" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_FinanceLeaseRightOfUseAssetAmortization" order="2" weight="1.0" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCost" xlink:label="us-gaap_LeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseInterestExpense" xlink:label="us-gaap_FinanceLeaseInterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:label="us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="sera_LeaseLiabilityPaymentDue" xlink:to="sera_LeaseLiabilityToBePaidYearOne" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="sera_LeaseLiabilityPaymentDue" xlink:to="sera_LeaseLiabilityToBePaidYearTwo" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="sera_FinanceLeaseLiabilityToBePaidYearThreeAndThereafter" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="sera_LeaseLiabilityPaymentDue" xlink:to="sera_LeaseLiabilityToBePaidYearThreeAndThereafter" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="sera_LesseeOperatingLeaseLiabilityToBePaidYearThreeAndThereafter" order="2" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_LeaseLiabilityPaymentDue" xlink:label="sera_LeaseLiabilityPaymentDue"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_LeaseLiabilityToBePaidYearOne" xlink:label="sera_LeaseLiabilityToBePaidYearOne"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_LeaseLiabilityToBePaidYearTwo" xlink:label="sera_LeaseLiabilityToBePaidYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_FinanceLeaseLiabilityToBePaidYearThreeAndThereafter" xlink:label="sera_FinanceLeaseLiabilityToBePaidYearThreeAndThereafter"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_LeaseLiabilityToBePaidYearThreeAndThereafter" xlink:label="sera_LeaseLiabilityToBePaidYearThreeAndThereafter"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_LesseeOperatingLeaseLiabilityToBePaidYearThreeAndThereafter" xlink:label="sera_LesseeOperatingLeaseLiabilityToBePaidYearThreeAndThereafter"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" order="0" weight="-1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" order="2" weight="1.0" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesEffectiveTaxRateReconciliationDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" order="0" weight="-1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationTaxCreditsResearch" order="0" weight="-1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="sera_EffectiveIncomeTaxRateReconciliationEquityBasedExpensesPercent" order="2" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments" order="2" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" order="3" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="3" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="4" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="4" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="sera_EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpPercent" order="5" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="sera_EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpAmount" order="5" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="6" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="sera_EffectiveIncomeTaxRateReconciliationEquityBasedExpensesAmount" order="6" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" order="7" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" order="7" weight="1.0" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:label="us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_EffectiveIncomeTaxRateReconciliationEquityBasedExpensesPercent" xlink:label="sera_EffectiveIncomeTaxRateReconciliationEquityBasedExpensesPercent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpPercent" xlink:label="sera_EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpPercent"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpAmount" xlink:label="sera_EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_EffectiveIncomeTaxRateReconciliationEquityBasedExpensesAmount" xlink:label="sera_EffectiveIncomeTaxRateReconciliationEquityBasedExpensesAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsNet" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="0" weight="-1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" order="1" weight="-1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsGross" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="sera_DeferredTaxAssetsLeaseLiabilities" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="sera_DeferredTaxLiabilitiesRightOfUseAssets" order="2" weight="-1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" order="2" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="3" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="4" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" order="5" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" order="6" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOther" order="7" weight="1.0" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_DeferredTaxAssetsLeaseLiabilities" xlink:label="sera_DeferredTaxAssetsLeaseLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_DeferredTaxLiabilitiesRightOfUseAssets" xlink:label="sera_DeferredTaxLiabilitiesRightOfUseAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:label="us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://seraprognostics.com/20241231/taxonomy/role/DisclosureSegmentInformationSummaryOfSegmentInformationForRevenueSignificantSegmentExpensesAndSegmentLossExpensesThatAreRegularlyProvidedT">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NonoperatingIncomeExpense" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_CostOfRevenue" order="0" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_InterestExpense" order="1" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OtherLaborRelatedExpenses" order="1" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="2" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_ProfessionalFees" order="3" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="sera_ClinicalStudiesAndOutsideProcessing" order="4" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="sera_EquipmentLabSuppliesAndFacilityExpenses" order="5" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_DepreciationAndAmortization" order="6" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_SegmentReportingOtherItemAmount" order="8" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_Revenues" order="9" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLaborRelatedExpenses" xlink:label="us-gaap_OtherLaborRelatedExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfessionalFees" xlink:label="us-gaap_ProfessionalFees"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_ClinicalStudiesAndOutsideProcessing" xlink:label="sera_ClinicalStudiesAndOutsideProcessing"/>
          <link:loc xlink:type="locator" xlink:href="sera-20241231.xsd#sera_EquipmentLabSuppliesAndFacilityExpenses" xlink:label="sera_EquipmentLabSuppliesAndFacilityExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingOtherItemAmount" xlink:label="us-gaap_SegmentReportingOtherItemAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues"/>
        </link:calculationLink>
      </link:linkbase>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="sera_CommitmentsAndContingenciesLineItems" name="CommitmentsAndContingenciesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sera_StockIssuedDuringPeriodSharesStockWarrantExpired" name="StockIssuedDuringPeriodSharesStockWarrantExpired" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="sera_RightOfUseAssetTotal" name="RightOfUseAssetTotal" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="sera_CommonStockConversionRatio" name="CommonStockConversionRatio" type="xbrli:pureItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="sera_EmergingGrowthCompanyStatusPolicyTextBlock" name="EmergingGrowthCompanyStatusPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="sera_LeaseLiabilityToBePaidYearOne" name="LeaseLiabilityToBePaidYearOne" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax" name="CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="sera_DomainNamesMember" name="DomainNamesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sera_CarelonResearchMember" name="CarelonResearchMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sera_FairValueAdjustmentOfPreFundedWarrants" name="FairValueAdjustmentOfPreFundedWarrants" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory" name="LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory" type="xbrli:decimalItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="sera_CommonStockWarrantAt9.03SharePriceMember" name="CommonStockWarrantAt9.03SharePriceMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sera_WarrantIssuedPricePerPre-FundedWarrantAndAccompanyingWarrant" name="WarrantIssuedPricePerPre-FundedWarrantAndAccompanyingWarrant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense" name="CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="sera_CapitalizedIntangibleAssets" name="CapitalizedIntangibleAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="sera_LaboratoryEquipmentMember" name="LaboratoryEquipmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sera_EffectiveIncomeTaxRateReconciliationEquityBasedExpensesAmount" name="EffectiveIncomeTaxRateReconciliationEquityBasedExpensesAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="sera_ProceedsFromIssuanceInitialPublicOfferingNet" name="ProceedsFromIssuanceInitialPublicOfferingNet" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="sera_PlanEspp2021Member" name="PlanEspp2021Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sera_CapitalSharesReservedForFutureIssuanceDomain" name="CapitalSharesReservedForFutureIssuanceDomain" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sera_ClassOfWarrantOrRightExercised" name="ClassOfWarrantOrRightExercised" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="sera_ClinicalStudiesAndOutsideProcessing" name="ClinicalStudiesAndOutsideProcessing" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="sera_TdCowenMember" name="TdCowenMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax" name="CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="sera_FinanceLeaseLiabilityToBePaidYearThreeAndThereafter" name="FinanceLeaseLiabilityToBePaidYearThreeAndThereafter" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="sera_LeaseLiabilityToBePaidYearThreeAndThereafter" name="LeaseLiabilityToBePaidYearThreeAndThereafter" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="sera_AtTheMarketOfferingMember" name="AtTheMarketOfferingMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sera_CommitmentsAndContingenciesTable" name="CommitmentsAndContingenciesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" name="CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="sera_CapitalSharesReservedForFutureIssuanceAxis" name="CapitalSharesReservedForFutureIssuanceAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember" name="CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sera_LeaseLiabilitiesTotal" name="LeaseLiabilitiesTotal" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="sera_EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpAmount" name="EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="sera_CommonStockWarrantAt10.84SharePriceMember" name="CommonStockWarrantAt10.84SharePriceMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sera_CurrentMarketableSecuritiesMember" name="CurrentMarketableSecuritiesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sera_DeferredTaxLiabilitiesRightOfUseAssets" name="DeferredTaxLiabilitiesRightOfUseAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="sera_ElevanceHealthIncMember" name="ElevanceHealthIncMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm" name="RelatedPartyTransactionCommercialCollaborationAgreementTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="sera_CommonStockWarrantAt1238SharePriceMember" name="CommonStockWarrantAt1238SharePriceMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sera_NonCurrentMarketableSecuritiesMember" name="NonCurrentMarketableSecuritiesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sera_DefinedContributionPlanEmployerMatchingContributionMatchingTierAxis" name="DefinedContributionPlanEmployerMatchingContributionMatchingTierAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sera_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" name="ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="sera_DefinedContributionPlanEmployerMatchingContributionFirstTierMember" name="DefinedContributionPlanEmployerMatchingContributionFirstTierMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sera_JohnJBonifaceMember" name="JohnJBonifaceMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sera_EffectiveIncomeTaxRateReconciliationEquityBasedExpensesPercent" name="EffectiveIncomeTaxRateReconciliationEquityBasedExpensesPercent" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember" name="CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sera_LeaseLiabilityNoncurrent" name="LeaseLiabilityNoncurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="sera_MasterServicesAgreementMember" name="MasterServicesAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sera_CommonStockAdditionalShares" name="CommonStockAdditionalShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="sera_OperatingLeasesOtherInformationAbstract" name="OperatingLeasesOtherInformationAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sera_RevenueCost" name="RevenueCost" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="sera_IssuanceOfStockToSettleAccruedAndOtherCurrentLiabilities" name="IssuanceOfStockToSettleAccruedAndOtherCurrentLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="sera_LeaseOtherInformationAbstract" name="LeaseOtherInformationAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sera_CommonStockWarrantAt520SharePriceMember" name="CommonStockWarrantAt520SharePriceMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost" name="CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="sera_LaboratoryServicesAgreementMember" name="LaboratoryServicesAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sera_PercentageOfMinimumOwnershipBeneficiallyOwnByHolderWithAffiliatesToWarrantExercise" name="PercentageOfMinimumOwnershipBeneficiallyOwnByHolderWithAffiliatesToWarrantExercise" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="sera_IndemnificationLiability" name="IndemnificationLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="sera_NumberOfVotesPerShare" name="NumberOfVotesPerShare" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="sera_ProceedsFromIssuanceOfSharesAndPreFundedWarrantsNet" name="ProceedsFromIssuanceOfSharesAndPreFundedWarrantsNet" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="sera_RelatedPartyTransactionOtherReceivablesRelatedToMinimumPayments" name="RelatedPartyTransactionOtherReceivablesRelatedToMinimumPayments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" name="CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="sera_EquipmentLabSuppliesAndFacilityExpenses" name="EquipmentLabSuppliesAndFacilityExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="sera_NoncashInvestmentIncomeExpenseNet" name="NoncashInvestmentIncomeExpenseNet" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="sera_LeaseLiabilityUndiscountedExcessAmount" name="LeaseLiabilityUndiscountedExcessAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="sera_DeferredTaxAssetsLeaseLiabilities" name="DeferredTaxAssetsLeaseLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="sera_CommonStockSharesConverted" name="CommonStockSharesConverted" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="sera_CommercialCollaborationAgreementMember" name="CommercialCollaborationAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sera_DefinedContributionPlanEmployerMatchingContributionMatchingTierDomain" name="DefinedContributionPlanEmployerMatchingContributionMatchingTierDomain" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue" name="CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="sera_ScheduleOfEstimatedUsefulLifeOfEachAssetCategoryTableTextBlock" name="ScheduleOfEstimatedUsefulLifeOfEachAssetCategoryTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="sera_FinanceLeasesOtherInformationAbstract" name="FinanceLeasesOtherInformationAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sera_OfferingExpenses" name="OfferingExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="sera_LeaseLiabilityToBePaidYearTwo" name="LeaseLiabilityToBePaidYearTwo" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="sera_Plan2021Member" name="Plan2021Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sera_CashAndCashEquivalentsAmortizedCost" name="CashAndCashEquivalentsAmortizedCost" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="sera_TwoThousandTwentyFourSalesAgreementMember" name="TwoThousandTwentyFourSalesAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sera_EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpPercent" name="EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpPercent" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="sera_RelatedPartyTransactionCashReceivedFromRelatedParty" name="RelatedPartyTransactionCashReceivedFromRelatedParty" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="sera_OfficeAndLaboratorySpaceMember" name="OfficeAndLaboratorySpaceMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sera_LeaseLiabilityCurrent" name="LeaseLiabilityCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="sera_Plan2011Member" name="Plan2011Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sera_LeaseLiabilityPaymentDueAbstract" name="LeaseLiabilityPaymentDueAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sera_DefinedContributionPlanEmployerMatchingContributionSecondTierMember" name="DefinedContributionPlanEmployerMatchingContributionSecondTierMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sera_IssuePricePerShareAndWarrant" name="IssuePricePerShareAndWarrant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="sera_CommonStockWarrantAt20.77SharePriceMember" name="CommonStockWarrantAt20.77SharePriceMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sera_NumberOfCommonStockClassesAuthorized" name="NumberOfCommonStockClassesAuthorized" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities" name="PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="sera_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock" name="ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="sera_AggregateOfferingPriceFromSaleOfCommonStock" name="AggregateOfferingPriceFromSaleOfCommonStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="sera_WarrantsIssued" name="WarrantsIssued" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="sera_WarrantsTextBlock" name="WarrantsTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="sera_OtherOfficersMember" name="OtherOfficersMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sera_LeaseLiabilitiesAbstract" name="LeaseLiabilitiesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sera_RightOfUseAssetAbstract" name="RightOfUseAssetAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sera_ProceedsFromIssuanceOfSharesAndPreFundedWarrants" name="ProceedsFromIssuanceOfSharesAndPreFundedWarrants" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="sera_LeaseLiabilityPaymentDue" name="LeaseLiabilityPaymentDue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="sera_LesseeOperatingLeaseLiabilityToBePaidYearThreeAndThereafter" name="LesseeOperatingLeaseLiabilityToBePaidYearThreeAndThereafter" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="sera_WarrantsToPurchaseCommonStockMember" name="WarrantsToPurchaseCommonStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="sera_StockIssuedDuringPeriodSharesStockWarrantExercised" name="StockIssuedDuringPeriodSharesStockWarrantExercised" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="sera_GrossSalesProceedsFromIssuanceOfCommonStock" name="GrossSalesProceedsFromIssuanceOfCommonStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="sera_AmountFromSaleOfCombinationOfSecuritiesUnderShelfRegistration" name="AmountFromSaleOfCombinationOfSecuritiesUnderShelfRegistration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Mar. 14, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40606<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">SERA PROGNOSTICS, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">26-1911522<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2749 East Parleys Way<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text"> Suite 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Salt Lake City<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">UT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">84109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">990-0520<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class A Common Stock, $0.0001 par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SERA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 183.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text"><p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:3pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Portions of the registrant&#8217;s definitive proxy statement relating to its </span><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2025 annual meeting of stockholders (the &#8220;Proxy Statement&#8221;) are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated. The Proxy Statement will be filed with the Securities and Exchange Commission within 120 days after the end of the registrant&#8217;s fiscal year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001534969<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Ernst & Young LLP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Salt Lake City, Utah<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorOpinionTextBlock', window );">Auditor Opinion</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Opinion on the Financial Statements</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have audited the accompanying balance sheets of Sera Prognostics, Inc. (the Company) as of December 31, 2024 and 2023, the related statements of operations and comprehensive loss, stockholders&#8217; equity and cash flows for each of the two years in the period ended December 31, 2024, and the related notes (collectively referred to as the &#8220;financial statements&#8221;). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2024 and 2023, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, in conformity with U.S. generally accepted accounting principles.</span></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,695,803<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">967,759<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorOpinionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X<br> -Number 210<br> -Section 2<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorOpinionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheets (unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 4,043<span></span>
</td>
<td class="nump">$ 3,880<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">42,193<span></span>
</td>
<td class="nump">45,199<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">34<span></span>
</td>
<td class="nump">160<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">11,310<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">1,311<span></span>
</td>
<td class="nump">795<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">47,600<span></span>
</td>
<td class="nump">61,344<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Property and equipment, net</a></td>
<td class="nump">1,239<span></span>
</td>
<td class="nump">1,999<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Long-term marketable securities</a></td>
<td class="nump">21,973<span></span>
</td>
<td class="nump">30,841<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">1,026<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">737<span></span>
</td>
<td class="nump">1,257<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">72,575<span></span>
</td>
<td class="nump">95,441<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,969<span></span>
</td>
<td class="nump">1,046<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities', window );">Accrued and other current liabilities</a></td>
<td class="nump">2,384<span></span>
</td>
<td class="nump">2,722<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance lease obligation, current portion</a></td>
<td class="nump">194<span></span>
</td>
<td class="nump">440<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">20,223<span></span>
</td>
<td class="nump">20,235<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">24,770<span></span>
</td>
<td class="nump">24,443<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease obligation, net of current portion</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">196<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease obligation, net of current portion</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">644<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">24,772<span></span>
</td>
<td class="nump">25,283<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.0001 par value; 150,000,000 Class A shares authorized; 33,206,909 and 30,736,513 Class A shares issued and outstanding as of December 31, 2024 and 2023, respectively; 1,500,000 Class B shares authorized; 967,759 and 1,405,259 Class B shares issued as of December 31, 2024 and 2023, respectively; 967,759 Class B shares outstanding as of December 31, 2024 and 2023.</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">327,534<span></span>
</td>
<td class="nump">317,066<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="nump">60<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(279,794)<span></span>
</td>
<td class="num">(246,896)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">47,803<span></span>
</td>
<td class="nump">70,158<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">$ 72,575<span></span>
</td>
<td class="nump">$ 95,441<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, price per share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">150,000,000<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">33,206,909<span></span>
</td>
<td class="nump">30,736,513<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">33,206,909<span></span>
</td>
<td class="nump">30,736,513<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, price per share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">1,500,000<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">967,759<span></span>
</td>
<td class="nump">1,405,259<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">967,759<span></span>
</td>
<td class="nump">967,759<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Statements of Operations and Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 77<span></span>
</td>
<td class="nump">$ 306<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense', window );">Cost of revenue</a></td>
<td class="nump">82<span></span>
</td>
<td class="nump">210<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">14,730<span></span>
</td>
<td class="nump">15,225<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Selling and marketing</a></td>
<td class="nump">5,771<span></span>
</td>
<td class="nump">8,349<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">16,129<span></span>
</td>
<td class="nump">16,343<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">36,712<span></span>
</td>
<td class="nump">40,127<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(36,635)<span></span>
</td>
<td class="num">(39,821)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(28)<span></span>
</td>
<td class="num">(55)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">3,765<span></span>
</td>
<td class="nump">3,634<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (32,898)<span></span>
</td>
<td class="num">$ (36,242)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share, basic</a></td>
<td class="num">$ (0.99)<span></span>
</td>
<td class="num">$ (1.16)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share, diluted</a></td>
<td class="num">$ (0.99)<span></span>
</td>
<td class="num">$ (1.16)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average shares outstanding, basic</a></td>
<td class="nump">33,156,936<span></span>
</td>
<td class="nump">31,200,652<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares outstanding, diluted</a></td>
<td class="nump">33,156,936<span></span>
</td>
<td class="nump">31,200,652<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized gain on available-for-sale debt securities, net of tax</a></td>
<td class="nump">$ 75<span></span>
</td>
<td class="nump">$ 966<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income</a></td>
<td class="nump">75<span></span>
</td>
<td class="nump">966<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (32,823)<span></span>
</td>
<td class="num">$ (35,276)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost Of Revenue, Excluding Selling, Marketing, General And Administrative Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-4<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482739/220-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Statements of Stockholders' Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock (Class A and B)</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive (Loss) Income</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at the beginning (in shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,017,946<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Dec. 31, 2022</a></td>
<td class="nump">$ 98,943<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 310,575<span></span>
</td>
<td class="num">$ (981)<span></span>
</td>
<td class="num">$ (210,654)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">593,091<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options</a></td>
<td class="nump">1,095<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,095<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock under employee stock purchase plan</a></td>
<td class="nump">123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock under employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">5,273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income</a></td>
<td class="nump">966<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">966<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(36,242)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(36,242)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at the ending (in shares) at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,704,272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the ending at Dec. 31, 2023</a></td>
<td class="nump">$ 70,158<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">317,066<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="num">(246,896)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options (in shares)</a></td>
<td class="nump">1,102,513<span></span>
</td>
<td class="nump">1,102,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options</a></td>
<td class="nump">$ 2,902<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,902<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,257,345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock under employee stock purchase plan</a></td>
<td class="nump">$ 147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock under employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,740<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_StockIssuedDuringPeriodSharesStockWarrantExercised', window );">Common stock warrant exercises (in shares)</a></td>
<td class="nump">7,971<span></span>
</td>
<td class="nump">7,971<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Other issuance of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,827<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Other issuance of common stock</a></td>
<td class="nump">$ 406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">7,013<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,013<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income</a></td>
<td class="nump">75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(32,898)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(32,898)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at the ending (in shares) at Dec. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,174,668<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the ending at Dec. 31, 2024</a></td>
<td class="nump">$ 47,803<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 327,534<span></span>
</td>
<td class="nump">$ 60<span></span>
</td>
<td class="num">$ (279,794)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_StockIssuedDuringPeriodSharesStockWarrantExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Stock Warrant Exercised</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_StockIssuedDuringPeriodSharesStockWarrantExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-4<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482739/220-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (32,898)<span></span>
</td>
<td class="num">$ (36,242)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">833<span></span>
</td>
<td class="nump">900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">7,013<span></span>
</td>
<td class="nump">5,273<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Non-cash lease expense</a></td>
<td class="nump">567<span></span>
</td>
<td class="nump">526<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_NoncashInvestmentIncomeExpenseNet', window );">Non-cash investment income, net</a></td>
<td class="num">(910)<span></span>
</td>
<td class="num">(1,182)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other</a></td>
<td class="num">(69)<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">126<span></span>
</td>
<td class="num">(47)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherReceivables', window );">Other receivables</a></td>
<td class="nump">11,291<span></span>
</td>
<td class="num">(5,310)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="num">(10)<span></span>
</td>
<td class="nump">465<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">455<span></span>
</td>
<td class="num">(442)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities', window );">Accrued and other current liabilities</a></td>
<td class="num">(575)<span></span>
</td>
<td class="num">(2,301)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="num">(12)<span></span>
</td>
<td class="nump">11,154<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(14,189)<span></span>
</td>
<td class="num">(27,188)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt', window );">Purchases of marketable securities</a></td>
<td class="num">(35,831)<span></span>
</td>
<td class="num">(54,143)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Proceeds from maturities and sales of marketable securities</a></td>
<td class="nump">48,675<span></span>
</td>
<td class="nump">54,398<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(56)<span></span>
</td>
<td class="num">(128)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from disposal of property and equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">311<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Purchases of intangible assets</a></td>
<td class="num">(1,045)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by investing activities</a></td>
<td class="nump">11,743<span></span>
</td>
<td class="nump">438<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">2,902<span></span>
</td>
<td class="nump">1,095<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans', window );">Proceeds from employee stock purchase plan</a></td>
<td class="nump">147<span></span>
</td>
<td class="nump">123<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Finance lease principal payments</a></td>
<td class="num">(440)<span></span>
</td>
<td class="num">(466)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">2,609<span></span>
</td>
<td class="nump">752<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Net increase (decrease) in cash and cash equivalents</a></td>
<td class="nump">163<span></span>
</td>
<td class="num">(25,998)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">3,880<span></span>
</td>
<td class="nump">29,878<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">4,043<span></span>
</td>
<td class="nump">3,880<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">55<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental disclosure of non-cash investing and financing information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_IssuanceOfStockToSettleAccruedAndOtherCurrentLiabilities', window );">Issuance of stock to settle accrued and other current liabilities</a></td>
<td class="nump">406<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities', window );">Purchases of property and equipment in accounts payable and accrued and other current liabilities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_IssuanceOfStockToSettleAccruedAndOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of stock to settle accrued and other current liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_IssuanceOfStockToSettleAccruedAndOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_NoncashInvestmentIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncash Investment Income Expense Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_NoncashInvestmentIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of Purchases of property and equipment included in accounts payable or accrued expenses that were incurred during a noncash or partial noncash transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in accrued expenses, and obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478345/912-310-45-11<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in receivables classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-11<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Excludes option exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">$ (32,898)<span></span>
</td>
<td class="num">$ (36,242)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements - Other Officers<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=sera_OtherOfficersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=sera_OtherOfficersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cybersecurity Risk Management, Strategy, and Governance Disclosure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems', window );"><strong>Cybersecurity Risk Management, Strategy, and Governance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock', window );">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</a></td>
<td class="text"><p id="item_1c_cybersecurity" style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 1</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">C. Cybersecurity</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cybersecurity</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We recognize the critical importance of maintaining the trust and confidence of stakeholders toward our business and are committed to protecting the confidentiality, integrity, and availability of our business operations and systems. Our board of directors is actively involved in oversight of our risk management activities, and cybersecurity represents an important element of our overall approach to risk management. Our cybersecurity policies, standards, processes, and practices are based on recognized frameworks established by the National Institute of Standards and Technology, or NIST, and other applicable industry standards. In general, we seek to address cybersecurity risks through a comprehensive approach that is focused on preserving the confidentiality, security, and availability of the information that we collect and store by monitoring, identifying, preventing, and mitigating cybersecurity threats and effectively responding to cybersecurity incidents when they occur.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cybersecurity Risk Management and Strategy; Effect of Risk</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Like all companies w</span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">e face risks related to cybersecurity such as unauthorized access, cybersecurity attacks and other security incidents, loss of data, and misappropriation of confidential information. To identify and assess material risks from cybersecurity threats, we maintain a comprehensive cybersecurity program to ensure our systems are effective and prepared for information security risks, including regular oversight of our programs for security monitoring for internal and external threats to ensure the confidentiality and</span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> integrity of our information assets.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We consider risks from cybersecurity threats alongside other company risks as part of our overall risk assessment process. We employ a range of tools and services, including third-party real-time risk assessments of cyber assets and mitigation of security risks, data loss prevention, regular air-gapped backups, continuous monitoring and threat response, next generation firewall systems, and security information and event management.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> As discussed in more detail under &#8220;Cybersecurity Governance&#8221; below, our audit committee provides oversight of our cybersecurity risk management and strategy processes, which are led by our Chief Information Officer.</span></span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We also identify our cybersecurity threat risks by comparing our processes to standards set by NIST. To provide for the availability of critical data and systems, maintain regulatory compliance, manage our material risks from cybersecurity threats, and protect against and respond to cybersecurity incidents, we undertake the following activities:</span></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">monitor emerging data protection best practices and laws and implement changes to our processes that are designed to comply with such;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">annual HIPAA security and privacy risk assessments performed with third party provider, as well as annual HIPAA compliance audits;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">through our policies, practices and contracts (as applicable), require employees, as well as third parties that provide services on our behalf, to treat confidential information and data with care, and to maintain applicable compliance standards;</span></span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">employ technical safeguards that are designed to protect our information systems from cybersecurity threats, including next generation firewall systems, endpoint detection and response, data loss prevention, regular air-gapped backups, and security information and event management, which are evaluated and improved through third-party real-time risk assessments and mitigation of security risks</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">provide regular, mandatory training for our employees and contractors regarding cybersecurity threats as a means to equip them with effective tools, information and education to recognize and address cybersecurity threats;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">conduct regular phishing email simulations for all employees and contractors with access to our email systems to enhance awareness and responsiveness to possible threats;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">leverage the NIST incident handling framework to help us identify, protect, detect, respond and recover when there is an actual or potential cybersecurity incident;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">carry and maintain information security risk insurance that provides protection against the potential losses arising from a cybersecurity incident; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">document internal policies and procedures for cybersecurity incident response and recovery.</span></div></div><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our incident response plan coordinates the activities we take to prepare for, detect, respond to, and recover from cybersecurity incidents, which include processes to prepare for the incident, while complying with potentially applicable legal obligations and mitigate damage to our business and reputation.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our policies and processes also address cybersecurity threat risks associated with our use of third-party service providers. In addition, cybersecurity considerations affect the selection and oversight of our third-party service providers. We perform due diligence on third parties that have access to our data to ensure they have adequate cybersecurity safeguards in place and continually monitor cybersecurity threat risks identified through such due diligence.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We describe whether and how risks from identified cybersecurity threats, including as a result of any previous cybersecurity incidents, have materially affected or are reasonably likely to materially affect us, including our business strategy, results of operations, or financial condition</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, under the heading &#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Security breaches, losses of data, and other disruptions could compromise </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">sensitive</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> information related to our business or prevent us from accessing critical information and expose us to liability, which could adversely affect our business and reputation</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">,&#8221; which disclosures are incorporated by reference herein.</span></p></div><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cybersecurity Governance; Management</span></p><div style="font-size:10pt;font-family:Times New Roman;"><div><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cybersecurity is an important part of our risk management processes and an area of focus for our board of directors and management. The audit committee of our board of directors is responsible for the oversight of risks from cybersecurity threats.</span></p></div><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At least annually, our audit committee receives an update from management of our cybersecurity threat risk management and strategy processes covering topics such as data security, results from third-party assessments, our incident response plan, and material cybersecurity threat risks or incidents and developments, as well as the steps management has taken to respond to such risks.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> In such sessions, our audit committee generally receives materials that include a cybersecurity scorecard and other materials discussing current and emerging material cybersecurity threat risks, and describing our ability to mitigate those risks, as well as recent developments, evolving standards, and information security considerations arising with respect to our peers and third parties. The audit committee discusses such matters with our Chief Information Officer.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our cybersecurity risk management and strategy processes, which are discussed in greater detail above, are led by our Chief Information Officer and the information technology team.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Such individuals have extensive experience in various roles, including in other publicly traded companies, involving managing information security, developing cybersecurity strategy, and implementing effective information and cybersecurity programs.</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These management team members monitor the prevention, mitigation, detection, and remediation of cybersecurity incidents through their management of the cybersecurity risk management and strategy processes described above, including the operation of our incident response plan.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As discussed above, these management team members report to the audit committee of our board of directors about cybersecurity threat risks, among other cybersecurity related matters, at least annually.</span></span></p></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag', window );">Cybersecurity Risk Management Processes Integrated [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock', window );">Cybersecurity Risk Management Processes Integrated [Text Block]</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">e face risks related to cybersecurity such as unauthorized access, cybersecurity attacks and other security incidents, loss of data, and misappropriation of confidential information. To identify and assess material risks from cybersecurity threats, we maintain a comprehensive cybersecurity program to ensure our systems are effective and prepared for information security risks, including regular oversight of our programs for security monitoring for internal and external threats to ensure the confidentiality and</span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> integrity of our information assets.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We consider risks from cybersecurity threats alongside other company risks as part of our overall risk assessment process. We employ a range of tools and services, including third-party real-time risk assessments of cyber assets and mitigation of security risks, data loss prevention, regular air-gapped backups, continuous monitoring and threat response, next generation firewall systems, and security information and event management.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> As discussed in more detail under &#8220;Cybersecurity Governance&#8221; below, our audit committee provides oversight of our cybersecurity risk management and strategy processes, which are led by our Chief Information Officer.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag', window );">Cybersecurity Risk Management Third Party Engaged [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag', window );">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag', window );">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock', window );">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We describe whether and how risks from identified cybersecurity threats, including as a result of any previous cybersecurity incidents, have materially affected or are reasonably likely to materially affect us, including our business strategy, results of operations, or financial condition</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, under the heading &#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Security breaches, losses of data, and other disruptions could compromise </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">sensitive</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> information related to our business or prevent us from accessing critical information and expose us to liability, which could adversely affect our business and reputation</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">,&#8221; which disclosures are incorporated by reference herein.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock', window );">Cybersecurity Risk Board of Directors Oversight [Text Block]</a></td>
<td class="text"><div><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cybersecurity is an important part of our risk management processes and an area of focus for our board of directors and management. The audit committee of our board of directors is responsible for the oversight of risks from cybersecurity threats.</span></p></div><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At least annually, our audit committee receives an update from management of our cybersecurity threat risk management and strategy processes covering topics such as data security, results from third-party assessments, our incident response plan, and material cybersecurity threat risks or incidents and developments, as well as the steps management has taken to respond to such risks.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> In such sessions, our audit committee generally receives materials that include a cybersecurity scorecard and other materials discussing current and emerging material cybersecurity threat risks, and describing our ability to mitigate those risks, as well as recent developments, evolving standards, and information security considerations arising with respect to our peers and third parties. The audit committee discusses such matters with our Chief Information Officer.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cybersecurity is an important part of our risk management processes and an area of focus for our board of directors and management. The audit committee of our board of directors is responsible for the oversight of risks from cybersecurity threats.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At least annually, our audit committee receives an update from management of our cybersecurity threat risk management and strategy processes covering topics such as data security, results from third-party assessments, our incident response plan, and material cybersecurity threat risks or incidents and developments, as well as the steps management has taken to respond to such risks.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskRoleOfManagementTextBlock', window );">Cybersecurity Risk Role of Management [Text Block]</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our cybersecurity risk management and strategy processes, which are discussed in greater detail above, are led by our Chief Information Officer and the information technology team.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Such individuals have extensive experience in various roles, including in other publicly traded companies, involving managing information security, developing cybersecurity strategy, and implementing effective information and cybersecurity programs.</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These management team members monitor the prevention, mitigation, detection, and remediation of cybersecurity incidents through their management of the cybersecurity risk management and strategy processes described above, including the operation of our incident response plan.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As discussed above, these management team members report to the audit committee of our board of directors about cybersecurity threat risks, among other cybersecurity related matters, at least annually.</span></span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Management Positions or Committees Responsible [Text Block]</a></td>
<td class="text"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our cybersecurity risk management and strategy processes, which are discussed in greater detail above, are led by our Chief Information Officer and the information technology team.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Such individuals have extensive experience in various roles, including in other publicly traded companies, involving managing information security, developing cybersecurity strategy, and implementing effective information and cybersecurity programs.</span></span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock', window );">Cybersecurity Risk Management Expertise of Management Responsible [Text Block]</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Such individuals have extensive experience in various roles, including in other publicly traded companies, involving managing information security, developing cybersecurity strategy, and implementing effective information and cybersecurity programs.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These management team members monitor the prevention, mitigation, detection, and remediation of cybersecurity incidents through their management of the cybersecurity risk management and strategy processes described above, including the operation of our incident response plan.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementThirdPartyEngagedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskRoleOfManagementTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskRoleOfManagementTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business and Financial Condition<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Description of Business and Financial Condition</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Description of Business and Financial Condition</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Sera Prognostics, Inc. (the &#8220;Company&#8221;) is a women&#8217;s health company utilizing its proprietary proteomics and bioinformatics platform, and significant data resources, to improve maternal and neonatal health by discovering, developing and commercializing blood-based biomarker tests and predictive analytic products and services. Our vision is to deliver pivotal and actionable information to pregnant women, their physicians, and health care payers to significantly enhance a mother's pregnancy journey, improve maternal and neonatal health, and reduce health care costs. We believe that our method of combining the disciplines of proteomics and bioinformatics with rigorous clinical testing, data, and economic analysis enables us to provide physicians and expectant mothers with personally insightful, clinically meaningful, and economically impactful information designed to improve the pregnancy experience and outcomes for mothers and babies.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company was incorporated in the State of Delaware on January 17, 2008 and its operations are located in Salt Lake City, Utah, including a Clinical Laboratory Improvement Amendments, or CLIA, certified laboratory. Since its inception, the Company&#8217;s activities have consisted of performing research and development, conducting clinical studies for its pipeline products and services, acquiring product rights, raising capital, establishing facilities, and organizing commercial operations to market the PreTRM test.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Liquidity and Capital Resources</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has incurred net losses and negative cash flows from operations since inception and had an accumulated deficit of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">279.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> as of December 31, 2024. The Company&#8217;s management expects the Company to incur significant additional operating losses and negative cash flows for the foreseeable future, principally as a result of the Company&#8217;s activities relating to the PreTRM test and the Company&#8217;s other pipeline products and services, including clinical and preclinical trials and anticipated research and development activities as well as commercialization activities. There can be no assurance that the Company will eventually achieve significant revenues or profitability to sustain operations, or if achieved, can sustain either on a continuing basis. If the Company is unable to achieve significant revenues or raise additional funds, when needed, it may not be able to continue the development or commercialization of its products and services and could be required to delay, scale back, or abandon some or all of its operations. No assurance can be given that the Company will be successful in raising the required capital on reasonable terms and at the required times, or at all.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In August 2024, the Company filed a universal shelf registration on Form S-3 with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;), which was declared effective on August 13, 2024 (the &#8220;2024 Form S-3&#8221;), pursuant to which the Company registered for sale up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of any combination of Class A common stock, par value $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share ("Class A common stock"), preferred stock, debt securities, warrants, rights and/or units from time to time and at prices and on terms that the Company may determine.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In August 2024, the Company entered into a sales agreement with TD Securities (USA) LLC (&#8220;TD Cowen&#8221;) with respect to an at-the-market offering program under which the Company may offer and sell, from time to time at the Company&#8217;s sole discretion, shares of Class A common stock having an aggregate offering price of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million (the &#8220;2024 Sales Agreement&#8221;). As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company has </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t sold any shares of Class A common stock under the 2024 Sales Agreement.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any additional equity financing, if available to the Company, may not be available on favorable terms and may be dilutive to current stockholders, and any debt financing, if available, may involve restrictive covenants and dilutive financing instruments. The Company&#8217;s future operations are highly dependent on a combination of factors, including (i) the commercialization and market acceptance of the PreTRM test and the successful development, commercial launch, marketing, and distribution of other pipeline products and services; (ii) the success of scientific and clinical studies and other research and development programs that support current and future products and services; (iii) the development of competitive products by other biotechnology and laboratory companies; (iv) the Company&#8217;s ability to manage growth of the organization; (v) the Company&#8217;s ability to protect its intellectual property, technology, and products; and, ultimately (vi) the timely and successful completion of any additional financing.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The principal sources of the Company&#8217;s working capital to date have been the proceeds from the sale and issuance of convertible preferred stock and convertible notes, bank loans, and the sale and issuance of Class A common stock in an initial public offering (&#8220;IPO&#8221;), which was completed in July 2021. As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company had aggregate cash, cash equivalents, and available-for-sale securities of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">68.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. See Note 3&#8212;Cash, Cash Equivalents and Marketable Securities.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company evaluated that its existing financial resources are sufficient to continue operating activities at least 12 months from the issuance date of these financial statements.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/810/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Significant Accounting Policies</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Basis of Presentation</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;). Any reference in these notes to applicable accounting guidance is meant to refer to the authoritative U.S. GAAP included in the Accounting Standards Codification (&#8220;ASC&#8221;), and Accounting Standards Updates (&#8220;ASU&#8221;) issued by the Financial Accounting Standards Board (&#8220;FASB&#8221;).</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The preparation of the financial statements in conformity with U.S. GAAP requires the Company&#8217;s management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The Company evaluates these estimates on an ongoing basis. The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that the Company believes are reasonable under the circumstances, including assumptions as to future events. Actual results could differ materially from those estimates.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s financial statements as of and for the year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> reflect the Company&#8217;s estimates of the impact of the current macroeconomic environment, including the impact of inflation and higher interest rates. The extent to which these conditions will directly or indirectly impact the Company&#8217;s business, results of operations, and financial condition is uncertain. The Company is not aware of any specific event or circumstance that would require an update to its estimates, judgments, and assumptions or a revision of the carrying value of the Company&#8217;s assets or liabilities as of the date of this filing.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cash and cash equivalents</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company considers all highly liquid financial instruments with maturities of 90 days or less at the date of purchase to be cash equivalents. The carrying amounts reported in the balance sheets for cash and cash equivalents are valued at cost, which approximates their fair value. As of December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, cash and cash equivalents consisted of cash and money market funds. Cash and cash equivalents are stated at fair value.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Marketable Securities</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has classified its marketable securities, all of which are debt securities, as available-for-sale securities. These securities are carried at estimated fair value. Available-for-sale debt securities with an estimated fair value below the amortized cost basis are assessed to determine what amount of that difference, if any, is attributable to expected credit losses. An allowance for credit losses on available-for-sale debt securities is recognized as a charge in other income, net on the Company&#8217;s statements of operations and comprehensive loss, and any remaining unrealized losses, net of the related tax effect, are included in accumulated other comprehensive loss in stockholders&#8217; equity until realized. Gains and losses on marketable security transactions are reported on the specific-identification method.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p></div><div><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Concentration of credit risk</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and marketable securities. The Company maintains bank deposits in accounts at federally insured financial institutions and these deposits may exceed federally insured limits. The Company is exposed to credit risk in the event of default by the financial institution holding its cash to the extent recorded in the balance sheet. The Company has not experienced any losses on its deposits of cash. The Company&#8217;s cash equivalents consist of money market funds and investment grade commercial paper. Marketable securities consist of investments in U.S. government securities, U.S. federal</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">agency securities, investment grade commercial paper, and investment grade corporate securities. The Company&#8217;s investment portfolio in corporate debt securities is highly liquid and diversified among individual issuers. The Company did not experience any credit losses related to its investment portfolio for the years ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p></div><div><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Property and Equipment</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Property and equipment are recorded at cost less accumulated depreciation and amortization. Depreciation and amortization are computed using the straight-line method over the shorter of estimated useful lives of the assets or the respective lease term.</span><span style="font-size:12pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The estimated useful life of each asset category is as follows:</span></span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
        <table style="border-spacing:0;table-layout:auto;width:98.0%;border-collapse:separate;">
         <tr style="visibility:collapse;">
          <td style="width:50.46%;box-sizing:content-box;"></td>
          <td style="width:49.54%;box-sizing:content-box;"></td>
         </tr>
         <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Computer equipment</span></p></td>
          <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Software</span></p></td>
          <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Machinery and equipment</span></p></td>
          <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Furniture and fixtures</span></p></td>
          <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Leasehold improvements</span></p></td>
          <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shorter of useful life or remaining lease term</span></p></td>
         </tr>
        </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Amortization expense of assets acquired through finance leases is included in depreciation and amortization expense in the accompanying statements of operations and comprehensive loss. Costs of repairs and maintenance that do not extend the useful life or improve the related assets are expensed as incurred. Costs of major replacements or improvements are capitalized. When assets are sold, or otherwise disposed of, the cost and related accumulated depreciation are removed from the accounts and any gain or loss is included in operating expense.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Leases</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s operating lease relates to office and laboratory space at its headquarters. The Company&#8217;s finance leases are for certain equipment related to the Company&#8217;s information technology infrastructure and laboratory operations. The Company determines if an arrangement is a lease at inception. The Company has elected not to separate lease components from non-lease components for all classes of leased assets except for building leases.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company elected to treat leases with lease terms of 12 months or less as short-term leases. No right-of-use assets or lease liabilities are recognized for short-term leases. For leases with a lease term greater than 12 months, right-of-use assets and lease liabilities are recognized on the balance sheets at the commencement date based on the present value of the remaining lease payments and includes only payments that are fixed and determinable at commencement. The Company&#8217;s lease terms may include options to extend or terminate when it is reasonably certain that the Company will exercise such options.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To date, the rates implicit in the Company&#8217;s finance leases have been determinable, and the Company uses those rates to calculate the present value of its finance lease liabilities. The implicit rate in the Company&#8217;s operating lease is not readily determinable. As such, the Company uses its incremental borrowing rate to calculate the present value of its operating lease liabilities.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Operating lease costs are recognized on a straight-line basis over the lease terms. Finance lease assets are amortized on a straight-line basis over the shorter of the estimated useful lives of the assets or the lease terms.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Deferred Revenue</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recognizes deferred revenue in accordance with ASC 606, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue from Contracts with Customers</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (&#8220;ASC 606&#8221;). Deferred revenue is recognized when a customer pays consideration, or the Company has a right to an amount of consideration that is unconditional before the Company transfers the good or service to the customer. The Company&#8217;s deferred revenue balance as of December 31, 2024 and 2023 relates to certain contractual minimum payments received by the Company as part of its commercial collaboration agreements. Deferred revenue is recognized as revenue when the Company delivers PreTRM test results to customers pursuant to its commercial collaboration agreements. The Company assesses its deferred revenue balance for current versus long-term classification based on expectations and the ability to meet performance obligations. As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company believes it has the ability and capacity to meet all performance obligations under its commercial collaboration agreements and has concluded to classify its deferred revenue as a current asset.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue Recognition</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Revenue is generated from the sale of PreTRM tests. The Company recognizes revenue based on accounting standards applied to determine the measurement of revenue and timing of when it is recognized. The Company applies the following five-step approach as set forth under ASC 606: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the Company satisfies a performance obligation. The Company applies the five-step model when it is probable that the Company will collect the consideration it is entitled to in exchange for fulfilling its performance obligation. The Company recognizes revenue upon delivery of test results, which it considers to be the only performance obligation, and allocates all of the transaction price to this performance obligation.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In determining the transaction price, which is an estimate of the amount of variable consideration expected to be received, the Company uses the expected value method under ASC 606. The Company considers all reasonably available information to identify various possible consideration amounts and considers the probability of the variable consideration for each scenario. The Company&#8217;s estimate of transaction price does not include any estimated amount of variable consideration that is constrained.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant judgments are required in determining the estimates for each transaction. These estimates include many assumptions, any of which, if incorrect, could result in significant differences between the estimated price and the amount ultimately collected for any given transaction. The Company applies this method consistently to portfolios of similar contracts when estimating the effect of any uncertainty on the amount of variable consideration to which it will be entitled. In the aggregate, across the numerous transactions within each portfolio, these differences can lead to material variances between estimated and actual revenue in any given period.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The estimate of revenue is necessarily founded on assumptions of payer behavior such as changes in payer mix, payer collections, current customer contractual requirements, and experience with ultimate collection from third-party payers and patients. Each of these aspects of payer behavior (and various others) can change significantly from period to period, and the Company currently has limited experience with historical payment patterns. Each of these contributes to the potential variability between estimated transaction price and actual consideration received as discussed above, which is expected to be more pronounced early in the process of commercializing a diagnostic test.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company makes its best efforts to continually refine its estimates of expected consideration as the Company gains additional experience with collections and historical payment patterns. Accordingly, the Company may update its estimate of the amount of revenue to be recognized for previously delivered tests.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cost of Revenue</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cost of revenue reflects the aggregate costs incurred in delivering the proteomic testing results to clinicians and includes expenses for third-party specimen collection and shipping costs, as well as the Company&#8217;s lab personnel, materials and supplies, equipment and infrastructure expenses associated with clinical testing, and allocated overhead including rent and equipment depreciation. Costs associated with performing the Company&#8217;s tests are recorded as the tests are processed regardless of whether and when revenue is recognized with respect to such tests.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Research and Development Expenses</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company expenses all research and development costs as they are incurred. Research and development expenses consist primarily of personnel costs, stock-based compensation charges, clinical trial costs, and third-party contracted services associated with research and development. The Company recognizes expense associated with third-party contracted services based on the completion of activities as specified in the applicable contracts. Costs incurred under contracts with clinical sites are generally accrued as patient encounters occur, consistent with the terms outlined in the associated contract. Upon termination of contracts with third parties, the Company&#8217;s obligations are limited to costs incurred or committed to date. As a result, accrued research and development expenses represent the estimated contractual liability to third parties at the reported period.</span></p></div><div><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock-based Compensation</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recognizes stock-based compensation for all stock-based awards in accordance with ASC 718, C</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">ompensation-Stock Compensation</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, which requires an entity to measure the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair value of restricted stock units granted under the Company&#8217;s equity incentive plans is measured based on the grant-date fair value of the Company&#8217;s Class A common stock.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair value of stock options granted under the Company&#8217;s equity incentive plans is estimated using the Black-Scholes option pricing model. Input assumptions used in calculating the fair value of stock options represent management&#8217;s estimates and involve inherent uncertainties and the application of management&#8217;s judgment. These input assumptions include the expected term of the awards, the expected common stock price volatility over the term of the awards, risk-free interest rates, and the expected dividend yield.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair value of the Company&#8217;s Class A common stock is determined by using the closing price per share of the Company&#8217;s Class A common stock as reported on Nasdaq. The Company uses the simplified calculation of expected life since the Company does not have sufficient historical exercise data to estimate the expected term. Volatility is based on an average of the historical volatility of the Company&#8217;s common stock and the volatilities of the common stock of select comparable publicly-traded entities with characteristics similar to those of the Company. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods corresponding with the expected life of the option. Forfeitures are estimated at the time of grant based on the Company&#8217;s historical experience and are adjusted as necessary.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair value of equity awards is recognized as compensation cost on a straight-line basis by the Company over the participant&#8217;s requisite service period, which is the award&#8217;s vesting period. All stock-based compensation costs are classified in the statements of operations and comprehensive loss based upon the underlying participant&#8217;s role within the Company.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recognizes deferred tax assets to the extent that it believes these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If the Company determines that it would be able to realize its deferred tax assets in the future in excess of their net recorded amount, the Company would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company records uncertain tax positions in accordance with ASC 740 on the basis of a two-step process whereby (1) it determines whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, it recognizes the largest amount of tax benefit that is more than 50 percent likely to be realized upon ultimate settlement with the related tax authority.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recognizes interest and penalties related to unrecognized tax benefits within the income tax expense line in the accompanying statements of operations and comprehensive loss. Any accrued interest and penalties related to uncertain tax positions will be reflected as a liability in the balance sheets.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Retirement Savings Plan</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company sponsors a safe harbor 401(k) plan that covers all of the Company&#8217;s eligible employees. The plan allows employees to make contributions up to a specified percentage of their compensation, subject to statutory limitations. The Company makes safe harbor matching contributions equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the first </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of a plan participant&#8217;s eligible compensation, plus </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the next </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of a plan participant&#8217;s eligible compensation. The Company may also make an additional discretionary match or profit sharing contribution to the plan. The Company recorded expense related to its 401(k) plan of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for the years ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Segments</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company operates as </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">one</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> operating segment, which is developing and commercializing its medical diagnostic products and services. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s Chief Operating Decision Maker ("CODM"), its </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_78f058f5-e77e-4f42-8f14-9e5f77a00420;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">chief executive officer</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, assesses performance for the Company&#8217;s one operating segment and allocates resources based on net loss, consistent with what is reported on the statements of operations and comprehensive loss. The CODM also assesses the performance of the Company&#8217;s one operating segment by using operating expenses to monitor budget versus actual results.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Improvements to Reportable Segments Disclosures</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, which updates reportable segment disclosure requirements primarily through enhanced disclosures about significant segment expenses. While ASU 2023-07 requires incremental disclosures, it does not change how an entity identifies its operating segments, aggregates those operating segments, or applies the quantitative thresholds to determine reportable segments. This ASU is effective for all public business entities for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Entities must adopt the changes to the segment reporting guidance on a retrospective basis. The Company </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">adopted</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> this standard effective </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">January 1, 2024</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and retrospectively to all prior periods. The adoption impacted the Company's disclosures and did </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">not</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> impact the financial statements. See Note </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">16 &#8212; Segment Information</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, for disclosures related to the Company&#8217;s single operating segment.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Comprehensive Loss</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Comprehensive loss consists of net loss and other gains and losses affecting stockholders&#8217; equity that, under U.S. GAAP, are excluded from net loss. For the years ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, comprehensive loss includes unrealized gains (losses) on the Company&#8217;s available-for-sale debt securities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Net Loss per Share</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basic net loss per share is calculated by dividing net loss by the weighted-average number of shares of common stock outstanding for the period, without consideration of potentially dilutive securities. Diluted net loss per share is computed by dividing net loss by the weighted-average number of shares of common stock and potentially dilutive securities outstanding for the period. For purposes of the diluted net loss per share calculation, stock options and warrants to purchase common stock are considered to be potentially dilutive securities. For periods in which the Company reports a net loss, all potentially dilutive shares are anti-dilutive and are therefore excluded from the calculation of diluted net loss per share.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has two classes of common stock and calculates net loss per share using the two-class method. The rights, including the liquidation and dividend rights, of the holders of the Company&#8217;s Class A and Class B common stock are identical, except with respect to voting and conversion. The undistributed earnings for each period are allocated based on the contractual participation rights of the Class A and Class B common shares as if the earnings for the period had been distributed. As the liquidation and dividend rights are identical, the undistributed earnings are allocated on a proportionate basis and the resulting amount per share for Class A and Class B common stock was the same for the years ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recently Issued Accounting Pronouncements Not Yet Adopted</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In December 2023, the FASB issued ASU 2023-09, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes (Topic 740): Improvements to Income Tax Disclosures</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, which is intended to improve the transparency of income tax disclosures by requiring consistent categories and greater disaggregation of information in the effective tax rate reconciliation and income taxes paid by jurisdiction. The ASU is effective for public business entities&#8217; annual periods beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of adopting this guidance on its financial statements.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2024, the FASB issued Accounting Standards Update No. 2024-03, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (ASC Subtopic 220-40) - Disaggregation of Income Statement Expenses</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, which enhances the transparency and comparability of financial statements by requiring companies to disclose more granular information about expense components. The guidance is effective for annual periods beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the potential impact of adopting this new guidance on its financials statements and related disclosures.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Emerging Growth Company Status</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;). Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards until such time as those standards apply to private companies. The Company has elected to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date that it is (a) no longer an emerging growth company or (b) affirmatively and irrevocably opt out of the extended transition period provided in the JOBS Act. As a result, these financial statements may not be comparable to companies that comply with the new or revised accounting pronouncements as of public company effective dates.</span></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash, Cash Equivalents and Marketable Securities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock', window );">Cash, Cash Equivalents and Marketable Securities</a></td>
<td class="text"><p id="section34" style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash, Cash Equivalents and Marketable Securities</span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has classified its marketable securities as available-for-sale. The Company&#8217;s cash, cash equivalents and marketable securities by major security type as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 were as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:42.137%;box-sizing:content-box;"></td>
        <td style="width:1.421%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.044%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.421%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.044%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.421%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.044%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.421%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.044%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amortized Cost</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gross Unrealized Gains</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gross Unrealized Losses</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,983</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,983</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,060</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,060</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total cash and cash equivalents</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,043</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,043</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current marketable securities:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,449</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,446</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">26,701</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">84</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8211;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">26,785</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. federal agency securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,453</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,459</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,502</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8211;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,503</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current marketable securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">42,105</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">93</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">42,193</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Long-term marketable securities:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,066</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">36</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,097</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Municipal debt securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,072</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,072</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. federal agency securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,863</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">59</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,804</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total long-term marketable securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22,001</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">36</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">64</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21,973</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total cash, cash equivalents and marketable<br/>&#160;&#160;&#160;securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">68,149</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">129</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">69</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">68,209</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:42.137%;box-sizing:content-box;"></td>
        <td style="width:1.421%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.044%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.421%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.044%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.421%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.044%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.421%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.044%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amortized Cost</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gross Unrealized Gains</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gross Unrealized Losses</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,608</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,608</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,272</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,272</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total cash and cash equivalents</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,880</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,880</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current marketable securities:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,769</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,773</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,155</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,153</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. federal agency securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19,644</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">102</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19,542</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,812</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">81</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,731</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current marketable securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">45,380</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">187</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">45,199</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Long-term marketable securities:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. federal agency securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,406</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,416</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,388</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,386</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,880</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">159</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,039</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total long-term marketable securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,674</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">189</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,841</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total cash, cash equivalents and marketable<br/>&#160;&#160;&#160;securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">79,934</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">195</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">209</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">79,920</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following tables summarize the Company&#8217;s available-for-sale debt securities and cash equivalents with unrealized losses as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023, aggregated by major security type and the length of time that individual securities have been in a continuous loss position (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:32.066%;box-sizing:content-box;"></td>
        <td style="width:1.08%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:7.942%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.08%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:7.942%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.08%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:7.942%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.08%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:7.942%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.08%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:8.842%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.08%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:8.842%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="22" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Less than 12 months</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">12 months or greater</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized Losses</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized Losses</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized Losses</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,446</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,446</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,059</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,059</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. federal agency securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,804</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">59</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,021</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,825</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">61</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,309</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">67</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,021</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,330</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">69</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:32.066%;box-sizing:content-box;"></td>
        <td style="width:1.08%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:7.942%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.08%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:7.942%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.08%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:7.942%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.08%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:7.942%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.08%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:8.842%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.08%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:8.842%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="22" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Less than 12 months</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">12 months or greater</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized Losses</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized Losses</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized Losses</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,453</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,453</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,153</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,153</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. federal agency securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,308</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">52</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,751</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">67</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,059</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">119</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,769</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,895</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">73</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,664</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">86</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">26,683</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">69</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19,646</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">140</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46,329</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">209</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company had </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t recorded any allowance for credit losses related to its available-for-sale securities. The Company attributes the declines in the fair value of its available-for-sale securities to normal market and interest rate fluctuations. The declines in fair value are not attributed to declines in credit quality. The Company does not intend to sell investments while they are in an unrealized loss position and does not believe that it is more likely than not that the Company will be required to sell the investments before recovery of their amortized cost basis, which may be maturity. All of the Company&#8217;s investments mature in less than three years.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2024, the Company received approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in proceeds from the sale of available-for-sale securities prior to maturity. There was an immaterial amount of gross realized losses on the sales. The Company sold the securities in order to reinvest the funds at improved rates. The Company did not sell any available-for-sale securities prior to maturity during the year ended December 31, 2023.</span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s marketable securities classified by contractual maturities as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 were as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:59.272%;box-sizing:content-box;"></td>
        <td style="width:2%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:16.363%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:2%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:16.363%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amortized Cost</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Due within one year</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">42,105</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">42,193</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Due after one year through five years</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22,001</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21,973</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">64,106</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">64,166</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/320/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Property and Equipment</span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table presents the components of property and equipment, net, as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:59.272%;box-sizing:content-box;"></td>
        <td style="width:2%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:16.363%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:2%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:16.363%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Laboratory equipment</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,663</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,734</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Computer equipment</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,099</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,054</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Leasehold improvements</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">772</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">772</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Software</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,141</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,141</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Furniture and fixtures</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">320</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">320</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total property and equipment</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,995</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,021</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less accumulated depreciation and amortization</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,756</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,022</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Property and equipment, net</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,239</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,999</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Depreciation and amortization expense was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for the years ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets, net</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5. Intangible Assets, net</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes intangible assets (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:57.477%;box-sizing:content-box;"></td>
        <td style="width:1.399%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:10.776%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.399%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:10.776%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.399%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:10.776%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gross Carrying Amount</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Accumulated Amortization</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Net Carrying Amount</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Indefinite-lived intangible assets:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Domain names</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">697</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">697</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Definite-lived intangible assets:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Software developed for sale</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">348</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">329</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total intangible assets</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,045</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,026</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company acquired domain names resulting in capitalized intangible assets of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The Company determined that the domain names have an indefinite useful life and are therefore not subject to amortization. The Company assesses its intangible assets for impairment annually, or more frequently if circumstances dictate. No indefinite-lived intangible asset impairment charges were recorded during the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company capitalized approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of costs associated with software developed for sale. The software was placed in service in November 2024 and is being amortized on a straight-line basis over a three-year useful life. Amortization expense was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> thousand for the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, and is recorded in cost of revenue</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/985-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued and Other Current Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract', window );"><strong>Accounts Payable and Accrued Liabilities, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock', window );">Accrued and Other Current Liabilities</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">6. Accrued and Other Current Liabilities</span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table presents the components of accrued and other current liabilities as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued compensation</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,041</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">779</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued vacation</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">403</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">365</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued 401(k) matching contributions</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">74</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease liability, current portion</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">644</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">578</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other current liabilities</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">296</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">926</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total accrued and other current liabilities</span></p></td>
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,384</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,722</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 720<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483384/720-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Income, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock', window );">Other Income, Net</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Other Income, Net</span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table presents the components of other income, net, for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:68.094%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.123000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.66%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.123000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest income</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,747</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,640</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Investment income, net</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,018</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,994</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other income, net</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,765</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,634</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 720<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/720/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Topic 610<br> -Publisher FASB<br> -URI https://asc.fasb.org/610/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Fair Value Measurements</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024 and 2023, the carrying amounts of the Company&#8217;s receivables, prepaid and other current assets, accounts payable, and accrued and other current liabilities approximate their fair values, principally due to the short-term nature of the assets and liabilities. The recorded values of the finance leases approximate fair value as the interest rates approximate market interest rates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Money market funds are highly liquid investments and are actively traded. The pricing information on money market funds is readily available and can be independently validated as of the measurement date. This approach results in the classification of these securities as Level 1 of the fair value hierarchy.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">U.S. government agency bonds, U.S. government bonds, commercial paper, and corporate debt securities are measured at fair value using Level 2 inputs. The Company reviews trading activity and pricing for these investments as of each measurement date.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company follows a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. The three levels of the fair value hierarchy are as follows:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 1 inputs are observable, quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company can access at the measurement date.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 2 inputs are observable inputs other than quoted prices included in Level 1 that are observable either directly or indirectly or quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Level 3 inputs are unobservable inputs in which there is little or no market data, which require the Company to develop its own assumptions.</span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table shows the Company&#8217;s assets measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands) as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:57.477%;box-sizing:content-box;"></td>
        <td style="width:1.399%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:10.776%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.399%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:10.776%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.399%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:10.776%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Assets:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash equivalents:</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,060</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Marketable securities:</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,446</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">42,882</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Municipal debt securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,072</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. federal agency securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,263</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,503</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets</span></p></td>
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,060</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">64,166</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table shows the Company&#8217;s assets and liabilities measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands) as of December 31, 2023:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:57.477%;box-sizing:content-box;"></td>
        <td style="width:1.399%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:10.776%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.399%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:10.776%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.399%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:10.776%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Assets:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash equivalents:</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,272</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Marketable securities:</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,773</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,192</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. federal agency securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">28,958</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,117</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets</span></p></td>
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,272</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">76,040</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 107<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-107<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 940<br> -SubTopic 820<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478119/940-820-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">9</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Related Party Transactions</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In June 2019, the Company entered into a master services agreement with Carelon Research, a subsidiary of Elevance Health, Inc. (&#8220;Elevance Health&#8221;). This agreement covers a range of research projects, including Carelon Research&#8217;s role as a contract research organization for the </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">P</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">rematurity </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">R</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">isk Assessment Combined With Clinical </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">nterventions for Improving Neonatal outco</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ME</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">s (&#8220;PRIME&#8221;) study. The Company paid fees related to this agreement of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for the years ended December 31, 2024 and 2023, respectively, which were recorded in research and development expenses in the Company&#8217;s statements of operations and comprehensive loss. In November 2020, the Company entered into a Laboratory Services Agreement with Elevance Health related to the PRIME study. This agreement provides a contracted rate for certain tests performed pursuant to the study. In December 2023, enrollment in the PRIME study was stopped due to efficacy, and as such, there was an immaterial amount of revenue recognized related to this agreement for the year ended December 31, 2024. The Company recognized revenue related to this agreement of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">61</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> thousand</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for the year ended December 31, 2023.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In February 2021, the Company entered into a commercial collaboration agreement with Elevance Health and its affiliates (the &#8220;Commercial Collaboration Agreement&#8221;). The Commercial Collaboration Agreement provides defined payment within a defined period for use of the PreTRM test within Elevance Health&#8217;s network of covered members. Pursuant to the Commercial Collaboration Agreement, Elevance Health agreed to purchase a certain minimum number of tests for each of the first three years of the term of the agreement. Additionally, Elevance Health agreed to pay a certain minimum amount per year for the first</span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> three years</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of the term of the Commercial Collaboration Agreement. The Company received $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million during the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, which amount related to the minimum payments for the year ended December 31, 2023. Such minimum payments were initially recorded as deferred revenue. Deferred revenue is recognized as revenue when the Company delivers PreTRM test results to Elevance Health patients pursuant to the Commercial Collaboration Agreement. The Company also agreed to develop a sales, marketing, and customer service program, and to provide training and marketing to duly licensed physicians specializing in obstetrics and gynecology or family medicine, or licensed nurse midwives, at the reasonable request of Elevance Health.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Elevance Health has been participating in the Company&#8217;s PRIME study and at the conclusion of the PRIME study, under the Commercial Collaboration Agreement, the parties agreed to use commercially reasonable efforts to enter into Elevance Health&#8217;s standard lab provider agreement. Unless earlier terminated due to breach, the Commercial Collaboration Agreement</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">will remain in effect until the later of (a) the third anniversary of the effective date or (b) the date on which Elevance Health has purchased a fixed number of PreTRM tests as agreed by the parties.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Commercial Collaboration Agreement with Elevance Health is considered to be within the scope of ASC Topic 808, Collaborative Arrangements (&#8220;ASC 808&#8221;), as the parties are active participants and exposed to the risks and rewards of the collaborative activity. The Company determined the PreTRM tests to be a performance obligation for which Elevance Health is a customer and a unit of account within the scope of ASC 606. The associated transaction price is based on the contractual minimum number of tests and the agreed upon defined payment amount per test. The transaction price was allocated to this single performance obligation, which will be recognized upon delivery of test results expected to occur over the term of the agreement. All other items promised to Elevance Health are immaterial in the context of the Commercial Collaboration Agreement. There were no material revenues related to the Commercial Collaboration Agreement for the years ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Structure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Capital Structure</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Capital Structure</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Common Stock</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">two</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> authorized classes of common stock, Class A and Class B. The rights of the holders of Class A and Class B common stock are identical, except with respect to voting and conversion. Each share of Class A common stock is entitled to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">one</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> vote and shares of Class B common stock are non-voting. Each share of Class B common stock may be converted at any time to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">one</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> share of Class A common stock at the option of its holder, subject to the ownership limitations provided for in the Company&#8217;s amended and restated certificate of incorporation.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In August 2024, the Company entered into the 2024 Sales Agreement with respect to an at-the-market offering program with TD Cowen, which allows the Company to issue and sell shares of Class A common stock pursuant to the 2024 Form S-3 for total gross sales proceeds of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million from time to time through TD Cowen, acting as its agent. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company has </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t sold any shares of Class A common stock under the 2024 Sales Agreement.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following shares of Class A common stock were reserved for future issuance:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.967%;box-sizing:content-box;"></td>
        <td style="width:1.16%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.357%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.16%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.357%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Warrants to purchase Class A common stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,646,247</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,775,978</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Options to purchase Class A common stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,113,155</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,251,663</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Restricted stock units outstanding</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,631,162</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,692,459</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Class A common stock available for future grants under the 2021 Equity Incentive<br/>&#160;&#160;&#160;Plan</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,071,498</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,002,091</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Class A common stock available for future grants under the 2021 Employee Stock<br/>&#160;&#160;&#160;Purchase Plan</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,060,293</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">801,668</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,522,355</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,523,859</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Preferred Stock</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is authorized to issue up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,000,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of preferred stock, par value $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share. There were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> preferred shares outstanding at </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">11</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Stock-Based Compensation</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Equity Incentive Plans</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2011, the Company established the 2011 Employee, Director and Consultant Equity Incentive Plan (the &#8220;2011 Plan&#8221;) and reserved shares of the Company&#8217;s common stock for sale and issuance under the 2011 Plan. Options granted under the 2011 Plan generally vest over a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">four-year</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> period and generally expire </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ten years</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> from the date of grant. Options are exercisable only to the extent vested. The 2011 Plan terminated in November 2021, and accordingly, no additional shares are available for grant under the 2011 Plan. The 2011 Plan continues to govern outstanding awards granted under the 2011 Plan.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The 2021 Equity Incentive Plan (the &#8220;2021 Plan&#8221;) was established in July 2021. The 2021 Plan provides for the grant of incentive and non-statutory stock options as well as other stock rights to employees, directors and consultants of the Company. Options generally vest over a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">four-year</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> period, are exercisable only to the extent vested, and generally expire </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ten years</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> from the date of grant. Restricted stock units (&#8220;RSUs&#8221;) generally vest over either a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">two-year</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> or a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">four-year</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> period. The 2021 Plan includes provisions for annual automatic increases to the number of shares of Class A common stock reserved for issuance under the 2021 Plan. In addition, any shares that otherwise would be returned to the 2011 Plan as a result of the expiration or cancellation of stock options may be added to the 2021 Plan. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, there were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,071,498</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of the Company&#8217;s Class A common stock that were available for future grants under the 2021 Plan.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The 2021 Employee Stock Purchase Plan (the &#8220;2021 ESPP&#8221;) was established in July 2021. The 2021 ESPP includes provisions for annual automatic increases to the number of shares of Class A common stock reserved for issuance under the 2021 ESPP. As of December 31, 2024, there were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,060,293</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of the Company&#8217;s Class A common stock that were available for future grants under the 2021 ESPP.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock Options</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unless otherwise noted, references to &#8220;options&#8221; in the subsequent disclosures, refers to the combined incentive and non-statutory stock options issued as employee and non-employee stock-based compensation, and authorized under the 2011 Plan and the 2021 Plan. </span><span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes information about these options granted and outstanding:</span></span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:52.241%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.164%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.16%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:8.403%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.164%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.16%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:8.703000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of<br/>Shares<br/>Subject to<br/>Options<br/>Outstanding</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted-<br/>Average<br/>Exercise<br/>Price Per<br/>Share</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Life (In<br/>Years)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Aggregate<br/>Intrinsic<br/>Value (In<br/>Thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding &#8211; December 31, 2023</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,251,663</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.66</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.9</span></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20,014</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Granted</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">84,392</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.43</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expired</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cancelled</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">120,387</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.68</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercised</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,102,513</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.63</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding &#8211; December 31, 2024</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,113,155</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.91</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.3</span></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27,008</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Vested and expected to vest at December 31, 2024</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,073,028</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.90</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.3</span></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">26,849</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Vested and exercisable at December 31, 2024</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,380,324</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.77</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.1</span></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,500</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The weighted-average grant date fair value of options granted during the years ended December 31, 2024 and 2023 was </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.54</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.28</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share, respectively. The total aggregate intrinsic value of options exercised during the years ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively. The total fair value of options vested for the years ended December 31, 2024 and 2023 was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair values calculated using the Black-Scholes option pricing model were estimated on each grant date using the following assumptions:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.16%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.343%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.16%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.343%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected volatility</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">78.8</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">% - </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">78.9</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">70.1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">% - </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">72.4</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Risk-free interest rate</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">% - </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.2</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.7</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">% - </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.2</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected term (in years)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.2 </span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">- </span><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.3</span></span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.3</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;- </span><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.0</span></span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected dividend yield</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">RSUs</span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes information about RSUs granted and outstanding under the 2021 Plan:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:68.88%;box-sizing:content-box;"></td>
        <td style="width:1.06%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.5%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.54%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.020000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of Awards</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted-Average<br/>Grant Date Fair<br/>Value</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding &#8211; December 31, 2023</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,692,459</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.01</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Granted</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">249,040</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.52</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Forfeited</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">52,992</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.02</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Vested</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,257,345</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.54</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding &#8211; December 31, 2024</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,631,162</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.60</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock-Based Compensation Expense</span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table presents the impact of stock-based compensation expense in the statements of operations for the periods indicated (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development expense</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,502</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,574</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Sales and marketing expense</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">390</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">657</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative expense</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,121</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,042</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total employee stock-based compensation</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,013</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,273</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information about unrecognized stock-based compensation expense for outstanding unvested stock options and RSUs as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 was as follows (in thousands, except years):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:68.88%;box-sizing:content-box;"></td>
        <td style="width:1.54%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.020000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.06%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.5%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrecognized<br/>Stock-Based<br/>Compensation<br/>Expense</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted-Average<br/>Period of<br/>Recognition<br/>(in years)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock Options</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,975</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.0</span></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">RSUs</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,099</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.9</span></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total unrecognized stock-based compensation expense</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,074</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract', window );"><strong>Warrants and Rights Note Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_WarrantsTextBlock', window );">Warrants</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12. Warrants</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All outstanding common stock warrants were exercisable immediately when granted. All outstanding common stock warrants are exercisable for shares of Class A common stock. </span><span style="font-size:12pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s common stock warrants outstanding were as follows:</span></span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:29.08%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:2.92%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:29.54%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:2.92%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:29.54%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of Warrants Outstanding as of:</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exercise Price</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.20</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,473</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.03</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">969,275</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,032,404</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.84</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">946,666</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,009,795</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12.38</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,083</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,083</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20.77</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">722,223</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">722,223</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,646,247</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,775,978</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">126,258</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> common stock warrants were net exercised, resulting in the issuance of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,971</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Class A common stock. Additionally, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,473</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> common stock warrants expired unexercised during the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_WarrantsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_WarrantsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsNoteDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingences</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">13</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Commitments and Contingencies</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Leases</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is the lessee in all of its lease arrangements. The Company did not enter into any leases with related parties during the presented periods. The Company makes assumptions and judgments when assessing contracts for lease components, determining lease classifications, and calculating right-of-use asset and lease liability values. These assumptions and judgments may include the useful lives and fair values of the leased assets, the implicit rate underlying the Company&#8217;s leases, the Company&#8217;s incremental borrowing rate or the Company&#8217;s intent to exercise or not exercise options available in lease contracts.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table shows right-of-use assets and lease liabilities, and the associated financial statement line items as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:27.18%;box-sizing:content-box;"></td>
        <td style="width:1.52%;box-sizing:content-box;"></td>
        <td style="width:40.46%;box-sizing:content-box;"></td>
        <td style="width:1.52%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.9%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.52%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.9%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Lease-Related Assets and Liabilities</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Financial Statement Line Items</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Right-of-use assets:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating leases</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_0f18ae55-e115-46af-9133-2a37b7dbec78;"><span style="-sec-ix-hidden:F_499cda77-bfd5-40a5-a5fa-38b8c2a78467;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other assets</span></span></span></span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">613</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,180</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Finance leases</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_b631bde4-1e5a-491c-8bd3-1cb6b5c51baa;"><span style="-sec-ix-hidden:F_72a4c378-6838-4602-82e9-f25639674292;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Property and equipment, net</span></span></span></span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">699</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,008</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total right-of-use assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,312</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,188</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lease liabilities:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating leases</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_556e664f-e809-4c83-9e64-ccae8a1500b7;"><span style="-sec-ix-hidden:F_e1166b60-a008-49df-82fa-558051a272f2;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued and other current liabilities</span></span></span></span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">644</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">578</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease obligation, net of current portion</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">644</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Finance leases</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Finance lease obligation, current portion</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">194</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">440</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Finance lease obligation, net of current portion</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">196</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total lease liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">840</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,858</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Lease costs and other information consisted of the following (in thousands, except terms and rates):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.882%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.882%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Lease cost</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Finance lease cost:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amortization of right-of-use assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">314</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">312</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest on lease liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">26</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease cost</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">636</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">636</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total lease cost</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">976</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,003</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Other information</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Finance leases:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating cash outflows</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">26</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Financing cash outflows</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">440</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">466</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Right-of-use assets obtained in exchange for lease liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average remaining lease term (in years)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.4</span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.4</span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average discount rate</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.7</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.5</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating leases:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating cash outflows</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">646</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">628</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Right-of-use assets obtained in exchange for lease liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average remaining lease term (in years)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.0</span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.0</span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average discount rate</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.5</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.5</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Future minimum lease payments for the Company&#8217;s leases as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 were as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:46.649%;box-sizing:content-box;"></td>
        <td style="width:1.74%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:14.043000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.74%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:14.043000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.74%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:14.043000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Operating Leases</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Finance Leases</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2025</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">666</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">197</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">863</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2026</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2027 and thereafter</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total minimum lease payments</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">666</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">199</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">865</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: imputed interest</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Present value of future lease payments</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">644</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">196</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">840</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: current portion</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">644</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">194</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">838</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Long-term portion</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Operating Leases</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company leases a total of approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,300</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> square feet of office and laboratory space under a single non-cancelable operating lease with a termination date of December 31, 2025 (as amended, the &#8220;Office Lease&#8221;). The Office Lease includes an early termination right which termination would occur under certain circumstances, as provided in the amended Office Lease, after July 1, 2024 if exercised. The Company is reasonably certain it will not exercise the termination right. The implicit rate provided in the Company&#8217;s operating lease is not readily determinable. As such, the Company uses its incremental borrowing rate to calculate the present value of its operating lease liabilities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Finance Leases</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company leases certain equipment related to its information technology infrastructure and laboratory operations. All of the Company&#8217;s current finance leases include bargain purchase options that the Company is reasonably certain to exercise. The Company has elected not to separate lease and non-lease components for its equipment leases. The rates implicit in the Company&#8217;s finance leases are determinable, and the Company uses those rates to calculate the present value of its finance lease liabilities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Indemnification</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has agreed to indemnify its officers and directors for certain events or occurrences, while the officer or director is or was serving at the Company&#8217;s request in such capacity. The maximum amount of potential future indemnification is unlimited; however, the Company purchases director and officer insurance coverage that provides for corporate reimbursements of covered obligations that limits the Company&#8217;s exposure and enables it to recover a portion of potential future amounts paid. The Company is unable to reasonably estimate the maximum amount that could be payable under these arrangements since these obligations are not capped but are conditional to the unique facts and circumstances involved. Accordingly, the Company has </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> liabilities recorded for these agreements as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023. The Company has never incurred costs to defend lawsuits or settle claims related to these indemnification agreements.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Employee Agreements</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has signed various employment agreements with key executives pursuant to which if their employment is terminated by the Company without cause or by the employees for good reason, or following a change of control of the Company, the employees are entitled to receive certain benefits, including severance payments, accelerated vesting of stock and stock options, and certain insurance benefits.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Legal Matters</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is not currently a party to any material litigation or other material legal proceedings. The Company may, from time to time, be involved in various legal proceedings arising from the normal course of business activities, and an unfavorable resolution of any of these matters could materially affect the Company&#8217;s future results of operations, cash flows, or financial position.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Income Taxes</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t recorded any income tax expense for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 due to its history of operating losses.</span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The provision for income taxes includes the following components for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Federal</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current benefit (provision)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Federal</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,981</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,178</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,198</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,198</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in valuation allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,179</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,376</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred benefit (provision)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total income tax benefit (provision)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The benefit (provision) for income taxes differs from the amount computed at federal statutory rates as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.36%;box-sizing:content-box;"></td>
        <td style="width:1.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:8.940000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.66%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:8.940000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.66%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Computed Federal income tax benefit (expense) at the<br/>&#160;&#160;&#160;statutory rate</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,908</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21.00</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,602</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21.00</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">R&amp;D credits</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">837</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.54</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">698</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.93</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equity-based expenses</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,366</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.19</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">63</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.17</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State income taxes, net of federal benefit</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,272</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.95</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,783</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.92</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State net operating loss carryforward true up</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">154</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.42</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in statutory rates</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">813</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.47</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">163</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.45</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,017</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.09</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">39</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.11</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Valuation allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,179</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40.06</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,376</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">28.66</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Income tax benefit (provision)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant components of the Company&#8217;s net deferred income tax assets (liabilities) are as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred tax assets:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net operating loss carryforwards</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">61,615</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,072</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">R&amp;D credits</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,693</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,856</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">R&amp;E expenses</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,127</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,219</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accruals and reserves</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">409</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">278</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equity-based compensation</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,193</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,440</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Depreciation and amortization</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lease liability</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">184</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">317</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred tax asset before allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">78,233</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">65,189</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: valuation allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">78,058</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">64,879</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred tax asset</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">175</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">310</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred tax liabilities:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Right-of-use asset</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">175</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">306</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Depreciation and amortization</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net deferred tax assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Management assesses the available positive and negative evidence to estimate if sufficient future taxable income will be generated to use the existing deferred tax assets. A significant piece of objective negative evidence evaluated is the cumulative loss incurred since inception. Such objective evidence limits the ability to consider other subjective evidence such as the Company&#8217;s projections for future growth.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On the basis of this evaluation, a full valuation allowance of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">78.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">64.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million has been recorded as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, as it is more likely than not that the deferred tax assets will not be realized. The valuation allowance increased by $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023, respectively, and there is no tax benefit presented in the accompanying financial statements.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is subject to minimum taxes in several of the state jurisdictions where it files income tax returns. The amounts paid are immaterial and not presented above as a component of the current state tax provision.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company had U.S. federal and state net operating loss carryforwards of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">239.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">182.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively. Of the federal amount, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">169.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million can be carried forward indefinitely, while the remainder begins to expire after 2028, if not utilized. The state amounts begin to expire at various dates after 2030.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Because of the change of ownership provisions of the Tax Reform Act of 1986, use of a portion of the Company&#8217;s NOL and tax credit carryforwards may be limited in future periods. Further, a portion of the carryforwards may expire before being applied to reduce future income tax liabilities. There are currently no federal or state tax audits in progress. All prior tax years remain subject to examination by Federal and State of Utah authorities due to the existence of net operating loss carryforwards.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recognizes the tax benefit of an uncertain tax position only if it is more likely than not that a tax position will be sustained upon examination by the appropriate taxing authorities, based on technical merits. The reversal of the uncertain tax positions would not affect the Company&#8217;s effective tax rate to the extent that it continues to maintain a full valuation allowance against its deferred tax assets. As of December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company did not record any material interest expense or penalties related to uncertain tax positions or the settlement of audits for prior periods. The Company does not expect a significant increase or decrease in its uncertain tax positions within the next 12 months. </span><span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A reconciliation of the beginning and ending amount of uncertain tax positions (in thousands):</span></span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at the beginning of the year</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,570</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,025</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gross increases&#8212;prior period</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">80</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gross increases&#8212;current period</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">559</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">465</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at the end of the year</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,129</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,570</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Share</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">15</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Net Loss Per Share</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company calculates net loss per share of Class A and Class B common stock using the two-class method. For periods in which the Company reports a net loss, all potentially dilutive shares are anti-dilutive and are therefore excluded from the calculation of diluted net loss per share. For the years ended December 31, 2024 and 2023, the Company reported net losses and as such, basic and diluted net loss per share are the same.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As the liquidation and dividend rights are identical for Class A and Class B common shares, the undistributed earnings are allocated on a proportionate basis and the resulting amount per share for Class A and Class B common stock was the same for the years ended December 31, 2024 and 2023.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company excluded the following potentially dilutive securities, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share for the periods indicated because their impact would have been anti-dilutive:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.967%;box-sizing:content-box;"></td>
        <td style="width:1.16%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.357%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.16%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.357%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Warrants to purchase Class A common stock</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,646,247</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,775,978</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Options to purchase Class A common stock</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,113,155</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,251,663</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Restricted stock units outstanding</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,631,162</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,692,459</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,390,564</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,720,100</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Information</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">16. Segment Information</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s revenue was generated in the U.S. for all periods presented and its assets are all located in the U.S.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table presents segment information for revenue, significant segment expenses, and segment loss expenses that are regularly provided to the CODM for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 (in thousands):</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:68.094%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.123000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.66%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.123000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revenue</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">77</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">306</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less:</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cost of revenue</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">82</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">210</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payroll related expenses</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,269</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,878</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation expense</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,013</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,273</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Consulting and professional fees</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,581</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,012</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Clinical studies and outside processing</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,383</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,728</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equipment, lab supplies, and facility expenses</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,635</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,037</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Depreciation and amortization</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(1)</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">814</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">900</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other segment items</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(2)</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,935</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,089</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss from operations</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">36,635</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">39,821</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest expense</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">28</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other income, net</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,765</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,634</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32,898</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">36,242</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(1) </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain amortization amounts are included within cost of revenue.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(2) </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other segment items consist primarily of insurance costs, IT services, travel expenses, marketing expenses, taxes, and other miscellaneous expense.</span></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">17</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Subsequent Events</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 12, 2025, the Company closed an underwritten public offering (the "February 2025 Offering") in which the Company issued and sold </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,250,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of the Company&#8217;s Class A common stock at a price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.00</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share and pre-funded warrants (the &#8220;Pre-Funded Warrants&#8221;) to purchase up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,250,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of the Company&#8217;s Class A common stock (the &#8220;Firm Shares&#8221;) at an offering price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.9999</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per Pre-Funded Warrant, which represents the per share offering price for the Firm Shares less the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per share exercise price for each Pre-Funded Warrant. These Pre-Funded Warrants were recorded as a component of shareholders&#8217; equity within additional paid-in capital. The gross proceeds to the Company from the February 2025 Offering were $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million before deducting underwriting discounts and commissions and other offering expenses. The net proceeds to the Company from the February 2025 Offering were approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, after deducting underwriting commissions and offering expenses. The Pre-Funded Warrants are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the warrant if the holder, together with its affiliates, would beneficially own more than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.99</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the number of shares of Class A common stock outstanding immediately after giving effect to such exercise. A holder of Pre-Funded Warrants may increase or decrease this percentage, but not in excess of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19.99</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, by providing at least 61 days&#8217; prior notice to the Company.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 13, 2025, the representatives of the underwriters in connection with the February 2025 Offering exercised their option in full to purchase an additional </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,875,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Class A common stock, which increased the aggregate number of shares of Class A common stock sold in the February 2025 Offering to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,125,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Company&#8217;s aggregate gross proceeds from the February 2025 Offering were $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">57.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, before deducting underwriting discounts and commissions and offering expenses; $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of which relates to the exercise of the underwriters&#8217; option on February 13, 2025. The Company&#8217;s aggregate net proceeds from the February 2025 Offering were $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, after deducting underwriting discounts and commissions and offering expenses; $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of which relates to the exercise of the underwriters&#8217; option on February 13, 2025.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Basis of Presentation</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;). Any reference in these notes to applicable accounting guidance is meant to refer to the authoritative U.S. GAAP included in the Accounting Standards Codification (&#8220;ASC&#8221;), and Accounting Standards Updates (&#8220;ASU&#8221;) issued by the Financial Accounting Standards Board (&#8220;FASB&#8221;).</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The preparation of the financial statements in conformity with U.S. GAAP requires the Company&#8217;s management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The Company evaluates these estimates on an ongoing basis. The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that the Company believes are reasonable under the circumstances, including assumptions as to future events. Actual results could differ materially from those estimates.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s financial statements as of and for the year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> reflect the Company&#8217;s estimates of the impact of the current macroeconomic environment, including the impact of inflation and higher interest rates. The extent to which these conditions will directly or indirectly impact the Company&#8217;s business, results of operations, and financial condition is uncertain. The Company is not aware of any specific event or circumstance that would require an update to its estimates, judgments, and assumptions or a revision of the carrying value of the Company&#8217;s assets or liabilities as of the date of this filing.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cash and cash equivalents</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company considers all highly liquid financial instruments with maturities of 90 days or less at the date of purchase to be cash equivalents. The carrying amounts reported in the balance sheets for cash and cash equivalents are valued at cost, which approximates their fair value. As of December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, cash and cash equivalents consisted of cash and money market funds. Cash and cash equivalents are stated at fair value.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Marketable Securities</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Marketable Securities</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has classified its marketable securities, all of which are debt securities, as available-for-sale securities. These securities are carried at estimated fair value. Available-for-sale debt securities with an estimated fair value below the amortized cost basis are assessed to determine what amount of that difference, if any, is attributable to expected credit losses. An allowance for credit losses on available-for-sale debt securities is recognized as a charge in other income, net on the Company&#8217;s statements of operations and comprehensive loss, and any remaining unrealized losses, net of the related tax effect, are included in accumulated other comprehensive loss in stockholders&#8217; equity until realized. Gains and losses on marketable security transactions are reported on the specific-identification method.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Concentration of credit risk</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and marketable securities. The Company maintains bank deposits in accounts at federally insured financial institutions and these deposits may exceed federally insured limits. The Company is exposed to credit risk in the event of default by the financial institution holding its cash to the extent recorded in the balance sheet. The Company has not experienced any losses on its deposits of cash. The Company&#8217;s cash equivalents consist of money market funds and investment grade commercial paper. Marketable securities consist of investments in U.S. government securities, U.S. federal</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">agency securities, investment grade commercial paper, and investment grade corporate securities. The Company&#8217;s investment portfolio in corporate debt securities is highly liquid and diversified among individual issuers. The Company did not experience any credit losses related to its investment portfolio for the years ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Property and Equipment</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Property and equipment are recorded at cost less accumulated depreciation and amortization. Depreciation and amortization are computed using the straight-line method over the shorter of estimated useful lives of the assets or the respective lease term.</span><span style="font-size:12pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The estimated useful life of each asset category is as follows:</span></span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
        <table style="border-spacing:0;table-layout:auto;width:98.0%;border-collapse:separate;">
         <tr style="visibility:collapse;">
          <td style="width:50.46%;box-sizing:content-box;"></td>
          <td style="width:49.54%;box-sizing:content-box;"></td>
         </tr>
         <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Computer equipment</span></p></td>
          <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Software</span></p></td>
          <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Machinery and equipment</span></p></td>
          <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Furniture and fixtures</span></p></td>
          <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Leasehold improvements</span></p></td>
          <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shorter of useful life or remaining lease term</span></p></td>
         </tr>
        </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Amortization expense of assets acquired through finance leases is included in depreciation and amortization expense in the accompanying statements of operations and comprehensive loss. Costs of repairs and maintenance that do not extend the useful life or improve the related assets are expensed as incurred. Costs of major replacements or improvements are capitalized. When assets are sold, or otherwise disposed of, the cost and related accumulated depreciation are removed from the accounts and any gain or loss is included in operating expense.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Leases</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s operating lease relates to office and laboratory space at its headquarters. The Company&#8217;s finance leases are for certain equipment related to the Company&#8217;s information technology infrastructure and laboratory operations. The Company determines if an arrangement is a lease at inception. The Company has elected not to separate lease components from non-lease components for all classes of leased assets except for building leases.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company elected to treat leases with lease terms of 12 months or less as short-term leases. No right-of-use assets or lease liabilities are recognized for short-term leases. For leases with a lease term greater than 12 months, right-of-use assets and lease liabilities are recognized on the balance sheets at the commencement date based on the present value of the remaining lease payments and includes only payments that are fixed and determinable at commencement. The Company&#8217;s lease terms may include options to extend or terminate when it is reasonably certain that the Company will exercise such options.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To date, the rates implicit in the Company&#8217;s finance leases have been determinable, and the Company uses those rates to calculate the present value of its finance lease liabilities. The implicit rate in the Company&#8217;s operating lease is not readily determinable. As such, the Company uses its incremental borrowing rate to calculate the present value of its operating lease liabilities.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Operating lease costs are recognized on a straight-line basis over the lease terms. Finance lease assets are amortized on a straight-line basis over the shorter of the estimated useful lives of the assets or the lease terms.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionDeferredRevenue', window );">Deferred Revenue</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Deferred Revenue</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recognizes deferred revenue in accordance with ASC 606, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue from Contracts with Customers</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (&#8220;ASC 606&#8221;). Deferred revenue is recognized when a customer pays consideration, or the Company has a right to an amount of consideration that is unconditional before the Company transfers the good or service to the customer. The Company&#8217;s deferred revenue balance as of December 31, 2024 and 2023 relates to certain contractual minimum payments received by the Company as part of its commercial collaboration agreements. Deferred revenue is recognized as revenue when the Company delivers PreTRM test results to customers pursuant to its commercial collaboration agreements. The Company assesses its deferred revenue balance for current versus long-term classification based on expectations and the ability to meet performance obligations. As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company believes it has the ability and capacity to meet all performance obligations under its commercial collaboration agreements and has concluded to classify its deferred revenue as a current asset.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue Recognition</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Revenue is generated from the sale of PreTRM tests. The Company recognizes revenue based on accounting standards applied to determine the measurement of revenue and timing of when it is recognized. The Company applies the following five-step approach as set forth under ASC 606: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the Company satisfies a performance obligation. The Company applies the five-step model when it is probable that the Company will collect the consideration it is entitled to in exchange for fulfilling its performance obligation. The Company recognizes revenue upon delivery of test results, which it considers to be the only performance obligation, and allocates all of the transaction price to this performance obligation.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In determining the transaction price, which is an estimate of the amount of variable consideration expected to be received, the Company uses the expected value method under ASC 606. The Company considers all reasonably available information to identify various possible consideration amounts and considers the probability of the variable consideration for each scenario. The Company&#8217;s estimate of transaction price does not include any estimated amount of variable consideration that is constrained.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant judgments are required in determining the estimates for each transaction. These estimates include many assumptions, any of which, if incorrect, could result in significant differences between the estimated price and the amount ultimately collected for any given transaction. The Company applies this method consistently to portfolios of similar contracts when estimating the effect of any uncertainty on the amount of variable consideration to which it will be entitled. In the aggregate, across the numerous transactions within each portfolio, these differences can lead to material variances between estimated and actual revenue in any given period.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The estimate of revenue is necessarily founded on assumptions of payer behavior such as changes in payer mix, payer collections, current customer contractual requirements, and experience with ultimate collection from third-party payers and patients. Each of these aspects of payer behavior (and various others) can change significantly from period to period, and the Company currently has limited experience with historical payment patterns. Each of these contributes to the potential variability between estimated transaction price and actual consideration received as discussed above, which is expected to be more pronounced early in the process of commercializing a diagnostic test.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company makes its best efforts to continually refine its estimates of expected consideration as the Company gains additional experience with collections and historical payment patterns. Accordingly, the Company may update its estimate of the amount of revenue to be recognized for previously delivered tests.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfSalesPolicyTextBlock', window );">Cost of Revenue</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cost of Revenue</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cost of revenue reflects the aggregate costs incurred in delivering the proteomic testing results to clinicians and includes expenses for third-party specimen collection and shipping costs, as well as the Company&#8217;s lab personnel, materials and supplies, equipment and infrastructure expenses associated with clinical testing, and allocated overhead including rent and equipment depreciation. Costs associated with performing the Company&#8217;s tests are recorded as the tests are processed regardless of whether and when revenue is recognized with respect to such tests.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Expense</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Research and Development Expenses</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company expenses all research and development costs as they are incurred. Research and development expenses consist primarily of personnel costs, stock-based compensation charges, clinical trial costs, and third-party contracted services associated with research and development. The Company recognizes expense associated with third-party contracted services based on the completion of activities as specified in the applicable contracts. Costs incurred under contracts with clinical sites are generally accrued as patient encounters occur, consistent with the terms outlined in the associated contract. Upon termination of contracts with third parties, the Company&#8217;s obligations are limited to costs incurred or committed to date. As a result, accrued research and development expenses represent the estimated contractual liability to third parties at the reported period.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-based Compensation</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock-based Compensation</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recognizes stock-based compensation for all stock-based awards in accordance with ASC 718, C</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">ompensation-Stock Compensation</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, which requires an entity to measure the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair value of restricted stock units granted under the Company&#8217;s equity incentive plans is measured based on the grant-date fair value of the Company&#8217;s Class A common stock.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair value of stock options granted under the Company&#8217;s equity incentive plans is estimated using the Black-Scholes option pricing model. Input assumptions used in calculating the fair value of stock options represent management&#8217;s estimates and involve inherent uncertainties and the application of management&#8217;s judgment. These input assumptions include the expected term of the awards, the expected common stock price volatility over the term of the awards, risk-free interest rates, and the expected dividend yield.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair value of the Company&#8217;s Class A common stock is determined by using the closing price per share of the Company&#8217;s Class A common stock as reported on Nasdaq. The Company uses the simplified calculation of expected life since the Company does not have sufficient historical exercise data to estimate the expected term. Volatility is based on an average of the historical volatility of the Company&#8217;s common stock and the volatilities of the common stock of select comparable publicly-traded entities with characteristics similar to those of the Company. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods corresponding with the expected life of the option. Forfeitures are estimated at the time of grant based on the Company&#8217;s historical experience and are adjusted as necessary.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair value of equity awards is recognized as compensation cost on a straight-line basis by the Company over the participant&#8217;s requisite service period, which is the award&#8217;s vesting period. All stock-based compensation costs are classified in the statements of operations and comprehensive loss based upon the underlying participant&#8217;s role within the Company.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recognizes deferred tax assets to the extent that it believes these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If the Company determines that it would be able to realize its deferred tax assets in the future in excess of their net recorded amount, the Company would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company records uncertain tax positions in accordance with ASC 740 on the basis of a two-step process whereby (1) it determines whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, it recognizes the largest amount of tax benefit that is more than 50 percent likely to be realized upon ultimate settlement with the related tax authority.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recognizes interest and penalties related to unrecognized tax benefits within the income tax expense line in the accompanying statements of operations and comprehensive loss. Any accrued interest and penalties related to uncertain tax positions will be reflected as a liability in the balance sheets.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PostemploymentBenefitPlansPolicy', window );">Retirement Savings Plan</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Retirement Savings Plan</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company sponsors a safe harbor 401(k) plan that covers all of the Company&#8217;s eligible employees. The plan allows employees to make contributions up to a specified percentage of their compensation, subject to statutory limitations. The Company makes safe harbor matching contributions equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the first </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of a plan participant&#8217;s eligible compensation, plus </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the next </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of a plan participant&#8217;s eligible compensation. The Company may also make an additional discretionary match or profit sharing contribution to the plan. The Company recorded expense related to its 401(k) plan of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for the years ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segments</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Segments</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company operates as </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">one</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> operating segment, which is developing and commercializing its medical diagnostic products and services. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s Chief Operating Decision Maker ("CODM"), its </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_78f058f5-e77e-4f42-8f14-9e5f77a00420;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">chief executive officer</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, assesses performance for the Company&#8217;s one operating segment and allocates resources based on net loss, consistent with what is reported on the statements of operations and comprehensive loss. The CODM also assesses the performance of the Company&#8217;s one operating segment by using operating expenses to monitor budget versus actual results.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Improvements to Reportable Segments Disclosures</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, which updates reportable segment disclosure requirements primarily through enhanced disclosures about significant segment expenses. While ASU 2023-07 requires incremental disclosures, it does not change how an entity identifies its operating segments, aggregates those operating segments, or applies the quantitative thresholds to determine reportable segments. This ASU is effective for all public business entities for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Entities must adopt the changes to the segment reporting guidance on a retrospective basis. The Company </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">adopted</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> this standard effective </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">January 1, 2024</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and retrospectively to all prior periods. The adoption impacted the Company's disclosures and did </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">not</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> impact the financial statements. See Note </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">16 &#8212; Segment Information</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, for disclosures related to the Company&#8217;s single operating segment.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Loss</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Comprehensive Loss</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Comprehensive loss consists of net loss and other gains and losses affecting stockholders&#8217; equity that, under U.S. GAAP, are excluded from net loss. For the years ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, comprehensive loss includes unrealized gains (losses) on the Company&#8217;s available-for-sale debt securities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Loss per Share</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Net Loss per Share</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basic net loss per share is calculated by dividing net loss by the weighted-average number of shares of common stock outstanding for the period, without consideration of potentially dilutive securities. Diluted net loss per share is computed by dividing net loss by the weighted-average number of shares of common stock and potentially dilutive securities outstanding for the period. For purposes of the diluted net loss per share calculation, stock options and warrants to purchase common stock are considered to be potentially dilutive securities. For periods in which the Company reports a net loss, all potentially dilutive shares are anti-dilutive and are therefore excluded from the calculation of diluted net loss per share.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has two classes of common stock and calculates net loss per share using the two-class method. The rights, including the liquidation and dividend rights, of the holders of the Company&#8217;s Class A and Class B common stock are identical, except with respect to voting and conversion. The undistributed earnings for each period are allocated based on the contractual participation rights of the Class A and Class B common shares as if the earnings for the period had been distributed. As the liquidation and dividend rights are identical, the undistributed earnings are allocated on a proportionate basis and the resulting amount per share for Class A and Class B common stock was the same for the years ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued Accounting Pronouncements Not Yet Adopted</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recently Issued Accounting Pronouncements Not Yet Adopted</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In December 2023, the FASB issued ASU 2023-09, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes (Topic 740): Improvements to Income Tax Disclosures</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, which is intended to improve the transparency of income tax disclosures by requiring consistent categories and greater disaggregation of information in the effective tax rate reconciliation and income taxes paid by jurisdiction. The ASU is effective for public business entities&#8217; annual periods beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of adopting this guidance on its financial statements.</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2024, the FASB issued Accounting Standards Update No. 2024-03, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (ASC Subtopic 220-40) - Disaggregation of Income Statement Expenses</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, which enhances the transparency and comparability of financial statements by requiring companies to disclose more granular information about expense components. The guidance is effective for annual periods beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the potential impact of adopting this new guidance on its financials statements and related disclosures.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_EmergingGrowthCompanyStatusPolicyTextBlock', window );">Emerging Growth Company Status</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Emerging Growth Company Status</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;). Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards until such time as those standards apply to private companies. The Company has elected to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date that it is (a) no longer an emerging growth company or (b) affirmatively and irrevocably opt out of the extended transition period provided in the JOBS Act. As a result, these financial statements may not be comparable to companies that comply with the new or revised accounting pronouncements as of public company effective dates.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_EmergingGrowthCompanyStatusPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Emerging Growth Company Status [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_EmergingGrowthCompanyStatusPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478898/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfSalesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cost of product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Topic 705<br> -Publisher FASB<br> -URI https://asc.fasb.org/705/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfSalesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477268/942-320-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PostemploymentBenefitPlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for postemployment benefits. Postemployment benefits are benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement, except for: a) benefits provided through a pension or postretirement benefit plan, b) individual deferred compensation arrangements, c) special or contractual termination benefits, and d) stock compensation plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 712<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/712/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PostemploymentBenefitPlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483044/730-10-05-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-18<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing unearned income or deferred revenue related to transactions involving the sale of a product or performance of services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 36<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-36<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_ScheduleOfEstimatedUsefulLifeOfEachAssetCategoryTableTextBlock', window );">Schedule of Estimated Useful Life of Each Asset Category</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The estimated useful life of each asset category is as follows:</span><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
        <table style="border-spacing:0;table-layout:auto;width:98.0%;border-collapse:separate;">
         <tr style="visibility:collapse;">
          <td style="width:50.46%;box-sizing:content-box;"></td>
          <td style="width:49.54%;box-sizing:content-box;"></td>
         </tr>
         <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Computer equipment</span></p></td>
          <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Software</span></p></td>
          <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Machinery and equipment</span></p></td>
          <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Furniture and fixtures</span></p></td>
          <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         </tr>
         <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Leasehold improvements</span></p></td>
          <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shorter of useful life or remaining lease term</span></p></td>
         </tr>
        </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_ScheduleOfEstimatedUsefulLifeOfEachAssetCategoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Estimated Useful Life Of Each Asset Category [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_ScheduleOfEstimatedUsefulLifeOfEachAssetCategoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash, Cash Equivalents and Marketable Securities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock', window );">Schedule of Cash, Cash Equivalents and Marketable Securities by Major Security Type</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has classified its marketable securities as available-for-sale. The Company&#8217;s cash, cash equivalents and marketable securities by major security type as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 were as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:42.137%;box-sizing:content-box;"></td>
        <td style="width:1.421%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.044%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.421%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.044%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.421%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.044%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.421%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.044%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amortized Cost</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gross Unrealized Gains</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gross Unrealized Losses</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,983</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,983</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,060</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,060</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total cash and cash equivalents</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,043</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,043</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current marketable securities:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,449</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,446</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">26,701</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">84</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8211;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">26,785</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. federal agency securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,453</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,459</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,502</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8211;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,503</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current marketable securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">42,105</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">93</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">42,193</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Long-term marketable securities:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,066</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">36</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,097</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Municipal debt securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,072</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,072</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. federal agency securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,863</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">59</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,804</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total long-term marketable securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22,001</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">36</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">64</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21,973</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total cash, cash equivalents and marketable<br/>&#160;&#160;&#160;securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">68,149</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">129</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">69</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">68,209</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:42.137%;box-sizing:content-box;"></td>
        <td style="width:1.421%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.044%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.421%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.044%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.421%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.044%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.421%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.044%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amortized Cost</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gross Unrealized Gains</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gross Unrealized Losses</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,608</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,608</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,272</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,272</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total cash and cash equivalents</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,880</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,880</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current marketable securities:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,769</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,773</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,155</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,153</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. federal agency securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19,644</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">102</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19,542</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,812</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">81</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,731</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current marketable securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">45,380</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">187</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">45,199</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Long-term marketable securities:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. federal agency securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,406</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,416</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,388</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,386</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,880</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">159</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,039</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total long-term marketable securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,674</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">189</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,841</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total cash, cash equivalents and marketable<br/>&#160;&#160;&#160;securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">79,934</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">195</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">209</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">79,920</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock', window );">Schedule of Available-for-sale Debt Securities and Cash Equivalents in Unrealized Loss Positions</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following tables summarize the Company&#8217;s available-for-sale debt securities and cash equivalents with unrealized losses as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023, aggregated by major security type and the length of time that individual securities have been in a continuous loss position (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:32.066%;box-sizing:content-box;"></td>
        <td style="width:1.08%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:7.942%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.08%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:7.942%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.08%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:7.942%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.08%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:7.942%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.08%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:8.842%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.08%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:8.842%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="22" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Less than 12 months</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">12 months or greater</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized Losses</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized Losses</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized Losses</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,446</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,446</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,059</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,059</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. federal agency securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,804</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">59</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,021</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,825</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">61</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,309</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">67</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,021</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,330</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">69</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:32.066%;box-sizing:content-box;"></td>
        <td style="width:1.08%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:7.942%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.08%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:7.942%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.08%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:7.942%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.08%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:7.942%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.08%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:8.842%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.08%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:8.842%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="22" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Less than 12 months</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">12 months or greater</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized Losses</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized Losses</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrealized Losses</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,453</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,453</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,153</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,153</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. federal agency securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,308</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">52</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,751</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">67</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,059</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">119</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,769</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,895</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">73</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,664</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">86</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">26,683</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">69</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19,646</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">140</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46,329</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">209</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Schedule of Marketable Securities Classified by Contractual Maturities</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s marketable securities classified by contractual maturities as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 were as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:59.272%;box-sizing:content-box;"></td>
        <td style="width:2%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:16.363%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:2%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:16.363%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amortized Cost</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Due within one year</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">42,105</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">42,193</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Due after one year through five years</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22,001</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21,973</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">64,106</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">64,166</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479081/326-30-55-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-6<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479106/326-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash, cash equivalents, and investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Components of Property and Equipment, Net</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table presents the components of property and equipment, net, as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:59.272%;box-sizing:content-box;"></td>
        <td style="width:2%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:16.363%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:2%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:16.363%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Laboratory equipment</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,663</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,734</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Computer equipment</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,099</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,054</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Leasehold improvements</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">772</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">772</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Software</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,141</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,141</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Furniture and fixtures</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">320</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">320</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total property and equipment</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,995</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,021</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less accumulated depreciation and amortization</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,756</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,022</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Property and equipment, net</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,239</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,999</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Intangible Assets</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes intangible assets (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:57.477%;box-sizing:content-box;"></td>
        <td style="width:1.399%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:10.776%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.399%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:10.776%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.399%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:10.776%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gross Carrying Amount</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Accumulated Amortization</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Net Carrying Amount</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Indefinite-lived intangible assets:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Domain names</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">697</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">697</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Definite-lived intangible assets:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Software developed for sale</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">348</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">329</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total intangible assets</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,045</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,026</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued and Other Current Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract', window );"><strong>Accounts Payable and Accrued Liabilities, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Components of Accrued and Other Current Liabilities</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table presents the components of accrued and other current liabilities as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued compensation</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,041</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">779</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued vacation</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">403</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">365</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued 401(k) matching contributions</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">74</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease liability, current portion</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">644</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">578</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other current liabilities</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">296</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">926</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total accrued and other current liabilities</span></p></td>
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,384</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,722</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Income, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock', window );">Schedule of Components of Other Income, Net</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table presents the components of other income, net, for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:68.094%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.123000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.66%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.123000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest income</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,747</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,640</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Investment income, net</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,018</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,994</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other income, net</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,765</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,634</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">Schedule of Financial Assets that are Measured at Fair Value on a Recurring basis</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table shows the Company&#8217;s assets measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands) as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:57.477%;box-sizing:content-box;"></td>
        <td style="width:1.399%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:10.776%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.399%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:10.776%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.399%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:10.776%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Assets:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash equivalents:</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,060</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Marketable securities:</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,446</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">42,882</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Municipal debt securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,072</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. federal agency securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,263</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,503</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets</span></p></td>
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,060</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">64,166</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table shows the Company&#8217;s assets and liabilities measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands) as of December 31, 2023:</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:57.477%;box-sizing:content-box;"></td>
        <td style="width:1.399%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:10.776%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.399%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:10.776%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.399%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:10.776%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Assets:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash equivalents:</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,272</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Marketable securities:</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,773</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,192</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. federal agency securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">28,958</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">U.S. government securities</span></p></td>
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,117</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets</span></p></td>
        <td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,272</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">76,040</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financial instrument measured at fair value on recurring or nonrecurring basis. Includes, but is not limited to, instrument classified in shareholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Structure (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock', window );">Schedule of Common Stock Reserved for Future Issuance</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following shares of Class A common stock were reserved for future issuance:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.967%;box-sizing:content-box;"></td>
        <td style="width:1.16%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.357%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.16%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.357%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Warrants to purchase Class A common stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,646,247</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,775,978</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Options to purchase Class A common stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,113,155</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,251,663</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Restricted stock units outstanding</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,631,162</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,692,459</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Class A common stock available for future grants under the 2021 Equity Incentive<br/>&#160;&#160;&#160;Plan</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,071,498</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,002,091</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Class A common stock available for future grants under the 2021 Employee Stock<br/>&#160;&#160;&#160;Purchase Plan</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,060,293</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">801,668</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,522,355</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,523,859</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The tabular disclosure of common stock reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of Options Granted and Outstanding</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes information about these options granted and outstanding:</span><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:52.241%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.164%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.16%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:8.403%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.164%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.16%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:8.703000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of<br/>Shares<br/>Subject to<br/>Options<br/>Outstanding</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted-<br/>Average<br/>Exercise<br/>Price Per<br/>Share</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Life (In<br/>Years)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Aggregate<br/>Intrinsic<br/>Value (In<br/>Thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding &#8211; December 31, 2023</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,251,663</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.66</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.9</span></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20,014</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Granted</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">84,392</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.43</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expired</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cancelled</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">120,387</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.68</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercised</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,102,513</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.63</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding &#8211; December 31, 2024</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,113,155</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.91</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.3</span></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27,008</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Vested and expected to vest at December 31, 2024</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,073,028</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.90</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.3</span></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">26,849</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Vested and exercisable at December 31, 2024</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,380,324</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.77</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.1</span></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,500</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Fair Values Calculated using Black-Scholes Option Pricing Model</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair values calculated using the Black-Scholes option pricing model were estimated on each grant date using the following assumptions:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.16%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.343%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.16%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.343%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected volatility</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">78.8</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">% - </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">78.9</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">70.1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">% - </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">72.4</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Risk-free interest rate</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">% - </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.2</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.7</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">% - </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.2</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected term (in years)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.2 </span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">- </span><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.3</span></span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.3</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;- </span><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.0</span></span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected dividend yield</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock', window );">Summary of Information about RSUs Granted and Outstanding</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes information about RSUs granted and outstanding under the 2021 Plan:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:68.88%;box-sizing:content-box;"></td>
        <td style="width:1.06%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.5%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.54%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.020000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of Awards</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted-Average<br/>Grant Date Fair<br/>Value</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding &#8211; December 31, 2023</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,692,459</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.01</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Granted</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">249,040</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.52</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Forfeited</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">52,992</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.02</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Vested</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,257,345</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.54</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding &#8211; December 31, 2024</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,631,162</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.60</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Impact of Stock-based Compensation Expense in Statements of Operations</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table presents the impact of stock-based compensation expense in the statements of operations for the periods indicated (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development expense</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,502</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,574</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Sales and marketing expense</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">390</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">657</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative expense</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,121</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,042</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total employee stock-based compensation</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,013</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,273</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock', window );">Summary of Unrecognized Stock-based Compensation Expense for Outstanding Unvested Stock Options and RSUs</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information about unrecognized stock-based compensation expense for outstanding unvested stock options and RSUs as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 was as follows (in thousands, except years):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:68.88%;box-sizing:content-box;"></td>
        <td style="width:1.54%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.020000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.06%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.5%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Unrecognized<br/>Stock-Based<br/>Compensation<br/>Expense</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted-Average<br/>Period of<br/>Recognition<br/>(in years)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock Options</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,975</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.0</span></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">RSUs</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,099</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.9</span></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total unrecognized stock-based compensation expense</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,074</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost not yet recognized and weighted-average period over which cost is expected to be recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (i)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract', window );"><strong>Warrants and Rights Note Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of Common Stock Warrants Outstanding</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s common stock warrants outstanding were as follows:</span><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:29.08%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:2.92%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:29.54%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:2.92%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:29.54%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of Warrants Outstanding as of:</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exercise Price</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.20</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,473</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.03</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">969,275</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,032,404</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.84</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">946,666</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,009,795</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12.38</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,083</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,083</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20.77</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">722,223</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">722,223</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,646,247</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,775,978</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsNoteDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitment and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock', window );">Schedule of Leases in Financial Statement</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table shows right-of-use assets and lease liabilities, and the associated financial statement line items as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:27.18%;box-sizing:content-box;"></td>
        <td style="width:1.52%;box-sizing:content-box;"></td>
        <td style="width:40.46%;box-sizing:content-box;"></td>
        <td style="width:1.52%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.9%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.52%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.9%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Lease-Related Assets and Liabilities</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Financial Statement Line Items</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Right-of-use assets:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating leases</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_0f18ae55-e115-46af-9133-2a37b7dbec78;"><span style="-sec-ix-hidden:F_499cda77-bfd5-40a5-a5fa-38b8c2a78467;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other assets</span></span></span></span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">613</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,180</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Finance leases</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_b631bde4-1e5a-491c-8bd3-1cb6b5c51baa;"><span style="-sec-ix-hidden:F_72a4c378-6838-4602-82e9-f25639674292;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Property and equipment, net</span></span></span></span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">699</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,008</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total right-of-use assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,312</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,188</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lease liabilities:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating leases</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_556e664f-e809-4c83-9e64-ccae8a1500b7;"><span style="-sec-ix-hidden:F_e1166b60-a008-49df-82fa-558051a272f2;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued and other current liabilities</span></span></span></span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">644</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">578</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease obligation, net of current portion</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">644</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Finance leases</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Finance lease obligation, current portion</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">194</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">440</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Finance lease obligation, net of current portion</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">196</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total lease liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">840</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,858</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Lease Cost and Other Information</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Lease costs and other information consisted of the following (in thousands, except terms and rates):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.882%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.882%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Lease cost</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Finance lease cost:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amortization of right-of-use assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">314</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">312</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest on lease liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">26</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease cost</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">636</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">636</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total lease cost</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">976</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,003</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Other information</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Finance leases:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating cash outflows</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">26</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Financing cash outflows</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">440</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">466</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Right-of-use assets obtained in exchange for lease liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average remaining lease term (in years)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.4</span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.4</span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average discount rate</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.7</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.5</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating leases:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating cash outflows</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">646</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">628</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Right-of-use assets obtained in exchange for lease liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average remaining lease term (in years)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.0</span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.0</span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average discount rate</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.5</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.5</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Future Minimum Lease Payments</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Future minimum lease payments for the Company&#8217;s leases as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 were as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:46.649%;box-sizing:content-box;"></td>
        <td style="width:1.74%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:14.043000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.74%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:14.043000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.74%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:14.043000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Operating Leases</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Finance Leases</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2025</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">666</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">197</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">863</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2026</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2027 and thereafter</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total minimum lease payments</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">666</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">199</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">865</span></p></td>
        <td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: imputed interest</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Present value of future lease payments</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">644</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">196</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">840</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: current portion</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">644</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">194</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">838</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Long-term portion</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Leases In Statement Of Financial Position</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Components of Income Tax Benefit (Provision)</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The provision for income taxes includes the following components for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Federal</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current benefit (provision)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Federal</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,981</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,178</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,198</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,198</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in valuation allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,179</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,376</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred benefit (provision)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total income tax benefit (provision)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate Reconciliation</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The benefit (provision) for income taxes differs from the amount computed at federal statutory rates as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.36%;box-sizing:content-box;"></td>
        <td style="width:1.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:8.940000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.66%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:8.940000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.66%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Computed Federal income tax benefit (expense) at the<br/>&#160;&#160;&#160;statutory rate</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,908</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21.00</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,602</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21.00</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">R&amp;D credits</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">837</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.54</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">698</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.93</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equity-based expenses</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,366</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.19</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">63</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.17</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State income taxes, net of federal benefit</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,272</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.95</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,783</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.92</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State net operating loss carryforward true up</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">154</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.42</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in statutory rates</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">813</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.47</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">163</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.45</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,017</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.09</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">39</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.11</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Valuation allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,179</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40.06</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,376</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">28.66</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Income tax benefit (provision)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant components of the Company&#8217;s net deferred income tax assets (liabilities) are as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred tax assets:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net operating loss carryforwards</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">61,615</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,072</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">R&amp;D credits</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,693</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,856</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">R&amp;E expenses</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,127</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,219</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accruals and reserves</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">409</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">278</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equity-based compensation</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,193</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,440</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Depreciation and amortization</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lease liability</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">184</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">317</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred tax asset before allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">78,233</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">65,189</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: valuation allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">78,058</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">64,879</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total deferred tax asset</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">175</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">310</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred tax liabilities:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Right-of-use asset</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">175</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">306</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Depreciation and amortization</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net deferred tax assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Schedule of Uncertain Tax Positions Roll Forward</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A reconciliation of the beginning and ending amount of uncertain tax positions (in thousands):</span><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at the beginning of the year</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,570</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,025</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gross increases&#8212;prior period</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">80</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gross increases&#8212;current period</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">559</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">465</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at the end of the year</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,129</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,570</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Anti-dilutive Securities Excluded from the Computation of Earnings per Share</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company excluded the following potentially dilutive securities, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share for the periods indicated because their impact would have been anti-dilutive:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.967%;box-sizing:content-box;"></td>
        <td style="width:1.16%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.357%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.16%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.357%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Warrants to purchase Class A common stock</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,646,247</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,775,978</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Options to purchase Class A common stock</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,113,155</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,251,663</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Restricted stock units outstanding</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,631,162</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,692,459</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"><p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,390,564</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,720,100</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Summary of Segment Information for Revenue, Significant Segment Expenses and Segement Loss Expenses that are Regularly Provided to the CODM</a></td>
<td class="text"><p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table presents segment information for revenue, significant segment expenses, and segment loss expenses that are regularly provided to the CODM for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 (in thousands):</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:68.094%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.123000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.66%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.123000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revenue</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">77</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">306</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less:</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cost of revenue</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">82</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">210</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payroll related expenses</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,269</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,878</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation expense</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,013</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,273</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Consulting and professional fees</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,581</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,012</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Clinical studies and outside processing</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,383</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,728</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equipment, lab supplies, and facility expenses</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,635</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,037</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Depreciation and amortization</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(1)</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">814</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">900</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other segment items</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(2)</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,935</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,089</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss from operations</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">36,635</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">39,821</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest expense</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">28</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other income, net</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,765</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,634</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32,898</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">36,242</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(1) </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain amortization amounts are included within cost of revenue.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(2) </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other segment items consist primarily of insurance costs, IT services, travel expenses, marketing expenses, taxes, and other miscellaneous expense.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business and Financial Condition - Additional Information (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (279,794)<span></span>
</td>
<td class="num">$ (246,896)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue', window );">Total cash, cash equivalents and marketable securities, Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 68,209<span></span>
</td>
<td class="nump">$ 79,920<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,206,909<span></span>
</td>
<td class="nump">30,736,513<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockNoParValue', window );">Common stock, no par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=sera_AtTheMarketOfferingMember', window );">At-the-Market Offering | Class A common stock | 2024 Sales Agreement | TD Cowen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_AmountFromSaleOfCombinationOfSecuritiesUnderShelfRegistration', window );">Amount from sale of combination of securities under shelf registration</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | At-the-Market Offering | Class A common stock | 2024 Sales Agreement | TD Cowen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_AggregateOfferingPriceFromSaleOfCommonStock', window );">Aggregate offering price from sale of common stock</a></td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_AggregateOfferingPriceFromSaleOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate offering price from sale of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_AggregateOfferingPriceFromSaleOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_AmountFromSaleOfCombinationOfSecuritiesUnderShelfRegistration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount from sale of combination of securities under shelf registration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_AmountFromSaleOfCombinationOfSecuritiesUnderShelfRegistration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash And Cash Equivalents, Debt Securities Available-For-Sale, Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockNoParValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount per share of no-par value common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockNoParValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=sera_AtTheMarketOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=sera_AtTheMarketOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=sera_TwoThousandTwentyFourSalesAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=sera_TwoThousandTwentyFourSalesAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=sera_TdCowenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=sera_TdCowenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Additional Information (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>Segment</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanDisclosureLineItems', window );"><strong>Defined Contribution Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Defined contribution plan, cost | $</a></td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">$ 0.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segment | Segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration', window );">Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]</a></td>
<td class="text">srt:ChiefExecutiveOfficerMember<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription', window );">Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description</a></td>
<td class="text">The Company&#8217;s Chief Operating Decision Maker ("CODM"), its chief executive officer, assesses performance for the Company&#8217;s one operating segment and allocates resources based on net loss, consistent with what is reported on the statements of operations and comprehensive loss. The CODM also assesses the performance of the Company&#8217;s one operating segment by using operating expenses to monitor budget versus actual results.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202307Member', window );">ASU 2023-07</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanDisclosureLineItems', window );"><strong>Defined Contribution Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted', window );">Change in Accounting Principle, Accounting Standards Update, Adopted [true false]</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect', window );">Change in Accounting Principle, Accounting Standards Update, Immaterial Effect [true false]</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate', window );">Change in Accounting Principle, Accounting Standards Update, Adoption Date</a></td>
<td class="text">Jan.  01,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_DefinedContributionPlanEmployerMatchingContributionMatchingTierAxis=sera_DefinedContributionPlanEmployerMatchingContributionFirstTierMember', window );">Defined Contribution Plan, Employer Matching Contribution, First Tier</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanDisclosureLineItems', window );"><strong>Defined Contribution Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Defined contribution plan, employer matching contribution, percent of employees' gross pay</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch', window );">Defined contribution plan, employer matching contribution, percent of match</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_DefinedContributionPlanEmployerMatchingContributionMatchingTierAxis=sera_DefinedContributionPlanEmployerMatchingContributionSecondTierMember', window );">Defined Contribution Plan, Employer Matching Contribution, Second Tier</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanDisclosureLineItems', window );"><strong>Defined Contribution Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Defined contribution plan, employer matching contribution, percent of employees' gross pay</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch', window );">Defined contribution plan, employer matching contribution, percent of match</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates (true false) whether accounting standards update was adopted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476173/280-10-65-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-7<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479832/842-10-65-8<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477123/405-50-65-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482477/820-10-65-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482477/820-10-65-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479845/805-20-65-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479845/805-20-65-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483194/926-20-65-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483194/926-20-65-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 326<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-3<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 326<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date accounting standards update was adopted, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476173/280-10-65-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-7<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479832/842-10-65-8<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477123/405-50-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482477/820-10-65-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482477/820-10-65-13<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479845/805-20-65-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479845/805-20-65-3<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479845/805-20-65-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483194/926-20-65-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483194/926-20-65-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-2<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 326<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 326<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br><br>Reference 38: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -SubTopic 10<br> -Topic 250<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates (true false) whether effect from applying amendment to accounting standards is immaterial.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480530/250-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 70<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480794/715-70-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 70<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480794/715-70-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage employer matches of the employee's percentage contribution matched.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates title and position of individual or name of group identified as chief operating decision maker (CODM) for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of how chief operating decision maker (CODM) uses reported segment profit (loss) measure to assess performance and allocate resource.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202307Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202307Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_DefinedContributionPlanEmployerMatchingContributionMatchingTierAxis=sera_DefinedContributionPlanEmployerMatchingContributionFirstTierMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_DefinedContributionPlanEmployerMatchingContributionMatchingTierAxis=sera_DefinedContributionPlanEmployerMatchingContributionFirstTierMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_DefinedContributionPlanEmployerMatchingContributionMatchingTierAxis=sera_DefinedContributionPlanEmployerMatchingContributionSecondTierMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_DefinedContributionPlanEmployerMatchingContributionMatchingTierAxis=sera_DefinedContributionPlanEmployerMatchingContributionSecondTierMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant Accounting Policies - Schedule of Estimated Useful Life of Each Asset Category (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember', window );">Software</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cash, Cash Equivalents and Marketable Securities - Cash, Cash Equivalents and Marketable Securities by Major Security Type (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Marketable securities, Amortized Cost</a></td>
<td class="nump">$ 64,106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities, Fair Value</a></td>
<td class="nump">64,166<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost', window );">Total cash, cash equivalents and marketable securities, Amortized Cost</a></td>
<td class="nump">68,149<span></span>
</td>
<td class="nump">$ 79,934<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax', window );">Total cash, cash equivalents and marketable securities, Gross Unrealized Gains</a></td>
<td class="nump">129<span></span>
</td>
<td class="nump">195<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax', window );">Total cash, cash equivalents and marketable securities, Gross Unrealized Losses</a></td>
<td class="num">(69)<span></span>
</td>
<td class="num">(209)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue', window );">Total cash, cash equivalents and marketable securities, Fair Value</a></td>
<td class="nump">68,209<span></span>
</td>
<td class="nump">79,920<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and cash equivalents:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CashAndCashEquivalentsAmortizedCost', window );">Cash and cash equivalents, Amortized Cost</a></td>
<td class="nump">4,043<span></span>
</td>
<td class="nump">3,880<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax', window );">Cash and cash equivalents, Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax', window );">Cash and cash equivalents, Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents, Fair Value</a></td>
<td class="nump">4,043<span></span>
</td>
<td class="nump">3,880<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and cash equivalents: | Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CashAndCashEquivalentsAmortizedCost', window );">Cash and cash equivalents, Amortized Cost</a></td>
<td class="nump">1,983<span></span>
</td>
<td class="nump">2,608<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax', window );">Cash and cash equivalents, Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax', window );">Cash and cash equivalents, Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents, Fair Value</a></td>
<td class="nump">1,983<span></span>
</td>
<td class="nump">2,608<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and cash equivalents: | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CashAndCashEquivalentsAmortizedCost', window );">Cash and cash equivalents, Amortized Cost</a></td>
<td class="nump">2,060<span></span>
</td>
<td class="nump">1,272<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax', window );">Cash and cash equivalents, Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax', window );">Cash and cash equivalents, Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents, Fair Value</a></td>
<td class="nump">2,060<span></span>
</td>
<td class="nump">1,272<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=sera_CurrentMarketableSecuritiesMember', window );">Current marketable securities:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Marketable securities, Amortized Cost</a></td>
<td class="nump">42,105<span></span>
</td>
<td class="nump">45,380<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Marketable securities, Gross Unrealized Gains</a></td>
<td class="nump">93<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Marketable securities, Gross Unrealized Losses</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(187)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities, Fair Value</a></td>
<td class="nump">42,193<span></span>
</td>
<td class="nump">45,199<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=sera_CurrentMarketableSecuritiesMember', window );">Current marketable securities: | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Marketable securities, Amortized Cost</a></td>
<td class="nump">1,449<span></span>
</td>
<td class="nump">11,769<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Marketable securities, Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Marketable securities, Gross Unrealized Losses</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities, Fair Value</a></td>
<td class="nump">1,446<span></span>
</td>
<td class="nump">11,773<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=sera_CurrentMarketableSecuritiesMember', window );">Current marketable securities: | U.S. federal agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Marketable securities, Amortized Cost</a></td>
<td class="nump">9,453<span></span>
</td>
<td class="nump">19,644<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Marketable securities, Gross Unrealized Gains</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Marketable securities, Gross Unrealized Losses</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(102)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities, Fair Value</a></td>
<td class="nump">9,459<span></span>
</td>
<td class="nump">19,542<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=sera_CurrentMarketableSecuritiesMember', window );">Current marketable securities: | U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Marketable securities, Amortized Cost</a></td>
<td class="nump">4,502<span></span>
</td>
<td class="nump">12,812<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Marketable securities, Gross Unrealized Gains</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Marketable securities, Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(81)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities, Fair Value</a></td>
<td class="nump">4,503<span></span>
</td>
<td class="nump">12,731<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=sera_CurrentMarketableSecuritiesMember', window );">Current marketable securities: | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Marketable securities, Amortized Cost</a></td>
<td class="nump">26,701<span></span>
</td>
<td class="nump">1,155<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Marketable securities, Gross Unrealized Gains</a></td>
<td class="nump">84<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Marketable securities, Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities, Fair Value</a></td>
<td class="nump">26,785<span></span>
</td>
<td class="nump">1,153<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=sera_NonCurrentMarketableSecuritiesMember', window );">Long-term marketable securities:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Marketable securities, Amortized Cost</a></td>
<td class="nump">22,001<span></span>
</td>
<td class="nump">30,674<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Marketable securities, Gross Unrealized Gains</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">189<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Marketable securities, Gross Unrealized Losses</a></td>
<td class="num">(64)<span></span>
</td>
<td class="num">(22)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities, Fair Value</a></td>
<td class="nump">21,973<span></span>
</td>
<td class="nump">30,841<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=sera_NonCurrentMarketableSecuritiesMember', window );">Long-term marketable securities: | U.S. federal agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Marketable securities, Amortized Cost</a></td>
<td class="nump">2,863<span></span>
</td>
<td class="nump">9,406<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Marketable securities, Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Marketable securities, Gross Unrealized Losses</a></td>
<td class="num">(59)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities, Fair Value</a></td>
<td class="nump">2,804<span></span>
</td>
<td class="nump">9,416<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=sera_NonCurrentMarketableSecuritiesMember', window );">Long-term marketable securities: | U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Marketable securities, Amortized Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,388<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Marketable securities, Gross Unrealized Gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Marketable securities, Gross Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities, Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,386<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=sera_NonCurrentMarketableSecuritiesMember', window );">Long-term marketable securities: | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Marketable securities, Amortized Cost</a></td>
<td class="nump">16,066<span></span>
</td>
<td class="nump">16,880<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Marketable securities, Gross Unrealized Gains</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">159<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Marketable securities, Gross Unrealized Losses</a></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities, Fair Value</a></td>
<td class="nump">16,097<span></span>
</td>
<td class="nump">$ 17,039<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=sera_NonCurrentMarketableSecuritiesMember', window );">Long-term marketable securities: | Municipal Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Marketable securities, Amortized Cost</a></td>
<td class="nump">3,072<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Marketable securities, Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Marketable securities, Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities, Fair Value</a></td>
<td class="nump">$ 3,072<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash And Cash Equivalents, Accumulated Gross Unrealized Gain, Before Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash And Cash Equivalents, Accumulated Gross Unrealized Loss, Before Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_CashAndCashEquivalentsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash And Cash Equivalents, Amortized Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_CashAndCashEquivalentsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash And Cash Equivalents, Debt Securities Available-For-Sale, Accumulated Gross Unrealized Gain, Before Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash And Cash Equivalents, Debt Securities Available-For-Sale, Accumulated Gross Unrealized Loss, Before Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash And Cash Equivalents, Debt Securities Available-For-Sale, Amortized Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash And Cash Equivalents, Debt Securities Available-For-Sale, Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 103<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=sera_CurrentMarketableSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=sera_CurrentMarketableSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=sera_NonCurrentMarketableSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=sera_NonCurrentMarketableSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cash, Cash Equivalents and Marketable Securities - Available-for-sale Debt Securities and Cash Equivalents in Unrealized Loss Positions (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract', window );"><strong>Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less than 12 months, Fair Value</a></td>
<td class="nump">$ 8,309<span></span>
</td>
<td class="nump">$ 26,683<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less than 12 months, Unrealized Losses</a></td>
<td class="num">(67)<span></span>
</td>
<td class="num">(69)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">12 months or greater, Fair Value</a></td>
<td class="nump">3,021<span></span>
</td>
<td class="nump">19,646<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">12 months or greater, Unrealized Losses</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(140)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total, Fair Value</a></td>
<td class="nump">11,330<span></span>
</td>
<td class="nump">46,329<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total, Unrealized Losses</a></td>
<td class="num">(69)<span></span>
</td>
<td class="num">(209)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract', window );"><strong>Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less than 12 months, Fair Value</a></td>
<td class="nump">1,446<span></span>
</td>
<td class="nump">5,453<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less than 12 months, Unrealized Losses</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">12 months or greater, Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">12 months or greater, Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total, Fair Value</a></td>
<td class="nump">1,446<span></span>
</td>
<td class="nump">5,453<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total, Unrealized Losses</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract', window );"><strong>Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less than 12 months, Fair Value</a></td>
<td class="nump">4,059<span></span>
</td>
<td class="nump">1,153<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less than 12 months, Unrealized Losses</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">12 months or greater, Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">12 months or greater, Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total, Fair Value</a></td>
<td class="nump">4,059<span></span>
</td>
<td class="nump">1,153<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total, Unrealized Losses</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. federal agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract', window );"><strong>Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less than 12 months, Fair Value</a></td>
<td class="nump">2,804<span></span>
</td>
<td class="nump">15,308<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less than 12 months, Unrealized Losses</a></td>
<td class="num">(59)<span></span>
</td>
<td class="num">(52)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">12 months or greater, Fair Value</a></td>
<td class="nump">3,021<span></span>
</td>
<td class="nump">8,751<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">12 months or greater, Unrealized Losses</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(67)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total, Fair Value</a></td>
<td class="nump">5,825<span></span>
</td>
<td class="nump">24,059<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total, Unrealized Losses</a></td>
<td class="num">$ (61)<span></span>
</td>
<td class="num">(119)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember', window );">U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract', window );"><strong>Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less than 12 months, Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,769<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less than 12 months, Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">12 months or greater, Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,895<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">12 months or greater, Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(73)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total, Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,664<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total, Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (86)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479081/326-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479106/326-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479081/326-30-55-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479106/326-30-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479106/326-30-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479081/326-30-55-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479106/326-30-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479106/326-30-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479081/326-30-55-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479106/326-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479106/326-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash, Cash Equivalents and Marketable Securities - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Debt Securities, Available-for-Sale, Allowance for Credit Loss</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt', window );">Proceeds from the sale of available-for-sale securities prior to maturity</a></td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479106/326-30-50-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479106/326-30-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-9<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cash, Cash Equivalents and Marketable Securities - Marketable Securities Classified by Contractual Maturities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost', window );">Due within one year</a></td>
<td class="nump">$ 42,105<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost', window );">Due after one year through five years</a></td>
<td class="nump">22,001<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Marketable securities, Amortized Cost</a></td>
<td class="nump">64,106<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Due within one year</a></td>
<td class="nump">42,193<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">Due after one year through five years</a></td>
<td class="nump">21,973<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">$ 64,166<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477268/942-320-50-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477268/942-320-50-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 103<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment - Schedule of Components of Property and Equipment, Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Total property and equipment</a></td>
<td class="nump">$ 8,995<span></span>
</td>
<td class="nump">$ 9,021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization', window );">Less accumulated depreciation and amortization</a></td>
<td class="num">(7,756)<span></span>
</td>
<td class="num">(7,022)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Property and equipment, net</a></td>
<td class="nump">1,239<span></span>
</td>
<td class="nump">1,999<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=sera_LaboratoryEquipmentMember', window );">Laboratory equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Total property and equipment</a></td>
<td class="nump">5,663<span></span>
</td>
<td class="nump">5,734<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Total property and equipment</a></td>
<td class="nump">1,099<span></span>
</td>
<td class="nump">1,054<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Total property and equipment</a></td>
<td class="nump">772<span></span>
</td>
<td class="nump">772<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember', window );">Software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Total property and equipment</a></td>
<td class="nump">1,141<span></span>
</td>
<td class="nump">1,141<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Total property and equipment</a></td>
<td class="nump">$ 320<span></span>
</td>
<td class="nump">$ 320<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=sera_LaboratoryEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=sera_LaboratoryEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">$ 833<span></span>
</td>
<td class="nump">$ 900<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets, net - Schedule of Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, gross</a></td>
<td class="nump">$ 1,045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(19)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net carrying amount</a></td>
<td class="nump">1,026<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember', window );">Software developed for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross carrying amount</a></td>
<td class="nump">348<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(19)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Definite-lived intangible assets, net carrying amount</a></td>
<td class="nump">329<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=sera_DomainNamesMember', window );">Domain Names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangible asset</a></td>
<td class="nump">$ 697<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 928<br> -SubTopic 340<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478859/928-340-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=sera_DomainNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=sera_DomainNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, net - Additional Information (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CapitalizedIntangibleAssets', window );">Capitalized Intangible Assets</a></td>
<td class="nump">$ 700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember', window );">Software developed for sale</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CapitalizedIntangibleAssets', window );">Capitalized Intangible Assets</a></td>
<td class="nump">$ 300<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_CapitalizedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capitalized intangible assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_CapitalizedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued and Other Current Liabilities - Schedule of Components of Accrued and Other Current Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract', window );"><strong>Accounts Payable and Accrued Liabilities, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedSalariesCurrent', window );">Accrued compensation</a></td>
<td class="nump">$ 1,041<span></span>
</td>
<td class="nump">$ 779<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedVacationCurrent', window );">Accrued vacation</a></td>
<td class="nump">403<span></span>
</td>
<td class="nump">365<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedEmployeeBenefitsCurrent', window );">Accrued 401(k) matching contributions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability, current portion</a></td>
<td class="nump">644<span></span>
</td>
<td class="nump">578<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">296<span></span>
</td>
<td class="nump">926<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities', window );">Total accrued and other current liabilities</a></td>
<td class="nump">$ 2,384<span></span>
</td>
<td class="nump">$ 2,722<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedEmployeeBenefitsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedEmployeeBenefitsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalariesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalariesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedVacationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for unused vacation time owed to employees based on the entity's vacation benefit given to its employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 710<br> -SubTopic 10<br> -Section 25<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483070/710-10-25-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedVacationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Income, Net - Schedule of Components of Other Income, Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeOther', window );">Interest income</a></td>
<td class="nump">$ 2,747<span></span>
</td>
<td class="nump">$ 1,640<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium', window );">Investment income, net</a></td>
<td class="nump">1,018<span></span>
</td>
<td class="nump">1,994<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">$ 3,765<span></span>
</td>
<td class="nump">$ 3,634<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income earned from interest bearing assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accretion (amortization) of purchase discount (premium) on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Financial Assets that are Measured at Fair Value on a Recurring Basis (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">$ 64,166<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">64,166<span></span>
</td>
<td class="nump">$ 1,272<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Recurring | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">1,446<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Recurring | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">42,882<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Recurring | Municipal Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">3,072<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Recurring | U.S. federal agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">12,263<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Recurring | U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">4,503<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Recurring | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,272<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">2,060<span></span>
</td>
<td class="nump">76,040<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Recurring | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">11,773<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Recurring | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">18,192<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Recurring | Municipal Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Recurring | U.S. federal agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">28,958<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Recurring | U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">17,117<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Recurring | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents:</a></td>
<td class="nump">2,060<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Recurring | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Recurring | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Recurring | Municipal Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Recurring | U.S. federal agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Recurring | U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Recurring | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents:</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 103<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2021</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,712<span></span>
</td>
<td class="nump">$ 40,127<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77<span></span>
</td>
<td class="nump">306<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=sera_MasterServicesAgreementMember', window );">Master services agreement | Healthcore Inc | Investor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,900<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=sera_LaboratoryServicesAgreementMember', window );">Laboratory Services Agreement | Elevance Health, Inc | Investor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 61<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=sera_CommercialCollaborationAgreementMember', window );">Commercial Collaboration Agreement | Elevance Health, Inc | Investor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm', window );">Term of agreement</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_RelatedPartyTransactionOtherReceivablesRelatedToMinimumPayments', window );">Other receivables related to minimum payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period for Commercial collaboration agreement , in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_RelatedPartyTransactionOtherReceivablesRelatedToMinimumPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Related Party Transaction, Other Receivables Related To Minimum Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_RelatedPartyTransactionOtherReceivablesRelatedToMinimumPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=sera_MasterServicesAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=sera_MasterServicesAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=sera_CarelonResearchMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=sera_CarelonResearchMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=sera_LaboratoryServicesAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=sera_LaboratoryServicesAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=sera_ElevanceHealthIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=sera_ElevanceHealthIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=sera_CommercialCollaborationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=sera_CommercialCollaborationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Structure - Additional Information (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Aug. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>Vote </div>
<div>CommonStockClass </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_NumberOfCommonStockClassesAuthorized', window );">Number of common stock classes authorized | CommonStockClass</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_NumberOfVotesPerShare', window );">Number of votes per share | Vote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CommonStockConversionRatio', window );">Common stock, conversion ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,206,909<span></span>
</td>
<td class="nump">30,736,513<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A common stock | At-the-Market Offering | 2024 Sales Agreement | TD Cowen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A common stock | At-the-Market Offering | 2024 Sales Agreement | TD Cowen | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_GrossSalesProceedsFromIssuanceOfCommonStock', window );">Gross sales proceeds from issuance of common stock | $</a></td>
<td class="nump">$ 50.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember', window );">Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_CommonStockConversionRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Conversion Ratio</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_CommonStockConversionRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_GrossSalesProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross sales proceeds from issuance of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_GrossSalesProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_NumberOfCommonStockClassesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Common Stock Classes Authorized</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_NumberOfCommonStockClassesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_NumberOfVotesPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Votes Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_NumberOfVotesPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=sera_AtTheMarketOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=sera_AtTheMarketOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=sera_TwoThousandTwentyFourSalesAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=sera_TwoThousandTwentyFourSalesAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=sera_TdCowenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=sera_TdCowenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Capital Structure - Schedule of Common Stock Reserved for Future Issuance (Details) - Class A common stock - shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares reserved for future issuance (in shares)</a></td>
<td class="nump">13,522,355<span></span>
</td>
<td class="nump">14,523,859<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Warrants to purchase Class A common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares reserved for future issuance (in shares)</a></td>
<td class="nump">2,646,247<span></span>
</td>
<td class="nump">2,775,978<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Options to purchase Class A common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares reserved for future issuance (in shares)</a></td>
<td class="nump">6,113,155<span></span>
</td>
<td class="nump">7,251,663<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Restricted stock units outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares reserved for future issuance (in shares)</a></td>
<td class="nump">1,631,162<span></span>
</td>
<td class="nump">2,692,459<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A common stock available for future grants under the 2021 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares reserved for future issuance (in shares)</a></td>
<td class="nump">2,071,498<span></span>
</td>
<td class="nump">1,002,091<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A common stock available for future grants under the 2021 Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares reserved for future issuance (in shares)</a></td>
<td class="nump">1,060,293<span></span>
</td>
<td class="nump">801,668<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_CapitalSharesReservedForFutureIssuanceAxis=sera_WarrantsToPurchaseCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_CapitalSharesReservedForFutureIssuanceAxis=sera_WarrantsToPurchaseCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_CapitalSharesReservedForFutureIssuanceAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_CapitalSharesReservedForFutureIssuanceAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_CapitalSharesReservedForFutureIssuanceAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_CapitalSharesReservedForFutureIssuanceAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_CapitalSharesReservedForFutureIssuanceAxis=sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_CapitalSharesReservedForFutureIssuanceAxis=sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_CapitalSharesReservedForFutureIssuanceAxis=sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_CapitalSharesReservedForFutureIssuanceAxis=sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Additional Information (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2021</div></th>
<th class="th"><div>Jul. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value of options granted (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.54<span></span>
</td>
<td class="nump">$ 2.28<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Aggregate intrinsic value of options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,500<span></span>
</td>
<td class="nump">$ 1,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Fair value of options vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,700<span></span>
</td>
<td class="nump">$ 4,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unamortized stock-based compensation cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unamortized stock-based compensation cost expected to be recognized over a weighted average period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares available for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,522,355<span></span>
</td>
<td class="nump">14,523,859<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=sera_Plan2011Member', window );">2011 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration term</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=sera_Plan2021Member', window );">2021 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=sera_Plan2021Member', window );">2021 Plan | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=sera_Plan2021Member', window );">2021 Plan | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=sera_Plan2021Member', window );">2021 Plan | Class A common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares available for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,071,498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=sera_PlanEspp2021Member', window );">2021 ESPP | Class A common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares available for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,060,293<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=sera_Plan2011Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=sera_Plan2011Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=sera_Plan2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=sera_Plan2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=sera_PlanEspp2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=sera_PlanEspp2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Summary of Options Granted and Outstanding (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Shares Subject to Options Outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at the beginning (in shares)</a></td>
<td class="nump">7,251,663<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">84,392<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Expired (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Cancelled (in shares)</a></td>
<td class="num">(120,387)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(1,102,513)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at the end (in shares)</a></td>
<td class="nump">6,113,155<span></span>
</td>
<td class="nump">7,251,663<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Number of shares subject to options outstanding, vested and expected to vest at the end (in shares)</a></td>
<td class="nump">6,073,028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Number of shares subject to options outstanding, vested and exercisable at the end</a></td>
<td class="nump">5,380,324<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted- Average Exercise Price Per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at the beginning (in usd per share)</a></td>
<td class="nump">$ 3.66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in usd per share)</a></td>
<td class="nump">8.43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Expired (in usd per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Cancelled (in usd per share)</a></td>
<td class="nump">3.68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in usd per share)</a></td>
<td class="nump">2.63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at the end (in usd per share)</a></td>
<td class="nump">3.91<span></span>
</td>
<td class="nump">$ 3.66<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price per share, vested and expected to vest at the end (in usd per share)</a></td>
<td class="nump">3.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Weighted average exercise price per share, vested and exercisable at the end (in usd per share)</a></td>
<td class="nump">$ 3.77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual life, outstanding</a></td>
<td class="text">6 years 3 months 18 days<span></span>
</td>
<td class="text">6 years 10 months 24 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual life, vested and expected to vest at the end</a></td>
<td class="text">6 years 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual life, vested and exercisable at the end</a></td>
<td class="text">6 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value, outstanding</a></td>
<td class="nump">$ 27,008<span></span>
</td>
<td class="nump">$ 20,014<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Aggregate intrinsic value, vested and expected to vest at the end</a></td>
<td class="nump">26,849<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate intrinsic value, vested and exercisable at the end</a></td>
<td class="nump">$ 24,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of Fair Values Calculated using Black-Scholes Option Pricing Model (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected volatility, minimum</a></td>
<td class="nump">78.80%<span></span>
</td>
<td class="nump">70.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected volatility, maximum</a></td>
<td class="nump">78.90%<span></span>
</td>
<td class="nump">72.40%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free interest rate, minimum</a></td>
<td class="nump">4.10%<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free interest rate, maximum</a></td>
<td class="nump">4.20%<span></span>
</td>
<td class="nump">4.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend', window );">Expected dividend yield</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">5 years 2 months 12 days<span></span>
</td>
<td class="text">5 years 3 months 18 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">5 years 3 months 18 days<span></span>
</td>
<td class="text">7 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the weighted average expected dividend for an entity using a valuation technique with different dividend rates during the contractual term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Summary of Information about RSUs Granted and Outstanding (Details) - Restricted Stock Units (RSUs)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding, beginning balance (in shares) | shares</a></td>
<td class="nump">2,692,459<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">249,040<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(52,992)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(1,257,345)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding, ending balance (in shares) | shares</a></td>
<td class="nump">1,631,162<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding, beginning balance (in usd per share) | $ / shares</a></td>
<td class="nump">$ 2.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in usd per share) | $ / shares</a></td>
<td class="nump">8.52<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in usd per share) | $ / shares</a></td>
<td class="nump">2.02<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in usd per share) | $ / shares</a></td>
<td class="nump">2.54<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding, ending balance (in usd per share) | $ / shares</a></td>
<td class="nump">$ 2.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of Impact of Stock-based Compensation Expense in Statements of Operations (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total employee stock-based compensation</a></td>
<td class="nump">$ 7,013<span></span>
</td>
<td class="nump">$ 5,273<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total employee stock-based compensation</a></td>
<td class="nump">2,502<span></span>
</td>
<td class="nump">1,574<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Sales and marketing expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total employee stock-based compensation</a></td>
<td class="nump">390<span></span>
</td>
<td class="nump">657<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total employee stock-based compensation</a></td>
<td class="nump">$ 4,121<span></span>
</td>
<td class="nump">$ 3,042<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Summary of Unrecognized Stock-based Compensation Expense for Outstanding Unvested Stock Options and RSUs (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unamortized stock-based compensation cost</a></td>
<td class="nump">$ 1,975<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</a></td>
<td class="nump">$ 5,074<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</a></td>
<td class="nump">$ 3,099<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</a></td>
<td class="text">1 year 10 months 24 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Warrants - Schedule of Common Stock Warrants Outstanding (Details) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding (in shares)</a></td>
<td class="nump">2,646,247<span></span>
</td>
<td class="nump">2,775,978<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=sera_CommonStockWarrantAt520SharePriceMember', window );">5.20</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in usd per share)</a></td>
<td class="nump">$ 5.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,473<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=sera_CommonStockWarrantAt9.03SharePriceMember', window );">9.03</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in usd per share)</a></td>
<td class="nump">$ 9.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding (in shares)</a></td>
<td class="nump">969,275<span></span>
</td>
<td class="nump">1,032,404<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=sera_CommonStockWarrantAt10.84SharePriceMember', window );">10.84</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in usd per share)</a></td>
<td class="nump">$ 10.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding (in shares)</a></td>
<td class="nump">946,666<span></span>
</td>
<td class="nump">1,009,795<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=sera_CommonStockWarrantAt1238SharePriceMember', window );">12.38</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in usd per share)</a></td>
<td class="nump">$ 12.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding (in shares)</a></td>
<td class="nump">8,083<span></span>
</td>
<td class="nump">8,083<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=sera_CommonStockWarrantAt20.77SharePriceMember', window );">20.77</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in usd per share)</a></td>
<td class="nump">$ 20.77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding (in shares)</a></td>
<td class="nump">722,223<span></span>
</td>
<td class="nump">722,223<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=sera_CommonStockWarrantAt520SharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=sera_CommonStockWarrantAt520SharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=sera_CommonStockWarrantAt9.03SharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=sera_CommonStockWarrantAt9.03SharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=sera_CommonStockWarrantAt10.84SharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=sera_CommonStockWarrantAt10.84SharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=sera_CommonStockWarrantAt1238SharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=sera_CommonStockWarrantAt1238SharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=sera_CommonStockWarrantAt20.77SharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=sera_CommonStockWarrantAt20.77SharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract', window );"><strong>Warrants and Rights Note Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_ClassOfWarrantOrRightExercised', window );">Class of Warrant Or Right, Exercised</a></td>
<td class="num">(126,258)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_StockIssuedDuringPeriodSharesStockWarrantExercised', window );">Common stock warrant exercises (in shares)</a></td>
<td class="nump">7,971<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_StockIssuedDuringPeriodSharesStockWarrantExpired', window );">Common stock warrants expired (in shares)</a></td>
<td class="nump">3,473<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_ClassOfWarrantOrRightExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of Warrant Or Right, Exercised</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_ClassOfWarrantOrRightExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_StockIssuedDuringPeriodSharesStockWarrantExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Stock Warrant Exercised</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_StockIssuedDuringPeriodSharesStockWarrantExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_StockIssuedDuringPeriodSharesStockWarrantExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period, shares, stock warrant expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_StockIssuedDuringPeriodSharesStockWarrantExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsNoteDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Schedule of Leases in Financial Statement (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_RightOfUseAssetAbstract', window );"><strong>Right-of-use assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating leases</a></td>
<td class="nump">$ 613<span></span>
</td>
<td class="nump">$ 1,180<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance leases</a></td>
<td class="nump">699<span></span>
</td>
<td class="nump">1,008<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_RightOfUseAssetTotal', window );">Total right-of-use assets</a></td>
<td class="nump">1,312<span></span>
</td>
<td class="nump">2,188<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_LeaseLiabilitiesAbstract', window );"><strong>Lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating leases</a></td>
<td class="nump">644<span></span>
</td>
<td class="nump">578<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease obligation, net of current portion</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">644<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance lease obligation, current portion</a></td>
<td class="nump">194<span></span>
</td>
<td class="nump">440<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease obligation, net of current portion</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">196<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_LeaseLiabilitiesTotal', window );">Total lease liabilities</a></td>
<td class="nump">$ 840<span></span>
</td>
<td class="nump">$ 1,858<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Other assets<span></span>
</td>
<td class="text">Other assets<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Property and equipment, net<span></span>
</td>
<td class="text">Property and equipment, net<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Accrued Liabilities and Other Liabilities<span></span>
</td>
<td class="text">Accrued Liabilities and Other Liabilities<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_LeaseLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_LeaseLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_LeaseLiabilitiesTotal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease Liabilities, Total</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_LeaseLiabilitiesTotal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_RightOfUseAssetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Right-of-Use Asset</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_RightOfUseAssetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_RightOfUseAssetTotal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Right-of-Use Asset, Total</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_RightOfUseAssetTotal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes operating lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Schedule of Lease Cost and Other Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Lease cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Amortization of right-of-use assets</a></td>
<td class="nump">$ 314<span></span>
</td>
<td class="nump">$ 312<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest on lease liabilities</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">55<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">636<span></span>
</td>
<td class="nump">636<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease cost</a></td>
<td class="nump">976<span></span>
</td>
<td class="nump">1,003<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_FinanceLeasesOtherInformationAbstract', window );"><strong>Finance leases:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Operating cash outflows</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">55<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Financing cash outflows</a></td>
<td class="nump">440<span></span>
</td>
<td class="nump">466<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Right-of-use assets obtained in exchange for lease liabilities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term (in years)</a></td>
<td class="text">4 months 24 days<span></span>
</td>
<td class="text">1 year 4 months 24 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate</a></td>
<td class="nump">6.70%<span></span>
</td>
<td class="nump">6.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_OperatingLeasesOtherInformationAbstract', window );"><strong>Operating leases:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash outflows</a></td>
<td class="nump">$ 646<span></span>
</td>
<td class="nump">$ 628<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for lease liabilities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term (in years)</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate</a></td>
<td class="nump">7.50%<span></span>
</td>
<td class="nump">7.50%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_FinanceLeasesOtherInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Leases, Other Information</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_FinanceLeasesOtherInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_OperatingLeasesOtherInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Leases, Other Information</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_OperatingLeasesOtherInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Schedule of Future Minimum Lease Payments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2025</a></td>
<td class="nump">$ 666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2026</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_LesseeOperatingLeaseLiabilityToBePaidYearThreeAndThereafter', window );">2027 and thereafter</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total minimum lease payments</a></td>
<td class="nump">666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(22)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of future lease payments</a></td>
<td class="nump">644<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Less: current portion</a></td>
<td class="num">(644)<span></span>
</td>
<td class="num">$ (578)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term portion</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">644<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Finance Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2025</a></td>
<td class="nump">197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2026</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_FinanceLeaseLiabilityToBePaidYearThreeAndThereafter', window );">2027 and thereafter</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total minimum lease payments</a></td>
<td class="nump">199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Present value of future lease payments</a></td>
<td class="nump">196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Less: current portion</a></td>
<td class="num">(194)<span></span>
</td>
<td class="num">(440)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Long-term portion</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">196<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_LeaseLiabilityPaymentDueAbstract', window );"><strong>Total</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_LeaseLiabilityToBePaidYearOne', window );">2025</a></td>
<td class="nump">863<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_LeaseLiabilityToBePaidYearTwo', window );">2026</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_LeaseLiabilityToBePaidYearThreeAndThereafter', window );">2027 and thereafter</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_LeaseLiabilityPaymentDue', window );">Total minimum lease payments</a></td>
<td class="nump">865<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_LeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(25)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_LeaseLiabilitiesTotal', window );">Total lease liabilities</a></td>
<td class="nump">840<span></span>
</td>
<td class="nump">$ 1,858<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_LeaseLiabilityCurrent', window );">Less: current portion</a></td>
<td class="num">(838)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_LeaseLiabilityNoncurrent', window );">Long-term portion</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_FinanceLeaseLiabilityToBePaidYearThreeAndThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Liability, to be Paid, Year Three and Thereafter</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_FinanceLeaseLiabilityToBePaidYearThreeAndThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_LeaseLiabilitiesTotal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease Liabilities, Total</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_LeaseLiabilitiesTotal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_LeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease Liability, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_LeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_LeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease Liability, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_LeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_LeaseLiabilityPaymentDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Payment, Due</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_LeaseLiabilityPaymentDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_LeaseLiabilityPaymentDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Payment, Due</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_LeaseLiabilityPaymentDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_LeaseLiabilityToBePaidYearOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, to be Paid, Year One</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_LeaseLiabilityToBePaidYearOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_LeaseLiabilityToBePaidYearThreeAndThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, to be Paid, Year Three and Thereafter</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_LeaseLiabilityToBePaidYearThreeAndThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_LeaseLiabilityToBePaidYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, to be Paid, Year Two</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_LeaseLiabilityToBePaidYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_LeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Undiscounted Excess Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_LeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_LesseeOperatingLeaseLiabilityToBePaidYearThreeAndThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Liability, to be Paid, Year Three and Thereafter</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_LesseeOperatingLeaseLiabilityToBePaidYearThreeAndThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Additional Information (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_IndemnificationLiability', window );">Indemnification liability | $</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=sera_OfficeAndLaboratorySpaceMember', window );">Office and laboratory space</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory', window );">Number of square feet under lease | ft&#178;</a></td>
<td class="nump">24,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_CommitmentsAndContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commitments And Contingencies [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_CommitmentsAndContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_IndemnificationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of indemnification liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_IndemnificationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The area of leased office and laboratory space.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=sera_OfficeAndLaboratorySpaceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=sera_OfficeAndLaboratorySpaceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="nump">78,058,000<span></span>
</td>
<td class="nump">64,879,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Increase in valuation allowance</a></td>
<td class="nump">13,179,000<span></span>
</td>
<td class="nump">$ 10,376,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">169,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">U.S Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">239,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">$ 182,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Components of Income Tax Provision (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current benefit (provision)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">8,981,000<span></span>
</td>
<td class="nump">8,178,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="nump">4,198,000<span></span>
</td>
<td class="nump">2,198,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Change in valuation allowance</a></td>
<td class="num">(13,179,000)<span></span>
</td>
<td class="num">(10,376,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred benefit (provision)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total income tax benefit (provision)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Effective Tax Rate Reconciliation (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract', window );"><strong>Effective Income Tax Rate Reconciliation, Amount [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Computed Federal income tax benefit (expense) at the statutory rate</a></td>
<td class="nump">$ 6,908,000<span></span>
</td>
<td class="nump">$ 7,602,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch', window );">R&amp;D credits</a></td>
<td class="nump">837,000<span></span>
</td>
<td class="nump">698,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_EffectiveIncomeTaxRateReconciliationEquityBasedExpensesAmount', window );">Equity-based expenses</a></td>
<td class="nump">2,366,000<span></span>
</td>
<td class="num">(63,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State income taxes, net of federal benefit</a></td>
<td class="nump">3,272,000<span></span>
</td>
<td class="nump">1,783,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpAmount', window );">State net operating loss carryforward true up</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">154,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate', window );">Change in statutory rates</a></td>
<td class="nump">813,000<span></span>
</td>
<td class="nump">163,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other</a></td>
<td class="num">(1,017,000)<span></span>
</td>
<td class="nump">39,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(13,179,000)<span></span>
</td>
<td class="num">(10,376,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total income tax benefit (provision)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract', window );"><strong>Effective Income Tax Rate Reconciliation, Percent [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Computed Federal income tax benefit (expense) at the statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch', window );">R&amp;D credits</a></td>
<td class="nump">2.54%<span></span>
</td>
<td class="nump">1.93%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_EffectiveIncomeTaxRateReconciliationEquityBasedExpensesPercent', window );">Equity-based expenses</a></td>
<td class="nump">7.19%<span></span>
</td>
<td class="num">(0.17%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State income taxes, net of federal benefit</a></td>
<td class="nump">9.95%<span></span>
</td>
<td class="nump">4.92%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpPercent', window );">State net operating loss carryforward true up</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.42%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate', window );">Change in statutory rates</a></td>
<td class="nump">2.47%<span></span>
</td>
<td class="nump">0.45%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other</a></td>
<td class="num">(3.09%)<span></span>
</td>
<td class="nump">0.11%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(40.06%)<span></span>
</td>
<td class="num">(28.66%)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Income tax benefit (provision)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_EffectiveIncomeTaxRateReconciliationEquityBasedExpensesAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Equity-Based Expenses, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_EffectiveIncomeTaxRateReconciliationEquityBasedExpensesAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_EffectiveIncomeTaxRateReconciliationEquityBasedExpensesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Equity-Based Expenses, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_EffectiveIncomeTaxRateReconciliationEquityBasedExpensesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, State Net Operating Loss Carryforward True Up, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, State Net Operating Loss Carryforward True Up, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.1.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 61,615<span></span>
</td>
<td class="nump">$ 53,072<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">R&amp;D credits</a></td>
<td class="nump">4,693<span></span>
</td>
<td class="nump">3,856<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment', window );">R&amp;E expenses</a></td>
<td class="nump">8,127<span></span>
</td>
<td class="nump">5,219<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals', window );">Accruals and reserves</a></td>
<td class="nump">409<span></span>
</td>
<td class="nump">278<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Equity-based compensation</a></td>
<td class="nump">3,193<span></span>
</td>
<td class="nump">2,440<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment', window );">Depreciation and amortization</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_DeferredTaxAssetsLeaseLiabilities', window );">Lease liability</a></td>
<td class="nump">184<span></span>
</td>
<td class="nump">317<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax asset before allowance</a></td>
<td class="nump">78,233<span></span>
</td>
<td class="nump">65,189<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less: valuation allowance</a></td>
<td class="num">(78,058)<span></span>
</td>
<td class="num">(64,879)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Total deferred tax asset</a></td>
<td class="nump">175<span></span>
</td>
<td class="nump">310<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesNetAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_DeferredTaxLiabilitiesRightOfUseAssets', window );">Right-of-use asset</a></td>
<td class="num">(175)<span></span>
</td>
<td class="num">(306)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_DeferredTaxAssetsLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_DeferredTaxAssetsLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_DeferredTaxLiabilitiesRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Right Of Use Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_DeferredTaxLiabilitiesRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from in-process research and development cost acquired in business combination or from joint venture formation or both.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Unrecognized Tax Positions (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at the beginning of the year</a></td>
<td class="nump">$ 2,570<span></span>
</td>
<td class="nump">$ 2,025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Gross increases-prior period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">80<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Gross increases-current period</a></td>
<td class="nump">559<span></span>
</td>
<td class="nump">465<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at the end of the year</a></td>
<td class="nump">$ 3,129<span></span>
</td>
<td class="nump">$ 2,570<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-10B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share - Schedule of Anti-dilutive Securities Excluded from the Computation of Earnings per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from the computation of earnings per share (in shares)</a></td>
<td class="nump">10,390,564<span></span>
</td>
<td class="nump">12,720,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=sera_WarrantsToPurchaseCommonStockMember', window );">Warrants to purchase Class A common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from the computation of earnings per share (in shares)</a></td>
<td class="nump">2,646,247<span></span>
</td>
<td class="nump">2,775,978<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Options to purchase Class A common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from the computation of earnings per share (in shares)</a></td>
<td class="nump">6,113,155<span></span>
</td>
<td class="nump">7,251,663<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from the computation of earnings per share (in shares)</a></td>
<td class="nump">1,631,162<span></span>
</td>
<td class="nump">2,692,459<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=sera_WarrantsToPurchaseCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=sera_WarrantsToPurchaseCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Summary of Segment Information for Revenue, Significant Segment Expenses and Segment Loss Expenses that are Regularly Provided to the CODM (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 77<span></span>
</td>
<td class="nump">$ 306<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">82<span></span>
</td>
<td class="nump">210<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLaborRelatedExpenses', window );">Payroll related expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">13,269<span></span>
</td>
<td class="nump">17,878<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,013<span></span>
</td>
<td class="nump">5,273<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Consulting and professional fees</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,581<span></span>
</td>
<td class="nump">5,012<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_ClinicalStudiesAndOutsideProcessing', window );">Clinical studies and outside processing</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,383<span></span>
</td>
<td class="nump">4,728<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_EquipmentLabSuppliesAndFacilityExpenses', window );">Equipment lab supplies and facility expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,635<span></span>
</td>
<td class="nump">2,037<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">814<span></span>
</td>
<td class="nump">900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherItemAmount', window );">Other segment items</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">2,935<span></span>
</td>
<td class="nump">4,089<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(36,635)<span></span>
</td>
<td class="num">(39,821)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(28)<span></span>
</td>
<td class="num">(55)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,765<span></span>
</td>
<td class="nump">3,634<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (32,898)<span></span>
</td>
<td class="num">$ (36,242)<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain amortization amounts are included within cost of revenue.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other segment items consist primarily of insurance costs, IT services, travel expenses, marketing expenses, taxes, and other miscellaneous expense.</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_ClinicalStudiesAndOutsideProcessing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Clinical studies and outside processing</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_ClinicalStudiesAndOutsideProcessing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_EquipmentLabSuppliesAndFacilityExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equipment lab supplies and facility expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_EquipmentLabSuppliesAndFacilityExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLaborRelatedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of labor-related expenses classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLaborRelatedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-3<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingOtherItemAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingOtherItemAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Additional Information) (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 13, 2025</div></th>
<th class="th"><div>Feb. 12, 2025</div></th>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Exercise of stock option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,902<span></span>
</td>
<td class="nump">$ 1,095<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Events</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_WarrantsIssued', window );">Issuance of warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_WarrantIssuedPricePerPre-FundedWarrantAndAccompanyingWarrant', window );">Offering price per pre-funded warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.9999<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_IssuePricePerShareAndWarrant', window );">Offering price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_ProceedsFromIssuanceOfSharesAndPreFundedWarrants', window );">Proceeds from issuance of shares and warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_ProceedsFromIssuanceOfSharesAndPreFundedWarrantsNet', window );">Proceeds from issuance of shares and warrants, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_PercentageOfMinimumOwnershipBeneficiallyOwnByHolderWithAffiliatesToWarrantExercise', window );">Percentage of minimum ownership beneficially own by holder with affiliates to warrant exercise</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_FairValueAdjustmentOfPreFundedWarrants', window );">Fair value adjustment of pre funded warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_OfferingExpenses', window );">Offering expense</a></td>
<td class="nump">$ 7,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_ProceedsFromIssuanceInitialPublicOfferingNet', window );">Proceeds from offering net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 53,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Exercise of stock option</a></td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A common stock | Subsequent Events</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonUnitIssued', window );">Common Unit, Issued</a></td>
<td class="nump">3,125,000<span></span>
</td>
<td class="nump">1,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CommonStockAdditionalShares', window );">Purchased additional shares</a></td>
<td class="nump">1,875,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_CommonStockAdditionalShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common stock additional shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_CommonStockAdditionalShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_FairValueAdjustmentOfPreFundedWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value adjustment of pre funded warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_FairValueAdjustmentOfPreFundedWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_IssuePricePerShareAndWarrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The offering price per common share and accompanying warrant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_IssuePricePerShareAndWarrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_OfferingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Offering expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_OfferingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_PercentageOfMinimumOwnershipBeneficiallyOwnByHolderWithAffiliatesToWarrantExercise">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of minimum ownership beneficially own by holder with affiliates to warrant exercise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_PercentageOfMinimumOwnershipBeneficiallyOwnByHolderWithAffiliatesToWarrantExercise</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_ProceedsFromIssuanceInitialPublicOfferingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from Issuance Initial Public Offering Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_ProceedsFromIssuanceInitialPublicOfferingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_ProceedsFromIssuanceOfSharesAndPreFundedWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Issuance Of Shares And Pre Funded Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_ProceedsFromIssuanceOfSharesAndPreFundedWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_ProceedsFromIssuanceOfSharesAndPreFundedWarrantsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of shares and pre-funded warrants net of underwriting discounts and commissions and offering expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_ProceedsFromIssuanceOfSharesAndPreFundedWarrantsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_WarrantIssuedPricePerPre-FundedWarrantAndAccompanyingWarrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The offering price per pre-funded warrant and accompanying warrant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_WarrantIssuedPricePerPre-FundedWarrantAndAccompanyingWarrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_WarrantsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants Issued</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_WarrantsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonUnitIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common units issued of limited liability company (LLC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonUnitIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>91
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    (  6"<UI&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    (  6"<UH1J>,(\@   "L"   1
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MNIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X8-DOV]:[MR_>X%<R)!%!,!FGK_#
M"J5,7K5::0##.'W)$Q+#W(*+"$MX%,O67.!;&B\CUNJTV]U6A&ELH1A'9&!]
M7BQH0-!445IO7R"TY1\S^!7+5(UEHP$35T$FN8BT\OELQ?S:WCYES^DZ'3*!
M;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO'T=)(@(+)?90%NDGVH],5"#(-.SJ=
M6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+<!P$X%&[GL*=]&R_I$$)M*-IT&38
M]MJND::JC5-/T_=]W^N;:)P*C5M/TVMWW=..B<:MT'@-OO%/A\.NB<:KT'3K
M:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8<';6S-(#EEXI^G64&MD=N]U!7/!8
M[CF)$?[&Q036:=(9EC1&<IV0!0X -\313%!\KT&VBN#"DM)<D-;/*;50&@B:
MR('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_::L!I^V[F\^3_'/HY)^GD]=-0LYP
MO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR
M([O=]EA]]D]';B/7J<"S(M>41B1%G\@MNN01.+5)#3(3/PB=AIAJ4!P"I DQ
MEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7H5A)VH3X$$8:XIQSYG/1;/L'I4;1
M]E6\W*.76!4!EQC?-*HU+,76>)7 \:V</!T3$LV4"P9!AI<D)A*I.7Y-2!/^
M*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S&L%&KQMUAVC2/'K^!?F<-0H<D1L=
M F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV&G*U%H&V<:F$8%H2QM%X3M*T$?Q9
MK#63/F#([,V1=<[6D0X1DEXW0CYBSHN0$;\>ACA*FNVB<5@$_9Y>PTG!Z(++
M9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'HYI9";V$5FJ?JH<T/J@>,@H%\;D>
M/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y?RY]SZ7ON?0]H=*W-R-]9\'3BUO>
M1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@YG\#L_6@^GO'M^MDDA*^:62TC%I!+
M@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2GD(;;NE3]4J5U^6ON2BX/%ODZ:^A
M=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA*]+',<$X>RPP[9SR2';9WH!TU^_9=
M=N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*TU*0;\/YZ<5X&N(YV02Y?9A7;>?8
MT='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#AWE[7YAGE<90-!1M;*PD+$:W8+C7
M\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B?$R,1>APYY=<7^/1DN/;IF6U;J\I
M=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*POFH]M!5.S_Y9K<B?#!%.%@L22&.4
M%Z9*HO,94[[G*TG$53B_13.V$I<8O./FQW%.4[@2=K8/ C*YNSFI>F4Q9Z;R
MWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=WP6#R_7#)1P_E.^=?]%U#KG[VW>/Z
M;I,[2$R<><41 71% B.5' 86%S+D4.Z2D 83 <V4R43P H)DIAR F/H+O?(,
MN2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7<N/O[Y-J=XS7^BR!;814,F35%\I#
MB<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@2\-Z;ITM)__;7M0]M!<]1O.CF> >
MLX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[
MM'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+!WP?D@9CC%OT-%^/%&*MIK&MQMHQ
M#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'50.4_V]0-:/8--!R1!5XQF;8VH^1.
M"CS<_N\-L,+$CN'MB[\!4$L#!!0    (  6"<UI\2LT'L H   Y"   8
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M^8)"XEF]D0?8_ 3$U7\!4$L#!!0    (  6"<UK 2[[+_P4  #P9   8
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MS)2IVQO8%!;WH*7/+V :.[,\>[#RJPUO7J3E3X#EA4=0URZH)(J].-P1$2_
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MQRAM:!0M,H4F:MK9$/ _]2$:MN.9"!U?GHA&G0C88T7(E*%1RL@4FJA9YT;
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MVQDA2&^$7.34]HOIJI\*_M127DEJF.PL]H4@W[4=^4VCQGF6O%RI,6/$:X!
MWG T.=IL66V^_0.7CTE.04K6/--ZYW.@\K"?]7#"BFV]__*A8*S(ZL,-P;Q*
MK0+X_751L)>3:DMGNZMX_B]02P,$%     @ !8)S6GT5_[+T!@  Q!\  !@
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M>\SU&@5A O3]AG.U-TR"?C$GOP%02P,$%     @ !8)S6K 6L]-0 @  FP8
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MK)1$?:,%>+YR\$F^( 7]?W67_P502P,$%     @ !8)S6D%YJ^:5'@  :V$
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M7!=."LST([:8Y3TA7G4M7(7M[X31(WF<^6VP#J2GUZ]$BK#O^;?/B=)E2SX
MJX#*V_*3*4P$ 10I"<'M#A!@@;(ORM6*++LP9 L</>VPZUPB-+,P\F*I%+,\
MG#*>"E5A;LIFX*U%9$90X$B(!NVZPZM+Z$G^*ES$[&L;2\8<(ML(",04DOH2
MX!)1R(GX1=&3J-9>1."F=+8;Z%5:R^VCWZ=[FL::&Q#*&5JL]%W+4CV0!7;\
M9&5=-6R)"B38M+Y(*C!(URU9*U9#/] RM!Y1BY2HZ@<"64$D]@Y-79 (0Q^
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MB$)7QA/!RH,6C,=SV:?CBH$^?A_6D;;[Q2,U.HA_\FUX=YX?P6L \$0 / &
M)S*3-[J&?D,RN.$I;-NGNHZW&RX[9:?T8#!-:U8VZ+H2@;'_Y@PFAN4X$"53
M;/&@L2]"LM$W8HQC])0>:PM7'=P=-$@QN>#^"5FQALU@,@Z-0W31(";0^]1!
MCV(6RUP<UOPNL_J7[5AS^A)XY^4Y2(]6PXV>3!Q#@=E3N:A-]MJE*J[+&T+
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MHR,+*8BBF'HJOS7)2+"7QY-$0ZN@W-@3)<Z:?7RVTM1LE).V'U&.O)8&8:$
M.#_4<;6Q9I4,'A-RXN/>$I]<<7QT]<NKMT>/%C+0QP]3AE\-'+'(21)7+,8!
MR'2&9]7-%\AFD9X,#!$=N\%E57KX?SF0/"V!WZJYWSO(^[4&D2E$"(NH1J0T
M0!V'D^9-S#Q>L=:S=X!'S$Q'[HZ/@=1K$^="R^QV$8XZ?\;1)8@=)$T"']Q0
M$VZXN;S^2(^<\J\G9]\N@NR1F051L.WQ!Y*DJKCX[NS1]\6;]# 4P2&/Z94!
M*K6O2#&),%P2"$(YZ&4[;GP^8%K'Q[,1A*2U%$ZKF793<E>[3G8HE]W09V,T
M8>% +QS2LK0A<%4\Q\PR'<U/EN7@(1:N-('9=+=)"3T<\];&^!X+$1&'YFXX
MPS#W$&KIR5C@;Q@I#K<AQ6#&Y^.A^V1D,21A!I*H&7/ZA25"<T%J4O'2D[$F
MQ5.!A#D10.S5DN)YB>[+%<;WH^4Z_V:A8B357I2PMK%ZI.''5RWU]+3X*<"Q
M'1!&U-U.!QMUJ$5M=F"JBW(9;Y;B\@UY M?%0Z S-PGQRJ:6+#U,WR9T^EO9
M#G DJ77.%I7@CTGI[%@UDUUX=9[ Y/MF3#:!\I\^EU@^62PGQ9+K:>9+"]?&
MD()2;'G^K&"3<?$\ZNB;9/AOP7Q,MWG@"!V,2S,CD:?\Y&CB_HYRT=5^!4FM
M*=O(8&,9-;F783V]5D$NF)* \^#E#(C*%EHBBE==+;32H)48.3^G.\HILJ_R
MM;,W1FCI(+FA0A X%N@?'2I9/GS]QFGQ,\'*5$21_IJ+]+@1KAK)-E;O,<H8
MC@-QP9^;"7RO5GA8BY*W?$.BJ4]"S;L=&&44I+%4'/,92]5#SW+/%0*E6JQ1
MDO+"CN83.NCI)[=/U+81#YYB]PI?FOH0,N$ ^.^+"F<;]T-V#[HB-+O!X5AN
M4FH[B$C2\%A,VF,\U<$'1L4AQJN(<GC=.-X89[4>).WKI#:?5>'&L'7'<UAE
M$N6P@9I=64C)I73Z\23^$ KLT%LY0Y3K&EOCO.5SF%;[!V/[VRX]T;K'QRCO
M?H[T8\,+-0U>)]ZH(GT1$AT_O65,[G 8#Z['EEQX/#2(Q H]U#3#$O+WRWV^
M2AQ 6"S"^=SI*,]-UX^A>,M72H1$ATR=]3I,R--Z+6>T<0)9"YS,M#CV-)E
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MC\8[E;547.6"5<CG+4 [*##LA:6"4V$=,SC?%P9%?@4G[TN,:<;$MCM<MZJ
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MCC&WOLQ][8?A]K&%^KK2"*(;=)=]: X""]BN#T[ZV8E%IF.]HN402/=;JVF
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M%F)38#_X71/9(Z;CXUES0ZPHOGX0=#2/P\ER0>:BB';+^/\;*:M"/R"V(YV
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M54[D:H6E_F@6#^LS>/O@])8O1Y?:H>'GX49)I!2:@.\KC?:V>: -NMORJ_\
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MK$J3FR5M"S(KL4FM$@[8#M.C4N@=8'_8G9W"L8[BK-TDU5N.A;1+TFU=612
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MG3?)=W9[^!?+4CR.JSN0?5:H5QN@#"_!X$_2>TJAG9ACWH>"B&"3?/ZX$_&
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M6&B9A(ADW4<A,RFI6P1?GH0O? \)S0J?KLQ- ;FRO*LY3:O#^PRZ&Y->1'#
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M:8S,W>-2<*@=BP#W<RG-[F %-%\3Q_\"4$L#!!0    (  6"<UJ^]6;%! ,
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M'+*]0^9Y#X$\RW?,LM5"JQUH9TUH3O"I>F\BQZ4[E#NK:9>3GUVM-9VOMD_
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M"J11EL_]/*>$C]W ^*!QM*BWOCT:.LQ>VJ&'C-JQ U\/C>?%?&C?7YC><FE
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MH<%UO^N!JOMBO3"R=+UH*0UU-C?-Z*\$E070^4I*LUO8!,V?T^0?4$L#!!0
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M^^K ]*ZX-*B* EWC_N@B(+J]R=N!5;6_/9?*XEWLNR4^?D [ _Q?*&7W [=
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MVUYX2\6F8!)*7&NH5C5P0+3]I=THOK4UO>)*=PB[S'5+1F$<]/F:Z^^]VY@
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M.C[!/[I:UV'KCI&5JWV>I,%*RC476+N"L@MP/I?2;#JVG&JKX<E?4$L#!!0
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M*FM ^ZF49C>Q[;Q]C*,_4$L#!!0    (  6"<UJ5'Y]UX ,  /<3   9
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M2$)3\48A?%W=HM>OWJ!7B.;HRY:50B6(J2L5;?WC[KJA^*ZFZ#]#\1;6URC
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M@YO#>2%7V(>!I4^?!+$&:_CQ@]MV/I4QKPFLX(=&YH=&%7H^0W":(0O!96F
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M^N^[DATW)"9PZ"762ON>WMM(JVC-Q:/, !1Y*@LF1U:F5'5IVS+)H*3RC%?
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MA$[ ]07G:A/H#;IG,/X+4$L#!!0    (  6"<UJ=!1T3 P<  ,X[   9
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MO'KG#>3WFSC.?IWDKW16K_ N_P=02P,$%     @ !8)S6N+]^UT/!   @Q0
M !D   !X;"]W;W)K<VAE971S+W-H965T-38N>&ULM5A1;]LV$/XKA%8,+=!%
MHN383F8;<*P4#="@09)N#\,>:.EL"95(CZ3M&-B/'RG)LF0K7+TQ+[9$W??Q
M[J../-UHR_AWD0!(]))G5(R=1,K5M>N**(&<B NV JJ>+!C/B52W?.F*%0<2
M%Z \<WW/Z[LY2:DS&15C#WPR8FN9I10>.!+K/"=\=P,9VXX=[.P''M-E(O6
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M0!%;4UFV(^K1LI,VTYTTW=TY&I_BZVG15W(/-&5[[I[P94H%RF"A*+V+@0J
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MT17%P<<<SZ>4[!&5M86:O% PE;7H?I3*<5]Q*IY&PH[/ESB+.(Z1*,L#GE-
M5V@1AI$<%%'\D!932P[1N0\<1S&[0&?(1FR+*3 4I>@YC3B[%(7B^C&*8U&7
M36TN&B==V$'9D/NB(=Z)AKCHD:1\R]#/:0AAV]X6G:IZYKWW[-[3"B[RS34:
MN)?(<[PA>E[YZ/SLHJ-=2[V,#T%#YA/A@)8D24BZXB1X7<:8L2:/XJ?#C?_]
M;@:=*BT(@VIX!TIV<&IX5?O(&JG6HK\_B.?H@4/"_ND:HD)LV"TFEZ [EN$
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M]SLB,<W%:X6PR+$0X!U(VVS19+\!8HLY$3-;JL+U]';:%?F^+1)=*/*.I#?
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MY;GTO/2/V/QNV_>[)R(TJ- &9V_\-_L88'P[V:"DQZVLE$ 5&N$C2R6\L*S
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M-3,J[E#9!32_E-(<.W:#JER,OP!02P,$%     @ !8)S6D.?W < !   QQ8
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MSD7XZ;BZ?+.WRZBV>'_#;)\6'&1D)Q,E>_)?*JMW3>L+0<MJX_&1"D'SZO1
M<$*8"I#?[R@5KQ=J+[/=NX[^!U!+ P04    "  %@G-:[C>P7'T"  #L!0
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MZG((7 NH[UO&Y,M 7S_*ZZ;_'5!+ P04    "  %@G-:P#U==R,$  !E$
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M^>L&D@NVQM! QA+,3[YM)<'JEY,SU/0*3*KS3N[V)4*25VW;#TG"7KODSXY
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MR4D+^_&[DAV3=*EI(7N))?G>HW..KG4S7"M];Q8 ECP(+LTH6%B[O A#DR]
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M;5?:0'V_9$R^WN@$S?'8_&]02P,$%     @ !8)S6H(L+VOJ P  E X  !D
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M@TMS5R6DS8K?9L6O_ 6]_IHT2)4&4J5A8@NJ]A+:O>@5.!$[DL',44M, #^
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M)6KN>'T$JF\DVU6GB"63ZDQ276[5L1&X%JCW:\;D\XT^F+0'T?E_4$L#!!0
M   (  6"<UHMTQJS 0,  !0(   9    >&PO=V]R:W-H965T<R]S:&5E=#<U
M+GAM;*U6VV[;, S]%<$KAA9H:\>Y=5UBH$F[K0\%@K3='H8]*#83"Y4E3Y*3
M=%\_2G:\W+<">XDDBCPZ/)+)]!92O>@4P)!EQH7N>ZDQ^;7OZSB%C.I+F8/
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M%N(9256-9'5C9%[V8O?28&=77L;8?(.R$_#Y6DKS?&-?T+3S\W\ 4$L#!!0
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M:1\]HLL(NHR7[D8^B8T7-\JU'P_=\D+[O+2^<0HA3@G$*2_BE?$:[JFX=[*
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MBF8?D[)0QKZ5C(HFEF5&62ACMM#/1:+>/!2(*V"]PYB4A3)F"R%,-*O_7%G
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M4$L! A0#%     @ !8)S6A&IXPCR    *P(  !$              ( !PP
M &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ !8)S6IE<G",0!@  G"<
M !,              ( !Y $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M    "  %@G-:?$K-![ *   .0@  &               @($E"   >&PO=V]R
M:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ !8)S6L!+OLO_!0  /!D
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M965T-BYX;6Q02P$"% ,4    "  %@G-:J?KH$$X"  "D!0  &
M    @('U+@  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @
M!8)S6K 6L]-0 @  FP8  !@              ("!>3$  'AL+W=O<FMS:&5E
M=',O<VAE970X+GAM;%!+ 0(4 Q0    (  6"<UH]''\^_PT  #!%   8
M          " @?\S  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4
M    "  %@G-:8E*Z8P$+  "W&P  &0              @($T0@  >&PO=V]R
M:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    (  6"<UI!>:OFE1X  &MA
M   9              " @6Q-  !X;"]W;W)K<VAE971S+W-H965T,3$N>&UL
M4$L! A0#%     @ !8)S6FJH'A?#!P  -Q<  !D              ("!.&P
M 'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    "  %@G-:"(A]
M>" #   )!P  &0              @($R=   >&PO=V]R:W-H965T<R]S:&5E
M=#$S+GAM;%!+ 0(4 Q0    (  6"<UH2[&'I&00  )X)   9
M  " @8EW  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%     @
M!8)S6L3VEB_9 @  K@8  !D              ("!V7L  'AL+W=O<FMS:&5E
M=',O<VAE970Q-2YX;6Q02P$"% ,4    "  %@G-:=S8ZZH\"  #(!0  &0
M            @('I?@  >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4
M Q0    (  6"<UK!2T*5;@8  )(1   9              " @:^!  !X;"]W
M;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ !8)S6OL+K7O%!P
M(A4  !D              ("!5(@  'AL+W=O<FMS:&5E=',O<VAE970Q."YX
M;6Q02P$"% ,4    "  %@G-:7PPKR^,$  " "P  &0              @(%0
MD   >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    (  6"<UH4
ML0@79@@  #D7   9              " @6J5  !X;"]W;W)K<VAE971S+W-H
M965T,C N>&UL4$L! A0#%     @ !8)S6FHC!D9! P  @0<  !D
M     ("!!YX  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4
M"  %@G-:IN!EF%P*  !$&P  &0              @(%_H0  >&PO=V]R:W-H
M965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    (  6"<UH=ZHQN:PD  &(8   9
M              " @1*L  !X;"]W;W)K<VAE971S+W-H965T,C,N>&UL4$L!
M A0#%     @ !8)S6DPC9Y'W P  =0D  !D              ("!M+4  'AL
M+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    "  %@G-:E=/'FTD$
M  #Y"   &0              @('BN0  >&PO=V]R:W-H965T<R]S:&5E=#(U
M+GAM;%!+ 0(4 Q0    (  6"<UIGA-JU'@4  #0.   9              "
M@6*^  !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @ !8)S
M6MX;3=[['P  Y&L  !D              ("!M\,  'AL+W=O<FMS:&5E=',O
M<VAE970R-RYX;6Q02P$"% ,4    "  %@G-:!CYIP9L"  #'!0  &0
M        @('IXP  >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0
M   (  6"<UKL6_%J= 8  %D4   9              " @;OF  !X;"]W;W)K
M<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ !8)S6K[U9L4$ P  HP8
M !D              ("!9NT  'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q0
M2P$"% ,4    "  %@G-:-BS<><X"   O!@  &0              @(&A\
M>&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    (  6"<UHX+#;A
MZ0(  *@&   9              " @:;S  !X;"]W;W)K<VAE971S+W-H965T
M,S(N>&UL4$L! A0#%     @ !8)S6N=^-:&@ @  U04  !D
M ("!QO8  'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4    "  %
M@G-:S;MYC'X#  !:"0  &0              @(&=^0  >&PO=V]R:W-H965T
M<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    (  6"<UI,J=+<& ,  -(&   9
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M970S.2YX;6Q02P$"% ,4    "  %@G-:$8CR$C0#  #9!@  &0
M    @($B%0$ >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    (
M  6"<UJV'P\E+@0  .<(   9              " @8T8 0!X;"]W;W)K<VAE
M971S+W-H965T-#$N>&UL4$L! A0#%     @ !8)S6L4L]#>^!   9!D  !D
M             ("!\AP! 'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q02P$"
M% ,4    "  %@G-:"3<UQ:P%  # &   &0              @('G(0$ >&PO
M=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    (  6"<UJ64%&?S0(
M !D+   9              " @<HG 0!X;"]W;W)K<VAE971S+W-H965T-#0N
M>&UL4$L! A0#%     @ !8)S6F(PV6E!"0  6$P  !D              ("!
MSBH! 'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"% ,4    "  %@G-:
M4?U 7*T%  "](@  &0              @(%&- $ >&PO=V]R:W-H965T<R]S
M:&5E=#0V+GAM;%!+ 0(4 Q0    (  6"<UKF:*JUL@(  -X&   9
M      " @2HZ 0!X;"]W;W)K<VAE971S+W-H965T-#<N>&UL4$L! A0#%
M  @ !8)S6D3Y?/BQ @  F <  !D              ("!$ST! 'AL+W=O<FMS
M:&5E=',O<VAE970T."YX;6Q02P$"% ,4    "  %@G-:E1^?=> #  #W$P
M&0              @('[/P$ >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+
M 0(4 Q0    (  6"<UK>D_UZ<0(  -,%   9              " @1)$ 0!X
M;"]W;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @ !8)S6@[3>#I#
M P  + X  !D              ("!ND8! 'AL+W=O<FMS:&5E=',O<VAE970U
M,2YX;6Q02P$"% ,4    "  %@G-:@O=NVIX"   ]!P  &0
M@($T2@$ >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0    (  6"
M<UJWK_P7  ,  ,D(   9              " @0E- 0!X;"]W;W)K<VAE971S
M+W-H965T-3,N>&UL4$L! A0#%     @ !8)S6AU)(^&M @  $@<  !D
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M=#4X+GAM;%!+ 0(4 Q0    (  6"<UHA\#"68@8  $$S   9
M  " @<=G 0!X;"]W;W)K<VAE971S+W-H965T-3DN>&UL4$L! A0#%     @
M!8)S6CW,Z?:1!0  X1L  !D              ("!8&X! 'AL+W=O<FMS:&5E
M=',O<VAE970V,"YX;6Q02P$"% ,4    "  %@G-:C2C#&*8#  #1#@  &0
M            @($H= $ >&PO=V]R:W-H965T<R]S:&5E=#8Q+GAM;%!+ 0(4
M Q0    (  6"<UI(KH4XIP,  (L+   9              " @05X 0!X;"]W
M;W)K<VAE971S+W-H965T-C(N>&UL4$L! A0#%     @ !8)S6H"E=9J5 P
MX0X  !D              ("!XWL! 'AL+W=O<FMS:&5E=',O<VAE970V,RYX
M;6Q02P$"% ,4    "  %@G-::.SKF$ #   Z"@  &0              @(&O
M?P$ >&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+ 0(4 Q0    (  6"<UI#
MG]P'  0  ,<6   9              " @2:# 0!X;"]W;W)K<VAE971S+W-H
M965T-C4N>&UL4$L! A0#%     @ !8)S6NXWL%Q] @  [ 4  !D
M     ("!78<! 'AL+W=O<FMS:&5E=',O<VAE970V-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    (  6"<UJ$\<#T2@,  %T-   9              "
M@>^9 0!X;"]W;W)K<VAE971S+W-H965T-S$N>&UL4$L! A0#%     @ !8)S
M6I$K044G P  ]PH  !D              ("!<)T! 'AL+W=O<FMS:&5E=',O
M<VAE970W,BYX;6Q02P$"% ,4    "  %@G-:;WFVU9($   J$P  &0
M        @('.H $ >&PO=V]R:W-H965T<R]S:&5E=#<S+GAM;%!+ 0(4 Q0
M   (  6"<UJ"+"]KZ@,  )0.   9              " @9>E 0!X;"]W;W)K
M<VAE971S+W-H965T-S0N>&UL4$L! A0#%     @ !8)S6BW3&K,! P  % @
M !D              ("!N*D! 'AL+W=O<FMS:&5E=',O<VAE970W-2YX;6Q0
M2P$"% ,4    "  %@G-:?9K1IYD#  #:#P  &0              @('PK $
M>&PO=V]R:W-H965T<R]S:&5E=#<V+GAM;%!+ 0(4 Q0    (  6"<UKS+'$$
M[ 0   ,0   9              " @<"P 0!X;"]W;W)K<VAE971S+W-H965T
M-S<N>&UL4$L! A0#%     @ !8)S6D)TKVT;!@  U"X  !D
M ("!X[4! 'AL+W=O<FMS:&5E=',O<VAE970W."YX;6Q02P$"% ,4    "  %
M@G-:*>,LRTL#  #,%   #0              @ $UO $ >&PO<W1Y;&5S+GAM
M;%!+ 0(4 Q0    (  6"<UJ7BKL<P    !,"   +              "  :N_
M 0!?<F5L<R\N<F5L<U!+ 0(4 Q0    (  6"<UH%1MN>_P4  'HS   /
M          "  93  0!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    "  %@G-:
M>@0#75P"   A+@  &@              @ ' Q@$ >&PO7W)E;',O=V]R:V)O
M;VLN>&UL+G)E;'-02P$"% ,4    "  %@G-:+B@*V!4"  #\+   $P
M        @ %4R0$ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     5@!6 )$7
(  ":RP$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>185</ContextCount>
  <ElementCount>420</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>67</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>8</UnitCount>
  <MyReports>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>100010 - Statement - Balance Sheets (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited</Role>
      <ShortName>Balance Sheets (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100040 - Statement - Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsParenthetical</Role>
      <ShortName>Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100050 - Statement - Statements of Operations and Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/StatementsofOperationsandComprehensiveLoss</Role>
      <ShortName>Statements of Operations and Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100060 - Statement - Statements of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/StatementStatementsOfStockholdersEquity</Role>
      <ShortName>Statements of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100070 - Statement - Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows</Role>
      <ShortName>Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>995455 - Disclosure - Cybersecurity Risk Management, Strategy, and Governance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernanceDisclosure</Role>
      <ShortName>Cybersecurity Risk Management, Strategy, and Governance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>995465 - Disclosure - Description of Business and Financial Condition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/DescriptionofBusinessandFinancialCondition</Role>
      <ShortName>Description of Business and Financial Condition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>995475 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>995485 - Disclosure - Cash, Cash Equivalents and Marketable Securities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecurities</Role>
      <ShortName>Cash, Cash Equivalents and Marketable Securities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>995495 - Disclosure - Property and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/PropertyandEquipment</Role>
      <ShortName>Property and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>995505 - Disclosure - Intangible Assets, net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNet</Role>
      <ShortName>Intangible Assets, net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>995525 - Disclosure - Accrued and Other Current Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/AccruedandOtherCurrentLiabilities</Role>
      <ShortName>Accrued and Other Current Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>995535 - Disclosure - Other Income, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/DisclosureOtherIncomeNet1</Role>
      <ShortName>Other Income, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>995545 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>995555 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>995565 - Disclosure - Capital Structure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/CapitalStructure</Role>
      <ShortName>Capital Structure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>995575 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/StockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>995585 - Disclosure - Warrants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/Warrants</Role>
      <ShortName>Warrants</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>995595 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>995605 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>995615 - Disclosure - Net Loss Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/DisclosureNetLossPerShare1</Role>
      <ShortName>Net Loss Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>995625 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/DisclosureSegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>995635 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/DisclosureSubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>995645 - Disclosure - Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://seraprognostics.com/20241231/taxonomy/role/SignificantAccountingPolicies</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>995655 - Disclosure - Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/AccountingPoliciesTables</Role>
      <ShortName>Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>995665 - Disclosure - Cash, Cash Equivalents and Marketable Securities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesTables</Role>
      <ShortName>Cash, Cash Equivalents and Marketable Securities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecurities</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>995675 - Disclosure - Property and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/PropertyandEquipmentTables</Role>
      <ShortName>Property and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://seraprognostics.com/20241231/taxonomy/role/PropertyandEquipment</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>995685 - Disclosure - Intangible Assets, net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetTables</Role>
      <ShortName>Intangible Assets, net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNet</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>995705 - Disclosure - Accrued and Other Current Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/AccruedandOtherCurrentLiabilitiesTables</Role>
      <ShortName>Accrued and Other Current Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://seraprognostics.com/20241231/taxonomy/role/AccruedandOtherCurrentLiabilities</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>995715 - Disclosure - Other Income, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/DisclosureOtherIncomeNetTables</Role>
      <ShortName>Other Income, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://seraprognostics.com/20241231/taxonomy/role/DisclosureOtherIncomeNet1</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>995725 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://seraprognostics.com/20241231/taxonomy/role/FairValueMeasurements</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>995735 - Disclosure - Capital Structure (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/CapitalStructureTables</Role>
      <ShortName>Capital Structure (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://seraprognostics.com/20241231/taxonomy/role/CapitalStructure</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>995745 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/StockBasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://seraprognostics.com/20241231/taxonomy/role/StockBasedCompensation</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>995755 - Disclosure - Warrants (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/WarrantsTables</Role>
      <ShortName>Warrants (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://seraprognostics.com/20241231/taxonomy/role/Warrants</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>995765 - Disclosure - Commitment and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/CommitmentandContingenciesTables</Role>
      <ShortName>Commitment and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>995775 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxes</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>995785 - Disclosure - Net Loss Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/DisclosureNetLossPerShareTables</Role>
      <ShortName>Net Loss Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://seraprognostics.com/20241231/taxonomy/role/DisclosureNetLossPerShare1</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>995795 - Disclosure - Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/DisclosureSegmentInformationTables</Role>
      <ShortName>Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://seraprognostics.com/20241231/taxonomy/role/DisclosureSegmentInformation</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>995805 - Disclosure - Description of Business and Financial Condition - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAndFinancialConditionAdditionalInformationDetails</Role>
      <ShortName>Description of Business and Financial Condition - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>995815 - Disclosure - Significant Accounting Policies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails</Role>
      <ShortName>Significant Accounting Policies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>995825 - Disclosure - Significant Accounting Policies - Schedule of Estimated Useful Life of Each Asset Category (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/DisclosureSignificantAccountingPoliciesScheduleOfEstimatedUsefulLifeOfEachAssetCategoryDetails</Role>
      <ShortName>Significant Accounting Policies - Schedule of Estimated Useful Life of Each Asset Category (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>995835 - Disclosure - Cash, Cash Equivalents and Marketable Securities - Cash, Cash Equivalents and Marketable Securities by Major Security Type (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails</Role>
      <ShortName>Cash, Cash Equivalents and Marketable Securities - Cash, Cash Equivalents and Marketable Securities by Major Security Type (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>995845 - Disclosure - Cash, Cash Equivalents and Marketable Securities - Available-for-sale Debt Securities and Cash Equivalents in Unrealized Loss Positions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecuritiesAvailableforsaleDebtSecuritiesAndCashEquivalentsInUnrealizedLossPositionsDetails</Role>
      <ShortName>Cash, Cash Equivalents and Marketable Securities - Available-for-sale Debt Securities and Cash Equivalents in Unrealized Loss Positions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>995855 - Disclosure - Cash, Cash Equivalents and Marketable Securities - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecuritiesAdditionalInformationDetails</Role>
      <ShortName>Cash, Cash Equivalents and Marketable Securities - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>995865 - Disclosure - Cash, Cash Equivalents and Marketable Securities - Marketable Securities Classified by Contractual Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails</Role>
      <ShortName>Cash, Cash Equivalents and Marketable Securities - Marketable Securities Classified by Contractual Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>995875 - Disclosure - Property and Equipment - Schedule of Components of Property and Equipment, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentScheduleOfComponentsOfPropertyAndEquipmentNetDetails</Role>
      <ShortName>Property and Equipment - Schedule of Components of Property and Equipment, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>995885 - Disclosure - Property and Equipment - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/PropertyandEquipmentAdditionalInformationDetails</Role>
      <ShortName>Property and Equipment - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>995895 - Disclosure - Intangible Assets, net - Schedule of Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsDetails</Role>
      <ShortName>Intangible Assets, net - Schedule of Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>995905 - Disclosure - Intangible Assets, net - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetAdditionalInformationDetails</Role>
      <ShortName>Intangible Assets, net - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>995915 - Disclosure - Accrued and Other Current Liabilities - Schedule of Components of Accrued and Other Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfComponentsOfAccruedAndOtherCurrentLiabilitiesDetails</Role>
      <ShortName>Accrued and Other Current Liabilities - Schedule of Components of Accrued and Other Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>995925 - Disclosure - Other Income, Net - Schedule of Components of Other Income, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/DisclosureOtherIncomeNetScheduleOfComponentsOfOtherIncomeNetDetails</Role>
      <ShortName>Other Income, Net - Schedule of Components of Other Income, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>995945 - Disclosure - Fair Value Measurements - Financial Assets that are Measured at Fair Value on a Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements - Financial Assets that are Measured at Fair Value on a Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>995955 - Disclosure - Related Party Transactions - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails</Role>
      <ShortName>Related Party Transactions - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>995965 - Disclosure - Capital Structure - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureAdditionalInformationDetails</Role>
      <ShortName>Capital Structure - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>995975 - Disclosure - Capital Structure - Schedule of Common Stock Reserved for Future Issuance (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureScheduleOfCommonStockReservedForFutureIssuanceDetails</Role>
      <ShortName>Capital Structure - Schedule of Common Stock Reserved for Future Issuance (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>995995 - Disclosure - Stock-Based Compensation - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails</Role>
      <ShortName>Stock-Based Compensation - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>996005 - Disclosure - Stock-Based Compensation - Summary of Options Granted and Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionsGrantedAndOutstandingDetails</Role>
      <ShortName>Stock-Based Compensation - Summary of Options Granted and Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>996015 - Disclosure - Stock-Based Compensation - Schedule of Fair Values Calculated using Black-Scholes Option Pricing Model (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfFairValuesCalculatedUsingBlackscholesOptionPricingModelDetails</Role>
      <ShortName>Stock-Based Compensation - Schedule of Fair Values Calculated using Black-Scholes Option Pricing Model (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>996025 - Disclosure - Stock-Based Compensation - Summary of Information about RSUs Granted and Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfInformationAboutRsusGrantedAndOutstandingDetails</Role>
      <ShortName>Stock-Based Compensation - Summary of Information about RSUs Granted and Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>996035 - Disclosure - Stock-Based Compensation - Schedule of Impact of Stock-based Compensation Expense in Statements of Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfImpactOfStockbasedCompensationExpenseInStatementsOfOperationsDetails</Role>
      <ShortName>Stock-Based Compensation - Schedule of Impact of Stock-based Compensation Expense in Statements of Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>996045 - Disclosure - Stock-Based Compensation - Summary of Unrecognized Stock-based Compensation Expense for Outstanding Unvested Stock Options and RSUs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfUnrecognizedStockbasedCompensationExpenseForOutstandingUnvestedStockOptionsAndRsusDetails</Role>
      <ShortName>Stock-Based Compensation - Summary of Unrecognized Stock-based Compensation Expense for Outstanding Unvested Stock Options and RSUs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>996055 - Disclosure - Warrants - Schedule of Common Stock Warrants Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/DisclosureWarrantsScheduleOfCommonStockWarrantsOutstandingDetails</Role>
      <ShortName>Warrants - Schedule of Common Stock Warrants Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>996065 - Disclosure - Warrants - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails</Role>
      <ShortName>Warrants - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>996075 - Disclosure - Commitments and Contingencies - Schedule of Leases in Financial Statement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeasesInFinancialStatementDetails</Role>
      <ShortName>Commitments and Contingencies - Schedule of Leases in Financial Statement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>996085 - Disclosure - Commitments and Contingencies - Schedule of Lease Cost and Other Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeaseCostAndOtherInformationDetails</Role>
      <ShortName>Commitments and Contingencies - Schedule of Lease Cost and Other Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>996095 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Lease Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails</Role>
      <ShortName>Commitments and Contingencies - Schedule of Future Minimum Lease Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>996105 - Disclosure - Commitments and Contingencies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails</Role>
      <ShortName>Commitments and Contingencies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>996115 - Disclosure - Income Taxes - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails</Role>
      <ShortName>Income Taxes - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>996125 - Disclosure - Income Taxes - Schedule of Components of Income Tax Provision (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails</Role>
      <ShortName>Income Taxes - Schedule of Components of Income Tax Provision (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>996135 - Disclosure - Income Taxes - Effective Tax Rate Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesEffectiveTaxRateReconciliationDetails</Role>
      <ShortName>Income Taxes - Effective Tax Rate Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>996145 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails</Role>
      <ShortName>Income Taxes - Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>996155 - Disclosure - Income Taxes - Unrecognized Tax Positions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesUnrecognizedTaxPositionsDetails</Role>
      <ShortName>Income Taxes - Unrecognized Tax Positions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>996165 - Disclosure - Net Loss Per Share - Schedule of Anti-dilutive Securities Excluded from the Computation of Earnings per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/DisclosureNetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromTheComputationOfEarningsPerShareDetails</Role>
      <ShortName>Net Loss Per Share - Schedule of Anti-dilutive Securities Excluded from the Computation of Earnings per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>996175 - Disclosure - Segment Information - Summary of Segment Information for Revenue, Significant Segment Expenses and Segment Loss Expenses that are Regularly Provided to the CODM (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/DisclosureSegmentInformationSummaryOfSegmentInformationForRevenueSignificantSegmentExpensesAndSegmentLossExpensesThatAreRegularlyProvidedT</Role>
      <ShortName>Segment Information - Summary of Segment Information for Revenue, Significant Segment Expenses and Segment Loss Expenses that are Regularly Provided to the CODM (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="sera-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>996185 - Disclosure - Subsequent Events (Additional Information) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://seraprognostics.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails</Role>
      <ShortName>Subsequent Events (Additional Information) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://seraprognostics.com/20241231/taxonomy/role/DisclosureSubsequentEvents</ParentRole>
      <Position>78</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" isDefinitelyFs="true" isUsgaap="true" original="sera-20241231.htm">sera-20241231.htm</File>
    <File>sera-20241231.xsd</File>
  </InputFiles>
  <SupplementalFiles>
    <File>img152117643_0.jpg</File>
    <File>img152117643_1.jpg</File>
    <File>img152117643_2.jpg</File>
    <File>img152117643_3.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="787">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="16">http://xbrl.sec.gov/cyd/2024</BaseTaxonomy>
    <BaseTaxonomy items="42">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>97
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "sera-20241231.htm": {
   "nsprefix": "sera",
   "nsuri": "http://seraprognostics.com/20241231",
   "dts": {
    "inline": {
     "local": [
      "sera-20241231.htm"
     ]
    },
    "schema": {
     "local": [
      "sera-20241231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/2023/calculation-1.1.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    }
   },
   "keyStandard": 361,
   "keyCustom": 59,
   "axisStandard": 22,
   "axisCustom": 2,
   "memberStandard": 36,
   "memberCustom": 27,
   "hidden": {
    "total": 12,
    "http://xbrl.sec.gov/dei/2024": 3,
    "http://fasb.org/us-gaap/2024": 9
   },
   "contextCount": 185,
   "entityCount": 1,
   "segmentCount": 67,
   "elementCount": 742,
   "unitCount": 8,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2024": 787,
    "http://xbrl.sec.gov/dei/2024": 42,
    "http://xbrl.sec.gov/cyd/2024": 16,
    "http://xbrl.sec.gov/ecd/2024": 4
   },
   "report": {
    "R1": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/Cover",
     "longName": "100000 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited",
     "longName": "100010 - Statement - Balance Sheets (unaudited)",
     "shortName": "Balance Sheets (unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "C_f652abc9-1d38-472f-bc10-183e164a2e16",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_f652abc9-1d38-472f-bc10-183e164a2e16",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsParenthetical",
     "longName": "100040 - Statement - Balance Sheets (Parenthetical)",
     "shortName": "Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "C_e26ec1fe-0438-4812-b032-9b354ebc1852",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_e26ec1fe-0438-4812-b032-9b354ebc1852",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/StatementsofOperationsandComprehensiveLoss",
     "longName": "100050 - Statement - Statements of Operations and Comprehensive Loss",
     "shortName": "Statements of Operations and Comprehensive Loss",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "sera:CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/StatementStatementsOfStockholdersEquity",
     "longName": "100060 - Statement - Statements of Stockholders' Equity",
     "shortName": "Statements of Stockholders' Equity",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "C_1897da0a-32c6-4bd9-ab52-d7b11d48dbc4",
      "name": "us-gaap:CommonStockSharesIssued",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1897da0a-32c6-4bd9-ab52-d7b11d48dbc4",
      "name": "us-gaap:CommonStockSharesIssued",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows",
     "longName": "100070 - Statement - Statements of Cash Flows",
     "shortName": "Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:ShareBasedCompensation",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "7",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R8": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "C_208b76c5-59c1-4209-a49b-266bd3873544",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_208b76c5-59c1-4209-a49b-266bd3873544",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernanceDisclosure",
     "longName": "995455 - Disclosure - Cybersecurity Risk Management, Strategy, and Governance Disclosure",
     "shortName": "Cybersecurity Risk Management, Strategy, and Governance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/DescriptionofBusinessandFinancialCondition",
     "longName": "995465 - Disclosure - Description of Business and Financial Condition",
     "shortName": "Description of Business and Financial Condition",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/SignificantAccountingPolicies",
     "longName": "995475 - Disclosure - Significant Accounting Policies",
     "shortName": "Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecurities",
     "longName": "995485 - Disclosure - Cash, Cash Equivalents and Marketable Securities",
     "shortName": "Cash, Cash Equivalents and Marketable Securities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/PropertyandEquipment",
     "longName": "995495 - Disclosure - Property and Equipment",
     "shortName": "Property and Equipment",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNet",
     "longName": "995505 - Disclosure - Intangible Assets, net",
     "shortName": "Intangible Assets, net",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/AccruedandOtherCurrentLiabilities",
     "longName": "995525 - Disclosure - Accrued and Other Current Liabilities",
     "shortName": "Accrued and Other Current Liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/DisclosureOtherIncomeNet1",
     "longName": "995535 - Disclosure - Other Income, Net",
     "shortName": "Other Income, Net",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/FairValueMeasurements",
     "longName": "995545 - Disclosure - Fair Value Measurements",
     "shortName": "Fair Value Measurements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/RelatedPartyTransactions",
     "longName": "995555 - Disclosure - Related Party Transactions",
     "shortName": "Related Party Transactions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/CapitalStructure",
     "longName": "995565 - Disclosure - Capital Structure",
     "shortName": "Capital Structure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/StockBasedCompensation",
     "longName": "995575 - Disclosure - Stock-Based Compensation",
     "shortName": "Stock-Based Compensation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/Warrants",
     "longName": "995585 - Disclosure - Warrants",
     "shortName": "Warrants",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "sera:WarrantsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "sera:WarrantsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/CommitmentsandContingencies",
     "longName": "995595 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxes",
     "longName": "995605 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/DisclosureNetLossPerShare1",
     "longName": "995615 - Disclosure - Net Loss Per Share",
     "shortName": "Net Loss Per Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSegmentInformation",
     "longName": "995625 - Disclosure - Segment Information",
     "shortName": "Segment Information",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSubsequentEvents",
     "longName": "995635 - Disclosure - Subsequent Events",
     "shortName": "Subsequent Events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "26",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/SignificantAccountingPoliciesPolicies",
     "longName": "995645 - Disclosure - Significant Accounting Policies (Policies)",
     "shortName": "Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "27",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/AccountingPoliciesTables",
     "longName": "995655 - Disclosure - Accounting Policies (Tables)",
     "shortName": "Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "sera:ScheduleOfEstimatedUsefulLifeOfEachAssetCategoryTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "sera:ScheduleOfEstimatedUsefulLifeOfEachAssetCategoryTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesTables",
     "longName": "995665 - Disclosure - Cash, Cash Equivalents and Marketable Securities (Tables)",
     "shortName": "Cash, Cash Equivalents and Marketable Securities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/PropertyandEquipmentTables",
     "longName": "995675 - Disclosure - Property and Equipment (Tables)",
     "shortName": "Property and Equipment (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetTables",
     "longName": "995685 - Disclosure - Intangible Assets, net (Tables)",
     "shortName": "Intangible Assets, net (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/AccruedandOtherCurrentLiabilitiesTables",
     "longName": "995705 - Disclosure - Accrued and Other Current Liabilities (Tables)",
     "shortName": "Accrued and Other Current Liabilities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/DisclosureOtherIncomeNetTables",
     "longName": "995715 - Disclosure - Other Income, Net (Tables)",
     "shortName": "Other Income, Net (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/FairValueMeasurementsTables",
     "longName": "995725 - Disclosure - Fair Value Measurements (Tables)",
     "shortName": "Fair Value Measurements (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/CapitalStructureTables",
     "longName": "995735 - Disclosure - Capital Structure (Tables)",
     "shortName": "Capital Structure (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "sera:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "sera:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/StockBasedCompensationTables",
     "longName": "995745 - Disclosure - Stock-Based Compensation (Tables)",
     "shortName": "Stock-Based Compensation (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/WarrantsTables",
     "longName": "995755 - Disclosure - Warrants (Tables)",
     "shortName": "Warrants (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "37",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "sera:WarrantsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "sera:WarrantsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/CommitmentandContingenciesTables",
     "longName": "995765 - Disclosure - Commitment and Contingencies (Tables)",
     "shortName": "Commitment and Contingencies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "38",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "sera:ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "sera:ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesTables",
     "longName": "995775 - Disclosure - Income Taxes (Tables)",
     "shortName": "Income Taxes (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "39",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/DisclosureNetLossPerShareTables",
     "longName": "995785 - Disclosure - Net Loss Per Share (Tables)",
     "shortName": "Net Loss Per Share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "40",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSegmentInformationTables",
     "longName": "995795 - Disclosure - Segment Information (Tables)",
     "shortName": "Segment Information (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "41",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAndFinancialConditionAdditionalInformationDetails",
     "longName": "995805 - Disclosure - Description of Business and Financial Condition - Additional Information (Details)",
     "shortName": "Description of Business and Financial Condition - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "C_f652abc9-1d38-472f-bc10-183e164a2e16",
      "name": "us-gaap:RetainedEarningsAccumulatedDeficit",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_84137556-2fb3-4bc3-987b-4443923c3d54",
      "name": "us-gaap:CommonStockNoParValue",
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "unique": true
     }
    },
    "R43": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails",
     "longName": "995815 - Disclosure - Significant Accounting Policies - Additional Information (Details)",
     "shortName": "Significant Accounting Policies - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:DefinedContributionPlanCostRecognized",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "us-gaap:PostemploymentBenefitPlansPolicy",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:DefinedContributionPlanCostRecognized",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "us-gaap:PostemploymentBenefitPlansPolicy",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSignificantAccountingPoliciesScheduleOfEstimatedUsefulLifeOfEachAssetCategoryDetails",
     "longName": "995825 - Disclosure - Significant Accounting Policies - Schedule of Estimated Useful Life of Each Asset Category (Details)",
     "shortName": "Significant Accounting Policies - Schedule of Estimated Useful Life of Each Asset Category (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "C_a3f22057-cfb4-4d74-a910-d271c95221d1",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a3f22057-cfb4-4d74-a910-d271c95221d1",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails",
     "longName": "995835 - Disclosure - Cash, Cash Equivalents and Marketable Securities - Cash, Cash Equivalents and Marketable Securities by Major Security Type (Details)",
     "shortName": "Cash, Cash Equivalents and Marketable Securities - Cash, Cash Equivalents and Marketable Securities by Major Security Type (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "C_f652abc9-1d38-472f-bc10-183e164a2e16",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_f652abc9-1d38-472f-bc10-183e164a2e16",
      "name": "sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
       "div",
       "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "unique": true
     }
    },
    "R46": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecuritiesAvailableforsaleDebtSecuritiesAndCashEquivalentsInUnrealizedLossPositionsDetails",
     "longName": "995845 - Disclosure - Cash, Cash Equivalents and Marketable Securities - Available-for-sale Debt Securities and Cash Equivalents in Unrealized Loss Positions (Details)",
     "shortName": "Cash, Cash Equivalents and Marketable Securities - Available-for-sale Debt Securities and Cash Equivalents in Unrealized Loss Positions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "C_f652abc9-1d38-472f-bc10-183e164a2e16",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_f652abc9-1d38-472f-bc10-183e164a2e16",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecuritiesAdditionalInformationDetails",
     "longName": "995855 - Disclosure - Cash, Cash Equivalents and Marketable Securities - Additional Information (Details)",
     "shortName": "Cash, Cash Equivalents and Marketable Securities - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "C_f652abc9-1d38-472f-bc10-183e164a2e16",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_f652abc9-1d38-472f-bc10-183e164a2e16",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails",
     "longName": "995865 - Disclosure - Cash, Cash Equivalents and Marketable Securities - Marketable Securities Classified by Contractual Maturities (Details)",
     "shortName": "Cash, Cash Equivalents and Marketable Securities - Marketable Securities Classified by Contractual Maturities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "C_f652abc9-1d38-472f-bc10-183e164a2e16",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_f652abc9-1d38-472f-bc10-183e164a2e16",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentScheduleOfComponentsOfPropertyAndEquipmentNetDetails",
     "longName": "995875 - Disclosure - Property and Equipment - Schedule of Components of Property and Equipment, Net (Details)",
     "shortName": "Property and Equipment - Schedule of Components of Property and Equipment, Net (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "C_f652abc9-1d38-472f-bc10-183e164a2e16",
      "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_f652abc9-1d38-472f-bc10-183e164a2e16",
      "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/PropertyandEquipmentAdditionalInformationDetails",
     "longName": "995885 - Disclosure - Property and Equipment - Additional Information (Details)",
     "shortName": "Property and Equipment - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R51": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsDetails",
     "longName": "995895 - Disclosure - Intangible Assets, net - Schedule of Intangible Assets (Details)",
     "shortName": "Intangible Assets, net - Schedule of Intangible Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "C_f652abc9-1d38-472f-bc10-183e164a2e16",
      "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "div",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_f652abc9-1d38-472f-bc10-183e164a2e16",
      "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "div",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetAdditionalInformationDetails",
     "longName": "995905 - Disclosure - Intangible Assets, net - Additional Information (Details)",
     "shortName": "Intangible Assets, net - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "sera:CapitalizedIntangibleAssets",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "sera:CapitalizedIntangibleAssets",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfComponentsOfAccruedAndOtherCurrentLiabilitiesDetails",
     "longName": "995915 - Disclosure - Accrued and Other Current Liabilities - Schedule of Components of Accrued and Other Current Liabilities (Details)",
     "shortName": "Accrued and Other Current Liabilities - Schedule of Components of Accrued and Other Current Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "C_f652abc9-1d38-472f-bc10-183e164a2e16",
      "name": "us-gaap:AccruedSalariesCurrent",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_f652abc9-1d38-472f-bc10-183e164a2e16",
      "name": "us-gaap:AccruedSalariesCurrent",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/DisclosureOtherIncomeNetScheduleOfComponentsOfOtherIncomeNetDetails",
     "longName": "995925 - Disclosure - Other Income, Net - Schedule of Components of Other Income, Net (Details)",
     "shortName": "Other Income, Net - Schedule of Components of Other Income, Net (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:InterestIncomeOther",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "div",
       "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:InterestIncomeOther",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "div",
       "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails",
     "longName": "995945 - Disclosure - Fair Value Measurements - Financial Assets that are Measured at Fair Value on a Recurring Basis (Details)",
     "shortName": "Fair Value Measurements - Financial Assets that are Measured at Fair Value on a Recurring Basis (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "C_f652abc9-1d38-472f-bc10-183e164a2e16",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_fad988d1-5034-478c-8516-20f5782f4f85",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "unique": true
     }
    },
    "R56": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
     "longName": "995955 - Disclosure - Related Party Transactions - Additional Information (Details)",
     "shortName": "Related Party Transactions - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:OperatingExpenses",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5a27522b-3fd7-4775-b4b1-c07ac5059bc8",
      "name": "us-gaap:OperatingExpenses",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "unique": true
     }
    },
    "R57": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureAdditionalInformationDetails",
     "longName": "995965 - Disclosure - Capital Structure - Additional Information (Details)",
     "shortName": "Capital Structure - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "C_f652abc9-1d38-472f-bc10-183e164a2e16",
      "name": "sera:NumberOfCommonStockClassesAuthorized",
      "unitRef": "U_CommonStockClass",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_f652abc9-1d38-472f-bc10-183e164a2e16",
      "name": "sera:NumberOfCommonStockClassesAuthorized",
      "unitRef": "U_CommonStockClass",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureScheduleOfCommonStockReservedForFutureIssuanceDetails",
     "longName": "995975 - Disclosure - Capital Structure - Schedule of Common Stock Reserved for Future Issuance (Details)",
     "shortName": "Capital Structure - Schedule of Common Stock Reserved for Future Issuance (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "C_e26ec1fe-0438-4812-b032-9b354ebc1852",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "sera:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_f375d679-1976-474c-901f-6de9f5d1164a",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "sera:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "unique": true
     }
    },
    "R59": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
     "longName": "995995 - Disclosure - Stock-Based Compensation - Additional Information (Details)",
     "shortName": "Stock-Based Compensation - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionsGrantedAndOutstandingDetails",
     "longName": "996005 - Disclosure - Stock-Based Compensation - Summary of Options Granted and Outstanding (Details)",
     "shortName": "Stock-Based Compensation - Summary of Options Granted and Outstanding (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "C_b8f625aa-6c52-4a2e-99d7-4c691c838229",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "unique": true
     }
    },
    "R61": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfFairValuesCalculatedUsingBlackscholesOptionPricingModelDetails",
     "longName": "996015 - Disclosure - Stock-Based Compensation - Schedule of Fair Values Calculated using Black-Scholes Option Pricing Model (Details)",
     "shortName": "Stock-Based Compensation - Schedule of Fair Values Calculated using Black-Scholes Option Pricing Model (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R62": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfInformationAboutRsusGrantedAndOutstandingDetails",
     "longName": "996025 - Disclosure - Stock-Based Compensation - Summary of Information about RSUs Granted and Outstanding (Details)",
     "shortName": "Stock-Based Compensation - Summary of Information about RSUs Granted and Outstanding (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "C_c65254c7-ac81-4069-a809-c971b11aa622",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c65254c7-ac81-4069-a809-c971b11aa622",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R63": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfImpactOfStockbasedCompensationExpenseInStatementsOfOperationsDetails",
     "longName": "996035 - Disclosure - Stock-Based Compensation - Schedule of Impact of Stock-based Compensation Expense in Statements of Operations (Details)",
     "shortName": "Stock-Based Compensation - Schedule of Impact of Stock-based Compensation Expense in Statements of Operations (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_82b9b7fb-68e4-45aa-8dc3-daea6ea244e1",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "unique": true
     }
    },
    "R64": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfUnrecognizedStockbasedCompensationExpenseForOutstandingUnvestedStockOptionsAndRsusDetails",
     "longName": "996045 - Disclosure - Stock-Based Compensation - Summary of Unrecognized Stock-based Compensation Expense for Outstanding Unvested Stock Options and RSUs (Details)",
     "shortName": "Stock-Based Compensation - Summary of Unrecognized Stock-based Compensation Expense for Outstanding Unvested Stock Options and RSUs (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "C_f652abc9-1d38-472f-bc10-183e164a2e16",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_f652abc9-1d38-472f-bc10-183e164a2e16",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "unique": true
     }
    },
    "R65": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/DisclosureWarrantsScheduleOfCommonStockWarrantsOutstandingDetails",
     "longName": "996055 - Disclosure - Warrants - Schedule of Common Stock Warrants Outstanding (Details)",
     "shortName": "Warrants - Schedule of Common Stock Warrants Outstanding (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "C_f652abc9-1d38-472f-bc10-183e164a2e16",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "sera:WarrantsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_f652abc9-1d38-472f-bc10-183e164a2e16",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "sera:WarrantsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R66": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails",
     "longName": "996065 - Disclosure - Warrants - Additional Information (Details)",
     "shortName": "Warrants - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "sera:ClassOfWarrantOrRightExercised",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "sera:WarrantsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "sera:ClassOfWarrantOrRightExercised",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "sera:WarrantsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R67": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeasesInFinancialStatementDetails",
     "longName": "996075 - Disclosure - Commitments and Contingencies - Schedule of Leases in Financial Statement (Details)",
     "shortName": "Commitments and Contingencies - Schedule of Leases in Financial Statement (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "C_f652abc9-1d38-472f-bc10-183e164a2e16",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "sera:ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock",
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_f652abc9-1d38-472f-bc10-183e164a2e16",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "sera:ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock",
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R68": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeaseCostAndOtherInformationDetails",
     "longName": "996085 - Disclosure - Commitments and Contingencies - Schedule of Lease Cost and Other Information (Details)",
     "shortName": "Commitments and Contingencies - Schedule of Lease Cost and Other Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:FinanceLeaseRightOfUseAssetAmortization",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:FinanceLeaseRightOfUseAssetAmortization",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R69": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails",
     "longName": "996095 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Lease Payments (Details)",
     "shortName": "Commitments and Contingencies - Schedule of Future Minimum Lease Payments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "C_f652abc9-1d38-472f-bc10-183e164a2e16",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_f652abc9-1d38-472f-bc10-183e164a2e16",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R70": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
     "longName": "996105 - Disclosure - Commitments and Contingencies - Additional Information (Details)",
     "shortName": "Commitments and Contingencies - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "C_f652abc9-1d38-472f-bc10-183e164a2e16",
      "name": "sera:IndemnificationLiability",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_f652abc9-1d38-472f-bc10-183e164a2e16",
      "name": "sera:IndemnificationLiability",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R71": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails",
     "longName": "996115 - Disclosure - Income Taxes - Additional Information (Details)",
     "shortName": "Income Taxes - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_f652abc9-1d38-472f-bc10-183e164a2e16",
      "name": "us-gaap:OperatingLossCarryforwards",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "unique": true
     }
    },
    "R72": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails",
     "longName": "996125 - Disclosure - Income Taxes - Schedule of Components of Income Tax Provision (Details)",
     "shortName": "Income Taxes - Schedule of Components of Income Tax Provision (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R73": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesEffectiveTaxRateReconciliationDetails",
     "longName": "996135 - Disclosure - Income Taxes - Effective Tax Rate Reconciliation (Details)",
     "shortName": "Income Taxes - Effective Tax Rate Reconciliation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R74": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails",
     "longName": "996145 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details)",
     "shortName": "Income Taxes - Deferred Tax Assets and Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "C_f652abc9-1d38-472f-bc10-183e164a2e16",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_f652abc9-1d38-472f-bc10-183e164a2e16",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R75": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesUnrecognizedTaxPositionsDetails",
     "longName": "996155 - Disclosure - Income Taxes - Unrecognized Tax Positions (Details)",
     "shortName": "Income Taxes - Unrecognized Tax Positions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "C_b8f625aa-6c52-4a2e-99d7-4c691c838229",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_bbe124b6-5e26-4340-9b7f-2ec3e167c7a7",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "unique": true
     }
    },
    "R76": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/DisclosureNetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromTheComputationOfEarningsPerShareDetails",
     "longName": "996165 - Disclosure - Net Loss Per Share - Schedule of Anti-dilutive Securities Excluded from the Computation of Earnings per Share (Details)",
     "shortName": "Net Loss Per Share - Schedule of Anti-dilutive Securities Excluded from the Computation of Earnings per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R77": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSegmentInformationSummaryOfSegmentInformationForRevenueSignificantSegmentExpensesAndSegmentLossExpensesThatAreRegularlyProvidedT",
     "longName": "996175 - Disclosure - Segment Information - Summary of Segment Information for Revenue, Significant Segment Expenses and Segment Loss Expenses that are Regularly Provided to the CODM (Details)",
     "shortName": "Segment Information - Summary of Segment Information for Revenue, Significant Segment Expenses and Segment Loss Expenses that are Regularly Provided to the CODM (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:Revenues",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:Revenues",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "div",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R78": {
     "role": "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
     "longName": "996185 - Disclosure - Subsequent Events (Additional Information) (Details)",
     "shortName": "Subsequent Events (Additional Information) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "78",
     "firstAnchor": {
      "contextRef": "C_1e202fd9-3575-429f-acb1-9d054feb99d5",
      "name": "us-gaap:ProceedsFromStockOptionsExercised",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_49e34717-cb5a-4860-9e99-7bca256906a4",
      "name": "sera:WarrantsIssued",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sera-20241231.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingStandardsUpdate202307Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingStandardsUpdate202307Member",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ASU 2023-07",
        "label": "Accounting Standards Update 2023-07 [Member]",
        "documentation": "Accounting Standards Update 2023-07 Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures."
       }
      }
     },
     "auth_ref": [
      "r236",
      "r237"
     ]
    },
    "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/AccruedandOtherCurrentLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]",
        "terseLabel": "Accrued and Other Current Liabilities",
        "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r427"
     ]
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable and Accrued Liabilities, Current [Abstract]",
        "terseLabel": "Accounts Payable and Accrued Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r821"
     ]
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r988"
     ]
    },
    "us-gaap_AccruedEmployeeBenefitsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedEmployeeBenefitsCurrent",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfComponentsOfAccruedAndOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfComponentsOfAccruedAndOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Employee Benefits, Current",
        "terseLabel": "Accrued 401(k) matching contributions",
        "documentation": "Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "us-gaap_AccruedLiabilitiesAndOtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedLiabilitiesAndOtherLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfComponentsOfAccruedAndOtherCurrentLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfComponentsOfAccruedAndOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities and Other Liabilities",
        "totalLabel": "Total accrued and other current liabilities",
        "verboseLabel": "Accrued and other current liabilities",
        "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedSalariesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedSalariesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfComponentsOfAccruedAndOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfComponentsOfAccruedAndOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Salaries, Current",
        "terseLabel": "Accrued compensation",
        "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r774"
     ]
    },
    "us-gaap_AccruedVacationCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedVacationCurrent",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfComponentsOfAccruedAndOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfComponentsOfAccruedAndOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Vacation, Current",
        "terseLabel": "Accrued vacation",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for unused vacation time owed to employees based on the entity's vacation benefit given to its employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r50"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r14",
      "r63",
      "r134",
      "r641",
      "r664",
      "r668"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive (Loss) Income",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r6",
      "r14",
      "r499",
      "r502",
      "r576",
      "r659",
      "r660",
      "r968",
      "r969",
      "r970",
      "r977",
      "r978",
      "r979",
      "r980"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r885"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital",
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital."
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r683",
      "r977",
      "r978",
      "r979",
      "r980",
      "r1049",
      "r1082"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r898"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "auth_ref": [
      "r898"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r898"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r898"
     ]
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update [Axis]",
        "documentation": "Information by amendment to accounting standards."
       }
      }
     },
     "auth_ref": [
      "r117",
      "r118",
      "r119",
      "r120",
      "r121",
      "r122",
      "r169",
      "r170",
      "r171",
      "r172",
      "r183",
      "r236",
      "r237",
      "r273",
      "r274",
      "r275",
      "r276",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r315",
      "r316",
      "r319",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r538",
      "r539",
      "r550",
      "r551",
      "r552",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r623",
      "r624",
      "r625",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation expense",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r39",
      "r40",
      "r384"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "sera_AggregateOfferingPriceFromSaleOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "AggregateOfferingPriceFromSaleOfCommonStock",
     "crdr": "credit",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAndFinancialConditionAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate offering price from sale of common stock",
        "label": "Aggregate Offering Price from Sale of Common Stock",
        "documentation": "Aggregate offering price from sale of common stock."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r943"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r856",
      "r867",
      "r877",
      "r910"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r859",
      "r870",
      "r880",
      "r913"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Pension Adjustments Service Cost [Member]",
        "terseLabel": "Aggregate Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r944"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "auth_ref": [
      "r898"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "auth_ref": [
      "r905"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "auth_ref": [
      "r860",
      "r871",
      "r881",
      "r905",
      "r914",
      "r918",
      "r926"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "auth_ref": [
      "r924"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSegmentInformationSummaryOfSegmentInformationForRevenueSignificantSegmentExpensesAndSegmentLossExpensesThatAreRegularlyProvidedT": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSegmentInformationSummaryOfSegmentInformationForRevenueSignificantSegmentExpensesAndSegmentLossExpensesThatAreRegularlyProvidedT",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfImpactOfStockbasedCompensationExpenseInStatementsOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Total employee stock-based compensation",
        "verboseLabel": "Stock-based compensation expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r416",
      "r425"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AmortizationOfIntangibleAssets",
     "crdr": "debit",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization expense",
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r302",
      "r308",
      "r798"
     ]
    },
    "sera_AmountFromSaleOfCombinationOfSecuritiesUnderShelfRegistration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "AmountFromSaleOfCombinationOfSecuritiesUnderShelfRegistration",
     "crdr": "credit",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAndFinancialConditionAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount from Sale of Combination of Securities under Shelf Registration",
        "documentation": "Amount from sale of combination of securities under shelf registration.",
        "terseLabel": "Amount from sale of combination of securities under shelf registration"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureNetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromTheComputationOfEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Anti-dilutive securities excluded from the computation of earnings per share (in shares)",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r193"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureNetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromTheComputationOfEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureNetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromTheComputationOfEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureNetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromTheComputationOfEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAndFinancialConditionAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r488"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets",
        "totalLabel": "Total assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r97",
      "r130",
      "r161",
      "r198",
      "r207",
      "r225",
      "r228",
      "r271",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r489",
      "r491",
      "r540",
      "r637",
      "r717",
      "r788",
      "r789",
      "r821",
      "r834",
      "r1007",
      "r1008",
      "r1065"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current",
        "totalLabel": "Total current assets",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r135",
      "r161",
      "r271",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r489",
      "r491",
      "r540",
      "r821",
      "r1007",
      "r1008",
      "r1065"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total assets",
        "documentation": "Fair value portion of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r519",
      "r520",
      "r810"
     ]
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsFairValueDisclosureAbstract",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "auth_ref": []
    },
    "sera_AtTheMarketOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "AtTheMarketOfferingMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAndFinancialConditionAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "At-the-Market Offering [Member]",
        "documentation": "At-the-market offering.",
        "terseLabel": "At-the-Market Offering"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r839",
      "r840",
      "r863"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLocation",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r839",
      "r840",
      "r863"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorName",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r839",
      "r840",
      "r863"
     ]
    },
    "dei_AuditorOpinionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorOpinionTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Opinion [Text Block]",
        "terseLabel": "Auditor Opinion"
       }
      }
     },
     "auth_ref": [
      "r947"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails": {
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Marketable securities, Gross Unrealized Gains",
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r244"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails": {
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedTerseLabel": "Marketable securities, Gross Unrealized Losses",
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r245"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "terseLabel": "Amortized Cost",
        "totalLabel": "Marketable securities, Amortized Cost",
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r241",
      "r289",
      "r636"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecuritiesAvailableforsaleDebtSecuritiesAndCashEquivalentsInUnrealizedLossPositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]",
        "terseLabel": "Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r291",
      "r797"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails": {
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "terseLabel": "Due after one year through five years",
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r992"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails": {
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "terseLabel": "Due after one year through five years",
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r249",
      "r634"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Amortized Cost"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Fair Value, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails": {
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Due within one year",
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r991"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails": {
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Due within one year",
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r248",
      "r633"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails": {
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0,
       "order": 0.0
      },
      "http://seraprognostics.com/20241231/taxonomy/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 0.0
      },
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale",
        "terseLabel": "Marketable securities:",
        "totalLabel": "Fair Value",
        "verboseLabel": "Marketable securities, Fair Value",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r242",
      "r289",
      "r519",
      "r628",
      "r810",
      "r813",
      "r990",
      "r1053",
      "r1054",
      "r1055"
     ]
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r921"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r922"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]",
        "terseLabel": "Award Timing Disclosures"
       }
      }
     },
     "auth_ref": [
      "r917"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r917"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r917"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r917"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r917"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r917"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfInformationAboutRsusGrantedAndOutstandingDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfUnrecognizedStockbasedCompensationExpenseForOutstandingUnvestedStockOptionsAndRsusDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r387",
      "r388",
      "r389",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r920"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r919"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "auth_ref": [
      "r918"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r918"
     ]
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BalanceSheetLocationAxis",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]",
        "documentation": "Information by location in statement of financial position where disaggregated cumulative balance has been reported."
       }
      }
     },
     "auth_ref": [
      "r318",
      "r1075",
      "r1076"
     ]
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BalanceSheetLocationDomain",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]",
        "documentation": "Location in statement of financial position where disaggregated cumulative balance has been reported."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r42",
      "r318",
      "r1075",
      "r1076"
     ]
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "sera_CapitalSharesReservedForFutureIssuanceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "CapitalSharesReservedForFutureIssuanceAxis",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureScheduleOfCommonStockReservedForFutureIssuanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The table relating to information on capital stock reserved for future issuance.",
        "label": "Capital Shares Reserved for Future Issuance [Axis]",
        "terseLabel": "Capital Shares Reserved for Future Issuance [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "sera_CapitalSharesReservedForFutureIssuanceDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "CapitalSharesReservedForFutureIssuanceDomain",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureScheduleOfCommonStockReservedForFutureIssuanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information on capital stock reserved for future issuance.",
        "label": "Capital Shares Reserved For Future Issuance [Domain]",
        "terseLabel": "Capital Shares Reserved for Future Issuance [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "sera_CapitalizedIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "CapitalizedIntangibleAssets",
     "crdr": "debit",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capitalized Intangible Assets",
        "documentation": "Capitalized intangible assets"
       }
      }
     },
     "auth_ref": []
    },
    "sera_CarelonResearchMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "CarelonResearchMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Carelon Research, a wholly-owned subsidiary of Elevance Health, Inc.",
        "label": "Carelon Research [Member]",
        "terseLabel": "Healthcore Inc"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails": {
       "parentTag": "sera_CashAndCashEquivalentsAmortizedCost",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash And Cash Equivalents, Accumulated Gross Unrealized Gain, Before Tax",
        "label": "Cash And Cash Equivalents, Accumulated Gross Unrealized Gain, Before Tax",
        "terseLabel": "Cash and cash equivalents, Gross Unrealized Gains"
       }
      }
     },
     "auth_ref": []
    },
    "sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails": {
       "parentTag": "sera_CashAndCashEquivalentsAmortizedCost",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash And Cash Equivalents, Accumulated Gross Unrealized Loss, Before Tax",
        "label": "Cash And Cash Equivalents, Accumulated Gross Unrealized Loss, Before Tax",
        "negatedLabel": "Cash and cash equivalents, Gross Unrealized Losses"
       }
      }
     },
     "auth_ref": []
    },
    "sera_CashAndCashEquivalentsAmortizedCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "CashAndCashEquivalentsAmortizedCost",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash And Cash Equivalents, Amortized Cost",
        "label": "Cash And Cash Equivalents, Amortized Cost",
        "totalLabel": "Cash and cash equivalents, Amortized Cost"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r126",
      "r773"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAxis",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents [Axis]",
        "terseLabel": "Cash and Cash Equivalents [Axis]",
        "documentation": "Information by type of cash and cash equivalent balance."
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails": {
       "parentTag": "sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash And Cash Equivalents, Debt Securities Available-For-Sale, Accumulated Gross Unrealized Gain, Before Tax",
        "label": "Cash And Cash Equivalents, Debt Securities Available-For-Sale, Accumulated Gross Unrealized Gain, Before Tax",
        "terseLabel": "Total cash, cash equivalents and marketable securities, Gross Unrealized Gains"
       }
      }
     },
     "auth_ref": []
    },
    "sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails": {
       "parentTag": "sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash And Cash Equivalents, Debt Securities Available-For-Sale, Accumulated Gross Unrealized Loss, Before Tax",
        "label": "Cash And Cash Equivalents, Debt Securities Available-For-Sale, Accumulated Gross Unrealized Loss, Before Tax",
        "negatedLabel": "Total cash, cash equivalents and marketable securities, Gross Unrealized Losses"
       }
      }
     },
     "auth_ref": []
    },
    "sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash And Cash Equivalents, Debt Securities Available-For-Sale, Amortized Cost",
        "label": "Cash And Cash Equivalents, Debt Securities Available-For-Sale, Amortized Cost",
        "terseLabel": "Total cash, cash equivalents and marketable securities, Amortized Cost",
        "totalLabel": "Total cash, cash equivalents and marketable securities, Amortized Cost"
       }
      }
     },
     "auth_ref": []
    },
    "sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails": {
       "parentTag": "sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAndFinancialConditionAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash And Cash Equivalents, Debt Securities Available-For-Sale, Fair Value",
        "label": "Cash And Cash Equivalents, Debt Securities Available-For-Sale, Fair Value",
        "terseLabel": "Total cash, cash equivalents and marketable securities, Fair Value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails": {
       "parentTag": "sera_CashAndCashEquivalentsAmortizedCost",
       "weight": 1.0,
       "order": 1.0
      },
      "http://seraprognostics.com/20241231/taxonomy/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash equivalents:",
        "verboseLabel": "Cash and cash equivalents, Fair Value",
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r1051",
      "r1052"
     ]
    },
    "us-gaap_CashAndCashEquivalentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents [Member]",
        "terseLabel": "Cash and cash equivalents:",
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsAndMarketableSecuritiesTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecurities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, and Marketable Securities [Text Block]",
        "terseLabel": "Cash, Cash Equivalents and Marketable Securities",
        "documentation": "The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r989"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents at end of period",
        "periodStartLabel": "Cash and cash equivalents at beginning of period",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r71",
      "r158"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash and cash equivalents",
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r71"
     ]
    },
    "us-gaap_CashMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash [Member]",
        "terseLabel": "Cash",
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Accounting Principle, Accounting Standards Update, Adopted [true false]",
        "documentation": "Indicates (true false) whether accounting standards update was adopted."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r113",
      "r122",
      "r168",
      "r236",
      "r272",
      "r273",
      "r274",
      "r280",
      "r281",
      "r315",
      "r319",
      "r462",
      "r471",
      "r472",
      "r480",
      "r481",
      "r483",
      "r494",
      "r495",
      "r507",
      "r508",
      "r538",
      "r539",
      "r551",
      "r571",
      "r572",
      "r623",
      "r624",
      "r657",
      "r658"
     ]
    },
    "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Accounting Principle, Accounting Standards Update, Adoption Date",
        "documentation": "Date accounting standards update was adopted, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r113",
      "r122",
      "r236",
      "r272",
      "r273",
      "r274",
      "r280",
      "r281",
      "r282",
      "r315",
      "r319",
      "r462",
      "r471",
      "r472",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r493",
      "r494",
      "r495",
      "r496",
      "r507",
      "r508",
      "r509",
      "r512",
      "r538",
      "r539",
      "r551",
      "r571",
      "r572",
      "r623",
      "r624",
      "r657",
      "r658",
      "r953"
     ]
    },
    "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Accounting Principle, Accounting Standards Update, Immaterial Effect [true false]",
        "documentation": "Indicates (true false) whether effect from applying amendment to accounting standards is immaterial."
       }
      }
     },
     "auth_ref": [
      "r169",
      "r182",
      "r277"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r896"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]",
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r893"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]",
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r891"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsParenthetical",
      "http://seraprognostics.com/20241231/taxonomy/role/Cover",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureScheduleOfCommonStockReservedForFutureIssuanceDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAndFinancialConditionAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r131",
      "r132",
      "r133",
      "r161",
      "r187",
      "r188",
      "r190",
      "r192",
      "r200",
      "r201",
      "r271",
      "r328",
      "r330",
      "r331",
      "r332",
      "r335",
      "r336",
      "r341",
      "r342",
      "r345",
      "r348",
      "r355",
      "r540",
      "r674",
      "r675",
      "r676",
      "r677",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r705",
      "r726",
      "r748",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765",
      "r950",
      "r973",
      "r981"
     ]
    },
    "us-gaap_ClassOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockLineItems",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureScheduleOfCommonStockReservedForFutureIssuanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r131",
      "r132",
      "r133",
      "r200",
      "r341",
      "r342",
      "r343",
      "r345",
      "r348",
      "r353",
      "r355",
      "r674",
      "r675",
      "r676",
      "r677",
      "r801",
      "r950",
      "r973"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightAxis",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Axis]",
        "terseLabel": "Class of Warrant or Right [Axis]",
        "documentation": "Information by type of warrant or right issued."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightDomain",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Domain]",
        "terseLabel": "Class of Warrant or Right [Domain]",
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureWarrantsScheduleOfCommonStockWarrantsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "terseLabel": "Exercise price (in usd per share)",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r356"
     ]
    },
    "sera_ClassOfWarrantOrRightExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "ClassOfWarrantOrRightExercised",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of Warrant Or Right, Exercised",
        "label": "Class of Warrant Or Right, Exercised",
        "negatedTerseLabel": "Class of Warrant Or Right, Exercised"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightLineItems",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureWarrantsScheduleOfCommonStockWarrantsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Line Items]",
        "terseLabel": "Class of Warrant or Right [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightOutstanding",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureWarrantsScheduleOfCommonStockWarrantsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right, Outstanding",
        "terseLabel": "Number of warrants outstanding (in shares)",
        "documentation": "Number of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightTable",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureWarrantsScheduleOfCommonStockWarrantsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Table]",
        "terseLabel": "Class of Warrant or Right [Table]",
        "documentation": "Disclosure of information about warrant or right issued that give holder right to purchase security from issuer at specific price within certain time frame."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "sera_ClinicalStudiesAndOutsideProcessing": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "ClinicalStudiesAndOutsideProcessing",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSegmentInformationSummaryOfSegmentInformationForRevenueSignificantSegmentExpensesAndSegmentLossExpensesThatAreRegularlyProvidedT": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSegmentInformationSummaryOfSegmentInformationForRevenueSignificantSegmentExpensesAndSegmentLossExpensesThatAreRegularlyProvidedT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Clinical Studies And Outside Processing",
        "documentation": "Clinical studies and outside processing",
        "terseLabel": "Clinical studies and outside processing"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r897"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r897"
     ]
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAndFinancialConditionAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r488"
     ]
    },
    "sera_CommercialCollaborationAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "CommercialCollaborationAgreementMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for the Commercial Collaboration Agreement with Anthem and its affiliates (the \"Commercial Collaboration Agreement\").",
        "label": "Commercial Collaboration Agreement [Member]",
        "terseLabel": "Commercial Collaboration Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommercialPaperMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommercialPaperMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecuritiesAvailableforsaleDebtSecuritiesAndCashEquivalentsInUnrealizedLossPositionsDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial paper",
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r327",
      "r829",
      "r830",
      "r831",
      "r832"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r91",
      "r639",
      "r704"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/CommitmentsandContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingences",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r321",
      "r322",
      "r767",
      "r1004",
      "r1006"
     ]
    },
    "sera_CommitmentsAndContingenciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "CommitmentsAndContingenciesLineItems",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments And Contingencies [Line Items]",
        "label": "Commitments And Contingencies [Line Items]",
        "terseLabel": "Commitments And Contingencies [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "sera_CommitmentsAndContingenciesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "CommitmentsAndContingenciesTable",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the table relating to information of commitments and contingencies.",
        "label": "Commitments And Contingencies [Table]",
        "terseLabel": "Commitments And Contingencies [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonClassAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonClassAMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsParenthetical",
      "http://seraprognostics.com/20241231/taxonomy/role/Cover",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureScheduleOfCommonStockReservedForFutureIssuanceDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAndFinancialConditionAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Class A [Member]",
        "terseLabel": "Class A common stock",
        "documentation": "Classification of common stock representing ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r1082"
     ]
    },
    "us-gaap_CommonClassBMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonClassBMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsParenthetical",
      "http://seraprognostics.com/20241231/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Class B [Member]",
        "terseLabel": "Class B common stock",
        "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r1082"
     ]
    },
    "sera_CommonStockAdditionalShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "CommonStockAdditionalShares",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchased additional shares",
        "label": "Common Stock Additional Shares",
        "documentation": "Common stock additional shares"
       }
      }
     },
     "auth_ref": []
    },
    "sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureScheduleOfCommonStockReservedForFutureIssuanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock Available For Future Issuance Under2021 Employee Stock [Member]",
        "label": "Common Stock Available For Future Issuance Under2021 Employee Stock [Member]",
        "terseLabel": "Class A common stock available for future grants under the 2021 Employee Stock Purchase Plan"
       }
      }
     },
     "auth_ref": []
    },
    "sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureScheduleOfCommonStockReservedForFutureIssuanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock Available For Future Issuance Under2021 Equity Incentive Plan [Member]",
        "label": "Common Stock Available For Future Issuance Under2021 Equity Incentive Plan [Member]",
        "terseLabel": "Class A common stock available for future grants under the 2021 Equity Incentive Plan"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureScheduleOfCommonStockReservedForFutureIssuanceDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Shares reserved for future issuance (in shares)",
        "verboseLabel": "Shares available for future issuance (in shares)",
        "documentation": "Aggregate number of common shares reserved for future issuance."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "sera_CommonStockConversionRatio": {
     "xbrltype": "pureItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "CommonStockConversionRatio",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, Conversion Ratio",
        "label": "Common Stock, Conversion Ratio",
        "terseLabel": "Common stock, conversion ratio"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock (Class A and B)",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r825",
      "r826",
      "r827",
      "r829",
      "r830",
      "r831",
      "r832",
      "r977",
      "r978",
      "r980",
      "r1049",
      "r1079",
      "r1082"
     ]
    },
    "us-gaap_CommonStockNoParValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockNoParValue",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAndFinancialConditionAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, No Par Value",
        "terseLabel": "Common stock, no par value",
        "documentation": "Face amount per share of no-par value common stock."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsParenthetical",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, price per share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r705"
     ]
    },
    "sera_CommonStockSharesConverted": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "CommonStockSharesConverted",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, Shares Converted",
        "label": "Common Stock, Shares Converted",
        "terseLabel": "Common Stock, Shares Converted"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsParenthetical",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAndFinancialConditionAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/StatementStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares, Issued",
        "periodEndLabel": "Balance at the ending (in shares)",
        "periodStartLabel": "Balance at the beginning (in shares)",
        "terseLabel": "Common stock, shares issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r57",
      "r705",
      "r723",
      "r1082",
      "r1083"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.0001 par value; 150,000,000 Class A shares authorized; 33,206,909 and 30,736,513 Class A shares issued and outstanding as of December 31, 2024 and 2023, respectively; 1,500,000 Class B shares authorized; 967,759 and 1,405,259 Class B shares issued as of December 31, 2024 and 2023, respectively; 967,759 Class B shares outstanding as of December 31, 2024 and 2023.",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r640",
      "r821"
     ]
    },
    "sera_CommonStockWarrantAt10.84SharePriceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "CommonStockWarrantAt10.84SharePriceMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureWarrantsScheduleOfCommonStockWarrantsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrant issued by the company that allows the purchase of shares of common stock at a price of $10.84 per share.",
        "label": "Common Stock Warrant At10.84 Share Price [Member]",
        "terseLabel": "10.84"
       }
      }
     },
     "auth_ref": []
    },
    "sera_CommonStockWarrantAt1238SharePriceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "CommonStockWarrantAt1238SharePriceMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureWarrantsScheduleOfCommonStockWarrantsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock Warrant At 12.38 Share Price [Member]",
        "label": "Common Stock Warrant At 12.38 Share Price [Member]",
        "terseLabel": "12.38"
       }
      }
     },
     "auth_ref": []
    },
    "sera_CommonStockWarrantAt20.77SharePriceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "CommonStockWarrantAt20.77SharePriceMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureWarrantsScheduleOfCommonStockWarrantsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrant issued by the company that allows the purchase of shares of common stock at a price of $20.77 per share.",
        "label": "Common Stock Warrant At20.77 Share Price [Member]",
        "verboseLabel": "20.77"
       }
      }
     },
     "auth_ref": []
    },
    "sera_CommonStockWarrantAt520SharePriceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "CommonStockWarrantAt520SharePriceMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureWarrantsScheduleOfCommonStockWarrantsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock Warrant At 5.20 Share Price [Member]",
        "label": "Common Stock Warrant At 5.20 Share Price [Member]",
        "terseLabel": "5.20"
       }
      }
     },
     "auth_ref": []
    },
    "sera_CommonStockWarrantAt9.03SharePriceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "CommonStockWarrantAt9.03SharePriceMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureWarrantsScheduleOfCommonStockWarrantsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrant issued by the company that allows the purchase of shares of common stock at a price of $9.03 per share.",
        "label": "Common Stock Warrant At9.03 Share Price [Member]",
        "terseLabel": "9.03"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonUnitIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonUnitIssued",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Unit, Issued",
        "documentation": "Number of common units issued of limited liability company (LLC)."
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r902"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r901"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r903"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r900"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofOperationsandComprehensiveLoss": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive loss",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r141",
      "r143",
      "r150",
      "r630",
      "r649",
      "r650"
     ]
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "terseLabel": "Comprehensive Loss",
        "documentation": "Disclosure of accounting policy for comprehensive income."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComputerEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComputerEquipmentMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentScheduleOfComponentsOfPropertyAndEquipmentNetDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSignificantAccountingPoliciesScheduleOfEstimatedUsefulLifeOfEachAssetCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Computer Equipment [Member]",
        "terseLabel": "Computer equipment",
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentration of Credit Risk",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r105"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred revenue",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r358",
      "r359",
      "r370"
     ]
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CorporateDebtSecuritiesMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecuritiesAvailableforsaleDebtSecuritiesAndCashEquivalentsInUnrealizedLossPositionsDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate debt securities",
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment."
       }
      }
     },
     "auth_ref": [
      "r802",
      "r804",
      "r810",
      "r822",
      "r824",
      "r1078"
     ]
    },
    "us-gaap_CostOfRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostOfRevenue",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSegmentInformationSummaryOfSegmentInformationForRevenueSignificantSegmentExpensesAndSegmentLossExpensesThatAreRegularlyProvidedT": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSegmentInformationSummaryOfSegmentInformationForRevenueSignificantSegmentExpensesAndSegmentLossExpensesThatAreRegularlyProvidedT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of Revenue",
        "totalLabel": "Cost of Revenue, Total",
        "terseLabel": "Cost of revenue",
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r161",
      "r271",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r540",
      "r788",
      "r1007"
     ]
    },
    "sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost Of Revenue, Excluding Selling, Marketing, General And Administrative Expense",
        "label": "Cost Of Revenue, Excluding Selling, Marketing, General And Administrative Expense",
        "terseLabel": "Cost of revenue"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostOfSalesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostOfSalesPolicyTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of Goods and Service [Policy Text Block]",
        "terseLabel": "Cost of Revenue",
        "documentation": "Disclosure of accounting policy for cost of product sold and service rendered."
       }
      }
     },
     "auth_ref": [
      "r957"
     ]
    },
    "srt_CounterpartyNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "CounterpartyNameAxis",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAndFinancialConditionAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r163",
      "r164",
      "r337",
      "r343",
      "r582",
      "r603",
      "r635",
      "r775",
      "r777"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentFederalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal",
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r955",
      "r975",
      "r1048"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current benefit (provision)",
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r459",
      "r975"
     ]
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current:"
       }
      }
     },
     "auth_ref": []
    },
    "sera_CurrentMarketableSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "CurrentMarketableSecuritiesMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current Marketable Securities [Member]",
        "label": "Current Marketable Securities [Member]",
        "terseLabel": "Current marketable securities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State",
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r955",
      "r975",
      "r1048"
     ]
    },
    "cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernanceDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r848",
      "r937"
     ]
    },
    "cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskBoardOfDirectorsOversightTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernanceDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board of Directors Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r848",
      "r937"
     ]
    },
    "cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernanceDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Expertise of Management Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r850",
      "r939"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernanceDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Flag]"
       }
      }
     },
     "auth_ref": [
      "r850",
      "r939"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernanceDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]"
       }
      }
     },
     "auth_ref": [
      "r852",
      "r941"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernanceDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r850",
      "r939"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernanceDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r843",
      "r932"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesIntegratedFlag",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernanceDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r844",
      "r933"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesIntegratedTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernanceDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r844",
      "r933"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r842",
      "r931"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceLineItems",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernanceDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r842",
      "r931"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceTable",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernanceDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Table]"
       }
      }
     },
     "auth_ref": [
      "r842",
      "r931"
     ]
    },
    "cyd_CybersecurityRiskManagementThirdPartyEngagedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementThirdPartyEngagedFlag",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernanceDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Third Party Engaged [Flag]"
       }
      }
     },
     "auth_ref": [
      "r845",
      "r934"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernanceDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r847",
      "r936"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernanceDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r847",
      "r936"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernanceDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r848",
      "r937"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernanceDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r851",
      "r940"
     ]
    },
    "cyd_CybersecurityRiskRoleOfManagementTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskRoleOfManagementTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernanceDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Role of Management [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r849",
      "r938"
     ]
    },
    "cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernanceDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]"
       }
      }
     },
     "auth_ref": [
      "r846",
      "r935"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesAvailableForSaleAllowanceForCreditLoss",
     "crdr": "credit",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecuritiesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Allowance for Credit Loss",
        "terseLabel": "Debt Securities, Available-for-Sale, Allowance for Credit Loss",
        "documentation": "Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r243",
      "r289",
      "r297",
      "r298"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecuritiesAvailableforsaleDebtSecuritiesAndCashEquivalentsInUnrealizedLossPositionsDetails": {
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecuritiesAvailableforsaleDebtSecuritiesAndCashEquivalentsInUnrealizedLossPositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer",
        "terseLabel": "12 months or greater, Fair Value",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset."
       }
      }
     },
     "auth_ref": [
      "r101",
      "r294",
      "r797"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecuritiesAvailableforsaleDebtSecuritiesAndCashEquivalentsInUnrealizedLossPositionsDetails": {
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecuritiesAvailableforsaleDebtSecuritiesAndCashEquivalentsInUnrealizedLossPositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss",
        "negatedLabel": "12 months or greater, Unrealized Losses",
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset."
       }
      }
     },
     "auth_ref": [
      "r101",
      "r294"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecuritiesAvailableforsaleDebtSecuritiesAndCashEquivalentsInUnrealizedLossPositionsDetails": {
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecuritiesAvailableforsaleDebtSecuritiesAndCashEquivalentsInUnrealizedLossPositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months",
        "terseLabel": "Less than 12 months, Fair Value",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset."
       }
      }
     },
     "auth_ref": [
      "r101",
      "r294",
      "r797"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecuritiesAvailableforsaleDebtSecuritiesAndCashEquivalentsInUnrealizedLossPositionsDetails": {
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecuritiesAvailableforsaleDebtSecuritiesAndCashEquivalentsInUnrealizedLossPositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss",
        "negatedLabel": "Less than 12 months, Unrealized Losses",
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset."
       }
      }
     },
     "auth_ref": [
      "r101",
      "r294"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale [Table]",
        "terseLabel": "Schedule of Available-for-sale Securities [Table]",
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecuritiesAvailableforsaleDebtSecuritiesAndCashEquivalentsInUnrealizedLossPositionsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecuritiesAvailableforsaleDebtSecuritiesAndCashEquivalentsInUnrealizedLossPositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position",
        "terseLabel": "Fair Value",
        "totalLabel": "Total, Fair Value",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r292",
      "r797"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecuritiesAvailableforsaleDebtSecuritiesAndCashEquivalentsInUnrealizedLossPositionsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecuritiesAvailableforsaleDebtSecuritiesAndCashEquivalentsInUnrealizedLossPositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss",
        "negatedTotalLabel": "Total, Unrealized Losses",
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r293"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecuritiesAvailableforsaleDebtSecuritiesAndCashEquivalentsInUnrealizedLossPositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table]",
        "terseLabel": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table]",
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset."
       }
      }
     },
     "auth_ref": [
      "r291",
      "r797"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Available-for-sale Debt Securities and Cash Equivalents in Unrealized Loss Positions",
        "documentation": "Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset."
       }
      }
     },
     "auth_ref": [
      "r98",
      "r797",
      "r998"
     ]
    },
    "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Federal",
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r975",
      "r1047",
      "r1048"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit)",
        "totalLabel": "Total deferred benefit (provision)",
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r111",
      "r975"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "State",
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r975",
      "r1047",
      "r1048"
     ]
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total deferred tax asset before allowance",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r452"
     ]
    },
    "us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsInProcessResearchAndDevelopment",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, in Process Research and Development",
        "terseLabel": "R&amp;E expenses",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from in-process research and development cost acquired in business combination or from joint venture formation or both."
       }
      }
     },
     "auth_ref": [
      "r1045"
     ]
    },
    "sera_DeferredTaxAssetsLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "DeferredTaxAssetsLeaseLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Lease Liabilities",
        "label": "Deferred Tax Assets, Lease Liabilities",
        "terseLabel": "Lease liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Net deferred tax assets",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r1043"
     ]
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Total deferred tax asset",
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1043"
     ]
    },
    "us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsNetOfValuationAllowanceAbstract",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Net of Valuation Allowance [Abstract]",
        "terseLabel": "Deferred tax assets:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1045"
     ]
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOther",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Other",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other."
       }
      }
     },
     "auth_ref": [
      "r1045"
     ]
    },
    "us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsPropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Property, Plant and Equipment",
        "terseLabel": "Depreciation and amortization",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment."
       }
      }
     },
     "auth_ref": [
      "r1045"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Research",
        "terseLabel": "R&amp;D credits",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1045"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost",
        "terseLabel": "Equity-based compensation",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation."
       }
      }
     },
     "auth_ref": [
      "r1045"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals",
        "terseLabel": "Accruals and reserves",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals."
       }
      }
     },
     "auth_ref": [
      "r1045"
     ]
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Valuation Allowance",
        "terseLabel": "Valuation allowance",
        "negatedTerseLabel": "Less: valuation allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r453"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilitiesNetAbstract",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Net [Abstract]",
        "terseLabel": "Deferred tax liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "negatedTerseLabel": "Depreciation and amortization",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment."
       }
      }
     },
     "auth_ref": [
      "r1045"
     ]
    },
    "sera_DeferredTaxLiabilitiesRightOfUseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "DeferredTaxLiabilitiesRightOfUseAssets",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities, Right Of Use Assets",
        "label": "Deferred Tax Liabilities, Right Of Use Assets",
        "terseLabel": "Deferred Tax Liabilities, Right Of Use Assets",
        "negatedLabel": "Right-of-use asset"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedContributionPlanCostRecognized",
     "crdr": "debit",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Contribution Plan, Cost",
        "terseLabel": "Defined contribution plan, cost",
        "documentation": "Amount of cost for defined contribution plan."
       }
      }
     },
     "auth_ref": [
      "r380"
     ]
    },
    "us-gaap_DefinedContributionPlanDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedContributionPlanDisclosureLineItems",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Contribution Plan Disclosure [Line Items]",
        "terseLabel": "Defined Contribution Plan Disclosure [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r380"
     ]
    },
    "sera_DefinedContributionPlanEmployerMatchingContributionFirstTierMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "DefinedContributionPlanEmployerMatchingContributionFirstTierMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Contribution Plan, Employer Matching Contribution, First Tier",
        "label": "Defined Contribution Plan, Employer Matching Contribution, First Tier [Member]",
        "terseLabel": "Defined Contribution Plan, Employer Matching Contribution, First Tier"
       }
      }
     },
     "auth_ref": []
    },
    "sera_DefinedContributionPlanEmployerMatchingContributionMatchingTierAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "DefinedContributionPlanEmployerMatchingContributionMatchingTierAxis",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Contribution Plan, Employer Matching Contribution, Matching Tier",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Matching Tier [Axis]",
        "terseLabel": "Defined Contribution Plan, Employer Matching Contribution, Matching Tier [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "sera_DefinedContributionPlanEmployerMatchingContributionMatchingTierDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "DefinedContributionPlanEmployerMatchingContributionMatchingTierDomain",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Contribution Plan, Employer Matching Contribution, Matching Tier [Domain]",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Matching Tier [Domain]",
        "terseLabel": "Defined Contribution Plan, Employer Matching Contribution, Matching Tier [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercent",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay",
        "terseLabel": "Defined contribution plan, employer matching contribution, percent of employees' gross pay",
        "documentation": "Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Match",
        "terseLabel": "Defined contribution plan, employer matching contribution, percent of match",
        "documentation": "Percentage employer matches of the employee's percentage contribution matched."
       }
      }
     },
     "auth_ref": []
    },
    "sera_DefinedContributionPlanEmployerMatchingContributionSecondTierMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "DefinedContributionPlanEmployerMatchingContributionSecondTierMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Contribution Plan, Employer Matching Contribution, Second Tier",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Second Tier [Member]",
        "terseLabel": "Defined Contribution Plan, Employer Matching Contribution, Second Tier"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedContributionPlanTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedContributionPlanTable",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Contribution Plan [Table]",
        "terseLabel": "Defined Contribution Plan [Table]",
        "documentation": "Disclosure of information about defined contribution pension plans or defined contribution other postretirement plans, separately for pension plans and other postretirement benefit plans."
       }
      }
     },
     "auth_ref": [
      "r380"
     ]
    },
    "us-gaap_DepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSegmentInformationSummaryOfSegmentInformationForRevenueSignificantSegmentExpensesAndSegmentLossExpensesThatAreRegularlyProvidedT": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSegmentInformationSummaryOfSegmentInformationForRevenueSignificantSegmentExpensesAndSegmentLossExpensesThatAreRegularlyProvidedT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "totalLabel": "Depreciation, Depletion and Amortization, Nonproduction, Total",
        "terseLabel": "Depreciation and amortization",
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r28"
     ]
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepreciationDepletionAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/PropertyandEquipmentAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization",
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r198",
      "r211",
      "r228",
      "r788",
      "r789"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StockBasedCompensation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "Stock-Based Compensation",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r382",
      "r386",
      "r417",
      "r418",
      "r420",
      "r806"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r839",
      "r840",
      "r863"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "terseLabel": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r839",
      "r840",
      "r863",
      "r906"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "terseLabel": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "terseLabel": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r884"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r837"
     ]
    },
    "sera_DomainNamesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "DomainNamesMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Domain Names [Member]",
        "documentation": "Domain names.",
        "terseLabel": "Domain Names"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DomesticCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DomesticCountryMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "U.S Federal",
        "documentation": "Designated federal jurisdiction entitled to levy and collect income tax in country of domicile. Includes, but is not limited to, national jurisdiction for non-U.S. jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r436"
     ]
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]",
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year"
       }
      }
     },
     "auth_ref": [
      "r895"
     ]
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net loss per share, basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r151",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r185",
      "r187",
      "r190",
      "r191",
      "r192",
      "r197",
      "r478",
      "r487",
      "r516",
      "r517",
      "r631",
      "r651",
      "r779"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Net loss per share, diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r151",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r187",
      "r190",
      "r191",
      "r192",
      "r197",
      "r478",
      "r487",
      "r516",
      "r517",
      "r631",
      "r651",
      "r779"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Net Loss per Share",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r21",
      "r194"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureNetLossPerShare1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net Loss Per Share",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r184",
      "r193",
      "r195",
      "r196"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "totalLabel": "Income tax benefit (provision)",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r436",
      "r809"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Percent [Abstract]",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Percent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Computed Federal income tax benefit (expense) at the statutory rate",
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)."
       }
      }
     },
     "auth_ref": [
      "r162",
      "r436",
      "r465",
      "r809"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "terseLabel": "Valuation allowance",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r441",
      "r809",
      "r976",
      "r1039"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent",
        "terseLabel": "Change in statutory rates",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates."
       }
      }
     },
     "auth_ref": [
      "r440",
      "r809",
      "r976",
      "r1039"
     ]
    },
    "sera_EffectiveIncomeTaxRateReconciliationEquityBasedExpensesAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "EffectiveIncomeTaxRateReconciliationEquityBasedExpensesAmount",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Equity-Based Expenses, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Equity-Based Expenses, Amount",
        "terseLabel": "Equity-based expenses"
       }
      }
     },
     "auth_ref": []
    },
    "sera_EffectiveIncomeTaxRateReconciliationEquityBasedExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "EffectiveIncomeTaxRateReconciliationEquityBasedExpensesPercent",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Equity-Based Expenses, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Equity-Based Expenses, Percent",
        "terseLabel": "Equity-based expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "terseLabel": "Other",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments."
       }
      }
     },
     "auth_ref": [
      "r809",
      "r976",
      "r1039",
      "r1040"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State income taxes, net of federal benefit",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r439",
      "r809",
      "r976",
      "r1039"
     ]
    },
    "sera_EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpAmount",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, State Net Operating Loss Carryforward True Up, Amount",
        "label": "Effective Income Tax Rate Reconciliation, State Net Operating Loss Carryforward True Up, Amount",
        "terseLabel": "State net operating loss carryforward true up"
       }
      }
     },
     "auth_ref": []
    },
    "sera_EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpPercent",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, State Net Operating Loss Carryforward True Up, Percent",
        "label": "Effective Income Tax Rate Reconciliation, State Net Operating Loss Carryforward True Up, Percent",
        "terseLabel": "State net operating loss carryforward true up"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsResearch",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent",
        "terseLabel": "R&amp;D credits",
        "negatedLabel": "R&amp;D credits",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit."
       }
      }
     },
     "auth_ref": [
      "r809",
      "r976",
      "r1039",
      "r1041"
     ]
    },
    "sera_ElevanceHealthIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "ElevanceHealthIncMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Elevance Health, Inc",
        "label": "Elevance Health, Inc [Member]",
        "terseLabel": "Elevance Health, Inc"
       }
      }
     },
     "auth_ref": []
    },
    "sera_EmergingGrowthCompanyStatusPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "EmergingGrowthCompanyStatusPolicyTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Emerging Growth Company Status [Policy Text Block]",
        "documentation": "Emerging Growth Company Status [Policy Text Block]",
        "terseLabel": "Emerging Growth Company Status"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfImpactOfStockbasedCompensationExpenseInStatementsOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfUnrecognizedStockbasedCompensationExpenseForOutstandingUnvestedStockOptionsAndRsusDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfUnrecognizedStockbasedCompensationExpenseForOutstandingUnvestedStockOptionsAndRsusDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "totalLabel": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r419"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfUnrecognizedStockbasedCompensationExpenseForOutstandingUnvestedStockOptionsAndRsusDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "verboseLabel": "Unamortized stock-based compensation cost expected to be recognized over a weighted average period",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r419"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfUnrecognizedStockbasedCompensationExpenseForOutstandingUnvestedStockOptionsAndRsusDetails": {
       "parentTag": "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfUnrecognizedStockbasedCompensationExpenseForOutstandingUnvestedStockOptionsAndRsusDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r1037"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfUnrecognizedStockbasedCompensationExpenseForOutstandingUnvestedStockOptionsAndRsusDetails": {
       "parentTag": "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfUnrecognizedStockbasedCompensationExpenseForOutstandingUnvestedStockOptionsAndRsusDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unamortized stock-based compensation cost",
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1037"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureScheduleOfCommonStockReservedForFutureIssuanceDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureNetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromTheComputationOfEarningsPerShareDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option",
        "verboseLabel": "Options to purchase Class A common stock",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r836"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding (in shares)",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r836"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r949"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r836"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r946"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r836"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r836"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r836"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r836"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r948"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote [Text Block]",
        "terseLabel": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r889"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]",
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r942"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments [Member]",
        "terseLabel": "Equity Awards Adjustments"
       }
      }
     },
     "auth_ref": [
      "r942"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r942"
     ]
    },
    "sera_EquipmentLabSuppliesAndFacilityExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "EquipmentLabSuppliesAndFacilityExpenses",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSegmentInformationSummaryOfSegmentInformationForRevenueSignificantSegmentExpensesAndSegmentLossExpensesThatAreRegularlyProvidedT": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSegmentInformationSummaryOfSegmentInformationForRevenueSignificantSegmentExpensesAndSegmentLossExpensesThatAreRegularlyProvidedT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equipment Lab Supplies And Facility Expenses",
        "documentation": "Equipment lab supplies and facility expenses.",
        "terseLabel": "Equipment lab supplies and facility expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r119",
      "r145",
      "r146",
      "r147",
      "r165",
      "r166",
      "r167",
      "r170",
      "r177",
      "r179",
      "r181",
      "r199",
      "r276",
      "r283",
      "r316",
      "r357",
      "r460",
      "r461",
      "r474",
      "r475",
      "r476",
      "r479",
      "r486",
      "r487",
      "r497",
      "r499",
      "r500",
      "r501",
      "r502",
      "r504",
      "r515",
      "r541",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r551",
      "r553",
      "r576",
      "r647",
      "r659",
      "r660",
      "r661",
      "r683",
      "r748"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r899"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r856",
      "r867",
      "r877",
      "r910"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "auth_ref": [
      "r853",
      "r864",
      "r874",
      "r907"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "auth_ref": [
      "r905"
     ]
    },
    "sera_FairValueAdjustmentOfPreFundedWarrants": {
     "xbrltype": "percentItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "FairValueAdjustmentOfPreFundedWarrants",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value adjustment of pre funded warrants",
        "label": "Fair Value Adjustment Of Pre Funded Warrants",
        "documentation": "Fair value adjustment of pre funded warrants."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r519",
      "r520",
      "r530",
      "r810"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]",
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r519",
      "r520",
      "r530",
      "r810"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]",
        "terseLabel": "Schedule of Financial Assets that are Measured at Fair Value on a Recurring basis",
        "documentation": "Tabular disclosure of financial instrument measured at fair value on recurring or nonrecurring basis. Includes, but is not limited to, instrument classified in shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r810",
      "r1051",
      "r1052",
      "r1057"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r338",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r518",
      "r520",
      "r521",
      "r522",
      "r523",
      "r529",
      "r530",
      "r532",
      "r590",
      "r591",
      "r592",
      "r799",
      "r800",
      "r802",
      "r803",
      "r804",
      "r810",
      "r813"
     ]
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByMeasurementFrequencyAxis",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]",
        "documentation": "Information by measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r519",
      "r520",
      "r521",
      "r523",
      "r810",
      "r1054",
      "r1058"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/FairValueMeasurements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r525",
      "r527",
      "r528",
      "r529",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r627",
      "r810",
      "r814"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r338",
      "r373",
      "r378",
      "r520",
      "r530",
      "r590",
      "r802",
      "r803",
      "r804",
      "r810"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r338",
      "r373",
      "r378",
      "r520",
      "r521",
      "r530",
      "r591",
      "r799",
      "r800",
      "r802",
      "r803",
      "r804",
      "r810"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r338",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r520",
      "r521",
      "r522",
      "r523",
      "r530",
      "r592",
      "r799",
      "r800",
      "r802",
      "r803",
      "r804",
      "r810",
      "r813"
     ]
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementFrequencyDomain",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]",
        "documentation": "Measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r519",
      "r520",
      "r521",
      "r523",
      "r810",
      "r1054",
      "r1058"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r338",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r518",
      "r520",
      "r521",
      "r522",
      "r523",
      "r529",
      "r530",
      "r532",
      "r590",
      "r591",
      "r592",
      "r799",
      "r800",
      "r802",
      "r803",
      "r804",
      "r810",
      "r813"
     ]
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsRecurringMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring",
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r810",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1058"
     ]
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseInterestExpense",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeaseCostAndOtherInformationDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeaseCostAndOtherInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Interest on lease liabilities",
        "documentation": "Amount of interest expense on finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r557",
      "r563",
      "r820"
     ]
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "crdr": "credit",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeaseCostAndOtherInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Interest Payment on Liability",
        "terseLabel": "Operating cash outflows",
        "documentation": "Amount of interest paid on finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r559",
      "r565"
     ]
    },
    "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Finance Leases"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails2": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability",
        "totalLabel": "Present value of future lease payments",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease."
       }
      }
     },
     "auth_ref": [
      "r555",
      "r569"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails2": {
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0,
       "order": 0.0
      },
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeasesInFinancialStatementDetails": {
       "parentTag": "sera_LeaseLiabilitiesTotal",
       "weight": 1.0,
       "order": 1.0
      },
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeasesInFinancialStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Finance lease obligation, current portion",
        "verboseLabel": "Less: current portion",
        "negatedLabel": "Less: current portion",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r555"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/CommitmentandContingenciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Future Minimum Lease Payments",
        "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r1061"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 0.0
      },
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeasesInFinancialStatementDetails": {
       "parentTag": "sera_LeaseLiabilitiesTotal",
       "weight": 1.0,
       "order": 0.0
      },
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails2": {
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeasesInFinancialStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Finance lease obligation, net of current portion",
        "verboseLabel": "Long-term portion",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r555"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails2": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://seraprognostics.com/20241231/taxonomy/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, to be Paid",
        "totalLabel": "Total minimum lease payments",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease."
       }
      }
     },
     "auth_ref": [
      "r569"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsDetails_1": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 0.0
      },
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "terseLabel": "2025",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r569"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsDetails_1": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      },
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2026",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r569"
     ]
    },
    "sera_FinanceLeaseLiabilityToBePaidYearThreeAndThereafter": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "FinanceLeaseLiabilityToBePaidYearThreeAndThereafter",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Liability, to be Paid, Year Three and Thereafter",
        "label": "Finance Lease, Liability, to be Paid, Year Three and Thereafter",
        "terseLabel": "2027 and thereafter"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails2": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less: imputed interest",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease."
       }
      }
     },
     "auth_ref": [
      "r569"
     ]
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeasePrincipalPayments",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeaseCostAndOtherInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Principal Payments",
        "terseLabel": "Financing cash outflows",
        "negatedTerseLabel": "Finance lease principal payments",
        "documentation": "Amount of cash outflow for principal payment on finance lease."
       }
      }
     },
     "auth_ref": [
      "r558",
      "r565"
     ]
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeasesInFinancialStatementDetails": {
       "parentTag": "sera_RightOfUseAssetTotal",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeasesInFinancialStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "Finance leases",
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease."
       }
      }
     },
     "auth_ref": [
      "r554"
     ]
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeaseCostAndOtherInformationDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeaseCostAndOtherInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Amortization of right-of-use assets",
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease."
       }
      }
     },
     "auth_ref": [
      "r557",
      "r563",
      "r820"
     ]
    },
    "us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeasesInFinancialStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes finance lease right-of-use asset."
       }
      }
     },
     "auth_ref": [
      "r556"
     ]
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeaseCostAndOtherInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted-average discount rate",
        "documentation": "Weighted average discount rate for finance lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r568",
      "r820"
     ]
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeaseCostAndOtherInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted-average remaining lease term (in years)",
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r567",
      "r820"
     ]
    },
    "sera_FinanceLeasesOtherInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "FinanceLeasesOtherInformationAbstract",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeaseCostAndOtherInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Leases, Other Information",
        "label": "Finance Leases, Other Information [Abstract]",
        "terseLabel": "Finance leases:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinancialInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancialInstrumentAxis",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecuritiesAvailableforsaleDebtSecuritiesAndCashEquivalentsInUnrealizedLossPositionsDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureWarrantsScheduleOfCommonStockWarrantsOutstandingDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]",
        "documentation": "Information by type of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r290",
      "r295",
      "r296",
      "r339",
      "r353",
      "r505",
      "r537",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r648",
      "r797",
      "r810",
      "r811",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r822",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962",
      "r963",
      "r964",
      "r993",
      "r994",
      "r995",
      "r996",
      "r1050",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1058"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsDetails2": {
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": -1.0,
       "order": 1.0
      },
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "terseLabel": "Definite-lived intangible assets, accumulated amortization",
        "negatedLabel": "Accumulated Amortization",
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r128",
      "r299",
      "r307",
      "r798"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "documentation": "Information by major type or class of finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r301",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r310",
      "r311",
      "r622",
      "r626",
      "r771"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Gross",
        "totalLabel": "Finite-Lived Intangible Assets, Gross, Total",
        "terseLabel": "Gross carrying amount",
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r299",
      "r307",
      "r626",
      "r798"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r301",
      "r307",
      "r310",
      "r311",
      "r313",
      "r622",
      "r771",
      "r798"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "auth_ref": [
      "r301",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r310",
      "r311",
      "r771"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Net",
        "periodEndLabel": "Finite-Lived Intangible Assets, Net, Ending Balance",
        "periodStartLabel": "Finite-Lived Intangible Assets, Net, Beginning Balance",
        "totalLabel": "Definite-lived intangible assets, net carrying amount",
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r622",
      "r999"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r860",
      "r871",
      "r881",
      "r914"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r860",
      "r871",
      "r881",
      "r914"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r860",
      "r871",
      "r881",
      "r914"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r860",
      "r871",
      "r881",
      "r914"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r860",
      "r871",
      "r881",
      "r914"
     ]
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]",
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year"
       }
      }
     },
     "auth_ref": [
      "r894"
     ]
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FurnitureAndFixturesMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentScheduleOfComponentsOfPropertyAndEquipmentNetDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSignificantAccountingPoliciesScheduleOfEstimatedUsefulLifeOfEachAssetCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture and fixtures",
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r728"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfImpactOfStockbasedCompensationExpenseInStatementsOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and administrative expense",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "sera_GrossSalesProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "GrossSalesProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gross Sales Proceeds from Issuance of Common Stock",
        "documentation": "Gross sales proceeds from issuance of common stock.",
        "terseLabel": "Gross sales proceeds from issuance of common stock"
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r839",
      "r840",
      "r863"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfImpactOfStockbasedCompensationExpenseInStatementsOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]",
        "documentation": "Information by location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r317",
      "r318",
      "r320",
      "r524",
      "r526",
      "r531",
      "r654",
      "r656",
      "r733",
      "r771",
      "r812",
      "r1077"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfImpactOfStockbasedCompensationExpenseInStatementsOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]",
        "documentation": "Location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r318",
      "r320",
      "r524",
      "r526",
      "r531",
      "r654",
      "r656",
      "r733",
      "r771",
      "r812",
      "r1077"
     ]
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxAuthorityAxis",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]",
        "documentation": "Information by income tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r157",
      "r436",
      "r437",
      "r445",
      "r456",
      "r809",
      "r1044"
     ]
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxAuthorityDomain",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]",
        "documentation": "Income tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r157",
      "r436",
      "r437",
      "r445",
      "r456",
      "r809",
      "r1044"
     ]
    },
    "us-gaap_IncomeTaxContingencyLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxContingencyLineItems",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Contingency [Line Items]",
        "terseLabel": "Income Tax Contingency [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxContingencyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxContingencyTable",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Contingency [Table]",
        "terseLabel": "Income Tax Contingency [Table]",
        "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months."
       }
      }
     },
     "auth_ref": [
      "r1042"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r162",
      "r430",
      "r436",
      "r442",
      "r443",
      "r444",
      "r449",
      "r455",
      "r466",
      "r468",
      "r469",
      "r470",
      "r679",
      "r809"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesEffectiveTaxRateReconciliationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax expense",
        "totalLabel": "Total income tax benefit (provision)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r114",
      "r180",
      "r181",
      "r198",
      "r212",
      "r228",
      "r435",
      "r436",
      "r467",
      "r652",
      "r809"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract]",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Amount [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r144",
      "r433",
      "r434",
      "r449",
      "r450",
      "r454",
      "r458",
      "r673"
     ]
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "terseLabel": "Valuation allowance",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r441",
      "r809",
      "r1039"
     ]
    },
    "us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationChangeInEnactedTaxRate",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount",
        "terseLabel": "Change in statutory rates",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates."
       }
      }
     },
     "auth_ref": [
      "r432",
      "r436",
      "r440",
      "r809"
     ]
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "terseLabel": "Computed Federal income tax benefit (expense) at the statutory rate",
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r436",
      "r809"
     ]
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount",
        "terseLabel": "Other",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments."
       }
      }
     },
     "auth_ref": [
      "r809",
      "r1039",
      "r1040"
     ]
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "terseLabel": "State income taxes, net of federal benefit",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r439",
      "r809",
      "r1039"
     ]
    },
    "us-gaap_IncomeTaxReconciliationTaxCreditsResearch": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationTaxCreditsResearch",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount",
        "terseLabel": "R&amp;D credits",
        "negatedLabel": "R&amp;D credits",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit."
       }
      }
     },
     "auth_ref": [
      "r809",
      "r1039",
      "r1041"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities",
        "terseLabel": "Accrued and other current liabilities",
        "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other."
       }
      }
     },
     "auth_ref": [
      "r971"
     ]
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "terseLabel": "Deferred revenue",
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r620",
      "r971"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOtherReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOtherReceivables",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Other Receivables",
        "negatedTerseLabel": "Other receivables",
        "documentation": "Amount of increase (decrease) in receivables classified as other."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Indefinite-Lived Intangible Assets (Excluding Goodwill), Ending Balance",
        "periodStartLabel": "Indefinite-Lived Intangible Assets (Excluding Goodwill), Beginning Balance",
        "totalLabel": "Indefinite-Lived Intangible Assets (Excluding Goodwill), Total",
        "terseLabel": "Intangible assets, net",
        "label": "Indefinite-lived intangible assets, net carrying amount",
        "verboseLabel": "Indefinite-lived intangible asset",
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit."
       }
      }
     },
     "auth_ref": [
      "r299",
      "r309",
      "r798"
     ]
    },
    "sera_IndemnificationLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "IndemnificationLiability",
     "crdr": "credit",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of indemnification liability.",
        "label": "Indemnification Liability",
        "terseLabel": "Indemnification liability"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "auth_ref": [
      "r860",
      "r871",
      "r881",
      "r905",
      "r914",
      "r918",
      "r926"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]",
        "terseLabel": "Insider Trading Arrangements:"
       }
      }
     },
     "auth_ref": [
      "r924"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]",
        "terseLabel": "Insider Trading Policies and Procedures:"
       }
      }
     },
     "auth_ref": [
      "r841",
      "r930"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r841",
      "r930"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r841",
      "r930"
     ]
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Intangible Assets, net",
        "documentation": "The entire disclosure for all or part of the information related to intangible assets."
       }
      }
     },
     "auth_ref": [
      "r300",
      "r312",
      "r314",
      "r770",
      "r771"
     ]
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsDetails2": {
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "totalLabel": "Intangible assets, gross",
        "terseLabel": "Intangible assets, gross",
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill."
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      },
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsDetails2": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "totalLabel": "Intangible assets, net carrying amount",
        "terseLabel": "Intangible assets, net",
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges."
       }
      }
     },
     "auth_ref": [
      "r301",
      "r999",
      "r1000"
     ]
    },
    "us-gaap_InterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpense",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      },
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSegmentInformationSummaryOfSegmentInformationForRevenueSignificantSegmentExpensesAndSegmentLossExpensesThatAreRegularlyProvidedT": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSegmentInformationSummaryOfSegmentInformationForRevenueSignificantSegmentExpensesAndSegmentLossExpensesThatAreRegularlyProvidedT",
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Expense, Operating and Nonoperating",
        "negatedLabel": "Interest expense",
        "totalLabel": "Interest Expense, Operating and Nonoperating, Total",
        "terseLabel": "Interest expense",
        "documentation": "Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense."
       }
      }
     },
     "auth_ref": [
      "r198",
      "r207",
      "r210",
      "r213",
      "r228",
      "r549",
      "r788",
      "r789"
     ]
    },
    "us-gaap_InterestIncomeOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestIncomeOther",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureOtherIncomeNetScheduleOfComponentsOfOtherIncomeNetDetails": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureOtherIncomeNetScheduleOfComponentsOfOtherIncomeNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Income, Other",
        "terseLabel": "Interest income",
        "documentation": "Amount of interest income earned from interest bearing assets classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r155",
      "r156"
     ]
    },
    "us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentIncomeNetAmortizationOfDiscountAndPremium",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureOtherIncomeNetScheduleOfComponentsOfOtherIncomeNetDetails": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureOtherIncomeNetScheduleOfComponentsOfOtherIncomeNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment income, net",
        "label": "Investment Income, Net, Amortization of Discount and Premium",
        "documentation": "Amount of accretion (amortization) of purchase discount (premium) on nonoperating securities."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "terseLabel": "Schedule of Marketable Securities Classified by Contractual Maturities",
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestorMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investor [Member]",
        "terseLabel": "Investor",
        "documentation": "Business entity or individual that puts money, by purchase or expenditure, in something offering potential profitable returns, such as interest income or appreciation in value."
       }
      }
     },
     "auth_ref": [
      "r1062",
      "r1063"
     ]
    },
    "sera_IssuanceOfStockToSettleAccruedAndOtherCurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "IssuanceOfStockToSettleAccruedAndOtherCurrentLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Stock to Settle Accrued and Other Current Liabilities",
        "documentation": "Issuance of stock to settle accrued and other current liabilities.",
        "terseLabel": "Issuance of stock to settle accrued and other current liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "sera_IssuePricePerShareAndWarrant": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "IssuePricePerShareAndWarrant",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issue Price Per Share And Warrant",
        "documentation": "The offering price per common share and accompanying warrant.",
        "terseLabel": "Offering price per share"
       }
      }
     },
     "auth_ref": []
    },
    "sera_JohnJBonifaceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "JohnJBonifaceMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "John J Boniface",
        "label": "John J Boniface [Member]",
        "terseLabel": "John J. Boniface"
       }
      }
     },
     "auth_ref": []
    },
    "sera_LaboratoryEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "LaboratoryEquipmentMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentScheduleOfComponentsOfPropertyAndEquipmentNetDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/PropertyandEquipmentAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to laboratory equipment.",
        "label": "Laboratory Equipment [Member]",
        "terseLabel": "Laboratory equipment"
       }
      }
     },
     "auth_ref": []
    },
    "sera_LaboratoryServicesAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "LaboratoryServicesAgreementMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for the laboratory services agreement.",
        "label": "Laboratory Services Agreement [Member]",
        "terseLabel": "Laboratory Services Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeaseCostAndOtherInformationDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeaseCostAndOtherInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease, Cost",
        "totalLabel": "Total lease cost",
        "documentation": "Amount of lease cost recognized by lessee for lease contract."
       }
      }
     },
     "auth_ref": [
      "r562",
      "r820"
     ]
    },
    "us-gaap_LeaseCostAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseCostAbstract",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeaseCostAndOtherInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease, Cost [Abstract]",
        "terseLabel": "Lease cost"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/CommitmentandContingenciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Schedule of Lease Cost and Other Information",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r1060"
     ]
    },
    "sera_LeaseLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "LeaseLiabilitiesAbstract",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeasesInFinancialStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease Liabilities",
        "label": "Lease Liabilities [Abstract]",
        "terseLabel": "Lease liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "sera_LeaseLiabilitiesTotal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "LeaseLiabilitiesTotal",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsDetails_1": {
       "parentTag": "sera_LeaseLiabilityPaymentDue",
       "weight": 1.0,
       "order": 0.0
      },
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails2": {
       "parentTag": "sera_LeaseLiabilityPaymentDue",
       "weight": 1.0,
       "order": 1.0
      },
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeasesInFinancialStatementDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeasesInFinancialStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease Liabilities, Total",
        "label": "Lease Liabilities, Total",
        "totalLabel": "Total lease liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "sera_LeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "LeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails2": {
       "parentTag": "sera_LeaseLiabilitiesTotal",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease Liability, Current",
        "label": "Lease Liability, Current",
        "terseLabel": "Less: current portion",
        "negatedLabel": "Less: current portion"
       }
      }
     },
     "auth_ref": []
    },
    "sera_LeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "LeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails2": {
       "parentTag": "sera_LeaseLiabilitiesTotal",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease Liability, Noncurrent",
        "label": "Lease Liability, Noncurrent",
        "terseLabel": "Long-term portion"
       }
      }
     },
     "auth_ref": []
    },
    "sera_LeaseLiabilityPaymentDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "LeaseLiabilityPaymentDue",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails2": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://seraprognostics.com/20241231/taxonomy/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Payment, Due",
        "label": "Lease, Liability, Payment, Due",
        "totalLabel": "Total minimum lease payments"
       }
      }
     },
     "auth_ref": []
    },
    "sera_LeaseLiabilityPaymentDueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "LeaseLiabilityPaymentDueAbstract",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Payment, Due",
        "label": "Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Total"
       }
      }
     },
     "auth_ref": []
    },
    "sera_LeaseLiabilityToBePaidYearOne": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "LeaseLiabilityToBePaidYearOne",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails": {
       "parentTag": "sera_LeaseLiabilityPaymentDue",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, to be Paid, Year One",
        "label": "Lease, Liability, to be Paid, Year One",
        "terseLabel": "2025"
       }
      }
     },
     "auth_ref": []
    },
    "sera_LeaseLiabilityToBePaidYearThreeAndThereafter": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "LeaseLiabilityToBePaidYearThreeAndThereafter",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails": {
       "parentTag": "sera_LeaseLiabilityPaymentDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, to be Paid, Year Three and Thereafter",
        "label": "Lease, Liability, to be Paid, Year Three and Thereafter",
        "terseLabel": "2027 and thereafter"
       }
      }
     },
     "auth_ref": []
    },
    "sera_LeaseLiabilityToBePaidYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "LeaseLiabilityToBePaidYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails": {
       "parentTag": "sera_LeaseLiabilityPaymentDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, to be Paid, Year Two",
        "label": "Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2026"
       }
      }
     },
     "auth_ref": []
    },
    "sera_LeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "LeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails2": {
       "parentTag": "sera_LeaseLiabilityPaymentDue",
       "weight": 1.0,
       "order": 0.0
      },
      "http://seraprognostics.com/20241231/taxonomy/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsDetails_1": {
       "parentTag": "sera_LeaseLiabilityPaymentDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Undiscounted Excess Amount",
        "label": "Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less: imputed interest"
       }
      }
     },
     "auth_ref": []
    },
    "sera_LeaseOtherInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "LeaseOtherInformationAbstract",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeaseCostAndOtherInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease Other Information",
        "label": "Lease Other Information [Abstract]",
        "terseLabel": "Other information"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentScheduleOfComponentsOfPropertyAndEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements",
        "documentation": "Additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r570"
     ]
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r561"
     ]
    },
    "sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The area of leased office and laboratory space.",
        "label": "Lessee Operating Lease Area Of Leased Space Office And Laboratory",
        "terseLabel": "Number of square feet under lease"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/CommitmentandContingenciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "terseLabel": "Lessee, Operating Lease, Liability, Maturity",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r1061"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails2": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://seraprognostics.com/20241231/taxonomy/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total minimum lease payments",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r569"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 0.0
      },
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2025",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r569"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/CommitmentsandContingenciesFutureMinimumLeasePaymentsDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      },
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2026",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r569"
     ]
    },
    "sera_LesseeOperatingLeaseLiabilityToBePaidYearThreeAndThereafter": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "LesseeOperatingLeaseLiabilityToBePaidYearThreeAndThereafter",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Liability, to be Paid, Year Three and Thereafter",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three and Thereafter",
        "terseLabel": "2027 and thereafter"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails2": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less: imputed interest",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r569"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities",
        "totalLabel": "Total liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r49",
      "r50",
      "r51",
      "r52",
      "r53",
      "r54",
      "r55",
      "r161",
      "r271",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r490",
      "r491",
      "r492",
      "r540",
      "r703",
      "r780",
      "r834",
      "r1007",
      "r1065",
      "r1066"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders' equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r92",
      "r643",
      "r821",
      "r974",
      "r997",
      "r1059"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Stockholders' Equity"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r125",
      "r161",
      "r271",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r490",
      "r491",
      "r492",
      "r540",
      "r821",
      "r1007",
      "r1065",
      "r1066"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MachineryAndEquipmentMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSignificantAccountingPoliciesScheduleOfEstimatedUsefulLifeOfEachAssetCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Machinery and Equipment [Member]",
        "terseLabel": "Machinery and equipment",
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MarketableSecuritiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MarketableSecuritiesCurrent",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Marketable Securities, Current",
        "terseLabel": "Marketable securities",
        "documentation": "Amount of investment in marketable security, classified as current."
       }
      }
     },
     "auth_ref": [
      "r966"
     ]
    },
    "us-gaap_MarketableSecuritiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MarketableSecuritiesNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Marketable Securities, Noncurrent",
        "terseLabel": "Long-term marketable securities",
        "documentation": "Amount of investment in marketable security, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r966"
     ]
    },
    "us-gaap_MarketableSecuritiesPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MarketableSecuritiesPolicy",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Marketable Securities, Policy [Policy Text Block]",
        "terseLabel": "Marketable Securities",
        "documentation": "Disclosure of accounting policy for investment classified as marketable security."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "sera_MasterServicesAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "MasterServicesAgreementMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for the master services agreement.",
        "label": "Master Services Agreement [Member]",
        "terseLabel": "Master services agreement"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MaximumMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAndFinancialConditionAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfFairValuesCalculatedUsingBlackscholesOptionPricingModelDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "auth_ref": [
      "r323",
      "r324",
      "r325",
      "r326",
      "r381",
      "r426",
      "r523",
      "r619",
      "r653",
      "r655",
      "r669",
      "r695",
      "r696",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r768",
      "r769",
      "r796",
      "r801",
      "r805",
      "r813",
      "r814",
      "r818",
      "r819",
      "r823",
      "r1009",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "auth_ref": [
      "r897"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r897"
     ]
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MinimumMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfFairValuesCalculatedUsingBlackscholesOptionPricingModelDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "auth_ref": [
      "r323",
      "r324",
      "r325",
      "r326",
      "r381",
      "r426",
      "r523",
      "r619",
      "r653",
      "r655",
      "r669",
      "r695",
      "r696",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r768",
      "r769",
      "r796",
      "r801",
      "r805",
      "r813",
      "r814",
      "r818",
      "r823",
      "r1009",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r917"
     ]
    },
    "us-gaap_MoneyMarketFundsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MoneyMarketFundsMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money market funds",
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities."
       }
      }
     },
     "auth_ref": [
      "r1010"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r925"
     ]
    },
    "us-gaap_MunicipalBondsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MunicipalBondsMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Municipal Bonds [Member]",
        "terseLabel": "Municipal Bonds",
        "documentation": "Long-term debt securities issued by state, city or local governments or the agencies operated by state, city or local governments."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r898"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by investing activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r72",
      "r73"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      },
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      },
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSegmentInformationSummaryOfSegmentInformationForRevenueSignificantSegmentExpensesAndSegmentLossExpensesThatAreRegularlyProvidedT": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSegmentInformationSummaryOfSegmentInformationForRevenueSignificantSegmentExpensesAndSegmentLossExpensesThatAreRegularlyProvidedT",
      "http://seraprognostics.com/20241231/taxonomy/role/StatementStatementsOfStockholdersEquity",
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows",
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofOperationsandComprehensiveLoss",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss)",
        "terseLabel": "Net Income (Loss)",
        "totalLabel": "Net loss",
        "verboseLabel": "Net loss",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r73",
      "r93",
      "r123",
      "r139",
      "r142",
      "r147",
      "r161",
      "r169",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r180",
      "r181",
      "r189",
      "r271",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r478",
      "r487",
      "r517",
      "r540",
      "r646",
      "r725",
      "r746",
      "r747",
      "r833",
      "r1007"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Issued Accounting Pronouncements Not Yet Adopted",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "sera_NonCurrentMarketableSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "NonCurrentMarketableSecuritiesMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-Current Marketable Securities [Member]",
        "label": "Non-Current Marketable Securities [Member]",
        "terseLabel": "Long-term marketable securities:"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r897"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "auth_ref": [
      "r860",
      "r871",
      "r881",
      "r905",
      "r914"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r888"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r887"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "auth_ref": [
      "r905"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r925"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r925"
     ]
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "Supplemental disclosure of non-cash investing and financing information"
       }
      }
     },
     "auth_ref": []
    },
    "sera_NoncashInvestmentIncomeExpenseNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "NoncashInvestmentIncomeExpenseNet",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncash Investment Income Expense Net",
        "label": "Noncash Investment Income Expense Net",
        "negatedTerseLabel": "Non-cash investment income, net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 0.0
      },
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSegmentInformationSummaryOfSegmentInformationForRevenueSignificantSegmentExpensesAndSegmentLossExpensesThatAreRegularlyProvidedT": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 0.0
      },
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureOtherIncomeNetScheduleOfComponentsOfOtherIncomeNetDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureOtherIncomeNetScheduleOfComponentsOfOtherIncomeNetDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSegmentInformationSummaryOfSegmentInformationForRevenueSignificantSegmentExpensesAndSegmentLossExpensesThatAreRegularlyProvidedT",
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Other income, net",
        "terseLabel": "Other income, net",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "sera_NumberOfCommonStockClassesAuthorized": {
     "xbrltype": "integerItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "NumberOfCommonStockClassesAuthorized",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Common Stock Classes Authorized",
        "label": "Number Of Common Stock Classes Authorized",
        "terseLabel": "Number of common stock classes authorized"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfOperatingSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NumberOfOperatingSegments",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segment",
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues."
       }
      }
     },
     "auth_ref": [
      "r789",
      "r983"
     ]
    },
    "sera_NumberOfVotesPerShare": {
     "xbrltype": "integerItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "NumberOfVotesPerShare",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Votes Per Share",
        "label": "Number Of Votes Per Share",
        "terseLabel": "Number of votes per share"
       }
      }
     },
     "auth_ref": []
    },
    "sera_OfferingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "OfferingExpenses",
     "crdr": "debit",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Expenses",
        "documentation": "Offering expenses",
        "terseLabel": "Offering expense"
       }
      }
     },
     "auth_ref": []
    },
    "sera_OfficeAndLaboratorySpaceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "OfficeAndLaboratorySpaceMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the information pertaining to office and laboratory space.",
        "label": "Office And Laboratory Space [Member]",
        "terseLabel": "Office and laboratory space"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses",
        "terseLabel": "Operating Expenses",
        "totalLabel": "Total operating expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSegmentInformationSummaryOfSegmentInformationForRevenueSignificantSegmentExpensesAndSegmentLossExpensesThatAreRegularlyProvidedT": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      },
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSegmentInformationSummaryOfSegmentInformationForRevenueSignificantSegmentExpensesAndSegmentLossExpensesThatAreRegularlyProvidedT",
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Income (Loss)",
        "totalLabel": "Loss from operations",
        "terseLabel": "Loss from operations",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r781",
      "r982",
      "r984",
      "r985",
      "r986",
      "r987"
     ]
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeaseCostAndOtherInformationDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeaseCostAndOtherInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease cost",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r564",
      "r820"
     ]
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Operating Leases"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails2": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Liability",
        "totalLabel": "Present value of future lease payments",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r555"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails2": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 0.0
      },
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeasesInFinancialStatementDetails": {
       "parentTag": "sera_LeaseLiabilitiesTotal",
       "weight": 1.0,
       "order": 2.0
      },
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfComponentsOfAccruedAndOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfComponentsOfAccruedAndOtherCurrentLiabilitiesDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeasesInFinancialStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating leases",
        "verboseLabel": "Less: current portion",
        "netLabel": "Operating lease liability, current portion",
        "negatedLabel": "Less: current portion",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r555"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeasesInFinancialStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes current operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r556"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails2": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 1.0
      },
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      },
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeasesInFinancialStatementDetails": {
       "parentTag": "sera_LeaseLiabilitiesTotal",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeasesInFinancialStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease obligation, net of current portion",
        "verboseLabel": "Long-term portion",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r555"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeaseCostAndOtherInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash outflows",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r560",
      "r565"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeasesInFinancialStatementDetails": {
       "parentTag": "sera_RightOfUseAssetTotal",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeasesInFinancialStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating leases",
        "verboseLabel": "Operating right-of-use asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r554"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Right-of-Use Asset, Periodic Reduction",
        "terseLabel": "Non-cash lease expense",
        "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r972"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeasesInFinancialStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes operating lease right-of-use asset."
       }
      }
     },
     "auth_ref": [
      "r556"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeaseCostAndOtherInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted-average discount rate",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r568",
      "r820"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeaseCostAndOtherInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted-average remaining lease term (in years)",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r567",
      "r820"
     ]
    },
    "sera_OperatingLeasesOtherInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "OperatingLeasesOtherInformationAbstract",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeaseCostAndOtherInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Leases, Other Information",
        "label": "Operating Leases, Other Information [Abstract]",
        "terseLabel": "Operating leases:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Operating loss carryforwards",
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r457"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DescriptionofBusinessandFinancialCondition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Description of Business and Financial Condition",
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r89",
      "r670",
      "r671"
     ]
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfComponentsOfAccruedAndOtherCurrentLiabilitiesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureAccruedAndOtherCurrentLiabilitiesScheduleOfComponentsOfAccruedAndOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other current liabilities",
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "us-gaap_OtherAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssetsDisclosureTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureOtherAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets Disclosure [Text Block]",
        "terseLabel": "Other Assets",
        "documentation": "The entire disclosure for other assets. This disclosure includes other current assets and other noncurrent assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets",
        "totalLabel": "Total other assets",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "terseLabel": "Unrealized gain on available-for-sale debt securities, net of tax",
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale."
       }
      }
     },
     "auth_ref": [
      "r136",
      "r137",
      "r138",
      "r647"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementStatementsOfStockholdersEquity",
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive income",
        "totalLabel": "Total other comprehensive income",
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r11",
      "r140",
      "r143",
      "r149",
      "r177",
      "r541",
      "r542",
      "r547",
      "r629",
      "r647",
      "r968",
      "r969"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherIncomeAndExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherIncomeAndExpensesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income and Expenses [Abstract]",
        "terseLabel": "Other Income and Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherIncomeAndOtherExpenseDisclosureTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureOtherIncomeNet1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income and Other Expense Disclosure [Text Block]",
        "terseLabel": "Other Income, Net",
        "documentation": "The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions."
       }
      }
     },
     "auth_ref": [
      "r956",
      "r1038"
     ]
    },
    "us-gaap_OtherLaborRelatedExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLaborRelatedExpenses",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSegmentInformationSummaryOfSegmentInformationForRevenueSignificantSegmentExpensesAndSegmentLossExpensesThatAreRegularlyProvidedT": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSegmentInformationSummaryOfSegmentInformationForRevenueSignificantSegmentExpensesAndSegmentLossExpensesThatAreRegularlyProvidedT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payroll related expenses",
        "label": "Other Labor-related Expenses",
        "documentation": "Amount of labor-related expenses classified as other."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNoncashIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Noncash Income (Expense)",
        "negatedLabel": "Other",
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "sera_OtherOfficersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "OtherOfficersMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Officers [Member]",
        "documentation": "Other officers.",
        "terseLabel": "Other Officers"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r897"
     ]
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherReceivablesNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Receivables, Net, Current",
        "terseLabel": "Other receivables",
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r858",
      "r869",
      "r879",
      "r912"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r861",
      "r872",
      "r882",
      "r915"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r861",
      "r872",
      "r882",
      "r915"
     ]
    },
    "us-gaap_PaidInKindInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaidInKindInterest",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Paid-in-Kind Interest",
        "terseLabel": "Non-cash interest expense",
        "documentation": "Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r886"
     ]
    },
    "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments to Acquire Debt Securities, Available-for-Sale",
        "negatedTerseLabel": "Purchases of marketable securities",
        "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r152",
      "r239"
     ]
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireIntangibleAssets",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments to Acquire Intangible Assets",
        "negatedLabel": "Purchases of intangible assets",
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r896"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r896"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r888"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "auth_ref": [
      "r905"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r898"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r887"
     ]
    },
    "sera_PercentageOfMinimumOwnershipBeneficiallyOwnByHolderWithAffiliatesToWarrantExercise": {
     "xbrltype": "percentItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "PercentageOfMinimumOwnershipBeneficiallyOwnByHolderWithAffiliatesToWarrantExercise",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of Minimum Ownership Beneficially Own by Holder with Affiliates to Warrant Exercise",
        "documentation": "Percentage of minimum ownership beneficially own by holder with affiliates to warrant exercise.",
        "terseLabel": "Percentage of minimum ownership beneficially own by holder with affiliates to warrant exercise"
       }
      }
     },
     "auth_ref": []
    },
    "sera_Plan2011Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "Plan2011Member",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to 2011 Employee, Director and Consultant Equity Incentive Plan.",
        "label": "Plan2011 [Member]",
        "terseLabel": "2011 Plan"
       }
      }
     },
     "auth_ref": []
    },
    "sera_Plan2021Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "Plan2021Member",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to 2021 Equity Incentive Plan.",
        "label": "Plan2021 [Member]",
        "terseLabel": "2021 Plan"
       }
      }
     },
     "auth_ref": []
    },
    "sera_PlanEspp2021Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "PlanEspp2021Member",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to 2021 Employee Stock Purchase Plan.",
        "label": "Plan Espp2021 [Member]",
        "terseLabel": "2021 ESPP"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1011",
      "r1012",
      "r1013",
      "r1014",
      "r1015",
      "r1016",
      "r1017",
      "r1018",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1023",
      "r1024",
      "r1025",
      "r1026",
      "r1027",
      "r1028",
      "r1029",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1011",
      "r1012",
      "r1013",
      "r1014",
      "r1015",
      "r1016",
      "r1017",
      "r1018",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1023",
      "r1024",
      "r1025",
      "r1026",
      "r1027",
      "r1028",
      "r1029",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036"
     ]
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Prior Service Cost [Member]",
        "terseLabel": "Pension Adjustments Prior Service Cost"
       }
      }
     },
     "auth_ref": [
      "r889"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Service Cost [Member]",
        "terseLabel": "Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r945"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote [Text Block]",
        "terseLabel": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r888"
     ]
    },
    "us-gaap_PostemploymentBenefitPlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PostemploymentBenefitPlansPolicy",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Postemployment Benefit Plans, Policy [Policy Text Block]",
        "terseLabel": "Retirement Savings Plan",
        "documentation": "Disclosure of accounting policy for postemployment benefits. Postemployment benefits are benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement, except for: a) benefits provided through a pension or postretirement benefit plan, b) individual deferred compensation arrangements, c) special or contractual termination benefits, and d) stock compensation plans."
       }
      }
     },
     "auth_ref": [
      "r371"
     ]
    },
    "us-gaap_PreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock [Member]",
        "terseLabel": "Preferred Stock",
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company."
       }
      }
     },
     "auth_ref": [
      "r825",
      "r826",
      "r829",
      "r830",
      "r831",
      "r832",
      "r1079",
      "r1082"
     ]
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in usd per share)",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r341"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, authorized (in shares)",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r705"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock outstanding (in shares)",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r705",
      "r723",
      "r1082",
      "r1083"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r967"
     ]
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "crdr": "debit",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Issuance Initial Public Offering",
        "terseLabel": "Proceeds from offering",
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "sera_ProceedsFromIssuanceInitialPublicOfferingNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "ProceedsFromIssuanceInitialPublicOfferingNet",
     "crdr": "debit",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from offering net",
        "label": "Proceeds from Issuance Initial Public Offering Net",
        "documentation": "Proceeds from Issuance Initial Public Offering Net"
       }
      }
     },
     "auth_ref": []
    },
    "sera_ProceedsFromIssuanceOfSharesAndPreFundedWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "ProceedsFromIssuanceOfSharesAndPreFundedWarrants",
     "crdr": "debit",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds From Issuance Of Shares And Pre Funded Warrants",
        "documentation": "Proceeds From Issuance Of Shares And Pre Funded Warrants",
        "terseLabel": "Proceeds from issuance of shares and warrants"
       }
      }
     },
     "auth_ref": []
    },
    "sera_ProceedsFromIssuanceOfSharesAndPreFundedWarrantsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "ProceedsFromIssuanceOfSharesAndPreFundedWarrantsNet",
     "crdr": "debit",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds From Issuance Of Shares And Pre Funded Warrants Net",
        "documentation": "The cash inflow from issuance of shares and pre-funded warrants net of underwriting discounts and commissions and offering expenses.",
        "terseLabel": "Proceeds from issuance of shares and warrants, net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Excluding Option Exercised",
        "terseLabel": "Proceeds from employee stock purchase plan",
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Excludes option exercised."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r10"
     ]
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Sale and Maturity of Marketable Securities",
        "terseLabel": "Proceeds from maturities and sales of marketable securities",
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
     "crdr": "debit",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecuritiesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Sale of Debt Securities, Available-for-Sale",
        "terseLabel": "Proceeds from the sale of available-for-sale securities prior to maturity",
        "documentation": "Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r152",
      "r239",
      "r270"
     ]
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "terseLabel": "Proceeds from disposal of property and equipment",
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromStockOptionsExercised",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from exercise of stock options",
        "verboseLabel": "Exercise of stock option",
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r10"
     ]
    },
    "us-gaap_ProfessionalFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProfessionalFees",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSegmentInformationSummaryOfSegmentInformationForRevenueSignificantSegmentExpensesAndSegmentLossExpensesThatAreRegularlyProvidedT": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSegmentInformationSummaryOfSegmentInformationForRevenueSignificantSegmentExpensesAndSegmentLossExpensesThatAreRegularlyProvidedT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Professional Fees",
        "terseLabel": "Consulting and professional fees",
        "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer."
       }
      }
     },
     "auth_ref": [
      "r788",
      "r833",
      "r1080",
      "r1081"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentScheduleOfComponentsOfPropertyAndEquipmentNetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentScheduleOfComponentsOfPropertyAndEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization",
        "negatedTerseLabel": "Less accumulated depreciation and amortization",
        "documentation": "Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease."
       }
      }
     },
     "auth_ref": [
      "r952",
      "r954",
      "r1003"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      },
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentScheduleOfComponentsOfPropertyAndEquipmentNetDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentScheduleOfComponentsOfPropertyAndEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net",
        "documentation": "Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset."
       }
      }
     },
     "auth_ref": [
      "r954",
      "r1001"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentScheduleOfComponentsOfPropertyAndEquipmentNetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentScheduleOfComponentsOfPropertyAndEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization",
        "terseLabel": "Total property and equipment",
        "documentation": "Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset."
       }
      }
     },
     "auth_ref": [
      "r951",
      "r965",
      "r1002"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentScheduleOfComponentsOfPropertyAndEquipmentNetDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSignificantAccountingPoliciesScheduleOfEstimatedUsefulLifeOfEachAssetCategoryDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/PropertyandEquipmentAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r570"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/PropertyandEquipment"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "verboseLabel": "Property and Equipment",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r106",
      "r109",
      "r110"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentScheduleOfComponentsOfPropertyAndEquipmentNetDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSignificantAccountingPoliciesScheduleOfEstimatedUsefulLifeOfEachAssetCategoryDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/PropertyandEquipmentAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r570"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and Equipment",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r106",
      "r109",
      "r645"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/PropertyandEquipmentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of Property and Equipment, Useful Life",
        "verboseLabel": "Schedule of Components of Property and Equipment, Net",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentScheduleOfComponentsOfPropertyAndEquipmentNetDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSignificantAccountingPoliciesScheduleOfEstimatedUsefulLifeOfEachAssetCategoryDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/PropertyandEquipmentAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Long-Lived Tangible Asset [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r570"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSignificantAccountingPoliciesScheduleOfEstimatedUsefulLifeOfEachAssetCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Property and equipment, useful life",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of Purchases of property and equipment included in accounts payable or accrued expenses that were incurred during a noncash or partial noncash transaction.",
        "label": "Purchases Of Property And Equipment Included In Accounts Payable And Accrued Liabilities",
        "verboseLabel": "Purchases of property and equipment in accounts payable and accrued and other current liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r886"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r886"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeAxis",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAndFinancialConditionAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfFairValuesCalculatedUsingBlackscholesOptionPricingModelDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r323",
      "r324",
      "r325",
      "r326",
      "r372",
      "r381",
      "r412",
      "r413",
      "r414",
      "r426",
      "r523",
      "r593",
      "r602",
      "r619",
      "r653",
      "r655",
      "r669",
      "r695",
      "r696",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r768",
      "r769",
      "r796",
      "r801",
      "r805",
      "r813",
      "r814",
      "r818",
      "r819",
      "r823",
      "r827",
      "r1005",
      "r1009",
      "r1054",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAndFinancialConditionAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfFairValuesCalculatedUsingBlackscholesOptionPricingModelDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "auth_ref": [
      "r323",
      "r324",
      "r325",
      "r326",
      "r372",
      "r381",
      "r412",
      "r413",
      "r414",
      "r426",
      "r523",
      "r593",
      "r602",
      "r619",
      "r653",
      "r655",
      "r669",
      "r695",
      "r696",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r768",
      "r769",
      "r796",
      "r801",
      "r805",
      "r813",
      "r814",
      "r818",
      "r819",
      "r823",
      "r827",
      "r1005",
      "r1009",
      "r1054",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072"
     ]
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesUnrecognizedTaxPositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]",
        "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure"
       }
      }
     },
     "auth_ref": [
      "r853",
      "r864",
      "r874",
      "r907"
     ]
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party, Type [Domain]",
        "terseLabel": "Related Party [Domain]",
        "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r238",
      "r379",
      "r580",
      "r581",
      "r638",
      "r644",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r722",
      "r724",
      "r755"
     ]
    },
    "sera_RelatedPartyTransactionCashReceivedFromRelatedParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "RelatedPartyTransactionCashReceivedFromRelatedParty",
     "crdr": "debit",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related Party Transaction, Cash Received From Related Party",
        "label": "Related Party Transaction, Cash Received From Related Party",
        "terseLabel": "Related Party Transaction, Cash Received From Related Party"
       }
      }
     },
     "auth_ref": []
    },
    "sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "RelatedPartyTransactionCommercialCollaborationAgreementTerm",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period for Commercial collaboration agreement , in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Related Party Transaction, Commercial Collaboration Agreement Term",
        "terseLabel": "Term of agreement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionLineItems",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Line Items]",
        "terseLabel": "Related Party Transaction [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r238",
      "r729",
      "r730",
      "r733"
     ]
    },
    "sera_RelatedPartyTransactionOtherReceivablesRelatedToMinimumPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "RelatedPartyTransactionOtherReceivablesRelatedToMinimumPayments",
     "crdr": "debit",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related Party Transaction, Other Receivables Related To Minimum Payments",
        "label": "Related Party Transaction, Other Receivables Related To Minimum Payments",
        "terseLabel": "Other receivables related to minimum payments"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]",
        "terseLabel": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party, Type [Axis]",
        "terseLabel": "Related Party [Axis]",
        "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r238",
      "r379",
      "r580",
      "r581",
      "r638",
      "r644",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r722",
      "r724",
      "r755",
      "r1064"
     ]
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/RelatedPartyTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "Related Party Transactions",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r577",
      "r578",
      "r579",
      "r581",
      "r583",
      "r680",
      "r681",
      "r682",
      "r731",
      "r732",
      "r733",
      "r752",
      "r754"
     ]
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAndFinancialConditionAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "auth_ref": [
      "r163",
      "r164",
      "r337",
      "r343",
      "r582",
      "r603",
      "r635",
      "r776",
      "r777"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Expense",
        "terseLabel": "Research and development",
        "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity."
       }
      }
     },
     "auth_ref": [
      "r429",
      "r771",
      "r788",
      "r1073"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfImpactOfStockbasedCompensationExpenseInStatementsOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development expense",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development Expense",
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process."
       }
      }
     },
     "auth_ref": [
      "r428"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "auth_ref": [
      "r854",
      "r865",
      "r875",
      "r908"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r855",
      "r866",
      "r876",
      "r909"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r862",
      "r873",
      "r883",
      "r916"
     ]
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents [Domain]",
        "terseLabel": "Cash and Cash Equivalents [Domain]",
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureScheduleOfCommonStockReservedForFutureIssuanceDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureNetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromTheComputationOfEarningsPerShareDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfInformationAboutRsusGrantedAndOutstandingDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfUnrecognizedStockbasedCompensationExpenseForOutstandingUnvestedStockOptionsAndRsusDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units (RSUs)",
        "verboseLabel": "Restricted stock units outstanding",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAndFinancialConditionAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r84",
      "r642",
      "r663",
      "r668",
      "r678",
      "r706",
      "r821"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r119",
      "r165",
      "r166",
      "r167",
      "r170",
      "r177",
      "r179",
      "r181",
      "r276",
      "r283",
      "r316",
      "r460",
      "r461",
      "r474",
      "r475",
      "r476",
      "r479",
      "r486",
      "r487",
      "r497",
      "r500",
      "r501",
      "r504",
      "r515",
      "r551",
      "r553",
      "r659",
      "r661",
      "r683",
      "r1082"
     ]
    },
    "sera_RevenueCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "RevenueCost",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Revenue Cost",
        "terseLabel": "Cost of revenue"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenue",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r95",
      "r198",
      "r208",
      "r209",
      "r224",
      "r228",
      "r232",
      "r234",
      "r235",
      "r368",
      "r369",
      "r621"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue Recognition",
        "documentation": "Disclosure of accounting policy for revenue from contract with customer."
       }
      }
     },
     "auth_ref": [
      "r115",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r772"
     ]
    },
    "us-gaap_RevenueRecognitionDeferredRevenue": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueRecognitionDeferredRevenue",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue Recognition, Deferred Revenue [Policy Text Block]",
        "terseLabel": "Deferred Revenue",
        "documentation": "Disclosure of accounting policy for recognizing unearned income or deferred revenue related to transactions involving the sale of a product or performance of services."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Revenues",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSegmentInformationSummaryOfSegmentInformationForRevenueSignificantSegmentExpensesAndSegmentLossExpensesThatAreRegularlyProvidedT": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSegmentInformationSummaryOfSegmentInformationForRevenueSignificantSegmentExpensesAndSegmentLossExpensesThatAreRegularlyProvidedT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues",
        "totalLabel": "Revenue",
        "terseLabel": "Revenue",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r95",
      "r148",
      "r161",
      "r198",
      "r208",
      "r209",
      "r224",
      "r228",
      "r232",
      "r234",
      "r235",
      "r271",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r540",
      "r632",
      "r788",
      "r1007"
     ]
    },
    "sera_RightOfUseAssetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "RightOfUseAssetAbstract",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeasesInFinancialStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use assets:",
        "documentation": "Right-of-Use Asset",
        "label": "Right-of-Use Asset [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeaseCostAndOtherInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "terseLabel": "Right-of-use assets obtained in exchange for lease liabilities",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r566",
      "r820"
     ]
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeaseCostAndOtherInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-use assets obtained in exchange for lease liabilities",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r566",
      "r820"
     ]
    },
    "sera_RightOfUseAssetTotal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "RightOfUseAssetTotal",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeasesInFinancialStatementDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfLeasesInFinancialStatementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right-of-Use Asset, Total",
        "label": "Right-of-Use Asset, Total",
        "totalLabel": "Total right-of-use assets"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r925"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r925"
     ]
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAndFinancialConditionAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Domain]",
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/AccruedandOtherCurrentLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Components of Accrued and Other Current Liabilities",
        "documentation": "Tabular disclosure of the components of accrued liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureNetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromTheComputationOfEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "documentation": "Disclosure of information about security that could potentially dilute basic earnings per share (EPS) in future that was not included in calculation of diluted EPS."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureNetLossPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Anti-dilutive Securities Excluded from the Computation of Earnings per Share",
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251"
     ]
    },
    "us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents and Investments [Table Text Block]",
        "terseLabel": "Schedule of Cash, Cash Equivalents and Marketable Securities by Major Security Type",
        "documentation": "Tabular disclosure of the components of cash, cash equivalents, and investments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAndFinancialConditionAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r488"
     ]
    },
    "sera_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/CapitalStructureTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The tabular disclosure of common stock reserved for future issuance.",
        "label": "Schedule of Common Stock Reserved For Future Issuance [Table Text Block]",
        "terseLabel": "Schedule of Common Stock Reserved for Future Issuance"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of Components of Income Tax Benefit (Provision)",
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years."
       }
      }
     },
     "auth_ref": [
      "r1046"
     ]
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r1043"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Effective Income Tax Rate Reconciliation",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r438",
      "r809",
      "r1039"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfImpactOfStockbasedCompensationExpenseInStatementsOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Schedule of Impact of Stock-based Compensation Expense in Statements of Operations",
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "sera_ScheduleOfEstimatedUsefulLifeOfEachAssetCategoryTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "ScheduleOfEstimatedUsefulLifeOfEachAssetCategoryTableTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/AccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Estimated Useful Life Of Each Asset Category [Table Text Block]",
        "documentation": "Schedule Of Estimated Useful Life Of Each Asset Category [Table Text Block]",
        "terseLabel": "Schedule of Estimated Useful Life of Each Asset Category"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Asset, Finite-Lived [Table]",
        "documentation": "Disclosure of information about finite-lived intangible asset. Excludes indefinite-lived intangible asset."
       }
      }
     },
     "auth_ref": [
      "r301",
      "r307",
      "r310",
      "r311",
      "r313",
      "r622",
      "r771",
      "r798"
     ]
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Asset, Indefinite-Lived [Table]",
        "documentation": "Disclosure of information about indefinite-lived intangible asset. Excludes finite-lived intangible asset."
       }
      }
     },
     "auth_ref": [
      "r301",
      "r309",
      "r313",
      "r798"
     ]
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Intangible Assets",
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment."
       }
      }
     },
     "auth_ref": [
      "r798",
      "r1000"
     ]
    },
    "sera_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/CommitmentandContingenciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Leases In Statement Of Financial Position",
        "label": "Schedule Of Leases In Statement of Financial Position [Table Text Block]",
        "terseLabel": "Schedule of Leases in Financial Statement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfOtherAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfOtherAssetsTableTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureOtherAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Other Assets",
        "label": "Schedule of Other Assets [Table Text Block]",
        "documentation": "Tabular disclosure of the carrying amounts of other assets. This disclosure includes other current assets and other noncurrent assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureOtherIncomeNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Other Nonoperating Income (Expense) [Table Text Block]",
        "terseLabel": "Schedule of Components of Other Income, Net",
        "documentation": "Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentScheduleOfComponentsOfPropertyAndEquipmentNetDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSignificantAccountingPoliciesScheduleOfEstimatedUsefulLifeOfEachAssetCategoryDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/PropertyandEquipmentAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r570"
     ]
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]",
        "documentation": "Disclosure of information about related party transaction."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r44",
      "r729",
      "r730",
      "r733"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSegmentInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Summary of Segment Information for Revenue, Significant Segment Expenses and Segement Loss Expenses that are Regularly Provided to the CODM",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r26",
      "r27"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfFairValuesCalculatedUsingBlackscholesOptionPricingModelDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfInformationAboutRsusGrantedAndOutstandingDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfUnrecognizedStockbasedCompensationExpenseForOutstandingUnvestedStockOptionsAndRsusDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r383",
      "r385",
      "r387",
      "r388",
      "r389",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Summary of Options Granted and Outstanding",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r9",
      "r85"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions Using the Black-Scholes Method",
        "verboseLabel": "Schedule of Fair Values Calculated using Black-Scholes Option Pricing Model",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Summary of Information about RSUs Granted and Outstanding",
        "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfStockByClassTable",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureScheduleOfCommonStockReservedForFutureIssuanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]",
        "documentation": "Disclosure of information about stock by class. Includes, but is not limited to, common, convertible, and preferred stocks."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r80",
      "r82",
      "r83",
      "r84",
      "r131",
      "r132",
      "r133",
      "r200",
      "r341",
      "r342",
      "r343",
      "r345",
      "r348",
      "r353",
      "r355",
      "r674",
      "r675",
      "r676",
      "r677",
      "r801",
      "r950",
      "r973"
     ]
    },
    "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/WarrantsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]",
        "terseLabel": "Schedule of Common Stock Warrants Outstanding",
        "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost [Table Text Block]",
        "terseLabel": "Summary of Unrecognized Stock-based Compensation Expense for Outstanding Unvested Stock Options and RSUs",
        "documentation": "Tabular disclosure of cost not yet recognized and weighted-average period over which cost is expected to be recognized for nonvested award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r88"
     ]
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "terseLabel": "Schedule of Uncertain Tax Positions Roll Forward",
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r446",
      "r808"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r835"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r838"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]",
        "documentation": "Indicates title and position of individual or name of group identified as chief operating decision maker (CODM) for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r206",
      "r787",
      "r795"
     ]
    },
    "us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingCodmProfitLossMeasureHowUsedDescription",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description",
        "documentation": "Description of how chief operating decision maker (CODM) uses reported segment profit (loss) measure to assess performance and allocate resource."
       }
      }
     },
     "auth_ref": [
      "r223",
      "r784",
      "r792"
     ]
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSegmentInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Information",
        "label": "Segment Reporting Disclosure [Text Block]",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r198",
      "r202",
      "r203",
      "r204",
      "r205",
      "r207",
      "r214",
      "r215",
      "r216",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r232",
      "r233",
      "r235",
      "r782",
      "r785",
      "r786",
      "r788",
      "r790",
      "r793",
      "r794"
     ]
    },
    "us-gaap_SegmentReportingOtherItemAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingOtherItemAmount",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSegmentInformationSummaryOfSegmentInformationForRevenueSignificantSegmentExpensesAndSegmentLossExpensesThatAreRegularlyProvidedT": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSegmentInformationSummaryOfSegmentInformationForRevenueSignificantSegmentExpensesAndSegmentLossExpensesThatAreRegularlyProvidedT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting, Other Segment Item, Amount",
        "terseLabel": "Other segment items",
        "documentation": "Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss)."
       }
      }
     },
     "auth_ref": [
      "r198",
      "r215",
      "r216",
      "r228",
      "r788"
     ]
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segments",
        "documentation": "Disclosure of accounting policy for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r231",
      "r234",
      "r783",
      "r784",
      "r791"
     ]
    },
    "us-gaap_SellingAndMarketingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SellingAndMarketingExpense",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Selling and Marketing Expense",
        "terseLabel": "Selling and marketing",
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SellingAndMarketingExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SellingAndMarketingExpenseMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfImpactOfStockbasedCompensationExpenseInStatementsOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Selling and Marketing Expense [Member]",
        "terseLabel": "Sales and marketing expense",
        "documentation": "Primary financial statement caption encompassing selling and marketing expense."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "terseLabel": "Vesting period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r806"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfInformationAboutRsusGrantedAndOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Forfeited (in shares)",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r404"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfInformationAboutRsusGrantedAndOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (in usd per share)",
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event."
       }
      }
     },
     "auth_ref": [
      "r404"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfInformationAboutRsusGrantedAndOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)",
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r402"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfInformationAboutRsusGrantedAndOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in usd per share)",
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r402"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfInformationAboutRsusGrantedAndOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Outstanding, ending balance (in shares)",
        "periodStartLabel": "Outstanding, beginning balance (in shares)",
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r399",
      "r400"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfInformationAboutRsusGrantedAndOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfInformationAboutRsusGrantedAndOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodStartLabel": "Outstanding, beginning balance (in usd per share)",
        "periodEndLabel": "Outstanding, ending balance (in usd per share)",
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r399",
      "r400"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfInformationAboutRsusGrantedAndOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted-Average Grant Date Fair Value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfInformationAboutRsusGrantedAndOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Vested (in shares)",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r403"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfInformationAboutRsusGrantedAndOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (in usd per share)",
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement."
       }
      }
     },
     "auth_ref": [
      "r403"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfFairValuesCalculatedUsingBlackscholesOptionPricingModelDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum",
        "terseLabel": "Expected volatility, maximum",
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfFairValuesCalculatedUsingBlackscholesOptionPricingModelDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum",
        "terseLabel": "Expected volatility, minimum",
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfFairValuesCalculatedUsingBlackscholesOptionPricingModelDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum",
        "terseLabel": "Risk-free interest rate, maximum",
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfFairValuesCalculatedUsingBlackscholesOptionPricingModelDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum",
        "terseLabel": "Risk-free interest rate, minimum",
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend",
     "crdr": "debit",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfFairValuesCalculatedUsingBlackscholesOptionPricingModelDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend",
        "terseLabel": "Expected dividend yield",
        "documentation": "Disclosure of the weighted average expected dividend for an entity using a valuation technique with different dividend rates during the contractual term."
       }
      }
     },
     "auth_ref": [
      "r413"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfFairValuesCalculatedUsingBlackscholesOptionPricingModelDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfInformationAboutRsusGrantedAndOutstandingDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfUnrecognizedStockbasedCompensationExpenseForOutstandingUnvestedStockOptionsAndRsusDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r383",
      "r385",
      "r387",
      "r388",
      "r389",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Shares available for grant",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionsGrantedAndOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of options exercised",
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares."
       }
      }
     },
     "auth_ref": [
      "r406"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionsGrantedAndOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period",
        "negatedLabel": "Expired (in shares)",
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements."
       }
      }
     },
     "auth_ref": [
      "r398"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionsGrantedAndOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Cancelled (in shares)",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r397"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionsGrantedAndOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted (in shares)",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r395"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-average grant date fair value of options granted (in usd per share)",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r405"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionsGrantedAndOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value, outstanding",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionsGrantedAndOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding at the end (in shares)",
        "periodStartLabel": "Outstanding at the beginning (in shares)",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r391",
      "r392"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionsGrantedAndOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number of Shares Subject to Options Outstanding",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionsGrantedAndOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding at the end (in usd per share)",
        "periodStartLabel": "Outstanding at the beginning (in usd per share)",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r391",
      "r392"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionsGrantedAndOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted- Average Exercise Price Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionsGrantedAndOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number",
        "terseLabel": "Number of shares subject to options outstanding, vested and exercisable at the end",
        "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r408"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionsGrantedAndOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price",
        "verboseLabel": "Weighted average exercise price per share, vested and exercisable at the end (in usd per share)",
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r408"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionsGrantedAndOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value, vested and expected to vest at the end",
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r407"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionsGrantedAndOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Number of shares subject to options outstanding, vested and expected to vest at the end (in shares)",
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r407"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionsGrantedAndOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price per share, vested and expected to vest at the end (in usd per share)",
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r407"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfInformationAboutRsusGrantedAndOutstandingDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfUnrecognizedStockbasedCompensationExpenseForOutstandingUnvestedStockOptionsAndRsusDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Award Types",
        "terseLabel": "All Award Types",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r387",
      "r388",
      "r389",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionsGrantedAndOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "verboseLabel": "Exercised (in usd per share)",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r396"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionsGrantedAndOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price",
        "verboseLabel": "Expired (in usd per share)",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired."
       }
      }
     },
     "auth_ref": [
      "r398"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionsGrantedAndOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Cancelled (in usd per share)",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
       }
      }
     },
     "auth_ref": [
      "r397"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionsGrantedAndOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "verboseLabel": "Granted (in usd per share)",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r395"
     ]
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Share-based Compensation",
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
       }
      }
     },
     "auth_ref": [
      "r382",
      "r390",
      "r409",
      "r410",
      "r411",
      "r412",
      "r415",
      "r421",
      "r422",
      "r423",
      "r424"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "terseLabel": "Expiration term",
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r807"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfFairValuesCalculatedUsingBlackscholesOptionPricingModelDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term (in years)",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r411"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "crdr": "debit",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionsGrantedAndOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value, vested and exercisable at the end",
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionsGrantedAndOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average remaining contractual life, outstanding",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionsGrantedAndOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average remaining contractual life, vested and exercisable at the end",
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r408"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionsGrantedAndOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "verboseLabel": "Weighted average remaining contractual life, vested and expected to vest at the end",
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r407"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "crdr": "credit",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value",
        "terseLabel": "Fair value of options vested",
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock."
       }
      }
     },
     "auth_ref": [
      "r406"
     ]
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/SignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Significant Accounting Policies",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r159"
     ]
    },
    "us-gaap_SoftwareDevelopmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SoftwareDevelopmentMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosurePropertyAndEquipmentScheduleOfComponentsOfPropertyAndEquipmentNetDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSignificantAccountingPoliciesScheduleOfEstimatedUsefulLifeOfEachAssetCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Software Development [Member]",
        "terseLabel": "Software",
        "verboseLabel": "Software developed for sale",
        "documentation": "Internally developed software for sale, licensing or long-term internal use."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StateAndLocalJurisdictionMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State",
        "documentation": "Designated state or local jurisdiction entitled to levy and collect income tax."
       }
      }
     },
     "auth_ref": [
      "r436"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsParenthetical",
      "http://seraprognostics.com/20241231/taxonomy/role/Cover",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureScheduleOfCommonStockReservedForFutureIssuanceDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAndFinancialConditionAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r131",
      "r132",
      "r133",
      "r161",
      "r187",
      "r188",
      "r190",
      "r192",
      "r200",
      "r201",
      "r271",
      "r328",
      "r330",
      "r331",
      "r332",
      "r335",
      "r336",
      "r341",
      "r342",
      "r345",
      "r348",
      "r355",
      "r540",
      "r674",
      "r675",
      "r676",
      "r677",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r705",
      "r726",
      "r748",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765",
      "r950",
      "r973",
      "r981"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r57",
      "r60",
      "r61",
      "r119",
      "r145",
      "r146",
      "r147",
      "r165",
      "r166",
      "r167",
      "r170",
      "r177",
      "r179",
      "r181",
      "r199",
      "r276",
      "r283",
      "r316",
      "r357",
      "r460",
      "r461",
      "r474",
      "r475",
      "r476",
      "r479",
      "r486",
      "r487",
      "r497",
      "r499",
      "r500",
      "r501",
      "r502",
      "r504",
      "r515",
      "r541",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r551",
      "r553",
      "r576",
      "r647",
      "r659",
      "r660",
      "r661",
      "r683",
      "r748"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsParenthetical",
      "http://seraprognostics.com/20241231/taxonomy/role/StatementStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r165",
      "r166",
      "r167",
      "r199",
      "r553",
      "r621",
      "r672",
      "r694",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r705",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r724",
      "r727",
      "r728",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r748",
      "r828"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsParenthetical",
      "http://seraprognostics.com/20241231/taxonomy/role/StatementStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]",
        "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r165",
      "r166",
      "r167",
      "r199",
      "r238",
      "r553",
      "r621",
      "r672",
      "r694",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r705",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r724",
      "r727",
      "r728",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r748",
      "r828"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r857",
      "r868",
      "r878",
      "r911"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Issuance of common stock under employee stock purchase plan (in shares)",
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r56",
      "r57",
      "r84"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesOther": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesOther",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other issuance of common stock (in shares)",
        "label": "Stock Issued During Period, Shares, Other",
        "documentation": "Number of shares of stock issued attributable to transactions classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "totalLabel": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures, Total",
        "terseLabel": "Issuance of restricted stock units (in shares)",
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r56",
      "r57",
      "r84"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionsGrantedAndOutstandingDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/StatementStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "terseLabel": "Issuance of common stock upon exercise of stock options (in shares)",
        "negatedLabel": "Exercised (in shares)",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r56",
      "r57",
      "r84",
      "r396"
     ]
    },
    "sera_StockIssuedDuringPeriodSharesStockWarrantExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "StockIssuedDuringPeriodSharesStockWarrantExercised",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/StatementStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Shares, Stock Warrant Exercised",
        "label": "Stock Issued During Period, Shares, Stock Warrant Exercised",
        "terseLabel": "Stock Issued During Period, Shares, Stock Warrant Exercised",
        "verboseLabel": "Common stock warrant exercises (in shares)"
       }
      }
     },
     "auth_ref": []
    },
    "sera_StockIssuedDuringPeriodSharesStockWarrantExpired": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "StockIssuedDuringPeriodSharesStockWarrantExpired",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Shares, Stock Warrant Expired",
        "documentation": "Stock issued during period, shares, stock warrant expired.",
        "terseLabel": "Common stock warrants expired (in shares)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "crdr": "credit",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Issuance of common stock under employee stock purchase plan",
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r56",
      "r57",
      "r84"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueOther",
     "crdr": "credit",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other issuance of common stock",
        "label": "Stock Issued During Period, Value, Other",
        "documentation": "Value of shares of stock issued attributable to transactions classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Issuance of common stock upon exercise of stock options",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r57",
      "r60",
      "r61",
      "r84"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited",
      "http://seraprognostics.com/20241231/taxonomy/role/StatementStatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity, Attributable to Parent",
        "periodEndLabel": "Balance at the ending",
        "periodStartLabel": "Balance at the beginning",
        "totalLabel": "Total stockholders' equity",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r60",
      "r61",
      "r75",
      "r707",
      "r723",
      "r749",
      "r750",
      "r821",
      "r834",
      "r974",
      "r997",
      "r1059",
      "r1082"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/BalanceSheetsunaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity, Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders' equity:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityNoteAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]",
        "terseLabel": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/CapitalStructure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Text Block]",
        "terseLabel": "Capital Structure",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r160",
      "r340",
      "r342",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r354",
      "r357",
      "r506",
      "r751",
      "r753",
      "r766"
     ]
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r548",
      "r585"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Events",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r548",
      "r585"
     ]
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Table]",
        "documentation": "Disclosure of information about significant event or transaction occurring between statement of financial position date and date when financial statements were issued."
       }
      }
     },
     "auth_ref": [
      "r548",
      "r585"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r548",
      "r585"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r548",
      "r585"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r584",
      "r586"
     ]
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAndFinancialConditionAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosure of cash flow information"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r904"
     ]
    },
    "sera_TdCowenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "TdCowenMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAndFinancialConditionAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "TD Cowen [Member]",
        "documentation": "TD Cowen.",
        "terseLabel": "TD Cowen"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r896"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r903"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "auth_ref": [
      "r924"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "auth_ref": [
      "r926"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecuritiesAvailableforsaleDebtSecuritiesAndCashEquivalentsInUnrealizedLossPositionsDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureWarrantsScheduleOfCommonStockWarrantsOutstandingDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]",
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "auth_ref": [
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r339",
      "r353",
      "r505",
      "r537",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r648",
      "r810",
      "r811",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r822",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962",
      "r963",
      "r964",
      "r993",
      "r994",
      "r995",
      "r996",
      "r1050",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1058"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r927"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r928"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Expiration Date",
        "terseLabel": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r928"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r926"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "auth_ref": [
      "r926"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r929"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r927"
     ]
    },
    "sera_TwoThousandTwentyFourSalesAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "TwoThousandTwentyFourSalesAgreementMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAndFinancialConditionAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Two Thousand Twenty Four Sales Agreement [Member]",
        "documentation": "Two thousand twenty four sales agreement.",
        "terseLabel": "2024 Sales Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TypeOfAdoptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TypeOfAdoptionMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update [Domain]",
        "documentation": "Amendment to accounting standards."
       }
      }
     },
     "auth_ref": [
      "r117",
      "r118",
      "r119",
      "r120",
      "r121",
      "r122",
      "r169",
      "r170",
      "r171",
      "r172",
      "r183",
      "r236",
      "r237",
      "r273",
      "r274",
      "r275",
      "r276",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r315",
      "r316",
      "r319",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r538",
      "r539",
      "r550",
      "r551",
      "r552",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r623",
      "r624",
      "r625",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668"
     ]
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureDescriptionOfBusinessAndFinancialConditionAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r488"
     ]
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecuritiesAvailableforsaleDebtSecuritiesAndCashEquivalentsInUnrealizedLossPositionsDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "US Government Agencies Debt Securities [Member]",
        "terseLabel": "U.S. federal agency securities",
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB)."
       }
      }
     },
     "auth_ref": [
      "r778",
      "r802",
      "r1074"
     ]
    },
    "us-gaap_USGovernmentDebtSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "USGovernmentDebtSecuritiesMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecuritiesAvailableforsaleDebtSecuritiesAndCashEquivalentsInUnrealizedLossPositionsDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "US Government Debt Securities [Member]",
        "terseLabel": "U.S. government securities",
        "documentation": "Debt securities issued by the United States government."
       }
      }
     },
     "auth_ref": [
      "r1074"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r923"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefits",
     "crdr": "credit",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesUnrecognizedTaxPositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized Tax Benefits",
        "periodStartLabel": "Balance at the beginning of the year",
        "periodEndLabel": "Balance at the end of the year",
        "documentation": "Amount of unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r431",
      "r446",
      "r808"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "crdr": "credit",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesUnrecognizedTaxPositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Gross increases-current period",
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return."
       }
      }
     },
     "auth_ref": [
      "r448",
      "r808"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "crdr": "credit",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesUnrecognizedTaxPositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Gross increases-prior period",
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns."
       }
      }
     },
     "auth_ref": [
      "r447",
      "r808"
     ]
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/SignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r23",
      "r24",
      "r103",
      "r104",
      "r107",
      "r108"
     ]
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "crdr": "credit",
     "calculation": {
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/IncomeTaxesScheduleofComponentsofIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "verboseLabel": "Increase in valuation allowance",
        "negatedTerseLabel": "Change in valuation allowance",
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset."
       }
      }
     },
     "auth_ref": [
      "r451"
     ]
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]",
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r892"
     ]
    },
    "sera_WarrantIssuedPricePerPre-FundedWarrantAndAccompanyingWarrant": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "WarrantIssuedPricePerPre-FundedWarrantAndAccompanyingWarrant",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offering price per pre-funded warrant",
        "label": "Warrant Issued Price Per Pre-Funded Warrant and Accompanying Warrant",
        "documentation": "The offering price per pre-funded warrant and accompanying warrant."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantsAndRightsNoteDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantsAndRightsNoteDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants and Rights Note Disclosure [Abstract]",
        "terseLabel": "Warrants and Rights Note Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "sera_WarrantsIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "WarrantsIssued",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Issued",
        "documentation": "Warrants Issued",
        "terseLabel": "Issuance of warrants (in shares)"
       }
      }
     },
     "auth_ref": []
    },
    "sera_WarrantsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "WarrantsTextBlock",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/Warrants"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.",
        "label": "Warrants [Text Block]",
        "terseLabel": "Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "sera_WarrantsToPurchaseCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://seraprognostics.com/20241231",
     "localname": "WarrantsToPurchaseCommonStockMember",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureCapitalStructureScheduleOfCommonStockReservedForFutureIssuanceDetails",
      "http://seraprognostics.com/20241231/taxonomy/role/DisclosureNetLossPerShareScheduleOfAntidilutiveSecuritiesExcludedFromTheComputationOfEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of common stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrants To Purchase Common Stock [Member]",
        "terseLabel": "Warrants to purchase Class A common stock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted-average shares outstanding, diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r186",
      "r192"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://seraprognostics.com/20241231/taxonomy/role/StatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted-average shares outstanding, basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r185",
      "r192"
     ]
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]",
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r890"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2A"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482739/220-10-55-15"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481142/505-10-45-2"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-10"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-4"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-5"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "710",
   "SubTopic": "10",
   "Section": "25",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483070/710-10-25-3"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-1"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-12"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-13"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "320",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-5"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478898/942-825-50-1"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205/tableOfContent"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/360/tableOfContent"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481573/470-10-45-12A"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/810/tableOfContent"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-6"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-6"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-6"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-7"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-7"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "326",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-3"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "326",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-3"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/606/tableOfContent"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-7"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-11"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-3"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-5"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/260/tableOfContent"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-24"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "36",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-36"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476173/280-10-65-1"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476173/280-10-65-1"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-11"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-2"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-11"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-14"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479130/326-30-45-1"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-5"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-7"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480265/350-10-S45-1"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-30/tableOfContent"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-2"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-4"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477123/405-50-65-1"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-1"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-2"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-17"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-19"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "712",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/712/tableOfContent"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "70",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480794/715-70-50-1"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483384/720-30-45-1"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483044/730-10-05-1"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-10B"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-15"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-9"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-9"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-9"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.1.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479845/805-20-65-3"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479845/805-20-65-3"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479845/805-20-65-3"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-5"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482477/820-10-65-13"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482477/820-10-65-13"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483013/835-20-50-1"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-5"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-2"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-4"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-1"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-1"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/850/tableOfContent"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/855/tableOfContent"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481444/860-30-45-1"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-9"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(4)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478345/912-310-45-11"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483154/926-20-50-5"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483194/926-20-65-2"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483194/926-20-65-2"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483194/926-20-65-2"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "340",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478859/928-340-50-1"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "940",
   "SubTopic": "820",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478119/940-820-50-1"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3A"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-3A"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-1"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-2"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/985-20/tableOfContent"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "8",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-8"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-16"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-21"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479081/326-30-55-8"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482640/350-30-55-40"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "217",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-217"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "101",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-101"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481395/860-30-55-4"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-17"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r888": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r889": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r890": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r891": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r892": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r893": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r894": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r895": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r896": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r897": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r898": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r899": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r900": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r901": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r902": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r903": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r904": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r905": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r906": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r907": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r908": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r909": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r910": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r911": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r912": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r913": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r914": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r915": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r916": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r917": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r918": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r919": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r920": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r921": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r922": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r923": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r924": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r925": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r926": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r927": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r928": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r929": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r930": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r931": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106"
  },
  "r932": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r933": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r934": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r935": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r936": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r937": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r938": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r939": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r940": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r941": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r942": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r943": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r944": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r945": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r946": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r947": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-X",
   "Number": "210",
   "Section": "2",
   "Subsection": "2"
  },
  "r948": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r949": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r950": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r951": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r952": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-4"
  },
  "r953": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r954": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r955": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r956": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Topic": "610",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/610/tableOfContent"
  },
  "r957": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Topic": "705",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/705/tableOfContent"
  },
  "r958": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r959": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r960": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r961": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r962": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r963": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r964": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r965": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r966": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r967": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r968": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r969": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r970": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r971": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r972": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r973": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r974": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r975": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r976": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r977": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r978": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r979": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r980": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r981": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r982": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r983": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18"
  },
  "r984": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r985": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r986": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r987": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r988": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2"
  },
  "r989": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/320/tableOfContent"
  },
  "r990": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-1"
  },
  "r991": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r992": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r993": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9"
  },
  "r994": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r995": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r996": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r997": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r998": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4"
  },
  "r999": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "720",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/720/tableOfContent"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-6"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r1060": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r1061": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r1062": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r1063": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r1064": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r1065": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1066": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1067": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1068": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1069": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1070": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1071": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1072": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1073": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1"
  },
  "r1074": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-2"
  },
  "r1075": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1076": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1077": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1078": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-1"
  },
  "r1079": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r1080": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r1081": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1082": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1083": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>98
<FILENAME>0000950170-25-042017-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-25-042017-xbrl.zip
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M>4H::Y18>5A9M"WT)"K\./?A,X-CR2:"&C8PE;JO!<';'@E>Q21OZPEC4A*
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MNF)NZ&4&V>H\RNN9\G'*6156%+NP.KTYU:9R@B"S)]% '\.9J:=*9R'.3,)
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MVXWAZH7@(^:3-+P2(AERA;Q [</\\:'0\V -?$YY!$=WJ[V9KZHS?^?A06#
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MU6%.VELS,\0,0D&2T?8&HB>Q6KRRVK<4SB0T)S]^*LS3:RJL)E_$D\=0B-Y
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MNY!H@('BXHD2K82ERH+.%_K:D?S*BS>N,'4IL7#^##*\J<-!;<!KVTE>JS@
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MX>&^>]S*Q,6I]O0AB0M?$S_7>(@#F&1X#P,'E/"*JWO=F"C37 _\NT!45//
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MMB4U%>F>)6(0"^5D9AN,.4X*ZY%70+R/+25*:'VI],81C(&U2@?@N?#:@.5
MND2])RXQ^NM?Y!AP4=01T4H> S:8]YL!N_7.X6-)':AH"_<H!Z4]A?NSHYP%
M[RB 2+56PVO?S.554I5]K 7KTK1>-45I1_\F"'YL7ZI:WHN6,N"QEO8<I ":
MQHC<ZWT@OC4LHH^#&0S%D]:<P-XIX9Z%?SIET]G.755 W_HF5>PB AY(5N&4
M-M7^^#216$)5X<&.F#"57!0!&]@+UA0L<;EX)#)*5^EV\TQ)2P/V?D&P/.HJ
M&GGXPC>6!0;43MWS'YC\F+:ZFBAV>(]H0 $\'H&1>*;Q%A3 >2H;'38"VU
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MZZ4[]B+K=&;62P%B5UUYTI.M,FL_TLN&7 MD2+:J$9[>*QF>\)=L:=4@>[1
M=&WZ"?=,$V%R%M0_519EF_[M^"^TO7DTU&_\-SRBD%!D7Z:RA1!9BYG*-TM"
ME#VF+ FALC-FBBS)+A0QV9)UDC7;V-<D^VX66Y9AQC*&V9[I]YSS_//<]SGW
M/_=?XWS.F'-=[^7U?KVNZWU=GW<U:/*%WC:V4=*&-4QY4N.$JG)>0.4@Z1V0
M@E86 A-$-U!N*+*<8 GE O5EDB4!V0T6<:+J>-FE+G5D-7>LZ^Z]$2L@"-A(
M$TIG6%/5%(?V5<A*"ZC.&Q_W40EP#OH%J/IX3+]2VP^O,C7THF6[F"\EC_ZU
M]1LM%^R%B '76K^767M-M2LBO_%N\XJ]Y"(Q41<:DMS @[*\&OZLVUPM2@N_
MC3O^.]6_D=FG.C:T/N9U?CY/N7(TB?F@5'>8?MJD<L,:P;M/ \G[7!SSQ6O8
MW?VO*--B_,*/5 <Q'0!E7?I-]N"ZU'_?;G'7D(>WQ$)POIQ4V*@_!0]:Z@R-
MS@OTWO$/4:=XB53ZH[<B7QVFZ7N6/1_(_,J!2S<@R*9J2<?S-NJZ8,+E<+PQ
ME>HYON:U$^ISM5P:M;]N&RVW]TE+8E[?VN!@\[,#<L-.!IMCV>KY@H/TJ\?<
MF]MR TX9K[+FUR2:I(MH/\*X8OP>U1!3$MB->VW"S42UR?JG_VIO[)1,CMP1
M6,NU_;_4;WSB?]D+_/?V__*QEQ1=G0'H8 #40^W<B3)_&0#]+33YBAQ50(R4
MPX288*@513(-BXSAA]X@7F  XL*Z^#RT_!P--DI=ZS_2R@;XY?M%XA7S^D3.
M"&9NB5&$R-?HIP^P2;S40/((T9!9GS7"=.?,L5K1>G)W"2L#R<.>?VYW_0B?
M/'.:\T/9]<_IP"_H6M06$@N9 V-.M1 .NTGYWBKV,8<VIU\/%S]247W49;Z0
M(H9X86=F%0N.1/Q@ 'IY8X&$6[[DRX',_Q*^\_(E]E.QB1)L5@!D@"S.D.4V
MF)8L_Y+I1.T7:?^MV3Y;)]$3TV2M5^\U%;"KPNOYX;.'AP:YX%AF9#_,G-=#
MLQ&&\/)U<7'A<YB;F^N1BEO48+$Z9\-B=1, N I #IB3=;Q(Q*EFUJ]D7XQY
M9"WGED\SQ(-6@)-7<IU3GTS$GQ?\)!Z5/FKPLEWA&VCS*KBD]01Q,8FHWVYO
M$TL%?[/?F)7\Z26!3UAIVHY;%3FO=AUQF^,0V88@:]-O#'/ VRV5#DR^N:9R
M0L%%Z%DI50MIH]V+@*77KG&W>D*&H5.:IG?,!3SVFXX^KNR/EU$6>.=XIX-(
MQH2UK0<4#;)O6ZO$][I:+RXC](.?"8:?2IP^0*[C##9^_>*Y-G+[6]M]]E@F
M-/HP $\<A4CMM/?-IJ6&17/]2TDLTR85SS+[A2G&M@_[-2JWRU,-@!S!Z.\'
M @?#;W5-W9<@G.NA/8C+V>83%9>:ZY+]4^7/7@=V&ZGGJD7T;':(EMMG"^_/
M7%EUJ -VGKLMO@_NS.UID,<I&-37HEK"/H^4R3Q 5 SW,P-.XY T-JGKE4>N
MQN2VA,OL2PK7B.[$0*?F275?+21^L8)WAUQ3!2VF!VC?3ZE0)?+H!1@@9?$B
M S#O& *FB@YA!YN0<XA>^YJ7UVQMR;)AQH5;J:9PUY&D[L?)_Z!]$HS!\QX
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M(NKL]+7,-008 -4L,N01$V3"8&>@^D1HZ&%2,X18@/,IC:W2&XZ#VI'ZOR;
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MO^@FO>!EFS'/ILE*V^[3VD&FE#^K\".-D?*J@9PS5TK ,,2UHSU'H!RSQLF
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M9NK.-!$APH0,>P;@*9J5S&-^=A[ZE,"-+^UR<_"^815'HM\[$?C^V?M[PDL
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MLE]Z?<#]7XM46MUPJ67 M5^YN:>4Q7I3WQ?.;OXY_PSSF2T<6@WM1+]6@U@
MHFTBC,274WT7",9L=VO'TO%Z%V^$<U7@O-SJ\B)[1SLGEO-8Y"?6]I%V'0DR
M7 4#YU:6=JFH+)HPLMT<<99J?/BIV91DH4/ZE&;/2#3J/5L/]PW^.]T#V287
MO!^.%EIZR!]O!9_S8@4?'P&J/P+5][XYSC,U<ZH3(0_X!!;:.2,$B!MUF4)3
MJ:6>K8L*99).5K-.?*DJ?WRJ1S&YAC)78=-605FC5SWK,$3&3L(E0_BJXM8Q
M.H]1Z&VP03 @9K(N5Q*'7C>;!7H3?M>0,6FZC:,*&TMU";>^[!F.!)X.Z]][
M?F-(F+0F6H/>T,9!?[/AWV<I =%ER(Y;^ 8/\9K@H<K'=@1K)0Y_;4&,NN9&
MVY;=+G>OM(5/LT6]V]K>S+\;?_ #OIDM2%M$Y(X/Q0@QK\5(.@)1>4:G%NI0
MEW>G7LO!+;+M/[8._M"<K/.:UI8K$3SS,I&YJ@1D"B)@W*Z#8Y#5Q]<'D&$D
M^F<<KZWICO_09XO=3W>?>'] 9R7.>=$%\>=2;ES*^;[*>/$=(CV[Z9H5\"CN
MAAB!D&1RV*JG\_+ABYR^=.\1NJP&T6"[-Y'Q6*)'[T;2EBMVII5Y*GK[Y^MD
M(Y)=4E9\W+Z:V>:>\Z\CD)#G#JT?+@?4XD0!6<]UO5*5S-06)SQ2P,HXQ[ZS
M\)>!F[>;>%=NC6/$#W]>2VL'N? T_KX*D:D%=$26((!V<',C0-G^9HG55378
M-L'\;O*5+80Y#OXV>V[.W6/"]THIL/3#Q83)TPD25@OQ=[*EIHL9;C,\U945
M*2G\T3-F!X&^L^R6B38H#_0#9T'#YE6!X^,\VXCI@[SZ&,V;/E]A:G;=F6OW
M\N2H.B_B; 0SK*.FKZ!\V.->-<WQG=\4S9\^/CY/D7,38:6--9 B6O*@[BR'
MR7[XF9[F00;!;+TWFHFT>B&1(*<-13Z8N X0^<4H#WBC-[H[H/3L?&IZ>+&=
M]A4-1R%N<%298 >X$M*.B3P87;5AZX!&V%S)$62P+6%C_C5S_ZL&^PK[2\I2
M36G"EZB:M?:= ),IRIA,OE@*-"@7JI8\B\<\\YRQZ +7U7TK=TM%LE!U<)@(
M5:][C2(E!*GXVB-0]!7_D.UNT'<CWT?0#Y6SS_G$SS-T'D=E)"!3W@&-0E:#
M4:T,@),]/<H(:9=VYKOZDU;JV6UM6S)_N2P$/G\$F9%0WU>3OLBNOX2Q+BRS
M48_Q79-ISK#I.VSZNP7PC96>&U]>G'%$ N>I4#I\<B+;;6E,M._H*IV]4)HD
MD+_3*9#7VN2#=%[6:VP.<[ZL[W7*5N\22[/!NS;O!#=RB)!^3']?Q?>\[ +^
MJ'#7A-QG8\%KR!%$=M>C> .?/+=][#]M'2Z(].M])#U,)-/?T 1G)"VO>Y*,
M\-"(9JA/*;"]?6]DQB16K[7>-O!+2]1 J\M3?7)A/&U-E0 2$IHZ3F#L64#E
M0N$#UF4#2+*&0$ZI'<Q_J%NW8\&T%67<T!*E>1*GGW2.^X_YO<2-#G;$R\0>
M)$*JW#Q+Z[W7%MOW]5T$N07<]"= C]OD>J8"Q&F9[N?+B MP*^(1J-<THE$Q
M3E.V$.D*"^BR+ HNF-N_H$V.>NQH^SRF[)OP1VUR64R,[$__UDCF;2V_PSH,
MK@A*!_LGM\R'#('7I:[L;M-YL:X\&NY9&;>ZTJZ=]67X^7 [32&NX<5IOYX;
MY5THX-+R!A:'_95#'IIJ-B.)6K2.46\0W)D6C%/)LC<4I@4CO]5_E$AT8+ED
M5_F==<(A54B ]LZY7(\E/L_P?9&ZVD 39K%@/_.]-_M;(2'/$'K4"O5"5Z,V
MKN'0TS-XO_)X+9$U*/$=[,6VRY.(G76?:4_8KYSXY&SUSI-*$(8ZMX4M0!%*
MY52&'#8B&%WLI8@ZQ?,P2IN84T27D%;E<T#I=F;SA"-KZ&Y_N:4-93MF,2?*
MU[6XIC%@:NM71R;$!$X$<R%Q*1BB_4WP;T%\=WD[%F4#COKZE!A*.9M6W/EL
MR.<IT^&,;9-_UYM^49FJD_[AYLT>X!= #HV9/G6*#[.$9?$QP-@"6VQYSPP+
M9^>\<'."6S1CFZ5;U,)T3I$CI&V9(2_$@G23[ "XD>IV/9J=B'MM-(5O<6>L
M_4J9IA[XG?K,(G.-4$Z]#@CCT&%DE"=NBP&P[?#2/]D<I)IR)DQ=^ 2'V)N8
MM=+HCO&T&K*[VN@! J)69/,6"Y;%E*'?85^WBI' L30.6+ E*2O6#3_$Y6II
M-N>J\:BYQW%,PKOINP)BY^(EZ\@S[Q-[9'<X:<P_Z,XJWD!DV#A!%]FA!ZU)
MD]CSNU+KGM2G2.XXB$;*[OLJM.I-176^!<=H*T80MOD=OY?/P;<R-_]6@1%/
M%=F5U.E>T]>;'E<\F[B<\SZB*D#H#HP,TF$H=H/^Y,/#/$T[R:YX7IU:0(^8
MI:]0,\32_A+C,K[8D.3M,16@IU15K'W)F> \\C'M8JBV$M!M8A7=.Y= @TQC
M/S\U-_=[7@,=O8EZ(THT0P.2;!TWA176.OUI9XBM7YY>D% ^ G4TMK@;"N><
M"NG[W=2T)_?\F:E$LOW(<4:18/#S%NB#B$G1V-05B9\<]^=%)C['B9(S-^X4
M[CT[$S2!H7(FDX/K7HM#7R,9^GJ^:"//K@QVL9D_E4"_\H$*TY_@C<%]!)^I
M*?^EUIVE2:P/;9;%03F!R^Z;&Q[-X/S._%Y?E+>0Z?F1CN($/J-WW0%G==I[
MM!N1#TO-[CP^:+*KV=OG%GUJ[JJ8 56AZ<V#.8[_#IVB2@+<?B3EQR3NKUJG
MJVMB:,;/)F\H/G6^_-SJC_;))HU*WW:=6SYCZ30$&%<.K6<+1;J: E)+T22&
MMOHIF^5P.-@MO\UC(+<N?[U=V>B2_M)#+RWWG%=E^K>^E8^7 ZI[78W+46!<
MNL##H*;'!F[Y:VGD= M#HQ?C&G5<:/R%FF(&]X:-&,ITC,J7U^42"S\G)LF6
ME"S,U0)S==<J8[N2THT#$6[*<??U6MD0L]O8WU1ETL/&S2_9-IT^A=/]>?;6
M+4D_WGU)=T[D6[2"QW6B[G.2TJC"]+B(67]-QQG3G;[2J5C-'5;8NUX7I0BZ
M4^V_1;:5[#+%_/D2%2ZS^E4\^R]VS7.X(]-JK+B .WL%.8G]LE]")[6<=,Q,
M@(M/(!WI#%'TE&T7A ?#=8F7//)W>R7MWN.-),)ZHTGEAY/[ES*6_&Z87_OD
M1,!,YW0+3%$YZ8X\YD.RZ XZLSCYVH\@6.H_JC\</BZG^"55VIY'G47"Z&;8
MMU-PF#J#"N7P\587ZJT6)_ C1R%C@8T9".BV";K0[_;5I0)[)Y>H;_ H$FRX
MFO?A#G>!1?)<NDO)WOHZIBS_'\DLWL HS<!^]9"FUV_/_Q\YB'G)R8F:8 IX
M1>0B4+Y0TN_WSOH(]&)V)<@CM@FE]J Q2\6*<'>J?X<9G:*D7_[]+9#C31%#
MMK\"XV6 ;P2I6K=R%J#*",6Q2O8WJ=A*XK$6D7J@'.C\O*.07R8GC@0=[J6+
MMK L%N!2SH\"0+%#BY\8@5;>3[)U3G\L %=2VXNY5\RX)];H:@7WDV$U9-][
M7EHRM56_LA>3*L,U8Y80;QN"%&^C'J=X! /\>.CO6&W@1R%L8?U8AQ@7UJ7D
MKQZ!?DV_"<E?M/%SIH:'#C:HCL4/\$&3RV71G4;@F8RV"F2[A^!"[&-746(H
MLL-6A:Y&$'WSR-\V:F^-%D..0 26>L'*'N5NI/Z_A_AK-84^-BP[5^K_TFSW
M:2?I$RY+*;=36]D3<:3(TGYA6)'NR!-86 8>%87!7QG^-T,>4_! M/LY+<Y^
M]>[[4450_X6_'/?G)$95^=UMZCNZZ"A5\51;F.IH$KT9\/L?\T=J^:9G@VP3
M:9M.'4^4S_3)REV140^B35YKM%,\F/FG_,7:O&3C O689/X0)1J+ E+0=NR,
M)&XKLOD$/L3?V+1K6O'MQI3MB,>_I@_&-2Y"7H8">G%W%GQ.O$VL$EQ#_1B:
M%B0' L>%RR\>MKC3Q&"F]QO'-5D5G[M+FCUWD?,3Y#<=>OH*)ZKP *,X\.8;
M]Y0Z]R'+HQ"H7@WI[,=;\8>E+;N9HWQ+]0U1!ES%026R)\]I1=1V+C'%&ZCW
MD%)7FFBJT,0\.?."*Z-[]BM'H$[1<]1+]&ZBD"]0(C"9FT<@CK6#Y=>[3_F4
M7=*FY><6/-O[>N5K7HF?3V#F&M0[]2FX?OWXS\(%8N_&2O':&(RW4^LZJJ-1
M0)>W*Z@LJ\Y2X_V@[37;"!_Q%"9FX<_G0[T3LXJQ9#9 V.5KO*[H&S#3LW'N
M^MA<8FI6]=E=[**3UG[Y@XJ*-T95$=.3?.X;&\-Z7&87[\7?;GMT*A2$.V$U
MF<5?L)Z]M42F@E6=S!^Z;TKN/)\ XNFR3IAZ?ASSHGQ&$+_7NW6NJ*)A,HLG
M?>G::YZ29]]'FAQ$$9?8UY(7;R%FI[KHT?$1^.POVA1&0(N1-@1^4=LBL%0'
M=R*HPNI;T3F_9&5]J*+.21;GGF;Y9&FLI$SZEA3Y5F/R8MH?_BE!I&.'5S&X
M!/J4[*(CCT!58;"I'I'GK6"@&ZD8KZE]/8=59&TI0M/O0<4^\A+EZ\^K&I")
M">',3T$AN9;$GLI.IG,C7$\?W6X#/4SIM<DI4E,;7RY2D[YQ-3M&5LD4A<1]
MQA MRU\CJSTB2;SXH:AFJ+=HE^RM"U9GH\\FADB@Y ?R 2Z32]MG%U,$K]R7
MDM2,@RQ J1R\Y FBY_H-BKLQ84C$;M9E7G#25[:4)_A[J42C:H1UZ2)$6N1Q
MV9/VZ:^!E()"6DIAN05;0IYA7-$KM0%,RWXP9LE_I/L.U^P-^Z9CV;J#_9U#
M+B2*;H03?\&:\(-TE<S(&VFS9*0=0):--9W/5U/XL1 /?%_V8"L-XN:"9,A"
MYV8._JDONOV%4R@OD>TF6ART-HN5233[;N:=J4>3[L^;*BJKQYR^):VPOT/X
M0>5?=7K^[$S.^C2%1U(YFL@[1/0ZA.*[.J])VH%>B23("^P992V-_OI)'E+I
MXBSY,)7T+9+!6<)C!3J:POWWJ7=-X6B*VMG]^DFL?Z2=T#WI]O:>/2P48) D
MWEPX+B/FC W74(QO%H<?I$5J:GLHO"RSG]<7N/=#*#?F:RZ[GG@M4O4(5+&W
M,5-(CRUT/_=D">Z=3!< 8DU2RGU+GPUY&P@,VGZ82U?[FR"1(,9\DFUNP5_O
MWPKT#8;HJ8!R(; !,@%=:[(4V^"UF^6,JZ2!,UUW]/,LBJP6K:W8M?^I3*3T
M<>39FT/B4]-6RBU><F5_,:O-J].B'2?!$-*C7 5B.XASG013SK)*[]IGPWH1
M6Q+CE_U[Q,VCAGE^]![,&_LDTCKL%>APBT:,S?,# R2,00,1VHDY%^[)"-=L
M.K'+'#XKNB& (G:-7M5UAGA/%\;ICC6M0T\B?H@R(7AAN6M9_( #<:^S<>:"
MR9<\X-7@X-_D3S2R>J=/,K8EB-NKV5C# W@^MCDW_6_,U&[0TYWOYHAQ(&9X
M!SW=2?8:1;J!?]=W8UEV(]U";G8+!-9PBFVJ5DE;7WK/2KFLCQ4F+\10%0^3
MZ".-BH$2/8] &T_+86X$R;>U@EL,:YMBX^YXPBUM<<F^ELJ/%0EMU_J2E 3=
MW)\P'8'N3,0OH"/M10%TMNI'@AV#+HDGO=>[9GP]IRD4;9<D#1TM84@@/TB1
M25QZ6P\M%A'E_,'+*-O]3TN%+KC?Q" =@\L9Z:^MC_/[Y5GWQT4>WS\&,]T+
MD'LA1#X"V:*"Z$S]MR!Y= KLXLD,Z^S5F.J<0^*'.D.NJ*3=;9PB7%M-;Y9"
M2>R9>GR[UL7;_XO7^Z46(XYUIPU=V=LA&MXX'I06@>"FJA$W<S@9C$H5.U4M
M?<19M=F$GKX6^5:N_]5UO'-Z//O0EOH5<S/QAGGM9_0 .A1)]#*E<B'QR UL
M$5QU#,&_FI8^5__&UCQXYO?+%]7QT[@9F6*Y[V5>%R4EV)IOR?Z#TAB/PZ %
M "9-X9"O6X56IA=WZQ,TI7%K#D4K8RMI)]AM;+,?*QFR]_3E/H>W53P--;E-
M28WY6QJ?I\'Q^?.4_/I^T]Z>L>NS2S*&:;)C[DB<Z!LT$7I<>P3;,303VV%_
MFHCMO.7P8'*JLS%^<3+'6S5#_I/F5Q>>H1N/!KTO47+BG+(8II!$W2U UJF]
M"?/;H0W#7"OO8#Y"=<0=@5A-/.67QB23>"/Z>%.MS?4GWJ,N\Q.]>D^#3$X<
M2F47YVO$5:S115ZM:<81J);QF4OC<3.&:">H!\CV=G#]?V0)G4$1>#NW $N-
MC=ZHKW!E!]_ZM/B"6>L>B93AMX\R.7Z<4#*9A7>>WH$6B1+OHP$9MG;4M!M^
M[S5"! ;MVKL [)@29\_NZ* -FZ(W:$-"+@HOK@6R1(@+/K_!L(:J^%M$'PSS
MM\Z%*OW!6AZ'A]AMI@]1AND%??]FZ$C0A2%ZM=9,0Z@7IGJ&ORYQ%-JO3'9K
M'X$>:TT(92"W19 XE6TP59#>T#-"=#4@BK. 2Y,BH\JN@_F!Y)X3OL$OQA3*
MQ,=M5IY$7+:^%#_!]D$5??4S/X/Z#]&JAP_'>NZH.T5^\@P(+O <23Y_[Q&O
MKE'I'IU>(H2.:]5A<&@P._@Y>N8,QD4TO"Y@S^8RK3#K4E-#]=N!*Z^+2O:3
M- L9#J*M>&<1CYMR'.*QYK0^-/'54+MBU/SI2FC,!5<T*]7LO&':KS$/%1:M
MP)-QS?(>5?ITSNQ[VK<_9.'@]M^J'%DIQZ=AY[Z+-3=9'T;0& '48W>+!\ M
M8MT1R/S%O,>FIO13N<7J3UO.L4Z:RRH%4T6/\@1@'^H6JDT&>] V;W%?K.UG
M5+[AD"Q@7$6ZWH8;Z<T](KH->@HH[YU4<KVF5P[+WS%--AFY;GOUKB'ESXGY
M9Z_#=/L^/L,$)T*='BFR IXFQ(CXLYFY*V0;>[2K:J>;R\G.\W=O=&2',FB%
ME4VQN&ACYGKZ)[<.]H5J+_,<=C_G,M-Y]N+_V$7Q/]U^BUGK_2S&FIEDATK-
MP3P&=PZ?RP*6?O1/7^F/#X\L(@;T)Q^XF6>(G*"EG  NY592,,#?LM$8A;8%
M J"8VX78^BNS6]_)HC![!"H>\'UHYG_6KSQ<SEUKG;FWU"YA4EVO+P:C;6YV
M^PP7W?0^C:>0D!O=!# *?0KNCIL98J$^&=[X!XV:!U<0\_(SP6&?/_YS5NC*
M!7]Z\7- -&5686-.5];0=W:Q+]V^_I!%>FS9_S[EADTF] )B!%S#T&7ZJYPP
MU"8,[LE2FX"'L,74EOJSF(NR =9/ODU.^.ZZR>IO.+@P^GWZH]28\*I+)ME^
MAJA')A)1W?OPIXXA!;"T-HWE4'F+!U,U*!ZK>(W5GH&1.07@A5YH%';9\B+7
MQ86X\4)C'2-?2M"O5]FC2[8BTQ"QY,U2^!I.$9!&O8%[$Q19.M7":>(PSTZ:
M2J.1(@N0\7C89DAW<ND=)Y.>]#/2?ML+<25=B06A=ZQ35*[@A8(HC)/HKV""
M: )<6J7T>-=JP>7NN/JKS%$YB?GQ2M^]!",TS<G*Y@_<+"^;/.Z[->1U)=Q^
MEX3J045CA3'/H*Q 0*^6#!".!T>W<C1/79\3A8RRA4?$%TH$U'/,?*U+ZKU9
M\D-0GZ]G94=*_>)4">!&8V+!B_(B1H/H^-(BJ4UJS2.P,;K>-9E2O#C*[!*D
MKOK#*WG(I^G9/3Q9D91JN>\?/[X8F33AVE1^J5%ISK49%7CJ;$95J]L8&%>$
M.#6^*;?+!NC1+FKCA(T>V"F-]28[W\\2:/B8MVWVEM+<SMS_UGKZ&L<SK9?L
M;CX$))6+N;,5!)04PQ3UB*@NTRC[B\3U:Z;E.GAY7LJ=6XR.=J2OV\K9^W'H
MJ]',^A &3W%I_*KDBP\M<101HCA_ 61 G,942?Q&%V6R1Z#8?CJIDJ1>"O*,
MU@O/3ZFILRVOR7C[!A:*5GX2P'_:$Q?_D5!/8Z5A6X6!<E+$3%O:/"<0C@-S
MK-:9K]I<%Y$=,<EJ7*RQA4_5/UEGONCX(I[<8)'4XK4869@R[>#K>MD?%9#K
M. ?5@,72F,SPY6=@58*>[#!>0GTD7%FK(OT"K-J"N&#KG+VRM.TPNTYSO;?]
M+E;V'GNJ$&ZI#/Z43CVB8)YX<&_\77PFYBU"#-;?<X!(<2]5S< /\&[D;;QP
MX3)H;LP^<PU?G[(XKD#P8GMJX188^VM@'878_E9P(H:8J4ACDB5./3C\N*DE
M:QQ8_ N&&-RO"<X0+-5X.($;GS1C'(O_?/:NW]*[,)5!@]-"/E:\=&YN@68!
M'#KL+T]0C8E[A.4W8QUU'&Z\[]RT!+>%UT5\PS<3)W6C4\7PN7<(.@]ZGTZ[
M! MD?@CFWW!84?KX<MC6T8N.O"ZB;/!;I,A07W[$[R)7Z(7RK"'=F(YKJG\2
MSC:D+OYXPG,Z7MN)?W$89,2$/P*YHZ=-N[ ,FYK,.&SD@7U:,5P?^%)LD.>,
MG(Y;,!ESB* K"3).<G"DDV^PN]W?D9\KQ\3<17%U)N;ZGSF4_XLO$.Z=K4ZV
M"&P-;RA-S'G/7A(HPI6+P&R689.E$L2BD<V7NAV/UA=C(.=/A3+]U%J1]-=3
M5Z+'"6N$<*]0>L=?40X)((![CQP,[%]G\&21"X-*_%C>W-%\+?G=B6/?FB;G
M8VR6[!_90I=HIUV3D6=;(\?OO<BH:F98X*5RF=(#+2-"K9](F.G L&NZ+%P>
MP4WEC%%5<F*W-$8AB9KMEQ+-[KS_\\ULY[-Y%\[[.+N@U5!D$#:\O+:%K?T(
MQ$/5R07\A(#LI<Z.I"I 9[@B57!X/=>(SWPPD9&I?& XKC:R<&)4X(M9R:^#
M?D<IOO*SP&]ZV.0F\K9+ K!J6R"Y:X!D/NJ&8>[%SZG4,JH\2>P6RQ9[%Z!Q
M/^_5R5"^:BG^$C"=^7DBF:@F6@J5&=JDWG"J!2[X1+'K//^D+R36BN<K7R[Q
M+K^W5X)9RGVYWT]K<+B'%('4%DS)S YO56:YPZS^G/%O>TYB"9DZ3!.CVHW"
M.4M@B@2]SCF?KM2QN;\&A!;>]6MK+DR1*4_] D[>NR/40WFLJ%YV\_CD5!WL
MRN!RC^CO5@:@EF D&MF8MY1"<+^K3QSY5C-B/]'W?9/V9+Y)&ZXKW/$T)B[4
MY4%1L(1(3\"O@\\*+.>]9/LU&2A/8& "N'M.N?W@\9ZRG1N-.[+'1GXO]4Q"
M=8$^GOGV?K\&3UPC]YE[48%#?%K7#HLV$1?AR@!:K=-.[<$X72D>E/R5][[\
M.6E^:?MZ? '/*M_'YO*KXD(@H:N=[A=[JU,'F'_WOP@.%;UUDWL17+D73W4D
M,>"Y6W,62L$4L*W+GS@VV?Z='+[.A==37N=!EDSGOM_0*C4T6_1_]O[ENIJC
M^GDFJ2*)<]_S/VQ+CS\X]4AU+&J Z\&I^[XR[@7_>\#Z3TS(GB[N)%GP4 IO
M+>I0>G2MINR_VR%I6:O%=X#XNMZ-9$T#H+2TBW2Q*A[W_UF=NO\!*REU)K>*
MC93]H_RR) P>\-9G71F4B!\OD>[5#--!*% %  C)A\:R?UBA:58"#H,;D&1Q
MR#AN]TT5>=93UZ.9;K8T5\F0A+NT<\VKW'59*= OHK7O(?:\7"O2VB4]MCE!
M*K.<L1!37[AU#K*]#5-]MC[O;&R/R$6!3K;]D_28)%]D$-+@=U]"G@<_1*WI
M%7;K!KM\TU)%MGODC<$9\*:G@0PZN6Y3WW)HFJ3J$)J@E:L:1-T^.9[<S>=\
MLSDI<ES59<,%_PYB&IZYC,+_?2G7G=OX^Q4CF*#RA6' 1&._B1:U<+S=[[6]
M\.''UO- 0!N"L]8-S :\&'BYP3'C&\<@MXGMVNS^B/)_YE:9'4-XGQ'P@J5N
MLR-&*O?B?W*\]-1.SH(3E7=IB.Q^6$.[!%<D27:*\K@%(6*O^\\+H>_4SH44
M_KP$57&,@3P8^5C_,E6.^F&?;SL$36/L)K[IS;I"\HQ':,+M1BPZYV\!J4_K
MQGS5^HWP\3PG:"CGWY0J94Z)-Z#4]B>",EH5V4TRSR[]Z#<1*LW-:-GR[#LT
MB;9$*<J)>QR$<YD]=E+_OQ8XP"'K&#9&_"C2;CR-[JAV5#R:2U%Q76";D2J(
MSRE<(;8NF9W?*5F2O/SJMNXE*R$A D88B4NNH#H?AF%>ME@0P+%@)S J:"FM
MW(4WR&XVR"G,TWA<UP6'_JD#&Q%D.<<GUZR"O#T.^1+9JYMRP^(!1O6@NCCA
MTAU6H:;-5^"3"'GZG/X#('FP$AH'FA=VD_+(#E.E:5J =%JM"[9+YM3^5L=9
M[_5GT4ID=\I,Q\MP8$YH*.3D_\-@_R^S\C.'C5KG -2""Z Q+UP=L0Z[2WB!
M(MB9_LQ\MOW2O;LMI6>K6>\#1NK/<LQ>\;5'_.K]'[GYU9MRVNAB>RA,Y"*0
M2($BAEH5QE[B&H:IIY"ELVY*S7VE'O4:WF$7"@-?/5??#_(KDUU KS\M@P<<
M%M#D[>R45EHY@#?$&-'3=XMZQ6HJ[3.:>I\]&R04)NO^UE03O^6V)F06,ZJ2
MQ^TXC8T_ BGE6!IB Q9\=J9P!>MW"2N[X%, M!=]=JM,CJH<X*B:1Y!N55P-
M:+R^\>(1X5OM6+HE4OEG@II5GLZ]/QYMW/\*J%QIN,@HI/,1Z!>4H!:F*>LF
MO!4%-RBX7/M>Z;%\X_<.V.SBKU",3.6/6R5SE=K\Q44QG_*+;TV5E]NFR&S[
M6*RB,A''?QN4$ (PO>X@WJA:'E)];*TG6U]:NBM0T!T44>N9/UM(</Z291FE
MC^F8,;#/84AW:F/[76)#[.UBFS:CZKBF:D"[3;E"JN\WU&?:6W_-T*^M<5)?
MY#,0:K!LWYIOC<_A+_);V@K [!<<7%@SWAP: (=CB2;E? "D34"T \E-O=Q*
M2HC,K]&PFXJ.[!XP&;LS?OWO'[Z4FDIIV.)VF]:=WD7/4^=Y"W)<:5=(;.N1
M% CU,12TAF'0-'9<B)V!<JP>J,5HVE\7-NV8*G41TG)#*T U)O4)>J>8^L.4
M?-(I'\Y#.$F*9%? AY1C4=]"0H5J<A+Z^Q^<5E[3$"ZE5KP>EC6,T\/;:MIF
M'!+&RI>QVY7EDS?0+95$WO4?1' /IB:-RIGZH@)E-%7+$K"02 ILIFO.>Q7C
M+Y],9:<'EWA+7N&Q<G1N7WS/FCLUA1:E,<,B>Z%UBFUHOA7_BOXO (^Q[QIG
M33$*U%C)<;>6[>>^=QAO@84]-L_%LI$GP]/)P<W3R<F-+X;O8IR>D-39D\5Q
M(-!?!FX';NYKYN_WD[: &%BD-'2*!%9$*"$ZL,((*:KD!/5&*4SO,4DO(9]T
M/BB\-\Y3Z_+@]9 [(RK7,\^TIBV=6WAZLC@J-]I,]0)_A@?B.Y&![MCLSF"B
M&5LTE+WL*QYZ'DAN/Q!)?/KJBF624:S+EKVC]-[[,^G*R>U#PK+SE3J<W29F
MBRY^5'?:G92 RYYK!\. $^0P'"$&A6N2%@?19^-=""TW%]YBN)HEW9 ^C;U6
MX:>U+V4F>\<.0*^?U)9JMXHAL[%2S4GE71EV0?T+:IT8)NHUP*_(I=<@T0_*
M/8.=74U3.]TS@I([9\D3_U%W:8<_JB/![:]K-^D(U.G)2H40NPXD8WQ9>+L:
MY4<L5")*'+@7O^:9Z/[]8VGQYOMWPON2;Y@09/H_WKHE (-O88M&XI+ YW>Q
M?$"&%2D@JC86RND,97KV#; C4A[&W)4+2LUP]^T))O9&!)Z<L4U['"8W<WJI
M98$\=YBI:48RI[0AU('@P+QIJBX *38J=B:ZAJ>93N"S.,],O%\/K7&3<UI\
M=ZHRQ>3<0+!GA*9\'B#>20XRB<W_Y2)@B>:+F.SKFY/?V'CG>R\>],CL+X@;
M$4T0+-H0/U0$+FD,#&6*J@-&!'"O9USKI?IA.ML/T %\\#>C%"Y.^<EB>.\6
M/?Z)8A8K?>__8Z^^XN:2;/AI]Q\+G4\.LS#.+,IDF63RT\BV5JX,77=AJCAO
MEWBY;IVXP<M><D3%[^7#K[>]*^!93@,8[H,3,=?N=-DZEQT&4(Y N--NMO=2
M6H,/EP?!#'0=9N>#3]L8*H=5KZ])OK7%#\;B[;1VEW6S7#84% 1TGE,Z_\ &
M@RZ8YCTX1-.OQG##&'"8#98<5W^>BE51]F9'0HB#GDZ#'J_J5&7Q3/4[K_#*
M,,&4+:@)(>XAQ>46%7/2SAK<202K4:$X=+0H"!Y,876V 4?ZNKOUVK,0(RJ=
M0K+G5F4]A:>2"ZR[O<]#+EF;/WZ>DUB1TGY1:"K'#7L"<1,.)PUUH6+D'?*H
MHJ24WL[]9DY<O*9KY:K: R,)K'-P?U/4^YZW#??B+1#MWU":HE4J; PK&O51
M-8?/UHS&/&K=+SL:"?YV3]R42WUP.DSZW.SKCM!V_5G0H+>-5>GE&(]INA9M
M_U8P>=W2Z"  K-7*AO@NRG'E\*L6(]"Q@,=&-4OGP7A"M*G:@031:&58^NJV
M];_]2]:7HA>35$RO;J_5SL#Z9$J#D>L_*!JP''Q!&S9>0*3<P=.S"#;639.<
M^/=]U#?10W[++KZI4DC:4?S2-_O=?W52W<;W'^9_/0*5>G!V&=H>@6QFJ;\!
MRI=5=%7D^C7BV36#<;B:)^4NG..-P<@Z7-/OW%+#A/T!=R7:Y#>_W,I%O_?L
MUV@)@NJG473H>0X.]:;]Q%;W1F@**6C-A138\M<:32[N"NY_& CPZOV6%)#X
M;?=4K:\-J@U[>O4(=$&^V3& SL.8[6"M YHE(:_<KS",?[[OX/J8:X?K26+H
MKZ7&=U>EBFS3F<"JQH:?1LRT$YRS8Y:O,4EEA_Z_-?668)J)8 >&K.@F>F"1
M-^7R^+\CVJ6N\&O_#JU_Q]"$%8F80P5M'2Y+/;[_FSI/_V7__[<3?6L"\A.]
M/4.LJ]+,M?%ET44SQE<IE3\D#H+%T/X<^GJ4B,9BJ>+W94D;1R!6-_.23PZ\
MY$<8GB/0@^P8F?MA_\EQMO^R_[+_LO_9)JO<8Z\RTBH$V.\])K&6YCMK*&2(
M9@04NJH9N+FY?CSEFW2#*4?B?!+#=<_L4R8Q) P *UBGTPN=*1R6QI/N>002
M*3<"D"3>SB,0#US<A<#&M#:M%ETC?!?YVT]>AGRS_V9FPDCK#X<7NM.K?5XF
M_/J:;R R/C'-R3J&2K8Y+V*D"B6DLK^5QR %-$6)RIW#J_.J)*>(9N'<V<?R
MN9#&I8*S:$^YGU_7+OQ0EDF326C7_G&NE^]LNG'318,6CM$1JT94%XKU+^V$
M)_?<VK1\>?CH3U?YK\8A%US67CY4_S1HV[_=]ZY]S[V=03W_.)$''AVGQ1UI
M1T1%U2AR_4UC)747NO"2H#;?O_M7?:U4OB2C??I4.U]!WT8PZY"/?TP!@8W#
MA79AQ$-%WO)@Z/[8U[&?6:N;CA%\O)2?ZW<*]ZXT8"..0+5.'5MQZ107+78@
M&2?*[9H89C.D1SJ3M]L1RGA#/_<%[M1,Y1==8[N+B^YVPKM<#P,"O*UL?FAN
MZYUG_Y)D(/&D1.!UDH$FB.&&BIA$=K,G342:HG4$&O$#U(Y X?D91Z#>DG&J
M] *+9&\Z2VO)E]5T_]J\.99A>ZO9O.[FS@D[1DLJR^.B0? %YR)=(U_G$1WN
MT^'_L>@%2:>-8VOIE!KSJP2_BXYIO0+$TC@RS]*AUEB&N;SB\7Q@FJ)0U==@
M^87$'G-^5L(7Q&,GB5-F<;G[S\IZ^>K648;9A8!3ES_B&G$>7;)2'9)C.B&?
MTUR;YB"9P14C+.@&ZI31;@<E$,H?1OVO7A'[7V\-1R .Q/#\"6)DEYLHP^J\
M.A&11MAX(%T]O+F;X>PG6_&;>7&F.EK4GU6U:) M3[V[)2(Y6#B<NP]N"6SA
MD*\%_$J7$S0=\:9G?V/UG]6A[29*__W=%#J?HOMQ7/G$X%EC/P.QOIB^]I0(
M;8:+,3?LRF1O=6?'2/^WX&L%Y:1)_,4R((3=$+(D;ES%,/6FH\*7$*\'F)3S
MKM91CTY7MN% !II,?S".BM-#[>"ZM Y9I"# 8-8P7B,;_:=N[E;)3#]7Y2<E
M)?73'+WB%\.NNK9\^A:X4?#JF]VWTB\K#\UT#"[I<*<M0(7^HEG@\H%E,)35
M*!6<O;(JLO9@O&RAMK;._$[8]O<[A7*W?X@GG1'\&SK^G[CTF"8CB4$;*,#;
MV@5T"BRA"+=8 4[W0I> Q'F;69!A9E*/H2H?NY?).;&RA\O"S]-ES)+F!+G,
M=+0OZ7 ]./%_&O>?(Q ?V$,T''M"2P5F@<?&:IH=)B^("G[HB2V@2YFY(3)6
MR>("@BR5+M%?)'I3X5IRKXK9V]P-[E<Y/'.):UR/C(/M*XEED<'%KFFIZ1X9
M^6U[D(  "[FK-ATQUG\2?X4_?'0Z50)TXLHW]-LC4(TI'>E0SP" M]>>E?1Y
MS#^DXJ_-1%T>V6[_]U*@PHR:^TLG_ND0J45W^VFFP:F; K*)0"7E-HP-)U_[
M:5Z#5/\6SLN:.YB:Y-;8W?JI_OX'.7%EC0C9;Z_.>C<$37VBOCP"A27"18 S
M!,_(1OL6PO?+R818O2/0N=V>3$[H]+R>N$RO6B;[\^W,S#L-$D++GR4>.@]"
MF5YZ%TB_1/EF-Z?/D/\ M@$4B\=P;E2W8.L5FYG2\48ULCNVG_-.<L0.M?SB
MDIIE6[+F0J%8RXO\!^_=?Y:&(+2E:AOI7#[W7?;_R.);*YC>^&*ZR'KD <:E
M!Z$[@V^"(Y7@=QJ!:'GJU6Z1^L-T\M9+]Y.%HDX9/Y4$/X/VO:M;-S7=S.FW
M'8%@:;BTJ'](P%ZT6K3+].T\_Z2'UH!(]:V%N>)ZRZY7-FV"SOLQ):EM$M(]
M;(Z:K2WZTAT:MVIM9OKV-,3#2Z2*=)RI(P=&.O"F(] 9.?H3TW[16P+&.&+/
M4Q^,P979NN35NC4&RCZZ<=E@R'!W[NZ\@;['<JWWFUY;@9AKGAM\BGM"Q9;0
M[VEKU0 @7UP05X 4RA7J72+TM8I:-,3>SJQ,7,SLFRJC'#X^]HJU=DJ  ^J!
M>1ND2 0F?POR9ZXCBR=WZCJ$@!J3D5U&3T?2F/@_4UGH#0G&(H:S^,8@O?:B
M"?VFXW+R9_!CM#GNN;F6AI\1-\Z_S$(8OI>4>HC;UK(ALE%Y!1?0W6 &%]HE
M(G;==&'#Y^[$LYVO6^O-VM<G]Z23U,3+,B+X3S\/,B]X76JN.6(CZ6YC0Y[X
M<I?%W.BCHOPH=6BT478!.L- 8ZHM0_1@*I"AM&NP9#P+56 Y=A=V/7:(T7[-
MV-$[1_.=W4#:Q](/E2?'6?(O#WVD=W]?ZWB#X6E7-%LM&]L\W/GP$T(,+D7T
MC+;FZ>_2Q>\R0UB;4BK(PV?M<J_]^CGSZD[]'7S:U*? ','->CNUND9JI)"\
MM6P>D/,O)H:$GMXA]_Q'(OA?35!@('>%3%,9K2G5F'I854^?[?41UW>S1DRZ
M*^H&5_->L++V?!?9YZ#]P-8EI%%T:%V-HCT#KWJP[0*J>?ESKO7#IB'DPG\-
M\HL?A=,]%6ZUR5VNKG!0;^\QT>J 9XU.VV.UYGX>'@-5WL;.K>(8ZGCC$>C-
MV]URH1]E;E!FS MD-)(#(0SSAQ@-<79>3R5E2RI*I@E_[0.9HEG$JHK.A/F@
M\FC'96(,X6#*(UHWXB)02RSH;.R-4S$^.>^(9.395I%LC>>F?3>4:U#@-VPL
M"6/U?G=[,O]LBTI@;[\?L%;P<]3*IA*21&NFP(?RI,K[H;%(HM=0-UMH>E:D
MTP+T-UNW/7<CZ7HY:S)/ 2%0'FWF>RW"ZHU+I_=9J_93^;N[Y468IZ8S!83R
M#5,2+V2$&DQ1!YIPDQD%*_ED[,.)\L6&&#)4A7-]56"47=!->=D;SR;<690V
M5< :>-GS$>VIIKQ^;[J1Z2.:T_A[2!M8&(EKLCPP[9USPP^UF[Y!* $[I8#=
MGU@KM.Y'?&T][ >$H\;+9%2F0K:YN,B#JTY;J^@XP3+=72MABC0FYL*U5N%(
MG4E-%A)#!ZZU")_Y^(VW@.S;@/B*O(X;Y_ I_ ;\9N]<G5Z7\P4;Z)FNY?\U
M[WP4%S@]?$ ??<IA$1)71Y,#Q"F^0 $.2I]NIPT'0L(W?$-IOH'O$'L-A#=:
M_CWORXZYEWDR[*8UF<LW?7J\U##/10'YS,A>Q>D7;&\P%V@\0 FNO.N6MD_!
M+]>=C*BRC*>)#G(C=_X.\<U^1+DYG*AZJ*+9VAA9LS@Z-><^/]5 *X&DI4_;
M4$I;U+26LF-DXY;_8XUB/XW&+'D$DFH'!HY 3SB/0#D.Y?DE2U! #DW-85A0
M.PPUI<4G-%Y%]T864P><D1>T"JE]QX>"D9T8##ZN6? (Q-Q$X\ "UD>@%<P,
MU)4VM8-<.%CX/I1(*0?VMKWKZY0'W=:1T]5DXO 1")<ARJ)UCBIY^*F9%W]X
M9X$0L$65%BD)O*ZA$E\[3M!)U4O228RK?IS:J=^D_4Q__R'5E#[R)/H+W])Z
MD*>0#MAS,%M";WO+S6X$>)0V<UA4W(^S4[8(+E<B$ZQ\O)4915\J7H!C SQ&
MVKC_,5"Y!,F9@"GE/FT(? ;^M)AZ8E+3@J+AQC$[?9=@=\NF$T*4KF\,OL%Q
ML;Y/CX/G[R-K:KT5*:Z0>XL@]>T9.)!??6[SWYJ;O)8AQ3FHMJ@>@C5WW0HH
M2*F[-8-+VRBE6#VF&I,B.\%1V),U38J\"F\" _%0[K^I :.P.\L/C""IT_.K
M_@&/$O28PIO_/>GT&'[,<7R^D%VQ2U3PTN$W+36]_+\(QHR[XYK&)X!DN5&C
MY96D:+^[['1H"#IA<>V3,,$TQ>++CYM0HAZ8?>VXRN+%AE'$20!%2(NFHX?4
MO]\9D+3N8NR+VHSO#@+M[]CU%313SCR2N+:?\9JY@8[Q8:9P1-UA# 97B!75
MX@9V.FE7*DF2W4.\7>F7$H:O7]3Q*?Q^.?%CY&;6S?>.ON?/,4QG^XY?LOPD
M5D;(K-TJBU]QWQC^>#=5.<[\-[BWWF1Y70?A2D>",>@VJISA"/3[3M41:,RC
M &I":\,2S4I%R< D3<)J!<%&,@U_#GB77$EY-=ULF+WQZ:?6XY#?O#]N+FA^
MAFV;;&K.T)C7*#(P-+GR,%2A9HMAQ6<M:"O<K\F30Z=@IB@XMB9&&I_XS&SO
MDY[73]ZD.^].O(2DO8G-B0TKR4NGF@AI^*YUFQH;8)Q1^[<3\HY S\.FCD#&
M(Y9@JF FW9NKB.C#\%K30]FDUKM ,GW8LH81TLAV%0MR\ A""'XO8^',<G@I
MG-\[+_/Z]:O?$_4\)7+<]GMEFE(T/]^]RO"ZX5"<R$MP7Z:R+]/.[>+H3AZE
MQ3FU._#"_4'^E[R5&;65)*R1YNIEGQ2=>X]T-9<@CT1A#E5E(KE>F\GV_PJR
MMW(T9,R3<G&393;B272T_0@_LW $XJ+* RY%*V2-S5)BCO;X<@,I)2NYZ:?Y
M?9'[8PX7+VI[%:\WF?W9CYYOV&$[A^C%5F(V*&IAMF0GX /Z)$W26<TM*'&(
M9?:@=+"[[W,$8>547QPWM3]0-+YM^08T#XG+Q]:@-SB(R2: 'BD6+U_64@R7
M:0B;W.F99T?=JVW 4&[6^*#5X$JF[# ;?;N<)V+/S;T_32UCJ5R<"P$=2$!:
M-)[*YD:Y2N4G(5"DUWZ^&>;C<K[.-:.Q<5+O;9L4/U1M.-S<V.[2D]/>#_*2
MR<DY5^ &?3B1!HP-S[ ,KG1+NN_:*I*N( [^3NZI!NE\54N3#0SDDDJ>E;,W
M'[H(4G[[8R8Y.>Z3$[]*(LF)9@"-QJQS^QV!LNU;D21/*I<N%A>YD4SL)8>0
M&,*IIJ6PG!X-335.6,S@K )ZV3W1+@S]\9VF1!,KN_I@X*F_;+'@;4.J,1VU
M2LH/+^SB##]]'DNS,UML,)17&S^N&ALF0!L$5^WUH$)%5%L!8NL9VG3U%#SV
M[!1<W[<H=6I]I/+7:9)C0.I^A9?/P$MD^U6DL[ %^2Y)<2/-FXAZ< 1ZB\9#
M.^?$=JR):ZX(QT&T?!?D?JI'MX 2_-?ICU(/OHLQQ&>7(MLQQRFYH6'(.NPZ
M92'>AX"D0SK^RL1U)(=\?.X1:'J/;'__RK3D3-T\;)SZTT1?,JNA?%AQ!DEV
M)K*M5]+A+0?XC<=&MG*/:DKFU(=OY2<Q\]5]_+-=V:HGT8P*/;O\S LT>":$
M59G;&)+)$.AS_2O9II0N7,4GNRQ1M2EJ ?XUP?)UFF :X_%^'-?#+^"7+ $=
M"#&28@>&^:_HV9<;NY8D=%SIQN8%/OMIYH\YP8^2\!\=[%))K98O*Y//J#/W
M62/;G8] +N6H5A920;?BFR/0*:ID(9R7*+<COSA9[B/N&G"U(\S 3G565TWN
MWDT9G2O#O_K9W5KH@RP'5TQ;0%+9.RCM7G/R<?.*U:0KT<+]3CP;KZ;8(]67
M%Q6S;A PJJVL@$,[IBHKG. 9 :XQQF[8X9 \T_-#+%G1N!:3>6%QJ]?#TF9<
MW^^FO:21F'O%]',#^@HBOVC47@AKMBLM&=W<G,)N7[E>9.AC*+,R/;T1L@>^
M0SM.E^9'-?H,4R/#@(]X*!O,KI6;:H9QE^UV*=+13$]]'7CFIXL?EX_$#[[#
ML>J> 4X/CM2+)[F"CD ]IH 4!E4*QI5E,1QFPAER ,N=.PUCS\:IUH6NJLG]
M@<\R'+-TPG,R.<!>%>$*\3L_U<7?[-1W87Z=TB%!J8*+(?D M&->B[BQ%#-*
MO5TQVOQDV+1DVIA3;9KKP[,HKN"GUU#72MZM&N[$#-(!P+]9EN Y+4HP[1&=
MENPR\O0CR*[=A#*Z!"B7!"H9<3=?>9EE!:JT/A7W29G-M>>A%ZW/[UFKB...
M^RM,*L;[4]'HG_>C@$?K8>O"".T*O=?WD2]98/#;I(!0C),=N!/-@A#)K;=0
M2U@O_UH;;S-Z.2!P8\'EXM#F@I-4(27@S.Q&.Q$-R!Z!-BJ=Z#YR7 A/DJH"
MQ'OF&GR>LX?KA=%#NJD+?+'N6T2G!>0<(/@N_BOKB1,5@6=;78CSM;C#$(2J
M%6)L_@Q0N[ U;?AG#MFAYKP%J_P%?G\$:F7D*N11_W/V;@H,7CCEW./J*>SJ
MOX<E>@2\$8MXF&2D&&]^5^/-3Q/?_BFF$'*C: [39L&; A.OI/CTI D_XZ"F
M@]_"9IT=2K%&#Z<6U\IQB'AX,+V!N; FW%7@,E$15Q[FBQ6%/R$%A%]?JXTT
M^YC4:QHU[6&'M[GUTUQ:XIGC[:B,Z)L1:F"'(Q @@^E"7: -BZ@"DJ29MB"V
MUP@Y6,#=#-LQ<%5>H.^&F?C;^PZG!M+0<M$GK/5EJDY5IC$0P( 4G7.WE\$E
M#W-H'/!7DV) RA&("=TEPCKR=;?%J2U-# L9GI>_=='7FM_:X<P]#[70JE-B
MCJ8_;S'0&*MQ;&_0?$<@5U,.^&W CVU#FQ!!Q+SU$X(U]4(F(0(._9=K*@0-
MF.Z(>ADP&E<MR_R^79+<*R?/5K*3%Z*(:)[:"@ZTZ;V98_3;QS:?AD3BW*F,
M].Y/TB;I@KI@_0=A2!BFC-OJE+<1!<W./G9K+$J%N8M5)\Q=V<ZN"6Z_GBS%
M>5/CFWFIP-M91D^W.OJM_UP$/*D7YOL7ZHKP44B\7.O$'V*SB&A]H]B\NS%7
MZ\:R0L6YV^^(^M_O_XDHS\3@WF*WH[#3*%K#*O;@13G]8Z"( ^7DU.-:=39K
M]FQCGGX#=_%'H*Y,/;/FL5*QG2NI?4:"SU,?FNW<U.U0>J1]TPB-+RT([S3,
M>9N=G2/1N#YE%YQN&,^KQI-D:!#REU)R]_CD.6($6XWL/@)%\F!JTMJQC "T
M792K;'3H_OAUZ3\4RT^##J#!"(*7]>G*U+BH&<&8/T4V*UHWD>T0VG6XZ6$5
MW)KH1'X"'&<Y<$6R6>I,[4+99VO\2^0\*OL%3FB>\#>\C[P>_C$EZD&QL0]-
MB/[&-:"3W *T$+%M1Z#JH4[9F3E;\T8=TM=YF3$)U<;S-^(,'6 *O")6.]&!
MWI\N/GSAGK, GE8DP^L/WX!QV4@NA=9K4&H0$=,)%795"VJ-)D C;=[ZEP:]
M: A<2,#_,4_BNJ"AM&@'9:DI>6,]VM%A<;BHPF^K4]+:-'W8O#L;X_ML<:M;
MVM83[0EHH(NP1"-%0%JE=V,9C^%SGI<ASMJ?!S*(6#/: $D$Q96'MY07DTO<
MO!PA(FWV+G7ZQU[44Z@59-F4R@[%'8$Z9P0Q,5#VYE,Y\%?5U:3+ZZJQ)?"[
M#34?@ 05)4./+U<[!3UWA+O"T[7[V!=CBVFQ$%3"VTOV9OE?F^"UZM?,XEQ5
M6,)BI,J4/_VW%3D,'3Y=CC\9IPWY CJFF,*A%"TZYIMV8"\8?)FQF:/S1_=N
M'^&?E:V9[G[7 A$S7(^O_P0Q:3U@D)3X]Y2X\W4ZO@82,';7YKJC6:U(.CJ?
M"])^G,^+N[=[7NZP. ,GNL%(W)["H[IEHWZFOZR#G#56L[S$_-;X)\5(YIN>
M]7/(Q;)'H2RE%!MDNP'5CRA(8\(0D3@35"Y@LM !9K_>;S2@N[D]B=^5LK<M
M^65U;TVCY[-\%4>CZ@WY']]/F19.+)-#W$/^N34Z'MH4J"FFT/1FWD.ZD<2'
MHH!,?C5%@&I*[\Q0I!83JA?-HW51SL=E$F+!MR%/2+*,$&LWK*[^G@":C?G"
M'WO^R?[E>BKW##GL,)$&ADEV8&K5.CS/P=QN Z]]R,9@&V+WF,:,ZC]=I[,$
MG+IN(G/9GR=EYUB&&P-#7-H-;.W,&YOJGW-TC+\/3+.KG:"B1@]D_V !&0B5
MF[6?QKB&+V=9"0)'_B$5="&%3=QK6#@DI.(C'BKU/>29:9EXQ.7XZ]VY=O%E
M43YD^V.P*_(7VIPXCZ$8PIF)9<G$Y2Z(RW,_-A8[GL:Q/T]L7Z)7($S/S_&_
M?2F.K0VK>Q3ZL(+;5<=0=<JM)J/><5P:[VJBV5\VO?47\=D,>A.!%26:LYVE
M=6"JNNN[^NETY&VBW\)Y>Z&QC0(.U6J)D8_LD1?7HW29JS?4^?CD^MAZ123H
MGTXUXC?ZM); RA&(1^L28K"5(Q)_&1]#>.KH+6>3EU*3=\_SFII2C6T]2,#(
MC_\B^S=^*9SK!.JZ>TO*-"0DI2-+P <"C:T]9)M@DOU#EWXT)NYR^AQ?XR5'
M ,).G]=&#M-G'KD9(T9='KF?;S7NXXIPCDKG9YR]FR)R_\-<>]D:^?QA72G2
M=>C7W4X,[VY.@4O5CWPZ]/UXD5!'MIBNB?6IM?LXP9#Z\\O'A$E[4XM/%;5<
MMW)L[+%*POR%.X$S2\&[W/M[=&;5?9PJ&6Y%5UH<5%?@=3DLH%U +[R9\?0*
M?K>JNM%ZL\R<7X'IL?*L1H4^-;[]Y 7'A5/<"Y@J,)5;D+Q.OTT8"BO'8SHP
MKQM[(O-77[EP#MQHJ'%LT,].27O9F%0I>"7NSWF?A)Y&<+5KP>4K:?+E ;-3
MJSY-)GTS:[.'+[);;XQC7(>F97%0*F<L(;)K*':>!0BA8VFT/4>2;;RH\=C]
M- &[@0]&3U!7;8N$*A,W3S#+$*/;5A$.QX6IS]P];&J5H_T<@3\?IK%0A:>T
M1#."2\;D"Z8O;%NYYR?Q]]V9?ITL,V+0TZ'_./25\O7M@V03@Q))MSD;VIT$
M'G.(L:?[ ?KK0\@/<!6$RF7T^%A'(]I:Q8 WQ'J=D7^8Z""9(8?#R*]I394"
M[Z62HJH%NS:X1AK?PLLF$0$O;[33K[>G(X/5L\-RC*.B$*R?<,]&,1QN1&P,
MCB 9M\0IM;N[N!9N=ZLG6$OX]>G)L \:P*!\W[D_5?B9)[OA_=W*<C4U1]U+
M,S^2\[CI'/_"*?+>\4'F,QPCS>X+ICRPX Y[80#I4*2:B:^MJ/YF1.DY7?WQ
M>5* +D?/2)%4#/_ORGH7"W**DTU<D?%8UM_T][.7^^4[8J2^WN^K=+.L7E,3
M"/H9'^)V/D"I0VM;3UR_L/=WG/D)&K[D4?=?]+:W")TK5?KH'X%&,TV:#!L3
M%_WMT@AEGE&Y10,Z_K$4 GKU>,T\U$P''D(1H8<:47+*88.6.)R9Q!8*:6L5
M)[(W.A=H[,VD0:P4>*Y(1<R+?8,8\)ZIRLUZHU*JH?SI<79-PM>&L??);E_(
M+-RDK8T1>M\>(W^+DVL!-Z)/YQ&(C:X%P"1(EZGXHL#?,8@)Y^P^.SVRZJ5Y
M77[^S,"X^.,?H00DC4F2?E_X).8I72Y4=V 8J;>(KR@$_V^$@0LL-C^M_S?&
MWBN@J>^)&HTB(D4CO1.D"%)$D:*T_"R @!@!Z24J($U >D\4I(,H""@M*DVE
M20F1&NE507I/041Z A(.I'##_WN[]WNX3WG).6>?F=EKUCI[S^RU[I]A,EG$
M/]P^KY)MDU]3O&=CN#:[K_9-%)RLV^AOE9D9?]+Z^'7'6&8Y9O+#'C\_:6N=
MSKSA#6"-[+L(BZ.I$U6F=GH8;,.[9>/US9-5ZK9+,28IRZJ-N2=.@&^L358$
M8-$PFL!L%XH%Z8/D9>(.?/T05$8SF]31Y:];N9A+%$@BDF5KHE?>VE>\*;[!
M7I_1O.P3^I-5B35$[U;F1M3$ N8KH\QL(%-%=W(?]?Z-=0>D1H4F,-&S&+)Q
MQ9<40G1K'^*/Y =B/U4&4L6= OSX1Y^H*KGFR#L*#_O<<)Z9^OXD\_0L8P))
MLF F)%?<;!4!V@8'KA^",%"">U0V0PXZ"W5E#.Y4%N#HAJ\8/O.YV(GS 2^U
MQ@98'&'3W]:\_LVV4&0)JQ?\9^WAOZ,>ZD?:,PUPB1F_F%4X"89+=6(AZ:61
MOJP1K2H6_VK:='E7B@KG!.==%V,7JG_;^[/S6/29VT+J::2;#(YWY&4BLAO,
M!80XTE,1D@#48 (M]&0K:*#"+DQRY&,(QRC3;JSWQ%XYA@?Q+3XOQW^QM=TO
M/ICS.FW64S 37K6CM_JQ%4:&T?@.00SN*D !%8]\S'P9VM;&F@!3,KW(H+KY
MODYFWZ30LWNUL6-/AO+T*'[=9[)I?!;,I^.W +DZ+8',L,(U"34R+NFGFB_7
MBC1=:L7DR9F-F&IAAGY[TQ47A;S+9[]FYA6>0*<W_F,T)4_=;TQ%AQ>NK"KN
M;!$$:8+/NLA-UTG0'O!SQE6 .XS8QR,NLF>5N:GL(SYM%MDAV](DY?.@>.RJ
MN<%&H4P4]=-J\(%!KE]8D%HPI;Y:;=1X RVM+_Q8[BN(-\?RZ^X%M2_*E+5]
M7O,4_(8,3#^2J21._&$:=S$TA,'!234-328,2IQ&<M2CO'0W4Y$7JRG8C4\?
MWYRC3[Z&O%D2=IEM +BN;/^F]FQ,4N\!:Q0;TLFTLE!._%:"WA5/D=3]NF^C
M@;FEF/1N%>7<GX^^WC'>/.97YS\?85' 4ZZ@8&&5_85&4;@O)[QMY!F1R;_O
MY7T(8N.BW6L&1OU(?R#3X"[S4,K/<VH,")RW-^C4J^Z:.*;KW7Q8!@*?+!:R
MP(V/OIS)DK-?0/$%"QK _&):M!;NN3J*;6[?A*!L81FZW)K0YRLR*.=E*5_T
M<XH^BBR3UB%7W&EM5A[,JJ\OJYPWSA(H]P["YJSMZ-5_;(93KM-K IESU9>B
M,MQZQ7,F4(]S!*VKMV;1@LEABBRSE5>S PJW-S2S)98XN?V#N< E7HLM%HPS
M8F,Z'E%5GB@.I!LX$<+3"@$\+20^$-U=TV>N9CZUI=75OY6?W7GXVXHSNBVL
MTZ+-*B_O4:NX1-G.U%O"JE%=UBRJ^(UU(J(-A\$^1^(_0$]B"2JD^Y/WU(MP
M+N-J3<-E8<5SWJ>KV],Y7OE7%I5Q_3N7B0BGQR/QC4[B]$JLU[POX60U'@=<
M1]O;^GC_B^B9Z/H7/EB_V4:<_:V_U*!_L5#E5;GJ*>',F/+]%EP\4O*@Q300
M"-';9@8TO1B*_P0A#4%)9K X. A+8&,P"6)LJK-W!+V)7DM!,B%#B[@JCG7;
M%AWLF<:X_7#8ZCZIBOA:OFJ6Q^-O7U9U0_:NF5'K!WT^*Q=6RS'U,L>+J_VB
MB>G"0<*I+348VR+NYEC#UM[YUB3/<3\D'_9W !!T"'+F0QUXCBD:^_T)1B"C
M-3M&+.7ZJ4;T/NSP!I/&#GZ7_UCFQ3MOMR)H;C/;$Q8F=G&"9*22GM'+EWD#
M\'Z?=WSJZL^GX?=8<YA$!)!=IO%;@0'Y^;VTP*:A$Y@.''<HQZJ03V!?T/-/
M1JJW7<SWMQ\J6!)=']8M*@Y)6L*/SI:UEAEEOK@(;'V4@(U?[)S,9N?+J6RA
M-RMG&)V<FQMXJ_>30+E9MZ.PZ<;9MC9&"GJS9%KQJ)(R-;NZRY>G_&4<]=#,
MR83JSYB8@:_K4B^%HI@0Y$;_+!'#P^FMXT#/1XLFBCN_Y#X_,9OU)&MFZEX/
M&W\;LNWB(0A?%,Y,VEA\7"FQ#,[,(^UR7]P;"U<P!]?'$'/#D4GD?MGMC_V-
M&(ADFY78HGI.QUA@ODO+V 92->K-G&YQG5[VD=?0V".O]6#16VVX6"@IAGD?
M_4,0YV/&2 _5@NJVCIQVBEJUV]R.3-29;]I;#'<3ZEV#V]S_F4+@OZ L^[7X
MR&5-K/S;43U'>+9^U#:#J98?^P+7]\*R(-[_!\Y*#\ S1VAV"'KF]G.OQW,'
M.^O&X(02H=,AE)$T/.H%X^0JG*_Y>M!#_HU2"J)U8D\S@N"1+S#O+2OW2/KR
MN32.NR<5W?%>QL87/"<UUGRHV6*Z!NO9)O^FJ"-)3"VJP<2:X5 DDSYN(GAI
M-TC@)#T.VMW71NA?NQ1E?O)LT\!+JY?G=SBB^T74S[#U#][FW\5T01)FW-K!
M<:V29">TZNR*GNAHZ=B6C,SIZINBM^<C"'=UU[2^A;]9ZE/_?*7XJIZMLNFJ
M(G$(D&4F0A,F7D3GAA9VS4!HYRKP4<X=EVZ&L39YL9@SAC'!+F''MJ6FJ^N/
M7\*M">;\P\XN4]J 5*I<%\$*0)(4.W$B/YM]NH 1%9=Z1L]V)$H%,>"Q%];J
MM:CM][N@@5C\HDRDM=MX9->I:?W^)U/8-/KS/WTFIN&'@*MN3(X(2\R9C/YW
M!&IVV&0=;2S5XG8=62=]P8,J)AU6G:KM3TBP>-UVM2J2_AZ++].3H;_#X@N8
M+&J>N!5]4!)//.ULR^AK)#TNK%"O^)G_SL=2QF-F4L[?OOSY'<7.P@+5X +'
MA&0S+^N/X\AWYNV6R485-&;.=C-SLD)ZP4\#SA3=K\ /XHI@AYY8=D=]Z[D6
MBW/?-))US!K;BQ3>B=4EBQ"N/Y9^GF?=$8!LZPH?9SP/6#2%4!X"V9\CI='?
M+AL1M]"J!E^$HKL$IC\(29^(*@3E"9RL+8RNL*(E>VLI1WB:ZN@:X3(AI7S6
MKR,EZ'7-$.HM1#\OS8&DLU'^UV\EV[I]QESR6Y)]X.,(C_@?2[T<&]#0!W&B
M;Z(C>1GLKDPD+R)MT?A*NPJD2&,, 68 <G9I*9F$>9?VE9^^Y1G<P+$MO7_I
M56_7S8NC'9_[?K,?5%@+FV3?WOJMXJQ]S=Y[J%Z^*N.?+W#A$$3!TO@M;.GO
MD 2V[4-0S1,>*H,'MI&WWU3^L&F6 I=.VYV]L@QIR@MXOAOK9IZR,IOOD^&4
M\F[TC?>/<8<C]'GV,4G^>&5&A=U:_8BIFZJ#OMC(;*V*?OH%D6N"JY7EI7.6
M7XB,$\C>_,_(J2XF[UT966TN8W"('AU 3H+2>*N^'S@N)U3LGD9V(J3>MGT,
M19J"YE>YOG%U%O"H*[VO[I-]9NF<Y[WNJM#:G]/4, X_L^AT_V%%+MSOGRG_
M_B\F55!9ZGFA)P6$& %+)+8>W(E .+]63ZE73EZ-@SV/,6U$*6N87W].DV^A
M[Y7Q8@X52BFFE]$$J1*1G&.MYX#1>^FXCH.G_WV</H$1K+GM)W:OQ&#/IT,2
MQ"XC+V-Y1];=R,#$&F-/[P[X8*Y\'C/U+TEQ1QR))^9[W1Y^0O.H0@Q">?ZE
MO<AYT:Z-%(SZ7'#-["5_M'K-C9" 9Q=/R9QEEUS</&U":2$ME%$%U^"B.E*_
M@+*.1F3L5J2IFXBQ-V.NGK)]Y\%CA>[S\\(&_>FI>9^E^2V?6GZ>S?<M65F;
M_>]S_&?. .4AFX^MTLP9:8%L<_LW!%RH2HVT)DSK<!^"3IVO)LQ>#>(,/?--
M';HA)-Q_NV/O[)OMJ4[P:91:X)8FC3^ P2EWU'KM<K,I0?E_'7O9)]!$+]NJ
MDGJ128K;E/)XN\'O?5[?'2%C4/MBOT[>Z$$JTGO]6M3F#"("O#H>55I37SHS
M9CT AR#QQ4A2(1*?4P"A?X02.!ECC(61P%0+!G,@&TCI7FIXYZS>Z&^-+97!
MM:73L^$70U$,=@^FJR^.''6I1;*I5_'8 X&A-^^3&)\"J3\D5Y$S7$G.UB]]
MK_0G+T5^9?$]J?%[3$?9TG0<TYB?NR/X-2<YO^YNS^B8]7(5C8^-P;E8S.A$
MHJMH"OE0PA09W56N@9H17.R\\=UV2$_HYA(]QW'6V7TJOR-;FD58[P?SR<9,
MJV4B.]!ZIT-]NW"D6";X,P?$?O*3&JX&Z<6$<3IJ3^4\G7&KJ77S<EW0SPC+
M*(,6? -"MW[R8 <R_B6B,=(>8FX&SVM$T@3@E(3Q\G.-:'HL0\;!WD%J@*]Z
M+:"FM\CE$G2Z.?I:U;VC?27(-EL5+#Y_!M+>%]].31/RA/.R]J="J4]6ME=&
MVI61S(PN,?)..&?9]U;;W7@=ZS'%G2_!UA&>C9$]NW9Y_1KC^TS^W/\1J[&)
MQ.,A9R-%R$Z)X![P="E1L!UZ9JUV_ZR7IF!:Z#-R0S,&'?/TO_M?#1ZW]9H_
M!<^AQ)">8%;$ST,0" U)+#@_(84AO40]SHY>/?='?2I#POQ&X59S[!OYOR8N
MKU1OW6^;*!E)QWG9XC8;KG2,Q1A5,/FMQ'-]A L*N!K3:4*H NZ"US%D;0:_
MT-L+9-^9W('M9-8=C:C<OM6GT!&-K,5@KPU%Z"R\?4&#GH!.>^ET^A"4E-TQ
M@XRK:M;W?3(2E642XW4B7;<VOV+IJGN.AK:]QPE"]4!9=,7=.?+\;.#N1@GN
M4H%$D9Y,A"S_SA:-UY"R<0B*3V#\2"1S,KCAP,T]3VL1) 5)R:;$Z51@H>^6
M]"=U-<@O2YJ;&!S53.>^/CIVBG&>]#*>.1&<0Q=MR.K-F-'9BU_5<.M4UZ>)
MY_3N-.U]?74LMN=-V)\W3S.+K:=DMX)'&4+2-PI1M286&UJ*; 1DIZ,*<:\C
ME:W+3JE]\3:9_X56:MXS.E#\WRKR//^.80<<4#"D*4&!"Y-)6#<(<!W1PWS:
MC[QL).G5(<@[#.4Q+::"66_];Q:E+;P#F]];O&J6M]]@W5[9EWK-F&+O$^6E
MS[]MO2[,'#!3A\?-T8L8BC1=)FH+,KA1@)6@J3?] QU-P6TH.9B<B<1*017I
M5NL^R):7TPI\;O(-71[B72+^Z?[VRD,5[E5#6T<-_.V1[K#30-/]T77D(TBB
M"#H_=>[K]0B!:JWB&45^6SZDF]A)D)C+[JJG+R 'IPDT=4(PV(UK2-(?V/.]
M5K CSTS8;M0=(&-CH+C.^ZNA#-(EP<>M/PVEPQM]K,=D8.W3M6E;SUWX'R]F
M0#9/C#+3Y-X\__XD.8/!F;\(.\68:M4 M/'PZ1X'(+<\]*+'B70/)RD_-=*'
M5#OGXU.]9C=O/Z/UL,;K3-8@.K"8H2[L3 QQ=SF^.8BJ%MJ!IZ3Y%IL@)3!?
M5GGF;NH,*-VN;[,;X6[(,GP:(B&E(_$!QF)W=CG="KUG'^Y$4%*_W?.N0M=Z
M'V5C!G]7R.#<6\0)1'J3>V)T.*G*0"[QQ +K6&E-2ZX!62R;9]]OD,Q^Q^A!
M5\BZS$68CLOD*%/Z0IG^.](*5B)=+S.<RT*MNPM$KD[H:)9]LB\S:_+Y)[WU
MWO=-GJ+BT_X&806\UVB:SF+I%V14P7,=99N+'LIZAJ-\9OI^>82C_83P-";]
MNX?;MQG ^]*?,E'MGVL7XKOU$E/J=Q"LDUI9CHZ589QFC,S 7Z@C^4.A[=7V
M]FM])08C/YZ08(K9B \L-^4Y;G,V2K$+]_VK^:SR9'%!6<5>_*U 2Z'CZ"T4
M*2B$EEO5?@BB@N<.07]C*]<H1^L9931/0(49/^!?B!,T=1(X)O+)S$2BKT:N
M=_"HO=. /^7'!>5K^8]L"D_]O/Z?\8=CSR73WAVU4$/7(-M"=3Q(6$):F\H)
M8,9$7.5^1(67S=@ZCU#@[BN#V+<]TE^*/%K>-K"^''Y?T(C#I/5PPJ>=&6?X
M28:I0>(01S)K6ER@4,[JD$$]U72M<\9U\.Z*L/335(?>N;1,H<G/AF#J-[,R
MT3X#GZ%QF_52D[G4:Q7F&9AYYU65*5\&1P/Y2A>RW@!-$J7$DU3B(]D7D^WE
MQI1\ZL+$GY3<2C&VQ Q<DNPT210P_69PXKCB#Q]FGJC!U;EMB(<L;@DPAE G
M:7)$\ O<F=(LQ0U#QWP&+ORUW-L-$>5!&U^5Y>UQ&4G571F6/\C:XJ-V=M9I
M@)+39W),>R,XH0X:YR1*VOB9/E-!XQ3525\9M67]+AO9[B/S-*F'4TC)X&D8
M:NHFA=3XOY7 JT %R8NHV7&T6;13>'<MW[K#R]OE?/7XXPCW#RF""R_:[?BB
MR)O]#3V2+"J<IAJ$$\ON"[K\>VLK?U4>BK;:E"HJ0Z%K'W9#7D+QK0608:;,
MEA $L*6 0425$-!T+_M&+:G#(?\U[F9G9[^@"D_T"V_''W^D:$7IS7E0D@UX
M1IIB#E3AO9 S 7BFI-11Q",3+"I:LLK>.US.O:-TC_>J)F\9WT+Q\+YW77I3
M4F:5,G/8:0 ;)8Y>C7T(B3X$B3:[D@XF9KOUCD]>1-L/<?T-MN;^(9"K;5]G
MWL>5IO8A?OK^-S:%FNC[WD_\L1C4QC,4R6'C)@'6#HMAL)&+0NP0GU1T]",^
M3\GX_?V0Z?R(*7_,^'IMWU82SX)LGAN_%$@VF;/R<?BYMU0_@22I\VOQX::M
MFII:Y]%Z6?0/2'PY5%SG,C-$-<ENWU7BH&=HO(N^-2O!>R)2\T:R^;^R3$0C
M2K.((=]L4HS^&&U_4=3L97&3(2/9H/AJ)!K6!4\L4 4TW4B*;>'QW5N<0^=R
M^\8D)O5'\2F9KY=Y'"X'-'QDKWDJ=DT:%)")GW5V.P2Q&87&\?8E=]3WPBK5
M3"[;8TFPH7T;;<J;0]#7)X>@ S,O\Y5?J=#GVM>/#KL(;;CP*5*1 *M<]OA?
M'U6G2$?J7<1/5)UE=EHD+\$;0C1L0X%7!3%VD69]>J\_AP7O01O3S[^>=4\_
MGB[_)LY:2#HO#!R'Q'\MN K('8).A ^W*H<:$O;:#D&G/3-"=YO5U$Q5;GRK
M_74.X^YSWH-G03'3]4WS@RQ<3-:^O[].!X7_$)2>S#004T-6V\,9=JFADTF'
MH"4'YO6'H&FG0]"L=O^*C9;.IDYC@"',,MAK-SQRHCX[C9A6QU!BCM@3ZP&>
M1ED"R$5((NJD#B^!F4$0>NDJ-49GWD^*E*:W:WIP%G?(>"^UDD7;H4U-DCE'
M)PS('S% (EL[,WVW8UD0+("@/KFGLP(QHCV;MA'\:F9:*<GEOD*Z?F^"L/",
MOJ5Y"XR?*01H@EL,LV*J!G+R*O)?M,(,_=MNBPF#_>CLQ102;D.<J')Z;6:Y
M \;O'DRQSFY\HN<V)6,O4^?2=^YFFH(FQV!3YD]VR:3ETOA"=>%MQ9E@NVFT
M%Y/WQ%])5? WRU; MI0&U^LZ4QXS@[@2,2RAR/S- B+PX"YX/(*%Y-HYH3I0
MIIQL&O34Q=[ZFY'D.Q^G<Z+/XCVL)7DXW4J'(22[H7W]GFXPE95I_>*LW?U=
MJC9BU Z^$<$,"X%0WYZ<\\E$9;#A>%V\_=6@INM>06H>Q:KLP2<?<%.R+#(R
M)?>JAN& LAOMX^(B&SV:.>-&!L*7.\WO=?ZJ"[,W\[ZXI_K9U "MK>B-M$?E
M(DDP7R!DB*8J]P))"$"V7SL$<4H/Y%*=-Z S#)\M/9B*GN'F(6A\G8H=4M_=
MVXBAPCV98&14=8PFU@I8XW&G%A"#!^6O9W&OO:/.?RA.++HBF&2% AF)UKY/
MU] N?'J[MZ>+&;00&A^4H@(H4L\#L XH7RO72JL\>2)7;.#SJC\ -AG+6<H)
M$V8O>,RCQ_TF<O[RR^B66@9')M,E;$R7O*.>IRD#FB28H2"3X8M>E+1WU%KM
MEB\:47K0</F63I'2U\TLGNL6VUV\@:<=Q__^M'E3*GRU?FOP'R9H9L"YI/B:
M,;HHOW(KI+1W#S;MQN H7=R:=:9\![)+:=!?-,E#$ M"S,9$T6M2(T354Z3X
M>^(+$[[HH!2E=.EO@[<27K'$/36,B3S&].,/QA0$+=<&%PC-_8X\R1#V^@5(
M;#\>W\HLC>-^4JT4+5]1\,]4YCN[4$WM<6'0G9A&+(TGH#LGGL:[M>C6#9U6
M8;(KYYA[#7%K=J0_1:\2LJU\:US?B+EBOG^6BKX[GW[A&LAZ"$XR9O(Q+)/-
M/T!-PXE_,H@JG$#/_6:R5?'57YMU5)DH/?L,3VF![<&?&I=DA0@V&T_P_Z[L
MWG9"_,S); B+'%T;]8]Z$;5YNQ3=/!GP3[H-2G*$G?9$D>[DXM)$,/%V.,<1
M-!0PV-2!GN[C'BKS/E/=<^%$N3?W3MB)+TN(1ZJ1E5! :6A#F@JU"Q7LP8GK
M<84:7@?4%]?>/D2/J24G0NO*G=^%%/96^*G\6%JBJ/EEG>J(OJ3G2M*D\>02
MX].@^"2[UL]>!/K#2.M/H3\B75W?OY'ZLW/'WL(W,_Y82FG [<(R28+1PP+>
M=K-(;OH'FC(!>FP-3/4&1HEBDU;U!]FQO#8U!0.P/,2F[2/;BKE8_8OWM2YP
M/!V,">"( W.&^5>Z#HZNCFQ/PJSN/_T75--:R3#9HL&8C&76@L%11F:Y3B\+
M1#U'UF*>_X- (F\VCF98MGZ;\ GVH#QM-E$%9]G44DL,E$;DZ4204,X.EI.)
M0&9Z5Q'#6 Z$)NW\N)XH8-B!E&AF*>Z3W2C"\.BE!3T*$)]+3$Q62A0]>>?.
M*G4L)26)"24SQYES%/_Z*#M_0Z@#:1V(BQ-Z/$!A1U]ISV>;V>+!"?-D=RF7
MC#>FQ-O7VQ0S,Z3]S!578%-;E!7@B..?]TW)%D" T,,(+F9@.$Z%&AQ0NNT=
MX=8-Z:J?*G]HW^CPD&VNXR@>\[VJ/J"@1C"^\H(W->./;\6N$R+N3)XSJWR7
MNLO6,CU0[W^GI;1>!=;PANO59'!GJ\Q74@OV.Y)Y7X_5R9P<M=0*I*=!?4^O
MY8Z&4([R%'W!)%.TR?H^BF2'G,GHPK'MJKQT$@6X\=-Z+![9/JGJ/_ZE?ND[
M;KJD798X*0GMM_5^9QD3Q.&W""69'(+.EG9M32$7K=>C9V"):K[)(CNK6N@O
MCC.GE'D'[!^]ZE]O6PQ.UWU[(44C8,SZ&4TQGC#4CGT1@N-J5?M!A;OCN-=+
MOM7 V4(#S#&87VC9BW?<7\$X54\._=CN96?-OC:C71Q7JC7ZAIC;.$IMV;/?
M^QMDG")K;IX^L;:YA24BWB.F4"3[.@!)A=+.C;>>!1Y!A$+7%A])_PUW! +X
M7RM5\[US=E61*UBX9QDD;"C[C 4JS!A%\K1J1![M5:EE#!8N5CW[!V$!:IAL
M].Y+_E\^C%_.G^S1U$NOD1$7#+ALC=^Q]R^G3& W/E,OXQ#="Z?HZ8PKH6YM
MR+,N)&C'K=C=5#G'[:*)NEBJ1^MTP))!0G'SRKW+EJ"/<1RP:]BZK8V6#T=K
M\Y;8Z;3N E[25K(:DFMF-5@D"+V <:G'SJA6D--OGK)ZT-OZJ!(?OERBJ*,N
M=#W /'6\.&3<UQ7[2'XTQ1)?MX=>^XMH0"Q MYU1PMAU_0DF)<?I(I20;<?T
M9#PA-=B-(+RMNF)L6CM2O&[@QP7QEU.++>AOKVX5'8(B^12TD<7*B%'&__OR
MRS1!0/I3*(9QRK:(=H=$K &:\*5I?\C*+WKU E\8G<H6!W-][;VM>PX:?]'>
M+2[_FO?Y[(5\K*@0?OUOOTJ9R1;3A Y'-0:(\W#$&!R=G:PV?W$%%J?'\C>+
MLJ>,FN]#!OD)O3Z)3%N>\>M6ADVTS!*1&X6?$(/(8\@'\P)#S*B,=#P$L:O$
M!][#+,C]$F'L&$1E^>W7F[-;]&6 \Z?D%%K?5K&2T]I/V\TR3KDN'H)2)!0]
MY,CQW4-B]E[9(3Q1*Y*VKC9# 3O7<JYGC)C983%06@8*D(/2GZG!Z1SM+:=&
M8U+D-S_^;O748FAJ-3P:\_AG6M6 ?+>1%=XL J.)<Q*3J7V%&#2:-&;-V]_#
MR7,QT7.P9PID&LC"X%2FWD:,I(>N=4- >IP S & D2AA'UO&@@823^^N=A8X
MOQUSN!F_36+8%:5\&/._S19+SHY.ZZP"KH&)@O&L;6@]29*)QT>_0Y!2Y,;Q
M!5U<W#J#?QO> 8Y?$*8GHE%"M&OTCVCP3/SWQDZ[%S$F]:0SI2=$[J)Y+[8'
MWWG[JH&%1UJUYNN)X\U+(GRK\@V*?3<$[%<F3:J DWZE[#(S34LO4>\.KI,-
M&9Q;)2N0KY!HACP ;S=;"!WMGBG*.1&NO/'+7O?\@7AK2+Y*O]TE88Y%#]=7
M/-8GK);;D;.EE&^DH>Y4N79F$C[QMS$V+5GM#\J8K/)\P]=7+5\UQ.!2\K1.
MWVN+P7M5[Z05RH5XOLG]:;$@Q,<BCC-14J%9[C?C!XY7)X0TU,F0:1BGZ;L2
M9X<+I$C?I>0+6^N];DM)::8ZE&F]_SD\;<W?P6A;D$R&,0,F!0#?I:?1],E(
M&\#^*0]<>(4A?9J>4=JU$_8IE/W-#0T!Q[9>CD&A":AEX?IRGW@#&F&O6%K<
M/%&"Z$8I-3CCD#LP6,$2D_2=1R8BW5F9M^RFV>3@.G#@V4[KF<_PA+-UZ734
MW7I-9*L7[[++MVNSS;VZJ5$L 4R8?4;_< CRW$IRNEI/SV:  8NN BX J6T_
MOYJST2&,EM(,.*[<";H2*WLO+#6U"/_5;AOY BZL!'6N BY:=U> B0*QQ#(;
MA+HG=&J&CQ+LN:8Y>_&-OL:?!SHU-;\;-V?K?KL\:L!-:5*^PX%SOHD,I4@U
MH >/%-5=^%R6?_-ZZ^B3S UTRKG4&]J-J2_Y3P7A4@=/L3X-JC"Z[_,Q^DV#
M<W^C'CVH?L$@\]S@_AN+8"M'*KUGA.=H]ZLZ3 +9=IGVD!S1SA#^%8A*6#@Q
MMA&8#[\Y_F+2RFQ )J'UT;XO7ZRPD0+G\?+R,^LN^]A.,*!<NF%"&L*#GS-4
M5W$G:,>\2%6=%SQ.["%]TDW*]A=4'0F6#<K>HF]>=<N^O%'H_MBY;W]BE/*$
M7-KA"T@C>W )"ZJ_+C:KRW6I\'ADSP3G!QV+?O@D6_M%M^HQR^#,Z.B3EM?%
MSL*J$'.H[8J0-M3!1B%3SN<FF74\7)05ZE);]M5WK6\1BA Q*DH/R<2>B()1
MF9JE[2$:&KL'YVB&D'S;)@JN ?GDB+N8\< FT?W!X'J-G91.UYE^V]PS3QV/
M?Q&0.V$)GH8R.+!DA1[*Y[%6#L9(P;'A2,Y%_1&9B;J!_../<T8.Y(D>!9=:
MGTS[7G!\;@N^W/BJ*("TM;%"50K-:+_,^'$($C]=U<F)BG?[WJB!JO*4.(WJ
MG5"3RIH5ZCG')0T6C19^9J4]_/H5[".R[2KM'"E^T6T#4Q*Z2-!%;1B1P7"2
M4V)4D%LEL&=1G6%@7^NK='G:0>N[@W1B+JOK"4T2/Y>77$Q'N>Y(:YK39US+
M>HO28]*_3,79PLFA+=V;WW%'PC>-\I$TE*)W+E(8T,2KG(W4)L65/'$9<2OX
ML]4YF:215W1O4,^[O/3X^4U!!'O5,%,J)2^>+R0S.04\OMF^#+C9*<$RKNX5
MM1=^!N,MV_(G7Z':VL"66RBUW[C:<JY(C&N2H-D#Y8X4>#G0E8TC/:,YT/.@
M'E[:>Z8J'0L".4OE0>R8TR^;QNW4Y602DAX\NW?I*K062[J3;T+TJ:*>"3V^
M2#R83Y,P>=0-S%?.EJ0-^DH.:NUW0Y1:P^:;=/XT["CIG#,UYC:;6(@(KYM\
MEZ6:PJ0<95X[M!E$:?,O?7YBP=/_OYTQ]B%,^0+UNA(:0@Q9;_ID/PW[[&"S
MFM/5&?SJN&NC2_;MAR)XWH:$[]]U"N)J#D&^L#1(G36-'T.XFTV*9VJS&E0G
M.'YXP4M@;R]\*'$DPBM40)?P=,>^/>GDMBWFRL.G?%G\NX8T_E$&>_5BU>PR
MT?H[W:WM //BWRP\+CQ_:?-3XX_Q3M6[&28/5L]Q7Y=_Q%K^;NZ>2Y6<',3'
MNEK,6^O^!?_B"P;T?V/_!*0NE7(JHI%9I4M@FI@HJ?A_7[[$6]D!\<K8G= K
MG2("+WQN; B>G+R%C4%H^TSG14PF,:;AI/M("<0O: U;S"'H\8H>ZQH2' 1.
MF)C1>.U<'EJ_5*&\>^IAUES1,#LA\7AS=6?DR)*9S=ZY^+\A-($8"C/=T?C@
M%(?A2%Y\ODF'EE-9,5""<\AR]">&*L^<VE YYVH5)VR/6'LAR<]RK.'GL:,R
MK53FN)1]L-Y;4VYMK6PUS</_MA)PX(UU;#7:OC33F^=6TE6?1ZHRWI))^H[3
MI^[^_2C#)>8=VS5\KW0C*/+'07#PKEJA4TZ*;LD>4N7* !3_ 5<;R32U'$WT
M0T7DM<;FY'NMI-;LCVUA?@*1#1<A#K59WN^6'Z0;<MP],WQ5G.T-\_%Z4'?4
M;'8[JAK9\4.;@/T. 0&%WR=R;$PAEBV3WN^_M<0/(O-_52VZ:F.X^)SR%==\
M9U0H:D 'U0S9)KVEQP44VI'NH/BWR@/7%%-M?2MSC9LT<F*;%R)ZO6D$F5?7
MLXY+Z4Q V_UUP'CDNBX3S+GH^0A>=P0["<74E<\U),1)2YCI)\J_HSUFY+?M
M67%WE.8R^LXGJ;__:\SKY[_LN]!2;U?&JO4Z<,YE$?%X%XO[X,PX$U&PO<Q@
M;\$+JY\R7V# Q%<V GC$!_A*3<:2/UV[=JQ&"_6YZJ@T-_/OS-VC&@ZY26C]
M.4RZ(HSU[Y[ #_E#D*5_R6B?JVYN&,?E23]Q=GX8@^,"\W^;P"0U$MFFW2I!
MTQUOAN&O,2ZXA]-;T56K&0.ZE=DA2[-.[0NPS"?VU[XE@SIC..:6A;=3 QCL
MHE1KQ#B#G[3\#*%%"R0]@7+0]+S;1FAR[C_\@E_)VXP/V,W&2<H?*_(XCLIU
MYA[\E:GB!LOQ\#?"8(/J"VZ-/OV=^CM;T9<AM*P694RU9+(SLP)' Z.E;XX2
M[O?Z]1YR(:1=7H IMXR?(6M81>H_1)4@VSZMG2\8*>YP)]_ZH]=J :2:F_V[
M7!NS;AK50'5&='B331CL3561[(!GSL5G->Z4<(.4QA<UAAZ^XLTDZ):$6HA,
MN6G63-?;W[OG/])?8Q]" &LXR527%P_IK%K/][8V;!Y1CRG^(3U[)V-([5WB
M[U0QU?*DFWRLMOY:+!:[_9%Y3#:ZD[-PB_Y(K!F':VE.@0'G&*DE[CB2"?2%
ML\E+_I=K=PN(P:G_[5P4V0RX\(A-":*8,=3/YKF*?0B./@35EK8UT+S!WT6'
MV'_.Q,ZIAF:)@[M4*I2;%W]RAR5,\B3[!USB^'"E+D4\!B(.2#/8#9FOU>_$
M/]XJ3N.GOZ=).Y,:M__8*AV"T!4+RA:F1C:U^]K>C[?G?J<[9QY[TOCBL?HN
MAL8+9K!W,=E#FZ;>2<=0_Z'[&9U.4I.5W1\JUU3 &92^Z(W[MP;X$T]NO$\W
M"G'>^WJY*T)]Z.H8]DJC,7UK*QSQ.*A!=^7"PI8KLA/H89RQ. 2E;U%E#T%3
M$?</02.I$MB[K6J>(G$9I)"N;#N+VXW%E:EARN_2MA*SV"ZD17VW[H.2K&'
M^9Z76%]4(IQE%\6VNL [ZHT07@W);ORXIFE]MD_+5#GFTPO]$Q\2!&K<_*ZG
M-^?E13783E:PQ1?REZ6I3P[F9$JM6)@$(0=I#<S L J<ET'T07G4A?HQ"96T
MA[]QER':]K+Y3?:_%U$+)D%S>WBW G^&4*0Z$["M5_S^0O^NE?T=T6@0_[;O
MXOS^SB&HF:7D3O#0D-5,>,Z6SG5FU(<"BU3YR"BR=3+6!9LL(4HR2%Q,O'.0
M%A]Y\XG=R'C->AGD0+>]L7L$FF6L*/FHZ2TOBFF(:$]DFYPZ;!JV"$YDJ-#N
MDS_2#($N8F=HZ9B9C=V4P=*= MNGPOGU4ILSS[EO*#S/V[/L-%LN2[# ZMB9
MV,_/(G+$+15&_^1;*NXHVE>VT,&)4'>5&4$G^ELD_C<X44*)A.NHXHTT'Y<<
M6=^8O#[LG&[29V7*\5WMF2%?*II-;HFF[\,8U%,EJ] $<AF<+(2C%3X)\5&&
M.(#$ZZ*+0G(<N_[F6CZ.\WKW*'7LB_;E!K?3VPJWDNN69I</=MJ9P9XF[@XE
MV>'X$".\G@N\OBQK=H]LKS_*MF:S,G14G1C.2ODNQ3(8F\:341>3\IL+Q8UL
M4T&<.]I=%UUKCQB&GPKR95UI%2!+FBWJ@BT:&^JS@/[@^3I%/AYIP5FQM9;L
MO=6 [;QQNF>:@EE-=JV1;DC]E]G(?LJ_#5>R?S%RF-J?)%]5H//_;5S0R@2
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MS 50WX/FW8JMT ]#D=@?.UR,&RI*BI"NHO:)!IS8^%D8,^[!Q<\[G\/@[C/
MA]1D6@QG;R]%.03!/\KCW$B+S\^Q'I_=9^E:5U>5SM?6(I6\;'3<Y40^C&P%
MX\:L_.ECV,T:=YY7?N/08#CU[.P#7P<J(G$K9?5.XL FC)R@;<!48Z&K;U33
M%J/4QI&?)4\DGXT-2$X^3 AYM?.3WN(F3-+^O"?09+"* ^\1Q8+[B(?O+"W6
M*Y/&S8UIPL_>F6$^WKCOX+;$;Q'R<@DQN9Q_>\WU"4"*#E:*@"!-*68;_5@9
M:1US;W1L;D,IS]77YQC6_;[$-><LDK6PROK[-B>9O?M.&T$S5 H;<W+K:U<M
M\!G./\OA3^@PG_.9JVW/]?.]G^'9RG$2'IWS<CZ;T*7;??FH9MMC%"J'VE"R
MVH!CCT&1>L[P:J%#?_;&!%%AZU]W,!%8*D&V+#(%ZR',_H;JT88GI<$//B2
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M,IZ N11O"<X/[,Y50@2^(JT9L8^E.2BE5T_K^59Y=RU;D4\[VJ8;!HUGGXH
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M":OQN+D)^V4X-GL6N[ZF7 .%4X7-5H$7V=T;L]'KZ@A0"3E?K3P.YF"9J:L
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M3?@7-L70=F[">HR_X_\VBH1"JZV9SR&T 80"@*3,2L"\J=\/-%T/WH9=+\B
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M]Q'!>ZMFR*6QSBA@6&K#]W?K68Q21>=(#SX=^B *^8P</&O:V<_EA!H6/<[
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MVV'>R/3PDV&1_9@>I66UMIQI_E#]&-[AH&>U-E-QOLWUT<0F+$J?'Z@G6H1
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M>Z-\L?/&78OO?10TMIT<V<(G$I_D$B-C4W#%<1-F^V[B<*4_>\&5[NK+ABL
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MKG/6_NT^]1]NF26OQHV*S7*LU*?#=QE97NRD4IZ!A\) P>LTN+A^6+YB^&_
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MPE>W'%[CW:\(F1D8!?^[QX,*.G4?BY7N9?CO;-?S62;AM&7,A<\R&: ];]-
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MYQ[U^AH1M[XYG)AHCYG(1]47G*^/[Q+:=/BF]^IFN\;237?U3&-DE96^Q.9
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MN#=#&V)'TB&A["9Q_P8U'QQ1R0W2<YDE*1;EQVAR#]Y\)^LI$9B1'^2ZIHR
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M"!U"9I_8'ZVV'&N%G-KU/;E\?D1+@:9#,(VN6NHC]C]9];O[<Y0AMMR_ D-
M1V'3IDT8?IH0*7\S[B3\WH$<W;[9=V2A!&SEMZIX[P-;DE;47=Z'J<>D8[>^
M2[GL"MW>7#H\G1QOES845\F$2 #8)HP 4MJ39#QE*O$#<R."&B!SSC4I-#10
M3JQM],+W'?:^[6=SH.!+L,GXW?4[2'BCKW=-N6@AI)R(J9LGN0\ YM;OJRK>
M#ZSDGMF3)]C5>Z+:-\I0>.?0KI0F/(W?@*)/1C=B$O&"J$->$GMZ<%Q :'O7
MC9,KT=LF1>(TT;L/V\[7F%QKK=5^0/\6!1%>4A"APJX1$4TK<-H^CX72.7=E
MN&L?:643VPIU-=,7G'WV_WAG^+_<H?T4&" M,H38&O$'  ,B9IA >OQC*--@
MA(;56L+?O#^]IN[C.!HX[S/US$6RU/&4]$G"G5RBU## V@+F!?11X4%"%!U<
MG^XN&I1DG8B45,<'S-L,;-@HS8:37]P[+3Q!.7!#G[=FWY?I$Z$A-Z D8X0(
MJA5#,L*,9+5#^:N4=!>G95JY-!T((S:&<_;?+M3H>G3<$WP9?/3.N?!BP3,R
M1W'KH(UU1GT@D):APVTS8#!"D\:0GH;EV;T;8!#H&?3LFJXD@54:_K13CE6@
MSWS@V:30E5$%RETF)*J&_D3;G42@NC!XF1# Z#57,B5Y6'>(8IIM'YC6H$$?
M<PG96'1JN/59A6>+S^R.<67VB,DV8?WB2E&"2<EL599UR/@P)@--,L8/<S2A
M_X!-IEKCJU#17F^<D#?ZZN6FO4IUR=CLTO45J8EO+VS.C%S5G.83__ L:O;"
M\2Y&(YQT&?\ 75E XUUL)PC2/%S\"Y'GZVN&JO3)XFWYOO,>Y2.*B2+R4)<_
M>C+N+'0R7/PV?;=CJ;RHU@!8N<J2Z7.:4'_53:3WJY_JVY'Y V.UZ&\S_<YU
MM>^R>UZL28VHCPE_G+@CI.V^<X9NS^ :JNU1JEKA (0H<4#L).$!X^A[CPTH
M6VF%0^OIZO&/KD*\>;>+ZW(.2%OJ(=I,>CHEY;YL' Q;+, V9?6]]Q(4DG.R
M&ORY6.,RB4B 5@DEX8Z"V:,P:E^0JLV@VM$>'UI@X<T,(<3A<9WL9P$KWIQ)
M!ITQ/M]'7DZ&/=74VD-P!"=I'MVHC1- -6= =\P!7E/#=T6J$B^$BE^Z@,N<
M7/B#L/3JU V^XW]<_K@E*R ^KBE,%P:&02'R <S(<(I C^[.;^UASV\R!!\[
M_:BM#'7'5]5OT3IB][%+G]A*"8Y?+1I3)XYDH>Z2VVEB1=/PN&V5R(PV6.5\
M0KUC<="%.=C25I6WR'*IMV*_RK;V,9V?QRL$+G^:._C K"9AL-]/_N#")8>B
M4^JO-W#=>G9!GQT^6\]:AWB54KX530WN9.Q/'\*/D%+NKS A?(4*G4C>&?N5
M* ()3ACQ:[%S@-WLK^3>M7@Z[:5^8'"J7L'PQ_@DO_0KQ^.H.RE@%A%^B@EI
M-D?UU<+;5/Z@69&AC2LQ5@'QKGY%'NE1/\9R\\Z_KG.+G/'C%_X6+?_IGO4;
M#U0[E*3?#=P #;>I#= 83+9W .X??9]G]&IB>+$6D14<>/(3)#/8IY-8K]KR
M_7#\K+7%6,"R3]!T8:BNNU*P@+=[[=JHN:!3AM(*5JGT!Y(50Q6"A""0<G0\
M;!(#%P#S.ZMWF:;BBZ<G"@[FJ/;[R_D]W[+ZVJG\3>2J.OMJ?;F(B4B0M(&D
M&.NLH$J0QI00C4]A:D]>/D %W8E(53(7\ ;&_I-QJJ^^O-P#95*D^=;\X-K1
MCR_9\<A'LX63G-P%]>"<[R&)B9NVBL*:L<DY6H _"=^6H:1;.CEJ[_:N.ML^
M@N>APX5\=5I>9^*G*X+Q.YS&R53&WGG2R@PWC7\-?$\%);70TTFH!RD3>"#_
MI>?-\(6@%>LOW-H?+\5>QMQ\5AX><0)9=^Z^G=&Q5R7R<7F^<PVEY57XEY5*
MTR^( N_'L:'VKO0 G6:*/@"=@H'"-,D=O0[;\R, !>UUKXJC$[W/\E:NMB5*
M/4OMD##U7"\F8[^94FZ0-9922:)0-J!DVJJ*;'ZEIB[X^J":0D!-BEC8HY<!
MGQ-/OCRR:V9^H?V^4X<3E[?;2.#:RF:.JVGL(OI8;IS"B;^?:O_[Q=T. TZK
M4$[D_*3)D#LN5*:<CU(CS<<@"U<EKS@9V8ZRW4]/.=&"[CZ<$XX76]RF 5A2
MQ3E@G#1J1TJ.K03\C=E:#B2[AGH=VG)-C(:=TSRTL6OG"#X3 <BMT/A6VF D
M$T1\A9U#<W!I$(?YG6VA&"OH^!?,6MN=O%M^;VY;3&IPOF=+?O-Q;>]GJ'76
M@/<<?E*"8A]GHOO9OC0Y0S8W;EMR$.8##E@B@62%&=ZD.+ PW()4/C"T@/OT
MZ.G$HV%GEU_CWVXH8&6-PK3+,"?$ A-FQ4TY?9\=/!A'2P?B2T> C.GD6#4%
M$>U%'3V+]^]K4CW@)S2>/C79N^L&S^TS:A]^_EL!AIGFR1<77BZTUG6@@3U/
M%!7EOEA*AG;X4:P9^^3 Z*V(Q-;</1S>]P&4NWHSWUQ/'+>"RTLG7+9_D!H'
M)^HG]_#TG=+]VO@GG 49X>T!7!I6) .:0 &#PWT**A D8P'G S0:1[AP96&W
M!P,/Y'55INB)+CWE35*6KM%.?.F./8(_ OK[!J=X4O*,00**<WQL+ C6FG.4
ME-^ZJAAXXN;V2XK*[>??%9X\-8(8'I)(ZU!\Q6Y>HC]RU3A88:5W_OR)&#^3
M4B$/0[7O6+P10V842G+$)$=/8XC/M56\576SP S>-*G99T^?_S'^+Q\VJ*7L
M4#W>[4PTR0"3 &4'8Q]\XG9W D,Z*/:N4:*&"?5HK)C'D ;J1@6?]&-AY[!(
M2<=G,T?\$B9G9K)6>!8D%(=\-HRMMM>N]E?MRYQ>6%YVRPQ]ZI#N'NAL^S16
M*L50:O!5UDAM7GCR0+I(@Y(7MGU%9TG7GBW<YNB(58476I>*\?MU8-4;S<$8
MA/)HR[A,AIEM)'," 9]M<Q8_YGPS\E>]MSC[.89P1%]"#+K:<^^'WYI0I%H\
MEMOK0$AD0J^]DTUGQH&UPUNYCX1/O-W<M1.P5OI=B\)NBD3*,[P:]7&SO%Y0
M6UE",P3-OC(_1K\.8*EH&C?])=Y-R:@Y<RA>Z/) _=D\E:?>RLEA&I2PY=:[
M'5+2]AU/5.2_:05I8KN(&E77//"]K$V$P@<YCWUJRPKPV0:-J'CP?B,#Y807
MYZYZFE"\M6 *T@#!Y7E?J/4$G&28''Y53P([L]BB<+!PQ"E'! 5\KBSG;K4\
MRX0@K;N@92M+C["H/MRQ),TCF=W-U7?D^OV/.BAZC4MV<QU>8C,I2,*7X+A)
M4=F34$Z;'R/&KP/L?+)YHO9>01;F;>>\W)0:2L.X\2;"2AH7-E?A)+3DAYDO
M1PH,V%=']J]EOR_MU1H=H! 7$N5E<W&:-(?_>^V4.(C"SNF"YC"5&6BS"@]@
M9!]-%(7%5BXF*E-TB9P]E8ADO2A-G20N1(^Q>O97&6\S6@;C&[Q"O8HJP>A%
M*0&!;]J/C <%;$V%NUT]0/E&^VKR?J>"E*M-F&^_Z-IIQB/\9!D30C(<A0&R
M!4W4,//F4M=\I GI\_$^Y;DMY_ZIQJ.];DL<UTJ8D'V+C9J, )0<38$LU*@"
M74 =(+LEAST'(@R>- :[!(HDV=AC32;#]TJ&[SWTT&OESEB39B9ZPA[;O_U,
M0LXJ&F.. 2U<[^FF_X")^U^O?;F+5OSYUJQUJ\>BY\NXS:PDBTD;@LZG62M/
MA27[!EGK5P\6S[XV?/'3*K74DK5N52G6DOGK6#QKC<J@_]=*EWQ3 &N-:M](
MQ,WTPZS%*?EZ'?F6L-U[>A3UP$9?+8-^G6,'GQI?=3E;7KC.XE,OV#3OAWR+
MH!/K3/?98D6P58Q\?=ANF_"(H-2"\9)CEC>H56[L7$? #OTZGL6L=:OG/UCK
M5\?1=J^SY3OA@Q$VJ>U61ZAI3J?+A,:>#Q_@9ZU56=Y=!.\]%FW)UMVP!?^\
M\6OAZFRE8=Z"?+^C_.LP?;OX_-\+6,?1ETJA9JR#OF+G<T R?JU@[?Z]@G7S
MU_'=XAZT7074S,(S-I=U@M:2M6[5K_,OEJRLUQMTPYRV)P8'97+F%O3C9+^Z
MO@S0M-S9G[+[:G7BJS1+RZ=/[A7O,=0-QWVGWT=?'UWA\*2@-,EA^&&?PU>W
MW;*.,%;5=8ZFPN[>SRX9>I;3]([\Y./UHK7N[W45'=VJG;K6D4%QW?#RVD\4
M>,F/8&TP(H?&F7]("8LW,%X0\X(7NE*TS?%3PQ@!_/R0/A@#AC,AD:AD,[@2
MX^UT/6X%D)EA0LC\JJBO3,@'.!,BA3I#LP2NER!%R>,KT6J543I&IKQ/TT6T
M6\1F;(6X"+/7'6@\AOZG]?E.IEQL-!/P<9.Y!UDV#G6G"1S=IXR_!>-O9?U'
M,8WWPIRS]R'(CK',;2V*&#W*!8#OQL<C'6^E $F6W.YN,W=^WF-"^$,^H\D3
MV7YP _,3B0<5O2PG#+4" V!76GTM#QXP-X#&#_H?/I!;^ZE5P^<3W+HG,(#_
M][-<=]?$USMZI@3%Z1/<70^-U5Z#M32_>)Q,G5_,W$Z/4Y@BVQ0_B4O*-\!^
M1^W(<@.>=?"1-3,"*(Y\2_7XJ8F"OR_(_>V.Q:]]>%'7&1OF--,U5@T<S?^L
M&OVGKG?X^X2*H0@FQ&V%"WZ3P=$#IG5WB49F&,OWT43SL> ,5?6?-\85ZKC:
MLY]'BM][TQOWQBTMO7DN@+7)[@C[UN:,#(VO;I*[?24F R5/MF[.UJ4Z]M_@
MF^A&A 4Z9T:0UTP%ZXL.MLRD'BG3GC^EMBXHF'\Z-:)>S"E34.2S,CE E:8P
MY:CQ84*LK&?=B\-8Y5+?(2,O(R.;!U=&S^>QQ^3=>PZ!"+[0%WQZ^+_[;/)?
M+QL8/^, X#=C?5]-A0.HT.^K/SM%=Y+D&H]</V+C!K\=PG-;CU/P$,]9R."&
M0)_'^&YB,4P*[94,J-7HD2]4*!>17-HBFH]_?)G-W\(A/5!>@U">53V"K7@9
M37\S0,8DX"?'T2,%S4)BBDBAW*#80,&UDRN\W]J>AS A+PUYVZ<PGHRD0JQ3
M4G#<J]<C&=CUY',YKG;RH]N8KJYD&H\6I3)Z!2G3#EU7_4&@9=@?@)/.J8R4
M0QM(6.CF"3#AH&7 >_P%:[9;8QDV]&[:EYAY_YER>/(6IML80^,9I;R,H1$X
MR$R(W]%'3,@GRU(7,#VX1"]X025PLNX>2&7=I4/,#/[]"4]\C\IK78#Y,2&J
M)*=VQEX\U4AO$R?FPI@35V!"4KR<P7OS5 /PWL$9QLPV2^^'EB,%T*]M,+/)
M8TQ(Y\]D(1?)2I=-&.,BS0!T5N'G43T\])7H=TS(N^6GX/L$RUA4/*,_/TR=
MV-%.;S])8%S$CK"SL&W+8!W0]ZSZ!1*:[>TW]98S6%9%'S 'PT-RG9FKD!.T
M[^2S9_S^):/5!/2XZE O? <K<K5#1V-SZ\F;,1?>EDUF:UVVBCH (U[^%B#Q
MN3AL<5E>071X6=[S4^&V"N"G:"WFEI;W2406'6E+)U;C+B >:(N]!'8V5X^8
MQ!;8_@SQSB1&C8P</GA3BZ25\S+'\/N:G869DYYW7<7W63G#]X;C;W/CY/C^
M9:W$:2:D:I/&OSEE0.R8\BM GB-5O7GA)RI8->#-A/1L*/ O'NSH%J:6OC?U
M5R,*6)H7R1IE[N\L_-0ZH85)9$(.PB;[7X4Y&S+$:%86;^\$V :EFHR?='KZ
M+@)D<N7SC/CB1U:</JB2''MGFEL4"4WA05FE7NTW>Q)Z_\896A=JT\SII6JG
M@^5[[,*CX8.?:Q<!Z'T\F4.%N)L)T8MNQ-/$/.&T^P:T<QW4L^BO4R306NT9
M 8?XD/5*FB!Z]!MN<5F!:H+/&$/M84):%/&50O3]4/ GR;L(O;H;^K<GP7$6
M9O2&^&7<)*,/.[OY'W^9 !KA3,6^@U4N;H6U3R+^WL:,">$I9WR%KVLBQ4#'
M4YW/A'P4I,[J0W\1R4T\S8#[ F+_HI$ ^F]TH[;,#"@4E5IJQ'\#;R'HQM>8
MRGV^=6TPMG/S*6J.%Q_"2'MJ.4P!-:/IBM$BS+1U\[>Y]LZRUJ %W0=MJEOL
M]*^YJ=V^84-CT!%+*H-M"D,[]X)LP(@+O(<F2:PP(3%YC,-7@#PF1%_K PS@
M#@2YL5YV%<#7'$=WXKZK$.7I3,A.4D ?@RL,>!H\DZUW%AZKN]MVG<IAO_FP
MT;]J,%B9UP+Y]*/ZDBFU>:(*/RW('0=;-V<=_;RWB:;IHSIO_JW :.W3026M
MH]6.0C?N3I<-O% 3QCU"(\W1\3!.)N2O_:%D]NA6Z+;<!"BT'T+QC"-X/]E"
MQE@K$W*"^JB+G@_'3Z)$0*+EH0+H'P5!;$S(CF4F!(B#_8V0.7#>YE2V,L8B
MJ)?PZ ^TPX._I#^QNF8G5;4=P[XBN3QDK4'IA.VN2MT:L&1"(AS0-R&P[[<!
M+?"WHQ$3\M!K,S<./?H.E!DYM[0ARTUHA"\H*6^8$.A#4%@(I%!PXFJ3P8GK
M[P!_X9%A\*TL'#?XFB%0 K^+TB=R,;]$)XXQV!(<UCZEB";=DFEO@:UJ( ^Q
M'L2J:J0F#_XJ0TO<9T(>U4UQ,[C4H(RSV'$[6<9$ZR;<UTBSY0W!%X!#:6*2
MY)_H.1\ #*4B6!5Q'GJR:';3U08YEG1O@M%$/:&T"/C[N[\%;QI?378<&D,=
M; =)ZT8&FFYEZ?*A)_NN@)3)/T)/CL"30*)5W9O@-)$%*"T2_NY/B9UB0GRF
MZ[#O:'K)#*X2X =^31W)^H27\P*DUO((2U7@!]MI7>A]H/B[%Z)7!5%C?ZI(
M'(/ HAG( JGU(W]"SWD"X$!$Z.B!U!:SZ$8P-%5H77!V-,D=S7H:U?%/G52@
M7V\+!'MBP9Z)Y 88V)/%'>@R&.>*A!A<G< 8?NTD#?R[,8U5S>;P$%'Z3U7!
M;J2*C8>US^1$@XQ^IUFD<RY(: )HKZ-!]H%UV:;37PM62T'%B_!E' 9]1,K]
MR6XJV8\E]HNS++$'526"?J,=#8K7%@^>Y(-ND69",N]/$JAKK%86H MJK 5-
M12K#?054>$(6!I1)A\)\^GMPK+[#-D!>.Y8-OL>!S>KP/ +HC_3)E=]=^WM8
M6V8Q//P,=P+;O_6TD\VC^@F!7?31I2+1:RKOH:E>(-T;033N+:@VE E!^:"!
MS!08H-'1_@F<GWDP+%OI N>0'_Y:P.S?7EIRG.&Z*;F:B)XD)$-!39$D/(#]
M;F4+9K\TGHIV"9&!2C%#;:\I6S$GO-?>I\[O6BXK%;P;(Z@8OSTV4\=.O_4W
MH!4/T].MEZR\;VTKMSL)Q:GNZRHR])8I_WE@:#KYBR#HB'<&D0UHR4Z\3 A>
M THSOH@AG2&(8VG=$GQ_WD$5F/U)X75&C9L1$60N'<PD=_&3P1#_Z4P3>G,.
M#/ECBU(9>]5FTJ"K6H I@S:&)JMMQX)B\ 04 WWT&Q',&I:V&YJQ"'8\3/X
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MKT("(15S/U-V=2L:TUUKT+.P+>L@%$<@>.U>,4(%,,UIV^VK FR^N$]+<F)
MHFZ;FR+M'\$E.4VJJAFZ!,,/?].M!_O"%2P=9DS,#>%3NAP)>8R.L=5_3PN]
M.]1XC-TWI0R\)WDH$;:M&T]3X:UJ-^9G6NDBK7G#,.>O8:?N2Q)G_NP?Z_PQ
M&&RZ7@N%;09?IN/-DK?\?W",&;((SGYK3?D6P105(:"E4+Q ,L4Z&@]#@Q$2
M,__@/?"_D.!/]O9M9-;I]AZ/9WE5XO,J<>3[FO7@K0\+;KV_H)7^JTZT8S,F
M*V.,BT#_$H-BP@$VH-<<MA9I.T(8E=H*UD>?N'E<SWV=X-D/[S)^W\&3^:DJ
MU>ZNFN+NN,LW7#Y:1=J,1Z$?/;*#R1VT;H:61\0C'T&:UV)K\ =0%Y0ZL ='
MC-T:9&$4_HYO-..HH@#U=YZQ?>T_XYLD6T?GO&(]<9*L]_I*CC"V"I6'#EW5
MI)D1\'*Y@VIXLC+5I"TH(\-#WO+('@ALE9I:?O6DB5JB4%C,T<L;-B7\2.+J
M+ -J^0M3?,5W?(2V@BJ]XWB'X84P;'6\Q$I G71K%!O6CN-I.Y)M;^^65F<T
M6YV6:-_2^ (F4Y;B._5=D!0;(9]]LA'$*H"0/F*$],\@Q0$!BD#$I:E\6 '"
MNH6&O$6;_(9=)K"RW3R\X##M#_6\4R73L%/'PH628U\:(Y"J14QU[#>M.L;W
M/(/!498V4#O3"UAB#B$M*.AR5CU;J%MQ^3Y#-V,N..=[V-P8_DB-WX0+SU]2
M.H]_ B=RL:5SZ!Y_D_.L8%; @)G6[RV!+\'%JU#G*<V*GZ,9M.7*8)59?"Q$
M?"N!:$A_"W3KQ%"N6+/%U@CX4.&H%37U67/([<$J%=-2I_3KK_CD3WT%>7*7
MD@>T2=,"'%_<(*.90N,&P&0VTQLHS -R6AIEJX<VXZ2[[HDWRH1,*EQ5<RZS
M5-%QZEGP._5NEH2LZCLL:B^<7)GAL(N-<XJPK_MF!XV&W&(:T%)GK@$;V8A3
M2#!E>=D!9I[%8AIY..--!H@ZAXYG/6,FZ9M:=LC3.KR@AX%\>@I-O)B!9/=L
M)V!A5AR1I$3 &CH.O8#9C8G_6+HC^4:S15*^?%WTBT)@]"SZJ7H(6@1/RMD#
M@>!L;7>(+/L,!V0;E>L;TUKJ=".T0Q]]_'W>4"O1KN-*>;:$_/F0N4X%&6_O
MCHN/U,3.7%;/&*IA_Q-TY.QD&A.R [9"&K%P$#*(5<GDHJ+90FL<]=?BE3/E
M/DV<AJ^SV^@^">J=ZSVLZ:FIKYO:JV([F0Q#ICR01E.G[X%8Z4R5&0%9=(OZ
MS'ND2 &!<@3=O"!\2V@/%.CA^&"PI?^E/EK]3&UU?/@W.[K!5YKUR@P'#4_1
M:IJ/X2/U+P%AI!VF/(R2J0&5<(^X/_AB\>;4_;*8\'WO):NO98'NQ,\.W50-
M$(D9'@E:+K:6^5UZ?V!XA&E1O1P!O*>E+I"G6Z'<O\\!D+;&XQ'M$M;B ^[I
MEFF9SA]Y<XXJ-" 3U&0RBP(ZN:U_@JG6DS[M'>U@$%*;A $CDLFK';'(Q[L.
M\]FY]AH7P[)GM1Z%F+Y*RE[G>C@3W0JLD2V$4=_1,GAG :Y%B&BC,B+#8KC!
MH?B([5JK_LFDI37KV'$^\6/A!M)=PN<O"PV&R2J?(=^[DQR4__F;R![HY",C
MK8R@:0LS3(!U'-.?A860;Z &\ ?8,N@6""M_#\0?N&Q9S>YC^">SDNG'C+[V
MILS59.+])N#F7WN[^QO%@ W:O?M0(IR2A^E0C\/(H+@=[);O$:C$!9.@.$B+
MYF+3/IA6OZ%(AV;%_B<BYR0EORN\4EKM9IA.H[H:S[&B40K(ZR-:N$B)*=F(
MUA$)6TQ8;R:<P@<V#S\MMU]48%HK\<FK2@F%YRKN"($ )>S &E[%O;?T\YN6
MI>3A1;:UR9*EV#J&*<Q$U,_XO_)$74*,=TBD_\FF7=*N'6BXDK_D7?V*#-.^
M8.:*);SK;B)REVNL3?#V^(OOEG]5N4?W>?YMQ>=^@FKMM>C3)=__=<+:(M2)
M80IU^%5PX:UR+>G@AC0-U8?BSD:J5SNY+LA^_\C_UGKA*&8/Q*.'/#*$S4T?
M:0++G'T4$Y&D)F#A>TNS4V)4Q@=JBVJ#4&^#PZ$UVZ_6M/$1@:TC+F:)CP=?
M,+X?^4;_T,-GH:&7& XBORW/S.5Z<W4)&X*[H3=TLE^G,*+X0(")(;'@4_3<
M^7_Y?,J82-^O#=H?H>[W2N(.8N"G?L9('GA_QTQ0XVH/C[?*1HW%'B@T"W5@
M*;7? DY2CQNP([#+'VQ>N=*O=SBS%2KST,=!]'D5##K63M?.-_;5YQ" P.B=
M$5(O4S2B>0]45;-20UF+A!Q4PR%]2P#'=C>!L$E41^&QJJ@L%3>Q<HF?X^MU
M$E:$ ZH_[OM"O^ Z<,=0_>B*U!0*+A(JH*T>KJ]8GXYPZ5-/_2?%4J:HJ_R^
MJ>"%6972H-D0OO>/%D0G4DI6%[8]S]Q]>P^>O2)Z!ZKT;S7]2'_S6Z];  \P
M-$..DTOM@7B/L+XE,,/1E:C)^9T]D.YN9$-#P!7]9W^6SO]LCYWC,U>3AS'I
MHFZ=;9W/:O2__!\S6>0T?(NX59%.H3Q875W]U:E:?NY^W-7.O]MV9Y/[BY=W
M60EA+RYW6]RKKQG89.F+?ZVM_?K&1%2HH$OS/ ETT%2;R5'AS8YX4B5*@57+
MM"Q Z#;76-L*M-A)I9\FQ<7Z  FP_4JU:Q4J;V,^RE3;Y?OQ[+LGIO_@=^I:
MV5!8RX_*DNJEWGXT<8%]5!.095Q<UOS-EG PHZ16P1/E7?L5;)\]TUS/R/_N
MM"9]87L5*H4@L(]B@<+ 54X/[($(D(C=QYQ/@XH-C?++Y==]=JWGXL2VWGK;
MJXH7O]_)FM.K>VU5Q,Y?_);/E!6CL6?6$!#2]DU:GCN$F6GKAZ'Z1'04LK=?
MHX10THX<4.X<VDG^3-^U8O\MV[/2H+0NWQ@/#0]J!N?YX:G>N [3WFXRY/5T
M^/L"]+J'NRVZN0,M<U9_.PPEAI)V_KOE17%DX2!FNQAMOFI"=Q39$5J\\^,Y
M/-"5)<H1%J&1^MKVP6O\S+-,K?$]$/LFULP"N" QH]8Q1>TEJ!-N->Z!9NN8
MVP-!U@:?Z?FLM-?L?P)?>.MQ327I,SG7AVPQ'WYE3!T#/ "W;3PSS3850W40
MB+$&!Q'P1_'\_+WL&[C0S:FA7V[?"M'.9$BB7)Z<;)?CYIWMCM=X4@U;SP9"
M\2(+\$[A[&TR8NXE%)N>"@93Y=F'VJAKE.Y-OTN#_EG\C6^.8)'+IS(P!AHS
M8&M+N:T=S;])/:8'@JPLRV^>,LH-@/JR'@SC#\PA(L<,$[=CT,EU3($IF-E7
MW*I3%I]\NM1;/6_CYI3!V!!>4LCEZ"2\.N01?AQGS<)H%SM(V'_].H@4.3]*
MU>W9]335?W*%EN2=>=3[XO*N?YY[]>Z?]_  %RU_G9H[)5^ZI";*Y0^'"'S%
M)?_4V'UGL]YUGXX>N;?><YP\86QI<ZVT+(UP-H&9OA0C>L<H8*'W/^J(_,^'
M6 Q-@*(80<UHOI06I6=>_.!WX-$$+ONI:<<;\N%3VE(*R;O[.B]P*5#PDFAX
M+W QH[51#5]/76NR$Z/VI(DFB  9=VM,UW"BPEP&7*$RRB87WUQ>OW#MB-^C
M<]IE&E7:&[]?/*(.J5PV ->(6J_?HSG1&X%"VH!U.J-M#R3(=*+P_=&GU@\]
M=6W:?+#][,[*QT,;GQ^OV$2IWC*]LDQ,./)C:LN"P#YT17).H 0O "C1=8W0
M,B\LT<7HS0TJ9\@A*^@U-IAJL>(=S;[P.X=EMP?*QT0P!=D=[#T0F2/PV!VG
M<3/QT9 A_&X @&X6^/_T_.6<?_9 R9$T759,N@G[[9(OT9K6870?\'\_3?1;
M'+.KK4+6$,TR,C[9^9GZKT/*?J@ ,Y_R__OM1<#_M68S)6S_TX.Z1[.O'%]2
M9N'_XT]:\2;H&LYO".Z'RHY(Z)H UM5@.V(X80O.SD*!J>8YA)$]4-K?9G<G
M/N&35> -*M?&UP[]]\MU$@Y/LQW1LWBJQ1(]FGW? P5@^5&5_S%D'G(B>.8W
M#I:@29C!+3'F5[O@I;[J1:"/C=T##?02V'SE),8>J&N-F;8'JH;D+ZGL)%;]
M5F;EW_@?+7!/LZ&<%EAE+/4^:'<P;E(LV\-DET/O+" "@&(?R8QS_=^-X7]O
MD'M(9:>W/"7;V?FIU;TW!LUBB] C:+?I2/0A]=09 EN3)I[^0V?%; 3Q(%!R
M]"V\5?K]\PGLGT&FVNZ7--"MZ?J2C(TXO/4.N&'0>J%W)89#\MX&&__IO084
MPP]I]?,FMXI[1?;Y3%%.-$EU],J!P"WGS(/W0)_=_7:',4<F/U G;2>.)YUY
M_+SS9)8!]W,#G(!8:'%$FIKEQN_>-S_78ZWVYRLJZC3VOF"!-SM_<\*V7M.G
M!EWZ>5:5%H880P"[?%U_,2W^X*RZJN$C%]#A;G'TRP^T)&N9V8<8;RSL3N:9
M.E^Q]$ME7Y5';_2$G]0KAXY,B+4Q[^Z!$GO)(ZS8N^C%XMM_BZU'0]<O,B_M
M@<JB+5C:[J*_F5"E'8TOD#8T&<-.E*_\6S3D_VDBA,+F1G_/+$2/MG&&;[%_
MZ>\<S__^S3">=FJIYR>!M90/8.8Y</3$ZU^BT7_ED/_T([8D.R6<5_YXM&T7
MK2:N,B%\2FBPBH6^6]&WZ2 W^0<']\P5(G@(QU9HRH'VA_E_$C#D4'- "<T4
M)MQAQ>Z!W'HC4>>'JK"7K7\]-7V! =D8:"69DEF*L$Z<8LT;/?>B;M5H+ZE'
M;SH@.@<7.M;&^&?D7C&>]=(J2(U55(J'H0-UTU%V:#-!NLVO>E'&XIMSB-WM
M'H')'X+[CG_X$-=(9FBAAJ<%]D#/!/BF8?BC59T-!CF+(T_;816?'<;:G4=Q
MKW6%3.:/E.9[>T+?^3@F.J2<MTRQ5LX@=FOOR@IC[V76PJOS"7L@+CPI"R*A
M=XID08SO;4>=INI\*T4B!A2E@U=#[&T)\* KKX?75?LD>]/VFYX\<-K9.]HF
M?"VUALFA1-PL6FH8!3K:L^YA05"36%G+AKIER?-Y782-N?2?*#=T>6>\)6S<
M^EXOIS(T!'6'?D1,H_V^!W[9$_K=0DB7%6"WKJ_, 0<GQC74#Y0F+36""FV;
MYI<'G&;4'&=L:Z"B-E-F1<!=6-93\4+>]5)!W9\Q*J=[[3?JD_L@I*1I02T.
M5N-:\!%^CJK4/%QKPFN4.J:MSGFBK]OW$_0'W#,__N)@>]+#W.6DPO4O#S5X
MW5G[/A4O#R%K+#Q6?7%3D)*;0,8U5L(>R)7CJ-7;+>A8L'#5VFNP,U7974?7
M%AQAQ1+F#XIY'*.J:2[E]MGMEHV]<62D3JKJ]55]+G8G1N1ODLUQ' 4:4SEI
MT128UK(6;1OBOOO:'P)+<"S[>OT0+\42>B)G.K9"QR_^/:[0M3!5V</.S';\
M!0>9-)P=S>W,L;N8@P /FT^)$J=+5^C7$PFFQ$D8 <FD:6E[8( @_>?]_*2M
MS81V5Y?TC=+$BASY5=]VS1#=?:$C=NR./9 ,Q\[PL5-<PVQ]()0<APMC2RW!
M<&[IX%<SW[R*W>_$&GCYGB*&A.@E%4KJ9=DVMG[*:+_O[SDR\GEDBK#;.KTU
ML;--5V>]11HQ+B%M@3D<S#]=;0C3VBO535%34WV::GJ\YH4E_SG$+]7WLH)?
M]T#N"8"2^DH.17V,GRP1N2D@/.5:,Y+>$>VKYBTQH)AZ/94_RO]369+6B:8E
MT'&YUR._[EO=;;UEFC\\'=YZHR1S;7CZU3J:8^U@RD($_MFBOC92=%A?KCH?
MYRJ$0#OV,9_6P-R713-RLJ34+#^<D[S[>E_SQ8O'D /D7D[\H6PEO$2[/T Z
M4'#[EN44@1T7P;*Z+W89=F:P!$5++]6GBJXS5F\.*#]Y7)P<X@5]PD2P/NK)
M,S28ES!M61>&\&5Z$ \]G7Z'X%189OD-RH7V[W>F4Q]J2'#ID:P?'>[R.O0]
MW_OKX?Q!:>*%NK*0 7.QU;%\V(ZK:W&W"9O'PR(%[889=6K#<W@_*=F<"C8;
MU+L,I\R0)\'7&<Z#&V<SYHGF,(6X;X_==!*Y5O4=357>7&R%@O%."=&.<JS\
M$GU-I, (4L"-4MQ]"'(42#:BN=OO@9S=J?_X'.XZ55=9J!S<MTXJD+W(LRRM
M+!]=4+F(FX&QK[\;3F*BP1RG +_"4V_!96!H08[%QD%G_+Z1P8*&M WC_LWQ
M,.J$CQV_0$6S%_])A<+U$IC"-=VS*_,:/?LNG&>>_[L?%;;VNO% 'TIZ$2S4
M>+2#U'W@\9=*VK-=Y[F.J$]E"?LD5DJ/Y-P0/##18[!DH#<R,'6"E8T$DRWB
MT@4(6,,'#$AL@[FS3O9G-\X39S8.<"L)0](+'ML':NX/XG+(LR^S]$^R\IMT
M^U1>,W&_V**(>=D5N4V"CD%:LSC=%1*'Z**PAM@QNA%Z1F0SV4-3W*D6-:I4
M'8=)O3))P]$(I5%K,88#)^BNX=T$Q@?(2FV7'>Z955#77K<DB(S>6#_57DBW
ML9TG/"X23?8@.->4D^\[^1ML=8M]\+*4/^O\#;M>%67Y&:.QZC3KX<_FJRUP
MAU(M@W5G2BY]3LT2"#5C&/6\L6$/*%9^.:;U56AE_4?P6U+M\_&7.Q93!?JG
MV=_1,OHR;.*4-E!+M;,'')[CA2LG]0FV PVP Z1+/C9M<R:GBL?W/Q#KTCA_
MVW26RLO8'XW##BZ7IN[P#"N-5#6:<'RQ+']E#U2,:@8?86M.,?UI>,)XMP2%
M)T9=S\*G)*"]A:][@C<YM^]'L4Q0K,LSU]YF>:4\+PCUZO18=2\9W60A@5@?
M]C!>&J'(U:K394;&-N*C7'L/1!Y?WP<]/U(])L$E@ZE&G42J4WO;UHY4)U!Z
MC_YV/-TO;?1N=(DNY#@NX6C94&N9]GS%*]%VUR\3GOO $.;&K5-=_?UDM.1M
M!:_CDH>*+H".@F25\V+>9I_^-@>C_RJT]E3S]<-_7^\=SZ%[U;%*(4\P,LB+
MY8,/^^%Z=QZJK?Y9N-9G=/)[TF?J1:(-2.')2]/F1<<3,^JC<,I".WJ,0?[6
M$=E@0!(XC/0 ((4Q:X>7TH4=)EW[_Y%_X,B?\DXA[VG<U>2'DDWCB1]8#C01
MBGXH-:$Y,")*[TZ)V^[1T#SC4PWXQLQ'-=5WFPU</ \^>'G%E*L0JZ9N636B
M-1[4I1+IN?(GQR8[2T) YCM!^>]DQ$5NJQ<TL1.B.55K-:GXP(G(P;=6$9WL
M(ZPWC1I(?U8.4F1F+8&X0$@I!YX.3 !!A$8^L_:J=+KEJ.>?SW66?LZ.8J(>
MW%R8;_4C>$_\6 3[F";=C(8C: ]E&":WZ22VB5$3?@J:BO;U9*0=3U$3+GZX
MX*:]?/]NZDG/&[!;#M@!W+R2E?5=!QT(A*V*:MT#526LBN0@-<MH$5&-7#:+
M>R#^!IM<1#RQRRCT3IQO>#EZ*_DZ#7PF1'S_Z>1'9[T)_ GV0#[5C)Y,->E0
M%T8DDZ%Q#5P4.#^B\<)-MA3P>C?4[K?PIU4?YU/5,W.=23>?%5T"(1:6;BA/
M:5A\JH%);$7Y0;UH8 *'@L);\:^@Y56E<21TM!5*"G@/CGE*2_F9:E5.(-?O
M.#]KS#Q5_@5=MGIH'X/@=OS(J#2&PQ<>[8&BIR7Q,"P7I:/##/.:/H"P,&KH
M*]GLY6Y&[(&(,.\\F<G>%V(_BC0/&$D>J$CL07W_%!%;\&>R= U;->(5_#AP
M#V2'$6"JLQ+P;M-C/"W6Z*.-@L  ^=0VP;<NRUR<T5:]W5N*")3*=3E?=.TS
M?X)JF;)]P94F&>L"9  +P[YLZD,"BR!U@;R\"41-2QV:CJKYC$B=@J$%@"_E
M<2,:;>YHKW/(-W<D04W/)7@6#YTQ$],]^S1E]W?5%H^M^>3XGPF 0#9ABM13
MC&MG<#$8P8:@&<A1A"Y%MW55>MJH&D,>M#YG^SO+0L5W_N9=M_FG_$E^<X9G
MGT^K7^1PM%%K^AM6X0O( 4")LAW5>'@"N-R\.Y1:PC[>AU6?I9W-HUM]EWS'
M^S# F*M.T^>[) <C[EL&^WU"$@/<JE-_H1]DKK%.?/E'C7Q]Y/*=:[$,ZW;,
M%P[KP[&E0FV!(7 4;K,;9@B$76E/R1XG=LGK9&9?'_A:_?QW\;'4VK?EG[<6
M.W_K=W\JR[=]'A/K&#^R(R2=%.WE8!&+?H0!%/.C(<ZXT0Y*Q"OM;G^C$3VG
MF>]KV.S!G/2G-?%<3U17<OQ<AUIRW3->6K7;':A?$QBU:.-HF1-[H$,B#!,"
MAOH.W:*:KC2NWZ=+AW\XE#3.Q&FZR"(;&-;#HE;E[???UF9M6\Q'IY[TF-RN
M78]/8? "1>/T=$!BYEC&VA'S3TPMZDVV]+#:SP&MD7N=TJ6/[HF/Q(0FK42
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MQM2.+L&"S=HCZ]KK^C+QM+.F4B=?OPDTTS@O+WN\PQ :D;+5P90PI'1/M^&
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MM+8;#> \<_A]W#0>5C7,7;TV?MWYN03BR'I<ONX>Z%$OH*#>ICYNV**CKSP
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MLL'*G==?NJ5^&_3P_LG/Y@FYH+V;R)!@$Z5=5B^3O6!^CP:8-H]?.A!=]I-
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M% C2P98B/)CFGV#Z1W2];"OO],YV<E,G->L: PYC:[@&:1S2TOR@06 &+0*
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M'O(2.-)*0A<E.M(@.0*#>6F7!R3;FLMV:48\V-8A76UR//KG AY0V8[=$HA
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M27;;<"#6I*GPO06K',W8"'W9M.'HXL/I&@E6 5*%(8/PIX?_-^K>,ZJI:%T
MC(K2! 1!.E%I*B4B(%6B(DT$Q$+H41$4$!!I04.BH/2.@-*B(+U$NK1$"%40
MI$M  @%4>@(8#J0P\;XV<^];:]Z\-3]F?IR5K+/V.?OKY>R]OV\<R4L),9 R
MP!0NV=<E>/FA A97'ZC).CG4;7)X=%Y</+H36T3P$^(+)JVT4, P2NWZ:KYH
MA,$!8'G6)UP?35D3H:3%^.6;DMP16Y/?,^1/MUCT55W%SBNIEYK>VM"AH6/Q
M7/H.)>A67 8Z=!4)(2LEB!426H[UU)RJF<#<=(CL*'S+7<_[,SBFMJKIR?FL
M>+Y;Q8.Q0U6C'<@,V'(!WM=28R2Y:A3;X3FRY9. J>M*:#:A[H$(>&X<QV^4
MP)B^73$0@KQ9LBQS*B> G7.*ZMVS,5533NYN/U)BO(^30P@6"231?5!#8$Z#
M_4C;!JHB <K;,9?P2LF]I"#?W14-><5PR&_XVEJ3E"VA0[;HZ]XPF H9ZS]D
M7#\+ET!U8FJ#7K'4)QEZU/J$9D5R0@3-69QZ,"*<[5[K/.VE5W%C<:SNJTV=
M7\[7Z=AP:L]H-;*^XD4,3J#&U8$-'TF&3N9G-,^?4Z+7OFE\17U=;38J[J16
M_3 /$LWH/>SUZ8S)1P.M^SG<'9U'HI.C?8<=EI\MX<T#1SH'HRWDQG+J<?CQ
MOE\L%=1T1OFO>/P#KP.S^14Q)5-(C]<>XS>6SO:<G'B8]+GZZ[G@)P43MMJW
MW)2;7GRI%_DCCW)GF_1C^ ?@(P_Q-5;M<>;MXQ^7)>"M9JHH,83Q(O?]#:$-
MA[?=JTDXX2G0\=,WOXTONOK-G6[+8F;I!JR'H)7$R;)BYLG0\:W0Z%,5ZEG_
MLT,\'UF*3E_O4B;;U5OE$@?XW_K)/3'NL#\OJ,8AV'U\,^GRZ'>^+TJ4=1:W
M.ET7^80=4[Q%2E--HBKPGC[Q,@*9A-U/0T-<M3\N[[CU<:MN6,S??P)TU=MO
MXP'Y=8:P)UFK#2_!&L0<1FE[UF..H&<Q6^7F3KJC567UX^=W_:H<V\L6](=F
ME(Q=3[R8$G_>2;I19S_;]UY>4=+)<V2U.,RW,;9B[#?3+!<GS\R"SN"@''@/
MJU@93@HDW']=!AO9'*#\K55D.MM+PCT.G($>LO,6XUL6=-U@$,(=5_L/H3LQ
M@+8?.S70I)K<H#0F2"&JZ<?\O(J6&@^E2'=F/CCN578XV4+R+%]2@\CKQ,=6
M(@-_#IMH*<HVI(]ZD-)3IW9C:%AF"D.4[HX4PU' "<K>V!K)12'TEF=Z?<;T
MPQZU+_&%ZZ<5PP]:/381V<2N_#WERB$#R%(DYPZES\7$#,@ VT[?7,UJJLDM
M=R%WAZ?5WTP(:>?R?=QXOPT*[KPH.XZ38S/=A"7(=AY)R@;:<,1;[^9]92?1
M;E/$R_<_C;@^^>S0(4@(;LU+/'?^?+!/TT,;V0U%%J\XVR#H &P#=U"X!C@S
MS3O\=T\D(LCQ4\;20+O$4_N^;P,T:^'*-_/)6L9JGV8WU+KG83:'PL^@&V-\
MXXMQ1+19YEWW\?2&8T-+J'5HI++LN*BYY[+FR(>(5=Z';O +N?U:+_M7&^:T
M.ST6D ?(+88S%S ,T4F"FN/$W^-EKWX%Y)I)EU5:>"!5%M"N4Y7N^] UW 9]
MR:=NPR'!-DI9GQ;Q[G@ DOX9,Q%#9I7/9!8QW,E,!\*&6( [4K. $.!98%K(
MGVPF-[B_&^&5&9I5O//B0.K,DI:(A99_#FDLQPT*RW2_I!7@MQI=6($()1 D
M_)P]8&-/0W*/E%_HZSWL8?;YX)L7/<=Y&*MLF7S/)J);&4.:SHF =^Z!]@=\
M?6)QDWRP/<Q\?-7_H:J7OT^5E7>]S7:/OV1/ZLO)ZV*9OARAA\9\+C#?X;W8
M;@!=S\D0$B#H_NJ*DYR['\CVU[F+NRVT&)>[A22/1A+-KSD]K7LC6,BNI_')
MN=+MD3*/BTKY^G6EUEFI*8&;].AP(:_3%S+K,5.HC]9P9:0-&Z1DAB@S%.\J
M$/YT#%_DF;8+BZSA5:#T1R?&M'C31ARNW'RR/M$@F*A7\R)(ZI!<;#7M)/NA
M#J0TLXD1$C +YNLA6_$!;5P9B!HKH>_YV3_F/;3TC!9ZY![=1MUK(JSV>AU7
MD]H#W2[M7CJ%NSTR\/W6PB^S[[NRY&V" R26G8$RK&>85\F[ Y94MY2@/"<K
ME^/Q2UP5)Q!.9+?#QRY67$W^L']?ZZ*S"?T0NO4\3H)-0%T&I-R==2#"MKF%
M*MQSOK#44^NT'QIQ1"LMMCORA:A?H@BG:ONO6(15)#LE)&.?LT3&FMWSG7[O
M@838=K59I.1\JBJ&/\%'8S=3+D6N:G+UT^D%X[N2&3:Q+)K^H=Z#NWHT,+,9
M]?=3X$66\ "9%+&M&U5;V7@>-F8?]ZF^^6/FP\=5)ZLA9SZ'V[CJ;R9>'/+W
MU2C6E!MQPDYV%]\LY](8MKZ0$<TH8A-J@7$%8&-)N0Z?(,T.A+).(39G^S%4
M'G.ODQM.!^P:JV][9INI,&C1IZWOWX=U3QG[QD;/XKT'N%"#&(I1IL!!QO6A
M/9 [1 )I^RV STLCSM"(ZC@\(%4Q:'ZNHJ?PC=BTMNN-W]:#=4?,H*I;&],(
M LFLUQ7[T_TP^%Q",U8EB7[""(FAFZ-;[^.$4%_&I@5KQM]3+1O( V*+YXE?
ML>'->G?J=V//6F9^ZVF8B_/;O.,S=3E95&IT8&(/Q.)A0XZFI0#B5-'.:>F4
M]J0>"M:T88QA.+N\+%P_YE4^$V[F<-_-ZG3/1K;QQ&/)?='>'!LA-^HA4*7*
MA-&E)YMVWW>3HQF;&!8_G)E#IE2DERK$4:_.0GZD_>2J<0A,,=U_.=I;<M7
M]D?<9^.U2=-NCA=P*\0FBT>>DCZ+7TG*9WB/ZE^M!#@=0D_[+[^N#_R$2[[8
M<=S4MZG_B_8IWYJ\M>.G3Y;<66[[<OWI[Y;+MD\K:\E_+C1& VRKPJ;^"E*
M68Y3<\<='':AIK_27/6+DT>:%71X\I>8RE^QDAJ*Q?%_HP<)ODB^"-5$M^I
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M=T%JVL3OLJ_*Y0..";ZW+OT0$FR$W*9?0+>:-H/I%Q'X#AGQE+8]D* ^YYP
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M>")FV(G4'DBX=IUKT8 '**<JWJ)$YR&BK0XA@NA7)R].-;5-F0X9'WATL*Z
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M,*?N%2VE0^+=QS>=*Y344Z^6=]#3+<?,%J<GF;\"'KEDFV/#ERMW*MF.11Z
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M<P^DE*IL1%)WV@-)8B20[$#H]=@/]$0C:0^T.%O: [W#YA%\EI.P#IS4_)E
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M.](+CM9XPP(O-DHNZ1I&O1M9S[V?87O7OSM[3-A_QV_D%)V@O_;>';PJ2^=
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MA?C4;L%^;VVY,FVT1K=7!^'XF1!!K=6(8F"8Q>-'66]E"5+34BJ0JE3H<TA
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M:M+;/,!VY?BD7AZ>]BLIX=ZM[3S:$AB"&X:+X'D-+-W3@6PR3Y"!3B',:6E
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M1<955XQ%P:,()9@PE '3%G"?5+VW:E?>;RB^(*&7$"^6W*TH(0P]^+J)E/G
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M 1[(+T!"@I;5#XP8D?(=]O9:!.8T6;4O\E4E7([T^'[(J6+GEU:F"*05O-_
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M=%M]B)B&NQ0E43[GS(88=RBEJ=+1D-I-FUO=(F0X4P1-SP&<)W.+#'R=&(9
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MQCX1[J8%$QKQ%ZX]*>[N9RTH6QR[3R ZK_%09.3!"T?PMVE8IC"&'-:B+H"
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M"FL?UNNS7LI1B^LVL4$V^(AGTBNKYX[?.RQ@(N;7YD$?3P?J:/IW6.D0MW%
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M27&*RSQ;&:-TEX!0,%'JN1JT^,+.*C]T)L[Z1@\W2"655^,\ D:F[KA<7A[
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MQ@=G\W )I<:MYFF6CQXF3>FG\GM-VJ7!1G]V8RE7L8 1DA )=^"((X0&8YQ
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M9SB'GY2*EDF<$%I \##3&WDH]':,YD@UEK]%:K,].*$:>-6OBS[GEO"IT]]
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MX7N8NCOUJH<=,O!?U[0J;IE$;@IF!VI4T T1O1!^CGT*W=M!P$=FBU513Z;
MGJ!OR54:'ZJMC-^;:"HHEX@^WW-6 S5ZG-STH=:M_Z>$_QA%%M>%\_9!+SC-
M@2-QI:5L$$/RW(S-O<_H#'?PBZJ.IY+/N-S]M=;/6^]).2%FS_WVK-[^,AV.
MYSCC( P#CI5'CU<W\.+F$XGCOER'3[F/&:\Z&;TBG>E)S T-W"4BVEQ>Q.)"
MMF@@]K/ZD(>7X;8SJ-UVOQQEAY;G/D4S-7BZ/R2)[7<^DG[BOMJ1O)_)WG^
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M+$5ZB%,\CW7\%N# !AGH=.$!?E<VJ-UZ\>51I/L#-BB+M6MCD0WZBK#FY"J
M>;"_"@+H;- N,@2(AA"%^%_B?ULT<J3B#QJ*88 H-#>BU:ILX6? ?P/]+P'-
MQJ/8("X,0ZT10!6[*%'ENTRX4/GCT/>A/ XK0[U^L06SG2#T;<BT_DC3/XN
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MD1I:%LM0H7H0T?$8\B745,B<2A?-(2O+4* XZI6%BF' Y0?Z7#S%>?O0?5!
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MLQ#>AC["X@@!OFW^(P#>]!-5-';[\AGCJN'[!YX=*#JJ':C567"T[*798Z=
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M6V*\#M>:A15@A$E*P/D:)I30.2=9\:6EKYVD;.'7.@#-Q$+=]/1#?<TQT^)
M!S4M_\6E5UVF#0@$;46ZQ+HDV%P*H"S8;J%PXJ!9)(#E5WXB3\:H9<.B/3N'
M@G4B]3#])3ON>'C\40"[EC/E[&UUS7U4'&*"3&$ =NCH+0/.3C" 3W'/?[[Z
MF2<!KI]AF4UOMO4>( T.VNE=EODQ=>LFW#=44.5\!MZ;2:W+?S6E:11I1!VA
M+A N/5Y>,8\$B[8.@RD=VQ#@/".>+%N*T+_$.3'!D)A3M%NL^FR#*,R^TR7?
M9WG^Y9++P*: .W0" \(#DA9H'HVP9M*XYJ<J5)*[&*MPZ+[IT;+O\>@2$]OX
MNG#/M(OI:C[WT]_41P^(RPH(+]L<3COVW,'^>T#+-F2F77'%IGN3P>E]C!<,
M<V8_'^!I^CHSI-_: PG60':Z=$RD7O.@<ZB1(B<U[GR/#I,R_$54(C'(6EY#
MJ!XUTLFVP8SH3>P:EZL9A -+C2_F9.DST27:IS$+BY;#*<U',$QW%Q3NJ-KQ
M]@@#&?(;DG'>C=R%)#8QQ]K7<Q()XW4PJB46-:90]W));60IG$Q-!8AACB@%
M+G#,E)^6%G?*+AOZ9%S_.!RU6U+F?,*'H/X]Q5K%_#SRI-TG5)(61:=Z%7 [
MAO#0R]=IT@C"&X->B;#) ,_X;@<U23>T[?77G1^:1M.$S4 9MHQ,T9!&=58#
M^AR?O! N9=/1U42!P9_W[!1PM[A).#0PRUQ.U@^0!1]UR!H]Z(WP+!*#BHG"
MU1?[X9!*^%XUS662?U1>[BS!@P9J3-.$:!YFMR?);?=M&.V*ZT2R0RTKOM!7
MSWA.RGW)*CA\/SJH_=M+CZB8J(E #,K>?BWI1VTIA9"C3'?ZYK:$0P&=; ]N
M&7X7SOA/$#.)3"0+CS31-77)S\$2A\^4:RQ#LL=SD:&%YU!K^.\[=MS1/*D@
MU-#=^S7@$LMJ<82)270_2/T4@A($'TW2."IRV>->Z7-RQ_3KLG*/RM_W]-(^
M5N$EM1[8$WG"XD*YHW^C5"0IZ+&O6;#Y_CZD!X(>.TEL&J%$\V3 .*"4*MOX
MEFY!2ER#:@VRSCUZ89OU0U8&YATN:7BXS.76;R=W[32=G1I:V& BA]?9'&X.
M1Q3 ./2MCJ%;E 4&=*K660<D+[O,B4(]?J\]ZF%Q;.<'=_,SGC''M%;[RT-@
M\3RE+QSL52:Z4=BBGJ6<)3;BXE=YJ6W]32"2D78B>=GBYMQS@?'J>&/K&GC]
MZE@UMF(J*;1A96OX!R(.>063@I3&JW(LP2Q6;)ORCGK6>J*I1/@$88_ODP-H
MRH+_WO&0("]?'Y3!XVEO[=.23VNAT4W?H6PI5B#_<V?%)Y[W>)\ !N<0#$@Y
ME,3NK;+C/IH]XH F9,W<F%CY-DNG_IE?F:U;4)-IAWNC,I3)00I\(])I;!C+
MIQ/SU;-I&R(>?/],ZYO-]?@ ?=N4DI3W,[8G9-^]>JBF?78Z3ZGNU),M/U([
MX>L0D](*H\>Z@'6 G#M@1J5,^9O3.]OQRJP8-UT20;WB1LS<$?\+[S($WQU\
M)0S/S.P<?'BA4^9X2? 0JV;CX'U?'3."U!2&N TI)W0&T!/8%QZUXHU815$A
M" 4WD(8:FHKOZL<J02TK:])=2J]D=H?/F.H)/_3*[CBYLU&*/<K--+7:LI['
M""[IFXQ)#B(3S/4K6<K/$3/9>F9O-<]HFZA%]A\ H-?Y8L"Y;\!^[=68*QU3
M%"DP8C/?O6;N4L_-Q!\.D^/MMBOAN /XP@D3BA X?_;/SZ:VWJ\?50V\[O]B
M$U_YXV''0BMY_%AT9G.G61%'6HMM3>56T'S:@?&44C1(:+MK3O%A[I%EST@9
M5(5FE[D>U=Q[UD=[KUYJ;&PJ+"B?-*C1H[!VG[8SLJJL\ M,)(S!UN2^(/ 7
MQ8];".?-TFJ#"=X(WH;$W?T^ +4!^@8(_6K>.[Y)H11TCGR-LKIW\EBHE/O(
ME@*^RUR5^QB/P 6QA&K"\\=<.&=9J>,J_?T=ONZ7=,9D3G]0-A [9&6ABZ13
MGKXL?I6<5_"^L-1?[C%?RA>ZV@7QQ4OL[8G' CS1(TR0YOV(MO<]DR+Q%VU_
M,"*19(X$LBN]9\9<7<]Z(PXX[V85R'BKNYU4*QJ'Q):6_/Q[J8K22:.;3##2
MJ(?#8B?&2HDMB^[8CGZ<;GV4G*CV'FC/S*BE2Z%&]TY3U<.[ECP",;?LG=?F
M<FMN-AI2V5KS>IQMB-14#L&3E@:K6.Z@*6$9E;Q&H&.^A299;36TAI0 ^06,
M:#W@U92+==&1SK9J,I'7_0UBZC4*9FU)<]!@@T:3FVW[$T.@)LG4 IAJKP!3
MVN3(7OZ&"E=#5/P75=,,Q[[%[%.PR1;+OI&)<;-W7*L;W\0T5M,9Z>;CZ#5>
M^@J,(^/)EA]"!L"&EU' >IQ!I%$K3[/?(&SYQAKT/3Q)-8Z9(?8?ZY9IK3B'
M)X8369#T@4!D30!',A=%1[?P)09&U,_U9NQ58"DB4N.2;8Z7Y8#^OL%%@PKI
M^S54_P)-2G406ML85O6R$"7GM%L3,=E(O;I[Y7[&]TVR#IX.*^]M0RESPD!?
M%GI2N69B'BF/,ZZN_TPZR_)R?$,B^!^'/ 8$X$%[P\_?3N_;"<WEYFU#O!DI
M!!&"OX0<+AA\S^0GR0_?^O4X*13-[>"HRZG\]^)-^2J/;_6)-.MH9PAK!U;M
MQ2X4%S )8KY/C("UF?12WS?&U,R7;7UNP^XCA>V- _ZM\/1:S:Z(&!']J>3<
M!+7J4O_JZJ7=577AF*+'Q-YE\!"R*6!W6#=OM];629P7<.<9ES)Q:4VCW_1$
MH(*$U[ICXI+!"9U$=7'\K8M.YT1Z\ F#F!B.1#['".@I2YD<@]GV!6-EAOVO
M%KE:8;$WZSY*'F^ZJ "?V.&:)9_\\?5&H]RHG5_>CUI["YGH_^^3LW[A%W[A
M%W[A%W[A%W[A%W[A%_XOL&-[^#\!4$L#!!0    (  6"<UK)4)YS!)($ "]8
M!0 2    :6UG,34R,3$W-C0S7S$N:G!G[+MY/)31'S_Z6,<^V9-E9(FRE259
M)V1+LI1L92K90Y),&49DR1J*4HPLJ6S)FF3LBDHA.[.1R#*33$_-=I^^=_G]
M\?O]<>]]W?O?]YCS>GF9>9SS.>?S>2]GGH<SS2$"NX[;.=H!7%Q<P'GH!^#,
M 38 -Q?7O]?_T7CX>/XU?EY>'CX8/PSVKPL("@L*" @)P&!"HD)"PB)0@PF*
MP45%Q/[]_N^?_+O\WU702T0 )B#R_[AQN@%Q 5XC6!P/EPK +<[%(\[%Z0<0
M ,#%Q_6?!OP?C8N;AY>/'YJ2D##T@99=T/1Y>+BAR?+Q\D+OQD/O [SB?!)[
M#UGQ2[I=@*E$2>G?RGLBH&K=V"/M_H6J9G#Q:I*@D(SL;KD]ZOLT-/<?,#0Z
M;'S$Q-3FF*V=O8/C\5.G/<YX>GG[^%\*" P*#@F-OA9S/19]XV;R[934M/0[
M&?D%]^X7%CUX6%Q>45GUM/K9\Q>OFII;6MO:7W?T]O4/# Z]>S\\-C[Q=7)J
M>F:61*8L+7];^;ZZ1ONY_6N'_AO\\_=?7%P #]?_V?Z7<8E#<7%#>\ +^Q<7
M%W?LOP^(\_+M/<0O8>4&NQ EJ:)_2T#*.N])8X^@JH$[5?KBU2]",FJ&)'7:
MO]#^$]G_O<"2_E]%]G\%]C_BF@5$>+B@S>,1!Y  BUF>H0G\M_^W_[?_M_^W
M_[?_M_^W_[?__]IY2L >VN$^8G4O2@H]XI'ZD^)$S<F+K?.S#<Z8DK )%_[P
M8W>@AZZ' -=#JR/O>8J9WT%5#@!SPABPGEZ.U.V29W_D *UZ_?+G#EM)SR_N
M ;%A-?:A2]PR=FWX*Y5)8F)BHO%-'(!/I#@,.RU,N5=(C^W(HC&14\5F3D>R
MIF1/&/[(LM\CYCU-?6&:SW<%2[6+G.D8H9_B $EGF7#J_=9[AG%;X+%:HW,7
M>62+].CWE[1BKE_:/.NL5>^BK*D R> _0>0&IJ(OM8+HDFV($P4I]!NL!G-Y
MLLX-MU\?M<Y2%4M+XI[5O/,_)6* JGFWYZBK-$S[T%3&C\XP* Z9[WC13IVX
M>G0FW8;5T2PJZYP^&OLL%"5$:6EIR1(IRO?6XWYQ:R(?:!@E@*8-[%/VC ,<
M8!IYG .,K[>PA#JTGPT/RWF=3](7*(.G8P-PH(YS+E,JB&X$WJ(9T,- )PHB
M74F3:ED37FE#')4([8A,C6@)40N[GC?YXU-[DN:8X*6[<@*ZYR_QJ.WYT\ 6
M7(#6:@XD,0(Y0$^0$3S1T@2,)N6FF")3#-]Z&)7P$US/A;(MK*>"X)C;QX8K
M\]+O\HQJ9,5AF>*^=%0;JP 9,CIGTV=JEW;X#NE&U[Z^9]\;,P-3I]9_'Q:?
METJ\RY5S^'X%UU79P,6O?Z8X &_/PW .0-S"YUYU&%&((J ;'SX@G1:452L&
MV*F:#5EL76@:O;A&7/=6N@LI'DL939GSS$"I6%5Y$\)D/G==OQ_WZ(CZ+0=S
MQ4^'B2N[C_Q-(U8/N?"SQQ!BAAQ %H0-[$%DF>N]X Z/L=BWH5M7=>#*R&M'
MKGM+^H_U[UH!M*.*YZ0\H01JB65*K]!#6.F=CKJ9-#,*_':G<8-O]</#]_(=
MGX7*4$(N?//UJ7SU]"A1/VG>WT2*ZU>*-(D#O/)D2E40D1N34X<PZF 5R66/
MW\S0REDOG_D'+0+^G\P'6^ZI]1C<:G\ZGS=JM"D%>"X%,64H;.$6Q@ELCV'M
MSA%M#A"D!T>C^CI:&Z/+P5-#-_%9=3'I+7>3;\Z+ZL^K?9;<K=,:U*W&\_@\
M^_4468^IM,$!]CVDNK '?^!9JH9<?W\S-#'')KKTV",H48QW;;->+;JBM\.O
M ?-Y:'EP?-['5CO%$_2,?BS6^^8O2(#FS)2*)$:NPZ&U_PW*WJ#%D8-2.Z6F
ML/!FQ_#:S8"0'>'F<Y;S!K8A0F_[,P2!>UF)#HH#L:A&/%-ZE![)PC.M#N=2
MB\CX-*9'O8W\B6O5&13G"3\CQF;A5-2 0?GO &M^.X=W9?"*9^7MH[F(9L]$
M#A"PE3:EI 5F4^!BH$9?X2?5>!OOKIPQ[HW?_NY+$=$YXE>'7AIRS7Q!R8,\
M;#$15A9;'?QR352/\CO9?T+)]HZO6\X/YY; R_ZRQH?L!==,"+=0%WT6!N+#
M%*B."I\_/*'D[=;OR+MKI;#+'MH:=>D!S$U6I3D/0P<MA)+"V-.*4IEP$GC6
M+G*G!EPGQ5JH6B]%_N^C&FW+IN")9-1TPZ"2WCFQ<0H'N$WJ#/200/DL3L\L
MO[*+"+JES+-LHDX]\DE?GXM^/^%?0H8AB43"[".VX,<8I20.T-20VK7'GEQG
MX]I"+<IHB93U1=\-.S-YZIC::U^S\ZGSG:?F7CK.:7VCK!R89CT>C]&*#SK9
MUMG4GKHVMF94+$B*4HM6!3SNIXE4[H)""*,BV/#'JPQHH'FH0MI] !8;II)!
M89NP/UO"6 ^ZY/W0?62-3$,$'^CO,MNTYO-VS6>NIFWAZ >[E<L7W*Y^0 /%
M3"M6*517'0@Q#A". H^,.]$FJ\@;L&X<GSD/L<ZWKU3^*\;M65_%',$\1<FI
M.BS52G[^")?J1?F15/-GX<, ,JZ&9LP6N@-!%#SA*ZH1-P"'H27/L$K,#U']
M76GW_\8GNW\U/Q=&?J^WGK]DJY8W%*KJ(,SO=B=6O"#11>MO&S69_A.49UBC
MWV/,B(@L@I!Y%%EP;US*N#F2O($\U1D\+C]O(U++\%35V"WW#;\+2Z3A_B C
M9]+8G6H0MF6=YF())>?98E88%[ ]OM@@^+3\Z5QGL)$6UN<G.ZDHX[)>*1GJ
M4ZQZI7ZRL''$],F*R#LIXG9/W=8T@2UD2X7FSE?E=PZ#  N@G)<_7)RILUSU
M.G^6_7$WR<_7>]*$8HT6><>EG/4MT:(C0[,,GH0E$AM K<A,+#$/^8J0PO0F
MY@I^[]I'D\TTM^XPU ]S-%AM%7CYWJ Y4WAP2Y5W-D/1GG#QY,>Z7PU,R=_T
ML@Y6,P>XV)"*E6ZX9DQ=7LEIEH\_0SFIGC'G\&/[LC97\ CWNZ$7^J4[;QFN
ML\S]7:#5<XW!,"S7.5!BP79YW>]@ZF2X]@W4D;RQI=WO;9($Y6"[OW7 ;UM:
M4D<']%*Z$#39I*UFEE.OZ<?;QCX67]/GPBQJE \9VO (>.[N5KB8:&JJ]8FM
MP9[D ")L$<QQ:G4RQHV2*_:=K4,;+.OP2ZEPOOZ4X=X>,"^]]VS[[J%/W9K:
MR28!L!X.$(P%]5#K:0QMC-VCW@1#D$1ZA-KE,WS^=<NXCIY10^-P=9B]P8R-
M_K$U]('U*@<3'OY$R\[R3@9Q90-%G:(G@=IX\4Y9"DX$3.NN4HN=W(BD,!3;
M<UGG[[]7.J5!T]K0FA?Z@^M'4*.JU]U(N'0D-6L>$T_]4%RXC2@)J5Z3O9E@
M9\],&(B8G"9N?Z-4FV<EQC?9^H,\9+%D&JK'!W7'_%!M2,)>*KLMHNAF0E7U
MV:J/=>O:^J_L521J*V/Y._$4 E,JF@A?;ZL+]?'L=\E&B& 0]2&[=#XNYCY'
MYX\INFLNV#R1B6/2YROU4ZR]=MG9 G&VTML: UO0W-??4.5)N#2F+WDTVQ(^
M=@TG'9(7YG/"[U+3FNRD>SU8+S%L&%:792JYZSVE08HPH\$6-F+HL><7=7+[
MH,5..(0.\J/Q+J=TW8]1'"S 7C]]*?U\9XZ<>C<O3L<WT>5H,,_JK&;#?M9S
M; 0JF0,TZJ75[;AD(L0[M8B^<=V#DQ8G__B_?COWN_,!?\ C16;SY4NNL!HW
ME"I3!)(@M(1WV&9LOSQ*"")RW.W-EA\_\@)"PN*E)XOH[S/YO,AQS\H=Y1XF
MNM[>TA N_DM.%#J 2^^TKP9MK#J_&H7]L-!S&B>%9=:,O)X4C@N>""A92/=P
M-5&["S3D,-V@VMZ5,-"UBY;X>1-* [C QYO>!1]>M75V-0U3D*NNO53_O&0\
M['$0#$ $NYTMZM'+]1-D55DB?, FJ*@RF$@*4G0Q_^6:C\6OV,+U/OF[KR1X
MZNU.D]*N:/UT8HM!$B*)BC$&HQG:8!\1WDN0#K$\!+% ^O)G<UO=^U=UPS$&
M%QV=VJL>ZJ=^.ZK$(Z!>(;HW_K9*.VS]JS0M<MT$DB)6K&)S=88T4WFL!36K
M2O1[^"*D5.A+G9[V)C.NRB8JQ/#ZP9HA%4-2WM=;?%[< LK;J/.KBP?'8G(%
MK1IFUHIC)E-B@CMNFV89[U>OG/Q0>O'3J^27@ZZI8F)CU28#0/ 7U!ZPABTF
MSLK"R%-PH'TD,AC.__[9C:>2ZH]C/5NM4@T>/;L0=\6$,7@B9B4YM\)2"@)#
MD02S-9G6!$'P#A$K0_ +<:RW"JL,*YPJDO R3%5_(SZXS"Q0OK1]J.WF_4]6
M4EP$-ULIP.TL;G TUU*0]<@2<0[=1(9!JT<<%9V^VQ3J,_#K^O6U(;-3<7>%
M6\6D G+/ARUS $%L3R^4+=ALS/EK9LA9GIZ7BZG"WU #L=4S2RMLO^H4Y2'%
M6&)L&;Q)2Y4,RS7$I93R3#)=&@@V3X,M%5[B3D\T[#N2,S8K,.M]R9_UU3;0
MLK?^N\].;L8UWW-.)SI;)J[]  O)LVN3 <7RZ=,!YQ0=S[@+*"=9\>.16"(9
M.W>*A.\C@/N"AG+31F@VW:;8_A$. +<-D4U9IDE7WIRGS7\$8GP-E$O:YMZT
M"0[GWY#B6D8V5F_$,<Y##!F.T:)$9B"$+%719I (=:Q<VUY5DDA:Z<D#<5XT
MGJ/BQ4Y/2VUSU,R2"E-\12X=K75U6,SF /Q0X#V>70>P/2Y=0ACK7/)*2MTU
MG!3&X"MQ+.#K^KK?H*A'I:,<&>V%T_W&LWM;^LHA0]2!QRM#$-?-1,YM$Y'=
M2% -D<@THN1FHP28LF2G<RZ>^2O'IS 7JD/:/M>L2;XRZ#,<7I,3NNNPM,M>
M^B^!]#'V),TE;;W%6>7GB/O8SA&)GY\V/WD4+V[N!ZX5&KM[?/V:S,^;)&9E
M4B;<[&&![9>QE/P<V>+L3A]U'OLU=T.W04_WJ5?XQH5L)_-\LUW/,LKR^Q,!
M-9H?O S;XX4/S-W-///97+P,$PT&D;%2Z ?#A@P=X7/)9[;-GRUZ&[^_/&8O
M,TVY_B&K<W\9_(EF0V:7#K:G']D8V^,B6P+W!?] Y;L3+:\H\XEQMO7,;EZY
M];)B\:DW?_\JQ*LRCB1\Q8IR@+ M0"_#<C=ZKB_!Y'/L'Y>82K^J[K8"N9_+
MKK&V^P3,%+3.)^?8 C?YI&:>^J*+'>7\<PYZ/\SAOC51X!=)':*_ SUICT[2
M6GZG,.-)\6'.8%3<OA)R&"-NZ;"/.:W_U;M7GZ)DQ.6U>S*>BPCR>0'PX^5=
M'J &5)YO6?<@Y!B=%4*D= F!7T@E<8-3[LTRA5%6,8IOF1F",Y$Q:D[A9KO$
M9/9[M5V>FIAJ>[G:&GWVK+/BV[<=<NJ%=D)YS^2T^ZF 0OY-5]Y[GH,< %("
M1/ST*"DW:\[JJR42?=C9*B!8KOG[9HN9QWE!D_;6#(>C?QS>8X)X3)0155V\
M"5^4>%G/+)7F(%":RNRTH*!$%PXY[(@J_35K-VX0R7(MJ7\KU+H[ECO1[( 6
M:1341C%E)4E!3(DM(N&.]M =PW/1%(/I![_T!.9.M,E&G1U.[+,@[[>T[4CU
M=GEP^EV%8/Y5RZL<(#D<2ZQ \;)EL#T:G8I5S./@*K6ZEZU?X#VY%2.,$$>/
MN+R<L'%^?O:X6O[^I][\U+D>U6^BI;^X_I)LH[&";'VT#64J*9SI3$1)HR,'
M2^4[8W,('I];CL3(R\WLKD@IEKETL5;H+IQWUPWID81Q0FML+V[Z3>^N'WCI
M3BPIEWNU[<3[RW_KUOK4*9HCVH>BU6IA:G:U1\O@SN5=SB"4!'SCK'QD2*3B
M'!@$D;JB.2*V?O&LL).O$RVJRFBIG^2?OC D,?P![7J[4,W?1'KG/B#EB6.Z
MLUZP%9A2X!T27 "L&?01RR0W(%"B9GU_C_U6W>BH93A=/%*DT^S/]TY T-5!
MN^Q/V@94IWS768\XP'D]2=_O6)DN;32V=W:G5SOYN$.$D8ZU6H3'4EMSCO=%
MNS6YKU9R/4<,N7[%2[]GJH$T(B$7(? +IP0B^SOLT\WEZWWCZT<\F]M%PPR/
MWO=OIX2<.7-&-*FVMI);H '9!M''70Q?!Q65C7' RYKS=RF L<^SY?M-:]:^
MJ.>4W'0[Z_OPCGCG[8/R_H%FR7J+[@"LU0VE@)&$=NL6TA\_*TM.P2=C=&@C
M?6U*RIWM,JV?"=.HU2L+QWU#*Z,7K*3T#8R%I#^1[0SR<)&L&FQ$ \3/+U=2
M+DPF:#-MJ%.WUC?OR(P\.\L!*A?]&PJX^0O/QDYGY_SB^B'E.8*%O)], ]V7
M]1IS0S:E:S?S I7]ENQ;TCMWO*/ES5BDGM#SP%T#-T1T#@D)B^^^R%WP><_?
M_$0A)AV*Z@N$#)86$-3I=ZHV@!6]N*;2 O)HZJQ%R],MI34_H];46>$W:3\+
M9<;N"K<):]D):R5VEY[&]/W:AS>&D&Y=\:0\'%3)[==\&O_*+_2OX<$LR;>#
M3X0I<\MVYK2A>DV>[SA0=6C#C8R?"V(+OJ:^(1=E$UP*!BQU&]M?XP\?ADQG
MVWQ1=/\;28W@N3V_C7Z]3?""9J.$)U9BN?'G1T$5C74.H#$P>F=1EGIVZJ;1
M4BO=V,#P;TJOJ-T//<7: ]L=]/EG=NB/\<X,"*LCD &H.=]!*AA$&AJ,%/VA
MI-*!U9TZT=76\65S"\6X:Q\GI6. ;=KMOW$4<=ISV84I9< 6$Z6UK4=!F70?
MC&&8!!-$?Y7X]YHN?\H-J$4MZ/1\U4.XW1>_U*A)/M@( ]+L]4U-DQY\3*CQ
MS&*B:47=R#2LO#FL#F/[B)1=U)^9;:<G!EHR/).^['SM>!-^)SQP_>FU;2=B
M^CM8K$4PS\RM=^49VP1N]E>"*%N#Z4^SAX2;&'K<:LK<G_@H6'=G0W]PR65?
M?H&L^)\/KSW\&^]8QVKV*/.['[40ROBS;X4MW,90F</$MX !'$!XKF<<W?%S
MX[)*SOQ9E^J',ZWI'__:7?[:AFDW$$/_0.E!Z(VE^L%3.<"KR'4\I>%V%Q<M
ML(@<F:VDW=Q.79J\Z='=#KE,]_T>Y:^+UXZ972S9U5%IV]FCJB4M5*V,>+&S
MC61*X>EOP%&&$L:TA8;HS4V\P@P=#[]LI&/?WW85G!WI>TY*U_'/.79WZ$K6
M;VM;@Y+&"T7KK)$Z-(HI(<L6\F28,(V@-$-A^*@<X(XE$B,%Y68%J'&B&3\>
MHZ<04MA6>$J] Y;C5?G8U/1Q4BT7?Q>.]1(35<YT@BZ[AO&DP5)WLO7Z]X@U
M4K>]W[R<:)YKWUS?>A)O>C7?5OM2107/W6$'E41+=ZC08I'$6IPXDEB'@EOJ
MH)N&9K%IU]!,"_(1[6OQ9@ZWQLRT@MK@C24SQ6=&SQQY_PE0@']YP52'+CQL
MN1\,(K:MV])^]R\>I/%GDB+%5A,TFPNW3WUM\&]J;D&]$O/S%O#XM?0S[)=D
M+YX:%;ON0=%+'R'Y(G-+Y7)/AY@_T5E.8166^BICA]8G5\-R;OYIMVSFHK=(
M2V?_,JVZ9WQXW#8J\DJFFGL_:>RTZMY[.0+*2^*3567<&5JC^&#";!\)MYY"
MK*+)#L 5T:CN8O/ZBZD4[PG5%L;IQ$M#$HT+6I229W*-GPX=5<!O]- :*++=
M6ZFS"4^HOL1BS%6:XO+OF?IK1;1X7&J12_+(=89C\>KQ89[;*)TK0PE7 2-:
M+%-^%$KQ"A"RT7Q)8"[MYX_!/? TC%X9B& (!)N>>="@5ICT/90;:QIK\O!.
M2U9RR]$5[K=3I#2F HPACT'1[MT4RZ1M]]0\=SZ8=.BY?4R5E6I)N[#1A%M_
M=#M@<_[QK7?*"?[8GAR-ZW4,=W$.X([?G@SF^?TWXSUM*O<:,H4M/F%N17;V
M=Z*RTZJLIV0[4BNN%;:VYCT;,<\W$7H!O%>[Y1>-9<1AY,>0 0QDMC%!O-.@
M&J,S<4%R%IU!7UF?+#KN=* VX?R9H, S0K><&G<#Q<#.,+,:7(#< PP]1XIE
MRO8=8]W;L)1?C?7C[YAHWN#?<D-OBK6H?UQN/I7YKA5_K_7+G:(#7QHULQA3
MF[DMR(L$\,#0.@-:$K')G1(#XE;_1XU!T^HTRG9#[9FQM<$US3:^[3-:S\IO
MJ(AXG$B7XPK@7<K:PCC0<J&ZYP#-6[<C.UV,^[006:5[%\K0US?7A.UHZL/2
M06'!EV8C>+W>*^_"&9OGW84'EG=.42(W<-18>M"4]B_\'82,Y1XF<J)%P/)K
M6 C917(FQ&"^K[WAP1WS9Q\>W4\E"KQ3;7&FFM'?@LZ,DPMK$$Z*)FABS,"4
MJ(IR1RPB%>,85&.1__I\MF9;WC#_@6Z9P>N/KQER?;_G^9@9R6JT%&=_*+Z?
MC>O'96#%$I060_.:)UW11?VM/B>*HI[WF8=%J<BZHM6O<M5%)N&:D8G($)3P
M?!A.#!--Y "([ZVQSOZ63TAO ^<\6E));HI/0I1C/>ZJY36Z7^5Y/BA0)M:;
M\1,U6TW?!,T8NX+/=*0-Y*8O2E.UC>>R*WWN$WUKNO'H/NYOWD<WW<3T#28\
M'[(_XJF^>C.>]';:0$,JAH?6U&O:EJY7== G9"HAH2@Z3EGM<HHN)7UX*$1Y
MGZ-"5I(H$.]L*^4*NX7M<<->?K0%:JRLB]*T*/Q%D-T#CQLA^4-HSB'5A[=T
M0YZ^3IU1<FZ//'#X@0.HO)[]TMYM"4FUT@,/(#,@1" T!FSU(^30GLY4?/HU
MU*[Y8&-5IYQ+XPW,]O,/G('["Q,7XU.<6N7@YL3X;,JC<#%&S]_[^#O^8T^I
MK*]O>I[9/J\-#S+4/?SJN-H?H8-F#A$"1^HEZ?:T(4C:R&*T\H>(\4.WEJCV
M*3O"V5*^H-WNO6.U$1?/C]OLZ>:U$?EC=D2]J0!*5"&MVR '8+@PS5CW,>+(
M.Y9JZ/&^!.$O.O3-CJ\-^0M>37Q<-HJ?'(]P61GU)$P0J*<(,QR OO]EXR-R
MV@!6 #SI?)SO=7-S\=(\ZFQOG]8!7VNE0&O3@R?B/L,ZW?Q$&7O_.16 O5AD
M+$,03-@/^@_N2:FU)H>;RBE-N>;H(M'A05[?IO6YPA_P)CH8;1E"/C!WD)#;
M)<!Z9,X71<Y-5]*F_DYBFH5:OW_VPY@V,Y=J(65P5R[GB%M^' ]*%QW$%MO+
MRL3XDNF?-["00^^[6:^J[S>WZ.V]](L#.!9+)2M5)\"N:O)L[#E0>HLL#)?^
M7EA<6A07\CRDC:8S4+=0.V(H>^CE<(=I?FWE+BO>)-$H[&YL*"X-"9A[D"Q@
M@W[ZGS$6]>@?I]+LJ>R2F*M\BW4Q6I>/9>PM.N\+M!Y..JIVZ1+/9\V&$@YP
M&0]JR:YO< !>QL3&-0Z0B9<VA NN3:6_&GJJ[;DGM6*Y;2&O+MR_,,#FD^+=
M_3T]Q*E:#!^T_D3\;!KI9 $E-VU1;8SI3;*X:J!>6'5!%PP4&O"Z?F"XNT8+
M&.Y.XN)UA5VP1>,W4! T2$ (*6H; O%M$#GV-E,RZIG&H["@^-@.^C)7S[6V
M+,,/B52OO<#O>B0=DBY)0PD?4*W5F640W_6ALDHEIYA6L;BFD%.&L^$[,SQJ
MMGQCMFJW11ZK%/SO!S(9F@W2D. C5B!XL!>^MJ(R$5+FJL1'-?W;X>L-D3RH
MDP\'?[5"8SRD7+&V^,XS^ZRA$!^(!'6PZPV,B^#/\5X"W-(0[>M-VU?V3<M"
M?UG7<*1F2O[5W:%8!6<M3.WU,K5;C\\GH]P_<]FB73:BH7B,01@#MN#KP_0!
MJTF1_&O&>?'EBJ;DP/8)M<R[:C*?:SZ^O'LT_(':+D&5UX0D+-4;.>-/3Z9>
MKVD @RA#?:ECS9JJKR>JOAIY?"GNU<B[Z*CN-+J?8J-:'A' $UV^<UX -B[E
MKGIGE_[=X3[EG-N>Q0GCN%94;\-T'V0A"-+F\?\L1-'_L!#OO?R_.7J).=A>
MU.09UVPHL.2%!& ,]A)VUF7H.EN.FCOD EL(*RKBGIR=9)X-<8[=?^3TG7K*
MG4N!YIK6L1*''F?\_:"0 6@5@!MD#B %PDBP=",<+XADR\ R#7_8/7*B;M%K
M33WIG7V[TS9.\2B8K*Q<.3H0@K$&LR$PN5TJ,F%N2ZZ+=J 2TGX]R/K=4?C\
MAF)55:5_C:/V[0.Y5VTQN="RP238 ]>[]-A]D;EL2>-'K7_NA-VDWWB'H/U4
M/NBO4<_T+WW\&38"*2V(A<(H*QO"T$K7?D8&$A"8?51"SYMSA^=<L;N"1VKM
MR:)65;Z2,1&6<V+3!V4OL&:WVY?HB'H/Y@Y[!"7!-*-ELN'[)LV=21;1CC2]
MM)A'OIF9HBXGWCC5.+T;3:OH^W?6:-&S@?I<!4BYN8;>+&G-?#KOYW?6*B0H
M1-+9?-M!-6?WA,2G#V@/0,*1R'54\M_)TM1_3I82$. 0 ^;ZKQ!F])CC@G$"
M]2W"'A>FC&6HG<IQ14-OXTVH]I25)&P(*JVU2QO$DM_R#/K)=ZE?F&B.F][<
MF$E;M'[G(/)6Z/&NF[>.*L9(+R&ED<0R L#F ]>V>]F'00(UK6=QW_BQP"T'
M2-)6A_R>+#_F+?DA->3^U+6(''U^CUL*N\)BB4$;(=0:.B[>+6$/Y@083Q-O
MMA*?L$_%V ;5R'/I<@"M3PSSW.6MGTMS;^1;#QLD'U5*MD7G9D+S?HIJPO9M
M2:_YB+UE6&'$/^]\E%ES4K0Y.6$>4S5W;GK>;D MU:OT"NU=EM"KE[R[K(#)
MK7[L7#(1WT. H2/[_73 M]2AWK^PK WGK;0='=^!PX>O%__B4HW6J7QU7(9T
MV$DR(NME?_K-@^]@S[Z@CJSBJ)ZXF8(SH'$-QCJ3$IEXJN?FX3K=%,LZRS+E
MI+#OY1F>;<EH_N7^Z&.$UV("5^QN-%B _XXSX>P!#K '<[U4_C/; AUHX>YM
M_HP#M-1&_HKS5G@,M,G>M16^]*MO.R^G/-'R<_G#R&C%Y<YH&Q4GJ0PY1?FK
M[>9) FNBZLM+IO&5;;(20WR= I?R'7<?L"N[U*B1""P5')6 _"73]I^_Y #^
MJ)0N@W#8&9!%G)IP/\6C:*+;8G8IZO$W\NS^O3S+JNJTQR)+62QUJBP]FRJ[
M >$K80 EAKE VI)'7U_.V/>D@J ^L7=HT>[ R2G%KR_[VJ6X9MV\V?MH?D7$
M.IEP)^^)9I;&R1;W\7-^\^J=A[C>:V]:WQJ*]G/ZAR<*(!S2:WH#(6P=M R!
M--$FZ6/3,/)B2+'DPQ<S>S6W0ZH?KPSWA?)K*/ <5?IJBWE$1;"%JQEJ[#&\
MN Y3 Q(<.7[B;VE\2^39R;&=B&NCK<>C;M_9++^C'J@&[,H?NE6 \N;).\H7
M@/YQYJLAG#=,=G9?'@<0Y&\)\#>G[T'-YD\QCI-4 W,(GS"U"?XISNL'W[Q"
M2P?U^ZF.,_>6+89VM+!*BZI6J2T#7Y?G?_"];3ZN_VFS_\ S(-\1$ )_#V"I
M5PCKYXBCLMB+?@F?E>"%VS=R/S0F;?X=5Y6#F"U)-DUAAY \^J0,?G<'#NJE
M;4"> 7X1M&*8@@1B9"H;UG9GQPOAW8SKOX)^^O?;L%?EH?1-'7J/TO%+S-IY
MKI_;N*E<.706&MF[I[YVLLVXIFKF(SI\8^K:^)]@U$6Q]>ENI4K/;0+#&W.3
MZKFA 26/+WOT/]57![&BW(3*V+$]A7DWBZYOCHAV!\S?3AQ&'[AB14P,^ZM<
M&)"T+]_N=#978. 1(9B[,Y#@!X$G%Y;XU@^RYTFO,?[@<Q)V-QK6QY9+ZQ6W
M>;9J[*,W*R>QZ.AW*/+:V!O^!^&\INOPM#^RX0GEGMGL3VQ=4+2:>88VE,R6
M>D\=&Q^8C+:O 5O[>B?I+S_M>_S2>\OR4YGA:./KNT64XC\V;.%'4 ;,@&$0
M%:^"@N0M03!VP/3D6]KXZ5<%)\=^B5HNN5BF:#=2-F(?&="Q.@H.Z> -L0^Z
M8Y_*$.77/)?QS%TPMM A*HPDRY2P(<'3F$&T<>)6"L:Y>F:!]<9I$A/R='IQ
MMLEO_HB$C?;P]^,OE0_*\2KM_/6@4LBX5,M#:*71?K8X32F9W""ZYC#F$SIK
M^41Z)WNL1MI?X8N!*D3F=T\*J+8 D6YGD;T<8-830OS!43ET11\;3DM+8SK7
MH@\$U^W,A>O3='V="CVT[^RW/GU(B*![54"9F.49;DZ;[?XY_$,AZGG0=3./
MHTOY<5Q'Q<K;<<GXYJ)$;+!3@[@-,5(VV%([4G -YOAUSNF-[X/UB-Z:!^>F
MM#JU]BM+9A&W/=F'F*'4W/7?U!_NM-@<<_L*\%2?Z3$[W[?VISI\X]!'>2G1
M2EX4+COO7$ BZJBBA?020H8#1(XF([DX0- &@HS+2E!%A_5!]EVTUK/C3$W<
M%?]S[B;^$D-T-.W;\(?;!X]93Z](/V)(8WL<NV!0!AQKUCGE"AK18$ZT2E/Y
MVINW#\W->R]X;RZ\?!\9K1!]H'5R=N!PZWC2E6">^>!Z) 6W(4A$S1206$,9
M72KH-WV+PM3E&MX"UTF]BN;D&XQG<N_F5U[5>]'YNP*HQDP%188<QI96_GU/
MY! 'X!]Z9IBYI_6)XF1)Z(?I0=V(O3F24_5,5]C,Z=-GC#^O%;K.SSE+#[SM
M%50IU!#+WR\G4GG%2F$)T@43^-:V7NSTH]Y=87AIMC(ZJ+LCG*+OTUI]72)L
M\JR,UP6Y?'=]0?$:\;S_".AE[,QOMG L0X,]8;K>@4I., 'W;;G=V7=O+E1_
MI-)A5:+)8;CMCGB,A]U%3]700D;GU%B" &WR#LVXUQ2;;FY<&^*G_#DF6.;;
MD/MX!.5-T]L[J6<<JK+NQ:C>'78PY*J!_ :7[7GFR7\EDY3 CZ?99W4ZEH'V
M?3Y>=F^_MM19:PG+']QL?)(?XNUF;%:>W1_P\.A2!HT QLFN-W$ >QT&D@.0
M^L:0?U02+1/+G[S$)WLTIJY-!D>$U^]RE&H\@EYVUY?S@H)/TH*1@@;U!)C7
MJ,4_%@5IGJE,_R>.VG=U*YZL75F3R5:[[/'925@_X@RO^.,D ?//,$?;&UM#
MB-DYDLOZ@"X.T=]P!P]/4'I?DQ8F33-.K_U5<%-2_H,U^1BA[>I*1%1[4)T]
M%4GO!IT8SH10&;QHUWZ,"9@275GN&"^;V@E91\? >@>[O/"EJ[<R7O(UEE0K
M:O)LX]F"RQ#V\*/GZ!\@[.C'6+-*C2+33$]F$UE"SNZB*O29"&1+W9[!"_)&
MM*!#X06ETI+^TF>[HE$OOE(L)6C5W4@1]J3ITS32GRXY;V8(+; T1O&,A:ZP
M[52+EM?QAH<Q:D[?7NT/X/D8P?1\""6I.Y[8B!7 $@OQ@CN^!&DPUQ%/8W@9
M_I5-#M_TV'%V/R.R-^C.U<]S1:<Z@KBNU,I&)U;R_#BPC9H=)6/[4;<1_!$[
M^!2\,)X4A>Z2(^? 1;&]CN%0?3?;?4PKV(@]\*6^Y].8_@+??TX4FR!'U9!R
M$[E^@;*!HL@.8E-*16E#69:JH8M[WS;3X!GKAF^>SRY?N/[ UOP%0^XWJ3$Y
M>53Z[Q0UC/+[%C*8(/2^ 6-!:[C=>>/)D)E/5P5IX2+A=(OC/>XO#\_''B7J
MY[]^]VZG#/Y!#U1+8\J>HNC].UH4^DII@-*4JI?"EO^N!*-V51E-I@7$L*IO
M\%>'8$,BV '?+<\FWABK5W5- Y)NXB9?L&/QQ$3CSY#LB-;;L(V.-CQ#I_\-
MR@PH]#ZK8I=9/R/QP04 !-5^-4QP@'04-0JQ[DL=(DNB4:?!/Z0;1L<*W@>-
M7VYH,9.^3'GT)EBM#5!B!_(!\56VT7@A2UW0E]*6:$B01NOU^R S.HUKAE:\
M0V^>FSWG,]]PHN:),G%)?&*754]]1J*09OG_YQU9BOM?W#<F[+D]#J6=!P<8
M#N8  2@&;!7U-[X0_R04T/I3Q,(A+^'@[#DD-08^A / -G>:>E&*7LN6Q/P/
MF>+#5?M*_RXT7TV:-'"2@]-O.+JI/.>[=U[\<>YJ.1X:39W K.>A4=B]2EH<
MX$O-440]8A>>> ?U"MN/39I*X&D'!:E#)[YLAB_NWFRNXYX=.M4<Z-IUS3.O
MK"10WG-%UW'6.$+!<UF/N2>$$A]+/P.511Y['/FJJZK&,;X23'"VWE2_6B,^
M85CB:#A3F1VK8/YE."5I12NBDUF.+Q-BHR'!FH;ZV4+8@,*[X**$7;-1!.)W
MH'"-L#T>.Z/@OMQUM^I5-E\7^R-81//9#%>UP[N;?U09DSK3V9FE]*JL</=G
MR'B>A7URY5E!4JW?^M,/L6Y#@B]7(&QV90@^\Q.576HR7DZ#9;5L^ ^9GBB>
M75S0*Z7GJC7]:?QC&53X/J_(/G#DD-%/629"M'S-E1G PL7(\>)FC/?H-H9'
MW)C5<-SP05W>R$<DP*H2:MD#>.I)W(PG!;E^@UH]0&-_PG.U\-'LDW^5>&X8
MH&&.A=X?Z%$.WM-SRX\+330>KT#8M(QE*O30AHBYMQ*T,(JLI\A >"9.1 V<
M>O*C(:#&F8B2\$*=\[-9>KCW=4?&I)UVS7*GR*=#*F<%"%=3>'Z?HINSRLZS
M:O !\%2"I,X&>PB1VVE0_6-PCC?^_J;.F&?F8]9@X-FEY#;EO(]7. !UE3 3
MQ,ZNIF,A?WVC$OO3(BXHJ5.RG&E$S7D$%;_8ZAZ_6V7?Z:LA%YZNMCX/"_(7
M$E%SL]TMN$<3X',%%/F 4,__Z>8U(T8,*AU/C6MC%@?U(!GR]1S@5]9GV!26
MZH0'5=/6(5B/G)$GC68R3Q$59<EM.9T72,Y:I[Z:VU-&O)@VF$'?W1D]\%F/
ML<5%S7>I1\@>W(:NL0H%?R*AG59G#R;(0XECEC"/X,('NR2:6N 2'WEVE6Z&
M:QSGGG-IF3#\H[,DJN#4'S5O<\4??5> )HFI^*#,WF%W(WY>@(05!UBW_HS_
M!0'940C(:,B?#O@@'$,D#/MWWZ=$9/A6EU9PL6>O8V=4S/7"1?G6,?ESQ:O3
MTAE?+FS/6ENI<A\\::6:T\+<AJXU1UY&I."I$!Z"!]IR$TP2IA"[+)70T:2M
M/B]_5%H"/PV??KF9I8ML=E).NRPKH1VK(^4J^YB4[*1M^[+<$ &M2VMJVG-T
M$5O@$$UBR-[[TH1N@L!";=10R39\W?T<H) _+!=%.+*%RL-3@Q#K6]1(.FX\
MP>([7M)R-],,O%7S/?][T6P8B.LKO-DTUZ/YUO'8/K+QH>PO0V]"Y.9+HHXB
MGA-:\4.H:12=S"HTMZ(V#& 5D8$WFK.=7 H))[#@2<.C?Q5[K/>^;K6,W:S,
MIK_4FN 6.." E,/V0)32-IIA:821 ).I]@,W2[XU1%('+N\@1)RO?O-L&=\4
M:1P)Z?R5LU\U:[#ZB*1^U@%-Q%/\_YQ/L4A>I'_#;533ONKX>.H<"=67F]96
M7.G$MS&4VFD44#D2NZ=D.-^H,_B<U1+_._Y$I+ZE#KL'*8\/@9;5A&!/*^K?
M2G,%Y^B7J7[Y**O7D]QGO]^\J*BU?.CHQY;Z3T^M J[Y)R(VA^3U)G'4<Z,S
M3CW89F.F1!C%MO4MB;7O6R0W:.Q.VY=\97)-?4SW&L-1US]XM\A0GGA62K?F
M>G52V#ML^"BHEU#U)&$:1X6H^M56WP.V,>:J8V7+Q-+K-PR]-*:Q6NB)<K*K
MU=V^6]\2:>6231_T P_U)BQR@";[#1*Y =2H'AR5Q)QD/>W:#9YR&F<C?DS-
M3B4Q9:F;6@P=GR^&/])*AS9^U^ONW?87111G>!M'R*G>%88V=6@#7LN$(DTZ
M=0Z-]>UJ[RH@-60V&(J:/+V>5_$R6*>>[#STZGV4Z8N590_7@P#/,A:TC*Y>
M?\,!HE%L4M@LGOA^X4 PEEB"E&QXH#>S::DZRJWPT\?"P"60LJHRE0%EZ78)
M,H# *.8 OX6/(CIPTETB: UZ!G4_%7**& T22A$=NDQY;1KQYJG5"Z_A'\..
MRR=J;^<\:<R;Q9?D@AJ(]>?4H2$4-08VV)#6,=6'Y?J!@/]Z!($++K4!@PR)
MJIC1=M=,MP^F/7#==^7-Z?#1W0W?1TF>S'P.( H1D^X4![#521""9B+/M(&G
MXXD;+K,99*/@KT&TE*<(N< TS[8[Z?1]^O8M0,(T4YF5G,#/'DW01XFC8<31
MWEP>,.F(WT(,$@[:NXSKR1@/_I*TD>B:['[W2<RDH0\+FD^Y%)QAM7* P#FO
M^L"F_!^.I6KMF:Q+? UDKJGY(-5YSU](U*@G4\F  VAL, YR@*G;N+]1&8E(
M'S8,VR.%#40EL86+3KX&G4F(]#V#E7([. F0XIS<?W/SK7G:M?'YA075-X:Y
MV_KU$Z.VNZ7!]PP4D^\+GIB*I5Y=Z5'T)9F'DW!I'$ BPO!-9LF!_1 UUM;I
M;:F-MPC;BLSW<__YKK!QYIK0T:QP=I[]<?9-+'&-\,<9OE[# <ZS(")U>?49
M]DO'EJ=*B@N\ 2%</+;'G U%2_?[B@R.1_8B@L !<JYLR!Z_:C)\PW>*X?QJ
MQHF[>J;8_W)[SB3?<+_\TJ>K7K@O6%#U=VHM!DHFWC 05K'FRJIV_MJU9[4P
M]LK6I>V+^1_=IJ[>[3O@\$XYBVJ+J8!&RH%$@@J$QNOQ8_A?MLOQT.B\$"G?
M<V!_0M)=FG-9ZL<!)N(?2V-[]+IVL4=Q5(@RNAMN$41^E821"+?, Y22(@L<
MIO34NK(W&R(NECK41Z@5>BU4V+JE]N[PJ*W\]L83TW&O4$S-54NEAFY$:DC9
M^Q"ZS15#KY,O+)V3+B18=6QW<X#"Q0@VWG@?'EH-8CWV)[29ZW@.<):IQP&J
MY8=98!E\&9+3AQA \-\TI@R>G+:>3!/VHJ6V4-/Z_M8_CX\EC<3[Q2DB^\=#
M\O,NZ/R*NJ^O5[#_JFR$;Y"Z'7QC9>,)%)D""ZJ!$-R,OQ_U<"XUED1(CJD:
M"TSNFYV\5387TC;K/'TF6,%9HL*A-$+NRW3-9OA\H]&?-PR^(U".Y5*NC\G_
M-GU'F9V=Q<<_XZ$VL$4>L"K,K<B(%(*\I>3:E&?3=[;(V_&6.B6Y!Z^FC0BS
M%1UWK):YXM"X8$JT UIM90)/I*)N)7!! H3X^#=R5QD5=FNH7\=_H.-D412Y
MXLD<-OQ1E-2ZJNPMWKDHH7UC_>$4Q4,D)#40SRR)W8!V]9PA@:4]$;:Z!9K'
MLMUD@R#9LGF? Y3K:?),XHES^!D#TE0/"E2':D8.'=U[TSDWDWGCB?WSL%G2
M;<=G:_I-1X3&#Y^UR^"N#+765!#)=_D(T?_U(*:D5F_7 59!!#(DDG_5%8PF
MQ_:9,4QVG%V<7)I&:Z9'KMY-N_M4V(5W;$#EX^_[O(GYAS<8I]@"JAQ \RJK
M%+_NGLP!;&ZN0&%1(M--8_MPH IA**S.?B1@XEIF_('%P^;O+3XN=^[/$3M>
M1/AE\VX-. 1]=CX7U/STF@/PJ4#Y%1&RYW?F)K0]0WZPB0#JT[<WF995:N*V
M:I[.:V-6AKZC-BKOT-__W:R3Y([M05H:H'/9PC:,XYB+K*JN/7,_9,)BC!J2
MF#9DW@R:SH0?[E6VCM=+KS,?-!=WZ0,U]P/S3F"I@?#>!9=N/-4Y4@%=<]HQ
M_!I!%CU+#C\RLE=\A*^EKE-//[E;*?B^<,P^R5*@?K0?2?7#W4&U83<<ZS'R
MK-0$!3!L:!Q]";$QFLX^V%&,$%ZM>5WPP8'4GS_XH=*.U.;@D6%->WX3&.4
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M7X\7-!2XW^[^\Q^0A\O-G30]\'%?TPTJI=_52UM#PJ@OI$AX-XK>=G_H+9
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M[7R=+3]&'B__6AL1<;$YW^3)+0_%O&\95GO/#3>V?Q*4'L/VM!->(GMQLQR
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M])E[P$[/BTF?NU;U=%*^F"-JKUN]Y =RF1&=T:Z0Y%%XS?^5M 9;7Q@:8>-
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MQ>U2RQVM2>K#&RJN.[X_^9EIM'*>?$_A/D\)#C*%4BG/E2UD:G-EC6<2X_:
MBD!)YRX)$%7T%<?UG"$G*5VH5?J./OLZ8./<@1-M#NZV=@'<MHHDR/=PM@]W
MZ\Q:$K*3#.IH<V4PC(+2:>I8"3MGR)(?>*&S5/[/O$4E,.C@*^V)M+H]0PHI
MEE=,CBI7\(U6<-[#4M@V[)300^)'2O4(UY3:^HBD2&IK!I\ M&7YL^Z;B,L@
MYQC4^:UP=6*7M\<*'(WS=3>M= %O2.S;)D*.&MP+[AMI1ZG@M=G^O!>&3=)
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M0GB_Q0L<E5R7LA"_QJOGFQX.^QN(B5-S/C>8_OOWOZVA!"E!E!U4;Z38(DH
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M)"A%Z&//,$Q[\][<B%K,$E[X2;Y5$(Z^J_1!OOR>O*OSU. SH_?NIE>/5#J
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M"G@/)$]Z%[I;:;Q327=;3<!J^0-&O80&+;;<23HMH&9Q_KPMB&<=Q9SG2HS
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M/D NI4.%[0@X) ;JFYBAA$)N-2+GKM6<5&TQFG/H,+FR;?_JE\=K>^!/M)_
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M3%>R6K:?^/V\(4(CV6M8/7_34?N7\\4OSA(:3A_TD:<;'(2QI\'O+#X,WAZ
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M?X;NZ[P*OV;V^IF\R#.#=\E/_1RE^5"'>.5T;JZ3Y1:)*SUT1!I%F!14-)*
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M>@GMO;YG]PX%0HGGD=?54A48)^ 927L+YK<>AY3'7T:"!IK%0!*O_Y+1 $6
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M$+,!,DHD3IYMQ"EAV]$(LR,7P6R 0#=-,OYKXJW3JX#/^!/\9;):)>MJ[%)
M\43E/7Y_?NKJSR=/EY#4N1%0)[^=MRZ(D]\P;#HP$FK:!T^4<UPBST\(UV1X
M[)#I&,&\:U-KSG2Y]&1?T*,8V*HC?/2U#D.H#R7WAPA"3L662Z)IK:S2LI)+
M]@'H3DILX^9H4P+;[+5=F0.MM?4(K?'Q9YMXX[3O9H^S6A6T'46-"+Q*QS&0
ME:2@S#HSSCS.F,XB^8W(8L^"1O2L'3^:"N/_13RB'SOSRV%Z==O9::<VM_-G
M/ES[*H0I3<F;LG1^&U[YGSF)>[R&PUC?2NR)_U3\YIO&GGH=XO&MO1)K\6G=
M1.F44_.=HM;E%%W?8(U\-XTOV0]SAGIS;-5S??[^K]EL]#\>.%Y')'L\-8:W
M@#F%%0ZF,1]RTAN&3]+"0YW?3JT9AQNNZOTIUKR3LK/IH+4TH;FM/DJC+?]]
ME[#?U=:L]:\XWC3[+B2UVD<9+*>-I"+J*+TD96."K(4R]CA#,#-;G_2JOD!9
M:SRS[#I#6.-1DPT@R8@^HK$W4^EYT%Z8Q0E.'HFZ4N5@.1D)CT<T"75-UR7^
MDQO]T_K#6"LE7O)5YL4&/>4O2HQ:HQWF'17W5; T4F2').9#-Z]^B1R(]P+L
MF;FO,*<NC"^^':V^V6A56SAZ/]I*B: __!:V"[:;+O.W"(*Q$#"*"HE?MI2?
M!XGQ"Q.!2&5>]R#&7-&0\XS.F,#=O.:WF1'F^RO]'NG6 ?@N\>E:?%<;!=XP
M,GN>*TP ,J=I5SXL/GI:WSXY;Q)L^69<=^V/:%J:?W:IBN:/;QG S'Y_\G'5
M&.0Q7D<]TD83?/4$KRN0TQ:L7/'H/P)W%YF3A UD>>.[S&^BQ3&*]JW3D08)
M'DO3D6*')LW??QLO6;!9T\B Z:Y*;#Q^N07+QP5SQ>&=%,#68.[48@0DK(4.
MX4914N:GZ)#;@VZ=MUF8%\<,_C?2WC0>JO^-'QZI),N$D'7(5M:2I6RCS9*D
MM"AB*OO6)&1DS(@LV<82BIA\)2V8;"ED[!*R1HB9(629G"'C,(O[S.^^']VO
M_[/_ T^\9N:<<UW7YWJ_WY_SN:[+;:2F/A)Y@7SMAPX[+C7\N5C#SQE]S9B,
MSTO1_O^*N*(0'8I^BNGC"K)80N#=#5KO>D?Z._8YQDYG"4SV=\-<>]FOS:JK
MW7<O7*:+)DCI/]RQ_,ES)RP$!01VTF=X*GB#*_@(&&JMNUMS:\H ="ET 5W<
M!D2^Y4VH55U"HT\05L+U6]+U/\F%29W_:\6_-LH5)9 SN7LSH9L4 ?E9ANS]
M4EPCQLKCZ1]RU[E]3^T#7YFSQCSO>MPL/;6GM*<R<T/J;)^&Y H"CG1? 57Z
M.A"PL4DW<(AVH3X\-(G5BVI'2>J%? F[7.#:L^8J@[[U]-ORC?QS;X2#J[$U
M&WBV1&<SO@(*OWSUF;.<YRL6>T@3PY%O&Y3+(*XX^NW5S/=\M8SP4VGW%'[R
MOW#/A6U0HBDB@5QAK#Q C*&K^I9A-8IN_.G_.NEAAQ&7U"!=C!JEH=GBQMQK
M-,X;Y!(Q$?EOQAOUQ4V5891'G12=N3QB**2@95_ENC8Y=>'#R3U?9;SO2%K9
MR!>LLR'*U*Q*#H3'UB'8\F.LL]CS##B!+4U#\2W1IY_]^Q+A/$+_QS'AN%RI
M794],>=AM>:>_/6=Z+GY<L&7\ 5-,J08025M+33DZ'/<\4L=[^6#"/*:[Y(U
M'TTOR<.T-NI=&:\)-+Q0=[F?\\>\$I\/9S0R+];5V02Z)\^(>M[9?_CK[Q?W
MM39YXW3$N6/DO5@$]$OBW!]0R-@RX,V-<$ O);#!);C(WTUY)+"ZWI01.NVO
M]4Q,+?^'S-2^[_O%SQ6)-:E'(3WPU"_$U7B]<3EN.X2%_PS^5TXY@-H\;1U/
M7O8>0?[#D,Y#J3L-A\1<IJZPQ>5FC/+*_7/MLRNF\R4-RC0NY-+%5R[E1B04
M[3C4R*+O>D&]I1U@"Q,W@_,X;2%V!Z0^S_?!V2<4CP/AX..ZOQ4X[!'#/#0]
M'3U_>*VQB_Q]%3A)J3JP8JG(>X2V;5C704X!?ODHQ*3_Y)EP&L ;VS#5SE8\
M4PC"R@$[%)1/@0C>0/:]F/(EJD/4OY1@FQ\-UH5]98LF7_*+I^TM,I*UIQ^?
M3\J(L[)M$HEAQ4V3[_%F(TDW(:NMF[_H703Q,P0!<+'SW,?:#U\^ \RJP+>M
MWO>44I+U#42;5?=^.W=TYP[1$R_AG4C00H-K*[V\!@F-%,A59\9&%U9X!TD4
MW_)4/8?AW_90NPS]?@$I9"BX/'\ZKC:'9=CRU;P_OW72?]64"P\$-VDH20=
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MD!\D@I^@U1>Y#?-DH<:TK,%7E/T->OB@,M^!OD":CO'%Q+6V*HJ9'[XJN_G
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M6J@"D8UQ=7IM3TH#V';%/JNNG<BQ4+O(RIKT9[=EGLOZWZ/&3BH%T.6C[E$
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M@:^>7]X$UJ:=V J^ -Z!DU/V+R[I[' (41S\!_J>]JT+G"U;KO([\VP;%GK
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M1_ECR_[X\*\*<86S$D>O<E[B?5+.+;![W5G';,6.J<]Y9$1T/%W14)F[#JZ
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MG6:MA)UZ?B@X%[P/H<"XP#P^8RY+VA(.9A^E-K0DZM\=<UQR@EG,"M7P5>F
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M<V'>_Y,+UZ?R%?*]JN_4VK^V!_K_PK5ZMB<G=00]\$E:A"0I\6'%4&G_2\=
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M(/]%9"A-7[Y0[5D59'/IO;*@CJB_;ZNT^6?F\L4_S_YT/K'83XU']X_O#\:
MF_*)WJ=%AH0M^)XE7Z -R@]5IX-D#EG;@H+>-FC2'5F%3 A#":%9T+LBUST+
M:_EH',:Z,?K&7K'YSURQ@<](1^[)N:LQ![46'SR_4?!Q=^1(I)G'J6=U,; $
MU V8( ("S-,BAR^-O@F53QM*G<K%!B!H=M>S J[K^MM>LJZ3)LK=(O^Y?KL%
MT4JR4/S7WQW0[RL)IE+R!L9SWS*/NP6 18>S^:G4=EA/X''9!?:(M64:Q4R@
M\6"O*N9=9>V"7=01UY+Y/9#MG_$SG*]?8T*H<TS)$08]J&6ZVQ6<H$]!U\O_
M\/$6=M3:W KH>:"6SJUVL\  O9G.+Z7XP(/%15B6T!<"D,,.[2'*PA8K9L$+
M9P6;*E.X\5Q/1=Z[CARYX+!Y\<7*6B)@QC[009WKAS1IIF/X<?VU0.E[C!8&
M.ZU?.7/4G:+AW374?3W_[$/R\<_GK-]'7$F_8SL6@\Z%X+/*Q#DI1G*AYN4A
M]9%?(&((D_B0P_4-Y42P]& 4;]&GZBOPB?!'#D:>GV!W-;^.U%E<*V'(9U9?
M"7,9<7W9>O%/)%N "P^[CQ1D/>@V(Z R+21I<UGF@E7C00$B5036B57&96K_
M8M]Y^:K3CR7/^FOQE4KDRY\Y(:V7E[0'"F9L)4# 2#YX<J\?+S!'FZ(W 07H
M$!,O2#+ST)N?D3^+.D^SIO5@TJP1FS#NVZ708Q_7_)J- @WZU^3 3;NNSO6C
MG/ /<6S71V'97*0\QD&X$Q%,AA)PR1!QHRY]Z>!8:-HN2WG=+OBW/><'ZJ@?
MNFYD6MU8RDWQ=.17[1ZWY^R*'?P><<<N>1!Z$!*LG^XG-W'T6E<K=2Z]VW]U
M/=76Q]P"5B#DO,0=X+8OY&F Y:G!>*C5V=>'FPU=U=NN6=W"MH I.OCR>6CO
M"8PJC=[6*9(3_WHQF.JC8+<9O>QC\<%_4<!,>&R(>"+W1>)8M*M,W,.@L!2I
MRV>2,K6>[_N_Q72^B2Z>HU?1<'TP0+N=[$]=[/^[1D<EL77M2%8TMV=TG1A4
MJW5YU6!D$&,NISIK],D3[-WUKI/A_9F@O^S_GRXE]^=/,YWHDA"UU(-#:]%7
MWU1-%TQV0X@UE'4"E-O>N"%'$:.&R2[4T-BF/-H#S9T5V0+X5?[.3M_ZI=WE
M[&[V]E2$CIS%12/%<GR/W^AJ7+4T=3@+ G,"PU.^R43+([,$E65FYST3]D"Q
M#DN,;'=I%,,*V+E\+\0<2N31FQOI@:=]>^'^6BBWV6_']N^(XO[<_!Z[(4@<
MJA KN7LGD[DZA0J!@$.NU%H1*5%/8F/F'(XQRU6[L'RHWC/FMY_;'YPN=IA3
M@6(T$LZIB0;F@<!W7F8^48JBM@RFXQ41TNL7#+:[G&AN3*?V5VA%P($1#M@0
M7:CS*W:::;^.P,5]WV[[_-7M%F7\T(N3,/V0^"C538Y;63C&]97+BS^A.N##
MV>^O'RN@PQ^?Q$(FR.RS$U;2#X?^=<7X?[,AD:C>OGM8B556\=T@ZM@>*#&<
MJ8S1^B+S5\FQ[V>XW=;G>A@],--VU786M'@Q\X-OZMFFI_*[N(6R<>+W8J;$
M*/T1-.MO<?\S>R]8VHK:B2MPB$-/8ZLWBIP!/(RH>9)=^OM.'2__P<]V:6S!
M#$*X^P"4ZD3QVK@P^4L8RA;'B@=[_2++'#/Z+1@4\GIQ[+;J4$?0O'SS@^?/
MWCB%UC(NLA>A@GN@FUN !HQB'$4='KS'UFO^PI8/2Z*O+BS "2DO)]$"&NOB
MEK?4PD<,G'/>2^B\-+F5^PSU82-E22U@CIDK2C<!JA@>"%]6IH7\!D[(W(0:
MU,>6;J:6/0FO\@#P/TWDV].OITYJL2?'0E2M@A0'!:T>&MZ\$2CXK)5<SHW"
MUR@KT<K)DD18#D>+173+:O873=_=D@L.UUX:>_$S%I&JDV7[]:JMUYE*PZ$M
M8\/DI[%.9(U*R-<T_,(K@5I\N!B(SVF77X?@E(IM/MK*N/ZO\?$>*$(TS4(Q
M_R33DBB::V$0?\SNUNRZ\1CF-2Q*RD'U@>L-N.L!=9#B6O;$YL>N]3>B]\*7
M/7WCYTYOV *UC#!X>Z\]J18,8@I.MBR^XJT(P0M?V -=ME"%\Z^\M7_U6J;1
MUX#6_N&&FXKL1MYSU(VM!6=KUK]A@O_FM)[Y0D$;,7SO')&)$YP1C'KI>TZM
M_W;8,<4#JB6GU&!1XV=U=MS[8G%DR1 "_S4:O93F3, -A'D4Z3F_[T1G(4)8
M'3QXD)'8V>*;$9:(^_!VG2-\N6=8HJQDM@1<$_^;W$\8=4ICB]),$A!F]=8+
M^"^(<Y%1%C4UXW<1ZVXDBJ&#ZHAO1L#*F>OQ#MJ-=N$ JO=ZO515*\:-Y?O9
MAM[!:C)WQ8OF^,D")M2"ODYHML51>)=CL8^:1W><@VR_Z<4K_-#+&/A,]0U#
M<0DKL25*^6-_(5PRTI15TWV(AC[W!7D$<"(49YFK$?EK1(FP?:<_E^^!^,FT
ME[O>7?;KSUYD7I3V5+EW]>M20J1?%,,UK+B\T8DIA;K >FY<+^HW:R$-5+T/
MP4,E0F-='W5FKXB]2V+;C\9]K,@VK_QL54B*E'C0(/TX(#4>C!]F2NL08)33
MM"H;*JRO])D_\5)W9M@S=^^)F^KL8>HWV_L5G1V/5&$/J5F* =\^?KS$9=01
MCXOR];X3 ]7O4JB%L6[>EH&VR0Z++C"([EGUD*!G@H2&8CQXW\]V97 G+2UW
MD#(=RZ[>'_XN<VAR@N0OY+0M]^T1[TV*<TL)!74#NB@[I'P26".BDR&R3,-*
MP)F(O;_[(>H']'Q7_IHUS;I -_40*C# M5!:0]GEX8<#UCH[)^!4\/Q^^ALJ
MFBD19TDSZ87DR<KZ<;5.=-O7AJY(TEPIV=L_V#J36[" ;FO9].S*S1//\FVK
MKY(.)+VGS2-'%\A[H'8P4^K-'HBTF?QB0SZZKYP'D&9*$\;<+S<6]3G)^BZM
M')X9G#X^4JLY?]TCW_CH<[..@!]G7EMYKM=8^[RN/6WT8P_4L*;/4$4NHUKU
M*3MX)>0>Z#V2L^$$CVX=HI[3V:XYA(-(E5[9:[V>Z0PIMZ);3JO7KFY?;/YX
MC-<FP/;M2S3BWV'K=/87G"+["+P C\RC]K_'@(%YZBKI_V#OO8.::M]VT2 J
M"B(B'82\"HA(4Q 0"$3E!03$B$HO49$N1J5#2%2D-P$%12#21*1$I-?041"1
M+J&$A"8ED%#"@K03?^><F5V^/?/-V=_>WYD][Q_/#/.LQ;6><K<KSUKWS5+2
M1UCAZFHI$0F9Y=WR"2.?3*J7 QILW*Y*O,QMH\_M)X;T R?/1C C5#\;["0R
M;L)PC.NJGQ"_=EBWN.EN;- OC1;H'F)8L3=MPWJ",7BB[O:'.NMW84NH#XNK
MLW0GY,T!J'<=ZR##[R=#!$'RN74IM8,E1@6_L"?I*SA71]Z.79@J77.:CR3)
MGCHO-65W^*_X([NL&@YG/  L4058O(>I%3,"[0+<@-3-1@"UI]*)B=[NKJ\9
M\G/0:]+B>^M,[PT(+<KV-#,\L@^<HJU,4/2:9N;@YK4X;">)&=VLS JP(F5S
M,<LKUW^ML_@4Z'?@P(3I2&FSY$IJD)G2NJC=TL:T0U  34V@Y6?![PC[J\2W
M<B^5"\QD.[A%-KERS\-NU\.IGXT/+Z=5-S6NNTPCQ>@N2!<F!N<)/LC08^8P
M]&9$!UD*3J8? )NNYL.A'_U&AV]JO?:C]SI\"#Z9=MMX8^J^ZY-:[K(>-JA\
MG?&!A\9Q&Y_=GZ*W"!]MN*A1M-B?Z)EB3"6\A:-V##'O==$@!6)-8DGSR:":
M+LJOOJ-)A5DZ;EI[2(VOGT[79MMPO;#C?3J7W*B&ILNP03UWT \(](-!/&R0
MQ5[$4:VXP1^$3SQ21E-V$_ F27@%1U6]5&"T"T I-93DIVL0E8?4H,*CM[YQ
M!E-ZWU*E(&*B4_"P7*(SR9FK_6QEXCDQS20B+@Y3C>V$[NN>[1-JP>UKU,A?
M%F6#\)*(Y_[T)F/X,4>'UX03OH2_>WT0CY9->N[Z7PFH.&H&:+> QXL=F%C<
M3!*Z,KV=P&_ZL/G4&$H^J,Q"Q3VU-S*T.,S#R4BH?$8YB3=G:H/X8[7,*)00
MR0;-U.(.*$/$3J!TZZEB3UGR^+93PT@N]'OG:IST;WC&]+1(-/.]QIQ<<DK\
M(3GL17DI[1[L1S-11(IV($/ &DBEFLQB8E#\0:?IQ/YV.+^G\SDJQ%2UPGO6
MQ[>WBA)Y[VCOV?&2I(")+\_NW5^UQ?X5C(E@@[S8H$1,Q2+9],^AJ,P%3,1>
M811*&>9;\%M&@6(&MRN-+.1OF.1S:'"HDW]@<>+A\:MS]-[G[T\D:7)TZ17#
MII'Z@% Q746] HTA<'RN._:X WR*<27\>O;"(/U:D[>'<]N0=5IKAJU/H$2X
M.$%JF$?Q&5P7R.VE/:EEUN)<0]?'U\:Z=.>C&,H>I!$([#'6.R,MIG9\\E5E
M1)545*+IC]$G/Q5_%46ZJ@J__) Q$LC"/A[*S_1WVD/5Z(?3HH>@'F_1,[4R
M C)2HRR^B>44)'0,W)Y0Y)&1.4KQA"*J)].?ZU5YJM8\:.^Z"3FXJ[,_3(=N
MCAIBZ3*SD.;T"QYBH\T"(YK8F&R5:LI8K.J]BEH'#\>ES5Y(->_0PSCUKBO!
M'V[*WCL*ZW.&T1$,QY_H^QC@[$XK&Q2+.58V3R&TOVT\4!KD!A,T]U&N%@T)
MGW*P.*'Q3;+F=9-(=7K+O4/[7SY:GZ@A_0BG#I%,5DU)ZWS3!AS2Y$NJ#!35
MMD#(@3WBZ+J[AB^2K5HN?IT\:"P0HM+7ZU^ ^PX74QE-8X,TAG >N EP-SZ=
MK,0&\9K,P"(;-;' SK7!G#&(12F03?+P Q_&7^OT&;T=OC,F)N3SY'/.M;-K
M*O&SX-8_N;4[V:#Q35HT!=9.P(L9 L@]= ?]K1_A2%!OJT7@T2QF?O2@*B;8
MV\_YJFN:IHM425G95V.N']-0$D_'GPS8#]&M)@8*2#,J#5.LT 9.S+@>+=49
M$* !=P#@MX=.IDRL[N3^U;]?R.A4O6E-[U'Q1^95+LA[S/>5?RK=DP]0H&VX
M@_<;J3;/45+ <B])+ [B+1)/61(%C_>>K_X<&2SX]V:_QDQTW'ZC!YFB7&>*
M?0IJCG\HJ1R<8.#Z<P: 0MH6,#6K!IQ)[T0_A?(SI&9"EY"RA;\S"J*B_;OJ
M(MM-JFNK@U4S=GI>-G64*EU*H[25WP_^OOZBSX_ @_,FQ(/Y< _ _ P)@&.C
MH"DK) -,:-A,OW"0$OF&Y\[&^%]IRUTD_-)<BF*:T$*DG82=R8G%A^A55"QZ
MYC.NVL''J;<@Z!!WXB5=5 YF#GHVD,Q94\5;S&CTJN(LE&GBFK^+Z'V(*>@8
M1GQ[F+Z[,9E(H)4PWT.]H(D883_P<RTHSQ_*_&*/'F2]QP9U49?%:O#-N2^-
M+C1;596\W!6=N?;IBYX!X_C[>/*>!NWQ"$K>"\<_S+ 98,CF ?5\17>3D1IH
MS>EW_KS)\_T2;X]?W?&E5W]S#)O--@ S/Z%.H3KQBV1I4H(A2;1N%O$,(Z:L
M9M#I7XKO+05,+$>MP2D2I(Q)9>WR+T]=?)MHSUIX>":@,R^;H=3U#K5GTVIU
M5.MR4K\08#;669,VS37&L+K_8+L)<<4JJ2>;*"$;\/W#G11=I?JG5[F%KQN0
M!VNV@8BKH>EF$W[,D"QW<C'==07##8'/X*+ 1Y$J/K-)<6S0\8R9WQD^Y/&*
M(;\5AT<?%F\TO[5ZJT*:SO-2#!8G.P?+N%#Y:(W,'.C=L0&&)77%B$.HU"*T
M]UY7ORWQGC[H=*5GL76!9!2K]^[-PVFKC&&SWZ6G=-77>.[^=F76HZNAKKB)
M5"*6+(.$E@:]:]&%1?J#]P=]]=1ZXB76+%-56_M\F=]4Y:5&H[FRD9M'>DB7
M;^0)@8O,1JA//S<GB+;@V*B$6S-@3D!29$Y5Z 0+R5<-5JE<:;>HU75_H<S?
M\<31>;I/SEM2.$%<V:&Q;>[.X^=$J8(/6?#MSTM#L'0+W6;"_#TL>1[</<?1
MC@;4CP' ^Q9P#O.PG!H"*"_OG<Y[Y >D]<*\NYHWUE*_OW[*)W1Y/L+Z4>LF
M'(T\&]=Y PD9O-4M]B=2N]>:<-WGZ+1WF*[ID^!(G:PYJZZ+[BZ9F_ SK!%[
MQQ P0R2/=N9+1+Y'R19:NB72>++3QF+HU?T=B#^VXM-9,VKL!M/NM9WS>6=X
ML8'8GSH@[W'2!B<YD[QLH,G@ N[.H+F];# "$\:U%531VAWKO8=Q[H$?6GV5
M",$/^WTU^A2OWGUJN&$\_VY>Q<G]^9\4_O&8BG7RR1E"%+H2&H4$X>$=*T47
M"+S 6*N:_]$,/">>+/MC*OKEU'MBIQU*XLML0/X3,ZQ]G+B"$P)Q @M%^ATO
M&<U!?V]$9/U<\_%8-J@S+03)$2WIQKA+SW+,!W@KD]O5(<]<SUK**)]WFAF[
M2XW[?UT_[+]T_;C_RO5S-DVYBP"+#!;Y>TRH9^9<W,D;)U*T(T;:>\U54/#1
MR(W"+_.#O?#T[9SA("R-"A!G8< 9=&<2QV) 3LXH?6L$%WK4<RR&YFR@2&(J
MPO?!AI/F[]@K.\<K2_>U'E$2O?2F@>C[YZP=3R %1%!MVJ '4))!Z-;F,T!?
M45 PQ(AD87XK@S34;B!6<?2S9F^N:&WJC\RKGUM*&U_(9QY0#L;^8@DC &43
M\NN31NJJKV?D_Q0S_(S[RO-S!G6E,9#%JT?7#E)H@5-N]*+CP>+(\[,)Z)G^
MN$8%'R+3T)ZR4%KB4!->I62W$+30$&?Q5E[+UU#1B6[GDAS,'7SOE4N?MQ\\
M[.6K>PMY#^,65I/"*&CR+6KJC$!WTL$@A5E:%&5OQ01X';0'BVITF<D+1+@<
M_7@JY?[0NHIJADG"0J(BI.ZXF_5]_&VA#2I+D=EH<!$88O&>I'IS0DHX#W!P
M \:SE*%:5 C$.8=^?.#W1M4GPSPUJ%PG]*VD<<2=6)&H9XK!Y]Z/9;*^$_BA
M]Z )A,JQ\ ?-@DL&4""F- BUBS0\VN!"2A+VDA2(+%.!AAY)UW"<ED*?S]QO
M6W[2IT.=K&!01P?G8@!E;?*K">/YP<;]7-U_24-O]&^ 7Q\];Q.P-';]H[QX
M<8/WPT]3-N:9<([<S.2"*VU65Z@$<T!M%A>)XJ(6=O1'T\C0]CZ'ML!T7734
M-E@1-W3P??II.[)1B<(/-T/5;:[;#^_P.)# ^"%:.#/90(FAGS2;EDQ)=P:"
MJ5(=HM/"3HC6PVCWQ\12X]^OJ^C7;)Y\/5V3W&)X5IR6;1;_T1M:#684T&D:
MG- 4D<0)30N'X10'[*[6>A289LV098,*SRRI6I-*<8QS)J]KBU70?=B?-"C>
MNP,L@R.>&;R #L^6!AXHKZE,AYEW9)\?5K6?[FSWL94MK]IGE_5LJK97$G0^
M<RP;U0^NPG0F'46-X2CY*%V/9NXDYS$(5#NF484$Y=$?#G$KYV\<Z/3UEF_J
MA7R>-%G(8X-*_.XKO#06B$.WFC6:$]^!)X8NE3-SD1:S"%[6CYM!.JX#!8/^
M^N86 PC&95JWT.D\WWLW_TZ^LQ%_=JW\I</^:NO&0IK#$.M(.X=3O /T_2D:
MYM0DQLD:9W[J,1^T[8AFZ(K^$W_1SHBWPQ]2#$^8]4A>'7$)2 75&59U9<R-
MU2"&92TN>M7#$:.+ERE)5YE%<ASS5X<,LA#K (/N4I\ L/9"RXR==GQCAC=>
MM(&NWB[I7!)W3JJQR]WU0<*G6AVZ$JF0?(L$YD:W_FUPG"%;63%PGT)(@FB7
MKDA&?/_<@\C)^#JQ:RX4L^\L6+/FH+$"]X'@_GZ#"\P"B!3]T)\7ZU!*0>](
MHZ4*X1 -JE@+_HBS]$A926%:_ZV,'^8%V5-R,>+!*TU7HQFKA_XZ$;^&FD9!
MDF;2R5'TBZQ!FY"'=47(LX-^62Y7J*(Y=S_T/89&Y0[GU*0,TCP$KS5?_]WS
M]<J"P<5[5P;DYN4+83_EZO++ZCU7$)OZQ2Q>1?KMH"B:,6!*U ]M#PC1W%YH
MFLWB:]<^7&0DEUQ0M8UO57J?^/>I2R5F*6;A([:/'=48PAJT;> 970DUA.9B
M@0&^UGJ3!"SJ?!G.JUI;34Z(K^'J _QX!Y%F^!#CD68WGI?<^/%ZBQ2V#T.Y
MG02<V>'L$KZ[!7<8J4])6U[IQMLS;E,Z%^I(4DHZLX-^'D,WXHT$:Y-%Y&K3
MK&^<BJ\X8"I139;8$Z-UQ/RI%XY#=:[VE+@,-8;T7*47TO5@$N!GLM0"24_Y
M[PVL*PF:PG5CFR@^0T-:)K,0I8[Z!JW@"=_NEW!@J(XPO+&,*P-(/7^95%>D
MW[M0J8GAZ-U[=B]*'TNF_/TB0ID[V&5M+![=:KUJH-7/$:7]S#<.;?B:MH8P
M+9BH<]+ALN)\0I]^TZ]!>;HAO#+PS)<VD[?E=P4_RP=JW E?QORWVK2BQ^(=
M(^FAPW&2?^I[Q=IO!::QN(&PV;@BI&FQH;=\1\@%;=T'%"-(KV2%LO-=+HR4
MC:S<?=>AWV,.+,.\@8)BW%P _#C:<ST._J4PFK6OFZJ/DE[.$$C27,'P!G5;
M4UB88,^CJ1\=Q70AU:30&*W+)ZV>(RZ4;TK;V>X[WL!Q$VIDTU)4+V;_ZFE*
M6&)Z"=*86MUTEP@[Y%D?G5SZ<%NJ[LK:&^.>!?$<NP]A^=+E@LF9\4FQ:3@!
M]$PI[G-WP@7802!2VN$2]8*0[5+&Z@USX8#Z^ /W:^JCZY7.11+O/?I]+D"Z
ML FYQ ;M7P1:26J (I:L1,2!@_I-,>:P<6S[.C&.KA?=LHE$/#FBF]_;=?Y
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MW/N31G<>]R>-[L40$S9(SO+?ZKS!\U/8II^S9#2U<7=6H@,-S0:U1^6C-XS
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M_-GOSCQ?0_-[C]976G\1K)5+>+@F&+W(PR/,-6EI) SZ=S0N*H$AJLVZ!*Z
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M%N*9;PMD@WDF@\STP=>&<\2TM&IN_3XFH?K]Z!$?W?RKR5\OWQ=0'=3.V!+
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M-6"^UJ6^H7(9)D1:\A8DPC3B=*->#*!Y?)T!J=@A5=5FO>S$X9[+V)22^>0
MGB%CYT;R<H#EC!MP43X&QY8"X71.[L8[)[*)58R[%*>24TWL;JUZ?-V(R5L
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M"G-=F2&/,C%UTV_LS.6G%<R&N>7QF.Q^VBG*4E:HP".U2^@ZR*>_,19-'QB
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M!\8N$F75C]$&:D94Y>QZCB:_)7WVV;)^(S0@$6[N<.7XH8X>.HB#83E3IJ4
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MF7C_K_"S!S')2'=1;Z9[B9_C=[.^:J2<L:29O+F'E="6/Z$JX(@A0"%O?YH
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M+X: <545*#!?JX&,)V=(EM4-EZ[WL,LV?Y:Y0-MEOK:?K:1WC6D-I,2S'\)
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MI0G2&?UUK6,S,E>5YE]_WV4HQDP6LL:@OTB:PE5\H^R[R-Q26)DF=1\MC<9
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M*I4](3\K@FR]%_C7#0'0^9B95"M1FR%5G9P*>,R[J7:U$U=***._T<G.R^R
M^)TRH+-0FE ==QZB>\6$9E?[4C$O-+T/A2]T\C6T.9"D]LIL,%\J;K1O'U<(
M$W#-+'+TDEIQ?Q6'7+YKW"8Z'4X1N_8^/:NT]X%D2M@<)'A35!(<J2J[SL9<
MFG>($?\*ETRI&%6-G-MVN>JRF4VCW&""]>B_ORC4G_N YVDQ?K30X8L&M\&'
M_]2'V/^5RC]X*@?\+9&)=B*7@#0G?L[%0P^OHD[3F-;&6Q<7#]9F:R)*9<]N
MYJI93$239C)FGX'VF,2:ZM$GJ74,3QX-(5TFU(2.@%G6:!!B1TP59!W)XF.L
MH4MJ?#8OMM==T\VM^VGRM^#&4?>HN%P%R7&Q]PLJXTSOK1A /_NJCUL9BX\=
M5R%5$!$)5?&6DKI V/S8U)&HM\>J&JYBHSPF;0Y&?])!%>#U!,(22?Y/!LR)
M&BR,>:6)IW_^P^2/)'*&\U@XLUV&O93H ,<G5R]Q$%L@\_Y2,QU4O;3AC@:6
MM"N&D,\NO[(\3CJXY%IEBI!>KE +J;C/L\D_)3+9QI%\O:"S_>?+WH /ROH%
MES?$ ?3/PO@"9RUJ+^*U!K?1O?\T_PQ31C9KOI*O!UYF.C$7=]LC?GX1:FCM
M@^QM-D66'B&A" )P#0!<:G*[OC0[;.,QNW'49@?^$#C:\XF3A.><^.3N;T$]
M[**L4[?M1:1F-J7OQ^HED>,1Y.R#OVP+GRK;[<9U?Z/*P"9A/)#GPX4DZQ#!
M>']C>[(:HI^= +,<1N]TG_5DZ8[4=1'H:=4X8^ZN*%@S)6AC'+N6<2'!P"7R
MPZQ0?<U(-?R\(RE VI<\*+^%_915<K9+L&+52EHZ3Y]M-MQ8;]G/+1;IR"X
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M)5/WHYS?1>/*UD^HL VM%(B1?9'-\GE:.@K>><D4+E)A!&6PBOI.78#6B2/
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M__7")W;,VN_1_X.]]PYJ*OKW1:.@H%0%I!,4%)4F2A$(B8@(B!A%D4Y40$J
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M#SI+^+L)[M']]_N@S/OUY?.=,5@D8JQ[1B,"(SF"YAF \D_[1MVH'JB$"ZQ
M50?^^-X7CNBWV 84>]]MW:BY%A![TO[B80A>:H,%CR< _3GE%XC/\!;8(8
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M^+74Q0%5'NC3P!)7X[RQR<QL]>'/L@/%%2<_'Y2.N?0R$F^O:%:I'W!DI;@
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M9Y-;<]^'9Y8I53M79>I4HOR^.#QH.0?VT.RXCN[]?X8 O\;S+O\O(:!O[6>
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MS,^)OJGC5Q%?8+/KV=H\Q8A.9Z1.[&U&;O6.+E$_D0W6C<E,6KL4]Z"7?+&
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MCM:;4;C:Q>"OMD4<+#!#@4K36O=II=>#E17".#@COUV!/'%^$N_M?"L]H=S
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M?BFR$5Q,'%6DGRSRK?%0#7!^T78GD5^AO/.$8+;Y\6[PEX^)+]I],-(L\7H
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MITN7PNAL\^.]/%.N=N":^E@XLX58W5A>-9 Q9^3NWF\Y&WF=OVV5?X+HK;9
MW<53B0ESV'#L#$&*NXS\.(9,L&HD;[34J"&XK($-L_J*LM 5VQN&^-_NT%[W
M<QI1QZU/@EN/*.+>A="Z9S5:&KAF?%H5.9J9(F7,'O)&J-NC@8I5A.;BIG3,
MU<R-9Y:?.>[+DH[1S)CM4QR,SYZ!DI [O,5YJQG"M1I38(I4V">CW%4,N%H&
M:83T$N5.2PZ]6R/.]BS^ +NKDH_<X)U/;R=PUKA+=*N_#NF*'V.;1[3P"?DF
MZ#)2Z;! <F][5>U7USVY"*_D(;O6Q=?,CDMG,H3BYT873(NN_CXZX=[CJ0XK
M)W821WKGE]KA0FBY/J@X^C8YMAUUG.4U@=FKJ94=87-<7+E!9QU"Y9NY?W1[
M0#[86Q[T"_@BRIZZC0A&D$TF^6;SVHO%.Z5D@ 1*U!PAO/[B:69K0@=&QCHM
M4#0GNEWVS?BX'ON9ZS'ON;Z\'GEV:4"4J?9W&X&+?V^;I$^;E##03KN"UM@'
MO4JEFAB8#D TYKF7RR>^^AB?U_/C:0IY7P,U@KN!0'CGJN5EQD5&YGA>'ET\
M0XT&QPRGHM8M65 GBE$@B@9_0L,H3D';/4ZZ%/.P#2M1A])!TU&'QP)7;S[/
MR@YON1,SL? 4\8C9/;WI#F;QAS7+ >QVDM8"4PC3#.;!'&=^QYP&$.XY4ZM2
MXI32AH2V :1&_[2KU*E4BKI-K]>SI6_QYC8\NX>NEDP\N(]=2Z9QCC*_U+Y>
MA\WY=/")NGC7HJC74[)]\8C7S%:#*N[HPH.R*NF?8N[87?>^]S4XR-7Q;/6H
MSRG3X"CC&K)!Z\;N/?]Y9EO4/HBA98+(PI;CF\"<@!Q5EXQK'3?A,$%QXD/7
MMY<KEA6'/M1%&H*2>VP>?DM[5Z.I8!G1I=;F/$V^.7W@%XY\B\!(>3A4;S/%
MEG CS5!CP\O#"WO>.O1]VK=-R/O9]!?H='L)@9Z C3!/P_I+LS1)]<EL7U6:
M[WJ6"Z?2UTA!@1>'GV@?T+\1L3Y9.O0I)\#'#4AF\I  \X]T'9:2'@#FM_O7
M[,-N4WCQQ= <[U;/G5"265TI88IA88!RYW;E.RK,)H1C13_2WS6<?&W_%WOO
M'=54U.V+1@$1I"B"-"$H*$I5>H^*-!$0I @(46E"I$H)$A)% :47 :E1Z372
M04JD"PA(A]!" $%J@A ":2]^[[OGO7/.N&.\-^ZY]]TQWO='1C+6R)Y[[;7F
MGO/WVVNOWUR8^0J)AN[1 0 2:]<0+GV/_-0@V0OU63?@12_0#-DO8^F;<51-
MU*.F4D!D?@I@N/4\U/'/ _3//?6="C&D5:JZ5W;%CEMS@J+!^:<WDA;;%T_P
M7E%7OQS?$3\UV@[DTO(EA#R,K=5^2'G6$G?0::V1W"6+['U:%W$ET<E"_&G:
M+ZY!(\D$M4*I=WTF^W0 :)?-RO2^-^J0#DC\X_82+@8?!=;(;PX7K@OQMZ&G
MD>T@=ICMQ[)441&"?)0R2RKG1:BBD&EJ*J>W4 T'FY[:#4.UB\V16%I3$$Z>
MI'QN%T=T:\@ 10C5EE2?3SRO,-LE1#VG9"7ZS68$?HXQ7%I0^7;,;5$AX%D=
M#0\@AZ<O+YA[1^NA,WYWYOAUUQMO';2+F+P3#C@%;UD6.TJ/Z;#2VD692$ R
M+P9V+$[;K!/)O;67V<+S=+\XR;ATQCXM)=]65"+6#[8*^%P,X/!3M-D2J]M.
MSRUEJ?=GI-$44CH.> 9J3&,3J?#(.?T'L7AU%,XS$)#WX<,[B]]*8<,*CW@>
M7F/15W]T0M]/YP6C?R'NH!IT!/HQ*J(.Q $3)E\QP4KO<&%FIXTDW^VC-*BN
MX79&7F'N*W8X?1G791J^05OZ]\ZT)I&SDIJ$BI]JO0QS)!0D>Q<@G'YC0-'*
M:_N<(,/:V7 +@0F!7BEQ2^N4O$?I]WQ,?/G!>,,%-FB0W=C"XFKG0NP"*PQ4
M-F<4$KR(8H%FR^S=5XK]:A,A^/$#)DTBF>CZE@//?^I=S.?D=]>+F;-@V[!L
MLBY\$'P:X3Q$NG3P5HN?(.7-\A1^G!#4[:D0:C'9EE$^UYVYB&)?%TJI=IS.
M-?-FDH#XN1[Z\;NT.7SC+-Q#=X'8FD\543A:\5[EGTC!<)&ZI E^C8=?>LZE
MB[S\YZ."]6N\'#%.RJ^PB*G5Q857(-<(DNZYL*^%+[=EW6J;OXQ77!H3OG>V
MR4AS0*)L<-=(O#G\W>"O[]TGM R,&$.I#+W<?S.R_6"!5T<;@N18/'X)+YJ[
MI))V$^*C+PL^(SN6BN4(EO?IK0\[^>VS%6]]X.318925N/9<+7K_EQ\"[_7"
MG8!HNU:C/.)5T#HRV8DA53>\_V7\%E&S.K5I1E# (I\[L%+.;=!,FA9[J"GH
MDW3 [SZ- ^04'4 TQ*,WC?$NL%/8PUJC&K5]S2V+ZW""4J+V7,>L%F3%0.CD
M>)Y4%/^%&\S) P^IQ0RLML-&FT*<4.8^3NH3_C7BG1^QKAE]JJ"F973[4:)+
M!&[>Y3 W5?6>+K?/3>;7<I^)S50Y^:<M]2#C' 9%81F9D%="DB3YW^7:-Y5K
M=ASE5'[^/2_97!=HY.GOOB\-13TX,SAZEL_+\EG@:N61Z<RB35@YG!WU&O>3
M @*^M#$F'_\-\188U8M/BY=WF]TEP@5^-2!? RM3T_%#BT/OFN5QWH*4&Z2V
M E+==>\B!IE'%'64>-?O_G!E,5R,NA13*O+M\H.L)#/E96E&K'?"/Q058B0+
M4^ZHA1H^=(>8UB>L(>49'3 5-E,XS200BZWOZ5\YE=VPQ.NHLH(V=]1JKI]F
M4!=FF7&4,I DF1KM3<PLW>%8.R+6YI/N;"]&MPQ&GLC5"KQ]?25!OXEWF?*V
M&=>\0V,OQ")9*'J,J2ZFM1^!XG.K&W[*[30_['>''JMM;3)VT# V=.;L.-%@
M^"7RPI140M"35CP>^$K).WR>?02FNCBG,*3WTU_SP:8_^93A&Q^[FT+AAL,&
MQVZ]E.Y!/.,F2<IW@&=R>QQ/3NI<M%_'))&X9BSK*K^$K=G/W/4>F7.T<0&K
MN[PK_YPD>"%)Q4"X:O91K-[6>202%RE4BFEL.8>.<@52^!BX!LY!2*.<!2\=
M([1C+F?F0KW^6%4VO3]V&5G4<4KY_4]5JP\/@SV:#&7 WOIBE.BE^-,P#]([
M<@"M[QTU&;]D1\A&M?$1^%(*XVNE^Z6/X?@A 6,%+^UG[@R$G'=TG'U5IYK>
M:G$"_JF&,1#Z)!"8<#GY.8$)9]8]%(T1?1TBFEM(\NYNO<J/4>(_P_,DR= I
MXG*CLV1\C5:+^J!IJ#>QA!H'XR8_(1F;C,(<($6Z(1_G8G5U)_:BIY6H3C>^
M,HF&YH\Y:WG&G5RQ9_++XK#TT-?P;KQ7+%#A<$!!E)NETG1H XC:M*VK2^"(
M%W4MG^ _:,!Q'1%257^G$+PV'YIF&WKG9&Y": 4&I&C*WNOK_4M_S73DI.1V
MF X1E=G*^Y?@^(..4Q[\A+GAO-\M".E(;8B>35S]F=RM<]D^6ONB:RS./;>^
M+N+D_/WS<9DK-L^N"Z+R(!I)IKV"8TF!QA_-]?C2W_Z//.RT!G;NB/3@T8L3
MC3CUF@&(7;QN5>IAF5*(2O.8/+.'?7\8WR\C80$K@5[Q?"\+K6@>1446*T&)
M+, 5ID6SMT"\-8(!$HY3.'0NPO2IR5H.B\ W*CMGUX6F"*'AOVKS9KZO1VL=
M68CY [[,MKJ[#(D%[K2J(]J,:R'R<=9T  ?M)$P635I<,MPS1IQ9_ZS]8N'F
MB#]$.#'3-777&=8K1>D7^G3)4'TC7IJ:JQ5:BFAS:;Y?!.,G@7TOH3;I@()Y
M&= 9G0NWN--02@K2=;%Y]49LCS[;OWIO_FWHN-E=TM_WC#'C^R",'/ =DADN
M-P\[0V@^8D%'[K\]>Z-NLJ;%M7M!^IES=?J2M(33E2IIZO@]P&%]@-TIG#4"
ME'*4G54SWIB"')RWV9C=1#O%_RVAY,X-A%8OT@$QL%-EL*LD%!:*_3K>K%@T
MWP%+PI@@I;9'UF4N#30^LFRPDNI@YH@B<L>(2A D7],$(1K(-UJ*_#'-)FY>
MSJ-[1LI*HV?-T\3/9*99/VCHG;6,T[#Y%;1I@^_I2D"T0>"*D!Q14DH (:W3
MD9]TQU\;T8GI],7\9L,9[21!C(_QE:2$8=0\OSW%S:[W7I>H/@-VA[$2Z( >
M)" VY $UMP+D1@=P0O7[YN6K%D@V5F,&*8IWSE(O[>3&*<5LWSNI/GNCJ-A$
MLC!M?W:P7"E_^]"=Z@&C$D T]F'R+=@Y4B6>X9R.EZE)>Z6(,[ [8]V9N>Y$
M\+ER^>T5JU^0B"AIGGYFXS]:Y;6\ 8\=%\D/$6TW43HG8']7?]J1D0BN ._H
M!7XMO<+6FJ\L.?E<:>[Y[M^[..=6EC^E,KL?NRTL4,GL$QAQ&$UC#\:G=0._
M@.*;W<D0DBJNMJ"P7$\TLP#1+HZ3O8SYU4T'W'5?C/D]H0K:P+JYNJ.?AVTU
MU!F(-Y!8<5 8(\BP8$B%= ";)6+J*X,;1&J<R%U40YE.-$:-.\C+YLK&STLT
MNKX+;D\5CVI]4/LCS4R; 0 5P6ZLHOZI0ZU'<)NU$(/-5W]7Q1M(!X203O I
MG0LPT+C.:0H8WY7D,4KR.C"/OE\_YK\:&AWB%GS:\J_RKSBLQ.HMLYO:D7[K
M6<)\I2=!D<;%AF<XEMQ%-')QH8/3D%2\17,9[1KOBWYZR?=;8OR@N%=@]M2J
M\H&+D\55VXJBU5+>#$A)PW]GI1#^B#'ZGK3CB ZS?Y3B1!YG#*O[$AT0B9Q)
M(E$0[3>QV6"RI,,HI5QTQ'LO)#M^96>74G]HNK8<L!2H[VKP>_^O.)J:/ UU
MG_BW=$Y'"QTP^Q[1$48'K.^#O.D BN8"M?>?TFC_H=7@/QUW[( *I0.V+I E
M"WN0T0NLS9Z0"J-%ZO-%X-N"\:T5>W.?^HGZ<TF8.;O3MH'!11M_P@*WR.4Y
MZHR\YT1DH@,B1!"\JA0Y-(,#LE(D<&-...\8T**8D%GB*J*G<-MI%S:D>9 =
M%&SN/S,XN?6)[#Q%^P[GP^,C.XX*8YO=EV*ME.3924YWD]0J:DN[+98%)2Y<
M"#]CNYQ"LS2?3>#4/SBX4S@PL+T-ZRE M)W7\G4AW!GMJ(+95Z<1H:.T"XCV
MWCK\AY\I 2XM9&.'\L3FN?BJZ C9!-7$'N +](W(XZVJ5"0"6Z'2JDU%TH1)
M,SV.3&/-HO +4-K&XE[BU()!\?2::O%S7V]OXKOO[Z+Z):1%]V**7'NEKB.K
MI-;_S(\JE:V&W/UO$L7I(#P&S*M$!_ B.F[!1Q?8T-5[#7OH362DJ":M;60[
MT%@)_305>-%DDG/UF7SB^ZCK\6G_)E#L Z8Z%F[]'?K($#J@\0KCFX4.&%^'
M+] !I" T.>G?]$K_0WO\?SKTGQ*H_[+X+XO_LO@OB__;6BS:D5D<DW4.PZG]
MBG"Y0OBZ;<-:=+&5^?_!64[-6 8R..FF0P!6T;<"ZJCNK?2((QFS.S(=EQ>W
MF4/5@QTX?D1@7]D"=U\@ZP]H(CNTY?)X1BYM.^4/C'RA-WL=%D+]W&P>X!,D
M09,F\!44$.K]'#POIE33QB):7S-EV?K9D.F 'U3Q"TMQAB6"X0ONLN"!@'V[
MPP MQZA-+48GF.L(JZ\+7*LGFVU1=G%)4^M+@=K#[U7@Z4>3Z1O(JHF6Q71;
M91%=G%[TU;:SLT; /W<.BG%7+2=X[E)/G4I_?)U]3TK?,1:\/3M;MG/6 SF-
M@?/BC.!6Q'WE<.YOTQ42TL!W6CY_BQ=]- *25LR;2=XAG]<5;3/19QR4W%);
MLZJ+>TQO?*MX:UL]UM&M4.RV;F!67Q]2;*TV5JUZ0VHKOL,]7[-"7BX7O%V6
M[HTO&,)[J;NYG^UTO%(_ASDU'FNPG%)3<JERS;*K7</ VONISGF':VP2AX7B
M>+NQ"D4:[P+5Q%&1,5Y(.L#)@'(5?931S,"5KT&T[B^>+;8K@WD%.^+_T$6^
MC]A7A@[1 2<0U%@@OH !*#P(2!H''4 6NIV=S=>-:,^D XI+NQ$DAKG-IW1
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M"6)!;V@J)&-??/5BX6N:Y$.*/D&TOLSCBW%(N8*'HB/F=UT=/JGM;ER8T3O
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MK\]F69,TH!Y3)5&6U._M=@$C&+1B+JO9*7M^:X7"I[=XJC:V]Q'SB%=K)N1
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MVR\F?SAR$K1:V0F!:64W6<K'CDQF;1*[_/(_)>;Z8-68>?)>)9S\COJ,7MQ
MG@&MG<*B*7]U4Y>C]BHM?2T7A1Y(2[2 P)U'63,LF8^+1MJ7V:^]L2Z?6:XU
M"[4/J1\C9+XA@#=1A S#$7<EY!E2X)+PDKH-\W'M'%4++FZ.<G"!Z&G2M#<.
M/3T/%-4[^73&(-DBB45+)K&[V["-Z.\R5 MWHGB1^DM@+TBO?7$F3Q;,:EN_
MQJEER^3Z1Y_\=/-8>IR/-F0G?DJSX_D&NC(B/6_C]/<ZNS#';V]O6$/<71*
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M2LCF5EW3[U\PQABR/*"&*W//E&)9"M(^.MK9DG([ZM$8H2#,5![_C4^V8JZ
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MO(7'@,\T+OBUWM 2V<W[D%]HJ!]Q=L%YDV,9/EJA_A&]!?]47W_*S5C+1S7
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M>O.;#SJ6J<95$\S"OYB%@I[FGKU_.B=:YZ72V*[N-N(Q$.$[:<@?0W8K7TF
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M'OKP(8C5DN!*U ,RB6O(]NPMIC>,$K$,\J>$G.[2P'3/38_JHKM%'PY![D:
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MJE8(E;\@2M6B](X/PH>_DZ/W.G)>F\_"XN*96R?/-C!](?&$,_Z>Q379)KT
MXYR]7*'[N*JV-NUA\$E!Z\EWYD)SP^T0HEYL"/PLEM609-M$OPS \U'B $*\
MW.,G$MQT$(K+=5_4CR&<(U.L'/X%WGTFUH5VUVZX'1G/XR\@F$P]/TY@;MQD
M14D38U))4OC)X9;QHC/(;T/CC5.<Y:4Q6QX(<ZMYU^WSA;\^SL;^=7&+3?K9
M?G+& I5^")*\1D8SW@=V86^GRS&-T[$I+4-I,_!P!Q IY^NC4(-4>^9FE90/
M0RLL)VONB%P O;^F8R)E1%ALPQVG@GH=!^H"9XU8 8G[51A)J0*,966_8R*P
M;[[@9Q)X\<2$Y0)DO3(?F=R0+@?PS(;0XC)F+(KQ\/!T2&DYR;FP%K\/Z_7T
M#*D[\"U>WE;J/DG27;'T[!T6P?7 RG%KF[,PIJ--_%G ($,<.K21(XC1TV\]
MRMCM1:=&<G)GV@E527K9997UXQR=STID%W2L;YG@ M[D%ML@]C%-_!3>I4V@
MJ-MI#1:*X].X1$IM@H\[@$F6H53KS!A.<G1>4]#3Z]T'?SXE?^UV2.P  LBC
M@"+A$'01TZB01;4#G'X@D[NV,"4>&J9.FF1ZJD;B!^SFTR=8P]H>Z$7ZV'1I
MP#H?L7(F+'@#YW((BA82[?D2ULQ_OPA?1MSX,MX<.J;7+#";Q&?6?39%/(%=
MZF)&LL9N=[/16]PQ+-]2"F3]%(5'KC&# P@\6G+]-KCS5K_&'7S:Y0<K7#-3
M-L55KS7^YG;%"T\K3#W7E1J56ST8T(_8WND[!!'1.DNJS7+AZ(N 'AX1[=."
M%N[54/PV-OMO0!FQE%_@V&W8]Z<C$[I0BN6B(HFPMDDN>Z/?Z8K$C&C?$4AG
M_.:MP?7=*R*>:!-B[14-(=8UQ)PF&%\4AO,H J2*6E+AX1854"GB(>AW 7M3
MYTSWZ17=2C5W@[P&F;__?LY=;!.MS;0R'^'Z"CXQYP1>'R8&-!Z"BAETUYQR
MG6H&N'Q;%F)T<@3]\@A*<WAMYZ7N&IX$3?B>U0@OT^(U3USO,KBFVR15MH5^
MP%,*!\.7$]:2FX:&M\861W 7Z#>0$C,J;X1^SF;P(FT;7M@5S6<OU/YHR+6M
M/03Y:OS[853AIJ%),FC"\4+Y[!%3'*3DL')#<<*4L5?A<L O=^X'*EW[J;U1
M3\]=>B<3Y3<SW(8KAC7$<M!',LHKU\^2[A#0"3E 9_,4"Q#RDM'")@NUOS4.
MMH"M?G'H\= IGLF+7L_[E?X*"WR4GQ-<@;XJI\72+]*[DPY!YS4L9V(YQI"6
M#TB%49WYMFXQY#&_@?=W9$?I?][>+#TSIQ3Q^N.Q^,".#X_*5J[>5NC/JZ=<
M6>49FBYE#MV%G$.9]*!E[&4^)%NB5?L+"I[ZKMMKM'E?DZDM8^<7/_>\ IQD
M-1-_*C8,5@%N-(J"7DMHPIX]@OD6!^&W"D%RNB2QM%V"Q\D*QPAM[U>GD;-,
M6!':ISH,L0V_1Q68):*](AWX:DAMH<HR4H:_*HF#V7DU-23N+WNC9:6A,AVB
M 9\LYY^P=?"JF/V",J3,*9W!.BV\U\C/!Z30#,KY=J+7 \#++Q=!%R2E,=1+
ME:R&@I)JQ5K4Y9+/$T^]*3GA9K%3CU^975OZOJU7I.Y+Q\Y:X?=S^C<](P_V
M(?[H"1S1M#ML^M=B-%00P-@.4054BF>-+EBYIB0F[D7(E(UGG':K5)A01)R[
MB_\XKMUS4NRMZ[TW>Q':X"J4--""A\2DG[-_V0"5)$Y'^5X50_(8]^Q>\6/7
MCKO^F*NQ*S6YBD$\(QEW'<$(;.L^+0S66[]+?O-MRF$%(DC5S)VT,W(^'S\Q
M+F"H^U$P8CY3],2O^>=J)I@&U\T-+ >]A<Y'#'A%51<K3"-)$9@B\3*F]XEK
M0V-*PQ:6SZO3IVZ,$F*8JK>2)CJLCBUNM^IFN'!_2UH+N7_-V, _2!4/&]O&
MPV*APNUX03 AK*D>T?*@.L:0NZG9/X 1>/F$?\?S'3OQ7<I^J++0&NFB6S6@
M+-5I#VW\IRC3\K?KYWEYX96NM9L/-/5:T BJ(\!>0#6@I1=J',LYRA\J6W=5
ML#QG$FS22[7'JS.(/GCR2Q=/TG:;KYA>YGNI3<XDX0V9JH6]YFX.H);\'>BF
M"*+.T;XJ[4NO;]9=_0X4M1Z<K/36\R*D>1F&CEU97T $"HJ'"UG+VLBWJG8L
M7A^#%-L?@B3VP2-MF=2,N6XTK1CCU<W626%'N9-<&KPBTD^1F"/KV/&(27W6
M'4Z')IL@6>2LF)#NAX[/*M?C=#7E$5/8$\@D2BOF1)U OKMI4*[)8)FZ5&=>
MA61@2;MGS'KY3>,DT1D0\T,I @Z0V5N[2LS"-*AB19"YNL3*, U.@M'QI7-&
M6>X'@F_5GI):+3OB6U+$[,G;S>NLX26XNI.@CJR@:(H<IKWL2.<4NQ@>@OJL
M5AYG_DG9I-_]IT!V:ZNEG8YLQ)WQA0C:N?<LO5B(S3?\,@W]E)<=/1? F6O_
M[:=F70.K0L>/)7T57B;FBQ$>R<VQIU<<U+'$<FS]MPEDAF%YS,&V;LR!.*ZL
M\GUBC)LPYX+H4_/@4A K\TD"UJ%/(HQ\_RB#]2JYDNM.+G"''$7$D==,_MQ]
MUE2T]%VDAF]&+BVWG2/?-J_,9R1E_^7,[D+>3'>LPW%:E5QV7:P!@)_M[&9!
MG&D7.5E&3/\Z-[+$59*1R*T>*6#]Z14?Y:7+H);^(2BW:->[-9J^KOD2S4'3
M&J1BO@"8EA?0-]\1+[1BJ@F7U-UL_%KFO"=7'IT"*P2+7YK?&DS,>*A^Y_@S
M3M3F-_1@"F8MF<+B#C^#%:$^)T):\F12S1/T2?P3;F.G8M]M7%:58TKV= P(
M*60>G0MCK>_4$C=+O/P==0I"[(,33>4B,L[,F:<V'8*8=I:P?$!@A[/ @^1.
MW)"X7;J@CY-7U;'F^YH^,[A?E6]WBG@P#=4U=2\J/N6NA#M]0VYM3'JN]SEZ
M77.W&1I](*]N__Q94US"W^L-MG"Y5CR_F\S+HM;%87BQT?HV<9,\"5CC@VR;
M'*2)]FT1Y;&GK1%CN)"R;BY;]Y2P,!MD9J!PFLAE+04]B0]=I-PN>7.]<0>C
MHP2AC!%XXW90N1;$D#S);4;A='#/+GLL#^+ $/NU:'K$-:[S5&&VQIG6+_O&
MQ;J#/,*>U]M%/P_[,2[]#B#PW>P,=X*B3[H?>(7M&*I;#& %D$&%FQY/'X42
MEBI2GZX]CC-3=,8ZQ3\/7(4K,W[+@7."A-%%@5.$Z7="XL2-!,+FV56L"HDS
ML>Y@\@<\^G*'X'V\5D%)!Y]C=/:V<] KGD"]1_Z%$&D9.?.#Q$YV@_:B 1H[
MT3*FS"C<@:]\J.Y&OIN#<&]1<E Y/35 <+"@\2 K+CY?LT$Y5S222U%1\D=4
M_'W0!1)XC6?&0^[H:._@K_1^" =5P(4I9(:O#'<:J!B^50Z7;=/'U<0LJ.=4
MO$,52T^9/?V3"?JVSL8DM50TGM & Z,%Z'^FH$-0J7'-O:;:(''=\D[=P12#
M$>?+EXZ?<G82C5F).'%U8C9NJ/2#C)2<7'.KV;JL^3R0K,%082@A4G*S EX0
MPA#-]K8MH7?.]#ZE&CE#O]GYP4OS<^YM71]/1_3]W/(BXWMD-1C <9).FGN!
M60._).[=ZD$I!A8L885CS8C_$H/PEA6O-R[CSC3!QKXAHQRGE(2<0.W!MLP[
MJ6034O8AJ#EVU =?^:Y<#T4S=2!6?/H^I8N9S^JWT1*I)'09FNN[216M;DAF
M*_-NR_7O0*T8O1%YE*-JC2I T46I C<8B'L(XD"?F408_;!'=C<G[Z4XSV^&
MS)8%3ZZO\[/G;CDF+1>B3=7F\J7-5%A@6O2_\/.^'Z%"@/J=(:@BP! I$1I:
M;GZ8'(1*B95U)^&E[KQ$=V5EA<_%R/,>_!KO@T-"U\1G,A?AX[9XN1 _!N_9
M7(LE,U 6O4EYWM1VS1WJG\:1,<8IE)&[_^1IT2;;XW69SRY1YIO1*=P9>#@@
M?0A:Z\Y=KO!_X1&->ZUA?9%[J"=?OEGQR;/O7T!JGX^9=_*<3WYR"%*\;U65
M5:NZ9W>PUWH(.EL'(W8:5M21Q.LSD>A_6QN"T*D@?;*Z[F+UIPJMXTI1)W37
M;O\ ?PK_?7(X&-V'@=39SX"!*WMKG3,R(A84B;?T2];(&J\S5K0D/NC4D(K_
M<YL,A??M0FU)=R@5]N._QE^!GC'HH>WR;!C9&W#/7RF0:^EFE3S^S(ZAM;[^
MWKU^DG8L#_<4MF^PN.9T"'HX+70(6L89Y>6>JMVFGE5:_FE/3IZ)P<TLKI\@
M;%[ -)B@E:@W<(/8WIEI5J11TUAZ0FY0T@6*6$MOS?;T7S,N[*;,]8"'"K_Y
M;APX8)5I##$QKW((*G.AO<.>HP>4+^' ,'=8M,-5X&ONTL'P6A,!QPZ@5]8:
MO FL5+<OD[=<>&!8^3O/^^5G4#^RJY>'(N*&[W=NB6<I]Y=08Z##='8IHHW<
M.$\+A'T7!D')]>X8<2ZIC*4 .:MMW ICDU/M&L4&N2<?77CR5ILO+,7*"_1M
M%W8?R"!POY[)8#$@<"+L>G>BF7C?]KE;5L:-C[;QM5[LF!,VC0N^?QI!@(<=
M@D[47?B!:?#&2KKM0<'$^I8(JE2OY]"8O23SVWL'(5/[Q\^WDC=&VC?M,-3S
MS*9#]*N8!HLZ 2+=*'@LK W" C#C1TA!86^&K?J5UJ$&^[NL'J>_:@24BEJR
MGWR6I2=PW'CQR1A3'V*TI59V6,GWV]P'W[XU2B>>9YUS!CS&?+^JCL@3HP&9
M?6F@S:IQP%3JD:?#?G%&\?;:>2(2^F'S'+H'>IQH\;70!B&D0HQ)\,-'NGKY
MO?/RBWP9J/117%1+IK'V#8<G(Y3-J)QF;4&!"1FA,&X-+8H)2@QX,X,9V3,#
M8 0Y3B!F:+Q9;3XV@JKT:P4M^*FNEF+[4::PH8I=@-7II(+U)?MZA*T>+1DE
M0=%B>.$+J!P<V6]03A)*F#E*R_.</*P](')N>6L*-V8BE2?\T$3OTBWYVS,A
MBL4G_%DT/P3@C"Z]Y-T,DD''YNTI802I8#FJB#K*&6_!4#5]K?9&32.#!=WD
M]2QOT3X[&]0A"!=^.?X&W^S$CYA\W9/\G0"<8D&5!:8)ZG\A#1B&S)_EA-\_
M.3FRE"Y<-B#K<?.Z^FRHMG/#S!P'/S!+9_.BJ (^LXO4\ZED2:)LL1L_4GUM
MZIIJC7G5EL>FA\=:V2CWWT1YC=#'T0ZPFM[0V_((=3K[&\HE /P;5\*@),XS
M02<,&/\ YT1FZO8IU6,:*[R7U4(2LW<[1HR.M[.8SG_TA+ ]/_]*F_-*?V3)
M)OU1]!6HV53)(4@EMBP?A^A^>Y#<C)])Q41 3F]H/'F\I?T:\FYMW$R.-EW*
MJC$Y->[C$ X79,A#(H/+!+]@IIZ+)#"'*7F%.?#TX(FQ;S?+9;@/&ENO^PFJ
M;/6-+@0OR][<CFK4'?PT&@G[6U4QF^%)>XN^Y)[! WL$?H.6&MK@7[4AJ;[>
ML;>@^XM^*I3X%6K-F[#2931K?*70P?53A\+\0OC*@+'6DR?_GZZ()&&:O<94
MR>])10V"M_O-:)$[&4(&><@WQKU%*.4@T@F]X+X@R;.LE?7O)UI)':6U]_XO
M]MX[JJGOVQ>-HJ* H/0>E2I5D:*"Q$87$9 F0D0Z"!$0B!*(TCM?NH(0Z2)B
MI"LED=Y[#T+H2HDD@&%#V@N_,]Z][YSSQAWWO?'N??^<C+&!S$'67FNN63XS
M>ZXY,98JF)N.K>7!>=!L)/$!$K=!S@%>,E'^!4"Y  #/VS>5P^T[S28RC4('
M%V\4YSB3%.__8U0^IA/PB%U742[XXZ7 ^&>M9SP]+C?4HB# "Z_;6@,3=G\#
M9E8CZ=W"KNVHZ<Y%K\__RKAT!S06XA^M+%OB:K'%5-,AY^^5-2D6.]!37%FD
M_!2ZX:73U: C[2&IG.G[:R2P'>TKQ!O&@] F8NHH6CCJ$2(Y8DE1N:T>'2L)
MO'/\<D]Q<W7'?DX^2,=*\9R(]K.\V; W*9#;G4=C<>L$I QR/!UJJ^&YKTG_
M+)L?V_;KWST> 3SIG*<Q8XJ0)Y2KFW6TW(UV=5.HUV^';6]KUYE^:ZRHU<^:
MUI 12!4YC&)*Y9ML/+VHO^RE_/BUKE.2N%=U[!T].9[AY);DJ2764)T 9R!Z
MJ*WE<ZWQE3JE-MU(N1QW G_V98C#+.MM(GXSB#@RV>IY]'=K:X;9C^$7_S3*
M_?E%*PYP<9ST$]V!7F1J>EO]B1@_B@3@:58?.TEY-=I6<<M!_HST=NZIOJZF
MGISDU"D^:&<*8$O1IN.P1).N52*J%=XH13+_4;O=X/YUW>KRW=JNMHH6(Y]C
MR=P&4OQZ-]N2WZ<^-B'8,J5GE58&>69RS'B)*]KJD7?Y8IF08^T0%5PT-W,+
MYLC^OE]>L[Z%"^0CT>#D_#7/Y'M8JUE)@O4[JR3%K:#UK=D7.]^WYK]6ESI.
MR%DL]0;-'33LV6EMY9$)2=3\=Y#-- ;HCW2C//WDQ85>F.!A*-5H4F@?Y7G#
MO.UZQ/L%$4_!Y9HZW>;-YR9JNTTE+>4ARH#,(B#V^?+B&V;43^'9M$<@2?NT
MG.5]>Y<M99IK;T/ W'ZGVA*6:)@T#5MTW1RDG(5GM[RBY6##&KV"/^'MW)-\
M%(3C+5>-X&9";^](R,LFGY*SA2A+L.9>G8@:E^M\9]>OAOZ"B>+PO+/N_Z$P
MU<_8<]0NF$L(,** Z1-@HK&7T>,1^AGE4#HSOC7'!M]ZIKQL+:/P4)ILE<*=
MDG:7U>E+B0=IS*H8P<J4V&IX,M)-C'TAL&,PXE5F*Y0'GO$P[%Z#@;"1;:E8
MK:ZZRB]/?396/9^&L'CNJUM<MYAJ<YR6:TN1GNC\P0 )J%*>.H;N/6@,"U*^
M*C7G:7/8<^D;)2NP!3VEMX0GF%(>PXT6.PFG?!88(,X9@-/-^T63@ %\.2#E
M(N+WZ-ZS]8^2K5=4$W^YF;[IVBK?]+AH(B#G.TP9AKUK<,^G>B<9UE5\*M)Z
M5MJKYZZ#<2$4QY'JKR$!)2YJKLGF+Z:MV&" BB;^'GB"#VH.K#J9D,02-B70
MQ@#5K(8Q70H/ M)854L:?.V=&Z3O[;2=059W^WG<;_MS-$E>:?/BSVF)V.^4
M"_ -,H8$[3BMKAPWQT94CD3P>+JK6J5,_6S;"_3=%'_\6L^/:2^?Q.M^<[G:
M9?J8+TU^OO1JO\QQ^>+-O?K*#;_^-ET^(N][&=ZU4CL-UZ;Q3-M]L!:\M^45
MD@DUYY>,M<4,YS0_/B.<Q\2(.M\==A=9@GWZ9BD><0L]B@-"-L@0($Z&RE^K
M'!>W@ ?JRDJB.<O(%!B6]F[9L7M':^LO2BG $7O?\P];IUJ9T"<Y)7*X5<'$
MQEBG1KG0)S9.<@GO)OG5["M4%I)HQ 1<$ )SCQSLS!F@^Y668"J?\ITAJA%S
MU]( KA(@P6MYV+NZ7TXS[9M7A2%G25"-2.V$UX>PY@'Y:29,@TTQ0(L:S5!
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MZYX\<KZA!AZX%+OZ&]>]7WVS-ZQ>^_RPU/"45 #NO967PFR]VR VA)7J,L0
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MA.%HGJ5I[/-_T7((Y;/U&A5D:G1E@;Q<Y=?F8TYGH9E8HB&!1X<X2>6;61I
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M/R#[U8I8UWW=D4Z.Y%;KO3S/8LOG86;8$5N84M%#90-<&2 VJ_FD,(0(>8O
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MTIJ*'Z_AW;:I@Q(#,07X.HD #5<AH0Z5ZY,R%''Z((K8S?3W^-<AP@P0T[O
MF%/BRK=U8X!P$&>*\@PBC7WUI2W>Q2>G84:\N '- 4<9D^HBJVF>.F,*_L%@
MJ]I$<L=!C_^WVJ90'2[1"OWPLH[UYO2T?VX=XSYM7[H:4"$Z\+,D@CZ#KTCH
M)#AZS@=;W22E_VK%BR/4)AB@ND8-])V2SE(=KRNWB;V\$Y4JGX<-1/[I_2[R
M)E+T5P8P2F&%CY+3:"D7@,"EK3C3C3DF4@S/-B%Q8"[$M0S;M%8.;(NDUR0.
M7"-^NJNI\<XF<KLST/" =5&FC1D;(LX31SWM%4C\40O!8E+ZPA0K;&S/M%,
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MGIXX/U$=(Y,Q7GC6X%CM:-N*5*2;LT6&D.F;TZ*Q7YI^?*F,,K.];%A(%V"
M6*F#Z:IH0*HX#4N\CP=16<>T'#\AW1 :02(T]O8#YRR;.?>#G+35(,^IO(!T
MB_1$MBN7Y*R=7"4&&2!W+"#%VKXU YT_T<3$XXLEA!LOR]WKAMK)LKM)++:_
MR?F+U\Y.!$TM?5<.K)8_R]W+<:OGVFU3G>!)';;J46S?Q\FL0+NM(1)R)I.L
M93*CO! 9430#+WA -(EI%%G4A/ #KM#JVD1"=?G]R3[K(KADR[ULJ?1[SVYJ
MUI-L5.CMCTHZ\-.H=C!GR U@$1+'OAB4?!5;,;1$7!NYK:#+55EH9CC<S5NQ
MWRNAW]^41*36;(T]+*W^?+M4\G/2/U*T-\S0Z[1M*Y08O0ZMF8R5)AK)3!=E
MC#;76N;*94T*;@]\ECKO--.<HSAQ)_X/J^1!$N$EA9,9?]1DAE'E$A:5SP)Z
M'2BNK1,E"U"!-7-E<G&"_\J^=^?SBZJ^);T*]]6[KB^!DKSSRW"&>^":]"VZ
M7BND6H/*[;<812@@!EH3H1TF.*,'),MDM;28XNDU<?:ZH<T,BH,U3+D@=B&7
MV-+99VUI_72'3Q#=<SPXE8AM1A++,<+PP%:L.P5&YGSG51)<T+M-98"DI9)"
M?N9\GWGOM'3#V'O8T$)R_*UA8>%GLG;08;<H>C/3KA\_ EPL 5PFVR=17'\)
M8'/AR)Q%>?GS_GXNE;?4RL?D&I8T76J_95W9X> NC\0=]X>*,U$K!_49+=X?
M'6J(G<((8XF+0)!)BN!>[3\7$BQ'W"8E%%DZ>6-5KL7[RD]\+!J4<IZR'[$T
MJEAF@"J4-^O F_Z4ZV[TDUZ^,#Z/KR:!I9[7=\DM."^_!PW?4E97UY8X*$:]
M\F<:LMW85&Y^"20;T,)W&:#I!K) TKPW,XZ.JWYW?J(<!DL96B/XGRAZ&>AW
MX61;RC.Y.A>MK6O3#?$$\;\ZHIMB!IK[ZXA)"D](!X0'Z_2V&L*YCA(M)@VV
M0D^Z@Z>RN*)^$1/*$V:;ZH\9^?B\2JFZ-]0IJ",O:G/L#X=/8BN9AY:"7(@-
M.6XTCP;T(0O2.VJSYK84UZF0SJ3:.2._E9<A3BB_OIF&P/ZZJX_G@Z1X#0N"
M$BTD]];A^%;\M S]#&0&MJC180+H:X\S0.PLMT=>F&PF?=U'/J&<>KN/0;Y%
M#%X9H& >$6;&JSIU*%8A_=KBM*]85S0O0IUD9-^>#^1/.V0$73L6J)ZB=\&8
M@W3YV"F)K*O+9K=$_G$2WI6370W\KO5GCUZM+0>4_ZM$]SA%AWJ6)-"*C<;7
M*)5^@5O9C"B]6#:^TLR?I;/2EL1>J (U$5WY(F' X:MERNZCWI(8H,EV@)ZW
M:H4 9MAC")%Y?!W2'=DBDS?MAG^VC4#5!.<>B^J;_E[K/9W3D"W48?)H_6.^
MA8BE\Z$(#8H!K1099,L4#4WGH%K2\?3#$JEZ7N@9!LB9%M5/GZ"/U=5%:0>^
MQ5BE+WMW=.*Q8"45/X@79"H1@FO9:-:^,-SH\!EQ#4@FCAPP$1P[O.1>J&:I
MZH[64\VWSJ'0V4&8BAQK0D7#TYWXL#_5#XK'&\,_&=A\B6I%"C'12 H#=!;B
MD3UX8AW,#W'S'.3WL#]"4LI95!2>:VTFK@GK-,S<3S%\-*&9\=(U1?6R0N6]
M7N[N\];;'9A0H)TB_:^)8S@0AYE(810(G8^O%@NC99+!&A1;BMG<G.C^W--]
M;:OD!A%P"!7QK9LL)]=4B$5?KA]%)BU]7T)R(9V2@)L,D-=@-%X(LG".8D55
M.,UN,(RLU&Y=H85M2L/F]ND..UJ#FG_V/>M@EH/BW3I\W*E!J1<UON] "%P4
M5J"N UK#BQ34YJ-:(R,PEQN)!W!'6P%[D:@V_NLU:7Y:0RAI@Z>7[R42HBS/
MQ1\M>?^;/H3\JHEX4444B"X/.0>/:T$*:8M.L]M=Z<39?0:[U<\*E[<%!CPK
M/D4H=MX1/@JR[!AI_/7[%7/BL>24T:[]P?FMS7>DL/O ]WQX"=/6G"Z#+TZV
MAGA._;[.%:E(O5STLUO2^&Q0FXUKRH9' ]^="_FU$^SIW6MT<7HWF/B&/H,Z
MBU%!MMPBHP%K8?[4?*13<%0OA77J7F?_#K5U%;:#V<IH"/C[C+19;?;KJ;\D
M4T28G&8"\^E#5O]W&8&A;?^3C)C\=QFQI02$=$.(./Q11Z()51),C-^<?-'D
M2< Z4%Q"VE_R#6:N["?3&"!E;P)>:7.A(FPSS;1OU.1K4V&J26VG/*EW 455
M2@JUOT2$S2"KD L*0ULO8+4OM0.G0X996E>?_6P@;PW,ME[MT'M40+F,$&2B
M1A]:MK8X]09]Y+!^53A7ZZ/ *&RU]B 961><,J&)U.S]2;=GWC!@EJGL/WVR
M_L@6]1&>K :LL,GF)Y_7X7UPY/_QA7AYV*I#5J_32\^>= S/A76"B, +6D+$
M&G)'C(T>DW10D5LU5U@J#:1RPKNV^Z+<9?O,^XX'_-*R/(S'CD<-#VZ>F@<G
M@CFI D%+GDG1<Q*5Q.+,A>Q9?7<-@X\_'QL\F]CNN?#.=,3ZO6^#]9/(9J'1
MJ=Z#BKH*U.[D+L9U.LUJ@ &J0C(%\395#\CF?$<2(?N,T(4!%Z.7DJFV88LZ
MQ=](707+29O#,[J=/DL!6YE#DTUPE!V4'8 ]&,N:.-A_L>&NE%"3=B(H^W6L
MK9,I6EG"D:T@15]LW9D_)WZ%/P>UG_D1'8$X/!_Z&!@E;BPT_6IK\B3?(M5F
M$C.-P_%SZX$A2J,+I.,YH=N3*N[' XO']V-5\UZSGCN2]1>-$Z&S.2QPA6$Y
MM$76YX2&_P[&V$L#W<<"M8\3.\)+R800F3?>')3WX9$G%_T#TP=X+\WOQ)+-
ME*?Z#F['$L'3@>0H8(FDUYGJCN1A@%Q3B25&%)Y9V_4A8+VS[4SWA6H/Q=GS
MB1H&)P.>W'1J\]IQ/=IT4&Q:577!U"? X?\NI<T*_W?_D/5UM(\(=LIA9I$%
MY DJ!LE=,PCH4GD62A$A_HI&FU8"*)>=W2 C.-8?)II2N^:2$/+PZFSJZU/<
M!@?!.H<%N<_JTEN0NX^QVWTD5@;HW/!_H@RQXG>M?H!)O+!-&09(IY<!4A@\
M@]P^_9\IH,/T.UGF5 RUU:B&(R'G$7S +6)96T;N<9)&1[DW?0#&9US<6:H>
MX^K@M)?Z]LD_^UY7/A',YM\,WHD4"SRL_WW< &#RY[@,DE>Y&2J&;'%#""K>
MKSIL=G3G/@6,0VQ)T+7GXT*VJOKW-!Q=KW9U4Q[]1%PFL1(N4FX 5AT3US?G
M+HTU&@1_ADMOF"3G)8YLMYIDN+>WQ:[/F?_H8W-([SH2*6^(Y.N_B+#Z2TT:
M (>">9D 41&R@&R%QN7*T4JH-F5P;29(G*2>NTZ/$P\K:;_0HG91(?^;S;%G
M-C9+)BJ7/C5+/46G'\&Z1AE2_])*&2 'R!MH15('DAWQ9-);6\[C.B0:([,V
MJ8XY54=BJSN$"V?P/_GL'KO_8=WBOOUX,T ",&=AV945C1VI3OL\N>P9G9)>
M!.YIUN';X2(PO>?Q#%HV<CX'RZO*_)OJ""0Q0">1,?YV2C<\)@;I9VGF#W:\
MQ&WR; )Q,X9A*K?D" HBRP.7;FG]NKS[]S O4D>$<HH!&O9E@'JOM(&I87K_
MB7(3C!QF2E6;*?8KBB:@3*W2NL4 =:G^)\*1/=I_#?A? _[7@/\UX'\-^/_W
M@),9(6/(JB9LI_(I(<6)JS6$&Z>JTI+^AI7&).41?GNN0(!8#3+3>^:O,$ 9
MKM&0_1-)_XE276#Y<+7D]/!X6(=%RT3"*Z61I+][XEYE:QK"G*4^SB\Y,O8L
M*U7-.I8XXCE/0NY8K-<1F'#C^,)A92.J=Z5G+S31= US/AZ1*=%L?WX:0E$Y
MXC X^7$/?0EPIO@A9(#!?#&C%HQJQ:3"'2^56U[//V.W)#K$M.,_3$X_(>V2
MSHX:!$"\NX XKG?F>U"%"=+&>@-Z+;="QP=%' HYPP!]P-(-^QF@-K,2PI$%
M(3$+?Z^^3A"[S7?(7GL@^*;_H]PB\4R/$0,&Z(C8U"3XX[K9NM]^BGHPJ_-'
M?ZR0[?ID_)S/]F2XB G+]B?H3 9V9Y(!$H,LV)U)2++ENG7+[H]M_B>D]R,&
M:!!*?<%$_Y9C6IY%[N>-QQ=O?GZ5]A1Y[E0YYSL#J8!GMC--/S=$/;^_G6?;
M5/62>I%M5\!$V#-CDP(%5%>B?;* <.T:UYR?N\;:M@4><(.<1 Y!&2 I%R9R
MD,_UPT1ODP03D0&:8CE\'<C66\ =>B@#M"^OP417>E15<#CDMS(#E%*%)/&]
MZPKP_X.J3"(XO"3V6M8._>W-_$9<[NS5^R?#\X3DDS#:P'>QJMSQ[<Y_]S'>
M_S"H]60>V]#SK*'%/I6#JSBE"/\7]%T*^@KY*&Y5LQ>^&C.AO_R@:]WW,]?M
MT]I8K9#3R&87.B>]%\SFC5WP!.:"!5K)W(4!KZ+(2GG!*UOS=WMAQQ)/Z'%8
MB2[=.,Y<5W0!T@%RH 3==X$S0><_GHL^UB\??%SKHHJH]\H]N6S6^G"MZD\]
M9*/T?U:<'__*.FP)\[\ @/[7F/]OQ_Q7%?MF_9##(ZJZU"OEGN 3"%<&Z%1&
M]L),4=68-+T+,TH?E#_G;U?WO*T__=S*+?'=(W]4_R</[" @3#LR"404424
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M,!7];V(:,E0^UZ6Z<*8)@1T';,D^0."BF$#'G ;P;C%!V%BW4[?1"+]Y0WR
MSKY11JF-KDOFCGOQP#K2[QR;2-;$(*[#3I7*K6X:,J&R5D!)^;Z7$^* . +
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MRI5.<:K(%^2>DN*G,T&/576HP:V:;5O:K[ U7%0;#)!!4WF3YC-;-I )]JI
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MC:R#GU+TINFC7UU=W]74_IIT/["XS>G[(''K=FF+>4IXX"NQ)KXEY%<D <8
MG:ZA:$T!>_2S#!"@&S(3Z.-)!M<%U[FFGS>><\T4]XM?@HG_W4RW*+V?-GNM
M3*U KD9HY./:0TOWZ8,(7E.;=\P?-X__QXLO>Y$!$OK- '$U7O/_['E0FYVW
MQB\GO$IY\-W(T_.Y_@-[O?,/^<_YOOKGHI;8DI?(HDPDP1_%M8YS:2B8"YW8
MPP6/V-G>/R)GJ!]>YO"&E?7CA;+TF2P<7P^AW^OT]7\SYZMJL 0,QU#(N4?
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M$U%BZ_!?W'-\J7[TS]<-HD(Q=$*/G$^'HA6[P5&0"_+6D!-_(#Q--HH=L%-
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M,F ^G]C:S$I"  :? .EVORU8#A XYN&1@O5)8+R^^?S&9N>'A%.6,=\JOF,
MJ;16-]3)D'&Z61,+@ZFB.! 6(WD_8;MK6D>@^TU/V+'>4NKK0WUO@]XGW#HY
M@9U#&ZSO$[_C)Z(ILF44?B#/:=ZZ@K7[AE[!;-N<0TL <^:VC,Z]EPR/V/ .
M F][Y7_/?5VF<(AUZY!UL10[ZB?5@+^L-%#53NZU]87!2??WQ[D?/HW1FOEA
MRBYZ+(&2NE)N;74A(/B%+X>'2K=U[:&:I-M:4(:#+RXRHVNT.,-E5GD&/;3B
M9CNPK_Z6^N8(Y)0!GH*2O BH4'<$FM;^U:3APRF&_N^(G>\_P>E:+V[VG#PW
MML)I:"NHF_3QXU+C6!:#;E*1XJW-F;D?1 S6FZ1 @&U4$3X@I/'=;OS1OW=\
M,A^R,W1&M H^$A*0N?!,548P^JRZ/@%)X2"3?@ 2V:S,@#3I)>$[7(OKO'6F
MYK.@$OCM;Q8=J55RM\_%)H-D9&,/DTE[U-<\I%G U!ZW1PQ!SY/[A0Y\520R
MS@L)/R\V/5NY9%F[F')MU>3CXL2/0]BZ$]D'SM>F+Z%!S4:((?.^'H2$E+4$
M]3?%1:7V.;$DX!\L8P+W;QSV/UHD5<[A/GJFI?LY8=*>\K63(1XL6]^59J3E
MU@=3,*X5D_A]4B"UAL;\IR$M7IHFC'A C$2[%;FAJRH'EIMC+CWB?<UP3.3@
M_2YO6R$HI(B&A5;.OB)[(A@;"8YH"8L?7R5G,PJU+R3IJR\=8YY_YFE4VO?]
M[9ON[%8A7C(GW;^*P=3/(3QAK\'<JFZ0CL3H.=G:#S\28<^6% (R%@\6G]>;
M]IC>AC]^J3WM4_6@M\^G^=U!ICQ1U ,6S./P]:=EK?.245HE2JZH(D;"=6;7
M)K6'L@0@<7-8+$EO^"DA*RH7 .,Q4;N?R0J9_H6S&@U*YILL@UX>LM\NM*=]
M4SKY4G9]KM*@;7 Z9&U!<#F>I@ ?T:L<=JQV4VJZE/_Y16M6R:6KVUI].@>O
M5+[,?SP&M3)\G%)UR^2U[0!3\W0"9K'E_D)9ANYG*]+SA]8U@D@5Z23MOU4#
M>%Y"W!,9*,CQ)DM"04<6+Q$2ON<1AFWW=U2*B,T1/^%.-N&^)3IL5Y><8AAJ
M:TXLP($WFLE!<'/:>0-!N/\W, L%7*C/-II7W1![Y_G;NC?<3-[>PG9A7TS%
MF31[!=UVO\866U87%4Y_O)5;M32AGT7"9,;F?M1-CR]J3U?12[-1")JF>0CQ
ME-/:T]7FUCD4OS6J:?F,=(4WF"B']YPYZ+OW6D5\X<,[64/L1?,>9-5R.Q*;
M2](&_%G;Z&P!T,;1*G'-"@&:D8T!P6<CQX3N+CMZ&I(V'2^JGM5:#SQV:*?I
MI'VCZ'0?1VQZ,J:IHB)X*//L<)E2'T><X^>#,M'@H#]#1"2%$T,Z3IS8$"L#
M6/'0]GX#_6&:.)S!_BKL>AVZ_NK%#ZI%@E[UHE*WWS#X>OHM,"9\&47.?P+S
ME*:U'>8G$O9Q_9]7G]03Y8SOB/[4ZG'2C/WMKG[+J/+2R03S0NJQG.(L%Z41
MDZ73W],<QZ8I2)6$+ \CN5S=1W'U?AXV%?I(%10C7;\N'(&>PJ+G*K=>MTBA
M$W8MY; &Y_4+XJ^MZI'="D:Y>9IF%S6$WRFEWMR9SYPA>'G3F"W)IQ Z0 3Y
M'EQZ =9:)/<]D0_^4'P^XT%3RB6R>>KF4$-UN-:4):^@9?+2"<9;W;_>/=IQ
M'>0D^CWNMRQQ'BMS.V?9Z?\:_EW*L72LVG6\IF(L "5/HZ-.:H&JPT+\TX6%
MJ' *#T[MQ/JU6NYI_38=Q6F-[6[W'4II^+*4C.GSIO0=R"3Z;QYS0AJ-V9>8
MBP='JZI04?-'(.XS6^ME&AND86K)CZ8$$^KP_>$KACH'8UYQ D(2F\P2D TF
MJ9#[7==<^T4VMB<H/S#5GYL+Z/1:WC')SS9]:Q_%3Q\13;HC5N[>8"*>T0:*
M".@.-D ;CXXR/>G=LR&@'-N-DI;ZM/[NN E[GN5]LV^\%3?'FOZ6?3A/=(H\
M N%XU+D(4I'#5\,,..[X/D-?9V4@DM*8;ZL9_6*+2PBH&-*5T+7,N]]J_-%>
M7K ^97I[QF5QTT-;L8C9J\"(+3WA5]]&@&?UMK^Z+=U#N2-;E3:.0':#Y]SX
M\FM*I6/5+\*+7JT>?CIKKWD2G<*&S Q]:IGYY?'\&QG0O!ST;TT)R0(*=Z,U
M4"\6Y4=1:QI).NT+16,%-^5Z+@KW[JCBR!T.O0^\LM[+[S-P@:=-J9]7OYO+
MX;>FL&Z!SHY5NK3A/$O+^L[.N:K:\9HRC^,M=%8<]N3O9B,[Q DY/;B@'=-D
MCQM<#V;M3).\DN)-S7;S(N4I&M\_U_/9R2#E'047>#@Q8V(FYV6<]] GUTU?
MA/;P4&#7*SE/-T]\>D0'DMP2M0SM2IRT7S@"K7>2G\$K\%OKP#1CM ?%5P[-
MEQI?^/VL9X5$C(/93KK\LQM+*4F:SYD8$ZP920E4U!'(PP"+G&^IMU]P S/!
M#1[6)-PJHUS-L?F6[%85]:AXNWK[<M?''O^!8]?JC)Z;[_;%;B;XFBKUMDD9
MUGP>;T <@?BA/W8O99F^COMX>8G?2M\M?\9C*0CZ@X !KE2T8M@1(&JL*AL.
MS.."F5*_-(2KLVXTJ-;T6N*N3YE8COEPSO0=H;NB#)Y&83.@:U\\602NAV>H
MZ) ^=P1J@ZBC"UO5DJ@MTUL#FMIGO4\F\)Q,X#_5@LNI=WAOXE7"G;;%!UO$
MCD A-U,MXRVU2JV@S2[-APJ[$X-E;2V<U!;,$VAL>M2&32XE$. M=,$0/EA@
M\VI^9P2+>!TLV3O[9R?ONY>QG>Y;NM]UI_<@9"VGJNWI<A1*5;(F/3 _:^7]
M/#%%9DPM3\5]1-]&;O\!A4 TB$!Z5DRC6ZW2(IHL\P%A7,(K7P<1GNT5__/-
MI-*,AW9:UA_:Y%#/,X>DF'J[[NRQ I>7U]$+%5,2)%>B6!3MHC-R4KEF/_;*
MJ.0\V:-YXL,)J^DNL ^[<ERUI\Q]59]6WD-:[$I9^D,?&X;379(%.;5SD!^K
M91D/\WBB'L4]G0Z4<&U!9@Z^.@*Y&  B#\N"B+_)>*=O8+!T.X1[IJ>_< KV
M5E+(4F930[L^U[ROZE[/JLY)D(Q$)C&1PD&GSM' R.=^L0U>XII>!F[@-3_4
MM59((+&7[-!TL0='PEI_^G9RTR'YPH#2A3F@]PATL@*HQ\W%9UTF+K<B$]+1
M4144RR!16JY=2>_%B#S[+"O19V^U-5G.F=[FE>^'+]"8^LDVM!$SMT\4$^
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M U_$51Z$:ZDNGY2]>-JPJ?[!PIGO:=!&:-WA=BREF/J>XC9O\!),,*D(HPD
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MO#B JCOLMFUGI; 0>-]4!D74#\WJN;><8BD.3&+G</R"K9Z]CA@>GD81 Z9
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M.N"T-$/K6HW#-HZGZ !=Z_Z_+W7"CVX/2M!:MU'[IHAR$*8$ONN!3J'"[.B
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M7NH6%*\=Y\.KW(,/!;JR>'->-H1>R13\7&##R#]WGCHW.:3=!5@X_]R,CW*
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M@KAY9##&4<H@%@.*_HGVI8CS3NX:O,"=UQ$JH@.>9628>E]YI&W\YW)&S24
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M@U2=T;U?S\=A:C]NQ>W'?<.2. H]V XE_1R[%->C$6@0OC5/K42VW0;FC$
MI FR%$4[9Z,SS*GQ\'XE*WB-&'/,]CF!O9P[AN5AT(\F/F;N(@S'-"-Q;"D0
M_EF?5T1.[+>$EZ4>".M9)OS(?LO1(O3@A(0;&O"PHO?N*W 1EW6E]'%E56%3
MI8^G1\0[BDZ/:E-/(K=54^CHY,)D?1OB5ZS16,&HXD:XH<VD8+C-)%^1TYMX
MP$.MER?,375"]%8KZ[>'-:F?VD_8TD90K-MU@G&<DP0;A]^.\MMDQ?6SI^B
MFKLW](I</W,?]>* K\$74,^&>7O] C]M"&@N)Q;/>%B]HF2*MKZ08WX]IM;1
M(5QQ$!9_X$]!?Q*0Y5E)6!O^BAVZU;5LL1S[W/(ZJ&9_(5PS(,+<""JQ#$X
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M.GKO<>TE LT*Z[J><=]XPB/N-H%BJI!?]#*6DK?]P!F%\[0?F$*!17=A=J1
M B_1E1 _V^>," DV13ZS052^_N+/'ONT8K<F'R=V(93[ER%#_3PB*,6[$TBU
MYAD/ST5DCO*MJ/(MXQ+5*"82^<CC5SIA)EI1F^LC9A$,+3E&&2Z'OWGG62+]
MC)7[6G,]BJW'*&*U!X4WAL?"+O#B1&H7=WAM2:^\Y12#ZNW;;(LY9W_LW=NH
M,]B[.2,H_/O;CP/N?8XM$[(Z&CH*8_LT\C137?/^-&VLU+%FZ>[-4X];-A_I
M>X4+<7ZT+AYQ<H1 UJUMWI K[29WM?1N+DKK2MRT35(LZU=>-G3Q;H,<AP+3
M:>(D6P(;T9WP+EA% (K\N,XC^X"7V-%:OWG_/DKJ)/O98>U(=<MA7N@HZA)-
MU9VM8%V 6/W%3I]'N;;^E?DP "_\^,[3):8]U]0-</D[ZPK:5PEWB^(/6> _
MH)]D#E+<!;B,@S'[I3+ADH@V.9ZI>8@"F9?VS6Z<)CM&L<0E,'WZ@PY/2'"4
M7X:-RA:;[V9?H':=<O7T?Z[:*[&)B@N#H!LZ4R[8S>B..3C\:;BH(Y"2/5?X
M"'"<=MI[Q,E8#FA^T=(";I3U#\3G19?-EV&>:IN$\!;Q&FL41?WO<&E;R$UJ
M;OL5>XKQ+P%?)E+-6>QXY;R!RVAILIAEAH'X]+V7@"&#;NBG$1WW]\_DNQN;
MI&S6%IVN57P8NE1Q6N2?R:P-'UKLZO#6 5Z[!RI#_710:6B A[\Y<-1:%_2]
ML3)@G+.H,G/*8T'^NM %/2S8&MJ9SSW>>HDL0P(_F)3VJ9N[-^O([UWE?&M
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M&8I)^.Q+"CS XW8R8WC,_\GG?9"BX9.3E_BG\\\[FRD,9J76OKR_C9^!HSK
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MH2PY&?OTT2G*N1>^O(.7IM>\51L&-2O**SZ9.!P_=N'<9&=7ULC(MLZB'=H
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M]1F_*>;R/U^"(M^)[$H&KV#I!S&R'P96L-@ %OVLQ)#D/B,[7 0!3IH>_1+
M^(30&T(8$R<PQQ#&0!(*16UPB_\ZY7Y/)==(TB)0Y2.Z<O>&TST.L>/)Q2R
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M-MF[T*:L2:KW<ZN9PO<2O,RL:&O/N&B[(_M2%"*,Q1QU9IT4,X[@N-4E5Y[
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MU_^]617V.RRD^R$+MB^HS5@"QSYH%&JW#^H?\PHY^:G:YV;5;,!*D0^N*(A
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MW>JX1&N#\B+">$M+R'/0#@&5I]DE/V/]FXME88LFG)N+\P?+?^?F2&F:E6P
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M]]KJI&BD[7S@Y6OYNHYWBA\:7[M1.6G?O!Z6339G<J6SW&1NA 2A>!,-T7E
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M_9X>?YB>=F_Z8>2]\/-BH*6&L!/&$$\UW]!5>QQ&Q^ /Q) )9@5G+4M--IZ
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M^FIJB_KEJ A*E6X0(EVE*?5(BXH(B$A36H"(2(T0D18D$)7>!004E!RD2Y=
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MP8,=&0,Z<[+-9DK9)G=^R1"'&ZZ*(@:C/ JI)0P!6*\D9\T4=E[5DAI>E1%
M&^LBG=G];# ?*H4;P::5*&5MC=[\ZG=[IO&:P\2GEJ(3M;P[/!;_[<* 2QP=
MSF%]DN>INY SNV\0K>J^I2XNPT&^ ? 2K$YHSZ_.4"6X;P =O0__;BJ5"M0Z
M$&$,X6PZ>C("1 (^DOH&B7ZYI3/> K-:T67RY7(3:W4S/2)YDY0=MR<)VV=2
M1 2D=2]>JC"._@FFWJE.&CX (8?I[GB:0M<L.$J;>+?%K7!]L@%7!Z1L06?[
M_39!E./+L] X%UN!UZ&#'3SMIG+E26.0Q:2\R^A(G1P2TI#,G:?3,J%A%I^#
M  ,$*^9HXMV$96NOWV;QH/4[3<9-'M&5^?X@C=K:5R:G15_YA!.HB?1Q $JC
M['71%\[08C"53L" >=O$;MS#A$?I:PM? W$M<L[_))-S;B8O9<#+!4Y_/_<L
M$W5P((22!N:I@N2^%R@%VO&>!4G:80.F>$VY>CW$#A<"ZB,N;)BZG5 SB=SD
M-_(;O?7KJZV=UY(O7OV?76'K"_^WSK____I_[UINUUAGP<<40?_NKXX\R5'&
M?<IG1N'8[KS9?1WGPL&=#[H#3Z1??[B5M,-?6Z>=C>6ND1E$+[Y%U_O5'CR)
MZ#IBXV,JPEFKI&!M0:V^L3EOV()$#WN2;7/S8]',&T9:E:G>NW?_/-=?: \Z
M3,$_A E&]$(^A73Q1;N @62$/YRZLGK$UH HI%(B*7#ML+>@&3?O::+V6PW?
M%<7/Z( DUZ\B.-Y"2#UB,XW"-S/;Q[P\4KFA(3X#)9.G&**(?],\)C2Q^(/C
MCH.=U ?>V[N/+!.JBD-#PS^+RI!%&4*B]D#"XVV^J"">VQ+:Y,E4BGG8K6^[
MJZJ:<;_;;O^!_XL%C-_(W$^!*O:\^G*C]YBI;&UWQ8]O:._4Z;4^>@;01,WN
ML7-LS4$P%'G\ZQU\1;[=:1Z'M+Q5?IO(IR2W61G][8'X2IW5BU<#/T)8""#^
M;X0HXS%U,S5)/KI=!6B&"-W8 SW(F[T=K4)NU[GW+?[>_(S94U6]Z8&>E>MH
M)9D'^U_&'7.)%ILDOI3?1VR\Q-4(29I?=J5J?#V$"Q[!WUHSMCQAS9PR"3=Q
MS(W&'\@:Y5^^_4FV3B;>ZE2J4O\0@<53QJUCZ$?5L1"1WQ8OT$+%(\SS7L]L
M/]9Z$5-CMYC]!A\>0N$FW7^26_<$;O\R7HY;7*#<G$MK_SG9M]%_Q'9B'%)'
M2JK\74S3CBU,AX!=@"USR WJAY\YCQ%!Y)^!'MB7_P2H9H"PMY[TO'M_P&NB
MUF 1<\2VB $+1X !M\6\M'R&$X VP%"U;^BH)/M6H:XVM\>$"DAY^T:LB]3^
M(^KOH)K6*!%=W/@D?N72+1_0>]LVUC-?&0E$B*XY.D&XF8H^-=[M%Q GV@O<
M/$M,X2JX[Q6UTZ7:'V +'-<4O";GN2)VO#ID?:ZS[CI6-\$$]51[X;F8BD"D
M%>LY[H_5AY_N&K#0SI/(-<_^T@)MB6V%LMU/>&U251@:*2CP6< \-A;OVJ\1
M^OML,>U>B* /3$B0<B]:HPY4SBD=-_/<P^WEP_F5'\G3T_X9/_!G((N9?$O.
MU[=$>Y@2[2EH062N2_9=&CCJ9'W1QF31BYGTF:H"JW"?&J&7FXGLT,3GKM(W
M_BFMU\&Q2+\(D/RS[SZ"4E\:/@/X2>A>GU1E&)?,$-$>JUF@T9.U3:_, B0(
M!2?%)\4>!9Y]F']K#39[Q$:G3.(?;I]#R8<Y'YMUHI;$UYO]ICU^(5&M\5YE
M<JA*OBV2]Q_^"^HF14YO/KRZP!/I=,3&TE)R)8Q+1VPOFJ=>'K&1=0Y"Z'V1
MK6 RI ']<-_%@L[>&+LIKO<+@W4+'B(,K#;?K=_$BQRQ><8Q%1F/ 4_*?OV%
M33(0ZE\V))]'?^@^(;+3:W8C>N"%F.5!^_I6[V7U'$W)0DC=CS[=X20,OX&J
M]P[:O;\($.UI:)9/#7!O//PTBN#S(I;DRB#<@]76U-D^"Z/JDQZ\<BAG=F,D
M--%$,[KO",JM"KK:T)Q7$%8VVR\<A3AWNH&8//217V+^D[6P@M+3[K07S_6J
M%T,8@@.]X$\6T:WWBQD*0!VBP+ :V8O@)SH D5T$Q[$-+'UT(W ]7#G-[[_W
MHZ.Z8HQXF<98SC.RIC?<V\#T^\#5ZHBAR6\,_9A_5?6.DS=Y%\*<?9Z6AY>O
MBVIGUZV=Z*VZ^23Y6W.94>>[4D^NG9P7'<@C-N;IS'RD9Y>!W 06$\O4GZQ\
M'.@+LZ/._U+.K,I=NE*4KBHRZ=&H=K.6C GJM@JMO;5];.[!2;J^\5)E;RI5
MQH)6N'"*ECE!+V O-R)7:BV(']X;>O(Y7L3M]6SIW")V6,T0Y/X]3=@^]7T$
M"-UYCB%%_8(0M?>FD[@?[YJ'F4P&OH=8U@!!GG#*NN9XUCTT%BX)U_S2<VY4
MFCU&Y!%1-M1$KBUL";Q17H7R/TQ3BI" NRB.S#K5@\+F?*Q^\AVF?M0OI)E_
MGUNM#!Q2?M<E=:YAY<>/6ZZM'LF&-HH=D(9MAG)U///DR.Y[WE^&SG;WIS0@
M JO/OENA?;RRF\-;G^Z+5_[(FLM8D?$SSCPK<;NFJIS^"5@M9W".,HX;I"&*
MY[036H,^  \W7&YMR32T-NX4(>G-E&NM95<MGY6MNC@?Z+ DI]86WO/]+9)U
M#2TD=FE<N?X0T6UE6(PT\6YVQO[)C*ZOSA;^.-?P^6$8^K+*CKW!:$>DS+.^
M/M+,RM[2=N>AH'$K3<@Q)*%5M\P[YS %=S*W>4'_;J_7BH-Y@4G(M:VD2M'<
MED=1IXZS+8[SJ=.V&4(@1!0:6YVL)UZ!]+2FL;]/*2 /"1*RVL&XN#7M*6)1
M5?Y5A[P5RH4;Z'QVVR_LI&S=IP/5;G^+[KXQKB,^3/_,.PXD5@%C]YK'-_T8
M8/A)C&1=/DO&]W/;C3J?K9:IWZ&$Y5J"+GX7."Q651SD<7&CX>G\P/LR9"PA
M3W4,9?X?,I+B5TX3OS&EV>8BP;&AHY)1LCHIVD![//:]W?N1$3Q&Y<-F4<!5
MXOU[[&L,U;\'#M @!(SP:IXNE=3MRSM%P>(<Y]JE)K=;9:=T7*IY*S7?X?A[
M'F;7MN&SB$&OHG,HME9<H7G!] (K'W?&&1:FY)N71?2#N9C22%)'A%(Z6!"P
M,:&))@0='K^3 N9%/B;Q)Y@Y.U6,76HWDRMM3A<BCK+S1C?/B]/GQAENE$J;
MNXW4O)9%+P:$IC+<L1"^YN"36'6JTCH :QC,@_O3+3=M6N]PN6I(FD#)4V -
M!T;[,LY1\2^G*!RQVTJ[X./>+MS:1-)+NWOMM3IAK?%!Q5=;KY=@EZ>&+3^]
M/6%%_E:JN5UY(.ICS;@]]=M4#^9!E"RC'3<'7G@_T+ 5M<T6H?L3YZ!M?42M
M@7,?Q!PXHT'2LB>^2 2#4FWXR'L,8>.."#7J,$,65!V+"EK$GYY#0JUIX3%-
M542B<EZ16TGHPX,!?J>A2Z9\.1BED5[9$V^2G@OHHI^C&^2J>X_8$G+Z7B)0
M'$O;;,B"F]\V4,::J?&N-7;I7W;@;QZDF1=-="WGC3XN$'XT&\/VG>_2!&0Q
MVU8;4@>.-0#[/-M=D*ZE#C]GF"VN?DCX9M]?P6-_ ]43(),8G-3!-OSFU!-3
M\2=V=![ @O;A@)Y.(_6H)F75K.)R2J(#89S>#9O%,ZM[=HIN065. _ZR6CDI
M^:?+-7>>=RVJU[QZXWK_6F]^V6>& 6M./R(SNEU$@67/"B\=WE3*=FR$\L3C
M5I6S<EH1LB/*FOL:J=C-7]KB<2[2&1]K3H_.MD\X9'*T(LOI<W541,\L[!0)
MI0^DG7@V61"0_U-GG&X;W!P25V^O]*-52VLA:/2N!*4!,Y#G];#^56_PU^O6
MJ&&*-D,@UAR(I[H@>'%)5;O;_(8T<7O:5FZUX^J!RZBRC5T6<_U.NJKVWC<]
M=3%QE?R\?SVF09I6?XO%8/VJFXA"U)W<'A?Q''V^WCU)S>?X*$-D0H!^YG*Y
M]R^?WG553S#Q%[?9,<Y)61O\/R]*?1RI' RAK#YG:NP+E"]E4_4>@"8?L9U!
MZ4XQ_$,+YXB&95_2O/= -SWN->,:E9#C6GW'9M4''\F^<=1,\1T*89ZVR$=J
M77S\MU\?!1'+<&I.R2CI(8>U^.J8W_WIDS[,GD3#:J<[8JW-?-4$?\0D9^PE
MO(?GQC)/!>:=!SQ90W$"!;T#9=Z2(*IJ7.MQCS\1B73%?.\RYU5MD2GN40LU
M\4381B%[0VB 1DMKX\O7OLHPYJE#"BP^#S+6ZKDT'$?TJZ=L0ARIFVOF14CW
MW:&KCP/#6G(;-]-GMA5<-4:=35?NCM;LVSR^_8\U2[ZXQVYVZUVG_B'9CD0(
M,>RGZH<WH?.@(S:"EJT.FAZ3ZN_A_T3%,YWV6(B[[ ;NL0>O7KZ\F!*F#K$9
M"3^XBW(=SZ>N.\P#O$MD4C3*/W]A7\ HU/^P.J"R=_V"1\?]U+LX8JYP9HYS
MSZ=\9'7"$1O5?+5=RB?-Q9""X)[WI7F44TPUA@61)O!FO?Z(5_FV6&TK1:?.
M[ROB,0\%AS*N7'YL9WIP)J(+?G"6N/JMCQ)#$WH60ACF0;*'>)/<531"Z[V-
M1@[7C]BJF.-]V0S)6R$&C(NE/DA5 IIEE1/UK&@8RU%8'_KX[X$#6*+V AN8
M>[=2C8QRY\WE;9-_HZGPVL>:QO/IL,%Z\DJO6\H='7?S,/ +_&+Q'^-N?.P"
M>$H#'$T2KE>L/JL_ "",3 *CQH,.H)8&4V'\X=>,SO'72=<VILM[I%\!?78.
M6 /7<6SL'[%QDQ:/V 2\(<0CMED8]162 *-YYM)A=8>8 QN;1OR!@7;[MN*F
MI LC^4#;UVE3DITR#,BZQ%)@SUG19V@&!2V"A9&19/;ZPZSW04N(8WT495XZ
MU^2M1H'5R@#Q4^K<[+)FT8^N8%JK/IL;E8T!ALS3\>1J8?C"A5;T:>2'O@Y)
M2:I\_%*CGOG%%RD%O"6:C,NSE0E-30Z)TV]&3HMZH[H?Q2F9ZS57,X263$=^
MMRD2,E!*0(W!>9^%\PA>8];#RYB"W@6PR,2BK$_Q-J(G[:49/-0D304*OVC'
M>?_E"H!CG@HH!/#7:1RQCR8UQ%5/ G7DA<S%<!OC6FI1&]9JN-C%9<%A@=B;
MHIR?9%[J)%H/#[7JZM:^P"N;N%C"$#S61]9.98*!K+,&PD#$0:?!A28:-[W]
M.(#@B'ZL^2C#J'UT*7K)["UFT *GU^L@^TJB2%B&YY6/OKFR O-T="& L1G;
MW(5%0T3KWS"NE_L0.6*W?"L#BR)AXX$#B6\0R@^]5<>[;#:RU4[Y1?%_ZK[Q
MV2E*FVD0,>]FPH(%!#)CJ>3%PSI<#L$T?6<4?&8V*^&+UY;!L$:(*?<7ODSI
MSY7+0]C7<DY58B1 \X +W54PUBX!94E5F_]I-,Z7A+*@#)%FVNU8BK?!<\+]
MP$!O<H>!V=1#[./VSQ)SJ5A-\/1)>"J@4(RCRO.)&7/_^43B_+VJ$2G=,:63
MA.O(M?I7B;^_[IC[/.ZJTR(HIN0?:@GSM' YLJJOQPHCR5 'D@N1B.YVKM'S
M-!SA\.S*J.:IH#8/W5-8 M>:C;33C>KCIFK.GV52F!?ULI&,[#6-8> B 2!8
M4UN0B$52=Z79-9IJBJH>CR0N**A@9M;4WULEGV?P52_"T5M8=JSP@-9=$2N%
M2U6:;CU\B;*B\74[3L7K!=$X"'^R$^K?&W?^PBZ J1FKH*>.0)B+N<>_20(N
M<T.R8]IO3[W=.MU;4?1PW^'1-^KP!K@4$%W$1:*T"X#1K_ING3#^WQ:21!_M
M''$+7\CL;XF[:V:FRI/+XLNQ][+D7MTQ0([>*/20]@&]1=>2&$(LT;\4O9!1
M . [FR<32Y&)W1$7ONTF!T\NL'\+TAX-,K_!CKLS;QI8=Y@^:+(I>U%0Y\N9
MQFDMI@S#'6A;PB=&&'R+$)P%!(@D<I)(8@@X;L//KYAFD*^/(_:\%C *..9P
M/GJSC_@(FIH7?/CYS/*/O]%DA;%@+.+_%$Z+_ULX&PPN17PQ4!MGR@,X&!!*
MNT3J>,*X^0F'I2G9_.0IFU.JN?E-;@MSN3G*T7F?G;^US!^\)>7*+X7+F>;\
MC9X]N$4=CL^U&&>(+YEL!D+;=$UH+O4^678Z=I'U9C\W"Q-Z-R<7S65*6QM4
MY;#JAJ#!I!WI[PG*?SM7?)K<18C[2(H#<)IXMR,LRLXAAF3W4O?$Z._$MDL>
M+W=FW ^LTB?2[[TZ'B)T[+JX6"OIM99?"TNK4=LS[*9VWX/[QNQ1NK2OU<7P
M!:71ZL"^<<U*VYTO7.*HGK+ZKGU3?Y'W/G7QYW-N&<!ET[!OSWCCJ7<'#JI3
MF-*TF*8E?=[5H$IUVU'4ID(GU>O/9 $[_;[@O=88Q*5#7\O-2)%OF;TKG@]-
M-7G,PU2!"\GO1@$+"PA/A P,&>M"G<A.U#17-4WI^H/F]=ZS[N>V^?)A]5&3
M-<UL9T9V)_I.JW?C\5F&SV&A:OL9!AQP)7.A3\ CI",I6B4&[_Y45FZ^N_R3
M>;]BBGO[W*>*=%=7I4X.3K&R$"Y!8*H;#\AO)QHH XJ=.BI--/'./3.RK_38
M;3B9^N=*J7<U0N;AWJV6 T^BQFR3],Y26F'ZFOKR29.EN;6%95K+8DP13;</
MSX,R*EB??*:\1]CFURJ7#7GF!C,L<QSPUB_J:>32N'41I!AS4<M)YF-6BM$7
M0<OQE0B^B'D#<6!HJ0U\NXYZQ):(;5/H&7$:)D/.K(G0!XJ0S;H1[G##<]LZ
MJ+=I[(.69]ULD812^29T"@FKT+,=#1:NK!8TIH;C7VRA/ N0QJ8C*LH+/[HE
M+R?0*HTF"^#^$M,),\HWI^X^R)F?7QKS#$:F94:G/H?4!.=3W;H7V.N;:44-
ME8N0*$MG*"!NB!OAR9S,R[@QN4Z?Q6--<+X\+?W<'O_Z]DXI48S_B6+J'F8;
M7& 18P,'0VE(G:+]'%*[\9@\AG7F<Z9*+!1IO3AU?+/:-T"DTB_1_^D,CSHT
MO;;":O$C[@W\P?@/ XF(:1@_XSI-IO-92KX[^2+J%$VWEV637NXJJQ&_(H-\
M57S5)!R]JOP0(#+EK9^@\;LW2PU)71[7VYT+TV?IVS18U_8+&!:<T"X'H+NH
M:Z23J&LY1@VYY/7U^$W$G3]::>&^IYIR-$(\,/?.G#UQJN/$31," J5]&/T;
M<@)E2]U<_I&</\[@6H0)_OT0NS=*PS.&R=+(-M#=-TXNAT7I%,X,FS;[5]#>
M+Q+:IE)WWJ>"F-U9!@;4U#YER2,VET;[=C4X?4$ZP4M9R/0_)ZBWHWD2>XBZ
MTK+\:$'C?N;U7UK"4F972GV\(OKQV)LDD('0&C$FO]P>B.PF\HS7K#V+R"6'
M&Q.R1?B6*VJAFEG%E!_^R:\K1CE''WQ9^UC<N,Z2%[$$W0,^M:^D'M%L022?
M!? "#I=X;::Y6;G1?T++/SO39O.#0V4FQ<,R9NT<?J@O].#?B.%G/[JJA8"!
M'I?+M%NYE&$0DA)FB XI]JHL6*5"B3<>XF+$/1L;_9^/JNL.+N<8/O\H;)P,
M()BG%/*!$*L1/]$>8E2)*?#6?ZE?:%KAC_D+9&']B'KK!NXE5/D*H7I!2^\_
MM2LG\\LF &V69]HVN((,Z>(BZX?T\",Q/08R(U"GE[K*6J1;SEIK]HR&Z*WO
M6>$)D8'EV&;RY.5!5Z=A0,&3(:1U0&\$_*D+$%% VY&*2=(+6(RF1;<-SRRF
M&DU2XHC&2+JN7\E[@;/5OMF^7WHWY&V=U[.J,(:'B?6JG, 208>>03GX=PNK
M"H(OR#>F;!MY%[1B)U:R3"NF?+O$EJ^M"3QU?AKUYNX&)]J=-&W&/-M 6$R"
M4#/1ONBN7""T%. *H7O.'+'5,Z>T4E59(FH2GU%WH" )&V[9/+N@Y3ID5-:]
MAF\83OU^6*%GM-ART4!BVOP_X.64>0U5OE:HP4".%I&UZC,%ZL6$:XX'CQH+
M#*OO7YD=P'QZ0[2?KVGC2/[;4CZ/ T 7(S/LQ_74E[8!HT!S"*QMC&$H\;[
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M SJS_3"V.\,HJ'2NLWV^^"8N2;8RKI>MBD!OH(KV5*?F5*=6Z<E084L<+]V
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MV.XL/RRK/;9]I\DKT*X"+8H\D?^H7UKW;WZU,>6#1W!XSGT3LTR)@ZR4=?4
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M[NIGU^OX5#-<GU#P<VK+]M7 CTZQ__56@?=<96.^M'.BSU&YG)N07$9(ZKN
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M.X^7SX7XFM0+:Q7_KR^$HG7_XB]911Z)"MZX37U?;"KI1]>0%L42_-U;*$R
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MQA" 4NU+ /=>#!LM'E=2\,0!P"?HN57,K+\^$\RQM1NC_A^:P-B,0OU8K7Y
M2]C$ <54B7^R;6=!=V#O?A91$S[;HKLA)5'7XG]I6APS'."JMF+2E)84URM2
M-;9/U EX5S'CJ^44D=;SIN0O_F%+SHFP"D;WG'S.=P^M"Y M&9D8,P46"EF4
M.48^ V,UHN- IZWEK?/D3AWKKBW/?]LWQMV9_>.W[S2XF+*3IEA-ZIL_9FXM
M^6@-QO<-X\]^$]]7Q\RW"\'DT/?J1OXH7+.$$]+G;H//\I0SO,I(9%^,"*&I
M7D<I)N(=-?UB#N+O>/@0OZX/[R?@6\+/83;FD/XIF!0JO$O'^G_S2N6-QM#W
M/?Q#!JQ'*OW]_Q1?JOT:X&[,I?G'DV?UY+Q(S*N\M:#AX]Y/SS<'6UX3OU$W
MD=<C>7F!Z"/Q)-_<D:00L12PD_'VV7LOWY<BD5H2KRIXAU5$&"ZT7&)[^E']
MR.W:XN]R^A'58'UJ0XJ[Y1,@>="6$7SP<5I3\[]\A5ZX=FQ::U%:Q:]L]+SD
M^+&/?]HXP;AEL@1SG,D+1E .(9)DM,X(VK":83VAX04LQA0K=?_VR5O-EVRT
MZG[U523E$Z-/4U1.54U7C3*]R8.D^X'!5&0B':,Z06!9JC3J)D5\(31,*P?I
M^C0H^'0A3F<KBW(G4]6-N45.EQ=?A=A7%0#YG2UFB95_4JRY0<RT?1UB.IHN
MJ2/0'%7]R +)^57X\<OOR5K/8_9[TK@>E9]=X8(68CG1<LO(9.P1O7O,.%/W
MTBL)9N4H7:KB$-7G[+A*P]5L#:430GP_2'K<+TWZ,N71 38#.\_/'4*BGZ$?
M9E%^1"'Y;>KR[]$<H@@*M$SZU=UFIZMHO;S[66#TM]GCOSP1*?<R'/M0WZKR
MG5=,H%CP]I)PE!Y'=9JS$> 06^]OZ]7:(IRC<ZVU]4O.GR)$GUZ7P=PO,7;N
MRE=?W5(;MU)2=*P[JMG6+OO4W -O$T-LUTC: +WPF<\STT8=MYV.FL1+..69
MOU<P*__A6ZQS5T2T[U6@N9;A<V;+U5T7=L7A)^91+3^99ZIY$/C3]>*'$!YG
MU .SP(?!%C)CKS_Y/T3Q54C7:.+^F_K;_"0H]7RB>Z@5!9Y>J$]#]BA9=P ;
M'QF*;6 4S6[NUF1#&M?-,0_"^"Q&:HWT@=2K^'$8&1BH]&V7_UN3TG=CVU,3
MB;UTX:,P\<0E0 4(%XO68.=![!*>SQLC=J4QH\PW3[!RI?2YNTU&/NKM]0P_
M&\&08Y$0$<$AS!BY!AO3[M,>GU<=K\%^=F2K8<B.Q]VNL-=DK%K<[E,\:Y-9
M<S1S;)6TE/@P_K)G7'_%Z3B%E5*N*_@3#"4PEZ:PC.\*IB4PE"2=+6A'TB:)
M.LBZ/[Z;IC1GFW*3EC;4\$K51.ESQ_>_]B,*?[UKK]Y,NIOTY ]NTY!:+8#:
M7Y[N2H/?IY4E_DE1&((2F^@DR0%GK)>/2IC;C_;9R7..IT_VIWZ:UX[89.&U
M ?GV)1FZ!P5,,1^8\(B>1DEK55;I_+KTQJ]OHLJ_*G]5B:UN:$N</2'?')J]
M;%.3$W : OFICHR%\0/;J<)=3M@XAJX[E75<9M3A=M.X6S+-3\9_E,1QU^@O
MYWSB[X]2!F],XG#)C(LT?BI;NKX/+P]#&QA.KX))^, N3&$NN&P(PZ  ,X.>
MY#$>O*"I:W'EVMN:W.YYIGNM</Y02(BJ?P8*SH:^TP)6TZ"=4"F]"*IEN',U
M-W,P!,OO3_I);,PK+:!$7-]8]"00FIIVIGY"S AO'?@&SMZ&OC@=!RT2PW8B
M.=>EI)NFE-!JE'T7IZ%J5ZZ9^C4[ZDE"AAQ!X:Q+OU?FA44[WFTQ=:7,UXGU
M*C$P7H"@25L_\OY3!9*%..&$!\XNJNSV/*J*?T,N"9K./>J;8_\K+,]YX2C;
M\%/81I4>2Q6IG_JGR#U26N,!Q31HY,,$!QHLE_))8P#A@HDP%2^/??KX6J*)
M\]5%Z0V/VS)(Y<^A3[5B&6XT?CBX#N#-)F&*J/[5:VS4A$3T%13-L)2$[;3V
M\2EU6;BN4IP\Z1[:6>&_HF@1MY@D$>6"*0"L-U, /*6DA4AICX?RZNES/YF[
M_]ZG3:*N_FX.R<*C\1G[,E1=U5JW9\&V-"/WQ$Q!)7()&8V^H82M)T I_D:;
M3F.H=/*6SLTS?\6*3O=A\I]MM=A#DA*VCXGR'$G_:O5,S/)>NAZ<1@M"2H#4
M/:>L;K&3)50>Z3$2V;0-F'J'0$8@V FC?[B.UU42$,%G]'2B"57CQ;*1QI1/
M+M949+H&EM1-8*%4"ULL2>IWXP4T%K1LVT=VKZEL#?.TQ_NIN#^8%JKM^1TV
M.UAG)B.H>^OZ:W@5@64?!G)1K)/_5(9W,MD!7/R?X3,6JQO_TK.+G6<7-G %
M<V4YZ@[9M18#F8]]=[&<>DJ\2>Y3N417J,M#\;Y@]NUX//LGRY=NSF%>9_SG
M95&V#[W8GDC'R98?3[FLQV5V4((V1!Y"6(<;::NM5!]%/5NZ7$VN4]WHN98\
M1#%:,=.\4G0YYEMV?]RI 4Z+LYXG-2[Y,+OTZY'I!(LB!FJ48:=G155RH"BW
M*0:1MV9VR_\,S)!-:B98A>&S\#6E"WE48_M(WJP![B(3](&H5N>1=YL'.9<[
M:U&AU[,Z]_[K\X>E3_&)<Q0]RY+U/TE6RD[17%&(:?ZA_1[/!>- J2QYIFD6
M+.'907C'OPBBS #BS;J-#_"U3ZPG+E/0YD9/8F1&Y_NH+\?33-%(Q+XYPQC
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M8U/:M$;TW"H,3ULYVXUO+=$N[BO-OPXKM*JGDQYWI5XGU@H:O([$--*:-DT
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M:B, WT5-T AH[Q$KJ7SO:!16"=KWVC3'+ZC:"885>?)5K7;&1&5%#06QT=&
M(OR,/\.?-QH-%4ZKJ#@2A"T]PX.4@& %1,1G8X7_!&Y(LZ1%?>D5>!RU@JTM
M2W8'G9?@J70+Q+L-,5XB7F1CV:IVW/\1H07ACCQ5--4X4NID:A'@F7SU&?^.
MK._)X[BX>F3:;S"KAUPO5%-M1I,QIIEU(4^"PC8T/9VRV(8A(;)1/9+/=VHZ
M1$%NH4)!X/1ZG1EO'F<ET214T>/E^9U#R*TV%K1$S%(H<65TZI^_LTW+YT^3
M&BXW'LV>+XEXHF8=J'V_('E,U]_ W)@]DF(2X"L%&0GV-[I#:!E53\EO?=QY
M3<$NS_GJHM7U;VI7+'U>I/9QYJ=$R_B5JPU$_6ZTY/Y+I#L#DKA.'$F>FAO#
ME!BBD$^ XH:T4QF*+8*ESXNMTU;'M.:=''O%>R4KJGJF0BY5P?Y>^?7BJ]XX
MM3>6<H!OD\20^$#7_2Y[*Q\* K':GNM :)\XIU+Z[?=-9<],B^QLRX\/R.=5
M/X>D1H0OM<\2*60B]I3W/_T$](FE5C9SX&#?M\4EO:#(V6G.IRDUTW3ZLIG8
MB>2'F?VEQL>2ORY??<AK)ARK_D)#\@9-O55;^<]S\S\<4[.LN?W)MJR5J5\%
M+6S$K[*F/W^<"/)3Y3?[W/[7?TTUB\0(@"H6$T<VIL4A"FU= 7*9"36*(9.X
M%G_BD4TF3R0_6%XCZ 159>GT7DZ^(G/LG/P)/38/FCR3PX/6N//#? *M1<%Q
MHF*ZM*2X1C:#IRVMSI-4!9QK9V_Y>Z:+9SS^<-KG06I:S7?IC+V0J'T%A@I0
M1K1RZ'@*)V*/K;?Q3K\DVXU4HO5]3KTLKUL.RUMPY_OJS"+W_ >+QN@0\).X
M!V-#<EN\7AM#^5>V=07EU*;.O+B"4^B;J_.\.I?JWB#QQOT9V$1%ICB=+W:'
M$LFL#%V:Z2MZ1Y4733BM6EVT*%=^Q7QIK/KN=, IZL9C\[D>ZVSF-)97O_%/
M=53;91I/Q13L<CTM/LWK6G9"HHIR?;Y6UE!8SM49(X'O^OW*4K-R'G<I;/VP
M5RS>7][KD..#R&=2X%M*L%Z;_1/]KLX1I2=R-W^7AMS(CR+]S(H7D9$_^6(X
MFJD,AINT@M4T\5X[Y[D^VFTB5I(A3AF2N>O-XML2DAVHDI"#$)&H K?DZCZU
M9BS?E/F;^?7QK"]U%QLEI0?H;[&4HH2-@ D,^Y&LIO'VX(%G: .K6]\L]-P%
M:)<_3MPW5%BH[0B6*Q3[=6&0+<CFU_79 \X))@L(=0++O)8_#)]$W=KN(?F=
MG!KOXO<1VO%MK)%8O?KK1MC[5_CGER7P3I\HR-@C^-9*:FA%&!\YTMT(]ZZZ
ME )79N^M^,6?=Y]#BBR3^(QN?(%H:<M#..\7U="&&?QU9O^;0[GOB"(26^!$
M%.8TB#4%SL<7GAN-.X@=O8]("W[:[H>LL5)T]1M5OIFI.C_89GDC9<=A?K)G
M#5[71/S?J2U"6*[UMA- 0 $E_T-&N&8&HFC.R%V1>O?%C9'WK*H<=Q_-FX:6
M^WUG<7DF(C 5PWFAZ,4) 5N#_Y\NP>!6H>&N%HW5_'*G.;+/OU@5_R?^>@_-
MJZ2#+ZUMH#P\9$^CSD[WP$3SEY ,/C(][DC>(]7UXUOTB7!6M%LZ=44/SK/<
M)]#2Q=I.C^C-_U1L'_LK82_?$FEB\/2@QM5K_S[S:R'+03.&S1?/BY%>^UF!
M"K\S=W:&Z=+]:J @J^/LJK:#/+?N&?9+YA>CGK?I@$<(=((+9*E8QW"!SX)Y
MA._';.[X+O+0V&:#KVD03W)G=J&_RMG;$B%/X^TXV-Z ;DNM*G1;4/04OA+U
MHTML*HOR5<JYG0\<=W3.)TI9"C=_>I 2]TW5 '(,GEZH=PB)N0F30TN"%?\[
M2WS_.BPE#'DQYUN$2T#0UHWAN:V0. )Q UT_7!+T&-O1\+\_-K9NEY,Z]DTQ
M4T[MB01]OXVMLID%N.\<[: C:+1;'-NPTG:-QXK\,&!?ZN+1RA\<5&I@P:LL
M])^ _N9O0#! P_H8Z/IGI66:U8KN_-*" _9Z_I$S4>HN1T>(.ZZMJ#T4Z[D=
M^4]ELP,0[X3S$G2%LXM ,\N8FXW#B\%IQ[>1]@\YY#^=)VS3.0XAT0B&W-$=
MB=;"GF*H D!MSF^?B8;PWGW3L@\ZNSZE7[Z*7C7A3,F*$]78OK,L57%F8_C(
M+RPUZY]61\9)\1X4,JRH2M<E%0Q'F*K>3;E[65X#C7$/"(I;D;?8/I8>00S@
M@(W4%SG*O,\=;:Q3I6 W=5C(>\_)-)\"/[4V_32NITR=IGX#MU^M?*'V2WVF
MZOMR^5</6^OHWP^R@W&D3'AL6O&&F&<A#(HV'"? GZIP'4+>SLV9Z1!LMV[O
M=WK<#_BRM*.P(!,GO?_^0V&S2+'-!*,)G+O6SN!GDID<%-[NH:?39M:0-%/B
M_0GYC)+X*=LWB2&_;"PAW\]> ZM^TX\,4/1SANA!O;X'610M#%J^/X1T4D$<
M3>5&KOGH+H_PK69\?QAG]5R G'>7C6% ]R,?R7C.U"=P2^8XMK:PAM9++P+9
MEC_P&%DVC&/X-TBE;\KGYK=_5Y_9Z*A\9M1P8^7>]U]GW4NM!?!-;)M)V'TC
M[S9QFGRTAJ4*)]H)#,5HZ',BLHK#V)VY CT>GPY 6";N9%Y@C6E(N*3J&%\6
MR9 %'R^>/5ID RJ<B($U6_G^7AKN5%+%\I@\^=TSW:0VP$,O%FMB-!QT!2(W
M!)9;(Q;>K]NW_,I]XA[ACPSS"N,W#$0>95]96I2]Z6WB1=9H7E:QO_OTBH.D
M/T@2[UW JPO*#;[#B#'\ *7/W66(J9!#"$E(C7CA=F#9PI=]GN[\VNB3MJ.1
MP6>_2\D[ 6Q;330S<RS/1J$Z> S8L_X,E][N6A3^.*G!X^&NI^;LO" 8+<K^
M3731)?;[<8-B-[S0>QSHI0_:MOLUZY],V#*3CS10S8FWXG#\-6ZE4NBF96"8
MNLQ5_]1ATQ173 +#+1H^UC3%?^O_)A?-?LX@HS/Y\OOW5R$0R'$"+U,R&^AE
MBB0P!:XV3.1V+L+S- 1;>BJ:F$C\P5OE*QFA/YA[&!A-1OP6B:)W#=BCSX"6
M;WLIK2H]< A&QB?$]VP=#9KL%VRE=<^[EW-:DUZRE&=P)<<L)5#TRQ"7H9_%
M_EWFZ*+8P6OL4B&VX3E,O*:]YG\E6!YH*P]XD,YW;:LUZ^4CG+OF=[D.[AGW
M;P;5^+83ZT>L MS )D!YF%=0(5,^;<<8IB-!I6!&\9RI(UJNO ]Y1KGU^*EG
M7T,J^\N7J(:%)A&\2SA07C^1(+//PP@ L>6H 6N:,*Y-J_'3>]^63Q]U,/DG
MB]\9N$M?N/-U_;ADJ^-,I#6:-P14 .ST69F#&%$PG'IU=\M74HW8^$^H!)J[
MZK3XWKE"57F:)<COF(C;5[UDQ1GH69015:DGZT@_( ?U>HX4BS<35948,53H
MW3&YR*3B3QE!<^MNETR-3CYH[KT_77T(Z1!ODUJ#<1Y%6A!#;4+=77)R+U4]
M$6U6Y2N[W3RIH=# ?W](#?_RU==!V$-S3N'7QS\=[<*:<:9_F7FD(_LF:-<I
M18;50>L25,S9)P<C-AZP:(%4%W=V"V3&#Q(11M""6KTKN@+'3VI;<=$5P85]
M$8132?7F#^IPPC3^E :B#TD!M'#^55-D8MV-E16QB*UWJK+<F_>,9 ,$LAKB
MO1T6HG@90@-&=<#V%R0+PWQ\5(EYEJ%/6TQ0B=N6[ERPD!O:M1\G*01[KT9;
ML)29<O+Z(I,P7.C @\QV7W@B7J!-$#3K) L1U&@/9GW%R DJP6_>_,SS6&FM
M=5Z=HAJCSL=E'-M9N9+M%QG81P)"-TUH1LO;/<-<X!X]G980VX!"LX4>E%"J
M65$ZWU!!XN( 9^6?P6ENS\\% @61[V4?Y7!EY:TS+X(*]&(@M%L)<0<,7.:-
M@UT&"FLN%Y(-:57XX+)Y;^R%DU=5%&/^UF1R/;QG>=Q\T43*7?T0X@&?.X28
M'+R%22-<CT_IR2RKQ.OS$[2]\^*.+ 7!&B$1RNN[:1M061KW/7Z59ZD*G%\"
M#+Y6:P!D1EEH-YQNMDL^T%Z8=MY79_;I\_'3"R?:M-!>--[8!JB$Y6N5N/HT
MF<Z<K.ZWWD^Q^!]?]>:B/9OS+#0S-\LA]T]T!SVUWJRLF,%VF 57IPZ5^Z2]
MWG ]40_4AQBTSPFA GX4O-57'E:L>,VM^9A7P)?M!7,>OI-%GIEFMA..HK^T
M>2.7P:]F6@?&[-_%3+2?;NBV'):<8QBW ,F6,#%_-?/:9#X?I%28^>R]_I E
M;?0K:FLH/>$@1P.7JM^P_06;F*,3GX\H85QLGBJ=\"]3H:?4A'L^,Y4FE6#L
M[9P#)8*& @\A4MB'O!+>^O52;V@I2]#4>NL3(+E+$YA#X8UH)V)SVR1HOIV:
M1,4!?L6I/?;V"WG2%C8L%S<,H=8N]PPC5OX"1*U,ZKV]U_[I:O&B:Z;6,E-M
M,H!7YR$$AP=N54LQ# \AL;R4Q2@:D5*6KF<;3IVAU$U31]'6;ZU0S$= [;S*
M[*\,9UW>/%PZK^\N,J'M^$&%7@1-WK 53%B&Q[:=!$I3@I2K=MN/S[AL:!6>
MA?!]MWJ">?_QND4?G_']Y6.]3C$N@-=6&$#NUJG \--".^")B^*$SSG4+V!G
M_[[II'KSPH BCUQR'T^G*;O-XGT_ U'9WP;?FNB^!U4,X7T4Z-XC)>'/UBTE
M2F-+D/ IO 3@DRK2TC^\K7_W28O5T]X,GJ?],.1V:C3[<L5! ?81^21F(.3I
M<]B9FKSI_;O/YM7380\B8VW>"YIJ79$7?U'CJ6BAT<'L@==J);?QH6^ 431=
MJD.2.OP,^A;X:LKG'=9M]EIA1@G)R=2]L:'14?3M?V]>O935?=5DF/Q/+.^W
MB*V)P)<+1<F0_^M5+7?P7M\WL=V+1]<J?MJ,N3BM$7\(,6T(6XD6@,.X@I5I
M1GJ?WS:W-$9?I<:;A<G#GTOW23\64]EJI_+R@\<#2QBJDRK,LTI_TEXYG1D.
MEDQ,_^5#M>S[];W>L;+2'6%9GUU2[\BW]=+XEM3Y9\U0XU&XZAJ^"9NBY^-?
M@@HU!(.+YADVA&F- J%M"P+-N)$DV$2W2'2]?_YMHXIL34[A@LSQ4<="NZJ:
ML  ': \4L&L_[<00SJ?*)V#.;.@DQ#"TEK[3\,E5?]+N[I;6I02/#;F544G>
M#5P@IO<*BO#5!METL.II:_GRV)]LP=_V=?OABY;[?I9 @ED#>+/V7EL!/8H*
M3406@_$TY8?\_7Y!&66#TTK<BN((:Z'5<Q:I:&+9P>MVW]9P"KD7Q\50!Y!Q
M:'VJM3 JWZQUNM@JO*O,H"X<X?@@V7PIPS_ -3PS0.#O0XV[MKE!K(^:I19,
M4*EDP$8_H4UTE'%I43FKRY5K2L^B=';#0<>T[(WKM=YXNPWK\^?>ZUW1TWE:
MOT%3;%*1L-,+X)OS49\ZTO<4AMS%ZGJ=X<1J?8K$] ^@LI.$TG?\A!ARXJB2
MSNOI<V]PCP@4=[JOUNLM]RA=YMQQ58E<@_ X02I9'.N?QD+YL:E"/82D%PK'
MH;W>@ CB=,N?UO+L77J;9O_^UGP?7^:BH2Q2_$-WFY:]O4&_R6,G/$/@S/(2
M;W*#E?QR3Q0%#VDHS/*O=%Y$N<,)-!?"Q^%WSNL9O=)8+^?[O0HN+LY%<5&C
M,36+>DV0%I9U7X7>[P<$C(@SJLYB5+DA#6$]H8&K>2V\*#JI=&[<DS!'MT2L
MOVV\M[O_,J7GS.)6T<O4Q.-G!O)"X8 M;VP(_#24J IFV;D8P^'K&4.'$/9?
M90<%H<%N_L'!X=S"[5[[BMM(P>SAO)H;W5(J2C4REX2#V!K_3WOO%=9D^[5]
MQH)(,]*E1J6I-$6* H*(-!$1D-Y4:@@A(BU(( K2!00$'N$!I K2I(10@T
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M)X2..'8%Y9F\4)0<D<8V9TZ2H7?.NW.QR;"#9$3G95X!MPX"D!'S,HF2&2:
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MWY>^*U]&V&S%;"YSL@7=?I']_X/GF?[?ACCZX"'*;D+K))UG@OXD'XE^0)5
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M&O1+_RIVH-802UG_]RHPMZ(]I7:ZV6>39?OKWOD!1BWG, [D?>G+N2\%#V\
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M@?7<QES$AQ.;!2=^!LAU&RMMA,&V\_5GGL0V86J+L'WPJ0A*+=!V> U%2&5
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M-P)->&^K).B5J"1'FG>SY@<@:@2:E:=,*+) $$P1@7PZTG@M]914?7YD;46
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M5!*$\F%>G95],;,R6A<W*&*<\\3)U?6JM!WS169LR')[QU"GX@W<L5&\I,>
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MMA>@BG:#?'^*M 7R?3C(]W^BYV;5'X 11Y;_4FAH#VQ_$""8\ 4*7 H9O<N
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MCSM2'[-!;?O-AKB#JE2.#?F..+U4Z9ML'9#=WL]J7D)O=LV?WLE>@[2DB1S
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MA*5F]-ZBM9991YC?M$3&:-(KY=(7?1U=/.V'ZWYPD\4W]1?TX@-_S$INDZ'
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MTW0#0\Q%[S=L!M%\J#QN7"C56=[30MN\DB[OOZ?/=@<#/#)(M?O:-Q:+/ F
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MI=\AB_5<B=52J&:XB1^SDS\TI.<8P)K5N!G9HBSKB-F$^=0+T6U1LK3X&?4
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MO/Z^4, ?GIE^TRR^HG +O[4M<;/DP4=9?ZV.N/U'YC:*6V.:=&'$E \T+*G
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MR#0AQSPX?YG,WO$$SIL^,E. -$:.1Y.+-I:D&)Y8[=ZJ*Y-XA&$@=:,A>]H
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M$Q!\#7)-H(;4FQW.@;+OF)JD?N]35,*37\Z5^?G2T[%Z:O'!C[YQ74E80.5
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MB#HOYH*M9!%%_INZT)"A$M0J2WG%\BMG7R59RJ[@V;R>'-ASRP;YK;G[S/#
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M/=704#FS,D.ZU5"V-\\.BE3=&DT'C'U1H-8Y<+.(;B3W8N'P9KC/L\#7Y&=
M,:I[BJKK?T#WY-FX5N6"SR.?-/?E.2 ?I>R/8BP9C"]SYWY;&KO7??NPZT#
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MF+:MN!<K":)EXU6"T!SGH%C"Q:SKF2,(?1O9TO,M+/?,#L] \IJNCC3?DDU
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MV-WB<-8'#2'Q\G'6'3']KMA!)Z0D_2MK4$(C>XL:[%+YD8WCP%Q00ZA&0L%
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M38']!,W,M %H'Y&48MPIX/M7R%(+1FPE!VOM((1) V2H,E;K%F$=D.7 WGD
MX&Z@=1T)>J$B"6L*P+1:#P<68_PO=UII/[WU$L$.:?EUA4V<!M9XC#@P&'Y3
M_'_]Q'\\$-G')+(?94,NP@=Y82\']L^GZC*5B8V=6T*DE;?NT!SE=)Q.F[<"
M-C<0Y5Q;I$0.[+L2DKD3.15$^.?S()=[T@="07%-A6V:BP3[ IV/A!A #J\U
MN7&< [-<(6WMA0;Y4)>)-_W74Q'4(1(_<M8%"BM_Z!QAXME4?+8C!S8S@IM"
MS+,M.;#+T#"I^R ?GP?^Y=PTMHCEA"OK('GS9A$'-FD^_<)X_2R2R<"/A+%0
M[5!P"1/8.Q KFD;_?)X9T.#!A&+N_1L.[$P_@>E151"EE0&%$\&'\1S(V42Q
M=FU_CB3!UH4FZE].Q?^SB2Q?&NOV?N; 5G\A?>&_;?G_35O2T;RX,>0AO^#B
MX(X.'IL3&VEEA==7M/+#3]:\!G<Q;KF1Q.2>\67W%#^U]"OQ55YJ*-=AG]B*
M G<6:PA-#'?NPJ1V6.3'I987OKB>+EXV#\_/TW QO?H)<=+XE8$;QGIFMS/8
M+C^_UJ?V5M0\D:%85#J!2S:V(L$U'.'X*H%,#_I4X(//$:J+H\=PN_ELS6F^
MT='3P83.=??VY-%+.8J+K%O&V@*G'/\C^_V_$M11#JP.S;YHA]5DO2XBPX<,
M)14P]6#=":.))\?SQ@G7RG4G4>Z6,UQ,4;& -F=J$IP2M^X.[]-^CMCB(YI*
M?<B,R10<)94K!POM43(]GRGT /W+D!WQL_B(,>H#XM.>(\:7_W\MN$B@;E^-
MAC)A LF'V;LR<8UG)7IA7Z=,P6GUVK7V4(";N43\0!I_GO2EXL$2;3SG+A1I
M.'FGA)0.IWN3ZSNK%H>BLL.R"'^01[.G9\S,[7BTST62*DWI%5&GB5_@K?7_
MT<$,WA$]<Q%UXVN'0KXT+>NC 0G<2F"M,N?56!<0_5V#T%"N7/G/N,E_+[!C
M'%B^V9(/0\7MX%)YJ=TSQH%(&-&<*,UZ"B&9H37XQB]@[8/->A1S0XR]:MK'
M=EWAP [-)=WQXL"0TAQ8QOGMK\II]?^97FTD92CQ41";Z:@-(0YLF)LE2?Q*
M E5UV>Z"K&: 7E_]+(S%)G1R8'JNY0W RH5,J-QW6V^60DAACFO^T7_!+/RS
M"&P),BYA5"@#3/YENL!WG#HFK3X(P%<%3@8G("+.KDORN#L6E1S;F;Y7Q#HZ
MY!?,I+@CNDGF@HU]VZ!47S+FRYWW G>GSZA+5I"^,]=2:Z91H"K_I.N0<DDT
M=<(0B:1-^$56/2>-<F H0G]5&GV4160CV/T. M_EBU#A048/->[O:<3G.K@[
MF@P87ZVZ?6XDWQOG?_9"S,_"C*>-Y5E]&7>WLJ71]H*4^S*JR:9),3;*1A_C
M ]8M4.&=R6[9<E[.->6QQYSBW3-N9PN?<?$-@G%)#J0"#2)8E#!JF$0Q8UYG
M'!W]NY'D8Y>-]N&%RHYFS55[W^Q]3$.)$G]'>$S&?&"U@-37HI>6%Z\I^EY3
M/&O<U9LCP;OO^,J^M=ROEA3=*#_$/O>4XS74@:=GU\3<O]@$9&@1% ,>_%)8
M:9(]K0?G"I>DNI=+E=_4\_Z&BYJK<J5:-J-X%=7E3!NU#M.4PS[,&Y9T+QMW
MSQ2'SDZJQHQ>S6_1X&]RQEC6"Y?&KI?Y?84;]/J_U9_4,L^(*1PQ.J6V],<>
M_/AITVB[MEGN=)N?1M?4HGYAO1CGF?J@>VI)QH111,HE*CLI3,X_VTW%XG/6
M1J#$@:T!GC]<A62;1DZ8*%B&D=X9VZ0<HNH4T[AL\(;?_4),[7I=IN7\&);E
MK]E/'^8S<])H XN=- D*[KD_G!^+I)$B_&C],Z;?\W)/(*B7#L'[$[*/;-I:
MGC*_G=$^5-YHK.TG3*K'"V" ^@J+2H!"/&0U&[3@U>-_($;-;<E_5^>A]O;#
MU^H8Z6L??0U\D^-'9F:)NJ6LV)IS8^Z[;D504(V!?PH]B'Y![5NX:CF P1_;
M^!HXW?>I1,7DFL;VG)M<']4O.*]Z/*SU."W,5#CN57W/*0%'9'CFK*ZVFNJ0
MNX"Y]>M8V"[)I#4#X =C8K3_6<4+U &<A%YFP;*@'B6G^3'1;GF%/DE6G#:Y
M +Z-4'L>T=R]KO$S*O[GD('LZQ-)ETXD'3T].V\>%['[4.#N(%.GF ]QYN:O
M_QJ'7=3[>-;+SV$O>&6"'$D?Z,&XUK-/THZHV>'\%Y-<WB@-#4EOI%_(WE>S
M],A>BKCX@.;+T+6_B@@G\'WH&?SO*N4]>$K#8P>&$-0_#EC_B=U%FQ>:C!=Z
M_]U>,@9RICVWKW ]OS*YM\SGKS[]Z)P#RKD#E?DS3H7[NM[+]"Z=RLU@%.&_
M)9U!+1-R/3$("KN:IMYX84Y<Y/LZ<&B^1U8QP,8Y^=6#PWN$[D@\.WJ<]R:7
MP-!4?*7Z2+REB[: <EJFG=O68_JKEZLVHS:MW[\>;'6*%S1]8F':>OO*;O$K
M MGCR CQDV F\5PB)8;+AB:>U=HME_+*66ZZSES(95#X9:UH0NQI7SW[15Z]
M<Z[YT=J&6>X;PH;,_M);AI[^7A+:BA??ZYWT5W5VU@C=!UE(*7O<Z$F-!)CQ
M29E (< 7'"1Z#RN_SBVJ%$*?,G.PCM))7Q+[=O[,)<D\^GX]J2_T4U1B/?X(
MN'RMMU@3WN!PO-]O5.S!O&" &G;@D!71KGTVPTE\4?O^^AIY,9_A@+W'(I!<
M.Q$@JLY!,,&$F@R1S9+EC._2%>S:LQEB268G3DJZLN[=OE KT,1NXL *"$^1
M;N1G#B)X]B&RP$(-SQOSJ '+FIZBA4BYW#3IGV0-#PLM]?@+=F2K>S.)MJ=;
MO+ 5=%?I_@RXNTR_<6Q_4+4\T?4'+:J:0C@PCU,:6%)\*W*SIJ_88'.W<DF
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M&\+2\SY4HS\9;JIWYWZY6*:-Y&,S%X7)ZD.?>-9.HWLXPFFS38='3IVC0<A
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M;&]\AA+L6]'26%J#VP91N?O9]WBA2_>&#S\+'L+&<" B2R144JGW=:C,C*J
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M&\[#D*.%H]SD[W_P>K'.8SMITY-P>O3L'21-<)!#<2_0QMF 1P'$8M;9 #:
MX8YFG=LO%8V1XR!H5404 S1+,M'ZLT76:-H_#W->7Y]CGB#!]!46-YH.91C3
M^NABH;X4KA@5^R_N>[@WJ\-ZTO./<\VK'/EJ3&\ @@ ;I[QG?2R[>/VE!(0*
M&S 5W;D+\Q=^>0I*HVY>\DP>FK9P^L-8^R_&T8@S'O"4]= D_MZ8@MHT6 E>
M_/SQI*_ZLG=75Y#YX3,/_O)"'@%IH&C21<3N#6L\Z^ 8&T I)?O6][8#A1[W
MM08AH6.D\<>.$7QB.RD_VQ,&C9)_M9&/!!BFBT*\NC)2X/']JB=5OBDU:MVP
MTV/)/^[,PZ3W@V<2(=4)M;FX+P_)6$.;H#,*5MO*0D'?\!\*LI]QC51 6S 2
MH1(4^6;X^=[/M*J'@PQPN4T8W691\.+MT2C81LZO.SQ(6Q4SP<3T3P,PO;LZ
M"EW\$"G)$K XXJ_?H(43V80:1JDE722B5B&':%!3BGB!0 C.[;PY/VLKP?LM
M9O4^RG48/I, KBYZ4X2>F#[I)?;.PL<FS,:@+N5"+R].65'MAW/:$]OCOG,E
ML@CG?OZGSB*I=3?T;X=E:;,D?E5;E(:*,-^IW0@-I"66!3YL53N-_4ZY%RF0
M_<4-7_6PJ->][D2Z@ Q0430!3=TA<<#3X=<47*SL>E09.8OP,N/<, R8 .1E
M)NRU=/N3+7<$-L4-;E<"YY\F!K?4.$47&LL67T-E#NBNK/R9;W,><9=SU/&S
MV]Y#RF+JMQ=ASGVVD Y$A-IU9H[:%;M BPY!"%6MJ?C-W3%F$2A1QOOG+M'Y
M(2Y?< Y4<\?X:5_ DRU1A:X;1@$&7SC(4>/_6N1WF##G,3D -?4U@V/L8?LN
M1P]OMAG_7[?C/L#K.6IQ$BON/0]9\X>WRG0B:DV--&#F,*5_?W,$LYED W"#
MB'7$@M%@!IRR+4%?V!WTW[-G>@B_Y\#H<___:R8;Q*G00V&4ASAKY\CBBA6D
MCO\;?>YCW',)R@=ZGA3DU>5T^-_0_"2LW2!6,9U\9RM;9-,.FS#<,4S<6#9Y
M'74L+EF1:G8X<\E+[4#@ND&UO(#(<<KS,]<[D_5$"(8\3U/;0];;L8E*\-67
MR8$\A+3L; SJ>;A_6+#K:_S9G@0S^6<^Z^_OOE+&IR\A:GG:]61,;0HI"?EW
MCTXX?A1-%J>.6%S8<_CN".$U\^N/,5IZN<::R]W<\CO9*\#C]:;PP@"<1R4S
M-4/+2: +H5M#S^\2%I2_T666.A.A>#2Y28@:26,*X,8GE0VS6H/U$\L?\MJL
M-*B4# *K^!=OKZ>LCV5SQ-V$$HV+U4;)ANA";6],I*488;-^UA@KQ8]<^S;M
MJE"!\,PWR*EMV&0:F-#59;]V\R:@I9>J^V%-7@.HM%[YO*:!-C#9P$O8+?/<
MSI[MPAN&:4W^G8=YR^)!J0&[5GP*6X<1[A2^XE^9T://XG,_:<_=>7P\]?E,
MA%*<X N?<\LK>A/E(BYOVHO(0^>03;5V92\>:H0XPG[DJ,%YQY:H2P636C[.
M&95VA=W7"O,4?IY5SF-,=0E6K #)^NN7K%TM!,;L"@E /B$SJ6LU*247BP#^
MA"3-L*I,'/WA*<;B;*A6NG@*2CB4OD/:_#8S:*%!WB043K<9"#\D;#<.O BI
MLWK?7:KC07B7\<6O^GV(HS!TN?<=XBLCN/@'^*C;'JR$//UDN+R6V6 6@A!7
MU;KVK<8I]L6'V?73@PZW![]TW<Z:WJM3S#AC?TO.K:]\.XN>EH4M2E>[G5</
M!S)NUM/"*$<:%:4+\Y<M=*]J4;/59GJ>Z\Y>\/A,R0E$:7.F#0N$MT!\"ETT
MSEC?3^DM:1K .9[Q?FR\%A[K\_.XC[4NOZ:DHC9HV=^\AVQJ?W'H2UY!!:IP
M&#&/V6Q=1*Y?#%5K),,3UAI5Q*N&4%+S9[AE%^ZV*E]R[%8X4K]G4;Z()1O(
M7+)SI>YDUN02P"?0?WZ9[W44V'_$'M$"T/DR;SB4F&C_UH;8$ZN>BXCP9@?'
MW+"!!"S6JEQM\ K''D GCAUJD\_TC/<K&NMU>H[7QU<J73$://@6!WX#H>'I
M-VFXF3M::FC'DV//1WB7SQL'42L,/$8. W=>]02[,/B463H=^\6GW*"7]"5O
MRI89N8W/>\_7M3FF#>+^*2IT>C%<YK>@I].^U:0>XG:\.GU#]KE%[N498FY%
M)L]A=RPO[/J$ZYY4ZEA4?E#0U?:3CBF;EY*# <HI/U!/(30)GKBS&E&S;3D'
MJ@<O'*)*HET$ 'L>O+R(#G1);*%^5T&RBYV$0C,AR%P\+]:=&K(W7OMQD\0_
M'/H/38((#(>)L[HH_.4O\:<QS_0N==_TD]A)+5G:;J96Z->^GE78U)@4W@(-
M(/7,"J]=;\H<NI47<R->_3_L)?(T@1W N_>:#C'I"*9D>I-#(X+*8<$IT#_@
MZ3H.U?X('09M3@30>PPL=A'=# TV0/2I 3,4P4IMB;E>\6\E$O]/K_\<3+:5
M_)\S/5#O\.SL[8>4Y2R<8@-^=OQKDH?YR7-&D )@Z?_=-!XQL"$.J&0\H BP
MCJW0Y<=I</5AN978D(\%Z5)*7;K%\3X*$\WGWM_MT(/YXY<%VH%C>*+ :CS'
MU,<P<[:]HC&7.;P#;CCT++U_&?)UW';W&X]J!#%P@N?#H?<'4**R"POYJR28
MATP>#5)"7!#I,\U=1?;T%FY!3C9([ (1+[&5B/83*Z^C@%$LU72KTT,:9.;H
M3?CZ9!B)?H5QL9'#)FQ@G6!>S+50XWA9'K[  5VE>]&YW;?H3PGA5ZQO9Y?;
M<'&E =;:0Z=].(RKD%DD;>\Z3G1\8Q]A<K^_#WM0*ASX)A#<P9,P=8?&!A"]
M2(F"@5F6E'OY$6=M5M+?J_.8Q<-6H;C)^UQHI>^AYE="E!C?$FWNC=?4#(%@
M5VQ.Q+7+.+V=BY-&=8U[CHV;(FD(/7@S=TTMX]S=1],[\$HYX=&MC5/.\&9U
M\$QNCA(MD;+>)BCPAJ%='FC0+"+<E&4PL(44F5N]XI%@KBW&^_Z9<QA.*FGQ
MJ+X7!Q6>P,Y=#@8SP]$R3 FY30,<:E?:[BX;\)6TSDI5U<GGGK^3.D2Z,+[^
MK%Q5Z>.G.;D0]7O8K"0JCG'VT,S?*1&:&T5HMI9Q=2\Z0<6(8&D]W1K\_-YZ
MD%S/K*34Y?@#SO8_?G,OB.9 N]6N3</&@/R-4'^4N[4$B?O4T*\BC1B<]A!2
M"JD9:)D7?S O(?*0BJ_V?!.6=0Q'R3*GR*]N4\ $><Z# *,88?Y\[I@+B+CJ
M\--D^3G+OZ=O#XCAW^RG'HIX#QO"<JFX!!'6SP6NMPN*?"NNTT9ZKDKE^W0*
M13GLILY&73SLRUUAV5']+>UYWE3Z?-.N1V%U, 1^-^$V2L4?JGE:9_C?VNQV
M-M6R:3(SZS' FNG5-[.)T0B14)Y975MHB[6?.TN 8O!6%A2KG?3G4IMSFNG/
MB3 KO^^9C!K1HYB66&HK\YN*%UG&FE+,$,NY74^6RF-FTHV4_.M_=(N;DM0,
M;S:^_U5W8B*&MO4)_])&\\6<R<>.'I) WDM\_YZR2)1%=(F.F>*GYU-]'@6D
M"BIZZR7X$1O@(+-_EAA5Q@8L'L0J@[8,J%<Y^.8.(W@/RWH%VJR,P]+0;$#[
MWN4N-B"10\Z K+%$+'PFXMZ&+6UZ5LQ(<T-7(J+PT2/;7W\Q@$-U<I055O<T
MGSR05@M3XK#N^T(HECR$0\*; =LV\2>(,NTK*U8J965@+A4RYL^X\+.3Q5R7
M9\*;B8UIV!DTO/K//E^7P3)/C%EP+)2%BM-;R[&I9@V&? ,T?_5C]T4'<S7L
MT""D&>:,UT]_,LA\!9_YP ;PJMUD./>AL?R!$$MR1OC6B0+L(%K8>7)K^]G;
M]?$+*=#;"O2N8\(_*R"LX]UT35=L]30I'P7-$<GVD@U3.U:=!2V@9Z@+CR;!
M1Z^]Y<+<[<=4T*SHZH&1K./K]'.T%,)O)#&D&QP[)12_3OK%QXR8;OO#,Y-^
M_64'&S )J@(07BU#-X%/^Z09<N63;CM4#HVV_/7'X&3D*;Z2*ZF)A@_X+8%N
M%GPW/L1*MFKP5QK83"-9FA]XW&P$E+YG2;9.&MF(;3=-[6S9 +] :G$=35!J
MP'YM+"?4A47YLS;+2H(/E=XX'/XIU;$X+FR6<3FR/;"8P>\WTY%(T6VUN\C,
M;^0ZCCA)8YVS=;^^R0J''3U-"(]OXU?L>'SATGP#B@9",3YXK:ZS 7;:;$ !
ML7&3Q:U(OT\+L(V&T+@HXAY3AVAQA1X%R;:1!HVX(Y:(E)=*;$#@03UO^RLW
M @.)2TB'.?\IE=]LP,O%36_3.8-3ESSDRB]5-. ^3L_7:J(8? 8$ZD<Z*/04
MQ8(D,PLRLR]XM!?P6LI9_=3<;#S&/>+^9;[J2XXEAQV:N*ANM,A2ACE'JPQ9
M_2)BPVL%C4/HLKJ*-2=GJ;I1O_!D?:[[=W\ +"(Y$F,.=U,5ZIA2[(.=I_$3
M(-'P$_\(^G\(3\4%O3@ZZMQ%-C!*FD 'KZ]R?-EU)]KV-IP),"-*=IFFBQ>W
M*ZIW5WOE,2%9LNTFJ5_*;<W6];TK22(> LN,4<K"ZCK%2Y.,3F@BR%S0"I*(
M5+$]JQ%TK73M^X#+PWK0%_SEVYK+Q>O2&B%'&PC3@N[3 BI"Q/73C,<T\3Z:
M<<M8J]Z0 \6IZ%.9UP&/J/G?&V;U4\UO7UB^7>7RVPCC7S-ME=3-5 VHKU\-
M._+D1NHN<6=J>:5VCL,0PH[0=4+MR#7O"/%>+:PS*5J#:)[S[J 2&L*TW^-:
MI.Y4?)W4S==S1;?*YKJ_'<@2TOP#6AB[CG3M,YWMBO]B9)K?A=ZTA^1!R(]1
MN[?A8P]9C7P< MP)R4;O7=MW5QQ_+\ L *\T@[>>I"TL0-:F%=B I<>;=]=W
MM%C7]S\R2*K0+4<6=QIYW)1VA'Z6UCT;_294H(0V3M1@#KCF7*JIZB_$9K9Y
MB]@+/DOK/FAY<H;WYT_4;[]AK#Y\YB-$H-&6\I#%/3XK$PTYR3#PR668DK/'
ME\?<)>,Z@SS;M=\=#H_B/A+L;5VLY&OI[U&7MHY&#4\JQZKY[5763/3-8X:Q
M-B_&6%H].==JF56-5L0Z=%F/##6!]2?31)KV@F1W.&Z[Y>IE4PC5]  )HAN(
M^@$^ _9 T"0,8L5IG3,0/M?ILS#^=BI2R'9H*^C%"M)ZXF3U<R>S*>];;=Z!
M*B(&O^RD.,+UF35H=Y B/)6(Y+C]>RFEEC\=OE<W#)"(F>>%/UJ?T8 R'C%+
MV0!H/)SJAV@7$<,SGDZ?WL8K/<\(.'^>\M#WT@LVP%S(\<7I6]PSE_!R3Z6"
M?)5-XC.K]*;[W)#XA\DU GS26NX^5>9N#7M2<O7]N#^0KQ@$T0/.X@81LX#A
M J<$VN\-=0X?*2>WEGRXHQ!?>>R(_'.QJ-^K@KM<UC0L70?6DR,>;3R,7H\3
M$6BJS;JQU]3.\-'YL>7T837)(/<P,/@O@XO !L1.'VP4=:& 6F\%CK?L26W*
MWEH9<\N9NO@R*<U-],=X3D^K7]P,O@]8)<,X+T2-:*0EY='@AH.7:2GV9;8:
MSGOZN04/95/R;YU"YVJ\K^&>B^4QL@ZS*U0T+='3++#QF-::1SE7;WY##;D;
MI^FD#M[0U*L- V8V90[\'E9SH]22]"B'< A^.8C@9&"9-9HB7GW.SL[25C5+
MYS- 8.>9?>#OOHX0BS$XV3(QCG6+;!=+OET-/Q^8H>WQL/E][XOG:$52SZ\W
M5W:GH:=Z.O_^W;3;WS,NH$D29"*PZ)6'!&4A/4%5J%ZT$69 ZI5E^4+HVEC^
MFU-Q),#)B!!\&*=OZ9]U<1J<#H9R>X&6O&9H'F_Z*QPV'QEF9]5[_I 0]CYE
M('<#?6M(5$B\L+C;0;50<,@;;2\D*>GFM;8:"B*"S[G#;@_]'90+TZ2;8;-$
MG'K^KJOT.PZ-),/Y3-UU8Q7+VYQ=G[U]$O%XI\1V.?C6]B41K4(MNXU*<ZT^
MT+5G'$)^Z'\TQN+_@7@+T#AX!G$6)T!ZF!?TQN*%R0U/%N5A#$7I#SDC1D:%
MGP@5MC%(Z6P:F+<BP#5-,G&\>H.%-Z"EKH2>6RC^R+*HV*I/UO0^-*6C:].
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M^;YSL2$P<+I$Y^N8/Z/'NG=2P<0MZT#IY$<OZTR/T[7..CK+9Q>:%X&9>O#
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MK*]7<.JZ+P 6J:%6P]78/V\0_?I6>@GT3M#U=JG'7C< BICVIY]S_[]IX"8
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M41I^NF$0<_B6,GWWJ.6][4X 0^-I1EOE:?CWH:=9( OH7#]3CP4"0?MEM]V
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M]?_\RY_^MR?-_V;M Q>*34:-IZ-6]=TAM/W*S##%63OXBLL& YPY/K9U@L!
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M7": +?*7QK!-EUU:A&N+^.+B'VX"$_:O<O%<^O6&)[^E/;\MX/:]*:GCR]]
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M2;NV4"21Z?Z-A>%G][JT5DY)UUNGY9D[L %M_>@5](P9?LZ[!S38WVMFN$_
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MA0/&-L; PBP\M!S7F,%O0KZ%)F%I>GYVEA\KA;7..>V=K_64EJUE \IEY]@
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M=>KU<(&<#\R%Q8TOJ*R@7Y]/30"(SW=,/]CS5CZ1"6M@2:#:K^#!"RP4\_A
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M@M>NXY8O<<B=X+8A-!U%?A3/Z%6@Q[ !2Q$A)[CH3#":E=#M^XRC\IU,9MB
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MYQ>#;C3C^&%*10B?A[BCF\\'G&B2ZF%AHK=7+C9W3&'GFB0X1_Y8N$4Q=?8
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M+,NB\1<76\BWYXDP@MZ#?E>;\<G=]'5/.S5MVNQRTEGL %UCD--).(A[R)\
MEZ#QM!!2\X[B,6K[ER.">[U+?2IO*(]I='^X^/IQ^Y>;^Q/ZF$Y6<37I<6KK
MQ9$CK)SUBL2?A:*1X::2#5^+([NBZ+ZA%3OIU)SI/< +K YT 'B<87:S#J]1
M&A/N4?VD*.R.Q!M6VW$>?4@I%;SB2+,A2;\J61+7>KK5LRPE5. \_CQ)^?:;
M%R=A/_[V;; (G2^(W&8)M+;RM("H-LM2PL8;SF:N%EU()L>I7I!!XM:1\6TZ
MAU:;"K_"R&_-DQI1:[P\C1+>)9MC!AY)?'_1HJN<0H1O7/8[E]=17Y" 4K;\
M\C&C+'=RMR;L3H>[;,)NTP%4=T$8'$7?[*>JQ2/^&2<X!;6YBM<S?._F70]Z
M\7&CNJ%3L7]*OJ0R?4=2G%RZIC;Z)G4\D<-;0.9_OGU,5<^5BOG91*1T7M+'
MR9+ 5X<0WTIGN4@23X]H8'_> WB#CC$T17\;1H6B8&V(HEK#>CN#YJNH(K)Z
M,:7ZL1\GIW #_ (E&=9@,[ZP6(LP']Q!M\WKA5-%.H#']*3>+W-.]_NKY\JW
M_7H;7#>OB'MT=3@CJ$%ZY@B!H<$48UFSWV^.-%+]GV[U1O1:Z#'<>04,?LSL
M9PB"+6#0H>JU\67.D>=$<)Q3<(X>+S'Q#4S;\Y1OC//#"W*>TF7VTDS(,,(/
MN \^G*?,>!M"Q,4:'*49QV+%&$&^F:F^^5U\U6$7W^_O?71%V62K7/N!C>D)
M6,7KK,MSH2;!;H](F1"K\U?7.P)=^MZ.RD8);S]B<1B_F*JP:^S<N><P"%'*
MJ_6/SZ_=]@4.I:FV6 GY:*["X!1+AB;?R2\^Q@AJB3#OJ$5-';HP]O<=O:=&
M%EHGKDAO[?HS!5E2[(^-H1K^L2"I1@DT!'B<9>RA#HDJ;;0Q^>1RT, YWU_9
MX)%]+XYJDGID#]#"RR6=MP:#01=ZV<EA1;]W8@(Y=IM]Y)H2[1QZB('(>:6%
M5>2.;XEDD'>D8NULX+,FTII(4Y/FL+00=9 NPZB@)3!OUU+[GFQ1G,Q5B135
M)*N#-PN,%+N:XJVO'I 4'*C":G"ZP0(X+T-^EMP4_PA,)XM'H"OHQ,6*S:E/
MY5%58$-$,[>9^*=*X2@2)']>AIE# Q41 ]-"J!34( M HR->D_4FG\:W<]]5
M]$9DL03]R5,XYD.8-*.8FD.ZL3FE,*C"TM<L+70A "^1?EZ7$NH['?!JX6'F
M9:$C9@)7.K.,1FI-=BCK+&.]4-5<H81BT?6'8R.+!K7CLPRD/*<=68%+!/GT
MQ6>"1@U$AS"$8[^73ABB^B!G.U3<@]+3' 36GP5>=AMF!G"+\#E8.)5)1L;;
M$Y&MA!-NT+]:SF@TC=:9Q/;G?)+-;96\2T<?9\?!Y:&)S<!JRYA@MHS34/"X
MBHU3C?-7E?F+!=^G#HD>;[1OX!X*S"760 F&,7V&EIE:P"AU^3(0$W"Z^ADE
M[;0XZ(TOC^0O)RBZO,@FK58I-&RU%@]OCB].W-U]KJWJ9K>R-NE?SFY,%6 _
MXYR&.5-%.D\0#OG.-M%"9E]_][46G=UX;SLQ4Q:CUJV][.9*4W(8T=@#Q#O-
MSL<[&>']U#[[&D(E8I@_J0&=?*\Z"Z*LN)5990_P^NDBD'YH"+=YM=R#[LS.
MJ]X#C$5RCC@'$%T=X^BW\LX,J:G9<"(-3PWHRI,.*7F[G[$4L.I2"U6H'5XK
M)'ZHKKA=\*)D5FBU67.W:9.EKH?G5K$5,YH'>36=_H=["KJ-E$6Z&)](X8*"
MD'=%_JT:630DW9D1Q]0S.\+ M^C@XV+V (%F;Q"ADQ5-)BY,+XTU0FT8ZQ2B
M8TJ!T5P*=6[6:<)'PWB)NED#U;U:9J 'UE_2GA/\K4W?1=IS^6?SI3T 9!)!
MSZ*M$ [ %=W,R)9'H#\'G"-#AQ!1FL@KUVQ?]9VMRE02.8)P>&>O2H$$-X7B
MLDA>R@\T3V&KKG1FXB%N]YM"F^J=YV!7J3U$1+S!)<9(7RM6=&!5(QERV[UF
MY.4KK U^?\#^K7+R-^27^?:^%]R?9;.)YYL3O2 J_^<(_H7DW\HGT7=4;UH;
MOY=K:N7P4J@=_M% JETOL*7J9._[Y3#-A+:92E5*##.CF05QYAP)9T8PUGOH
M[VC&SU@R9:X,4 M'HA%ROWH0^)WI4GALP]0^T[T3][=BB8>2V8FB?M.?BO9A
M:[-UMA>'YU_<N;#HV&ZZRF;5<C &W@P\\QS,E)U[.M9? JKE1-T4S"W6:+OZ
M47XP(NT]4]#ET-O/+LM.,9J9H1NNKBY74LZ[7UN3D7ZRKTMC5YX; E_9'U@W
MF&Y0?Q*0RUWC=Y.FE'_Y5_.N/0):&037!)U%UG>^U&7?".=G"=#)+5A>=KU'
M+<V\ \DW)+P=6F_>/G6PWNV)+:_*MW,IEZ?2.N_$^)14N/3;#S[(F\J[6R7^
MY;FMD\+/;&Q6E;GW7&.?[@ 7_+T! T-RI=0H'!'&*\I]\Z59#VMC9D$S6ZG+
MX SL(DV$BRQ,/C%R;@P%ZQL)QCY;WR\!#,@[O"TF1%>C:$_[CXL0]P!MDT%.
MV*^TK>%W]M;F_E$%$]7TN;-MA9E%04^^DOV%-H 4&>95!I/^A&:;M <X@5[S
MQT0)#SD4CKU??Y#, [KR33<U,%SC,[^ 4ZFUWW'0I-_R!IOOPI7L+:?TU[+
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M5( /LD1HM2D@3_18D .&$2:Q)"U74=_P"_6D4L3: /]PN^0NJU7L0'!)*[G
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M.,0>X/-RR4['OULE_P!-^B!BP>E7@M2V=7#$K)F^\9+S'W%*(*G_3 :5U3T
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M2,]'1LG\6==(IZ^-S9(E-:1\J@M_2R.7^^GO >1[:5J<5FO$@I*;*W6#9-!
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MK:SWI?V@3\==9BJ58TDRNBC1'#8XXH[K,VVR,#]5N<$!I^A3KR[S6=_-/X=
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M\K6P\'E1TH4=+E;=_GG>X:B"C) ^CSJIO_AE@$6*\8A]$FQ-E24'UW@*.$)
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M;"/A!.TN!F"-=_FMG+YY6N[KDP.KN&,;.@O/,J).[&V04[:\ZC/7PG<SM-@
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MCOV<(=)\3!8I;-"5339(OAK#!DF:LD&\D<QTZ*]T-NBG_RT.PU';UZ*@I<K
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M2#7FVZ\''U\0Z;7TR)S2@1CTO^]!JKFK#YA6ABW?*TN9D_BKM6>M>Y@V.4&
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M9M!'*6S0DB%];[ Y+6#2L03)AR)<P!CW-(^.7]\#:]' \W:UWA;>V<H)9BV
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M.,UMG=]M"4NSZ6-+V \7Y6TO. S<60NDF,FTIH4*Z[SCYKUGLVL2YQ,1N%I
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M<2@XI0PC:7?\VLO3/I<_ID$,,OKD%3)<_L")!%J(!!$*!0*(Q'ILC0YCEC=
M]LK2=G2SPY.@S$S^0WL6]J1&YEW[<.T#N_HU_M[?]9DKDI-FEV&N3^ -D/K6
MP[JN?K:FD2EIXGJ[UXR>2H343RPVWC?I$/O30R$ !HZ,#-M]&!D?6'7%,%Q
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MV$R[ZSX8Q8B_,<__TXIH7,<?5NG5 OV4N+_$B22X. D<UZ;?T*C]<L6^MJB
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M4GX(7Y?H4=K7],U& [[(6'@,39TYXBRDSQ*X]C=\TH0$)$F32Z-A]-_@":^
M/97S/O1+W4,.TK2<_?UROL/C.?^OZGW^_UU[8^C LL6I ] /Q39#Y&1^&#T6
MCCX '4MG?:*Q8T63V#P _1-"8[!^!Z"IMBTJEI'&E(.KUXRI_',8E/2L]0IP
MMA+(TK.!NTS]%_W-]:/FGAZY@LD7RRA$' -\_R$YF6-93,GAQ=<_QYL1J##>
MF\L5#RU&2<7SBRVSZUC"%BK522">:D]V?C:]/;#5TSA-PCO<[['>5'GXWZDB
MES$C#\^=?CL 14DF+*^'L(SY/\9[NC+-'%"ED41J0MS\PXIA@89*7S_H_8A]
MU[;Z)/C>RZ /MM8T660[>EX<"*=D#I(X>P83[!M[P )V/QH%'&:53[__4?K4
M8_[^Y%&Z JDMC;7\9F2[#%V/9=RF0!"QQ7FC%P,AI1_[\7BH_HS<7_G$6Y<D
M2W=A[*[L)\[>WQ2)1*6CR/;:4 'DXUS!KD2:V"KD2##-HB^H%/9Q=N9<+R\V
ME--L8&E6/26-+TJ0]A16<9L%?B6@Y)F[8ZJ/,:WO@H/#'^NX<Y69)>^=*Z,K
M8X ^EKQ)]$A&,?.86FR; F(L)SM9<6B>+7]ZSN['M-NG4VPI&=FS@[6QLA1G
M([@;:\(7??!"4$(R0HCQADCI2?>J!,+6W^\L?\ZH<M_VRPM*B/$3YTMK-3YL
MZ&9X$8@Y )U+^(/<O'H *JYR:F1)D<I(?W( \DL'M#[AB3M=-W8GQAL;=1_'
MAFEH9Y@Y*<K0XJ 2N_XGD>T2FAM!S./=+C05=)I&PDZR9HHT;-+,U^')DO..
M0V/PY34;!#^P_ U*]O<XK(;\9L@+M"^8U7,PAS-[>#9TNW'3,M<>?$ZH>?B)
ME1@KPL[-T2"OG6OCZ2+R=_]GA_QDO!""?37,5@0KJ.%H2=?.__83#E15BU72
MHO2S>$%;;5A'* $_./D<^0@%*'G$$MKJ[?3O+#R6D1V;K%8X9GWL3._:-BZ]
M9,'Y)93[ .2.96.A'7LLH;4YKHI<:SE: E@PJB )(2WEOC\#,F0D;O(G*3P%
M<6::[Z!7'@T,JQ@.*\-<[?)CV0,*4LZ=$0.!KYR]?@>JB22L#B:T*9#5Z((G
M27BCG*7QO@?C&T]"[N<'EJXO+KO@K$/9S+;N0\FFAQ6(ZV,422:7"M'1RHZ<
M'0LWUD[62/2#&U<Z?NH+$)IZ2OBZ!#W/]KQ'=Q?]RW\ZC.I%3M\()QLY <B%
M*)T0-7X@^B@O9=FG!QEWW>_3:CA[,+HWU8+)YP#$$EI2+3JQ8*27I2LK0_/M
M))HW#RLUON^']?ZVREI]L9"2,1CAM]LTMQ7T TF8W#J)!Z#4.D8QAH-(6WN_
M%1^JZTMO2%X2/\48Z^MF__AO=HCP.(13LQO9WH3\4MJ!FG9@01Z@7:G+\I(Y
M1:28N*>JJN&K?/L*14]S1OF'$/EG8<K#!1WTQ!:@= "BG\02#_^N4;TI(L^)
M:G7>.0,U'N>;VQI#"S>TU^6?\%_^S^F',AG-Y))F6=C$&)*0#ZU#]Z0#)@BY
M-19XNT^8^8K6F+O1=]JN=>;4_2,O9YX&M9?75UKFU*Q#R$YJT8;'&7%(0@62
M?2<]6BO429BB6'Y>M/E-7,9V%8:TJI&*J:>57'?_OI74Q?* 7[#&;F=1E@5A
M$)+DS9:/?YP4XZUB;C4.8?1(>KOUPZKP;I5$Z8!ZQVUP]5!_U ;MZ&%G41$D
MRSZ\>*#)SN)M"D[P!Y2X5Y>;:^[+!=??S][L57K[<]WV\P#>>Q<**'/2!92^
M(<G_L97X9$N\68Y!R'H&[-G8;V3&><ESRNG8 L_THW6DR[?CE:&7D?Y@X+3_
MAC#-#N;:.4Y&#*! B)-K$KZSCSIMR5L)CQN:4+3/+DS;079>#_FD_@-0S&N,
M/&F+C_D=^24OAL)1Z"]F-UT?5SUDL53^YL2I4P>@A(VC*/M]92(G7=*68@:W
M(@^4LBA"'D4[44.-R\DTK'1JI0/FGM[W\#__C$G^9X]Y)WX=@,CV8$ ^KX45
MQVZ,M$G-_&F[/ )7/@ =U]@Z_\5;*]"QE2#+_ZF3,R4S8OCW+YU@_3#J"DN2
M#^!\@#]+8PJ48_E%<.BO)SN#?(",=,2$C<53-<OE5U*IRN:C6>XZ,A]L\'0)
M-Y+>A@>3*S' -R1$LTLW+'%+KL'VR=Z9:]*%OSP^V$Y!ZL'K\5&T*\AV?8PY
M^=:$??U("%]0AQ>Q:^ST\Z(X);M,J,9'V3=[02G+.7]9UB=O2Q?TMSF\H!S1
M9XL$AZ0+>3'/-W\=5QSM_IU;.&-2(7M;U$==1VPMI\+;NE[O\-8B>F'8@A4C
MJ1&USX'P8&FUB05>Z8)D*^;Q.<JK+I3 .R219V1'+^932?^&A@K_<%+K5.TS
M Y^="BH6$ ^@W63^E-$%D!YE1L6.L!8SU,VD;<^?&3-UR<]^?HR^\N]8FPXC
M%DMXD86MQ=,%&TF0;^ $PW-U%'?4PEII[E9=GVV=S\UJH;)0I<"7_!%W1G51
M)U=0)]LDF<,L4(E/?,+D94T)NI/J2FR>=G0P)<6$^ @-83RMIHT:((%1"RG_
MNKU9#Y08GAE5Q;I93:N99:YZ::S9C<,>NO_HVO Y\ZBP(7*?U.I!5*)+OJ=T
M$D5CZB'Q$58;CN@5Y^,AQU[WYD_>Q]PSDWH8I]< FO7[)HX.9DG/ -DNHCD(
M*$(ZMY*:98H74I6ZY4G<QS<>U]=DXM>OF/S1WG1MV3K:HWO7?-9<#_6>92Q/
MP.O9Y&QJ!J,4<=Z9?F58 WERK4UZKR[UTIVK"MY5REQ*QV&/+DOS7\KQIXOH
M$79?0%V@@(I:^\S6\U ;A/1$/4^R7JN1Q?"MR8UEGUBK'9]=>-=YLZVD7;5X
M"-D+EXJ0L*SVV8?BJ.3=-,762RL1<>FNFIC;73/)IA?P7[_*1A<%HP]WTT)9
MXFC<]UCOHUV?ICL ]91C?TFXM+JIMI''VUTK/D+X3N7PV-QWD4>>&IQ5V' )
M;+&C ZRO5:_-GP-8KL3)TQ@?XLP'A/7X%,W:3\(BKU!,/E*;+=?=+WR7SI8T
MTO'3/5G(^GWJ!NM+]Q##D/HG3J*1:E-;!.T.R FOL*0G(59\0)Q%9'+',1MI
M="<A)84WQ?9/*5T8R3SN0? 'SI;4E@!?#-QIWPY  G6>+[3VYS(W!3_J6+^)
MR"TM/'(<_0%Q&%L:44(:@REM(A31;O!T4+?,F1&X=*3T4JY7R3O"&WCMR^+%
MT)ZG;+(>XH>]0C\@";^E(=TRTN3E]9A28*P0*>*U'SCC7265]ZBU0__<<ACE
M<<KR5TU:)SF=:6X5!UT79&&Z@KMM<JQ%]+'2<L@6< Z2TB:V&J&=IH'EQA%$
M0]^IK1<U1_8/I+;;B$'5X#OH%GW)?.U8^JFBE72YG_LA'[0J5R](%7!\EP$^
M.;QNU&!ASH+H_X51L1I00C1D.^  5!_/2 EUWK>NL%V)^M\<0J^F0VFM_F9,
M#V,UHM7O/53QOSO&3Z6(_Z>"6<X7S!&6>=U*C\/63Z1K8 5AS9 3JK6%,YJY
M]3WO*OH?]4I*?69,27OA:U%TP72B[3J6M$SAC/OG,U,5];*G.0N-5,T/X<[+
ME[E[(V;#:<48]'3?=OTO,1>RL%E#.2?IDP[<J-]0E#ZY:9.;(]J0V%>0P/RC
MEZY4CCZ+84GG+EV\&4@.(QG_VM&['\*#;IA;H>X7#7DUWO.;O;\QNOXD+USX
M7X@0VS*+S2/=U3B9 X:@48P:,<I@XY^EP^WFT4V5TM<_JU3:?W[T^Q/_T>F9
M;0:>I5XY0^XY6.;R[<;A^@U5R5[,7MT:GS=IQBJC]M5;X>B'>9/HTC,?P883
MK"&/ S$DCQCX?8/<CE4F6WWFH(GZ[,5N]EOY-U[_F04=B[!Q;Z1)PB#W&065
MAN=,/:)*@($><*WF7.S"3/$B<BY7]/=+9*M3N3%(^/?TUGH0 7H2,:+KT=W7
MKWH?[ELT]5XY$F6 R9<YSH[;M>#]H+[HWFJ2!-K&)SK78)^UJ< CR*5=53X6
M.0O="-Z[S;X=MWHE%I>7KW:^C/ H#H&(&W+#G*G/R-+X.+ACX?2:O0%ACY ;
M5)>64OKI\[IQR'^W.0>@?(<]QB&<" D ;35^:GBGRCWJ=%?6A35=S'YLZ_NC
M+^_JB)7)-TK9?H(_9N1BU"FDY<Z+0-+TDCLYK22G[?WBP*^$S1,N%FR[<6"C
M[C#6D'R496HH&;<A3^R'WJ!8MHYUYV67&97/)*A*B-PG/?QN[E0H7QJ1O3#X
MS8J?.0SE+R8W)CUL:AI:RI/,,E/R?("Y)6WHMKS%AHL88W$!T\/VQ/K@,ECV
M8;UG:K[7_ZSWC-LF.M^K$]SC'OFEN085^F-CGX?2G;/SOG!ZK*XW]TO/JKB=
MQP=A6:8&6S<]@/%67Y!F M>+[V"J#16,!;?XEN"#A'.F7C_4]S-T<UE5CCG$
M/.S3@"M9$J>%D!OVI1N7>3=[R@U8.MLW81UN4K;/IUS+V?UQYFA\/#6,_!,"
M60+>-NPZD]_,>B47Z>,]_<_,5/@=[5OYL+MV&WZ5D0-7IN@M<+[ A%0X.)J3
MP.Q[J*E T\!>*83'_&Q,W,I\R_X9$%KXL(,( 87EQ7IAA1U\F'+#_BKPJ][1
MFF,:[U<T:#U7A^S-OI_GS$=[5T(2G06#(3'S/&T4T<1ZY2B(\8AM5/_LM_78
MH)0/1Y W0(L(,.)['@<@3YZX1\Y[5=P74KAVL[],L?CI[A>G+#%#U^_F?@8^
M/ZJ0A'04^Y,=?QV-U$@:=("5E+_PUP<PLC\L0SSF:OT;U)UO>NZW-B9H)#O0
M=+)( U2A/"[;S>\I1Y7!9;)C.2 2XBQST$D8P)+=M[Y)-*!^ T[;<[[VP_W]
M;=\GQ*R5=P.>#U?!6@@E,0O(Z%TGMM%33:\ZLW,\AQ\G*BJ?:CQ^@F_AP\;1
MO/KQ.U>D\G+)]ZX.M_'B"&(N33)2R9;,'W8I7;V+3Z92&4%I#)_?*. LKIT!
M)H31!16AQ_Z<L)")R5^5<"NNO/?#W04R_9KX[JM?:554;#E0:S&D::$GV6]A
M5=LZ:E=<C)G@DFJ\J?OB;B!NTKUDO&Y&^MZM3 .3^7'2$!*V%IA$2<4LQBVD
M?=VX E%?09'-L=%,I2AMNY8A3?<DZR3*O^*Q4D>5XG-<BC-AV;W+8MV1'CW^
M4[@.I#13"!U=OR8.)4J;RV:H5)W68MZ/C3$10E\Y+F5[GX@]Z95W;CCSKQFV
M9K32[K5YY;)Y@<+3*VX* 2LVU=6DFH9,K\4T,5?)W+GH3^"[5D>>7:2;$RRA
MW0CV%O+<8J!A=I3[$S?CP,I'RG7/YJ[B(K998 ?Q#<L/=R&#.[%\FY4[GG1M
MX@.D>Q3J;I9DQ:-+W]^9/=F.G(@JH8>036HK55$>"VK<<ZLGM;H;XFVBS=^U
M'N$<B*IQM ;!<.M[M*-P;48.QE8+2V1HWVZAL ^%0Z8CZNG-L;,!>65?S,RM
M#:/+#UM"1P?!51D%\%#].U5>.7DHDMQSA=$Z7Q-'71+1]*J\R=4GD1/-=Z[(
M1-(,F'WS8,9;N%I8$7#WQY)8"!?[1.#<G,'H[JUC;&&!%D^MEIU<2/[ :7 [
M2I!^A66\5$-TJ>6GFQZM7T9VO#:>J$E]>*5P_)J6E9,.NLBSX%LXBC5->0!"
M=1J#WPDAS&DYJF,<0X3G\\5S\U0HI5EY]GDG.-:5JX!B\H0%@".OW2<W?)4:
M\9+8J9B:*[HK-E?H$GV4_^JN,-88!(]U93FU*:!4/&WJ[ZO=91$),QE-4Q-U
M*I#]!S+DB&(C:U.?DB?6&2P6<V)..$2YGQ>3TOMIOA=Y/L]CGG?[Y V:;:2Q
M" _D(AA0@'ZCD+)&L43(:'?%;%39"F2Z]@#D%OYN -'?TK<V(\S"UE+(Q_Y'
MF+_V.>."L2=7K%3B7_@7C 8W^9;ZA#1FJ;\@!KPYFB*C/%SRSI?H)=U0]+ 6
M<D5W0H_<0MJ-8VK" BT=.IKK&^I+.D-47@V"?"LT/'Q*?[+]R#MS=!#I!9F$
M?H/6FR;4;3AW#:W]\LYY8')<-;C*WH?KB&!N48^)Z7@]U@,RN< B;>OE7K V
M_B%$7UC92[^M37>?]S.5P?A+F?U[$V4LI[/JMIHZ '4B)?2O$EN-NFX[.J&X
MYU.O]<P,NC5<>AX;+O_G=Z1'L?;"X/H&T7G:HD/@3]NYSY$5D>%92]-V;IY^
M*J>=,HWEZ-\[1VU*NY')\^* )*$E70#68E?[*]C"UNPWYJN"2<JR=QJ;C@*I
M42/7!N\XO(&N7+)(MOB>!7,S>I,A=J32($'V%V?>X84 7\)BD.Z%Y9;$%H<5
M3;Z'Y:VC(9*-F-:O/+O6Q8%V9>NZML4RG@7/#$,.M\38:X&KE'NXL'D%E,6X
MAN.]_TZCWU\?*QG)W$F_)]=SY5&4902^'?I<1IB5IP3 \7!(X<R?_<<W'Q2Y
MJEW*JUX/=S<L:=X_<_0Y($K3 &RIP4B!QMB-ZJK!I/JSFKY&@TU>C;.&%L*#
M<U+_I&Q]/ZV\7+-W[,_MV,O:#="X6!WPU>Z$Z:)WMQ#;7_YXUESB )5"GQ.S
MYB5 \MWZA@\/C$M6)7[W#^2EZ$":W&>>KSAU4_!4;[+_ACRYP>H84&ONT,_5
M($9*_:GFU[LKH>5T)UM*8+B%E5*^8Z T,-UP".K1-QBG+2*ZO_QB:ZXH1]II
MWV+EW7NIO<R3G6)BN!M_WUL!\MCVX_!+X46#13[3J?6CB+N:F_4&75GF'S:>
MOT6=#]V+#'"^,V0<C>.C"%+]R?[=Z3$9 +C+7E^W,8[4D#:N%SZPE.IZNZR]
M.0X$?AN40TEV/KSMI-T,HU+N)6KOD1!BX6@R5:7M+3'7/9J5T7B'1P^BMEJ_
MPR'$D9Z#?>(\G4P<7(\AJ]./!EQNFZBN$RSUE)$4, \(*?^88B21<C1C1"'G
M<,.IGI&]R'B#? P!_YD8]_) >[^OM[P#6M(I7E1"_V@2V^B/',\G6JK9C.9C
MFD>":15]?J?R'(+#67 W).$[7?G:<PX$DJ[-R,)(TFXSYP] ==;IR>?]%'VA
MMT>6ZEKJOD8ZM)A<>/CV]S7Q(#QG#@/TJ:%9)3=UIWM4)/3S[-P)]S=RUIE/
M@F>_N6$ECH6GKT_0A. &C->0V^\[=*T[O'5K(#ZC_M5YVU0"__/BEUGR,YK?
MZ<:LJ.<(EP7>471IW8TYAN6NG[P'%$8%+<<4:QM'Q<)R-$XY&_P=;XLK>*:/
M(PRNQQ*<GXDXG6L@-[S7RO59.'N].44NU'-;?OM9"A(T,VFS^RW]N9,,XX.A
MQ!3,JH/\P.%/<Z2>D=3?N@&>&O<^;:5,G\^LD4P7('3!!>+AS7LI(@C]L<H0
M'ZC@]#EYQY6<#PTF*[<WK5^;F+YE6_=I&$9ZH'G_H" A5HFAU%T+4I6'>;SQ
MU[>SZHE5!8%_V*/8>M=&)P*,03!P#Q)01'8@TR G/"@V^<6KS2:M,/60L +O
M("]T^,QNWAU)8"%G;@SK8A5O/_A-4BTN<Z6QC^C \T?S#,EBBKU?_R+7G>F;
MF_YOCP2-M\8E@0 4%0 ""NB'M#T:?HR\E7#^U&A=E(75F$O>_)TW(9/8#.F$
M1=L*^BG6 X_AIP%URLF);GM$=H6W_0#J "1S=TVB:#IZ\@ T<?KER[=4=-C7
MH2=;(<?]EFKK<U9'!7@'3]9E>%2/R\L;CGD_MZ-L3=^C"@%!-)LU7;]R4NM%
M2DBJ] U[;_N0]2S;C+.K;8\?:^&]RUE,B6N'C",@NPP@W4[2+.04TB\R['.F
M^G%KIDVN.^[M\*;"]V5(^%?TDX+G'Z Q6 \D+R"X()H(#RF=F3,E042,A>Q3
MT$_[I9(A<]/QL?1S?*943W))!>T:*Y0+*38T&ZJ.!.^.R+Y]\/G%M0,03&Q?
M<,N1(<1&0DDC":QEL5"SIW.2+C)5LT_:9J*K&>[#C?>*2&FX:"7QX=,-5_F(
MF,EQSJXMX#2^ YLLHX^EB!1#DJJV=ARQOA;2B*5Q'LP9YSS-AZ6GKAC6_[,^
M=##6@(.3H6K"<"&R;2?DB%>S4SSAO4'$]%_[9] LRTJK)>E"\3"/HSIKSF;V
M]CA7+ZD+!3BA,P+")D>>70"5G_G(#R&)KF\148D'($']LZ0-^_E52Y_V0'/5
M;(4P/@F3@0LSKY_.1HQ/= W&Z8)[U-CQL+"N:;=J=,'JG;TPD=KJQ9?(A)VJ
MU3-'EY <R/;33'Y M$LK(K8>E5A=.+(D.&,W[S-Q:?+;MT7?V/=^QRX+KT&E
ML>[IW,RA&E@$5,C!\8%:[(["6"6[*!]_[TBL2N,6V+4[[-\A'7C/PLR#N'*,
MME)"U6:I/]>J5X77O&6G\1?B,:$&0S)5W\9T0YXF#7!2T</K&W2WPOK%:1__
M6DSCNRJT"M?:[Q\O+BY/'F8OF4LLR-&.!"/=TX4LJV$(O'W+N.*+=FJ_@W4.
MT_/7CO5%P;JH<]!I>287BY0.4C]0C!M:22J*VS-=(N6_2\J+G7I+YR_R)PV;
M7'UHP!=I+<2VA.4X #U&L],Y@?!RF+/1R*;[\$X!RQ\W=JW"59:(,:VSF;,2
MBTP^9+L.4YS.7DLY71JW$3(3!>T6R;2;NV]18:E9IVX6V,?[)!1W &)#A[+<
M^OU_C"0,9R6BOSFL([QR:Z:]V?D-%<:QD)C]X]7/F[V[Z:Q<[+.P]6(?VH6-
MS4F/";$K>64T=OX6*D#BQEV3%]7#+ B#BUAA44PV1CY<C8RDPAB9E73YA2HM
MKS;)Z:((NS0[)_(,FEQ[H8\W!#]JVX&4H1O0M%:=N4/4CM'Y7CD N0N#8@ZL
ME:UD2/:UWI 64)35P+9*NG!_I=<X5]IG9?M43M>)9E%W;VO/IWEV)2$^4OX+
MMF+S=!)ONN35K/JJ],><T_3 Y;?,<QS*W#UJZS3R2IL G9^,BGOL.^(98=WZ
MH>K#[^$+DCO]M@">I@]X4.,^#VU@+/U# D1BRKH_V1_WDSA9VQ-8M%!&U;<-
M,%;_@.].?X&0 8CD ]!M,C9)8R;*P6AT87M3I02BS(^;3/M(17,,L^C02SQ'
M,)Y_WBO0*X*:[QL<K4 +K37HO/_1=\;EO%7695S?3-)^1!*(R%1B#LCP ?WD
M<GU14I0(WNZ77.RI-'&F>_)#MOL.92[I&!VT'B#^?] ZFB%L=:3+7L%0KF6T
M;N=QK6Y)?4"4]$<_<%:F.H_3GC$H'/L<Z@9FIQN,8-P\/$IZ#5#I?HN8\8<M
M[TK3?L^Z-/DW%X5*V;X!(IE< F2K3I/-R\&^WCZ2KS-.]BS8YOGH&2RP=PI*
MUV1,/N^.TF$-9Y4$=04?@752HX8-Q?#W\=HO_NGXNM?%^DN[V32^-!=YO/KT
MFX>!SYC\52'OBB$3#MTDT%_(M"WU*AFRX5%P?PHV8N[3,U+T]\GFQI)/9(O)
M3MI_G6H$G\%@+' :TMYZD>^2[JV:L/"B577OI_BYU5HKV#!N]^B-KEI9YM:-
M_6LL^= M#M72C97$7*)P;\^O8"R)DGK)?+K636YIETN_O;P8_.CI!:L;O8P2
MEI5 CC G(A332X$%R_>W&W]MV3!'>G/S'[^,>+-8OED:XY1K#/I/E^_=KP-0
MK?VTR.=MQ."B\$]W?=^9])L!SEI.+ AQRI![L-K1<<:K38X%]TY?LBR9]&G4
MFH[,#$0^K13E'&[+8_G%#,EY_3T!E83G_0<][IT3W/<1"%V:7^V9GR;F;^<=
MX86GF;$'@NWG@$&6C ] $(34'&#;E;4K*F&PA%=WR<U_*:QSM[KHQ-5-Y4K6
M<)P$/%W0E&C;KB8U!61V6HW71WE8'H#2)5/];=[?T3(=5[OPLG36ME"-%17?
M /L'H)/,P9 #$-=_+#IZD\79E=>)C6R__PU$[E23DD 4M20(V0H=AQ=!:,S0
MKV!KQBKA=_C;3P^\+[=P;W3A_^]FV9678&K%$AHX8]J%XD:V7]$/(>"?,SG<
M*";%;J3+F_I&X;P7PR/8+T#FCP5^]'\BC'MJB7AN@WA'=%2[CLDA#5J.K&^J
MWEIQBYN3#[>J.'$1*6$C' \$7:TGH^/7@V<N9TD:&+(WQFG^2?@D!/YN;94@
M QIBGH5=ND-F8EV/%1>N_JIO':OK^WK::%1BLN#M8/8_+*# V:YRR6A,8Z3(
M)SM+XDUEUB.>5O?PA2]I5JV+RB?E#&,C;#_"G1EQ]*.4%B(VCJY6Y; FL#(O
M&'=9H_=\_5E?/]^Q$W+,G>.NV\\GJB(YA-@6H;7H=6WR%M5Y;$O3BG<E.W/-
MMO>WU2?OL$QGIV9D4/_+K)EUY8FR_P\-&\?(5O04*I8,9;!5G/N_OBB_.WEW
M\D=!TMF4_VWGPD4\H&I*+Y@AQ3,ZL/^VW)SO_S]N:6Q^BMPZP5(QO=\3>=*P
M;'?P_]Y"KXO9C]SV0X .0#7^MPY PW9K#97GX#<3_3J2SI0KG$&S,;"'EWA#
MP5!"#A,T#+>BR($%I27O8[34K8I6\$\$+.H^GX3WU9VX;- ?D=VQE3HO!722
M7<THS'AX+>!J/V)KW=CLTGA":-:"_^E_1XZO7_W(_R5ISX)Z6!C:#Q=@5*ZW
MR7G+2(S6KUER$H-]55LK5R/"IOX!UG;5=Z_TM^A9\!^SS:%4A3'Y4QF9P5;B
M2%=THOX=>-M#JPT>1^&\0<;&[W8<_5CV1>&A_=/& <YL6$\T!W/$F7L=[D-
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MMNA5F1_(&MO(#3@>]DC*^S=.Q+C-QN"FW[Y)>3!3OJT,A0/MU8%!Y!%R@&U
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MLS@#1.>IT^.]QP+!'R?S2N ?'2V#PP,#O.#[LE_X%(CA#ROT*()V1J6CD=H
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M\.UA]/'%:+19S*/:19,PTBAR7OYQ(*K2/Q*6;*[*TU5$(W'8L?,]7_Q?ZL>
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M4[(+N)C"&#,L,X'STH T9<N\TT87:4J17X1>I+R$#O@^2#&Z6%KM"%IH!?=
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M6/?LG;^B$5K.-Q$J:XCED !-+'O?8CVR^?90#9$=J#WB@9[*",HX?_+1GLK
MDS1]K=6X#L$Q0E,O8H4H"V^#+7J?P5@?DGAHIGGH?B:NUG1Z>-.56(U[HF<<
MQ%,+/G'65*",6RW*VB6T8W?=L[X:'>#'L4^<*_A6VL?NN?]YD^W+^YK?7\VC
M/V-:(@+>X_\\8^<'9%"5,TY@5@R#<ZY]=D)[IV#,V[FQ7"6':J7 55D.4RBA
MO2DP+(YS>0>%$$D\0:Y$7B&#._5CD8'P 08=OGFA2Y;AIXZYAY/ K-O<&7N=
MB :6SY"/WP5WSV7^IHG546(9=PD,P5A+ !PA'RJBCV&I-*3TPI_3-J$M@0',
MI-1</\I:GDD,&5/".%JS^^!M7,UIP5%I&Z_DH6<W]HV C1!/YV%B?K2BFDM"
M#8,DL*V0'J4S3)10JQ" LU'QS&[<N=P9L4P,J]EXY@/F\L.<^0=?7BU-4&VI
MS#X);#"*-<^U$[C@#GX3;\4ZV/'PI,NYQJV-E/P;>D>]S5Z-K)A/,N)2P7T.
M8AE=@8U03W2O>OZ!IPH0$PT%.?;.>3Q]5R;5UYW=6=72_FRO ^K8X]'28S?Z
MD6X(#:'3%[P)J(_BZ<=8!!AC#O?F*0]YNGW0B?>V7;O]]^U2*3Y+5-9@)9#!
M=^9L!=/8(69^RYJ7\BLZQAN_%_^5;-#TG>2%SD0#OHQ6LB*VEN\)QK*RCX4G
M)*K2[C08%_Q^>.'2KU,)SR=K#NQ3X3" D%!N9 2OD%,(Y?JK$IC,\:73[B-V
MH6\.RXQ.C'XZ=%A12I";XO#VS<2W\6"_X#D&J*<J5(7HN@0FW$CGG%N*O,58
M/X9%G:^ML*QY/B>!<>&!LGB?4^-Z:S67V!0A>;R6_U3T!.<($5I94:-8'DL[
MGCGGI%9\?=$J_\KM#CT5S):NW'8VM6 ^BKJQBII(E;-!LKE*K%U59,7SK1&!
MVY[=*\TK7U1K6MIHM[26,NEH]V\\"_,W+OEW%=<)JE!S$,JHL ;1(\*5:( 4
MBU'O:D4K?0^TMO(*K' ?6B&8U'X*WQ4QL_"<FDT&;:):4R^*ATAR57NX_'"3
M50GCQP'M ,%+_9^1!,.GUX_7("TEL,O$@<HV.'!280AI!X:S-A_/&'J9-3<W
MHJSR$";\9;4@]<M"!!,B*T3Q!"8#%;O[_(QZ34(1[LCY@XW96YU$_G,7@Z/5
M-I3>66EO!)#Y4%6Y1P0S^)J@ <=6@S7ZT@WY4'B]'1/,QLW55U2<#%X'']G9
MHC2*+>T0R_1"$9L/MD(KPH#Y(:\N=(1@<HL%U405__SOB>>?/7KY2R?G/6^L
MDIC\#$?L0?UIOOR.7]EM$1-+HZX5.KZ^L/VR;UW/\\AG=V:'@G[WY^(@-A.5
M0[U*'5[S4V$M#@5$+$5O[5M;HW\^QO@P2O?M[P&%1^'L\A &:#;#'%VBR6DA
MZ'1/TW+>$9A&XMG?-QUNAA-W)+Y!/.OO1%9-"M4D,$Z7%!81Z,3*($*I;S-Z
M^!YC,/,^W"O]$K)NR\<Y_K:B,:,Q:P5PEXE08YA%E<>9-8(<@<UPVY!F4 3U
MW)>=PYU1'[8'O:UNPY^T,MQ'WT8UI3(SD35)=8+5X@%/9=Y$6K"Y2TUM'.;-
M<$RSQ]#^U<F;(ZSXK?B?T%(;J+)4OZXHTOJ&,\ [SN3]$ WTBD'W)PN.U5:<
MM"_*-4XAL)2O:59J4^@8 N!*';S#X!^ K!\M/ KXW,>?2,.\MIC(R;VT4QG/
M.\!7VQ)AX/0V?Q3>/Q_9<-F')]>4>:*QX&.EWW+K2]?TGU(T^K:8,[_5>\G)
M!.9]"4RYE&($J6!$49QVK3#/.#F%]@KU2AD[4Z$@O+4"[>%24/A9 JMA/"#X
M(A_4)Z4!)$[T9-35.IZ-27"AW]!P\=4#A:N3AU=HZ"?9!S"I0Y7B]=ZB9PT^
MS-$S+8B5O((\IEZ2=%W<]QZOAF[[%4C3X&9"?< PE5E*  [82HEE@WE*#+K+
MF'5?@SY'SLBN,@$KL(NS:T>GOM',>6,?P#*3P-:\Q'^I/':K#F'KQ\TK'WC?
MCCU;* K^9=I=[;2@YQG["-*^!EZED$3Y@X].JK).9+'ELH.;ZLL;*RFU\2XI
MGU';;W<\H=M]]]W^RH+#V""6 7WYB9#]P "\#"^A'1Z#L^/4!5JL<2)6EL4]
MF500(MU$?P83'"4TR>%60Y%;%] 986$@1'.XQ^#;(CS9INKN]G=>&@BW+.FG
MHC7P4' #_L1$Y#7T4$(;6M&<D3"D%T_1Z_7IN10KV.ME7!;\R+(HR>'5Z_';
M^FD#_%1H29WB5L+"AA[H@\42V&S1%",>@G.J FB3-AG:8)APV)AN?XS0F+6_
MPQV]\#5DFX']=;-[-V^BW(1T">R! V(GX2O-#:J[Q@P)3(M< _V5@P3L"9OP
M;=3R_M:N&+>EE@"""@-W-.YY#77WL4TT4W-<4;E^>M>J6V^(>:<6D*N13$B/
M]7]>DAF'W&SC'"@PGU&MMXR[U"WL/.$4P+K6%3@!6W%%'G\]R)7*S%U"5Y74
MTKD:K PNDD-2;L;]\%;RMW0.]<5LO*]@NY*YSS-XY H5@V3&4X%#R V$)B/\
M7K"H-9-*-">IV+&-=_I-80*N\+DR2M(C3J9=QUU+"4U>D-;$96FARAG6WJRK
M]='DF :_W$ZJ<U\.HU-.3< [NF+UX\69IO]B-=]9-(!D882*2V*9C+ 2+.%\
MU/DOQ;<*>2K\MT<EL+B6$NWQRT26S6I/AIOX-F(C_AM<!6$@9BQG<%?G"FU[
M\+HSM]V&I]OZ9Y7'W-_/HE+@':L2BQXJ^(MR>PC,& D,;D$"];>)/X>2-&UL
M@UA@M4Y=_&)5NW"\^B*I@D1ZS+AG6V$TK0!NIPJ5V%!&"Q#L&\4><S[=W>*Y
MI7=^:.ET#ZMV=['P\@8#'99]^%+A5?K5+AH<-+3D]@L@!9N.(3;Z96):X(-B
MP8&HYJ7U!/DBOSQ/NFY]X%::6>E*KU32,=%&**FAJ#<@Z'614+FW!""X-?RR
MZ(K]&;9\\P/#)GV/=I2(SA&O1A=[Z@&M&0D-5H1\]$'-/K>T=\,HC1VT%Z]=
MX,GD#H4!5_%Z)J]P5E& ([<29' GOT(00RU@.'+7@R%<@D[-GG*$8^# 2.Y#
MS9"--ZOF$"[97;W+.YX7Y_X'?#OZM_PO"#6' =H06=G<6NYAH+ -Z?MHJC]'
M)5"SLW9<B19J,QP\[8+C#/0OZ'K:":Z*:21Y)(9PG\MDQ+FISZB??^0L]>))
MJ;&.)B;IX,><D=,I]>5[7!U^UOWYM@7*<E>Q"6)97X'S /;J1ZM9H5%!_2@V
MZJPLM%NB/DIU?\+?Q5N(?/!=\,I^J%KX4._?0=[#J;X<^K$LG["2MFYWKL=W
M>0\BS]0FY4[F[WF^[C>J+W+ A,WMG^T%IK\VF+%_%*=>2-'X,-S9=ZKR5S'W
MTZ?<F_M=^\^^T%CE=>DYY:R( J4!TIBUZ TN@D56QDIQ0A]2E*;OJ&N$/UB@
M,P+#U+9\S^-@Z6[+^BS+J$43&&[?UX5 +S2%9U]8.+S3TKJ$_:8+QRE^J/J0
MY/\\*9Z:A@:M$EKY>&-H;15@[\Y!S:G;-35F*E8B=@%*?-]H^8BH00(+1,N(
MF]"5MZD<"4P%?7BE'W]V9Z 3<:_X>]1X2\)(ZL-E63&:X(6^F_-G.%';GU<,
MI#N]NOH,F^H6B&E1/>CDX'--9^0]:>G @?T]$-&?)=@3@,,FT;7(M51F.F'M
MPKL/0_M?WR+5'"W>[9 Y"]U%:QNENI@AC77I>C^FW'W+PUJEMNQ;H%=5;:*#
MC/J.<_"[*ZO>="!M);!K&"AKT /@X Z3>,1JH39XABF!J8UB?8]&N69RSO;J
M5@5KQDH7:FJ>S21Q:0(,=DWGHFTX'PWDE.0/)?YJRL/&O6PPM)YU93YS-?MS
M<.3C!PC10&7F4*4$]O4Y]=B%9H.K6\_9.]J^<;21XT/;]MX#K*585HJI=?@D
M(%2/B64K*(Q$)'@ XH(<#W[RONFD1OK%W3/HW6"66+908"<\)*I"&.*,0"00
MVH3860MZA6JJJMY))UN\3#%Z7K9/,Y1['EGFDN?%@8,FL5R58JP6*ZL)N':[
M)K.!_VRHX[6TQPCQ\5LI4EZ)":C;+RQ \B$#ET5GB../64CE]A,P$MCP?I9\
MMEXU!SX8>JCWEL9N[W?H=3-<V]F@I MI\*C( 6^(V9=!!*F=21KF,+_C=P,7
ME]8^^A@8HF7-M7G7N6L<O["G\*KT+_*E=V_CO_4Y^F(Y,1;&V^N:WR2]3!VB
M&A"83]"*QC@#P6GQ"'R#C7J>6&MJJ3/8&U!8N#"_+3KA">\GZ<G>H)GCOCWH
M6E6A"IU&K9ALR4+'4-8#GZMY:/;$RT@6T/= 2N.<K3;[1#*Y?X&\"S,LQU^N
MJ1$/I?*O@^%Z*=)/;@T(#^OST\?>!66_HVI>S842/!8O-X2-XM_L0]@&?*@O
M;%%(6&[L>Q'Z^H1EY_JWR>G[%(F&+Z0CN>CGCVM[W*=QV0)I*/@NV!@)+F.[
M3@+:C;DS\'7BG=>*ZB6PYOJAV>S'(5ATY#8!L0_BX1P&G2$C_D227<2H8X?/
M5W\1VKXXXO.V[FGYPCEX"SU7*B6 20;WF;&\D3(V!H $QB<"]7IIG*X8BDY%
MW/PE#9W&RLR3Q'7W(\8G\TI#Q;)JKPDT J')CG"5=*\^ZZB-3$0!7#/@]OX/
MS@>>&]$UDF;ZXW>I_@BIAZIX*)\H*GU83YK]+; V[H^24_0E@Q]%5>"BRBRO
MC;JW>TZAK\J8RBQB:$'<&*/L=UL"JT+/_@[. X//U#FAP*/"K;>&\O-?U,E2
MKMP$VZ=-T;ENVK&^K&SM?E0W]W)E>67BY7MK3^H$;7NX&O873(7$DVI%P('0
MF*L]-J<B7D[5V^Q\?F%136G_K2OXBQF_@W-R%MK^@M=(<W5-9L<%<+"#C<_P
MDG^M'[/@:!$>X)[]M:1MXVZ7'S2KY?X,0I,^E?G:$Z+B]W)Q4FA%/][P#['A
MM^'VOH6#>A,5J96[PDS+?@0XB66GPN5?0(GS'=@>%*@3[-[)<LJ(/SJPISYM
MU0:'58KH9PB8*,/&0[!5W Z'ZF( ,9)_T['XFEBKEDC':]6L<F!KV2A3/***
MXQLFR6IY<6.37(>XQ:M?;"Q>H0V+$WT"=5@H>\/\\F77+C3@1!C.. .I=!??
M94U,M A4HA^LJ^B?OQ6$\=O><+ULW\G?7L^>]:,!2WX10.*2!-MJB4*-"*V)
MM.(IY7=ZA# _D\?#[$>W?6P4T9#-FU;@+DM@L@*Q3!1/RJ.-\P+,\FR0ZFD+
M51AW.+5HV\&?@FY5!4'CX[Q%(JU+#@QV _-Y 2[.?135+VU36\Y\G<3_YS W
MD,!B:"(*I5-4+8&M&P26!/K:OGR,4&</P2]PIE9M^)TVV.G[A]9(8&NYN# @
MH!59I?\@+00%QYWOWS7GTZ.O,5Y3=4&6+JO\\17]X ^CA9OIRPG!WTD0<)'M
M9Y&&NNA+#'GA*=:H%PO36J(KYP&BW36\GSJX1BX?I:+ZZO^,_G,5;G2B4<O@
MD0MA9/-LIU;/73R/@6[A?M:H^=69<V]M8Y?.AEK\<A!J&@/W&._1,@UPP6%L
MX!DGWE(S=<,%1^T\V*!Q9W'%?>Q%8D/#Y!HH-3)?(U:#46P%5?QG0K5"I% W
MB-.!CBTKX9-9,YC,<>Z<HF:'TI(/?^*N]2MD 'R8<Z'*P[^?'PKZ!N0?M>GM
MOM'@L*.G)J1):GPT:; M@ )@N%V\>8[J["_RM+8F*(6(Y!VFW7GL8JFN$(<1
M9AE5W? \[XMJR#U'B"0!GEV#'6P1EY+Q!OMFAK7TX'MS^TNPX*,SXAJI?CQF
M3.&F740$BZ RA=_[=4M/5: ]W:6[-..6I4MJ\9>/MH<-MG2K(\V1_A#>)'"3
M!=K";0T\>A+2EQ'#1\#+,XW"?&);E#^QOE^*^TD,]B#?IP::#)/;*!K=(>'P
MP6'6PW3U_(;0DU:\G>^K;N0]YOP("!7+6TM@C]W!%^+F(8SX<4E$@& /H;T.
M5!:_WX1>WFH0HNH.1^*_HH&3C$T0.*A"S?( P6F@- E#V>W$C[A,^<(5I>XX
M-[)M"^ON%7OW;Y1DL(.704-#=J9YN+>.F?26W$(I_"A[.C<WIP'5;5I/SEUY
M1_*?\YDE\)]IQ($N,2T#_ND<&MSYS S?0ZHES$X*K,<N.JO>QSF&6SZP$-P*
M+(I0*5]U9"QW^8Q<IINE4.4=9XD;%A(4)M@G[@HL JTM#3!LE.I8#2GP%0R_
M<!3*00,_#1<(P#D&$5TI_>#6 %1KNP;Y@:HTZ[1F-Y(BB)A:W.]N&1PY88_'
M>2]N)E,;C%B!R"9MS8IOYEG[(Y#.W7GGC4N8!Y*;XW?#I");W2C=W$4GK_4]
M&T8.M2BEY(;LFVIB)]KC^@5A?P"#S7[!)M"DF>N7-SUFP2LDCEX&Z#&SRH%]
MSV=7K*Y V*FIZ;@FT 4N8H;EWHYB_=EYX*.M<>P3\WZ>)G5H_QTNDD;EM07
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M>F@T@9E-6IG%@M+DO(415T-P*.*@^N^HHXD&:A>3:##9+'\C?YP7E-.N@*(
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M&Y+]FE^*K!M*>ZO&M)4C,LA1BP@>.TWC/"I9N',\41?E4TIZ65'W[L"E^ZF
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MK$0K8^3I+R>>_&-J]1+,4\C%,)$I5S_KH3--'*M?FQ_4^5)HT[W92LN?VYM
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M^-3WW_I1[I&FP7-KANA4-O_W<"295=C-".0"U:ZS.+81:>RK#,\/>'WZRK-
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M&"TN($2._ETAP+1W'<357]=^RQD<^H4=P/G\[.J=M]07SS$,GDJ/K8L^<H0
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ML9N0>4CL!(P/%XR>X*#5,**<OKK!T%1'ZH;'\.PP=7BM_+=;?O][TZ_=7,#
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M#WB=I9U1NC"[\A;G\K*0M'9<DB%9>'"U0$:KNTKIL+!LZ#0""&O<1!!QR3#
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M3/"?6)>V=>3X(BHD\>,N!Z,:905"J3&L@\%L<= $5^ER#.W,@!8A0J$QG#?
M<7QK3"&GRKLQ*U+0/%R@><7]K5O5W\KKM\M@L[ ^;")!JQ>>J" )P)(WDW I
M#&@YX5OG34Z6N^?28)/5P:W(DM&MZ,:$N["#WS'M,(:<=0WRE8;I,&4 _PJ:
MH/0^XV_[ ;M&T:">&R^T54Y^#_7;_OG3)^^L%9\<.MV!@RV;(B8'*U&70$P#
MTM\M]<4TRK+R4V!44T*"LMCP!YLW_VI%/-E>X9<:>Q7O@+E5F+YN*.".DV9
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M24)%2,1="S2H\)-9?VNX+#S9D7<X)O&VX(%[O%1$' X(W=F(HNN![U8&%<1
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MH!(0E<80(4$ED%90M;'W?S(4ENGV<+4'3:$G]'S\#GS2&EN2^$JP9H@NT'P
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MKZ)V4@8'9#-=U%"RL71='N:0XOPR?GW9LG#YJWZ>JG=FG0[/OX3+>RVTW@7
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M@.^OV('-0OFCP0-)[4+^:])CY2"WC&S9B.,[,.,/.[!P%#@?P+L5/^_/SD9
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MAZ>?6TM'[#9TQ=22Q0#;\XVC&I?B^:<2LH0M'VBI*?HD+)E.4"$ZVD<=G&X
MX OPE!V8OSSTV8NLJ343-_-N /(C7C?KR80[[*XS1NKE8K?TFK^_1YWAS'.J
M;L.%P&]XB,1V.TUMV#)<[H4M!).$':[B2\I[[<.*^F+0>I/7&]+\,L\F*_KZ
M)GSNLB)UD@"#XH497#^Q=K%K;6JF^S"HS'!IKKPR]7NBPT8UR-0WNSTZB,>\
MO^K\S&F<ISO<YP2BV/( G;M%:$]G@<*886DG)]9C]%)=ULA_@JFW+MH<_F:E
M)+PD5 $ED!YH)'79W&K@)X/(<FI #HT$6\Y'$M1&O3]-M'LD_!B*HTW.KF59
MA07#'/M,TXI"9G#HIMKM]"NH! CX$OF F07;!Y9*OT#UT5J]?1C+ 0@N>8ZL
M/NXYD"?;9_<^^HM 1]2ZK^K1F4^QG2>KLG@ U Y,$(-QZ>Y&T2^@IZRMO^YG
MG7M29LM4:(B2W;B:=^F>TBTAM<,=OHH;J)8"&?H D4H6_=UDF>D7_/JWJ6.9
M2Z1+[G#R?&VBH5#FBPQ9YQ,P"=@N,C^2NJ)T$4HI<6]QGR.#9OZ43\]%)4N<
MM"3MOO2[)[W;^RMK [%=NWU>D(@;)U;GIK*\(3YA!OC0X'GVC('4\)>.*E[]
M-_S2[C^QW2J.J=)CV6DQ@D'Q0YSBS<&IN\PL8(JE@#VIYU?^Z\ZK<=++-K6L
M2F^/AMHQE9-WDISC+L_$G@HW,2O=>D$FHH#C9O.6W&6*;NAQWK/W<*J;1:\Q
MII;OW!>MT"!_K@Z2"U++U0Q-9?:;/VY0_&>@__UGK.4J]-O2*=)J'U?+AI./
M]&NH^P:@;3[@4[D*V.N="*?W/N()S84WAP=O^YX^B>%74.3U<F(K-K).!A&K
MB6S)>EKMSR3#NB9BBEHMO<E)0?9(>_3-S"M_%W_6;8R27 6?_4?#M\&]R,%K
M*4CE'=@-K4E=7!^CM,/:BNXT_:AT!O"WZR\3>W="_TF)N\>IO?PO^#:R8I"@
M:#]+*1A1CV1+5=-*[K%-@B9:#J4,**%/U]E\T_C:_Z@G_+O*G_5NQ4P]IWR;
M18@,]I$!X^I6<EU) K<"@.N^DI4-^$I!@2A#+T4/K:L!81<F]&\V+^RE\1_Y
M*;A6KZC(#:7H:]%&3-M5&Y89=[LL$F*(,UU$L69'DQ6UD$+,LCW1EIS?QKZ<
M=[[S<(Z>M%U&JNKB87?Y73QM)"+42N_:]*C#!/XZZ0&*#TVZEM0Q)S<QTS%N
MG-7@KOF^*>6@[_I$J5!);)Y%^A?<"S+Z("^5 )B00.%4;EUZ6Y8&4#)/Z5B3
M!&P[I)=PA_*NC"+GE3\V-M75)#IX8IZ+7O'\U-LY?WWZG>NS1>VO_[C;Y,5J
M$ED@7!K8EVVC^/GM"SO9L2-B[Z\<?:8\'ZO"5-G'Z0"<6*< S86*1MHWLS;(
M-9IM(JA>KBRX%TMZK]K[%DE; \\G^I7/+UZ>E7P:J.$I)H1(W('5MY3P0TZK
M;$7WEO>%:SP<OOK\)C[RYT 4+_@OPOS.D.#:#SR2O/?V8RP4VP3K,.<6'5%5
M/:4695L*Q\1&,-YV1 (S)WI3@W 'C"VEBS(3FA,70?@U^JFP/L4LSU3Y'Q 2
M.XLU40NY.KGJ=\SBL?)?'E82ZSR^IX9]:@=6Z7\1(NGNP0PR*)8XE$!N11(\
MB(\=O(!4QUK]U?E3+NMUX6L_,PG,F&6F%O,]O7,QG>Q'?."A6[!A^R8(E/VJ
M75X@JZ/JH/'R3<()E5RQ=ICD8!@*,E^ZKV9'OR4Z"8$PEQ\]F5];4/HZ6$L2
M/^<H5NDH_-_'3S4J4@;QJHM[]\(X5%(K>MH$=+U"A[-R4=L9?:BF0XSZ3U)8
MG^SY)2#;!JW8_4H\K&;_;2+:4UKSD2ZV[,\Z>S O4O_9G13V 4YAA$.,-0CW
MH]\X\ED]J[/LZO,3R _A\WD/X:P?8XSE$P@W?!N%7!-*HD,3;U>@-/PS?]KI
M0<NAZB&]'P]Z)7TS^Z-4_RBRUT)$)(<SGRE+P+E+2%44T;^41 3=!A]/_,\S
MW"19I66<]/I!>_3&8,SQ/LFN[VFVRJ:$@[R?C7KP;6.HRNN-+(CXM&E%>))$
M)V>7/* \R;D&E]=XWO0G]\_XP=>)OR]'38FM&@M^P::)9<=W0;]]@:Q3SF0,
M@L+Q@?1OI"*T+!8Q]J=,=V6JN^!&14GNTG3,1VR57ZY*3,CG[5A<.FX,Q5^&
M#]B!355W4^";6I@_9<V!\ZS5?7;?K!#D>PMB!K%['00$U?AX'YX.IIN 8H^
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MX_3;"..GQ>6SV?U%<]/1XF"ZFK1Z[KHV:]]QT8)W#F5/+_-N1[]X UQ;7[Y
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M J?\V_) P_O4,!]%$Q-=ON -Z5K5RSV:(;AL*++IX;Y0Z&<&A=@R0#N\$Z&
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MZ#?([7-OJ?TG197.N)TQ-5>^,72V5"%I,2BQMT+>AYA,]B4#1CNP>>2*%>/
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M%!/[@:]03*SGKIN0 ^J 6AHA U_+O]6AT1RW/7'%2>9WIG?@2*MS>7]S:HE
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MB[FG_F>W*-E^0&YH=\H6XO'>[3WL.CZH0-KC.KP8Q9B5A\08*G/O\!9B;2[
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M:Z; >TJ1(1'-R9HN=?G5T6 H23=Y$&W]?4)4UVME]-;I3-3VTOC9QE5;CEV
M!)\R#*:'RE[>/1CUVGXAF_>[<.:%^*J/[[]=FC#1+^DX$7-LW_,.FQUD>"&C
MQB@_&HWV;B'&3F,X>E-6?+4X&*HB?[*-P3=Y/G@Q3B9>R)R10R^D1*]M(41"
MVE<>D-Z'8!I[ KVST)XO@N[I?(_VW$*8FHL#_$)_RO=5P,OUA]#DOYV8SXL'
MBEH3"7%R?-_8NN7LD]FM-2]S"UOO^V\ZA^6+;-SM5.PX$O8LG=4NM'^_QO%-
M58A_AJ4=@F9>@_^ 'UOA6X-L85M1R]L0+\N1O\<_[YRY.JBIGO>"/NOU^\_7
M'T*<P6NGHZVY\SA5>*5?!,"2-.HVH]E:O@L,/M.W;*A/XUQH/2R<_-"FC_K[
MC,2*R_4$?<F<+J%%@::3]ZWXPJ$)$N#X"R^!'V(2*K,:T;'K&%D([;(#>_3C
M@[6*/O;1E\:5&.=W"O9[8MSW"3Z2ZON2?X>P?[M[T"']10S0=07,F%F&G4#E
M%J*5PO/KMLR2HQD81E>_(GSW0O6UG?9VDZV=ARX:Z*>EG%E-4CV)RX+7Q8Y]
M!"/M0ZJ2;%^Z;_Z7L"\DRJ'F&_7:Q];T=PKEMWJ?X&\,7#BZ>\/PR:._Y9,^
M+QWC'(Z+NZ><LLZ(L8[XS9^+? Y;3C8!N(:*)@'6J(C2&<N8#]'-745FF>-3
ML?@W<H4OG?Y1ON)NH^@7WJ9TY7)SS6[K#/P>SB?T]"PE 058EH_WX$7 %N:9
M'):?758/T!W/.#%NPA!^F)7N,#YYQ-CM2+.GM^/Z)=8WH.4E6@"&9[V_LL:0
M0"P,MM? (IIF=+ =J-CVXO @6\LH8\\!D5??V]<_W(]6$OZF5=,R_3SOU+&[
MI'?HZ17L:.86HH-4&1M.\48+%_0MH 2P\%(%AOJO*%D8_;FVHJ*VTS0]J#@_
ME5A=L=3(M]#;2!$/J8754>#>2<<.%]%J0"41FZOMZ\!;\_Y#ZWWWG"?\;>,=
MTETKT4HE" '%9^X0 3\ "Y XSL<,XM17H2,>0>T4X)&?B^%0H""6QZF%X=)H
M3C]Y8MCF\NLN'IL[U4GJ_&(BMVVOBPI5)#/^HMFB;YA3,%)%QD&-E-U&JHZ=
M2&;FIU=JTM]%PBD>0_('9>J8C&K<CR"7G9>_K1T@;Y]H8^;]6-CM$[0MA ]A
M/)MQ;BZV03V(PF<D=S'4LL).=C.YU2O?5'U 53&E_SQYD&N4T'2>,ET/>S;@
MXJ<3,Y H<6Q])BO.J.75V.3DPJ;-H]BFX1%)[AU#U4'7R3>^V.BP7EP0VF%V
M=1D%7$1/<%MQR!179"Q!\J^%1&_+"*1?^>*/\XEASVP9YZRK9\2=P]53]QR7
MOV.!JX?%X[*%^")J!,/XZ-6S6XB!YY_N(]DRB;"SN@3R;2&N/Z!PCDU^X^M&
M5Z/9LH%N )(^%\X^'  #H"^(QUF\L4\VF:,'Q4"H;.J%T-:KDXX.9STS:>FS
MC5>XCIBJ_"Q_#<E#?90:;/OR[IIZP&"ZMYG"^TM=YH+K%D+PKB,YRF$H705>
M(B^[]G.OIKD$ FZ_1[3<;V\L_C=!^:G_\.IVLH9,<_LY^TL/DRZ/ZR' Z ZA
M G&CZ4C5]95PM#:LV+"! )BP8.9C3C7[-$L;AP=]_ #B3%#"B("_>.%&W<!?
M>]?3:IF_9-32]MW5UFZ(5_/MWH=[N86XJ%%&KZA."_V1LL_URHK9HOCE4YU*
M+Q#<S[(A/#QNU:8#6V$[+8WB<?*N,?K&H"%&/\IST"/)WZ=[?/+KTX-TI$'I
MC6N; ?V4:Y3I!H>1N"HDJ#BR)!!(NWO[0R[PF/'QE%E@5=#9C\=Y;JL[W+',
M/>G-/<>1@03]&!>@72C6F9!*VO*B.3#71-;H-]PU95/-4.U87]<C[S-WO)TL
M'S,8EG=]D5C].+))\*9 K*'^4L1V!PG.*_B_I6ZJP892M=X$^Y_5D/1+'V'7
M>:&-)!RHVI)K6:)TL\_>N264!39MV#_YYT9$@BJMY@:L?QG!FT)4P((49\-T
M<0 C47%9FJ\C&[_TU9#<?NAS']"IL>+J[7XO]_<WO*)!S/0"7PQ@@A3O>:U<
MZ>(#'>@KZD\JN'4A_9ZB&XKE<C:+FTA37SXECN<G-!VG^&KNQ8^0>*"3=M 8
M7IY!:IFTO50]@O-Y*7L>LWC2QOQR@7?5&]4 IJ*;TIT#BN:LUK%9OM0G/!S#
M\J_;K5HC9UIKT< YS>BY5HL[?:53;[-/UTW.AH7[BL5U]'S]!EUWF=@1T2B^
MJ7"*EZ!#$4=/)XZ@:FS98C)M5#FRQ.AWS7;-&)(HSFX]<WB7S4QKMKM#P7M7
MO95;I2O])J;=OV1WSHIP<;1LF]# K2+VD_4DPF()",>$E^Y8\:G"^#JS7?5M
MNX _">KNH1&D?/<0FN?!8.S^$S_\H].=*_>951]UB0U04!9L[HR*%LTMKX<G
MO*&'C:,PU7PQFQ?4\=O[$;>W$*X8:4*3* %KN1L:)U6V?;0#T=;#N&61>2L%
M"0?KQ1[60FAJ0*+,M-WU@/T%T8<N(O!DG!*GWA .+GFW TR7!:IX@^#MGD(_
M2'1P^/<7FYUS9@T7['F8=[GZS29@1W]D(2-0B3L*5LL RL]=*,068E$D& YN
M94K6L.#A6K:X+8W %JVE\9;'&Q+NAA;[2?\@^M&6A7U\W__._ML<D9$LP.5V
MI9-LLV%[G_CTJ4C#'"0,H^?C0SCN_S/?^@T<;GW@%!L&LMP)38./]&-P7"KM
MB=2'Y",D8Z HPFO$?\WNEN/9F%!/P<#;0EHW?D_-_LKBPW^+*@GGVJ31T..*
MT"XT([$) +M,0!G6<3:Z_Y:;OA5XH5U.>7"6H92Z?]$D;4K+?V_!]52-_OJ6
M(X].S<,JG8$&'":1T"Y!!G?;%F(7VXLF2'U(0!G)73CJL!Y57A;]Y<N[SP<R
M_>PCRY\4_S0^+.7\^W2@P0(2DD.Q@@C])RBK)[<K&26-M+P0XD00;FXA$@C
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M9#C/J["1$!H,FQO#?/=+"]D<]7'X^?#=N,R3? G^WI\Q5@+:YFEE!8=^A^G
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MD.80."_QF@[X7@JB(6!FZ;1A%Y(G!"9:F/J+,_=L,OLOS1@M2.4BTRG3A6C
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MJ7].#%HF=4U&3U8A'D3_CTJ]QO7 ,R=P/J5# MME>%B,];9C;C$++@-+Z98
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M1<!]6(]]F@PLDE6CSK.4YO!/9;\XGNQX7MFY+_NL<_3ZLQ^'$:D3W_ZKOWT
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M#!8UWC]8^8!NS.WAKE4X88K=F_)4YE%D8;S)%6X82347]8$/\+M2,$7SQUF
M3W,UQW'B0%%KUOBK_.+VHD[">\?GVGW6'R0R[]E>)F4?*W1])(QGX_M(7 UH
MUF4V#R.VA23NF%.^&YPPJ^\K[PL)3/#^(FG,UJ@7*AVROY9R+I3$%HN"!-X
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M2\O.]S<<?S4QGYGJ]%;'LJYE1\G.&Q5I 9G[>ATV'VPG(T2:P2]>,!(&=2Z
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M[D8?;FY^&I04J$<(@W/VK 3-$6.(=0*/4,I^N59AH8P4^O!H@FY$LF2X1]/
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MV("STNR+)0P))K\9"'6&QU?]B%7][#VP&@'.GO54SO4!+DBD%-4+6U?@?(<
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M9K7YL&>$2GU] >;'_/9OX1KLYGML.WY"E;&TG98"]15?A7F$]L6*A+637]#
M\=:)]8_) R3?@EBRP63//6?^[)-J?SL,C$R/D!U_"T;,$:GC/!D* ?>91WRX
MH-J:&27 _PU+:T2IYH<B30^7=JAC)/?!SX2L#!NE9^%%2B?,OMR([:A\N>]K
M"=P^8[$)R938,(+5-"%&*[>V]PYMKQS (K6VTUX41X,[WK-LCM.IPYTM40-E
MHG\^9W%L,"9-;R]=P/@D'@XUFEXMO#FW8*71O2%D&'@X@/8M^OP=D4\6W88F
MZU@"!-""L\2-.W#*["R\>^K3&:DAEL$[;,="5^T#SS+ _](HI_UH;,_G&&SY
MK]5<_:PSRD\5TZ*#/LO3>:^!:&*7<78NSN@"Y23BA MYI0T3O:6<)'JVR*]Q
M7_FOQ:\?/S0'U62=J$GOTP]1?7'O!OAYL%O;XFDY_/P?G=*9XW^FN2"!/ZAD
M6_@S-,UZ!3@*H>J1$(#J:&?J1 8CE<X'%)(YF44=..'!H@&*;F^R [5"DO^%
M7FWSG8\F@V8'O*=?-O&W1<\<VIX\"V1C3;QIT+FYF'JJ!E/C3\C'3OTB2%O.
MAJOZ:3=_G\T,2,81.8Q1=/1']MN+<]+M!Y(XI1JU#]YACK,OAOHM64/10<Q)
MM_M,.\X('HR_C7TR%#8WBW@*(\O0:J1LK[>LC 4B]'N/'I;JK4^Q-%)8J^?[
M)/&WA[F]H:LCMR6.)69*XA$-<"Q.IA*>")'3":RQLC[U1R[157;QV_E8^O ]
MDT&/++"RTZ/$&.]O@\FK*RQ)_S9XO7>[S9@D!/!!2/$ E MZA+3]X-0RN^!P
MY2R:;#4\K61[\BQBYRF#KS%Q+YNR=T2I?[-KJU<J?E>WMM=)_^?SZ=KZ_+PQ
M]CS@3E<U WIHH^TS.K3I>49V'-+^G8N_K"LQ0PGF5]L0[Q5KG:[>N)S\@_I
M^&3TCN[2?'5Z2 ;)=??<M5$]:YCY(%4*N9D]>A2!V+M5_6EOX50N?050,6 5
MNC,B>#ZS+[F?K3?I^&N4ZOMZ$4-S(@(ZG9N4M3F8B+^S>>O*$P8B9$OOY;NI
M11V)9K#FR]2-=.N['Y0.U[7%>0E)&K4E/,_%/?WV2N)H;83R_8UVLB/U,2UC
MK@ZW9?.(<Q1I1,\JD<V*. WNR'J8W!8EJ$003OH,$ER8:)'%[:(36'*WF,<6
M&XE/'MCL^0-5 1 ?PAQMZUN8B#B6Z<-ZJ06QP-7I7YD3^JJ84T?2'P\T2*_9
M3&9S]MK1F7,0EG@DWF-EW TN#"#@-':T:]CCSES*D26*=X\EQB=3V49;-TM9
M\W;FC/GGO>)9J&\GT4VH^C][D[RHUEM$*\C['XZ_$)0FGG9!V&]A[D3@J$$<
MV@L[T;C6QM&#/WVFA).AQR;Z2[P.?=;]<=EI+D9&UB)?TE2T.UW"R$.A_AE+
MD]T,"T1,BG'V&C//LT0 6SI?VRE4#HDHOOA]?$E>X3NEPTUBJ%SO*/5-@J)$
MM4S1,^GGX0M'CXC>@X84;UP/=:A==OSQ:]IY%&\%J9-()&/CY0_1\XLC/ N7
M)K3+P]_5339HKKS)=[%+;TBSC[=[9F[X4Y;UB8<+]WEJ:<H#J'@NJ$:5T#]N
M/EO_M%F;*&>B17YU;KXM_T3=QT=: =@1P[GXHA3#\U<[&W\+/5&9.E1RI+'R
ML#F!2#/%/\'7%,>C205P.44:N!,F'!9ZA;893T+$B[DNW/V*.QK_0"/MU&1L
M+5JI2:N5?Y?3FF/:HX2MTNK?_E8HY4CK(FVOFOI9]'E=QSF#+AU #4[-I(MQ
MA,SH=HQP0&,6+USW2OBVEO;I",MJ23?)F "J:OK&.POAU6.:])B,;[NF(MO.
M9:Y#)JTX>\\RK9!:0"?M/L,<\(XDVQS@#.0K?2<UT&V2*LJ&*$=AV9HI---?
MFA:[KEB>K#[7>B6J,FL!YI"5L&2/3H-=R\HMMV?SS%^EFP&)"*B!VV!/(;4I
M+30#"SIB$GHTS&NZHE9+C*G-@%5?*!639)J>TYH4TC47.@PSJ"3,IZ1NKV9C
ME\%(V9BZE79X'*S6JX6T$I_/!WRZ5W<J-'[=7[J,>/E%K[AF^Y?H*8F8^2=?
M4D64E1S,N]7#N: Q(L>A"UCA@FZS^SD9"P^LP!Z3U >WLR1[/D&S'6"78![X
MR36R#O4KTIH+VEO=B:$]1[?)/3B47\D%B3;U0BI[5=B)G SAB+5?^*,-^UK"
M91CJ+%F>@ ]P1AXB>$Q/$36!D:BUTO^AQ8*4+@QU^I174T-%>T/YF\T^AL3E
M.OVHV\\G]CC)/@(,:(12P^=LHJ4@![7POO!QN&EM[-%:-8[XE%_CM8?-(P,K
M*C"5\P90?W[^6TR+S*[CL8=EBYX@^\P1L'/%T4BJJ6< 6QO%&'W)^4&L+6Y?
M&2LEZ\X8 GFS8. "4@MQ7^)E-O[6I^9)S;=/X-HS1DH_'W^;VO_3<5Z5:L:#
M>='%$0C->CN2U@&H7)A7)TH3Z=?2^)VJN_0Z4"O8O]1(5*[>OGO-,MW))//V
M;FT)C/%%@UXB[7JJ(&H:LP]VTP)/+D#":5P0@<-/OU!R>S.QZ/I9?BXH!N$8
MG':^C[]YSQ_B"4GYNU,-PCL<PHMC BUMK -^6VO*W;L8.#'9;TU!K2&/ 1EO
M6)Z /WE%.BQPC6G5CE,?TJI-UE[I28?4.D^=KVI7Z9%P#54LF5B4]M[%E^;F
M7X%N-8=Y8X3]'7,#B^ASI&^8]PMK+;7#Y?W)-6->=9G2I5U_AG8[..R24#AP
M=G<);] =1_^2@U03V1GP_>B%B@G\:32)C 54!#ZC'^$_0CH@"?GB0.B[/QQ8
MXZAFA>>(8G-CN)M5Z<^U2?<O[G\WZU!N)[O4CPXE8I2P+4D+0T\^W+O('(>\
MS0>Q6W#\+$=Z3&I<LQ:]D R+?\"V_AKRT"MSE@I=7:5&9VD<M/WR[:=Z1HQ
ME(W?1@)KDJ<D5WDOI(<2"!-CB +F]%Y+ /UNG.503[OV\"=*0<I1Z\1,2]YR
M7J^O\/E7?:W6S>O8O']DDZXC4+?-^\DG4V.L\S17[&.DS*Q+N(DI=G%"^;E4
M8WE3N.:6:_-=YQ= \J&D6-T@!F:C6;W\E.!TYY^F+-K"=.O"H654$NH;FN:
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M,M:]%7QQ\<_A:,.!_*/EOV]\^-7\YX*@PHLL>4N#!2!-4W,V;V""F&JW/IC
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MB6RZ]O''85^#J5[9@Y8FICZW"2%!41:;*RGH72R;.0B@C$E"'?1M])XP\?[
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M_=&>>8917\U6V9DNX9VX)3JT)_U.JU;A:7U_<@*7=5[92+BE[.QCH;7K%2&
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M7^?=VO;:;7:@!X9;_VU4$J [XR7.0VTH*]UD4V#'H+R#?8)HR"$=_PHB>S<
M:UI7)I2JA*YXO;E_+YW:@_I*YJ='!8DC.GSFM2X,^L]W&Z))]X4 -;-%DFC^
M'<*O%8C?X0#",'YTVZXARVS#Y7)FM5N.!NK-C 2?)E]VL<GF^N,==M[0PV_;
MX_&2=0_X#90+P3]_$P<-:T)WH@2[O;BJ&VJ)QCUECU5LJ8L?/1!/KI&;-7?O
M,#"E;QJ.^^3P;XUX&LF5'+0-9;N")WE*UV\I[-9D6E4UH:VRZ/]Z.PR]&\!#
M8_%?,N$&1#JQJU%:C@0TK@]H.J\3^1B_<)8:2K:*KML*R+99B)C]XB'KK7_C
MQP"2%;F8!N5M4X!; &\6FTUQ<TI=R#/\ F/;M6PDO8]/>G79HQ+>\HGL;GV1
M8=*^D9[865*OFG\,"D%KG]J35VY^9>=Y,+/WZ[ MYL"$XU\=$,5R"1T?E!X&
M5\6;@( ,#DX3X?PRO*.Z/7= L&%]CVU^L\L#M2QFT*>PN-=W/#$F4^"N!<8V
MP?IX>;@QG4L@>.J;[$6VS=NQ0Z1/P@Z#\=%>[_43_6Z<BG-Y\\[V%=(A9^#K
M0/DQR+%ME]9ZLU?WH^,,<69G+<"=[V_Z&_3B!Z?+1*4P+4C)YKP*8$D@>?)]
M3P]22\>CN6(Y#,S"B<L_DI@76 ]%_/FDM1F=*9?H<, 7;@A4DPV 3-P]M2:G
MQ"43UO6]Y^I63:F=$G>3#FULLE1>#HIGJ-UZ^5;-_X31YICJ05IF"O5KQ %*
MX\#WWZD; :,T%O<E$PX*A*C6G /TXUSC5PD.'+[E:S1A(N=,K8+L!:D[NP;+
MQ3BUNJTK$)GOU\K-%SFWSN,K$L%GRK6>J+4NHD" A@CZFUX9@+:F#52W-O;<
M>_ Y8?>RZ!V'E_K>I:#*FG,.8ZEUC!^<9\^-C:?4#Q7,!WSFVUP0@CP"B\%%
M@"0<BD.U+1/OIO52TI-C0P?<+(#U:Q,-Y:P> '%$/&06YWIG<HIG!WR:;@7)
M-%G"Y#83SHC#OAO"1+E9ZB;<'3[?N-B,/'MAHE(T>XAG5BIM4-" C>O1FFA5
M8\_6ZZ?Y.F\E?_ZNM;X]/O"-$*F9,:[6!AVOU9');E4B#?UZ 5<@/X1;CJKT
M:SJJ&X^V0$OL[;!V'=_:8=Q.=XN$)5X7%W\!?0&!0-;_RHYWJ5EP;6(B7CT*
M;KC4;UO>)DQ1'5:D1T0NO7-E;$ZR.<P*EL/CJ;]3DD*5)9V3WL$,'TD*ZV#M
M[6A!?_?7W+0LG'5G^F'2J^7]XUMPLE[P$(470GHU#'&EN_N7LP&JCC31@(5[
M]41P^%-E+?3:JWQX]LX>?WQGN6#:S+?*WC(30;J:*E.>$/86GZ83V9R(T,X0
MD<ZC@XA%HMC[^J917=]B%F>W\$]<*C=SFRQ84L$7G]PXMQ>=H!S[]NE<8UT;
M+:NDZ K&].7;F7JUR871<5\=[^RVG!'TXGN=R\@()UYB0N/2SEL$!V$U[N],
MB)%Q"Y$S2JK25NOWO/CY+U)]):'M_I?8=1YC?_Y[8/0&B%V,UU^!" 54X*"=
M9'!-K+NF*5$@VFIBTO&"Y8$=G[[K R%O6^M32X77$K?/J6[_1%<,)&[?NT#_
M U=?'QP(EAEV7-V6)*L#)21SH"1P\1@D8-?I66R7;7*N;C>P;O)=0Y\QVZ*G
M_NJGD\SBKV\RA)4W6,3A"P1\?F)]):\5M<]I?S#5X]/[3X\?@^FGU(3>#9Z7
M.@95RNX<@XQ>R)'2T/SHQ3GHH?8.-W(JU9_N1.OXR$;03*(Z>>^OP7(+'1Q)
M,JV%QERJ0.FX_$_<YK][R>U&TIA%CT$R#^B6&8.<OI5X#+H?M(RH^*_S40JW
M^A(&J$[9,;*&_SM\0 ?TK]+L&-0;_ NY=0),>T_'W>/[G!0^),UH/NP8])#Y
M&/0W&]_F5#&L7'%P%Q'Y=X%.-W^D<]+ X^%T#/[F[]?_%!7XRA9-3CM1;A/3
M/GY=[RL++IZ]4&/?MI%VK9?$($5FN&MFZ)ABENLL<+WY0@E"WYAOQ^E: W"3
M(.V0V:FPN*V+/UV4UQAF-O;']V/-6MQF9ZD,/^+!M)#G_=+K6D\K%Q5$EB#=
M1AQ*.(_4<MD-+Z9@T5NW/2M[>^%&68],$S\>'B7+963)&+ZZ5BOZ9QL6<@!5
M253BS-3/)B477#*O?NZ];%HU00>P,..0WXG7LEN#NY"5Z5$UGQDLVD95%TX#
MQ<9<[$WQ6='%(?D;O:?]KWZU7'RX>NJO*E/GSC1#%_ALFZ ]T*']N*/I?IC*
M$'NZ<-Z>O4*1U4SZ!=;%>H93*>LFF^\# QM3*SP_'(/J+XL-8<F6L+R]Y^OV
M(59S1V*F>D'^<<@GQK!VX9]O1%?J<0;#+7=L[&"$#<:_7ZPUP_JK90W G0MQ
MBTMEU$KT4PZ!Q9]EI#).!\*6WR.VESXI15I-*9I*@Y?TH?LN>Y_G..]"'7)7
M!:6)3@L25H%AJ<]]G.6:HJ?S?',,"Z;G9OI^DK2X8_8K8B&5"U$ZK("3H[G#
MI-8%UJBE-.RXZFFRU9?2!^"+:C?L/8Y!F=<88+X[CV]3HUL,D?EN5<^#5L.T
MKH:4BB=C[DVH0JL7'$I"1B29I^:FN,\$?-<RW>\[US+;UTF;_:YQMZJXT;XJ
M9+ND/MAW>XR(E5N /$&'#7ZA>!/](^'0KUBCP%S [TB_KO6-M$V>J9"A@'C<
MXK*-WW6F#()MQ$7/HC*9B;B5);$T_WV-RX?A&OL%=[.*916IPJG;G@WTJ":]
M54&0;&_:>0.I:Q,W4)X!<LP<F6ZZ?%RZ_--RSVOWVRS#]KW+XEP_Q">3YBD7
MQ^7I3JB#[W+$@I6[J<^7)_(2W"JAJH]N_!QXYWUBZ1W'O2L/WB\SDA [FD&^
M5W(^.6],EMQTU BNK]YQG4Q=5QQ87JNP!,+)$IL+[+5S$,.Q_0J68Q!LP^Y3
MT NKLQNGC5+WSA7?7^.18_E^':(F"&_$-[$-33%T"R.C1/117?,G(IW<>Q:,
M0AS*EA>%Q'LB=.).2/K-:\LB6F]*':;E&NGTCUG,63[-='+SH J$)+)FMU:8
M4-_";?U5K*YNZK"/4O2T]&W^LI4Y*.8OG7JS'"Z7?/J&_+7-&.*@^;V&85^Y
M6,T&E_JFVJ3L#!D!F/[&RYMB7R;>$WDW-&_.;G2LV+PP\NH<-"R?RQH:U-F\
MU<IK:B_ZGPV43G9'4(2[QZ##ZVS'(#)H%KFV)O=7&?TO>2'U&+3K34>*I!,-
MQZ#A7]9K3^#J9Y&ME"0*&6] 28 "CX_^V?UYPOG_B4OWTGWP,6CY*NK4,6@K
M(Z" [CM5BGL!:8(Z*8ZN86#U3DADD$F'IVC :>P1R9,#ID%K#<Y]+LPN(,#Y
MZK>3O:Z;\MRANWQ,!6_EU4+'=N;>(YXN5+53)#X1Z]EQ#.(K5ZQU(0J\K='6
MO5%=GV#3_?Z=DZ&G5)G$>T47CA>9=YM>L[F<"]4ZP)ML,;PBJG?;C8]C,)Z)
MV*>1%0Z]7KZX[:M=:FD3EZI<?:[<5="99K>YQB;:L0UZ&#-M;'O11S^[R@2&
M_/@;2;B-/+&1=?H7^EEB74 DC3M3VVCI=(DOM?B;_.6-H#>UU<*?NU@;V3PF
M.W!<_FK#+*>2V=2?D*T<R^/I+MJ"FN+Q!^D+"\P#9@QCGHK+-*6-WL^ZAIY_
MMNTJ[K\[&,)%\%_<B8"X[D1HT/&:4/8T@.P4 ]?SU_'S?SE\>=%(S%!^8,#V
MXU3:TZ=/I9+O@[?ER)<##$C? "1G9(LC+&!X:D&W>#V=)&#B6KA6_ROY47-M
M0UQDA$OOB?>[0N]#2V]J9[]:04ZD26.ES3]N'X-.8F+H >VE!S<$N"#=4VC[
MWAB9K1!?A>3=&_1B][J=TZQ95<B0?(=O_PD<ASL& 1?K(KV6D)R;3II *M$?
M_QO!TQ)K-OP7+0!3&W'SLTXZU^GM7J90-A*8HY4SRW(7]0$^I;JI<PF0YHQ!
M7 .L,<9X3\$I8YR1YLR%X1>UNF?BBV/?O6Z=JV/^N#3%[IY4DQRXQ'.QT2)$
M3UK,DI=,0_V&$W,1=!: =NDOLX2XHF/$A"+;T[&?)\H\%SG%GB4[K6?X3)K5
M'+"X(=TE'&:Z1IH;XI.?6+W[)*8;A/K7$F$#7.O9"3GK$!#6Z893$@0$NNK;
M.(F*'QE79]PEQA2TJG8\=<;WSONDJ9M9<#44+1MJA==3>!0Q'28*%:&(JY0@
M(!C7>*X)0!H0Y07L0KX]3KNC,^?^2K6)^SZ_T /%^[]:'A<-(Q^:, %*BYA(
M"B?.'89QXASU@7"WXYMCYR0=TQ2,H*V& W22]LQ!9[7)*!+29@VYQGK"L23F
M??8$.LG[O4MMT$']*A4^= LX!N%,N +V%@WB:R!,FW*X(?Y-.X[]A.B2*P]5
MFM?=?QL%AUKPD!MMP:]-^G]-K@YU@-\N,*-=\@ETCM&C-)W3 V&#/REXKO&$
M3MNY7_BJ3L@K^:IE2"7 RNZ/;,UM9:W))@6R?MVSA"[#K=>&NA)!TW!SPNE*
M7.M=]_L+)I/ROZL:TN^C,WK6N<:*K@RQR2?5<;*7,E>@Z/<U96<25:Y2XBD,
MMP?FB)(=1]K4MCRFB!:C"KO!_$'5EA*5TZ\X2JT%)*Z;GI/?N\,FD7SF4H%*
MZH<B"T-;].;1'V\H$XTOP'/)?YM(=@FP[L9>S,1#SL!8%G_L^,P MR<.[C8]
M;C@3&<H@FQ7\Q@E)!X'>U,PV40KGO[K6-8A RU7":J<A45B;Q]%U;+O44FF?
M+^9HYP6'1/RRC2[WHFLX]";4A:)%_50#B4")ZDC ;U8VC3^=:+N(?'H,>JZK
M55E;"GY8#PN AUNP-R=%NV\=:JLER$514<B'\6"2"_$W-O(MQ9<H.],103IX
M4$>XA\WE!OPZ8/7)ABV% ^!G+"MW=^7=-26:N7G-21FJB(50D>)&!\\9@I7K
M=W0U4ZC6!;(^8I F0CP&=4&F$TD10"-1$I/A8K=\T*5I_UE4T0R/TQI8-T>^
M,+B0VG*!="LI5TH>ULK@P;=!DP*XB ND>&IR&Q.DRP2TV:83^?VHKL1SR1.T
M<42M2RD*P/;>GCARG.O,[9FP3;[".](NA9>1\I?ZQ'K$2/?/'YS A(F<0LPB
M)!HEI,,'>%HUI9$V.YUX)[]$&O+<73&T.]50GV%D_&>@V]TE^N:C&WP3%%UJ
MI I2 )!K;]*)7D+%T!@ROZ<E/LY[[@0F6AR#7@0XZ MY(,97NP-3N,_-8B1/
M7I.45I?M.T(T(9WTD\LSFZ@^%*3D 'HQJPHN0%#O7N /@'Q?8*78$]0QX&DU
M;%8>3N'I7"DNH_]G$O_NQ"6/BY6^>Q^7 L7=IUE%OE24RRU#P+3O_N@S"#:*
MTR1%&K\3XZ0%3./1C(Y L 'Q8AF>+4 U]H54E=V,G=$Y/]*$&RG]C*.D.>I#
MLH7U"(1#2S5X$1TI!A[>5S#;=!A3^:R&_;EIVN@^^IP;PYWS<[59\V37467I
M<]OF?&>KP;V+\.L$#,TXC,9*1]&/AV+1^X*CSR>W_HVY>P<8$!-)7(!G8<"D
M41M1H(LCN#W#?2:@+T1_B>QJV)#<=S%N:K!%Q&9[-Y;7E#%._BXK*A-R=PU:
M"0V':R]"XN9%(Q\0&6SAWN.^HH\=_;-X%'(G)\[:]-7EWCXI'C/'&GWJ[95'
M1NR7=FB\\.N5@":AOM.):_1"$\J84)X*R[4S].D;[>5KD>-6";>T:+0X]>Z+
MZS6&/(OB]3_'(#L!V4$EWV.0%42K19JXUX.J==VZ2>8!3+KF92?^EG@F"D"F
MYU4G_Y(QU>BQ+]6CBG]T>DEO.V\?5-E+:.;(?5-FE/3"C!^#V)"+'R%,.B<H
M1L-:MH2=3C.*SOC?T$TOZIM@A;*V1A[]M4?HJ.H+O_J9.,65F?3.8\1[LY'M
MUW1$UA<J/2,0I^8QY3 Q+@+\<GD2T@OY&\8O</9Z,MN/\K()2;X!CZ[2I/"_
MXJ'?JW'0+2;71:7H#.F8EIM$\R7IKN8AMG1W_LEN#8JRS7J5EB=7>F]MZ)QK
M>G_2F*'7RC?V.^)[EK*Q6\T>URWN4\IG*$,???*4_G7@H9M]I&SHP/Q%X!V(
MH8)RMSODIL+??W/?E8675Z(51G%O4O-<3_"=3OW<];?G^M#=3007HJ]- -#^
M"K\ULMTV5^I&!_1:!H5 NFW]N/#U'+>*<?Z L[*7=M6^G+!_]?!3905/+(V9
MO$@DK'B"^HF:2[Z3'1-ORAX2[M&D8HPE)D[JW.$;1&/G3RV]4)[5"GA06MIH
MUIA]\$?Z6C]B-9H>>>"FU"3D(FJ!\4_M9^L;!(-N)-,4LL-$+=./9&V7UX;"
M-7CDC#)VG"7F=2:B'LO5O&P*BWC^CZ<]H6\-"9>CIB-=R$IGX5=''P(P+^DX
M+=7'A>M8XZYOTT Q_\2+'Q'XD_>\!Q+/O2KM8C&8GO+$;I61I*/_?2,GY0GY
M8H#<(JFP:7DBDK!C,OJ"HEV""2$YOKJ;:?+F?%U;Q :?+M](L3>Q.*RQ9Z[4
MJF43@R;<@;)07']]J08BZ;LUZ#)4Z6_6G!-;<II4$*VY[E[NW,!YZ@$6<R*)
M@I+)3[M^<3?_HY7>O+'#\SRIG<E]E?AG1=+!<M2C-+HV'AHOO*5CN$@8] @Q
M NM&/X),2>,.MO6(DJ3WDSJ7W.26!G7 <5GBE2,^VF:!4B,^M6*Z1LK8/URJ
M7>6=RE75X3$7S+Z<18RV4#_Y:"Y@,TV IDF[;\2+F3C["F:]%Q<2MQ3<O/P]
M_?[T5B,SI.KB3IY3'/E>)'46?0+BJL!)\M51H74UC7N@<1I$RX/8'=J<O.?O
MN;FM/6Z%J(:H0%B-VHK0]<>V9",%32&RO<'<?/^>CG ]4(LWF1(@^5 ;M:XN
M:@[>)1L!?%H"6:?#'F08'1 HUD<*>>OAPK<&)D@C0Y+9U\5EW]W7"#8)I;O7
M=W1]? A8NA;I-^6M)I3+FQW0^$,WK9FZ1N:4/6F_C+;)Z8KP=D'JS\O-K$2G
M_@)$/TV4 ([540:JYC$/B'H'W43/5V5KZ57VM9^G:T<??S-ZEIIT*_=;Q]>N
M\N_5E7T5#+AK+9RX$,YVG@"UR0YP?1="Y'(-%_RBVE71$^_HA)N;6"+_@GM@
M3VQA&R(O+3CSVL=L!4 @O7*?#!*:W9': IN[.HETK1*JAE"XFW&ZJK^#P@15
MN2?O?+7Z?0QRFZ,1&!=/;[[!J+XABN"RTLET$;;?I7@1EO"/'3>@9^AQV4AO
MW ?-K#WV;7W^?,O8DU8>Z-SM<,38-S:7<*Y^_7Q]37\Q;22-I8BLL0FN\M^Z
M0EC]KB.>T+?@^.OO:LBM^<$P^^DAK5T'+>;."!OL8T'G]NFD]C(P5I=TD3"T
M+8JG\G1#9\04">J)6M=/I07YQ[1(%[%QF,G9,KO6I@09LA.N@N8=B'>^1MPX
ME?QJQ6$7T?2Q*=HBQ='3=4\+0JH%(/^&<"A!G(?B$6J 1#V-(R-$C,L]S\#G
M0/ABV,O1*!'3NIH4[QMK*1]%S5\8DWPNG!;,S/KW*^8-"A=AM=U8UZS:T=J(
MN)R0J4!!\J(<FH]!;S/DNJ/0I+?I>),K;<XK*H%7N%*GZV-(_YH5?#N(0 B[
M92DE.DZV/"'>.@9ATF(+8/4TU;%)T^ 95>X3S\_?3L *>JDTWG&^T=W[XI/U
M9VD*MTF':Z<IH(^,7CCGJ2.@?TKR^RN@5"UNHA-D6]-F,H.=?,;VNW;:&*VH
M1K0H#J1O2+B(NKHY>UC0<Y3UK]L((\&3PH-^0/3X6KRF4=_%XBLRZ+=DU)AB
MTM <%>"W8I27<"<J('E#*LDPKN14@Z;M?>9UI <4D#YX<PQZNA"%8EA8)#\_
M!C'E #E+,TA00(<2BU/_HS;QD?+2\C]/;&\\XH=/,]J'GWRR]RGRAR#9O =5
MA8F NQ&OXDQBA"IJ9A+#Z@52UM2L.'BM;CNL[ZYOGRM\D!S-7OI \J*0M=1K
MBRE@DWQM#5DC5D:@[=DUC9>Y )[X0BUH/IO,8[VL/R*PS">&]3D>47EC;\.Q
M,ZF(AR=.D2:>S\".$C?YGV,5?,A#*4@WDVF>?X,C1(FO%J7CVS@#$.#(HXE&
MHM(]0D(C-5VELAW/H4%5Y _8D92W\I^-EN@[?+EV9LFBQ98L$^!*^I>(. J_
M7T6L<H2)<8\@A( @>Q2G2)'$Z'[@_(ZI3=:&BN30G??&49\^]-\5++J4A_@.
M')*O/T/6/"! 27,3);!C$+-23"D<ZDP2>FRB\6<4F9:\8S!@,.#>[E?YO9/5
M-1+RM)6S$URS$*,C9S_W? BOQ+_F)\RXW)+<\R(G]*=1M,2S,7&O\[#T6=NI
MLP*@A\FICEK;1\DE;L&;GF- VA"-97\Q1)+&&OB*X-'AZ-&Y>/\KX5#+/Y"P
MPG'+Y5>YKPLZ^&S/Y4/[5R([L"<2TDF6'^V?,8RTG82+$.C'XOLOK=TS$LFQ
M-11. P.C./>%Z!VX.DR.+F'[#;^@VL]5#C,=7:7LA+FFACA&]RBO=X9')C2A
M?MUC4$3N,2B\D51F3>,V ?20N+-D]4SP%**7A*[=F:Y&9JYX?2;[$>NU1IP0
M/^U$=[:-"B@.L#*+@!1C0MGD6XDZ;@R)OZ:AN;[9WV4:/<AMKW_BC(#;0XMD
M9E'[-3)"?!.J?X20_L<6I07!I^!>#I1>(J8'%^G[LT)&B,(,N277A^"=,_ G
M7T:VZV)E)).L,4Y*MTS#0/VXS]=M0FZ>XIH*E9O3<J;[TME?^^!8IXM$Y%N$
M)-P.L/==@KT)Q,MQLL#42$>(2F^N![,UUOQ[@5>592.29[L&7QM*9[02-&DL
MK?^>Y@8"#$1-7'W$GQ9C<"1"SFEA86/0%UZO[K<[/]7YY'J$:USE!7%;=>.5
MQJ2YCYG7.+/4O7<>M>8J+L]CWB+ZP 1#SK=(P6.0,V?$462\3_,.%_S&9(M(
M_EQ]7,&8QYGJW%G#)R+Z+Y[.<Y3Z'>K%7 K]8O.>#Z(6D(F.<Q('J/3;+Z3&
MM3CB,]=53<YN@GETP+74+=2FT@7C1Y<&RH.;MV8QS=RPOTHX2&<L. S-IJ6*
M$U6V+_J[P+INU:27FWZO3"O)OJ-2\HZEI5'J#4/6TZ]>:UB_"_"GL6 6D>RT
M 20KC==^(TO6\PQ%8M('=?;9 ;?#3.;,Q[\SE;XG9R^_E=0?8;]V^Y;U:XL]
M@]KFEN;0,O] _V,0!& :@@JB'RZ$0?@AB[5V3RJBVX0"U!WJB0(=\= NC5S_
MIA?>9;0O&3\_LCH:)NW=K;RS)KC+%[7CE(I7.#U$.D^WK%C VF%T,?8>$$PD
MFX2U-\5=B4\[0D;Y +8UC: >)JS\2+#'-.S9Z2"&#51-P99I-FVX38<P%"=!
MM$[0.K%DPF(_.S6U.<_;%HHEEBFR"I4]L<5E"$D\35#KU+];=3)7^'"5M-M,
M1Z-N)J'6Z&KK""TF8N8#8MAS8:?/3Y;B/?4R%HQ'NLNZ6PJ<:%..E5J5\B\V
M))VUDN/;;-B-K_5G]!W9#5$ZE%>K/(UL#P-I!CF(3@Q-V)Y.M3Z3;]YK>YI8
M=&^>@2"9+"@J</_SQ,KV&:9^_T*663 ^9GZ6Q-=.5]U'%#'TV3891%\0>Y;$
MF);<F5JB[M;5YVH"X*=--GDC.V9WG-_#AWN5^<,=[_BXZ<JPGP!#X6# /)O"
M"ICCT(R QYCM,QV^T8<C-<"U/EUVF+#+:^4IAY39Y.#)@6,0P<)DNA7MAHY>
MJ$9$!^/*'G>)"=43E[M[&B_$75VZ&T86HSYN#,0=EL4,/)I66Y:33K,,<R]Z
MFUZ#-@%.C6;X*HW23JRBZA>VK D+) ;JQWU4_,)I'R7 &LFE<\[0K=!N;EW]
MU26B.*PP.[F#*C3MR;_L<F7EP0B+J) -5YCGDNL6FNY<L2@:FUNAFY.R>D;B
M6Q6Z7.T<Q_^\33>["2L=\!TT?21P2SG_V0,A^[['E9]R+FLR!I^._X\)QM2%
M^!9(2< ,WJ![)V9"AZ?%V$#_5PNT_*9O[O2<00K[#KL:(?/C(^E+!PI790[?
M#*ENI*&J$R)=R>;/P0+\FY8Z4F,M<C <BT)<)37<7>'/'\7A<37/O7OIRB>-
M4K&\C*>XH355"T['("\G;']PJR\Y,9U.-$,X%STJB#NZ@'\)G!^()G;:$5#A
M"L)@IH"@2ZN_X.KYAU483ZVZ26N_"0G7*U4RFLO3K(N,0CJN9"GX\W'TTSDE
MTL@H7& 1(A+ >0.PQ<F!A0.,VG5DTD2B:S(;:P;O&IY_\["A\79=&HQY[I'M
M&?:$DX7BUI-0,:0SA\B2>H\@0GR-I@;$$C ]"].P[/GG\YQC[MLSEM6&8G>R
M&R-66!93^MVD+JUH;ZZ<%1$$43] 'G*>IO6AN'3$ TH,QEN@>%$8WK<-Q1GE
M2A3+595N#;[BPVTV\.;@6I/O0YLO%O&FDI98/3.M.N3$EV),\M#1.#Q1B/H9
MO9B*.DU310QF<1.1<:7[8%'X;6):I%LY%'ZS<?P/I#[CSPKCAUG;.<DPF' -
MJBF!H[(X7,0^.9 3NTHZ Q@NH0!9DZUU&#[Q)(#LK@ZH[A23$3O?.O$BI[&)
MR)X1DA_/D3OI61-8I1_^^M%I]7,G/EE7=-+%G$5H"\N;"T!V0GAUU $EW/+O
MY*N M"[QEOW:L,'YI\G,0E]@S3:"U8B->;R*D#B(A6\-+$;WEA7L<.\J@HC=
M9M9E@E@C 3-@PKZ9)81.$-6]%W/'BL5YL.N5@;RW?E1I5<_A5$'AH-C("/KJ
MAAB6?MW<;=*J)X42_-().S16)K)P /+6Z+;/9Q[=&J(5JF#:7E\RXN>\@I@@
M/IKW97%A\9<SKUF7D*X5TXGM2((I*AHMW.)&K#:$1@F("0#1I0&2MPBT,I5D
M-QWAT;\'-H^NV/XV(,6&0YZYS1DEJ3C;7!)I2XXEZ0RO$H<ZD-P;3E+$B,9R
M^/E(TUCCEC'/\VF.#Q9NB'_<88X2$I0-S8?(,XQQ=;^"\M%Q?E804T*;PL:\
M!J$B0><"Y0+1.EHR0=MOISVHE'\8UJ,R?2Y=;?*R@WW+#]2E#_H76$%SKQDO
MF-I-'E)Z+?G*0MS1@]7?Z1_S)8NO@1J'=$6%'X-8X0QT\GV7W([F1DA<C"_$
MKAW]0-F%W0N&9=:/J)!+BK)WK9Z^UF\NYQNY*IO#;7&&VS,\&2Y)3 QKT2-K
M(_H@YW2X@&;#27EK,W]WL1E]XIGW>]G0FT52=C7YCW^K)&-DHI=MLV/?L5E/
MR]"E2P'\0\C7H/ K$]E$@1@5Q_O QD%06G79[!SLZG.=1WWU'7LOT^3>^NKK
M1WTQ_G*)(>8G$$AF,,"!SSW#_FPDABTE)IXG;'?,K3<YM>+OI/6P6)R-E\#>
M9)AS9P]H#+RY<5-K--XB?;_(M#2Y_N]0!DT%\6-DBC:&Y&FQ)6:2 B?1SQ;.
M +%61D-LL";]'%BA V!_G__;E]'1>XV-;[X^6TEPTYIYL"V=P7+XFH_$M&6-
M/P:!@$T2E)"00^@(T?=D4*UYYQ9;:.ASX-<ADQMC%&@\?#5:(E4J.NW6W0\_
M>D'6X"7/*<86W:6RQW:_:&KP(()>&]K_PC8I)0=(9OE+2M.?I9G-SSAH5Z6@
MTN:6+'NQ G%!D5MTSRS0":D&=W (?)_GK,[ =!YQW_DF-<GII5(AE:@R:BB9
M/&(H564H67VN6E-L_VJ&5R6?K(P>'75!)Q\O<6*9Z%21.$-*!R+J4=7H[B'L
M58=?2OB1VC+]B6M**L@SCF6E["]*CT$UJFP!N-3' <O(JJ_G"WKA[Y@RUG34
MQK7^I5'*44O^BMY:Z%;C=SK10G2-\'&'=*6S>96XV?G(5ME/S]ZIZBLER,];
MW2Y7Z\GQZ@X)7U("I"\F%E-LB.JQ<#FB''ZU4Z;%W2>==GX4+E,Z,[-^U#K2
MDR02D1 <&'=5RZNG3(J#Y_(-PQ^#>HO'(.#":F?%"5HODIO&[A84&?N5D-@M
MUWIKSR+#\::B*IMK:[QD>F_6G:E/S.T<EU/[^>5_&C\KUKNPJVKY,-DI,@&@
MXUAC0CYT"K'3E1&>4!1(M.OLX"B5[@)O&X43SPF_]WMJV1BQBEA+=1&RX7DA
M^T7\QA?67J))E[8_Z2=!?<M@$2((L\M+C*!I!NA ^0*FUOT]"P;Q+&4JL2*U
MHRUK?2U>Q@H#R3\JJZHO5%\2YY?\8PS%Y274$K(WVT<&_9J>K"0?7>V+R_9B
MN^4L?V:NF?1IU>/J3&T@,OJ?F2YP4IS)\@ G3F\/>+V^P/["9Y/NC>JPD5/[
M5#%[06YF15Q3N'E_PU3#4SW6F0^\6+\Q_8H]H9Y:FA+@SOD.O5BX\,VZXQ@T
M#<69=,;[X[(RF3K]6H#/.$>(Z8A/T>]8$Z*4JWGX^(4ZJ9[1GN'2DLNFBE._
MS;IMPHZ<-*S[Q/Z5*^H'F."KUP[$=("/Q!3\Q1Q<JQ7&:MACG_I\1#?7"/:*
M[_NN<\2$YLL1P;?>=X=5>M1\N2\]1I5@>(OO$N\>7,S=X:T(Z8BY5'KOOTNA
MY>S^5QO523.Q[D"3I+#'H/40*IP)BD"V]X!W@]KH_JKRXN0QR&AG<U&#:GZ!
M'E4+UA#=[XY!/]K2OYCJ\6V(??M?FE><^"N]Q4>(Q&/B55L?=X%/PYWSUA J
MO\:YM2_X_MA2U7;B7Z84YDI<S[%B:731].YO5]UGVCZ?&["[2A(C[N]L6WX-
MT.C'\.>/*#$\OYO&!220</D#?0M/W,N8$X5^G&.2]L+"]CQB]C8?YID5%V*'
M"PADK,]*VU!YY,>H_F6KJD*LE1M%A_29MZ)Z,V<8]15<A]X*7X("ES#=\0+X
M^@X6E2'! -VN#.WXYN]-M36<.($(7D.%@@0#1K[[ZV?F,/*4D+EI="6F,SB1
MSGC9D2]0[+T5S]K$FX8IY^I&G]NICCK8SEZQ/7C[KCBM!Q^/F6>_?@X5^HQN
ME]6K6ZUAJ*8R=]7A@I*V9OLG"^:0+6P69N,/+-5N_D^3RK[_).Q%<S/*DXX1
M)6A2;DA"!4*)<CVA'T?=B6MQA3G[?ID.Z+F88C@I-F$HM+4L]NCDU,OA^.]_
M+B3<>NB+K,%$MUV%GZ2F:;G!\!7_)O>A.SZ+]-P2%=N8-*RW#X%:.G:/V'"+
M]/)UR:L_:9]I%N=*AF@_*S!7,"O?F+.MP;K]*:MNVJJ_YZM<*Z];YOMTU"U_
MWVIZ[D+5W-7]T:7\6OP.MN#!+ZU @O\B>NN0&-LI/)_ZHGINL^[L8.FSJ[G/
MQ2:V>@/%?GU<>G:H?W-KL)TV!!;2LB72>:@,T<R$%]G!!JL C'#W"W)8X +R
M9?F)DC]<=N=^^\UGDLYQU6#B3N:CKZR52J84MH\VU9;6^#LU35.2K^.2>E3F
M=)[ ;#4UR^H/2DEUT>!'] /B^6H_A*WNMAKQ>*9(X2CI5'9Y(P&6DPU!=[06
MD)X1?0\PT'_#JX]!9RA7@6""*]XUKDW,<8._:2A""_I444G"*#9,UA'+HBCA
M6,ZY<^:^C;-7M3OBV; ]WGL!IFZ>Z2@\:LQCMU'A0TF(L[+>+M;X-('8M'/+
MACE:_D'Y>JRN^U-4F:+1KIS8G$6Q6&)8!^0T0FQ-1W1,2?5\/G#][B!NSY]]
MHM1CV$,JX8*2Q#V_U?/^+N^L&J%TP1#N06*@G&@/%"<P:3.I\H'"Z8R/#7D*
M$:$CT1E#_KIX[T3AGA+I#Z,.5TN#_99\(G?8/2CD[!RRFJE5@51YZ5^TU9_:
MX8V#%T-DV9<FT\9ZO;;D>OMZWYUG^\'UB((2Q!QZ-Q@EB-[RFT#^;7I^5#<"
M>4NWU(.M$SATQ#&(+[*+>7\G[I&2X.9EX,ZTPF_^F*6MR_<]TF7?7DIYZ!#-
M?_\&#@VY5)[1 '%C-O<>49LIJ_L[:5Y<QX0U+S#LS1-Q;W9S6W>MF$6\AM^(
MQ?EO?Z1'EKTQK:N$"AI/;^W"ZQ.U_==:;"82"V?7K;FO-">HA;$.W_9K8^[;
MTA.:E>M'+A9B\[J:.+=F7$;O3J0=@T[[L.2\K?^10/-N/K'1H7+J *LMMRPL
M>VE1^]/8^_(4=^F5VLF)'8]\'^6%)Z:&=]?51H+)_8XA'J2-$#JZ8;S>F-0&
MHO6__'BN$]P)L[:0]RLY^_J=]AW+WITWZS9(@KG26>AS'7[J)W=%Q?P,+.=;
M#2UBS_:[\ET'.?6Q4M-$ %21]JPX)Y0$SZ H.FHN4/J_II-UC#W[?I-H,)JU
MSK_?>_+N'SPF!32D9AC^T6$#@@Q=7C7F/O+P'@A*#C&&E^CQ#4?F;!45^[<F
M?%+@?&QHWKI-<];CM<+<^%^]WY\%@@D2N'@,>O.O_@ I7 N.G(>,PZUSUIJL
MXA71O//@QOKZ)C=\!C.?;7[$D]V^V4;Q2]?9?H#"2 :4FZODJ\>@7WO$T6,0
MDX;U,4BNY"?DOTCY^D14R>AI]C-8GK6]6/EG+NE?!<790!J=&_[5HOC0C>=G
MZC&H;P."YX1,HVB1J 04<'T$?>@(+1FS'MK[<5@>"'X/(3*AMH:.0;I#&!/*
MN74HI3R')KY'I8MZ+1!8/P:%?:8#D]3QHU:]<[MG_N_Z_[O^__CZ0G?DXD\Z
M/FJ5_C"XM!,_HH\YN)N1GQ87AFHQ?C,W\X7OJ/?_,WOYO^O_?[P^4><:/8(\
M WAH+.[%!HO0R*/Z6-]X:8<H6/4@7J0D./;MY][7Q35G;WU5^Q[):-CKX?7Z
M"FP##,@>@RCIK4RT[UQTW*W7#6^%?GV"_//N+R2_ 4*[/84DT$HO9<?\Y<S]
M3^FS&VU,\-O0MPL"6A"\C(3;UY$*?EM3Q)X^PAK3-N*U$[/\K.B313:>]-1R
MK:/VNEE138K)\-K05QU9Q \G":!DR5&W&\QI;T*,C%0E?U1R3L.2!)=K]LXL
M\?9*REB9W:$HOPS@;V,,4)M9!/<8PSJ"5J.U-,\4X1,Y9M>3H%C'CY(C'GG?
M;?(0)^O[?U[]^8M3=2^>#[-OER#69SXR,0.5VW0]D.Q*,XW.$L7)6=WGKZIQ
M5U!SWU/9]DB*/T*9PD\"''BE:6N,^KP:<2 -*_8F=]I!/]SS_,?:NB367%/9
M2GF6SE<)L3/75N&^+T>0[=H4Z=H/!M+1Y?8> 9!-+]0 S7>/RAMR__[SW&5_
MG[]6=M#!@_G?QZ!'%I]]HRM,KQ?IK8O(Z1E>\'BZ$Z@VMP 3VRE'J=-8<%^K
M^3VENY,E7*C?'[U[!Q&#(4DKP)/2@$FS>B \[R;C0=B,0348R^5XVT+MI/M,
ML]]VEP_3X>2@BNDYD7@],^6-^3G1\OK=!8)BEI%&0!1>9LS:+-.MY\@X?[*K
M=%(Q$:J[9C(S:B/LORV3Z^"@KZ2PY3/#=/GZH2.(W7PMD#+HB?@%J49&(]T2
M8RJ63!A[\S>SA(BG'FC,A[1=FC2>$<Z1ZNM2WI8- 'T*)D(5AV^_]'[KO+5<
M:EEK?9^T[CO3R.NM42,S;!-4=/^3@^*2SVCMWQ4K?\.R$(^0(MR"J!M"C5JF
M=3O#F#!^?AC.XI5O#&^8]I=__F;NSH:R5U;D.:\P*!AXW#&9=8T8DI!8@%E9
M>.YOY,ZZ%_]S2@ASXVIR,,CXR;!E9 =99+<M.J3GT./>-X?Y/O^6QWR^]0K[
M09O!VU_WK3$+ I3S(ZH<(NUV[]%G432^+<C#&&..K9QZ-T"Y-YTQ+KQ'D*#<
M<F9EJ(OL",9/=BN%0WDIRO7QSL6P.@VK?,50MJARYZS+\9=TXX<$MWMXQ?9W
MG_#%>>_S-KK\J4#;[Q1DCN$+.F4_/5P?3U>Q2/&T&)MLS1NOD#,*&=Z:UV[)
M(). %K?<0"'X\\I0S#7+%M:<-1 HF'4,Z/97HFC)Y.Y)[0ET\[^Q]_IQTN8[
M^#6^A3]FSOG%1+-!^N[8GX3[[[,/VX0]LN:VRVGV".GZ )1EXW_TR^Z5&Y2\
MTZ9^1]?CMW@+L\!ZS>-U!^BVUE?(LP51T.73K4$@431\OV/8VH2S]X+<5JE[
M>+^E\+O"/$+[K8EM=__=&2+=,ILX'_Q7B?5'YC06Z#%(^CSR&/10))$JRHB(
ML%Y%4;C1M/NWCD&T[^K@(PU6*GM%!)[S )T,0<'O'(.2^O_1SP?9,7)=.J?^
MQ]3]"A#U TT-0.'!V^EDHP 3FS':]!<X9%)%3OODY-:P 8FYW$?.J#$]J#!0
MW40^\:-0U-SK6Z]/$-27/*,IC_]C> QUT=W(G&P0WL+S%;B_IU=%5C$DR7BF
MF*L;K\A&@P/K(R.?LE4OLZ5DDCP)Z 7//162)_0VC8S\N+/?2WD%+.&0T]6X
MBXU+%<(;J*DV/L(X&KLOMU-M_(KTK)YQ;KFC0M+[N[-%%@P_-'5QE?2)VHQT
M&13!8"<Q$4"PZM8!">L09!!64]);>ZJ^-8OK%=Q#PD4SAL^F;(3=0)A[:VO0
M"AY(#J;<!Q,,H'&HL[G-(Q0(,0RG_;,6%[MM=*\F 28P5C-X ZL]=OEG>;.4
M)6=E)\@FX;4E66#04U,XF&FP/WC3<U/WSS;8NG[R;ZP]^;K6IM&:&9X%)#E@
M<.+]XMX/\3TKN=4*(<I+HG5[(G I,KSE*I[#>AO*3E-<XYX&_-3KPB&5+7H/
M[0(?[EE:3GMLS7V^'?=;.^7M=V^Y.*"1_')CGAD@$G.ZOLV;2'= IM'MRD-X
M$4T;B:=$@:C\**<+Q0/#U0739=R7VX4,/A;F4Z)^<!?55Z*J/#TWCX+ #J;0
M# WK;31>%(9S0&AZSF22?+\1J>-?QA\#@1>_XG8 ?7'OMD?KW@X?];]F):EB
ML*=%Y"5[&/U10A!/DVCP.1_P-(,M(%GH1A.%8D^N$'W9W)TZ--?<G6D_,OS=
MF,X,/EO;#4^XTU4&TG\8-^[4HX^RIG,$W%!+B22&ICG2)A# :4]4:_4EB7)V
MUO%L9,0/O=^E9LTS8VVACTYNU_(E\')[O6;!MVE0JVE7*'>I2345;Q%\DSI7
MGPMS1E#, ^D<JL.>Z$V_IEW5B1F6\K:=/C3MD"][N[QBF1'PB;&N77ZPJ0G-
M2C$@&M"YJ@MG'$)E&/WL,]M2:E8B+GA;MQ,[EY:9)U23V:"@^&0@>>H8E/V3
M95?(XGO#U/2\R,F0K'0:6B(DMLJ?<@SZ<23Y'2FB)4=4PM5':#GF;/J]"O#O
M\2--:BC,3M?2?AF]Y62^_5YNQ_<ZLP7DP0WQF W8GC\)-]P23-PD(:AQ%*<%
M7HKN%Z> S&X$.]F"WTX_74K7O+$N[7&Q4N:+W_?RHKA<?[2O2#JM$YLQ8'IT
M?L1AL/@'C5>*UL DMC"H1T$[Q:XWC:O$:TSX"J<P_YV[D6GT+$VEOFGWR\MF
MR^3-5R>M7U:X3H?EU*)>;6S(?4=<@7L0I:.0[CL1"RPM?,5(5\QC-Z\E$S$'
M T_>0;'D-V6E6Z\D+NLW-WO/I+\(U12J^_835@GXDV%P8:!UZ0-%"0>)1;*W
MF.+=X(,9^DGX6)&9U=UVMROL9M6?OQIZ7 .EQ%G!RR<EIYL=UF@\<'<"!B/"
MX;W9@461<L5$)I5:U OKI_/"MH["WP\R#EQ+LJC[?]A[SZ FHVYM.$I3JC1I
M0E10E"(6BB(FHM)$1$2Z$!7I0@0$@H1$07J)@(""$*6* I$N+9$N3:1&0@D)
M @H$$I5P2T+RQ>?7.\_SG//-.>][OIEOYOVQ,\F>2>ZUU[[VNM9U9^]U]\I4
M;O3IGRSOR%E^]PO#W 'X,+#S*H6,+7('6EJ) H[6Q::@3B6.1&I>J!H/\0]:
MJ'/*MW!==\^2]Y^?KGKBF-2LE7S7IA8<" @QUJE/&>!N>#3J.$/B"1QR&&DP
M3 O)$^D^^:/"KV1EK\'P=&3.XL]AM9WJL7X^4AZIY\M?.P6F:UI<KPGU^)R2
M6_-UJS*1/0P,L9"NJ %%64R*+F'*G8+N?D?3<:B*=J$KXN+N<,;J<I8U(Q[?
MJO=G?BI)4/.QNYN%_'-)W]1O#.J/)1$Z\W=MUVH;">&0=^.8_D# K&*T[6B+
M@WZ2AR&0:Q.14)A/I)&>7'>:VB5YRUU)_?EL**WMH4HW;+QG(QS]5VECX38P
M.<X7:+U./,'=^FN_\7@E_A@2"J3@D.<9(0TQ2+WY/'M-5W7C4?M%@^ PY,3/
M</$LQM2,^17/$P=NG)=YB=5AJ+-E#,&3GK\Z.$>LI]0IUC2!@OZW)$=$1GL[
M6L)EV=(_.'"?=EBQB)"%B$NVE+SGKZ3.:B3ED:^JJ?5M,PGUAA4.[,66\<V*
MGFZRJ#,;7@L$'BYMZ XC[>.H15]EZ1(@6+%.^Y]6B[2?L9->":%RXF%WCX+2
M?E76,<#4!EH<ZP;[$MVZ8PB,:X?Q(?<WUH[H^=_I-ZD;U\/N\<T@]80R+NE(
MSC4TQ!Z]<[U;/2STWIY7BK\(48IFG00A=%O  RY(@FU*K.6"%-&>;.EQCV&V
M%;ST<"ZD%'ZXL7@M=7'VY!TGZH/]+2XV$^:?+IV1T8@D6S[QWHP\%LDP0?30
M%EA6OMCJGH]V$T9GBB97\D\R]C:4 +8=^@:5C,FAM[X&-J2I%Y.0V\*ZN>2
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M%:3-3+Z_ ?)^D!,*_[7;QF>2,,3&E'_'I;(-6#!@BFD,9##.?D0KU+V#@:<
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MD;9VX\="9-+]_"Q/KV564%/\YW^I>%GL]I&\D'SB];#?%^7=VFYDZ$](/,.
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MYM#QH.1EV5.Q=T"031/;-]W+]>O;ON$PFK10]R>]E+TLBBX7)+JN11NY,?X
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M.8+3UDN1=JE+\,!>'*.I6R99UIH>@-VM*CMB+EJ<K7I&Y0 #.J=.,V-=0Y[
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MHX+YYPZ"\9%"%EJ.!W4N2!)\AN/-0YOZ$IEMB*&J;PNVR'%!C\.@;(S9/W?
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MI<6D G&QDUF6.R2Z_&7[Q:LF#*L?FV7>VQD_4"K$?X>MLEU>!R>!.<(>K#.
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ML[K -Q2PO [I-(N/)- /?.,/VJ^C2Q!$#K!6?I.;+@6.E=5#ZB3) !Y'TO>
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MO]A:,Z\T(UKYDQDPI:M5[?S]C23SD56X!GP,/4K08P#AL'=H*E=8,_P@4J>
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MB89*$7F?GVT<>SCR<;?*^BN>=&_"U]W%]%QC['?BHNF(*4'0_.(7Z<CB8"?
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M5F94#E70_W$4?0V7 =+()MVB/#$!%:$Y??IG1GR?S"!!AR 7A^H.Q;%:$<9
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M?V$!N1SZ:\LT[%SM(6@TIC&"':K'!)E[V*4N> 1C(XWQ1K&RF)T>^JSFV]K
M(6B^XA"4@/"@NS,O;Y-W]%^Z,6&-VE4642( ,V*ET72173*4_*X%MI3V>1F:
M%4Q?-1.'Q;<U*KTTJ3\(R8G]CMC*@W1 "S0VP*(0CT%^HM)Z$-F&L)%272G4
M2"8Z!NQ=+$_4:'P#=2P9#E,0KW]T+W:V,FK4_V=SP)CK_=$[*_(=2GY/'?7=
M"UX_^G5_Y/8_OUT'9-"5IE2_."Q+(R0>BY;M0AZA6P-%;^&^9 8ZX(K';IJ8
M \S?[F+"P-DL6R=AMQ1V#H.S-N>;D=-K5"0Y+16Y^)XY0GB"+60WG+@S>^QB
M\_!(?-G-F9Y?ZY8:#N:]/;\0MZ[(YE&VIH=(3 Q=)U"&NAA71GU(;6WD\;].
MG&%B7K-O"2195M\EA;9/ 6^H-34(408>7#?4M84O1:@\ $Q(BD,)U5OEV!S+
MUHS/#7.JGOMA=9U"1AEWM9KOI[](6=J[WW?^G,9*T(7S6R>R&O:K]QIWYV!+
M 8^+XDN_593+?RX=*"T-J:HI6X-*\7<RA&K)D/5Z6I!'JP/8=?1)@95!?4-<
M."1+X-GL:E)+@G,,R"7#,N@>9+%X8=L=4H<Z2.1C4A '8>,0Y WFZB'W4?.'
M+5+;J#4IHMFHL'>78Y4NC2ON7?1]XX!2D[OI"YH2]_TBS0-3H]8?5- A%-(B
M^+,EQV_JLT%,$7G!($+)*F/[PLCI93^E$WQU*JY_>!4$=HEEA9(UZ.0ES/@A
M:#L/6OBB.*YJ+_Z[&=T&>]!UXQ"$B#59YZ1=[J/=08S^98WSH_819E3QV'C9
MD*GLO\$8R<=]9R(7%,+$H\[HL=2\9T#HWFAF#R]A#&(%RM"-Z+ANZ(G&,*:6
MX>Y._WC7G-#7'=AM'.81#9-Z"1*Y>D474%HOH/GBF11;OY!23(8_ZT'U; DY
MS=C/K$'=T!D#-T;?G9V2??V@H4Y_V55E W]OD^M=F]\+"-EN*!DC 52^FPL]
M!/5H(93)-F\>3S0@UV=$\-3QL>(8>3Z)KV*!*5]%WA^+M!!IO9R75>!A%)Z]
MW%:_N?Z1H107_*GVE<I]6.LNL6,@<&YZY>/'?_9:-PE3C0$]LMLH@WV/Y)>X
MP-=^]CU0?(^\D)AI\>G%T/WF6M@/*OE5TU/CJ?3-IT]?GO47!NVR0DB67;PQ
M2''LHX&:9 @7G?\]7&NL799X;%BCXW1CPA[,_'7IU>'O&8,Y7)QGI);%T:S+
MLB@*>.,.F69^D,J0HLN3>](2LR&G0G^'QEW/_HL_;AY^/.74XX)LMT?*,VFO
M5 O;8OU5,**(,0:8[$?GWR$*=^57ZKE9G@JM=VH85]@\EZCF*GXGS#XZV85'
M9/TRB\B3I?MR]UL*[@\B@DOG6IY@<M"!6:+T[W4_L=IU;6CYQMV.MMV.H4JD
MN^64/0[)OPMEZY-=3R)YZFI4&?A(;"4%*TF*61A+K+XS+ZV?$U65Y_NJR;VJ
M*ORR\2OB&^1X#C68LK"1M?AZ4W1[ 8=@'U?8^!6T,\"7LSW]"31KY7MU47S"
M)@7IIQ0)%F%<!MR)^TEP+<H+2TD/Y,.L!G/[&4TR/<C^&,=PO?+K,RY\85XG
MU8YF:*GHCOSS;D972%^3,>(DS1B@0*80*AY:SYQ2P-.+.SZN6?YEBV%3]R6^
M"NOW-A>;"\K(2*^/C-I\R)ANT5F)N&O^A9 B[C)6K+X^,CPW7:&8GXG)&9=N
M3S6D9AR\:=<A\DZW+1Z"NK=BGW%-/&4H&!(ZD!;H0AA*UC&A=IO=)<. ^CS[
M^K'(]]I"/1%'%Q>FU C<DQM2P>0%&B^#SU(0KD%6#\$7)IVHUTC&7)DL,.SG
M^+XM$'MA//UIMR#ZBO3+:"OD8BX5<^$@2U\ ;MT*-"Y*W!WJU!=&-U">O@F>
M4?,4IH[Q''^/5KW 9Z;TI>U501M_T2-4)H87;@4$$+&)"(5)C*8G0VM\B2*=
M%LY32LA_?Z;C4WM8<IIRZDWCI5^1ID<+V<]4'X(P%4.W^)[&K(^VP2=@'[!R
MK?-_RQJU(4@;O%7T7%&X^N:"1MYJS=?JPHKUB2:]*)(E#LON >5GB'OXT72
M@45D? W<UOW8]NS:Y'[VLY3<#.6NTZ4X]J.7_[SSRP%M]G?1CB^L/UKTBT>B
M0S:.PH()&\Y$H:)%&$P,Q0NH0@6&CB_$V]TS4--8&E%?/POBW\G<>7XP[&1%
MD6)PL),/09; H\6%(X 10CXTWW 8[NY*')BSZ=/*WK=+J9O9 +O5IVI>2+0)
M6)[,0&),>X LFB6<]> MUFLHGJ%!:8JCW%JPH,CT% S%;>U>W/#9LSA+2%;(
M)X:)GE>X[Q^2413Z^<JI=8JBCTSQZ@Q0/+=P'X&^075## A,C*2F^#)WS=O8
MV-!L;E#=S]*>A,)P^B=%N5-19' /\BC]:IU#!&;!:OS25E4P6^QGL:O[9]0>
M;LW:R']=?$/9&8^PH+DR9A#\ )JF"]@0D"\FB4*U)0#2*L<ZTY'2LVXCVE#]
M]>L9@U.N#R)]\]MX+O?_<>OPYH74WGCGN=;F5Y/OMS0?UYA#LWR<=7VT;:YI
M?\%ZH;^#F6ZK<<W_:F8D(Z;A/[)2K!D:ZO]W&P1>X8,VR%+J-!.W[90.!#7@
M:5"'?YP&3;R964U1F)&8AS&I"5=B\'X[0$<RV?$>MN?,/PZ2-.7_5934V!W$
M()?6=24.05!^Y(INXU+C+&(0RZ^ X*'[_H";5^#"]%)S%-(4GGZH4CN1\,.'
MZZOVIU43P:'$I*S3O3H-AR"I[]\OWJH^TB'GM?U*.F-SULZD+G2K<U[;DL]K
M!T<9[;(F5W579V/);[YD&&OQ\;N[26C^I3CPM)%))H>@6)U:2I1=0Z%T*T5^
MV@(^R:>2K:0X<]S<>Y5E+IDVF0O@'J1U2\J/U139"HD-5)R_NGB"XYOI=_;3
MOR8ZU @FO2AV5)1-X5'*<EJ\+%/]-AA7.(<4ZT(]&W/<)N[6G?Q8XEX!":4Y
M9PU7W#H5,'D_7%XG>$_7\V'  SOU7ZR#GD;]QG)*6>?SAFDSY>Y3:5: :]$,
MHU?;+XFOSR_^DJ[Q!)]CV C\1WS!"^^Y^O?B&T,=$>!#T)53H\CU!^"_EDZ<
ME"02]GDP=GK&@@R.VD6=G*K.K>0DZ!<OJSDJ91,*IL42."%SG V@*QN.8+HF
M.!9)^+!.#Z)*A-#.+YB(AALN]5"C9+/JS\('VX(6G@;@F]?N5-W1',4_Q19\
M# 6^2>KPWPKRS_[0:K;YJN6*]>9D?=UO^'+$(0A<C\0L?,>D GHD,XCS4"0>
MF@C/\CL9NF.50DR(^Z;>]O3XW^2C9Z6/]MY_O@'5?=#QYN^N(MS7^O.FP*P(
M2(TM"3[#<GD.?;F_%S:+D4(L8"X=@J)SWY(ERX,(6/9IG&!3P6/JTW5*;[RP
M8A;"[-BBRM'29R)?@RH&;JFTSLU->XZZ3SJV@@T+']6*E%IRWLI[)5G_T_=B
M:8/OJ\+J(9]W$SFJ"!WZV5'X%=I-SXMNZ;.A-KTVFJU9<=E3J>:P!.' BPX/
MC]@:\_BS#(:@!'877F Y&/I:+V8(&XPBEN98SOR=:H=>;_QM[&KQL:W[7*J.
M=;?"G753.VAVGRE6GR7%F%?[P\LN+JE=OEIFHZG(SX<ME?BC3CW],M=K>,U
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M:DOZ(C,BHZ,:3U$&B M)FYAS=#5*\ORY?,O&\75=_D>*55FQQ7[\/SV/Y=B
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M/4"QL08W",$)/X/;Q6P*X4PF9>OK:=+U;=RU.0F7I%*F%M5.:F;W_W7KHYH
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M*C[>!9,Z",/Z!JJ'QPCF+XO.C$-<G^X;&?D)SV#"OEAZ#VS37IMI?C/P#PR
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M<ZZL*H;?DQ=I7M7^B]00\[+=%5.1WW'V;-^1_M<0>2R;;!%,@*I/6FM>*V,
M'O"QL^&4KBD]2NB*Q93OA/MX7=B*NRWQP\RRJ4&%CA[<Y\16N=<U*:]K%\+C
MKM_K6-*]POKDBNBL^>N_>3 G,*_-&OI7>6] \:-J=[13MP0/WC:WUK%;WZ[[
M\K=&XLB/@XE\QE?(!\*CO-_X<)[=[3$M_<+:Z@6_T,7Q_CC7D.F51M8GSZ)
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M=.\*.L6TV0SFYM33>_"BJ.ET;2D2+)AJY4Q$'?.?<9/\7(8M?WLK_?C\Z;&
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M<Y=P^@RU\X8I=?MJ;4F6#&8'<,WO6_@6\I@]""Z:Q$*IALJ%? \2+%OOFZQ
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M<";NX1I[A$ =="#3NP1'K@M\4=2Q//W*(NFB=.S5\WVOYQSDSO;CK[#IY7A
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M,K+MY!@QY VIWDV6)YJJJV-FQ@VS/S35_B376Z,8Y 0&?P<5#FDT+"FP1SS
M!U+$>?2$8A\^/:1.M%>3M6X_:.JI&X[\8D">$A5TS-Q&*E*'[-E(!WC+NZ3
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MD+:"<CA#@MGI&"Y^^($&>'@5_)N)GG&A Y0AN7]J"\3W0%AH@%6Z%_T)6!I
M"'V_( G]&+2RU$X$;IQQIP&NJX+PFJ@WRWG_V++PG[+ [&#3B$+)F.OZ5RS_
M%<O_/I9Y;)L.^&],7!E=,K=I@"#J6M224T]0!&=(X+\Y6_T?S5U@$:U"121)
M4QM=47#MJ%<&U6JF^P+0+['DYT0:IZ5*T4R+3G.:N*;FX&P[^DE!K/3%_T[
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M5@-/F8/QD REGT;W;X^;M9H6E]N<[Y;>.R$=>?G.YL4ST &D+LG(^AC=JK_
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MV295@.QKEM;%.5NYS:FV]D7*,[U.#9$J3KD_^<:,E?L9//%5$WN^57C)O_'
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M[4G]9A-P]V*6"$VY62.&\#@7B_CR8'-HQ&WA& MXGU-I>?=(("HFCYE20A5
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M_(Q-\'UPXQ#H!NG@^(WDHI3IS2K*S3C8=4-5-F?%#0T;#PN43#ING$G_)Z'
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MF0UJM%9:T*S"SEPDH+\GUS0X)??Q3KVHX;-/F.WL$*$I2B=2)>#V1/>$3'P
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M ;'N#7%:6S\PL'C+PJN$]?4#[Z41C)MBG:Q<=5^MRH/+W]?^K4=%G0#8?Y\
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MMJAROYS@$79QU+CA]+H5-3](/0'8 >_!K2F\JZ!$]9GB?ETV(BK^VL3S,>_
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M?/AU"UEW.DAC':^2HF/@EW'@V.Q4&*2GI2&R\!=9%B=%'/VBNKU9_KTE8^]
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MV;4]JP0!<.>4;OI87!F2L?5JP:S]&DL6CYE+JN>0';3G.5^NJ$5*$0>MKR6
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M/<U;ZL@HG^&+-28W@I+?C5^L8DO^QJ62 (RWHSE;-4_XS$)1Z^F"7H33K L
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MJZD-X)_?*":VL0%@DDJ4=Z529"V0]:GW\YJ\6$?16""8L?7&_@;;L\E]C]S
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M)5DU-6:IS>A+O_4TZ=P6N\U_IEJX=I/K98.R?I9+GR;[T4F.=97[8,<DP^
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MRKW>-4W663>Z>)TR>7/J;.Z+_ 0_%>.GU&R= \WZB7(DQ$L";Q@=2QYFU0F
MNI _^J1\$]3'5&>@K[*&UKI^)L[^EX52\'DR^]<I;O$RQ+[U$EU^'"D!AY8A
M\H]P(N1YK>ZT\0W>4B\O_^ @& H&R5E3;X1-N+R.4Z9\J 1%'##?7+/_F=:N
MS?4RF<M(&_1_+;.A''5*,F,TMY80A>,D8[@0XUHC2 42C?6%]BA2C1RTR]I?
M5K,W)XZGIRM?:?>5[QKMN?!!?R4OQ2=J6$PZ6V[+I6*#TZT%0MDB+A23XYG:
M0J2S.EO 4[Z"B;4+MD1M%]<];9G>M35]JP;/K4P7&2E!T9_J*1<=7[$Y8]*0
MYVBN="=@' U,XC@I+]H/OX:1V'@V6KBLYG7(TFF\O(FO?0ZVY3XJ]IYFFJF7
M^SP]).^5>9C98G1RU#V G]J4OQ$A"EHE4 &;N'YJ8O<EA_JFA!MG:,:V;[J$
M3+JG/,8NOL4Z3$%<AHEIB\O"Q60V-F@+> +'M#Q\X<+*% Y2VB^$OG1E9Z]B
M*4?>H;XVQ2$\U2LB?C*57Q>]"PH9MV-E2 $5NP\HV"[P&2#=>KP=BE9[0H#!
M9;??J8J3XV<(3 GW,9\8LDB/41R4NDC^V\W&ZF9$?P2@*%B2;!&I^:55_O!7
M(/UY 'YVNN<&\]!'_$6+#'_)X!*,-+].+OWEE-*11,\QJ+JB*)B<.-.<]K<G
M4.= )C=4'>)UOE2(,XQKDYLP*_:X]G:?T7#R-UH!R?Q+V8%;9A#7<'&KZR[1
MH1M\)N0"8\16IJX9\"ZW1BI50@>9#&L#?C9423E<[4G]UBUF7*6FN6_>Y\P;
M]U,F\Z\&6W>@8;22QI..SI?C\%I6GD=AQG78!KT;XRN(*1.])+T[U8\WEFZ?
M+;OUZP$FK-4=\T\413%B^RO3NL\UMCEU#'*#1#7"MQ1HSXA(R\F5(+O3P-_.
MZE\M-WR98"T%Q0^4=G(A>0&O>.N.8N5G;XHM/2<5I>_G,SU;%V^EGPU6* *J
M]0E*P8:&E1,UM/XCGI=A1G7O26*9'3KQ3H]23]U0=IT7.@]*]15]S_J6H794
MW") EZ'Z8B+I!E26-L95 D:7Y]"S%&,YL_#LV9VJ6T)J+J)\0BMF"C1VI-QD
MB!"=^3VM:^2?IB(5O\60HE[_;TUJL_OW):&#]Q#)>=0,UO(?EBP7OQ,B!40N
M.UBPS>2VM?"/^#8U\W8]1_1W>F]8UI5?QT;;[OSL;:J3K,H[FB9NC6Z)1*N6
MQKWPNZXXGF+#5L6XB72AH-JOGE*""R"J.VW9QU8^/DK/7"@^G^LY%'@SP.)E
MROI_$X%V/7)G-W,$QWW+Y/@0EK]UIF2U4\/_")1?L;)[9O)9FRNTKU?$Q)Y;
M3^R6ZA*A8[&ZYX-LBSC]S-%G>H#+,B9B#ZGU/X/VJ(K11IV >L-+9ZRE0?./
MM,I'GJ(]V(?*;NP[F_+?O9M;\Q=_##I'-S_*4)<"Q^/$28M,"'C',>BJ]!\(
M3P]I-L\W;T--9C5Y;5W"/$_>LG$PNO^:$\L]S2><)ENUE2%XVYX%U*5CD"LF
M<E&@5HTF=Q[8;&^1P8TER+T:K2V#_O,8\J+AHZ>+U9'3:]5(-JHME,50<$-8
MG@KIK/^3S=;UUNW [)[3OT?CZ)BV2JL--JEM_47EA\P5DUT?W\D'4%#$+ ;W
M.M!*83M)%?3KRV1>^@WEW)E%2F)4R.11]*K>44%K[S$H'5+]T^\8E()*3<R%
M!23VR%SY/^U=63C4[]^>E!9K%"K+9,N>RC)9IY(M"96EK&4=&O.SE66:L90U
MA! R4\@2L@VC+&.GDDF*C 8S"EEGJ/%EMG?ZG[[7>_">_0]^!_=S^AP\G_NY
M[_NYKL_S 1]"]4.;$XO^&5/N?$'WU2H+<!M4J"8'O+]4_]-U7[SA,45;Z/+P
M?Y:=Y0&TG!;2O R6#Q9E!=$Z-X?H<$Q<S8?*I9( >YT7K0W)7:S $Q!/=16.
MBOO[\Q+XN762'66BYPD!<3B2V>TA[:[N4KM^I?JUZXTT ^5S]#*,]^N!</DG
M^H*[L[(\])C>+--/'"GD:0!2$HFP' LW41BD(A)OQX\,D+T2E5UCG_/;[Q-X
MCN*K8@D!$ I6 MUM00C(%%]Z:Y)153W)!7G!QANG+S2E6;E>3ODAMG>/?%8\
M0C%/S$*4?/B-8QT[7"5/RW-G\;XV!2T!0T%H[/+:DB6G8P.YZ"-Y),9[RDFM
M-?O?/ED'G*XM'9#X 3Y""$0?6B3(* %AM(4N_6E#NE-QJ5E=8&U5T)S9V.]E
MV'SVD7W%/^R4LH<^7;E;XWK=<O.4)G\8%T2S2Q<@=F,4 2Z(0E:?EH6:?>I4
M=;>L<#D7;Q1SN.C2Y[4?5H__2?5OQ=B6QOK<<2Y"WJ9!$WFU 074/-Z4 LS^
MM_C8,AKTP8HO[?FG/U7&!I7+G]S;!S;N=C[,CBI)=,D[+6 E)JAS)N<$S$)]
MC7+DI/_]S&NTS-40^FZJ7 %U]9 E<*/<DF[6%9W[$M-,6;7I+YFQ.^@VM4UW
MZZZT#-(NK"D#I?.=,L+S=Q&MF=JH;X:0P?7)H"[T(;WFSRQ1<.9Q)WQ#QU>'
MKRH(G8-*(PW;KYT@7GSQ%S!G]7Y":5>*I6P 7_KZ7%)<NWSM.^KZ[D5\M%^I
MR)N(4YV=AL5?KK$;W\?0(!ZZ:A+5>W,Q+N,4;S_YZZ)\@!UMTQJHXX+VO.0E
M3*.ZF[6<]%>18Y89&U^YH*_DBY+L0A5PO_1<D!HE]ZF<L*="1P=4@7P6C[ ;
M8BYT<T'-4KW0Y.C@AB@*%Y2,X9_09!D*!C;]VOE3^R7:2_;R2K:8)'2J'X;4
M!&9F"1F%NJ3\>*0[!7WD%V,CZ@PY(+KFV(/34/<:6I,JXG:8YUG..+8I*0YI
MQ@Q$C?#-]>Q <O36FN 1>YRJ9""T7F]&Y>WBP_R%9]?D4WTL^1WGA$!Z6!X7
M\7)\/$7,"1S'BOXF&UE.&-O0H,YM?)_)7J[D"Q/VS1D#UGRQ1Q]_MWJ1K*3A
M?99:D6N2S B) 5MZ<L:PPKBZY-I99EVRQ[X6>F#\X,5\]V;;BZ #*BL_62,@
ME37&Z[I>E-(8RYNR+.MI16C\&EY\==JH36/*8#PFIM7'_IUFJ)KZXOOS0F7Q
M^X]3.\& .1<DQ.2"1$KQG&]<T .[#[S%BPOJ.<](QTZAIZ;M=NP*VM@J3)O5
M@D%6\^;=U07X?4'> <QR04^B60*#=H S2913]/REZJ3;M?)L0G%F0$FJAL[Q
M_X)1;O\MV+V /HCJBR;T<4%IT18=<W6'(BT]Q\*-"N;C:MIE=,G1:VKP<KP^
MWC"5?"HH-$?VW6$QJ8TQ%5#"9Y88($P_1-%;2/I=1$S5+UR(0VH=:&X<(R:*
M"]_<X7]8$F_T8<ZH+/Z4 ]X,L;O-HJT@+@+A75)=W"'(2*\&0TF<?M("2PTA
MBS1LI?<_PQR:J&AOXVE5[O/MZ,0DD_[?^$F,]S^CY)JP(;[*5#Z'NTTZXG^^
M!<SL9IE7(<UIX#2D,S5=T6FB'>Q=/>G&!?D%A,+&\5Q0<(R?D]6/-\4OQ+0:
M7PL.N;6$=HA6.ECJ2!D9>UY@9T$;H'ZB#PC"O,M+?A-*<<(*8U?!]7#.&&=(
M?X'M7,"L,QKB,%?(K,B%>2Z(I-'3>6;,5(YU&;"<A9M1]3 YU'=Z ;JK@AR)
MCC]] T&_E+/Z3!6L1;"(B@^Z(PLC9L8.1J]RO6+OT\VO!^K^4=<[=L^?GPZ9
MU:KHUXX+ 4ZL7VUOTG_GK57^,H"/Z!_EJPO1QUO5YI)E^]NO\M])P.\[7O@#
M*<'4!TB(C&E9^E9&ISP,I=1)ZRRZ__*&"TQ.&JXP^.'M*:G<W+4UV?(3^S>F
M&%ZW',[T=[Q.Q?@WJ-MJ@'5_>=97I.D210#I'D4JO!*X1YNX.:9GLMLFL]<U
M8F]+?;%2_/LU&EFB4#=]3\!HMR!?\L=YN#KYY\(*GE&72#C:;L1NPW,D?XZ_
M"&-D-J"'5%9OADNZ3,VCMOQS" :7UZ8&(.";O/0!A2D24;*L_3Q2[J-RZJB$
M5<]F+B@0L+M (TRB/O[<]IQL6@K=9FX]VR:0SD[B[FR$O<%3>%$ W*TQ,^EM
M2?.HI; 1?:- CD61>^RRDRE_.]T"PXC.>,'8PK6/:99+P9F]!S-<7."GWMQ^
M]=-N/-R^;$V@]/+V#(.G02F:+P'LG.@A]\CX)80<D&?$-(@HEO\=4S";9(?#
M;_+GY"B7G;#Z:?4B_\S^4HO0D94@+'"?ID-M*:4?FKM<*)I1U%6HG8*$*49%
M)STD,6:[V<5>B<NVSX@"?<-FK[<56S.1-P3V>Z$J2[!&'8.KLE/&!(K*RIN7
M+ D@SKLJX)ZM2%HIH&)#NX)]B3,O)$WW6)/4A/H;^\K>/U4WG0\-BXNCN3+\
MZ1-=?[_\3PRO2\F#TP9[:A3&PJ.,S]16UV:KN6@J$8(2I,^+KYAK!#;=23__
MY%D#8T<M[$S4Y/8?YL7(?0.%?[O1DSUW&TM5(2\VC!I?8[]\"8O6Q0HC"ET=
MHG3?<$&I#RZ%4\J#<Y^6I0:;$I]N)2ETCM*P/:* .<< ^#" )<FA6<HD5($W
M ZJ(F#3M9]05H>8(:%(TW+W-L"5R5;5"K:7F^BO]&N0"3W:^9?9AA9Q[(-."
M]/GT<B"I-]J<D1 250W<:M:(J;:I[KY[V4'KN]:>][/"'.]2H>#T^K:[G8*<
M@5"6,@X(S %:YMR***LC;\*4AW>B^T^^)CUK'+)9O=_0>#1*O<S@J$#L;$SN
MX3??.LH*J*:&['0"19L.26O^X'G8#68XWTRUA?0;ZGW7UU!A*)-S'SF=.Z.S
MVIIA]?G<TEUD3F/\D7VO_1FI#?03:4QCH+IW1DQ/]"#2?!P9XJ^'R9**0XI&
M(!#E[I9RRZ%Q/F]C8$+3KFEIU5D"[8%A1_: 7ZJ6%O\Y5KGS3'2EEU:X.4OH
MEI4R__JZ](NQN<*[RN6)H39S3D68HIO'Y7V^L!^/*SD2I-)8_I"\F?KQI'MT
M"#6OH2;PVM);<%^MH?L9D\-3-2&+663S8X$>UPN4T\=Z]]3F2GL8;V),!E(-
M,#\VV[YO;YFQD]991C3O'D,X/O/D%!7R0*\:*SY(W<9]S8J0M5@FNK:TXC9/
MT6QDAQNV+SBJEIADJYDKEHP3_.N.("T!;W;FG"?8)<BP@J4<#4Y1;!UC&>HR
MI:UP'Z\,L&Z:[<+<"-&XT5B@W)K[9,2%[Y5BG5=)AA^/D4,<)0ZQ4S6?^F<B
MPU0.&+.EY377_'H,,_S:6?="O[EB2<RUO0ZAWI>O3SQ,W]Y4#9&W<-Z5U5(E
MJYV&$K&F@QGA7]MW4=UC[+^6T463*CY%V-ZZG3$^OT#$!_@67SU>)2V[TJ6Z
MZXJ)!IZWWTF_2,]>XF3,  D]L'Z 5V_@@SCW4.V],"G2R>*RQ>G#G &<F!N[
M:*NNJ.K;>_[&!%Q-Y'&ED,VV/)XE\L**DU$C&%' %9QN+/HJTKD7<["!5COL
MH4 3"/QL-<ZHOC.15[&:E1;EINK5F/;08G<B:.$7297QJ ZFV 4G^( E68;Y
M+LW /;IJI+\E_8)K2V-A>3*I?^/[($RBR'WR^_UR^3T;9GN4'S5\5WE:U./[
M5&[,DYW+@E2A/K1P00=PC(Y1I%$YS*G0(U^O-"&LG)WS0;])\91\68;5[7]<
M#@YC3QU_?%\]U:# ]+-E=@!!$*4M*^66Y@(T//_NZ0Y#5/S2@74*2H:X#/?=
M9H1GK_EA*.?.[J?U9ELGT_9I!?%\R.]/2".*]L%(Y_,3S>[@;HY*?5S=G7.;
M:_DWXJU^I-W,H$REY05DS8MD-%G+!-_%Z@SOB/]M-2G+&TP"!AG!0!(]83:I
MSXX?F*+ZI569S7D*>@*W/]NJ]'A.TEW8KZ:M;'\L;H49;ZHBJ0;'DQ^EIUKY
MCM('5_Y0OP*$FLBF+I1A/:T(>/U^_(,[GO!W/'O+)GP^^;66].K!Y)/ZE^P+
MG"*',J!D']EI@KG,L-O*]DP7%]0@UT'S[YH1F:/996II(MUGH2)@09NJ9<-#
MO##QLR \9XN1$B%8DZ84,SK7>E6P%4ZIE[W%% IT,CU,0 ,N$.*<'[V.I?(6
MD0QMG!.\5:F/R=.Q&)]BO(,KG9B':H<V]H?@3'^+8U]4EI+.=)1E'AWG:3<7
M=(1E T1%^,[9)=_%3RLE..'&?YO87*1M_,J+%OY8K='?2+)>DW.\?<2JZ0IS
MW,)Q U"P2T0W#:;AB)FGD!?I=1GA1/&@4XL0#["KEDKO:MFO^EZM?MRR4LB[
MB+#CCW5%9'"OP=%>%HKR[%3>B1JO4(D]FIQ/,S0,+YB@A]O8<0RP(@>#Y((@
MPV0N:-<4?L:D.J&>G5XVBO:W2T*)CK$<M; III)$?L9#*G^]4$J$S*$I'>L[
M/MO4[.EYJDKF\)Z:"I&:W:+_\(@A,[S-=&>G_D&DR('IN1./VGV]7P%3 TY.
MAM<""U&)XX:H(F__T&#O>$'(FX*!7W).]V(2-6]$[W&LNS)A*H:^P_F$D:(O
M,)+RN:#]$TG-Z?M63"W6<>S.!1OLQTT(LM.3$4QNN[)N9.#^-'@DU>!I6$L(
M>F^G&+JGS%2#"TI)8B2QE#@*;1-<T)<H3[]-!FIY77^US73K*/&\&WQA)9U!
MF*SNFQ'A>:#C4SPF2"4WP]%,LY6C3.A4\[L_"(WWFZ8(;>(&/EBZ9;UGP8L1
MJ#I_:YAH J30%#F'UM-(T%1",^H=.X=B&]8+]F5""N;_SJPNMUE8GS[]$^WO
M[3=&&!GY.9DX_QL[*<W49EP X+0*CKBHSG_2.YJNR]QK.L-.BKD5P:D89L]@
M&;+8^^T$"-3T.Z2)9]5$[C4,(",!2RY($-_%,-1F)#'\O[',7BQ/W\M:0' ^
M?JW5 VL$_QPL8'AJWT79Z=R5#AY[04^CU&('T ]0ZC34"[V/M4EINFD=Q^:#
M[D[I.KA=H+7)KW2[/;Y_[G5&JO/M>?^'+&-V/A)>P8+3L(^0GG1!\PD%FD?6
M_5+8VROI%+N5H/,2Q$E"]/;;9P7G6NSOKF;NX<\PO>?^B>!CMV(WF4"!]/YM
M.B$"CH.]24S+%6DTC@MJ%.8ILN,\:GED ]K)A*#E#!C1:IM_:[Q@G0NZ)2IA
M T=0EJ$IQR*28N^T1\#G6G\/L;3;KK[%F 2;W+8)*AJ+:'$I=(QP<E',LLL;
MWGC@DP-A% /!*#!+%TBAL/4G^J>5Z.A^X2C6-0I,-U/$W191LL2@?]/*))TL
M=4XDB\^/JSUJPEUR\)$]1_[C*'&I=$G/8>9:[SK4%RT6 -UMK#%+% 2*>AJZ
M2V_@CN%0:K2G$RL1VS]Z/T1H:H3=6=89]GN<=?+SF/YU>@:Z"UO?0J"=(%YL
M Q!SJ]#S$S6_$UXL)5VGS3 2LZI<!3]4#TEH4M_@@V[!E5<_=S5\;%#(O^4L
M4'9?WMS.2 J7-YB"O,I^UO[WFZ9"C\R0N<P]RY^TDIN_SM'1L?+C\(BCUK<G
MQ'HE/C;V])VRK_$]]^I,3>A@#1O#$0K$\K5K!%$FVV_<HVJ++NXX%;^$'70G
M*;A-UM8V]FIF7Z[0T1TN,7O\PG3ID?/S44N=YH?#JUXEJ>K6_ZLS\?_ 6>*C
MF:;,7B()<KFQ$7@X"]T;N4&TS:W )?3=5&ZIDJAY=,I#KUA&0ZQ;<4_JHO'1
MV0XPA?A0E[VOEW2EX/EB]&7!(.\*V'A5$,Q?_)%FR,58A>,R_/:@6D-54)T*
M76I%BJ;3SU'J'(] Q//H]<?6^_J;[(V-G?4>0^06)&RH?_J&4D":49-X_]-L
M:Z5G$S4.MM:UB67C_;+[>@T1#\.E[VO8C*V$DT]^AIX0-'*1E(Z\QGR5RO>*
MN2MUSEB%J<Q2ITFLY!M*]4*32%I]$UE+XC:W*%-&_MGS^C,R/\J\"L0Z?<,V
M=P\=GW@^:OXM3 ?[%24..'LTTB4ZMA*1T"@$E24<K?9[T<<6(::IN'K^20I=
M7 G=3MY0J#O''XD?!,>"Q=&PNN1CB"1C5]'>(O0#0\OD6KV-\1QWMZ";;V^>
MQ4R/6_DDFPEL+TL;IVCD7505,\LV32DIS#%[5/@%U/4:TH=NJNB=.<*ZV$1'
MU<W:[5W":(XQV/FN[:/PBB_P%C8Y7RC1?&I*Z+1[K@2D 1+DG4"W7&FF#0[*
M"7QF06J1!C2Y!@I9Y+1DT4N/1<E\R9O10J#Z'OJ31T(BAW?UAW)!,FC?5N2M
MYTCM4:1B!8 X_PEY@,HT"84;')=L*1E1#7:@)JJ6JK7B9A_*7T^?5"0T.C@.
MO[\:,(<ZRADAB'8*+-W;ZA2F:2<@E:->/9LFE@:TC(M/RRQLI8NKH:*VFS["
MW)$JM%I&UBO89J1_[Z9+4'Z"PY=:[)6'+[Z</&]Q:/AAB%)<Z:-U+]?35<3W
MIS\YV!2D%:SY PD]-YW3;N,R'<=TV;:ZS,JZ6J>UR1.2$V+%H\-Q<5,*<HZ)
M I@'#N6 W:71YH\VUYK&=)GN-BX!4_9MB61%## 0IWBF5;I,/59]307DY>7T
M\/ #_T64^.?VT_>JW&!O/; 5Q%KW^VWVV:1)^1AFII;"YDOU7=EV)\^.A?FL
MIN_]Y[D0(A6[&WF(/G$IOG> (TK#/ZJ!N[T3[GQ3UEUI+BCCF^MG :(9[&Z.
MT'4((:_Y . N7AF!A5T7.Z5'P[&B 0SO@RZPO!"2ZSD3R;-=CBS^JY\YHI&6
M%VGC:263/(^6%PU-K+ I5A@0UC^RBJNR/V6M-2?8<L)^/?'<_N_?EH)*2]+J
MVW3^0 _\NCG>7+[D7.B'O5>Y^%'QU]8UU[(<%USR5;-#66_/#%W*+O.1D5/+
MCM2P*!JP!U)PQ:?;SR/\=L)O%C2;1<E6OQVB:7Z;5O"_>#MV53/5:DBBPIS/
MU)">OY)#C^G'J':VYW2C&^<BRW>F7>7IJC"(&!!/EKUA^BDOD:?>T:\F!1 M
MDER0_\^Z2I0(\O08YP!2D49(",_+Q1$._-)_:U+PY.>P/JW&NG5G]7SA+]57
M3XJ<3CI*._$NA[+8_X)GF7_Q+_[%O_C_8C=W\G\ 4$L#!!0    (  6"<UI4
M0!A;)W\$ #K#,P 1    <V5R82TR,#(T,3(S,2YH=&WLO7MSW,BQ)_K_?@JL
M?,[Q3%P652\ !6K&&QR)LKG6:TG*/KXW;C#J2<+3;+0!-!_^])M90#>[24JB
MI"8)4NT(C]C=>%15OGZ9E9GUR_\Z/QDEI[YNRFK\ZQ_9)OUCXL>V<N7XZ-<_
M;N^_W-W]X__ZT__XY7\2DKQZO?LN>>?/DFW;EJ?^5=G84=5,:Y_\M/_VYV1W
M/"K'/OGOW_;>)*\J.SWQXS8AR7';3K:>/S\[.]MTH1PWU6C:PKN:35N=/$\(
MZ1_^LO8:OT]>Z=8G6YSRE%!!6'' TBVAMH38Y$KF_P^E6Y0NW%9-+NKRZ+A-
M?K(_)W@7O'L\]J.1OTA>EV,]MJ4>)?NSMV[ ,.UFLCT:)7MX6Y/L^<;7I]YM
M=@\];F$]8$W&S:_/%H9^)C:K^N@Y*XKB^3E>\ZR[:.O<U"-7SJ_%C_%*3FGV
MO/MQZ=+VQDO3[M)V\=)R:0"+5XOGL(XM3,W/KH>5__TSE^//1C?SR\^O7;\T
M/_QU=FEY_JGG,AP&DAPI/KM\7(W? >7KTMY\FVOKY^W%Q#^'"\FXNW(^JJ:\
M:4PP _;\O]^^V;?'_D23JU.?-N1(Z\G\SJ ;$^_K?X#[N9Q=#*\G^/KF"Z.#
M>SBRGV"S.^V%6Z9<X^WF477Z''Y8>D5YWA+X;>D%LVLOU^MY6^MQ$ZKZ)'(]
M+B?PNUIXH;>.-%-S\TO['Y=>W-3M]46 +Y<NFK;U)_FD> Z_SE?*ES>_&GY8
MGF]32<[RSS%K=\7"Q#XYJ:4G>^ /?I.X</K<G[=^W)1FY(F/;!27L2%\DRX0
MXN9!?8X*2'9.6#9?5'CR_"GX85)71^.J:4O;:3 <,.- MC_]C^278Z\=_)O\
MTI;MR/^)4?+77YYW?^.W)[[541\2_Z]I>?KKLY?5&*;1D@/@N6>)[3[]^JR%
MV3V/2N8Y/O5Y_]A?3.4NDJ:]&/E?GTVT0QV]I2;G+TYT?52.M_2TK?YG>3*I
M:A"0]L6S^$Y7GLYN<64S&>D+E%$/O_Y2GF_ADWW=_5DZY\?QSTLA3DJ@U>M#
M3E-)79X1F&M.I%2>*"D%T5(6A4\SKYQ^EHSU";[%EUO;H/L=ZO_7(WW43^R\
MW?,!IGS(/*Q9< 41:9X2R8M M#6,% [>$KPI"I<^^U/0H\;#W)>&\XG194$K
MS1P15',B-97P+)62(M-Y9KPPC/K%T<V,TVLP8'KT 9Y4N=?P7?-M(WW]CUN-
M4H6",4ESPO-<$"E21W0.J^D49ZQ0BBI!%T>Y,P;&N7@)XZSU:'?L_/E?_<6W
MC9""!DV%+++B$R-]76L;C6\_5*^$UJ(@F;09/)5;HG+CB:',I]2)/+-J-M1>
MRVZ]K$Y.RA:7M=D>.V1LX$Y $J6_MJPA2[DVMB#,"45DS@,Q%F2%*>%9)C7W
M*'_3<=G=\/'PX_XKD,>FW!J7(Y".>NJ!>Y\O#_T34]$VP-IF =[E8(&<!K8H
M,DDD?!>X"U1I^AU3,2ID/-6:9#9%UN,>'N] 1&Q6,*N$XKSXYJDL\T^N DU5
M2(G/<T]DD)RHP(#5?1KR7%,J^;69[/LCG,:>1YT DWA9N1-@I?*T=%,].D#%
M!#/\4#4EOO=]_>>ZFD[>U]T"M-Z_@Z?MS#7MSJ6B_38^_)1Q^L/+X]*'G7-O
MIP@LWX=06E^_]2?&U[>2+1J8TCZ%M6%@1F6F RF8$(1KD9O<&6_S:PS[?A+G
M,CYZXP$913#X/GQL_';3^':_!12*2_<^S$'D;)DN%^1-V;3?Q-S75F(1J_SA
M?7OLZSB,YETUMM.ZAH'<:AU &UNG\YR8@-Q.@=MU&C01RBC+=:YDEM_3.MQ*
M,NYJ'4PFF'%>$M!7FDAX(5'&@3=A3692FS*C]=5UZ.;G!\<-'^H**-1>?!B!
M40=IW0'H,,'!P-^?&?-V:&'Q+%BZZ0A&[U[Y2>UAX#AFN'/[!#7"O^/'6RUI
MSK6T(E<D4SB3#%"2XKX@@:>9*+(<9)[?RY*N@+$&LJ0I *<LDX%X10L8OQ*@
MS,$V6:L]X)F44O,%:7U3:E..$"9TPO&@C HK ^;,S<8$UA(6)<KPPE>W6AC0
MXEEF,DK JL%@"A> UT"-I:FB*=,<1G>-U^YJ85; ;M^V,,^7,7GM@X>96-_\
MZ1?TS[>:Z [#*)/HKV^AW_KKLP;P_PA]X_C=<8V30+>%S/R4S?/&@5L1'[_X
MS/BQJ:9U_!3C#UO]2D2JO#P$)C6%DY;83   <:D@ !13DCF9*>E%1@OW;':K
MC^AU]JET^#F4OD[BL/V-WO'+W;\N8]6K-\\>UW2PIOOHX&7GDU%IR[9##(DK
M3Y"@U1BF7K=;>QK0V_9YV3S[$WY\6X[+D^G)#%W<^(A;/'G&=ZA#$";U+X"E
MCE_!<K,OO.+YE<D\OVGE)M$[F4^\U76+ ;(_X?,).!.4S9\S_VU. K=TJ6"7
MK^A^F7V>O>3Y$MD_P07,49GZE(!';\ 5U J@5F#$TDPH9O( .'!H7#"CU6]Z
MA+I]_]C[]DUE.\4=Z3:'_KHY1LP/_Z!1.-4C] )6Q2LW/_WZ"%;/.%W0K$5>
M !3$%WAA]LLW\0(W!5#< "8 K"512RIG!7':Z\QK+J5G0^6%W;&M3OS<+MS,
M#A@;UK5%HKWRIWY4192P<SZ!I_D[%F\)LGU+\9;+)/TN\>;6<JL*,+T6D#.L
M._APFA(NK,_2E&?<FZ&2=$[,ER/=-._#?EO9WZ](%WBVU3C^OKTJJ=Z?FL;_
M:XJ,<0K_P5C>\DNO7'"GTIW&\*58B71+)G+ J(0'(X@T(-B%BCI?B@+X0;A4
M_ABL\'TDD5U<?T4D";90G!1:2R2$(8H!(C7*\9"*5&3.#Y4DKW59_TV/IOZW
MB_F??X$GHGZ]>(/:=9D^\XMVQY-IV\0KQ*ID=NX$[ (UZA@-OLX=OHYN@IY<
MQJ*^^[V7B_ 6_)1I'9GT=1W5@[WXQ HL7-KL>0R$@)_S:$""E%Q3SXCA5"!(
M@+\"$^"0I%F66X />K@\^RDVB3B_TR!1M?Q=US7&$EIPL=3^L:[]!W#B[@ B
MW!6-"E#I7A-;&%#PF465 NXN:'\.?] TT'RH-/ID,.>WBQM,<17:,Z#. II[
MFC!.VHRGH2 \H^BKFX*87!M"G6,L9RI+Z6"]-*3:^["- G7D;Q"Y3BV_K$8C
M;:IN.V+[J/;^%L3\XA@P0/"RFL)2UA,@U,45SWYGY$_1@_R+UZ/V&%R(5=F%
M/1\CBA_PG0>X)]WM!#6_72S^LLS+N^-3W[35EVS3"L(,_/9A!DZX6@D#IXSZ
M7#*0!VF)Y"R0PK"49++PM! 4WF:'RL#?'A*Z%7]>C6?I\UO$LQYIL"D%L)L6
MDHC<!< .SA!#34JT*AQ3J?#>/C[L,+O@X_Z?JU-?C_&75]ZT^XCL8BSX#M#F
M-T/N[V;9QP9]Y0IA5<:I%QF *584X$%S1Y2U'/[2#(RST,+2H;+O-CS!E:.X
M(7_)F3OG=C1UWKVNJQ.PQ< ET?Z^#SNZ'@-EF@^^CO#WMXN;'[!,YIV3R:BZ
M\#YBZ/<3?-0=ZS%Q>S@F5@C'+#4\\)0(A[D_'/28$IJ2@N?.RLRD:>!#983;
M!*W?5F-_\5;7O_OV]73LU@KLJ?CNMLB!<3.2F> (./*!*)<&$G"#VDK!J1XL
M"GML\:9Z@LZ,OW,D,&C>7:7QM5893")PA<=<*)43G>=@AJETU&8"6'>P.O>K
ML.-VGYOX59PS'#*! ?1,Y\2X LADC2):JQ1>8(50W&AM!I=5\.7]Y"Y8T>6>
M='91FY%_?-0I&$M3!@Y8&M(,$:P&Z@2+R4J:IMRD63;8'=Z[%Z(UCGDL;)P*
MEG)M"348#M44'#%M4F(5RP/+O&#^SN/;7[UIF!%!5S-YE4O0IB3/8U)P+HG1
M12"I+ 3\0'V>%D.3X:@_7_E0CGU,P*]+$^OW,([6.XWU6]W:XYC4?OG[[+L#
M>.N")OZ&)X$2J,8.G_,D-PB*7 F:>4J8QFH(@1YIP0S1)@_"<<_S8K#(_A:;
M^Q]B:F/M7?SML;A;A<H9*"1!-+>&2,904@42Q:0^]:"FS&!W;;Y^JS3E])YV
M2E=I20IAE924*"\X^A*>Z%0Y(C+OTEQJ(ZT8+(E6@$+XO7G$#X+.!@V(5JEI
MBH(;827QE (F2$/ /15!J*  $@2XQL5@(]./+;#S0R<2K5+U>G Z9>%(5H#^
ME2RUQ 11$,"O',MHLI"F0^79KTI2>3VMQV4+=(KE2.?XU]T&#%:H6#2U)D.K
MR&P*BL6[@FBI<RQ:55X[G7HUV'#.X[*/:\6R,IYE7M$\U80:S@@FF! PCQXP
M718"@\_2/-XL@[?3,3QAHD>_52O<F/M"Y/-=-7X"P4_-@@'>* @KK *#(QA1
M*@?H3[U-,Z^MEWJH?'$K@Q-I]:;+HJOJB_DUC\;8".LRR3,"OEA&I/* 8O,L
M)RY31GM !48-UE^>!S%PU=L+3*:HQM=WUA?*C6/%*%Y7^V-\VJGO:I@>C3B)
MP#E-<V*#D42Z7!)=,$H<SYDM4LZ9&^Q>PE?AMRXQQM?W(T^KI)#4A<(T%058
MFTB;.V(\]AGA6EO+I1=JL(;PX:NPEJ*Z5^JP/A?5O7+I]T1U=6JML3EN;*!;
M[PI# (U;DN:9\,%3+=1@J_<^E_;]5C<@3_N^/BVM;U:6[7T/V==?',,7,LY?
MZMJ/JO&L$/5)9L?I/+="@=TN,HZ=L9@@.@7^#9R!?><&.'>PF1I#5#NW(V"Z
MNF1]7?B,T:( 91,$MM8"M2,$4)&& JN&"V<'M\-X]VG:PX')($U@NSVQ3 +P
MRI0G!0@<=E?)/*.F2.E@]_I6' 89#DVLR(+WV-T&,Q* 0."Z &%H87*'15I*
M#]:W_)REOO0F5VZMU[590['7U@7#A2%YCEG!1>Q;98%W*7>:>Y-+/C@WX<$*
MIQZ(1)Z#@M'@"$C0+#*H @MZ*4E9R.$W\+:SP8;ANZC&@3[?GK;'%9C:*[(5
M(R?@@V/<<?2_P18WKK1W4SIR1VZV#RFC&>Z[V@*((\#A]D:0- AI8$VUE</%
MNP,.6PU![H(OA)2,.(?M<ZA'J&4\R8QWX-UXEJ>#->M#ZIG2]?Z7JY V0SEU
MCN;$IIA4E3$#?F:> _I-)<>V@B%3@R4).(^E*S6@*3WR2R2)F&>[/3CVW1;+
M^Q#\+3;='H@;5H(M#\ZJ@^-JVNBQ.SB#GRY>5],:%^;>,.:!>UG!FU?QE@<!
M([$5T6US39>Z%GV/4C2,IC8K+"D$S4 "'2<F8Y9H&W+P=X0W1394"7SHPJWA
M;K2NT!DVS*4YM8YX$;#'J@7> )[ 1JO*!YI9(P?;:6S0+8)6"%H-MSIS&2=6
M:4R2T Z$6'G"66 ^#9DQV7 37P><F[Q*,1)!<IESDFF.)QP@TN&%@:<SHTV:
M9CH?;!CVEG[%'J@XK.28M1MXDK490"JKF0HD9QA?H;X@!8L=J#4M0E$$$0;K
MO'^]J!6;5#Q"64LS9ZC*B"AX %G#XV:4!>W(<SQN@,K<#]?1>_ ]J[MI6&IR
MDQ6Z ")([K$V0Q!E,D,RSTQ*BRP3;G">WH_F"N2^$)H[DE,LRK?"$4P))ES0
M-!@54CW<!(7M,UV[Z\*RYT'1E;;M:\T^CLNVV=O_^#0MTZT.0[A;\CV<RB^8
M8RP$8H7$-(4L(TH$37PFI?4ZL,(/SDOYYO,/'F?XU6B:98ICI ' KW0YYJZQ
M@@1?Y!FW1MGT::08QD-.CJN1VSV9U-5IEWC_:%Q)P_/4V$!, =Z)3"V%OT)&
M<AG R0R.:C58*GU=6/2W1P-GC6=<FHRD'C.IA:0$3W8@W%L\_R>WN1Y8@P2^
MPLE;Q4/.LJ[[C/0N RQ/<Y)KD0&<SUV1#S8_YHFVZ7L@>..DHM)IXH(/>(R@
M)": CZ<TTR$HG>I\L!NS0V\9M4IEY7U:.*Z(3ZT%/\\61(-])UF>9T"XS&@S
M6'D=='QDA3;>4BN$=9XP(Q@@,28!+!M/A)+>9$I;/^":NB$5F ^D_>:@:T%7
MJ%LL<R9-"]#^7,-_<H_;'.#A&JYUQC-G9#K<O<HUWSXNOEVEOA6I4]10XA7N
M_:1@#DTF%6$V4P53QLA\<,&)(;#*'1T).!R^R%*>2IL3;17889H!5L+39FV1
M,\,8*K7!0MJ'#KC>D87)TBS7K"#"!$.D063D0T[ U<RD%4$+-CB*]*5HD[+5
MHXA%&RQ(JT_!PZSJUU/L4++;-%.4I)O1[/:I+D>8G'+M^H]CYVL\-6+)R1QF
M%MN I-IQ"7X.D9@W++47I,"#-X'HVKA,HF,T-!ZZEXA%Y+O>=6H.J@]3@#ZZ
M\0N<^"3CWE89*IS41*49ZI04(UB%(1S0K!=:N'1X6Q/+Z?[[GS^(]<]^#)0=
MX2GK[J0<EV !--)_YPD?Q6J593G5!6&AB&6Q"OM""F)2KGW&79H/N%_"S4<@
M[323R2J.07KJZKT(S CN2:Z<(Y(!F"\H9ICD!>76L9#:P24R#+.)U@_H"&HA
M%%6@*[R@V,,#_BK0,@3+J>02(?]@>>?AC\QZ^BW]K=8LI3PC/#4%, CEI/":
M$B<YS0)6"1:#Q0K#;J.X4B(%(!*H_#2>O8V5X9KKE"A>6 RM2W7W^[&/6(K7
M1NB!8QQ&>"V])H4(.9%.IL0HX0G+%'-.9QG8IL&R[Z!X9]TE^R&UL-699"*0
MHL@H9L48@%$\D!P,9<YS#_PWV)J76Q94W&EDY(ZHXH455F'1/!X*JU)+=.X,
MIF4JFYN,B72PP:\[*B<<#&T<SWB>XG9#%ACNH:(?PG+"/<V$# P\D3OW/AY'
MR,X)F;HB!#R</24R !97G!F"M2->!^/I<(\$'=1&\]I$/JC 9ZQ0,L?C(X3"
M1C,9."I%(-91D8LT52(;;$''L$YE6_=[OR_OQ&52 T-1$IC&)CS.D\)GEF2I
MDZ$(SE$WV/K*!VK+,<"20;X25E#:"NTL<=P"*X %)B;+.$DS4Q2<!2O88+'D
MNCG,8VP.,QS+K6W*6":(L!F6?!A-%(6G^RS-F;7!N %G.@ZI*^@J:6)RG14Y
M(SS%C3]O,> @%<E8&G1AN)?R\=)D'?8=)+!:*?NZD'HTGZ+@X-@J0PKM\06I
MY<Q[KOA@MY:&Y0P\$MY9)2BW(6,T.*(=SXEDTA%5 #SG3&?&20H_/_;F-0]]
MELLJJ>53SVGP!, R&"H7,J)R+8AE-!-,> =08O#4&D )[PK[7+K ,R,R3;3!
MT"OV%B\P7:PH3,A%\+KP3SII:'4!Q1]0^88B<]YY(HH<##=ZP,9(/)I)ZA *
M+@HUV(VN;VC 1S>5?'PMISS/O&6@<ZG$4*N"!QLJ."F,2*4WEJETL#L&3S11
MT\L<'&5;$.LDQY8PX*_I5,/3 Q-2%#IS@SV [E9YU[-SA[;'[A4JV2IF6]U/
MUO7#[,OY%-R6(/ 4'1LSK[!/K:($<(Z5&6.YR@9+TCM+7EQ=$. A]K=7J8/S
MPBA++;'4&2*U*(AB5A*1*J$E5KB;P09H'BAH^XE2@%N4 0Q'S2O&T@!DIHYJ
M(HT$:)TI390T:5#837ZXY5;K!M;WP2 :+8,P!+" )Y([150PAJ1,%(&J-)5B
ML$9CV/AYI42RF4\Y/*[ C!LG<=N7!N(\%<YE-DU#.E0BK4OD[]"FFS1+/;?$
M!!.PHI8275A*K#',64,S;0?;RO>);+JL ^??P;X6E%>F!<EIT%CPY8G&3M0F
M$\(+[PLYW$[4Z[C? YM$&W2N ;=DFN))?CX0L(V,\& =HSE/"SG<N-^@>&>=
MA/J0*M!GX(IY2[@6 I"=D\0X@-\4&#@U.?AJZ7#+C8;#.<-UU5;(*X&;8+GP
MQ N*]=%4$%4X3IS*J#2%L)0/-H+SU*-K0>2IR_*",&SG*7-I24%9()GS14@=
M8YD<+)2YY^C:MW5DNN?..'<#6H(PRND4'/><,R*-+DC!I21IP YXVE$UW/;A
MM]ITV?>C$5A?\*@[10M_/^4^-T$&)P60TAN!/;@S0;21'NC)<Y\)Z>1PSRI^
M^+SX)0)>R8S_' &O7/I=!,RDE H<"(I'W4KE@(#,*R(4T\'2PBH[7).Z3AE]
M6).?I5SC#CISF-20\T",990PA><.X DS; @%HW=DR7)E"ZT\H;G*L!6D ;_%
M"I)YSHUPA1!AL"E;M\UY=*Y$"X>)^*7;'?>0Y6D:LH*98')*J 8,"R;-$2VS
MC 0A;,J\E04=K"%[7-&4.]ZS_!'U<)%)Q2P#Q8NGI'.A22&9(RX-U!<I?/;K
M2."P>&=UXO1V.H8G3/3HM^K+^X;#\0,U"ZG(<U)DFA*9X@'C17"$(Y/E:<KY
M<!N9K:,%]Z;8M"N4<HRD5,@NGT^E+ ,N"6FN.#B?:K"[_NNMU0?6,,:GUBEP
M;#,\K337&=%I2(F2F95947@JAA^/' @^OR,*!1!@$&$2G 4;X,%]5!9PMTIS
M9W+& U>#M0'#W6Y9(8$H]RD3/A!OLMC$VH (24^ /"S/7!:$&>S6W#J=^LZY
M [1HZH G%,W0..><&-R;*[RGBJ;<&3[8 ,A33XN#Y4\!03,\! L\0E9@:6[!
M2*&IE%0+QX;;B^ 12.X#'\>X2B$&1LFL=R2U>&HF8X%H[@0P"K,N9\S9=+ H
M:4#9%VNP_\#Z+J/&^$*3G&%Z.)4I =M$"0M!2QN*E-/!ZKNAAQ,6R@D?\]%=
M5&EOJ)>DR)@';T.!DC,!_I,;[K62UM'!PI6A^8,#*/6D16!4I)RX/"V(3 4%
M'%HH8C)>%"QG.J6#;3ER+^=^WYNX#H$9--.%$))8B[V+A"N($04E,EBO+*,6
M4,Y0F>%S??$N.Z&]K$8C;=!;1#1\3TWQ=D;^%.W 7[P>M<>[8[LJA++G8R.=
M#_C. YAXHRW.J_GM8O&797[>'9\"1U>/IAT<U3Q/,5IB?:HPNH7G0&%/.$--
M;N%=N1YL=&L-2>Z'19QP@G%-M (T(FD&SI=4''27U@;/_:5B<,F0WTRKI2-"
MWT]0WE>E3H;4H&2%B)7Q5%%T:K07%IM\IL0XF1.;>VFLH=BO;W#L 19E#RU9
M;T;@X]MR7)Y,3YYDUA 3+A7,<Q(P$"JY4$2G+B<\N-QDN4UI/CB_<WT>\,#$
M/&/@L>A C/8Y'E23@R<#"-9255"G0IH.]]"_6YWI%OGG38=>J_IB?LUC,=,L
MRZBF0!L7&)IIGI/"@Z2S-&0.OF.&#C9&.G0D]RVZ)<9 P!O!U3GUR'J/1M1S
M:B4F"4O+ I&IRHFV!=@,XZT1R@HSX%XT@TJV7Q^X<7\\6SA*E2;,6 [:#_-H
MK"J(RGQ&&<6C8@;+L\.NV'J86!E3>;"RL,1E+B-2X1&R 09BBC1WU%BE[&#C
M$L/20>MDX?L"8*K(G:::"&ZQU ; L38Q]&\8<U(Y,UR6O>76S7TEY_)54L4$
M'D!]@)M; %44(SJ G?#2>2\RD7(]V*J#AVS)M<X5>&!M4G E>>&(POH#F7H
M-)DV)"NDHS[5K!BN._=59ZB_U?:X'/OZ8O'"1T,ES92SMB I+_!L0JQI<ART
MB\\9\YK9?+C[NT,ZI&"E)/',4V%([G+LI,HT,5DP1#/J3:Z#YW[X/<P?T P/
M(5ZMO>"Q=X['9DM6@NX+U!.F&*/4@#.G!WOBYRU)N.=;#5K/S;(FGJ839XO@
M4L:(D!+;7EI&"I][4N3,!>_ N@VWC<I7V; W@#3\<35RNR>3NCKM(,>C"9V
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M--0$6Q/=M5[JQCM7-[[Y^<Z423!%[J3B1/"H0A0C.G6*V,PHG5MEN5R1V[!
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M;?2P.AL#)CDN)P"<#@&>M+H<@'K]X3LY#IE$??GX1?)^-K!XPGTWL.0W/_8
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M<!;>/8$+JGEJWK1)S,4&3@.'MCR8S62_&GEX-*X=L,:IAV_'UB^.Z)(H'4W
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MAE34#2>PZS?6DXZV#/Z*.;@!$1;D.'8YB_LZ2#"J[N1IBPU[%H*^<'\O&(T
MM<GTDK34%TV^8D(+J+\JK6#QVUJQ 'RG\$3HXMD(@,P\=*Q.UORKYO4*8(J9
M%/*7.+I*<#[9S2L%G=(?E=A)4(M%Q-3INI?)6^9=Q>8FX;.@JPC^ [[=(:?&
MONP-XA"))O\X%XP*GS$T^JNT62F!S&CK4@05Y^5< ,.R@F: 7J;N"">+A^$B
ML1#1K2G>Z;DRCO&LWLDXRS+?W4AZ(.^"KCGXQ 8)7'*"2$\B)!T$F0YIU9BC
MLX.W84V[D'TI%+T >!0OC"9L#KRMC6 B $0SVU+N,%LDWG+8N F0RG8Q7:MK
M+<G.UF2T[T.-C0;2=6V#RJIGG8.>KK+7(^C[!,1'UJ!QIDC?B.[M=6:8XGGN
MD+'FO1E>BV:ID&ZWWC)DMUSN#_NZHY17@TC(MU-:>Z2#LPUC7X^S<U1GY6DB
M&[Z2C_M9R9;E98&W*(>5;W"S?CN-P@*,S_HX GV->8W K0$XO=.29X'MNFO6
M=:O(:"Z<"*":DPV\WLE'O*9=(PO#'.D).[N<&<F;AK'DCH[4C )'B&R8Q%9\
M'@?.X6W//P++^9W]7K] ORSB_%]'G/\+Q?F/%B_M2M3$Z&] Z=L>'&SVB(Y;
MKJ:LY@Z!&?J6O1F(/4YBD30JE,L<N4VF=C"D'^C ?6,TUV0"&#PJP4BXD2%C
M^0#S+1F*X+Z]PP/;6IJZ1)6764MYZVOG##T5N>'(4S1TZTV#9NA55]7T=XH7
M79M<[):(/>#6*+;;63,),:,T(),EXD"V\;T*B<._M]DF-9TIO'NW&VT\WA.F
MDBJ&W]9G7O*1NKGBPJ5U?S>BN.6Q(!I:]QN-,@9.,]RZWYPD?;,@$Z@5R.1Z
M'O&"T??X#("<)D6R.[(P&Z(;E<LE(X($'Z2JJ]_2EL@9$^V5&>P[Q+I37L6P
M*\\A9)HC=EP*#*(JG!14Z)QJ=QJL='-->GLN:>5)NN=S#:RU)4G_5M4;V H#
MO[>&?N>84;D/NY9^ZWVIC>@\*&<"!:Q26; I0T.)OY?T3!7AGW-V/UKA.+Y"
M,U=H'.7KIKBDLNWW?!E#18]NP&L;]GM:=/JLWRW SVP:_9!:P5RI-S5/+&*+
MEE/XFCQ/HEX!3Q.Q!:?,HH/$2#%48U96C0'90$K&S+WH]*+P*/Q3>18IVA7[
M7XLU4 QVW$ZR9QT+T$RR\[:4K,+Y)7<$(%TO'<VTEC'UL\(*5'E'[[HI-Y*V
M_]F@6>>SG%XE+*55E8 K^OG\8I(MNG(.*F7U5M?KY5;%$JI:"P!L\X^\S;_5
MR&.ZHIF'VE]5WRR+^:+P1L6S/%3%A@\V(YV8%N&UQOD#GT,@D!C:^&H6<%;2
MX*I(ABL$ACDRF17 UM<#4O$N[PBZ53OS-G7-9-H6?*R8A)'6 JT5F%1)&C98
M5!Q*B(Y0N9!XE"NYI3G.O-"NRC4G-3<W["8$\RE/$V000[NHZ\:+BW\$&WW6
M8*/[(]AH!!N-8*._)-CH$T7T3_6\H'#L:8SY)!I[LM-O>JXERS'VZ4VC"?O9
M\;OU24U$ :&WGBN31ND1Z!#@72H1E20/M=FZQ[15M))^#S>:9/N%O?O9T_<B
M6$ORBYLFKUK$(P.YAKR15&+L[)W7LZ"?):4'N%9(<E!4LM'N\K70J"?Q#IXB
M7XL22BE4=$KHH-7JFNSH:J?Y8*)=X)QM#>PY0XW/PA;62L6,7J?0UD>*[HE1
MVK,GAP2)2W>X6"-,&IBO'>U*I-H)J6@XO!MR,ET!7QO=?^DE6_IOL=?GC?B$
M/-%ZR90*>"VX"5K*:Y2P;5B(%8*3'1>F376;?1T=TUYNYHZ4[GUZ1K(LCF4=
M0\$K9=@"N.DF@C_2L&G=J1U!\Q#-3%HM/?89Q&0*Y!FU.$\3)CV-; :6157,
MWB#T&>K9QOHE-UD@3?(*F7;BJE[B;&=X0_KM?#5%HSC_BO-KGT<^^HLTLTQ7
MWQ;*=\]0&83;W9+B![IYP@BC7/"<F\B;V=7D'798P=B-3?O=_@AIE"SZDB2+
M/GC?L^\._+5B*.S/Q6&U)GV797QJT^KC5$BHM/J#K1GF3XK$4[TLI&/Z=!F9
M(49/S5T(,Q =I[ZZVF&Z1-\0=UKFLS>N,D*A71>+'P?D=7BGX]^*CYTK0FC)
MU0=-9'.7)1"L@P\MV>M0VH[T;BF;X1 9H><B'$7:1HOW<1E<7,9WGCU.DZC]
M$O(!&4!AVRY2B\$*.8&N+:DK2HH).$0QG<7\U@HMO!7.S/CT[83ES&A5#)<T
MX&6K6I!N? OJ_E#,IZ3:FEHVD'2"2(=#)3:5;!=:/#HM@7 9[+>-4LE9&IZ+
MP7"\VYR]_S8AU *E9;'.&*XN'(' 60$HY!F9F3JKE/J;L'AMZF@",<194ZNI
M[I5#0G4EK>?:,\ISA9INP.H+#$SKY<KX%$-P+=(9%Z![5A0+$'K!,Z4GSARG
MNCVV*!N!Z5HGQ&2:I'ZI5=1;,%+Q-:^=/):$HOQLA2#2XD&Z!QDUG@+C*?"1
M*91<5N&PC/V_8]L'$-+3>JZNH&U$;\D][:K;G$G61%@]A3F%#09S'3*T!T;G
MR4_/SS.M(]<-ND>\BJ;'&%Z:&AS+G^GU:'G\^HJ,?-.4\O/C;-S+XU[^J'OY
M,4[V)R&E-LE^JA=ENS$.Y!="YDO7.;B=7B"%*EBW)K^A YB]&2[6PT_)-MNU
MT 6'="'2P.5_.R.LI:UK;,5B)10#M !A<>.X)PT1SNZ(ID*[5G/F/9B^9= E
M2=5N>FTLICH;O#?N>J&8N1@W_[CY/_+F?]IOU?I'S'L\L[S'\Z!SS)'%:\:M
M\^>OT0_\2JL:AV4<,@_^ST$R!&R2;AIS_MM.]G?PW'<;1@3^#VC/;96HT#DB
MS8P1W!1P:%-!5O5BNU"XFJE1V>%ZKF\G#0YUI)P+0&!4&FQQ,034G)ZF*JV!
M(WE8[B\7H"5:%?;P'Z>$8(.XR90[6(I.Q@;.7I.;2(#X\NG6;H,:U3(0/J&C
M4ZC<<A20/.FZ;Y5JMRW9*5-7^L6QU$]\]YT?F7(!3SQW[V1O7R@:H,CV4_S>
MB8:T'@A#E&OH0=Q P(IF#)AD5 X?@CHC@/\"1X:B &.#?MZL7.(S]DF%@#3M
M$5_G:[2&20.'7P3@I0XK..E&]Y3%EO_82RT<V2?V4T F/6+R_K@?$?04N[04
MRAC?:RF*"'<TA/8>TS>H7=["[OF>1NAM *,/8J3^WVGSC?Z_ S*=_]::,+^'
M%!2KNTT-BJ6EZF:15VJ4X,FPW,8\8B+0)=V:<6G)$$^9B?%&4O@IN:@S>X.;
M2DVM;Y-,3%R2 <(#<+I&]DXRD*!L5B ?IJLK]#'J<'BG%^&DT%&,N9;11?O(
M-4;0!)'Q_C& M0_)8'RWT^TK_0/]_F9K0$(2-O14AK,C?B+L'$J/PWW!@3S
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M\PF XOVQSG\P*^PX1MYIWL)4I9+PH.4+2=\TA:GG1WB31W =.>LK81]M@J.
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M?2X3RH89'29!&RW : $^>9;)<LWIPL?&R1TJ49LH:H9A6EY$@"$': 687TM
MKOQ0V(X]>.Z,7GD->AC:9R5#+(7O0?M@ M1TYZFY/EO3TPD+M.A;.-RL5L*1
M8MD8J2)H%$=>OW'[']SV?ZPD(T V\*.>/OR^C8#) )@NJ\LF9R+U&=>/#G#'
MRSZ-Z)[V*E];;TY\CDG6YLLB2.QPN12110^KRL<]=G_7-(5P="Z*S,G"+<M+
M^G0[6Q:N^@2T7,C+3]2A, [Z:'IT"(/- #JH5@>:J;]25SKF).QQ!"BAD!FH
MP\+3<545!>V!=@P+F;2]P^$W;O*FR;G-]49E?!PR,+F4C0_I;*T\%UG!TE=Z
M5;*J>;_[:L7EUF:T@*,%_-06\)GPS!>A.6]F\0,7_G?;F@0JV-OU 2-[@):1
M?:'P;)IJV0#\AII5PDO*\9VH;-PV!6[_1_]PM^O&5>O:S5X["4\3+9A<L&P9
M9ZV7VF6,YD<Q@;+XNNB92A'*J7M$J\CX1!9]*(T8Y=,D[>97+)S!+0:IT#!^
M&_=HNT;;]:EMEWAO4=90JC&TD;%M [I4ZK4YF@6E(AR"'V[(%YKS?628AV?2
M5/!P$&S;]\&,7&4%O9[$[W&/+M-B61HW"TB>/W;X"X-X^YF.$QWG];K,R=0L
M^(T&;)GU:(I$E.!R)4A%#TD*KS4"ODF"4_>L+] 3V6F$49!9Q1V$;:'F%\RH
M3/5079,IEF"_2D9,9O*_7:E0:?;5]B:GOF0Z$09[/XY]+B_Z4G4CM0CGE"-Z
MGM8R4B#<,20TA73J;JM\)6ARB&TC7\)X?*>M'9JF6.SCJF.QCVF!4.8'J*VR
M*BP=_54%S"Y3)+43 <Z755 $(B^ (CH.<!K8"NY@$_&,/&9TF!4^ITTLOH*B
M0['3ECEC,G)IV.W(O'9M<&C4C*;&<P?Q2AN?S?.\:Y+&.>D9F'>->T98[[6?
MN*Z5.'9:;&Z8&.KN0]S]WAF9M.*-:_H=E]S?_K_SC0H<SXKUCC#@)'F?LG!:
MK*&$_Y;7:J 507$@JPI>H8PG1:Y/TR);]Z("K@NM+_ETVULB\J[#O1F$*XVI
MPBLJG?TB#]U?)EXOQ/3X="^I@HNM<>6"]0+3%><"&"1]C1/(<8->=I5225G7
M$F@ 2BE>1*K4=-S:HMZ4*YX-)KL![%;YKA0G9TO5[1";#9Z:X^RG\I+A0$J;
M5?S&!^-"VZQ^VRZ82*CJ-HUCW.8M;5TH ;3KTAXTW%5,1V<W>6L;/D>J04#L
M_OV/&R>UU<YFJ@$U6XE0J'%ZI)'M6,,9.$P,+@W\R'G3;"7KM@$84XU\86EQ
M%G''F]A=[EQILYTTN'I>[ YOEE<@VD/M;2;-9;IGR*</U$4F!2GU?]%-NJ6-
MN<?/]RYMS!2!+)<BF33<T?R:R31D87*[ P73=/;05CZ]=Q)4E/#[-ELLZZF$
MZ9Q#8VF\X^PY6(^X264E.%">S;P5MY;^]^[)5][F"79^:P(HJR"RWNJ^L/)&
MG.AO% ^!N1[WB-LC%U;JE;84.#4W- F0L!<3*LA8JPE/LLO"*-3,["Q[MG(&
MEP:"+FM>&O/C[%4WW7!KRK1B_T>3T=+&T5_WI3>R(6LOX^/W;@WKM+/9(VXM
MU^,7@DD8.#*1K:PK'1O%'](&A(-(:N![-^=K\%^J08=Z!-8YG1BRSD7B0>$]
M(BN[H='N$Y-8!]FWO']37JARTG+'>E,H-4U]PPPIMKU=(ML_GV^LGS(\2#J)
M).'3;I;\(-+)/R!)T<K[L4.+K^'\17I<#QA']Q!S8WH]B-;K9"""I5-Z4:@4
M',Q/;[/*'(.&QS.^13)TBUS1UIE/$SJ8<?-2Q%9SXS&Y3CFH"XK&%I]2&FFJ
M,=UTL*0[FRZ(\K'/X3P+VN&0)1R\L#LSKW%BWL+,H8%!&D4X8D'/ YKL6FU(
M:QW_@_8+1S;1.#I9:#J <;7LY-,$:OAGJ=C'EY/WY(]6M(KL+=/G==?,C!^*
M+2?W^A6)ZFS/PG!:_*B^/*(?'.44@FK:N_8D!=(H/Y- NX;;?)175;V!%V%A
M0>AU%#L2I.%[G>:^2MI?-V.'Q^?5X7%Z,K9XC"T>8XO'[V_Q^)+SX"]<J_7K
M2(CS0@EQ1I\B;78PDIQ^E[JG>MDY;8>(A@:Y(C4("6D:/;X#YIB&2P;0/(WH
MF!@9022'_B7A[R-7IM2.?VVG9U_"?(,5Y*C2?GQ+?.Q2V-Q"8&,QF2E5MQV3
M4M3->Y':*?.:Z@E&9RS]TO"33M!@C8K8O.1R'*96NFUKY:Q.F8<TO&XC#;H/
MPZ2"J 1!4MK[0^XD%PCV9JW< O!$=#[J],QPF$!X@:BGX-URTLW%]+<F@ YO
MNWZ*I@FWA1_KSAA-WD!_E^RK 5Z.-LBE]D(/ZW.'#H?P53G&8<Z%!GO!Z1].
M,8?0R2*M><)F>6O8[TR)Q/\6_^S9;<?9XZVA3"VAO%@P.?&FZ#^GM^4A#[?(
M2V;G M%):.Z70@K=[8JF@1PM$$FZ& U,)F&>)L;<:6UQ_FEW) H2$N\_K%?@
M(MN-(T,3BY?(/8B%;,9LU([JAC0C^,4"(FU[S[:<N9:E&VBZ#10_W,N(;:,"
M/G77T@MXVQ+J;33\-O)\:TI4=YL(V32<XP37CRMWH/E)=JD2;SCIFWFQJA<T
M<70Q.D9Y S&[$=HQ"_<!BR1.N][1'-:2B$\,8_]T"@K).L>G82_GIM9I777+
M37DDH79&M\J7[7=PNUZ<OW@IA!F3"!T0WHK3T\@E^/KELV>O?WFQ[YL/+-'-
M=S0J#WJ5\(-DVN,PW8X-A']%Q:\I%[(J%/*STX>AC'#VJ%>XQIN2N0FE-4XC
M58NE)-XQ\@E7@ !T._E>B)H8@H0_G'X?Z3OBR'J\M(F-&&)!C"6R"&E_[R+9
M_L)86_1. ;$G-$OUK(S' 6J1]/]$CQK64ZL3@PR_X2&OO6P6I^"4E-#4FLD&
MS4$"%1]X7:\[Q7?IVH/)I]W&[<=D=S61+_3L8>R,YXKLGEB:7OS<7H1(>F$S
M&Y_\KHZT <UZZ> _8,*=3SE:Y5LB-+Q?:?3:]5LX N/%;3)F72O(D810U(*?
MR$3*U;<8SKBE%E41%+TQ2&D:/(5T0:467?:6:S49[CH5%P=&6VXN&TFJS8'T
M;KKU<)(T4)4;T?+CUI6  Y!&.TM!V[&B:YUN*P::56DUHM1EB;W-*SX9 !N&
M"$\)5&\"F %@7X^0<"%K6=R3O(XO PY4,!E"!-Y/WQNAZ6VNX+\130E&PF3[
M<O#@;TS"/ER3/J(E>,1W7.;")N@E^GIO,H2A<=WEUWFYM+L(=)3>SV6IA.>!
MR16SA3A8@V(O#ABIN8,AP J8SW=,%\+&8(2F.4_^=)L:0EDY_#G>;:.>>AOJ
MGVYMTK7K&]KI:[IIS3YZ(,+R(LXU31N^WVM+P)L-+==275_Q0W#V5;8>HWZ$
M:? *KO%R'C6U;7;F_3V]>RAHUD-CA 12&$C6>'%(KH*A)^%!X_GZWNJ*?2+E
MO$THDY5P=V-$NF%9L5[*).-VU<NM87"LD4$1'O[KGD\>V0(RJ:64Y(O+RQ):
MC<F!XR.J-*Y #;%7D(RD\F/^X';=4#51%YQ#>^5S:.?!2HTG= +!Z2<;/;18
M5RS )2F'N$3W2-XM385UQK(0*2GHA#5"/4DHMOM ^M'L030M_MY:HBTB"\QU
ML5NFW4V<1KIS((IG36$DXP"AV.%*]NK(^9H,%5 HM4%2AL%"-1\'C08Q/LVA
MF =WN+F]?[PC2N)(ZME%NES6-ZWE'FFD=#X5?5N2^ @T?U=DH,EFM(EM;4N.
MVO*JD%-%[;^(VI/-;\J9!^<AF(U>DX*4TAA&'!29R,#9'";8&L@<$BDPG<0(
M0!ZV\"$/3KDC,<8T;\NCEA9:D9#HRCV9XAY#H(U$WSZ:EI)U$G)97.#ES^>.
MN3U?U7S@((=,G@\]UG)C",%PM#M//I[I<&8V%*ZW2PA&B8HB^P43:_'877 Q
M\PV3+:,SP1-=V.:XS>7P%9?&LL2.ESZ\X)09&ZNG*945B:R*Y"7BD<:O:67J
M!AR<KJ9(C>%NAG,.*8S(C!Q#5Q#>AS!PNMW=:N^!7_BR[:OYVCTI B^E$'$A
M;1+EM+''RGQJ-0/1Z]J#80*H_A8'^[FE(IC7=,]*UB:24KS(H[:#PT7+AE:_
MP.QCQ^<.+3EP]%K3F3)G-5L4_@FOOXSIP%9ILZMT:#F--VD.D>7,'*L;D_!@
M-(0LT^-L]_1*[**"$753BQ@>A@LCH]D[&4S(UI4(:)BGG6FSZR9* ^[AKX?K
MAXXQ!CI&%F]ZE0XW9!8)]I5CD_RZ5EG4%3.**QB3;EB0F9:,Q"81Y$LQ2CLO
M[$CD_MQ10OMVE2./K<LK!)0#C_)-X&+G9XH#/Z@.Q1$9]7DCHTY'9-2(C!J1
M47])9-2?/0NAOVDWA\,.2^@"<.=B^XX'H_4H<(PA>DX65JG08,JH@[9 ]E7J
MD ?D[!!<=W'K([V]%B9,TC$P%OI&$-4%%@J?T5ONU0OZ;%/2HV]\4X-29IS1
M+MNH>B*('(#-K0??Z?%8T-67+_$9OEOU>,C/E<!Y4'AGC<;IU(D*SK2F$WSE
M"P])YP;;=%DN.[\"2<P;&O!&<HMAN4Z<XVD:.(9&2@5B)DS@\OK\]7%VGF#E
M%S4B/]E20:U <B"K<A&Y7KR&"_\ +8$T0]Q[M\'LM^)F,I]7W;FT0N#/TJ9!
M!3QHB;"IK)H9/%W;(&_*#8L&N>[4IG#<8=93)9FAUI>X9;#S,E]4-#- X7-C
MI$#\MEI*Z&@2*"I EJM=EQOC(.*^*LN[^@1$U"1,HO'SRB(2#L[Z:D [VCIX
M$>=/CBY>38S01R[/H 31?)!.^K.3LWNZL"U8Y'"HU34]21)(L867X_UNK79M
M11-0;"#@K20 );D-;*;LUMA.@7CUEF#J6 8=L(3KG)6+4-\)$E&^.#'10.N*
M6_A_PD]#J8D79,N9P7+&.1=30:+EJ1LG+FJ_4T1%U3BE7+7.-3#3-X8>+:(Z
M>T5?QGC<(.SSZ_OKXGAQG#W[Z?FK\SM@/HHB,,B)-$? &M!=N:M0=8V>**,=
M[4YZYE9"7D]J?:M<DN7)>N-+AG49.:1,Y?DPZ8+'&L6[U"@>)SFTT0\8@#G2
MPB]64V2_A96'$UWN*!8 [UM;JGH4%+QYZ>Y59$Y3TW[<>R>2!LW8#17K<5D6
MRSGLQDR<"3+4DC92O.,$J5(N<\X\I)OOV 7<COU8Z(2<#&HLK(@7I(E;+EUL
MVTV!0>7+X*3V46F"-K $OV.F<#>13LA]DR:P[.#6XIRD_UZ(FA%R\GRL)#DV
MP3)(<LTK\";@'8,.]23!)RDH*NBB+A<UO:RK57#J-(M(L\()2&L3W=3?T:DU
MN]):=2.D-7D#*RO<JIMB2:N[0#Y_EG>MS 9# /@O0,1?EQP?V.\-3S_)YA@]
M7AD#[FAXFJ'TB/LPD_&]TU')RTUTK)"^+.EQM+#/4QK)4X4^1P75E2@B'NHQ
M1\P,#GUH_VYJN*^W[J81KY2":JZN;P$6I"]TK(_EB0W@&H?2U2XG!!]ZC6EE
M,:* CO<;0*D")<3 [XZSIT6QW@O<10/]WNX#/*,X'?.>X*Z5YU.8QNZ">BO2
M?XS!]D/,\\K%3O-;,OZ;(E_%V(JAX6YI<\[9&3U: E>%KH/(! 266RS>L&/V
MP;7@%C+@=8:0?2YAB"PC\L:O>-E+H<5IC*@BG%2T?CZ_8(-UQ503M=L9#NX=
MEI1D#?QR@GJF[HB>K07HBA$E!L!T(U#0!V:Q7"]AW-.0LX=L*L!A+-\QT*^,
MM81-,FX#_[-I<5E+H+0-?!.M*_314]:>:'BIW?$\(SS67$1KE\L 2I?:N.!@
M,&$]\$LNDS\M9%[4E:VBL;.(KK09VT@GS2Y,BS[GB %X6 D8]<JFO!IH*_H#
MP!RQ9-^54LS76EF-\Q^-)L@&#//E$%X<3KJN"&0<=LR&WKENY,9-@0047XPC
M1O=0^BQXK\9A3S91-=&K=\4P?1G>]+L2X $:_9BAT:/5]NGYE.;...Z6>0M&
MOV&FN^R%AYJ+ROTEK!([S)6G8W/B#6I@Z&*XBI+D1&1ZO*QQGL74'*/[5_E_
MV !QKJEF+>+O!' HZ.J*_TOPA D*WC)-A;;_A3Z\@A^//;M"6C7(>C5: 4_Y
M7/:3,DG6@0&4BI5);^[NK;]?U(7Z+<C6^9^:B%8%Q&J.C !]XTW%&$VR E<C
M-\AN[XZ\G,C!Y:F[\HISI'T&KTF?[.M^G^M+>J7P&H]9 '< -+K9PQQV]_CA
M\.TG(4W#V3D6A9]A:3W%H[\LP%?YA-F2V#%ND\/*K2=TTM)FHS61G9X<WP/!
MF+8J\6W&U3%D\W7N )>PO@!1F-"]3_NORH%?KIMI])=6' [ 6U)D"3/H.2CS
M\-I(5\39R80>VA;#G*)A6F% _YDU9!4+>HJ)2>BQ>]LU?%=I!\Z#V:/1'F>Z
MY/<NXK!@0#R50=NN@"GE3DV?Z^8=P21,4WXL&D&XQ+PL-!+E##QYGD4$JI=-
MW[Z"[HY<[5R<%/%3?:5 ;72@986O8]@S=":J)*#2/U-8?1U0<R%]J_[UP,F#
M=*EK3,(\^@%$+FYRG\T!EKQU)0?'=3FGUY/T4H6H/OQ&<N1,_-5PE$O?)V,R
MHY5!SC%[9^M2JR\TC72XX&J<1"AF&[S[<&^6&2G_!]!V+;SD96-YV^NRM9H2
MG4 -\A*1(,T0@#W:HG;3]M<HGY\2O1KI)IAOF\(2.;(B83Q\EZA>K%:* LG#
M'VEVW>8Q9423Z,.]E.@I.W9$../ILOW[V7WZ!1;=I(?R%Y1-6#LR*GH[G"K?
MI>_E<E:["5BP:W[!<UDWZ<@4$<]AJ>QX\!K,?<>#+P_$1<7/CI9;NE0Z*/,7
M7+L^9EJF.4Y SL6*A:1MJA9C"(-S[LY <Y 5<FS>#CEC/R*K/C-DU=F(K!J1
M52.R:D16O<,L_/W!??9FC[-GRE.;'*[*\=USQ%1M4<Y*/9,%""5=UBT[IYJ1
M[+D5OD?&N[,4&AE1;I\*X3C[D59H!6#)1%E$Q=^#*U#S,2ZWMQ^:!S#=@@T4
MCC!G)P9XG: HZ_RN-K^&UYI#1>0F4 !?E@O.O4[)7[U)2CHR(FL*#P2^JC;0
M;B+5K[;P1&VV'<I:_S#+HEIHJH(YXX48'WR\TI(J3K1ZT#JAK)Y03^29Y0>"
MN-#IT&MIW%H'=% (E=1GU" F.C!,%C7E[AV>LH^<@?QC1^L'ST$^[3%MP/=.
M$I,2$#P+/N.Y^HP/CB[H*E=DYUN\H>S%Z\>\8G]TR_^<U1 WMR<X/YH[\S:;
M]+:7_ <L\\=[X'*UR-IF]G_^1O]Q>O_L]/3A@WMW_^_I\7_6B[]15+H9_B"1
MNGKP\&S]V_=ZX-Y]^)#^02[2QWB,WW.>?JRW]E[9JC]U!C[5R?HKERHW787X
M;L+-@R$(=;31QL#>2PI"R#@O03RH4+%M/&,E?:0GK*_9"UB#9405<%!6O0,]
M0-.6*MB")#S;((":N9FK$X1TJ&OMY (P.C@&3)J3.SU;LH:<+<$ORGH@&':G
MTHS!%AQSZU'G>QPO@55ECV";4'#O46C L"7I=0I-#!K  ^7OV=35_FQ^&P4"
ME#<?* L%>KN.S #ZTU<GF8#=EQ'OV;L/AF@Z,U8+N+E2&1=,XTXE0:KJF#E.
M0FXT:;2N2P ::M.G<<23ZU@#K6K+<)"[WS(Z4>4Q^'3?<:3>LLB$'.GFJL;J
M0D'VDFX_L?&%)"?6NB3&N6(?*3M,>RW,KB:C) ')2VH2":_Z+-Y=1?,>DC15
MH:V/4'7C[Z[+ZWJ3*.YN U":P6(<[@ ><ZEHGZ$43U!9&#/N*0MCOL=?-8D%
MC0<&C 2+9!CJ%0O@LD'N&1+(&[IN!(EH47SBDW61"H0E\V@/X!HQT\P@K(C7
M)^M5DOEQO(/6K;F;6V1HU=5VR4\VHSO2PY= O$<" HXFR)VFT $[<5/2F[]<
MYJN5)(1E+:ITH!SV!6JE-[RU>5:$Y$MU,X(!%-!&+GP_MB=6:T:N"'F1,@S(
MU:^+7>MK,8SOH5\TTATSH@-B(B6*Y+ZF5\EGU,GI]SBJSK[7?W'S_"M5@(1%
M&"$%>[T9$$ 86-$40(=5?G?X,76/*H31I#-I5]- HN[+)F^8ES%1!TG+_FRV
M9W!/>!"79=-NWN&^AL&ODVZLY-K"HR 7U&>3$_)%E%F>6"N,'.5,[.5H(^:3
M!$7EB*30,J1]9RG1I\HF@TQY&:!$N >L)UHH]G@NXH"XX0E5"[-?E=5U#O,H
MS4KX<"$IE)I/0T<&R;I>NXR'E\6&>W;4:BI]XJ-(GWB2,%;*2 )F*S!%:.:D
M-\1YD]]P1D;@THF[%)&G!K%HM#*>%<QR:OH]SB\P :B:-64*=+DG,\![0G(;
M7&5#\X^QE:#WYN?G+U[A/\A7;O*6O<Y8UA>?AP?.=EW1QAMIHO<'!*K&=FHA
M%^9<_?75LJ"]7:^D/%E/&;@FL]WG$L ";XJ9M!Y&6@=!%L^!>]_3A?:F--]/
M'&*E:VDUE<3,#38EER7[A.2>S]ZH,RMI.KM6Y-SAS0]J'DW[Y=D/?%L>SM.F
M6V3GR;%Y1"^PY!EA^'.'-JQ&DUJTG83R;]KDS (Y%KO&8M>?5NRZ.Q:[QF+7
M6.P:BUWO, M\3&*U&U$ +[__=@((DZZJ@'>2AB9@=@3ZLN@JH]#A4Y6O%9T\
M8,6M$PF]472.7@D9M8M$_W?;8PEG_R826K*:O7,8+$W(2HR<EK-;IP?_)"'J
M5B>5IAI]&+5X#\XGXW/XR4_/SP&B)S_*LWZY=G.Y&W\9)$WJ^ZV[O<1Z F7-
M?F$OK=>Z'GI]\; "^6<_2[S<1I"2]%GD0@MDILX+LOZEX)])BE,[#IB:C69_
M8PU)A30,E$%DKLRK79\Y*(SDU3Y9$Y3W?N/'C0(D(>$9@690\)0L5M1 1Z?A
MFF*" IWP$R?]S -+D<)O0U)//**)UY79,YG&M!^K"-BDR+&-[[UWXA)@OCC0
MR=L!T#YM"<^1,[(0T+6\YPB ?K?$!=:H=GZ*+X\C&ZFEBA8_76%9O@D,))R1
MK9M @VC-=_<0X3Q__.+>!&C,XK?LJFY6-9_M^E7&C?+E\,U7_WC\X\1<_EZ"
M'R<KWK!X%*F([+O&K>B@D<$Y7FD',30>PR0.HF]#=V#-(CQ[2(K%.6TS\EGL
M-^]#$.P".41C'JW*+7"AK[7X37&-Z/"B3R^[!IN!]1DJ(<_H4;8Y[GB#"4B2
M4-.J2@ MO;-^ :B=V[5>@8 Z2*;ZYE)."+8['(%Z D2=!HX,ZR4(4NY/[I^<
M:MA+WSL]I7"5SD3NK L3NU\[XA<TL:IU]S>(-]?&SCX=="3;4T)*U_U[VUIR
M!FV ?MO/E&<OSUOKTM+YX X];EQ.VK6"?(AI3DAI7P4K5+]B8@!H.9D5W\\[
MC9<$[Z-81TO:[]+$#S_&D<31E]O8'0;A!)Y/=D5\4Z"; ?H7,O)@P 5CB_%'
M*-HV7$U8TTTJ.EMRVDP$3<@F*WXXEH/VCHZ/<&N=!YL\HUHTGS8K52V^\44I
M9;^?:Y?S,C@&K=--+V1Y-$4ZYTA!L+<S3Z6VE-5\,*G[XN6S?SW[^?71B]>/
M:8?_Z]G+UQG]Z?4S3@2_?'[^$\;RXN7SBV>#/P<N/=W#S#*"965%,O0^2M$#
M!L\GKXQQ1:'_>XLG^Y7"O,A95=PP/FKL KE-22(A/X@$.<%FA^PA,G!=DQI1
M20G32%CEJEBJX[_.M_P.K/G!-Z V1;F:=MP&JJVLKL?@N_WI))J<%1W73"8F
M-\$$D>'Z6R])P3-M[S+)(+DW^8#F<C!1A-3&]WAE1WS']CL^4SB0WWFY<7;U
M9@?SMN\>W[OW\-O3;T_OW3\]>7#WVX=??7]#TR\)F>_>%,6:AKGL)RHP1[=,
M"D?!C\[.'H0PV"45Y+ZG)R=?]:YZ*$O><9VE3>+ <&A+=22<KA/AD- S'C,
M::)L7*;C,OU3EJD3[[!%BL4(4SNNPG$5?MQ5B#J8)#@DH>4E:@)E!%9H  D%
M%#1"M._9#1O7Z[A>/^1Z#7D!7:\3(65I-[%; ) B[2 -C9W:K7"\9WU^V4'"
MK] <F0D@#)D'EW3I)PB04Q9B,R4^G=R2OG%F9>="6A1''7Q5SH\\>Y5F:1+N
M(>XR-KG(F'[0MZQWE$99U^:^+_WUGYJ97O?W:'R1"P'P%'JYH:'FJE U/*LR
MF$C:P/N$$&'".+:FT*_CC$8BX2&ZZ&3\I8#A@] =1-)Q]FQ9@"DN^P?>,R?5
MF4%-WSI9*.B<,:Y6U,:OZ&ZG)Y$:PB<<I.L;L-M%4TARB:+7P6 7&1MZ0> J
M#4"@52%Z<CF87+5Y221>03!@0!#)$B6:<=*I;SRP,D&AH1UCMP3IWJ3*_JT8
M)E&3CJ)W&V&=3CX4Z1;:(KV)=84:BH7P 29W9$C];!A2'X=\\=.$;NZ)6>9_
M[83##O;Y^4SMQ^":O5+P.VW'GT./V2RGK8FS[,*.D1\#2]IXD*1I1U]@"42#
M*<F@4>?M$ V*MO69B"7%QLV>F*38W5V60=.]0_+9\UJ6%=,'%@DBWWCJH@*T
M\MDU2L#H.FI0#X[C57H_2\9?@=H='2 BQYQ(*$'I+M5;-?W,P/C:3XE^-FOH
M;3BI#]50JD;N!4_](9U3QUG&@@'%9D!X-I29Q)$Q,E6@!Z3:CWZQ'C:8_ C4
M3FD1>*7BT*43R>H<HX]6IJNPR/5F3 #;=NW.5X4])]_ MREGY#$TX2?@=I_L
MMM"YKB84V_32&\^K1U^^<YR=1UI=?D+A264N44;-./K=A,O36L*GA<&+=4(J
M6G*RYSY;%_Z3[)I_,?>O<>D?Y,;Y1X^.>3U(<-T67MHX\NO"^"J)G1*PECTM
M5&#[]Q&JRI[=,=51GR&T83G8EA0DN;H[=ZBJ(!NXI^SNZ;HI="HWHI8>!L.0
M#KPMAH AS0$93?[7="L,PQK;!A+MDML4N/>P@68V7?&0WNZ((/_,$>3W1@3Y
MB" ?$>0C@OQ=RO#.W9O1^I\KN[@_SA65IUCH>-@!,21D+P.B#'RZ\SYA*D1/
M/,0,^,P^OMZ4*X",13'+^Y )NH^<Z10CH"&<PHMWDY&CH_D^CF:<UX-T,QG
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M=A>%-HU]8CHQGA:S\)=!?Y@=N:?<:OXJO^3.]XM8+WA<YXU(0#Y]=?%X O:
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M_7ECP&$Y(P^K86=J54/:UY%^\(^X#@<@;EDWY5XB8U#(M5L:)+E6M,[EC;;
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MY*RML'Y_+HKY(05QR&%([D23.)JI8P.Q$S+'E XSW[$R22$Z4,T.?\%>56/
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MI[]S2>V6M/+AK;I/$ T]A4+9D_"BS^U%8W*?F<RLV N^Y3-]F^/V]MM;&QJ
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M-D8O!LM5D76:T_S7<\[?M0UM1;OVTR\Q4H^_?B)8T,U*5-M>-6V)W*?TZ_!
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M6D<6YK2Q:B--_,S914T;B_XSHXY30Y(G#]<_Z6@J>W;TZ*)@E)':=F-@Q5C
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M@_:!\L+7YIC0"GK,ZT:BDJ:4DR2N%!IS&3EB2VZA@"BSV1/N7^5'*TR=UG)
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MX1212>C<+'1^&O)_>!H\A2+KN-251(5P42Y1.N9.)%BW/LSL"#K\MAI2(S7
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M5M2JG"\CUX".'RU'G@93LHFMX_QUS%O%DIR.PZ'GZQ;2*^N,.":W<[/;Z0'
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M)4<TL,Q$K>:@)9TS)EA.^U)U>"1_/N'^^H8+QEMN V19BBVDP4*^5QG'N!"
M7*YVEU]C]7!V90O3QJV5TS*@IA-XWG3O,,X. _>6W>*8_+FA0A$38+F:D+:$
M=: +<HP&_;>FV\!E,ZXGVN -\TDIP-NM\&[6[LB;V(==774VJI/LY2+1!)%3
M%[Q-N2L)QCV8:E76Y5*DTT:-R@\7PGI@D]%,]"K:"-Z,\="$DTPJDCD+]X=
M)ECU#^'B=.,(ZF!6,"W(EINB]2_0A>BIO<0-G!LZ@H%$QNX?> 0.<4??N%N+
M?D6N7JC>7A4M3!]+=#;0X:-7XTC4T")"A!I%89':O0'MA +6=*5J4^RR% SD
M4U6!+<?4>V5NI=$45MGA-\>GXJO07,TH(M;W2%&'J.;C:OCG52,Y=U8=8#H@
MI=,[?"YYEJ/W%XN)56'5,2T/X./Z !G+F5CQ#5\-/M4]8%RVO")[]0B%_"$0
M@J<@HRFSK- _<I1^#A[0T.<BHB+W;X]*(.,$DR=QDF.H5BBUF^FJ10U(X^6U
M?#S=\8K.!?AC$%_OE+5#]&54$ D^]JH_4GK<%@[$$YI"O*RK#@1M\XX.P>D*
M_1\&?KS'E^J-7)']DX 6'VEC_W=79=MB?:?0('SD-^U]WO,2WNBI"MG,\K)8
M+?JX1.\^K-#%1U\ZP,S+?(M[TEU*XP ;R9 VLVA(EL? Q;EDQ(0-LELYR\T>
M$%F;J[+F2WIQ<?&XM [F+J3?[<(WMX$=)UE<?,=N6TG^;P;P::B 194\H\N)
M-XA:CCQ>(]SGSA[DYT=@:;9@+4?LHF=IO=M>MA3WB;UF5(F D8V3M",;*E9/
M-:']";U9[?K!6'LB!V(/MY:$;\=2P1^5 ?XL9_LOOMU'(R]+95H"1QI[FCD9
M&@J4%EN7JA<WRE"H@@27%M< !1>$?T@XA))_CTUQ<*XX,A(YT2&V[U0U8 @#
MRRZGU,A=W:$/C!U7Q(%<967\WE$^,<A4>B]J&/_!4P;GE/8[$$[<R2$M]._4
MM8S!L$I ^NL&YU_F60R!>-S\J3S,;0@G&FYT:T."$58C1[=JA9.4(X>ZN,(*
MTAX4#97GKH>N59B6)!>:Q1C]NG7ANU%?A+R:Q,07%O",B*Q^3#QT%$E:TK9.
M4CHYU@PV+_E+P@7NKS4E)X_N:B;S1CN7G?8[<6(>J=>YJ67<%.4M+0#^H'4>
MY.!9*WYK&A3'6\: \-AKXZN25LQ=_"IY -R:64(W3'B@X?5"Y675TL2_Z-5*
ME*AG8!.D8R_OA> Q<!]0/H99H3.P,MULETV IS0P*1A '(FY[X[ZU;/ Y3$W
M#R.BZQ-'='TY(KI&1->(Z/K<F:L^T@\[XWCXE:6(8KC^8W$]>E]'O*^;!DWE
MFL[EYP\TZ]][>)\= 6O.#ZEY%MQ>'.!=B@AX;USP*P["K,+#&"A=0AEX0M)-
M?<EU.OQ;HJODTESX?%=JW%TO5KO0>>FN';)N7>E$9PJ1.)KM1+V"6U: N&'T
M 3Z$?^$)I!N]]3WJ2<L^,CG^]8KCH?R-&/5OLGN/[BO&PLHL#:A<)=-MH .7
M T_K1Y&:&QF&P1&L.G%=@5MASU6& (S3JLIP(\L />'C^]D4W$=*=. &Y']W
M9:?,;07G_IF"I)RG?0;RXO($]JS?L+M[[TEZ:57 6:'<&_N*H_]X4_,HDUG+
M6@Z9NI[/?O#F-V7+\B0KIU&!E\D^GOY;@_. 7PRU,8JSC1)"(O2:'-XV,!1@
M/]&8C1'W8 ?4N16B+G8 'M3E6'X^!&8.Y9ML:7]@* 7[F/PB*O<-B1YB$=,#
M[A!M"F\4"*]#DY*V&\W;W5)%66B#-LMJ=C0A"IR5G0Z!)N3LLEK-VS+*!V@.
MYB4">@:[G)MUQ1'VW<OS/.&LB^@T!M/)*=4%NA--Q*\%@88D*_@!P/S7:;\2
M^=7;MII"7*SC\I>'M6R!_</ !""+X%BL17)^A4><LTI]M(2ID8DG3IK8;Z[Q
M*_17J6@$65B-RRFT*:%-<UFNV.2Z5C.5;ZB.-G,%#(_-J9JY[!X.B=I:W5Z3
MJ8H+13\C;6]!%$OL_=DK)I*H=]PJ9DQDOO&+<]262==*N5]I8_+9;^-O2X9W
M@#"2=E&Y:C:BK_;L;8=0CZD4!6Z!T6]:*\6S2-*UPV&)=)5)3:H ;?D>NBZ!
MT+4KC^SN2?979;X$2DL92J:@-4I16;NCHJ@.?@DJ$#$/2K=):R9E?]=B\+-3
MNP1 S[B!X 20*J?I>U<"(E(6LO'A4(#J\DIYW#  6]X7M(9-0D\-47;/:$BF
M.KRQZ3MRE2C DF:'TV=-/)OENMIASF)UQ[3MY)K_#5^K$DT!FKE$?3$^ U 3
M6VDK8?;32#:IVBH,[7Q?MC-HJD0-96;FY 5Q^*;WV0XFD/PNDNBR]BHD@[H^
M9 77E(YM>BJ^]M;I/L-$TK]E@H+ZBLK?;"^/K:((XW>[/7LIM*Y2_6 73TP/
MH(I8&0Q,A.!-(\  N;Z.T4+SQ'-^F WHP$PM@$>+,7S"*MB6O (Q6_Q"Z4C!
MJ('#INL!9E<(@3@%JRL&6^P2 $R%3()IN-U&K]N_7#BFCHR'8BZ75:U,K:N
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M-T_>V5U@VV!D[AGXA"7\K$?EEZ0_1/Y4-Y$=5&5,%!9:SKG77,7+UAO8JQM
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M#JH1KFA< #DD+9JL0G8UE/96:Q P6EAVI;E*-HZ/'P6MLH@UMB4@_RIFID$
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M51K0]8CN<QR2F6CK. Z("&]P+,AWT\^VM .N;O</;V__'*,QM(ZTQ5O:()6
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M7EG+70^A94A@_*)<;&L'M;P7Q=J,WI>#5#_JU8F8,(P 0_>K>CAM&$X69?&
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MDF/?V)<Y4-4?4',PC>QRLPRZ60_>8J89[H13"*G-/XH%C'D<Q[.?RYVGK#3
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M(0 I(50AEVW%Q848W%QL3D>(MK:"V!;^$R%'UFE;U0N"0=N1(OO$36?0EP?
M9X7/5PBC]*L-P3W?DA8,N-)N]DVL,0N_YY:'3Y4#!3O5>"N6XO.RN9Y\<XUG
MJ#J'V,V!N4P?J">+#Y/N"OY,#ZW!LE/ZEW2)H6Y!T=X,/5896'[:205/:&V:
MRY:LA@?E!\9K5Q:8T9&U"UY#WM%])CS7LCF6S?&DF\.!E%02U<@BI5$#1+5T
M:P1.G08S3!<R S/:> :S_X+:DP5;K2V?0%.*-_8BF)%U:L\D99S:*#;X/+2>
MAPVSH5_H^?)&4(N1=[-;O6;F!CJKOGCSS6O:Q'10;9KFK:51#$[NA,JYBR30
M@BGL2[*#<A-$]]3_'KC.CN)/YF(P3EVZ/()1[-T)&%PE;U2=092TTZGN.EO_
M12NY:TZK/^E7OY9S^N7S%\^CF-[?;O[KQO_!*WZ8Q3$LCN$I'0/]KF6$8;8Q
MLEH #SHQKS?G6A!U@*)"N#H,,;7Z]>K_%?2H_A2,@$;Q!X64):#8:3QZ!FC0
MFW&4(GQ+(_H1V8CP&54X *9##@>RS$9Y@MD1QTN0;ZA_[_&:UZ)0):2;.FUQ
M/[F=3G+DN7B:L<*;CL 3_N<Z*8+V-C2B].[ZFA?QJW<<</O?6>VT"%).$+<T
M>*G(3>E*T0(?R[/;@@G4##;^:Q+J'>;66[",>G&$961M]'9X+$LFP!*Y>48$
MOHY:<E:*#3:[K_)/?A97YFI%N<P6/1O;4GDE9N/A31A818]S$MP %-TQ9<K:
M!P./=]AW<;!CU=YI*5GFP'=,>-H[CI%LZT.>[]0P8-+NNSYT4>.73/,$%2M>
M$7+[B:7<.Y[\8<7]B&+$:#YM[9YR/67XTLS-"4 X*P7&TX]R.UW =_% _ZXV
MO067S.HP\*1#'Y*,H\T]QM)K')VO+K'EEFD*T.M1L29U4[E;8@-9_U/[A<<;
M8P\0 ^)0*6%OQP+47\:2\5"/O*>_*S'.=-_K*Z*5:J#1.)FX9://E;*O7!K$
MEB!WL% ,D@-6Y5<TT> EYCL:VGHR.SE/U[&8[=@58U9VEPG$>W4RYDA'M0C.
M4T0:>N$/:&8,=&1Q"'2D%9'9O[N&,ER["ZTEY:XA.:Z\Y^[7(ZY!?^/&W6%[
M[UR4XLVSFXHV/+KL7YH[$>RYB]O:<GIVN')Q9*?,50?:*?*19&8R4-VF<5[Z
M$%>>HS J[H?V0R/EA&Q F!8_\*;L(O_YO$N16[9GP!5I+??\_Z(C0J<*JS.:
M" @E,0 5V7YM6RY$BZ<!)Y2JH.P+>ORFSCV!7^"H@9)>R8,O?FX--3P2[O88
M"H-]<N>'$9#-S$T8;)0./?NF)21^8*<G=BR_![BO81%-;*; "F+]]WRL BU!
M<[K$AL=Z%/URR$#A2VOAU/@O2PME4L=$,E>N7AFKXH0I8!'D>X<7Z;1)?^S[
MS,+=%.:JHXK1QB4CFXO^0RR"RVU1IHP>C=S>S>IS>=&.*L*9 CN6(.0]2G'
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MX$(0*+E$7]X"*9XCVY9G#"MJ",J-X'NT57RU2"H\33LI\$B9QF%68KG%U@'
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M^#;$..X[[3A@XEL49!QE?SO#_AGXDE^AD/WEXJ4<INU >^&0<0(%,!V]' J
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M$9$U<IG8DF^.%!.N5V^*NM@5XH6_"C^4VX9"U'KU1=BT V]6*7'_?CU##67
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MH",BMJ_PGN([NN]+,(\I[H7Q*.IA)EW/U0#UX^24XCB>#7O1&B2J<Y!G4B:
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M32R-TA_XG82RMMWP;6+/=B9[4@1/)^Q@J/&8"@/P+^&1D-7 4<M[C+'IN5A
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M 0:E<#C>3:C@2->&O"ON7-/+4G\'A2:+[4!_.5;4R'/?(U#8C*G6(::S%*;
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M.TWDA"RY.7F:W;T)GC?8/Q!S%]HN(&IQB8J8+H^<"\6?/8P"U?IQF+*=+D%
M7Z,=I0OAX <.$@&'K$)"%H6UA%NZ90KR3P_4L:4YZNF+IW4)C#@Z48%M(NHL
MU]ZJF7-"T/15A;VC(7_:FWJJC@;WX3R\-&$H$'V\=3@[(D/4'7QP&*,ZVTGT
M@EB9L,E.;3!ITWL=C--+R**\BU#GW01N*SHHGPI8W"<@ ]."=T<F "ARD*IN
M".4PB.?6WS!-[OA=%8);K(_*,\?ZA*HIG-#.^%-<'@&L.F%VS7(@"1T/GRCZ
MX9%1?,HV",[?)DS_4Z+!$V],F(CDE84I)S9CW@B]6T96CLDD#ZG#3!&<4Q:;
ML@/#R&QK?XXETZ"Z$K-HLIC W(S=N+-&5=7/6U5K%B86;\*FSVU'^KN^N+@+
M^W.[;>1UF6MCH.3"0;Y3[VJ\(\TCD-P#\B1UMV;TM68]UN6>Z"[%0PA^WG!4
MH/18<?EAR?:<FS.>-$ZREN\\*SU,>A]]-H?)7"VV77OGTT.;&%LPXJ]IY)PR
M/E,6CC"FZ#EG^=-REF<U6RC 4IK")3?L($ S8^E]P<3_&YWH\-%*!*W:K!=S
MBAWD&9J( 1T7:VE[(]RB-YY(A16+KU^^OK+^$C)ZV[*1ZBX;7%I_H^Y8 ^R>
M,X2C)+TW;$H_+FY4& UW+F(LP4!1)\?:?2IYS.1T([:3KU\6=BUAJRXXITK5
M:[:P"GU--X*O?J7I53K/6G,1TDY(RC.<>LXP #M**0;N72@W%?&%K%4FE4;.
M]0+O/\VFS6TA7GG:O7QF!;H-E:X.)3:G\Z^BD^Z(96ZTYBTSVYSB)HP\/KPZ
M$?XWM)_"=D3(!N #.]TD.@QV6:Z[@X3E\X_IYA7Y)N&<//4.T4Z+C49"CM'&
M?+JA\3UO*R9BH)Z\PBU0=0'":N:,PH(0<E1HPL#[Q6<??YR,':2QK#U=CE3,
MZ%/O2I)P03I#C WG#,X'95%GS.AO&S/ZQQDS.F-&9\SHC!E]C,Z6 3>(<(#5
MAE96]L#W2&:F;*IVZ#5,IP-]A=ATZDPOC+\ #1:4\$^<SK2M@L_8W/5KRKV1
M6>&\/+E2A_^9=)]Q()X6!/+C>U/=J0.1G>2%).C<^7SBTUE<%WX8X]K:U%WX
M+'@A<#X4*&H^B/DFD%\*O^%0/0Z;"Q+A7K,?ZM?B:\5],$_C=$\^.ZNB!F2"
MN-Q-)L49@IF<$[XUL):D+<42PEE,F^RI1&7]]#JR2[T_07;-I^S/@;109!5.
M3OXAY&INRMTF0KN"VUG3BX9<]$"T:D146!*=NV2!*%?4FCBJW461!)NJZ@W[
M2Y(6=:L!:[@)WU=9AJ .<;GX_J;>Z9"L+=,X]Q$0T\B47U]FL-05[KU@(,H)
M8H;P#G.XHL? 2^0[Q $5C,.QO*(4K*N&H\6RYUU2]K7*!:P'3H-#_0H9,SP+
M9H[O1K(<$1+&9>X-%R##$J^$JB4LAG<DWH1LC>SC?=T+EEOW)7O_\ZYTN_):
M8BC69I94(Y8_A><L'/:X]$D1O"DVZXG  F(HJITV6P 2R4#++N.M:K+!2869
MF?SHRPC8T(4ZF;110I6$)S\XL&':CL;PKBVX*]Z!L;Z74'FX-$[!3(C8,ZA6
M.ZHOU:MSR79HF2KOB<%\E6M,@""*8Z>2Q#8<9Q13-M!ZNV(8NR3%*?]3^!1C
ML;@."R?\H:E+8.""O6*&J? C]]$UZ$8K$F[B=W8E1'S7UZ^OR+H0?RJ58.0A
MHDZ'#$S>D;[R,-]<7J#?L_Y+3#G_I6Q8_P7R+Q]+<KE:T=$N1A'.KN $W3"O
MQ,(M_D?,*%V-%#+E4N%\/QHPQ+$"Z[!@MWBRW557\O#]XJ-2J2NK;D\YJV77
MEFM 2(DB:_U$<@^<X^L%USJQRC,I*HOLPZI<[^ *R.:QL@*W3-N4F8PE^M%3
M]"/^YDVG%SHX:Z/I1RB-LDDC8X\[F94'?20$9$?)O(E\8'@Y<G!U$XMI@X.K
M9OF', 8%OKUTU\02(Y@SAA$"^9W0)7/5/C)RGJ^_W%0[-Y(\CU*8[><?-]5N
MD1#-)(53;B9QO)8L,AP9VS#,>"ZQK)\3E22&I4B+RE 9?BI8MP2G!&3+37LG
M^?X[LT5F@(3?2?;#[!"FK!P>E^16WFU[-)DADS@LD=EWEJG(%ZP:O6_9/)CM
M>_WM%0*)OX?K &[["9L99=3DFEXB)J>V+7SM$_9+?85/6L!X[;'EHB]>XE:Z
MHOJXVI(.-RWSRJ\U+>O653&N]&(-@3$!SFBU!R4JJA"J'61^M'B1KOYAJ$.H
MUA(PB65AM% ^Z8Z+%:,GXOIS[Z^96$9FO"@;IOOAW2M6WTA*E([X_8%P'-%8
MJY,K-CVO9JB!C3"T:;R$C96UJ>3LX#7CZC0<^YU=.:\CW.0*C&>*RPLV@&J^
MX;D8?N3EZ&*)QNWT^/*57YE&ET#QZ+=Q#,)0_MWEFTMUQ0"7I(,>/1.L&^HG
MM- CC'LIS1<1]Z0^GOPY!S8P- Z*^GB*JR(IO&; ]B#@$M:D&XP/X*_)7 3O
ML* C M6>U1"VVHL0H82@)C@K7X7/ZW5XI)?A["X;^H_V+OS_OX9)&E;OPJR^
M"IMK![G?5\$:X"MD0+X.WDY_4],UZ)]_H2)W^/8WX0W2XWY[TX;([V7/OWQ;
M->3L5U6AFGG?'4N&,/RC)OL'7XEYG ZM%*O4<4J]'V=5^M'V<6\CXB(X&S";
M\QR\Q8ZFKG>!F>C2)>]=6D485,( #K=P1\2ZT4HQYL09+3)^9Y((S.?AX$:&
M',48[H'Q37()7H5#W6],K"K/\ND<LE3G ;=C0'BXV:[DHBXSX(0;;'8DPNCS
M'BR/L".ZQ'TX)#0O%\9@"Y(LO(8S<51<NQ9\C5K7%#\W$3MQ]/,0?DU+SGHI
M:Z^YT*R$:[>=-,_?5Z8.'#&<3&OMWDOZS!K%LT 9^F[\/)MA%@%2Z>"-)V5M
M6W\&6D[NU7L1BQ$"9[V#0G$/A-4F#7E<TM?GCE1V= BOH0H/_5U#R^>C+[][
MXL\3NY)$+'3!(E,7P&6^,\8?#1Q?T+W=J?VMK6V,^W]>O/Y6CW"-3(TQM15I
MW,_(&WSZ!?L0] NZ=9BSZH+X/L5-8_D%063 &3(P:6IHO"^D?*:0"DGFRS]^
M\GNNV# 5HYMOF9FXS:(_Q)>+2BVT]V7#'%G,TJ?R[FY4'SU[?3L^Y3E@S:(J
M3JG$Z\27K2!='2?:5R1J2U0>IG$;R'EHL"V,87G,F<U;'&!B:$GMP4?%$L"5
M[WR4O@^'#F-F2-_/==#4W?J"DC$G?9:VZ]UZ@$^I[UV4<XDDK]<6$=TLXWV!
M@VEHN/\E1(N4"I;%G-=$R);SL \$O27.O0P"[74TCCJB8#J[;74VK:#K@+>"
MVW0Q*""$&WUM.-!5PQ[[Y/-/GX?P*)B8G31[?/J?3.#74!I& -H=&>:ATJ9T
M: O5A)0CW[O+IX_>+(*ZLYF-\']X8-GUO2X(/LG*J+J,A]^UZVT5I:<E<@ N
M[K;N,TQ6 47HQ3_#H^-LI]VV-BBFT#[2M<*NBL+.DIQW\1I\CNFYO5Q\D\('
MH\#+NA6^"K9F@]'5\^],,E:J<7RB4N B[;EAEX>15I?;L#QBUF.BST@Z@(3W
MMR*V%@:OL&*WK$2C/J$E"&;F9&#L(C QYAC!:\.>$2TSHN5G0[1\,2-:9D3+
MC&CY&1 MO\M@YJ5+PA9IQ.'9?Z2>2<7W=3C@*.%#9-#&%\S9PGU%HC)USS+T
MZMEU2: "/\5X@+_\3@_T!/(-Y.Q3@LCB.Q>(U25@X7335UV(2*C956,4*Q>%
M2^8H6BM0,&, 94MS#Y(]JDBH'@7KN0-+0H4N>CQ=IR$]L9!%&K-P7?Z,E3Y#
M=,[2)BA\2<)CW%?\P%,RMWR21NZJ=0>R(G8E1R4QUW!!-*Z$$[B!NTM+G"12
M*I:U.PP,M+"N,7V)HK,3!MHM:Q5%#TNVVK&#.K504,015GQ1GR2I#L]&9Z%M
M^L9+4IODMT7^^VB941HG^U.OLI7ENL3R5,5,NLJZ*^^:41XD&0?GKG0%H'3,
M?.46-<C/7<NLQRV3&CN*U$8!O:'5=U_H09G0,\))X,@=MV@<+12@ )J*%1HP
MI?H4J+#%:KEE'J2#0/='QVE$*A.TC7(J]9%;8#K7M0PA08]XD-W:O2?#U@RP
M5%<ML:7M90.R:F&)'$4?32CC2TB(\A%(.X76CH3O='UI9TPU$/"B6A:Q4IJF
MMO/TBU-S8*U(? 2&)[JI#W,3UP23H%5[-F9YSK?J4L=G<,DD Z:MGI+CTM61
M-,3$3H!@&F*^^/X4:#'5M3QNMS3]21;W<%LHY\>X+;L3IVD\U*4'=((J_&%]
MU6#%$$9LS;$**"<O4'/%?BWA(K2$#"U AT'3USU-<NSJ,4E0ZT!^;%>HJ=HF
M;9%\92W)4M <FWNS()09QWC#1B%3:,'1@%A_38^0Q"@4DK<9(9>$I>3D20#:
M+MG^ON2)3)J,%++)P'_ZISG;B%ZH[9)F4T>]+[IKW#8:Z;=HUC+%(<&AM)UE
M4YC&E(]AY+_#&:L4'@Y(*3A#DZI4D@.FWS=J$3!9=)6T,'N)E5QC+HY;2S/:
M ^<$VU2.LEQ-;"&QB%!V/IJZS:8=V+0OP:&UXV2@S[UTCNN#[KVK?-9&%3NE
MSS9MLETXA;IS- X3E2"E )C@=YCM<-),NZ.NKRVV!YWOMV/IK>B-C)K3T][T
M(FGSSC:B9^I@Y<3D0[9[28+=<Q 9#QY0BHP#*KQI+$:VL4FMH5A*A )A0A+/
MBI-I&%MDW$N+?O03%2V.^RA_CLPRND+:H_OPI5F>LHOMJ:HPWT)!IOE%G6%8
M$:1=J11'QN):/EE\JTG%;WSK((-LOOT&/]OMRB7E)' 5>Z34-&9+ 98A+:)T
MXCJ#+CG8$<0(DP@]TG,(*[*/>A1# ]-!+R_OZ\]@-1D*A@Y98K2>,AC%PQ;C
M1]B&#\\0_!MH?][HJXRE&W*.N23!$6O<XR'4ZX:#)-A9!(R '.V>#H%IJBH'
MG$\59.GLY)@J;!#L8(Z743&B4&>5P12EM$PU%XX@'$O'#^/EC0MK/C>R1 ZY
M BT5%PE^1VCMR.P=S^8[\^'EK #$/"N)QMS!ZZ]?+CXR$*DP[RE-74=)U'6:
M2ZG0N(NM_*28\.P)G( JY8;]CASK@(H7C^H,'W,:&H3GQ],PR)DLQY%Q@FQN
MF<P^4N$G/SZ"MC@8Q'!B)><A,[IQLTO"93&UN--44GG4.7<GAL6DY+^=%,T>
M33YG5A31_CTD2<F2\M$7GK$4QAOD%H9CK=)\M(>7JBQ&]VTNJ,MKT9\(Z=@7
M<B&!V7#I0C_D,>S:87W!<F43W^%7$MX%4=P !:Z9HS8)[1:1R5!9Z,07T8&D
MZ3;FJ*F.B$]P(M&>EPJR("@@;6Y+=&KF"5X4O25H:EF=VE,<3!HWF*V)[O>T
M[5TI=2:?5!C2NC(X:L,J\D'Y5> KY$O)<.C+KR1^T=Q, E+(TC:%>ENWPXX
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M@ADEQ"CQ17,N6%*H^C,#I8I1D=M>AOU-.60/6R1U^F4413E2]',0)FNQ&[R
MPCTY?0GZIW+)67-S_5'-:5GP2K&2N@3-,+H[AS/U&*'H1)]&Q'#!^&PP [MP
MC7Y5'BK%$8VJ1I2 'WK4+4(4RQPH<KB%H\4P5%ZRO.7:49]/PKS6$_TH7^Z!
MH/EBV[5W4E4'%%9K(DE]*X&AP7D@"6<*,=E3H8T2#<[H?0+&K(I V$^[Y)@
M*EL[Z,E4KH<N:[+'4H=_)"KGXDZIN8OZ5'+6C+RK.-3HRQ6I\^8].QOHF=%=
M+KZO<$#<D3<\&D8J8#>2PI)!>OPP.@2G!JE[=5D2,SCA'85YG'6]@!.@?(Y7
M!"L2/3"YF\92ZM'6X1P%,0$]#9L/&K_3RDH&W0MI7'"^V79!MTX_8<;ZE,'0
M)8%FOL(?RK9@%<J$9_ ,PVZZ6=QKN[4J$;^,8_FNPG(9.X@69+,C.T4@S.FX
M2LO/!JM/J*OZ,[5_U*#1X>4^H>4YMBSY[A:I.#".:I<$NGLW+-K(?P]_S+F)
MF6*4%_[4H.;C82J!+.N-:D;KX\W$:Z5/FW#,4NXNXBZX!9G6CQ.!4+A6;"*Y
M+>L=G1.%\-I9V(NWKA"0]HPRW%3)UQR!I"-."LIL@UHN@0/,KI'@F1-@.]1K
M.I<NP;^6; /)>8A"72H,NFG%]C?R&Z;,GFP#0>/K_<]NZ #=!/:0+K<N5[Q<
M?"E['#TIT.["!8$8'[H.@Z>M+AIZ-J_>792"O3L5)L04#197<.2=5.WO<0%R
M8X ?BT9$T@L#5/OEXN4F"UJ\6TV?C(?N?7A+B)_IY@6M2+0=(],A1?V(^A/F
M<;YH3%%FX%TF5M8<Q- 7SHA-0102N! ]1#L(7$CABNNP5RDJABDO[FWK+;3%
MUIK\@Q^];;NMX"74(QC0!R'?C,J91+I2=GOZ%>YYPZ2&Q%'@UTY5PI#TW/ 1
M%E<(^G>1Z3D,=:!PN&8AG/P=/D2+M!GQV$^J>GRD@!ECHZ0?:%WFB>RP5'?$
M=6_$9M^85/(])5@^EH%DF,HX@UP:Z(8;S+9(R" UG6:OXY_0N==CS7OO*4P4
M%5OR1CCOIR8HDWMR@IH"HJ!?A#I32RH;VJL6$+GD?!(F)^%U>!5E([JE-%^6
MXVM7J[(7C*0H9%69P[6N]A3B0J?TT(;MR7EA=;_!+2K*-*ZPAPTQ]LH26Q/]
ML.^ME!(F(BQ[#KC#X&#MH3%-VYBDJ5C1F=TF$5S>Q'Z<U,5G-6A96?I3DWJ-
MYR<OS2P\X&4I'$AL'B"=M3(=)S-?%(Y$"\8,U&Q5_%D@9LR3'23VD/IUP^^J
M/L931^1C46>]9V_V'Y2G?UYF=H9M_19@6Y_.L*T9MC7#MGX&V-;__XX%'+O)
M,SW%,SD4<YJT)?=QR,(4/HV%'<R.88ZMQHSASOVE8&MW.B.;CF1/7[GN8FK4
M)O=%9 R=1SWA-,"?<6".U%G0PC;W9$3.-D$@X4I2KFN;#$8B 04W'9#ORO[^
MO3V]AP]]H7GS^(NLO&_K_EV_^#;"QUZ&3X!%HX#PM4CI_#XF[$>FB<DW=JWH
M# (JK/1=^+RI1 UNBDVM2%@09)\&E[SN\MA-]5(Y$]2&0)9YO\(?;QH"+IYB
M:J8+_S5';_X]?3.0F,5JI0&OFU@R=1518* 2BIPQ)2$*M3(^?K[W]1[*(^?=
M0RRRIOKLJJOLGP0*T^R9-(#<LQ"D_J_QNN:!@FGD0I#+R%'$"":.,*RZ+P^\
M-DH1AV8Q66%EJ/3RFDPG0! 1 3$" RDVP2,-C0$%[GWFZ:=P! [&SWDF\<AX
M.'0TZ3HNI/G/<OTR$F*Q@^88M[2%<V;BQXLHC1C#1DJ^:?&9(*E#U]N<AN!T
M8#8E?"6L.]Q/X-(XIYA6(T&!\:](WXSS+W>/RK_H4I,J-P,%+Q??I-_JP\;+
MWK'3Q:09P/\(&J"(@C3T6YH6#NLUBV6@PW2>ZEY6/$KH!ZDH*MBDU>>2YY6%
MPVGFV["_UWX98,9D^2LUTJWEHV.JWLDP"U"!;J:>"(.RZW+;A/FN5Y@M9%RR
M1"]Y"HQCN FC0CY?\=%2H82; Q>F>D_80O$B-I+J1+K%6 @C%61'RT6^'_90
M\!P..^"^:>V'NTBB;LTU+_21OAD(\%F%6&'H>%WCS_S/\#A7AT.E$J8HV)ER
M4=B7]5$7DT#O!-@E,,O2H95#9"25OYP-@B?QH@HFMXY@+S>-^RHL=.T4G4H3
M<<<>YX'XC<6[T1;$&,\9PT6L6=L*\$,<#:37U<\&  -*,,1-"Z^R[F5Q 'S(
M+;VV2Q76RBM1UI'UPLI3;.IJM^XASQI>42?EPG49-^!W#;IP08$DE4RY5EB1
M@Z6@Z:OQ.7J7^1N.?2V)K>1:#)2K>[\TE3L'*D3QS:*OM!.6-44I8Q')4%!L
MV"!)"' FXS 3-5OA$XB31"A/_W,N31GC66$E.]SH-7^3_O96SZK%-YN-:M-_
M]^;UVV\*/P:LT!Y$GQ'_D*[(17\B8(!?<(0EH/.,)2RQ]N04T"=0/:.DBDRS
MY!^&CK7(H. _P?K9(T6_]*0)X6L[TL1]"PR=_IC6MF-_=B9;%W([\L(4Y<U?
M2$CKN*-4+%-#DHS:Z\%'4O 4]?PC5FE^<!F]U,E<(2P3> K7XF!LXP>G1Q)^
MH0T^+IA+_<3Q&<"FK[1QD!WWR]#=2E%BR4AYODM9#^G&MJ*KU-@()B^=O"<Y
M"&MD;-%=<BR),>,;FWL[%&@3N0I+0ZQ@1%CC*S84QN1TP)MVMP.7^)_/YU)G
M:HR9&N,GY&UXB6NS.NB(=?%&_W<CP+/&EX.[ROD; L:5Z.3YS.@R+]M?<MD^
M_AQ2 QZ/(G%,Y5B8E^J\5']I"RN>(X&=Q(\VGZ?JV/'>U!TSLH!E?FHA:_#E
M[+!2^R]/YME,_9+Q]Y85"4,YA]_I:FE]H]Y#,(&2]:=Y'8@@<]XJ\U;Y%9R1
MI;7^<*Q;]PB*D4<"8&VW4V@F-3AZJESOZS_VV\EFF=?XO,9_%8?[G)E?#D?K
MA*1$D/*/5>@-O(L1J<LI@]R!<$^4[0!W%R@6Y!.B8D#>FB^(TP!<S^P2%79%
M20L <-756V"8Y$?KJL=VC$-0B)@;GR;GKF)O&10$)A#![CGT0FA7&T<>Z,AH
M_!S-6W3>HK^XQR98 ]1"CIPN+)=AZU"/DR[3MIO8P85L*^XCX<[#EGL)W+)V
MA]"]);2Z257N.<]Z0CY2\GJ:-PZ?A,6';47-,$K<GHSF_J$S%ACY,7Y4TALR
MALC,YN"0KAL .V$7ZHW[ QL5,DB5W0FG;[FF5;.?(Z]Y'__B^YAY#7!^"60_
M#?VG=T$O' [\U=AT0Z7 ,V7(>27/*_D77<E)(4:*,]O(].&K/7?:1[:NB$M#
M5"JX0U'L]G3E6RLQI=4UVLZ()D#0DY5=]$;<;Y3>1>$<?FB^,G)V[XV;PI:G
M$53$RF61X81[)QWB7HE%4!^DTA^^POT)X$=E*MR.KJI<:>'>=%;NN;KGY[!N
M>-*(9JYQLX;*(G<,<L,RBKJS/9CMP2]]LG66*T'6;E$R5,, +TJ^6]Z5VC4)
MGF^N#].NP(H6I(4YAC@OC1N9ZO\/W@5W8%9P^_NZ%7^1(1%\USZ[;1?MCT$^
M2AZ!HR8OJ(>,"&5V ,FF&]1Z'==$E/&(?3=WGOP6.D\^FSM/YLZ3N?/DQW>>
MS)[&[&G\3)Z&=[W)%U"$UEG8<JK83"AGH:.5OA?&+BN'*!W?+J@P/#/B!X7^
M6@0!-I_QF!BHB#%K"[/#C/OP:$E$NB6C=)4#K4)Z>]MP4,*4=BQ:@BQ]$I\P
MV]\6)*\QD< Y;0Z(R+*"QF^0O+OPU,Q!P;Q5?\6@(**8JUL'T)K:M6?#AGG)
MSDOV%UVR6@/1].QD*>0N'!AD[%'A1#E3DUK ?;M63)AE+-VU)HZJQ=^5!>9E
M$R;Q2$ 6NA]SV4<,N;M,N0IN])K9CPAWKZ.,-9EP O73H_4(WA+L)T(-0RPW
M]$]ELA>FJ*ZK;EOF%@J+8;>^(Y"QM#(QUT[">>K /QNA[DF:;@]#1S(%<E!J
M'Q:?CDQ?H7RO)-85/&SE=N6O:M@-<78C5%:^:H/:N[DZ1B9=9A"7=^"?@:$7
MT4EHN?9\H/Z(93Q@FV.FG$0\_I0]$,HHZG]QQ2K#=$0[AB*4U+UJ O;320[8
M> M>FMO:,>^08\+:H$U5$:L)-6=5E0DQ&+5VQB.G;@ ]:XW1T615@,BW/#_:
M6C';S]E^_J+V<US_)>W0NY/P3I?KV[IO.]< Q46#@8E[F/W4=SM@00]@+FR[
M#L[Z&GS0;:<WF-?TO*9_\:JM5H8::XOS=(7</[5A6D$MY_QSZ.I^+4*-OFT'
M_>;W@BSDB$*X*JVCX=3'7:9:[+18)!U 3*>%W14. 2XJA>]Z73Q2SR, AY6O
M! BBZM?A &FB<$QT,R:?31N<[6;\J^0>#-,B7QY-R*#R#6\-'L!:5/R<_($;
MSX/=_>>&5>3*H2U1:1]38DO7RDR<?-K#Y]!@P8&A)BS"MO@F-8^=(1S+CH N
M_S19T?XY76>V3+-E^A6@F[1,)]H4[VWC=YV)9U;I[YO9XLH3_FR$WEN8=#2/
MYAI8M].6(9,G2E*+OQ/*G!_) /,R!48E?!>3B=I5BOXXCX\($5D$<\QT+CF=
MB\ZX<W6F\#"N24?KYT5>/6<>?^G@T9X=Y@/PG==6ZJ][0;8UDJ 0[>/ZV$N>
MH85^7<&@EN*>RKU(1"O%\P^%^ !UI#U\;=UPQW@M#)T'+?85KBF)8+;5^U+5
MK8H/G(@?7 #(8E4?%D=G5]W6U5U!\/SC!>=N^$^,J JCUN2&,;UJ.<>!K9A>
M59I_-\..2S07]+PGQV(N.6A='YI(2SBHXU7%QJ0< LZZ"&:D4^.C"E'D#1N+
M4<0O[ZIRS= T9N5?Q_Y]EK+*-/T<(_&(S.T!(K<)QC:%A3,4U3%'B_H&.\L9
M*1ZGPR!I!VD$X72)&+>2#L*>=D^LB9V8+)W)3"*N9VS1,[HB\(,@$BDYG;!;
M*T:.VZ^8RCW.[B.N26TFEKPL%DB:&OKPO_+# D\_AO9-QV#)4&V0/?-/BPR=
MLU>C=4->&='XMDWP-%>)'+S1,VP[.MQZ)A82FHEDI@F**2)O#]S.&=[+Q?_(
M=9'"C68U;A0[7<O&1"(<01O2E$KE3DQ$)/!J(@4^?^G3T>$QWS$E=_!=Z?QH
ME[=U>$R6.N@X60W&K/UXE,W$#.+!F1XK&ZY3'*0@G4B6PTYH6-Z(2>W#DJ]6
M@\_DRINGCR&,:J6K$9LTR_S)I]K1$)E>(-I2$I$8[7G$U;1HF"]]S1SN[O[T
MZB<+REU)<;.:.UE? BO-")N7[;JNIM,%,&_+KBU#L O=.\^W TO\'MGUN.(E
M>[^OB..E[L$&Q,G[#_N0J][S"?>!'7 7SD_XL">P6/SV_ 3OE#&FW,1[DJ,J
M; TR,*B/9(DC%3V(GE[J6V W^&OEC@'7T-26T'X+>WVM]:G,Y>"[D>B="7-2
M3+_8M<'R=M+H(:>R<55.G&Z7B^_)D%$A2SSS'%3K;ES BM)"/-!!>)X3@(OX
M<,WU2&$6LDG\+2?=N-1&,EN0I6"8>]86IF5.3:=B2U0=$Q ,#:.$IVVCH[Y5
M.B*EH],3 %Z-.P'I;J/S0J\^/N")84RXM,0/H-,RGO#F>OJSEZD3B+2@(N6=
M!3KSLG%EPYHXF/$N&+FS(UHM(SAC]DRL@ZJ[*0_P+(KLK/(=?8V]R%(RG[($
MIN+G#\:_3/20"%D;G/TM:R.YAS.M==%C>RAJK0D2%:X:/J$<+U.Z[9RDDHDW
MU.IJKA&CKBN74\=93[KR+"5)BP>^ Q>:M< \G:T&@P7GZ%"[VN])WQEZP!/$
M,3\H8?2[S%5\GS:>PUP 0I?&>O>6#HQP&PHCD5WQK(%]#;WI*"9#3!"(.:*K
MU:/?':*Q83O3LA\PLG"GX/"2W/%-+:9/)8+B18KS"WC*D8NTMVFQ"0T6IP,A
M%'9:Q0@#A])0"$UJX!:Z]KWV+3S]0J60 4,GE"&BJ ZTO:AJK4* VA>X%E_!
MQUW95J-Z2:D&G[DQF3V0?BV"O563LLP0"^T];#)5N;JQ$^Q^9AD4;QZZW4.D
M-KT?2#ASVB@6S^;6B&DVHZ\;EPWC3ELGOH3\49+$2"19G./BO0L[;9ROXS_W
MC77675;<FQ^YS_L1IMGHT7Q0?M^LX?+;[J3Y?.ZDF3MIYDZ:6</E446*D6(E
M0U M>E0FDQ!1#8XNW84*:<!HZ7A_%#H^Z<O%WQ_H;.>#^!R_L+D<T4%0FH:)
MWV31CZ-?=B&=@HNFV+!)LQV2VV5'B5/O($SG+EQ##'O.X;F ,.H9>$->KR.R
MAEZ&2-/UG I LM'-UU=#1W_?@ZP9\9M/72Y5 J"O)NL$249B')6%&*D^3KXT
MD3EUW[^[J?!N!&<4:S^<W8 _0XKVP<^F5^OA4*Q$H#H?88V6+.6IE<$U\JJ4
M*^:ZDHR.IF+;T@-2&M601;]>\#PC"!XH9D]'?_)6E1)"L/LNE3-'VLFI/RI&
M1#*-5*PRV<U1GR5&(O=%XU,:"O6F8/(;"$J@'):DW-+!/( 41!BG$$7]%==@
MIGD>$23Z+\(6#W4LX\KY0&:E8< "V4W""9#6PD#455K'XPQJQEYOJ;ZE-UA,
MC+52L0L2H*\EY05C6N;UU=KD:A"VCU_*F&8HOATV:5),(N/)Y4.UT&$&08>W
MMIDP(!1J4C2LEF-WLO&R2HZM7B<KALI5"?!MA5&="GN3?/),OLL\8>@HQ)(W
M%<^*PN:2FT577.K")%JICL5K7#EX C=$%=>6>6E,S(A>\[$;*G=@&T6-/#*3
ML>Q.6F$.1^C ;2BB2%.94T'O$CE&:-'DW20D)X+<BHC*:#%XQ+@C7!<F%I/H
MTS2FTY)I':/*.*6THR?5Y>)+<H,B;V^Z8G5]CA?OPROV@9W[H K$^7UT4S+7
MG"XINV>4S\E*(<>;,*];JLB$(01+R4OKG\'EX4GS A&&.1LHT497H1G")D#J
MS8YVT?X+5@+L=-HJ19CC'.G!^;)2V$3"\ELS?H*M%GJ5--,\(7RM>M;^4?W$
METQ[UR]V HH.ME[9EB(T.Z:G:2F$^3P<E69OP()K-%7OAN(&02^K";X18")K
MT3<R[X9JUL<[SLE1B0-0!'*?4<CA"[(IS?_<=C8[[+["-8W)WRSU*_8*DQ+6
M M=BR#QONI).PPUGXOFU"&D3+56JJV#%$8\UTX2>*-303>F G\OJ![S8-\,(
ML"$O.BHM8OLDE%#=2<X^]UII+?018H_R U4<*[4RJO<RWE*()^2V.".2JXC)
M$_S<Y'2.%,3ZH3>>5G:E(<##.E'I^1EK;+BUQ_QC5=WI)E^5,))4"H4_G6+U
MMRCE=!#I',)PY1 +NVU*[RM[ !$?2RNV""3#_S)\?]'?R)+J'8QP$G>JFU[1
M7%0FW!%)4' BAI46H?\+A\9-O31Q4$8WF1H:\5,V Z2T.N8H*#G58L78J9N'
M]3GT]WH8Y1136E@+86P54Z[U[<Y[P./-@YD"PD>JN:JOCNY# OC0FUF'4(S[
M/,P0EQM8,&H9]40)HSM, =6%[[3KJO#M<KG3+06@S6&($D;G>LAU_R9THSZ;
MH&^<0S[WUB7&"H9QCK#N#0Q>Q.7;L\,DB_5H;7PJ6@4L6*721Z@FP350&:Q%
M-^PJB^JMJQ7^O4FHG<$RJ'L_!VV34&XM=JK1ALGEH'?]2[_ R\57J6LU4B?4
MHX(+[%6S+;?,6YC91US95\W- #@I/+&17>48BKV0X>7B.BJB5;4@.+),6S>A
MDY9_Z1RLCLS)1#U6R9L9YRNP89WJ6J:-3\Y@O.'6JZN1P1+/U3SIJ[XC$6B#
M#7MFFRS\XY<"8N2& (KLG=$5_E:5-Z>+-WOR(:\H][8J0[C%N:VKU5%\WVKZ
MLZ@+MW@3_,4*2GS//G[ZM)B8*Y .8 %4<FIR:59A_A9^L]P=!U\A2BEPONTM
M:M2CR#7(;PSE[Y&U^^I8N!+PZ#[EQ-32B4HUW>..!^E6 4[U6/,]DXI,73VB
MC4B*T/SSA;$",ZTG7U$UP:.$'P,N2P4\^:,T'&O[\(YUC1@P2\;,&S1%._EU
MQ5+@7M[.20\ZL/PYBL9@2?@6BD%%U7ZZ6.WQOQ/0O0\;#OF!@R&E=W<*0\!5
MD(E]R]JN!$0D$PW2#H>@_CE,UIG:QR/,UCAS5:AXRK\'K#9[&&[1_4-J3DCU
MC(0BQS*^A4@>DS8RV8>HAGM,E7*C#FUJQA.) @,)T9)Q**Q<QW=7;P23M2)[
MYK!<;\([10%HM^-FDT2A%R&-25Q1\*P."T:;:N/B3UWX[;&R<EW#P"^EKPI7
MV??5[K;J[:EVM*5P9' :)+VF1+TFH.(,]*;"M>6^*@3J2&G2$% >0$CD:$#;
MJAD(/R#3>)M3RFUD1'B6L!?83RJM%V;=E1M,LC#)"5T=GY+[MFE)7OA?;#7@
M)-IT!$M3[3:7B^\98Q0)D$KE 8J/K$Q XR?/2K9I";)9<+?8)G^GQ2)8@# I
M+ZJ5.2>?%NZ$)&JE")1C Q>FIQE$$I<_@K&E;JWM$*:=(!?>YS @,^? (8.#
M"@;_7=#,]"[T1?O?1K7IW-;,.*??&,[ICS/.:<8YS3BGGP'G]+OTKI(JY]B9
MHG0+<# ,Y5&]APGOR7=-E-27(K1]YDLQ+RTG Q1 7;ZK&KF<9(_B]=H[G&[N
M"F$=#Q. )M?;3,>>3R[=<:,2Q<Q:)3FK!I\R@M%Y79/3N5]*!QT-3? WX$9$
M:6 ]=;N\+VKPPN]%"!2HJ1SW)J#/BTJ!YJ0X:HZA8JSIE03SL.T04V" 0LO'
M#K'%-X+&%E]HG.-D[L(8FFNZB"-_>OJD%^G_L??FS6U;V;[H5T'E)G6<*E#-
M0:-SSZER'*?;YR:QRW)NOU.O7KE 8%-$# )L#)+9G_ZM:0\ 04T6)=+:_4?'
MDDA@#VNOO<;?#_O$'(KXVSD_ZXN;@TRZ33/(6$#M32X-"Z,%?P&/WAV>;5'0
M.,.ZX%Z>W=HP[S1UNE:DQ(6,=!6LBJ:;P \0470&5UYA:PJGE$\5!D/QE6S!
MO^X?,C+/_<4Z<@EB%]*&QRW5@<E/&PY%:S826 4G B3^M]M9T--8X'8\HXO!
M)!AS@1 %"YV:I+$N!D]?NI!8<)^3R$]NGZ5P_<CI4"2/"$^"G!=2@38?U7$B
M!3J$9-B-91FR(LX47^<Y<KB,T27F>@5#C1FAET2?0V>%>VHZ>X+%83NJH7==
M^\>WBV:8D$4HZJ8GN.%S6[=H+VLCW8C'ID.B.M;A8M-T(6=LBU9_.9/7CK=<
M=%*2"+L 2ZD6RZQ8*46'17=C%J53:-BN0N:S))U7BL+_/;6*0:7 >*AO+%=$
M#)'<9A"HAF2@?^QDO-Q.L):8:#@D4)98<".=I?DL2P7V<)I)I00=V]:,<SS-
M4>Z,%"D""PKMP$N*C*OU=/KL.MBL;@6ZI2"3*C[BZ>4W4BT=@207&+^#A52(
MV0R_*V8UMVMW\G6=XB1!LN"Z0-OJKG>'#4M<''>?^O= WF1JB[B'OBPCJ>^H
M!+I%9P%#:ZSV#M8.D? >!9]>HLRF'7Y-INPPB+7-''X89IFJ&I&>S?MTT9+.
MY%#<S@F JB]+O-@R6B$L_N%B*[LJTMUZTX)PQ07>V-4:-\5!\*JB7X<NQ*7A
MQV!@;0WRG4F3IWUT_ZO='3#KN*FF5DQ$J?*J-'R*N[)4E()/,Q]R&WV-"T-)
M"J=,#?V,(N>:)*IP<XJY!%N8:@<= '2-7!HQY("4,\D0VT-8'Q1%=@V@MXX4
M;RKI"3<GL*]IR9<]4KQVL4G%/.!;#H+?G*(L6207IUR[!5*YRT%5>[I[[L1K
M[L.[J5J]/X2_3@I-X]):^XM>SX7 CM^YC%;XL042M>$\DF@1D9DF2TK0"J9I
MZ/K:4XT&8L2F=29)N-R#$VYX'&<Y*-$&]KW#@&%M.9M"P=]KS1&B%?UYEA57
M6OLO<-3&MH.)P<,^IZ+T>+@Y^\3[?PP9VAB6=.U,/M;YN+;JV1%).2 ML70*
M'KL5A]W.-GXQKJWI-Q)A=AJ2[+ES+ *:DX[F-!68> *WCEN9ZX+-A"@4J,+&
M!:[@;G[V30RKMU@G**Y88HD&Q8;.IUU)P>Z><;QC3HL),FPV)='=P)@7U\?F
M)()H5=/N7I7@>7.=>U,QP3KF75&14IYLEN+W<$M==+2BTQ#H_9W.?O%NX-*G
MEVD"%P:;\E1!CT!"F&*')9=-(V12/O_3M&A7(3MU<*:@SNTEV" 25USZ?W_!
M@*.,IQVGQ#T0MHW@;H+2&H-TT70\OHTNGIDH]23=UH&\V6/L]TE:#'#W,9]X
M2.W"[8LF(A(WW:1,.>+6#>-^E_4BWTK2[R.X4TZ[:^?2!Z.H=>N(421WHD&<
MLB0$UE398)YMO!KO=/-MO/@ZW;@]EY^_#ZY-(IF=H8BS&%8H)U3%P:>RL6V"
M;=O<+K?KSSJ'-FPG4FZ&YG9ZKC-$A*9JP;E'X5Z[%4J,\N,9<#;$3>31+EHP
M0*V;-)>'V:S/>7$UF!=<&:CIZ*D,:$8=M:E%)B8Q:;4"B0%NL;6[-5[NFZ+L
M O$.Y@MSJV ,X3K\^^[3WI?JXX??Z:.=)B]'<AT Q+:L)J#G",R*OBOV*)8A
MQ62TLAK4GI5SO86&DTC[!FX\L=UXYUY>5%=LHT8:.\ HILY73<$:<Z[9H\=O
MQ=\Q^+-RGGH0_*.X0C3=L-W8LXY*<:4TWPO7WG*?X)(W*&H]E U_#.Z8*)^!
MA)A'"77[52;TUUKET,J3A:3J5PW.U48W\EICTDZ5S_I:J_VNM3KUM5:^ULK7
M6GE,J5NL0B=/P246NH::\>^1CSNE8$<+3[?'1K[#C:@K -CVQEQ.CJD3T#1S
M,)S^C9DL;J-OF^6M.[55Z'SEH*7PZ+NMO_EJS:T.V[:/=N81ZJ!"//R,TYF.
M#13J1CDP#,CXB03J0.,DX +B4BVP"C_'GN?0UJUP&W>EN%6 '4X#@5T6%V6T
ML,83@=<KM P=0 ;J4^0EH=R"C9YOWHA-6V#RF4RS ;/SGD?+7ZR-P2:P!\K&
M#>\M^,;]T[5U7$W4RC54S,"+G@>(+%ZZ\5S9?.I\55%G XH%1B'*(D]C'$M#
M&&O<)"@@ .WSTPHX)5$=L6U,[@N!^09)L1 WAW[O#DO#W"#,6D=P"'%!166^
MP7$6](*N!G 97BP63B<++RE]!C<RD;=L91I=-KQSHRV.RV*C*FYQG^90K((L
M_4PH#!0]:T,8<4F@QCC2;).@O;):(PA/,7/CAG\DU6.#/KB_"Y78/!A#U#B9
M(YV.TZV/95I]9K<4?9(<:TRYKJ&-CH$;Q?@8NG\76T[<KC+IC%'K+)SNBFEN
MZDK07*+-;;YO&HR \;JV5/A-(95K=)-.I)2+EJ@1H;-8+\\DV'4K5?6!A.,#
MFG,<W,2&]]?HM 6OP)1$&AW8,+!:G\>:W3- ^)&AK&,CKGH%F8@(,53BSSJL
M?5F@[9R) L#"52=H3'V9G''$9ZTX+'6IJIJX>_PUVUEUU O<#';3ZG=U\QRD
M!+6E[(83O6^G/:[(H,V:6!?G!T1,0@5<BGG[V"H3=LO08-T(L52)P.FK0HPS
M,A6+K,7?E"Y(,>JY7&+$0ZWU %#"6#)&J"";JM(0#S W:?O#\QS\RI_2C7^5
M,O@Y<.U7BK6\_N*K/,=DQ >%!J%NX-3OD2*KEYLC.YYY]];2ZYEW>WGN7:PI
M8_E@KO8+=K\KJ8N3RUS,G"Y2VQOB# ,-\ \591B7Q=/&<7=BZ%(&FRA*BJ7K
MASKA<NO3>YYI+^U;D'8A*J$6!\UDD=#]86\6.A'FKC!^DL[C;RKN0<C1#%O6
M _0EN>U<?Y;*&)A3*<JC;"698C8K*$* -4'\*'\&_!G8NL9W&"];&K_-YB2Q
M+8R$880N0<(TY074"^B6E72>%]@ R&%M0H;4E5UNW JQ.+#WDP6T"KC.5Y67
M&" )6[#X4?RO)N700Z4;\R1&BV!K".$5Z:8UZQ783[1K;4TUZCQ=ZBY8Z8'%
MWX3!7T2TC>%Q[#P,P5= /9_*3P[MFL"^Q-$2'5YZ14INIC]D_I!M]Y Y[9RE
M2A?3IJRZ,48X>0Z?GZ&8P^H[$'XOH5Y"MRJAVD:A#",9S5S*J3G;*3 O[124
M3,",G(X_4=TP5F8A]67.@2F\+233PFTA_%!KV"\) LITDZ->)ZV?)PZGWJ;P
MEC\/_CQL]SP4Y54$2Y 5Q>?495X7K#AE$$AL4TH'"^$OI:V<CA/ H-CHB"+.
MXNT>TH%=N-5W_"'QA^0) CPM8\> O>.=43'<R\SU=:N6)^%%UHOL5D76;=]G
M)F;&4X@1QHGQE#;3RO36K' !@!=<+[C;=2')-M: Q]P_+MER;+2E7Z>YVT#E
M1=*+Y*.%#H-V8H7\2 O FZ@I?^)?#:8^Q7*U2,!>5+VH;EE4D3/K+^-$608?
MW2;J1="+X-8S@2VF,54A,B="@[>3%,2'C. D*O%"Z85RNWHQT=R*Q*&!N3;"
M[X3K^[-:,8YEC8D]#@";GGK3^.$EU$OH8Y;,N=2/+(]TCU^4Q54]]\+HA7&[
MPHB)+VS\4R6U8$BNBQKTV+7ALDOOT'A)W'(_:I391K=6X3^5\'#.B5$%L'R'
M2BP)9[NL3.A(E^; M^9%E@@\O\5@]T+LA7BK0MSN +FNG<6+HA?%QZK0BF+J
M$.4V*RG/NH7\><R7?<!\.?.8+Q[SQ6.^W!_SQ=^X_L9]$!F#H>A83BX$V :4
M,&>(9^P<]JZT%\3M"N(%R!^21B'LHS#A8N<X?*!8$"JR0(U7/^$?O#1Z:=QJ
MB)&1BIF9L"@MS,)"@+FN@UDXV""=SQLXHX62Q$1OC$]"'?)(8L<:(#3DB_*G
M60L?O;( Z02*Z[ $S8GG8XE<XGFL$/6H)G(ZAND@UC@.<;2 -2R":@%. X*S
M*F1MU/7E#.I&'.(EU='42N-B2"\T>JCKD6@S2K>]K@.5E>8S;J+#"D8B$.)V
MN:HAZFGPAA%"/*W*9LECQ3E<J,+J2,2@DKS,0? S@@X8R %JMD[@?"+!C2!K
M,.&&H2*,F.'!6>L;$4U"8?[,'&-!%R#W+0<!BC!!156';B\*Z6F-;.4 CN,N
M.CN1:IIQ"\-N!6!6(+R7O#(MF#-0P%4P#R"!U.[D(GG$2OI@*F=<"&"5@E2L
MF(?5#HP* NQH--7?39P@$;5"EI648]GLK7EW5%.7F6"E(&5'4\8>'?U&G&U!
MSD=3-3<0^<3$ #]7FK>D7XBK@A 62U4W92XXDE-E07&*=73TO@=Y:*0N/RHW
M3Z)N,;T(!N6:5AF6'+4:YS8"!.$C/M->"BX#-J%![*)<GR.7DH;^*M+@O#91
MH&(8-KS4G%*XZ7%4S1TYT6]&8+I**8IN"/MM&[-3AJRK*(7KU!11N@1VS&E:
M<*,>,RG!#3)/IVDMXR%)T^CIT0)#G5P)KX=E2(*G>B9\&2VC-+E.MAG8C@6;
ML [<Q!+M (Y;X6Q[)!YAQU6<.OPO*BUOD/7=$^PGT$?OB&P9L8.(8\PD^=K)
M/UY.N';A>B(\0HN>ZNP2_A=%X^@'JO<I+"!A*\587"$PH]OS#\<% [UN4V@?
M*!G1A(O&T^C\,/:R;CU,C%EJ&4)RJ!J'YD"4.4-FM'K0EEX?WETF[KO]O?(T
M!1L:7L.8G/B@&R6D:&IB7,8W]NL3!O1TAQB2V8;*J[A0J$Z0Y4Y [+1 M>E"
MT-)M5"[ I1U:&!A_E-H3@D.*!<W.D3O04TZ_9VO%"/E91+#+3$&0LZ+-V@M/
M-(010B(N5'F!DT#05(RFB[T'3\6_:^Y._-&:>'C%X2_%!*XJ56O;D;J8$)O9
M0'X9(B)]J(CMB'G6[F>'!].5Q\?SP8^MZ*T$7-\5$083[: QH9AZB&P=IX!?
M1-H'B+U4;E4J4:/"#3+7S:&=2P25Y[2(RJ2EZ+U4>JG<;OYLL50<VMMD1=31
M9\6X[]IG-'XK7.A3\!\%7QX[2/%)C>;[7"\,9"K8"J2;LB!_*THOWUZ^MVH+
M(&M!4S+M<.0@8A&^7(D1$&2?7D2?^0,8BT-9G\T<B2<^4;3D%TMQ&S1.KG$R
M9\BD<%/>9/=<QB>"?4>N60F@5W79$#UVKY-(=.D8XF%0=Z>%PWID<5$NL:Q(
M&6]+<T0XW[Q,JU2^3-C'B$6N*5J%O=K%%/2!@,?=,F0;Y"OBVL!/22R#:9V)
M(YTC,0 \98D7S9SIZN>(2S_O>]K/ZT_#D*O[1/2I\8F5?>1!\ >\!]1 1NSA
M2 [#?[CVX1+YA#4D>F+B3L:'$[D)L<#@X'N>TYUR+:DZ[8NG=26SPQI]9E\B
M2O42XPLYS@A=;WA!0YDX$^_"Q]"^2-Y0B)L2BCYH#&4$3L/!<B*G9B0>F !%
M0FHAA=*[1_0NKQ'1_U\-!<TIQ72;I<=H79PR2TU:ZMD1V_QGQ0C[O'*59%M3
MB?U2GI/"(D+N3N.!ZZW2\1)=<(?;2(FUXHKTN< [+\L4IGN+,6I&SI)9"W"-
MD01'M5ZV_HX-HM?-WW#Z_9Y'Y96!1, E;P?(YP4-(-2IP^CB A.>-4:),!('
MEED>C(8_W!A@[5^3:5/SM\O S:#V3Y*"5'+(G'N4<J(@>67HTJRZ7-$,Z^="
M0(F<F#A4TG 6VU'96H9[!6[9E @J2 ?A7 )JH^,7T8]ZU]Y\D8C *Z00TQ>(
MC*USBJHYC&Y0<=ZV+$!7\F&JN 5VYKYAVON&[O7B"\#WJP#\=.@+P'T!N"\
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M+V-&<3E%;WMHC[[8K/=]]?6>55^/??6UK[[VU=??9/7U$W$YWMW/14?G(B=
M*.W#HX/&>!/4*%=D2B +XPRNVDLJ@6X6G"31) JKI2 KQ);R&0P&!*RCG+S+
M"ZK=V*0O!1/V%+UV/Z.[?1WD=+%V(L<Z^:M)B%+0&2[JAZ96$I"PQISQQ\+
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M3WGO.;OF2,IB:@HUJJ'TQ*'! %=T2MW]_ACX8[#M8X"048200K63;\\_FO1
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MK(VI]U",U[[S(;?">FDH-G^1W+-E;>IF:2C5G.6R9173^["HFCI(NNVJ8F#
M.B14H:I' 'H"L=*$6%'UE7.9\]BRT/7AA&>Q[8-O(2 T+Y4]/46D:;-6PXY+
M24<_6H?)%DQNZ,NII&W'*7,69XZC'S&7(]O>9AVGXQA,UXZJE#R/]"-GAPG?
M"ZO0"L&9<EN6NK86?(A:>71I5ZKS?P?!*X<M5'<3<8:Z5*WI\Q7CMH[H3A8)
M"IAJ05U,KJ\H8YE2=1SJ\_5F%QUGL4AD,^IKIFX=[@A"<<Y4A-2J8HO"#=<L
MN?T7S@.6.4=EB?#58L:X3<\8LD"%PFK"7Q0[>R315G%:^QDPV=!:;B:O=+O,
MH^MX(L]3P@ED5FBUY 2W9GH$B2]JI1M_;<L \4G.\+[0O?32#T@'P7K@UQ!:
M$@H?!83XF&$[V1S%M(R8?"Z.R*$*\0!%=(_@;RV%9ZAK3>G#[3)4Z?URO^A4
MC[>@$O2PUIH0E;DDM/JS^LRJ!@[SIMEJ'6)3@_)F:#UBHSUF )FWTQD!][4)
M%JL-31!&'MFY5=4PE..,:W=A$]';!K$#/4>G'O%&L:%R6ELP QC:-,H_@U5M
M.A0W/K87OU00OV%92;%*?)R4*X78L:#N_3OM86$<G1IYE%BANKYG1"'37]6T
M=)(#5\KY<)1;Z$ ,C/:]"8?>>D;PSOP97B9C, B8E-0IT.0W.*V]<Y3[:B [
M<T7Z4BXJ@;J[X1'N,;OA93*V9DDQ192RRMP)#G9B]1\.L:H9A7/=:C3&G&*G
MH<2V&1?] NY,O%4NRJ*JK%2MD=5^?W1R<&0;USCRG2A]FLQP-'(#.,ERTBT\
MH]/993:+KK*\\MFQ?GAND)6&CZQCG8@N@,7+"LP%8"<'^8.BC=E?S<%%D+]3
MV.O[R?C@S.P@[L3WD^.#L?F-MB#(QL8D%+RUR^I[R$')X7@2ZN YV7VDNFR0
MG$;=&K(CC6NCYS;E"TZ&6(9.,Z!U &]2HCEZL-24TT9.*7H;0RSKJ'FNVP6T
MR^:,KWS:L\JG,U_YY"N??.63KWRZQ2KHG ;[X>X]:1P4DV]TXW2Z),,&<C=Y
M3OI.E!!%NE1TL/J13[P1UC;">NJVQ2'C/G['FM&&+)@:9$M'5,6VI-**#K=)
M0(7^%*[!]M/1J1OC7 M8+LLFX>0I?"JM!9EN[<5!AGO>CK62+8065=GD5YPJ
M<]  ,#7!^#6,K,*/5$[K[_C4=M.3!Z]Q".S;"3R/7KHV<(6Y1!UFA>4H;!%'
M00D5'0)@E@"JHVD%"KB36F7*!&N[H6]YE)O$T8ZK>P0(#H*R'^39.*4;_CC<
MY3BLRV93@H]J>$A,<"*]I!H99/=!6<\I1Y;I/(2#?E2MJEHM]/=TSTZ[Z,)M
MZ)7DP[6]MWEQU:VS"PFKXT+#/V[,5#@>*E?[*1)PM_+'% 6U \Q:9A=PS*A'
MF5$^;(&"P::C%N8&8\?_**ZP5R<,TIF.&#=\(/%*0)A\2;@["TQKJHN07!>K
M)RMDDT \# ;#;'U+#X:")CR,691FW3!7U5"K$\8/5OI-I 7M4:IMVK^O2,J^
MZ$K1(DV5#4,SPA96]%8QQINF4?R9J$"FF C-"<:/1AAA_$(.O7O =>;5C3"8
MB-E!\"=(;(:3F'.[#2L<+"#I74H9:SNV9K2X#>6EF&C"_9,I85T#SL4](9KW
MRJCBG (L6L<JYD30X9!J+2IG.2TDO!D8(#63Q,A63E )>^XY6LMY$?WU*H7S
M'Y6M$/\!>/CNVW1\2^*$,C@7[W1F,3!"FK,&-HTN2M4&/.4F?DP'Y10CRV
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M=MRJI=V4S;+M0N5M#MLB.<$ Z:('BLO%:,W@(=]U@H$N:50K4NML[C$L;V]
MED*(/]$N#O"-U4OTW="[6=MON^#RLIT1 &31.CD;G8T.CT;#X\G9R0\_@:6>
M<.#SY6>EEC#,K!L0I#6Z9E$PVG0Z'A^;<),3O./WCH;#'SI/W953T+&/9DU9
M[U*Z FU+T[)/J4EIOW"=]$Z^Q8;]VM'Q;_#,/,)^[/Z9>72A[)R9C:YLNWPC
MAS?U!H(,.P'9A5YZO?1N57JY)8P-E+58OA,&Y0:6:V"WO:1Z27U,/=N*6:Y%
M>9TH)IGD-C;:%Y&D*B[CX':#!EZRO61O%Y)"BDK=%CPW.RL!%S?:ZU;=$B,!
MG(9:Z=R92?YA0B$,FJV&I/WQ\,=CNXI_BKQ=.F6 #;/Z9^S2)=3?AF&W$?M?
MR&.XBUESJUF, @TX3#+\$_[DQ=>+[U;%EU)B.G!H^>NN":P\>MSG]I1^=-O<
MP+]X\XGRQ:5[4%QZ-O3%I;ZXU!>7?I/%I5M//_X?M2*" _A,+FS,8(C=B9SY
MVUJU>\+6?Y 8Q2YG:Q_]:CJWGC)VY=@B"^V[&GCEJ*0J$B(S<_K_$:^)'5SC
MW/:U2-H^(V9RZ12U2$ND?,O6@YE23^9O0L+E*]6N5\TO$%>:2Q$W5BI:. !L
MC*YJ%VL @146-)6L:%>Z.!62U'I(I&'.W'M+!GO*Y[C"HQ_I@71[[Y)]-7)$
MW L<43)J?0_Z>A_&NH%@LYF4[E=- :B+^&6I(7DC3<VF#I0P;XZ1KB]U, /Q
MI3ZVUNPYE)A.#;*#0?ZC0+I&)S)S-0A.TY7(,4W7B<=7'+Q$.CIJD^XCOA'*
M-FDP9C[/)(BN8*T-- U+'D7X1?H,JT^+BTSV5=,>BRAEU"YGQF^#IF9^;*EC
MG]X'-XYTV[: [D$E^F0LIJ.41-ZMX.LK%H6WT,&P,S-R%KJ\0]2=NT#N9V+\
M"QF@;.I0N-&DP$I4^X%!L'MZ_PGNRW>FJN:-=$GLSW)M?W5>$]7Y3)]-;U3T
MK(VV(< [S!1GD)33OD[TQ;9;.LU=:CFCT_!B;BJ8+UYI+]3!Q4%H\Z<&N$$7
M>M$UCCU8R#'\HU"E"?BD:?;1\"A$B9:6R0 K=5>]%P%IU'FZ7'*5=D4(*Q;N
MFBV*J3 6YRH+316F:.-FN<RHBA<+934J!HUJANBR)<RQ$;."&Y&JJHA3<T'V
ML"Y3F0XWYF Q**P70H4XETZINV?,*U'SPV62"L+B.=74"D,M832(;X&9C$L$
M7VC7YQ*LDW3I8/%R9&]CFM_*M%<@@7*1" \S8L$&&)' A4;D2H:RY!6A7O>K
MHOPLF+C%M$&[YU<"RHD0-8)(Q\&:*O6MR#"51<67NT4#2M*J;):&.J-O&\VE
M:*.&MX_4:=#&5FS.HJ=H*U'O&%AES$%SJ7K'8FTU YU<5,HIA(2G68X7O5[]
MZ"S4ER#,Y(+D(@AR+3.V:]>X)CF?0N>T4JDEFVED"Q0$:1"0I6%X87HS6;M3
M-+P#%\0'M[73X8BZ\39]EE?&ATV-L$8Q$I85WRN=BT/GIFPSK<6-V-!7NU[C
MKSFDS?ODVG@&%<(^F_44$M^",'3Q2[FIT1<#>/G;JOQ9=#A&D$)8'R]T7NBV
MS!GD7/.MLE?GTO92Z*5PJU((@H>HB:9WVHEG2Z^H%T$O@EL501,P&NA@E'8\
M6EB3$3:[*XZV(Z!\4$=?*)BT6&;%2BF#=LPQ (*@'##Z"U&$Y!6+=3Q'=%*&
MT=/?K22#H4,AE=H,1^25LS\9CW0R..TE:437&V=GGPJ!7. *"DD)+ULJ  @Z
M)&<%NB@OHEP  ;P,>QG>LF\/0M9D-2&H.$JV':3J!KJ\Y>%E\W']_OY4E9=
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M64R\LO FGS?YO,FW\[[\,Y7#%]137#15E"=5+]S%-W_0GT(7WP *NUUE_)Q
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MKW'5&K*Y#)M;'^L$?8J&USF0C>>2+A!1*@LZU6Y$?^!J$>/T;]K&J%I;4MW
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MB]N-L\[NRN2L4FHH3&-XIW?D;O7N=KNXA,F7/  JEW9\U*,ZHFW.2ZAO+6]
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M&A33$ABYS^8'&-\KV?53R<X&XR.T2^QE@0*-4,U9X$C;@B!;:$D$Y4XQUT;
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M J=YNH0A4PB-/"\+H3!GVK V0K=#0CKG1\\+GI*U'6-C$$[YO&\UYL3/!],
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M5$;+09Q2BZ0P'AE,?($=$Z65MY_BUI=H&Y2498@NGBL0=[J(QEARQ.-K@;J
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M!5$:Y@H279!6:D#?^KD>3;Q[H?.M5AL@^$N-@6U['%2HH5!'WY+L#UJTZIC
M20_ <,!PP' =8#@:."\\1E+Q5!D;PV;#@D.8^])C%0FK,&T$V$=@.%X.I3KZ
MAFQ_T.+(H7>[>[=PK.&^QQI6&].._ZV9<PP1./@GX)^<LW]RQP@@(4LO'4,%
M2Z/DO%1(J](CPCTKI2#$R%8J=3<GL+_(B-32?BX70XF/WEX#%@O!+Y +J"J0
MRXWQCHD-F.&(4JIC:,I*I+CER)2A*#QSVH6M\8[[A*8'(Q>!AZ200"[=KAEN
M=\L7XLY]X\[Q^K31/%@'XM"3<A7H!4W(XZ8+,_:=@YY]<U]_.K+7\!U2/1N_
M@05#4RR)"#.V]@%T83 2F@>%C65<M+)INW$\\K.).YP708>%.'I]6)^,N6>>
M_RUA0IAZ9NH*W',ZW..L#<3+$F$OTB!^1U$:*8J"H+B4EK,(Y6W$K(_$/:H8
M<K[K8!4PYD>(8>/?.JXQ_WC(=:Q-\GZP7U^=QJM_[8(/D,1Q%GQ?>%C?RS>7
MG[_Y26HX']GO"8@O_4#;U#BK)U_BNP>3Z3Q%Q;/X<D2:^+:/LSP*:39/@VGG
M\>UA--$3.\K[MWKNK^(75;<DZD:?!C8-N4T&^M&CQJS2$N,UHC#2&QI9_#-G
M%#X_0>QI&/O/R(UF/MO^DRBEQ=7DJ1M5UV/]Y4GZ[9;-7A 9K2^MKDF]X M1
MQ%?^=U'-1^'+<J7YP\A/W-/K:96[])_,_%BGN='1YC\G02=1K<S_\Z$-^M'T
MXEY:0-)8_@UTB(^G^3,]S<M5>JM9T&@R'DWBG<VC5CS1B_GTZ<U?1#G7+]</
M/^>X=(CK?:+'?^@OU=,?_K)4D\>!33VXG"6"^I?(7A_23=TM]U07<J?<_ZAU
MS$3^JR\3Z6LZTUF?%E&+9VGY=<ISI;:-3,PX$N=AGM[[!-W).I_7+ZVM46\\
MSZ5=[B1.ECALPQ*W#:HC=O-]44/;DMY!I$O1=A<L-I7V(%)Y]^+ML\&;MZ__
M^NKUN_<OG[\;#EZ^>G[Q_23[39Z_AXBR<[SFI0_3\&%Z[6L3K3[HB?N0N.Y#
MF@G167&N[C[9].OEW3^D:O/@]USGT6^T,@Y2%^,I>EKW*[(=3:*S-%U442[5
M<. _6Y\VPRYKQ\H-XE-M_N7T7/_TB'+:!T$/[(#GV&/7KE-V(FXZCVDQZ>TH
M<NMTT;REOE+T8B[PGY?OM^F,S^O*/ZE\]%ZC22V%4L=M^7,_W-Z_^S2J1CG:
M_?)D^?D=&W/UY<KR0OUYDP6;5=8T^)<[/D4N1+G'I_;X"+V0)=[X;Y_OV&=]
M)3V=]7UECU=^M;1XET$]8-_W$+N(\@03N0^3TZZLW@$%U\2HCRN[J*?I-__Q
M0_G#_>6X_U2*I7(<4(PM>\?W$O+_>#T;O(C1DGNXDO90N =34<!;P%O VX-6
M<IXH(F\>F79(3.[Q P#4[@$:M;IS/ !(/R2D4X#T0T)Z.O@2H/QQH?P19/OU
MJK/3ER[ QZ/!!P/XZ(PG>+">F$.VP!RE+O.!3^>M_^0G"]^-!I9[^H.M2?<H
M#N%A:A&[J9Q=+AH^[X)@R8*5LA2(T$(@7I8228P5HM(ZHYVAUH7;!<'$1Y8,
M3J%4+8PX50%I:PA2#A<\>*.4*[;G*V5\^74VO4H%1^DF_CZ:7SZ/EC>]\K,7
MG^UXD1[#LZKR\?]=>R/QA3AV?7!7;/*1H0O( ,@ R*!/9*!5P)@*APIE*>+,
M!&0*SB.ZB\)Z;&AAML;E.%K2^%N!=!E() ,MD?9$()J.4^&!**YWC),]%ADP
M?/2!>UTQRN-$;H^3Q#^GR*VI]9Q\'/C/UWX2+>9)5Q/X_>;HEE-P':::SB>*
M079@P&# G5="D-VQT]QPVL_#GN;S:95;6&>0'H>,2,>"+TB$'&Y,1N&)YAHC
M39Q"'"N!I)8>L<"M)#0H1_1#LN)5#-F>)&QY'9I<R"KG\<Z/Q_&O_]*SWWV*
MZO[J)_'-XV<3]\S%18RJ^2QWTKZH@[V6\B*20EJD4Y8)E "*!Y30(4K@3'LN
MO4+.BH"X41(I$>&=*D:#%HH%2AZ2&^\<)5 "9XEW(E4.T=_QBJ(JKV?V,C??
MNVB5X^EUFK$ G ^<WQE@ <X_7!@HO(\17XFP#1YQPA22I(ATKB6Q92&,P&4[
MQ5$USD1&_V6-,NW2.>%#P8#1NV5X@/B@>(#X'4)\X8)G7A!$*"YCE(<YTE(X
M1#@K#%,R1FQ;\W'WJX!Z!,0OAI0>?3#[*1D>[.#U+X9KDB<YA+M:9E" SH'.
M.X,J0.<'HW-+R\(Q+Q&FA41<I:2MT1ZI4M$8BCFOE6\C@&M )K+Y*DG;+I<7
M0R&./N<>C [0'M#^^(H':+\;[8TMG-.6H%(1'(,WHY%QLD2>!*U+QTI<X#:"
MMX.CO1PRK@#M8?/MG .W9I<[!V[ZQCXW\'G/^?R\COR%0[J/6;:#-2/."21E
M81&WJD@^ 4;24^68X5Z76RVM^T2 CU.30\HAH4?W#,!\6V.6-B:> ?N ^@+[
M=))],,$E9I@C3IR)3((]4L872!/J>-#Q#[K51[!/1/IH[,,X _;I=N3:[I8C
M?<S(E9Y&Y/I^.H]QZW1K+@/$K> Y] AZP',XHN<@@RX]IS%DE38DSX''N)5B
M1+@F3/,R,-%*W+J:'M.X"E5;@Y;*H2!';RH$@X5(%?CF?-07^&;OO5.E/&7&
M(UG0&'423)&*82ARRC*O'"\\YVU$JH?B&XZ'A!Y]TNMY&>PQ=E5A;OO-IY/.
M2QZ$V?1JL#ZQ&N+,GO-^5S2U\ZQ^+IS]XT/.<7](_AJ34(@445HJ$2^90EIX
M@S +P4FL5(FW*JH>%(6^G-CIE4^@=G^_H(K/(/[T[8"T9- -LU-W[J\F/P&W
M +< MP"W/)Q;E ]8>%P@510*<2<ID@H3Y$KBRA@E:+%]\LB#(LX#<HL:2@KM
M&8?@%C@;[/@QYLL$=+Z:+S<RP0< 'P!\ / !6CAP1ABI="&0-3+Q.1/1&\ *
M2<_*&#,6%K.MH7K[Q)=+!&MY0IX$RH=P$JBD"QH(5'+F5!)<D$[%<))@SQ#G
M6")#E$*^9 I3I@K-6@DG#T,E!60FNQ$]P@YEV^;Z>G[I9X-13KX,!Q,/TU/[
MSOGG5>4 94E'+$MR2A!?!(4LEPIQ1CQ2.,9^05$C@RM(H;?*DO8)$%]-)].;
M>>)V^9T-17ETB@>[A6I8H)WS45^@G;UIAV-2V()$GO$N#?ZFR##-D'-"2N-*
M'?C6X.]]@LG#TTZ\--!.MXMB8<.R;:-^Y>>#\;2"0MC3HGQZ01-VN.G"C'WG
MP&/?Q-6?CLS^WR'5$^3_8Z6K;8$+5_*(^-QPQ$VAD2(NH%*[$)T.XX-H)[#U
M\P/6/=&A5$??!#T'D'C\C=*O2A5B7-!E(#P@O.\9Q">I++ I$2N#0%P3GX[1
M$D@:2CQCV <G6@FI#TIXY9#RCDTU.$V0@.W<CL?6@VL?G\&EGOGAP.AJ9.M#
M,D?CQ=P["+S!#^D\Q( ?<HY^B/2.6%5RY)FCB#O'D*(NG>.-B3'*8KM]2, ^
M@?<+G6^Q>N-G[Q)*_IPP\J8_$G_T[MU<SWWU.CR[\K.H1+],QV,]J_)'5MX*
MWO16Z'V=E=WK)TJ55'F)2J9\],/B6HRA$A6$JV!\4832'&+]O]3,\*@2P!=J
MU[!D\-X@70%N N@RN G@)MPY#\OZH*V.;$=\B;CB)3(R!*28,Z7#GE,JVTA7
M=-5-L,'Z@K@"!2Q"=!.D0EI:A6@HF/1"L>@J'6+]QW 3R 4IP4WHBIL !13'
M3_+\/<O;.Z2C$/1'7R=ZJL%T,:_F>I(6W$[69W/8=W'/2>/?F06Z:]AX<:Q9
MX^#H=;^*"_R[H]9?6BR-)D(@KZA''!<22:$"\H461A4L4G<K29HESCVK8>[5
MXLKXV>N0G8KJ]1KLMKVR&A WW0V\GY^%C2D"IXB4RD4_LW1(<L&0$=0YRR@.
MVWYFBRMMW*VM!3]PK8P-25$.%0._Z@20#+(N0,8]5V$@X_W)6'ACI>$%HCP=
M1<&HCG1C)2H,YH5T!?9E*YWUQR=C;G",):6-BS0XNAUEY&'#);*18B63EK?4
M]O'(9$R&%.-A6>PJ7 $R[G9SR+* 99=A/R#A<<:YC7H>@9U>Q<]>^DDU^N2;
MZ01/]M#^]G(3)Y%]B$\J_:9.OMY7:'?C0X>)]UB.(\CN6+(#8P6% V-M3W:P
MT7-\9^AODRC <;QG-_BH1Y-!#(7T)ST:Z^B!HQA5H$I'5]QY,Q]4WBYFH_G(
M5WF*TV :!G/]N1N5OB<'S>?>B=_78AT8I7$[IU(&*FQ@$E'#"L25E$@RRU"0
M!2Z8X1SC5AI=<UCW?#.J6[<!/5M"VJ_3V;L(:.]64/;,I;SP55S *S]_'=[K
MSRU-WA P[:EO.6*8]@1<!5QUUEQ%K>"$!,2EC+R#@T'&%!999175E%C#MGHC
M]CJ2IEM<I<I=V_1@[1W<!H#(MRT$>#^=Z_%@>N=F  2VX"QT%#[ 1SBBCT"E
M#U+0&,4ZZB+?&XLT\QH16M!2%Y(QM54-T78\"['JN=OO 6)5H!I05:":+E&-
MP)IJ+3TB!6>(DZ) 1E*!'+=E!.\R!IL'#T<AU.RW <,FZ_%#S1NFU:'!Q,#X
M)U>DVM=<]'G7W1]M%A)FPEMF$+>ILM]9@PR7'''-M2UXR:3?:O+?)Y;=X5M\
MOU]Q_Y'$E'7+QSA-R( 9/^>X$7N:N@ST=X[TYX*F'!N'A"@BZ3E&D22!(RE(
M&8/FTA?.MQ%?/R;]%4,J.A9BGR9D?'5V3?P[;>'G'[L38M77IO':7[O< ^CH
MQG(W9ZNP"\;8GP\Q8&6-@?N Q_I>OBF1_,U/1O-X6?L]V\R7?J!MVF#6DR_Q
MW8/)=!Z_7,_BRQ&'XML^SO1X<*UG=45U?'L83?3$CN*K51IYE0H^JEM"=J-/
M SO6595,]Z-'C<&E)<9K1&&D-S2R^&=^")^?(/8TC/UGY$8SGU'A2932XFKR
MU(VJZ['^\B3]=LN:+XB,=IE6UV2-\(4HXBN-@[-<:?XP\A/W]'I:C?*WS_Q8
MSR/@133XG 2=1+4"AL^'-O5'TXM[:0'!Y 9<Q,?3_)F>YN4J,]<L:#09CR;Q
MSN91*Y[HQ7SZ].8OHISKE^N'G]-S.L3U/M'C/_27ZND/?UFJR>, JAY<SA*'
M_<M\:C^DF[I;[G<UL^8[^*/6,3,=N_HRD=BFZ7B\J$^+J,6SM/PZ6[M2VT8F
M9CRUOQ_FZ;U/6)ZL\WG]TMH:]<;S7-KE3DIEB=TV+'';H#IB-_LP2GN2WA'@
M+$7;7;#85-J#2.7=B[?/!F_>OO[KJ]?OWK]\_FXX>/GJ^<5=O'NW?+Y)_?<0
M47:=U[ST81H^5-'H?[^,J_>SZH/_QV(T_])92:YN/)GSNW3C#XD]#GZ_C53_
M]5\D)>+IX$46[O<_^!-AT1]'D^@@31>5GKAJ./"?K4][=VD@QL#IN?[I$273
M0<\[AQRW/(D\Z3"["C==Q+28W.,7&72Z:-Y27XG@&(S]>?E^F\:L7E?^2>6C
MCQJM9RF4.F[+G_OA]@;CIU$U,J-QU-4GR\_OV#FL+\?(!5;JSYMLUZRSIKN_
MW/&Y^#%,]OC8]W]$75 LU/H_^2A734-I'V=]Q07#Q8FM25Y@+DYL323:I3PU
MY9,7@I8;QK4/$IS[^KY2XR&/.%2HE6H$>8+%"""G(TXA62[P@#+<[35W1-M
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M2'$J$ E"E*H,SJJMK'3.C#W?3(R]S'FQWZ95]<K/7X?W^G-;F>4"TLI]MCT
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MVL2^;X\5Z()A'Q8=-QO8#X:/_1 T(.A)(@;(XPX$I8"@;2#H=T_].#T!=\&
M]Y+AJG#I]*4(9M^ZV3,P^T=WF+YQR-\!/:8[IEX=O?JN;<7.VS)YCVL09M.K
MP?3:IVWIR<=!*JSZ-)J/_/>=_+=,D#0%,E&7[V\(F]+=W!-(7[+YI?@0!3=]
M\,WN]EN[4<#8!=< 9 0R>CSGZ!SD!3)JV7]YR.#.ATWM[+#_<KC#B'>X)/<1
M(?@I]U?#[ZV?/[H>WE\XW]?%\N 6EFZ Y4DT6WJ3^RD]4F41$"]-1%N;CIN0
M@AF'2V7L><SD/A]C_;Y6R7L:Z]EZ-J!0@/Z]17\N*%>"EX@(ZQ%/<"ZM)ZC
M,I3:,(LUO8W^CI94%%8@7082T5]+I#T1B'I<,AZ(XGJKT_&PZ%\.*:> _H]Z
MK@*DE_>UQ&<NM<_5#0GSZ6#FXZ_L:.P'DR9N2Z^FGU-KQ6!1>3<837;FG)]
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M1O \2]-"'B5L^> P462/FV/_9(]E#%T^K+57S77M(Y<O@+?]3]_#WX(1B".
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M+P]5<U_2T];::J_JM5;NVL:J >_"=4"5"M\ )=DA_7&X;GC+CW8VP_\.[>P
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MC\?*]]=HP$S#Q^WWBVT0=8>;S<*&8& 7$/>I$'U4YXL[T'GX\*\8-YI;$X]
M?P2&DVS[T45M&*_-R*UV3\EZZ%2_Q8.-ZQK'K[_5;=UEZZKK1B)-_69V;>I]
MAW;LA%[7OOFX;H<NH>ST3<4':UWW=6_@7"T_VM;UN&:,P#V]ORZP"=S)?XPI
M$@$KVD06GZP*)W.^\R)[(,K/\O1'LQO:,<=15G"Z^NYGWNO7@#(RDW6/I$V
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M*!2,>*Z/:GO&>7R194?)LA&*[@I%C"N1:J:)4=HG8^98&D:)4MQQ7AK#RX>
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MUDD=DT]>&L:W5C\/3)%[61 E/<P'.DZLZ<.::.7*JK^5*X?*E?>5Q(F6>L*
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M8+)7X&W@D7&GO9*'IXXU9?P\^\MT\B'-'L<5>?0Y1?@MS:;%2 VC[$TEBQK
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M&X%6GJHJ6WFJ!U$RQL91^Q"0T)(#D0T'ZTL&8DA:<Q-MZ",3[BE^[L7.ZN%
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MY[.17\SQ(L4R49SCT03_&$VZO[,;S9J/;KQ(!6.^>.WR ),R!.,&P?/7-.]
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MI\.&+T^MUC]$I-]+^/+1A1JZ5*X<FJ/U8BB29JTEHQRDXPX$8P2L)\B8TI/
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MFEU]<RHO4 6FXU%LUOIU;&"U5Z?AD>)\,6Z%<,X[2BCZ$9Z41,(,CGH&99.
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MMR M*2"N/'@>$A@K;;3),D[2;>!/(3OMN ?E"$8(%GG">DF!Y1 IT4Q:\<S
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M=X5PY$AI1"%@D] O2@%*&P'2&$:L-C)Y0]N-"C@QUFG GBI@DD2P#J/D,]&
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M#I01BPBUM.#=J-OAO[3=*%QWH\J5S KKQ=*I1W[%B_$9O$5(JAB 2A* "4-
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M,]AJ<FN>:I,^3 IMG$%QT&)Y.VLA+3H>_#HRXSI?H=?S%=2Y4H\=/8">>?0
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M0YO-3K%:VOV2J'I0\ANO7_A\&+J@A2X)0<X)"- ,]4A8RI#AA9+:P >,'#)
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M@>DNX&G+9N6V%3J.4C6W(*H3-F6,??7R4<CJ4^J #Z8.OYZYZR8' H1MS1_
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M$ >UZMN9:K94'S/MY@Z^S+Y>-/7[J@7;2)M&QN^_T"D-\&+KE9ZY)X,O?QZ
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M=V0$*B)+1[V!X<9<RE#O"R-)RASYW%GO.)6"F,>N]_5E*E+PZ<W5O@:E(F<
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M<<$QYU84XB E5X^;P<0FA XP<AVV*8\P$$@'!R>U30STQ!B(6NV$#%&L5L!
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M+"IJ^*0O3&VK=ME4.BJ)ZSFIT_X9L%&LA!Q>&@ZLZ,_3" 6HNT/'^Z,0P[%
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M2II2O083KJ1EDX&$*V_^M:H6X72H2393.FM7B\6L6A\<Y96)IQ&E32F)LD9
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M1'$EA8=[A R'Y)K2(NTX#7FV"CQ![IAPMS%SC$?>1N-OUU-N]F# .6P'\.C
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MJ?R@VAC+1%H,A1G 06Q]%YZ%HB/1 7\?IA%\V+P0'K/E@GQMOHFSH="^/G4
M.H*V?91E[Z.H2Q_EAMR!Z$MS++Y6W\2WN--5M\R8O4/_[_&G18O#5:U_!+?P
MU6)1PS">]_7)_ALBSL9=9+].LS=A6T&8&,B^Z_V QW 1#RC=(]0M^+L"8\E(
MN2Y:$ Q%UZH)FW>VW"?5"1G4=4^^DZT8OWL:Q=W3=LISOME<]!U@T;I"9Y>6
ML'G1.DGBFA8$ W5-6#,,-W0;SG_X83.RW;R>R@+:A>U&5=.7M0B/@\84Z]GR
MOSO7K^9F<=--7\HNNHOQT>=NO;\] L'*5LMN8]-ZMB9\O-_ JV::-EB,;8,%
MW\L:3QLLT@:+M,'BRS=8/%,Z_7MSR8E@8!D'5@5'M..MGEW>N7FHJ/3*OJ_:
M.K+,MW6[!$\/%+==S2(U_:VI5PMX1'8ZJW4WS[[^*GBEDZRMPDK6J]4I('R_
M,''Y[NU7]CE$U] I_/)_5RH </41WMTL>AO.OOY)M5;]ZR3[O[_^\O\%?NX/
MK0AK_.#0PD-GE0<#-Y6#1L2U4A=9OYMO4:=SZ$]EVJPO&'U-:]>5X]]7]:J%
MYWY.8]]\!(F&)0\SO6SB__>WGZYMX37-Z';$K_T3(H,_\=^K6=P73\*J9M5Y
M'V%5)Z9.A-3&>A:2%K=$&T*&FU*DND::9?9N+9HML896GL/CS"ID95XKIMC
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M1BCE^R&HH,$$B1N7'E'-%FVL3L>%8\5VN_'L"L\ ;/L8$]#EHX@>/%M%LCI
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M0.>8$D(JI=?5Z5J=7[R$'"SB:I%_=:Q W6(@6K[.>'?<EXP+\2H!*2(:3/]
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M#9H7NR6:_3/VJZ&O+/N>;)^?XMA_"8HJLC45>R 9ES80W2A/61TINBQM4M\
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M\](3HE=0\Z#>W=*_\6*2K;O@476/'UXT$+?>*I#/['Z9*4ZTWH^[FXIZOKA
MU;'@S<\N(>JOGU^L.QZP)QWC7L&F#(QVUY=>F017F$Y1G;T[=_F: '":/M%
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MDC^D^%\YO);/W';1*L3JGY^ANM"'SLI"'Q905:@% KR'^;W:PC&T#Y.=^R5
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M:UTMW-9P:VTCET)^ AK'.6;_O8HJ=7_UDGY'NR4$7Y1!>CMDA^YV+D#Z^']
M,ON@S7MI>G8).15@3!T:X-6[N>48+R:L7$0^8)^WQ'>5GUN:68Q;K55KUC!S
M6!,!IX4[XH@:5T\ZJW94'K2T?:[6FX3#&9YD&4Y9?>&&I/F.AP\ +U S]P,(
MN%5I2L<,*(Z=H:BMC=PI,],J7;?6K#-#>_$H,">0\[.*\/U3$N>/3Y>$6\@+
M2DV5MNVFOX0DL?N82!34#0[5C@)R^G/?HJY.#GD)4J(W<K@Z=A,JQ2M:9V[N
M;I=P29WVO:1.YP'X4T,2Y10S$U-7!&/U\46!'1 A91-D$+?QD2@C>8+_&K^
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M,;+NJ_Q=!DF:&2_R5Z7JTOH29/B:J(5^-;Y50:OH 8PQ@M "(BHT7F6EOL/
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MV+^,D\L<(B"%"#HN4;'R"JNX!>1_:QYBQ,37A'=-W^H-[9SZGJ'WN=_0^69
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M\8Z0Z(F#_?'.#IOU$K +IW[L<89]P3 @]\UZ]%X0H?F1W-@_)?$+$:-9?!Z
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ML9N,7_AI$3"OQLH33BE@^U5TLEX#F%E*1#30:B%G8KU.<NPKD",3I9;[)PQ
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M4,!&HH)N:#?HA?=S@*R&"I?<PU]PN=H@T@%B/:!?#I?+RNDS9$WG/7'.R#>
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MR#5C-E:BGKS_\.W#=V*99O,[F!BY.O^6A]^TM69[@9;PWLSROCP6/,[_KG0
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M>T)78NY8U8"JCT5NUH*GFP1HGIJV3NCP)@@DZJ(2DNB!'>$7^\$.,!7-%\O
M+3I8\%MBX5W,#'D[-65<^FRDZ%BGK19Z: Y34RM.CT$,X(TN" ):+H(.=E0J
M,1,[/Q>-%7@D>X0.P3<<,ZN#P0WG94-#-.QRC8]#FEB:/.W+R=#.R)M\ 'QX
M]ZAS:0!4I5%-(@>X*$0S,".PNGD&\07SSAC.F+]0QL0D"R=7=!.VT%2HY1#J
MA9HG!@(K2-94$9X*.&1I&*_#'<&05:->+8-DEP^V*I[S/*V>!'TE.EUX#8!8
M$*='NO;^D:>0R\"/LOFO%98CFWMEJ=^[0E5+-+P9N=/E[^"%=IOD?T<Y\^?Z
M]V &MKJ_B;%P=3-Q@<.]>P<D7.'^#5IE,YZ^SC"PKD=XY^( +DKJ[Z/A(I/B
M\9&*6'A(_%P6ZA^3,P1.FN#)^_B2(LBJ_D@R38,S[NAW&?2\\$3?7OU=DR?>
M$_)@" OJ_DQ&0:Z+8AQOA3_B=??.%^T1]>G#IS_Q_-DSD]GRL@#/J#0/,_RT
M*GZ\1]DNB;-P@L04C0\-3_0.NG[I=VD 1K./2/DINIS)+.B!1+$4!QYU[H;3
M<'0*\M9#F#FVT:@+*2TH/W3MYOBPRT,=&N#U=@<)LG@J#(7%0;A;AN QC,53
M:LC'-8H 1%,&[6E=2H6!WJ9OZ<2D-1CM+81W5B.-*BA>LS[2.\5O=7BN/\W^
M7+?#K?++_;$M1:"UI_ML#P)RX#$G)&-O5-K?VWUEC6&J?$=]B7T!J9?IPKG6
M!K#VOH T>)GEX19ODZ'KY L5ZD0S"X\Y,%AP9!A'4&F.*E3-G:Q0E>V&+>3T
MLY^O7TC<3?&=__88HG2(^U0]&:4Z$PZ6/-DH/-YEJ="B^!F&\M;85$A3D[!G
M9G\T6USJE%/)+58)Y;G2DD!/KM%/8FXJJ)M2[!V1LQ!<RY>MHMI,9"]X"8T*
MF6*QEM#.8N;HHXJ+)9$O;D:F<A-.HRPQ_8VY[&63D%&/KK9"R^ P!@$@L<1+
M9TN%17CV@J_9+PE^XA"-(Z =?0[C<+O?V@MA*  ^/&FP5-=$7..*\1*P*'Q"
MTR&?+O-+ *2<3:^BY86W-<.AXAE;/*)'>25+[V)9KV#OGIJ.PES]_"^:-9#4
M!GQJRC8'#IDS259HUD.+Y46@])C7%<_( IWV]VJ?0WY'MM%9^GEV6,PVY1#:
MRA;6X?+;FOA)W/K;H=Y;O"F/M^5!8ZX/OC0C1BD@#Z N&<>)LO\6Y85!,,FR
M<TC^M*'A>(_I'GW9#4,HJ[RMNX,ODE$1Y'3)F J*27ED'@S-^[(S8FZWSDNV
M$=YY.(*'9?@H8 ^D.DL$>R)@SUIF#W'-VN]F8TN:_W:/=@QS:/F<(B+5G0-Q
M*-V!9S^<$A?)U@^'PLC(C9$SQ_L';6\^[<N<5)6>1<9)$UE,^)IAAKRAC]1B
M:_*&G!]Y*>7*$0Z_9CLM]C^:F0B: )D""_O/X(!"9;+5UQ@S]27<47OP.O2C
MZ(!_/#O\E6 6_!KF+\O-AIR1*'M,6 CJY3?<5)@-CG,0 R&^*$P\%&/QY,'
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ME#3,^^<*;S@_@B3>EW$ ,%(C/9EI>S1A.6Z10&T= QDJKV63M-3\'JD*!J]
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M'_RWP0>EO=O6?!>P41HL%@A7N*+A"M-@:4EQGUJT&D!?C#S6K54PK;FYHHL
M_A*O*11(&9"GQ!@;:<RNX=7E1W?[)_RH6VVPR(Z/ZTGRU8H<;ZP+C_;A\4Z.
MEEI]5K;$$&G-$(Z?18[<Y0:/=16CQY<TV3^_7.'3#YX &3N0* SW?(BC"T]T
M1-Q/%R)U,?X2X=WE\Z##!\PTO$]$9N,+(I#[,'SZ:,%$>(P*#\AXTQPNW:A[
MQ/B08!8<@!<YX\,&G#WA%P/.%EF^V@ ?LFD47] @G(H_)TE ,SD_H/25A >:
M5W=-1UW9$X.2>#^_]N,<T+A2Y)\GP>"',^PZ:,.#1EP=;(F_1D;,U\A-D==Y
M'!Z]U) Q$/KQ@Y<=UHB#H\=Q]0PDO"9O7>&R1B* ,@([)87&#;4T5/0BA4LA
M[89!:ID(PIN32K;V.E!GP,(R)Z&E) F"6I*:W0!,^'J=[O$#L-@1RS@@E$D_
M#0>?AK8]J24*Q$LF\,9<UOE9B*P?+SZC%VA,"(T&#YQ9:2W;:9<VZ:0H//XN
MQ!RG\?#W"/_VB@(L]5[ML8R+^,-I2&*_RMGZ^ (!-_#P3R$'$(/$E,$R\?^M
MZ6A86NN4#8<X)FS(@+R0C6A>W,SYN,(%+D8H@T&XERFEG10/Z'D3(,Y,;TEF
M<XSHPON:CHC"4.7]T2 : <(8M:+Q(Z%)/-7> "T*%WG#!/6)>USF5S04D7CZ
M 3IMJ?#L :)^[K$!>&($U4I.!8I.S+#*:MGM04W%.5*$CO) 4>\[%CKU>XZ5
ME0FNI3.:DD4T3_KLQ\R\@-=QED1AP..K[U("2LU2)XL 21$V.=9%2^Z;P <6
MO1.91NZ_'*)9#,&@5Y<55I4>)<?!+U#4D*CKNY<D'@<I1&/,23L&0DC&#KH<
MUF9JY$T051(*V<306P:3N$Q,6 /XEIQ=V03XEG@KQGD8A-$>;JK"6'#Y;1WM
M RQ)$U=*N$G8\5(%4KD)8W2-]_=@_8#4O625\?@ N(NI& (<+BKD%1B(1T8R
M?WR1)9:5(I..D&]D#\$["047>S WT@PJ;%>-Q>.G&B7^R@9RUU),J<DM-3V=
M;+.0ACW:LD>;9MER^-EH*)5".>%>U>8(/E-AO$_V&3@M^!&8$R'4FCL/W* L
M>WSQXX^?/N.2+[(?RXBH^DYVW6)H7C$VFBJ=CV[AP?AH*N&/GSPZQ+(?%)0_
M#18K781*_-DR_E38.;^2<X 3(7OY0<)6_-&\GR7KGV9SQ27>'(M4;I9KF4\[
MPB?$^;3E?%J7^+0K^+0UP2?QZ&:PJOEAA()4TC>(YF96"DY+1QEDQ3XQTWAN
M%)38S+4R%5'J.9K_T 4=9)A3K4(<T%OH&<60?W6R-)=2'T2U4.K%3N;+6<FN
MZG@=H9WF;.^@Q*1@A00#D<$Z@1?9OK^S1L48T5WOR^ 2*7@D'P-QXMO/I^<U
MSY_>^O 3X8L6.9.IM^>WMU>D\XKL+KM48G('2Q8#/%>/G?*2RN-M42:YCFAR
MSILEN @UJ*'A I1IX=4Q>?2% D"8HKQ*/D,V0R]FY8<N[J(#4PP$(FSP4Q\?
MU7YTA0:[@,G->-".Z^,N"V0Q3U(-W-_)M&P,T%+V-Q3Q[>-\>2O^E%(8OS'7
MWFGI:G*?/"Y*REYVH&G[+^%91W"4YH_$FX@@H3K,U1,C' 7QHCMR"JO*46-3
M)L,O2%[(-R.-<@)^H>1@?3._I6AJ>I28$J:)$N@TY?PCJR>(JH2HWLMO:P+_
M &Z+4KZ2L5 N]5PC'N\3@"9XK]2)44Y38@[5Q1A+2M@]G"_[C(=W>XG$&"0S
MIGQ4S>[3K$)-Y.G41CMW5K$35PP[<2$RMLWL%CDI=5Q;^$:H*E\FCTV8EP8I
MU%L61N&3JLT*AJ!)IZ*EW4XR,T%D^7WV,SP0%H6:+9]3A(8#+=8B'\+,VY*6
M/.*;E)$S$3Q%MZ1;+V/]>C[O>-[PADFIC;CVA9#"&_5$JV; <"8E25Z3GW53
M-#\,'[U,N;O1J-GAC17.2Z:P5Z<AHZ3!E'Q(P#R^GC]9C\8%8$R*8JT#A*E<
MQ5/2U D8RA1A+)=O]I@LU_^S#U.DQ5T=JHIC'4  &^O"JP#.+LPBK\Y LO)9
M?H?'\ +J(!"D=C+(+#(&,BL4RL1'3\Z^0\4'9@6;7+]./2/E_D3BF4L> &)3
MOSXG.W3J=?",36*R%P2':+<+[Q;-OA:N_)#F3%$9%#[C-^<^1<$JO@=K$+AY
MX@*802G_)[$X3;).8" T98S'NB7;<>&)KGFJ*-&YA;5BGUVZ=53$N3 ;3?[B
MYQYX5O-AD:BT@LL0+R,Q]PF&9D*=]HB?CM0WE +RCU4-%NTQA/]C($*I#S1&
MB8 U07BI((T2FE^(%WL"R/3X-1D:OT1ZD7.^U8T]6 QXPA* 'P8+"E>%NSMR
MZN4I_O3ATW^:N\9&AH6,$<GE$VFRR! S,J]=_NF.]2-A(E$@5)3H4[@A*E3D
MLZ'03$E#17]5MX < Q%Z\XW!]+?*M-9+T#\_4PGQ[%"48:?V$K! 5P2*/..:
MZ>PZIA%*OR*@!P7+5\RJ9\2_WZ7A>O"IITL9+H_3>SJ4<HNSL7IDL' [DN$6
MJO0,3$ \J(H/VF.C%J4\,N[3GH6RJX(P19!(NWT60!0'C;B;+>"N"K;!#"3+
M_*=/'PA?"%V3J,)E\ UAB%GFWD\_?/K SGK2F1F=\4PT<Y/:*= J7W= V/PA
M!#'$--$LL_=A]J]S_#8,<_AK\#1)+7K0T,*CC;)_V MSF9#8BC.>1#%H<0IR
MYTY8P#U )<5#Y;X?BS-6\O@LP6W2#(>KC2=$@7G=$.8AMS ?O&DRE:F$WAJM
M2AU[_=4PITYHN<=;']R#TNWU4.<1U@;D]=AZUQ?.#K=D1#0SYBS-?_L<QN%V
MOQUG7:=MS"\KC!UOR71.&S(15LA$F^D$-E/F\=&#UV';>=]1CZ<EL3R<S0[7
MP<+A$7/!T#RZ*.P_T3S=BT0<]%$%T3G9S4B?6^4;M7CI+7C\'H5<98"4, 8>
MSV?4E]4RSTIJ.\*XIR-A7.N3ON5%_PO*X/D>DY#)-7@*)O"3A$FU?'Y.R;5\
M#5X,<1:NB>%I1AU+5Q4+'3OU+V"C!PL$_+R00;WPQ' :/$$$-9^]3X]*(A#<
M"@6W7J'1A?=:L!Q)+(>?.>8CBF?W'AW,51K->QUG>4I>2A0]"8!M&+]O ?X4
M2*PHMGX&/0$D8Q&68WOKGQ+A250P?P,"H2-VAR!%H78DY)#D,I(I^7W6ZK.V
MHTA;N9^*J"/Y7'E"SV$<4[M[1 (>S"DKCY^MEW&@8BJBF(7V.%JV)5>M,%(.
M.R8)3!4U6;?0+)CE !_ ]RC8K\T'LTU/O7S3X!7V_=K/7EA8#,-7F#?A!DM-
MQB$BADX>:T; 8#@]Z&IV%S[XN0$M)AE\*1BW,O+941N"@'CR^!$XM5S'3-P?
M];HNVB2>,M]#.G26#\#46WM2LDJB8X6V:T';O/ PW.<6#^-AO]M%-$7)E;\F
M7D C][IHW</->[Q]#W?@\1[,' ,SD5G%21+DXKZ]C),+,O^&D\L/CGFC<V:B
MMXKOTY78.=6YEW&.N_H51='?XN1K_(#OPP0B5P&;=>A!0]OTH-'O_P6M>KQ9
MBODZ*P#YI 259LP65=0GAV8Q')+-4I$&R!<O[37+DOA,$D'NT@1+>^RAG241
M^X-'7J581$9@!@HH9B\\NU/B:@K_HL+UO#MS!!O8XF0MS I%-':HJC26Z;QI
M+(L;^I_[+&>A+!SG#-VBG 85 "3N8W*.1>>[-'D- Q2<';",CJ]R(;XO 2^-
M@DN-<QR3A@*Z'C$8B&L0@1\PH-_#9QB3QP<%FHSO8%Q>&/]>\APNQF;0!\T%
MEI9EI1)?4\'7&/,U @AI_"O\35Y(>\I%KXBY\<5H9L_H1S0#H%Y(T0N^"@4.
M'_ ,,W"U 012<NS@WU-XRUT@^M^Q:56(8JO4<WG)D>@:V)=@$3>8/\4X0^K0
M].L25V@ZGGF]:CMG$L<L&)?*0I5,'/;"T9(7J2AKRPP_9^38[!17Q!UW*"_C
M-HAT0C?,MC@%$(5HU..M&D:CF(@J!22%1=*Z1OK<HF_YXU<4O2*:K,!DP-,J
MGC\%MR$V5"*??C)RIU*_L5LL"8U#)"0W)&V,F,+6AF (IZ"A?M7[LSKT33OX
M6@KCQ" )5)WYMS#&_XO9B 8_3YEF]GMHRN-MN3]ZI7$E9(V94IK+4@5 ':\V
M5?#C(@(.8) GD:6@68ISVPIJ?>STZT5EDG.3,<(OT4U^+<"@O1U^FZ1P?6W]
M''Z;'9KOYR0)OH91M"2+&S<2XJ'1PV:R3 ^\#Z(M*WKAH?1&TQT4.M!:]M[Q
MF0R9#E29P== -L-Y:%,H>=L(-)F%C=R.5 C&:YC\BQD@BG4U%CU#Q@TABYC^
MP/HI+6"#T3>S4EX7=@S"IE25,]?Q<KU.]TB& ^$D%P)W\6WX*Y%TYWW'._X]
MJ/98WR6<^F(12,\0<Y#MIAE403<C[  64!F2HR ;@$^=)VV>BZD(WS8'2WF,
M57D&S?D_$M0@+ NNU^ E#FD\21SE-.G(2.,$:4(T;S-@<QY:Y<D4!,N9PLV!
MB\!JY1$(LM\EF F%WR1QLYPHOTE;.(?HE+L)$X.E31@V8RPJ16_LMUL_/<#"
MD/NG(B2+ZBCY77/9"H!H9<GR"V<GC2%B+K'D,KI_^&+YU(1(F*^@/\?_IC'+
M<R>Z%3T21K$X:?MY:Z=A1#G$UF5N*,'KQR5O*4'UVTC=,B5-\DQRPJAO<?(4
MA<\LCYWA]"!3$NA /I=)R+&?ZT01=SHFL*>LJOB%ADO1U.JN4Z (G,TH&?_K
MPP\?/GSXZ.W\E$: _6_OXT\?%O@W^'^/Q]52#8SG4Z1Z?-W^;^_''Q>?/OSG
MXB\?_D*NS!\_+/[TXW\N?OKX8[522+//DT>>=/WZ&57FKBE:_(\?%]ZG#Y_^
M2,KA/WY<>+CRCN:$C YX6(N?2H,Z4PWJ+__YI\6??J(C^KCXXX>?%I_PORH5
M^(!Z#H"W76FM#TVSN>P5"R7"OR3P2G]%,NP3Q3==:SX30$N?!)^,#DLN#:$4
M] 9<D/\MQ;25*YD,KY7/NH90F&FN7E7\C]S+D1*KR+DI '?2.C#@[)O SUX@
MZ3+^#SA_XV,-=H (92M4FD-7.)C<:&@X_D/J0M8U2*K<HZ6W=&T K:AH?G:/
MQ-FH*@M88C+7%0)-*(YX]%2X!KW[#3T!D_3PL/,G0J&[1SNJ/<F(Z3"4,ID!
MH+T?DMC6/ $?/ !H TY$8AQ>!@.9U]%\6O*YF852 P$\1;,>:=<,!MVT5%4"
MY'0392D+XN0Y18^$#MD1ANDHJ0P-]]YFGX,5CSY-=\QGRQCJ_=E!PN:_2O&Q
MAN+U8?EM<"9QJ3E/M.?] UHTA^4_'54EZ":+I$E8UC6KV^19/5361YOJXZE)
M[I:Y0S8ZLN #IHXP:'6M)0@OCJ0DR\[]-#W@BYIHSJ< 3>1NDM*1"U;#4C]'
M3'+))PZ"18J\P4#FVB29H%X)<_[FIL;/9WRB#/<ED%JDKPZYS2,BIZJ$,DZ3
M  ?6$#0H'T"SO)V3TS5%$5V.6,Z6)7!\&JTKC%C+ YI7\)Z:$XKENJQ.K9'T
M!E,3IENX]JBKHEM__/3CGPW!EW_\],./?W8#TWL*JA6Z_3=,K;R2"6ENNP9Q
MEZ!5>I/@/99*V3#GMH9W\K42'E9>DGITB M/3MEIWWQNBL5*:Y]PP@+^/./N
M<V!0A9_SRS 5<+/;/6R=U>8"LO6@8"J/[1H$'^T'+OFZ6_/"8[T?.>WR@<*[
M^MYG#*@;R!9>8(;LA_ Y#C?A&D[.LH<:" %CW]1%XY(SGL>;-^JY/0^AI9=T
M,[7FU 4/Z!GDDWL.@W)=2-)G!_9Q2G4):](3'7I2CPL"X<E*V%2BS,H5C=\=
MIUOJB[A),2"6A2>O&5Z88SF19P[^D8<89UGQ2:3"O$?/^!)*HT,!-(+?3O"B
M.E]=?)Y5]OHYQ4."JS-3Q<ZO-I)L-C2("7H@X6R9IPF:IUHK(9(>*\&5-P4E
M/".$[TJ$AQ+A:\E!9=X7\(R4RSNG/]FS ^70<SR[1VL4OL+A=8OR<4Z&O$FO
M:'/A^9L<@K1UOI3&'!"GI+<2P$*)3D7#SH(!=\8;IS+B4:&_TR&?*NM+ZF_Q
MZ&#2=[9_^B?NC)CXF8=[22#OAO=N,@RS*_J%$="/8R6V#M*P96EUS%BDR?U:
MIF8XXD1%C"#-RM,U/_K'I.2(A7C<9)0"[Y+X^7O\PW9NGVY"P3)_?$&?_?1?
M@,-&X:3&X37GW^-S[GO:8H%09435.QDME4W":-I2FCC"VKSR]&2TE&0LY>3,
M1<?Z$/QV?GB"_HE*]0"9(C_[L<\<I5_"%%_M:7ZXC)_Q;\%5Y ]5&):Z(1DI
MO:(CC_3DD:X\UI?W#^C-J$?T6!\O7>C14=#@CG]7_=P>@5#:>)O.;7Z?B@CE
M'6H&;792.LK1ZT",!'TPFX]U >_RL/6CZ&R?A3$:;%!C4"ZD*8^WY?C0%5 T
M9L;?<L$01108Q:X2 M269:#3#?"7<', @.(X((7QGX\O8%$;;<UHOH;$>(CN
M1HQHX4EC6I#7(Q^6Q\9EU@PB].'7<8 V^*F3X]WYBFI(5&,\6ZIX4Y@)HK/O
M26]S.X!P<IFB?>B&Y=5=':9\\=Z;06,?/%3I'#$T5**/IG&G%R0[ (6AIK;<
M>X3OH1"T.*0843\1N&I\GFQ0"#++X'RCQ#F&=NS1GEGR*@[<M?"*[IDO#=/I
M,0AO:1!OCDORHIV650N/:'#>'L=D[&')$I(6G"'6$&^/3]C,I JR5=.;M:AZ
M+[_MPI14RJYCRL>*)\;E-Y2NPXQZ<\VH;,^Z:MNE(0-4&5^N-;<6/G#J#W?J
M,U$.)B2=H<!@1D.]N^"''_[\QXE]0KEC) N@QPL+S .0I<"/#\QX#[8^ZON\
MP\-](< <PAA1,7."@<$'H%*Z[_\7&7/!M/G=GV=A&I>KU2ZEE$8W/$JGH+;D
M4@H-SGTB@.56D<*%:GRFS(H#%W%#KAO1H9U<-_.SH1;]O2%;FS@N; 3Q18X:
MZU=!RTT@V5DMW<5=K^*2;=OU"]@.UQOR"U?-UD>2K-D$OS1IKCG'BF37YOG&
M76DP2T"%H@>AE7XJ,""8+\]879CPYV&C6*AB9A=2Z*BL>2Y&(_R:C.K [')0
MA^MK+<2VJOG#%^;EMW6TAP7/8>0G4@1F]-7^G6C?XQW,OFWFH%+69$BD^HQ4
MFK N30_DY-C"FCM**DN9CU14SJ]P\7,"$9*L_>B_]VF8!2'!X!KU[B"MDJU'
MVO7DAHVEGYZ8M)(?.C0]NSJX#(ZU>@*D')"O\;)[@9O\*DFG14.I0X-YO%=0
MQ_!^*8IMV77-G%G=(%M*BO4ZAIB72,Q!,G.BJA75&#R)"IQD5*XY#3*)H61L
M,]#5 79E9N*T21%7&ZKHQH?678JN]C%^5#--239!-LBK4GC'2L0$0@PY[L^C
M'7(]468E+^3$+%!DPV;)JD"14 ^ X'">F",[_$3>4(Y\Y1R)J5T$?DV_0K K
M/OX"++Y2@9UB)VRWN$&!XBW2BIK)96^ I?J\4!I&<NX9D6=J""]P>M#G+X\
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M\S.)L@13>8_62;S&KW":%(@\T:_C^:3$2RSO$[1^GE\1I,5[T(:51[+PZ%A
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M4Q+"6O!!&I+040)%HC17#&K)$>7&+TFTQ\^!]' 51OC]HU9L5 I9'_H2K[(
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MBJ,._^.W&E5GB9\&J\U%F*(U;CQ;87HRL.0^XI&=X2[_5=GU0UN9).)R*($
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M/%'.6CM03I7U$YPJ#1K?.6*/G66EZ56L44B?%,\G6+Y]U>!SQ,@YRU\S:WJ
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MCL<<AC^RE-M8RFTL=2G&W]T5/98V&V6S-[^Y7 .VS16GE5GASW'TQJ7=\$=
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M2XKEJ,)O2XXQL@;K'8ZSM]U=\)XOA_!1SF&^X2Q4IO:#?'PP$$W^A1:+3U:
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M:Z#F$]_%H7^_)TKK.\IS5(5\(>IA[[R)M^E78L9\1.\HC.7,S6]OKVI5AJ.
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MXE(6C=#79E&?G9D/RLWKU^  G=T=;' KX)H@JJF^L_ 0SO+F);Q5<&N?#.0
MII^&M"J3NB:W\/P@]M-RVV*:U]ALQYU^]W!^*_UR/A/H]W&4 W/ZH^MOPMR$
M7I*LMB4Y*_Q$KSV(_.V"#M:<"'=!Y$6;P LO-SL$KG1>:VO37Q,D$[)=:/RQ
M$)J$FU9;QCP3NH\3]I^$'CJCG^@*%-V%WYVV78X _<T?[5UUE?[\X8=<FCT2
M6<3.W-3J:FUIF;M%%G&5=()%S.TWA#=!4L!]_F-2_C7A^3>[C66-]--4:(9
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M*NIAGXPSK$+?![>Y-0+(]Q&5RC<T,0(?F1X1<5M[4R\/.0HG+4R;_-,+L^*
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MCU4&[^B*7D(J5I"2\!!'&\Z?\]=^O?PQMZ3EF6@5OS3X"7M5F#8[Y&?4F#5
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MR1TSN4.8U&%[<C?"?(-Z&PAY!D*=FY]MP.X&@2#YW.U-4^H49TY=ULMFIH?
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M5_)U8_:S1Y)N$(I-H.8H%LEMQT X%+4:@F"[?M$+*7?V&AX.$PM<T6K\RQ\
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M,+CFT3RAN,*?X^@-8?#.7]"\V423QYL@7\_MPY"MI)\.0P$E7%^Z=X!$^R-
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MZ#I6K+;J#3_.G<!&,<Q.7U7\H#N%^9V"OPAX:BX"4%UQ/.#;=Z^'_K!SH-K
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M<OJ6S.0E,YD]IY:R*)M8LP/XQ,DE4WG)5+:6J=Q2/W6V5Y_9N9^7;&(Q.BF
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MA]MJ]T]\C+#C]1IPGE=&SN'<IL?"R[$VQ#?5H&Q![W8IU%$$BCF1)M9J"I?
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M:0'(!S%>,BT\]4 F$A@#CB[D7R/;*0AXH<EV'1'CIFS<'NNAF/24H^">A4B
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MK919K0)NJ<#\K@[>$&]\Z[>\O0ILJ:JN)]BWL'QS"8_NNKFG>1Z U .0>KN
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MHGPZ5NINT4Y<QVJ!\>5UAF0F5JA<C-BR#S4>UF3B>*#=N'$SCL*09+!%$;"
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M$S-RB%Q,2@Y6!LD7&]T21_5Y5$/_"31#QT4#H!\\SI%2!@ 3QK%CV9GM9$Q
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MG9(RQN4\?E4NDX+J.9<QK:SZCA>ETI9*F^SX1AF_Z*I\"KADL(R#45)P&>3
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M,3$W-C0S7S,N:G!G4$L! A0#%     @ !8)S6E1 &%LG?P0 .L,S !$
M         ( !^FX/ '-E<F$M,C R-#$R,S$N:'1M4$L! A0#%     @ !8)S
M6GIF4AX-?P$ ,G(7 !$              ( !4.X3 '-E<F$M,C R-#$R,S$N
M>'-D4$L! A0#%     @ !8)S6D7=X]QE.0  [A\"  \              ( !
MC&T5 '-E<F$M97@Q.5\Q+FAT;5!+ 0(4 Q0    (  6"<UIHX90;L ,  !8F
M   /              "  1ZG%0!S97)A+65X,C-?,2YH=&U02P$"% ,4
M"  %@G-:<#EY0S@(   5.   #P              @ '[JA4 <V5R82UE>#,Q
M7S$N:'1M4$L! A0#%     @ !8)S6ISKXTHU"   -#@   \
M ( !8+,5 '-E<F$M97@S,5\R+FAT;5!+ 0(4 Q0    (  6"<UJQR.]0104
M  HF   /              "  <*[%0!S97)A+65X,S)?,2YH=&U02P4&
/  L "P"O @  -,$5

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>sera-20241231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cyd="http://xbrl.sec.gov/cyd/2024"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:sera="http://seraprognostics.com/20241231"
  xmlns:srt="http://fasb.org/srt/2024"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="sera-20241231.xsd" xlink:type="simple"/>
    <context id="C_809b9d4c-c63e-4d53-8e85-6d4684e3609d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sera:Plan2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="C_81d045e5-217b-44a8-91f1-c06381b7f02f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_82b9b7fb-68e4-45aa-8dc3-daea6ea244e1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_82cc2c89-a0ca-4534-9da0-23ce655262eb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-13</instant>
        </period>
    </context>
    <context id="C_84137556-2fb3-4bc3-987b-4443923c3d54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-31</instant>
        </period>
    </context>
    <context id="C_841fc982-9aa4-444b-812e-b8d2f53536de">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_8442a0e1-b203-45a1-bf13-205667c7fbae">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt1238SharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_849392ea-c9bb-46ce-b852-5562b8505f07">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_84c625f9-260e-4db9-b7ab-0dd11718650f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sera:ElevanceHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sera:CommercialCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-28</endDate>
        </period>
    </context>
    <context id="C_8510e741-314c-421f-9b15-649e0930202c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sera:Plan2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="C_85982594-37df-45db-b0b5-a89d1853eece">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_8620e36e-b199-4b2d-8cc2-4ba15f93a3c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_8c0b2f25-3d73-42db-83a0-927dc46b55f2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_8c97b2f6-6bfd-442f-8d5f-fae8ac4320ac">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_8cc8bb60-d9e5-4087-a779-404d0c630ac2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_8dc4e1a7-bd95-4cb8-aa85-12c3382baabd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_91155194-5f56-4b2a-aafc-4c8a052b5661">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_953152ac-0b0e-4a0d-8ab5-c817f16e31e7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_958742c3-77d5-4074-ba9f-54937420e759">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sera:DefinedContributionPlanEmployerMatchingContributionMatchingTierAxis">sera:DefinedContributionPlanEmployerMatchingContributionSecondTierMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_978306e0-1a64-43db-891b-ab7f3d2e279c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_987117f3-a2cb-4114-ba3b-abb5e5ee31bf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt520SharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_993c8440-8e32-404e-a58d-36ed574ab4c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_9992b3c4-e005-45ff-a893-0307d53ac290">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_9ec8a49d-6940-415c-bf39-e752664f6f55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_a0cb604e-1c55-4ed9-a4a7-e778eada5e8d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_a1e8075a-0b21-49e0-992e-366ff149e4be">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:NonCurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_a1fba1e9-19c8-4131-8870-80ec56eace4a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sera:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_a3cd6426-e326-48ef-a767-d68bae526b8f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_a3f22057-cfb4-4d74-a910-d271c95221d1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_a4a98f25-89ec-4c7d-be42-82aacc24e38e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-13</startDate>
            <endDate>2025-02-13</endDate>
        </period>
    </context>
    <context id="C_a5ccbc75-c805-4d9b-b60c-5763efe0a38b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sera:CarelonResearchMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sera:MasterServicesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_a77c3867-9623-4313-a505-f21cd62befe2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="C_a9e61099-b6f3-486b-b333-a0f9e6559dc9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_aa504e3e-c144-468e-9c38-a006e10b950c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_ac36fee8-490e-4504-a78e-09b7ddd118aa">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sera:ElevanceHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sera:LaboratoryServicesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_acdfb23b-77fd-4983-9ece-002da2eb742e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_ae2c36a5-c404-4f89-b850-51f7ae29526d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_aef51065-45c9-4f35-8eb3-5f34b000ac42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_afe93441-ddca-40ee-9cbe-6bed962e175a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-14</instant>
        </period>
    </context>
    <context id="C_b020dd07-c5cb-461b-9677-a054282faf68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sera:TdCowenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sera:AtTheMarketOfferingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sera:TwoThousandTwentyFourSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-08-01</startDate>
            <endDate>2024-08-31</endDate>
        </period>
    </context>
    <context id="C_b105c69c-9306-46d2-b61c-acf709b3eb96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:NonCurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_b1d570cd-e3f2-4acc-ab96-99d8ef06cb44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt1238SharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_b2ca6d62-c8a1-49ad-b68e-21f1e5f6bb63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt520SharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_b3f42472-6a24-481b-929b-311bab556a79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_b55ca18f-71fd-40e9-91aa-6ca09f99f3fd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt9.03SharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_b56db086-392f-4885-98c2-c27491c047ea">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-13</instant>
        </period>
    </context>
    <context id="C_b7b69a92-c42e-4043-8b6b-6e1b509663d8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-08-01</startDate>
            <endDate>2024-08-31</endDate>
        </period>
    </context>
    <context id="C_b7e93a2d-70e5-4c3d-a5e8-2305fb8f5a8b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_b8f625aa-6c52-4a2e-99d7-4c691c838229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_b91d11ff-c343-4366-83fa-e644ceaf19e4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_ba06682c-931b-4d72-8219-fe9762cb8c51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_bb275bcf-b99b-45c0-b9f6-74f2cafd0a81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_bbe124b6-5e26-4340-9b7f-2ec3e167c7a7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_bc82f716-4cb8-4ed6-9807-7a362747d97c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_bd4804da-dfef-46a4-bf86-8a1aff8a5a72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_bee59d28-e5cc-40c9-a976-6776fef6babc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt9.03SharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_c0c33cde-1b31-4d14-83be-384eb68acebe">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_c1db559f-42af-47ed-b6d7-b2aa626db456">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_c35d80b0-e824-4576-b648-1c68918bb474">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_c65254c7-ac81-4069-a809-c971b11aa622">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_c6567a19-3bfb-4b14-8ef7-62764c3fa312">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">sera:CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_c6d246ba-4eb3-4ae3-9dc3-001abd64e5cc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">sera:WarrantsToPurchaseCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_c8b03d4a-856b-4b56-989b-21dbe3a3d5e4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_c8c170a9-1f93-4318-a2c3-b52ae62d57d1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sera:PlanEspp2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_c9f1b32e-78dd-4176-9085-97902cd1f5c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_ca338088-ae30-4c78-a94a-8fc204241aa6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_caa15026-25b9-4c02-9ea0-d4206fb85094">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_caf15085-5fb3-478e-a2a5-829cc0c348a7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_cb3ea4ea-93f7-4d45-b83e-1681dda66e30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_cca6413f-9960-434b-8f2f-706f727e0013">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_ce3c3c85-8edf-485c-a7db-c348c7b6135c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_d345d9ff-4db5-4fb9-821b-1c04eafbe0f2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_d619847f-a838-4f86-a29f-cd037355836b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_d64a0010-f1a5-45de-9e6c-65d4f9fdd0dd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-12</instant>
        </period>
    </context>
    <context id="C_d8ac3adc-d2c5-4821-b662-56b9921fc31c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sera:TdCowenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sera:AtTheMarketOfferingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sera:TwoThousandTwentyFourSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_dac51163-3c66-43ba-8012-e6571ccfbd56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_db7a6971-25dd-4ecb-8f48-615fa9b2e446">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_dbdf5e62-5392-4d8b-9ae4-125c21ee2824">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_dcf610fd-ad27-414d-89a5-21a6bd40cf69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_de5e20fe-662d-4df6-87a3-c106313ed801">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-14</instant>
        </period>
    </context>
    <context id="C_df26b36a-abf1-4ee8-92c3-99bf73fea9e8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_df96dede-3972-4662-bb40-d24aff923983">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt10.84SharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_e26ec1fe-0438-4812-b032-9b354ebc1852">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_e47cfbc9-cd42-436b-8a5a-31f13439a6df">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_e5d8bf32-01c3-478c-ac80-62dc4611786f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_e79b8c0c-c0db-4a39-81c4-3583a483beb6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sera:Plan2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_e8115fc4-0d0a-4b48-968a-84b5f89677cc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:NonCurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_ea61173b-bc9e-42d8-8fbb-5139f085543f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt10.84SharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_eac6e522-39b5-4d4e-9e0f-de03dd6c55f5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_eb565e2c-bfbf-4eb0-a9c0-cbb1dcb06aca">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_ecdd66a3-70fa-4c7e-a8c2-b633e3ee94ea">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_ecfa7a3b-6a0d-49ef-9b51-2fcd10725943">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_ee684bec-2a33-4dd4-bdbb-02595b796850">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:NonCurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_f2bfc23e-e300-4c03-89d2-d8604b93c026">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_f375d679-1976-474c-901f-6de9f5d1164a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">sera:WarrantsToPurchaseCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_f3b8da5f-d721-4ba9-9244-5fd80bad0881">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_f4fd4321-eb36-4c63-ab4e-5f27e634d46d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-12</startDate>
            <endDate>2025-02-12</endDate>
        </period>
    </context>
    <context id="C_f644480d-0cbe-48d3-a1e8-381afc09c8c6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_f652abc9-1d38-472f-bc10-183e164a2e16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_f78c9a8e-0786-4b1b-bdc3-6e22b3d933f8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_f91bfb70-0a79-432d-a466-f33c51ec490d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_f96481c1-18cb-423a-941d-d5f0e9523ae3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_fa1f5377-96a0-459c-99fd-200157552294">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">sera:WarrantsToPurchaseCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_fad988d1-5034-478c-8516-20f5782f4f85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_fbe5cd8d-06e5-47a6-a5f5-846c4699e03a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_fff4f4f8-fdc0-4e2f-8c2d-857db712f284">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:NonCurrentMarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_02e513ef-eb63-431b-a54e-7db176d6f3b0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_04695d1b-8064-4772-b23e-9ee08052db28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_05252941-47eb-419d-ad91-9a0440a3d146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_05256ced-5cef-411f-a2d3-9a1cd711dc5a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_060bbe9a-71b5-4045-95d0-1ffa4cf95206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_08aeb0e4-961e-4e83-9bf3-97b2ea84cd08">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_09f10352-d759-4530-8098-b6299171a509">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_0a1a9334-cc92-43d9-b390-4fce8c10c525">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sera:ElevanceHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sera:CommercialCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_0a27554e-ce58-4e26-90cb-8b0b7c2027a4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_0d3d312a-a883-406f-a482-b3aab18bb031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_12580e9a-ae3c-43b5-bd47-c7e4bcb0df5e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_13d531e2-fd1b-4238-a5d7-2fd7b67c5076">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">sera:CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_161991af-bae7-4347-80d9-c0890d8f55a6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sera:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_1660a0e7-df13-4027-9e38-15f6ddf11b0a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">sera:CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_170c4dc3-4c1f-4587-ac98-abecb38c3bcc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_179d008a-1bc2-40a6-ac89-86e6010d037c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_187fc49c-d6d6-4802-9f01-b957d0bc88c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_1897da0a-32c6-4bd9-ab52-d7b11d48dbc4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_18bf2f02-7c59-4b81-af8a-e4dee36352a3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_1928429d-8377-45e6-a6ab-694d0e5a190a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_1a18dcc9-5298-4f3a-9d2a-ee711ea1c709">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_1ae1e03b-7d7a-4b1a-b6fb-a10eb7afe2e2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_1ae32300-4e33-4c46-af0e-181100bd03ab">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_1c9fd511-344f-4ec1-9e7e-971dfed29d81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_1d2ae6de-1a53-435d-93ea-e493cb1853b9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_1e202fd9-3575-429f-acb1-9d054feb99d5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_1e828831-28e3-4d62-916b-97cfb64c3c0f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_1ea882d4-0679-4c9f-9dff-1ef9e04dcf6b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_1faeebd3-23ce-493d-af5a-c79bb9e92d83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sera:Plan2011Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="C_208b76c5-59c1-4209-a49b-266bd3873544">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">sera:OtherOfficersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20e6caf7-a789-4725-a954-593c6c8d5ceb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202307Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_23ca8b3a-fc86-4de2-84db-b4ac53b0b0a2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_275f65a9-d875-4114-9eef-facc7efca0e4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_28f64bcb-45ac-4b38-ac92-aba2705b7334">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_34623022-fd17-429b-802b-fd3f934c6118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_36d0dab8-25a4-4445-bd06-e502a277df24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sera:OfficeAndLaboratorySpaceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_3759c1ab-699f-41b4-a2c6-1a2c4e3d2044">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_3823e7c9-9de3-4740-a0b6-1918db41ffaa">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_3879982c-10a3-45e6-8f45-744fccd1614e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_3b6bd3f1-4ef1-4f65-afbc-9caec8647ffa">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_4066f0e7-4d45-4120-9721-5f25ca3c40f2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sera:DefinedContributionPlanEmployerMatchingContributionMatchingTierAxis">sera:DefinedContributionPlanEmployerMatchingContributionFirstTierMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_41343767-6b2c-42a9-a746-3a9c961b2efb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_428b350f-b950-4c70-b038-a16d2e148ef6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_43042710-b071-477a-ab25-8b8bacc949b5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_44bf1f0c-7e45-4ddb-a68d-b3794ce96d49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_44f85d7b-18dc-4a86-bed7-b1560a6fe25f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt20.77SharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_4604871b-61c7-42a4-83ac-1df44766218b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_472b27ba-d433-4ec0-97d1-4934923032a3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_49022522-db49-4ec2-87f5-e2146f11c06f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_4902770f-8a0e-430e-93da-63b3fc8fb693">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_49e34717-cb5a-4860-9e99-7bca256906a4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-12</instant>
        </period>
    </context>
    <context id="C_4a4b0457-af40-4380-abc2-adf8d6e99ae1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_4b80e6fd-7982-44e8-a550-11ab6d1ec368">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_4c8e016f-98b6-437d-bf3b-2afd8d1a2252">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_4d86a42a-d0b5-4b77-9427-1f77696fdc95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_5a27522b-3fd7-4775-b4b1-c07ac5059bc8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sera:CarelonResearchMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sera:MasterServicesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_5c263358-4220-4048-b609-a9b779332d4c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_5daf51f1-d84a-4a9b-8b05-31cbd8535172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_5e807c43-ac3c-4c9f-8c9f-aa73f1509b36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:NonCurrentMarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_5f4da6b1-9c8a-4b7e-8a90-5d3ea9ae78a1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_638a878b-120b-4eee-b75c-90162633cf80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_645b404b-8bbd-4848-a0d4-aeaf0829da3f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_66868af1-9b8d-4e30-a6a8-7b403eee8c4e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_67bb9b90-53de-4dc1-9ea3-fca6651bdf57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">sera:DomainNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_6926825c-e381-4fc0-8ca5-c547d26c00af">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:NonCurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_6a5f0bd4-0f79-4071-ac0b-e3d379500212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sera:Plan2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="C_6b649540-a349-4de7-a667-163e2396f87b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_6df1f8d2-5436-460d-9378-2e480850c840">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">sera:WarrantsToPurchaseCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_6e3121ea-3b26-4fbf-a9e4-ba6bb516cb52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt20.77SharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_700f906f-1edc-4815-8c6f-063af0170797">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_710fd514-29df-4675-8ad6-a812b659c2ba">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_72fc74dc-bc8c-4dc3-9e53-0a0e671982ea">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">sera:CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_7330604e-585d-4c2f-b88a-fa3bec9d68eb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_743227ba-f29d-4c56-aaf6-1d4fe3a4d79e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_762a6bec-dfb1-4943-9527-797ae4764d93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:NonCurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_79fad083-6839-4292-87a4-80611ccece36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_7c6f287f-0cf6-4dfb-9a02-3a6ce54488cd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_7e2de8e1-9b90-401b-b5d2-78a35f931945">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <unit id="U_pure">
        <measure>pure</measure>
    </unit>
    <unit id="U_UnitedStatesOfAmericaDollarsShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="U_sqft">
        <measure>utr:sqft</measure>
    </unit>
    <unit id="U_shares">
        <measure>shares</measure>
    </unit>
    <unit id="U_CommonStockClass">
        <measure>sera:CommonStockClass</measure>
    </unit>
    <unit id="U_Vote">
        <measure>sera:Vote</measure>
    </unit>
    <unit id="U_USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="U_Segment">
        <measure>sera:Segment</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_20540d76-2417-448e-8443-a4499e56e8da">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_26fa8a1d-30a2-4a04-9d85-96a76be3b10e">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_8f911407-2773-435d-a717-d82119880830">0001534969</dei:EntityCentralIndexKey>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      id="F_8e83aa39-64c6-422c-87be-b01e50d376c8"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      id="F_acf9886f-1dd5-4da5-9964-486ff2df08a0"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_78f058f5-e77e-4f42-8f14-9e5f77a00420">http://fasb.org/srt/2024#ChiefExecutiveOfficerMember</us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      id="F_0f18ae55-e115-46af-9133-2a37b7dbec78">http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      id="F_499cda77-bfd5-40a5-a5fa-38b8c2a78467">http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      id="F_b631bde4-1e5a-491c-8bd3-1cb6b5c51baa">http://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      id="F_72a4c378-6838-4602-82e9-f25639674292">http://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      id="F_556e664f-e809-4c83-9e64-ccae8a1500b7">http://fasb.org/us-gaap/2024#AccruedLiabilitiesAndOtherLiabilities</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      id="F_e1166b60-a008-49df-82fa-558051a272f2">http://fasb.org/us-gaap/2024#AccruedLiabilitiesAndOtherLiabilities</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <dei:DocumentType
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_1b124054-d698-433a-bb21-4ba5e87f4630">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_35f25447-a0c2-4084-96c8-bf1db37ea299">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_2dd1f789-9ad1-4c80-bb2e-e5bca6663881">2024-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_92b69695-4b87-41cf-a73c-3558a732a74d">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_38d4a575-c0a2-4c7c-b61b-c8fe288a6029">2024</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_98673e51-40a3-4d58-8a46-a6f738faa412">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_b9f323f6-49ab-4565-a2da-c4ab47660f01">001-40606</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_fcb5d6d4-c1b0-4c58-afed-d6743af28f1f">SERA PROGNOSTICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_10fd54cd-86f5-4988-ab5c-fed0d01dd476">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_815ae5f1-6b0a-4a4e-b4c3-17bb8201c72f">26-1911522</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_2dbf3e1c-6ad0-4103-a636-06a7e7023d4c">2749 East Parleys Way</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_0b70c593-2cf5-4f28-b57b-39ad7a42018c"> Suite 200</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_5747d6ba-f673-4277-b442-3c285296f60c">Salt Lake City</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_c2570b19-d17f-4129-870e-5b52cb64bab0">UT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_2972d1ec-fbea-4ba8-b827-a76e03020207">84109</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_f2f2953c-8675-4042-8a03-f9b3ccc4e757">801</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_dab6fefd-8b56-44ba-80be-4e56019af833">990-0520</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_4213036d-3a5f-4215-a318-c55c7529f48b">Class A Common Stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_7cb445c6-a907-417f-bdd4-52b5caf743ee">SERA</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_69451bb4-a01d-4a6e-8a58-6f756dad90e3">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_78934355-e031-464a-8d73-027c51643fd5">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_d5a66e34-f456-45f2-96d1-d327dd69ca60">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_2b4a694b-f3dc-4cd2-9404-4fbdcbfbc8fd">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_fb97d482-3204-4f81-a5d8-c6b8a7c8c245">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_3e9e63a6-b61a-4f87-a28c-4a0bf4336af2">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_baeae65a-ad30-436b-afad-f738fd76e4c3">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_a3cb1b09-f088-492a-8778-9e437fda0f8b">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_3fef36e6-bb93-48b8-92d1-96448c733b1c">false</dei:EntityExTransitionPeriod>
    <dei:IcfrAuditorAttestationFlag
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_16e86883-361d-40f6-844c-d0dad58aca26">false</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_a765e5c2-c136-44a9-9b86-fc8810705cd9">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_7adef727-1057-443b-8d48-46401a28b537">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="C_953152ac-0b0e-4a0d-8ab5-c817f16e31e7"
      decimals="-5"
      id="F_b1d958e2-b49a-4701-9092-bb64ba88cba0"
      unitRef="U_USD">183800000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="C_afe93441-ddca-40ee-9cbe-6bed962e175a"
      decimals="INF"
      id="F_b7d6b8e6-c3b3-4699-b4f1-3be98f60d08c"
      unitRef="U_shares">36695803</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="C_de5e20fe-662d-4df6-87a3-c106313ed801"
      decimals="INF"
      id="F_c2b71523-6131-4432-923c-7da94d00b548"
      unitRef="U_shares">967759</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_a604322c-3ddd-431e-80a2-40b51ca729dd">&lt;p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:3pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Portions of the registrant&#x2019;s definitive proxy statement relating to its &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2025 annual meeting of stockholders (the &#x201c;Proxy Statement&#x201d;) are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated. The Proxy Statement will be filed with the Securities and Exchange Commission within 120 days after the end of the registrant&#x2019;s fiscal year ended December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;</dei:DocumentsIncorporatedByReferenceTextBlock>
    <cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_35886bec-98ff-4347-a279-8a96d85eccbb">&lt;p id="item_1c_cybersecurity" style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Item 1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;C. Cybersecurity&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Cybersecurity&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We recognize the critical importance of maintaining the trust and confidence of stakeholders toward our business and are committed to protecting the confidentiality, integrity, and availability of our business operations and systems. Our board of directors is actively involved in oversight of our risk management activities, and cybersecurity represents an important element of our overall approach to risk management. Our cybersecurity policies, standards, processes, and practices are based on recognized frameworks established by the National Institute of Standards and Technology, or NIST, and other applicable industry standards. In general, we seek to address cybersecurity risks through a comprehensive approach that is focused on preserving the confidentiality, security, and availability of the information that we collect and store by monitoring, identifying, preventing, and mitigating cybersecurity threats and effectively responding to cybersecurity incidents when they occur.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Cybersecurity Risk Management and Strategy; Effect of Risk&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Like all companies w&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;e face risks related to cybersecurity such as unauthorized access, cybersecurity attacks and other security incidents, loss of data, and misappropriation of confidential information. To identify and assess material risks from cybersecurity threats, we maintain a comprehensive cybersecurity program to ensure our systems are effective and prepared for information security risks, including regular oversight of our programs for security monitoring for internal and external threats to ensure the confidentiality and&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; integrity of our information assets.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We consider risks from cybersecurity threats alongside other company risks as part of our overall risk assessment process. We employ a range of tools and services, including third-party real-time risk assessments of cyber assets and mitigation of security risks, data loss prevention, regular air-gapped backups, continuous monitoring and threat response, next generation firewall systems, and security information and event management.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; As discussed in more detail under &#x201c;Cybersecurity Governance&#x201d; below, our audit committee provides oversight of our cybersecurity risk management and strategy processes, which are led by our Chief Information Officer.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We also identify our cybersecurity threat risks by comparing our processes to standards set by NIST. To provide for the availability of critical data and systems, maintain regulatory compliance, manage our material risks from cybersecurity threats, and protect against and respond to cybersecurity incidents, we undertake the following activities:&lt;/span&gt;&lt;/p&gt;&lt;div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;monitor emerging data protection best practices and laws and implement changes to our processes that are designed to comply with such;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;annual HIPAA security and privacy risk assessments performed with third party provider, as well as annual HIPAA compliance audits;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;through our policies, practices and contracts (as applicable), require employees, as well as third parties that provide services on our behalf, to treat confidential information and data with care, and to maintain applicable compliance standards;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;employ technical safeguards that are designed to protect our information systems from cybersecurity threats, including next generation firewall systems, endpoint detection and response, data loss prevention, regular air-gapped backups, and security information and event management, which are evaluated and improved through third-party real-time risk assessments and mitigation of security risks&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;provide regular, mandatory training for our employees and contractors regarding cybersecurity threats as a means to equip them with effective tools, information and education to recognize and address cybersecurity threats;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;conduct regular phishing email simulations for all employees and contractors with access to our email systems to enhance awareness and responsiveness to possible threats;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;leverage the NIST incident handling framework to help us identify, protect, detect, respond and recover when there is an actual or potential cybersecurity incident;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;carry and maintain information security risk insurance that provides protection against the potential losses arising from a cybersecurity incident; and&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;document internal policies and procedures for cybersecurity incident response and recovery.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our incident response plan coordinates the activities we take to prepare for, detect, respond to, and recover from cybersecurity incidents, which include processes to prepare for the incident, while complying with potentially applicable legal obligations and mitigate damage to our business and reputation.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our policies and processes also address cybersecurity threat risks associated with our use of third-party service providers. In addition, cybersecurity considerations affect the selection and oversight of our third-party service providers. We perform due diligence on third parties that have access to our data to ensure they have adequate cybersecurity safeguards in place and continually monitor cybersecurity threat risks identified through such due diligence.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We describe whether and how risks from identified cybersecurity threats, including as a result of any previous cybersecurity incidents, have materially affected or are reasonably likely to materially affect us, including our business strategy, results of operations, or financial condition&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, under the heading &#x201c;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Security breaches, losses of data, and other disruptions could compromise &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;sensitive&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; information related to our business or prevent us from accessing critical information and expose us to liability, which could adversely affect our business and reputation&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;,&#x201d; which disclosures are incorporated by reference herein.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Cybersecurity Governance; Management&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;div&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Cybersecurity is an important part of our risk management processes and an area of focus for our board of directors and management. The audit committee of our board of directors is responsible for the oversight of risks from cybersecurity threats.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;At least annually, our audit committee receives an update from management of our cybersecurity threat risk management and strategy processes covering topics such as data security, results from third-party assessments, our incident response plan, and material cybersecurity threat risks or incidents and developments, as well as the steps management has taken to respond to such risks.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; In such sessions, our audit committee generally receives materials that include a cybersecurity scorecard and other materials discussing current and emerging material cybersecurity threat risks, and describing our ability to mitigate those risks, as well as recent developments, evolving standards, and information security considerations arising with respect to our peers and third parties. The audit committee discusses such matters with our Chief Information Officer.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our cybersecurity risk management and strategy processes, which are discussed in greater detail above, are led by our Chief Information Officer and the information technology team.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Such individuals have extensive experience in various roles, including in other publicly traded companies, involving managing information security, developing cybersecurity strategy, and implementing effective information and cybersecurity programs.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;These management team members monitor the prevention, mitigation, detection, and remediation of cybersecurity incidents through their management of the cybersecurity risk management and strategy processes described above, including the operation of our incident response plan.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As discussed above, these management team members report to the audit committee of our board of directors about cybersecurity threat risks, among other cybersecurity related matters, at least annually.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_b33f3706-9285-4db1-98dd-39c33c5d7386">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;e face risks related to cybersecurity such as unauthorized access, cybersecurity attacks and other security incidents, loss of data, and misappropriation of confidential information. To identify and assess material risks from cybersecurity threats, we maintain a comprehensive cybersecurity program to ensure our systems are effective and prepared for information security risks, including regular oversight of our programs for security monitoring for internal and external threats to ensure the confidentiality and&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; integrity of our information assets.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We consider risks from cybersecurity threats alongside other company risks as part of our overall risk assessment process. We employ a range of tools and services, including third-party real-time risk assessments of cyber assets and mitigation of security risks, data loss prevention, regular air-gapped backups, continuous monitoring and threat response, next generation firewall systems, and security information and event management.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; As discussed in more detail under &#x201c;Cybersecurity Governance&#x201d; below, our audit committee provides oversight of our cybersecurity risk management and strategy processes, which are led by our Chief Information Officer.&lt;/span&gt;</cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedFlag
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_e5291f75-56df-4510-b3d3-099cc872a6d6">true</cyd:CybersecurityRiskManagementProcessesIntegratedFlag>
    <cyd:CybersecurityRiskManagementThirdPartyEngagedFlag
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_8d92a08b-b4e2-4c44-a664-3f765ed77d4a">true</cyd:CybersecurityRiskManagementThirdPartyEngagedFlag>
    <cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_97d81745-74f8-413f-85ef-9cac1b229089">true</cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_38bb06cf-8503-4c99-afb6-a71e37cdb845">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We describe whether and how risks from identified cybersecurity threats, including as a result of any previous cybersecurity incidents, have materially affected or are reasonably likely to materially affect us, including our business strategy, results of operations, or financial condition&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, under the heading &#x201c;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Security breaches, losses of data, and other disruptions could compromise &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;sensitive&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; information related to our business or prevent us from accessing critical information and expose us to liability, which could adversely affect our business and reputation&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;,&#x201d; which disclosures are incorporated by reference herein.&lt;/span&gt;&lt;/p&gt;</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_e2537937-015c-4b91-acf1-97c8ea7efe06">true</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag>
    <cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_a734fffd-f3d1-4615-bf85-78c923615af3">&lt;div&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Cybersecurity is an important part of our risk management processes and an area of focus for our board of directors and management. The audit committee of our board of directors is responsible for the oversight of risks from cybersecurity threats.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;At least annually, our audit committee receives an update from management of our cybersecurity threat risk management and strategy processes covering topics such as data security, results from third-party assessments, our incident response plan, and material cybersecurity threat risks or incidents and developments, as well as the steps management has taken to respond to such risks.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; In such sessions, our audit committee generally receives materials that include a cybersecurity scorecard and other materials discussing current and emerging material cybersecurity threat risks, and describing our ability to mitigate those risks, as well as recent developments, evolving standards, and information security considerations arising with respect to our peers and third parties. The audit committee discusses such matters with our Chief Information Officer.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock>
    <cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_362e804d-1215-40fd-8f76-65c2483c52fb">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Cybersecurity is an important part of our risk management processes and an area of focus for our board of directors and management. The audit committee of our board of directors is responsible for the oversight of risks from cybersecurity threats.&lt;/span&gt;&lt;/p&gt;</cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_1d6a09c5-1c83-40f1-b232-148a17708128">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;At least annually, our audit committee receives an update from management of our cybersecurity threat risk management and strategy processes covering topics such as data security, results from third-party assessments, our incident response plan, and material cybersecurity threat risks or incidents and developments, as well as the steps management has taken to respond to such risks.&lt;/span&gt;</cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskRoleOfManagementTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_bf2820d4-8788-4b78-80c4-ee945bed1f32">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our cybersecurity risk management and strategy processes, which are discussed in greater detail above, are led by our Chief Information Officer and the information technology team.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Such individuals have extensive experience in various roles, including in other publicly traded companies, involving managing information security, developing cybersecurity strategy, and implementing effective information and cybersecurity programs.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;These management team members monitor the prevention, mitigation, detection, and remediation of cybersecurity incidents through their management of the cybersecurity risk management and strategy processes described above, including the operation of our incident response plan.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As discussed above, these management team members report to the audit committee of our board of directors about cybersecurity threat risks, among other cybersecurity related matters, at least annually.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;</cyd:CybersecurityRiskRoleOfManagementTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_b0a4a6ec-a375-4516-b025-0cfe36f3f2b3">&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our cybersecurity risk management and strategy processes, which are discussed in greater detail above, are led by our Chief Information Officer and the information technology team.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Such individuals have extensive experience in various roles, including in other publicly traded companies, involving managing information security, developing cybersecurity strategy, and implementing effective information and cybersecurity programs.&lt;/span&gt;&lt;/span&gt;</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_072de6cd-0dac-494e-8d50-193ddd10328a">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag>
    <cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_40250cc6-1105-4de7-aae6-eb0479500469">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Such individuals have extensive experience in various roles, including in other publicly traded companies, involving managing information security, developing cybersecurity strategy, and implementing effective information and cybersecurity programs.&lt;/span&gt;</cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock>
    <cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_93770e55-89a5-47d4-84d7-0a8d20320fe8">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;These management team members monitor the prevention, mitigation, detection, and remediation of cybersecurity incidents through their management of the cybersecurity risk management and strategy processes described above, including the operation of our incident response plan.&lt;/span&gt;</cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_5a11cf93-6fe4-42f8-9247-ce81d5141001">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag>
    <dei:AuditorFirmId
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_03726a05-9974-4b6b-9f4d-8009271dbffc">42</dei:AuditorFirmId>
    <dei:AuditorOpinionTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_3819071b-cee0-401f-8d65-d438bcea9ec1">&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Opinion on the Financial Statements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We have audited the accompanying balance sheets of Sera Prognostics, Inc. (the Company) as of December 31, 2024 and 2023, the related statements of operations and comprehensive loss, stockholders&#x2019; equity and cash flows for each of the two years in the period ended December 31, 2024, and the related notes (collectively referred to as the &#x201c;financial statements&#x201d;). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2024 and 2023, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, in conformity with U.S. generally accepted accounting principles.&lt;/span&gt;&lt;/p&gt;</dei:AuditorOpinionTextBlock>
    <dei:AuditorName
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_54784db8-af05-453c-8b1d-3fd9899f07e6">Ernst &amp; Young LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_683e2755-b0fe-47ff-8928-423824084a0f">Salt Lake City, Utah</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_900f1095-4dcd-46bb-b144-7a3879cd33d3"
      unitRef="U_USD">4043000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_4fe8c58f-ff6a-478e-bb54-107739436e21"
      unitRef="U_USD">3880000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_286ba177-2e30-46be-b9d2-a6c62c74808f"
      unitRef="U_USD">42193000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_45d51203-8dfd-4de8-9975-81474e1a5e58"
      unitRef="U_USD">45199000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_325a3d2b-ff18-4898-9edd-887750eef58f"
      unitRef="U_USD">34000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_265bda49-994f-4732-a20e-caac835fa23a"
      unitRef="U_USD">160000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_78a91325-6972-4f38-95cb-f0395ca81b07"
      unitRef="U_USD">19000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_4dac3b7d-81ea-4678-8876-2021d98b9cce"
      unitRef="U_USD">11310000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_47e6bb85-b58b-49e6-b109-ae0492abe462"
      unitRef="U_USD">1311000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_d9a10fe9-67eb-4755-97dd-0b6c1d0f5129"
      unitRef="U_USD">795000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_46ed9c47-f439-4eea-832d-6b858e6cf26e"
      unitRef="U_USD">47600000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_67a7af21-2df5-4574-a155-b8ed4a642375"
      unitRef="U_USD">61344000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_857ea9fc-9ca0-4af9-a811-1cbc98816251"
      unitRef="U_USD">1239000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_82aac161-bbc1-43c1-91ad-2e1a2f7daa19"
      unitRef="U_USD">1999000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_7bdf0288-966a-48f3-b529-58a113d59df7"
      unitRef="U_USD">21973000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_388235aa-3793-43b1-b1e2-709985f23671"
      unitRef="U_USD">30841000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_ddc637b6-7432-428a-8631-ad87beb0369e"
      unitRef="U_USD">1026000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_74380e85-f22f-43f4-ac51-c5a81724d93d"
      unitRef="U_USD">0</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_ef0f27e2-69aa-4406-897f-8bdac0cfdef2"
      unitRef="U_USD">737000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_37ba9fbf-48ab-4134-856d-1e4f43d3de34"
      unitRef="U_USD">1257000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_c0e72cc3-78f6-40a8-b846-faa288374387"
      unitRef="U_USD">72575000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_d3f170e6-e19c-4f8b-aaf7-d07394c292da"
      unitRef="U_USD">95441000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_8e0cb871-dcaf-4b7b-8ba4-efe878b2538e"
      unitRef="U_USD">1969000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_95b5e006-4b88-47a7-af9d-2bb5fe31438b"
      unitRef="U_USD">1046000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_c41e582f-67b2-456c-b433-41f2f4ff6701"
      unitRef="U_USD">2384000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_32d75fc8-e406-4512-b7a9-ae30be90b0fa"
      unitRef="U_USD">2722000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_f5d68177-204c-40d8-89e1-380a1a97d62a"
      unitRef="U_USD">194000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_6642750a-24ba-48a7-8be0-f34a8bdf3c9e"
      unitRef="U_USD">440000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_9b2f7cbb-3c9c-437b-b20d-a1c014a76f5e"
      unitRef="U_USD">20223000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_b00cad88-aac8-4194-a74f-c8e214b3dc12"
      unitRef="U_USD">20235000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_2a0a4992-b994-4d66-bbfa-7df7a18dbc8d"
      unitRef="U_USD">24770000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_63bfc8b3-950c-4f13-b57a-e46579043ab3"
      unitRef="U_USD">24443000</us-gaap:LiabilitiesCurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_2a42fa76-6275-42ae-aa6d-18b2dd5fef78"
      unitRef="U_USD">2000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_9b1f0aae-5150-4c25-aa16-f61a9e5ddd9b"
      unitRef="U_USD">196000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_c88f1fd2-bdf3-450f-96bf-7b0ab5bba2c5"
      unitRef="U_USD">0</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_ddd60159-ba45-4156-8631-63307b972cf9"
      unitRef="U_USD">644000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:Liabilities
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_d859a383-c448-4406-9028-b2e3bec40fa7"
      unitRef="U_USD">24772000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_fe26ed70-11e1-41d1-b3bf-3dc13ed6d121"
      unitRef="U_USD">25283000</us-gaap:Liabilities>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_e26ec1fe-0438-4812-b032-9b354ebc1852"
      decimals="INF"
      id="F_c6d8b86c-46ed-408b-993e-41f084912cec"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_7e2de8e1-9b90-401b-b5d2-78a35f931945"
      decimals="INF"
      id="F_dcfc2b9f-0647-4feb-9c44-e34b3e2c00ae"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_1a18dcc9-5298-4f3a-9d2a-ee711ea1c709"
      decimals="INF"
      id="F_4e49d761-37e0-48e8-a36f-40014798c0b6"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_bb275bcf-b99b-45c0-b9f6-74f2cafd0a81"
      decimals="INF"
      id="F_2b85c712-57a8-4d6d-8aae-e7c7cf0a6180"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_e26ec1fe-0438-4812-b032-9b354ebc1852"
      decimals="INF"
      id="F_d80ee4db-4943-49ea-9f4d-1601d7b23c6f"
      unitRef="U_shares">150000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_7e2de8e1-9b90-401b-b5d2-78a35f931945"
      decimals="INF"
      id="F_ca88c19b-630b-4dc8-a5f8-b14e19f6e0ef"
      unitRef="U_shares">150000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_e26ec1fe-0438-4812-b032-9b354ebc1852"
      decimals="INF"
      id="F_eb926258-cc9d-459c-9be3-96f99cc9e9c4"
      unitRef="U_shares">33206909</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_e26ec1fe-0438-4812-b032-9b354ebc1852"
      decimals="INF"
      id="F_72568580-e9e2-4daa-92e3-a08852212b45"
      unitRef="U_shares">33206909</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_7e2de8e1-9b90-401b-b5d2-78a35f931945"
      decimals="INF"
      id="F_3ce3dd21-1005-4ca1-8211-a4c930616c8e"
      unitRef="U_shares">30736513</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_7e2de8e1-9b90-401b-b5d2-78a35f931945"
      decimals="INF"
      id="F_fabbf274-df39-4e17-9ca2-8a4e7cb069e7"
      unitRef="U_shares">30736513</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_1a18dcc9-5298-4f3a-9d2a-ee711ea1c709"
      decimals="INF"
      id="F_935fa58f-ad1d-423f-b7c4-04c1ed383b60"
      unitRef="U_shares">1500000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_bb275bcf-b99b-45c0-b9f6-74f2cafd0a81"
      decimals="INF"
      id="F_4a3d291e-c28b-4823-9bae-7287f7fff6b8"
      unitRef="U_shares">1500000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_1a18dcc9-5298-4f3a-9d2a-ee711ea1c709"
      decimals="INF"
      id="F_1546ee53-aeb6-4347-be02-1a523d8b0b53"
      unitRef="U_shares">967759</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_bb275bcf-b99b-45c0-b9f6-74f2cafd0a81"
      decimals="INF"
      id="F_2dfe623f-29ac-40be-bd73-68ac0bbe53cd"
      unitRef="U_shares">1405259</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_1a18dcc9-5298-4f3a-9d2a-ee711ea1c709"
      decimals="INF"
      id="F_18a95d24-50d0-46f0-af58-3e0aea53e2b6"
      unitRef="U_shares">967759</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_bb275bcf-b99b-45c0-b9f6-74f2cafd0a81"
      decimals="INF"
      id="F_a1380144-9612-4f20-a53a-5ada1768044e"
      unitRef="U_shares">967759</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_5724bfaa-dbea-4d2b-bd9a-d1a3fea10d8c"
      unitRef="U_USD">3000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_11d29cfc-a631-45db-ad23-6111a887f977"
      unitRef="U_USD">3000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_cd1bd377-7993-499b-bca5-66fa2e7748a2"
      unitRef="U_USD">327534000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_c3830e82-a7cf-4f1e-8390-730fea02adf5"
      unitRef="U_USD">317066000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_af82fbc9-544f-40dc-8e9c-20e063ffb336"
      unitRef="U_USD">60000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_9887f2a4-30cc-4814-a675-8a1c0cb425e3"
      unitRef="U_USD">-15000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_9bb4bc39-cdc0-4edf-81a8-476b3d510cbc"
      unitRef="U_USD">-279794000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_92f445e0-8941-45aa-b3fd-04e6e091645b"
      unitRef="U_USD">-246896000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_f786e8d3-53db-4e89-a96e-14e368711b82"
      unitRef="U_USD">47803000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_e164a3b4-222a-4536-94c4-b6f55e3dadf4"
      unitRef="U_USD">70158000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_3fb283e1-13bc-4a2e-a5b0-7a4f90bc347c"
      unitRef="U_USD">72575000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_dccf1e86-0e78-48d2-a18d-f72068c43575"
      unitRef="U_USD">95441000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_83fc8867-1257-4668-8009-28cdbadb2cdf"
      unitRef="U_USD">77000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_a9f0027d-59c2-43bf-b544-ac75ce0b25b2"
      unitRef="U_USD">306000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <sera:CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_d5e1a4a0-a1d9-4097-8a8e-3f4c812f9d1a"
      unitRef="U_USD">82000</sera:CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense>
    <sera:CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_43ae48e9-dc7f-4b98-97b1-2932fa793f21"
      unitRef="U_USD">210000</sera:CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_d7eef4c6-0cfe-4139-8157-aa81c657b706"
      unitRef="U_USD">14730000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_7dfe3e71-1206-4b04-a87d-1435b39894a5"
      unitRef="U_USD">15225000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_c265d3e8-0258-4998-9bae-9692eb9dea9e"
      unitRef="U_USD">5771000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_bc5ddac1-6910-4bba-bd86-e1faa6d36050"
      unitRef="U_USD">8349000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_40a31dd7-885c-4c95-bd80-8e29d3b4ea62"
      unitRef="U_USD">16129000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_01060304-41db-420e-9be5-a12d4fa2d42a"
      unitRef="U_USD">16343000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_8fa6e42c-48cf-4204-bd20-14a13a46f372"
      unitRef="U_USD">36712000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_b99e23be-8521-4102-9275-d9c3e9d45e44"
      unitRef="U_USD">40127000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_001f57d9-3c28-4639-a7eb-03ffd8099600"
      unitRef="U_USD">-36635000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_9ef07e05-9559-4d82-8901-d61d6fffa7df"
      unitRef="U_USD">-39821000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_a7b89a57-cb81-4237-9509-8e36cb15c031"
      unitRef="U_USD">28000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_fdf8d905-10e3-4408-b199-e63902395a3f"
      unitRef="U_USD">55000</us-gaap:InterestExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_d971e5f9-c489-431e-90d9-f92b8fd515a4"
      unitRef="U_USD">3765000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_d4015c51-f9ed-4132-b3a3-dd788bd6af46"
      unitRef="U_USD">3634000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_c505d64d-b4b4-4b5a-91df-6adff9ebef74"
      unitRef="U_USD">-32898000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_482850b6-36f7-4a1e-aa87-8b21e330efd7"
      unitRef="U_USD">-36242000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="2"
      id="F_8ed1c964-e3d2-4dd3-92d1-2901bb9c0c50"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-0.99</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="2"
      id="F_199629e8-639e-4a9f-bb28-5149fbe55f6b"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-0.99</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="2"
      id="F_bcefaca5-41e6-4946-b8ff-93db6d0e4228"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-1.16</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="2"
      id="F_cfce51d5-f07f-4a89-a8c9-2f538e793b9c"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-1.16</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="0"
      id="F_c08ba177-e92e-4058-879f-e5a7b953dec0"
      unitRef="U_shares">33156936</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="0"
      id="F_c0bb5f42-169d-496d-8473-b72ddc320f28"
      unitRef="U_shares">33156936</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="0"
      id="F_7ebc8b45-24cf-432a-acc8-5b0458d50e6f"
      unitRef="U_shares">31200652</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="0"
      id="F_4b0cff8c-43b0-4063-bb48-c29f838c4f46"
      unitRef="U_shares">31200652</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_6f27cf38-2b35-4988-83c3-f85053b44004"
      unitRef="U_USD">75000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_62c7411f-4885-40fb-bb5c-c9c92a21cb3b"
      unitRef="U_USD">966000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_28ef8728-8d2d-42bc-a3ea-12526a58339f"
      unitRef="U_USD">75000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_70a2aa8e-1543-4155-b827-d4c6dec642ab"
      unitRef="U_USD">966000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_8037ec3b-4ccf-4dcb-b484-4a4ac54638ec"
      unitRef="U_USD">-32823000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_dfa240bd-7754-4d32-81f4-8716ae16e5de"
      unitRef="U_USD">-35276000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_1897da0a-32c6-4bd9-ab52-d7b11d48dbc4"
      decimals="INF"
      id="F_86db99e7-2e1f-4012-b1a0-07665b200fe5"
      unitRef="U_shares">31017946</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="C_1897da0a-32c6-4bd9-ab52-d7b11d48dbc4"
      decimals="-3"
      id="F_b7ca321f-af4e-48f9-bdbf-6963ccef6017"
      unitRef="U_USD">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_4902770f-8a0e-430e-93da-63b3fc8fb693"
      decimals="-3"
      id="F_b85f0a90-8b77-407a-954d-8df5af1c1027"
      unitRef="U_USD">310575000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_4604871b-61c7-42a4-83ac-1df44766218b"
      decimals="-3"
      id="F_a48d7175-87f6-4ba0-9ff0-f2f02d869500"
      unitRef="U_USD">-981000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_4a4b0457-af40-4380-abc2-adf8d6e99ae1"
      decimals="-3"
      id="F_d9b6727f-9d5a-4d74-90aa-e47d58b66a4a"
      unitRef="U_USD">-210654000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_bbe124b6-5e26-4340-9b7f-2ec3e167c7a7"
      decimals="-3"
      id="F_d93704b1-383d-41f4-b23c-3ea98e6463fc"
      unitRef="U_USD">98943000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_34623022-fd17-429b-802b-fd3f934c6118"
      decimals="INF"
      id="F_adbff6d3-7779-4837-b110-84fe5173589c"
      unitRef="U_shares">593091</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_08aeb0e4-961e-4e83-9bf3-97b2ea84cd08"
      decimals="-3"
      id="F_3fc868d6-683d-4b3a-8b05-4ecbdf22d2b2"
      unitRef="U_USD">1095000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_5ffa846b-af2e-498d-9f67-7d8eee6ea3ed"
      unitRef="U_USD">1095000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="C_34623022-fd17-429b-802b-fd3f934c6118"
      decimals="INF"
      id="F_44173446-442b-4ce8-8f69-e0fce814c112"
      unitRef="U_shares">93235</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_08aeb0e4-961e-4e83-9bf3-97b2ea84cd08"
      decimals="-3"
      id="F_79f4fa24-e936-43ed-b170-4ea5c903c2c7"
      unitRef="U_USD">123000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_1bcef833-c34f-4e22-9207-d378e8e4716f"
      unitRef="U_USD">123000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_08aeb0e4-961e-4e83-9bf3-97b2ea84cd08"
      decimals="-3"
      id="F_e17aa25d-1ead-48e4-8eaf-e21277b0b5ba"
      unitRef="U_USD">5273000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_16009326-99ef-4de5-9aad-747fa9e8bf68"
      unitRef="U_USD">5273000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_aef51065-45c9-4f35-8eb3-5f34b000ac42"
      decimals="-3"
      id="F_f8ef88c4-c355-46fa-92b4-e773de8bf596"
      unitRef="U_USD">966000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_94bd10a7-c657-4f3d-9e79-6e5e437bae56"
      unitRef="U_USD">966000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="C_1ae32300-4e33-4c46-af0e-181100bd03ab"
      decimals="-3"
      id="F_7ea0cacc-e402-4f4b-8387-242d7752c3da"
      unitRef="U_USD">-36242000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_8ac03d62-18a5-470c-9eca-4a37b77150cd"
      unitRef="U_USD">-36242000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_23ca8b3a-fc86-4de2-84db-b4ac53b0b0a2"
      decimals="INF"
      id="F_7a6e01fd-30b3-4241-9e25-895aa1fa4c5a"
      unitRef="U_shares">31704272</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="C_23ca8b3a-fc86-4de2-84db-b4ac53b0b0a2"
      decimals="-3"
      id="F_33dc8ead-b5f8-4402-889a-fd31f43f2f4c"
      unitRef="U_USD">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_710fd514-29df-4675-8ad6-a812b659c2ba"
      decimals="-3"
      id="F_a539fb15-5ad2-4552-bc17-c6b1945d0248"
      unitRef="U_USD">317066000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_dcf610fd-ad27-414d-89a5-21a6bd40cf69"
      decimals="-3"
      id="F_6183d400-bdaf-4dbb-8f37-9d1aaf1bc162"
      unitRef="U_USD">-15000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_66868af1-9b8d-4e30-a6a8-7b403eee8c4e"
      decimals="-3"
      id="F_9a224115-c3ac-4f4d-9a79-bd4c29644f01"
      unitRef="U_USD">-246896000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_2a4f464c-1e94-4dbc-8607-e76d09ac2dec"
      unitRef="U_USD">70158000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_1ae1e03b-7d7a-4b1a-b6fb-a10eb7afe2e2"
      decimals="INF"
      id="F_ade17afb-c6b7-4029-bedd-1711a4372f7b"
      unitRef="U_shares">1102513</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_f78c9a8e-0786-4b1b-bdc3-6e22b3d933f8"
      decimals="-3"
      id="F_03a1fac3-82ff-4f6d-9390-5740b727c6e8"
      unitRef="U_USD">2902000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_e7c35921-1d3b-4949-8660-7a7d0e3e24ec"
      unitRef="U_USD">2902000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="C_1ae1e03b-7d7a-4b1a-b6fb-a10eb7afe2e2"
      decimals="INF"
      id="F_e5bbff5d-b0a9-41bf-8bb7-5cf8013617b5"
      unitRef="U_shares">1257345</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="C_1ae1e03b-7d7a-4b1a-b6fb-a10eb7afe2e2"
      decimals="INF"
      id="F_966b8dea-c50d-4a22-88b9-06404da38d7b"
      unitRef="U_shares">48740</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_f78c9a8e-0786-4b1b-bdc3-6e22b3d933f8"
      decimals="-3"
      id="F_c6d42a2d-35bb-40d9-a229-c8a8f896827d"
      unitRef="U_USD">147000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_5f8a03f1-f083-4a7a-9682-4424f9a519a0"
      unitRef="U_USD">147000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <sera:StockIssuedDuringPeriodSharesStockWarrantExercised
      contextRef="C_1ae1e03b-7d7a-4b1a-b6fb-a10eb7afe2e2"
      decimals="INF"
      id="F_cdfc457b-ff57-45c8-8215-5154bee2c86e"
      unitRef="U_shares">7971</sera:StockIssuedDuringPeriodSharesStockWarrantExercised>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="C_1ae1e03b-7d7a-4b1a-b6fb-a10eb7afe2e2"
      decimals="INF"
      id="F_f441f52d-062f-4cb6-9b27-b160786f79d6"
      unitRef="U_shares">53827</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="C_f78c9a8e-0786-4b1b-bdc3-6e22b3d933f8"
      decimals="-3"
      id="F_b387187f-f0e6-4f68-be85-baccc9e7eb43"
      unitRef="U_USD">406000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_da0a76b9-cfcd-4708-aed9-91143f868c8f"
      unitRef="U_USD">406000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_f78c9a8e-0786-4b1b-bdc3-6e22b3d933f8"
      decimals="-3"
      id="F_c9ccdffa-341c-4dd3-8153-56139543c033"
      unitRef="U_USD">7013000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_74225255-3878-4778-b093-577e5886b374"
      unitRef="U_USD">7013000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_4d86a42a-d0b5-4b77-9427-1f77696fdc95"
      decimals="-3"
      id="F_f7fc08e5-42d9-498e-9cf1-b7b6c8927157"
      unitRef="U_USD">75000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_f5b038dd-bd0b-47f7-b6d3-edc862af9630"
      unitRef="U_USD">75000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="C_b3f42472-6a24-481b-929b-311bab556a79"
      decimals="-3"
      id="F_ed708596-6f30-40a8-bc03-81abd1f600d3"
      unitRef="U_USD">-32898000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_5106d171-fd5c-473a-8e79-f30f9a546493"
      unitRef="U_USD">-32898000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_cca6413f-9960-434b-8f2f-706f727e0013"
      decimals="INF"
      id="F_238f4b6b-376d-4930-9443-e6a679c9e309"
      unitRef="U_shares">34174668</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="C_cca6413f-9960-434b-8f2f-706f727e0013"
      decimals="-3"
      id="F_06cb4e6d-5673-4569-b1f7-50fbc3231bcf"
      unitRef="U_USD">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_fbe5cd8d-06e5-47a6-a5f5-846c4699e03a"
      decimals="-3"
      id="F_1888d418-65ef-4847-86df-5cb2af537890"
      unitRef="U_USD">327534000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_a3cd6426-e326-48ef-a767-d68bae526b8f"
      decimals="-3"
      id="F_6854dd43-4068-47c9-8178-94b0e9656da3"
      unitRef="U_USD">60000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_5f4da6b1-9c8a-4b7e-8a90-5d3ea9ae78a1"
      decimals="-3"
      id="F_819891ea-c149-4837-8ced-722fcaf98380"
      unitRef="U_USD">-279794000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_107504b2-b376-4f2a-92b3-5405a757f13e"
      unitRef="U_USD">47803000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_eb98380e-965f-46bd-bc96-6873bd069bc3"
      unitRef="U_USD">-32898000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_47249746-17ce-4575-8ce1-508f6ab3c0a2"
      unitRef="U_USD">-36242000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_d99c4824-0a57-4196-85ba-1f3d0e5b5393"
      unitRef="U_USD">833000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_19253910-c3f8-4b46-9442-4a9c1259baf0"
      unitRef="U_USD">900000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_a3e2037e-84a5-4c03-878d-a06d531f93ff"
      unitRef="U_USD">7013000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_04d6e5ff-0655-404c-9b68-9070bce4cb37"
      unitRef="U_USD">5273000</us-gaap:ShareBasedCompensation>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_7dc237e2-f2fe-4e82-a631-43d2db04fc69"
      unitRef="U_USD">567000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_c8e7dedc-1a38-4749-a3f9-1024dbce9a09"
      unitRef="U_USD">526000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <sera:NoncashInvestmentIncomeExpenseNet
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_347dfd5c-0f38-406f-b1bd-e94abe3e42cd"
      unitRef="U_USD">910000</sera:NoncashInvestmentIncomeExpenseNet>
    <sera:NoncashInvestmentIncomeExpenseNet
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_732294eb-93d6-429e-8521-df7f70594155"
      unitRef="U_USD">1182000</sera:NoncashInvestmentIncomeExpenseNet>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_f6060645-d39c-479b-a67d-3ead9ef25e88"
      unitRef="U_USD">69000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_a8f74708-019e-42b1-897c-ce67ee0b3574"
      unitRef="U_USD">-18000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_01f519a0-80d0-425b-be60-9427a5ddc654"
      unitRef="U_USD">-126000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_311e35f4-d73c-4a1d-87e1-8c5df03dfb03"
      unitRef="U_USD">47000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInOtherReceivables
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_e76a8a3c-d0da-4b45-9182-d9e3ea1f2f8f"
      unitRef="U_USD">-11291000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInOtherReceivables
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_08d6397e-16e7-443e-a0ef-8a0b79434db4"
      unitRef="U_USD">5310000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_eb4ef8aa-9118-4e14-a7f4-f9ef8e360ce6"
      unitRef="U_USD">10000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_613f6095-88fa-4859-85a3-7dd6bbdd5bc8"
      unitRef="U_USD">-465000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_31f9c80f-f4f4-4ed1-a089-7128120c8d49"
      unitRef="U_USD">455000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_55f9e9ab-097b-4d58-86f5-0102408c81d0"
      unitRef="U_USD">-442000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_034fa077-f54e-4cea-a8fd-2d5f8c617bfd"
      unitRef="U_USD">-575000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_2774ff9d-85a7-4e14-b5f3-d1a2e5360099"
      unitRef="U_USD">-2301000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_f1b9c57a-06be-401b-9a88-dc756716b275"
      unitRef="U_USD">-12000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_a2e532ae-b40e-4787-a0b3-d8c64cf5dacb"
      unitRef="U_USD">11154000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_cc2d52b1-eca2-461a-8403-4cb4521c7a29"
      unitRef="U_USD">-14189000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_865cce26-6418-4e47-9c29-70c7d0af84e2"
      unitRef="U_USD">-27188000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_ae7e9ff7-0fdb-4c18-a9e8-46c77fb0e755"
      unitRef="U_USD">35831000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_57b8131e-1d2e-46bb-89ac-6815accca035"
      unitRef="U_USD">54143000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_e658973e-faed-4f9d-87a5-f0de152050f4"
      unitRef="U_USD">48675000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_766057ec-76a6-4bb5-927e-abf548777bd6"
      unitRef="U_USD">54398000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_37fb7875-92b2-40a2-99a7-9d6d4520715e"
      unitRef="U_USD">56000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_bb4c45dc-0fe2-4a36-abe0-cd0bc861e420"
      unitRef="U_USD">128000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_d72478fc-a5a4-4511-beae-86762d7b00e7"
      unitRef="U_USD">0</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_32575993-6c3e-489e-8081-98121a6ed34a"
      unitRef="U_USD">311000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_b0645ec4-c5d3-49e3-b719-44a6b3089901"
      unitRef="U_USD">1045000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_78a8ddca-e54e-40e2-a1d1-b0390a8c6d59"
      unitRef="U_USD">0</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_85f157c5-1a89-44ad-88ec-01391ad69d5a"
      unitRef="U_USD">11743000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_5c088d23-0c24-4ef6-86ca-18e541817605"
      unitRef="U_USD">438000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_7a7a995d-eb23-4c86-8cf9-bdf72b1ffcd9"
      unitRef="U_USD">2902000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_f12d7921-319d-4a02-979a-85fd669fcd4d"
      unitRef="U_USD">1095000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_259babac-7700-40f7-90f9-77a95121f9fd"
      unitRef="U_USD">147000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_5cbf852f-460c-432b-906b-54881c862567"
      unitRef="U_USD">123000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_e6d7ee2d-3a14-438a-9077-584601eae0ec"
      unitRef="U_USD">440000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_89f3566a-90cb-45dc-abfd-8b52a6514a23"
      unitRef="U_USD">466000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_4c068946-1542-4abc-820f-6931f3bbb639"
      unitRef="U_USD">2609000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_d1152f34-8d74-431c-8643-a6d8465337a7"
      unitRef="U_USD">752000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_62402ec0-c8eb-49b5-8353-7a68d8a4c5ef"
      unitRef="U_USD">163000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_7820cb3d-2b1d-4339-a95c-3d8d511045da"
      unitRef="U_USD">-25998000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_27ffc23a-4547-4a74-8c91-152177ed4ca9"
      unitRef="U_USD">3880000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_bbe124b6-5e26-4340-9b7f-2ec3e167c7a7"
      decimals="-3"
      id="F_2b03abd7-f5c7-43c7-a8ef-8bb43f770bda"
      unitRef="U_USD">29878000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_efecd9c4-6d3c-4f95-af4d-4540a5d7ad35"
      unitRef="U_USD">4043000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_63f96fd7-134a-4a1e-818f-acb8417bfb07"
      unitRef="U_USD">3880000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_cab533bd-a1a6-4815-aeca-3b813d99f9ec"
      unitRef="U_USD">28000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_ddfb13e5-4bfd-45e7-9f19-a5b3cb92e38f"
      unitRef="U_USD">55000</us-gaap:InterestPaidNet>
    <sera:IssuanceOfStockToSettleAccruedAndOtherCurrentLiabilities
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_b05d05b0-2c0d-4a1c-8297-874da6b01d27"
      unitRef="U_USD">406000</sera:IssuanceOfStockToSettleAccruedAndOtherCurrentLiabilities>
    <sera:IssuanceOfStockToSettleAccruedAndOtherCurrentLiabilities
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_c3b349db-7135-4e0e-ba3f-da18caa5b204"
      unitRef="U_USD">0</sera:IssuanceOfStockToSettleAccruedAndOtherCurrentLiabilities>
    <sera:PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_eae7a8c9-cd72-42fe-92c6-3ff10e1bdddf"
      unitRef="U_USD">0</sera:PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities>
    <sera:PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_bfade963-d2c6-4b83-8408-ba96ae34023e"
      unitRef="U_USD">20000</sera:PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_e54bf638-8466-4714-9b2a-0227f410ee4b">&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. Description of Business and Financial Condition&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Sera Prognostics, Inc. (the &#x201c;Company&#x201d;) is a women&#x2019;s health company utilizing its proprietary proteomics and bioinformatics platform, and significant data resources, to improve maternal and neonatal health by discovering, developing and commercializing blood-based biomarker tests and predictive analytic products and services. Our vision is to deliver pivotal and actionable information to pregnant women, their physicians, and health care payers to significantly enhance a mother's pregnancy journey, improve maternal and neonatal health, and reduce health care costs. We believe that our method of combining the disciplines of proteomics and bioinformatics with rigorous clinical testing, data, and economic analysis enables us to provide physicians and expectant mothers with personally insightful, clinically meaningful, and economically impactful information designed to improve the pregnancy experience and outcomes for mothers and babies.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company was incorporated in the State of Delaware on January 17, 2008 and its operations are located in Salt Lake City, Utah, including a Clinical Laboratory Improvement Amendments, or CLIA, certified laboratory. Since its inception, the Company&#x2019;s activities have consisted of performing research and development, conducting clinical studies for its pipeline products and services, acquiring product rights, raising capital, establishing facilities, and organizing commercial operations to market the PreTRM test.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Liquidity and Capital Resources&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has incurred net losses and negative cash flows from operations since inception and had an accumulated deficit of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;279.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; as of December 31, 2024. The Company&#x2019;s management expects the Company to incur significant additional operating losses and negative cash flows for the foreseeable future, principally as a result of the Company&#x2019;s activities relating to the PreTRM test and the Company&#x2019;s other pipeline products and services, including clinical and preclinical trials and anticipated research and development activities as well as commercialization activities. There can be no assurance that the Company will eventually achieve significant revenues or profitability to sustain operations, or if achieved, can sustain either on a continuing basis. If the Company is unable to achieve significant revenues or raise additional funds, when needed, it may not be able to continue the development or commercialization of its products and services and could be required to delay, scale back, or abandon some or all of its operations. No assurance can be given that the Company will be successful in raising the required capital on reasonable terms and at the required times, or at all.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In August 2024, the Company filed a universal shelf registration on Form S-3 with the U.S. Securities and Exchange Commission (the &#x201c;SEC&#x201d;), which was declared effective on August 13, 2024 (the &#x201c;2024 Form S-3&#x201d;), pursuant to which the Company registered for sale up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of any combination of Class A common stock, par value $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share ("Class A common stock"), preferred stock, debt securities, warrants, rights and/or units from time to time and at prices and on terms that the Company may determine.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In August 2024, the Company entered into a sales agreement with TD Securities (USA) LLC (&#x201c;TD Cowen&#x201d;) with respect to an at-the-market offering program under which the Company may offer and sell, from time to time at the Company&#x2019;s sole discretion, shares of Class A common stock having an aggregate offering price of up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million (the &#x201c;2024 Sales Agreement&#x201d;). As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company has &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;t sold any shares of Class A common stock under the 2024 Sales Agreement.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Any additional equity financing, if available to the Company, may not be available on favorable terms and may be dilutive to current stockholders, and any debt financing, if available, may involve restrictive covenants and dilutive financing instruments. The Company&#x2019;s future operations are highly dependent on a combination of factors, including (i) the commercialization and market acceptance of the PreTRM test and the successful development, commercial launch, marketing, and distribution of other pipeline products and services; (ii) the success of scientific and clinical studies and other research and development programs that support current and future products and services; (iii) the development of competitive products by other biotechnology and laboratory companies; (iv) the Company&#x2019;s ability to manage growth of the organization; (v) the Company&#x2019;s ability to protect its intellectual property, technology, and products; and, ultimately (vi) the timely and successful completion of any additional financing.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The principal sources of the Company&#x2019;s working capital to date have been the proceeds from the sale and issuance of convertible preferred stock and convertible notes, bank loans, and the sale and issuance of Class A common stock in an initial public offering (&#x201c;IPO&#x201d;), which was completed in July 2021. As of December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company had aggregate cash, cash equivalents, and available-for-sale securities of approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;68.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. See Note 3&#x2014;Cash, Cash Equivalents and Marketable Securities.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company evaluated that its existing financial resources are sufficient to continue operating activities at least 12 months from the issuance date of these financial statements.&lt;/span&gt;&lt;/p&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-5"
      id="F_238c4f53-cb95-458f-945e-52e8c56979c4"
      unitRef="U_USD">-279800000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <sera:AmountFromSaleOfCombinationOfSecuritiesUnderShelfRegistration
      contextRef="C_b7b69a92-c42e-4043-8b6b-6e1b509663d8"
      decimals="-5"
      id="F_33baed85-f99e-440f-8620-f148fed17765"
      unitRef="U_USD">100000000</sera:AmountFromSaleOfCombinationOfSecuritiesUnderShelfRegistration>
    <us-gaap:CommonStockNoParValue
      contextRef="C_84137556-2fb3-4bc3-987b-4443923c3d54"
      decimals="INF"
      id="F_c26c443a-186c-4992-a40a-2e40796a2650"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:CommonStockNoParValue>
    <sera:AggregateOfferingPriceFromSaleOfCommonStock
      contextRef="C_b020dd07-c5cb-461b-9677-a054282faf68"
      decimals="-5"
      id="F_1f282820-7a4d-4b90-a819-c67688a17872"
      unitRef="U_USD">50000000</sera:AggregateOfferingPriceFromSaleOfCommonStock>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_d8ac3adc-d2c5-4821-b662-56b9921fc31c"
      decimals="INF"
      id="F_d9e13839-2ce7-482b-a931-597509e5c105"
      unitRef="U_shares">0</us-gaap:CommonStockSharesIssued>
    <sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-5"
      id="F_102d4b24-21fe-467b-b48c-300749838e69"
      unitRef="U_USD">68200000</sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_0607dae5-555c-4cad-9229-0c8f57e84399">&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. Significant Accounting Policies&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Basis of Presentation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;). Any reference in these notes to applicable accounting guidance is meant to refer to the authoritative U.S. GAAP included in the Accounting Standards Codification (&#x201c;ASC&#x201d;), and Accounting Standards Updates (&#x201c;ASU&#x201d;) issued by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;).&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Use of Estimates&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The preparation of the financial statements in conformity with U.S. GAAP requires the Company&#x2019;s management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The Company evaluates these estimates on an ongoing basis. The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that the Company believes are reasonable under the circumstances, including assumptions as to future events. Actual results could differ materially from those estimates.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s financial statements as of and for the year ended December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; reflect the Company&#x2019;s estimates of the impact of the current macroeconomic environment, including the impact of inflation and higher interest rates. The extent to which these conditions will directly or indirectly impact the Company&#x2019;s business, results of operations, and financial condition is uncertain. The Company is not aware of any specific event or circumstance that would require an update to its estimates, judgments, and assumptions or a revision of the carrying value of the Company&#x2019;s assets or liabilities as of the date of this filing.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company considers all highly liquid financial instruments with maturities of 90 days or less at the date of purchase to be cash equivalents. The carrying amounts reported in the balance sheets for cash and cash equivalents are valued at cost, which approximates their fair value. As of December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, cash and cash equivalents consisted of cash and money market funds. Cash and cash equivalents are stated at fair value.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Marketable Securities&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has classified its marketable securities, all of which are debt securities, as available-for-sale securities. These securities are carried at estimated fair value. Available-for-sale debt securities with an estimated fair value below the amortized cost basis are assessed to determine what amount of that difference, if any, is attributable to expected credit losses. An allowance for credit losses on available-for-sale debt securities is recognized as a charge in other income, net on the Company&#x2019;s statements of operations and comprehensive loss, and any remaining unrealized losses, net of the related tax effect, are included in accumulated other comprehensive loss in stockholders&#x2019; equity until realized. Gains and losses on marketable security transactions are reported on the specific-identification method.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;  &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Concentration of credit risk&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and marketable securities. The Company maintains bank deposits in accounts at federally insured financial institutions and these deposits may exceed federally insured limits. The Company is exposed to credit risk in the event of default by the financial institution holding its cash to the extent recorded in the balance sheet. The Company has not experienced any losses on its deposits of cash. The Company&#x2019;s cash equivalents consist of money market funds and investment grade commercial paper. Marketable securities consist of investments in U.S. government securities, U.S. federal&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;agency securities, investment grade commercial paper, and investment grade corporate securities. The Company&#x2019;s investment portfolio in corporate debt securities is highly liquid and diversified among individual issuers. The Company did not experience any credit losses related to its investment portfolio for the years ended December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Property and Equipment&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Property and equipment are recorded at cost less accumulated depreciation and amortization. Depreciation and amortization are computed using the straight-line method over the shorter of estimated useful lives of the assets or the respective lease term.&lt;/span&gt;&lt;span style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; The estimated useful life of each asset category is as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;table style="border-spacing:0;table-layout:auto;width:98.0%;border-collapse:separate;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:50.46%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:49.54%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"&gt;&lt;p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Computer equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"&gt;&lt;p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"&gt;&lt;p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Software&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"&gt;&lt;p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"&gt;&lt;p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Machinery and equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"&gt;&lt;p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"&gt;&lt;p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Furniture and fixtures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"&gt;&lt;p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"&gt;&lt;p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"&gt;&lt;p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Shorter of useful life or remaining lease term&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Amortization expense of assets acquired through finance leases is included in depreciation and amortization expense in the accompanying statements of operations and comprehensive loss. Costs of repairs and maintenance that do not extend the useful life or improve the related assets are expensed as incurred. Costs of major replacements or improvements are capitalized. When assets are sold, or otherwise disposed of, the cost and related accumulated depreciation are removed from the accounts and any gain or loss is included in operating expense.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Leases&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s operating lease relates to office and laboratory space at its headquarters. The Company&#x2019;s finance leases are for certain equipment related to the Company&#x2019;s information technology infrastructure and laboratory operations. The Company determines if an arrangement is a lease at inception. The Company has elected not to separate lease components from non-lease components for all classes of leased assets except for building leases.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company elected to treat leases with lease terms of 12 months or less as short-term leases. No right-of-use assets or lease liabilities are recognized for short-term leases. For leases with a lease term greater than 12 months, right-of-use assets and lease liabilities are recognized on the balance sheets at the commencement date based on the present value of the remaining lease payments and includes only payments that are fixed and determinable at commencement. The Company&#x2019;s lease terms may include options to extend or terminate when it is reasonably certain that the Company will exercise such options.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;To date, the rates implicit in the Company&#x2019;s finance leases have been determinable, and the Company uses those rates to calculate the present value of its finance lease liabilities. The implicit rate in the Company&#x2019;s operating lease is not readily determinable. As such, the Company uses its incremental borrowing rate to calculate the present value of its operating lease liabilities.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Operating lease costs are recognized on a straight-line basis over the lease terms. Finance lease assets are amortized on a straight-line basis over the shorter of the estimated useful lives of the assets or the lease terms.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Deferred Revenue&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company recognizes deferred revenue in accordance with ASC 606, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; (&#x201c;ASC 606&#x201d;). Deferred revenue is recognized when a customer pays consideration, or the Company has a right to an amount of consideration that is unconditional before the Company transfers the good or service to the customer. The Company&#x2019;s deferred revenue balance as of December 31, 2024 and 2023 relates to certain contractual minimum payments received by the Company as part of its commercial collaboration agreements. Deferred revenue is recognized as revenue when the Company delivers PreTRM test results to customers pursuant to its commercial collaboration agreements. The Company assesses its deferred revenue balance for current versus long-term classification based on expectations and the ability to meet performance obligations. As of December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company believes it has the ability and capacity to meet all performance obligations under its commercial collaboration agreements and has concluded to classify its deferred revenue as a current asset.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;  &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Revenue Recognition&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Revenue is generated from the sale of PreTRM tests. The Company recognizes revenue based on accounting standards applied to determine the measurement of revenue and timing of when it is recognized. The Company applies the following five-step approach as set forth under ASC 606: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the Company satisfies a performance obligation. The Company applies the five-step model when it is probable that the Company will collect the consideration it is entitled to in exchange for fulfilling its performance obligation. The Company recognizes revenue upon delivery of test results, which it considers to be the only performance obligation, and allocates all of the transaction price to this performance obligation.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In determining the transaction price, which is an estimate of the amount of variable consideration expected to be received, the Company uses the expected value method under ASC 606. The Company considers all reasonably available information to identify various possible consideration amounts and considers the probability of the variable consideration for each scenario. The Company&#x2019;s estimate of transaction price does not include any estimated amount of variable consideration that is constrained.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Significant judgments are required in determining the estimates for each transaction. These estimates include many assumptions, any of which, if incorrect, could result in significant differences between the estimated price and the amount ultimately collected for any given transaction. The Company applies this method consistently to portfolios of similar contracts when estimating the effect of any uncertainty on the amount of variable consideration to which it will be entitled. In the aggregate, across the numerous transactions within each portfolio, these differences can lead to material variances between estimated and actual revenue in any given period.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The estimate of revenue is necessarily founded on assumptions of payer behavior such as changes in payer mix, payer collections, current customer contractual requirements, and experience with ultimate collection from third-party payers and patients. Each of these aspects of payer behavior (and various others) can change significantly from period to period, and the Company currently has limited experience with historical payment patterns. Each of these contributes to the potential variability between estimated transaction price and actual consideration received as discussed above, which is expected to be more pronounced early in the process of commercializing a diagnostic test.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company makes its best efforts to continually refine its estimates of expected consideration as the Company gains additional experience with collections and historical payment patterns. Accordingly, the Company may update its estimate of the amount of revenue to be recognized for previously delivered tests.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Cost of Revenue&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Cost of revenue reflects the aggregate costs incurred in delivering the proteomic testing results to clinicians and includes expenses for third-party specimen collection and shipping costs, as well as the Company&#x2019;s lab personnel, materials and supplies, equipment and infrastructure expenses associated with clinical testing, and allocated overhead including rent and equipment depreciation. Costs associated with performing the Company&#x2019;s tests are recorded as the tests are processed regardless of whether and when revenue is recognized with respect to such tests.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Research and Development Expenses&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company expenses all research and development costs as they are incurred. Research and development expenses consist primarily of personnel costs, stock-based compensation charges, clinical trial costs, and third-party contracted services associated with research and development. The Company recognizes expense associated with third-party contracted services based on the completion of activities as specified in the applicable contracts. Costs incurred under contracts with clinical sites are generally accrued as patient encounters occur, consistent with the terms outlined in the associated contract. Upon termination of contracts with third parties, the Company&#x2019;s obligations are limited to costs incurred or committed to date. As a result, accrued research and development expenses represent the estimated contractual liability to third parties at the reported period.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Stock-based Compensation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company recognizes stock-based compensation for all stock-based awards in accordance with ASC 718, C&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;ompensation-Stock Compensation&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, which requires an entity to measure the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The fair value of restricted stock units granted under the Company&#x2019;s equity incentive plans is measured based on the grant-date fair value of the Company&#x2019;s Class A common stock.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The fair value of stock options granted under the Company&#x2019;s equity incentive plans is estimated using the Black-Scholes option pricing model. Input assumptions used in calculating the fair value of stock options represent management&#x2019;s estimates and involve inherent uncertainties and the application of management&#x2019;s judgment. These input assumptions include the expected term of the awards, the expected common stock price volatility over the term of the awards, risk-free interest rates, and the expected dividend yield.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The fair value of the Company&#x2019;s Class A common stock is determined by using the closing price per share of the Company&#x2019;s Class A common stock as reported on Nasdaq. The Company uses the simplified calculation of expected life since the Company does not have sufficient historical exercise data to estimate the expected term. Volatility is based on an average of the historical volatility of the Company&#x2019;s common stock and the volatilities of the common stock of select comparable publicly-traded entities with characteristics similar to those of the Company. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods corresponding with the expected life of the option. Forfeitures are estimated at the time of grant based on the Company&#x2019;s historical experience and are adjusted as necessary.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The fair value of equity awards is recognized as compensation cost on a straight-line basis by the Company over the participant&#x2019;s requisite service period, which is the award&#x2019;s vesting period. All stock-based compensation costs are classified in the statements of operations and comprehensive loss based upon the underlying participant&#x2019;s role within the Company.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Income Taxes&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company recognizes deferred tax assets to the extent that it believes these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If the Company determines that it would be able to realize its deferred tax assets in the future in excess of their net recorded amount, the Company would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company records uncertain tax positions in accordance with ASC 740 on the basis of a two-step process whereby (1) it determines whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, it recognizes the largest amount of tax benefit that is more than 50 percent likely to be realized upon ultimate settlement with the related tax authority.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company recognizes interest and penalties related to unrecognized tax benefits within the income tax expense line in the accompanying statements of operations and comprehensive loss. Any accrued interest and penalties related to uncertain tax positions will be reflected as a liability in the balance sheets.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Retirement Savings Plan&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company sponsors a safe harbor 401(k) plan that covers all of the Company&#x2019;s eligible employees. The plan allows employees to make contributions up to a specified percentage of their compensation, subject to statutory limitations. The Company makes safe harbor matching contributions equal to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the first &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of a plan participant&#x2019;s eligible compensation, plus &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the next &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of a plan participant&#x2019;s eligible compensation. The Company may also make an additional discretionary match or profit sharing contribution to the plan. The Company recorded expense related to its 401(k) plan of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; for the years ended December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Segments&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company operates as &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;one&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; operating segment, which is developing and commercializing its medical diagnostic products and services. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s Chief Operating Decision Maker ("CODM"), its &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_78f058f5-e77e-4f42-8f14-9e5f77a00420;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;chief executive officer&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, assesses performance for the Company&#x2019;s one operating segment and allocates resources based on net loss, consistent with what is reported on the statements of operations and comprehensive loss. The CODM also assesses the performance of the Company&#x2019;s one operating segment by using operating expenses to monitor budget versus actual results.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Improvements to Reportable Segments Disclosures&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, which updates reportable segment disclosure requirements primarily through enhanced disclosures about significant segment expenses. While ASU 2023-07 requires incremental disclosures, it does not change how an entity identifies its operating segments, aggregates those operating segments, or applies the quantitative thresholds to determine reportable segments. This ASU is effective for all public business entities for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Entities must adopt the changes to the segment reporting guidance on a retrospective basis. The Company &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;adopted&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; this standard effective &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;January 1, 2024&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and retrospectively to all prior periods. The adoption impacted the Company's disclosures and did &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;not&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; impact the financial statements. See Note &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;16 &#x2014; Segment Information&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, for disclosures related to the Company&#x2019;s single operating segment.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Comprehensive Loss&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Comprehensive loss consists of net loss and other gains and losses affecting stockholders&#x2019; equity that, under U.S. GAAP, are excluded from net loss. For the years ended December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, comprehensive loss includes unrealized gains (losses) on the Company&#x2019;s available-for-sale debt securities.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Net Loss per Share&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Basic net loss per share is calculated by dividing net loss by the weighted-average number of shares of common stock outstanding for the period, without consideration of potentially dilutive securities. Diluted net loss per share is computed by dividing net loss by the weighted-average number of shares of common stock and potentially dilutive securities outstanding for the period. For purposes of the diluted net loss per share calculation, stock options and warrants to purchase common stock are considered to be potentially dilutive securities. For periods in which the Company reports a net loss, all potentially dilutive shares are anti-dilutive and are therefore excluded from the calculation of diluted net loss per share.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has two classes of common stock and calculates net loss per share using the two-class method. The rights, including the liquidation and dividend rights, of the holders of the Company&#x2019;s Class A and Class B common stock are identical, except with respect to voting and conversion. The undistributed earnings for each period are allocated based on the contractual participation rights of the Class A and Class B common shares as if the earnings for the period had been distributed. As the liquidation and dividend rights are identical, the undistributed earnings are allocated on a proportionate basis and the resulting amount per share for Class A and Class B common stock was the same for the years ended December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;  &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Recently Issued Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In December 2023, the FASB issued ASU 2023-09, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Income Taxes (Topic 740): Improvements to Income Tax Disclosures&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, which is intended to improve the transparency of income tax disclosures by requiring consistent categories and greater disaggregation of information in the effective tax rate reconciliation and income taxes paid by jurisdiction. The ASU is effective for public business entities&#x2019; annual periods beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of adopting this guidance on its financial statements.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In November 2024, the FASB issued Accounting Standards Update No. 2024-03, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (ASC Subtopic 220-40) - Disaggregation of Income Statement Expenses&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, which enhances the transparency and comparability of financial statements by requiring companies to disclose more granular information about expense components. The guidance is effective for annual periods beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the potential impact of adopting this new guidance on its financials statements and related disclosures.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Emerging Growth Company Status&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company is an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012 (the &#x201c;JOBS Act&#x201d;). Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards until such time as those standards apply to private companies. The Company has elected to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date that it is (a) no longer an emerging growth company or (b) affirmatively and irrevocably opt out of the extended transition period provided in the JOBS Act. As a result, these financial statements may not be comparable to companies that comply with the new or revised accounting pronouncements as of public company effective dates.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_ce810c1f-34b9-44ac-8c3a-752fca0e983f">&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Basis of Presentation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;). Any reference in these notes to applicable accounting guidance is meant to refer to the authoritative U.S. GAAP included in the Accounting Standards Codification (&#x201c;ASC&#x201d;), and Accounting Standards Updates (&#x201c;ASU&#x201d;) issued by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;).&lt;/span&gt;&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_a9a7491e-8746-46da-b958-20050144dc15">&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Use of Estimates&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The preparation of the financial statements in conformity with U.S. GAAP requires the Company&#x2019;s management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The Company evaluates these estimates on an ongoing basis. The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that the Company believes are reasonable under the circumstances, including assumptions as to future events. Actual results could differ materially from those estimates.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s financial statements as of and for the year ended December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; reflect the Company&#x2019;s estimates of the impact of the current macroeconomic environment, including the impact of inflation and higher interest rates. The extent to which these conditions will directly or indirectly impact the Company&#x2019;s business, results of operations, and financial condition is uncertain. The Company is not aware of any specific event or circumstance that would require an update to its estimates, judgments, and assumptions or a revision of the carrying value of the Company&#x2019;s assets or liabilities as of the date of this filing.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_e8f711d9-be45-453b-8334-72327f1c1360">&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company considers all highly liquid financial instruments with maturities of 90 days or less at the date of purchase to be cash equivalents. The carrying amounts reported in the balance sheets for cash and cash equivalents are valued at cost, which approximates their fair value. As of December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, cash and cash equivalents consisted of cash and money market funds. Cash and cash equivalents are stated at fair value.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:MarketableSecuritiesPolicy
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_e3a62bdc-8122-4be1-a8c2-58cb4228111d">&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Marketable Securities&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has classified its marketable securities, all of which are debt securities, as available-for-sale securities. These securities are carried at estimated fair value. Available-for-sale debt securities with an estimated fair value below the amortized cost basis are assessed to determine what amount of that difference, if any, is attributable to expected credit losses. An allowance for credit losses on available-for-sale debt securities is recognized as a charge in other income, net on the Company&#x2019;s statements of operations and comprehensive loss, and any remaining unrealized losses, net of the related tax effect, are included in accumulated other comprehensive loss in stockholders&#x2019; equity until realized. Gains and losses on marketable security transactions are reported on the specific-identification method.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;  &lt;/span&gt;&lt;/p&gt;</us-gaap:MarketableSecuritiesPolicy>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_96ee8c78-670f-41dc-aac5-4535e45a4267">&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Concentration of credit risk&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and marketable securities. The Company maintains bank deposits in accounts at federally insured financial institutions and these deposits may exceed federally insured limits. The Company is exposed to credit risk in the event of default by the financial institution holding its cash to the extent recorded in the balance sheet. The Company has not experienced any losses on its deposits of cash. The Company&#x2019;s cash equivalents consist of money market funds and investment grade commercial paper. Marketable securities consist of investments in U.S. government securities, U.S. federal&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;agency securities, investment grade commercial paper, and investment grade corporate securities. The Company&#x2019;s investment portfolio in corporate debt securities is highly liquid and diversified among individual issuers. The Company did not experience any credit losses related to its investment portfolio for the years ended December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_20b98139-53a4-4a3a-959c-15d6049539cd">&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Property and Equipment&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Property and equipment are recorded at cost less accumulated depreciation and amortization. Depreciation and amortization are computed using the straight-line method over the shorter of estimated useful lives of the assets or the respective lease term.&lt;/span&gt;&lt;span style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; The estimated useful life of each asset category is as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;table style="border-spacing:0;table-layout:auto;width:98.0%;border-collapse:separate;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:50.46%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:49.54%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"&gt;&lt;p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Computer equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"&gt;&lt;p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"&gt;&lt;p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Software&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"&gt;&lt;p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"&gt;&lt;p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Machinery and equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"&gt;&lt;p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"&gt;&lt;p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Furniture and fixtures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"&gt;&lt;p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"&gt;&lt;p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"&gt;&lt;p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Shorter of useful life or remaining lease term&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Amortization expense of assets acquired through finance leases is included in depreciation and amortization expense in the accompanying statements of operations and comprehensive loss. Costs of repairs and maintenance that do not extend the useful life or improve the related assets are expensed as incurred. Costs of major replacements or improvements are capitalized. When assets are sold, or otherwise disposed of, the cost and related accumulated depreciation are removed from the accounts and any gain or loss is included in operating expense.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <sera:ScheduleOfEstimatedUsefulLifeOfEachAssetCategoryTableTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_254e9cb3-a7ff-45f7-86e0-cabd2cd16956">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; The estimated useful life of each asset category is as follows:&lt;/span&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;table style="border-spacing:0;table-layout:auto;width:98.0%;border-collapse:separate;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:50.46%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:49.54%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"&gt;&lt;p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Computer equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"&gt;&lt;p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"&gt;&lt;p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Software&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"&gt;&lt;p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"&gt;&lt;p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Machinery and equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"&gt;&lt;p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"&gt;&lt;p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Furniture and fixtures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"&gt;&lt;p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"&gt;&lt;p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"&gt;&lt;p style="font-size:10pt;margin-top:3.25pt;font-family:Times New Roman;margin-bottom:1pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Shorter of useful life or remaining lease term&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;</sera:ScheduleOfEstimatedUsefulLifeOfEachAssetCategoryTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_a3f22057-cfb4-4d74-a910-d271c95221d1"
      id="F_91972586-101b-427b-8ec9-cc58fd01a955">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_1d2ae6de-1a53-435d-93ea-e493cb1853b9"
      id="F_9cd086db-1a1b-4a24-b3a7-27ab41cb2a81">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_1928429d-8377-45e6-a6ab-694d0e5a190a"
      id="F_3ecdae4f-beae-4b85-a40a-a039654dc0d0">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_caa15026-25b9-4c02-9ea0-d4206fb85094"
      id="F_f8d60565-c7da-4fdc-876f-284207ab8d23">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_c69935b8-25c5-4c36-ad5b-ca1bc86c5e0e">&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Leases&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s operating lease relates to office and laboratory space at its headquarters. The Company&#x2019;s finance leases are for certain equipment related to the Company&#x2019;s information technology infrastructure and laboratory operations. The Company determines if an arrangement is a lease at inception. The Company has elected not to separate lease components from non-lease components for all classes of leased assets except for building leases.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company elected to treat leases with lease terms of 12 months or less as short-term leases. No right-of-use assets or lease liabilities are recognized for short-term leases. For leases with a lease term greater than 12 months, right-of-use assets and lease liabilities are recognized on the balance sheets at the commencement date based on the present value of the remaining lease payments and includes only payments that are fixed and determinable at commencement. The Company&#x2019;s lease terms may include options to extend or terminate when it is reasonably certain that the Company will exercise such options.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;To date, the rates implicit in the Company&#x2019;s finance leases have been determinable, and the Company uses those rates to calculate the present value of its finance lease liabilities. The implicit rate in the Company&#x2019;s operating lease is not readily determinable. As such, the Company uses its incremental borrowing rate to calculate the present value of its operating lease liabilities.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Operating lease costs are recognized on a straight-line basis over the lease terms. Finance lease assets are amortized on a straight-line basis over the shorter of the estimated useful lives of the assets or the lease terms.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:RevenueRecognitionDeferredRevenue
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_f890e758-3a52-41c3-977e-3aeb1197206c">&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Deferred Revenue&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company recognizes deferred revenue in accordance with ASC 606, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; (&#x201c;ASC 606&#x201d;). Deferred revenue is recognized when a customer pays consideration, or the Company has a right to an amount of consideration that is unconditional before the Company transfers the good or service to the customer. The Company&#x2019;s deferred revenue balance as of December 31, 2024 and 2023 relates to certain contractual minimum payments received by the Company as part of its commercial collaboration agreements. Deferred revenue is recognized as revenue when the Company delivers PreTRM test results to customers pursuant to its commercial collaboration agreements. The Company assesses its deferred revenue balance for current versus long-term classification based on expectations and the ability to meet performance obligations. As of December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company believes it has the ability and capacity to meet all performance obligations under its commercial collaboration agreements and has concluded to classify its deferred revenue as a current asset.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;  &lt;/span&gt;&lt;/p&gt;</us-gaap:RevenueRecognitionDeferredRevenue>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_7ff3e80f-7f9e-4ae3-9774-e918f18a2060">&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Revenue Recognition&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Revenue is generated from the sale of PreTRM tests. The Company recognizes revenue based on accounting standards applied to determine the measurement of revenue and timing of when it is recognized. The Company applies the following five-step approach as set forth under ASC 606: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the Company satisfies a performance obligation. The Company applies the five-step model when it is probable that the Company will collect the consideration it is entitled to in exchange for fulfilling its performance obligation. The Company recognizes revenue upon delivery of test results, which it considers to be the only performance obligation, and allocates all of the transaction price to this performance obligation.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In determining the transaction price, which is an estimate of the amount of variable consideration expected to be received, the Company uses the expected value method under ASC 606. The Company considers all reasonably available information to identify various possible consideration amounts and considers the probability of the variable consideration for each scenario. The Company&#x2019;s estimate of transaction price does not include any estimated amount of variable consideration that is constrained.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Significant judgments are required in determining the estimates for each transaction. These estimates include many assumptions, any of which, if incorrect, could result in significant differences between the estimated price and the amount ultimately collected for any given transaction. The Company applies this method consistently to portfolios of similar contracts when estimating the effect of any uncertainty on the amount of variable consideration to which it will be entitled. In the aggregate, across the numerous transactions within each portfolio, these differences can lead to material variances between estimated and actual revenue in any given period.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The estimate of revenue is necessarily founded on assumptions of payer behavior such as changes in payer mix, payer collections, current customer contractual requirements, and experience with ultimate collection from third-party payers and patients. Each of these aspects of payer behavior (and various others) can change significantly from period to period, and the Company currently has limited experience with historical payment patterns. Each of these contributes to the potential variability between estimated transaction price and actual consideration received as discussed above, which is expected to be more pronounced early in the process of commercializing a diagnostic test.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company makes its best efforts to continually refine its estimates of expected consideration as the Company gains additional experience with collections and historical payment patterns. Accordingly, the Company may update its estimate of the amount of revenue to be recognized for previously delivered tests.&lt;/span&gt;&lt;/p&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:CostOfSalesPolicyTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_3be424e5-9461-4aed-b449-321da219f0e0">&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Cost of Revenue&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Cost of revenue reflects the aggregate costs incurred in delivering the proteomic testing results to clinicians and includes expenses for third-party specimen collection and shipping costs, as well as the Company&#x2019;s lab personnel, materials and supplies, equipment and infrastructure expenses associated with clinical testing, and allocated overhead including rent and equipment depreciation. Costs associated with performing the Company&#x2019;s tests are recorded as the tests are processed regardless of whether and when revenue is recognized with respect to such tests.&lt;/span&gt;&lt;/p&gt;</us-gaap:CostOfSalesPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_2465e8d8-ce74-4892-bfb5-3f402e64a90b">&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Research and Development Expenses&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company expenses all research and development costs as they are incurred. Research and development expenses consist primarily of personnel costs, stock-based compensation charges, clinical trial costs, and third-party contracted services associated with research and development. The Company recognizes expense associated with third-party contracted services based on the completion of activities as specified in the applicable contracts. Costs incurred under contracts with clinical sites are generally accrued as patient encounters occur, consistent with the terms outlined in the associated contract. Upon termination of contracts with third parties, the Company&#x2019;s obligations are limited to costs incurred or committed to date. As a result, accrued research and development expenses represent the estimated contractual liability to third parties at the reported period.&lt;/span&gt;&lt;/p&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_1a3b37dd-ffad-454f-acbe-710791a911de">&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Stock-based Compensation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company recognizes stock-based compensation for all stock-based awards in accordance with ASC 718, C&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;ompensation-Stock Compensation&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, which requires an entity to measure the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The fair value of restricted stock units granted under the Company&#x2019;s equity incentive plans is measured based on the grant-date fair value of the Company&#x2019;s Class A common stock.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The fair value of stock options granted under the Company&#x2019;s equity incentive plans is estimated using the Black-Scholes option pricing model. Input assumptions used in calculating the fair value of stock options represent management&#x2019;s estimates and involve inherent uncertainties and the application of management&#x2019;s judgment. These input assumptions include the expected term of the awards, the expected common stock price volatility over the term of the awards, risk-free interest rates, and the expected dividend yield.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The fair value of the Company&#x2019;s Class A common stock is determined by using the closing price per share of the Company&#x2019;s Class A common stock as reported on Nasdaq. The Company uses the simplified calculation of expected life since the Company does not have sufficient historical exercise data to estimate the expected term. Volatility is based on an average of the historical volatility of the Company&#x2019;s common stock and the volatilities of the common stock of select comparable publicly-traded entities with characteristics similar to those of the Company. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods corresponding with the expected life of the option. Forfeitures are estimated at the time of grant based on the Company&#x2019;s historical experience and are adjusted as necessary.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The fair value of equity awards is recognized as compensation cost on a straight-line basis by the Company over the participant&#x2019;s requisite service period, which is the award&#x2019;s vesting period. All stock-based compensation costs are classified in the statements of operations and comprehensive loss based upon the underlying participant&#x2019;s role within the Company.&lt;/span&gt;&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_73e16ad1-f981-4dfa-9c44-cdc7f59b4ddd">&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Income Taxes&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company recognizes deferred tax assets to the extent that it believes these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If the Company determines that it would be able to realize its deferred tax assets in the future in excess of their net recorded amount, the Company would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company records uncertain tax positions in accordance with ASC 740 on the basis of a two-step process whereby (1) it determines whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, it recognizes the largest amount of tax benefit that is more than 50 percent likely to be realized upon ultimate settlement with the related tax authority.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company recognizes interest and penalties related to unrecognized tax benefits within the income tax expense line in the accompanying statements of operations and comprehensive loss. Any accrued interest and penalties related to uncertain tax positions will be reflected as a liability in the balance sheets.&lt;/span&gt;&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:PostemploymentBenefitPlansPolicy
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_e4727564-7c9b-4577-a5bf-093899fbce7e">&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Retirement Savings Plan&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company sponsors a safe harbor 401(k) plan that covers all of the Company&#x2019;s eligible employees. The plan allows employees to make contributions up to a specified percentage of their compensation, subject to statutory limitations. The Company makes safe harbor matching contributions equal to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the first &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of a plan participant&#x2019;s eligible compensation, plus &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the next &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of a plan participant&#x2019;s eligible compensation. The Company may also make an additional discretionary match or profit sharing contribution to the plan. The Company recorded expense related to its 401(k) plan of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; for the years ended December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:PostemploymentBenefitPlansPolicy>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
      contextRef="C_4066f0e7-4d45-4120-9721-5f25ca3c40f2"
      decimals="2"
      id="F_badefe53-69a1-4d6e-80e6-2e338a25d342"
      unitRef="U_pure">1</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent
      contextRef="C_4066f0e7-4d45-4120-9721-5f25ca3c40f2"
      decimals="2"
      id="F_c7752def-10ff-43e0-ab4b-21551246b678"
      unitRef="U_pure">0.03</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
      contextRef="C_958742c3-77d5-4074-ba9f-54937420e759"
      decimals="2"
      id="F_28fcc7c3-9355-4f9d-b396-6cdbf55ab342"
      unitRef="U_pure">0.50</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent
      contextRef="C_958742c3-77d5-4074-ba9f-54937420e759"
      decimals="2"
      id="F_8e730684-7c1a-4585-b361-61e8c6a15bb8"
      unitRef="U_pure">0.02</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-5"
      id="F_dbcc892b-c993-4c0b-bba7-d84ff9d15fb6"
      unitRef="U_USD">400000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-5"
      id="F_17beaaa8-e201-43ab-b2df-c0a179ca5b8f"
      unitRef="U_USD">600000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_36bca3f1-fe25-4c4e-af02-b92f545f912e">&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Segments&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company operates as &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;one&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; operating segment, which is developing and commercializing its medical diagnostic products and services. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s Chief Operating Decision Maker ("CODM"), its &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_78f058f5-e77e-4f42-8f14-9e5f77a00420;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;chief executive officer&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, assesses performance for the Company&#x2019;s one operating segment and allocates resources based on net loss, consistent with what is reported on the statements of operations and comprehensive loss. The CODM also assesses the performance of the Company&#x2019;s one operating segment by using operating expenses to monitor budget versus actual results.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Improvements to Reportable Segments Disclosures&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, which updates reportable segment disclosure requirements primarily through enhanced disclosures about significant segment expenses. While ASU 2023-07 requires incremental disclosures, it does not change how an entity identifies its operating segments, aggregates those operating segments, or applies the quantitative thresholds to determine reportable segments. This ASU is effective for all public business entities for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Entities must adopt the changes to the segment reporting guidance on a retrospective basis. The Company &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;adopted&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; this standard effective &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;January 1, 2024&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and retrospectively to all prior periods. The adoption impacted the Company's disclosures and did &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;not&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; impact the financial statements. See Note &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;16 &#x2014; Segment Information&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, for disclosures related to the Company&#x2019;s single operating segment.&lt;/span&gt;&lt;/p&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="INF"
      id="F_0c67911e-f28e-48fc-a367-682e4073a2ec"
      unitRef="U_Segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_e33153f7-b723-4e6a-826b-d750e993fbec">The Company&#x2019;s Chief Operating Decision Maker ("CODM"), its chief executive officer, assesses performance for the Company&#x2019;s one operating segment and allocates resources based on net loss, consistent with what is reported on the statements of operations and comprehensive loss. The CODM also assesses the performance of the Company&#x2019;s one operating segment by using operating expenses to monitor budget versus actual results.</us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription>
    <us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted
      contextRef="C_20e6caf7-a789-4725-a954-593c6c8d5ceb"
      id="F_e2c5baab-3b70-4e09-8168-ac1e34971330">true</us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted>
    <us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate
      contextRef="C_20e6caf7-a789-4725-a954-593c6c8d5ceb"
      id="F_1ff67354-b7bb-4252-a647-cecd6451cc60">2024-01-01</us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate>
    <us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect
      contextRef="C_20e6caf7-a789-4725-a954-593c6c8d5ceb"
      id="F_ea0a1cd2-1cb8-4ca4-a62a-873c66ceb10b">true</us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_1f55bf83-e39a-424c-af1b-6f4ba72644e4">&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Comprehensive Loss&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Comprehensive loss consists of net loss and other gains and losses affecting stockholders&#x2019; equity that, under U.S. GAAP, are excluded from net loss. For the years ended December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, comprehensive loss includes unrealized gains (losses) on the Company&#x2019;s available-for-sale debt securities.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_2ec1ec6b-4335-4a28-b0c4-f69fa878d5a2">&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Net Loss per Share&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Basic net loss per share is calculated by dividing net loss by the weighted-average number of shares of common stock outstanding for the period, without consideration of potentially dilutive securities. Diluted net loss per share is computed by dividing net loss by the weighted-average number of shares of common stock and potentially dilutive securities outstanding for the period. For purposes of the diluted net loss per share calculation, stock options and warrants to purchase common stock are considered to be potentially dilutive securities. For periods in which the Company reports a net loss, all potentially dilutive shares are anti-dilutive and are therefore excluded from the calculation of diluted net loss per share.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has two classes of common stock and calculates net loss per share using the two-class method. The rights, including the liquidation and dividend rights, of the holders of the Company&#x2019;s Class A and Class B common stock are identical, except with respect to voting and conversion. The undistributed earnings for each period are allocated based on the contractual participation rights of the Class A and Class B common shares as if the earnings for the period had been distributed. As the liquidation and dividend rights are identical, the undistributed earnings are allocated on a proportionate basis and the resulting amount per share for Class A and Class B common stock was the same for the years ended December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;  &lt;/span&gt;&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_fb42a72c-bd34-47a7-8f2e-0e0d0a4c343f">&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Recently Issued Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In December 2023, the FASB issued ASU 2023-09, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Income Taxes (Topic 740): Improvements to Income Tax Disclosures&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, which is intended to improve the transparency of income tax disclosures by requiring consistent categories and greater disaggregation of information in the effective tax rate reconciliation and income taxes paid by jurisdiction. The ASU is effective for public business entities&#x2019; annual periods beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of adopting this guidance on its financial statements.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In November 2024, the FASB issued Accounting Standards Update No. 2024-03, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (ASC Subtopic 220-40) - Disaggregation of Income Statement Expenses&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, which enhances the transparency and comparability of financial statements by requiring companies to disclose more granular information about expense components. The guidance is effective for annual periods beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the potential impact of adopting this new guidance on its financials statements and related disclosures.&lt;/span&gt;&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <sera:EmergingGrowthCompanyStatusPolicyTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_844f33c9-20da-4a27-8815-97830643e9e0">&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Emerging Growth Company Status&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company is an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012 (the &#x201c;JOBS Act&#x201d;). Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards until such time as those standards apply to private companies. The Company has elected to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date that it is (a) no longer an emerging growth company or (b) affirmatively and irrevocably opt out of the extended transition period provided in the JOBS Act. As a result, these financial statements may not be comparable to companies that comply with the new or revised accounting pronouncements as of public company effective dates.&lt;/span&gt;&lt;/p&gt;</sera:EmergingGrowthCompanyStatusPolicyTextBlock>
    <us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_d160e401-0b6c-4619-9740-13ef1e424934">&lt;p id="section34" style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Cash, Cash Equivalents and Marketable Securities&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has classified its marketable securities as available-for-sale. The Company&#x2019;s cash, cash equivalents and marketable securities by major security type as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 were as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:42.137%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.421%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.044%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.421%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.044%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.421%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.044%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.421%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.044%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amortized Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Gross Unrealized Gains&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash and cash equivalents:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,983&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,983&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,060&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,060&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total cash and cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,043&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,043&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Current marketable securities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,449&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,446&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Corporate debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;26,701&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;84&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2013;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;26,785&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. federal agency securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,453&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,459&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,502&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2013;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,503&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total current marketable securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;42,105&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;93&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;42,193&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Long-term marketable securities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Corporate debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16,066&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;36&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16,097&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Municipal debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,072&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,072&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. federal agency securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,863&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;59&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,804&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total long-term marketable securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22,001&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;36&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;64&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21,973&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total cash, cash equivalents and marketable&lt;br/&gt;&#160;&#160;&#160;securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;68,149&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;129&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;69&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;68,209&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:42.137%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.421%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.044%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.421%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.044%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.421%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.044%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.421%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.044%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amortized Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Gross Unrealized Gains&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash and cash equivalents:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,608&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,608&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,272&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,272&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total cash and cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,880&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,880&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Current marketable securities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,769&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,773&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Corporate debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,155&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,153&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. federal agency securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19,644&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;102&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19,542&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,812&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;81&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,731&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total current marketable securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;45,380&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;187&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;45,199&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Long-term marketable securities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. federal agency securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,406&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,416&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,388&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,386&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Corporate debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16,880&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;159&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,039&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total long-term marketable securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30,674&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;189&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30,841&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total cash, cash equivalents and marketable&lt;br/&gt;&#160;&#160;&#160;securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;79,934&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;195&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;209&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;79,920&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following tables summarize the Company&#x2019;s available-for-sale debt securities and cash equivalents with unrealized losses as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023, aggregated by major security type and the length of time that individual securities have been in a continuous loss position (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:32.066%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.08%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:7.942%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.08%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:7.942%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.08%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:7.942%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.08%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:7.942%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.08%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:8.842%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.08%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:8.842%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="22" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Less than 12 months&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;12 months or greater&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrealized Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrealized Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrealized Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,446&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,446&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Corporate debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,059&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,059&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. federal agency securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,804&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;59&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,825&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;61&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,309&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;67&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,330&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;69&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:32.066%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.08%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:7.942%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.08%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:7.942%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.08%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:7.942%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.08%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:7.942%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.08%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:8.842%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.08%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:8.842%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="22" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Less than 12 months&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;12 months or greater&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrealized Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrealized Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrealized Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,453&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,453&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Corporate debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,153&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,153&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. federal agency securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,308&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;52&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,751&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;67&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,059&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;119&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,769&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,895&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;73&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,664&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;86&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;26,683&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;69&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19,646&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;140&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46,329&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;209&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company had &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;t recorded any allowance for credit losses related to its available-for-sale securities. The Company attributes the declines in the fair value of its available-for-sale securities to normal market and interest rate fluctuations. The declines in fair value are not attributed to declines in credit quality. The Company does not intend to sell investments while they are in an unrealized loss position and does not believe that it is more likely than not that the Company will be required to sell the investments before recovery of their amortized cost basis, which may be maturity. All of the Company&#x2019;s investments mature in less than three years.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the year ended December 31, 2024, the Company received approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in proceeds from the sale of available-for-sale securities prior to maturity. There was an immaterial amount of gross realized losses on the sales. The Company sold the securities in order to reinvest the funds at improved rates. The Company did not sell any available-for-sale securities prior to maturity during the year ended December 31, 2023.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s marketable securities classified by contractual maturities as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 were as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:59.272%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:16.363%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:16.363%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amortized Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Due within one year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;42,105&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;42,193&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Due after one year through five years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22,001&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21,973&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;64,106&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;64,166&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock>
    <us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_241f92cb-721f-4214-a9b8-7c504967d84e">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has classified its marketable securities as available-for-sale. The Company&#x2019;s cash, cash equivalents and marketable securities by major security type as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 were as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:42.137%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.421%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.044%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.421%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.044%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.421%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.044%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.421%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.044%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amortized Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Gross Unrealized Gains&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash and cash equivalents:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,983&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,983&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,060&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,060&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total cash and cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,043&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,043&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Current marketable securities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,449&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,446&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Corporate debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;26,701&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;84&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2013;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;26,785&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. federal agency securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,453&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,459&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,502&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2013;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,503&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total current marketable securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;42,105&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;93&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;42,193&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Long-term marketable securities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Corporate debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16,066&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;36&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16,097&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Municipal debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,072&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,072&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. federal agency securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,863&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;59&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,804&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total long-term marketable securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22,001&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;36&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;64&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21,973&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total cash, cash equivalents and marketable&lt;br/&gt;&#160;&#160;&#160;securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;68,149&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;129&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;69&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;68,209&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:42.137%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.421%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.044%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.421%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.044%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.421%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.044%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.421%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.044%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amortized Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Gross Unrealized Gains&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash and cash equivalents:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,608&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,608&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,272&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,272&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total cash and cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,880&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,880&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Current marketable securities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,769&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,773&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Corporate debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,155&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,153&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. federal agency securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19,644&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;102&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19,542&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,812&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;81&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,731&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total current marketable securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;45,380&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;187&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;45,199&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Long-term marketable securities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. federal agency securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,406&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,416&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,388&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,386&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Corporate debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16,880&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;159&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,039&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total long-term marketable securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30,674&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;189&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30,841&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total cash, cash equivalents and marketable&lt;br/&gt;&#160;&#160;&#160;securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;79,934&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;195&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;209&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;79,920&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock>
    <sera:CashAndCashEquivalentsAmortizedCost
      contextRef="C_49022522-db49-4ec2-87f5-e2146f11c06f"
      decimals="-3"
      id="F_2c871f5d-1b39-4c1c-bc08-866da0188941"
      unitRef="U_USD">1983000</sera:CashAndCashEquivalentsAmortizedCost>
    <sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_49022522-db49-4ec2-87f5-e2146f11c06f"
      decimals="-3"
      id="F_d88a84a6-0b80-411c-abde-362e50d32a5e"
      unitRef="U_USD">0</sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax>
    <sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_49022522-db49-4ec2-87f5-e2146f11c06f"
      decimals="-3"
      id="F_cc2d59dc-35d5-4d8e-bf24-24836c8d5362"
      unitRef="U_USD">0</sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_49022522-db49-4ec2-87f5-e2146f11c06f"
      decimals="-3"
      id="F_b84c9bf7-f7a1-4ad7-9b9c-ea8c44b5276c"
      unitRef="U_USD">1983000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <sera:CashAndCashEquivalentsAmortizedCost
      contextRef="C_c35d80b0-e824-4576-b648-1c68918bb474"
      decimals="-3"
      id="F_dbe93419-2450-499e-9c9f-9640f83bea49"
      unitRef="U_USD">2060000</sera:CashAndCashEquivalentsAmortizedCost>
    <sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_c35d80b0-e824-4576-b648-1c68918bb474"
      decimals="-3"
      id="F_f1825818-c20c-4394-afdf-bee6ff72d604"
      unitRef="U_USD">0</sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax>
    <sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_c35d80b0-e824-4576-b648-1c68918bb474"
      decimals="-3"
      id="F_ad0fbb6e-144d-49fc-9b18-65b06192a84b"
      unitRef="U_USD">0</sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_c35d80b0-e824-4576-b648-1c68918bb474"
      decimals="-3"
      id="F_121ce6d6-5567-4495-996d-0d4203229be8"
      unitRef="U_USD">2060000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <sera:CashAndCashEquivalentsAmortizedCost
      contextRef="C_5c263358-4220-4048-b609-a9b779332d4c"
      decimals="-3"
      id="F_b3afbc89-f145-4601-bd1f-eb7883c06a5e"
      unitRef="U_USD">4043000</sera:CashAndCashEquivalentsAmortizedCost>
    <sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_5c263358-4220-4048-b609-a9b779332d4c"
      decimals="-3"
      id="F_7ac21e18-6003-4bda-9d49-0e546def8223"
      unitRef="U_USD">0</sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax>
    <sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_5c263358-4220-4048-b609-a9b779332d4c"
      decimals="-3"
      id="F_f946eaf5-bc96-4fd4-a35a-b5ec392c3ff0"
      unitRef="U_USD">0</sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_5c263358-4220-4048-b609-a9b779332d4c"
      decimals="-3"
      id="F_1e5564ab-8ffb-46d7-95d4-c75ee774d4c5"
      unitRef="U_USD">4043000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_41343767-6b2c-42a9-a746-3a9c961b2efb"
      decimals="-3"
      id="F_85f6a0c9-add3-4763-adb0-4c3419247a25"
      unitRef="U_USD">1449000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_41343767-6b2c-42a9-a746-3a9c961b2efb"
      decimals="-3"
      id="F_b3468057-9ce7-433c-9b0a-50ac46fd9057"
      unitRef="U_USD">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_41343767-6b2c-42a9-a746-3a9c961b2efb"
      decimals="-3"
      id="F_c7d8c7f4-b50d-44ea-85ec-8e66a96ad046"
      unitRef="U_USD">3000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_41343767-6b2c-42a9-a746-3a9c961b2efb"
      decimals="-3"
      id="F_30c04b6f-ac77-424c-8912-b857e406f0cc"
      unitRef="U_USD">1446000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_02e513ef-eb63-431b-a54e-7db176d6f3b0"
      decimals="-3"
      id="F_069fd1b7-05bc-4cd6-bbf2-3424fcc80371"
      unitRef="U_USD">26701000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_02e513ef-eb63-431b-a54e-7db176d6f3b0"
      decimals="-3"
      id="F_7e8ef983-95bc-492f-93a0-209448ff0624"
      unitRef="U_USD">84000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_02e513ef-eb63-431b-a54e-7db176d6f3b0"
      decimals="-3"
      id="F_5b3b7028-816f-4e06-ab04-a74f03834a62"
      unitRef="U_USD">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_02e513ef-eb63-431b-a54e-7db176d6f3b0"
      decimals="-3"
      id="F_d9814207-1af4-4b61-838f-2353c7796ebe"
      unitRef="U_USD">26785000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_05252941-47eb-419d-ad91-9a0440a3d146"
      decimals="-3"
      id="F_9f92ba4c-41d7-4c75-8e9e-1bf0df6ddc5d"
      unitRef="U_USD">9453000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_05252941-47eb-419d-ad91-9a0440a3d146"
      decimals="-3"
      id="F_146e8f4c-a1b7-4933-b0a3-108de4abe69d"
      unitRef="U_USD">8000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_05252941-47eb-419d-ad91-9a0440a3d146"
      decimals="-3"
      id="F_aea680b9-fb5d-4735-91fa-94d9a50cdbd6"
      unitRef="U_USD">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_05252941-47eb-419d-ad91-9a0440a3d146"
      decimals="-3"
      id="F_12f30ed0-956c-4b3a-9fe2-328a2668d8a8"
      unitRef="U_USD">9459000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_ca338088-ae30-4c78-a94a-8fc204241aa6"
      decimals="-3"
      id="F_539f14c9-517d-4c38-baca-d8319807f9bc"
      unitRef="U_USD">4502000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_ca338088-ae30-4c78-a94a-8fc204241aa6"
      decimals="-3"
      id="F_6dc08813-b3a1-456a-a67a-8c48e2f8dd28"
      unitRef="U_USD">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_ca338088-ae30-4c78-a94a-8fc204241aa6"
      decimals="-3"
      id="F_951e5c88-0b3d-4c40-be15-1dc76e792901"
      unitRef="U_USD">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_ca338088-ae30-4c78-a94a-8fc204241aa6"
      decimals="-3"
      id="F_ece2c848-dee5-4317-9102-cc7ac10990ca"
      unitRef="U_USD">4503000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_8dc4e1a7-bd95-4cb8-aa85-12c3382baabd"
      decimals="-3"
      id="F_677a27dc-d822-4ef9-9792-993a00594a16"
      unitRef="U_USD">42105000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_8dc4e1a7-bd95-4cb8-aa85-12c3382baabd"
      decimals="-3"
      id="F_28526a02-9d91-4d0a-85c4-b8eabd99cd5f"
      unitRef="U_USD">93000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_8dc4e1a7-bd95-4cb8-aa85-12c3382baabd"
      decimals="-3"
      id="F_b28bdf65-970a-4780-a201-bf40618b8c38"
      unitRef="U_USD">5000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_8dc4e1a7-bd95-4cb8-aa85-12c3382baabd"
      decimals="-3"
      id="F_6998ec1d-09a7-4614-84d1-f75c75618fda"
      unitRef="U_USD">42193000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_e8115fc4-0d0a-4b48-968a-84b5f89677cc"
      decimals="-3"
      id="F_1fc0b05d-1366-444b-baad-7b97957da409"
      unitRef="U_USD">16066000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_e8115fc4-0d0a-4b48-968a-84b5f89677cc"
      decimals="-3"
      id="F_c75893b3-b1ec-47ad-885e-060abc031a82"
      unitRef="U_USD">36000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_e8115fc4-0d0a-4b48-968a-84b5f89677cc"
      decimals="-3"
      id="F_8a4f74e6-a447-47bb-969e-1e18ca7c4d07"
      unitRef="U_USD">5000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_e8115fc4-0d0a-4b48-968a-84b5f89677cc"
      decimals="-3"
      id="F_8e4cd624-548a-4619-b883-860124993489"
      unitRef="U_USD">16097000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_a1e8075a-0b21-49e0-992e-366ff149e4be"
      decimals="-3"
      id="F_8a4b2158-8667-4163-b5c2-8fb148785a9f"
      unitRef="U_USD">3072000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_a1e8075a-0b21-49e0-992e-366ff149e4be"
      decimals="-3"
      id="F_37aa2a2c-f945-4767-8e6c-71d726f6ecdf"
      unitRef="U_USD">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_a1e8075a-0b21-49e0-992e-366ff149e4be"
      decimals="-3"
      id="F_bfb3abf5-e965-4f7b-bea8-a4defb26298e"
      unitRef="U_USD">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_a1e8075a-0b21-49e0-992e-366ff149e4be"
      decimals="-3"
      id="F_7057f39a-30cd-4a98-8c2c-68aaef94f08b"
      unitRef="U_USD">3072000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_6926825c-e381-4fc0-8ca5-c547d26c00af"
      decimals="-3"
      id="F_f463734f-2bf0-4b9c-b1e7-28df48473949"
      unitRef="U_USD">2863000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_6926825c-e381-4fc0-8ca5-c547d26c00af"
      decimals="-3"
      id="F_54f30270-290e-466f-8fef-1e0e5e66c55f"
      unitRef="U_USD">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_6926825c-e381-4fc0-8ca5-c547d26c00af"
      decimals="-3"
      id="F_ef70ee04-5646-459b-984a-b85ebdfc7f5d"
      unitRef="U_USD">59000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_6926825c-e381-4fc0-8ca5-c547d26c00af"
      decimals="-3"
      id="F_95a76028-f8bc-4ff0-9e57-1b25bc7e3496"
      unitRef="U_USD">2804000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_fff4f4f8-fdc0-4e2f-8c2d-857db712f284"
      decimals="-3"
      id="F_cdccc645-1aba-4f2a-8ff7-c3a9f3f22588"
      unitRef="U_USD">22001000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_fff4f4f8-fdc0-4e2f-8c2d-857db712f284"
      decimals="-3"
      id="F_b6fa5e25-0f4d-4225-8358-e4bcd4ee1fc8"
      unitRef="U_USD">36000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_fff4f4f8-fdc0-4e2f-8c2d-857db712f284"
      decimals="-3"
      id="F_008d310b-fb73-4b3e-93aa-706e38a99e7b"
      unitRef="U_USD">64000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_fff4f4f8-fdc0-4e2f-8c2d-857db712f284"
      decimals="-3"
      id="F_c74fe402-7a76-41b3-92e5-e9a6d0395a8d"
      unitRef="U_USD">21973000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_6a6b3b35-4bc5-4240-8409-1eb40ee8f82f"
      unitRef="U_USD">68149000</sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost>
    <sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_b4d75e41-d704-4f4b-957e-42d5bad77da8"
      unitRef="U_USD">129000</sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax>
    <sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_24f52198-c615-4d2b-841d-e283583a2d66"
      unitRef="U_USD">69000</sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax>
    <sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_bd46c95c-3f48-4dff-9d04-3dca7e46c789"
      unitRef="U_USD">68209000</sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue>
    <sera:CashAndCashEquivalentsAmortizedCost
      contextRef="C_81d045e5-217b-44a8-91f1-c06381b7f02f"
      decimals="-3"
      id="F_e5261b47-4b56-43e9-8339-5de01ac2ce95"
      unitRef="U_USD">2608000</sera:CashAndCashEquivalentsAmortizedCost>
    <sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_81d045e5-217b-44a8-91f1-c06381b7f02f"
      decimals="-3"
      id="F_7f42fc4c-a9dc-4a58-8c51-d7c7d9d76a4c"
      unitRef="U_USD">0</sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax>
    <sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_81d045e5-217b-44a8-91f1-c06381b7f02f"
      decimals="-3"
      id="F_e4027ac1-693b-4054-9f0d-dee427b8302e"
      unitRef="U_USD">0</sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_81d045e5-217b-44a8-91f1-c06381b7f02f"
      decimals="-3"
      id="F_ece325bf-5766-410a-b652-2c17b3dd6a46"
      unitRef="U_USD">2608000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <sera:CashAndCashEquivalentsAmortizedCost
      contextRef="C_eac6e522-39b5-4d4e-9e0f-de03dd6c55f5"
      decimals="-3"
      id="F_c748b3a9-ba23-4dcf-89a1-40afa5ece5f3"
      unitRef="U_USD">1272000</sera:CashAndCashEquivalentsAmortizedCost>
    <sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_eac6e522-39b5-4d4e-9e0f-de03dd6c55f5"
      decimals="-3"
      id="F_d5e1285c-5e83-4afe-a742-2c83e974e712"
      unitRef="U_USD">0</sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax>
    <sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_eac6e522-39b5-4d4e-9e0f-de03dd6c55f5"
      decimals="-3"
      id="F_cdd7e54b-3fef-4e35-b268-58f8aeef9b00"
      unitRef="U_USD">0</sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_eac6e522-39b5-4d4e-9e0f-de03dd6c55f5"
      decimals="-3"
      id="F_831e7286-b777-4355-be29-589b5c400c33"
      unitRef="U_USD">1272000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <sera:CashAndCashEquivalentsAmortizedCost
      contextRef="C_04695d1b-8064-4772-b23e-9ee08052db28"
      decimals="-3"
      id="F_1658bdb0-9c5b-483c-823c-9ca06fe235a0"
      unitRef="U_USD">3880000</sera:CashAndCashEquivalentsAmortizedCost>
    <sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_04695d1b-8064-4772-b23e-9ee08052db28"
      decimals="-3"
      id="F_5af1f620-287d-41ce-a396-671e3fc2dd5d"
      unitRef="U_USD">0</sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax>
    <sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_04695d1b-8064-4772-b23e-9ee08052db28"
      decimals="-3"
      id="F_ea0e1c89-275c-4e68-ae5c-506d8620eb96"
      unitRef="U_USD">0</sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_04695d1b-8064-4772-b23e-9ee08052db28"
      decimals="-3"
      id="F_d6567c61-fe53-4002-9f10-7d7e9a5b50b3"
      unitRef="U_USD">3880000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_4c8e016f-98b6-437d-bf3b-2afd8d1a2252"
      decimals="-3"
      id="F_bdbc613f-efa3-4b85-b024-80da6d89fa01"
      unitRef="U_USD">11769000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_4c8e016f-98b6-437d-bf3b-2afd8d1a2252"
      decimals="-3"
      id="F_a0112ae7-1e27-4a00-a0e0-65b8a0e52ec9"
      unitRef="U_USD">6000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_4c8e016f-98b6-437d-bf3b-2afd8d1a2252"
      decimals="-3"
      id="F_e6101819-8e37-41b2-8edf-72257d22c23d"
      unitRef="U_USD">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_4c8e016f-98b6-437d-bf3b-2afd8d1a2252"
      decimals="-3"
      id="F_5bbfdbae-700e-4e85-8076-b44fa5de3b3d"
      unitRef="U_USD">11773000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_e5d8bf32-01c3-478c-ac80-62dc4611786f"
      decimals="-3"
      id="F_0e892835-6362-40dc-a54a-05cdf93cb585"
      unitRef="U_USD">1155000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_e5d8bf32-01c3-478c-ac80-62dc4611786f"
      decimals="-3"
      id="F_a1e5fb90-41e3-4f3e-b96c-a08acf13f396"
      unitRef="U_USD">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_e5d8bf32-01c3-478c-ac80-62dc4611786f"
      decimals="-3"
      id="F_8c69c182-84c4-4461-87d8-d5e3f1763445"
      unitRef="U_USD">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_e5d8bf32-01c3-478c-ac80-62dc4611786f"
      decimals="-3"
      id="F_3b309d10-b010-409d-afbf-6585edd592f8"
      unitRef="U_USD">1153000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_638a878b-120b-4eee-b75c-90162633cf80"
      decimals="-3"
      id="F_ee0e1dd2-07dc-44eb-ab32-4823813e6174"
      unitRef="U_USD">19644000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_638a878b-120b-4eee-b75c-90162633cf80"
      decimals="-3"
      id="F_ee8680b3-7497-4a5e-bc72-ac81fe83a316"
      unitRef="U_USD">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_638a878b-120b-4eee-b75c-90162633cf80"
      decimals="-3"
      id="F_ca0325c4-2b78-4dab-8dc5-db23e27f3893"
      unitRef="U_USD">102000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_638a878b-120b-4eee-b75c-90162633cf80"
      decimals="-3"
      id="F_40985960-dc67-4aa2-80ca-adcab8c3464b"
      unitRef="U_USD">19542000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_3b6bd3f1-4ef1-4f65-afbc-9caec8647ffa"
      decimals="-3"
      id="F_1240cce2-bd56-4677-9701-c5db5b2dc1a5"
      unitRef="U_USD">12812000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_3b6bd3f1-4ef1-4f65-afbc-9caec8647ffa"
      decimals="-3"
      id="F_24b83c2c-dbc0-4096-b960-bb4f449dd495"
      unitRef="U_USD">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_3b6bd3f1-4ef1-4f65-afbc-9caec8647ffa"
      decimals="-3"
      id="F_98f532aa-efc4-47f5-beac-e532d25ee3c9"
      unitRef="U_USD">81000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_3b6bd3f1-4ef1-4f65-afbc-9caec8647ffa"
      decimals="-3"
      id="F_f7defe03-437f-402c-a21e-c4fb3f10b33e"
      unitRef="U_USD">12731000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_5daf51f1-d84a-4a9b-8b05-31cbd8535172"
      decimals="-3"
      id="F_1af20f05-1068-438f-8fa3-3aab96f294f7"
      unitRef="U_USD">45380000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_5daf51f1-d84a-4a9b-8b05-31cbd8535172"
      decimals="-3"
      id="F_774328b2-baf4-4d44-a34c-a6f2077cf86b"
      unitRef="U_USD">6000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_5daf51f1-d84a-4a9b-8b05-31cbd8535172"
      decimals="-3"
      id="F_24ac2beb-9a45-44ed-98e0-d202bebc898d"
      unitRef="U_USD">187000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_5daf51f1-d84a-4a9b-8b05-31cbd8535172"
      decimals="-3"
      id="F_18bec175-4249-4e4b-ba41-4d029b8a37e4"
      unitRef="U_USD">45199000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_ee684bec-2a33-4dd4-bdbb-02595b796850"
      decimals="-3"
      id="F_208d75fc-75f2-42fb-87a4-a7dfba1fc9ec"
      unitRef="U_USD">9406000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_ee684bec-2a33-4dd4-bdbb-02595b796850"
      decimals="-3"
      id="F_daefa73b-6633-4860-ae40-ed105b2fbbcf"
      unitRef="U_USD">27000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_ee684bec-2a33-4dd4-bdbb-02595b796850"
      decimals="-3"
      id="F_d23f2d5b-77a7-4c80-ae17-626c2c44c02e"
      unitRef="U_USD">17000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_ee684bec-2a33-4dd4-bdbb-02595b796850"
      decimals="-3"
      id="F_11ab0326-2841-4d3e-86ae-da185a4c9d9b"
      unitRef="U_USD">9416000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_762a6bec-dfb1-4943-9527-797ae4764d93"
      decimals="-3"
      id="F_44ff14a0-f06d-4fed-aa83-36116c53308d"
      unitRef="U_USD">4388000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_762a6bec-dfb1-4943-9527-797ae4764d93"
      decimals="-3"
      id="F_330747e3-3a10-4162-85dc-d425724df438"
      unitRef="U_USD">3000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_762a6bec-dfb1-4943-9527-797ae4764d93"
      decimals="-3"
      id="F_d2d0e44b-22d3-4bd4-ab4d-b531bfac9e7d"
      unitRef="U_USD">5000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_762a6bec-dfb1-4943-9527-797ae4764d93"
      decimals="-3"
      id="F_f774c012-dd50-4125-87b0-8e047d502780"
      unitRef="U_USD">4386000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_b105c69c-9306-46d2-b61c-acf709b3eb96"
      decimals="-3"
      id="F_0e4ae9cd-5245-4b0f-8a17-d1490c582d38"
      unitRef="U_USD">16880000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_b105c69c-9306-46d2-b61c-acf709b3eb96"
      decimals="-3"
      id="F_4abdcd6e-5a6a-4e11-a1e6-8216b1ca1bad"
      unitRef="U_USD">159000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_b105c69c-9306-46d2-b61c-acf709b3eb96"
      decimals="-3"
      id="F_eb3d1ce7-06ca-4d46-a144-bfee67a8fd94"
      unitRef="U_USD">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_b105c69c-9306-46d2-b61c-acf709b3eb96"
      decimals="-3"
      id="F_54ecdae0-a17c-46b5-89c8-3124da89d568"
      unitRef="U_USD">17039000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_5e807c43-ac3c-4c9f-8c9f-aa73f1509b36"
      decimals="-3"
      id="F_4161107a-2bea-46a7-ad4e-290483809ebc"
      unitRef="U_USD">30674000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_5e807c43-ac3c-4c9f-8c9f-aa73f1509b36"
      decimals="-3"
      id="F_7343d866-0cac-4830-874f-d12c7cb96a04"
      unitRef="U_USD">189000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_5e807c43-ac3c-4c9f-8c9f-aa73f1509b36"
      decimals="-3"
      id="F_087a37d6-75c5-4f8f-bd60-52f07fd471f7"
      unitRef="U_USD">22000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_5e807c43-ac3c-4c9f-8c9f-aa73f1509b36"
      decimals="-3"
      id="F_5d66a186-07d4-4639-986e-15bb52caf848"
      unitRef="U_USD">30841000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_2b004d85-66b3-4d3a-b73c-991c5023e72f"
      unitRef="U_USD">79934000</sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost>
    <sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_3c798ead-af9b-41a6-a9f2-575b4146735d"
      unitRef="U_USD">195000</sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax>
    <sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_bbe76a74-8778-461a-8db3-57debeb58237"
      unitRef="U_USD">209000</sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax>
    <sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_4ad91b02-3175-4c34-a2af-d3c1c7d63306"
      unitRef="U_USD">79920000</sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_dcc1bb86-7c01-44ca-bc69-e3461c3e0487">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following tables summarize the Company&#x2019;s available-for-sale debt securities and cash equivalents with unrealized losses as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023, aggregated by major security type and the length of time that individual securities have been in a continuous loss position (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:32.066%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.08%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:7.942%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.08%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:7.942%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.08%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:7.942%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.08%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:7.942%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.08%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:8.842%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.08%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:8.842%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="22" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Less than 12 months&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;12 months or greater&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrealized Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrealized Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrealized Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,446&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,446&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Corporate debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,059&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,059&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. federal agency securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,804&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;59&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,825&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;61&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,309&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;67&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,330&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;69&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:32.066%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.08%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:7.942%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.08%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:7.942%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.08%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:7.942%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.08%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:7.942%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.08%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:8.842%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.08%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:8.842%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="22" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Less than 12 months&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;12 months or greater&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrealized Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrealized Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrealized Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,453&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,453&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Corporate debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,153&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,153&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. federal agency securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,308&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;52&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,751&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;67&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,059&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;119&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,769&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,895&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;73&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,664&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;86&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;26,683&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;69&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19,646&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;140&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46,329&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;209&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="C_dac51163-3c66-43ba-8012-e6571ccfbd56"
      decimals="-3"
      id="F_03bfcef2-153a-4585-b371-bc67c3205937"
      unitRef="U_USD">1446000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="C_dac51163-3c66-43ba-8012-e6571ccfbd56"
      decimals="-3"
      id="F_2cb8743f-37af-4944-bec7-09610391e7e0"
      unitRef="U_USD">3000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="C_dac51163-3c66-43ba-8012-e6571ccfbd56"
      decimals="-3"
      id="F_61c6f6d7-d57b-460c-8fb6-b9c3d23a7b65"
      unitRef="U_USD">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="C_dac51163-3c66-43ba-8012-e6571ccfbd56"
      decimals="-3"
      id="F_713c142d-5ccd-49f9-bcaf-42c94e8eff42"
      unitRef="U_USD">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="C_dac51163-3c66-43ba-8012-e6571ccfbd56"
      decimals="-3"
      id="F_01f1a87e-3d32-49b1-bed3-2b9b7865b75b"
      unitRef="U_USD">1446000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="C_dac51163-3c66-43ba-8012-e6571ccfbd56"
      decimals="-3"
      id="F_4d878524-9e5e-4a92-a305-80ecdad017d4"
      unitRef="U_USD">3000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="C_ce3c3c85-8edf-485c-a7db-c348c7b6135c"
      decimals="-3"
      id="F_d2e98c8d-470e-4ca0-ae66-c2c46e32ab93"
      unitRef="U_USD">4059000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="C_ce3c3c85-8edf-485c-a7db-c348c7b6135c"
      decimals="-3"
      id="F_b2e1cb4f-3459-4f6a-93a3-87d28c7b38c5"
      unitRef="U_USD">5000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="C_ce3c3c85-8edf-485c-a7db-c348c7b6135c"
      decimals="-3"
      id="F_d1995b08-8fac-454a-a1ce-db01db2d7ae4"
      unitRef="U_USD">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="C_ce3c3c85-8edf-485c-a7db-c348c7b6135c"
      decimals="-3"
      id="F_a07ab0ef-3397-4a73-bdeb-275632da8ba2"
      unitRef="U_USD">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="C_ce3c3c85-8edf-485c-a7db-c348c7b6135c"
      decimals="-3"
      id="F_7f55accc-7ccc-432e-8eb4-58dcc0314917"
      unitRef="U_USD">4059000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="C_ce3c3c85-8edf-485c-a7db-c348c7b6135c"
      decimals="-3"
      id="F_f340e4bf-39f3-4397-a307-72c1e7805f05"
      unitRef="U_USD">5000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="C_8cc8bb60-d9e5-4087-a779-404d0c630ac2"
      decimals="-3"
      id="F_2f6f55e3-da08-4464-b89b-9a2778689ef6"
      unitRef="U_USD">2804000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="C_8cc8bb60-d9e5-4087-a779-404d0c630ac2"
      decimals="-3"
      id="F_43eda637-50a3-478a-9ae4-eaf21f51bebc"
      unitRef="U_USD">59000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="C_8cc8bb60-d9e5-4087-a779-404d0c630ac2"
      decimals="-3"
      id="F_01625950-58a7-4c2c-a87f-68226c43709b"
      unitRef="U_USD">3021000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="C_8cc8bb60-d9e5-4087-a779-404d0c630ac2"
      decimals="-3"
      id="F_27b70d0a-f3a2-408c-b13c-97382575c9a4"
      unitRef="U_USD">2000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="C_8cc8bb60-d9e5-4087-a779-404d0c630ac2"
      decimals="-3"
      id="F_99044edd-3f0e-44e3-94e8-b17233c356a9"
      unitRef="U_USD">5825000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="C_8cc8bb60-d9e5-4087-a779-404d0c630ac2"
      decimals="-3"
      id="F_0c854f46-40f5-4ff8-9069-f31214ceed18"
      unitRef="U_USD">61000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_833256b5-8de8-4e9c-9f90-cc5f78d406a7"
      unitRef="U_USD">8309000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_cdce33c3-cf9c-4f5e-ae29-fdd3c7d5f4dd"
      unitRef="U_USD">67000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_0bbbb1f9-adb3-4e1a-bc8c-5468c65bd92c"
      unitRef="U_USD">3021000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_4f4c5e55-d322-4004-8bed-15610d455d44"
      unitRef="U_USD">2000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_67457e53-65b9-4cbc-9648-21e59d1e6bf5"
      unitRef="U_USD">11330000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_1a85ddc9-b166-4c89-b398-23795368853a"
      unitRef="U_USD">69000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="C_aa504e3e-c144-468e-9c38-a006e10b950c"
      decimals="-3"
      id="F_c0634d7c-3207-4853-8940-1e7082e5b20f"
      unitRef="U_USD">5453000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="C_aa504e3e-c144-468e-9c38-a006e10b950c"
      decimals="-3"
      id="F_89691ebe-533a-4b2e-9821-342a0c3ba78b"
      unitRef="U_USD">2000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="C_aa504e3e-c144-468e-9c38-a006e10b950c"
      decimals="-3"
      id="F_0346c4f5-bac8-4ff3-9183-357108754bc2"
      unitRef="U_USD">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="C_aa504e3e-c144-468e-9c38-a006e10b950c"
      decimals="-3"
      id="F_82e0de90-b90d-4b99-bfe1-cd3f07a8c8bc"
      unitRef="U_USD">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="C_aa504e3e-c144-468e-9c38-a006e10b950c"
      decimals="-3"
      id="F_ce38ef35-ae0a-46af-bc87-082fe148debd"
      unitRef="U_USD">5453000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="C_aa504e3e-c144-468e-9c38-a006e10b950c"
      decimals="-3"
      id="F_309a3d00-02bd-4ffb-963c-92a899ce51a9"
      unitRef="U_USD">2000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="C_f2bfc23e-e300-4c03-89d2-d8604b93c026"
      decimals="-3"
      id="F_5d000c02-dcbe-4d25-a424-67e1a68d15e9"
      unitRef="U_USD">1153000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="C_f2bfc23e-e300-4c03-89d2-d8604b93c026"
      decimals="-3"
      id="F_26cad724-c05b-4519-80df-e0ddb6fb53da"
      unitRef="U_USD">2000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="C_f2bfc23e-e300-4c03-89d2-d8604b93c026"
      decimals="-3"
      id="F_7202e4d0-6594-4204-91c8-72e98136c1e1"
      unitRef="U_USD">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="C_f2bfc23e-e300-4c03-89d2-d8604b93c026"
      decimals="-3"
      id="F_7f1b2310-5a53-408c-baf4-ece592b60621"
      unitRef="U_USD">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="C_f2bfc23e-e300-4c03-89d2-d8604b93c026"
      decimals="-3"
      id="F_cc27b044-58ba-4506-9e18-08894f0769ed"
      unitRef="U_USD">1153000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="C_f2bfc23e-e300-4c03-89d2-d8604b93c026"
      decimals="-3"
      id="F_32576350-b5ff-4493-8e69-8b41619670f9"
      unitRef="U_USD">2000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="C_bd4804da-dfef-46a4-bf86-8a1aff8a5a72"
      decimals="-3"
      id="F_14e23381-d4ee-4b99-92df-939b84481cb8"
      unitRef="U_USD">15308000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="C_bd4804da-dfef-46a4-bf86-8a1aff8a5a72"
      decimals="-3"
      id="F_fd362439-370a-4527-8e6e-a38e18236b64"
      unitRef="U_USD">52000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="C_bd4804da-dfef-46a4-bf86-8a1aff8a5a72"
      decimals="-3"
      id="F_df1d3cc6-e32c-40da-b80f-92704b1c94a6"
      unitRef="U_USD">8751000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="C_bd4804da-dfef-46a4-bf86-8a1aff8a5a72"
      decimals="-3"
      id="F_58f74bab-c7c7-4b30-a795-f33706706669"
      unitRef="U_USD">67000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="C_bd4804da-dfef-46a4-bf86-8a1aff8a5a72"
      decimals="-3"
      id="F_9026de99-7cb5-42dc-8668-1da793ff2e01"
      unitRef="U_USD">24059000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="C_bd4804da-dfef-46a4-bf86-8a1aff8a5a72"
      decimals="-3"
      id="F_33eaec2c-700d-4e26-805d-7ab5b29b6bc0"
      unitRef="U_USD">119000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="C_a9e61099-b6f3-486b-b333-a0f9e6559dc9"
      decimals="-3"
      id="F_f0a191a3-ee99-4a7e-8413-408abbd92122"
      unitRef="U_USD">4769000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="C_a9e61099-b6f3-486b-b333-a0f9e6559dc9"
      decimals="-3"
      id="F_00dd7bcc-48ea-4f83-9b39-3ce7738d9c22"
      unitRef="U_USD">13000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="C_a9e61099-b6f3-486b-b333-a0f9e6559dc9"
      decimals="-3"
      id="F_e51da0f3-2ec9-45ba-a852-1dff9cd5aa49"
      unitRef="U_USD">10895000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="C_a9e61099-b6f3-486b-b333-a0f9e6559dc9"
      decimals="-3"
      id="F_27a43c71-7c53-4d7e-869a-c92fbf3a333b"
      unitRef="U_USD">73000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="C_a9e61099-b6f3-486b-b333-a0f9e6559dc9"
      decimals="-3"
      id="F_e665f067-a247-4a7a-ad1e-e0d8ff8a0510"
      unitRef="U_USD">15664000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="C_a9e61099-b6f3-486b-b333-a0f9e6559dc9"
      decimals="-3"
      id="F_7d0ed5b6-3f08-4b10-8a84-f2e3d1d74a8b"
      unitRef="U_USD">86000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_940d7c9d-e311-45b6-96e2-37db046abd48"
      unitRef="U_USD">26683000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_d1224de5-1615-4dcf-9bb4-4352268ce908"
      unitRef="U_USD">69000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_5b73c4cc-23bd-443d-af47-45d658b88662"
      unitRef="U_USD">19646000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_b32cb1fd-6bc1-4527-bac1-bbdfa64e01cc"
      unitRef="U_USD">140000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_afceaed0-6bc8-4050-87d8-fc33b3e88adc"
      unitRef="U_USD">46329000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_6d813749-c915-43f2-b5b7-19a084978f67"
      unitRef="U_USD">209000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="INF"
      id="F_8e4cbc6e-443c-432a-a4ab-73ae17bf046c"
      unitRef="U_USD">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="INF"
      id="F_f95be004-a9dc-4fb0-bd71-59e8e5d4e0f9"
      unitRef="U_USD">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-5"
      id="F_ae54dd3f-e161-42fd-a146-d30697903e0a"
      unitRef="U_USD">5000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_85c3f410-ccdf-4ab0-a1eb-3685e840b5b6">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s marketable securities classified by contractual maturities as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 were as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:59.272%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:16.363%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:16.363%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amortized Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Due within one year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;42,105&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;42,193&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Due after one year through five years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22,001&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21,973&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;64,106&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;64,166&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_0c06e295-11e1-4826-8d0a-2140ac30eb9d"
      unitRef="U_USD">42105000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_2d905c93-a580-432f-b00e-3b5b6717fd6c"
      unitRef="U_USD">42193000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_4c6ffbbb-f04c-422f-882b-eeb857dd0e98"
      unitRef="U_USD">22001000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_388de662-5845-4420-80ee-1e71d70bf206"
      unitRef="U_USD">21973000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_44cde81a-c5e6-4c58-add7-e72b9da8754c"
      unitRef="U_USD">64106000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_9ee47b8e-a573-43e1-b8e9-861e8de86fda"
      unitRef="U_USD">64166000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_1b4dd2e9-bdec-4314-97c3-b7c2254ebd1e">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. Property and Equipment&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table presents the components of property and equipment, net, as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:59.272%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:16.363%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:16.363%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Laboratory equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,663&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,734&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Computer equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,099&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,054&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;772&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;772&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Software&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,141&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,141&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Furniture and fixtures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;320&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;320&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total property and equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,995&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less accumulated depreciation and amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,756&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Property and equipment, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,239&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,999&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Depreciation and amortization expense was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; for the years ended December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively.&lt;/span&gt;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_decd56f5-12a7-4e86-996b-3f2f1ea44a93">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table presents the components of property and equipment, net, as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:59.272%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:16.363%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:16.363%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Laboratory equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,663&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,734&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Computer equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,099&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,054&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;772&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;772&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Software&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,141&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,141&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Furniture and fixtures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;320&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;320&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total property and equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,995&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less accumulated depreciation and amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,756&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Property and equipment, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,239&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,999&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="C_161991af-bae7-4347-80d9-c0890d8f55a6"
      decimals="-3"
      id="F_b18871dd-be3a-4b8b-9a70-0144aa11446a"
      unitRef="U_USD">5663000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="C_a1fba1e9-19c8-4131-8870-80ec56eace4a"
      decimals="-3"
      id="F_98b893b3-c934-44fa-9741-e6c8accb2f8c"
      unitRef="U_USD">5734000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="C_a3f22057-cfb4-4d74-a910-d271c95221d1"
      decimals="-3"
      id="F_74cf9fe9-bbfc-4028-a3b5-e0b96385c5d4"
      unitRef="U_USD">1099000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="C_275f65a9-d875-4114-9eef-facc7efca0e4"
      decimals="-3"
      id="F_3a3f42d1-6103-44cc-b1ad-df198d1317d4"
      unitRef="U_USD">1054000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="C_ba06682c-931b-4d72-8219-fe9762cb8c51"
      decimals="-3"
      id="F_723d7be0-90ff-4bf9-95c2-f38571fff9b1"
      unitRef="U_USD">772000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="C_1c9fd511-344f-4ec1-9e7e-971dfed29d81"
      decimals="-3"
      id="F_ce7f60b8-ee04-454f-9731-c42ed7052698"
      unitRef="U_USD">772000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="C_1d2ae6de-1a53-435d-93ea-e493cb1853b9"
      decimals="-3"
      id="F_d6e1b7ad-45d9-4f54-96bf-98f219ae775a"
      unitRef="U_USD">1141000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="C_428b350f-b950-4c70-b038-a16d2e148ef6"
      decimals="-3"
      id="F_7710a37d-2579-49d8-bc8e-9f55a90ba2ff"
      unitRef="U_USD">1141000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="C_caa15026-25b9-4c02-9ea0-d4206fb85094"
      decimals="-3"
      id="F_1d6bd3b9-d9a9-48a3-afaa-c7d476f9333c"
      unitRef="U_USD">320000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="C_9ec8a49d-6940-415c-bf39-e752664f6f55"
      decimals="-3"
      id="F_a18b3018-d0f6-414d-a079-648f222c92a9"
      unitRef="U_USD">320000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_054f640a-616b-48c6-a5df-d881c0d02a52"
      unitRef="U_USD">8995000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_085118e7-709e-4d6e-9ff1-e241fde70fc1"
      unitRef="U_USD">9021000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_236f9a05-c0ea-402f-bdc9-5d9c52f89d8d"
      unitRef="U_USD">7756000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_84522eba-72d2-4ce8-8cfe-5252df339494"
      unitRef="U_USD">7022000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_e6801eca-c150-411c-a312-e113af75b755"
      unitRef="U_USD">1239000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_7a6e81d0-caa4-4c37-b074-615390532083"
      unitRef="U_USD">1999000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-5"
      id="F_e73a754d-f596-4c4e-b86e-5463c57210b7"
      unitRef="U_USD">800000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-5"
      id="F_624fe7bc-cd71-4a58-993a-e9bf2e5aac57"
      unitRef="U_USD">900000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:IntangibleAssetsDisclosureTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_554a43e1-cf82-4ca5-80fd-ec11a9b94521">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;5. Intangible Assets, net&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table summarizes intangible assets (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:57.477%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.399%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:10.776%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.399%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:10.776%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.399%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:10.776%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Accumulated Amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Net Carrying Amount&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Indefinite-lived intangible assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Domain names&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;697&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;697&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Definite-lived intangible assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Software developed for sale&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;348&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;329&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total intangible assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,045&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the year ended December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company acquired domain names resulting in capitalized intangible assets of approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. The Company determined that the domain names have an indefinite useful life and are therefore not subject to amortization. The Company assesses its intangible assets for impairment annually, or more frequently if circumstances dictate. No indefinite-lived intangible asset impairment charges were recorded during the year ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the year ended December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company capitalized approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of costs associated with software developed for sale. The software was placed in service in November 2024 and is being amortized on a straight-line basis over a three-year useful life. Amortization expense was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; thousand for the year ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024, and is recorded in cost of revenue&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_777cf1c3-96b8-461d-89a2-d862733cba5e">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table summarizes intangible assets (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:57.477%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.399%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:10.776%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.399%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:10.776%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.399%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:10.776%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Accumulated Amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Net Carrying Amount&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Indefinite-lived intangible assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Domain names&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;697&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;697&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Definite-lived intangible assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Software developed for sale&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;348&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;329&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total intangible assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,045&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="C_67bb9b90-53de-4dc1-9ea3-fca6651bdf57"
      decimals="-3"
      id="F_e38b3c6e-7c4f-4038-91fc-5e2c18c7fae1"
      unitRef="U_USD">697000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="C_67bb9b90-53de-4dc1-9ea3-fca6651bdf57"
      decimals="-3"
      id="F_ff921688-5d8f-417d-8cee-0d250c6465d2"
      unitRef="U_USD">697000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="C_1d2ae6de-1a53-435d-93ea-e493cb1853b9"
      decimals="-3"
      id="F_7539b478-ee09-416f-837d-cb9cfe66b7c0"
      unitRef="U_USD">348000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="C_1d2ae6de-1a53-435d-93ea-e493cb1853b9"
      decimals="-3"
      id="F_db08757b-e41f-4bfb-b901-5adf887850c7"
      unitRef="U_USD">19000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="C_1d2ae6de-1a53-435d-93ea-e493cb1853b9"
      decimals="-3"
      id="F_767c57d3-f3d5-4f83-94cd-3857070b4d2c"
      unitRef="U_USD">329000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_2969e6eb-3fcb-48ce-979f-3a9980ac7eb9"
      unitRef="U_USD">1045000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_f77e96c7-e59a-4cbc-b410-cf2dd5794e13"
      unitRef="U_USD">19000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_a34b2e8d-4d54-4bad-b159-0fb80468a7d0"
      unitRef="U_USD">1026000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <sera:CapitalizedIntangibleAssets
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-5"
      id="F_48c3b726-9719-4bec-9ecf-7a838ec259a0"
      unitRef="U_USD">700000</sera:CapitalizedIntangibleAssets>
    <sera:CapitalizedIntangibleAssets
      contextRef="C_849392ea-c9bb-46ce-b852-5562b8505f07"
      decimals="-5"
      id="F_a5135ea3-dae4-485a-968d-6772cbe40b2e"
      unitRef="U_USD">300000</sera:CapitalizedIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_8650bd0f-fe5e-469f-9c6d-3c278a0cff82"
      unitRef="U_USD">19000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_643cdbf2-b70f-4d6d-b088-508caffb731f">&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;6. Accrued and Other Current Liabilities&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table presents the components of accrued and other current liabilities as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,041&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;779&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued vacation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;403&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;365&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued 401(k) matching contributions&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;74&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating lease liability, current portion&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;644&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;578&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other current liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;296&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;926&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total accrued and other current liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,384&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,722&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_cad49438-d783-416f-bc3a-3b2c84866f9d">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table presents the components of accrued and other current liabilities as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,041&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;779&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued vacation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;403&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;365&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued 401(k) matching contributions&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;74&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating lease liability, current portion&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;644&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;578&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other current liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;296&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;926&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total accrued and other current liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,384&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,722&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedSalariesCurrent
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_aaf9f8c3-b0af-4ce3-a282-954b3a43037b"
      unitRef="U_USD">1041000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:AccruedSalariesCurrent
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_dfa9d446-3df6-4486-89a2-a8c5e249a06f"
      unitRef="U_USD">779000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:AccruedVacationCurrent
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_1f775213-5a3a-4220-9b06-35b0c2533ba0"
      unitRef="U_USD">403000</us-gaap:AccruedVacationCurrent>
    <us-gaap:AccruedVacationCurrent
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_1324b308-f025-4b4c-be2d-3c977ee6230c"
      unitRef="U_USD">365000</us-gaap:AccruedVacationCurrent>
    <us-gaap:AccruedEmployeeBenefitsCurrent
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_ab61965b-15b9-4a15-a9e0-7718416bd874"
      unitRef="U_USD">0</us-gaap:AccruedEmployeeBenefitsCurrent>
    <us-gaap:AccruedEmployeeBenefitsCurrent
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_1c441a64-05aa-4418-843c-cece0741d4d6"
      unitRef="U_USD">74000</us-gaap:AccruedEmployeeBenefitsCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_a5abbc00-c915-4115-acc0-7e9cd055b280"
      unitRef="U_USD">644000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_6984c642-6e15-4494-ae19-eaa63a472a51"
      unitRef="U_USD">578000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_2518d465-e41e-4250-8ddb-72b193ee2ed4"
      unitRef="U_USD">296000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_4e915a12-c1f8-4f97-878c-8a5748171e5a"
      unitRef="U_USD">926000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_ff55f0d2-42b7-4cf0-963d-3bf46b688004"
      unitRef="U_USD">2384000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_bf23ac63-0766-4267-a9b6-24cc2a444bcc"
      unitRef="U_USD">2722000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_4310fb03-31ca-477b-b1fa-ccf58dbb3ecf">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. Other Income, Net&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table presents the components of other income, net, for the years ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:68.094%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.123000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.66%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.123000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Interest income&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,747&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,640&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Investment income, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,018&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,994&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other income, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,765&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,634&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock>
    <us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_895fa288-1eb4-4e23-9a14-b9be6a9f1a06">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table presents the components of other income, net, for the years ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:68.094%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.123000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.66%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.123000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Interest income&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,747&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,640&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Investment income, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,018&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,994&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other income, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,765&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,634&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock>
    <us-gaap:InterestIncomeOther
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_4f891b0e-f124-40fd-8a31-f1deaed8767d"
      unitRef="U_USD">2747000</us-gaap:InterestIncomeOther>
    <us-gaap:InterestIncomeOther
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_5f689409-daca-419c-8bfd-42146369ee9b"
      unitRef="U_USD">1640000</us-gaap:InterestIncomeOther>
    <us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_697ce95e-442e-45d2-965f-1722fc9d7ca4"
      unitRef="U_USD">1018000</us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium>
    <us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_411d7075-a1e1-4cdf-b9fa-66ad49a51e52"
      unitRef="U_USD">1994000</us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_d78d63a1-fef7-4ea8-9938-8b5b507e9476"
      unitRef="U_USD">3765000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_86f6e268-c280-48d3-9b52-8f8f48be3a43"
      unitRef="U_USD">3634000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_22bbe70b-f99a-4fcc-a343-d8efb931979b">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. Fair Value Measurements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024 and 2023, the carrying amounts of the Company&#x2019;s receivables, prepaid and other current assets, accounts payable, and accrued and other current liabilities approximate their fair values, principally due to the short-term nature of the assets and liabilities. The recorded values of the finance leases approximate fair value as the interest rates approximate market interest rates.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Money market funds are highly liquid investments and are actively traded. The pricing information on money market funds is readily available and can be independently validated as of the measurement date. This approach results in the classification of these securities as Level 1 of the fair value hierarchy.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;U.S. government agency bonds, U.S. government bonds, commercial paper, and corporate debt securities are measured at fair value using Level 2 inputs. The Company reviews trading activity and pricing for these investments as of each measurement date.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company follows a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. The three levels of the fair value hierarchy are as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Level 1 inputs are observable, quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company can access at the measurement date.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Level 2 inputs are observable inputs other than quoted prices included in Level 1 that are observable either directly or indirectly or quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Level 3 inputs are unobservable inputs in which there is little or no market data, which require the Company to develop its own assumptions.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table shows the Company&#x2019;s assets measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands) as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:57.477%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.399%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:10.776%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.399%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:10.776%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.399%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:10.776%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash equivalents:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,060&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Marketable securities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,446&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Corporate debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;42,882&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Municipal debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,072&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. federal agency securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,263&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,503&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,060&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;64,166&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table shows the Company&#x2019;s assets and liabilities measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands) as of December 31, 2023:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:57.477%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.399%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:10.776%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.399%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:10.776%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.399%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:10.776%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash equivalents:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,272&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Marketable securities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,773&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Corporate debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,192&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. federal agency securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;28,958&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,117&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,272&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;76,040&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_1b4b7268-ae71-47bb-b5e8-d4c3a94256bc">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table shows the Company&#x2019;s assets measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands) as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:57.477%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.399%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:10.776%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.399%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:10.776%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.399%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:10.776%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash equivalents:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,060&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Marketable securities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,446&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Corporate debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;42,882&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Municipal debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,072&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. federal agency securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,263&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,503&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,060&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;64,166&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table shows the Company&#x2019;s assets and liabilities measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands) as of December 31, 2023:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:57.477%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.399%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:10.776%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.399%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:10.776%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.399%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:10.776%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash equivalents:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,272&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Marketable securities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,773&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Corporate debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,192&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. federal agency securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;28,958&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;U.S. government securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,117&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:15pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,272&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;76,040&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_7330604e-585d-4c2f-b88a-fa3bec9d68eb"
      decimals="-3"
      id="F_e1925ac0-0140-4cf7-92e3-61e8ed4d204d"
      unitRef="U_USD">2060000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_18bf2f02-7c59-4b81-af8a-e4dee36352a3"
      decimals="-3"
      id="F_4ba174c6-bb30-4a8a-b4bb-f09adeb291e9"
      unitRef="U_USD">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_c1db559f-42af-47ed-b6d7-b2aa626db456"
      decimals="-3"
      id="F_3a9bcd4d-3cf6-4126-ac19-50b69715f6bc"
      unitRef="U_USD">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_a0cb604e-1c55-4ed9-a4a7-e778eada5e8d"
      decimals="-3"
      id="F_67c9df9a-bc21-4bb4-b6f5-2301812c8a9e"
      unitRef="U_USD">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_700f906f-1edc-4815-8c6f-063af0170797"
      decimals="-3"
      id="F_2c2fa8f6-c0c6-42e7-89b6-4b1f223c6d2c"
      unitRef="U_USD">1446000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_9992b3c4-e005-45ff-a893-0307d53ac290"
      decimals="-3"
      id="F_95da331e-47d7-4d7c-8cf5-d30cd04582c1"
      unitRef="U_USD">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_4b80e6fd-7982-44e8-a550-11ab6d1ec368"
      decimals="-3"
      id="F_19213756-5f04-4a09-80b2-8d4be0b57b67"
      unitRef="U_USD">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_472b27ba-d433-4ec0-97d1-4934923032a3"
      decimals="-3"
      id="F_e56ab853-30a1-4698-809d-5f15a5b46f48"
      unitRef="U_USD">42882000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_8c97b2f6-6bfd-442f-8d5f-fae8ac4320ac"
      decimals="-3"
      id="F_237724e8-458b-4b4a-b87b-a648f30efa4c"
      unitRef="U_USD">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_187fc49c-d6d6-4802-9f01-b957d0bc88c4"
      decimals="-3"
      id="F_30a9544d-43f6-4d5d-a4df-17e8c765da15"
      unitRef="U_USD">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_79fad083-6839-4292-87a4-80611ccece36"
      decimals="-3"
      id="F_a5df092e-9b32-47d1-8674-0add0349c698"
      unitRef="U_USD">3072000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_f96481c1-18cb-423a-941d-d5f0e9523ae3"
      decimals="-3"
      id="F_c3ad8eee-1e31-4664-b803-c92105bcef3d"
      unitRef="U_USD">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_cb3ea4ea-93f7-4d45-b83e-1681dda66e30"
      decimals="-3"
      id="F_afccf2bc-91d3-41d9-a686-7eab4500469a"
      unitRef="U_USD">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_91155194-5f56-4b2a-aafc-4c8a052b5661"
      decimals="-3"
      id="F_03343683-ab68-46f4-ba7c-f3b4110f046f"
      unitRef="U_USD">12263000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_d345d9ff-4db5-4fb9-821b-1c04eafbe0f2"
      decimals="-3"
      id="F_67b56a67-0948-40c6-bc36-da9f19ff4d0a"
      unitRef="U_USD">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_db7a6971-25dd-4ecb-8f48-615fa9b2e446"
      decimals="-3"
      id="F_4aaba101-dab0-4d5f-a1b2-e8ac514774f8"
      unitRef="U_USD">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_85982594-37df-45db-b0b5-a89d1853eece"
      decimals="-3"
      id="F_f4431a93-b649-4e8c-9575-75ec97b64080"
      unitRef="U_USD">4503000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_743227ba-f29d-4c56-aaf6-1d4fe3a4d79e"
      decimals="-3"
      id="F_497479da-a705-4dff-badc-7540a9a06acc"
      unitRef="U_USD">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_c9f1b32e-78dd-4176-9085-97902cd1f5c8"
      decimals="-3"
      id="F_3eaa49c3-3aa3-4e9d-871d-f208fb1b0e8d"
      unitRef="U_USD">2060000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_fad988d1-5034-478c-8516-20f5782f4f85"
      decimals="-3"
      id="F_516e7e4d-9997-4c19-904a-99309c46eaa7"
      unitRef="U_USD">64166000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_ecdd66a3-70fa-4c7e-a8c2-b633e3ee94ea"
      decimals="-3"
      id="F_14cd40b5-6b90-4c34-8524-03117ae7cc46"
      unitRef="U_USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_8c0b2f25-3d73-42db-83a0-927dc46b55f2"
      decimals="-3"
      id="F_e03fb90a-979e-42b6-a9b3-afc17c836edf"
      unitRef="U_USD">1272000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_3759c1ab-699f-41b4-a2c6-1a2c4e3d2044"
      decimals="-3"
      id="F_15b0ba67-ce7a-4cab-92bf-81ee3a1e5ff8"
      unitRef="U_USD">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_c0c33cde-1b31-4d14-83be-384eb68acebe"
      decimals="-3"
      id="F_e047e2ce-ea38-49c4-89f6-98dbaa0cb809"
      unitRef="U_USD">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_d619847f-a838-4f86-a29f-cd037355836b"
      decimals="-3"
      id="F_dd8607c9-e499-4f6c-8974-d01008f2b207"
      unitRef="U_USD">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_170c4dc3-4c1f-4587-ac98-abecb38c3bcc"
      decimals="-3"
      id="F_2ed66490-e382-4631-8689-5f0ab825d916"
      unitRef="U_USD">11773000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_841fc982-9aa4-444b-812e-b8d2f53536de"
      decimals="-3"
      id="F_f5e986e6-cf76-4745-afce-12fd7d99aa06"
      unitRef="U_USD">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_6b649540-a349-4de7-a667-163e2396f87b"
      decimals="-3"
      id="F_89207f22-53cb-4807-8d89-7f513a46dee4"
      unitRef="U_USD">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_3879982c-10a3-45e6-8f45-744fccd1614e"
      decimals="-3"
      id="F_28c7e05c-f2a1-4bd2-ac5f-b708b3cfb792"
      unitRef="U_USD">18192000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_f91bfb70-0a79-432d-a466-f33c51ec490d"
      decimals="-3"
      id="F_3483f1bd-2034-4336-801a-5644915f1e79"
      unitRef="U_USD">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_05256ced-5cef-411f-a2d3-9a1cd711dc5a"
      decimals="-3"
      id="F_48c223f3-fbcd-4153-96dd-189f428f7c12"
      unitRef="U_USD">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_993c8440-8e32-404e-a58d-36ed574ab4c3"
      decimals="-3"
      id="F_05662441-1710-435a-8cef-18e5bac1c599"
      unitRef="U_USD">28958000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_ecfa7a3b-6a0d-49ef-9b51-2fcd10725943"
      decimals="-3"
      id="F_9ab651b9-5902-406b-b3ce-8959d9e9230e"
      unitRef="U_USD">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_eb565e2c-bfbf-4eb0-a9c0-cbb1dcb06aca"
      decimals="-3"
      id="F_ce3415f2-f796-43c3-85d5-c004fb7db90b"
      unitRef="U_USD">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_caf15085-5fb3-478e-a2a5-829cc0c348a7"
      decimals="-3"
      id="F_ad647ab5-abba-4e79-af6b-041dbe6a97df"
      unitRef="U_USD">17117000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_28f64bcb-45ac-4b38-ac92-aba2705b7334"
      decimals="-3"
      id="F_d4000ae0-3092-4f99-9e24-82cb6e5261f8"
      unitRef="U_USD">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_dbdf5e62-5392-4d8b-9ae4-125c21ee2824"
      decimals="-3"
      id="F_98a8e4dd-44bf-4aa0-89d5-60ac7a087026"
      unitRef="U_USD">1272000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_f644480d-0cbe-48d3-a1e8-381afc09c8c6"
      decimals="-3"
      id="F_6e02e365-7096-4c89-b70c-16b2e908aade"
      unitRef="U_USD">76040000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_df26b36a-abf1-4ee8-92c3-99bf73fea9e8"
      decimals="-3"
      id="F_ec03751c-aaad-4174-88f9-c68312541a94"
      unitRef="U_USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_6647a8f8-6b37-4945-8fd8-18fbea4736a4">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. Related Party Transactions&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In June 2019, the Company entered into a master services agreement with Carelon Research, a subsidiary of Elevance Health, Inc. (&#x201c;Elevance Health&#x201d;). This agreement covers a range of research projects, including Carelon Research&#x2019;s role as a contract research organization for the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;P&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;rematurity &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;R&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;isk Assessment Combined With Clinical &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;I&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;nterventions for Improving Neonatal outco&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;ME&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;s (&#x201c;PRIME&#x201d;) study. The Company paid fees related to this agreement of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; for the years ended December 31, 2024 and 2023, respectively, which were recorded in research and development expenses in the Company&#x2019;s statements of operations and comprehensive loss. In November 2020, the Company entered into a Laboratory Services Agreement with Elevance Health related to the PRIME study. This agreement provides a contracted rate for certain tests performed pursuant to the study. In December 2023, enrollment in the PRIME study was stopped due to efficacy, and as such, there was an immaterial amount of revenue recognized related to this agreement for the year ended December 31, 2024. The Company recognized revenue related to this agreement of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;61&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; thousand&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; for the year ended December 31, 2023.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In February 2021, the Company entered into a commercial collaboration agreement with Elevance Health and its affiliates (the &#x201c;Commercial Collaboration Agreement&#x201d;). The Commercial Collaboration Agreement provides defined payment within a defined period for use of the PreTRM test within Elevance Health&#x2019;s network of covered members. Pursuant to the Commercial Collaboration Agreement, Elevance Health agreed to purchase a certain minimum number of tests for each of the first three years of the term of the agreement. Additionally, Elevance Health agreed to pay a certain minimum amount per year for the first&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; three years&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; of the term of the Commercial Collaboration Agreement. The Company received $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million during the year ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024, which amount related to the minimum payments for the year ended December 31, 2023. Such minimum payments were initially recorded as deferred revenue. Deferred revenue is recognized as revenue when the Company delivers PreTRM test results to Elevance Health patients pursuant to the Commercial Collaboration Agreement. The Company also agreed to develop a sales, marketing, and customer service program, and to provide training and marketing to duly licensed physicians specializing in obstetrics and gynecology or family medicine, or licensed nurse midwives, at the reasonable request of Elevance Health.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Elevance Health has been participating in the Company&#x2019;s PRIME study and at the conclusion of the PRIME study, under the Commercial Collaboration Agreement, the parties agreed to use commercially reasonable efforts to enter into Elevance Health&#x2019;s standard lab provider agreement. Unless earlier terminated due to breach, the Commercial Collaboration Agreement&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;will remain in effect until the later of (a) the third anniversary of the effective date or (b) the date on which Elevance Health has purchased a fixed number of PreTRM tests as agreed by the parties.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Commercial Collaboration Agreement with Elevance Health is considered to be within the scope of ASC Topic 808, Collaborative Arrangements (&#x201c;ASC 808&#x201d;), as the parties are active participants and exposed to the risks and rewards of the collaborative activity. The Company determined the PreTRM tests to be a performance obligation for which Elevance Health is a customer and a unit of account within the scope of ASC 606. The associated transaction price is based on the contractual minimum number of tests and the agreed upon defined payment amount per test. The transaction price was allocated to this single performance obligation, which will be recognized upon delivery of test results expected to occur over the term of the agreement. All other items promised to Elevance Health are immaterial in the context of the Commercial Collaboration Agreement. There were no material revenues related to the Commercial Collaboration Agreement for the years ended December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:OperatingExpenses
      contextRef="C_5a27522b-3fd7-4775-b4b1-c07ac5059bc8"
      decimals="-5"
      id="F_bd09b866-74f8-4bd6-87b9-9235a187a3d8"
      unitRef="U_USD">2900000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_a5ccbc75-c805-4d9b-b60c-5763efe0a38b"
      decimals="-5"
      id="F_0884b22b-6ff4-4269-84b4-aaa44b4bd8c4"
      unitRef="U_USD">4000000</us-gaap:OperatingExpenses>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_ac36fee8-490e-4504-a78e-09b7ddd118aa"
      decimals="-3"
      id="F_1081f29c-bf49-466e-beaa-7fff4e50aa37"
      unitRef="U_USD">61000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <sera:RelatedPartyTransactionCommercialCollaborationAgreementTerm
      contextRef="C_84c625f9-260e-4db9-b7ab-0dd11718650f"
      id="F_b9647126-d194-48bd-9f61-b68b75759dcd">P3Y</sera:RelatedPartyTransactionCommercialCollaborationAgreementTerm>
    <sera:RelatedPartyTransactionOtherReceivablesRelatedToMinimumPayments
      contextRef="C_0a1a9334-cc92-43d9-b390-4fce8c10c525"
      decimals="-5"
      id="F_9655e0ae-7170-41d3-918d-1f5dfc59e818"
      unitRef="U_USD">11200000</sera:RelatedPartyTransactionOtherReceivablesRelatedToMinimumPayments>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_10a3d855-90c0-4da0-b1e9-a81c808f12f2">&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. Capital Structure&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Common Stock&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;two&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; authorized classes of common stock, Class A and Class B. The rights of the holders of Class A and Class B common stock are identical, except with respect to voting and conversion. Each share of Class A common stock is entitled to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;one&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; vote and shares of Class B common stock are non-voting. Each share of Class B common stock may be converted at any time to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;one&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; share of Class A common stock at the option of its holder, subject to the ownership limitations provided for in the Company&#x2019;s amended and restated certificate of incorporation.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In August 2024, the Company entered into the 2024 Sales Agreement with respect to an at-the-market offering program with TD Cowen, which allows the Company to issue and sell shares of Class A common stock pursuant to the 2024 Form S-3 for total gross sales proceeds of up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million from time to time through TD Cowen, acting as its agent. As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company has &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;t sold any shares of Class A common stock under the 2024 Sales Agreement.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following shares of Class A common stock were reserved for future issuance:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.967%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.357%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.357%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Warrants to purchase Class A common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,646,247&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,775,978&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Options to purchase Class A common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,113,155&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,251,663&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Restricted stock units outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,631,162&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,692,459&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Class A common stock available for future grants under the 2021 Equity Incentive&lt;br/&gt;&#160;&#160;&#160;Plan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,071,498&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,002,091&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Class A common stock available for future grants under the 2021 Employee Stock&lt;br/&gt;&#160;&#160;&#160;Purchase Plan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,060,293&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;801,668&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,522,355&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,523,859&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Preferred Stock&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company is authorized to issue up to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,000,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of preferred stock, par value $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share. There were &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; preferred shares outstanding at &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <sera:NumberOfCommonStockClassesAuthorized
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="INF"
      id="F_1f508903-e1a5-4f76-89a6-7aa42b9a78fd"
      unitRef="U_CommonStockClass">2</sera:NumberOfCommonStockClassesAuthorized>
    <sera:NumberOfVotesPerShare
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="INF"
      id="F_a18416c2-408b-499a-9ac8-0f00344aa36c"
      unitRef="U_Vote">1</sera:NumberOfVotesPerShare>
    <sera:CommonStockConversionRatio
      contextRef="C_e26ec1fe-0438-4812-b032-9b354ebc1852"
      decimals="INF"
      id="F_52794771-027b-47f6-a68b-8648f34ccc53"
      unitRef="U_pure">1</sera:CommonStockConversionRatio>
    <sera:GrossSalesProceedsFromIssuanceOfCommonStock
      contextRef="C_b020dd07-c5cb-461b-9677-a054282faf68"
      decimals="-5"
      id="F_ef6fdfad-2e75-4fb7-af6c-345904b52354"
      unitRef="U_USD">50000000</sera:GrossSalesProceedsFromIssuanceOfCommonStock>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_d8ac3adc-d2c5-4821-b662-56b9921fc31c"
      decimals="INF"
      id="F_dc8e5150-8232-419a-a409-24d525587094"
      unitRef="U_shares">0</us-gaap:CommonStockSharesIssued>
    <sera:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_dfd408c2-0777-4cf1-98c3-1d12ab647eb5">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following shares of Class A common stock were reserved for future issuance:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.967%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.357%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.357%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Warrants to purchase Class A common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,646,247&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,775,978&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Options to purchase Class A common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,113,155&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,251,663&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Restricted stock units outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,631,162&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,692,459&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Class A common stock available for future grants under the 2021 Equity Incentive&lt;br/&gt;&#160;&#160;&#160;Plan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,071,498&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,002,091&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Class A common stock available for future grants under the 2021 Employee Stock&lt;br/&gt;&#160;&#160;&#160;Purchase Plan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,060,293&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;801,668&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,522,355&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,523,859&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:middle;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</sera:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_f375d679-1976-474c-901f-6de9f5d1164a"
      decimals="INF"
      id="F_30c7fe63-ec50-45e5-a38e-258542aa7c98"
      unitRef="U_shares">2646247</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_fa1f5377-96a0-459c-99fd-200157552294"
      decimals="INF"
      id="F_1ac6ca9e-4067-4865-b96d-a09e769408bc"
      unitRef="U_shares">2775978</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_44bf1f0c-7e45-4ddb-a68d-b3794ce96d49"
      decimals="INF"
      id="F_1909e7fe-4bfe-4d74-991a-e9297053684e"
      unitRef="U_shares">6113155</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_0d3d312a-a883-406f-a482-b3aab18bb031"
      decimals="INF"
      id="F_9bc409a7-0192-4f0b-827b-a16f65ac9932"
      unitRef="U_shares">7251663</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_0a27554e-ce58-4e26-90cb-8b0b7c2027a4"
      decimals="INF"
      id="F_23370249-c262-44a3-953a-e2a796db52fc"
      unitRef="U_shares">1631162</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_060bbe9a-71b5-4045-95d0-1ffa4cf95206"
      decimals="INF"
      id="F_83458099-e271-4649-bb8a-a92d78bc8794"
      unitRef="U_shares">2692459</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_72fc74dc-bc8c-4dc3-9e53-0a0e671982ea"
      decimals="INF"
      id="F_ddc1cf61-5a50-4f05-8ff2-c387e2771681"
      unitRef="U_shares">2071498</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_1660a0e7-df13-4027-9e38-15f6ddf11b0a"
      decimals="INF"
      id="F_132cdb3b-65ab-46fa-8284-77f695a71dfa"
      unitRef="U_shares">1002091</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_c6567a19-3bfb-4b14-8ef7-62764c3fa312"
      decimals="INF"
      id="F_61a2864a-8f0e-424c-b691-eceb5dc9be30"
      unitRef="U_shares">1060293</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_13d531e2-fd1b-4238-a5d7-2fd7b67c5076"
      decimals="INF"
      id="F_036c0dd4-4f1f-4436-a0e7-981e64fbd583"
      unitRef="U_shares">801668</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_e26ec1fe-0438-4812-b032-9b354ebc1852"
      decimals="INF"
      id="F_aa9da507-ece5-418c-adfd-9ad0d778c630"
      unitRef="U_shares">13522355</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_7e2de8e1-9b90-401b-b5d2-78a35f931945"
      decimals="INF"
      id="F_8e8b89e3-a5c5-430a-a93e-5a3d47bd77a3"
      unitRef="U_shares">14523859</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_1ea882d4-0679-4c9f-9dff-1ef9e04dcf6b"
      decimals="INF"
      id="F_b6b89078-a0e8-4a25-90f1-64a3c9b29638"
      unitRef="U_shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_1ea882d4-0679-4c9f-9dff-1ef9e04dcf6b"
      decimals="INF"
      id="F_c6d60388-54e9-4298-be14-68d4bb43094c"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_1ea882d4-0679-4c9f-9dff-1ef9e04dcf6b"
      decimals="INF"
      id="F_1e64f15f-bad4-45b6-af33-20bc0837c6d8"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_978306e0-1a64-43db-891b-ab7f3d2e279c"
      decimals="INF"
      id="F_57d6de8f-aad9-4d9f-b798-81ab8f37a3a9"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_cf4d93b8-a8dd-4b8d-b30c-d7b4d8984dac">&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;11&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. Stock-Based Compensation&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Equity Incentive Plans&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In November 2011, the Company established the 2011 Employee, Director and Consultant Equity Incentive Plan (the &#x201c;2011 Plan&#x201d;) and reserved shares of the Company&#x2019;s common stock for sale and issuance under the 2011 Plan. Options granted under the 2011 Plan generally vest over a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;four-year&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; period and generally expire &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;ten years&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; from the date of grant. Options are exercisable only to the extent vested. The 2011 Plan terminated in November 2021, and accordingly, no additional shares are available for grant under the 2011 Plan. The 2011 Plan continues to govern outstanding awards granted under the 2011 Plan.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The 2021 Equity Incentive Plan (the &#x201c;2021 Plan&#x201d;) was established in July 2021. The 2021 Plan provides for the grant of incentive and non-statutory stock options as well as other stock rights to employees, directors and consultants of the Company. Options generally vest over a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;four-year&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; period, are exercisable only to the extent vested, and generally expire &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;ten years&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; from the date of grant. Restricted stock units (&#x201c;RSUs&#x201d;) generally vest over either a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;two-year&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; or a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;four-year&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; period. The 2021 Plan includes provisions for annual automatic increases to the number of shares of Class A common stock reserved for issuance under the 2021 Plan. In addition, any shares that otherwise would be returned to the 2011 Plan as a result of the expiration or cancellation of stock options may be added to the 2021 Plan. As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024, there were &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,071,498&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of the Company&#x2019;s Class A common stock that were available for future grants under the 2021 Plan.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The 2021 Employee Stock Purchase Plan (the &#x201c;2021 ESPP&#x201d;) was established in July 2021. The 2021 ESPP includes provisions for annual automatic increases to the number of shares of Class A common stock reserved for issuance under the 2021 ESPP. As of December 31, 2024, there were &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,060,293&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of the Company&#x2019;s Class A common stock that were available for future grants under the 2021 ESPP.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Stock Options&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Unless otherwise noted, references to &#x201c;options&#x201d; in the subsequent disclosures, refers to the combined incentive and non-statutory stock options issued as employee and non-employee stock-based compensation, and authorized under the 2011 Plan and the 2021 Plan. &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table summarizes information about these options granted and outstanding:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:52.241%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.164%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:8.403%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.164%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:8.703000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Number of&lt;br/&gt;Shares&lt;br/&gt;Subject to&lt;br/&gt;Options&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price Per&lt;br/&gt;Share&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Life (In&lt;br/&gt;Years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value (In&lt;br/&gt;Thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding &#x2013; December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,251,663&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.66&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.9&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20,014&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;84,392&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.43&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expired&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cancelled&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;120,387&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.68&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,102,513&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.63&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding &#x2013; December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,113,155&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.91&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.3&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27,008&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Vested and expected to vest at December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,073,028&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.90&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.3&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;26,849&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Vested and exercisable at December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,380,324&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.77&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.1&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The weighted-average grant date fair value of options granted during the years ended December 31, 2024 and 2023 was &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.54&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.28&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share, respectively. The total aggregate intrinsic value of options exercised during the years ended December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, respectively. The total fair value of options vested for the years ended December 31, 2024 and 2023 was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, respectively.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The fair values calculated using the Black-Scholes option pricing model were estimated on each grant date using the following assumptions:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.343%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.343%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;78.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;% - &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;78.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;70.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;% - &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;72.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Risk-free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;% - &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;% - &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected term (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.2 &lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;- &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.3&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.3&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;- &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.0&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;RSUs&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table summarizes information about RSUs granted and outstanding under the 2021 Plan:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:68.88%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.06%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.5%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.54%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.020000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Number of Awards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted-Average&lt;br/&gt;Grant Date Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding &#x2013; December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,692,459&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.01&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;249,040&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.52&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Forfeited&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;52,992&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.02&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Vested&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,257,345&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.54&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding &#x2013; December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,631,162&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.60&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Stock-Based Compensation Expense&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table presents the impact of stock-based compensation expense in the statements of operations for the periods indicated (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Research and development expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,502&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,574&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Sales and marketing expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;390&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;657&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;General and administrative expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,121&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,042&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total employee stock-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,013&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,273&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The information about unrecognized stock-based compensation expense for outstanding unvested stock options and RSUs as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 was as follows (in thousands, except years):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:68.88%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.54%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.020000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.06%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.5%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrecognized&lt;br/&gt;Stock-Based&lt;br/&gt;Compensation&lt;br/&gt;Expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted-Average&lt;br/&gt;Period of&lt;br/&gt;Recognition&lt;br/&gt;(in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock Options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,975&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.0&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;RSUs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,099&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.9&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total unrecognized stock-based compensation expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,074&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_1faeebd3-23ce-493d-af5a-c79bb9e92d83"
      id="F_15b67bf7-a316-44e4-b2a0-3aac6ca84a54">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="C_1faeebd3-23ce-493d-af5a-c79bb9e92d83"
      id="F_7ce46bc5-f359-49ea-889f-14ce39e769a1">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_6a5f0bd4-0f79-4071-ac0b-e3d379500212"
      id="F_763c7cb6-4e14-4d7d-8dc3-0189fd7987a4">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="C_6a5f0bd4-0f79-4071-ac0b-e3d379500212"
      id="F_2233805b-1dcb-4df6-a242-617876b88372">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_809b9d4c-c63e-4d53-8e85-6d4684e3609d"
      id="F_d652a980-f293-45b7-9cbb-90071bbc125e">P2Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_8510e741-314c-421f-9b15-649e0930202c"
      id="F_3a7401ca-1b67-4505-bbc3-afe46e270a4a">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_e79b8c0c-c0db-4a39-81c4-3583a483beb6"
      decimals="INF"
      id="F_5e396114-b18b-4811-b932-1c9ff5474e81"
      unitRef="U_shares">2071498</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_c8c170a9-1f93-4318-a2c3-b52ae62d57d1"
      decimals="INF"
      id="F_055e5c27-cf7e-4520-9afa-87ec9cb6de24"
      unitRef="U_shares">1060293</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_1dbb36a6-6b2b-41e3-a364-750bce65cf82">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table summarizes information about these options granted and outstanding:&lt;/span&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:52.241%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.164%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:8.403%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.164%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:8.703000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Number of&lt;br/&gt;Shares&lt;br/&gt;Subject to&lt;br/&gt;Options&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price Per&lt;br/&gt;Share&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Life (In&lt;br/&gt;Years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value (In&lt;br/&gt;Thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding &#x2013; December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,251,663&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.66&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.9&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20,014&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;84,392&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.43&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expired&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cancelled&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;120,387&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.68&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,102,513&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.63&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding &#x2013; December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,113,155&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.91&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.3&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27,008&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Vested and expected to vest at December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,073,028&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.90&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.3&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;26,849&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Vested and exercisable at December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,380,324&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.77&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.1&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="INF"
      id="F_058030a3-3ee4-42dc-810c-5143028ac6d7"
      unitRef="U_shares">7251663</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="2"
      id="F_0a7c3d20-3fc8-4547-b33c-7b06435fce61"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">3.66</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      id="F_f0cc5662-f045-4dbf-aa8c-ce8e86317a09">P6Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_f0f0d88c-0bc5-4816-b698-d07ea2c25070"
      unitRef="U_USD">20014000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="INF"
      id="F_dff64cb1-4cf6-4be3-b202-38f615450671"
      unitRef="U_shares">84392</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="2"
      id="F_898745b3-3bef-40d5-af3a-eaf5b8c6e5e7"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">8.43</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="0"
      id="F_cc4e3f9f-2c86-4f64-b639-2ce6a0009e2f"
      unitRef="U_shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="0"
      id="F_a4147e75-0d6f-41d9-a387-1507295e269f"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="INF"
      id="F_bcc5ebe7-2627-4499-b5bb-1e0655c2ba5b"
      unitRef="U_shares">120387</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="2"
      id="F_6b8a8717-5f68-4149-aa9b-830718046220"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">3.68</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="INF"
      id="F_877a619c-34a6-4770-8f4f-a27361c216d4"
      unitRef="U_shares">1102513</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="2"
      id="F_785c738f-a8c9-4865-83b3-86bbcc952860"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.63</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="INF"
      id="F_2dcbbdea-c14b-4fc0-9532-33b8f01fab82"
      unitRef="U_shares">6113155</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="2"
      id="F_87b2f6d9-28bf-43fa-9546-69d10b28b99b"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">3.91</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_6e12f4ad-6cb1-47c2-ae07-9fa301861300">P6Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_83aecce7-3cb7-4bf3-9eb0-06b332db84fd"
      unitRef="U_USD">27008000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="INF"
      id="F_bc91743e-27ed-499f-a637-3ecef47b7540"
      unitRef="U_shares">6073028</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="2"
      id="F_0373d022-f2c8-4122-921a-1a46667b139c"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">3.9</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_e0a00184-ba6d-4867-84ca-ddf5447908ef">P6Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_022a1bac-c33d-4787-8b18-239201a130fe"
      unitRef="U_USD">26849000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="INF"
      id="F_c98d06d5-4214-4b94-8dd4-cfd467abda5f"
      unitRef="U_shares">5380324</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="2"
      id="F_68bab7bc-e2b9-419f-9447-394bc4fb9371"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">3.77</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_131d637d-be4b-471a-a897-d9e342b023b3">P6Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_db0078fe-372e-46a2-976b-029a41728853"
      unitRef="U_USD">24500000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="2"
      id="F_cd659edb-8878-4608-b980-fa9f42643a31"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">5.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="2"
      id="F_facda6b5-22b6-443d-bb30-e1e9fc912c02"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-5"
      id="F_55f53b47-03b0-460b-959a-7dd1d6d8683e"
      unitRef="U_USD">5500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-5"
      id="F_df0757e2-91b0-44cb-a01c-28d73bad68af"
      unitRef="U_USD">1400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-5"
      id="F_5f31d270-fa0c-4fa2-936d-f38390f46fdd"
      unitRef="U_USD">3700000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-5"
      id="F_640f0959-dcde-4cf8-8d86-355706adfdd7"
      unitRef="U_USD">4800000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_305d43b7-32fc-4f86-a928-c2a6464de20a">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The fair values calculated using the Black-Scholes option pricing model were estimated on each grant date using the following assumptions:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.343%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.343%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;78.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;% - &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;78.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;70.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;% - &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;72.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Risk-free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;% - &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;% - &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected term (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.2 &lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;- &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.3&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.3&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;- &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.0&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="3"
      id="F_41aaec42-f2dc-4321-bd67-a7f9d54bdaa4"
      unitRef="U_pure">0.788</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="3"
      id="F_76f856fa-cd97-4d85-8fc2-b9bf0bb81fe2"
      unitRef="U_pure">0.789</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="3"
      id="F_2eefab42-fc10-460c-a6f8-22ef0d572b03"
      unitRef="U_pure">0.701</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="3"
      id="F_1dced4d4-b6b1-4c16-b7f6-23c1d43d02a6"
      unitRef="U_pure">0.724</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="3"
      id="F_a3ceb8f2-9385-435e-bccc-19c9be4203c0"
      unitRef="U_pure">0.041</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="3"
      id="F_6f74a057-b75d-4207-93a2-01f6d1832365"
      unitRef="U_pure">0.042</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="3"
      id="F_4c62f924-84ea-43c6-bd73-8e077e608aea"
      unitRef="U_pure">0.037</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="3"
      id="F_90bc513e-6924-4817-8c36-edf65bd85edb"
      unitRef="U_pure">0.042</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_12580e9a-ae3c-43b5-bd47-c7e4bcb0df5e"
      id="F_1104f191-a7d1-4da4-bf6e-2081cdf1e670">P5Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_645b404b-8bbd-4848-a0d4-aeaf0829da3f"
      id="F_4cdc751a-d569-42d9-9dea-43460b5c1618">P5Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_b91d11ff-c343-4366-83fa-e644ceaf19e4"
      id="F_606e1304-1d2f-4eb1-b6c3-8ba3c8956cb4">P5Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_acdfb23b-77fd-4983-9ece-002da2eb742e"
      id="F_88406945-24f8-418e-9d80-f8cb98d977fc">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="0"
      id="F_a9b52a30-ca06-4221-9c7b-6b410964f204"
      unitRef="U_USD">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="0"
      id="F_8a3c6b76-557b-44dd-a4a9-ac18f551f644"
      unitRef="U_USD">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend>
    <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_59dc700a-52dc-4916-ab47-802a3a319b3d">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table summarizes information about RSUs granted and outstanding under the 2021 Plan:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:68.88%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.06%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.5%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.54%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.020000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Number of Awards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted-Average&lt;br/&gt;Grant Date Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding &#x2013; December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,692,459&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.01&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;249,040&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.52&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Forfeited&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;52,992&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.02&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Vested&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,257,345&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.54&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding &#x2013; December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,631,162&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.60&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_c65254c7-ac81-4069-a809-c971b11aa622"
      decimals="INF"
      id="F_358ab3fd-5039-4cc2-8bed-cabf74b62934"
      unitRef="U_shares">2692459</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_c65254c7-ac81-4069-a809-c971b11aa622"
      decimals="2"
      id="F_46737bad-cf43-4c3d-9680-d2bd0e5b3e13"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_b7e93a2d-70e5-4c3d-a5e8-2305fb8f5a8b"
      decimals="INF"
      id="F_37762d20-732a-42d3-a02c-133a3c4db668"
      unitRef="U_shares">249040</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_b7e93a2d-70e5-4c3d-a5e8-2305fb8f5a8b"
      decimals="2"
      id="F_f1172988-54ba-471e-98bd-76366ebeb920"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">8.52</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="C_b7e93a2d-70e5-4c3d-a5e8-2305fb8f5a8b"
      decimals="INF"
      id="F_21870b27-0cc9-4b9d-b929-3175bb648315"
      unitRef="U_shares">52992</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="C_b7e93a2d-70e5-4c3d-a5e8-2305fb8f5a8b"
      decimals="2"
      id="F_8e0c77a9-bf92-40fd-8934-1597a019590e"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.02</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="C_b7e93a2d-70e5-4c3d-a5e8-2305fb8f5a8b"
      decimals="INF"
      id="F_26b55749-4a5a-4de8-aa16-5c9dd488a767"
      unitRef="U_shares">1257345</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_b7e93a2d-70e5-4c3d-a5e8-2305fb8f5a8b"
      decimals="2"
      id="F_5bf55164-ff35-4c02-b3e1-5900d628ae74"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_1e828831-28e3-4d62-916b-97cfb64c3c0f"
      decimals="INF"
      id="F_2c442635-d4a8-470b-a19b-e40f28ac5875"
      unitRef="U_shares">1631162</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_1e828831-28e3-4d62-916b-97cfb64c3c0f"
      decimals="2"
      id="F_eae6e444-df64-4ba0-bdd7-955c938d76e9"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.6</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_f7267973-a04e-4372-8f29-e8ab14c16fa2">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table presents the impact of stock-based compensation expense in the statements of operations for the periods indicated (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Research and development expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,502&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,574&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Sales and marketing expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;390&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;657&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;General and administrative expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,121&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,042&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total employee stock-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,013&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,273&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_82b9b7fb-68e4-45aa-8dc3-daea6ea244e1"
      decimals="-3"
      id="F_1fe87e85-79b8-453c-9c72-20c95e9fde12"
      unitRef="U_USD">2502000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_e47cfbc9-cd42-436b-8a5a-31f13439a6df"
      decimals="-3"
      id="F_47178c76-610d-4eac-9809-b6b0ac2433a8"
      unitRef="U_USD">1574000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_f3b8da5f-d721-4ba9-9244-5fd80bad0881"
      decimals="-3"
      id="F_8bd8d315-ba66-451e-a8c7-184f5efac2ba"
      unitRef="U_USD">390000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_179d008a-1bc2-40a6-ac89-86e6010d037c"
      decimals="-3"
      id="F_5397cf3c-79de-44b2-bc46-60a5864e9786"
      unitRef="U_USD">657000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_c8b03d4a-856b-4b56-989b-21dbe3a3d5e4"
      decimals="-3"
      id="F_5cebda52-6be2-43c9-a313-36322f6bd6fd"
      unitRef="U_USD">4121000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_3823e7c9-9de3-4740-a0b6-1918db41ffaa"
      decimals="-3"
      id="F_4b4e59ab-c907-4730-bdec-3e3399346b48"
      unitRef="U_USD">3042000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_6f2ac375-3a5d-4352-b26c-2e31e93b4e38"
      unitRef="U_USD">7013000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_16303fa4-ed6d-416c-9682-616bedeed16b"
      unitRef="U_USD">5273000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_906c630b-4119-416c-b6bc-913444d34f34">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The information about unrecognized stock-based compensation expense for outstanding unvested stock options and RSUs as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 was as follows (in thousands, except years):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:68.88%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.54%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.020000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.06%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.5%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Unrecognized&lt;br/&gt;Stock-Based&lt;br/&gt;Compensation&lt;br/&gt;Expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted-Average&lt;br/&gt;Period of&lt;br/&gt;Recognition&lt;br/&gt;(in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock Options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,975&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.0&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;RSUs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,099&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.9&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total unrecognized stock-based compensation expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,074&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_265f5620-217f-46c0-817b-7b56ed425a39"
      unitRef="U_USD">1975000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_b883805c-a8b1-485f-91fe-fe46951719fe">P1Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="C_1e828831-28e3-4d62-916b-97cfb64c3c0f"
      decimals="-3"
      id="F_09ca5baa-e964-41ba-9c33-de3e810f8ad0"
      unitRef="U_USD">3099000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_b7e93a2d-70e5-4c3d-a5e8-2305fb8f5a8b"
      id="F_f5dd5e42-bedf-451a-a318-55d8382df102">P1Y10M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_369db8a0-771d-4728-9297-abe26a51d3a5"
      unitRef="U_USD">5074000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <sera:WarrantsTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_c031851b-2401-4ed1-b874-6980763bdd6e">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;12. Warrants&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;All outstanding common stock warrants were exercisable immediately when granted. All outstanding common stock warrants are exercisable for shares of Class A common stock. &lt;/span&gt;&lt;span style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s common stock warrants outstanding were as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:29.08%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.92%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:29.54%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.92%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:29.54%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Number of Warrants Outstanding as of:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Exercise Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.20&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,473&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.03&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;969,275&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,032,404&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10.84&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;946,666&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,009,795&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12.38&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,083&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,083&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20.77&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;722,223&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;722,223&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,646,247&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,775,978&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the year ended December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;126,258&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; common stock warrants were net exercised, resulting in the issuance of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,971&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Class A common stock. Additionally, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,473&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; common stock warrants expired unexercised during the year ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</sera:WarrantsTextBlock>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_d6f9f668-07a8-4eba-9dc7-19f88431a02d">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s common stock warrants outstanding were as follows:&lt;/span&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:29.08%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.92%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:29.54%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.92%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:29.54%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Number of Warrants Outstanding as of:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Exercise Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.20&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,473&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.03&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;969,275&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,032,404&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10.84&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;946,666&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,009,795&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12.38&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,083&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,083&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20.77&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;722,223&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;722,223&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,646,247&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,775,978&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_987117f3-a2cb-4114-ba3b-abb5e5ee31bf"
      decimals="2"
      id="F_2211fbf6-bc02-4511-91c3-bb10b65fb3ec"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">5.20</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_987117f3-a2cb-4114-ba3b-abb5e5ee31bf"
      decimals="INF"
      id="F_6a936abd-94c9-4c2b-887d-febbed063bcc"
      unitRef="U_shares">0</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_b2ca6d62-c8a1-49ad-b68e-21f1e5f6bb63"
      decimals="INF"
      id="F_4e7dda8c-c612-4e29-9d23-937205822a91"
      unitRef="U_shares">3473</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_bee59d28-e5cc-40c9-a976-6776fef6babc"
      decimals="INF"
      id="F_d7fcbc5a-a8ec-4873-8cce-d13f6b1881aa"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">9.03</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_bee59d28-e5cc-40c9-a976-6776fef6babc"
      decimals="INF"
      id="F_0505f1b3-7c8b-4af1-9f7e-462aca180cab"
      unitRef="U_shares">969275</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_b55ca18f-71fd-40e9-91aa-6ca09f99f3fd"
      decimals="INF"
      id="F_d33faf2e-a530-4859-a173-2eb6d65cbe47"
      unitRef="U_shares">1032404</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_ea61173b-bc9e-42d8-8fbb-5139f085543f"
      decimals="INF"
      id="F_6dbdc5e6-1d58-42e2-8a26-22b310ed53ad"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">10.84</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_ea61173b-bc9e-42d8-8fbb-5139f085543f"
      decimals="INF"
      id="F_1617107b-3cdb-499d-960f-e4052d399022"
      unitRef="U_shares">946666</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_df96dede-3972-4662-bb40-d24aff923983"
      decimals="INF"
      id="F_497a8ac4-1f6f-4831-90ba-e50c5cd20c52"
      unitRef="U_shares">1009795</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_b1d570cd-e3f2-4acc-ab96-99d8ef06cb44"
      decimals="INF"
      id="F_38363434-b5ed-4092-b7e5-4197ac5b2fd0"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">12.38</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_b1d570cd-e3f2-4acc-ab96-99d8ef06cb44"
      decimals="INF"
      id="F_70c4b5f7-73bc-4aff-b87d-25df3bebfdac"
      unitRef="U_shares">8083</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_8442a0e1-b203-45a1-bf13-205667c7fbae"
      decimals="INF"
      id="F_29ebff23-3411-4217-a3f1-c14cc1a4af70"
      unitRef="U_shares">8083</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_44f85d7b-18dc-4a86-bed7-b1560a6fe25f"
      decimals="INF"
      id="F_50bb9390-ec64-4c16-8bda-ec70fb674a9b"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">20.77</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_44f85d7b-18dc-4a86-bed7-b1560a6fe25f"
      decimals="INF"
      id="F_e409d6b3-e769-4b0d-bf33-78df114d697a"
      unitRef="U_shares">722223</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_6e3121ea-3b26-4fbf-a9e4-ba6bb516cb52"
      decimals="INF"
      id="F_3770fdf3-1182-4340-bf48-63088bb7e9cb"
      unitRef="U_shares">722223</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="INF"
      id="F_b47ebfc0-283d-4443-a232-ef83e61ca023"
      unitRef="U_shares">2646247</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="INF"
      id="F_e28254d5-788d-483a-9796-44bab940759f"
      unitRef="U_shares">2775978</us-gaap:ClassOfWarrantOrRightOutstanding>
    <sera:ClassOfWarrantOrRightExercised
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="INF"
      id="F_b58f192d-b792-4c2b-81ea-f6029550205f"
      unitRef="U_shares">126258</sera:ClassOfWarrantOrRightExercised>
    <sera:StockIssuedDuringPeriodSharesStockWarrantExercised
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="INF"
      id="F_e758925d-7373-40c4-be8f-c20cae6cbce4"
      unitRef="U_shares">7971</sera:StockIssuedDuringPeriodSharesStockWarrantExercised>
    <sera:StockIssuedDuringPeriodSharesStockWarrantExpired
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="INF"
      id="F_fe913a09-5e41-4aea-8341-4804ec9d3b5d"
      unitRef="U_shares">3473</sera:StockIssuedDuringPeriodSharesStockWarrantExpired>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_bf0e7080-1ea5-480a-a1cb-f02d8d208474">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;13&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. Commitments and Contingencies&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Leases&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company is the lessee in all of its lease arrangements. The Company did not enter into any leases with related parties during the presented periods. The Company makes assumptions and judgments when assessing contracts for lease components, determining lease classifications, and calculating right-of-use asset and lease liability values. These assumptions and judgments may include the useful lives and fair values of the leased assets, the implicit rate underlying the Company&#x2019;s leases, the Company&#x2019;s incremental borrowing rate or the Company&#x2019;s intent to exercise or not exercise options available in lease contracts.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table shows right-of-use assets and lease liabilities, and the associated financial statement line items as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:27.18%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.52%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:40.46%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.52%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.9%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.52%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.9%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Lease-Related Assets and Liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Financial Statement Line Items&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Right-of-use assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_0f18ae55-e115-46af-9133-2a37b7dbec78;"&gt;&lt;span style="-sec-ix-hidden:F_499cda77-bfd5-40a5-a5fa-38b8c2a78467;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;613&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,180&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Finance leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_b631bde4-1e5a-491c-8bd3-1cb6b5c51baa;"&gt;&lt;span style="-sec-ix-hidden:F_72a4c378-6838-4602-82e9-f25639674292;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Property and equipment, net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;699&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,008&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total right-of-use assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,312&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,188&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Lease liabilities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_556e664f-e809-4c83-9e64-ccae8a1500b7;"&gt;&lt;span style="-sec-ix-hidden:F_e1166b60-a008-49df-82fa-558051a272f2;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued and other current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;644&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;578&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating lease obligation, net of current portion&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;644&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Finance leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Finance lease obligation, current portion&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;194&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;440&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Finance lease obligation, net of current portion&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;196&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;840&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,858&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Lease costs and other information consisted of the following (in thousands, except terms and rates):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.882%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.882%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Lease cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Finance lease cost:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;314&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;312&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;26&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating lease cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;636&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;636&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total lease cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;976&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,003&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Other information&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Finance leases:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating cash outflows&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;26&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Financing cash outflows&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;440&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;466&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Right-of-use assets obtained in exchange for lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average remaining lease term (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.4&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.4&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating leases:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating cash outflows&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;646&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;628&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Right-of-use assets obtained in exchange for lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average remaining lease term (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.0&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.0&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Future minimum lease payments for the Company&#x2019;s leases as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 were as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:46.649%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.74%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:14.043000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.74%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:14.043000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.74%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:14.043000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Operating Leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Finance Leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;666&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;197&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;863&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2027 and thereafter&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total minimum lease payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;666&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;199&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;865&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less: imputed interest&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Present value of future lease payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;644&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;196&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;840&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less: current portion&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;644&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;194&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;838&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Long-term portion&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Operating Leases&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company leases a total of approximately &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,300&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; square feet of office and laboratory space under a single non-cancelable operating lease with a termination date of December 31, 2025 (as amended, the &#x201c;Office Lease&#x201d;). The Office Lease includes an early termination right which termination would occur under certain circumstances, as provided in the amended Office Lease, after July 1, 2024 if exercised. The Company is reasonably certain it will not exercise the termination right. The implicit rate provided in the Company&#x2019;s operating lease is not readily determinable. As such, the Company uses its incremental borrowing rate to calculate the present value of its operating lease liabilities.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Finance Leases&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company leases certain equipment related to its information technology infrastructure and laboratory operations. All of the Company&#x2019;s current finance leases include bargain purchase options that the Company is reasonably certain to exercise. The Company has elected not to separate lease and non-lease components for its equipment leases. The rates implicit in the Company&#x2019;s finance leases are determinable, and the Company uses those rates to calculate the present value of its finance lease liabilities.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;  &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Indemnification&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has agreed to indemnify its officers and directors for certain events or occurrences, while the officer or director is or was serving at the Company&#x2019;s request in such capacity. The maximum amount of potential future indemnification is unlimited; however, the Company purchases director and officer insurance coverage that provides for corporate reimbursements of covered obligations that limits the Company&#x2019;s exposure and enables it to recover a portion of potential future amounts paid. The Company is unable to reasonably estimate the maximum amount that could be payable under these arrangements since these obligations are not capped but are conditional to the unique facts and circumstances involved. Accordingly, the Company has &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; liabilities recorded for these agreements as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023. The Company has never incurred costs to defend lawsuits or settle claims related to these indemnification agreements.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Employee Agreements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has signed various employment agreements with key executives pursuant to which if their employment is terminated by the Company without cause or by the employees for good reason, or following a change of control of the Company, the employees are entitled to receive certain benefits, including severance payments, accelerated vesting of stock and stock options, and certain insurance benefits.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Legal Matters&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company is not currently a party to any material litigation or other material legal proceedings. The Company may, from time to time, be involved in various legal proceedings arising from the normal course of business activities, and an unfavorable resolution of any of these matters could materially affect the Company&#x2019;s future results of operations, cash flows, or financial position.&lt;/span&gt;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <sera:ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_375a6b36-43ad-4a50-a938-015031cdbf17">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table shows right-of-use assets and lease liabilities, and the associated financial statement line items as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:27.18%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.52%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:40.46%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.52%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.9%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.52%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.9%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Lease-Related Assets and Liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Financial Statement Line Items&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Right-of-use assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_0f18ae55-e115-46af-9133-2a37b7dbec78;"&gt;&lt;span style="-sec-ix-hidden:F_499cda77-bfd5-40a5-a5fa-38b8c2a78467;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;613&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,180&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Finance leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_b631bde4-1e5a-491c-8bd3-1cb6b5c51baa;"&gt;&lt;span style="-sec-ix-hidden:F_72a4c378-6838-4602-82e9-f25639674292;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Property and equipment, net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;699&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,008&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total right-of-use assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,312&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,188&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Lease liabilities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_556e664f-e809-4c83-9e64-ccae8a1500b7;"&gt;&lt;span style="-sec-ix-hidden:F_e1166b60-a008-49df-82fa-558051a272f2;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued and other current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;644&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;578&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating lease obligation, net of current portion&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;644&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Finance leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Finance lease obligation, current portion&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;194&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;440&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Finance lease obligation, net of current portion&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;196&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;840&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,858&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</sera:ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_3a79fc84-90fd-4b0a-b2a3-f7641c1b34a1"
      unitRef="U_USD">613000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_720239b0-7d1b-4ec6-be23-fb0dbd22d1f7"
      unitRef="U_USD">1180000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_9881803b-4543-4a56-a676-9711838f5c9a"
      unitRef="U_USD">699000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_411cad9e-3622-4af8-8a90-c05552c6602d"
      unitRef="U_USD">1008000</us-gaap:FinanceLeaseRightOfUseAsset>
    <sera:RightOfUseAssetTotal
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_d610d91d-ac51-424f-84aa-83ad258f60dc"
      unitRef="U_USD">1312000</sera:RightOfUseAssetTotal>
    <sera:RightOfUseAssetTotal
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_13174817-0ad4-42b0-a828-ea77218a2175"
      unitRef="U_USD">2188000</sera:RightOfUseAssetTotal>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_783943b5-5796-41f3-98a5-34dd08c8e84d"
      unitRef="U_USD">644000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_8f9f5bfb-fa71-4242-a6e3-c21f4a433a71"
      unitRef="U_USD">578000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_797eddb1-89f7-4e43-bedd-5ade242bec84"
      unitRef="U_USD">0</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_5d04ca00-0a93-4100-9d78-7bba5be8366a"
      unitRef="U_USD">644000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_846f76c7-0cd3-4acd-a160-72bd8b529eea"
      unitRef="U_USD">194000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_81deb444-fb38-4e5c-b81f-91318cd60efa"
      unitRef="U_USD">440000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_fd1e7f75-9661-4325-8f96-dc76d2dc426f"
      unitRef="U_USD">2000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_4b333e9d-87c1-4f48-a9b8-173c2ca50262"
      unitRef="U_USD">196000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <sera:LeaseLiabilitiesTotal
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_2909f2f6-06ed-4904-b857-f1d3cad74c4e"
      unitRef="U_USD">840000</sera:LeaseLiabilitiesTotal>
    <sera:LeaseLiabilitiesTotal
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_6b50b7f5-8cb4-4fae-b6a5-9fb140b64870"
      unitRef="U_USD">1858000</sera:LeaseLiabilitiesTotal>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_2860dd50-a731-427c-b632-6e6c957fd5fb">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Lease costs and other information consisted of the following (in thousands, except terms and rates):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.882%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.882%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Lease cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Finance lease cost:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;314&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;312&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;26&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating lease cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;636&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;636&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total lease cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;976&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,003&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Other information&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Finance leases:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating cash outflows&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;26&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Financing cash outflows&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;440&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;466&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Right-of-use assets obtained in exchange for lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average remaining lease term (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.4&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.4&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating leases:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating cash outflows&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;646&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;628&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Right-of-use assets obtained in exchange for lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average remaining lease term (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.0&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.0&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_fe40b275-ab66-42b9-9161-75e848c95a54"
      unitRef="U_USD">314000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_3822d63f-d358-4c22-a434-0d9d17d3eb26"
      unitRef="U_USD">312000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_75897362-4265-46d7-8382-4842f286e453"
      unitRef="U_USD">26000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_2e87a8c8-b890-4c38-8f01-72bb53cb3818"
      unitRef="U_USD">55000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:OperatingLeaseCost
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_1d2f5696-57a9-4b22-9cea-b213258e0944"
      unitRef="U_USD">636000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_e93d6403-e24d-468b-981a-9a1070f9e3b5"
      unitRef="U_USD">636000</us-gaap:OperatingLeaseCost>
    <us-gaap:LeaseCost
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_c6b81855-6fe0-412e-88e6-780782c22e1a"
      unitRef="U_USD">976000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_1a1dc5fc-f108-4a42-a149-88a6b2213f70"
      unitRef="U_USD">1003000</us-gaap:LeaseCost>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_4ff3546f-9a37-40df-ae4c-1969cf7ffa5b"
      unitRef="U_USD">26000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_14fe2600-7de4-4db7-9b06-3f5b33074ad4"
      unitRef="U_USD">55000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_81220d79-68d9-46f5-b9f0-23adc10d16b0"
      unitRef="U_USD">440000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_da9a69ec-e2f1-4968-a679-308ca25a3171"
      unitRef="U_USD">466000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_39e91f4a-7e5e-4769-bfc3-ada2ab5c7db0"
      unitRef="U_USD">0</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_894033ba-b59b-4bf2-b9d3-12b9b4b9d01f"
      unitRef="U_USD">18000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      id="F_0ef53702-ab2b-4976-b260-4865cf8aafba">P0Y4M24D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      id="F_6059f189-bc64-43ec-9237-8074313e42d0">P1Y4M24D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="3"
      id="F_8544f795-4edf-43a4-a27f-f611f59f9504"
      unitRef="U_pure">0.067</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="3"
      id="F_6e4b374c-1c57-4a82-8599-bd7fecf470c1"
      unitRef="U_pure">0.065</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeasePayments
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_bd41cc94-813e-42ef-ba86-9605921b7b00"
      unitRef="U_USD">646000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_265b0944-be9b-4ae4-8c7f-84dec7811614"
      unitRef="U_USD">628000</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_3c756995-5029-422c-89ec-937a4e065dd3"
      unitRef="U_USD">0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_0163fc01-045d-462b-a7ed-7a35a67271e0"
      unitRef="U_USD">0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      id="F_4ea3ecd3-9160-4cc5-95ca-4084230629b6">P1Y</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      id="F_472980ff-2c67-4d0a-b292-699121efb22e">P2Y</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="3"
      id="F_de714f13-4a2b-48bd-9d9f-1b6fade25753"
      unitRef="U_pure">0.075</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="3"
      id="F_e33ddfb9-1e3e-4f21-a3f9-9fcf7a28253b"
      unitRef="U_pure">0.075</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_66d46088-206e-4424-9411-3a81e2359d1d">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Future minimum lease payments for the Company&#x2019;s leases as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 were as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:46.649%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.74%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:14.043000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.74%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:14.043000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.74%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:14.043000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Operating Leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Finance Leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;666&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;197&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;863&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2027 and thereafter&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total minimum lease payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;666&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;199&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;865&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="border-top:0.5pt solid #000000;padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less: imputed interest&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Present value of future lease payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;644&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;196&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;840&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less: current portion&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;644&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;194&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;838&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Long-term portion&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_ad6a893e-2eb3-4847-8372-2a9e1ebee815"
      unitRef="U_USD">666000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_7e5ac8e0-58cc-45a8-ae65-d1cc483b73c2"
      unitRef="U_USD">197000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <sera:LeaseLiabilityToBePaidYearOne
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_7dc48371-0023-4574-aab5-90cde76bfb43"
      unitRef="U_USD">863000</sera:LeaseLiabilityToBePaidYearOne>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_b6dc8ab6-8a89-436b-b354-6b62a62cfbe6"
      unitRef="U_USD">0</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_4e37c4e6-cc75-42fa-8708-32cbfd9c7879"
      unitRef="U_USD">2000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <sera:LeaseLiabilityToBePaidYearTwo
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_e50b4e53-28d7-48bf-969a-07b6386f756b"
      unitRef="U_USD">2000</sera:LeaseLiabilityToBePaidYearTwo>
    <sera:LesseeOperatingLeaseLiabilityToBePaidYearThreeAndThereafter
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_848f41e1-8d4f-42b5-8a7d-6682260555f9"
      unitRef="U_USD">0</sera:LesseeOperatingLeaseLiabilityToBePaidYearThreeAndThereafter>
    <sera:FinanceLeaseLiabilityToBePaidYearThreeAndThereafter
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_0a55a20c-a9e5-4504-8823-bffbc852a296"
      unitRef="U_USD">0</sera:FinanceLeaseLiabilityToBePaidYearThreeAndThereafter>
    <sera:LeaseLiabilityToBePaidYearThreeAndThereafter
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_d29ae8c5-79ff-4b63-b02d-b9cb140182a0"
      unitRef="U_USD">0</sera:LeaseLiabilityToBePaidYearThreeAndThereafter>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_e3dce93b-07f2-4248-9968-59d4fa8e5c7a"
      unitRef="U_USD">666000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_08f3c15c-795f-4b97-ba9c-8fcae7d9c22d"
      unitRef="U_USD">199000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <sera:LeaseLiabilityPaymentDue
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_9e429eb3-f817-41e3-9bf5-97986a37b64b"
      unitRef="U_USD">865000</sera:LeaseLiabilityPaymentDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_1fb37d29-557a-4f96-9f59-06e360d7abd0"
      unitRef="U_USD">22000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_a64848c2-28cd-4e7f-9d9b-ed36c2d9fea2"
      unitRef="U_USD">3000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <sera:LeaseLiabilityUndiscountedExcessAmount
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_9c715b37-2f09-4870-921f-fe2a3e2510e7"
      unitRef="U_USD">25000</sera:LeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_2e93db67-5d77-4358-9ec8-4c6a564bfdc3"
      unitRef="U_USD">644000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_de769ec4-47aa-4369-9247-f04a5a7dae2e"
      unitRef="U_USD">196000</us-gaap:FinanceLeaseLiability>
    <sera:LeaseLiabilitiesTotal
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_8f03ee5e-6dc9-4250-a3b8-7bf420fb3ae0"
      unitRef="U_USD">840000</sera:LeaseLiabilitiesTotal>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_f296cf1a-b628-40a0-9bf2-528cb8364f9f"
      unitRef="U_USD">644000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_ea6f54dd-9d4c-488a-8106-735eb7f5625f"
      unitRef="U_USD">194000</us-gaap:FinanceLeaseLiabilityCurrent>
    <sera:LeaseLiabilityCurrent
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_0dd5248d-c8a0-4829-a2f9-2daac121325f"
      unitRef="U_USD">838000</sera:LeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_0350fee2-c39e-469d-bc52-1cc127b57f67"
      unitRef="U_USD">0</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_b719851b-54db-490f-a4d3-8d3201a0120f"
      unitRef="U_USD">2000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <sera:LeaseLiabilityNoncurrent
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_29e31ddd-4d88-43db-930d-c6f444c42909"
      unitRef="U_USD">2000</sera:LeaseLiabilityNoncurrent>
    <sera:LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory
      contextRef="C_36d0dab8-25a4-4445-bd06-e502a277df24"
      decimals="0"
      id="F_ce77bf01-70a4-4923-a940-d1177275e833"
      unitRef="U_sqft">24300</sera:LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory>
    <sera:IndemnificationLiability
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="INF"
      id="F_7f5ea489-f5da-4712-860e-c74125a30455"
      unitRef="U_USD">0</sera:IndemnificationLiability>
    <sera:IndemnificationLiability
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="INF"
      id="F_110fa6fc-8bdb-49b8-81e3-ef85d8af0aa3"
      unitRef="U_USD">0</sera:IndemnificationLiability>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_f6a61e1d-5b3c-4e24-b739-f91f5c159573">&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;14&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. Income Taxes&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;t recorded any income tax expense for the years ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 due to its history of operating losses.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The provision for income taxes includes the following components for the years ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Current:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Federal&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;State&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total current benefit (provision)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Deferred:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Federal&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,981&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,178&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;State&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,198&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,198&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Change in valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,179&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,376&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total deferred benefit (provision)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total income tax benefit (provision)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The benefit (provision) for income taxes differs from the amount computed at federal statutory rates as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:50.36%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:8.940000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.66%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:8.940000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.66%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Computed Federal income tax benefit (expense) at the&lt;br/&gt;&#160;&#160;&#160;statutory rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,908&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21.00&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,602&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21.00&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;R&amp;amp;D credits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;837&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.54&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;698&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.93&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Equity-based expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,366&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.19&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;63&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.17&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;State income taxes, net of federal benefit&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,272&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.95&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,783&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.92&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;State net operating loss carryforward true up&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;154&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.42&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Change in statutory rates&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;813&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.47&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;163&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.45&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,017&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.09&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;39&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.11&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,179&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;40.06&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,376&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;28.66&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Income tax benefit (provision)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Significant components of the Company&#x2019;s net deferred income tax assets (liabilities) are as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Deferred tax assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;61,615&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53,072&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;R&amp;amp;D credits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,693&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,856&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;R&amp;amp;E expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,127&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,219&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accruals and reserves&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;409&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;278&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Equity-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,193&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,440&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Depreciation and amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Lease liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;184&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;317&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total deferred tax asset before allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;78,233&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;65,189&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less: valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;78,058&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;64,879&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total deferred tax asset&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;175&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;310&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Right-of-use asset&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;175&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;306&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Depreciation and amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Management assesses the available positive and negative evidence to estimate if sufficient future taxable income will be generated to use the existing deferred tax assets. A significant piece of objective negative evidence evaluated is the cumulative loss incurred since inception. Such objective evidence limits the ability to consider other subjective evidence such as the Company&#x2019;s projections for future growth.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On the basis of this evaluation, a full valuation allowance of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;78.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;64.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million has been recorded as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively, as it is more likely than not that the deferred tax assets will not be realized. The valuation allowance increased by $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million for the years ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023, respectively, and there is no tax benefit presented in the accompanying financial statements.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company is subject to minimum taxes in several of the state jurisdictions where it files income tax returns. The amounts paid are immaterial and not presented above as a component of the current state tax provision.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company had U.S. federal and state net operating loss carryforwards of approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;239.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;182.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, respectively. Of the federal amount, $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;169.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million can be carried forward indefinitely, while the remainder begins to expire after 2028, if not utilized. The state amounts begin to expire at various dates after 2030.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Because of the change of ownership provisions of the Tax Reform Act of 1986, use of a portion of the Company&#x2019;s NOL and tax credit carryforwards may be limited in future periods. Further, a portion of the carryforwards may expire before being applied to reduce future income tax liabilities. There are currently no federal or state tax audits in progress. All prior tax years remain subject to examination by Federal and State of Utah authorities due to the existence of net operating loss carryforwards.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company recognizes the tax benefit of an uncertain tax position only if it is more likely than not that a tax position will be sustained upon examination by the appropriate taxing authorities, based on technical merits. The reversal of the uncertain tax positions would not affect the Company&#x2019;s effective tax rate to the extent that it continues to maintain a full valuation allowance against its deferred tax assets. As of December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company did not record any material interest expense or penalties related to uncertain tax positions or the settlement of audits for prior periods. The Company does not expect a significant increase or decrease in its uncertain tax positions within the next 12 months. &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;A reconciliation of the beginning and ending amount of uncertain tax positions (in thousands):&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance at the beginning of the year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,570&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Gross increases&#x2014;prior period&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;80&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Gross increases&#x2014;current period&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;559&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;465&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance at the end of the year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,129&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,570&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="INF"
      id="F_2571faa0-87de-40db-b227-6ee390d7fa4a"
      unitRef="U_USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="INF"
      id="F_df40cfd0-e9b0-48fa-b0e6-41574e1e54e6"
      unitRef="U_USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_47ae5b6f-31f1-42bf-9856-925d74d09afe">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The provision for income taxes includes the following components for the years ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Current:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Federal&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;State&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total current benefit (provision)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Deferred:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Federal&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,981&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,178&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;State&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,198&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,198&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Change in valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,179&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,376&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total deferred benefit (provision)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total income tax benefit (provision)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_a428abda-8063-47e6-b696-c144099be8d6"
      unitRef="U_USD">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_a2e225d0-df61-4cb3-a692-b46e3069bf5c"
      unitRef="U_USD">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_babe92b8-a1d3-469d-8454-9a0003b572a8"
      unitRef="U_USD">0</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_547155eb-0dbb-4e03-8307-c09cab2e9187"
      unitRef="U_USD">0</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_037e646b-16dc-48ba-8cbe-d6d6cabda947"
      unitRef="U_USD">0</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_e1e91f75-904a-4560-9df4-844e790ded2e"
      unitRef="U_USD">0</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_ce050f94-16a2-447d-ab75-78cbd4a9c618"
      unitRef="U_USD">8981000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_ed160817-fc88-438a-b3ac-56a87a9d9ef9"
      unitRef="U_USD">8178000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_e626b711-ee82-4c2f-8d23-c46a9bc4c231"
      unitRef="U_USD">4198000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_f2a1a4c2-1712-4eac-915d-db99c7e3e4cd"
      unitRef="U_USD">2198000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_b3c24c6e-aec2-4154-8900-ccc2db73f7d2"
      unitRef="U_USD">13179000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_2b496e9a-dc0d-4fb9-91dd-fa27eb2d1159"
      unitRef="U_USD">10376000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_f1bd2165-d3b5-4ee0-82a9-72152a429609"
      unitRef="U_USD">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_b3d6fdda-1162-498c-bb6f-b997f2fa948d"
      unitRef="U_USD">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="INF"
      id="F_8d87d28f-66a2-455c-a478-5083738d3be3"
      unitRef="U_USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="INF"
      id="F_0ac98ce0-dd29-4a90-970a-635e72d146fe"
      unitRef="U_USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_623cc598-b197-48c1-9a5b-2530d3ab6d74">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The benefit (provision) for income taxes differs from the amount computed at federal statutory rates as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:50.36%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:8.940000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.66%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:8.940000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.66%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Computed Federal income tax benefit (expense) at the&lt;br/&gt;&#160;&#160;&#160;statutory rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,908&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21.00&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,602&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21.00&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;R&amp;amp;D credits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;837&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.54&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;698&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.93&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Equity-based expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,366&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.19&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;63&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.17&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;State income taxes, net of federal benefit&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,272&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.95&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,783&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.92&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;State net operating loss carryforward true up&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;154&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.42&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Change in statutory rates&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;813&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.47&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;163&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.45&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,017&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.09&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;39&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.11&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,179&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;40.06&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,376&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;28.66&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Income tax benefit (provision)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_3803a476-72c0-46ff-9fd7-0f62806d8bfa"
      unitRef="U_USD">6908000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="INF"
      id="F_c215f7a2-4192-4bf9-92f5-fbcb406de710"
      unitRef="U_pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_a03e685b-8901-4493-bc92-f49f6c96e9b2"
      unitRef="U_USD">7602000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="INF"
      id="F_93537ac5-2177-48e3-9891-bb9b83b6682e"
      unitRef="U_pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_77b7ecf5-e789-4fcc-9131-e735cc03b493"
      unitRef="U_USD">-837000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="4"
      id="F_0a760076-1faf-442f-9adb-6d2728ba6d00"
      unitRef="U_pure">-0.0254</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_59171449-5195-4a8c-9e05-08e019ca7a47"
      unitRef="U_USD">-698000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="4"
      id="F_c456652c-a4fa-4b14-8f3c-616673ae8f6c"
      unitRef="U_pure">-0.0193</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <sera:EffectiveIncomeTaxRateReconciliationEquityBasedExpensesAmount
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_8c6e29ba-ecb5-4179-88c1-4623785e988b"
      unitRef="U_USD">2366000</sera:EffectiveIncomeTaxRateReconciliationEquityBasedExpensesAmount>
    <sera:EffectiveIncomeTaxRateReconciliationEquityBasedExpensesPercent
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="4"
      id="F_132311c2-d238-476e-a05d-95c1b02140f9"
      unitRef="U_pure">0.0719</sera:EffectiveIncomeTaxRateReconciliationEquityBasedExpensesPercent>
    <sera:EffectiveIncomeTaxRateReconciliationEquityBasedExpensesAmount
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_3ba23ea5-3597-4d77-9305-0b13e8ed4286"
      unitRef="U_USD">-63000</sera:EffectiveIncomeTaxRateReconciliationEquityBasedExpensesAmount>
    <sera:EffectiveIncomeTaxRateReconciliationEquityBasedExpensesPercent
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="4"
      id="F_618bd9c4-9409-4d40-9cf2-50f560c142bd"
      unitRef="U_pure">-0.0017</sera:EffectiveIncomeTaxRateReconciliationEquityBasedExpensesPercent>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_4b22e65c-2ee9-4c18-9f0a-41b65d071f1c"
      unitRef="U_USD">3272000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="4"
      id="F_3cbf4a8e-cfda-441a-b1ab-846b79bcb580"
      unitRef="U_pure">0.0995</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_ed7fcd36-b776-4250-af22-91dbf31f3012"
      unitRef="U_USD">1783000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="4"
      id="F_c8ebb853-2c51-4be7-bd0d-a51e5a3b820d"
      unitRef="U_pure">0.0492</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <sera:EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpAmount
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_993e5cc5-9a34-4bb7-a2e8-a026f892c353"
      unitRef="U_USD">0</sera:EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpAmount>
    <sera:EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpPercent
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="2"
      id="F_472d6472-48d0-4e1f-b958-a4ee08552405"
      unitRef="U_pure">0</sera:EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpPercent>
    <sera:EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpAmount
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_4c622d30-de54-4e16-bca4-829032bc0ebe"
      unitRef="U_USD">154000</sera:EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpAmount>
    <sera:EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpPercent
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="4"
      id="F_92bf802c-1960-4580-9257-9a34e50a97d8"
      unitRef="U_pure">0.0042</sera:EffectiveIncomeTaxRateReconciliationStateNetOperatingLossCarryforwardTrueUpPercent>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_c77a235f-0b05-496c-bb28-fdbb372478e8"
      unitRef="U_USD">813000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="4"
      id="F_7a107438-017f-4ab2-97f2-44f786132752"
      unitRef="U_pure">0.0247</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_4c2d429e-0857-462a-b3ae-d585a90056f8"
      unitRef="U_USD">163000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="4"
      id="F_c0e10b14-df70-4bea-8636-57260fbecdf7"
      unitRef="U_pure">0.0045</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_d9379bfe-56ba-454a-8aa0-d22c440daba3"
      unitRef="U_USD">-1017000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="4"
      id="F_d2d1c7b3-1f9f-4128-8c47-9156abdd2208"
      unitRef="U_pure">-0.0309</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_70522c5f-d3c1-405c-a82d-68ae4f685692"
      unitRef="U_USD">39000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="4"
      id="F_ec5ffc8e-ef6a-4ca4-97a9-cdd3c3904bc9"
      unitRef="U_pure">0.0011</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_12b70770-2372-4eaf-9504-db9ad9d88097"
      unitRef="U_USD">-13179000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="4"
      id="F_28b64c20-6603-4bc3-945f-d15a5e614800"
      unitRef="U_pure">-0.4006</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_fc5750b2-ec77-41ba-85e8-c20c7139c52c"
      unitRef="U_USD">-10376000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="4"
      id="F_5e8e4504-e43f-497e-880f-0ebc28b593e5"
      unitRef="U_pure">-0.2866</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_66c4a045-1866-4173-ac54-0d63f13e10ff"
      unitRef="U_USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="2"
      id="F_381ad98e-585a-4e1c-a7d1-6c40d63e8791"
      unitRef="U_pure">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_53be27ac-c932-482a-b52f-bc7c5bcd0f5d"
      unitRef="U_USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="2"
      id="F_7e401488-e7b1-43a4-a7c2-3a1aacd2e3af"
      unitRef="U_pure">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_25686407-724a-4f7c-a1b3-9116f118189d">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Significant components of the Company&#x2019;s net deferred income tax assets (liabilities) are as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Deferred tax assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;61,615&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53,072&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;R&amp;amp;D credits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,693&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,856&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;R&amp;amp;E expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,127&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,219&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accruals and reserves&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;409&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;278&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Equity-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,193&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,440&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Depreciation and amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Lease liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;184&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;317&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total deferred tax asset before allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;78,233&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;65,189&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less: valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;78,058&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;64,879&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total deferred tax asset&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;175&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;310&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Right-of-use asset&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;175&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;306&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Depreciation and amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_8de97f4a-97d9-4b1c-a21a-5e73c755fb26"
      unitRef="U_USD">61615000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_1de62604-1639-4ddf-8a4e-41d666c99ad6"
      unitRef="U_USD">53072000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_472de35a-62f3-4971-8de2-bfb5295d7d09"
      unitRef="U_USD">4693000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_ba4e65ab-3ade-496f-88ed-343b9b0e32c3"
      unitRef="U_USD">3856000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_9b562895-7ed9-43b6-9985-7933be7c9046"
      unitRef="U_USD">8127000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_6878e48b-b6b9-4e95-a21e-988ccc1ef9d7"
      unitRef="U_USD">5219000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_86bf524e-aa49-4441-8170-5ffb39defa78"
      unitRef="U_USD">409000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_6f7db906-a148-4afb-8239-78d9c07bc949"
      unitRef="U_USD">278000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_39a50b7f-5687-43c5-90ee-19735607c84e"
      unitRef="U_USD">3193000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_9c58656d-4293-42a3-9e02-55127418278c"
      unitRef="U_USD">2440000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_037ebebe-ca9d-4ba8-baa7-855694ad74b6"
      unitRef="U_USD">5000</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_ba109a19-4d9c-4f9a-8186-be95f38eb663"
      unitRef="U_USD">0</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <sera:DeferredTaxAssetsLeaseLiabilities
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_012bab27-6b3d-482b-b248-557ad3ce8dc6"
      unitRef="U_USD">184000</sera:DeferredTaxAssetsLeaseLiabilities>
    <sera:DeferredTaxAssetsLeaseLiabilities
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_6bee4584-d20b-46f7-b434-5ad26d4a6ef4"
      unitRef="U_USD">317000</sera:DeferredTaxAssetsLeaseLiabilities>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_25315cf1-f948-4538-b70b-58226b813086"
      unitRef="U_USD">7000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_7e57a639-9ac4-4f74-9081-bc718101ac94"
      unitRef="U_USD">7000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_b65d2d88-9946-4e60-927d-ae20657a10e6"
      unitRef="U_USD">78233000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_59f69086-da82-4805-8dc9-f95f1e7cb2a2"
      unitRef="U_USD">65189000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_db13fc30-576f-400d-b050-4165de70968b"
      unitRef="U_USD">78058000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_06a042aa-4900-4d75-bdbf-4b57bc0b6ff6"
      unitRef="U_USD">64879000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_d9be1189-f6f7-4938-9705-103beeff118d"
      unitRef="U_USD">175000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_21be7105-dd1b-47e0-be5f-2bf3711e707b"
      unitRef="U_USD">310000</us-gaap:DeferredTaxAssetsNet>
    <sera:DeferredTaxLiabilitiesRightOfUseAssets
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_9953280e-b254-4be1-896e-9c20d23730ff"
      unitRef="U_USD">175000</sera:DeferredTaxLiabilitiesRightOfUseAssets>
    <sera:DeferredTaxLiabilitiesRightOfUseAssets
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_9bfddd28-84c0-4338-a75a-06dfb19fa9c4"
      unitRef="U_USD">306000</sera:DeferredTaxLiabilitiesRightOfUseAssets>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_aee079ba-12a9-4c25-93f4-fef3ce12992b"
      unitRef="U_USD">4000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_8b909d95-7e62-40bf-8d4f-12a4b17f1e11"
      unitRef="U_USD">0</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_052fab6e-aebe-49ae-bca4-5bbf3259a584"
      unitRef="U_USD">0</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-5"
      id="F_ffeeafd2-aa9d-4e1f-befb-462a7d0bd65f"
      unitRef="U_USD">78100000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-5"
      id="F_97e2fcc9-0499-4d70-9175-f5edfe42981c"
      unitRef="U_USD">64900000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-5"
      id="F_2caffd96-91c5-4360-8c93-2a275deab40b"
      unitRef="U_USD">13200000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-5"
      id="F_20dd3c13-29e7-4f80-9c30-4d603e41115d"
      unitRef="U_USD">10400000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_43042710-b071-477a-ab25-8b8bacc949b5"
      decimals="-5"
      id="F_66039dc1-f865-468f-be0f-67def062d2c2"
      unitRef="U_USD">239600000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_ae2c36a5-c404-4f89-b850-51f7ae29526d"
      decimals="-5"
      id="F_3ceba08c-ae75-4392-9d05-b3c3e21cc46f"
      unitRef="U_USD">182600000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-5"
      id="F_f2fa59e3-f060-4171-8c72-bba1f05b1799"
      unitRef="U_USD">169300000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_479298b4-8749-4612-9090-609fa6e0f163">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;A reconciliation of the beginning and ending amount of uncertain tax positions (in thousands):&lt;/span&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance at the beginning of the year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,570&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Gross increases&#x2014;prior period&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;80&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Gross increases&#x2014;current period&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;559&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;465&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance at the end of the year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,129&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,570&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_e5690328-d722-4391-af93-e2d2f29f0035"
      unitRef="U_USD">2570000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_bbe124b6-5e26-4340-9b7f-2ec3e167c7a7"
      decimals="-3"
      id="F_2d714ef5-6d6f-4572-bce4-b31407346ed8"
      unitRef="U_USD">2025000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_a59837de-4d08-42e8-9a30-fd469359cb1a"
      unitRef="U_USD">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_88c0f062-63b9-42ea-8324-a0f53eee0b17"
      unitRef="U_USD">80000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_cfa4daee-9f6d-40ab-8fcc-82c89b0fcf27"
      unitRef="U_USD">559000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_40a9cfc6-b7eb-46f8-8542-da51d9a09471"
      unitRef="U_USD">465000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_f652abc9-1d38-472f-bc10-183e164a2e16"
      decimals="-3"
      id="F_9bcc5a56-587c-4abe-a371-0064044d8689"
      unitRef="U_USD">3129000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_b8f625aa-6c52-4a2e-99d7-4c691c838229"
      decimals="-3"
      id="F_92dbe89b-46ba-4a1b-83e3-f245aafead2c"
      unitRef="U_USD">2570000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_d3f05e52-ca59-42ee-8879-330e0cb13f5c">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. Net Loss Per Share&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company calculates net loss per share of Class A and Class B common stock using the two-class method. For periods in which the Company reports a net loss, all potentially dilutive shares are anti-dilutive and are therefore excluded from the calculation of diluted net loss per share. For the years ended December 31, 2024 and 2023, the Company reported net losses and as such, basic and diluted net loss per share are the same.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As the liquidation and dividend rights are identical for Class A and Class B common shares, the undistributed earnings are allocated on a proportionate basis and the resulting amount per share for Class A and Class B common stock was the same for the years ended December 31, 2024 and 2023.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company excluded the following potentially dilutive securities, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share for the periods indicated because their impact would have been anti-dilutive:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.967%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.357%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.357%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Warrants to purchase Class A common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,646,247&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,775,978&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Options to purchase Class A common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,113,155&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,251,663&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Restricted stock units outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,631,162&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,692,459&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,390,564&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,720,100&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_36e14c48-e350-44d2-bf9a-40a65ec62e8b">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company excluded the following potentially dilutive securities, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share for the periods indicated because their impact would have been anti-dilutive:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.967%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.357%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.357%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Warrants to purchase Class A common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,646,247&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,775,978&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Options to purchase Class A common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,113,155&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,251,663&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Restricted stock units outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,631,162&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,692,459&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;text-indent:5pt;white-space:pre-wrap;vertical-align:middle;padding-bottom:0in;"&gt;&lt;p style="margin-left:5pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,390,564&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,720,100&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_6df1f8d2-5436-460d-9378-2e480850c840"
      decimals="0"
      id="F_dc18f44b-5b08-409f-bdf7-aba78b6ebcdf"
      unitRef="U_shares">2646247</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_c6d246ba-4eb3-4ae3-9dc3-001abd64e5cc"
      decimals="0"
      id="F_22e8660d-cd31-4f93-8ca2-cc951c17d797"
      unitRef="U_shares">2775978</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_bc82f716-4cb8-4ed6-9807-7a362747d97c"
      decimals="0"
      id="F_9e744b8b-3fc6-4db1-8997-09a93a2b275a"
      unitRef="U_shares">6113155</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_8620e36e-b199-4b2d-8cc2-4ba15f93a3c0"
      decimals="0"
      id="F_b7376e45-3566-4435-9c7d-7e2416171652"
      unitRef="U_shares">7251663</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_7c6f287f-0cf6-4dfb-9a02-3a6ce54488cd"
      decimals="0"
      id="F_60c86d44-87b2-4775-915a-11ddb35f3d85"
      unitRef="U_shares">1631162</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_09f10352-d759-4530-8098-b6299171a509"
      decimals="0"
      id="F_b35e2415-cdda-4c90-b325-3727d69d644a"
      unitRef="U_shares">2692459</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="0"
      id="F_67b05d94-5d76-412c-8a15-d5218908b422"
      unitRef="U_shares">10390564</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="0"
      id="F_2fcdc85c-1842-40a5-a3d7-7acec601d348"
      unitRef="U_shares">12720100</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_451dab98-6c3c-49f0-90eb-63d20fd6f61d">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;16. Segment Information&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s revenue was generated in the U.S. for all periods presented and its assets are all located in the U.S.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table presents segment information for revenue, significant segment expenses, and segment loss expenses that are regularly provided to the CODM for the years ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 (in thousands):&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:68.094%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.123000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.66%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.123000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;77&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;306&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cost of revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;82&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;210&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Payroll related expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,269&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,878&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock-based compensation expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,013&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,273&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Consulting and professional fees&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,581&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,012&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Clinical studies and outside processing&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,383&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,728&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Equipment, lab supplies, and facility expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,635&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,037&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Depreciation and amortization&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;814&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;900&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other segment items&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;(2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,935&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,089&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Loss from operations&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;36,635&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;39,821&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Interest expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;28&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other income, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,765&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,634&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;32,898&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;36,242&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Certain amortization amounts are included within cost of revenue.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(2) &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Other segment items consist primarily of insurance costs, IT services, travel expenses, marketing expenses, taxes, and other miscellaneous expense.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_c56bcfce-6cde-4ed3-aff9-48cf2d4b142a">&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table presents segment information for revenue, significant segment expenses, and segment loss expenses that are regularly provided to the CODM for the years ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 (in thousands):&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:68.094%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.123000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.66%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.123000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;77&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;306&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cost of revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;82&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;210&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Payroll related expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,269&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,878&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock-based compensation expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,013&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,273&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Consulting and professional fees&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,581&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,012&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Clinical studies and outside processing&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,383&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,728&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Equipment, lab supplies, and facility expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,635&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,037&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Depreciation and amortization&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;814&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;900&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other segment items&lt;/span&gt;&lt;span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;(2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,935&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,089&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Loss from operations&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;36,635&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;39,821&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Interest expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;28&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other income, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,765&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,634&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;32,898&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;36,242&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Certain amortization amounts are included within cost of revenue.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(2) &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Other segment items consist primarily of insurance costs, IT services, travel expenses, marketing expenses, taxes, and other miscellaneous expense.&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Revenues
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_9c383f3c-adfb-42ee-a69c-38d74d298da2"
      unitRef="U_USD">77000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_93aa8d90-2705-4b46-af7f-5228f0c49546"
      unitRef="U_USD">306000</us-gaap:Revenues>
    <us-gaap:CostOfRevenue
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_9a91ca32-ccef-4453-a613-1868f1625ac8"
      unitRef="U_USD">82000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_1a7621b7-1c21-4a0f-b2fa-bbeef8ba473f"
      unitRef="U_USD">210000</us-gaap:CostOfRevenue>
    <us-gaap:OtherLaborRelatedExpenses
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_5ae1871b-ccfe-43cf-b590-278095485feb"
      unitRef="U_USD">13269000</us-gaap:OtherLaborRelatedExpenses>
    <us-gaap:OtherLaborRelatedExpenses
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_12c8872a-c056-4057-865c-4c7b05280290"
      unitRef="U_USD">17878000</us-gaap:OtherLaborRelatedExpenses>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_03b98036-7a96-4ff9-9fe6-b735a56d4599"
      unitRef="U_USD">7013000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_fbd35f3c-2185-487f-89db-e7fe310fd4a5"
      unitRef="U_USD">5273000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ProfessionalFees
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_bec39c92-cb88-44ce-8e6d-b11e3068d866"
      unitRef="U_USD">7581000</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_030b4a0e-888f-4898-86d3-10cc21fe1139"
      unitRef="U_USD">5012000</us-gaap:ProfessionalFees>
    <sera:ClinicalStudiesAndOutsideProcessing
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_cf56b1f4-370b-4015-8ae7-120aa65ebfa7"
      unitRef="U_USD">3383000</sera:ClinicalStudiesAndOutsideProcessing>
    <sera:ClinicalStudiesAndOutsideProcessing
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_d42107a0-9d3d-4133-8dc0-55d2eed357b1"
      unitRef="U_USD">4728000</sera:ClinicalStudiesAndOutsideProcessing>
    <sera:EquipmentLabSuppliesAndFacilityExpenses
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_7507b8da-73a6-4c89-aeed-0eefaaf3071a"
      unitRef="U_USD">1635000</sera:EquipmentLabSuppliesAndFacilityExpenses>
    <sera:EquipmentLabSuppliesAndFacilityExpenses
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_47a1f0d7-6762-4c23-a45d-d466ec6b35c0"
      unitRef="U_USD">2037000</sera:EquipmentLabSuppliesAndFacilityExpenses>
    <us-gaap:DepreciationAndAmortization
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_caaf99d2-d8a8-431a-b018-f19a87936092"
      unitRef="U_USD">814000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_f9c4a6fc-3bec-484b-b399-d505aff6f469"
      unitRef="U_USD">900000</us-gaap:DepreciationAndAmortization>
    <us-gaap:SegmentReportingOtherItemAmount
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_5ac347dd-685a-4ec6-af84-254528d32312"
      unitRef="U_USD">2935000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:SegmentReportingOtherItemAmount
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_9dfc5991-3acf-4daa-9315-2bf66f7f4e40"
      unitRef="U_USD">4089000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_8e56f7b6-2f77-496c-9866-c2d59143ed97"
      unitRef="U_USD">-36635000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_1bfc62a5-f82b-4603-bc95-8d3d5936c072"
      unitRef="U_USD">-39821000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_1a5d7ae0-ffe5-49c0-b3f9-fbf2515513f5"
      unitRef="U_USD">28000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_756c83ef-b7a5-47d0-b6b0-437b4df8cb9f"
      unitRef="U_USD">55000</us-gaap:InterestExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_5da40c2b-8231-4748-b5e4-ad285bff41d2"
      unitRef="U_USD">3765000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_55debb58-92b3-4a32-98d7-b1bdae851549"
      unitRef="U_USD">3634000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      decimals="-3"
      id="F_759593d6-07e8-4a16-bec8-01ff5906d475"
      unitRef="U_USD">-32898000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_d26275c7-a6f1-42a8-ae17-2e0634f194a6"
      decimals="-3"
      id="F_327b4fb9-fb29-49a1-a5ef-3bf257ad4818"
      unitRef="U_USD">-36242000</us-gaap:NetIncomeLoss>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="C_1e202fd9-3575-429f-acb1-9d054feb99d5"
      id="F_8a1c9c74-82a0-4f21-a259-e890779f9e5f">&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;17&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. Subsequent Events&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On February 12, 2025, the Company closed an underwritten public offering (the "February 2025 Offering") in which the Company issued and sold &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,250,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of the Company&#x2019;s Class A common stock at a price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.00&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share and pre-funded warrants (the &#x201c;Pre-Funded Warrants&#x201d;) to purchase up to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,250,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of the Company&#x2019;s Class A common stock (the &#x201c;Firm Shares&#x201d;) at an offering price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.9999&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per Pre-Funded Warrant, which represents the per share offering price for the Firm Shares less the $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per share exercise price for each Pre-Funded Warrant. These Pre-Funded Warrants were recorded as a component of shareholders&#x2019; equity within additional paid-in capital. The gross proceeds to the Company from the February 2025 Offering were $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million before deducting underwriting discounts and commissions and other offering expenses. The net proceeds to the Company from the February 2025 Offering were approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, after deducting underwriting commissions and offering expenses. The Pre-Funded Warrants are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the warrant if the holder, together with its affiliates, would beneficially own more than &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.99&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the number of shares of Class A common stock outstanding immediately after giving effect to such exercise. A holder of Pre-Funded Warrants may increase or decrease this percentage, but not in excess of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19.99&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%, by providing at least 61 days&#x2019; prior notice to the Company.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:3.333%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On February 13, 2025, the representatives of the underwriters in connection with the February 2025 Offering exercised their option in full to purchase an additional &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,875,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Class A common stock, which increased the aggregate number of shares of Class A common stock sold in the February 2025 Offering to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,125,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The Company&#x2019;s aggregate gross proceeds from the February 2025 Offering were $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;57.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, before deducting underwriting discounts and commissions and offering expenses; $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of which relates to the exercise of the underwriters&#x2019; option on February 13, 2025. The Company&#x2019;s aggregate net proceeds from the February 2025 Offering were $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, after deducting underwriting discounts and commissions and offering expenses; $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of which relates to the exercise of the underwriters&#x2019; option on February 13, 2025.&lt;/span&gt;&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:CommonUnitIssued
      contextRef="C_d64a0010-f1a5-45de-9e6c-65d4f9fdd0dd"
      decimals="INF"
      id="F_12883359-fea4-4a6e-9271-9bdd76c928c6"
      unitRef="U_shares">1250000</us-gaap:CommonUnitIssued>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_d64a0010-f1a5-45de-9e6c-65d4f9fdd0dd"
      decimals="INF"
      id="F_6fcc08f4-7936-42e5-b266-0325c6b76690"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">4</us-gaap:CommonStockParOrStatedValuePerShare>
    <sera:WarrantsIssued
      contextRef="C_49e34717-cb5a-4860-9e99-7bca256906a4"
      decimals="INF"
      id="F_d19d57c3-7880-481a-a098-0f6c466028a7"
      unitRef="U_shares">11250000</sera:WarrantsIssued>
    <sera:WarrantIssuedPricePerPre-FundedWarrantAndAccompanyingWarrant
      contextRef="C_49e34717-cb5a-4860-9e99-7bca256906a4"
      decimals="INF"
      id="F_bc4fc840-f0c2-4fb3-8ac7-0b6ebc09661a"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">3.9999</sera:WarrantIssuedPricePerPre-FundedWarrantAndAccompanyingWarrant>
    <sera:IssuePricePerShareAndWarrant
      contextRef="C_49e34717-cb5a-4860-9e99-7bca256906a4"
      decimals="INF"
      id="F_a1405f98-3511-456e-a505-b8baf0f35be6"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</sera:IssuePricePerShareAndWarrant>
    <sera:ProceedsFromIssuanceOfSharesAndPreFundedWarrants
      contextRef="C_a77c3867-9623-4313-a505-f21cd62befe2"
      decimals="-5"
      id="F_0a398f8e-25ee-4e92-b872-50dc8829a9a8"
      unitRef="U_USD">50000000</sera:ProceedsFromIssuanceOfSharesAndPreFundedWarrants>
    <sera:ProceedsFromIssuanceOfSharesAndPreFundedWarrantsNet
      contextRef="C_a77c3867-9623-4313-a505-f21cd62befe2"
      decimals="-5"
      id="F_7fbebdec-ad4a-4f2a-9813-143b6f942599"
      unitRef="U_USD">46600000</sera:ProceedsFromIssuanceOfSharesAndPreFundedWarrantsNet>
    <sera:PercentageOfMinimumOwnershipBeneficiallyOwnByHolderWithAffiliatesToWarrantExercise
      contextRef="C_49e34717-cb5a-4860-9e99-7bca256906a4"
      decimals="4"
      id="F_66486d99-f012-4de0-982c-b91d38d4d582"
      unitRef="U_pure">0.0499</sera:PercentageOfMinimumOwnershipBeneficiallyOwnByHolderWithAffiliatesToWarrantExercise>
    <sera:FairValueAdjustmentOfPreFundedWarrants
      contextRef="C_f4fd4321-eb36-4c63-ab4e-5f27e634d46d"
      decimals="4"
      id="F_68efdfd7-dbd3-43aa-b720-987cde38f2e9"
      unitRef="U_pure">0.1999</sera:FairValueAdjustmentOfPreFundedWarrants>
    <sera:CommonStockAdditionalShares
      contextRef="C_82cc2c89-a0ca-4534-9da0-23ce655262eb"
      decimals="INF"
      id="F_977ac64b-73d8-4bd7-b827-7e87ef56210d"
      unitRef="U_shares">1875000</sera:CommonStockAdditionalShares>
    <us-gaap:CommonUnitIssued
      contextRef="C_82cc2c89-a0ca-4534-9da0-23ce655262eb"
      decimals="INF"
      id="F_26a605cc-1f55-49e2-a94a-cf65509e6f1c"
      unitRef="U_shares">3125000</us-gaap:CommonUnitIssued>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="C_a77c3867-9623-4313-a505-f21cd62befe2"
      decimals="-5"
      id="F_59f1e0c5-4595-419d-9a03-71c603e2c50c"
      unitRef="U_USD">57500000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <sera:OfferingExpenses
      contextRef="C_b56db086-392f-4885-98c2-c27491c047ea"
      decimals="-5"
      id="F_72c040b1-8c08-476d-8c3e-9ef2f0513fb4"
      unitRef="U_USD">7500000</sera:OfferingExpenses>
    <sera:ProceedsFromIssuanceInitialPublicOfferingNet
      contextRef="C_a77c3867-9623-4313-a505-f21cd62befe2"
      decimals="-5"
      id="F_144c557c-3166-4185-a272-dc6b54105818"
      unitRef="U_USD">53600000</sera:ProceedsFromIssuanceInitialPublicOfferingNet>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_a4a98f25-89ec-4c7d-be42-82aacc24e38e"
      decimals="-5"
      id="F_e8c5f925-c747-4bd4-bbdc-5856ed52f7fd"
      unitRef="U_USD">7000000</us-gaap:ProceedsFromStockOptionsExercised>
    <ecd:Rule10b51ArrAdoptedFlag
      contextRef="C_208b76c5-59c1-4209-a49b-266bd3873544"
      id="F_0149da50-ea7e-4309-bea0-499cbfb32218">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrAdoptedFlag
      contextRef="C_208b76c5-59c1-4209-a49b-266bd3873544"
      id="F_4e817ffd-2b11-4c41-ac44-b0007145f6a6">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag
      contextRef="C_208b76c5-59c1-4209-a49b-266bd3873544"
      id="F_0512cf42-08c6-42c8-8ce9-931905fbc93b">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrTrmntdFlag
      contextRef="C_208b76c5-59c1-4209-a49b-266bd3873544"
      id="F_4475edec-bb1b-4253-882f-e983aa3847a8">false</ecd:NonRule10b51ArrTrmntdFlag>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#F_f9c4a6fc-3bec-484b-b399-d505aff6f469"
          xlink:label="F_f9c4a6fc-3bec-484b-b399-d505aff6f469"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_caaf99d2-d8a8-431a-b018-f19a87936092"
          xlink:label="F_caaf99d2-d8a8-431a-b018-f19a87936092"
          xlink:type="locator"/>
        <link:footnote id="FNT_2dcb3b77-9a24-48d2-af9f-a1d39507d595" xlink:label="FNT_2dcb3b77-9a24-48d2-af9f-a1d39507d595" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain amortization amounts are included within cost of revenue.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_f9c4a6fc-3bec-484b-b399-d505aff6f469"
          xlink:to="FNT_2dcb3b77-9a24-48d2-af9f-a1d39507d595"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_caaf99d2-d8a8-431a-b018-f19a87936092"
          xlink:to="FNT_2dcb3b77-9a24-48d2-af9f-a1d39507d595"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#F_5ac347dd-685a-4ec6-af84-254528d32312"
          xlink:label="F_5ac347dd-685a-4ec6-af84-254528d32312"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_9dfc5991-3acf-4daa-9315-2bf66f7f4e40"
          xlink:label="F_9dfc5991-3acf-4daa-9315-2bf66f7f4e40"
          xlink:type="locator"/>
        <link:footnote id="FNT_a7b0fa6b-e70a-4d12-b747-675c650fdd97" xlink:label="FNT_a7b0fa6b-e70a-4d12-b747-675c650fdd97" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other segment items consist primarily of insurance costs, IT services, travel expenses, marketing expenses, taxes, and other miscellaneous expense.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_5ac347dd-685a-4ec6-af84-254528d32312"
          xlink:to="FNT_a7b0fa6b-e70a-4d12-b747-675c650fdd97"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_9dfc5991-3acf-4daa-9315-2bf66f7f4e40"
          xlink:to="FNT_a7b0fa6b-e70a-4d12-b747-675c650fdd97"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
